PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Miller, AG; Aldrich, RW				Miller, AG; Aldrich, RW			Conversion of a delayed rectifier K+ channel to a voltage-gated inward rectifier K+ channel by three amino acid substitutions	NEURON			English	Article							SHAKER POTASSIUM CHANNEL; TEA BLOCKADE; INACTIVATION; MUTATIONS; REGION; EXPRESSION; CELLS; S4-SEQUENCE	Single, double, and triple mutations progressively shift Shaker activation to more hyperpolarized potentials, resulting in an increase in the fraction of inactivated channels at negative resting voltages. The most negatively shifted mutation, the triple mutant, behaves like an inward rectifier. What is usually considered activation for an inward rectifier is, for the triple mutant, recovery from inactivation, and what is usually considered deactivation is inactivation. This conversion from outward rectifier to inward rectifier does not rely on a difference in sign or direction of charge movement of the voltage sensor, since activation of the Shaker outward rectifier is due to a different gate than activation of the triple mutant inward rectifier. Other voltage-dependent inward rectifiers in the Shaker family may work by a similar mechanism.	STANFORD UNIV,HOWARD HUGHES MED INST,STANFORD,CA 94305	Howard Hughes Medical Institute; Stanford University	Miller, AG (corresponding author), STANFORD UNIV,DEPT MOLEC & CELL PHYSIOL,STANFORD,CA 94305, USA.							ARMSTRONG CM, 1965, J GEN PHYSIOL, V48, P859, DOI 10.1085/jgp.48.5.859; BEZANILLA F, 1994, BIOPHYS J, V66, P1011, DOI 10.1016/S0006-3495(94)80882-3; Chandy K. G., 1995, LIGAND VOLTAGE GATED; DEMO SD, 1991, NEURON, V7, P743, DOI 10.1016/0896-6273(91)90277-7; FICKER E, 1994, SCIENCE, V266, P1068, DOI 10.1126/science.7973666; GOMEZLAGUNAS F, 1994, BIOPHYS J, V67, P1806, DOI 10.1016/S0006-3495(94)80662-9; HARTMANN HA, 1991, SCIENCE, V251, P942, DOI 10.1126/science.2000495; Hille B., 1992, IONIC CHANNELS EXCIT; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1995, J GEN PHYSIOL, V105, P309, DOI 10.1085/jgp.105.3.309; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; KOREN G, 1990, NEURON, V4, P39, DOI 10.1016/0896-6273(90)90442-I; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; LIMAN ER, 1991, NATURE, V353, P752, DOI 10.1038/353752a0; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; LOPEZ GA, 1991, NEURON, V7, P327, DOI 10.1016/0896-6273(91)90271-Z; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MULLERROBER B, 1995, EMBO J, V14, P2409, DOI 10.1002/j.1460-2075.1995.tb07238.x; NICHOLS CG, 1994, J PHYSIOL-LONDON, V476, P399, DOI 10.1113/jphysiol.1994.sp020141; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; RUPPERSBERG JP, 1991, NATURE, V353, P657, DOI 10.1038/353657a0; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; SCHACHTMAN DP, 1992, SCIENCE, V258, P1654, DOI 10.1126/science.8966547; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; SHIBASAKI T, 1987, J PHYSIOL-LONDON, V387, P227, DOI 10.1113/jphysiol.1987.sp016571; SILVER MR, 1990, J GEN PHYSIOL, V96, P109, DOI 10.1085/jgp.96.1.109; Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0; SUCHYNA TM, 1993, NATURE, V365, P847, DOI 10.1038/365847a0; TAGLIALATELA M, 1994, SCIENCE, V264, P844, DOI 10.1126/science.8171340; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; TYTGAT J, 1992, NATURE, V359, P420, DOI 10.1038/359420a0; VERSELIS VK, 1994, NATURE, V368, P348, DOI 10.1038/368348a0; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; YOOL AJ, 1991, NATURE, V349, P700, DOI 10.1038/349700a0; ZAGOTTA WN, 1990, J GEN PHYSIOL, V95, P29, DOI 10.1085/jgp.95.1.29; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P279, DOI 10.1085/jgp.103.2.279	40	54	55	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1996	16	4					853	858		10.1016/S0896-6273(00)80105-1	http://dx.doi.org/10.1016/S0896-6273(00)80105-1			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UG611	8608003	Bronze			2022-12-24	WOS:A1996UG61100018
J	Shi, GY; Nakahira, K; Hammond, S; Rhodes, KJ; Schechter, LE; Trimmer, JS				Shi, GY; Nakahira, K; Hammond, S; Rhodes, KJ; Schechter, LE; Trimmer, JS			beta Subunits promote K+ channel surface expression through effects early in biosynthesis	NEURON			English	Article							BRAIN POTASSIUM-CHANNEL; RAT-BRAIN; ENDOPLASMIC-RETICULUM; XENOPUS OOCYTES; BOVINE BRAIN; CLONING; PROTEIN; IDENTIFICATION; DIVERSITY; NEURONS	Voltage-gated K+ channels are protein complexes composed of ion-conducting integral membrane alpha subunits and cytoplasmic beta subunits. Here, we show that, in transfected mammalian cells, the predominant beta subunit isoform in brain, Kv beta 2, associates with the Kv1.2 alpha subunit early in channel biosynthesis and that KvPP exerts multiple chaperone-like effects on associated Kv1.2 including promotion of cotranslational N-linked glycosylation of the nascent Kv1.2 polypeptide, increased stability of Kv beta 2/Kv1.2 complexes, and increased efficiency of cell surface expression of Kv1.2. Taken together, these results indicate that while some cytoplasmic K+ channel beta subunits affect the inactivation kinetics of alpha subunits, a more general, and perhaps more fundamental, role is to mediate the biosynthetic maturation and surface expression of voltage-gated K+ channel complexes. These findings provide a molecular basis for recent genetic studies indicating that beta subunits are key determinants of neuronal excitability.	SUNY STONY BROOK,DEPT BIOCHEM & CELL BIOL,STONY BROOK,NY 11794; WYETH AYERST RES,CNS DISORDERS,PRINCETON,NJ 08543	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Pfizer					NINDS NIH HHS [NS34383] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034383, R37NS034383] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABEIJON C, 1992, TRENDS BIOCHEM SCI, V17, P32, DOI 10.1016/0968-0004(92)90424-8; BERGERON JJM, 1994, TRENDS BIOCHEM SCI, V19, P124, DOI 10.1016/0968-0004(94)90205-4; CHANDY KG, 1995, LIGAND VOLTAGE GATED, P1; CHOUINARD SW, 1995, P NATL ACAD SCI USA, V92, P6763, DOI 10.1073/pnas.92.15.6763; CHRISTIE MJ, 1989, SCIENCE, V244, P221, DOI 10.1126/science.2539643; CHRISTIE MJ, 1990, NEURON, V4, P405, DOI 10.1016/0896-6273(90)90052-H; DEAL KK, 1994, J NEUROSCI, V14, P1666, DOI 10.1523/JNEUROSCI.14-03-01666.1994; ENGLAND SK, 1995, J BIOL CHEM, V270, P28531, DOI 10.1074/jbc.270.48.28531; ENGLAND SK, 1995, P NATL ACAD SCI USA, V92, P6309, DOI 10.1073/pnas.92.14.6309; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; GREEN WN, 1995, TRENDS NEUROSCI, V18, P280, DOI 10.1016/0166-2236(95)93915-K; HARTL FU, 1994, TRENDS BIOCHEM SCI, V19, P20, DOI 10.1016/0968-0004(94)90169-4; Heinemann SH, 1995, FEBS LETT, V377, P383, DOI 10.1016/0014-5793(95)01377-6; Hille B., 1992, IONIC CHANNELS EXCIT; HUBBARD SC, 1981, ANNU REV BIOCHEM, V50, P555, DOI 10.1146/annurev.bi.50.070181.003011; HURST RS, 1991, MOL PHARMACOL, V40, P572; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; ISOM LL, 1994, NEURON, V12, P1183, DOI 10.1016/0896-6273(94)90436-7; JAN LY, 1990, TRENDS NEUROSCI, V13, P415, DOI 10.1016/0166-2236(90)90123-R; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; MAJUMDER K, 1995, FEBS LETT, V361, P13, DOI 10.1016/0014-5793(95)00120-X; MCCORMACK K, 1995, FEBS LETT, V370, P32, DOI 10.1016/0014-5793(95)00785-8; MCKINNON D, 1989, J BIOL CHEM, V264, P8230; MORALES MJ, 1995, J BIOL CHEM, V270, P6272, DOI 10.1074/jbc.270.11.6272; PARCEJ DN, 1992, BIOCHEMISTRY-US, V31, P11084, DOI 10.1021/bi00160a018; PAULMICHL M, 1991, P NATL ACAD SCI USA, V88, P7892, DOI 10.1073/pnas.88.17.7892; PELHAM HRB, 1989, ANNU REV CELL BIOL, V5, P1, DOI 10.1146/annurev.cb.05.110189.000245; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; RHODES KJ, 1995, J NEUROSCI, V15, P5360; RUPPERSBERG JP, 1990, NATURE, V345, P535, DOI 10.1038/345535a0; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SCHMIDT JW, 1986, CELL, V46, P437, DOI 10.1016/0092-8674(86)90664-1; SCOTT VES, 1990, J BIOL CHEM, V265, P20094; SCOTT VES, 1994, P NATL ACAD SCI USA, V91, P1637, DOI 10.1073/pnas.91.5.1637; SCOTT VES, 1994, BIOCHEMISTRY-US, V33, P1617, DOI 10.1021/bi00173a001; SHEN NV, 1993, NEURON, V11, P67; SHENG M, 1993, NATURE, V365, P72, DOI 10.1038/365072a0; SHI GY, 1994, J BIOL CHEM, V269, P23204; STERN M, 1989, J NEUROGENET, V5, P215, DOI 10.3109/01677068909066209; STUART RA, 1994, TRENDS BIOCHEM SCI, V19, P87, DOI 10.1016/0968-0004(94)90041-8; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; SWANSON R, 1990, NEURON, V4, P929, DOI 10.1016/0896-6273(90)90146-7; TRIMMER JS, 1985, CELL, V40, P697, DOI 10.1016/0092-8674(85)90218-1; TRIMMER JS, 1991, P NATL ACAD SCI USA, V88, P10764, DOI 10.1073/pnas.88.23.10764; WANG H, 1993, NATURE, V365, P75, DOI 10.1038/365075a0; XU J, 1995, J BIOL CHEM, V270, P24761, DOI 10.1074/jbc.270.42.24761; Yu WF, 1996, NEURON, V16, P441, DOI 10.1016/S0896-6273(00)80062-8	47	322	328	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1996	16	4					843	852		10.1016/S0896-6273(00)80104-X	http://dx.doi.org/10.1016/S0896-6273(00)80104-X			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UG611	8608002	Bronze			2022-12-24	WOS:A1996UG61100017
J	Oliet, SHR; Bourque, CW				Oliet, SHR; Bourque, CW			Gadolinium uncouples mechanical detection and osmoreceptor potential in supraoptic neurons	NEURON			English	Article							ACTIVATED ION CHANNELS; CULTURED CHICK HEART; MECHANOSENSITIVE CURRENTS; SINGLE-CHANNEL; MDX-MYOTUBES; ADULT-RAT; STRETCH; BLOCK; ELECTROPHYSIOLOGY; OSMOSENSITIVITY	Stretch-sensitive ion channels are ubiquitous, yet evidence of their role in mechanotransduction remains scarce. The presence of stretch-inactivated cation channels in supraoptic neurons is consistent with the osmoreceptor potentials regulating vasopressin release. However, whether osmosensitivity depends on mechanical gating and ion flux through stretch-inactivated channels is unknown. Here we report that changes in channel open probability associated either with modification of pipette pressure or with external osmolality selectively result from variations in closed time. While channel mechanosensitivity and osmotically evoked changes in cell volume are not affected by gadolinium, similar concentrations of the lanthanide inhibit cation permeation through the single channels and macroscopic osmoreceptor potentials. Mechanotransduction through stretch-inactivated channels is therefore necessary for osmoreception in supraoptic neurons.	MCGILL UNIV,MONTREAL GEN HOSP,CTR RES NEUROSCI,MONTREAL,PQ H3G 1A4,CANADA	McGill University				Bourque, Charles/0000-0002-1594-742X; Oliet, Stephane/0000-0003-0595-9029				ABE H, 1982, J PHYSIOL-LONDON, V327, P157, DOI 10.1113/jphysiol.1982.sp014225; [Anonymous], [No title captured]; BERRIER C, 1992, EUR J BIOCHEM, V206, P559, DOI 10.1111/j.1432-1033.1992.tb16960.x; BOURQUE CW, 1984, J PHYSIOL-LONDON, V349, P631, DOI 10.1113/jphysiol.1984.sp015178; BOURQUE CW, 1994, FRONT NEUROENDOCRIN, V15, P231, DOI 10.1006/frne.1994.1010; BOURQUE CW, 1990, FRONT NEUROENDOCRIN, V11, P183; BOURQUE CW, 1989, J PHYSIOL-LONDON, V417, P263, DOI 10.1113/jphysiol.1989.sp017800; Colquhoun D, 1983, SINGLE CHANNEL RECOR, P191; ELINDER F, 1994, BIOPHYS J, V67, P71, DOI 10.1016/S0006-3495(94)80456-4; FRANCO A, 1990, NATURE, V344, P670, DOI 10.1038/344670a0; FRANCO A, 1991, BIOPHYS J, V59, P1164, DOI 10.1016/S0006-3495(91)82332-3; FRENCH AS, 1992, ANNU REV PHYSIOL, V54, P135, DOI 10.1146/annurev.physiol.54.1.135; FRIEDMAN JE, 1993, J NEUROSCI, V13, P63; GUHARAY F, 1984, J PHYSIOL-LONDON, V352, P685, DOI 10.1113/jphysiol.1984.sp015317; GUSTIN MC, 1988, SCIENCE, V242, P762, DOI 10.1126/science.2460920; GUSTIN MC, 1991, SCIENCE, V253, P800, DOI 10.1126/science.253.5021.800; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; KULLBERG R, 1987, TRENDS NEUROSCI, V10, P387, DOI 10.1016/0166-2236(87)90001-4; MASON WT, 1980, NATURE, V287, P154, DOI 10.1038/287154a0; MORRIS CE, 1990, J MEMBRANE BIOL, V113, P93, DOI 10.1007/BF01872883; MORRIS CE, 1989, SCIENCE, V243, P807, DOI 10.1126/science.2536958; MORRIS CE, 1991, SCIENCE, V251, P1246, DOI 10.1126/science.1706535; MORRIS CE, 1992, EXPERIENTIA, V48, P852, DOI 10.1007/BF02118418; NEHER E, 1978, J PHYSIOL-LONDON, V277, P153, DOI 10.1113/jphysiol.1978.sp012267; OLIET SHR, 1993, AM J PHYSIOL, V265, pR1475, DOI 10.1152/ajpregu.1993.265.6.R1475; OLIET SHR, 1992, J PHYSIOL-LONDON, V455, P291, DOI 10.1113/jphysiol.1992.sp019302; OLIET SHR, 1993, NATURE, V364, P341, DOI 10.1038/364341a0; OLIET SHR, 1994, TRENDS NEUROSCI, V17, P340, DOI 10.1016/0166-2236(94)90177-5; POULAIN DA, 1982, NEUROSCIENCE, V7, P773, DOI 10.1016/0306-4522(82)90044-6; RICHARD D, 1992, NEUROENDOCRINOLOGY, V55, P609, DOI 10.1159/000126174; RUKNUDIN A, 1993, AM J PHYSIOL, V264, pH960, DOI 10.1152/ajpheart.1993.264.3.H960; SACHS F, 1992, SENSORY TRANSDUCTION, P242; SAKIN H, 1993, CELLULAR MOL PHYSL C, P215; SIGURDSON W, 1992, AM J PHYSIOL, V262, pH1110, DOI 10.1152/ajpheart.1992.262.4.H1110; SOKABE M, 1991, BIOPHYS J, V59, P722, DOI 10.1016/S0006-3495(91)82285-8; SOKABE M, 1992, ADV COMP ENV PHYSL, V10, P55; YANG XC, 1989, SCIENCE, V243, P1068, DOI 10.1126/science.2466333	37	63	64	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1996	16	1					175	181		10.1016/S0896-6273(00)80034-3	http://dx.doi.org/10.1016/S0896-6273(00)80034-3			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TT307	8562082	Bronze			2022-12-24	WOS:A1996TT30700020
J	HOPE, BT; NYE, HE; KELZ, MB; SELF, DW; IADAROLA, MJ; NAKABEPPU, Y; DUMAN, RS; NESTLER, EJ				HOPE, BT; NYE, HE; KELZ, MB; SELF, DW; IADAROLA, MJ; NAKABEPPU, Y; DUMAN, RS; NESTLER, EJ			INDUCTION OF A LONG-LASTING AP-1 COMPLEX COMPOSED OF ALTERED FOS-LIKE PROTEINS IN BRAIN BY CHRONIC COCAINE AND OTHER CHRONIC TREATMENTS	NEURON			English	Article							IMMEDIATE-EARLY GENE; TRANSCRIPTION; SYSTEM; PHOSPHORYLATION; ACTIVATOR; MORPHINE; ANTIGEN; FORM; JUN	Following chronic cocaine treatment, we have found a long lasting increase in AP-1 binding in the rat nucleus accumbens and striatum, two important targets of the behavioral effects of cocaine. This increase develops gradually over several days and remains at 50% of maximal levels 7 days after the last cocaine exposure. Supershift experiments, along with one and two-dimensional Western blots, indicate that this chronic AP-1 complex contains at least four Fos-related antigens (FRAs), some of which display Delta FosB-like immunoreactivity, that are induced selectively by chronic, but not acute, cocaine treatment. The same chronic FRAs were also induced by several different types of chronic treatments in a region-specific manner in the brain. Thus, the chronic FRAs and associated chronic AP-1 complex could mediate some of the long-term changes in gene expression unique to the chronic-treated state as opposed to the acute-treated and normal states.	YALE UNIV,SCH MED,DEPT PHARMACOL,NEW HAVEN,CT 06508; CONNECTICUT MENTAL HLTH CTR,NEW HAVEN,CT 06508; NIDR,NEUROBIOL & ANESTHESIOL BRANCH,BETHESDA,MD 20892; KYUSHU UNIV,MED INST BIOREGULAT,DEPT BIOCHEM,FUKUOKA 812,JAPAN	Yale University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Kyushu University	HOPE, BT (corresponding author), YALE UNIV,SCH MED,DEPT PSYCHIAT,MOLEC PSYCHIAT LAB,NEW HAVEN,CT 06508, USA.		Hope, Bruce T/A-9223-2010; Jansen, Heiko T./A-5770-2008; Kelz, Max/E-4054-2010; Nakabeppu, Yusaku/A-8902-2011	Hope, Bruce T/0000-0001-5804-7061; Jansen, Heiko T./0000-0003-0178-396X; Kelz, Max/0000-0002-2803-6078; Nakabeppu, Yusaku/0000-0002-6739-242X	NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH045481, R29MH045481, R01MH045481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA000203, R01DA007359, R37DA007359] Funding Source: NIH RePORTER; NIDA NIH HHS [DA07359, DA00203] Funding Source: Medline; NIMH NIH HHS [MH45481] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BEITNERJOHNSON D, 1992, J NEUROSCI, V12, P2165; BRONSTEIN DM, 1994, MOL BRAIN RES, V23, P191, DOI 10.1016/0169-328X(94)90226-7; COHEN DR, 1988, MOL CELL BIOL, V8, P2063, DOI 10.1128/MCB.8.5.2063; DOBRZANSKI P, 1991, MOL CELL BIOL, V11, P5470, DOI 10.1128/MCB.11.11.5470; HOPE B, 1992, P NATL ACAD SCI USA, V89, P5764, DOI 10.1073/pnas.89.13.5764; HOPE BT, 1994, J NEUROSCI, V14, P4318; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; JIAN M, 1993, MOL BRAIN RES, V19, P156, DOI 10.1016/0169-328X(93)90161-H; KORNER M, 1989, NEURON, V3, P563, DOI 10.1016/0896-6273(89)90266-3; LIN WC, 1993, SCIENCE, V260, P953, DOI 10.1126/science.8493533; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; NAKABEPPU Y, 1991, CELL, V64, P751, DOI 10.1016/0092-8674(91)90504-R; NESTLER EJ, 1992, J NEUROSCI, V12, P2439; NESTLER EJ, 1993, NEURON, V11, P995, DOI 10.1016/0896-6273(93)90213-B; NISHINA H, 1990, P NATL ACAD SCI USA, V87, P3619, DOI 10.1073/pnas.87.9.3619; PRASAD SC, 1992, ANAL BIOCHEM, V207, P121, DOI 10.1016/0003-2697(92)90512-6; SHARP FR, 1991, J NEUROSCI, V11, P2321, DOI 10.1523/jneurosci.11-08-02321.1991; SONNENBERG JL, 1989, NEURON, V3, P359, DOI 10.1016/0896-6273(89)90260-2; TERWILLIGER RZ, 1991, BRAIN RES, V548, P100, DOI 10.1016/0006-8993(91)91111-D; YOUNG ST, 1991, P NATL ACAD SCI USA, V88, P1291, DOI 10.1073/pnas.88.4.1291	20	469	477	0	13	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1994	13	5					1235	1244		10.1016/0896-6273(94)90061-2	http://dx.doi.org/10.1016/0896-6273(94)90061-2			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PU763	7946359				2022-12-24	WOS:A1994PU76300019
J	RIEKE, F; SCHWARTZ, EA				RIEKE, F; SCHWARTZ, EA			A CGMP-GATED CURRENT CAN CONTROL EXOCYTOSIS AT CONE SYNAPSES	NEURON			English	Article							SALAMANDER AMBYSTOMA-TIGRINUM; TURTLE RETINA; CYCLIC-GMP; SENSITIVE CONDUCTANCE; TIGER SALAMANDER; HORIZONTAL CELLS; CHROMAFFIN CELLS; PLASMA-MEMBRANE; CALCIUM CURRENT; INNER SEGMENTS	The voltage-gated Ca2+ current in cone photoreceptors operates over only a small part of the physiological voltage range produced by light and, consequently, appears insufficient for controlling transmitter release. We have used a whole-cell voltage clamp to measure membrane current and the capacitance change produced by exocytosis in solitary cone and rod photoreceptors isolated from the salamander retina. In both types of photoreceptor, Ca2+ influx through voltage-gated Ca2+ channels initiated exocytosis. In addition, Ca2+ influx through a cGMP-gated channel in the inner segment and synaptic processes of cones also initiated exocytosis. The cGMP-gated current sustained exocytosis over the entire physiological voltage range.			RIEKE, F (corresponding author), UNIV CHICAGO, DEPT PHARMACOL & PHYSIOL SCI, 947 E 58TH ST, CHICAGO, IL 60637 USA.				NATIONAL EYE INSTITUTE [F32EY006456, R37EY002440] Funding Source: NIH RePORTER; NEI NIH HHS [F32-EY06456, R37-EY02440] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AHMAD I, 1993, EXP EYE RES, V56, P51, DOI 10.1006/exer.1993.1008; ATTWELL D, 1987, NATURE, V328, P522, DOI 10.1038/328522a0; BADER CR, 1982, J PHYSIOL-LONDON, V331, P253, DOI 10.1113/jphysiol.1982.sp014372; BARNES S, 1989, J GEN PHYSIOL, V94, P719, DOI 10.1085/jgp.94.4.719; BAYLOR DA, 1971, J PHYSIOL-LONDON, V214, P265, DOI 10.1113/jphysiol.1971.sp009432; BAYLOR DA, 1986, J PHYSIOL-LONDON, V371, P115, DOI 10.1113/jphysiol.1986.sp015964; BELGUM JH, 1988, J PHYSIOL-LONDON, V396, P225, DOI 10.1113/jphysiol.1988.sp016960; COREY DP, 1984, J PHYSIOL-LONDON, V354, P557, DOI 10.1113/jphysiol.1984.sp015393; DOWLING JE, 1966, PROC R SOC SER B-BIO, V166, P80, DOI 10.1098/rspb.1966.0086; FAIN GL, 1976, J PHYSIOL-LONDON, V261, P71, DOI 10.1113/jphysiol.1976.sp011549; FESENKO EE, 1985, NATURE, V313, P310, DOI 10.1038/313310a0; FIDLER N, 1989, BIOPHYS J, V56, P1153, DOI 10.1016/S0006-3495(89)82762-6; FUORTES MGF, 1973, J PHYSIOL-LONDON, V234, P199, DOI 10.1113/jphysiol.1973.sp010341; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HAYNES L, 1985, NATURE, V317, P61, DOI 10.1038/317061a0; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; JOSHI C, 1988, BIOPHYS J, V53, P885, DOI 10.1016/S0006-3495(88)83169-2; LASANSKY A, 1973, PHILOS T ROY SOC B, V265, P471, DOI 10.1098/rstb.1973.0033; LASANSKY A, 1971, PHILOS T R SOC B, V262, P365, DOI 10.1098/rstb.1971.0101; LEEPER HF, 1979, VISION RES, V19, P407, DOI 10.1016/0042-6989(79)90105-6; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; MACLEISH PR, 1984, J PHYSIOL-LONDON, V348, P645, DOI 10.1113/jphysiol.1984.sp015131; MARICQ AV, 1988, NEURON, V1, P503, DOI 10.1016/0896-6273(88)90181-X; MATTHEWS G, 1989, J PHYSIOL-LONDON, V418, P105, DOI 10.1113/jphysiol.1989.sp017830; Missotten L., 1965, ULTRASTRUCTURE RETIN; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; NORMANN RA, 1979, J PHYSIOL-LONDON, V286, P509, DOI 10.1113/jphysiol.1979.sp012634; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; RAVIOLA E, 1975, J CELL BIOL, V65, P192, DOI 10.1083/jcb.65.1.192; SCHAEFFER SF, 1978, J CELL BIOL, V79, P802, DOI 10.1083/jcb.79.3.802; SCHWARTZ EA, 1986, J PHYSIOL-LONDON, V376, P411, DOI 10.1113/jphysiol.1986.sp016160; SJOSTRAND FS, 1958, J ULTRA MOL STRUCT R, V2, P122, DOI 10.1016/S0022-5320(58)90050-9; STANLEY EF, 1993, NEURON, V11, P1007, DOI 10.1016/0896-6273(93)90214-C; TORRE V, 1992, P ROY SOC B-BIOL SCI, V250, P209, DOI 10.1098/rspb.1992.0151; WATANABE SI, 1988, J NEUROSCI, V8, P2334; ZUCKER RS, 1993, J PHYSIOL-PARIS, V87, P25, DOI 10.1016/0928-4257(93)90021-K	38	184	188	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	1994	13	4					863	873		10.1016/0896-6273(94)90252-6	http://dx.doi.org/10.1016/0896-6273(94)90252-6			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PP533	7946333				2022-12-24	WOS:A1994PP53300009
J	TAKAO, K; YOSHII, M; KANDA, A; KOKUBUN, S; NUKADA, T				TAKAO, K; YOSHII, M; KANDA, A; KOKUBUN, S; NUKADA, T			A REGION OF THE MUSCARINIC-GATED ATRIAL K+ CHANNEL CRITICAL FOR ACTIVATION BY G-PROTEIN BETA-GAMMA-SUBUNITS	NEURON			English	Article							NUCLEOTIDE-BINDING PROTEINS; ALPHA-SUBUNIT; GTP-BINDING; POTASSIUM CHANNEL; FUNCTIONAL EXPRESSION; MOLECULAR-CLONING; PERTUSSIS TOXIN; CDNA SEQUENCE; RECEPTORS; CELLS	Complementary DNAs encoding two types of inwardly rectifying K+ channels, GIRK1 and IRK1, have been cloned from rat atrium and mouse macrophage, respectively. GIRK1 expressed in Xenopus oocytes was activated by acetylcholine when m2 muscarinic acetylcholine receptor was coexpressed. The acetylcholine-induced activation of GIRK1 was enhanced by coexpression with the C protein beta 1 gamma 2 subunit but not the beta 1 beta 1 or alpha subunits. Deletion of the C-terminus of GIRK1 impaired the channel activation associated with the beta 1 beta 2 subunit. More over, replacement of the C-terminus of IRK1 with that of GIRK1 produced a chimera channel that was activated by the beta 1 gamma 2 subunit, whereas intact IRK1 was not activated by the beta 1 gamma 2 subunit. These findings define the C-terminus of GIRK1 as a regulatory region for the G protein beta gamma subunit.	TOKYO INST PSYCHIAT,DEPT NEUROPHYSIOL,SETAGAYA KU,TOKYO 156,JAPAN; NIHON UNIV,SCH MED,DEPT PHYSIOL,ITABASHI KU,TOKYO 173,JAPAN	Tokyo Institute of Psychiatry; Nihon University	TAKAO, K (corresponding author), TOKYO INST PSYCHIAT,DEPT NEUROCHEM,SETAGAYA KU,2-1-8 KAMIKITAZAWA,TOKYO 156,JAPAN.							BIRNBAUMER L, 1990, BIOCHIM BIOPHYS ACTA, V1031, P163, DOI 10.1016/0304-4157(90)90007-Y; BREITWIESER GE, 1985, NATURE, V317, P538, DOI 10.1038/317538a0; CERBAI E, 1988, SCIENCE, V240, P1782, DOI 10.1126/science.2454511; CLAPHAM DE, 1993, NATURE, V365, P403, DOI 10.1038/365403a0; CODINA J, 1987, SCIENCE, V236, P442, DOI 10.1126/science.2436299; DASCAL N, 1993, P NATL ACAD SCI USA, V90, P10235, DOI 10.1073/pnas.90.21.10235; DIDSBURY JR, 1987, FEBS LETT, V219, P259, DOI 10.1016/0014-5793(87)81228-0; FUKADA Y, 1990, NATURE, V346, P658, DOI 10.1038/346658a0; FUKUDA K, 1987, NATURE, V327, P623, DOI 10.1038/327623a0; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HAGIWARA S, 1979, J PHYSIOL-LONDON, V292, P251, DOI 10.1113/jphysiol.1979.sp012849; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; HURLEY JB, 1984, P NATL ACAD SCI-BIOL, V81, P6948, DOI 10.1073/pnas.81.22.6948; INIGUEZLLUHI JA, 1992, J BIOL CHEM, V267, P23409; ITOH H, 1986, P NATL ACAD SCI USA, V83, P3776, DOI 10.1073/pnas.83.11.3776; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; MATSUOKA M, 1988, P NATL ACAD SCI USA, V85, P5384, DOI 10.1073/pnas.85.15.5384; NAKAMURA F, 1991, J BIOL CHEM, V266, P12676; NAKAMURA K, 1994, J PHYSIOL-LONDON, V474, P35, DOI 10.1113/jphysiol.1994.sp020000; NICHOLS CG, 1993, TRENDS PHARMACOL SCI, V14, P320; NUKADA T, 1986, FEBS LETT, V197, P305, DOI 10.1016/0014-5793(86)80347-7; NUKADA T, 1986, FEBS LETT, V195, P220, DOI 10.1016/0014-5793(86)80164-8; OKAMOTO H, 1976, J PHYSIOL-LONDON, V254, P607, DOI 10.1113/jphysiol.1976.sp011249; PARKER EM, 1991, J BIOL CHEM, V266, P519; PFAFFINGER PJ, 1985, NATURE, V317, P536, DOI 10.1038/317536a0; PONGS O, 1992, PHYSIOL REV, V72, P569; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; SAKMANN B, 1983, NATURE, V303, P250, DOI 10.1038/303250a0; STRATHMANN M, 1990, P NATL ACAD SCI USA, V87, P9113, DOI 10.1073/pnas.87.23.9113; TAGLIALATELA M, 1994, SCIENCE, V264, P844, DOI 10.1126/science.8171340; TANABE T, 1985, NATURE, V315, P242, DOI 10.1038/315242a0; VANMEURS KP, 1987, P NATL ACAD SCI USA, V84, P3107, DOI 10.1073/pnas.84.10.3107; WICKMAN KD, 1994, NATURE, V368, P255, DOI 10.1038/368255a0; YATANI A, 1988, NATURE, V336, P680, DOI 10.1038/336680a0; YOSHII M, 1994, BRAIN RES, V642, P123, DOI 10.1016/0006-8993(94)90913-X	38	74	75	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1994	13	3					747	755		10.1016/0896-6273(94)90041-8	http://dx.doi.org/10.1016/0896-6273(94)90041-8			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PJ284	7917304				2022-12-24	WOS:A1994PJ28400021
J	ELMSLIE, KS; KAMMERMEIER, PJ; JONES, SW				ELMSLIE, KS; KAMMERMEIER, PJ; JONES, SW			REEVALUATION OF CA2+ CHANNEL TYPES AND THEIR MODULATION IN BULLFROG SYMPATHETIC NEURONS	NEURON			English	Article							CHICK SENSORY NEURONS; LIQUID JUNCTION POTENTIALS; CALCIUM CURRENT MODULATION; OMEGA-CONOTOXIN GVIA; FUNCTIONAL EXPRESSION; NEUROTRANSMITTER INHIBITION; VOLTAGE DEPENDENCE; PERIPHERAL NEURONS; GANGLION-CELLS; KINETICS	With 90 mM Ba2+, the main Ca2+ current in frog sympathetic neurons peaks near +30 mV and is blocked by omega-conotoxin GVIA (omega-CgTx). It is modulated by norepinephrine (NE) in a voltage-dependent manner via a membrane-delimited mechanism, Surprisingly, a different current dominates at more negative voltages (-30 to +10 mV). That novel current is not sensitive to selective blockers of L- or N-type channels (respectively, dihydropyridines or omega-CgTx) and is inhibited weakly if at all by NE. It is selectively inactivated at -40 mV and is selectively blocked by Ni2+, whereas Cd2+ is slightly more potent against the main current. The novel current is associated with a 19 pS channel (0.6 pA at 0 mV). This channel may have been misidentified as the single-channel correlate of the whole-cell N-type Ca2+ current in some previous studies.	CASE WESTERN RESERVE UNIV,DEPT PHYSIOL & BIOPHYS,CLEVELAND,OH 44106; CASE WESTERN RESERVE UNIV,DEPT NEUROSCI,CLEVELAND,OH 44106	Case Western Reserve University; Case Western Reserve University			Jones, Stephen/AAJ-4465-2020	Elmslie, Keith/0000-0002-2988-4482	NINDS NIH HHS [NS 24471] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024471] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AOSAKI T, 1989, PFLUG ARCH EUR J PHY, V414, P150, DOI 10.1007/BF00580957; BARRY PH, 1991, J MEMBRANE BIOL, V121, P101, DOI 10.1007/BF01870526; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; BERNHEIM L, 1991, NEURON, V6, P859, DOI 10.1016/0896-6273(91)90226-P; BLEY KR, 1990, NEURON, V4, P379, DOI 10.1016/0896-6273(90)90050-P; BOLAND LM, 1993, J NEUROSCI, V13, P516; BOLAND LM, 1994, IN PRESS J NEUROSCI; BYERLY L, 1985, J GEN PHYSIOL, V85, P491, DOI 10.1085/jgp.85.4.491; CARBONE E, 1984, NATURE, V310, P501, DOI 10.1038/310501a0; DELCOUR AH, 1993, J NEUROSCI, V13, P181; DELCOUR AH, 1993, SCIENCE, V259, P980, DOI 10.1126/science.8094902; ELLINOR PT, 1993, NATURE, V363, P455, DOI 10.1038/363455a0; ELMSLIE KS, 1992, J PHYSIOL-LONDON, V456, P107, DOI 10.1113/jphysiol.1992.sp019329; ELMSLIE KS, 1992, J PHYSIOL-LONDON, V451, P229, DOI 10.1113/jphysiol.1992.sp019162; ELMSLIE KS, 1990, NEURON, V5, P75, DOI 10.1016/0896-6273(90)90035-E; FORSCHER P, 1986, J PHYSIOL-LONDON, V379, P131, DOI 10.1113/jphysiol.1986.sp016244; FOX AP, 1987, J PHYSIOL-LONDON, V394, P149, DOI 10.1113/jphysiol.1987.sp016864; FOX AP, 1987, J PHYSIOL-LONDON, V394, P173, DOI 10.1113/jphysiol.1987.sp016865; FUJITA Y, 1993, NEURON, V10, P585, DOI 10.1016/0896-6273(93)90162-K; GRASSI F, 1989, NEUROSCI LETT, V105, P113, DOI 10.1016/0304-3940(89)90021-9; HIRNING LD, 1988, SCIENCE, V239, P57, DOI 10.1126/science.2447647; JONES SW, 1989, J GEN PHYSIOL, V94, P151, DOI 10.1085/jgp.94.1.151; JONES SW, 1992, CAN J PHYSIOL PHARM, V70, pS56, DOI 10.1139/y92-244; JONES SW, 1990, J NEUROSCI, V10, P2261; JONES SW, 1989, J GEN PHYSIOL, V94, P169, DOI 10.1085/jgp.94.1.169; KASAI H, 1992, J PHYSIOL-LONDON, V448, P161, DOI 10.1113/jphysiol.1992.sp019035; KONGSAMUT S, 1989, ANN NY ACAD SCI, V560, P312, DOI 10.1111/j.1749-6632.1989.tb24112.x; KUFFLER SW, 1983, J PHYSIOL-LONDON, V341, P257, DOI 10.1113/jphysiol.1983.sp014805; KUO CC, 1993, NATURE, V365, P258, DOI 10.1038/365258a0; LIPSCOMBE D, 1989, NATURE, V340, P639, DOI 10.1038/340639a0; LIPSCOMBE D, 1988, P NATL ACAD SCI USA, V85, P2398, DOI 10.1073/pnas.85.7.2398; LOPEZ HS, 1991, NEURON, V7, P1061, DOI 10.1016/0896-6273(91)90350-9; MARCHETTI C, 1986, PFLUG ARCH EUR J PHY, V406, P104, DOI 10.1007/BF00586670; NARAHASHI T, 1987, J PHYSIOL-LONDON, V383, P231; NEHER E, 1992, METHOD ENZYMOL, V207, P123; NOWYCKY MC, 1985, NATURE, V316, P440, DOI 10.1038/316440a0; OHMORI H, 1977, J PHYSIOL-LONDON, V267, P429, DOI 10.1113/jphysiol.1977.sp011821; PATLAK JB, 1993, BIOPHYS J, V65, P29, DOI 10.1016/S0006-3495(93)81041-5; PATLAK JB, 1988, J GEN PHYSIOL, V92, P413, DOI 10.1085/jgp.92.4.413; PLUMMER MR, 1991, J NEUROSCI, V11, P2339; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; REGAN LJ, 1991, NEURON, V6, P269, DOI 10.1016/0896-6273(91)90362-4; RITTENHOUSE AR, 1994, J PHYSIOL-LONDON, V474, P87, DOI 10.1113/jphysiol.1994.sp020005; RUKNUDIN A, 1991, J CELL BIOL, V112, P125, DOI 10.1083/jcb.112.1.125; SOONG TW, 1993, SCIENCE, V260, P1133, DOI 10.1126/science.8388125; STANSFELD CE, 1993, NEURON, V10, P639, DOI 10.1016/0896-6273(93)90166-O; SWANDULLA D, 1991, TRENDS NEUROSCI, V14, P46, DOI 10.1016/0166-2236(91)90018-P; THEVENOD F, 1992, BIOPHYS J, V63, P162, DOI 10.1016/S0006-3495(92)81575-8; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; WAGNER JA, 1988, J NEUROSCI, V8, P3354; WANKE E, 1987, P NATL ACAD SCI USA, V84, P4313, DOI 10.1073/pnas.84.12.4313; WILSON GF, 1993, NATURE, V366, P433, DOI 10.1038/366433a0; YAWO H, 1993, J PHYSIOL-LONDON, V460, P153, DOI 10.1113/jphysiol.1993.sp019464	53	44	44	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1994	13	1					217	228		10.1016/0896-6273(94)90471-5	http://dx.doi.org/10.1016/0896-6273(94)90471-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NZ247	8043277				2022-12-24	WOS:A1994NZ24700017
J	TERZIC, A; FINDLAY, I; HOSOYA, Y; KURACHI, Y				TERZIC, A; FINDLAY, I; HOSOYA, Y; KURACHI, Y			DUALISTIC BEHAVIOR OF ATP-SENSITIVE K+ CHANNELS TOWARD INTRACELLULAR NUCLEOSIDE DIPHOSPHATES	NEURON			English	Article							PANCREATIC BETA-CELLS; RAT VENTRICULAR MYOCYTES; POTASSIUM CHANNELS; B-CELLS; GUINEA-PIG; CHLORIDE CHANNEL; MEMBRANE PATCHES; SKELETAL-MUSCLE; ADP; ACTIVATION	ATP-sensitive K+ (K-ATP) channels are intracellular ligand-gated channels which regulate diverse cellular functions. Intracellular nucleoside diphosphates (NDPs) are essential for the physiological opening of K-ATP channels which would otherwise be permanently closed by their overt sensitivity to intracellular ATP. We find that K-ATP channels exhibit dualistic behavior toward NDPs depending on their operative condition. When channels are in the spontaneous operative condition, NDPs antagonize channel inhibition by intracellular ATP. When channels have ''run down,'' NDPs induce channel opening but no longer antagonize intracellular ATP. The switch of the K-ATP channel response to the same ligand, i.e., NDPs, is controlled by a Mg-ATP-dependent reaction. The condition of the target protein therefore determines the effect of the ligand. This property provides a novel basis to evaluate the dynamic regulation of ion channels by their ligands.	MAYO CLIN & MAYO FDN,DEPT PHARMACOL,ROCHESTER,MN 55905; UNIV TOURS,CNRS,EP21,TOURS,FRANCE; YAMAGATA UNIV,SCH MED,DEPT CELL BIOL & SIGNALING,YAMAGATA 990,JAPAN; OSAKA UNIV,FAC MED,DEPT PHARMACOL 2,OSAKA,JAPAN	Mayo Clinic; Centre National de la Recherche Scientifique (CNRS); Universite de Tours; Yamagata University; Osaka University	TERZIC, A (corresponding author), MAYO CLIN & MAYO FDN,DIV CARDIOVASC DIS,ROCHESTER,MN 55905, USA.		Findlay, Ian/P-5049-2016	Findlay, Ian/0000-0003-0650-2602				ALLARD B, 1992, PFLUG ARCH EUR J PHY, V422, P185, DOI 10.1007/BF00370419; ANDERSON MP, 1991, CELL, V67, P775, DOI 10.1016/0092-8674(91)90072-7; ASHCROFT FM, 1984, NATURE, V312, P446, DOI 10.1038/312446a0; ASHCROFT FM, 1989, J PHYSIOL-LONDON, V416, P349, DOI 10.1113/jphysiol.1989.sp017765; ASHCROFT SJH, 1990, CELL SIGNAL, V2, P197, DOI 10.1016/0898-6568(90)90048-F; ASHFORD MLJ, 1990, PFLUG ARCH EUR J PHY, V415, P479, DOI 10.1007/BF00373626; BARNARDI H, 1993, P NATL ACAD SCI USA, V90, P1340; BOKVIST K, 1991, P ROY SOC B-BIOL SCI, V243, P139, DOI 10.1098/rspb.1991.0022; Colquhoun D, 1983, SINGLE CHANNEL RECOR, P191; COOK DL, 1984, NATURE, V311, P271, DOI 10.1038/311271a0; DAUT J, 1990, SCIENCE, V247, P1341, DOI 10.1126/science.2107575; DUNNE MJ, 1988, J MEMBRANE BIOL, V104, P165, DOI 10.1007/BF01870928; DUNNE MJ, 1986, PFLUG ARCH EUR J PHY, V407, P564, DOI 10.1007/BF00657518; DUNNE MJ, 1986, FEBS LETT, V208, P58; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; FINDLAY I, 1988, PFLUG ARCH EUR J PHY, V412, P37, DOI 10.1007/BF00583729; FINDLAY I, 1986, PFLUG ARCH EUR J PHY, V407, P238, DOI 10.1007/BF00580683; FINDLAY I, 1987, PFLUG ARCH EUR J PHY, V410, P313, DOI 10.1007/BF00580282; FINDLAY I, 1988, J MEMBRANE BIOL, V101, P83, DOI 10.1007/BF01872823; FINDLAY I, 1987, J PHYSIOL-LONDON, V391, P611, DOI 10.1113/jphysiol.1987.sp016759; FORESTIER C, 1993, J MEMBRANE BIOL, V132, P87; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HOPKINS WF, 1992, J MEMBRANE BIOL, V129, P287; KAJIOKA S, 1991, J PHYSIOL-LONDON, V444, P397, DOI 10.1113/jphysiol.1991.sp018885; KAKEI M, 1985, J PHYSIOL-LONDON, V363, P441, DOI 10.1113/jphysiol.1985.sp015721; KAKEI M, 1986, FEBS LETT, V208, P63, DOI 10.1016/0014-5793(86)81533-2; KOZLOWSKI RZ, 1990, PROC R SOC SER B-BIO, V240, P397, DOI 10.1098/rspb.1990.0044; KURACHI Y, 1985, J PHYSIOL-LONDON, V366, P365, DOI 10.1113/jphysiol.1985.sp015803; LARSSON O, 1993, J PHYSIOL-LONDON, V463, P349, DOI 10.1113/jphysiol.1993.sp019598; LEDERER WJ, 1989, J PHYSIOL-LONDON, V419, P193, DOI 10.1113/jphysiol.1989.sp017869; MISLER S, 1986, P NATL ACAD SCI USA, V83, P7119, DOI 10.1073/pnas.83.18.7119; NELSON MT, 1990, NATURE, V344, P770, DOI 10.1038/344770a0; NICHOLS CG, 1991, AM J PHYSIOL, V261, pH1675, DOI 10.1152/ajpheart.1991.261.6.H1675; NOMA A, 1983, NATURE, V305, P147, DOI 10.1038/305147a0; OHNOSHOSAKU T, 1987, PFLUG ARCH EUR J PHY, V408, P133, DOI 10.1007/BF00581342; SCHWANSTECHER C, 1992, MOL PHARMACOL, V41, P480; SHEN WK, 1991, CIRC RES, V69, P1152, DOI 10.1161/01.RES.69.4.1152; Smith RM, 1975, CRITICAL STABILITY C, V2; STANDEN NB, 1989, SCIENCE, V245, P177, DOI 10.1126/science.2501869; TAKANO M, 1993, PROG NEUROBIOL, V41, P21, DOI 10.1016/0301-0082(93)90039-U; TAKANO M, 1990, AM J PHYSIOL, V258, pH45, DOI 10.1152/ajpheart.1990.258.1.H45; TERZIC A, 1994, IN PRESS CARDIOVASC; TRUBE G, 1984, PFLUG ARCH EUR J PHY, V401, P178, DOI 10.1007/BF00583879; TUNG RT, 1991, J PHYSIOL-LONDON, V437, P239, DOI 10.1113/jphysiol.1991.sp018593; VENKATESH N, 1991, CIRC RES, V69, P623, DOI 10.1161/01.RES.69.3.623; VIVAUDOU MB, 1991, J MEMBRANE BIOL, V122, P165, DOI 10.1007/BF01872639; WELSH MJ, 1992, NEURON, V8, P821, DOI 10.1016/0896-6273(92)90196-K; WIBRAND F, 1992, P NATL ACAD SCI USA, V89, P5133, DOI 10.1073/pnas.89.11.5133; ZUNKLER BJ, 1988, FEBS LETT, V239, P241, DOI 10.1016/0014-5793(88)80925-6	49	62	62	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1994	12	5					1049	1058		10.1016/0896-6273(94)90313-1	http://dx.doi.org/10.1016/0896-6273(94)90313-1			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NM831	8185943				2022-12-24	WOS:A1994NM83100009
J	BABILA, T; MOSCUCCI, A; WANG, HY; WEAVER, FE; KOREN, G				BABILA, T; MOSCUCCI, A; WANG, HY; WEAVER, FE; KOREN, G			ASSEMBLY OF MAMMALIAN VOLTAGE-GATED POTASSIUM CHANNELS - EVIDENCE FOR AN IMPORTANT ROLE OF THE FIRST TRANSMEMBRANE SEGMENT	NEURON			English	Article							RAT-BRAIN; K+ CHANNEL; DROSOPHILA; EXPRESSION; PROTEINS; CLONING; GENE; DIVERSITY; DOMAIN; FAMILY	Three different experimental approaches were used to establish that the first transmembrane segment (S1) is important for K+ channel assembly. First, hydrodynamic analyses of in vitro translated Kv1.1 N-terminal domain containing the S1 segment coassembles to form hometetrameric complexes, whereas deletion of the S1 segment abolishes coassembly. Second, coimmunoprecipitation experiments of cotranslated Kv1.1 and Kv1.5 truncated polypeptides show that the S1 segment is essential for coimmunoprecipitation. Third, dominant negative experiments in Xenopus oocytes confirm that overexpression of either the S1 segment or the N-terminal domain is sufficient for abolishing the expression of functional Kv1.1 and Kv1.5 K+ channels. These data indicate that S1 segment plays an important role in the coassembly of homo- and heterotetrameric K+ channels.			BABILA, T (corresponding author), BRIGHAM & WOMENS HOSP,DIV CARDIOVASC,75 FRANCIS ST,BOSTON,MA 02115, USA.				NHLBI NIH HHS [HL6005] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ATTALI B, 1993, J BIOL CHEM, V268, P24283; BAUMANN A, 1988, EMBO J, V7, P2457, DOI 10.1002/j.1460-2075.1988.tb03092.x; CLARKE S, 1975, J BIOL CHEM, V250, P5459; CLARKE S, 1975, COMP BIOCH PHYSL TRA; COSSON P, 1992, SCIENCE, V258, P659, DOI 10.1126/science.1329208; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; ISACOFF EY, 1991, NATURE, V353, P86, DOI 10.1038/353086a0; KAIN KC, 1991, BIOTECHNIQUES, V10, P366; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; KOREN G, 1990, NEURON, V4, P39, DOI 10.1016/0896-6273(90)90442-I; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; LIMAN ER, 1991, NATURE, V353, P752, DOI 10.1038/353752a0; MATSUBARA H, 1991, J BIOL CHEM, V266, P13324; MORI Y, 1993, J BIOL CHEM, V268, P26482; PONGS O, 1992, PHYSIOL REV, V72, pS69, DOI 10.1152/physrev.1992.72.suppl_4.S69; PONGS O, 1988, EMBO J, V7, P1087, DOI 10.1002/j.1460-2075.1988.tb02917.x; ROSENBERG RL, 1992, NATURE, V360, P166, DOI 10.1038/360166a0; RUPPERSBERG JP, 1990, NATURE, V345, P535, DOI 10.1038/345535a0; SADLER JE, 1979, J BIOL CHEM, V254, P4443; Sambrook J., 1989, MOL CLONING; SCHWARZ TL, 1988, NATURE, V331, P137, DOI 10.1038/331137a0; SHEN NV, 1993, NEURON, V11, P67; STRONG M, 1993, MOL BIOL EVOL, V10, P221; SWANSON R, 1990, NEURON, V4, P929, DOI 10.1016/0896-6273(90)90146-7; TAKIMOTO K, 1993, NEURON, V11, P359, DOI 10.1016/0896-6273(93)90191-S; Tanford C., 1961, PHYS CHEM MACROMOLEC; TEMPEL BL, 1988, NATURE, V332, P837, DOI 10.1038/332837a0; VANDONGEN AMJ, 1990, NEURON, V5, P433, DOI 10.1016/0896-6273(90)90082-Q; VERRALL S, 1992, CELL, V68, P23, DOI 10.1016/0092-8674(92)90203-O; WEI A, 1990, SCIENCE, V248, P599, DOI 10.1126/science.2333511	31	104	105	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1994	12	3					615	626		10.1016/0896-6273(94)90217-8	http://dx.doi.org/10.1016/0896-6273(94)90217-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NC769	8155323				2022-12-24	WOS:A1994NC76900013
J	BAPTISTA, CA; HATTEN, ME; BLAZESKI, R; MASON, CA				BAPTISTA, CA; HATTEN, ME; BLAZESKI, R; MASON, CA			CELL-CELL INTERACTIONS INFLUENCE SURVIVAL AND DIFFERENTIATION OF PURIFIED PURKINJE-CELLS IN-VITRO	NEURON			English	Article							CENTRAL NERVOUS-SYSTEM; CEREBELLAR CORTEX; HIPPOCAMPAL-NEURONS; MOUSE CEREBELLUM; GROWTH-FACTOR; POSTNATAL-DEVELOPMENT; DENDRITIC DEVELOPMENT; NEURITE EXTENSION; RAT MOTONEURONS; MUTANT MOUSE	To determine the role of cell-cell interactions in Purkinje cell survival and dendritic differentiation, perinatal moose Purkinje cells were purified, and their development was analyzed in vitro. In isolation at low density, Purkinje cell survival was poor, improved by neuronal contacts, either with purified granule neurons or with Purkinje cells themselves. Moreover, coculture with specific cell populations led to widely different degrees of Purkinje cell differentiation. Purified Purkinje cells cultured alone or with an inappropriate afferent, the messy fibers, did not progress beyond immature forms. With astroglia, Purkinje cells had thin smooth processes. Proper Purkinje cell differentiation was driven only by coculture with granule cells, resulting in dendrites with spines receiving synapses. These results suggest that Purkinje cell differentiation is regulated by local epigenetic factors, provided in large part by the granule neuron.	COLUMBIA UNIV COLL PHYS & SURG, DEPT PATHOL, NEW YORK, NY 10032 USA; COLUMBIA UNIV COLL PHYS & SURG, DEPT ANAT & CELL BIOL, NEW YORK, NY 10032 USA; COLUMBIA UNIV COLL PHYS & SURG, CTR NEUROBIOL & BEHAV, NEW YORK, NY 10032 USA; ROCKEFELLER UNIV, DEV NEUROBIOL LAB, NEW YORK, NY 10021 USA	Columbia University; Columbia University; Columbia University; Rockefeller University	BAPTISTA, CA (corresponding author), MEM SLOAN KETTERING CANC CTR, DIV ENDOCRINOL, 1275 YORK AVE, NEW YORK, NY 10021 USA.				NINDS NIH HHS [NS 16951] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS016951] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ACKLIN SE, 1990, J NEUROSCI, V10, P1082; ALTMAN J, 1972, J COMP NEUROL, V146, P355, DOI 10.1002/cne.901460305; ALTMAN J, 1978, J COMP NEUROL, V179, P23, DOI 10.1002/cne.901790104; ALTMAN J, 1972, J COMP NEUROL, V145, P399, DOI 10.1002/cne.901450402; Altman J., 1982, CEREBELLUM NEW VISTA, V47, P8; ALVARADOMALLART RM, 1982, J COMP NEUROL, V212, P247, DOI 10.1002/cne.902120304; ARMENGOL JA, 1991, DEV BRAIN RES, V64, P95, DOI 10.1016/0165-3806(91)90213-3; BAIRD DH, 1992, J NEUROSCI, V12, P619; BANKER GA, 1980, SCIENCE, V209, P809, DOI 10.1126/science.7403847; BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; BARTLETT WP, 1984, J NEUROSCI, V4, P1944; BERRY M, 1976, BRAIN RES, V112, P1, DOI 10.1016/0006-8993(76)90331-0; BLATT GJ, 1985, J COMP NEUROL, V232, P117, DOI 10.1002/cne.902320110; BOLIN LM, 1986, J NEUROCYTOL, V15, P29, DOI 10.1007/BF02057902; BRADLEY P, 1978, BRAIN RES, V142, P135, DOI 10.1016/0006-8993(78)90182-8; BRADLEY P, 1976, BRAIN RES, V109, P133, DOI 10.1016/0006-8993(76)90384-X; CALVET MC, 1983, BRAIN RES, V280, P199, DOI 10.1016/0006-8993(83)90051-3; CHAMAK B, 1987, J NEUROSCI, V7, P3163; Changeux J P, 1978, Prog Brain Res, V48, P43; CHAO MV, 1992, NEURON, V9, P583, DOI 10.1016/0896-6273(92)90023-7; CHEDOTAL A, 1992, EUR J NEUROSCI, V4, P1159, DOI 10.1111/j.1460-9568.1992.tb00142.x; CHEN S, 1989, DEV BRAIN RES, V45, P137, DOI 10.1016/0165-3806(89)90015-1; CHRISTAKOS S, 1987, METHOD ENZYMOL, V139, P534; CLARKE PGH, 1985, J COMP NEUROL, V234, P365, DOI 10.1002/cne.902340307; CLENDENING B, 1990, J NEUROSCI, V10, P3992, DOI 10.1523/JNEUROSCI.10-12-03992.1990; COHENCORY S, 1989, EXP NEUROL, V105, P104, DOI 10.1016/0014-4886(89)90177-5; COHENCORY S, 1991, J NEUROSCI, V11, P462; DENISDONINI S, 1984, NATURE, V307, P641, DOI 10.1038/307641a0; ERNFORS P, 1992, EUR J NEUROSCI, V4, P1140, DOI 10.1111/j.1460-9568.1992.tb00141.x; GAO WQ, 1991, NEURON, V6, P705, DOI 10.1016/0896-6273(91)90168-Y; GASSER UE, 1990, J NEUROSCI, V10, P1276; GOLDMAN JE, 1984, J NEUROIMMUNOL, V7, P179, DOI 10.1016/S0165-5728(84)80017-X; GOSLIN K, 1990, J NEUROSCI, V10, P588; GREGORY WA, 1988, J NEUROSCI, V8, P1728; Hatten M E, 1993, Curr Opin Neurobiol, V3, P38, DOI 10.1016/0959-4388(93)90033-U; HATTEN ME, 1981, DEV BIOL, V87, P102, DOI 10.1016/0012-1606(81)90064-6; HATTEN ME, 1988, DEV BIOL, V125, P280, DOI 10.1016/0012-1606(88)90211-4; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; HENDELMAN WJ, 1980, J COMP NEUROL, V193, P1063, DOI 10.1002/cne.901930417; HENDERSON CE, 1993, NATURE, V363, P266, DOI 10.1038/363266a0; Hillman D., 1988, INTRINSIC DETERMINAN, P83; HOCKBERGER PE, 1989, J NEUROSCI, V9, P2258; Ito M, 1984, CEREBELLUM NEURAL CO; KUHAR SG, 1993, DEVELOPMENT, V117, P97; LAFONT F, 1992, DEVELOPMENT, V114, P17; LANDIS DMD, 1987, J COMP NEUROL, V260, P513, DOI 10.1002/cne.902600405; LAXSON LC, 1983, J COMP NEUROL, V214, P290, DOI 10.1002/cne.902140307; LIEM RKH, 1985, EXP CELL RES, V156, P419, DOI 10.1016/0014-4827(85)90548-8; LINDEN R, 1987, J COMP NEUROL, V266, P141, DOI 10.1002/cne.902660202; LINDHOLM D, 1993, J CELL BIOL, V122, P443, DOI 10.1083/jcb.122.2.443; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; MARIANI J, 1977, PHILOS T R SOC B, V281, P1, DOI 10.1098/rstb.1977.0121; MARTINOU JC, 1989, J NEUROSCI, V9, P3645; MASON CA, 1990, J COMP NEUROL, V297, P77, DOI 10.1002/cne.902970106; MASON CA, 1988, J NEUROSCI, V8, P3124; MATTSON MP, 1988, NEURON, V1, P865, DOI 10.1016/0896-6273(88)90134-1; MATTSON MP, 1989, J NEUROSCI, V9, P1223; MESSER A, 1984, CELL MOL NEUROBIOL, V4, P285, DOI 10.1007/BF00733591; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; MOUNT HTJ, 1993, J NEUROSCI, V13, P3173; OKADO N, 1984, J NEUROSCI, V4, P1639; Palay S. L., 1974, CEREBELLAR CORTEX CY; PRIVAT A, 1976, J COMP NEUROL, V166, P201, DOI 10.1002/cne.901660207; RAFF MC, 1989, SCIENCE, V243, P1450, DOI 10.1126/science.2648568; RAKIC P, 1975, ADV NEUROL, V12, P117; Ramon y Cajal S, 1960, STUDIES VERTEBRATE N; REZAI Z, 1972, DEV BIOL, V29, P17, DOI 10.1016/0012-1606(72)90039-5; ROUSSELET A, 1990, DEV BIOL, V137, P33, DOI 10.1016/0012-1606(90)90005-4; ROUSSELET A, 1988, DEV BIOL, V129, P495, DOI 10.1016/0012-1606(88)90395-8; SCHAFFNER AE, 1987, J NEUROSCI, V7, P3088; SCHILLING K, 1991, NEURON, V7, P891, DOI 10.1016/0896-6273(91)90335-W; SEGAL RA, 1992, NEURON, V9, P1041, DOI 10.1016/0896-6273(92)90064-K; SOLOMON F, 1981, J CELL BIOL, V90, P547, DOI 10.1083/jcb.90.3.547; SOTELO C, 1975, BRAIN RES, V94, P19, DOI 10.1016/0006-8993(75)90874-4; SOTELO C, 1976, BRAIN RES, V111, P389, DOI 10.1016/0006-8993(76)90782-4; TROPEA M, 1988, GLIA, V1, P380, DOI 10.1002/glia.440010605; VAUGHN JE, 1989, SYNAPSE, V3, P255, DOI 10.1002/syn.890030312; WASSEF M, 1990, J COMP NEUROL, V294, P223, DOI 10.1002/cne.902940207; WASSEF M, 1985, DEV BIOL, V111, P129, DOI 10.1016/0012-1606(85)90441-5; WEBER A, 1984, BRAIN RES, V311, P119, DOI 10.1016/0006-8993(84)91404-5; WETTS R, 1983, DEV BRAIN RES, V10, P41, DOI 10.1016/0165-3806(83)90119-0; YAMADA T, 1991, CELL, V64, P635, DOI 10.1016/0092-8674(91)90247-V; YAN Q, 1988, J NEUROSCI, V8, P3481	83	221	222	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1994	12	2					243	260		10.1016/0896-6273(94)90268-2	http://dx.doi.org/10.1016/0896-6273(94)90268-2			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MY500	8110456	hybrid			2022-12-24	WOS:A1994MY50000002
J	CASTILLO, PE; WEISSKOPF, MG; NICOLL, RA				CASTILLO, PE; WEISSKOPF, MG; NICOLL, RA			THE ROLE OF CA2+ CHANNELS IN HIPPOCAMPAL MOSSY FIBER SYNAPTIC TRANSMISSION AND LONG-TERM POTENTIATION	NEURON			English	Article							OMEGA-CONOTOXIN GVIA; CHICK SENSORY NEURONS; CALCIUM CHANNELS; P-TYPE; PERIPHERAL NEURONS; AGA-IVA; SYNAPSES; BRAIN; ANTAGONISTS; MECHANISMS	We have addressed the role of Ca2+ channels in messy fiber synaptic transmission and long-term potentiation (LTP). Whereas the induction of messy fiber LTP is entirely normal when synaptic transmission is blocked by the glutamate receptor antagonist kynurenate, LTP is blocked in the absence of extracellular Ca2+. These findings suggest that presynaptic Ca2+ entry is essential for messy fiber LTP. Therefore, the role of different types of presynaptic Ca2+ channels in synaptic transmission and LTP was investigated. Messy fiber responses were little affected by the L-type Ca2+ channel blocker nifedipine. They were blocked partially by omega-conotoxin-GVIA (N-type) and almost entirely by omega-agatoxin-IVA (P-type). None of these antagonists blocked messy fiber LTP, nor was its expression associated with a change in sensitivity of synaptic transmission to either of the two toxins. These results, together with previous findings, suggest that the induction of messy fiber LTP is critically dependent on the entry of Ca2+ into the presynaptic terminal to trigger a series of steps resulting in the long lasting enhancement of evoked glutamate release. Whereas P-type Ca2+ channels are of primary importance in messy fiber synaptic transmission, both the induction and expression of messy fiber LTP can occur in the absence of P-type (or N-type) Ca2+ channels.	UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,NEUROSCI GRAD PROGRAM,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco	CASTILLO, PE (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT PHARMACOL,SAN FRANCISCO,CA 94143, USA.			Castillo, Pablo/0000-0002-9834-1801				AOSAKI T, 1989, PFLUG ARCH EUR J PHY, V414, P150, DOI 10.1007/BF00580957; BASHIR ZI, 1993, NATURE, V363, P347, DOI 10.1038/363347a0; BEAN BP, 1989, ANNU REV PHYSIOL, V51, P367, DOI 10.1146/annurev.physiol.51.1.367; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; CHATTARJI S, 1989, BRAIN RES, V495, P145, DOI 10.1016/0006-8993(89)91228-6; COX DH, 1992, J NEUROSCI, V12, P906; DUTAR P, 1989, EUR J PHARMACOL, V174, P261, DOI 10.1016/0014-2999(89)90318-X; FOX AP, 1987, J PHYSIOL-LONDON, V394, P149, DOI 10.1113/jphysiol.1987.sp016864; HARRIS EW, 1986, NEUROSCI LETT, V70, P132, DOI 10.1016/0304-3940(86)90451-9; HESS P, 1990, ANNU REV NEUROSCI, V13, P1337; HORNE AL, 1991, BRIT J PHARMACOL, V103, P1733, DOI 10.1111/j.1476-5381.1991.tb09855.x; ITO I, 1991, NEUROREPORT, V2, P333, DOI 10.1097/00001756-199106000-00008; JAFFE D, 1990, J NEUROPHYSIOL, V64, P948, DOI 10.1152/jn.1990.64.3.948; KAMIYA H, 1988, NEUROSCI LETT, V91, P84, DOI 10.1016/0304-3940(88)90253-4; KATSUKI H, 1991, NEUROSCI RES, V12, P393, DOI 10.1016/0168-0102(91)90070-F; KAUER JA, 1988, SYNAPTIC PLASTICITY, P65; KEMP JA, 1988, P NATL ACAD SCI USA, V85, P6547, DOI 10.1073/pnas.85.17.6547; LLINAS R, 1992, TRENDS NEUROSCI, V15, P351, DOI 10.1016/0166-2236(92)90053-B; LUEBKE JI, 1993, NEURON, V11, P895, DOI 10.1016/0896-6273(93)90119-C; MILLER RJ, 1993, CURR BIOL, V3, P481, DOI 10.1016/0960-9822(93)90364-T; MINTZ IM, 1992, NEURON, V9, P85, DOI 10.1016/0896-6273(92)90223-Z; MINTZ IM, 1992, NATURE, V355, P827, DOI 10.1038/355827a0; MONAGHAN DT, 1985, J NEUROSCI, V5, P2909; NICOLL RA, 1981, J NEUROSCI METH, V4, P153, DOI 10.1016/0165-0270(81)90049-2; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; REYNOLDS IJ, 1986, P NATL ACAD SCI USA, V83, P8804, DOI 10.1073/pnas.83.22.8804; STAUBLI U, 1990, SYNAPSE, V5, P333, DOI 10.1002/syn.890050410; TAKAHASHI T, 1993, NATURE, V366, P156, DOI 10.1038/366156a0; TERRIAN DM, 1990, NEUROSCI LETT, V119, P211, DOI 10.1016/0304-3940(90)90836-X; TSIEN RW, 1991, TRENDS PHARMACOL SCI, V12, P349, DOI 10.1016/0165-6147(91)90595-J; TURNER TJ, 1992, SCIENCE, V258, P310, DOI 10.1126/science.1357749; WATKINS JC, 1990, TRENDS PHARMACOL SCI, V11, P25, DOI 10.1016/0165-6147(90)90038-A; WEISSKOPF MG, 1993, NATURE, V362, P423, DOI 10.1038/362423a0; WILLIAMS S, 1989, NEURON, V3, P583, DOI 10.1016/0896-6273(89)90268-7; YAMAMOTO C, 1992, NEUROSCI LETT, V138, P111, DOI 10.1016/0304-3940(92)90484-O; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039; ZALUTSKY RA, 1992, NEUROSCI LETT, V138, P193, DOI 10.1016/0304-3940(92)90503-Y	37	263	265	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1994	12	2					261	269		10.1016/0896-6273(94)90269-0	http://dx.doi.org/10.1016/0896-6273(94)90269-0			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MY500	8110457				2022-12-24	WOS:A1994MY50000003
J	PERKEL, DJ; PETROZZINO, JJ; NICOLL, RA; CONNOR, JA				PERKEL, DJ; PETROZZINO, JJ; NICOLL, RA; CONNOR, JA			THE ROLE OF CA2+ ENTRY VIA SYNAPTICALLY ACTIVATED NMDA RECEPTORS IN THE INDUCTION OF LONG-TERM POTENTIATION	NEURON			English	Article							HIPPOCAMPAL-NEURONS; DIVALENT-CATIONS; PYRAMIDAL CELLS; CALCIUM; CA-2+; GLUTAMATE; RESPONSES; DENDRITES; CHANNELS; SLICES	Influx of Ca2+ through the NMDA subtype of glutamate receptor is widely accepted as a trigger for many forms of neural plasticity. However, direct support for this model has been elusive, since indirect activation of dendritic voltage-sensitive Ca2+ channels is difficult to exclude. We have optically measured synaptically induced changes in cytoplasmic free Ca2+ concentration in pyramidal cell dendrites in hippocampal slices. Steady post-synaptic depolarization to the synaptic reversal potential eliminated the effect of voltage-sensitive Ca2+ channels. Under these conditions, synaptically induced Ca2+ transients were observed, which were blocked by the NMDA receptor antagonist APV. In addition, the magnitude of LTP was diminished when induced with the postsynaptic membrane held at progressively more positive potentials. LTP could be completely suppressed at potentials near +100 mV. These results provide important experimental support for a role for Ca2+ influx through NMDA receptors in synaptic plasticity.	UNIV CALIF SAN FRANCISCO, DEPT PHARMACOL, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, DEPT PHYSIOL, SAN FRANCISCO, CA 94143 USA; ROCHE INST MOLEC BIOL, ROCHE RES CTR, NUTLEY, NJ 07110 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Roche Holding								ALFORD S, 1993, J PHYSIOL-LONDON, V469, P693, DOI 10.1113/jphysiol.1993.sp019838; ASCHER P, 1988, J PHYSIOL-LONDON, V399, P247; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; BLAUSTEIN MP, 1988, TRENDS NEUROSCI, V11, P438, DOI 10.1016/0166-2236(88)90195-6; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOURNE HR, 1993, CELL, V72, P65, DOI 10.1016/S0092-8674(05)80029-7; COLEMAN PA, 1989, J NEUROPHYSIOL, V61, P218, DOI 10.1152/jn.1989.61.1.218; CONNOR JA, 1986, P NATL ACAD SCI USA, V83, P6179, DOI 10.1073/pnas.83.16.6179; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HENZI V, 1992, NEUROSCIENCE, V46, P251, DOI 10.1016/0306-4522(92)90049-8; HESTRIN S, 1990, J PHYSIOL-LONDON, V422, P203, DOI 10.1113/jphysiol.1990.sp017980; KOHLER M, 1993, NEURON, V10, P491, DOI 10.1016/0896-6273(93)90336-P; KONNERTH A, 1990, EXP BRAIN RES, V81, P209; KULLMANN DM, 1992, NEURON, V9, P1175, DOI 10.1016/0896-6273(92)90075-O; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; LYNCH GS, 1976, NATURE, V263, P151, DOI 10.1038/263151a0; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; MAYER ML, 1987, J NEUROSCI, V7, P3230; MIYAKAWA H, 1992, NEURON, V9, P1163, DOI 10.1016/0896-6273(92)90074-N; MULLER W, 1992, J NEUROPHYSIOL, V68, P2264, DOI 10.1152/jn.1992.68.6.2264; MULLER W, 1991, NATURE, V354, P73, DOI 10.1038/354073a0; MURPHY SN, 1988, P NATL ACAD SCI USA, V85, P8737, DOI 10.1073/pnas.85.22.8737; NICOLL RA, 1988, NEURON, V1, P97, DOI 10.1016/0896-6273(88)90193-6; OZAWA S, 1988, BRAIN RES, V443, P85, DOI 10.1016/0006-8993(88)91601-0; REGEHR WG, 1990, NATURE, V345, P807, DOI 10.1038/345807a0; REGEHR WG, 1992, J NEUROSCI, V12, P4202; SAH P, 1989, SCIENCE, V246, P815, DOI 10.1126/science.2573153; WESTENBROEK RE, 1990, NATURE, V347, P281, DOI 10.1038/347281a0; WIGSTROM H, 1985, ACTA PHYSIOL SCAND, V123, P519, DOI 10.1111/j.1748-1716.1985.tb07621.x	30	113	116	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1993	11	5					817	823		10.1016/0896-6273(93)90111-4	http://dx.doi.org/10.1016/0896-6273(93)90111-4			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MJ041	7902109				2022-12-24	WOS:A1993MJ04100003
J	TANG, LH; AIZENMAN, E				TANG, LH; AIZENMAN, E			ALLOSTERIC MODULATION OF THE NMDA RECEPTOR BY DIHYDROLIPOIC AND LIPOIC ACID IN RAT CORTICAL-NEURONS IN-VITRO	NEURON			English	Article							MICROSOMAL LIPID-PEROXIDATION; OXIDIZED GLUTATHIONE; REDOX MODULATION; HUMAN-SERUM; MEMBRANE; BIOSYNTHESIS; LIPOAMIDASE; REDUCTION; SITE; ENHANCEMENT	The mitochondrial cofactor dihydrolipoic acid (DHLA) was observed to potentiate N-methyl-D-aspartate (NMDA), but not non-NMDA, receptor-mediated whole-cell responses in cultured neurons. This potentiation was readily reversed by the oxidizing agent 5,5'-dithio-bis-(2-nitro-benzoic acid) (DTNB). DHLA was unable to increase NMDA responses previously potentiated by dithiothreitol, nor did it have an effect on NMDA receptors alkylated with N-ethylmaleimide. Single-channel recordings revealed that DHLA produced an increase in NMDA channel open frequency, with no change in single-channel conductance or open time. In contrast, lipoic acid reversed the potentiation of NMDA-evoked responses produced by dithiothreitol and had no effect on NMDA receptors previously oxidized by DTNB. DHLA and lipoic acid are pervasively found substances that readily permeate cellular membranes and thus may influence NMDA receptor activity in vivo by modifying its redox site.			TANG, LH (corresponding author), UNIV PITTSBURGH,SCH MED,DEPT NEUROBIOL,PITTSBURGH,PA 15261, USA.			Aizenman, Elias/0000-0001-9610-4194	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029365] Funding Source: NIH RePORTER; NINDS NIH HHS [NS29365] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AIZENMAN E, 1992, J NEUROSCI, V12, P2362; AIZENMAN E, 1990, NEURON, V5, P841, DOI 10.1016/0896-6273(90)90343-E; AIZENMAN E, 1989, NEURON, V2, P1257, DOI 10.1016/0896-6273(89)90310-3; AIZENMAN E, 1992, BRAIN RES, V585, P28, DOI 10.1016/0006-8993(92)91187-J; BACKMANGULLERS B, 1990, CLIN CHIM ACTA, V191, P49, DOI 10.1016/0009-8981(90)90057-Y; BAST A, 1988, BIOCHIM BIOPHYS ACTA, V963, P558, DOI 10.1016/0005-2760(88)90326-8; BERTL A, 1990, P NATL ACAD SCI USA, V87, P7824, DOI 10.1073/pnas.87.20.7824; BUSSE E, 1992, ARZNEIMITTELFORSCH, V42-1, P829; CLELAND WW, 1964, BIOCHEMISTRY-US, V3, P480, DOI 10.1021/bi00892a002; DELEAN A, 1978, AM J PHYSIOL, V235, pE97, DOI 10.1152/ajpendo.1978.235.2.E97; DUPRE S, 1980, ARCH BIOCHEM BIOPHYS, V202, P361, DOI 10.1016/0003-9861(80)90438-5; GILBERT KR, 1991, NEUROSCI LETT, V133, P11, DOI 10.1016/0304-3940(91)90045-U; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HAYDEN MA, 1992, J BIOL CHEM, V267, P9512; KAGAN VE, 1992, BIOCHEM PHARMACOL, V44, P1637, DOI 10.1016/0006-2952(92)90482-X; KOIKE M, 1975, METABOLISM SULFUR CO, P87; LEVY DI, 1990, NEUROSCI LETT, V110, P291, DOI 10.1016/0304-3940(90)90862-4; Mascio P.D., 1991, AM J CLIN NUTR, V53, p194S; MURPHY ME, 1992, EUR J BIOCHEM, V210, P139, DOI 10.1111/j.1432-1033.1992.tb17401.x; NOWAK LM, 1992, NEURON, V8, P181, DOI 10.1016/0896-6273(92)90119-X; OIZUMI J, 1989, BIOCHEM BIOPH RES CO, V162, P658, DOI 10.1016/0006-291X(89)92361-9; OIZUMI J, 1992, MOL CELL BIOCHEM, V115, P11; PAGANI S, 1989, BIOCHEM INT, V18, P923; PARRY RJ, 1977, J AM CHEM SOC, V99, P6464, DOI 10.1021/ja00461a061; ROJAS L, 1991, BRAIN RES, V551, P10, DOI 10.1016/0006-8993(91)90906-C; SCHOLICH H, 1989, BIOCHIM BIOPHYS ACTA, V1001, P256, DOI 10.1016/0005-2760(89)90108-2; SHIH JCH, 1981, ANAL BIOCHEM, V116, P65, DOI 10.1016/0003-2697(81)90322-5; SINGH R, 1991, J ORG CHEM, V56, P2332, DOI 10.1021/jo00007a018; SPECTOR A, 1988, BIOCHEM BIOPH RES CO, V150, P156, DOI 10.1016/0006-291X(88)90499-8; STRYER L, 1988, BIOCHEMISTRY-US, P373; SUCHER NJ, 1991, J NEUROSCI RES, V30, P582, DOI 10.1002/jnr.490300316; SUZUKI YJ, 1991, FREE RADICAL RES COM, V15, P255, DOI 10.3109/10715769109105221; TANG LH, 1993, MOL PHARMACOL, V44, P473; TANG LH, 1993, J PHYSIOL-LONDON, V465, P303, DOI 10.1113/jphysiol.1993.sp019678; TAUCK DL, 1990, BRAIN RES, V519, P129, DOI 10.1016/0006-8993(90)90070-R; WOODWARD JJ, 1991, J NEUROCHEM, V57, P2059, DOI 10.1111/j.1471-4159.1991.tb06422.x; [No title captured]	37	45	46	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1993	11	5					857	863		10.1016/0896-6273(93)90115-8	http://dx.doi.org/10.1016/0896-6273(93)90115-8			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MJ041	8240809				2022-12-24	WOS:A1993MJ04100007
J	BROCARD, JB; RAJDEV, S; REYNOLDS, IJ				BROCARD, JB; RAJDEV, S; REYNOLDS, IJ			GLUTAMATE-INDUCED INCREASES IN INTRACELLULAR FREE MG(2+) IN CULTURED CORTICAL-NEURONS	NEURON			English	Article							CYTOSOLIC FREE MAGNESIUM; FLUORESCENT INDICATOR; RAT HEPATOCYTES; HEART-CELLS; CHANNELS	Intracellular free Mg2+ concentrations ([Mg2+]i) in single rat brain neurons were measured with the Mg2+-sensitive fluorescent dye magfura-2. Addition of glutamate with glycine raised [Mg2+]i from 1 to more than 11 mM compared with the resting concentration of 0.5 mM, an effect mediated by N-methyl-D-aspartate receptors. Most of the increase in [Mg2+]i was independent of extracellular Mg2+, but was dependent on extracellular Ca2+. The second component of the increase induced by glutamate was independent of extracellular Ca2+, but required extracellular Mg2+ and was amplified by extracellular Na+ removal. These results indicate that regulation of [Mg2+]i by neurotransmitters such as glutamate may be important in controlling neuronal excitability.	UNIV PITTSBURGH, DEPT PHARMACOL, PITTSBURGH, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	BROCARD, JB (corresponding author), ECOLE NORMALE SUPER, DEPT NEUROBIOL, F-75231 PARIS 05, FRANCE.		Reynolds, Ian Jeffery/ABH-3197-2020; Reynolds, Ian/C-4358-2008; Brocard, Jacques/I-3135-2017	Reynolds, Ian/0000-0003-3028-5070; Brocard, Jacques/0000-0002-0752-5737				BELAN PV, 1993, CELL CALCIUM, V14, P419, DOI 10.1016/0143-4160(93)90001-M; BRINLEY FJ, 1977, J GEN PHYSIOL, V70, P355, DOI 10.1085/jgp.70.3.355; CORKEY BE, 1986, J BIOL CHEM, V261, P2567; FLATMAN PW, 1991, ANNU REV PHYSIOL, V53, P259, DOI 10.1146/annurev.ph.53.030191.001355; FONTANA G, 1990, AM J PHYSIOL, V259, pC541; HARMAN AW, 1990, BIOCHEM BIOPH RES CO, V170, P477, DOI 10.1016/0006-291X(90)92116-H; HARTLEY DM, 1993, J NEUROSCI, V13, P1993; ISHIJIMA S, 1991, AM J PHYSIOL, V261, pC1074, DOI 10.1152/ajpcell.1991.261.6.C1074; JOHNSON JW, 1990, BIOPHYS J, V57, P1085, DOI 10.1016/S0006-3495(90)82626-6; KUO CC, 1993, J PHYSIOL-LONDON, V466, P683; LONDON RE, 1991, ANNU REV PHYSIOL, V53, P241, DOI 10.1146/annurev.physiol.53.1.241; MCLAUGHLIN S, 1981, J GEN PHYSIOL, V77, P445, DOI 10.1085/jgp.77.4.445; MURPHY E, 1991, ANNU REV PHYSIOL, V53, P273, DOI 10.1146/annurev.physiol.53.1.273; MURPHY E, 1989, P NATL ACAD SCI USA, V86, P2981, DOI 10.1073/pnas.86.8.2981; RAJU B, 1989, AM J PHYSIOL, V256, pC540, DOI 10.1152/ajpcell.1989.256.3.C540; REGEHR WG, 1992, J NEUROSCI, V12, P4202; REYNOLDS IJ, 1992, J NEUROSCI, V12, P970; ROMANI A, 1992, ARCH BIOCHEM BIOPHYS, V298, P1, DOI 10.1016/0003-9861(92)90086-C; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; WHITE RE, 1989, BIOCHEM PHARMACOL, V38, P859, DOI 10.1016/0006-2952(89)90272-4	20	123	123	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	1993	11	4					751	757		10.1016/0896-6273(93)90084-5	http://dx.doi.org/10.1016/0896-6273(93)90084-5			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MD068	8104432				2022-12-24	WOS:A1993MD06800017
J	DAVIES, AM; LEE, KF; JAENISCH, R				DAVIES, AM; LEE, KF; JAENISCH, R			P75-DEFICIENT TRIGEMINAL SENSORY NEURONS HAVE AN ALTERED RESPONSE TO NGF BUT NOT TO OTHER NEUROTROPHINS	NEURON			English	Article							NERVE GROWTH-FACTOR; TRK PROTOONCOGENE PRODUCT; TYROSINE PROTEIN-KINASE; MOLECULAR-CLONING; FACTOR RECEPTOR; FACTOR FAMILY; GENE-TRANSFER; HIGH-AFFINITY; SYMPATHETIC NEURONS; BIOLOGICAL-ACTIVITY	The role of the common low affinity neurotrophin receptor, p75, is controversial. Studies using cell lines suggest that p75 is either essential or dispensable for neurotrophin responsiveness. To resolve this issue, we studied the survival response of developing neurons obtained from normal mouse embyros and embryos with a null mutation in the p75 gene. Embryonic cranial sensory and sympathetic neurons from mutant embryos responded normally to NGF, BDNF, NT-3, and NT-4/5 at saturating concentrations. Dose responses of sympathetic and visceral sensory neurons from mutant embryos were also normal. In contrast, embryonic cutaneous sensory trigeminal neurons isolated from mutant embryos displayed a consistent displacement in the NGF dose response. Compared with wild-type neurons, the concentration of NGF that promoted half-maximal survival was 3- to 4-fold higher for neurons from homozygous embryos and was 2-fold higher for neurons from heterozygous embryos. These findings indicate that p75 enhances the sensitivity of NGF-dependent cutaneous sensory neurons to NGF and may explain, at least in part, the cutaneous sensory abnormalities of mice homozygous for the p75 mutation.	WHITEHEAD INST MED RES, CAMBRIDGE, MA 02142 USA; MIT, DEPT BIOL, CAMBRIDGE, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	DAVIES, AM (corresponding author), UNIV ST ANDREWS, SCH BIOL & MED SCI, ST ANDREWS KY16 9AJ, FIFE, SCOTLAND.		Davies, Alun M/A-4334-2010	Davies, Alun M/0000-0001-5841-8176	NCI NIH HHS [5 R35 CA44339-05] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL CANCER INSTITUTE [R35CA044339] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALLSOPP T, 1993, IN PRESS J CELL BIOL; ANDERSON D J, 1992, Current Biology, V2, P461, DOI 10.1016/0960-9822(92)90651-P; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; BERG MM, 1991, P NATL ACAD SCI USA, V88, P7106, DOI 10.1073/pnas.88.16.7106; BERKEMEIER LR, 1991, NEURON, V7, P857, DOI 10.1016/0896-6273(91)90287-A; BUCHMAN VL, 1993, IN PRESS DEVELOPMENT; CHAO MV, 1986, SCIENCE, V232, P518, DOI 10.1126/science.3008331; CHAO MV, 1992, NEURON, V9, P583, DOI 10.1016/0896-6273(92)90023-7; CHUN LLY, 1977, J CELL BIOL, V75, P705, DOI 10.1083/jcb.75.3.705; CORDONCARDO C, 1991, CELL, V66, P173, DOI 10.1016/0092-8674(91)90149-S; DAVIES A, 1984, J COMP NEUROL, V223, P124, DOI 10.1002/cne.902230110; DAVIES AM, 1987, DEVELOPMENT, V100, P307; DAVIES AM, 1986, J NEUROSCI, V6, P1897; DAVIES AM, 1985, DEV BIOL, V111, P62, DOI 10.1016/0012-1606(85)90435-X; DAVIES AM, 1987, DEVELOPMENT, V101, P185; DAVIES AM, 1988, TRENDS GENET, V4, P139, DOI 10.1016/0168-9525(88)90137-0; DAVIES AM, 1987, NATURE, V326, P353, DOI 10.1038/326353a0; DAVIES AM, 1986, J COMP NEUROL, V253, P13, DOI 10.1002/cne.902530103; DAVIES AM, 1993, IN PRESS J NEUROSCI; DRINKWATER CC, 1991, P ROY SOC B-BIOL SCI, V246, P307, DOI 10.1098/rspb.1991.0159; DURKOP H, 1992, CELL, V68, P421, DOI 10.1016/0092-8674(92)90180-K; ERNFORS P, 1990, P NATL ACAD SCI USA, V87, P5454, DOI 10.1073/pnas.87.14.5454; GLASS DJ, 1991, CELL, V66, P405, DOI 10.1016/0092-8674(91)90629-D; GOEDERT M, 1984, P NATL ACAD SCI-BIOL, V81, P1580, DOI 10.1073/pnas.81.5.1580; GREENE LA, 1977, DEV BIOL, V58, P96, DOI 10.1016/0012-1606(77)90076-8; HALLBOOK F, 1991, NEURON, V6, P845, DOI 10.1016/0896-6273(91)90180-8; HALLBOOK F, 1990, DEVELOPMENT, V108, P693; HARPER S, 1990, DEVELOPMENT, V110, P515; HATANAKA H, 1988, DEV BRAIN RES, V39, P85, DOI 10.1016/0165-3806(88)90069-7; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HEMPSTEAD BL, 1989, SCIENCE, V243, P373, DOI 10.1126/science.2536190; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; HYMAN C, 1991, NATURE, V350, P230, DOI 10.1038/350230a0; IBANEZ CF, 1992, CELL, V69, P329, DOI 10.1016/0092-8674(92)90413-7; IP NY, 1992, P NATL ACAD SCI USA, V89, P3060, DOI 10.1073/pnas.89.7.3060; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; JOHNSON JE, 1986, J NEUROSCI, V6, P3031; JONES KR, 1990, P NATL ACAD SCI USA, V87, P8060, DOI 10.1073/pnas.87.20.8060; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KESSLER JA, 1985, J NEUROSCI, V5, P2719; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KLEIN R, 1992, NEURON, V8, P947, DOI 10.1016/0896-6273(92)90209-V; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; KORSCHING S, 1988, DEV BIOL, V126, P40, DOI 10.1016/0012-1606(88)90236-9; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; LINDSAY RM, 1989, NEUROSCIENCE, V33, P53, DOI 10.1016/0306-4522(89)90310-2; LINDSAY RM, 1985, DEV BIOL, V112, P319, DOI 10.1016/0012-1606(85)90402-6; LINDSAY RM, 1989, NATURE, V337, P362, DOI 10.1038/337362a0; LOEB DM, 1991, CELL, V66, P961, DOI 10.1016/0092-8674(91)90441-Z; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MALLETT S, 1991, IMMUNOL TODAY, V12, P220, DOI 10.1016/0167-5699(91)90033-P; MATSUSHIMA H, 1990, MOL CELL BIOL, V10, P5015, DOI 10.1128/MCB.10.9.5015; MAYER N, 1982, NEUROSCI LETT, V29, P47, DOI 10.1016/0304-3940(82)90362-7; MEAKIN SO, 1992, TRENDS NEUROSCI, V15, P323, DOI 10.1016/0166-2236(92)90047-C; MEAKIN SO, 1992, P NATL ACAD SCI USA, V89, P2374, DOI 10.1073/pnas.89.6.2374; NEBREDA AR, 1991, SCIENCE, V252, P558, DOI 10.1126/science.1850550; PLEASURE SJ, 1990, P NATL ACAD SCI USA, V87, P8496, DOI 10.1073/pnas.87.21.8496; PURVES D, 1988, NATURE, V336, P123, DOI 10.1038/336123a0; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; RODRIGEUZTEBAR A, 1988, J NEUROSCI, V8, P3337; RODRIGUEZTEBAR A, 1992, EMBO J, V11, P917, DOI 10.1002/j.1460-2075.1992.tb05130.x; ROSENTHAL A, 1990, NEURON, V4, P767, DOI 10.1016/0896-6273(90)90203-R; SCOTT SA, 1993, IN PRESS J COMP NEUR; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; SUTTER A, 1979, J BIOL CHEM, V254, P5972; Theiler K., 1972, HOUSE MOUSE; THOENEN H, 1971, P NATL ACAD SCI USA, V68, P1598, DOI 10.1073/pnas.68.7.1598; WESKAMP G, 1991, NEURON, V6, P649, DOI 10.1016/0896-6273(91)90067-A; WRIGHT EM, 1992, NEURON, V9, P139, DOI 10.1016/0896-6273(92)90229-7; WYATT S, 1990, NEURON, V4, P421, DOI 10.1016/0896-6273(90)90054-J; YAN H, 1991, SCIENCE, V252, P561, DOI 10.1126/science.1850551; YASUDA T, 1990, BRAIN RES, V524, P54, DOI 10.1016/0006-8993(90)90491-S	78	310	318	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	1993	11	4					565	574		10.1016/0896-6273(93)90069-4	http://dx.doi.org/10.1016/0896-6273(93)90069-4			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MD068	8398147				2022-12-24	WOS:A1993MD06800002
J	FUNTE, LR; HAYDON, PG				FUNTE, LR; HAYDON, PG			SYNAPTIC TARGET CONTACT ENHANCES PRESYNAPTIC CALCIUM INFLUX BY ACTIVATING CAMP-DEPENDENT PROTEIN-KINASE DURING SYNAPTOGENESIS	NEURON			English	Article							APLYSIA SENSORY NEURONS; BAG CELL NEURONS; TRANSMITTER RELEASE; CYCLIC-AMP; ACTION-POTENTIALS; OMEGA-CONOTOXIN; GROWTH CONES; CHANNELS; MODULATION; ACETYLCHOLINE	Individual dissociated supralateral radular tensor (SLT) muscle fibers were manipulated into contact with fura-2-filled neurites of presynaptic buccal motoneuron 19 from Helisoma in cell culture. Within 30 min of contact, action potential-evoked calcium accumulation was reversibly augmented from 228 +/- 82 nM to 803 +/- 212 nM, an action that was blocked by H-7 (40-100 muM). Calcium accumulation was not augmented when buccal motoneuron 19 contacted muscle or neuronal targets with which it does not form chemical synapses. Addition of pCPTcAMP (500 muM) to cultures reversibly enhanced calcium accumulation. Injection of IP20, a peptide inhibitor of cAMP-dependent protein kinase, prevented pCPTcAMP and SLT muscle from enhancing calcium accumulation. These data demonstrate that SLT muscle target retrogradely regulates calcium accumulation in presynaptic nerve terminals by locally activating presynaptic cAMP-dependent protein kinase.			FUNTE, LR (corresponding author), IOWA STATE UNIV SCI & TECHNOL,DEPT ZOOL & GENET,SIGNAL TRANSDUCT TRAINING GRP,AMES,IA 50011, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024233] Funding Source: NIH RePORTER; NINDS NIH HHS [NS24233] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON MJ, 1977, J PHYSIOL-LONDON, V268, P731, DOI 10.1113/jphysiol.1977.sp011879; ARMSTRONG D, 1987, P NATL ACAD SCI USA, V84, P2518, DOI 10.1073/pnas.84.8.2518; AUGUSTINE GJ, 1987, ANNU REV NEUROSCI, V10, P633, DOI 10.1146/annurev.ne.10.030187.003221; BEVAN S, 1977, J PHYSIOL-LONDON, V267, P195, DOI 10.1113/jphysiol.1977.sp011808; BLUMENFELD H, 1990, NEURON, V5, P487, DOI 10.1016/0896-6273(90)90088-W; BUCHANAN J, 1989, J NEUROSCI, V9, P1540; CASTELLUCCI VF, 1982, J NEUROSCI, V2, P1673; CHENG HC, 1986, J BIOL CHEM, V261, P989; COHAN CS, 1987, J NEUROSCI, V7, P3588; COHEN MW, 1991, J NEUROSCI, V11, P1032; DERIEMER SA, 1985, NATURE, V313, P313, DOI 10.1038/313313a0; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAYDON PG, 1988, J NEUROBIOL, V19, P636, DOI 10.1002/neu.480190706; HAYDON PG, 1989, NEURON, V2, P1483, DOI 10.1016/0896-6273(89)90194-3; HAYDON PG, 1985, J NEUROSCI RES, V13, P285; HEUSER JE, 1979, J CELL BIOL, V81, P275, DOI 10.1083/jcb.81.2.275; JONES OT, 1989, SCIENCE, V244, P1189, DOI 10.1126/science.2543080; KACZMAREK LK, 1980, P NATL ACAD SCI-BIOL, V77, P7487, DOI 10.1073/pnas.77.12.7487; KACZMAREK LK, 1984, J NEUROPHYSIOL, V52, P340, DOI 10.1152/jn.1984.52.2.340; KANDEL ER, 1982, SCIENCE, V218, P433, DOI 10.1126/science.6289442; KANDEL ER, 1992, SCIENCE, V258, P243, DOI 10.1126/science.1411522; KANDEL ER, 1986, FIDIA RES F NEUROSCI, P7; Katz B., 1969, RELEASE NEURAL TRANS; KLEIN M, 1982, P NATL ACAD SCI-BIOL, V79, P5713, DOI 10.1073/pnas.79.18.5713; KNOX RJ, 1992, NEURON, V8, P883, DOI 10.1016/0896-6273(92)90202-O; LLINAS R, 1981, BIOPHYS J, V33, P289, DOI 10.1016/S0006-3495(81)84898-9; LOHOF AM, 1992, J NEUROSCI, V12, P1253; MATTSON MP, 1988, J NEUROSCI, V8, P1704; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; MCMAHAN UJ, 1989, DEV NEUROSCI-BASEL, V11, P227, DOI 10.1159/000111903; PERIONI JP, 1992, J NEUROSCI, V12, P2633; REIST NE, 1992, NEURON, V8, P865, DOI 10.1016/0896-6273(92)90200-W; ROBITAILLE R, 1990, NEURON, V5, P773, DOI 10.1016/0896-6273(90)90336-E; SIEGELBAUM SA, 1982, NATURE, V299, P413, DOI 10.1038/299413a0; SMITH SJ, 1988, TRENDS NEUROSCI, V11, P458, DOI 10.1016/0166-2236(88)90199-3; STANLEY EF, 1991, NEURON, V7, P585, DOI 10.1016/0896-6273(91)90371-6; STRONG JA, 1987, NATURE, V325, P714, DOI 10.1038/325714a0; SUN YA, 1987, P NATL ACAD SCI USA, V84, P2540, DOI 10.1073/pnas.84.8.2540; XIE ZP, 1986, P NATL ACAD SCI USA, V83, P7068; ZORAN MJ, 1989, J EXP BIOL, V142, P225; ZORAN MJ, 1993, IN PRESS DEV BIOL; ZORAN MJ, 1990, NEURON, V6, P145; ZORAN MJ, 1989, DEV BIOL, V138, P202	43	53	53	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1993	10	6					1069	1078		10.1016/0896-6273(93)90055-V	http://dx.doi.org/10.1016/0896-6273(93)90055-V			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LK373	8391279				2022-12-24	WOS:A1993LK37300007
J	WU, GY; ZOU, DJ; KOOTHAN, T; CLINE, HT				WU, GY; ZOU, DJ; KOOTHAN, T; CLINE, HT			INFECTION OF FROG NEURONS WITH VACCINIA VIRUS PERMITS IN-VIVO EXPRESSION OF FOREIGN PROTEINS	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM	Vaccinia virus can be used to infect cells in the CNS of frogs, Xenopus laevis, and Rana pipiens, both in vivo and in vitro. In vivo infections were accomplished by injection of viral solution into the tectal ventricle of stage 40-48 tadpoles or by local injections into distinct neural regions. Infections with high titer of virus injected into the ventricle resulted in the majority of cells in the brain expressing foreign protein, while cells in the retina and optic nerve showed no expression. Infection with lower viral titers resulted in fewer infected cells that were distributed throughout the otherwise normal tissue. Intense expression of foreign protein in the brain was observed 36 hr after injection and remained high for at least 4 days. Infected animals developed normally and had the same number of cells in the optic tectum as control animals. Infection with a recombinant virus carrying the gene for Green Fluorescent Protein labels neurons, so that infected cells can be observed in vivo. Vaccinia virus provides a versatile means to alter proteins in distinct populations of neurons in amphibia.			WU, GY (corresponding author), COLD SPRING HARBOR LAB,POB 100,COLD SPRING HARBOR,NY 11724, USA.							CHALFIE M, 1994, SCIENCE, V283, P802; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; HOLT CE, 1990, NEURON, V4, P203, DOI 10.1016/0896-6273(90)90095-W; KESSLER DS, 1994, SCIENCE, V266, P596, DOI 10.1126/science.7939714; KROLL KL, 1994, SCIENCE, V266, P650, DOI 10.1126/science.7939720; MACKETT M, 1985, DNA CLONING PRACTICA; MOSS B, 1991, SCIENCE, V252, P1662, DOI 10.1126/science.2047875; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; PETTIT DL, 1994, SCIENCE, V266, P1881, DOI 10.1126/science.7997883; STEEN P, 1989, J COMP NEUROL, V289, P467, DOI 10.1002/cne.902890311; STEWARD O, 1983, COLD SPRING HARB SYM, V48, P745, DOI 10.1101/SQB.1983.048.01.077; YEN LH, 1993, J NEUROSCI, V13, P4949	12	47	49	1	3	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1995	14	4					681	684		10.1016/0896-6273(95)90211-2	http://dx.doi.org/10.1016/0896-6273(95)90211-2			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QU826	7718230	Bronze			2022-12-24	WOS:A1995QU82600001
J	MOTTES, JR; IVERSON, LE				MOTTES, JR; IVERSON, LE			TISSUE-SPECIFIC ALTERNATIVE SPLICING OF HYBRID SHAKER/LACZ GENES CORRELATES WITH KINETIC DIFFERENCES IN SHAKER K+ CURRENTS IN-VIVO	NEURON			English	Article							ACTIVATED POTASSIUM CHANNELS; DROSOPHILA-MELANOGASTER; MESSENGER-RNA; ESCHERICHIA-COLI; XENOPUS-OOCYTES; HEAT-SHOCK; LOCUS; INACTIVATION; EXPRESSION; PHOTORECEPTORS	Alternative splicing of the Shaker (Sh) locus of Drosophila generates several transcripts with divergent 5' and 3' domains that produce kinetically distinct K+ currents in Xenopus oocytes. Although suggestive that alternative splicing may be involved in generating K+ channel diversity, clear tissue-specific differences in the distribution of particular Sh gene products have not been demonstrated. Using lacZ as a reporter gene for accurate splicing of variable Sh 3' domains, we observe differences in beta-galactosidase expression patterns in transgenic animals that indicate both temporal and spatial regulation of 3' splice choice. The differences in 3' splice choice can account for variation in recovery kinetics of Sh-encoded K+ currents recorded in adult flies. The results indicate that tissue-specific expression of functionally distinct Sh K+ channels is regulated, in part, at the level of pre-mRNA splicing and implicate sequences in or around the 3' splice site's in regulating the choice of 3' domain.			MOTTES, JR (corresponding author), CITY HOPE NATL MED CTR,BECKMAN RES INST,DIV NEUROSCI,DUARTE,CA 91010, USA.				NINDS NIH HHS [NS28135, NS18858] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS018858, R29NS028135, R01NS028135] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; BAINBRIDGE SP, 1981, J EMBRYOL EXP MORPH, V66, P57; BAKER K, 1990, NEURON, V2, P129; BENYAJATI C, 1983, CELL, V33, P125, DOI 10.1016/0092-8674(83)90341-0; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; CHANDY KG, 1994, IN PRESS CRC HDB REC; ELKINS T, 1988, J NEUROSCI, V8, P428; FOWLER AV, 1977, P NATL ACAD SCI USA, V74, P1507, DOI 10.1073/pnas.74.4.1507; Frohman M.A., 1990, PCR PROTOCOLS GUIDE, P28; HARDIE RC, 1991, NEURON, V6, P477, DOI 10.1016/0896-6273(91)90255-X; HARDIE RC, 1991, J NEUROSCI, V11, P3079; HARLOW E, 1988, ANTIBODIES LABORATOR; Hille B., 1992, IONIC CHANNELS EXCIT; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; IVERSON LE, 1990, J NEUROSCI, V10, P2903; IVERSON LE, 1988, P NATL ACAD SCI USA, V85, P5723, DOI 10.1073/pnas.85.15.5723; KAMB A, 1987, CELL, V50, P405, DOI 10.1016/0092-8674(87)90494-6; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; KELLER EB, 1984, P NATL ACAD SCI-BIOL, V81, P7417, DOI 10.1073/pnas.81.23.7417; LASKI FA, 1986, CELL, V44, P7, DOI 10.1016/0092-8674(86)90480-0; LICHTINGHAGEN R, 1990, EMBO J, V9, P4399, DOI 10.1002/j.1460-2075.1990.tb07890.x; MCCORMACK K, 1990, BIOCHEM BIOPH RES CO, V171, P1361, DOI 10.1016/0006-291X(90)90836-C; MCCORMACK T, 1990, P NATL ACAD SCI USA, V87, P5227, DOI 10.1073/pnas.87.13.5227; MOTTES JR, 1992, THESIS CALIFORNIA ST; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; PIKIELNY CW, 1983, CELL, V34, P395, DOI 10.1016/0092-8674(83)90373-2; PONGS O, 1988, EMBO J, V7, P1087, DOI 10.1002/j.1460-2075.1988.tb02917.x; REDDY R, 1985, NUCLEIC ACIDS RES, V13, P155; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; RUDY B, 1992, P NATL ACAD SCI USA, V89, P4603, DOI 10.1073/pnas.89.10.4603; SALKOFF L, 1983, COLD SPRING HARB SYM, V48, P221, DOI 10.1101/SQB.1983.048.01.025; Sambrook J, 1989, MOL CLONING LABORATO; SCHWARZ TL, 1988, NATURE, V331, P137, DOI 10.1038/331137a0; SCHWARZ TL, 1990, NEURON, V2, P119; TANOUYE MA, 1981, P NATL ACAD SCI-BIOL, V78, P6548, DOI 10.1073/pnas.78.10.6548; THUMMEL CS, 1988, GENE, V74, P445, DOI 10.1016/0378-1119(88)90177-1; TIMPE LC, 1988, NATURE, V331, P143, DOI 10.1038/331143a0; TSENGCRANK J, 1991, J NEUROGENET, V7, P229, DOI 10.3109/01677069109167435; WEI A, 1986, SCIENCE, V233, P780, DOI 10.1126/science.2426780; Wu C F, 1992, Ion Channels, V3, P261; YOST HJ, 1986, CELL, V45, P185, DOI 10.1016/0092-8674(86)90382-X; YOST HJ, 1991, MOL CELL BIOL, V11, P1062, DOI 10.1128/MCB.11.2.1062; ZHAO ML, 1995, IN PRESS J NEUROSCI; ZHUANG Y, 1989, Proceedings of the National Academy of Sciences of the United States of America, V86, P2752, DOI 10.1073/pnas.86.8.2752	46	26	26	0	0	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1995	14	3					613	623		10.1016/0896-6273(95)90318-6	http://dx.doi.org/10.1016/0896-6273(95)90318-6			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QP230	7695908	Bronze			2022-12-24	WOS:A1995QP23000015
J	ROBERTSON, LM; KERPPOLA, TK; VENDRELL, M; LUK, D; SMEYNE, RJ; BOCCHIARO, C; MORGAN, JI; CURRAN, T				ROBERTSON, LM; KERPPOLA, TK; VENDRELL, M; LUK, D; SMEYNE, RJ; BOCCHIARO, C; MORGAN, JI; CURRAN, T			REGULATION OF C-FOS EXPRESSION IN TRANSGENIC MICE REQUIRES MULTIPLE INTERDEPENDENT TRANSCRIPTION CONTROL ELEMENTS	NEURON			English	Article							SERUM RESPONSE ELEMENT; GROWTH-FACTOR; NERVOUS-SYSTEM; SEQUENCE ELEMENTS; GENE-EXPRESSION; TERNARY COMPLEX; PROTEIN ELK-1; CYCLIC-AMP; PROMOTER; INDUCTION	Transcription control regions of eukaryotic genes contain multiple sequence elements proposed to function independently to regulate transcription. We developed transgenic mice carrying fos-lacZ fusion genes with clustered point mutations in each of several distinct regulatory sequences: the sis-inducible element, the serum response element, the fos AP-1 site, and the calcium/cAMP response element. Analysis of Fos-lacZ expression in the CNS and in cultured cells demonstrated that all of the regulatory elements tested were required in concert for tissue- and stimulus-specific regulation of the c-fos promoter. This implies that the regulation of c-fos expression requires the concerted action of multiple control elements that direct the assembly of an interdependent transcription complex.	HOFFMANN LA ROCHE INC,DEPT CNS RES,NEUROGENET UNIT,NUTLEY,NJ 07110	Roche Holding	ROBERTSON, LM (corresponding author), ROCHE INST MOLEC BIOL,340 KINGSLAND ST,NUTLEY,NJ 07110, USA.		Morgan, James/GRO-2905-2022; Curran, Tom/C-1164-2008; Morgan, James/N-8104-2018; Curran, Tom/D-7515-2011; Curran, Tom/F-5234-2018; Curran, Thomas/AAE-7631-2019; Kerppola, Tom/AAG-4457-2022; Kerppola, Tom/AFK-6155-2022	Morgan, James/0000-0002-8920-1065; Curran, Tom/0000-0003-1444-7551; Curran, Tom/0000-0003-1444-7551; Curran, Thomas/0000-0003-1444-7551; Kerppola, Tom/0000-0002-0611-9446; Kerppola, Tom/0000-0002-0611-9446; Smeyne, Richard/0000-0002-8459-5472				BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; BERKOWITZ LA, 1989, MOL CELL BIOL, V9, P4272, DOI 10.1128/MCB.9.10.4272; BONIFER C, 1990, EMBO J, V9, P2843, DOI 10.1002/j.1460-2075.1990.tb07473.x; BONNI A, 1993, SCIENCE, V262, P1579; CHAMBERLAIN JW, 1991, MOL CELL BIOL, V11, P3564, DOI 10.1128/MCB.11.7.3564; CURRAN T, 1982, J VIROL, V42, P114, DOI 10.1128/JVI.42.1.114-122.1982; Curran T, 1988, ONCOGENE HDB, P307; DEY A, 1991, DNA CELL BIOL, V10, P537, DOI 10.1089/dna.1991.10.537; EDMONDSON DG, 1992, MOL CELL BIOL, V12, P3665, DOI 10.1128/MCB.12.9.3665; FISCH TM, 1989, GENE DEV, V3, P198, DOI 10.1101/gad.3.2.198; FISCH TM, 1987, MOL CELL BIOL, V7, P3490, DOI 10.1128/MCB.7.10.3490; GILMAN MZ, 1988, GENE DEV, V2, P394, DOI 10.1101/gad.2.4.394; GINTY DD, 1994, CELL, V77, P713, DOI 10.1016/0092-8674(94)90055-8; GRIGORIADIS AE, 1993, J CELL BIOL, V122, P685, DOI 10.1083/jcb.122.3.685; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; HAYES TE, 1987, P NATL ACAD SCI USA, V84, P1272, DOI 10.1073/pnas.84.5.1272; HERRERA RE, 1989, NATURE, V340, P68, DOI 10.1038/340068a0; HILL CS, 1993, CELL, V73, P395, DOI 10.1016/0092-8674(93)90238-L; HIPSKIND RA, 1991, NATURE, V354, P531, DOI 10.1038/354531a0; HUETTNER JE, 1986, J NEUROSCI, V6, P3044; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; JOHNSON RS, 1992, CELL, V71, P577, DOI 10.1016/0092-8674(92)90592-Z; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; MCCAFFREY PG, 1993, SCIENCE, V262, P750, DOI 10.1126/science.8235597; MEYER DJ, 1993, J BIOL CHEM, V269, P4701; MORGAN JI, 1991, TRENDS PHARMACOL SCI, V12, P343, DOI 10.1016/0165-6147(91)90594-I; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; OBERDICK J, 1990, SCIENCE, V248, P223, DOI 10.1126/science.2109351; PALMITER RD, 1993, MOL CELL BIOL, V13, P5266, DOI 10.1128/MCB.13.9.5266; SADOWSKI HB, 1993, SCIENCE, V261, P1739, DOI 10.1126/science.8397445; SASSONECORSI P, 1988, GENE DEV, V2, P1529, DOI 10.1101/gad.2.12a.1529; SASSONECORSI P, 1988, NATURE, V334, P310; SCHILLING KLD, 1991, P NATL ACAD SCI USA, V53, P5665; SHAW PE, 1992, EMBO J, V11, P3011, DOI 10.1002/j.1460-2075.1992.tb05371.x; SHAW PE, 1989, CELL, V56, P563, DOI 10.1016/0092-8674(89)90579-5; SHENG M, 1988, MOL CELL BIOL, V8, P2787, DOI 10.1128/MCB.8.7.2787; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; SMEYNE RJ, 1992, NEURON, V8, P13, DOI 10.1016/0896-6273(92)90105-M; SMEYNE RJ, 1993, NATURE, V363, P166, DOI 10.1038/363166a0; SMEYNE RJ, 1992, MOL BRAIN RES, V16, P158, DOI 10.1016/0169-328X(92)90206-Q; STERN S, 1989, NATURE, V341, P624, DOI 10.1038/341624a0; SWIFT GH, 1989, GENE DEV, V3, P687, DOI 10.1101/gad.3.5.687; TREISMAN R, 1986, CELL, V46, P567, DOI 10.1016/0092-8674(86)90882-2; TREISMAN R, 1992, TRENDS BIOCHEM SCI, V17, P423, DOI 10.1016/0968-0004(92)90013-Y; WAGNER BJ, 1990, EMBO J, V9, P4477, DOI 10.1002/j.1460-2075.1990.tb07898.x; WANG ZQ, 1992, NATURE, V360, P741, DOI 10.1038/360741a0	46	270	273	0	13	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1995	14	2					241	252		10.1016/0896-6273(95)90282-1	http://dx.doi.org/10.1016/0896-6273(95)90282-1			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QH294	7857636	Bronze			2022-12-24	WOS:A1995QH29400004
J	GOMI, H; YOKOYAMA, T; FUJIMOTO, K; IKEDA, T; KATOH, A; ITOH, T; ITOHARA, S				GOMI, H; YOKOYAMA, T; FUJIMOTO, K; IKEDA, T; KATOH, A; ITOH, T; ITOHARA, S			MICE DEVOID OF THE GLIAL FIBRILLARY ACIDIC PROTEIN DEVELOP NORMALLY AND ARE SUSCEPTIBLE TO SCRAPIE PRIONS	NEURON			English	Article							HUMAN GLIOMA-CELLS; MONOCLONAL-ANTIBODY; FILAMENT PROTEIN; RAT-BRAIN; INTERMEDIATE FILAMENTS; NERVOUS-SYSTEM; HOMOLOGOUS RECOMBINATION; KERATIN EXPRESSION; MOLECULAR-BIOLOGY; INCUBATION-TIME	Glial fibrillary acidic protein (GFAP) is an intermediate filament protein specifically expressed in astrocytes in the CNS. To examine the function of GFAP in vivo, the Gfap gene was disrupted by gene targeting in embryonic stem cells. Mice homozygous for the mutation were completely devoid of GFAP but exhibited normal development and showed no obvious anatomical abnormalities in the CNS. When inoculated with infectious scrapie prions, the mutant mice exhibited neuropathological changes typical of prion diseases. Infectious prions accumulated in brains of the mutant mice to a degree similar to that in control littermates. These results suggest that GFAP is not essential for the morphogenesis of the CNS or for astrocytic responses against neuronal injury. The results argue against the hypothesis that GFAP plays a crucial role in the pathogenesis of prion diseases.	NATL INST ANIM HLTH,TSUKUBA,IBARAKI 305,JAPAN; KYOTO UNIV,FAC MED,DEPT ANAT,SAKYO KU,KYOTO 60601,JAPAN	National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; Kyoto University	GOMI, H (corresponding author), KYOTO UNIV,INST VIRUS RES,SAKYO KU,KYOTO 60601,JAPAN.		Itohara, Shigeyoshi/I-8769-2012; Katoh, Akira/B-2683-2010	Itohara, Shigeyoshi/0000-0002-2410-9989; Katoh, Akira/0000-0001-7867-2964				ARTHUR FE, 1987, DEV BRAIN RES, V36, P155, DOI 10.1016/0165-3806(87)90075-7; BARIBAULT H, 1993, GENE DEV, V7, P1191, DOI 10.1101/gad.7.7a.1191; BIANCHI R, 1993, J BIOL CHEM, V269, P12669; Bradley A, 1987, TERATOCARCINOMAS EMB, P113; BROWN HR, 1990, ACTA NEUROPATHOL, V80, P1, DOI 10.1007/BF00294214; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; CARLSON GA, 1988, MOL CELL BIOL, V8, P5528, DOI 10.1128/MCB.8.12.5528; CASHMAN NR, 1990, CELL, V61, P185, DOI 10.1016/0092-8674(90)90225-4; CHIU FC, 1989, NEURON, V2, P1435, DOI 10.1016/0896-6273(89)90189-X; COLLINGE J, 1994, NATURE, V370, P295, DOI 10.1038/370295a0; COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3; DAHL D, 1981, EXP NEUROL, V73, P496, DOI 10.1016/0014-4886(81)90283-1; DEARMOND SJ, 1987, NEUROLOGY, V37, P1271, DOI 10.1212/WNL.37.8.1271; DIEDRICH JF, 1991, P NATL ACAD SCI USA, V88, P375, DOI 10.1073/pnas.88.2.375; ENG LF, 1988, CURRENT ISSUES NEURA, P247; FLIEGNER KH, 1991, INT REV CYTOL, V131, P109, DOI 10.1016/S0074-7696(08)62018-5; FRANKO MC, 1987, P NATL ACAD SCI USA, V84, P3482, DOI 10.1073/pnas.84.10.3482; FREDERIKSEN K, 1988, J NEUROSCI, V8, P1144; HILMERT H, 1984, BIOSCIENCE REP, V4, P165, DOI 10.1007/BF01120313; HIRANO A, 1972, ARCH NEUROL-CHICAGO, V26, P530, DOI 10.1001/archneur.1972.00490120070008; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; ITOHARA S, 1993, CELL, V72, P337, DOI 10.1016/0092-8674(93)90112-4; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; KLYMKOWSKY MW, 1983, J CELL BIOL, V95, P494; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; KRETZSCHMAR HA, 1986, AM J PATHOL, V122, P1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Liem RKH, 1993, CURR OPIN CELL BIOL, V5, P12, DOI 10.1016/S0955-0674(05)80003-1; LUDWIN SK, 1976, J COMP NEUROL, V165, P197, DOI 10.1002/cne.901650206; MACKENZIE A, 1983, J COMP PATHOL, V93, P251, DOI 10.1016/0021-9975(83)90012-9; MANUELIDIS L, 1987, P NATL ACAD SCI USA, V84, P5937, DOI 10.1073/pnas.84.16.5937; MCBURNEY MW, 1991, NUCLEIC ACIDS RES, V19, P5755, DOI 10.1093/nar/19.20.5755; NORENBERG MD, 1994, J NEUROPATH EXP NEUR, V53, P213, DOI 10.1097/00005072-199405000-00001; OESCH B, 1990, BIOCHEMISTRY-US, V29, P5848, DOI 10.1021/bi00476a029; Peters A., 1991, FINE STRUCTURE NERVO; PETITO CK, 1990, J CEREBR BLOOD F MET, V10, P850, DOI 10.1038/jcbfm.1990.141; PIXLEY SKR, 1984, DEV BRAIN RES, V15, P185, DOI 10.1016/0165-3806(84)90096-8; PIXLEY SKR, 1984, DEV BRAIN RES, V15, P201, DOI 10.1016/0165-3806(84)90097-X; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1982, ANN NEUROL, V11, P353, DOI 10.1002/ana.410110406; PRUSS RM, 1981, CELL, V27, P419, DOI 10.1016/0092-8674(81)90383-4; QUINLAN RA, 1983, EUR J BIOCHEM, V132, P477, DOI 10.1111/j.1432-1033.1983.tb07386.x; RAKIC P, 1981, TRENDS NEUROSCI, V4, P184, DOI 10.1016/0166-2236(81)90060-6; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; REESE TS, 1967, J CELL BIOL, V34, P207, DOI 10.1083/jcb.34.1.207; REIER PJ, 1988, PHYSL BASIS FUNCTION, P87; SAPIRSTEIN V S, 1983, Developmental Brain Research, V6, P13; SCHIFFER D, 1986, BRAIN RES, V374, P110, DOI 10.1016/0006-8993(86)90399-9; SCHMECHEL DE, 1979, ANAT EMBRYOL, V156, P115, DOI 10.1007/BF00300010; SCHNITZER J, 1981, J CELL BIOL, V90, P435, DOI 10.1083/jcb.90.2.435; SHINAGAWA M, 1985, MICROBIOL IMMUNOL, V29, P543, DOI 10.1111/j.1348-0421.1985.tb00856.x; STEINERT PM, 1988, ANNU REV BIOCHEM, V57, P593, DOI 10.1146/annurev.bi.57.070188.003113; SZARO BG, 1991, J COMP NEUROL, V308, P576, DOI 10.1002/cne.903080406; TORPEY N, 1992, NATURE, V357, P413, DOI 10.1038/357413a0; VASSAR R, 1991, CELL, V64, P365, DOI 10.1016/0092-8674(91)90645-F; WANG E, 1984, P NATL ACAD SCI-BIOL, V81, P2102, DOI 10.1073/pnas.81.7.2102; WEINSTEIN DE, 1991, J CELL BIOL, V112, P1205, DOI 10.1083/jcb.112.6.1205; WEIR MD, 1984, DEV BRAIN RES, V15, P147, DOI 10.1016/0165-3806(84)90092-0; WIEIGREFE S, 1985, SCIENCE, V230, P1177; XU ZS, 1993, CELL, V73, P23, DOI 10.1016/0092-8674(93)90157-L; YAGI T, 1990, P NATL ACAD SCI USA, V87, P9918, DOI 10.1073/pnas.87.24.9918; YAMASAKI H, 1991, ACTA NEUROPATHOL, V82, P427, DOI 10.1007/BF00293376; YOKOYAMA K, 1981, FEBS LETT, V135, P25, DOI 10.1016/0014-5793(81)80936-2	67	216	222	0	3	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1995	14	1					29	41		10.1016/0896-6273(95)90238-4	http://dx.doi.org/10.1016/0896-6273(95)90238-4			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QC548	7826639	Bronze			2022-12-24	WOS:A1995QC54800004
J	TRAPP, T; RUPPRECHT, R; CASTREN, M; REUL, JMHM; HOLSBOER, F				TRAPP, T; RUPPRECHT, R; CASTREN, M; REUL, JMHM; HOLSBOER, F			HETERODIMERIZATION BETWEEN MINERALOCORTICOID AND GLUCOCORTICOID RECEPTOR - A NEW PRINCIPLE OF GLUCOCORTICOID ACTION IN THE CNS	NEURON			English	Article							RETINOID-X-RECEPTOR; THYROID-HORMONE; NUCLEAR RECEPTORS; MAMMALIAN-CELLS; NERVOUS-SYSTEM; RAT-BRAIN; STEROIDS; ACID; ADRENALECTOMY; HIPPOCAMPUS	In the mammalian central nervous system, responsiveness to glucocorticoids is mediated by both the mineralocorticoid receptor (MR) and the glucocorticoid receptor (GR). These pharmacologically distinct receptors are believed to bind to common response elements as homodimers. We provide evidence that MR and GR can form a heterodimeric complex with DNA-binding and transactivation properties different from those of the respective homodimers. There was a high degree of cooperativity of MR and GR in binding to a glucocorticoid response element. Transient transfection of a neuroblastoma cell line revealed a transcriptional response pattern of coexpressed MR and GR distinct from that obtained by MR or GR alone. Our findings demonstrate that heterodimerization of MR and GR is a hitherto unrecognized principle for the transcriptional regulation of glucocorticold-responsive genes in tissues coexpressing these receptors.			TRAPP, T (corresponding author), MAX PLANCK INST PSYCHIAT,INST CLIN,DEPT NEUROENDOCRINOL,KRAEPELINSTR 10,W-8000 MUNICH,GERMANY.		Reul, Johannes/B-4132-2019	Reul, Johannes/0000-0002-8787-4012				ALNEMRI ES, 1991, J BIOL CHEM, V266, P18072; ARRIZA JL, 1987, SCIENCE, V237, P268, DOI 10.1126/science.3037703; ARRIZA JL, 1988, NEURON, V1, P887, DOI 10.1016/0896-6273(88)90136-5; BAULIEU EE, 1987, J CELL BIOCHEM, V35, P161, DOI 10.1002/jcb.240350209; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BINART N, 1991, P NATL ACAD SCI USA, V88, P10681, DOI 10.1073/pnas.88.23.10681; BOHN MC, 1991, J STEROID BIOCHEM, V40, P105, DOI 10.1016/0960-0760(91)90173-3; CHU G, 1987, NUCLEIC ACIDS RES, V15, P1311, DOI 10.1093/nar/15.3.1311; CIDLOWSKI JA, 1990, MOL ENDOCRINOL, V4, P1427, DOI 10.1210/mend-4-10-1427; DEKLOET ER, 1991, FRONT NEUROENDOCRIN, V12, P95; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; EVANS RM, 1989, NEURON, V2, P1105, DOI 10.1016/0896-6273(89)90177-3; FUNDER JW, 1987, ANNU REV PHYSIOL, V49, P397; HERBOMEL P, 1984, CELL, V39, P653, DOI 10.1016/0092-8674(84)90472-0; HOLLENBERG SM, 1985, NATURE, V318, P635, DOI 10.1038/318635a0; HOLLENBERG SM, 1988, CELL, V55, P899, DOI 10.1016/0092-8674(88)90145-6; KLIEWER SA, 1992, NATURE, V355, P446, DOI 10.1038/355446a0; LANDFIELD PW, 1978, SCIENCE, V202, P1098, DOI 10.1126/science.715460; LOMBES M, 1993, BIOCHEM J, V292, P577, DOI 10.1042/bj2920577; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCEWEN BS, 1986, PHYSIOL REV, V66, P1121, DOI 10.1152/physrev.1986.66.4.1121; MCEWEN BS, 1991, TRENDS PHARMACOL SCI, V12, P141, DOI 10.1016/0165-6147(91)90531-V; PEARCE D, 1993, SCIENCE, V259, P1161, DOI 10.1126/science.8382376; REUL JMHM, 1985, ENDOCRINOLOGY, V117, P2505, DOI 10.1210/endo-117-6-2505; RUPPRECHT R, 1993, NEURON, V11, P523, DOI 10.1016/0896-6273(93)90156-L; RUPPRECHT R, 1993, MOL ENDOCRINOL, V7, P597, DOI 10.1210/me.7.4.597; SAPOLSKY RM, 1991, EXP NEUROL, V114, P246, DOI 10.1016/0014-4886(91)90041-A; SLOVITER RS, 1989, SCIENCE, V243, P535, DOI 10.1126/science.2911756; STRAHLE U, 1987, P NATL ACAD SCI USA, V88, P6092; THOMAS HE, 1993, NATURE, V362, P471, DOI 10.1038/362471a0; TRUSS M, 1993, ENDOCR REV, V14, P459, DOI 10.1210/er.14.4.459; VANEEKELEN JAM, 1988, J NEUROSCI RES, V21, P88, DOI 10.1002/jnr.490210113; ZHANG XK, 1992, NATURE, V355, P441, DOI 10.1038/355441a0	34	241	244	1	6	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1994	13	6					1457	1462		10.1016/0896-6273(94)90431-6	http://dx.doi.org/10.1016/0896-6273(94)90431-6			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PZ689	7993637				2022-12-24	WOS:A1994PZ68900020
J	TONG, G; JAHR, CE				TONG, G; JAHR, CE			BLOCK OF GLUTAMATE TRANSPORTERS POTENTIATES POSTSYNAPTIC EXCITATION	NEURON			English	Article							AMPA KAINATE RECEPTORS; SYNAPTIC CURRENTS; TIME COURSE; HIPPOCAMPAL-NEURONS; RAT-BRAIN; CHANNEL KINETICS; NMDA RECEPTOR; AMINO-ACIDS; DESENSITIZATION; ASPARTATE	We have studied the effects of blockers of glutamate transporters on excitatory synaptic transmission to determine whether transporters increase the clearance rate of transmitter from the synaptic cleft on the millisecond time scale. The transporter blockers Li+ and THA increased the amplitude, but not the decay time, of spontaneous miniature AMPA receptor EPSCs recorded at 34 degrees C but not 24 degrees C. Evoked AMPA receptor EPSCs were similarly affected by THA. The rapidly dissociating AMPA receptor competitive antagonist PDA inhibited evoked AMPA receptor EPSCs less in the presence of THA at both temperatures, implying that transporter blockade slows clearance. We suggest that transporters speed glutamate clearance mainly by binding glutamate and that AMPA receptors are not saturated by synaptically released glutamate at 34 degrees C.	OREGON HLTH SCI UNIV, DEPT CELL BIOL & ANAT, PORTLAND, OR 97201 USA	Oregon Health & Science University	TONG, G (corresponding author), OREGON HLTH SCI UNIV, VOLLUM INST, PORTLAND, OR 97201 USA.		Tong, Gary/AAC-9426-2022		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021419] Funding Source: NIH RePORTER; NINDS NIH HHS [NS21419] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARRIZA JL, 1994, IN PRESS J NEUROSCI; ATTWELL D, 1993, NEURON, V11, P401, DOI 10.1016/0896-6273(93)90145-H; BALCAR VJ, 1977, J NEUROCHEM, V28, P1145, DOI 10.1111/j.1471-4159.1977.tb10682.x; BARBOUR B, 1991, J PHYSIOL-LONDON, V436, P169, DOI 10.1113/jphysiol.1991.sp018545; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; COLLINGRIDGE GL, 1989, PHARMACOL REV, V41, P143; COLQUHOUN D, 1992, J PHYSIOL-LONDON, V458, P261, DOI 10.1113/jphysiol.1992.sp019417; ECCLES JC, 1958, PROC R SOC SER B-BIO, V148, P38, DOI 10.1098/rspb.1958.0003; FORSYTHE ID, 1990, J PHYSIOL-LONDON, V429, P1; GARTHWAITE J, 1985, BRIT J PHARMACOL, V85, P297, DOI 10.1111/j.1476-5381.1985.tb08860.x; HARRIS KM, 1989, J NEUROSCI, V9, P2982; HESTRIN S, 1990, NEURON, V5, P247, DOI 10.1016/0896-6273(90)90162-9; HESTRIN S, 1992, NEURON, V9, P991, DOI 10.1016/0896-6273(92)90250-H; ISAACSON JS, 1993, J NEUROPHYSIOL, V70, P2187, DOI 10.1152/jn.1993.70.5.2187; IVERSEN LL, 1971, BRIT J PHARMACOL, V41, P571, DOI 10.1111/j.1476-5381.1971.tb07066.x; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; KATZ B, 1973, J PHYSIOL-LONDON, V231, P549, DOI 10.1113/jphysiol.1973.sp010248; KORDAS M, 1969, J PHYSIOL-LONDON, V204, P493, DOI 10.1113/jphysiol.1969.sp008926; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; LESTER RAJ, 1993, J NEUROSCI, V13, P1088; LIVSEY CT, 1992, NEURON, V8, P745, DOI 10.1016/0896-6273(92)90095-U; MAGLEBY KL, 1975, J PHYSIOL-LONDON, V244, P467, DOI 10.1113/jphysiol.1975.sp010808; MAGLEBY KL, 1972, J PHYSIOL-LONDON, V223, P151, DOI 10.1113/jphysiol.1972.sp009839; MANABE T, 1992, NATURE, V355, P50, DOI 10.1038/355050a0; MAYER ML, 1987, PROG NEUROBIOL, V28, P197, DOI 10.1016/0301-0082(87)90011-6; MENNERICK S, 1994, NATURE, V368, P59, DOI 10.1038/368059a0; MOORE WJ, 1972, PHYSICAL CHEM; PATNEAU DK, 1993, J NEUROSCI, V13, P3496; PETERSON NA, 1974, BIOCHEM PHARMACOL, V23, P2491, DOI 10.1016/0006-2952(74)90249-4; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; SARANTIS M, 1993, NEURON, V11, P541, DOI 10.1016/0896-6273(93)90158-N; SCHWARTZ EA, 1990, J PHYSIOL-LONDON, V426, P43, DOI 10.1113/jphysiol.1990.sp018126; SHEARDOWN MJ, 1990, SCIENCE, V247, P571, DOI 10.1126/science.2154034; STORCK T, 1992, P NATL ACAD SCI USA, V89, P10955, DOI 10.1073/pnas.89.22.10955; TANG CM, 1991, SCIENCE, V254, P288, DOI 10.1126/science.1681589; TONG G, 1994, NEURON, V12, P51, DOI 10.1016/0896-6273(94)90151-1; TRUSSELL LO, 1993, NEURON, V10, P1185, DOI 10.1016/0896-6273(93)90066-Z; TRUSSELL LO, 1989, NEURON, V3, P209, DOI 10.1016/0896-6273(89)90034-2; VANDERKLOOT W, 1991, PROG NEUROBIOL, V36, P93, DOI 10.1016/0301-0082(91)90019-W; VYKLICKY L, 1991, NEURON, V7, P971, DOI 10.1016/0896-6273(91)90342-W; WYLLIE DJA, 1991, J PHYSIOL-LONDON, V432, P235, DOI 10.1113/jphysiol.1991.sp018383; YAMADA KA, 1993, J NEUROSCI, V13, P3904	44	306	311	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1994	13	5					1195	1203		10.1016/0896-6273(94)90057-4	http://dx.doi.org/10.1016/0896-6273(94)90057-4			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PU763	7946356				2022-12-24	WOS:A1994PU76300015
J	TAJBAKHSH, S; VIVARELLI, E; CUSELLADEANGELIS, G; ROCANCOURT, D; BUCKINGHAM, M; COSSU, G				TAJBAKHSH, S; VIVARELLI, E; CUSELLADEANGELIS, G; ROCANCOURT, D; BUCKINGHAM, M; COSSU, G			A POPULATION OF MYOGENIC CELLS DERIVED FROM THE MOUSE NEURAL-TUBE	NEURON			English	Article							SKELETAL-MUSCLE; TRANSGENIC MICE; NERVOUS-SYSTEM; EXPRESSION; EMBRYO; GENE; DIFFERENTIATION; SOMITES; LINEAGE; MYF-5	Embryonic mouse neural tubes produce a variety of terminally differentiated cells in vitro, mostly neurons and glia. We report here that some of these cells differentiate into skeletal muscle cells. The possibility of mesoderm contamination was ruled out as follows. First, Dil(+) muscle cells were present in cultures from a Dil-labeled neuroepithelium. Second, a small fraction of cultured neural tube cells coexpressed muscle myosin and neuronal pill tubulin within the same cell. Third, embryos generated from embryonic stem cells in which nlacZ was targeted into the myogenic gene myf-5 expressed nlacZ in a localized region of the neural tube. These myf-5(+) cells coexpress neuronal and muscle markers in culture. The developmental significance of this phenomenon is discussed in the context of overlapping regulatory networks between myogenesis and neurogenesis.	INST PASTEUR,DEPT MOLEC BIOL,CNRS,F-75724 PARIS 15,FRANCE	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	TAJBAKHSH, S (corresponding author), UNIV ROME,INST HISTOL & GEN EMBRYOL,I-00161 ROME,ITALY.			Cusella De Angelis, Maria Gabriella/0000-0003-2642-3346	Telethon [A.013] Funding Source: Medline	Telethon(Fondazione Telethon)		BADER D, 1982, J CELL BIOL, V95, P763, DOI 10.1083/jcb.95.3.763; BONNERFRASER M, 1993, BIOESSAYS, V15, P221; BRUNNER G, 1982, CELL TISSUE RES, V224, P665; BUCKINGHAM M, 1992, TRENDS GENET, V8, P144, DOI 10.1016/0168-9525(92)90373-C; BUCKINGHAM M, 1993, CR ACAD SCI III-VIE, V316, P1040; CHENG TC, 1992, J CELL BIOL, V119, P1649, DOI 10.1083/jcb.119.6.1649; CUSELLADEANGELIS MG, 1992, J CELL BIOL, V116, P1243, DOI 10.1083/jcb.116.5.1243; DELVECCHIO G, 1934, OSP PSICHIATR, V2, P1; DEVITRY F, 1994, CR ACAD SCI III-VIE, V317, P332; DIMITROVA Z, 1901, NEVRAXE, V2, P259; EASTER SS, 1993, J NEUROSCI, V13, P285; Emerson CP, 1993, CURR OPIN CELL BIOL, V5, P1057, DOI 10.1016/0955-0674(93)90092-5; FAUST C, 1993, CURR OPIN GENET DEV, V3, P491, DOI 10.1016/0959-437X(93)90125-9; GODINA G., 1939, MONITORE ZOOL ITALIANO, V50, P39; GURDON JB, 1993, CELL, V75, P501; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; HOFFMAN SF, 1971, J NEUROL NEUROSUR PS, V34, P761, DOI 10.1136/jnnp.34.6.761; KRENN V, 1988, ANAT EMBRYOL, V179, P49, DOI 10.1007/BF00305099; LAWSON KA, 1991, DEVELOPMENT, V113, P891; LENNON VA, 1979, NATURE, V281, P586, DOI 10.1038/281586a0; LI Z, 1993, DEVELOPMENT, V117, P947; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; NODEN DM, 1983, AM J ANAT, V168, P257, DOI 10.1002/aja.1001680302; OHANIAN C, 1968, ACTA ANAT, V71, P108; ORDAHL CP, 1992, DEVELOPMENT, V114, P339; OTT MO, 1991, DEVELOPMENT, V111, P1097; Pappenheimer AM, 1910, VIRCHOWS ARCH A, V200, P122, DOI 10.1007/BF01949541; QUAY WB, 1959, ANAT REC, V133, P57, DOI 10.1002/ar.1091330107; RONG PM, 1992, DEVELOPMENT, V114, P339; RUBINSTEIN LJ, 1985, J NEUROSURG, V62, P785; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; SANTERRE RF, 1993, MOL CELL BIOL, V13, P6044, DOI 10.1128/MCB.13.10.6044; SCHUBERT D, 1974, NATURE, V249, P224, DOI 10.1038/249224a0; SELLECK MAJ, 1991, DEVELOPMENT, V112, P615; SERBEDZIJA GN, 1990, DEVELOPMENT, V108, P605; TAJBAKHSH S, 1994, P NATL ACAD SCI USA, V91, P747, DOI 10.1073/pnas.91.2.747; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; VALZ NLM, 1991, NEW BIOL, V3, P364; VIVARELLI E, 1986, DEV BIOL, V117, P319, DOI 10.1016/0012-1606(86)90374-X; VOSS H, 1964, NERV ANAT ANZ, V115, P469; Wachtler F., 1992, SEMIN DEV BIOL, V3, P217; Walsh F. S., 1991, SEMIN NEUROSCI, V3, P271	43	113	117	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1994	13	4					813	821		10.1016/0896-6273(94)90248-8	http://dx.doi.org/10.1016/0896-6273(94)90248-8			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PP533	7946330				2022-12-24	WOS:A1994PP53300005
J	CONDRON, BG; PATEL, NH; ZINN, K				CONDRON, BG; PATEL, NH; ZINN, K			ENGRAILED CONTROLS GLIAL/NEURONAL CELL FATE DECISIONS AT THE MIDLINE OF THE CENTRAL-NERVOUS-SYSTEM	NEURON			English	Article							DROSOPHILA CNS; EMBRYONIC-DEVELOPMENT; GRASSHOPPER EMBRYOS; AXON PATHWAYS; GROWTH CONES; GENE; EXPRESSION; PROTEIN; NEUROGENESIS; PATTERN	The molecular mechanisms involved in glial/neuronal fate decisions during embryonic development are largely unknown. Here we show that the segment-polarity gene engrailed, which encodes a homeodomain protein, controls these decisions within an insect CNS lineage. The grasshopper median neuroblast (MNB) generates both neurons and midline glia in distinct temporal phases. engrailed expression in MNB progeny can be inhibited by injection of antisense oligodeoxynucleotides into the MNB nucleus. This produces a phenotype in which the midline glia do not develop and extra midline neurons are generated. In the absence of engrailed function, midline glial precursors are apparently converted into neuronal precursors. Thus, engrailed is required for execution of the decision between the glial and neuronal fates.	CARNEGIE INST WASHINGTON,DEPT EMBRYOL,BALTIMORE,MD 21210	Carnegie Institution for Science	CONDRON, BG (corresponding author), CALTECH,DIV BIOL,PASADENA,CA 91125, USA.		Condron, Barry/AAX-3952-2020	Condron, Barry/0000-0003-2610-5065; Patel, Nipam/0000-0003-4328-654X	NIGMS NIH HHS [GM47268] Funding Source: Medline; NINDS NIH HHS [NS28182] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM047268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028182] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARRES BA, 1993, CURR BIOL, V3, P489, DOI 10.1016/0960-9822(93)90039-Q; BASTIANI MJ, 1992, DEV BIOL, V154, P129, DOI 10.1016/0012-1606(92)90054-K; BATE CM, 1981, J EMBRYOL EXP MORPH, V61, P317; CHULAGRAFF Q, 1993, SCIENCE, V261, P1594, DOI 10.1126/science.8372355; CONDRON BG, 1994, IN PRESS J NEUROSCI; DESAL CJ, IN PRESS J NEUROSCI; DOE CQ, 1988, NATURE, V333, P376, DOI 10.1038/333376a0; DOE CQ, 1988, SCIENCE, V239, P170, DOI 10.1126/science.2892267; DOE CQ, 1992, DEVELOPMENT, V116, P855; DUFFY JB, 1991, DEVELOPMENT, V113, P1223; Goodman Corey S., 1993, P1131; GOODMAN CS, 1982, NEURONAL DEV; GUTJAHR T, 1993, DEVELOPMENT, V118, P21; JACOBS JR, 1989, J NEUROSCI, V9, P2412; JACOBS JR, 1989, J NEUROSCI, V9, P2402; JAN LY, 1982, P NATL ACAD SCI-BIOL, V79, P2700, DOI 10.1073/pnas.79.8.2700; JOYNER AL, 1991, SCIENCE, V251, P1239, DOI 10.1126/science.1672471; Joyner Alexandra L., 1991, Seminars in Developmental Biology, V2, P435; KATZ F, 1988, EMBO J, V7, P3471, DOI 10.1002/j.1460-2075.1988.tb03222.x; KLAMBT C, 1991, CELL, V64, P801, DOI 10.1016/0092-8674(91)90509-W; KLAMBT C, 1991, GLIA, V4, P205, DOI 10.1002/glia.440040212; KLEUSS C, 1992, NATURE, V358, P424, DOI 10.1038/358424a0; KLEUSS C, 1991, NATURE, V353, P43, DOI 10.1038/353043a0; KLEUSS C, 1993, SCIENCE, V259, P832, DOI 10.1126/science.8094261; LAWRENCE PA, 1984, EMBO J, V3, P2839, DOI 10.1002/j.1460-2075.1984.tb02217.x; LOGAN C, 1993, DEVELOPMENT, V117, P905; Martinez Arias Alfonso, 1993, P517; MERRITT DJ, 1993, NEURON, V10, P741, DOI 10.1016/0896-6273(93)90174-P; MILLEN KJ, 1994, DEVELOPMENT, V120, P695; MYERS PZ, 1993, J NEUROSCI, V13, P127; PATEL NH, 1992, NATURE, V357, P339, DOI 10.1038/357339a0; PATEL NH, 1989, GENE DEV, V3, P890, DOI 10.1101/gad.3.6.890; PATEL NH, 1989, CELL, V58, P955, DOI 10.1016/0092-8674(89)90947-1; SHAH NM, 1994, CELL, V77, P349, DOI 10.1016/0092-8674(94)90150-3; SHEPHERD D, 1990, DEVELOPMENT, V108, P83; SINGER MA, 1992, DEV BIOL, V154, P143, DOI 10.1016/0012-1606(92)90055-L; SINK H, 1991, DEVELOPMENT, V112, P307; SNOW PM, 1987, J NEUROSCI, V7, P4137; TAGHERT PH, 1984, J NEUROSCI, V4, P989; THOMAS JB, 1984, NATURE, V310, P203, DOI 10.1038/310203a0; THOMPSON KJ, 1991, J COMP NEUROL, V305, P659, DOI 10.1002/cne.903050409; UDOLPH G, 1993, DEVELOPMENT, V118, P765; UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0	43	77	80	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1994	13	3					541	554		10.1016/0896-6273(94)90024-8	http://dx.doi.org/10.1016/0896-6273(94)90024-8			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PJ284	7917290				2022-12-24	WOS:A1994PJ28400004
J	STUART, G; HAUSSER, M				STUART, G; HAUSSER, M			INITIATION AND SPREAD OF SODIUM ACTION-POTENTIALS IN CEREBELLAR PURKINJE-CELLS	NEURON			English	Article							ELECTRO-PHYSIOLOGICAL PROPERTIES; HIPPOCAMPAL-NEURONS; DENDRITES; INVITRO; SLICES; RECORDINGS; ANKYRIN; PATTERN; VOLTAGE; BRAIN	Simultaneous whole-cell recordings were made from the soma and dendrites of cerebellar Purkinje cells in rat brain slices. Sodium action potentials, evoked by either depolarizing current pulses or synaptic stimulation of parallel or climbing fibers, always occurred first at the soma and decreased in amplitude with increasing distance into the dendrites. Simultaneous somatic and axonal recordings showed that these action potentials were initiated in the axon. Outside-out patches excised from the soma and dendrites revealed that the sodium channel current density decreased with distance from the soma. Consistent with this finding, comparable attenuation was observed for evoked action potentials and simulated action potential waveforms when sodium channels were blocked. These results show that sodium action potentials in cerebellar Purkinje cells are initiated in the axon and then spread passively into the dendritic tree.			STUART, G (corresponding author), MAX PLANCK INST MED RES,ZELLPHYSIOL ABT,POSTFACH 103820,D-69028 HEIDELBERG,GERMANY.		Hausser, Michael/AAW-6827-2020; stuart, greg j/F-7328-2011	Hausser, Michael/0000-0002-2673-8957; stuart, greg/0000-0001-9395-2219				BABITCH JA, 1993, NEUROSCIENCE, V54, P1063, DOI 10.1016/0306-4522(93)90596-8; COOMBS JS, 1957, J PHYSIOL-LONDON, V139, P198, DOI 10.1113/jphysiol.1957.sp005887; CREPEL F, 1986, J PHYSIOL-LONDON, V372, P1; Eccles JC, 1967, CEREBELLUM NEURONAL; FATT P, 1957, J NEUROPHYSIOL, V20, P61, DOI 10.1152/jn.1957.20.1.61; FUORTES MGF, 1957, J GEN PHYSIOL, V40, P735, DOI 10.1085/jgp.40.5.735; GAHWILER BH, 1989, J PHYSIOL-LONDON, V417, P105; HOUNSGAARD J, 1988, J PHYSIOL-LONDON, V402, P731, DOI 10.1113/jphysiol.1988.sp017231; HOUNSGAARD J, 1979, EXP BRAIN RES, V37, P387; JAFFE DB, 1992, NATURE, V357, P244, DOI 10.1038/357244a0; JEFFERYS JGR, 1979, J PHYSIOL-LONDON, V289, P375, DOI 10.1113/jphysiol.1979.sp012742; kandel, 1977, NERVOUS SYSTEM, V1; LASSERROSS N, 1992, P ROY SOC B-BIOL SCI, V247, P35, DOI 10.1098/rspb.1992.0006; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P171, DOI 10.1113/jphysiol.1980.sp013357; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P197, DOI 10.1113/jphysiol.1980.sp013358; Llinas R., 1992, CEREBELLUM REVISITED, P167; MIYAKAWA H, 1986, BRAIN RES, V399, P303, DOI 10.1016/0006-8993(86)91520-9; MOORE JW, 1983, J PHYSIOL-LONDON, V336, P301, DOI 10.1113/jphysiol.1983.sp014582; RAPP M, 1994, J PHYSIOL-LONDON, V474, P101, DOI 10.1113/jphysiol.1994.sp020006; REGEHR W, 1993, NEURON, V11, P145, DOI 10.1016/0896-6273(93)90278-Y; REGEHR WG, 1992, P NATL ACAD SCI USA, V89, P5492, DOI 10.1073/pnas.89.12.5492; Sakmann B, 1983, SINGLE CHANNEL RECOR, P37; SHELTON DP, 1985, NEUROSCIENCE, V14, P111, DOI 10.1016/0306-4522(85)90168-X; SPENCER WA, 1961, J NEUROPHYSIOL, V24, P272, DOI 10.1152/jn.1961.24.3.272; SPRUSTON N, 1994, TRENDS NEUROSCI, V17, P161, DOI 10.1016/0166-2236(94)90094-9; SRINIVASAN Y, 1988, NATURE, V333, P177, DOI 10.1038/333177a0; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; TURNER RW, 1989, J NEUROPHYSIOL, V62, P1375, DOI 10.1152/jn.1989.62.6.1375; WONG RKS, 1979, P NATL ACAD SCI USA, V76, P986, DOI 10.1073/pnas.76.2.986	31	256	260	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1994	13	3					703	712		10.1016/0896-6273(94)90037-X	http://dx.doi.org/10.1016/0896-6273(94)90037-X			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PJ284	7917300				2022-12-24	WOS:A1994PJ28400017
J	NAKAMURA, M; OKANO, H; BLENDY, JA; MONTELL, C				NAKAMURA, M; OKANO, H; BLENDY, JA; MONTELL, C			MUSASHI, A NEURAL RNA-BINDING PROTEIN REQUIRED FOR DROSOPHILA ADULT EXTERNAL SENSORY ORGAN DEVELOPMENT	NEURON			English	Article							ACHAETE-SCUTE COMPLEX; PERIPHERAL NERVOUS-SYSTEM; LOOP-HELIX PROTEINS; CELL FATE; PRONEURAL CLUSTERS; PRIMARY TRANSCRIPT; GENE-PRODUCT; SEX-LETHAL; WING DISK; MELANOGASTER	A family of neural RNA-binding proteins has recently been described in both vertebrates and invertebrates. We have identified a new member of this family, the Drosophila musashi (msi) locus, which is required for development of adult external sensory organs (sensilla). In contrast with wild-type sensilla, which contain two outer support cells, the msi mutation typically results in the appearance of extra outer support cells. The msi putative RNA-binding protein is localized to the nucleus and appears to be expressed in all cells in each sensillum and predominantly in neurons during embryogenesis. We propose that the msi protein regulates sensillum development by controlling the expression of target genes at the posttranscriptional level.	JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205	Johns Hopkins University	NAKAMURA, M (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT BIOL CHEM,BALTIMORE,MD 21205, USA.		Okano, Hideyuki/I-7584-2019; Montell, Craig/AAH-3357-2021	Montell, Craig/0000-0001-5637-1482				BANG AG, 1991, DEVELOPMENT, V111, P89; BELLEN HJ, 1992, GENE DEV, V6, P2125, DOI 10.1101/gad.6.11.2125; BIER E, 1988, SCIENCE, V240, P913, DOI 10.1126/science.3129785; BODMER R, 1989, NEURON, V3, P21, DOI 10.1016/0896-6273(89)90112-8; BRAND M, 1993, DEVELOPMENT, V119, P1; BROWN JL, 1991, EMBO J, V10, P665, DOI 10.1002/j.1460-2075.1991.tb07995.x; CABRERA CV, 1991, EMBO J, V10, P2965, DOI 10.1002/j.1460-2075.1991.tb07847.x; CAUDY M, 1988, CELL, V55, P1061, DOI 10.1016/0092-8674(88)90250-4; CUBAS P, 1991, GENE DEV, V5, P996, DOI 10.1101/gad.5.6.996; DAMBLYCHAUDIERE C, 1987, GENE DEV, V1, P297, DOI 10.1101/gad.1.3.297; DAMBLYCHAUDIERE C, 1988, ROUX ARCH DEV BIOL, V197, P419, DOI 10.1007/BF00398993; DELPRADO JM, 1984, W ROUX ARCH DEV BIOL, V193, P242; DREYFUSS G, 1988, TRENDS BIOCHEM SCI, V13, P86, DOI 10.1016/0968-0004(88)90046-1; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; ELLIS HM, 1990, CELL, V61, P27, DOI 10.1016/0092-8674(90)90212-W; GHYSEN A, 1993, GENE DEV, V7, P723, DOI 10.1101/gad.7.5.723; GHYSEN A, 1989, DEVELOPMENT, V105, P35; GOOD PJ, 1993, NUCLEIC ACIDS RES, V21, P999, DOI 10.1093/nar/21.4.999; GORIELY A, 1991, DEVELOPMENT, V113, P1395; HARRISON SD, 1990, EMBO J, V9, P207, DOI 10.1002/j.1460-2075.1990.tb08097.x; HARTENSTEIN V, 1990, DEV BIOL, V142, P13, DOI 10.1016/0012-1606(90)90147-B; HARTENSTEIN V, 1989, DEVELOPMENT, V107, P389; HEDLEY ML, 1991, CELL, V65, P579, DOI 10.1016/0092-8674(91)90090-L; HEITZLER P, 1991, CELL, V64, P1083, DOI 10.1016/0092-8674(91)90263-X; HORTSCH M, 1990, NEURON, V4, P697, DOI 10.1016/0896-6273(90)90196-M; HOSHIJIMA K, 1991, SCIENCE, V252, P833, DOI 10.1126/science.1902987; HUANG F, 1991, DEVELOPMENT, V111, P1087; INOUE K, 1992, P NATL ACAD SCI USA, V89, P8092, DOI 10.1073/pnas.89.17.8092; INOUE K, 1990, NATURE, V344, P461, DOI 10.1038/344461a0; JAN YN, 1990, TRENDS NEUROSCI, V13, P493, DOI 10.1016/0166-2236(90)90083-M; JARMAN AP, 1993, DEVELOPMENT, V119, P19; KARPEN GH, 1992, GENETICS, V132, P737; KENAN DJ, 1991, TRENDS BIOCHEM SCI, V16, P214, DOI 10.1016/0968-0004(91)90088-D; KHAN FA, 1991, FEBS LETT, V290, P159, DOI 10.1016/0014-5793(91)81249-8; KIM YJ, 1993, J NEUROSCI, V13, P1045; Lees AD, 1942, PROC R SOC SER B-BIO, V131, P87, DOI 10.1098/rspb.1942.0019; LI H, 1991, CELL, V67, P335, DOI 10.1016/0092-8674(91)90185-2; Lindsley D.L., 1992, GENOME DROSOPHILA ME, P1075; MANIATIS T, 1978, CELL, V15, P687, DOI 10.1016/0092-8674(78)90036-3; MANIATIS T, 1991, SCIENCE, V251, P33, DOI 10.1126/science.1824726; MARTINEZ C, 1991, SCIENCE, V251, P1485, DOI 10.1126/science.1900954; MATTOX W, 1992, J BIOL CHEM, V267, P19023; MATUNIS EL, 1992, J CELL BIOL, V116, P257, DOI 10.1083/jcb.116.2.257; MISMER D, 1987, GENETICS, V116, P565; MONTELL C, 1988, CELL, V52, P757, DOI 10.1016/0092-8674(88)90413-8; MORGAN BA, 1986, EMBO J, V5, P3335, DOI 10.1002/j.1460-2075.1986.tb04648.x; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; NASH D, 1970, GENETICS, V64, P471; PALKA J, 1990, DEVELOPMENT, V109, P167; PARKS AL, 1993, DEV BIOL, V157, P484, DOI 10.1006/dbio.1993.1151; PATEL NH, 1989, CELL, V58, P955, DOI 10.1016/0092-8674(89)90947-1; Pirrotta V., 1986, DROSOPHILA PRACTICAL, P83; POSAKONY M, 1994, CELL, V76, P415; REA D, 1992, EMBO J, V11, P1035; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; RICHTER K, 1990, New Biologist, V2, P556; ROBINOW S, 1991, J NEUROBIOL, V22, P443, DOI 10.1002/neu.480220503; ROBINOW S, 1988, SCIENCE, V242, P1570, DOI 10.1126/science.3144044; ROMANI S, 1989, GENE DEV, V3, P997, DOI 10.1101/gad.3.7.997; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; RUBIN GM, 1990, RUBIN LAB METHODS, P16; RUIZGOMEZ M, 1993, EMBO J, V12, P1121, DOI 10.1002/j.1460-2075.1993.tb05753.x; RUTHER U, 1983, EMBO J, V2, P1791, DOI 10.1002/j.1460-2075.1983.tb01659.x; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHWEISGUTH F, 1992, CELL, V69, P1199, DOI 10.1016/0092-8674(92)90641-O; SIEFERT HS, 1986, P NATL ACAD SCI USA, V83, P735; SIMPSON P, 1990, DEVELOPMENT, V110, P927; SIMPSON P, 1990, DEVELOPMENT, V109, P509; SKEATH JB, 1991, GENE DEV, V5, P984, DOI 10.1101/gad.5.6.984; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; SZABO A, 1991, CELL, V67, P325, DOI 10.1016/0092-8674(91)90184-Z; UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0; VASSIN H, 1985, J NEUROGENET, V2, P291, DOI 10.3109/01677068509102325; VILLARES R, 1987, CELL, V50, P415, DOI 10.1016/0092-8674(87)90495-8; XIONG WC, 1993, GENE DEV, V7, P1085, DOI 10.1101/gad.7.6.1085; YAO KM, 1993, J NEUROBIOL, V24, P723, DOI 10.1002/neu.480240604; Yoshikawa E., 1981, MUSASHI; ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2	79	270	290	1	18	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1994	13	1					67	81		10.1016/0896-6273(94)90460-X	http://dx.doi.org/10.1016/0896-6273(94)90460-X			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NZ247	8043282				2022-12-24	WOS:A1994NZ24700006
J	MEFFERT, MK; PREMACK, BA; SCHULMAN, H				MEFFERT, MK; PREMACK, BA; SCHULMAN, H			NITRIC-OXIDE STIMULATES CA2+-INDEPENDENT SYNAPTIC VESICLE RELEASE	NEURON			English	Article							LONG-TERM POTENTIATION; DEPENDENT PROTEIN-KINASE; FROG NEUROMUSCULAR-JUNCTION; SOLUBLE GUANYLATE-CYCLASE; MOTOR-NERVE TERMINALS; L-ARGININE; TRANSMITTER RELEASE; HIPPOCAMPAL SLICES; SUPERFUSION SYSTEM; CALCIUM CHANNELS	A new fluorescence method using the dye FM1-43 was used to examine exocytotic release from hippocampal synaptosomes. Nitric oxide caused a marked transient stimulation of vesicle release. Several structurally unrelated nitric oxide donors, sodium nitroprusside, S-nitroso-N-acetylpenicillamine, 3-morpholino-sydnonimine, and acidified sodium nitrite, were effective. Release stimulated by nitric oxide and KCl were comparable in time course, using both the fluorescence assay and [H-3]L-glutamate to monitor neurotransmitter release. Activation of guanylyl: cyclase was not responsible for nitric oxide-stimulated release. Unlike release stimulated by KCl or A23187, nitric oxide-stimulated release was found to be independent of a rise in intrasynaptosomal Ca2+. Indo-1/AM measurements indicated that nitric oxide actually decreased intracellular Ca2+, and the Ca2+ channel blocker Cd2+ did not affect nitric oxide-stimulated vesicle release. Nitric oxide does, however, appear to act on the Ca2+-sensitive pool of vesicles. Nitric oxide may be the first physiological mediator that induces vesicle exocytosis without raising Ca2+ and may provide an interesting new tool for the study of molecules involved in vesicle exocytosis.	STANFORD UNIV, SCH MED, DEPT MED, STANFORD, CA 94305 USA	Stanford University	MEFFERT, MK (corresponding author), STANFORD UNIV, SCH MED, DEPT NEUROBIOL, STANFORD, CA 94305 USA.				NIGMS NIH HHS [GM07065] Funding Source: Medline; NIMH NIH HHS [NIMH MH48108] Funding Source: Medline; NINDS NIH HHS [NS07280] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH048108] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BARRIE AP, 1993, J NEUROCHEM, V60, P1081; BETZ WJ, 1993, J PHYSIOL-LONDON, V460, P287, DOI 10.1113/jphysiol.1993.sp019472; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; BETZ WJ, 1992, NEURON, V9, P805, DOI 10.1016/0896-6273(92)90235-6; BLAYNEY LM, 1991, BIOCHEM J, V273, P803, DOI 10.1042/bj2730803; BOHME GA, 1991, EUR J PHARMACOL, V199, P379, DOI 10.1016/0014-2999(91)90505-K; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; COSTA A, 1993, BRAIN RES, V605, P187, DOI 10.1016/0006-8993(93)91739-F; DESAI KM, 1991, NATURE, V351, P477, DOI 10.1038/351477a0; DOERNER D, 1988, NEURON, V1, P693, DOI 10.1016/0896-6273(88)90168-7; DUMAN RS, 1993, J NEUROCHEM, V61, P1542, DOI 10.1111/j.1471-4159.1993.tb13652.x; GALLY JA, 1990, P NATL ACAD SCI USA, V87, P3547, DOI 10.1073/pnas.87.9.3547; GEIGER J, 1992, P NATL ACAD SCI USA, V89, P1031, DOI 10.1073/pnas.89.3.1031; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HALEY JE, 1992, NEURON, V8, P211, DOI 10.1016/0896-6273(92)90288-O; HALEY JE, 1993, NEUROSCI LETT, V160, P85, DOI 10.1016/0304-3940(93)90919-C; HATA Y, 1993, NEURON, V10, P307, DOI 10.1016/0896-6273(93)90320-Q; HAUGLAND RP, 1994, MOL PROBES HDB FLUOR; HESS DT, 1993, NATURE, V366, P562, DOI 10.1038/366562a0; JAHN R, 1994, ANNU REV NEUROSCI, V17, P219, DOI 10.1146/annurev.ne.17.030194.001251; KNOWLES RG, 1989, P NATL ACAD SCI USA, V86, P5159, DOI 10.1073/pnas.86.13.5159; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; LONART G, 1992, EUR J PHARMACOL, V220, P271, DOI 10.1016/0014-2999(92)90759-W; MALENKA RC, 1991, NEURON, V6, P53, DOI 10.1016/0896-6273(91)90121-F; MARCINKIEWICZ J, 1993, IMMUNOLOGY, V80, P146; MAYER B, 1992, J NEUROCHEM, V59, P2024; MCNAUGHTON BL, 1978, BRAIN RES, V157, P277, DOI 10.1016/0006-8993(78)90030-6; MERY PF, 1991, P NATL ACAD SCI USA, V88, P1197, DOI 10.1073/pnas.88.4.1197; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; MONTAGUE PR, 1994, SCIENCE, V263, P973, DOI 10.1126/science.7508638; MULSCH A, 1988, J PHARMACOL EXP THER, V247, P283; NAGY A, 1984, J NEUROCHEM, V43, P1114, DOI 10.1111/j.1471-4159.1984.tb12851.x; NICHOLLS DG, 1987, J NEUROCHEM, V49, P50, DOI 10.1111/j.1471-4159.1987.tb03393.x; NICHOLLS DG, 1986, NATURE, V321, P772, DOI 10.1038/321772a0; ODELL TJ, 1991, P NATL ACAD SCI USA, V88, P11285, DOI 10.1073/pnas.88.24.11285; PETRENKO AG, 1991, NATURE, V353, P65, DOI 10.1038/353065a0; POENIE M, 1990, CELL CALCIUM, V11, P85, DOI 10.1016/0143-4160(90)90062-Y; PRAST H, 1992, EUR J PHARMACOL, V216, P139, DOI 10.1016/0014-2999(92)90223-Q; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; SCHMIDT HHHW, 1992, SCIENCE, V255, P721, DOI 10.1126/science.1371193; SCHUMAN EM, 1991, SCIENCE, V254, P1503, DOI 10.1126/science.1720572; SCHUMAN EM, 1994, SCIENCE, V263, P532, DOI 10.1126/science.8290963; SPERELAKIS N, 1990, MOL CELL BIOCHEM, V99, P97; STAFFORD SJV, 1993, BIOSCIENCE REP, V13, P9, DOI 10.1007/BF01138174; Sudhof TC, 1989, CURR OPIN CELL BIOL, V1, P655, DOI 10.1016/0955-0674(89)90030-6; TOHSE N, 1991, CIRC RES, V69, P325, DOI 10.1161/01.RES.69.2.325; TURNER TJ, 1989, ANAL BIOCHEM, V178, P8, DOI 10.1016/0003-2697(89)90347-3; TURNER TJ, 1991, ANN NY ACAD SCI, V635, P497, DOI 10.1111/j.1749-6632.1991.tb36538.x; TURNER TJ, 1989, BIOCHEMISTRY-US, V28, P586, DOI 10.1021/bi00428a026; VERHAGE M, 1992, J NEUROCHEM, V58, P1313, DOI 10.1111/j.1471-4159.1992.tb11344.x; YATES SL, 1992, J NEUROSCI RES, V32, P255, DOI 10.1002/jnr.490320215; ZHU XZ, 1992, J NEUROCHEM, V59, P932, DOI 10.1111/j.1471-4159.1992.tb08332.x	53	248	252	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	1994	12	6					1235	1244		10.1016/0896-6273(94)90440-5	http://dx.doi.org/10.1016/0896-6273(94)90440-5			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NT463	7912090				2022-12-24	WOS:A1994NT46300005
J	KAWASAKI, M; UCHIDA, S; MONKAWA, T; MIYAWAKI, A; MIKOSHIBA, K; MARUMO, F; SASAKI, S				KAWASAKI, M; UCHIDA, S; MONKAWA, T; MIYAWAKI, A; MIKOSHIBA, K; MARUMO, F; SASAKI, S			CLONING AND EXPRESSION OF A PROTEIN-KINASE C-REGULATED CHLORIDE CHANNEL ABUNDANTLY EXPRESSED IN RAT-BRAIN NEURONAL CELLS	NEURON			English	Article							IMMUNOCYTOCHEMICAL LOCALIZATION; CYSTIC-FIBROSIS; FUNCTIONAL EXPRESSION; RECEPTOR SHOWS; PHORBOL ESTERS; ION CHANNELS; K+ CHANNELS; HIPPOCAMPUS; INHIBITION; VOLUME	cDNA (CIC-3) encoding a protein kinase C-regulated chloride channel was cloned and characterized. The open reading frame encodes 760 amino acids, which possess significant amino acid identity with previously cloned CIC chloride channels. The chloride currents expressed in Xenopus oocytes injected with CIC-3 cRNA were completely blocked by activation of protein kinase C by 12-O-tetradecanoylphorbol 13-acetate. Abundant expression of CIC-3, mRNA was observed in rat brain, especially in the olfactory bulb, hippocampus, and cerebellum. These findings suggest that CIC-3 may play an important role in neuronal cell function through regulation of membrane excitability by protein kinase C.	UNIV TOKYO,INST MED SCI,DEPT MOLEC NEUROL,MINATO KU,TOKYO 108,JAPAN; KEIO UNIV,SCH MED,DEPT INTERNAL MED,SHINJUKU KU,TOKYO 160,JAPAN	University of Tokyo; Keio University	KAWASAKI, M (corresponding author), TOKYO MED & DENT UNIV,SCH MED,DEPT INTERNAL MED 2,BUNKYO KU,1-5-45 YUSHIMA,TOKYO 113,JAPAN.		Uchida, Shinichi/D-1111-2013; Miyawaki, Atsushi/K-3569-2014; Mikoshiba, Katsuhiko/N-7943-2015; Monkawa, Toshiaki/F-2361-2010	Miyawaki, Atsushi/0000-0002-2329-3235; Monkawa, Toshiaki/0000-0002-7876-7661				BRETAG AH, 1987, PHYSIOL REV, V67, P618, DOI 10.1152/physrev.1987.67.2.618; BUSCH AE, 1992, SCIENCE, V255, P1705, DOI 10.1126/science.1553557; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; GRUNDER S, 1992, NATURE, V360, P759, DOI 10.1038/360759a0; Higuchi R., 1989, PCR TECHNOLOGY, P61; HOSODA K, 1989, P NATL ACAD SCI USA, V86, P1393, DOI 10.1073/pnas.86.4.1393; HYDE SC, 1990, NATURE, V346, P362, DOI 10.1038/346362a0; ITO A, 1990, P NATL ACAD SCI USA, V87, P3195, DOI 10.1073/pnas.87.8.3195; JAN LY, 1992, CELL, V69, P715, DOI 10.1016/0092-8674(92)90280-P; JENTSCH TJ, 1990, NATURE, V348, P510, DOI 10.1038/348510a0; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; KOCH MC, 1992, NATURE, V257, P797; KOSE A, 1990, BRAIN RES, V518, P209, DOI 10.1016/0006-8993(90)90974-G; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8123; KURAHASHI T, 1993, NATURE, V363, P71, DOI 10.1038/363071a0; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; MADISON DV, 1986, NATURE, V321, P695, DOI 10.1038/321695a0; MALENKA RC, 1986, NATURE, V321, P175, DOI 10.1038/321175a0; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MAYER ML, 1985, J PHYSIOL-LONDON, V364, P217, DOI 10.1113/jphysiol.1985.sp015740; MCCANN JD, 1990, ANNU REV PHYSIOL, V52, P115; NAKAGAWA T, 1991, J NEUROCHEM, V57, P1807, DOI 10.1111/j.1471-4159.1991.tb06385.x; OLDS JL, 1989, SCIENCE, V245, P866, DOI 10.1126/science.2772638; RIORDAN JR, 1989, SCIENCE, V245, P1066; SAITO N, 1989, P NATL ACAD SCI USA, V86, P3409, DOI 10.1073/pnas.86.9.3409; SCHOFIELD PR, 1987, NATURE, V328, P221, DOI 10.1038/328221a0; SHUSTER MJ, 1985, NATURE, V313, P392, DOI 10.1038/313392a0; STEINMEYER K, 1991, NATURE, V354, P301, DOI 10.1038/354301a0; STEINMEYER K, 1991, NATURE, V354, P304, DOI 10.1038/354304a0; STRANGE K, 1991, AM J PHYSIOL, V260, pF225, DOI 10.1152/ajprenal.1991.260.2.F225; THIEMANN A, 1992, NATURE, V356, P57, DOI 10.1038/356057a0; UCHIDA S, 1992, P NATL ACAD SCI USA, V89, P8230, DOI 10.1073/pnas.89.17.8230; UCHIDA S, 1993, J BIOL CHEM, V268, P3821; VASSILEV PM, 1988, SCIENCE, V241, P1658, DOI 10.1126/science.2458625; WELSH MJ, 1990, FASEB J, V4, P2718, DOI 10.1096/fasebj.4.10.1695593; WEST JW, 1991, SCIENCE, V254, P866, DOI 10.1126/science.1658937; WORRELL RT, 1989, AM J PHYSIOL, V256, pC1111, DOI 10.1152/ajpcell.1989.256.6.C1111	40	223	237	1	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1994	12	3					597	604		10.1016/0896-6273(94)90215-1	http://dx.doi.org/10.1016/0896-6273(94)90215-1			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NC769	8155321				2022-12-24	WOS:A1994NC76900011
J	FREEMAN, RS; ESTUS, S; JOHNSON, EM				FREEMAN, RS; ESTUS, S; JOHNSON, EM			ANALYSIS OF CELL CYCLE-RELATED GENE-EXPRESSION IN POSTMITOTIC NEURONS - SELECTIVE INDUCTION OF CYCLIN D1 DURING PROGRAMMED CELL-DEATH	NEURON			English	Article							NERVE GROWTH-FACTOR; RAT VENTRAL PROSTATE; WILD-TYPE P53; C-MYC; SYMPATHETIC NEURONS; MESSENGER-RNA; MOLECULAR-CLONING; TRANSGENIC MICE; DNA-REPLICATION; PROTEIN-KINASES	Sympathetic neurons undergo RNA and protein synthesis-dependent programmed cell death when deprived of nerve growth factor. To test the hypothesis that neuronal programmed cell death is a consequence of conflicting growth signals which cause the inappropriate activation of cell cycle genes, we have analyzed cell cycle-related genes for their expression in postmitotic neurons. Surprisingly, many of these genes are expressed in neurons, although cdc2, cdk2, and cyclin A are not. During programmed cell death, the expression of most of these genes, including several cyclins and the Rb and p53 tumor suppressor genes, decreases similar to that of neuronal genes. In contrast, cyclin D1 expression is selectively induced in dying neurons. Cyclin D1 mRNA levels peak 15-20 hr after nerve growth factor withdrawal, concurrent with the time that neurons become committed to die. These results provide an extensive characterization of cell cycle gene expression in postmitotic neurons and provide the evidence for a gene induced during neuronal programmed cell death.			FREEMAN, RS (corresponding author), WASHINGTON UNIV, SCH MED, DEPT MOLEC BIOL & PHARMACOL, ST LOUIS, MO 63110 USA.				NINDS NIH HHS [NS09294] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALUBAIDI MR, 1992, P NATL ACAD SCI USA, V89, P1194, DOI 10.1073/pnas.89.4.1194; ASKEW DS, 1991, ONCOGENE, V6, P1915; BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; BERNARDS R, 1989, P NATL ACAD SCI USA, V86, P6474, DOI 10.1073/pnas.86.17.6474; BRIEHL MM, 1991, MOL ENDOCRINOL, V5, P1381, DOI 10.1210/mend-5-10-1381; BUTTYAN R, 1989, MOL CELL BIOL, V9, P3473, DOI 10.1128/MCB.9.8.3473; BUTTYAN R, 1988, MOL ENDOCRINOL, V2, P650, DOI 10.1210/mend-2-7-650; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; COLOMBEL M, 1992, CANCER RES, V52, P4313; COWAN WM, 1984, SCIENCE, V225, P1258, DOI 10.1126/science.6474175; DANIELSON PE, 1988, DNA-J MOLEC CELL BIO, V7, P261, DOI 10.1089/dna.1988.7.261; DECKWERTH TL, 1993, J CELL BIOL, V123, P1207, DOI 10.1083/jcb.123.5.1207; DOWD DR, 1991, J BIOL CHEM, V266, P18423; DOWDY SF, 1993, CELL, V73, P499, DOI 10.1016/0092-8674(93)90137-F; EDWARDS SN, 1991, J NEUROCHEM, V57, P2140, DOI 10.1111/j.1471-4159.1991.tb06434.x; ELLIS RE, 1991, ANNU REV CELL BIOL, V7, P663, DOI 10.1146/annurev.cb.07.110191.003311; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; EWEN ME, 1993, CELL, V73, P487, DOI 10.1016/0092-8674(93)90136-E; FEDDERSEN RM, 1992, NEURON, V9, P955, DOI 10.1016/0896-6273(92)90247-B; Freeman Robert S., 1993, Current Opinion in Neurobiology, V3, P25, DOI 10.1016/0959-4388(93)90031-S; GARCIA I, 1992, SCIENCE, V258, P302, DOI 10.1126/science.1411528; GIRARD F, 1991, CELL, V67, P1169, DOI 10.1016/0092-8674(91)90293-8; GOLDSTONE SD, 1991, BIOCHEM BIOPH RES CO, V178, P746, DOI 10.1016/0006-291X(91)90171-3; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; GRIMA B, 1985, P NATL ACAD SCI USA, V82, P617, DOI 10.1073/pnas.82.2.617; HAMMANG JP, 1993, NEURON, V10, P1197, DOI 10.1016/0896-6273(93)90067-2; HAYASHI K, 1987, NUCLEIC ACIDS RES, V15, P6419, DOI 10.1093/nar/15.16.6419; HAYES TE, 1991, NEW BIOL, V3, P259; HELLMICH MR, 1992, P NATL ACAD SCI USA, V89, P10867, DOI 10.1073/pnas.89.22.10867; HENDRY IA, 1977, J NEUROCYTOL, V6, P299, DOI 10.1007/BF01175193; HINDS PW, 1992, CELL, V70, P993, DOI 10.1016/0092-8674(92)90249-C; HORIGOME K, 1993, J BIOL CHEM, V268, P14881; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; KATO J, 1993, GENE DEV, V7, P331; KLIGMAN D, 1988, TRENDS BIOCHEM SCI, V13, P437, DOI 10.1016/0968-0004(88)90218-6; KOFF A, 1991, CELL, V66, P1217, DOI 10.1016/0092-8674(91)90044-Y; KUWANO R, 1986, TANIGUCHI S BRAIN SC, V9, P243; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; Lee S, 1993, CURR OPIN CELL BIOL, V5, P286, DOI 10.1016/0955-0674(93)90118-A; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; LEW DJ, 1991, CELL, V66, P1197, DOI 10.1016/0092-8674(91)90042-W; LUCIBELLO FC, 1993, J CELL SCI, V105, P123; LUSCHER B, 1990, GENE DEV, V4, P2025, DOI 10.1101/gad.4.12a.2025; MARTIN DP, 1988, J CELL BIOL, V106, P829, DOI 10.1083/jcb.106.3.829; MARTIN DP, 1992, J NEUROBIOL, V23, P1205, DOI 10.1002/neu.480230911; MATSUMOTO K, 1987, EMBO J, V6, P637, DOI 10.1002/j.1460-2075.1987.tb04802.x; MATSUSHIME H, 1992, CELL, V71, P323, DOI 10.1016/0092-8674(92)90360-O; MATSUSHIME H, 1991, CELL, V65, P701, DOI 10.1016/0092-8674(91)90101-4; MEYERSON M, 1992, EMBO J, V11, P2909, DOI 10.1002/j.1460-2075.1992.tb05360.x; MILLER FD, 1991, J CELL BIOL, V112, P303, DOI 10.1083/jcb.112.2.303; MOTOKURA T, 1991, NATURE, V350, P512, DOI 10.1038/350512a0; MURRAY AW, 1989, NATURE, V339, P280, DOI 10.1038/339280a0; NAPOLITANO EW, 1987, J NEUROSCI, V7, P2590; OHTSUBO M, 1993, SCIENCE, V259, P1908, DOI 10.1126/science.8384376; OKANO HJ, 1993, J NEUROSCI, V13, P2930; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; OWENS GP, 1991, MOL CELL BIOL, V11, P4177, DOI 10.1128/MCB.11.8.4177; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; PATERNO GD, 1991, GENE, V108, P315, DOI 10.1016/0378-1119(91)90454-J; PINES J, 1993, TRENDS BIOCHEM SCI, V18, P195, DOI 10.1016/0968-0004(93)90185-P; QUELLE DE, 1993, GENE DEV, V7, P1559, DOI 10.1101/gad.7.8.1559; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; RYAN JJ, 1993, MOL CELL BIOL, V13, P711, DOI 10.1128/MCB.13.1.711; SCHWARTZ LM, 1990, NEURON, V5, P411, DOI 10.1016/0896-6273(90)90080-Y; SHAW P, 1992, P NATL ACAD SCI USA, V89, P4495, DOI 10.1073/pnas.89.10.4495; SHERR CJ, 1993, CELL, V73, P1059, DOI 10.1016/0092-8674(93)90636-5; SOUSSI T, 1988, NUCLEIC ACIDS RES, V16, P11384, DOI 10.1093/nar/16.23.11384; STEIN GH, 1991, P NATL ACAD SCI USA, V88, P11012, DOI 10.1073/pnas.88.24.11012; STRANGE R, 1992, DEVELOPMENT, V115, P49; UCKER DS, 1991, NEW BIOL, V3, P103; WANAKA A, 1990, NEURON, V5, P267, DOI 10.1016/0896-6273(90)90164-B; WITHERS DA, 1991, MOL CELL BIOL, V11, P4846, DOI 10.1128/MCB.11.10.4846; WRIGHT LL, 1983, J NEUROCYTOL, V12, P727, DOI 10.1007/BF01258147; Wyllie A H, 1980, Int Rev Cytol, V68, P251; XIONG Y, 1993, GENE DEV, V7, P1572, DOI 10.1101/gad.7.8.1572; XIONG Y, 1992, CELL, V71, P505, DOI 10.1016/0092-8674(92)90518-H; YONISHROUACH E, 1991, NATURE, V352, P345, DOI 10.1038/352345a0; YONISHROUACH E, 1993, MOL CELL BIOL, V13, P1415, DOI 10.1128/MCB.13.3.1415; YUE X, 1991, CELL, V65, P691, DOI 10.1016/0092-8674(91)90100-D	79	571	579	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1994	12	2					343	355		10.1016/0896-6273(94)90276-3	http://dx.doi.org/10.1016/0896-6273(94)90276-3			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MY500	8110463				2022-12-24	WOS:A1994MY50000010
J	DICICCOBLOOM, E; FRIEDMAN, WJ; BLACK, IB				DICICCOBLOOM, E; FRIEDMAN, WJ; BLACK, IB			NT-3 STIMULATES SYMPATHETIC NEUROBLAST PROLIFERATION BY PROMOTING PRECURSOR SURVIVAL	NEURON			English	Article							NERVE GROWTH-FACTOR; TRK PROTOONCOGENE PRODUCT; HUMAN NEUROTROPHIC FACTOR; MESSENGER-RNA; RAT-BRAIN; NEURONAL DIFFERENTIATION; MITOTIC-CYCLE; FACTOR FAMILY; FACTOR-I; EXPRESSION	Although proliferation is fundamental to the generation of neuronal populations, little is known about the function of trophic mechanisms during neurogenesis. We now describe a novel role for neurotrophin-3 (NT-3): the neurotrophin stimulates proliferation of sympathetic neuroblasts through trophic mechanisms. NT-3 promotes survival of the dividing precursors, but does not directly stimulate mitosis. NT-3 trophic effects differ markedly from those of the sympathetic mitogen, insulin. Furthermore, whereas NT-3 exhibits trophic activity for dividing neuroblasts, nerve growth factor characteristically promotes survival of postnatal sympathetic neurons. The stage-specific activity of NT-3 and nerve growth factor in culture parallels the sequence of trkC and trkA receptor gene expression detected in vivo. Thus, neurotrophins apparently serve as trophic factors during ontogeny, acting sequentially during establishment of individual populations.			DICICCOBLOOM, E (corresponding author), UMDNJ,ROBERT WOOD JOHNSON MED SCH,DEPT NEUROSCI & CELL BIOL,PISCATAWAY,NJ 08854, USA.							ANCHAN RM, 1991, NEURON, V6, P923, DOI 10.1016/0896-6273(91)90233-P; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BIRREN SJ, 1990, NEURON, V4, P189, DOI 10.1016/0896-6273(90)90094-V; BOTHWELL M, 1991, CELL, V65, P915, DOI 10.1016/0092-8674(91)90540-F; CHAO MV, 1992, NEURON, V9, P583, DOI 10.1016/0896-6273(92)90023-7; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CORDONCARDO C, 1991, CELL, V66, P173, DOI 10.1016/0092-8674(91)90149-S; COUGHLIN MD, 1985, DEV BIOL, V110, P392, DOI 10.1016/0012-1606(85)90098-3; COUGHLIN MD, 1981, DEV BIOL, V82, P56, DOI 10.1016/0012-1606(81)90428-0; DICICCOBLOOM E, 1989, BRAIN RES, V491, P403, DOI 10.1016/0006-8993(89)90080-2; DICICCOBLOOM E, 1990, J CELL BIOL, V110, P2073, DOI 10.1083/jcb.110.6.2073; DICICCOBLOOM E, 1988, P NATL ACAD SCI USA, V85, P4066, DOI 10.1073/pnas.85.11.4066; DRAGO J, 1991, P NATL ACAD SCI USA, V88, P2199, DOI 10.1073/pnas.88.6.2199; ERNFORS P, 1990, P NATL ACAD SCI USA, V87, P5454, DOI 10.1073/pnas.87.14.5454; ERNFORS P, 1990, NEURON, V5, P511, DOI 10.1016/0896-6273(90)90090-3; ERNFORS P, 1991, EUR J NEUROSCI, V3, P953, DOI 10.1111/j.1460-9568.1991.tb00031.x; ERNSBERGER U, 1989, DEV BIOL, V135, P250, DOI 10.1016/0012-1606(89)90177-2; FRIEDMAN WJ, 1991, EUR J NEUROSCI, V3, P688, DOI 10.1111/j.1460-9568.1991.tb00854.x; FRIEDMAN WJ, 1993, EXP NEUROL, V119, P72, DOI 10.1006/exnr.1993.1007; FRIEDMAN WJ, 1991, J NEUROSCI, V11, P1577; GAO WQ, 1991, NEURON, V6, P705, DOI 10.1016/0896-6273(91)90168-Y; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; IBANEZ CF, 1990, EMBO J, V9, P1477, DOI 10.1002/j.1460-2075.1990.tb08265.x; KAISHO Y, 1990, FEBS LETT, V266, P187, DOI 10.1016/0014-5793(90)81536-W; KALCHEIM C, 1992, P NATL ACAD SCI USA, V89, P1661, DOI 10.1073/pnas.89.5.1661; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KNUSEL B, 1991, P NATL ACAD SCI USA, V88, P961, DOI 10.1073/pnas.88.3.961; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; LUTHMAN H, 1983, NUCLEIC ACIDS RES, V11, P1295, DOI 10.1093/nar/11.5.1295; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; MURPHY M, 1990, J NEUROSCI RES, V25, P463, DOI 10.1002/jnr.490250404; PINCUS DW, 1990, NATURE, V343, P564, DOI 10.1038/343564a0; RECIOPINTO E, 1988, NEUROCHEM INT, V12, P397, DOI 10.1016/0197-0186(88)90021-6; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; ROSENTHAL A, 1990, NEURON, V4, P767, DOI 10.1016/0896-6273(90)90203-R; SCHECTERSON LC, 1992, NEURON, V9, P449, DOI 10.1016/0896-6273(92)90183-E; SEGAL RA, 1992, NEURON, V9, P1041, DOI 10.1016/0896-6273(92)90064-K; THOENEN H, 1991, TRENDS NEUROSCI, V14, P165, DOI 10.1016/0166-2236(91)90097-E; WRIGHT EM, 1992, NEURON, V9, P139, DOI 10.1016/0896-6273(92)90229-7; WU DK, 1988, J CELL PHYSIOL, V136, P367, DOI 10.1002/jcp.1041360222	44	185	188	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1993	11	6					1101	1111		10.1016/0896-6273(93)90223-E	http://dx.doi.org/10.1016/0896-6273(93)90223-E			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MP548	7903858				2022-12-24	WOS:A1993MP54800011
J	LI, SH; SCHILLING, G; YOUNG, WS; LI, XJ; MARGOLIS, RL; STINE, OC; WAGSTER, MV; ABBOTT, MH; FRANZ, ML; RANEN, NG; FOLSTEIN, SE; HEDREEN, JC; ROSS, CA				LI, SH; SCHILLING, G; YOUNG, WS; LI, XJ; MARGOLIS, RL; STINE, OC; WAGSTER, MV; ABBOTT, MH; FRANZ, ML; RANEN, NG; FOLSTEIN, SE; HEDREEN, JC; ROSS, CA			HUNTINGTONS-DISEASE GENE (IT-15) IS WIDELY EXPRESSED IN HUMAN AND RAT-TISSUES	NEURON			English	Article							BULBAR MUSCULAR-ATROPHY; STRIATAL NEURONS; REPEAT; PROTEIN; CORTEX	Huntington's Disease (HD) is notable for selective neuronal vulnerability in the basal ganglia and cerebral cortex. We have investigated in human and rodent tissues the expression of the gene (IT15) whose mutation causes HD. IT15 is widely expressed, with highest levels of expression in brain, but also in lung, testis, ovary, and other tissues. Within the brain, expression is widespread with a neuronal pattern and is not enriched in the basal ganglia. Expression of IT15 is not reduced in the brain of HD patients when corrected for actin (though it is slightly decreased in the striatum when uncorrected, consistent with neuronal loss). Thus, the widespread distribution of IT15 expression does not correspond with the restricted distribution of neuropathologic changes in HD. We suggest that pathophysiology may relate to abnormal cell type-specific protein interactions of the HD protein.	JOHNS HOPKINS UNIV,SCH MED,MOLEC NEUROBIOL LAB,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT PSYCHIAT,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,NEUROPATHOL LAB,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT PATHOL,BALTIMORE,MD 21205; NIMH,CELL BIOL LAB,BETHESDA,MD 20892	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)			Ross, Christopher A/H-8395-2013; Young, W Scott Scott/A-9333-2009; Young, W Scott/N-3716-2019	Young, W Scott Scott/0000-0001-6614-5112; Young, W Scott/0000-0001-6614-5112	NINDS NIH HHS [NS 16375] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS016375, P01NS016375] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABITBOL M, 1993, NAT GENET, V4, P147, DOI 10.1038/ng0693-147; ADLER AJ, 1992, P NATL ACAD SCI USA, V89, P11660, DOI 10.1073/pnas.89.24.11660; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; APPEL SH, 1991, CURRENT NEUROLOGY, V11, P287; Battey, 1986, BASIC METHODS MOL BI; BEAL MF, 1993, TRENDS NEUROSCI, V16, P125, DOI 10.1016/0166-2236(93)90117-5; BERGER FG, 1989, ANNU REV PHYSIOL, V51, P51, DOI 10.1146/annurev.ph.51.030189.000411; BRADLEY DJ, 1992, J NEUROSCI, V12, P2288; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BRUYN GW, 1986, HDB CLIN NEUROLOGY, V49, P267; CRAPO JD, 1992, P NATL ACAD SCI USA, V89, P10405, DOI 10.1073/pnas.89.21.10405; DEBOULLE K, 1993, NAT GENET, V3, P31, DOI 10.1038/ng0193-31; DELAMONTE SM, 1988, J NEUROPATH EXP NEUR, V47, P516, DOI 10.1097/00005072-198809000-00003; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; FERRANTE RJ, 1987, J NEUROPATH EXP NEUR, V46, P12, DOI 10.1097/00005072-198701000-00002; FERRANTE RJ, 1985, SCIENCE, V230, P561, DOI 10.1126/science.2931802; FOLSTEIN SE, 1989, HUNTINGTONS DISEASE; FU YH, 1993, SCIENCE, V260, P235, DOI 10.1126/science.8469976; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; HEDREEN JC, 1991, NEUROSCI LETT, V133, P257, DOI 10.1016/0304-3940(91)90583-F; HINDS HL, 1993, NAT GENET, V3, P36, DOI 10.1038/ng0193-36; JANNE OA, 1993, ANN MED, V25, P83, DOI 10.3109/07853899309147863; LAM EWF, 1992, ONCOGENE, V7, P1885; LASPADA AR, 1992, NAT GENET, V2, P301, DOI 10.1038/ng1292-301; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; MARTIN JB, 1986, NEW ENGL J MED, V315, P1267; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; RICHARDS RI, 1992, NAT GENET, V1, P7, DOI 10.1038/ng0492-7; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; ROSS CA, 1993, TRENDS NEUROSCI, V16, P254, DOI 10.1016/0166-2236(93)90175-L; ROWLAND LP, 1984, TRENDS NEUROSCI, V7, P110, DOI 10.1016/S0166-2236(84)80236-2; SABOURI LA, 1993, NAT GENET, V4, P233, DOI 10.1038/ng0793-233; SOTREL A, 1991, NEUROLOGY, V41, P1117, DOI 10.1212/WNL.41.7.1117; STINE OC, 1993, HUM MOL GENET, V2, P1547, DOI 10.1093/hmg/2.10.1547; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; 1993, CELL, V72, P971	38	261	267	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1993	11	5					985	993		10.1016/0896-6273(93)90127-D	http://dx.doi.org/10.1016/0896-6273(93)90127-D			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MJ041	8240819				2022-12-24	WOS:A1993MJ04100019
J	SHACKLEFORD, GM; WILLERT, K; WANG, JW; VARMUS, HE				SHACKLEFORD, GM; WILLERT, K; WANG, JW; VARMUS, HE			THE WNT-1 PROTOONCOGENE INDUCES CHANGES IN MORPHOLOGY, GENE-EXPRESSION, AND GROWTH-FACTOR RESPONSIVENESS IN PC12 CELLS	NEURON			English	Article							FACTOR-INDUCED DIFFERENTIATION; EMBRYONAL CARCINOMA-CELLS; MAMMARY-TUMOR VIRUS; PHEOCHROMOCYTOMA CELLS; XENOPUS EMBRYOS; TRANSGENIC MICE; NEURONAL DIFFERENTIATION; DEVELOPMENTAL EXPRESSION; TRANSIENT EXPRESSION; INT-1 PROTOONCOGENE	The product of the Wnt-1 proto-oncogene is a secreted glycoprotein that is normally produced in regions of the embryonic neural tube. We show here that expression of mouse Wnt-1 cDNA in the rat PC12 pheochromocytoma cell line causes a dramatic conversion from a round to a flat cell morphology. In addition, PC12 cells expressing Wnt-1 (PC12/Wnt-1) fail to extend neurites after treatment with NGF, despite the presence and activation of high affinity NGF receptors encoded by the trk gene and the induction of early response genes. Furthermore, PC12/Wnt-1 cells fail to express several neuron- and chromaffin-specific genes, indicating that PC12/Wnt-1 cells have assumed a new phenotype. Although NGF and FGF utilize similar signal transduction pathways in PC12 cells, only FGF is capable of inducing a morphological response and synthesis of transin mRNA in PC12/Wnt-1 cells.	UNIV SO CALIF,SCH MED,DEPT PEDIAT,LOS ANGELES,CA 90033; UNIV SO CALIF,SCH MED,DEPT MICROBIOL,LOS ANGELES,CA 90033; UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT MICROBIOL & IMMUNOL,SAN FRANCISCO,CA 94143	University of Southern California; University of Southern California; University of California System; University of California San Francisco; University of California System; University of California San Francisco	SHACKLEFORD, GM (corresponding author), CHILDRENS HOSP LOS ANGELES,DIV HEMATOL ONCOL,LOS ANGELES,CA 90027, USA.							ALEMA S, 1985, NATURE, V316, P557, DOI 10.1038/316557a0; ANDERSEN JK, 1990, J NEUROCHEM, V55, P559, DOI 10.1111/j.1471-4159.1990.tb04170.x; AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; BOTHWELL MA, 1980, CELL, V21, P857, DOI 10.1016/0092-8674(80)90449-3; BOULUKOS KE, 1993, ONCOGENE, V8, P237; BRADLEY RS, 1990, EMBO J, V9, P1569, DOI 10.1002/j.1460-2075.1990.tb08276.x; BROWN AMC, 1987, MOL CELL BIOL, V7, P3971, DOI 10.1128/MCB.7.11.3971; BROWN AMC, 1986, CELL, V46, P1001, DOI 10.1016/0092-8674(86)90699-9; CHRISTIAN JL, 1992, EMBO J, V11, P33, DOI 10.1002/j.1460-2075.1992.tb05024.x; CHRISTIAN JL, 1991, DEV BIOL, V143, P230, DOI 10.1016/0012-1606(91)90073-C; CHRISTIAN JL, 1993, GENE DEV, V7, P13, DOI 10.1101/gad.7.1.13; COWIN P, 1986, CELL, V46, P1063, DOI 10.1016/0092-8674(86)90706-3; EDELMAN GM, 1986, ANNU REV CELL BIOL, V2, P81, DOI 10.1146/annurev.cb.02.110186.000501; EDWARDS PAW, 1992, ONCOGENE, V7, P2041; FILLMORE HL, 1992, J NEUROSCI RES, V31, P662, DOI 10.1002/jnr.490310410; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; GAVIN BJ, 1990, GENE DEV, V4, P2319, DOI 10.1101/gad.4.12b.2319; GREENE LA, 1987, METHOD ENZYMOL, V147, P207; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; HEMPSTEAD BL, 1992, NEURON, V9, P883, DOI 10.1016/0896-6273(92)90241-5; HEMPSTEAD BL, 1989, SCIENCE, V243, P373, DOI 10.1126/science.2536190; JUE SF, 1992, MOL CELL BIOL, V12, P321, DOI 10.1128/MCB.12.1.321; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KIMELMAN D, 1992, DEVELOPMENT, V116, P1; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KWAN H, 1992, MOL CELL BIOL, V12, P147, DOI 10.1128/MCB.12.1.147; LEONARD DGB, 1987, MOL CELL BIOL, V7, P3156, DOI 10.1128/MCB.7.9.3156; LIN TP, 1992, CANCER RES, V52, P4413; LINDENBAUM MH, 1988, J BIOL CHEM, V263, P5662; MACHIDA CM, 1989, NEURON, V2, P1587, DOI 10.1016/0896-6273(89)90047-0; MARUYAMA K, 1987, ONCOGENE, V1, P361; MASON JO, 1992, MOL BIOL CELL, V3, P521, DOI 10.1091/mbc.3.5.521; MATRISIAN LM, 1986, P NATL ACAD SCI USA, V83, P9413, DOI 10.1073/pnas.83.24.9413; MATRISIAN LM, 1986, MOL CELL BIOL, V6, P1679, DOI 10.1128/MCB.6.5.1679; MCCLAY DR, 1987, ANNU REV CELL BIOL, V3, P319, DOI 10.1146/annurev.cellbio.3.1.319; MCCREA PD, 1991, SCIENCE, V254, P1359, DOI 10.1126/science.1962194; MCGUIRE JC, 1978, CELL, V15, P357, DOI 10.1016/0092-8674(78)90004-1; MCMAHON AP, 1992, CELL, V69, P581, DOI 10.1016/0092-8674(92)90222-X; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; MCMAHON AP, 1989, CELL, V58, P1075, DOI 10.1016/0092-8674(89)90506-0; MCMAHON JA, 1989, DEVELOPMENT, V107, P643; MOOS M, 1988, NATURE, V334, P701, DOI 10.1038/334701a0; NODA M, 1985, NATURE, V318, P73, DOI 10.1038/318073a0; NOORDERMEER J, 1989, NUCLEIC ACIDS RES, V17, P11, DOI 10.1093/nar/17.1.11; NUSSE R, 1992, CELL, V69, P1073, DOI 10.1016/0092-8674(92)90630-U; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; OLSON DJ, 1992, DEV BIOL, V151, P204, DOI 10.1016/0012-1606(92)90227-8; OLSON DJ, 1991, SCIENCE, V252, P1173, DOI 10.1126/science.252.5009.1173; PAPKOFF J, 1990, MOL CELL BIOL, V10, P2723, DOI 10.1128/MCB.10.6.2723; PAPKOFF J, 1987, MOL CELL BIOL, V7, P3978, DOI 10.1128/MCB.7.11.3978; PEIFER M, 1990, CELL, V63, P1167, DOI 10.1016/0092-8674(90)90413-9; PETERS G, 1986, NATURE, V320, P628, DOI 10.1038/320628a0; RIGGLEMAN B, 1990, CELL, V63, P549, DOI 10.1016/0092-8674(90)90451-J; RIJSEWIJK F, 1987, EMBO J, V6, P127, DOI 10.1002/j.1460-2075.1987.tb04729.x; ROELINK H, 1991, GENE DEV, V5, P381, DOI 10.1101/gad.5.3.381; RYDEL RE, 1987, J NEUROSCI, V7, P3639; SCHUURING E, 1989, MOL CELL BIOL, V9, P1357, DOI 10.1128/MCB.9.3.1357; SHACKLEFORD GM, 1993, ONCOGENE, V8, P1857; SHACKLEFORD GM, 1987, CELL, V50, P89, DOI 10.1016/0092-8674(87)90665-9; SHACKLEFORD GM, 1993, P NATL ACAD SCI USA, V90, P740, DOI 10.1073/pnas.90.2.740; SOKOL S, 1991, CELL, V67, P741, DOI 10.1016/0092-8674(91)90069-B; STARNAUD R, 1989, ONCOGENE, V4, P1077; STEIN R, 1988, NEURON, V1, P463, DOI 10.1016/0896-6273(88)90177-8; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; THOMAS KR, 1990, NATURE, V346, P847, DOI 10.1038/346847a0; THOMAS KR, 1991, CELL, V67, P969, DOI 10.1016/0092-8674(91)90369-A; THOMAS SM, 1991, MOL CELL BIOL, V11, P4739, DOI 10.1128/MCB.11.9.4739; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; WILKINSON DG, 1987, CELL, V50, P79, DOI 10.1016/0092-8674(87)90664-7; WOLDA SL, 1992, ONCOGENE, V7, P1941	70	53	53	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1993	11	5					865	875		10.1016/0896-6273(93)90116-9	http://dx.doi.org/10.1016/0896-6273(93)90116-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MJ041	8240810				2022-12-24	WOS:A1993MJ04100008
J	SATHER, WA; TANABE, T; ZHANG, JF; MORI, Y; ADAMS, ME; TSIEN, RW				SATHER, WA; TANABE, T; ZHANG, JF; MORI, Y; ADAMS, ME; TSIEN, RW			DISTINCTIVE BIOPHYSICAL AND PHARMACOLOGICAL PROPERTIES OF CLASS-A (BI) CALCIUM-CHANNEL ALPHA(1)-SUBUNITS	NEURON			English	Article							DEPENDENT CA2+ CHANNELS; OMEGA-AGA-IVA; FUNCTIONAL EXPRESSION; BETA-SUBUNIT; SKELETAL-MUSCLE; N-TYPE; P-TYPE; DIHYDROPYRIDINE RECEPTOR; PERIPHERAL NEURONS; MOLECULAR-CLONING	Transcripts for the class A Ca2+ channel alpha1 subunit (also known as BI) are present at high levels in many parts of the mammalian CNS and are widely assumed to encode the P-type Ca2+ channel. To characterize the biophysical and pharmacological properties of alpha1A channels, macroscopic and single-channel recordings were made in Xenopus oocytes injected with alpha1A cRNA. Alpha1-specific properties were identified by making systematic comparisons with the more familiar class C alpha1 subunit under the condition of a standard ancillary subunit (alpha2/delta + beta) makeup. alpha1A currents activate and inactivate more rapidly and display steeper voltage dependence of gating than alpha1C currents. Unlike alpha1C, alpha1A channels are largely insensitive to dihydropyridines and FPL 64176, but respond to the cone snail peptide omega-CTx-MVIIC (SNX-230), a potent and fairly selective inhibitor. In comparison with P-type Ca2+ channels in rat cerebellar Purkinje cells, alpha1A channels in oocytes are approximately 10(2)-fold less sensitive to omega-Aga-IVA and approximately 10-fold more sensitive to omega-CTx-MVIIC. Alpha1A channels are not inhibited by Bay K 8644 and inactivate much more rapidly than P-type Ca2+ channels. Thus, alpha1A is capable of generating a Ca2+ channel phenotype quite different from P-type current.	YALE UNIV,HOWARD HUGHES MED INST,NEW HAVEN,CT 06536; KYOTO UNIV,DEPT MED CHEM,KYOTO 606,JAPAN; YALE UNIV,DEPT CELLULAR & MOLEC PHYSIOL,NEW HAVEN,CT 06536; UNIV CALIF RIVERSIDE,DEPT ENTOMOL,RIVERSIDE,CA 92521; UNIV CALIF RIVERSIDE,DEPT NEUROSCI,RIVERSIDE,CA 92521	Howard Hughes Medical Institute; Yale University; Kyoto University; Yale University; University of California System; University of California Riverside; University of California System; University of California Riverside	SATHER, WA (corresponding author), STANFORD UNIV,DEPT MOLEC & CELLULAR PHYSIOL,STANFORD,CA 94305, USA.		Adams, Michael/ABF-6728-2020	Adams, Michael/0000-0003-0519-6113; Sather, William/0000-0003-1482-8055	NINDS NIH HHS [NS24067] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024067] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS ME, 1992, NEUROTOX 91, P33; BEAN BP, 1989, ANNU REV PHYSIOL, V51, P367, DOI 10.1146/annurev.physiol.51.1.367; BIEL M, 1990, FEBS LETT, V269, P409, DOI 10.1016/0014-5793(90)81205-3; CATTERALL WA, 1992, TRENDS PHARMACOL SCI, V13, P256, DOI 10.1016/0165-6147(92)90079-L; DUBEL SJ, 1992, P NATL ACAD SCI USA, V89, P5058, DOI 10.1073/pnas.89.11.5058; ELLIS SB, 1988, SCIENCE, V241, P1661, DOI 10.1126/science.2458626; FENWICK EM, 1982, J PHYSIOL-LONDON, V331, P599, DOI 10.1113/jphysiol.1982.sp014394; GUY HR, 1990, TRENDS NEUROSCI, V13, P201; HAGIWARA S, 1983, TRENDS NEUROSCI, V6, P189, DOI 10.1016/0166-2236(83)90084-X; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; HESS P, 1984, NATURE, V311, P538, DOI 10.1038/311538a0; HESS P, 1990, ANNU REV NEUROSCI, V13, P1337; HILLYARD DR, 1992, NEURON, V9, P69, DOI 10.1016/0896-6273(92)90221-X; HUI A, 1991, NEURON, V7, P35, DOI 10.1016/0896-6273(91)90072-8; HULLIN R, 1992, EMBO J, V11, P885, DOI 10.1002/j.1460-2075.1992.tb05126.x; JAN LY, 1990, NATURE, V345, P672, DOI 10.1038/345672a0; KIM MS, 1993, FEBS LETT, V318, P145, DOI 10.1016/0014-5793(93)80009-J; KOCH WJ, 1990, J BIOL CHEM, V265, P17786; LACERDA AE, 1991, NATURE, V352, P527, DOI 10.1038/352527a0; LANSMAN JB, 1986, J GEN PHYSIOL, V88, P321, DOI 10.1085/jgp.88.3.321; LEE KS, 1982, NATURE, V297, P498, DOI 10.1038/297498a0; LIPSCOMBE D, 1989, NATURE, V340, P639, DOI 10.1038/340639a0; LLINAS R, 1992, TRENDS NEUROSCI, V15, P351, DOI 10.1016/0166-2236(92)90053-B; LLINAS R, 1989, P NATL ACAD SCI USA, V86, P1689, DOI 10.1073/pnas.86.5.1689; METHFESSEL C, 1986, PFLUG ARCH EUR J PHY, V407, P577, DOI 10.1007/BF00582635; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; MINTZ IM, 1992, NEURON, V9, P85, DOI 10.1016/0896-6273(92)90223-Z; MINTZ IM, 1991, P NATL ACAD SCI USA, V88, P6628, DOI 10.1073/pnas.88.15.6628; MINTZ IM, 1992, NATURE, V355, P827, DOI 10.1038/355827a0; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; NACHSHEN DA, 1984, J GEN PHYSIOL, V83, P941, DOI 10.1085/jgp.83.6.941; NOWYCKY MC, 1985, NATURE, V316, P440, DOI 10.1038/316440a0; PEREZREYES E, 1989, NATURE, V340, P233, DOI 10.1038/340233a0; PEREZREYES E, 1990, J BIOL CHEM, V265, P20430; PEREZREYES E, 1992, J BIOL CHEM, V267, P1792; REGAN LJ, 1991, NEURON, V6, P269, DOI 10.1016/0896-6273(91)90362-4; REUTER H, 1977, J PHYSIOL-LONDON, V264, P17, DOI 10.1113/jphysiol.1977.sp011656; RUTH P, 1989, SCIENCE, V245, P1115, DOI 10.1126/science.2549640; SINGER D, 1991, SCIENCE, V253, P1553, DOI 10.1126/science.1716787; Snutch T P, 1992, Curr Opin Neurobiol, V2, P247, DOI 10.1016/0959-4388(92)90111-W; SNUTCH TP, 1990, P NATL ACAD SCI USA, V87, P3391, DOI 10.1073/pnas.87.9.3391; SNUTCH TP, 1991, NEURON, V7, P45, DOI 10.1016/0896-6273(91)90073-9; STARR TVB, 1991, P NATL ACAD SCI USA, V88, P5621, DOI 10.1073/pnas.88.13.5621; TAGLIALATELA M, 1992, BIOPHYS J, V61, P78, DOI 10.1016/S0006-3495(92)81817-9; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; TANABE T, 1988, NATURE, V336, P134, DOI 10.1038/336134a0; TSIEN RW, 1991, TRENDS PHARMACOL SCI, V12, P349, DOI 10.1016/0165-6147(91)90595-J; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; TURNER TJ, 1992, SCIENCE, V258, P310, DOI 10.1126/science.1357749; USOWICZ MM, 1992, NEURON, V9, P1185, DOI 10.1016/0896-6273(92)90076-P; VARADI G, 1991, NATURE, V352, P159, DOI 10.1038/352159a0; VENEMA VJ, 1992, J BIOL CHEM, V267, P2610; WILLIAMS ME, 1992, SCIENCE, V257, P389, DOI 10.1126/science.1321501; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; YUE DT, 1990, SCIENCE, V250, P1735, DOI 10.1126/science.2176745; ZHENG W, 1991, MOL PHARMACOL, V40, P734	56	418	430	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1993	11	2					291	303		10.1016/0896-6273(93)90185-T	http://dx.doi.org/10.1016/0896-6273(93)90185-T			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LU065	8394721				2022-12-24	WOS:A1993LU06500009
J	ZORUMSKI, CF; YAMADA, KA; PRICE, MT; OLNEY, JW				ZORUMSKI, CF; YAMADA, KA; PRICE, MT; OLNEY, JW			A BENZODIAZEPINE RECOGNITION SITE ASSOCIATED WITH THE NON-NMDA GLUTAMATE RECEPTOR	NEURON			English	Article							AMINO-ACID RECEPTORS; HIPPOCAMPAL-NEURONS; NERVOUS-SYSTEM; DESENSITIZATION; ANTAGONISTS; KYNURENATE; GYKI-52466	GYKI 52466 is a benzodiazepine molecule that has muscle relaxant and anticonvulsant properties not attributable to a gamma-aminobutyric acid receptor-mediated mechanism. Here it is shown that GYKI 52466 exerts no blocking action at N-methyl-D-aspartate (NMDA) glutamate receptors, but acts noncompetitively to block ion currents and associated excitotoxicity, including ischemic neuronal degeneration, mediated through non-NMDA glutamate receptors. The inhibition of non-NMDA responses by GYKI 52466 is antagonized by cyclothiazide, hydrochlorothiazide, and diazoxide, benzothiadiazide drugs that inhibit non-NMDA receptor desensitization. These results suggest that non-NMDA receptor-ion channel complexes may contain a novel benzodiazepine recognition site where receptor desensitization is regulated; this postulated site represents a promising new target for rational development of drugs to treat neurological disorders.	WASHINGTON UNIV, SCH MED, DEPT ANAT & NEUROBIOL, ST LOUIS, MO 63110 USA; WASHINGTON UNIV, SCH MED, DEPT PEDIAT, ST LOUIS, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	ZORUMSKI, CF (corresponding author), WASHINGTON UNIV, SCH MED, DEPT PSYCHIAT, ST LOUIS, MO 63110 USA.				NIMH NIH HHS [MH38894, MH00964] Funding Source: Medline; NINDS NIH HHS [NS01443] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH000964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS001443] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BIRCH PJ, 1988, EUR J PHARMACOL, V151, P313, DOI 10.1016/0014-2999(88)90814-X; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; COLLINGRIDGE GL, 1989, PHARMACOL REV, V41, P143; ELMSLIE KS, 1985, BRAIN RES, V330, P265, DOI 10.1016/0006-8993(85)90685-7; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HONORE T, 1988, SCIENCE, V241, P701, DOI 10.1126/science.2899909; MAYER ML, 1989, P NATL ACAD SCI USA, V86, P1411, DOI 10.1073/pnas.86.4.1411; MONAGHAN DT, 1989, ANNU REV PHARMACOL, V29, P365, DOI 10.1146/annurev.pa.29.040189.002053; OLNEY JW, 1990, ANNU REV PHARMACOL, V30, P47; OLNEY JW, 1988, EXCITATORY AMINO ACI, P337; OLNEY JW, 1991, GLUTAMATE CELL DEATH, P77; PATNEAU DK, 1991, NEURON, V6, P785, DOI 10.1016/0896-6273(91)90175-Y; SHEARDOWN MJ, 1990, SCIENCE, V247, P571, DOI 10.1126/science.2154034; SMITH SE, 1991, EUR J PHARMACOL, V201, P179, DOI 10.1016/0014-2999(91)90342-N; TARNAWA I, 1989, EUR J PHARMACOL, V167, P193, DOI 10.1016/0014-2999(89)90579-7; TARNAWA I, 1990, AMINO ACIDS CHEM BIO, P538; THIO LL, 1991, J NEUROSCI, V11, P3430; TRUSSELL LO, 1988, P NATL ACAD SCI USA, V85, P4562, DOI 10.1073/pnas.85.12.4562-a; YAMADA KA, 1989, J NEUROSCI, V9, P3230; YAMADA KA, 1992, J PHYSIOL-LONDON, V458, P385; ZORUMSKI CF, 1992, PROG NEUROBIOL, V39, P295, DOI 10.1016/0301-0082(92)90020-F; ZORUMSKI CF, 1992, MOL PHARMACOL, V41, P931	22	201	202	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1993	10	1					61	67		10.1016/0896-6273(93)90242-J	http://dx.doi.org/10.1016/0896-6273(93)90242-J			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KK012	8427702				2022-12-24	WOS:A1993KK01200007
J	Frantz, GD; McConnell, SK				Frantz, GD; McConnell, SK			Restriction of late cerebral cortical progenitors to an upper-layer fate	NEURON			English	Article							VISUAL-CORTEX; CELL LINEAGE; MIGRATION; NEURONS; NEOCORTEX; INVITRO; FERRET	Early in development, neural progenitors in cerebral cortex normally produce neurons of several layers during successive cell divisions. The laminar fate of their daughters depends on environmental cues encountered just before mitosis. At the close of neurogenesis, however, cortical progenitors normally produce neurons destined only for the upper layers. To assess the developmental potential of these cells, upper-layer progenitors were transplanted into the cerebral colter of younger hosts, in which deep-layer neurons were being generated. These studies reveal that late cortical progenitors are not competent to generate deep-layer neurons and are instead restricted to producing the upper layers.			Frantz, GD (corresponding author), STANFORD UNIV,DEPT BIOL SCI,STANFORD,CA 94305, USA.				NEI NIH HHS [EY06342, EY08411] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY008411] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ARTINGER KB, 1992, DEV BIOL, V149, P149, DOI 10.1016/0012-1606(92)90271-H; Brustle O, 1995, NEURON, V15, P1275, DOI 10.1016/0896-6273(95)90007-1; Campbell K, 1995, NEURON, V15, P1259, DOI 10.1016/0896-6273(95)90006-3; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; EDMONDSON JC, 1987, J NEUROSCI, V7, P1928; FISHELL G, 1995, DEVELOPMENT, V121, P803; FRANTZ GD, 1994, J NEUROSCI, V14, P5725; JACKSON CA, 1989, J NEUROSCI, V9, P1242; LO LC, 1995, NEURON, V15, P527, DOI 10.1016/0896-6273(95)90142-6; LUSKIN MB, 1985, J COMP NEUROL, V242, P611, DOI 10.1002/cne.902420409; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; MCCONNELL SK, 1988, J NEUROSCI, V8, P945; MCCONNELL SK, 1991, SCIENCE, V254, P282, DOI 10.1126/science.1925583; OROURKE NA, 1992, SCIENCE, V258, P299, DOI 10.1126/science.1411527; Parnavelas JG, 1991, CEREB CORTEX, V1, P463, DOI 10.1093/cercor/1.6.463; PRICE J, 1988, DEVELOPMENT, V104, P473; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1971, BRAIN RES, V33, P471, DOI 10.1016/0006-8993(71)90119-3; REID CB, 1995, NEURON, V15, P299, DOI 10.1016/0896-6273(95)90035-7; ROBERTS JS, 1993, DEV BIOL, V155, P396, DOI 10.1006/dbio.1993.1038; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; SHAH NM, 1994, CELL, V77, P349, DOI 10.1016/0092-8674(94)90150-3; TEMPLE S, 1986, CELL, V44, P773, DOI 10.1016/0092-8674(86)90843-3; WALSH C, 1988, SCIENCE, V241, P1342, DOI 10.1126/science.3137660; Zigova T, 1996, DEV BIOL, V173, P459, DOI 10.1006/dbio.1996.0040	27	259	265	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1996	17	1					55	61		10.1016/S0896-6273(00)80280-9	http://dx.doi.org/10.1016/S0896-6273(00)80280-9			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UY981	8755478	Bronze			2022-12-24	WOS:A1996UY98100007
J	Cantrell, AR; Ma, JY; Scheuer, T; Catterall, WA				Cantrell, AR; Ma, JY; Scheuer, T; Catterall, WA			Muscarinic modulation of sodium current by activation of protein kinase C in rat hippocampal neurons	NEURON			English	Article							ACTIVE-CHEMICAL SYNAPSES; ACETYLCHOLINE-RECEPTOR GENES; FROG SYMPATHETIC NEURONS; CALCIUM CURRENT; NA+-CHANNEL; PHOSPHORYLATION; EXPRESSION; SUBTYPES; CLONING; CELLS	Phosphorylation of brain Na+ channels by protein kinase C (PKC) decreases peak Na+ current and slows macroscopic inactivation, but receptor-activated modulation of Na+ currents via the PKC pathway has not been demonstrated. We have examined modulation of Na+ channels by activation of muscarinic receptors in acutely-isolated hippocampal neurons using whole-cell voltage-clamp recording. Application of the muscarinic agonist carbachol reduced peak Na+ current and slowed macroscopic inactivation at all potentials, without changing the voltage-dependent properties of the channel. These effects were mediated by PKC, since they were eliminated when the specific PKC inhibitor (PKCI19-36) was included in the pipette solution and mimicked by the extracellular application of the PKC activator, GAG. Thus, activation of endogenous muscarinic receptors on hippocampal neurons strongly modulates Na+ channel activity by activation of PKC. Cholinergic input from basal forebrain neurons may have this effect in the hippocampus in vivo.			Cantrell, AR (corresponding author), UNIV WASHINGTON, DEPT PHARMACOL, SEATTLE, WA 98195 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007278] Funding Source: NIH RePORTER; NIDA NIH HHS [T32DA07278] Funding Source: Medline; NINDS NIH HHS [NS15751] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARGAS J, 1994, J NEUROSCI, V14, P6667; BONNER TI, 1987, SCIENCE, V237, P527, DOI 10.1126/science.3037705; BONNER TI, 1988, NEURON, V1, P403, DOI 10.1016/0896-6273(88)90190-0; BOWLBY MR, 1995, J NEUROPHYSIOL, V73, P2221, DOI 10.1152/jn.1995.73.6.2221; BRANN MR, 1993, PROG BRAIN RES, V98, P121; BRUSSAARD AB, 1991, J PHYSIOL-LONDON, V441, P385, DOI 10.1113/jphysiol.1991.sp018757; CATTERALL WA, 1992, PHYSIOL REV, V72, pS15, DOI 10.1152/physrev.1992.72.suppl_4.S15; COSTA MRC, 1984, J BIOL CHEM, V259, P8210; DASCAL N, 1991, NEURON, V6, P165, DOI 10.1016/0896-6273(91)90131-I; EAHOLTZ G, 1994, NEURON, V12, P1041, DOI 10.1016/0896-6273(94)90312-3; ELMSLIE KS, 1992, J PHYSIOL-LONDON, V451, P229, DOI 10.1113/jphysiol.1992.sp019162; FROTSCHER M, 1985, J COMP NEUROL, V239, P237, DOI 10.1002/cne.902390210; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hille B., 1992, IONIC CHANNELS EXCIT; HOEHN K, 1993, NEURON, V10, P543, DOI 10.1016/0896-6273(93)90341-N; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; HOWE AR, 1995, J NEUROSCI, V15, P458; HULME EC, 1990, ANNU REV PHARMACOL, V30, P633, DOI 10.1146/annurev.pa.30.040190.003221; IKEDA SR, 1989, J PHYSIOL-LONDON, V409, P221, DOI 10.1113/jphysiol.1989.sp017494; JEFFERYS JGR, 1982, NATURE, V300, P448, DOI 10.1038/300448a0; KONNERTH A, 1984, NATURE, V307, P69, DOI 10.1038/307069a0; KRNJEVIC K, 1993, PROG BRAIN RES, V98, P285; KUBO T, 1986, NATURE, V323, P411, DOI 10.1038/323411a0; LEVEY AI, 1995, J NEUROSCI, V15, P4077; LIAO CF, 1989, J BIOL CHEM, V264, P7328; LINDEN DJ, 1989, J PHYSIOL-LONDON, V419, P95, DOI 10.1113/jphysiol.1989.sp017863; MCKINNEY M, 1984, ANNU REV PHARMACOL, V24, P121; NATHANSON NM, 1987, ANNU REV NEUROSCI, V10, P195, DOI 10.1146/annurev.ne.10.030187.001211; NICOLL RA, 1985, TRENDS NEUROSCI, V8, P533, DOI 10.1016/0166-2236(85)90190-0; NUMANN R, 1994, J NEUROSCI, V14, P4226; NUMANN R, 1991, SCIENCE, V254, P115, DOI 10.1126/science.1656525; PRICE DL, 1993, PROG BRAIN RES, V98, P51; RANE SG, 1989, NEURON, V3, P239, DOI 10.1016/0896-6273(89)90037-8; RENGANATHAN M, 1995, J MEMBRANE BIOL, V144, P59; SIGEL E, 1988, P NATL ACAD SCI USA, V85, P6192, DOI 10.1073/pnas.85.16.6192; STAFSTROM CE, 1985, J NEUROPHYSIOL, V53, P153, DOI 10.1152/jn.1985.53.1.153; SURMEIER DJ, 1991, NEUROSCI LETT, V122, P41, DOI 10.1016/0304-3940(91)90188-Y; SURMEIER DJ, 1992, P NATL ACAD SCI USA, V89, P10178, DOI 10.1073/pnas.89.21.10178; SWARTZ KJ, 1993, NEURON, V11, P305, DOI 10.1016/0896-6273(93)90186-U; TAKANO K, 1995, NEURON, V14, P999, DOI 10.1016/0896-6273(95)90338-0; TAYLOR CP, 1993, TRENDS NEUROSCI, V16, P455, DOI 10.1016/0166-2236(93)90077-Y; TAYLOR CP, 1982, SCIENCE, V218, P810, DOI 10.1126/science.7134978; TAYLOR CP, 1984, J NEUROPHYSIOL, V52, P143, DOI 10.1152/jn.1984.52.1.143; Tukey JW, 1977, EXPLORATORY DATA ANA; WAINER BH, 1993, PROG BRAIN RES, V98, P9; WEST JW, 1991, SCIENCE, V254, P866, DOI 10.1126/science.1658937; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; WU T, 1995, NEUROSCI LETT, V184, P121, DOI 10.1016/0304-3940(94)11185-L; YANG J, 1993, NEURON, V10, P127, DOI 10.1016/0896-6273(93)90305-B	49	140	143	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	1996	16	5					1019	1026		10.1016/S0896-6273(00)80125-7	http://dx.doi.org/10.1016/S0896-6273(00)80125-7			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UN480	8630240	Bronze			2022-12-24	WOS:A1996UN48000017
J	Naranjo, D; Miller, C				Naranjo, D; Miller, C			A strongly interacting pair of residues on the contact surface of charybdotoxin and a Shaker K+ channel	NEURON			English	Article							POTASSIUM CHANNELS; BINDING-SITE; BLOCKING PEPTIDE; TETRAETHYLAMMONIUM; PORE; INACTIVATION; INHIBITOR; MUTANTS; ION	Charybdotoxin, a peptide neurotoxin of known molecular structure, blocks Shaker K+ channels by binding to a receptor at the outer opening of the ion conduction pathway. Analysis of variants of CTX at position 29 and of Shaker at position 449 shows that these two residues interact closely in the channel-toxin complex. The CTX mutation M29I leads to a slight strengthening of block when tested on Shaker-449T; the same CTX mutation weakens block 1700-fold when tested on Shaker-449F. The known position of CTX-29 on the toxin's interaction surface thus locates Shaker-449 within 5 Angstrom of the pore axis of the closed channel. All four subunits must carry the 449F mutation to produce a highly toxin-insensitive channel.			Naranjo, D (corresponding author), BRANDEIS UNIV,HOWARD HUGHES MED INST,GRAD DEPT BIOCHEM,WALTHAM,MA 02254, USA.			Naranjo, David/0000-0003-3482-5126	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM031768, R01GM031768] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-31768] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AIYAR J, 1995, NEURON, V15, P1169, DOI 10.1016/0896-6273(95)90104-3; BONTEMS F, 1991, SCIENCE, V254, P1521, DOI 10.1126/science.1720574; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; FERNANDEZ I, 1994, BIOCHEMISTRY-US, V33, P14256, DOI 10.1021/bi00251a038; GOLDSTEIN SAN, 1992, BIOPHYS J, V62, P5, DOI 10.1016/S0006-3495(92)81760-5; GOLDSTEIN SAN, 1993, BIOPHYS J, V65, P1613, DOI 10.1016/S0006-3495(93)81200-1; GOLDSTEIN SAN, 1994, NEURON, V12, P1377, DOI 10.1016/0896-6273(94)90452-9; GOMEZLAGUNAS F, 1995, BIOPHYS J, V68, P89, DOI 10.1016/S0006-3495(95)80162-1; HEGINBOTHAM L, 1992, NEURON, V8, P483, DOI 10.1016/0896-6273(92)90276-J; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; JOHNSON BA, 1994, BIOCHEMISTRY-US, V33, P15061, DOI 10.1021/bi00254a015; JOHNSON BA, 1992, BIOCHEMISTRY-US, V31, P8185; KAVANAUGH MP, 1992, NEURON, V8, P493, DOI 10.1016/0896-6273(92)90277-K; KREZEL AM, 1995, PROTEIN SCI, V4, P1478, DOI 10.1002/pro.5560040805; LU Q, 1995, SCIENCE, V268, P304, DOI 10.1126/science.7716526; MACKINNON R, 1993, SCIENCE, V262, P757, DOI 10.1126/science.7694359; MACKINNON R, 1995, NEURON, V14, P889, DOI 10.1016/0896-6273(95)90327-5; MACKINNON R, 1989, SCIENCE, V245, P1382, DOI 10.1126/science.2476850; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MACKINNON R, 1990, NEURON, V5, P767, DOI 10.1016/0896-6273(90)90335-D; MILLER C, 1988, NEURON, V1, P1003, DOI 10.1016/0896-6273(88)90157-2; MILLER C, 1991, SCIENCE, V252, P1092, DOI 10.1126/science.252.5009.1092; MILLER C, 1995, NEURON, V15, P5, DOI 10.1016/0896-6273(95)90057-8; PARK CS, 1992, BIOCHEMISTRY-US, V31, P7749, DOI 10.1021/bi00149a002; PARK CS, 1992, NEURON, V9, P307, DOI 10.1016/0896-6273(92)90169-E; PARK CS, 1991, P NATL ACAD SCI USA, V88, P2046, DOI 10.1073/pnas.88.6.2046; SCHREIBER G, 1995, J MOL BIOL, V248, P478, DOI 10.1006/jmbi.1995.0235; SCHWARZ TL, 1988, NATURE, V331, P137, DOI 10.1038/331137a0; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; STAMPE P, 1994, BIOCHEMISTRY-US, V33, P443, DOI 10.1021/bi00168a008; STOCKER M, 1994, P NATL ACAD SCI USA, V91, P9509, DOI 10.1073/pnas.91.20.9509	32	137	138	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1996	16	1					123	130		10.1016/S0896-6273(00)80029-X	http://dx.doi.org/10.1016/S0896-6273(00)80029-X			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TT307	8562075	Bronze			2022-12-24	WOS:A1996TT30700015
J	WADICHE, JI; ARRIZA, JL; AMARA, SG; KAVANAUGH, MP				WADICHE, JI; ARRIZA, JL; AMARA, SG; KAVANAUGH, MP			KINETICS OF A HUMAN GLUTAMATE TRANSPORTER	NEURON			English	Article							EXCITATORY SYNAPTIC CURRENTS; NA+ GLUCOSE COTRANSPORTER; RAT-BRAIN; TIME COURSE; ELECTROGENIC PROPERTIES; ASPARTATE TRANSPORTER; HIPPOCAMPAL SLICES; CHARGE MOVEMENT; XENOPUS OOCYTES; GLIAL-CELLS	Currents mediated by a glutamate transporter cloned from human motor cortex were measured in Xenopus oocytes. In the absence of glutamate, voltage jumps induced Na+-dependent capacitive currents that were blocked by kainate, a competitive transport antagonist. The pre-steady-state currents can be described by an ordered binding model in which a voltage-dependent Na+ binding is followed by a voltage-independent kainate binding. At -80 mV, two charges are translocated per molecule of glutamate, with a cycling time of approximately 70 ms, which is significantly slower than the predicted time course of synaptically released glutamate. The results suggest that glutamate diffusion and binding to transporters, rather than uptake, are likely to dominate the synaptic concentration decay kinetics.	OREGON HLTH SCI UNIV,HOWARD HUGHES MED INST,PORTLAND,OR 97201	Howard Hughes Medical Institute; Oregon Health & Science University	WADICHE, JI (corresponding author), OREGON HLTH SCI UNIV,VOLLUM INST,L474,PORTLAND,OR 97201, USA.			Wadiche, Jacques/0000-0001-8180-2061; Amara, Susan/0000-0001-8914-1106	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048709] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM48709] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Almers W, 1978, Rev Physiol Biochem Pharmacol, V82, P96, DOI 10.1007/BFb0030498; ARRIZA JL, 1993, J BIOL CHEM, V268, P15329; ARRIZA JL, 1994, J NEUROSCI, V14, P5559; ATTWELL D, 1993, NEURON, V11, P401, DOI 10.1016/0896-6273(93)90145-H; BALCAR VJ, 1972, J NEUROBIOL, V3, P295, DOI 10.1002/neu.480030403; BARBOUR B, 1991, J PHYSIOL-LONDON, V436, P169, DOI 10.1113/jphysiol.1991.sp018545; BARBOUR B, 1994, NEURON, V12, P1331, DOI 10.1016/0896-6273(94)90448-0; BOUVIER M, 1992, NATURE, V360, P471, DOI 10.1038/360471a0; BREW H, 1987, NATURE, V327, P707, DOI 10.1038/327707a0; BRIDGES RJ, 1991, J MED CHEM, V34, P717, DOI 10.1021/jm00106a037; BRUNS D, 1993, NEURON, V10, P559, DOI 10.1016/0896-6273(93)90159-O; CAMMACK JN, 1994, NEURON, V13, P949, DOI 10.1016/0896-6273(94)90260-7; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; COLQUHOUN D, 1992, J PHYSIOL-LONDON, V458, P261, DOI 10.1113/jphysiol.1992.sp019417; DANBOLT NC, 1990, BIOCHEMISTRY-US, V29, P6734, DOI 10.1021/bi00480a025; ELIASOF S, 1993, J NEUROSCI, V13, P402; ERECINSKA M, 1983, J BIOL CHEM, V258, P9069; FERKANY J, 1986, J NEUROSCI RES, V16, P491, DOI 10.1002/jnr.490160305; HESTRIN S, 1990, NEURON, V5, P247, DOI 10.1016/0896-6273(90)90162-9; HILGEMANN DW, 1991, NATURE, V352, P715, DOI 10.1038/352715a0; ISAACSON JS, 1993, J NEUROPHYSIOL, V70, P2187, DOI 10.1152/jn.1993.70.5.2187; JAHR CE, 1994, SEMIN NEUROSCI, V6, P81; Jonas Peter, 1994, Current Opinion in Neurobiology, V4, P366, DOI 10.1016/0959-4388(94)90098-1; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; KANNER BI, 1978, BIOCHEMISTRY-US, V17, P3949, DOI 10.1021/bi00612a011; KLOCKNER U, 1993, J BIOL CHEM, V268, P14594; Lauger P., 1991, ELECTROGENIC ION PUM; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; LUCAS DR, 1957, ARCH OPHTHALMOL-CHIC, V58, P193; MAGER S, 1994, NEURON, V12, P845, DOI 10.1016/0896-6273(94)90337-9; MAGER S, 1993, NEURON, V10, P177, DOI 10.1016/0896-6273(93)90309-F; MENNERICK S, 1994, NATURE, V368, P59, DOI 10.1038/368059a0; NAKAO M, 1986, NATURE, V323, P628, DOI 10.1038/323628a0; OLNEY JW, 1969, SCIENCE, V166, P386, DOI 10.1126/science.166.3903.386; OLNEY JW, 1971, SCIENCE, V172, P294, DOI 10.1126/science.172.3980.294; PARENT L, 1992, J MEMBRANE BIOL, V125, P63; PARENT L, 1992, J MEMBRANE BIOL, V125, P49; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; RAKOWSKI RF, 1993, J GEN PHYSIOL, V101, P117, DOI 10.1085/jgp.101.1.117; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; SAH P, 1989, SCIENCE, V246, P815, DOI 10.1126/science.2573153; SARANTIS M, 1993, NEURON, V11, P541, DOI 10.1016/0896-6273(93)90158-N; SCHWARTZ EA, 1990, J PHYSIOL-LONDON, V426, P43, DOI 10.1113/jphysiol.1990.sp018126; SHAFQAT S, 1983, J BIOL CHEM, V268, P15351; STORCK T, 1992, P NATL ACAD SCI USA, V89, P10955, DOI 10.1073/pnas.89.22.10955; TANAKA K, 1993, NEUROSCI RES, V16, P149, DOI 10.1016/0168-0102(93)90082-2; THOMPSON SM, 1992, J NEUROPHYSIOL, V67, P1698, DOI 10.1152/jn.1992.67.6.1698; TONG G, 1994, NEURON, V13, P1195, DOI 10.1016/0896-6273(94)90057-4; TRUSSELL LO, 1989, NEURON, V3, P209, DOI 10.1016/0896-6273(89)90034-2; TRUSSELL LO, 1994, SEMIN NEUROSCI, V6, P71; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687	51	341	343	0	2	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1995	14	5					1019	1027		10.1016/0896-6273(95)90340-2	http://dx.doi.org/10.1016/0896-6273(95)90340-2			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QY935	7748550	Bronze			2022-12-24	WOS:A1995QY93500014
J	HEVERS, W; HARDIE, RC				HEVERS, W; HARDIE, RC			SEROTONIN MODULATES THE VOLTAGE-DEPENDENCE OF DELAYED RECTIFIER AND SHAKER POTASSIUM CHANNELS IN DROSOPHILA PHOTORECEPTORS	NEURON			English	Article							SQUID GIANT-AXON; K+-CHANNELS; MOLECULAR CHARACTERIZATION; SENSORY NEURONS; XENOPUS OOCYTES; SINGLE CHANNEL; SH5 MUTATION; CURRENTS; LOCUS; GENE	We describe the in situ modulation of potassium channels in a semi-intact preparation of the Drosophila retina. In whole-cell recordings of photoreceptors, rapidly inactivating Shaker channels are characterized by a conspicuously negative voltage operating range; together with a delayed rectifier, these channels are specifically modulated by the putative efferent neurotransmitter serotonin. Contrary to most potassium channel modulations, serotonin induced a reversible positive shift in the voltage operating range, of +30 mV for the Shaker channels and +10-14 mV for the delayed rectifier. The maximal current amplitudes were unaffected. Modulation was not affected by the subunit-specific Shaker mutations Sh(E62) and T(1;Y)W32 or a null mutation of the putative modulatory subunit eag. The modulation of both channels was mimicked by intracellularly applied GTP gamma S.			HEVERS, W (corresponding author), UNIV CAMBRIDGE, DEPT ZOOL, DOWNING ST, CAMBRIDGE CB2 3EJ, ENGLAND.			Hardie, Roger/0000-0001-5531-3264				ACOSTAURQUIDI J, 1993, J NEUROPHYSIOL, V70, P541, DOI 10.1152/jn.1993.70.2.541; AIYAR J, 1993, AM J PHYSIOL, V265, pC1571, DOI 10.1152/ajpcell.1993.265.6.C1571; ALKON DL, 1985, BEHAV NEURAL BIOL, V44, P278, DOI 10.1016/S0163-1047(85)90296-1; ALKON DL, 1991, BRAIN RES REV, V16, P193, DOI 10.1016/0165-0173(91)90005-S; ATKINS PT, 1991, NATURE, V344, P240; BAKER K, 1990, NEURON, V4, P129, DOI 10.1016/0896-6273(90)90449-P; BAUMANN A, 1987, EMBO J, V6, P3419, DOI 10.1002/j.1460-2075.1987.tb02665.x; BAUMANN A, 1989, NATO ASI SER, V32, P231; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; BELARDETTI F, 1988, TRENDS NEUROSCI, V11, P232, DOI 10.1016/0166-2236(88)90132-4; BERRIDGE MJ, 1972, J EXP BIOL, V56, P311; BEZANILLA F, 1994, ANNU REV BIOPH BIOM, V23, P819, DOI 10.1146/annurev.bb.23.060194.004131; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; BOSMA MM, 1993, J NEUROSCI, V13, P5242, DOI 10.1523/JNEUROSCI.13-12-05242.1993; BRUGGEMANN A, 1993, NATURE, V365, P445, DOI 10.1038/365445a0; CUTTLE MF, 1995, IN PRESS J COMP PHYS; DRAIN P, 1994, NEURON, V12, P1097, DOI 10.1016/0896-6273(94)90317-4; DRYSDALE R, 1991, GENETICS, V127, P497; ELMSLIE KS, 1990, NEURON, V5, P75, DOI 10.1016/0896-6273(90)90035-E; ESGUERRA M, 1994, NATURE, V369, P563, DOI 10.1038/369563a0; GAUTAM M, 1990, NEURON, V5, P67, DOI 10.1016/0896-6273(90)90034-D; GUY HR, 1991, SCIENCE, V254, P730, DOI 10.1126/science.1658932; Hardie R.C., 1989, P235; Hardie R.C., 1985, Progress in Sensory Physiology, V5, P1; HARDIE RC, 1987, J COMP PHYSIOL A, V161, P201, DOI 10.1007/BF00615241; HARDIE RC, 1991, NEURON, V6, P477, DOI 10.1016/0896-6273(91)90255-X; HARDIE RC, 1991, J NEUROSCI, V11, P3079; Hille B., 1992, IONIC CHANNELS EXCIT; HOGER JH, 1991, NEURON, V6, P227, DOI 10.1016/0896-6273(91)90358-7; Homberg U., 1994, PROG ZOOL, V40, P1; Hoshi T, 1993, Curr Opin Neurobiol, V3, P283, DOI 10.1016/0959-4388(93)90119-J; HUANG XY, 1994, P NATL ACAD SCI USA, V91, P624, DOI 10.1073/pnas.91.2.624; IDFRANCESCO D, 1994, J PHYSL, V474, P473; IVERSON LE, 1988, P NATL ACAD SCI USA, V85, P5723, DOI 10.1073/pnas.85.15.5723; JAN LY, 1992, ANNU REV PHYSIOL, V54, P535, DOI 10.1146/annurev.physiol.54.1.535; JI S, 1993, J GEN PHYSIOL, V101, P355, DOI 10.1085/jgp.101.3.355; KACZMAREK LK, 1987, IN PRESS NEUROMODULA; KAMB A, 1987, CELL, V50, P405, DOI 10.1016/0092-8674(87)90494-6; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; KANDEL ER, 1982, SCIENCE, V218, P433, DOI 10.1126/science.6289442; LAUGHLIN SB, 1993, J COMP PHYSIOL A, V172, P593, DOI 10.1007/BF00213682; LEVITAN IB, 1994, ANNU REV PHYSIOL, V56, P193, DOI 10.1146/annurev.ph.56.030194.001205; LICHTINGHAGEN R, 1990, EMBO J, V9, P4399, DOI 10.1002/j.1460-2075.1990.tb07890.x; LOPEZ GA, 1991, NEURON, V7, P327, DOI 10.1016/0896-6273(91)90271-Z; LOPEZ HS, 1991, NEURON, V7, P1061, DOI 10.1016/0896-6273(91)90350-9; MACKINNON R, 1989, BIOCHEMISTRY-US, V28, P8092, DOI 10.1021/bi00446a020; MAYER ML, 1988, J PHYSL, V369, P417; MCCORMACK K, 1991, P NATL ACAD SCI USA, V88, P2931, DOI 10.1073/pnas.88.7.2931; MEVES H, 1994, PROG NEUROBIOL, V43, P175, DOI 10.1016/0301-0082(94)90012-4; MORAN O, 1991, FEBS LETT, V279, P256, DOI 10.1016/0014-5793(91)80162-V; NASSEL DR, 1991, PROG NEUROBIOL, V37, P179, DOI 10.1016/0301-0082(91)90027-X; NASSEL DR, 1988, PROG NEUROBIOL, V30, P1, DOI 10.1016/0301-0082(88)90002-0; PAPAZIAN DM, 1987, SCIENCE, V237, P749, DOI 10.1126/science.2441470; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; PEROZO E, 1991, J GEN PHYSIOL, V98, P19, DOI 10.1085/jgp.98.1.19; PEROZO E, 1991, J GEN PHYSIOL, V98, P1, DOI 10.1085/jgp.98.1.1; PEROZO E, 1990, NEURON, V5, P685, DOI 10.1016/0896-6273(90)90222-2; PEROZO E, 1989, J GEN PHYSIOL, V93, P1195, DOI 10.1085/jgp.93.6.1195; PONGS O, 1992, PHYSIOL REV, V72, pS69, DOI 10.1152/physrev.1992.72.suppl_4.S69; PONGS O, 1988, EMBO J, V7, P1087, DOI 10.1002/j.1460-2075.1988.tb02917.x; POULAIN C, 1994, PFLUG ARCH EUR J PHY, V427, P71, DOI 10.1007/BF00585944; RUDY B, 1988, NEUROSCIENCE, V25, P729, DOI 10.1016/0306-4522(88)90033-4; SALKOFF L, 1981, NATURE, V293, P228, DOI 10.1038/293228a0; SALKOFF L, 1992, TRENDS NEUROSCI, V15, P161, DOI 10.1016/0166-2236(92)90165-5; SALKOFF LB, 1983, J PHYSIOL-LONDON, V337, P687, DOI 10.1113/jphysiol.1983.sp014649; SAUDOU F, 1992, EMBO J, V11, P7, DOI 10.1002/j.1460-2075.1992.tb05021.x; SCHWARZ TL, 1988, NATURE, V331, P137, DOI 10.1038/331137a0; SCHWARZ TL, 1990, NEURON, V4, P119, DOI 10.1016/0896-6273(90)90448-O; SINGH S, 1989, NEURON, V2, P1325, DOI 10.1016/0896-6273(89)90070-6; STOCKER M, 1990, P NATL ACAD SCI USA, V87, P8903, DOI 10.1073/pnas.87.22.8903; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; TIMPE LC, 1988, NATURE, V331, P143, DOI 10.1038/331143a0; TIMPE LC, 1988, NEURON, V1, P659, DOI 10.1016/0896-6273(88)90165-1; TIMPE LC, 1994, J NEUROSCI, V14, P1195, DOI 10.1523/JNEUROSCI.14-03-01195.1994; VOLTERRA A, 1988, P NATL ACAD SCI USA, V85, P7810, DOI 10.1073/pnas.85.20.7810; WARMKE J, 1991, SCIENCE, V252, P1560, DOI 10.1126/science.1840699; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; WEI A, 1990, SCIENCE, V248, P599, DOI 10.1126/science.2333511; WHITE JA, 1994, BIOPHYS J, V66, P710, DOI 10.1016/S0006-3495(94)80845-8; WITZ P, 1990, P NATL ACAD SCI USA, V87, P8940, DOI 10.1073/pnas.87.22.8940; Wu C F, 1992, Ion Channels, V3, P261; WU CF, 1985, J NEUROSCI, V5, P2626; WU CF, 1983, SCIENCE, V220, P1076, DOI 10.1126/science.6302847; ZAGOTTA WN, 1990, J GEN PHYSIOL, V95, P29, DOI 10.1085/jgp.95.1.29; ZAGOTTA WN, 1990, J NEUROSCI, V10, P1799; ZHOLOS AV, 1994, J PHYSIOL-LONDON, V478, P195, DOI 10.1113/jphysiol.1994.sp020242; ZHONG Y, 1993, J NEUROSCI, V13, P4669; ZHONG Y, 1991, SCIENCE, V252, P1562, DOI 10.1126/science.2047864	88	59	59	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1995	14	4					845	856		10.1016/0896-6273(95)90228-7	http://dx.doi.org/10.1016/0896-6273(95)90228-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QU826	7718246	Bronze			2022-12-24	WOS:A1995QU82600018
J	REUTER, H				REUTER, H			MEASUREMENTS OF EXOCYTOSIS FROM SINGLE PRESYNAPTIC NERVE-TERMINALS REVEAL HETEROGENEOUS INHIBITION BY CA2+-CHANNEL BLOCKERS	NEURON			English	Article							FROG NEUROMUSCULAR-JUNCTION; LONG-TERM POTENTIATION; CALCIUM CHANNELS; SYNAPTIC TRANSMISSION; TRANSMITTER RELEASE; DENDRITIC SPINES; HIPPOCAMPUS; NEURONS	The effect of various Ca2+-channel blockers on exocytosis has been studied at the level of single presynaptic terminals in rat hippocampal cell cultures. The fluorescence change of the styryl dye FM1-43 has been used as a measure of exocytosis during electrical stimulation. omega-Conotoxin GVIA (2-10 mu M) completely inhibited exocytosis in similar to 45% of the boutons in the field of view, while in similar to 55% exocytosis was inhibited incompletely (by 38%). This heterogeneity in response of presynaptic boutons was not seen with isradipine (5 mu M) or omega-agatoxin IVA (80 nM), which inhibited exocytosis by 23% and 17%, respectively. However, it was observed with a combination of all three blockers. Pre- and postsynaptic events could be separated in single synapses by measuring FM1-43 release and NMDA- induced changes in the intracellular Ca2+ concentration independently.			REUTER, H (corresponding author), UNIV BERN,DEPT PHARMACOL,CH-3010 BERN,SWITZERLAND.							ALMERS W, 1990, ANNU REV PHYSIOL, V52, P607, DOI 10.1146/annurev.ph.52.030190.003135; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; BETZ WJ, 1993, J PHYSIOL-LONDON, V460, P287, DOI 10.1113/jphysiol.1993.sp019472; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; DETOLEDO GA, 1993, NATURE, V363, P554, DOI 10.1038/363554a0; GUTHRIE PB, 1991, NATURE, V354, P76, DOI 10.1038/354076a0; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HOFMANN F, 1994, ANNU REV NEUROSCI, V17, P399, DOI 10.1146/annurev.neuro.17.1.399; HORNE AL, 1991, BRIT J PHARMACOL, V103, P1733, DOI 10.1111/j.1476-5381.1991.tb09855.x; Katz B., 1969, RELEASE NEURAL TRANS; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; LIU H, 1994, P NATL ACAD SCI USA, V91, P8383, DOI 10.1073/pnas.91.18.8383; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; MALINOW R, 1994, SCIENCE, V266, P1195, DOI 10.1126/science.7973700; MINTZ IM, 1992, NEURON, V9, P85, DOI 10.1016/0896-6273(92)90223-Z; MULLER W, 1991, NATURE, V354, P73, DOI 10.1038/354073a0; MURPHY TH, 1994, SCIENCE, V263, P529, DOI 10.1126/science.7904774; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; SCHNEGGENBURGER R, 1993, NEURON, V11, P133, DOI 10.1016/0896-6273(93)90277-X; SOLLNER T, 1994, TRENDS NEUROSCI, V17, P344, DOI 10.1016/0166-2236(94)90178-3; STANLEY EF, 1993, NEURON, V11, P1007, DOI 10.1016/0896-6273(93)90214-C; TAKAHASHI T, 1993, NATURE, V366, P156, DOI 10.1038/366156a0; TSIEN RW, 1991, TRENDS PHARMACOL SCI, V12, P349, DOI 10.1016/0165-6147(91)90595-J; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; VONGERSDORFF H, 1994, NATURE, V370, P652, DOI 10.1038/370652a0; WESTENBROEK RE, 1992, NEURON, V9, P1099, DOI 10.1016/0896-6273(92)90069-P; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; WU LG, 1994, J NEUROSCI, V14, P5613; ZUCKER RS, 1993, J PHYSIOL-PARIS, V87, P25, DOI 10.1016/0928-4257(93)90021-K	32	101	102	0	0	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1995	14	4					773	779		10.1016/0896-6273(95)90221-X	http://dx.doi.org/10.1016/0896-6273(95)90221-X			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QU826	7718239	Bronze			2022-12-24	WOS:A1995QU82600011
J	MULLER, D; HEFFT, S; FIGUROV, A				MULLER, D; HEFFT, S; FIGUROV, A			HETEROSYNAPTIC INTERACTIONS BETWEEN LTP AND LTD IN CA1 HIPPOCAMPAL SLICES	NEURON			English	Article							LONG-TERM DEPRESSION; METABOTROPIC GLUTAMATE RECEPTORS; RAT VISUAL-CORTEX; SYNAPTIC PLASTICITY; DENTATE GYRUS; AREA CA1; POTENTIATION; INDUCTION; REVERSAL; STIMULATION	Experiments in which several high and/or low frequency stimulation patterns were applied to different groups of afferents in CA1 hippocampal slices revealed the existence of heterosynaptic interactions between LTP and LTD. Specifically, we report that repeated induction of LTD on one input was associated with a heterosynaptic reversal of the LTP previously induced on a separate pathway. Reapplication of high frequency stimulation at the end of the experiment reinstated LTP. This heterosynaptic reversal occurred without modification of naive responses, and it was prevented by D-AP5, an NMDA receptor antagonist, or cyclosporin A, a calcineurin inhibitor. Similarly, induction of LTP on one input was found to reverse hetero-synaptically the LTD previously induced on a separate pathway. This effect was also sensitive to D-AP5, it occurred without modification of naive pathways, and LTD could be reinstated by low frequency trains. These results indicate that repeated induction of LTP or LTD on one group of afferents can reset synaptic efficacy at other nonactivated synapses.			MULLER, D (corresponding author), CTR MED UNIV GENEVA,DEPT PHARMACOL,CH-1211 GENEVA 4,SWITZERLAND.							ABRAHAM WC, 1983, NATURE, V305, P717, DOI 10.1038/305717a0; ARTOLA A, 1993, TRENDS NEUROSCI, V16, P480, DOI 10.1016/0166-2236(93)90081-V; ARTOLA A, 1990, NATURE, V347, P69, DOI 10.1038/347069a0; BASHIR ZI, 1993, EUR J PHARMACOL, V239, P265, DOI 10.1016/0014-2999(93)91009-C; BASHIR ZI, 1993, NATURE, V363, P347, DOI 10.1038/363347a0; BENARI Y, 1992, TRENDS NEUROSCI, V15, P333, DOI 10.1016/0166-2236(92)90049-E; BITTAR P, 1993, BRAIN RES, V620, P181, DOI 10.1016/0006-8993(93)90154-F; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BONHOEFFER T, 1989, P NATL ACAD SCI USA, V86, P8113, DOI 10.1073/pnas.86.20.8113; BRADLER JE, 1990, NEUROSCIENCE, V35, P265, DOI 10.1016/0306-4522(90)90080-N; BROCHER S, 1992, P NATL ACAD SCI USA, V89, P123, DOI 10.1073/pnas.89.1.123; CASTRO CA, 1989, NATURE, V342, P545, DOI 10.1038/342545a0; CHRISTIE BR, 1992, SYNAPSE, V10, P1, DOI 10.1002/syn.890100102; CHRISTIE BR, 1992, NEURON, V9, P79, DOI 10.1016/0896-6273(92)90222-Y; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; DEBANNE D, 1994, P NATL ACAD SCI USA, V91, P1148, DOI 10.1073/pnas.91.3.1148; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; DUDEK SM, 1993, J NEUROSCI, V13, P2910; FUJII S, 1991, BRAIN RES, V555, P112, DOI 10.1016/0006-8993(91)90867-U; KATO N, 1993, P NATL ACAD SCI USA, V90, P3650, DOI 10.1073/pnas.90.8.3650; KIRKWOOD A, 1993, SCIENCE, V260, P1518, DOI 10.1126/science.8502997; LARSON J, 1993, BRAIN RES, V600, P97, DOI 10.1016/0006-8993(93)90406-D; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; LYNCH GS, 1977, NATURE, V266, P737, DOI 10.1038/266737a0; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; MULKEY RM, 1988, SCIENCE, V242, P81; SCHUMAN EM, 1994, SCIENCE, V263, P532, DOI 10.1126/science.8290963; STEVENS CF, 1993, NATURE, V364, P147, DOI 10.1038/364147a0; ZORUMSKI CF, 1993, BIOCHEM PHARMACOL, V46, P777, DOI 10.1016/0006-2952(93)90484-E	32	50	50	1	5	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1995	14	3					599	605		10.1016/0896-6273(95)90316-X	http://dx.doi.org/10.1016/0896-6273(95)90316-X			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QP230	7695906	Bronze			2022-12-24	WOS:A1995QP23000013
J	BACSKAI, BJ; WALLEN, P; LEVRAM, V; GRILLNER, S; TSIEN, RY				BACSKAI, BJ; WALLEN, P; LEVRAM, V; GRILLNER, S; TSIEN, RY			ACTIVITY-RELATED CALCIUM DYNAMICS IN LAMPREY MOTONEURONS AS REVEALED BY VIDEO-RATE CONFOCAL MICROSCOPY	NEURON			English	Article							COMPUTER-BASED MODEL; REALISTIC SIMULATIONS; MEMBRANE-PROPERTIES; FICTIVE LOCOMOTION; NEURAL NETWORKS; SPINAL-CORD; NEURONS; RECEPTORS; CHANNELS	In lamprey spinal cord, intracellular calcium ([Ca2+](i)) plays a key role in mechanisms regulating neuronal activity in the segmental network for locomotion. In this report, measurements of [Ca2+](i) with fluo-3 in various regions of motoneurons in the intact spinal cord were obtained on a high speed confocal microscope following electrical stimulation. Likewise, rhythmic calcium fluctuations within dendrites and axons were seen during ''fictive swimming'' and were directly correlated with electrical activity. Antidromic stimulation of motoneuron axons induced large calcium transients and revealed spatially restricted ''hot spots,'' both of which required external calcium and were blocked by nickel, but not by known calcium channel antagonists. These results suggest that lamprey spinal cord axons may possess a pharmacologically novel class of calcium channel.	KAROLINSKA INST,NOBEL INST NEUROPHYSIOL,DEPT NEUROSCI,S-17177 STOCKHOLM,SWEDEN	Karolinska Institutet	BACSKAI, BJ (corresponding author), UNIV CALIF SAN DIEGO,HOWARD HUGHES MED INST,DEPT PHARMACOL,LA JOLLA,CA 92093, USA.		Bacskai, Brian/AAE-9583-2021		NINDS NIH HHS [NS27177] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027177, R37NS027177] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALFORD S, 1991, J NEUROSCI, V11, P3718; BRODIN L, 1991, J NEUROPHYSIOL, V66, P473, DOI 10.1152/jn.1991.66.2.473; EKEBERG O, 1991, BIOL CYBERN, V65, P81, DOI 10.1007/BF00202382; ELMANIRA A, 1994, J NEUROPHYSIOL, V72, P1852, DOI 10.1152/jn.1994.72.4.1852; GRILLNER S, 1981, ACTA PHYSIOL SCAND, V113, P549, DOI 10.1111/j.1748-1716.1981.tb06937.x; GRILLNER S, 1985, SCIENCE, V228, P143, DOI 10.1126/science.3975635; GRILLNER S, 1991, ANNU REV NEUROSCI, V14, P169, DOI 10.1146/annurev.neuro.14.1.169; GRILLNER S, 1987, TRENDS NEUROSCI, V10, P34, DOI 10.1016/0166-2236(87)90123-8; HELLGREN J, 1992, BIOL CYBERN, V68, P1, DOI 10.1007/BF00203132; HERNANDEZCRUZ A, 1990, SCIENCE, V247, P858, DOI 10.1126/science.2154851; HILL R, 1992, NEUROREPORT, V3, P943, DOI 10.1097/00001756-199210000-00032; HILL RH, 1985, BRAIN RES, V358, P40, DOI 10.1016/0006-8993(85)90946-1; Hille B., 1992, IONIC CHANNELS EXCIT; HILLYARD DR, 1992, NEURON, V9, P69, DOI 10.1016/0896-6273(92)90221-X; HORN R, 1977, BRAIN RES, V133, P177, DOI 10.1016/0006-8993(77)90061-0; MATSUSHIMA T, 1993, J NEUROPHYSIOL, V70, P2606, DOI 10.1152/jn.1993.70.6.2606; MINTZ IM, 1992, NEURON, V9, P85, DOI 10.1016/0896-6273(92)90223-Z; MINTZ IM, 1992, NATURE, V355, P827, DOI 10.1038/355827a0; ODONOVAN MJ, 1993, J NEUROSCI METH, V46, P91, DOI 10.1016/0165-0270(93)90145-H; OHTA Y, 1989, J NEUROPHYSIOL, V62, P1079, DOI 10.1152/jn.1989.62.5.1079; PERES A, 1991, CELL CALCIUM, V12, P599, DOI 10.1016/0143-4160(91)90057-L; ROSS WN, 1986, J NEUROSCI, V6, P1148; ROSS WN, 1989, P NATL ACAD SCI USA, V86, P1679, DOI 10.1073/pnas.86.5.1679; ROVAINEN CM, 1979, PHYSIOL REV, V59, P1007, DOI 10.1152/physrev.1979.59.4.1007; SRINIVASAN M, 1993, EUR J NEUROSCI, V6, P168; STOCKBRIDGE LL, 1986, J NEUROPHYSIOL, V56, P1669, DOI 10.1152/jn.1986.56.6.1669; TEGNER J, 1993, J NEUROPHYSIOL, V69, P647, DOI 10.1152/jn.1993.69.3.647; TSIEN RY, 1994, IN PRESS HDB BIOL CO; WALLEN P, 1987, J NEUROSCI, V7, P2745; WALLEN P, 1992, J NEUROPHYSIOL, V68, P1939, DOI 10.1152/jn.1992.68.6.1939	30	62	63	0	4	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1995	14	1					19	28		10.1016/0896-6273(95)90237-6	http://dx.doi.org/10.1016/0896-6273(95)90237-6			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QC548	7826636	Bronze			2022-12-24	WOS:A1995QC54800003
J	VERDI, JM; ANDERSON, DJ				VERDI, JM; ANDERSON, DJ			NEUROTROPHINS REGULATE SEQUENTIAL-CHANGES IN NEUROTROPHIN RECEPTOR EXPRESSION BY SYMPATHETIC NEUROBLASTS	NEURON			English	Article							NERVE GROWTH-FACTOR; NEURONAL DIFFERENTIATION; SENSORY NEURONS; CHOLINERGIC DIFFERENTIATION; MITOTIC-CYCLE; CELL-DIVISION; PC12 CELLS; RAT TRKC; SURVIVAL; NGF	We have examined the mechanisms controlling the induction of the two NGF receptors, trkA and p75, in proliferating neuroblasts immune-isolated from thoracolumbar embryonic sympathetic ganglia. Contrary to prior studies, we find that induction of p75 follows rather than precedes that of trkA; this late induction is consistent with the fact that p75 functions at relatively late stages of sympathetic development. trkA induction is apparently not controlled by a cell-intrinsic mechanism. Rather, this receptor is induced by environmental signals including NT-3, which also acts as an interim survival factor for these neuroblasts. trkA induction by NT-3 is consequent to its promotion of mitotic arrest, as anti-mitotic drugs also efficiently induce trkA. p75 expression is induced in trkA-expressing cells by NGF. Thus, the development of sympathetic neurons involves sequential actions of different neurotrophins, which also regulate the expression of their own and each other's receptors.	CALTECH,HOWARD HUGHES MED INST,PASADENA,CA 91125	California Institute of Technology; Howard Hughes Medical Institute	VERDI, JM (corresponding author), CALTECH,DIV BIOL 21676,PASADENA,CA 91125, USA.							ANDERSON DJ, 1988, NATO ASI SER H, V22, P188; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BARKER PA, 1994, NEURON, V13, P203, DOI 10.1016/0896-6273(94)90470-7; BARRES BA, 1993, DEVELOPMENT, V118, P283; BATISTATOU A, 1991, J CELL BIOL, V115, P461, DOI 10.1083/jcb.115.2.461; BENEDETTI M, 1993, P NATL ACAD SCI USA, V90, P7859, DOI 10.1073/pnas.90.16.7859; BIRREN SJ, 1993, DEVELOPMENT, V119, P597; BIRREN SJ, 1992, SCIENCE, V257, P395, DOI 10.1126/science.1321502; BIRREN SJ, 1990, NEURON, V4, P189, DOI 10.1016/0896-6273(90)90094-V; BOTHWELL M, 1991, CELL, V65, P915, DOI 10.1016/0092-8674(91)90540-F; BUCHMAN VL, 1993, DEVELOPMENT, V118, P989; BUJBELLO A, 1994, DEVELOPMENT, V120, P1573; CARNAHAN JF, 1991, DEV BIOL, V148, P552, DOI 10.1016/0012-1606(91)90273-6; CHANDLER CE, 1984, J BIOL CHEM, V259, P6882; CHAO MV, 1992, NEURON, V9, P583, DOI 10.1016/0896-6273(92)90023-7; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLARY DO, 1994, MOL BIOL CELL, V5, P549, DOI 10.1091/mbc.5.5.549; CORDONCARDO C, 1991, CELL, V66, P173, DOI 10.1016/0092-8674(91)90149-S; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; DAVIES AM, 1994, TRENDS NEUROSCI, V17, P195; DAVIES AM, 1994, CURR BIOL, V4, P273, DOI 10.1016/S0960-9822(00)00064-6; DAVIES AM, 1993, NEURON, V11, P565, DOI 10.1016/0896-6273(93)90069-4; DECHANT G, 1993, J NEUROSCI, V13, P2610, DOI 10.1523/JNEUROSCI.13-06-02610.1993; DICICCOBLOOM E, 1989, BRAIN RES, V491, P403, DOI 10.1016/0006-8993(89)90080-2; DICICCOBLOOM E, 1990, J CELL BIOL, V110, P2073, DOI 10.1083/jcb.110.6.2073; DICICCOBLOOM E, 1988, P NATL ACAD SCI USA, V85, P4066, DOI 10.1073/pnas.85.11.4066; DICICCOBLOOM E, 1993, NEURON, V11, P1101, DOI 10.1016/0896-6273(93)90223-E; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; ERNSBERGER U, 1989, NEURON, V2, P1275, DOI 10.1016/0896-6273(89)90312-7; FARINAS I, 1994, NATURE, V369, P658, DOI 10.1038/369658a0; HANTZOPOULOS PA, 1994, NEURON, V13, P187, DOI 10.1016/0896-6273(94)90469-3; Hawrot E, 1979, Methods Enzymol, V58, P574; IP NY, 1992, CELL, V69, P1121, DOI 10.1016/0092-8674(92)90634-O; IP NY, 1993, NEURON, V10, P137, DOI 10.1016/0896-6273(93)90306-C; JOHNSON EM, 1988, TRENDS NEUROSCI, V11, P299, DOI 10.1016/0166-2236(88)90090-2; JONES KR, 1994, CELL, V76, P989, DOI 10.1016/0092-8674(94)90377-8; KAHANE N, 1994, J NEUROBIOL, V25, P571, DOI 10.1002/neu.480250509; KORSCHING S, 1988, DEV BIOL, V126, P40, DOI 10.1016/0012-1606(88)90236-9; KORSCHING S, 1993, J NEUROSCI, V13, P2739; KURKI P, 1988, J IMMUNOL METHODS, V109, P49, DOI 10.1016/0022-1759(88)90441-3; LAMBALLE F, 1993, EMBO J, V12, P3083, DOI 10.1002/j.1460-2075.1993.tb05977.x; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; LEDOUARIN NM, 1986, SCIENCE, V231, P1515, DOI 10.1126/science.3952494; LEE KF, 1994, DEVELOPMENT, V120, P1027; LINDSAY RM, 1994, TRENDS NEUROSCI, V17, P182, DOI 10.1016/0166-2236(94)90099-X; LO LC, 1994, PERSPECT DEV NEUROBI, V2, P191; LOPRESTI P, 1992, CELL GROWTH DIFFER, V3, P627; MEAKIN SO, 1992, TRENDS NEUROSCI, V15, P323, DOI 10.1016/0166-2236(92)90047-C; MILLER FD, 1994, DEV BIOL, V161, P206, DOI 10.1006/dbio.1994.1021; RAFF MC, 1988, NATURE, V333, P562, DOI 10.1038/333562a0; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; RAO MS, 1992, DEVELOPMENT, V116, P731; RODRIGUEZTEBAR A, 1990, NEURON, V4, P487, DOI 10.1016/0896-6273(90)90107-Q; RODRIGUEZTEBAR A, 1991, DEVELOPMENT, V112, P813; ROHRER H, 1987, J NEUROSCI, V7, P3739; ROTHMAN TP, 1978, DEV BIOL, V65, P322, DOI 10.1016/0012-1606(78)90030-1; RUBIN E, 1985, J NEUROSCI, V5, P685; SAADAT S, 1989, J CELL BIOL, V108, P1807, DOI 10.1083/jcb.108.5.1807; SCHECTERSON LC, 1992, NEURON, V9, P449, DOI 10.1016/0896-6273(92)90183-E; STEMPLE DL, 1988, NEURON, V1, P517, DOI 10.1016/0896-6273(88)90182-1; STEMPLE DL, 1991, NEUROSCI LETT, V124, P57, DOI 10.1016/0304-3940(91)90821-A; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; TESSAROLLO L, 1993, DEVELOPMENT, V118, P463; TSOULFAS P, 1993, NEURON, V10, P975, DOI 10.1016/0896-6273(93)90212-A; VALENZUELA DM, 1993, NEURON, V10, P963, DOI 10.1016/0896-6273(93)90211-9; VERDI JM, 1994, P NATL ACAD SCI USA, V91, P3949, DOI 10.1073/pnas.91.9.3949; VERDI JM, 1994, NEURON, V12, P733, DOI 10.1016/0896-6273(94)90327-1; WOLINSKY EJ, 1985, J NEUROSCI, V5, P1497; WYATT S, 1993, DEVELOPMENT, V119, P635; YAN Q, 1988, J NEUROSCI, V8, P3481	70	121	124	0	0	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1994	13	6					1359	1372		10.1016/0896-6273(94)90421-9	http://dx.doi.org/10.1016/0896-6273(94)90421-9			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PZ689	7993627				2022-12-24	WOS:A1994PZ68900010
J	LIN, DM; GOODMAN, CS				LIN, DM; GOODMAN, CS			ECTOPIC AND INCREASED EXPRESSION OF FASCICLIN-II ALTERS MOTONEURON GROWTH CONE GUIDANCE	NEURON			English	Article							CELL-ADHESION MOLECULES; CENTRAL-NERVOUS-SYSTEM; GENE FUSHI-TARAZU; IMMUNOGLOBULIN SUPERFAMILY; DROSOPHILA-MELANOGASTER; NEURONAL RECOGNITION; PATHWAY SELECTION; MOTO-NEURONS; CHICK-EMBRYO; SPECIFICITY	We used the enhancer detection/GAL4 system in Drosophila to direct increased levels of Fasciclin II (Fas II) expression on motoneuron growth cones and axons and to direct ectopic Fas II expression on other cells they encounter. Four classes of abnormal phenotypes are observed: ''bypass'' phenotypes, in which axons fail to defasciculate at the choice point where they would normally enter their muscle target region and instead extend past their target; ''detour'' phenotypes, in which these bypass growth cones enter their muscle target region at a different location; ''stall'' phenotypes, in which axons that enter their muscle target region fail to defasciculate from one another to probe their muscle targets; and ''misroute'' phenotypes, in which growth cones are diverted onto abnormal pathways by contact with Fas II-positive cells. These phenotypes show that changes in the pattern and level of Fas II expression can alter growth cone guidance, apparently in part by modulating the ability of these growth cones to respond to other guidance cues.			LIN, DM (corresponding author), UNIV CALIF BERKELEY,HOWARD HUGHES MED INST,DEPT MOLEC & CELL BIOL,DIV NEUROBIOL,BERKELEY,CA 94720, USA.				NICHD NIH HHS [HD21294] Funding Source: Medline; NIGMS NIH HHS [5T32 GM07232] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD021294, R37HD021294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007232] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASHBURNER M, 1989, DROSOPHILA LABORATOR; BASTIANI MJ, 1987, CELL, V48, P745, DOI 10.1016/0092-8674(87)90072-9; BIEBER AJ, 1989, CELL, V59, P447, DOI 10.1016/0092-8674(89)90029-9; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROADIE K, 1993, DEVELOPMENT, P227; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; CAVENER DR, 1987, NUCLEIC ACIDS RES, V15, P1353, DOI 10.1093/nar/15.4.1353; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; DOE CQ, 1988, SCIENCE, V239, P170, DOI 10.1126/science.2892267; Doherty Patrick, 1994, Current Opinion in Neurobiology, V4, P49, DOI 10.1016/0959-4388(94)90031-0; EDELMAN GM, 1983, COLD SPRING HARB SYM, V48, P515, DOI 10.1101/SQB.1983.048.01.056; ELKINS T, 1990, CELL, V60, P565, DOI 10.1016/0092-8674(90)90660-7; FISCHER JA, 1988, NATURE, V332, P853, DOI 10.1038/332853a0; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; GRENNINGLOH G, 1990, COLD SH Q B, V55, P327; HARRELSON AL, 1988, SCIENCE, V242, P700, DOI 10.1126/science.3187519; HARTENSTEIN V, 1992, ROUX ARCH DEV BIOL, V201, P194, DOI 10.1007/BF00188752; HIROMI Y, 1985, CELL, V43, P603, DOI 10.1016/0092-8674(85)90232-6; KESHISHIAN H, 1993, J NEUROBIOL, V24, P757, DOI 10.1002/neu.480240606; KLAMBT C, 1991, CELL, V64, P801, DOI 10.1016/0092-8674(91)90509-W; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; LANCEJONES C, 1981, PROC R SOC SER B-BIO, V214, P19, DOI 10.1098/rspb.1981.0080; LANCEJONES C, 1981, PROC R SOC SER B-BIO, V214, P1, DOI 10.1098/rspb.1981.0079; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Manning Gerards, 1993, P609; MAYFORD M, 1992, SCIENCE, V256, P638, DOI 10.1126/science.1585176; NOSE A, 1994, NEURON, V13, P525, DOI 10.1016/0896-6273(94)90023-X; OKANE CJ, 1987, P NATL ACAD SCI USA, V84, P9123, DOI 10.1073/pnas.84.24.9123; PETER N, 1994, J NEUROSCI, V14, P1413, DOI 10.1523/JNEUROSCI.14-03-01413.1994; PINI A, 1993, SCIENCE, V261, P95, DOI 10.1126/science.8316861; RAMOS RGP, 1993, GENE DEV, V7, P2533, DOI 10.1101/gad.7.12b.2533; ROBINOW S, 1988, DEV BIOL, V126, P294, DOI 10.1016/0012-1606(88)90139-X; Rutishauser U, 1993, Curr Opin Neurobiol, V3, P709, DOI 10.1016/0959-4388(93)90142-L; RUTISHAUSER U, 1988, SCIENCE, V240, P53, DOI 10.1126/science.3281256; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; TANG J, 1992, NEURON, V8, P1031, DOI 10.1016/0896-6273(92)90125-W; Tessier-Lavigne M, 1992, Curr Opin Neurobiol, V2, P60, DOI 10.1016/0959-4388(92)90163-F; TOMASIEWICZ H, 1993, NEURON, V11, P1163, DOI 10.1016/0896-6273(93)90228-J; TOSNEY KW, 1985, J NEUROSCI, V5, P2336; TOSNEY KW, 1985, J NEUROSCI, V5, P2345; TOSNEY KW, 1984, J NEUROSCI, V4, P2518; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5	44	542	545	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1994	13	3					507	523		10.1016/0896-6273(94)90022-1	http://dx.doi.org/10.1016/0896-6273(94)90022-1			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PJ284	7917288				2022-12-24	WOS:A1994PJ28400002
J	HANTZOPOULOS, PA; SURI, C; GLASS, DJ; GOLDFARB, MP; YANCOPOULOS, GD				HANTZOPOULOS, PA; SURI, C; GLASS, DJ; GOLDFARB, MP; YANCOPOULOS, GD			THE LOW-AFFINITY NGF RECEPTOR, P75, CAN COLLABORATE WITH EACH OF THE TRKS TO POTENTIATE FUNCTIONAL-RESPONSES TO THE NEUROTROPHINS	NEURON			English	Article							NERVE GROWTH-FACTOR; TYROSINE PROTEIN-KINASE; HUMAN NEURO-BLASTOMA; MOLECULAR-CLONING; FACTOR FAMILY; PROTOONCOGENE PRODUCT; GENE-TRANSFER; CELL-LINES; BIOLOGICAL-ACTIVITY; PC12 CELLS	NGF and the other neurotrophins all bind to the low affinity NGF receptor (LNGFR). Although early studies suggested that the LNGFR was absolutely required for the formation of a functional neurotrophin receptor, current evidence indicates that the Trk family of receptor tyrosine kinases, in the absence of the LNGFR, can directly bind to and mediate responses to the neurotrophins. Here we describe a functional approach, in fibroblasts, designed to assay for the ability of the LNGFR to potentiate Trk-mediated responses to the neurotrophins. We report that although collaboration between the LNGFR and the Trks could be detected in this system, a truncated form of the LNGFR displayed a much more dramatic ability to interact functionally with each of the Trks, potentiating masked autocrine loops as well as responses to limiting amounts of exogenously provided neurotrophins.			HANTZOPOULOS, PA (corresponding author), REGENERON PHARMACEUT INC,777 OLD SAW MILL RIVER RD,TARRYTOWN,NY 10591, USA.		Glass, David/AAI-3910-2021; Glass, David/C-4782-2012	Glass, David/0000-0001-6187-4164				BAKER DL, 1989, CANCER RES, V49, P4142; BARBACID M, 1991, BIOCHIM BIOPHYS ACTA, V1072, P115, DOI 10.1016/0304-419X(91)90010-I; BARBACID M, 1993, ONCOGENE, V8, P2033; BERG MM, 1991, P NATL ACAD SCI USA, V88, P7106, DOI 10.1073/pnas.88.16.7106; BERG MM, 1992, J BIOL CHEM, V267, P13; BERKEMEIER LR, 1991, NEURON, V7, P857, DOI 10.1016/0896-6273(91)90287-A; BERND P, 1984, J BIOL CHEM, V259, P5509; BIRREN SJ, 1992, SCIENCE, V257, P395, DOI 10.1126/science.1321502; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; CHAO MV, 1986, SCIENCE, V232, P518, DOI 10.1126/science.3008331; CORDONCARDO C, 1991, CELL, V66, P173, DOI 10.1016/0092-8674(91)90149-S; DAVIES AM, 1993, NEURON, V11, P565, DOI 10.1016/0896-6273(93)90069-4; DAVIS S, 1991, SCIENCE, V253, P59, DOI 10.1126/science.1648265; Davis S, 1993, Curr Opin Neurobiol, V3, P20, DOI 10.1016/0959-4388(93)90030-3; DISTEFANO PS, 1988, P NATL ACAD SCI USA, V85, P270, DOI 10.1073/pnas.85.1.270; ERNFORS P, 1990, P NATL ACAD SCI USA, V87, P5454, DOI 10.1073/pnas.87.14.5454; Glass David J., 1993, Trends in Cell Biology, V3, P262, DOI 10.1016/0962-8924(93)90054-5; GLASS DJ, 1991, CELL, V66, P405, DOI 10.1016/0092-8674(91)90629-D; GUNNING P, 1987, P NATL ACAD SCI USA, V84, P4831, DOI 10.1073/pnas.84.14.4831; HALLBOOK F, 1991, NEURON, V6, P845, DOI 10.1016/0896-6273(91)90180-8; HANTZOPOULOS PA, 1989, P NATL ACAD SCI USA, V86, P3519, DOI 10.1073/pnas.86.10.3519; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HEMPSTEAD BL, 1989, SCIENCE, V243, P373, DOI 10.1126/science.2536190; HEMPSTEAD BL, 1990, J BIOL CHEM, V265, P9595; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; HOSANG M, 1985, J BIOL CHEM, V260, P655; HOSANG M, 1987, EMBO J, V6, P1198; IBANEZ CF, 1992, CELL, V69, P329, DOI 10.1016/0092-8674(92)90413-7; IP NY, 1992, P NATL ACAD SCI USA, V89, P3060, DOI 10.1073/pnas.89.7.3060; IP NY, 1993, NEURON, V10, P137, DOI 10.1016/0896-6273(93)90306-C; JING SQ, 1992, NEURON, V9, P1067, DOI 10.1016/0896-6273(92)90066-M; JOHNSON EM, 1988, TRENDS NEUROSCI, V11, P299, DOI 10.1016/0166-2236(88)90090-2; JONES KR, 1990, P NATL ACAD SCI USA, V87, P8060, DOI 10.1073/pnas.87.20.8060; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KIMATA H, 1991, IMMUNOLOGY, V72, P451; KLAGSBRUN M, 1991, CELL, V67, P229, DOI 10.1016/0092-8674(91)90173-V; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KLEIN R, 1992, NEURON, V8, P947, DOI 10.1016/0896-6273(92)90209-V; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; KOKAIA Z, 1993, P NATL ACAD SCI USA, V90, P6711, DOI 10.1073/pnas.90.14.6711; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; LEE KF, 1994, DEVELOPMENT, V120, P1027; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; LOEB DM, 1993, J NEUROSCI, V13, P2919; LOPEZCASILLAS F, 1993, CELL, V73, P1435, DOI 10.1016/0092-8674(93)90368-Z; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MAISONPIERRE PC, 1991, GENOMICS, V10, P558, DOI 10.1016/0888-7543(91)90436-I; MATSUSHIMA H, 1990, MOL CELL BIOL, V10, P5015, DOI 10.1128/MCB.10.9.5015; MEAKIN SO, 1991, NEURON, V6, P153, DOI 10.1016/0896-6273(91)90130-R; MEAKIN SO, 1992, TRENDS NEUROSCI, V15, P323, DOI 10.1016/0166-2236(92)90047-C; MEAKIN SO, 1992, P NATL ACAD SCI USA, V89, P2374, DOI 10.1073/pnas.89.6.2374; MIDDLEMAS DS, 1994, J BIOL CHEM, V269, P5458; MIRANDA RC, 1993, P NATL ACAD SCI USA, V90, P6439, DOI 10.1073/pnas.90.14.6439; MIYAJIMA A, 1992, ANNU REV IMMUNOL, V10, P295, DOI 10.1146/annurev.immunol.10.1.295; NICOLA NA, 1991, CELL, V67, P1, DOI 10.1016/0092-8674(91)90564-F; NOWAK R, 1994, SCIENCE, V262, P1818; NYE SH, 1992, MOL BIOL CELL, V3, P677, DOI 10.1091/mbc.3.6.677; OMICHI M, 1991, J BIOL CHEM, V266, P14858; OTTEN U, 1989, P NATL ACAD SCI USA, V86, P10059, DOI 10.1073/pnas.86.24.10059; PLEASURE SJ, 1990, P NATL ACAD SCI USA, V87, P8496, DOI 10.1073/pnas.87.21.8496; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; RODRIGUEZTEBAR A, 1990, NEURON, V4, P487, DOI 10.1016/0896-6273(90)90107-Q; RODRIGUEZTEBAR A, 1992, EMBO J, V11, P917, DOI 10.1002/j.1460-2075.1992.tb05130.x; ROSENTHAL A, 1990, NEURON, V4, P767, DOI 10.1016/0896-6273(90)90203-R; ROVELLI G, 1993, P NATL ACAD SCI USA, V90, P8717, DOI 10.1073/pnas.90.18.8717; SCHECTERSON LC, 1992, NEURON, V9, P449, DOI 10.1016/0896-6273(92)90183-E; SCHLESSINGER J, 1992, NEURON, V9, P383, DOI 10.1016/0896-6273(92)90177-F; SONNENFELD KH, 1982, J NEUROSCI RES, V8, P375, DOI 10.1002/jnr.490080226; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; TAPLEY P, 1992, ONCOGENE, V7, P371; TARTAGLIA LA, 1993, J BIOL CHEM, V268, P18542; THOENEN H, 1991, TRENDS NEUROSCI, V14, P165, DOI 10.1016/0166-2236(91)90097-E; VALENZUELA DM, 1993, NEURON, V10, P963, DOI 10.1016/0896-6273(93)90211-9; VETTER ML, 1991, P NATL ACAD SCI USA, V88, P5650, DOI 10.1073/pnas.88.13.5650; WESKAMP G, 1991, NEURON, V6, P649, DOI 10.1016/0896-6273(91)90067-A; YAN H, 1991, SCIENCE, V252, P561, DOI 10.1126/science.1850551; ZHAN X, 1987, ONCOGENE, V1, P369; ZHAN X, 1986, MOL CELL BIOL, V6, P3541, DOI 10.1128/MCB.6.10.3541	81	256	259	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1994	13	1					187	201		10.1016/0896-6273(94)90469-3	http://dx.doi.org/10.1016/0896-6273(94)90469-3			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NZ247	8043276				2022-12-24	WOS:A1994NZ24700015
J	KLEIN, M				KLEIN, M			SYNAPTIC AUGMENTATION BY 5-HT AT RESTED APLYSIA SENSORIMOTOR SYNAPSES - INDEPENDENCE OF ACTION-POTENTIAL PROLONGATION	NEURON			English	Article							GILL-WITHDRAWAL REFLEX; SQUID GIANT SYNAPSE; PROTEIN-KINASE-C; CRAYFISH NEUROMUSCULAR-JUNCTION; SPONTANEOUS TRANSMITTER RELEASE; SENSORY NEURONS; PRESYNAPTIC FACILITATION; MEMBRANE CURRENTS; INSULIN RELEASE; CA-2+ CURRENT	Short-term augmentation of synaptic transmission at sensory neuron synapses of Aplysia contributes to behavioral sensitization and is one of the current models for a cellular mechanism of learning. This neuromodulatory process, mediated at least in part by the facilitatory neurotransmitter serotonin (5-HT) acting through cAMP, has been thought to result largely from prolongation of the sensory neuron action potential (AP). The quantitative contribution of AP prolongation to synaptic augmentation was examined using a new culture preparation that is favorable for controlling the voltage at the presynaptic terminals. Preventing AP prolongation by using unvarying voltage-clamp commands in place of triggered APs did not reduce augmentation significantly, and pharmacological prolongation of APs caused by a high concentration of 5-HT led to a negligible increase in the synaptic response. Together with earlier evidence against the involvement of changes in Ca2+ current, these results suggest that synaptic augmentation may result from modulation of steps in the secretory process that lie distal to the flow of ion currents across the nerve terminal membrane.	UNIV MONTREAL,CTR RECH SCI NEUROL,MONTREAL H2W 1R7,PQ,CANADA	Universite de Montreal	KLEIN, M (corresponding author), CLIN RES INST MONTREAL,NEUROBIOL & BEHAV LAB,MONTREAL H2W 1R7,PQ,CANADA.				NIMH NIH HHS [MH45397] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH045397] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AMMALA C, 1993, NATURE, V363, P356, DOI 10.1038/363356a0; AUGUSTINE GJ, 1990, J PHYSIOL-LONDON, V431, P343, DOI 10.1113/jphysiol.1990.sp018333; BAILEY CH, 1979, J NEUROCYTOL, V8, P415, DOI 10.1007/BF01214801; BAILEY CH, 1988, J NEUROSCI, V8, P2452; BELARDETTI F, 1987, NATURE, V325, P153, DOI 10.1038/325153a0; BOYLE MB, 1984, P NATL ACAD SCI-BIOL, V81, P7642, DOI 10.1073/pnas.81.23.7642; BRAHA O, 1993, J NEUROSCI, V13, P1839; BRAHA O, 1990, P NATL ACAD SCI USA, V87, P2040, DOI 10.1073/pnas.87.5.2040; BYRNE JH, 1987, PHYSIOL REV, V67, P329, DOI 10.1152/physrev.1987.67.2.329; CRITZ SD, 1991, J NEUROPHYSIOL, V66, P1912, DOI 10.1152/jn.1991.66.6.1912; DALE N, 1990, J PHYSIOL-LONDON, V421, P203, DOI 10.1113/jphysiol.1990.sp017941; DELANEY K, 1991, J NEUROSCI, V11, P2631; DIXON D, 1989, J NEUROPHYSIOL, V62, P1251, DOI 10.1152/jn.1989.62.6.1251; EDMONDS B, 1990, SCIENCE, V250, P1142, DOI 10.1126/science.2174573; ELIOTLS, 1993, NATURE, V361, P634; GHIRARDI M, 1992, NEURON, V9, P479, DOI 10.1016/0896-6273(92)90185-G; GINGRICH KJ, 1985, J NEUROPHYSIOL, V53, P652, DOI 10.1152/jn.1985.53.3.652; HAYDON PG, 1988, J NEUROSCI, V8, P1032; HOCHNER B, 1986, P NATL ACAD SCI USA, V83, P8794, DOI 10.1073/pnas.83.22.8794; HOCHNER B, 1986, P NATL ACAD SCI USA, V83, P8410, DOI 10.1073/pnas.83.21.8410; HUGHES SJ, 1989, MOL CELL ENDOCRINOL, V65, P35, DOI 10.1016/0303-7207(89)90162-7; ICHINOSE M, 1991, BRAIN RES, V549, P146, DOI 10.1016/0006-8993(91)90611-X; JESSELL TM, 1993, CELL 72 NEURON S, V10, P1; KANDEL ER, 1982, SCIENCE, V218, P433, DOI 10.1126/science.6289442; KLEIN M, 1980, J EXP BIOL, V89, P117; KLEIN M, 1993, J NEUROSCI, V13, P3793; LLINAS R, 1982, P NATL ACAD SCI-BIOL, V79, P2415, DOI 10.1073/pnas.79.7.2415; LLINAS R, 1991, J PHYSIOL-LONDON, V436, P257, DOI 10.1113/jphysiol.1991.sp018549; MANSONHING H, 1989, NATURE, V341, P237, DOI 10.1038/341237a0; PIERONI JP, 1992, J NEUROSCI, V12, P2633; PINSKER H, 1970, SCIENCE, V167, P1740, DOI 10.1126/science.167.3926.1740; SACKTOR TC, 1990, P NATL ACAD SCI USA, V87, P2036, DOI 10.1073/pnas.87.5.2036; SIKDAR SK, 1990, FEBS LETT, V273, P150, DOI 10.1016/0014-5793(90)81072-V; SOSSIN WS, 1992, J NEUROSCI, V12, P1160; SUGITA S, 1992, J NEUROPHYSIOL, V68, P643, DOI 10.1152/jn.1992.68.2.643; SWEATT JD, 1989, NATURE, V342, P275, DOI 10.1038/342275a0	36	62	62	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1994	13	1					159	166		10.1016/0896-6273(94)90466-9	http://dx.doi.org/10.1016/0896-6273(94)90466-9			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NZ247	7913820				2022-12-24	WOS:A1994NZ24700012
J	ROSEN, LB; GINTY, DD; WEBER, MJ; GREENBERG, ME				ROSEN, LB; GINTY, DD; WEBER, MJ; GREENBERG, ME			MEMBRANE DEPOLARIZATION AND CALCIUM INFLUX STIMULATE MEK AND MAP KINASE VIA ACTIVATION OF RAS	NEURON			English	Review							NERVE GROWTH-FACTOR; SIGNAL-REGULATED KINASES; LONG-TERM POTENTIATION; PROTEIN-KINASE; PC12 CELLS; TYROSINE PHOSPHORYLATION; NEURONAL DIFFERENTIATION; ACETYLCHOLINE-RECEPTOR; THREONINE KINASE; PHORBOL ESTERS	A pathway by which calcium influx through voltage-sensitive calcium channels leads to mitogen-activated protein kinase (MAPK) activation has been characterized. In PC12 cells, membrane depolarization leading to calcium influx through L-type calcium channels activates the dual specificity MAPK kinase MEK1, which phosphorylates and activates MAPK. Calcium influx leads within 30 s to activation of the small guanine nucleotide-binding protein pas. Moreover, activation of MAPK in response to calcium influx is inhibited by the dominant negative mutant Ras(ASN17), indicating that pas activity is required for calcium signaling to MAPK. Ras is also activated by release of calcium from intracellular stores and by membrane depolarization of primary cortical neurons. The pleiotropic regulatory potential of both Ras and the MAPK pathway suggests that they may be central mediators of calcium signaling in the nervous system.	HARVARD UNIV,SCH MED,PROGRAM CELL & DEV BIOL,BOSTON,MA 02115; UNIV VIRGINIA,HLTH SCI CTR,DEPT MICROBIOL,CHARLOTTESVILLE,VA 22908	Harvard University; Harvard Medical School; University of Virginia	ROSEN, LB (corresponding author), HARVARD UNIV,SCH MED,DEPT MICROBIOL & MOLEC GENET,BOSTON,MA 02115, USA.				NIGMS NIH HHS [GM47332] Funding Source: Medline; NIMH NIH HHS [MH10169] Funding Source: Medline; NINDS NIH HHS [NS28829] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047332] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH010169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028829, R37NS028829] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AHLIJANIAN MK, 1990, NEURON, V4, P819, DOI 10.1016/0896-6273(90)90135-3; AHMED S, 1993, J BIOL CHEM, V268, P10709; Ahn Natalie G., 1992, Current Opinion in Cell Biology, V4, P992, DOI 10.1016/0955-0674(92)90131-U; AHN NG, 1991, J BIOL CHEM, V266, P4220; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; BARABAN JM, 1993, J NEUROCHEM, V60, P330, DOI 10.1111/j.1471-4159.1993.tb05855.x; BARBACID M, 1993, ONCOGENE, V8, P2033; BARSAGI D, 1985, CELL, V42, P841, DOI 10.1016/0092-8674(85)90280-6; BEAN BP, 1989, ANNU REV PHYSIOL, V51, P367, DOI 10.1146/annurev.physiol.51.1.367; BIRNBAUMER L, 1990, BIOCHIM BIOPHYS ACTA, V1031, P163, DOI 10.1016/0304-4157(90)90007-Y; BLENIS J, 1993, P NATL ACAD SCI USA, V90, P5889, DOI 10.1073/pnas.90.13.5889; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BORASIO GD, 1989, NEURON, V2, P1087; BORASIO GD, 1993, J CELL BIOL, V121, P665, DOI 10.1083/jcb.121.3.665; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BROTT BK, 1993, CELL GROWTH DIFFER, V4, P921; CAMPOSGONZALEZ R, 1992, J NEUROCHEM, V59, P1955, DOI 10.1111/j.1471-4159.1992.tb11032.x; CHAD JE, 1986, J PHYSIOL-LONDON, V378, P31, DOI 10.1113/jphysiol.1986.sp016206; CHAO TSO, 1992, J BIOL CHEM, V267, P19876; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; COBB MH, 1991, CELL REGUL, V2, P965, DOI 10.1091/mbc.2.12.965; COLLIN C, 1990, SCIENCE, V250, P1743, DOI 10.1126/science.2176747; CREWS CM, 1992, SCIENCE, V258, P478, DOI 10.1126/science.1411546; CREWS CM, 1993, CELL, V74, P215, DOI 10.1016/0092-8674(93)90411-I; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; DENT P, 1992, SCIENCE, V257, P1404, DOI 10.1126/science.1326789; DIVIRGILIO F, 1986, J BIOL CHEM, V261, P32; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; DREWES G, 1992, EMBO J, V11, P2131, DOI 10.1002/j.1460-2075.1992.tb05272.x; EGAN SE, 1993, NATURE, V365, P781, DOI 10.1038/365781a0; ELY CM, 1990, J CELL BIOL, V110, P731, DOI 10.1083/jcb.110.3.731; Errede B, 1993, CURR OPIN CELL BIOL, V5, P254, DOI 10.1016/0955-0674(93)90112-4; FEIG LA, 1993, SCIENCE, V260, P767, DOI 10.1126/science.8484117; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; FIORE RS, 1993, NEUROSCIENCE, V55, P463, DOI 10.1016/0306-4522(93)90516-I; FIORE RS, 1993, J NEUROCHEM, V61, P1626, DOI 10.1111/j.1471-4159.1993.tb09796.x; FRANKLIN JL, 1992, TRENDS NEUROSCI, V15, P501, DOI 10.1016/0166-2236(92)90103-F; GASS P, 1993, NEUROSCI LETT, V162, P39, DOI 10.1016/0304-3940(93)90554-X; Ginty D D, 1992, Curr Opin Neurobiol, V2, P312, DOI 10.1016/0959-4388(92)90121-Z; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; GOMEZ N, 1991, NATURE, V353, P170, DOI 10.1038/353170a0; GREENBERG ME, 1986, SCIENCE, V234, P80, DOI 10.1126/science.3749894; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; GRISWOLDPRENNER I, 1993, J BIOL CHEM, V268, P13050; GULBINS E, 1994, MOL CELL BIOL, V14, P906, DOI 10.1128/MCB.14.2.906; HAGAG N, 1986, NATURE, V319, P680, DOI 10.1038/319680a0; HANSON PI, 1992, ANNU REV BIOCHEM, V61, P559, DOI 10.1146/annurev.bi.61.070192.003015; HARLOW E, 1988, ANTIBODIES LABORATOR; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; Hille B., 1992, IONIC CHANNELS EXCIT; HOPFIELD JF, 1988, NATURE, V336, P677, DOI 10.1038/336677a0; HOWE LR, 1992, CELL, V71, P335, DOI 10.1016/0092-8674(92)90361-F; HUANG WD, 1993, P NATL ACAD SCI USA, V90, P10947, DOI 10.1073/pnas.90.23.10947; HUANG XY, 1993, CELL, V75, P1145, DOI 10.1016/0092-8674(93)90324-J; ITOH T, 1993, P NATL ACAD SCI USA, V90, P975, DOI 10.1073/pnas.90.3.975; JAISWAL RK, 1993, J BIOL CHEM, V268, P7055; KENNEDY MB, 1989, TRENDS NEUROSCI, V12, P417, DOI 10.1016/0166-2236(89)90089-1; KOSAKO H, 1993, EMBO J, V12, P787, DOI 10.1002/j.1460-2075.1993.tb05713.x; KYRIAKIS JM, 1993, J BIOL CHEM, V268, P16009; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; LALLEMAIN G, 1992, MOL CELL BIOL, V12, P2222, DOI 10.1128/MCB.12.5.2222; LANGECARTER CA, 1993, SCIENCE, V260, P315, DOI 10.1126/science.8385802; LINDBERG RA, 1992, TRENDS BIOCHEM SCI, V17, P114, DOI 10.1016/0968-0004(92)90248-8; LOWY DR, 1993, ANNU REV BIOCHEM, V62, P851, DOI 10.1146/annurev.bi.62.070193.004223; LU Q, 1993, J NEUROSCI RES, V35, P439, DOI 10.1002/jnr.490350411; MATSUDA S, 1993, J BIOL CHEM, V268, P3277; MCCORMICK F, 1993, NATURE, V363, P15, DOI 10.1038/363015a0; MESSING RO, 1989, J NEUROSCI, V9, P507; MOBLEY WC, 1976, BIOCHEMISTRY-US, V15, P5543, DOI 10.1021/bi00670a019; MORGAN JI, 1986, NATURE, V322, P552, DOI 10.1038/322552a0; MURPHY TH, 1991, NEURON, V7, P625, DOI 10.1016/0896-6273(91)90375-A; NG NFL, 1993, J BIOL CHEM, V268, P25329; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; ODELL TJ, 1991, NATURE, V353, P558, DOI 10.1038/353558a0; OSTERGAARD HL, 1991, SCIENCE, V253, P1423, DOI 10.1126/science.1654595; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; PAVLOVICSURJANCEV B, 1992, J NEUROCHEM, V59, P2134; PELECH SL, 1992, TRENDS BIOCHEM SCI, V17, P233, DOI 10.1016/S0968-0004(00)80005-5; QIU MS, 1992, NEURON, V9, P705, DOI 10.1016/0896-6273(92)90033-A; RAY LB, 1987, P NATL ACAD SCI USA, V84, P1502, DOI 10.1073/pnas.84.6.1502; RIVERA VM, 1993, MOL CELL BIOL, V13, P6260, DOI 10.1128/MCB.13.10.6260; ROBBINS DJ, 1992, P NATL ACAD SCI USA, V89, P6924, DOI 10.1073/pnas.89.15.6924; SAMUELS ML, 1993, MOL CELL BIOL, V13, P6241, DOI 10.1128/MCB.13.10.6241; SEGER R, 1992, J BIOL CHEM, V267, P25628; SHAFER TJ, 1991, NEUROTOXICOLOGY, V12, P473; STURGILL TW, 1991, BIOCHIM BIOPHYS ACTA, V1092, P350, DOI 10.1016/S0167-4889(97)90012-4; SZEBERENYI J, 1990, MOL CELL BIOL, V10, P5324, DOI 10.1128/MCB.10.10.5324; THASTRUP O, 1989, AGENTS ACTIONS, V27, P17, DOI 10.1007/BF02222186; THOMAS SM, 1992, CELL, V68, P1031, DOI 10.1016/0092-8674(92)90075-N; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; WESTENBROEK RE, 1990, NATURE, V347, P281, DOI 10.1038/347281a0; WILSON GF, 1993, NATURE, V366, P433, DOI 10.1038/366433a0; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O; WU J, 1993, P NATL ACAD SCI USA, V90, P173, DOI 10.1073/pnas.90.1.173; WU J, 1991, P NATL ACAD SCI USA, V88, P9508, DOI 10.1073/pnas.88.21.9508; WU J, 1993, MOL CELL BIOL, V13, P4539, DOI 10.1128/MCB.13.8.4539; YATANI A, 1990, CELL, V61, P769, DOI 10.1016/0092-8674(90)90187-J; ZHAO YH, 1992, P NATL ACAD SCI USA, V89, P8298, DOI 10.1073/pnas.89.17.8298; ZHENG CF, 1993, J BIOL CHEM, V268, P11435	102	603	611	0	32	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1994	12	6					1207	1221		10.1016/0896-6273(94)90438-3	http://dx.doi.org/10.1016/0896-6273(94)90438-3			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NT463	8011335				2022-12-24	WOS:A1994NT46300003
J	GEORGIOU, J; ROBITAILLE, R; TRIMBLE, WS; CHARLTON, MP				GEORGIOU, J; ROBITAILLE, R; TRIMBLE, WS; CHARLTON, MP			SYNAPTIC REGULATION OF GLIAL PROTEIN EXPRESSION IN-VIVO	NEURON			English	Article							FIBRILLARY ACIDIC PROTEIN; FROG NEUROMUSCULAR-JUNCTION; TERMINAL SCHWANN-CELLS; GENE-RELATED PEPTIDE; MOTOR END-PLATE; TRANSMITTER RELEASE; MESSENGER-RNA; C-FOS; INTRACELLULAR CALCIUM; DENERVATED MUSCLE	We investigated signaling between individual nerve terminals and perisynaptic Schwann cells, the teloglial cells that cover neuromuscular junctions. When deprived of neuronal activity in vivo, either by motor nerve transection or tetrodotoxin injection, perisynaptic Schwann cells rapidly up-regulated glial fibrillary acidic protein. Addition of transcription or translation inhibitors to excised muscles prevented this increase. Stimulation of cut nerves prevented glial fibrillary acidic protein increases even when postsynaptic nicotinic receptors were blocked, but not when neurotransmitter release was blocked with omega-conotoxin GVIA. We conclude that there is a nerve terminal to glial signal, requiring presynaptic neurotransmitter release, which regulates perisynaptic Schwann cell genes. This may be a general principle since many types of glia are sensitive to transmitters applied in vitro or released in situ.	UNIV TORONTO,MED RES COUNCIL CANADA,NERVE CELLS & SYNAPSES GRP,DEPT PHYSIOL,TORONTO M5S 1A8,ON,CANADA; UNIV TORONTO,CTR RES NEUROSCI NEURODEGENERAT DIS,TORONTO M5S 1A8,ON,CANADA; UNIV TORONTO,DEPT PHYSIOL,TORONTO M5S 1A8,ON,CANADA	University of Toronto; University of Toronto; University of Toronto	GEORGIOU, J (corresponding author), UNIV TORONTO,NETWORK CTR EXCELLENCE NEURAL REGENERAT & FUNCT R,TORONTO M5S 1A8,ON,CANADA.		Georgiou, John/E-9873-2013; Georgiou, John/ABA-1687-2020	Georgiou, John/0000-0003-4503-6384; Georgiou, John/0000-0003-4503-6384				ANDERS JJ, 1990, GLIA, V3, P17, DOI 10.1002/glia.440030104; ANDERSSON PO, 1982, J PHYSIOL-LONDON, V322, P469, DOI 10.1113/jphysiol.1982.sp014050; ARMSTRONG RC, 1993, ANNU REV NEUROSCI, V16, P17, DOI 10.1146/annurev.ne.16.030193.000313; BARRES BA, 1991, J NEUROSCI, V11, P3685; BEVAN S, 1973, NATURE-NEW BIOL, V241, P85, DOI 10.1038/newbio241085a0; BIGNAMI A, 1976, NEUROPATH APPL NEURO, V2, P99, DOI 10.1111/j.1365-2990.1976.tb00488.x; BROCK TO, 1987, J NEUROSCI, V7, P931; CANADY KS, 1992, J NEUROSCI, V12, P1001; CARDONE B, 1990, GLIA, V3, P180, DOI 10.1002/glia.440030305; CLEMENCE A, 1989, J NEUROCYTOL, V18, P185, DOI 10.1007/BF01206661; CONNOR EA, 1987, J CELL BIOL, V104, P109, DOI 10.1083/jcb.104.1.109; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; CORNELLBELL AH, 1991, CELL CALCIUM, V12, P185, DOI 10.1016/0143-4160(91)90020-F; CURTIS R, 1992, J CELL BIOL, V116, P1455, DOI 10.1083/jcb.116.6.1455; DAHL D, 1985, J COMP NEUROL, V239, P75, DOI 10.1002/cne.902390107; DANI JW, 1992, NEURON, V8, P429, DOI 10.1016/0896-6273(92)90271-E; DEARMOND SJ, 1983, BRAIN RES, V262, P275, DOI 10.1016/0006-8993(83)91018-1; DEBUS E, 1983, DIFFERENTIATION, V25, P193, DOI 10.1111/j.1432-0436.1984.tb01355.x; DECAMILLI P, 1990, ANNU REV PHYSIOL, V52, P625, DOI 10.1146/annurev.ph.52.030190.003205; DENNIS MJ, 1974, J PHYSIOL-LONDON, V237, P431, DOI 10.1113/jphysiol.1974.sp010490; DREYER F, 1974, PFLUG ARCH EUR J PHY, V348, P257, DOI 10.1007/BF00587416; DUFFY PE, 1982, EXP CELL RES, V139, P145, DOI 10.1016/0014-4827(82)90328-7; ENG LF, 1971, BRAIN RES, V28, P351, DOI 10.1016/0006-8993(71)90668-8; FEINSTEIN DL, 1992, J NEUROSCI RES, V32, P1, DOI 10.1002/jnr.490320102; FINKBEINER SM, 1993, GLIA, V9, P83, DOI 10.1002/glia.440090202; GABELLINI N, 1991, EXP CELL RES, V194, P210, DOI 10.1016/0014-4827(91)90356-Y; GIULIAN D, 1993, GLIA, V7, P102, DOI 10.1002/glia.440070116; GRAY WR, 1988, ANNU REV BIOCHEM, V57, P665, DOI 10.1146/annurev.bi.57.070188.003313; GREENBERG ME, 1986, SCIENCE, V234, P80, DOI 10.1126/science.3749894; HARRISON BC, 1992, J NEUROCHEM, V58, P320, DOI 10.1111/j.1471-4159.1992.tb09313.x; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; HEUSER JE, 1977, HDB PHYSL 1, P261; INAGAKI M, 1990, J BIOL CHEM, V265, P4722; JAHROMI BS, 1992, NEURON, V8, P1069, DOI 10.1016/0896-6273(92)90128-Z; JESSEN KR, 1991, GLIA, V4, P185, DOI 10.1002/glia.440040210; KERR LM, 1984, NATURE, V308, P282, DOI 10.1038/308282a0; KINDY MS, 1992, MOL BRAIN RES, V13, P199, DOI 10.1016/0169-328X(92)90027-9; KO CP, 1987, J NEUROCYTOL, V16, P567, DOI 10.1007/BF01668509; Kuffer S. W., 1966, Ergebnisse der Physiologie, V57, P1; KUPFERMANN I, 1991, PHYSIOL REV, V71, P683, DOI 10.1152/physrev.1991.71.3.683; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAGAMMA EF, 1989, MOL BRAIN RES, V5, P17, DOI 10.1016/0169-328X(89)90013-2; LAZARIDES E, 1982, ANNU REV BIOCHEM, V51, P219, DOI 10.1146/annurev.bi.51.070182.001251; LEPRINCE G, 1991, GLIA, V4, P322, DOI 10.1002/glia.440040310; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUNDBERG JM, 1983, TRENDS NEUROSCI, V6, P325, DOI 10.1016/0166-2236(83)90149-2; MACVICAR BA, 1989, J NEUROSCI, V9, P3577; MALHOTRA SK, 1990, CYTOBIOS, V61, P133; MARTIN DL, 1992, GLIA, V5, P81, DOI 10.1002/glia.440050202; MATSUOKA Y, 1992, EMBO J, V11, P2895, DOI 10.1002/j.1460-2075.1992.tb05358.x; MATTEOLI M, 1988, P NATL ACAD SCI USA, V85, P7366, DOI 10.1073/pnas.85.19.7366; MATTEOLI M, 1990, NEUROSCIENCE, V37, P271, DOI 10.1016/0306-4522(90)90213-N; MORGAN L, 1991, J CELL BIOL, V112, P457, DOI 10.1083/jcb.112.3.457; MURRAY MA, 1982, NEUROSCIENCE, V7, P1823, DOI 10.1016/0306-4522(82)90040-9; NISHIZAWA K, 1991, J BIOL CHEM, V266, P3074; NOETZEL MJ, 1990, J NEUROSCI RES, V27, P184, DOI 10.1002/jnr.490270208; ORKAND RK, 1982, NEURONAL GLIAL CELL, P147; PHILIBERT RA, 1988, J NEUROCHEM, V51, P122, DOI 10.1111/j.1471-4159.1988.tb04844.x; POMEROY SL, 1988, J CELL BIOL, V107, P1167, DOI 10.1083/jcb.107.3.1167; REEVES SA, 1989, P NATL ACAD SCI USA, V86, P5178, DOI 10.1073/pnas.86.13.5178; REIST NE, 1992, P NATL ACAD SCI USA, V89, P7625, DOI 10.1073/pnas.89.16.7625; REYNOLDS ML, 1992, J NEUROCYTOL, V21, P50, DOI 10.1007/BF01206897; ROBITAILLE R, 1993, J PHYSIOLOGY-PARIS, V87, P15, DOI 10.1016/0928-4257(93)90020-T; ROBITAILLE R, 1993, NEURON, V11, P645, DOI 10.1016/0896-6273(93)90076-4; ROBITAILLE R, 1992, J NEUROSCI, V12, P297; RYE HS, 1992, NUCLEIC ACIDS RES, V20, P2803, DOI 10.1093/nar/20.11.2803; SAKAGUCHI M, 1991, J PHYSIOL-LONDON, V434, P257, DOI 10.1113/jphysiol.1991.sp018468; SCHLAEPFER WW, 1981, NEUROCHEM RES, V6, P243, DOI 10.1007/BF00964040; SILINSKY EM, 1975, J PHYSIOL-LONDON, V247, P145, DOI 10.1113/jphysiol.1975.sp010925; SMITH DO, 1991, J PHYSIOL-LONDON, V432, P343, DOI 10.1113/jphysiol.1991.sp018388; SPACEK J, 1971, Z ZELLFORSCH MIK ANA, V112, P430; STAFFORD CA, 1990, GLIA, V3, P33, DOI 10.1002/glia.440030106; SZEKELY AM, 1989, MOL PHARMACOL, V35, P401; TETZLAFF W, 1989, J NEUROSCI, V9, P1303; TETZLAFF W, 1988, GLIA, V1, P90, DOI 10.1002/glia.440010110; THOMSON CE, 1993, J NEUROCYTOL, V22, P590, DOI 10.1007/BF01181486; TREJO J, 1991, J BIOL CHEM, V266, P7876; VOLKNANDT W, 1986, J NEUROCHEM, V47, P1449, DOI 10.1111/j.1471-4159.1986.tb00778.x; WEINSTEIN DE, 1991, J CELL BIOL, V112, P1205, DOI 10.1083/jcb.112.6.1205; WEIS J, 1991, J CELL BIOL, V113, P1385, DOI 10.1083/jcb.113.6.1385; WHITTAKER VP, 1990, NEUROTRANSMITTER REL, P59; WITZEMANN V, 1991, J CELL BIOL, V114, P125, DOI 10.1083/jcb.114.1.125; WOOLF CJ, 1992, J NEUROSCI, V12, P3999; [No title captured]	84	87	88	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1994	12	2					443	455		10.1016/0896-6273(94)90284-4	http://dx.doi.org/10.1016/0896-6273(94)90284-4			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MY500	7906531				2022-12-24	WOS:A1994MY50000018
J	WU, F; SCHACHER, S				WU, F; SCHACHER, S			PRESYNAPTIC AND POSTSYNAPTIC CHANGES MEDIATED BY 2 2ND MESSENGERS CONTRIBUTE TO EXPRESSION OF APLYSIA LONG-TERM HETEROSYNAPTIC INHIBITION	NEURON			English	Article							SMALL CARDIOACTIVE PEPTIDE; SIPHON-WITHDRAWAL REFLEX; SPONTANEOUS TRANSMITTER RELEASE; DEPENDENT STRUCTURAL-CHANGES; DISSOCIATED CELL-CULTURE; FMRFAMIDE-LIKE PEPTIDES; TAIL SENSORY NEURONS; S-K+ CHANNELS; PRESYNAPTIC INHIBITION; CYCLIC-AMP	FMRFamide evokes long-term inhibition of the sensorimotor connection of Aplysia that includes structural alterations in the presynaptic sensory cell. FMRFamide also evokes a down-regulation of the adhesion molecule apCAM from the surface of the postsynaptic motor cell L7. We examined the second messenger pathways mediating the long-term actions of FMRFamide on both the pre- and postsynaptic cells and determined whether the activation of each pathway is required for the expression of long-term functional and structural plasticity. Inhibition of the lipoxygenase pathway of arachidonic acid metabolism, but not the cyclooxygenase pathway, blocks the long-term changes in the presynaptic sensory cell evoked by FMRFamide. The down-regulation of apCAM in L7 appears to be mediated by cAMP-dependent activation of protein kinase A. Blocking the cAMP-dependent changes also blocks FMRFamide-induced long-term functional and structural changes. These results suggest that the expression of long-term heterosynaptic inhibition in Aplysia may require concomitant presynaptic and postsynaptic, changes, each transduced by specific second messenger systems.	NEW YORK STATE PSYCHIAT INST & HOSP, NEW YORK, NY 10032 USA	New York State Psychiatry Institute	WU, F (corresponding author), COLUMBIA UNIV COLL PHYS & SURG, CTR NEUROBIOL & BEHAV, NEW YORK, NY 10032 USA.				NIGMS NIH HHS [GM32099] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM032099] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAMS TW, 1984, P NATL ACAD SCI-BIOL, V81, P7956, DOI 10.1073/pnas.81.24.7956; BACSKAI BJ, 1993, SCIENCE, V260, P222, DOI 10.1126/science.7682336; BAHLS FH, 1992, NEUROSCI LETT, V138, P165, DOI 10.1016/0304-3940(92)90497-U; BAILEY CH, 1992, NEURON, V9, P749, DOI 10.1016/0896-6273(92)90037-E; BAILEY CH, 1983, SCIENCE, V220, P91, DOI 10.1126/science.6828885; BAILEY CH, 1992, SCIENCE, V256, P645, DOI 10.1126/science.1585177; BAILEY CH, 1988, P NATL ACAD SCI USA, V85, P2373, DOI 10.1073/pnas.85.7.2373; BAXTER DA, 1990, J NEUROPHYSIOL, V64, P978, DOI 10.1152/jn.1990.64.3.978; BELARDETTI F, 1987, NATURE, V325, P153, DOI 10.1038/325153a0; BERNIER L, 1982, J NEUROSCI, V2, P1682; BLUMENFELD H, 1990, NEURON, V5, P487, DOI 10.1016/0896-6273(90)90088-W; BRAHA O, 1990, P NATL ACAD SCI USA, V87, P2040, DOI 10.1073/pnas.87.5.2040; BREZDEN BL, 1991, J PHYSIOL-LONDON, V443, P727, DOI 10.1113/jphysiol.1991.sp018860; BREZINA V, 1987, J PHYSIOL-LONDON, V388, P565, DOI 10.1113/jphysiol.1987.sp016632; BROWN TH, 1990, ANNU REV NEUROSCI, V13, P475, DOI 10.1146/annurev.ne.13.030190.002355; BRUNELLI M, 1976, SCIENCE, V194, P1178, DOI 10.1126/science.186870; BRUSSAARD AB, 1991, J PHYSIOL-LONDON, V441, P385, DOI 10.1113/jphysiol.1991.sp018757; BUCKETT KJ, 1990, J NEUROPHYSIOL, V63, P1426, DOI 10.1152/jn.1990.63.6.1426; BULLOCH AG, 1988, J NEUROSCI, V11, P3851; BUTTNER N, 1989, NATURE, V342, P553, DOI 10.1038/342553a0; CASTELLUCCI VF, 1980, P NATL ACAD SCI-BIOL, V77, P7492, DOI 10.1073/pnas.77.12.7492; CASTELLUCCI VF, 1978, SCIENCE, V202, P1306, DOI 10.1126/science.214854; CAWTHORPE D, 1990, NEUROSCI LETT, V113, P345, DOI 10.1016/0304-3940(90)90609-D; CHANGEUX JP, 1976, NATURE, V264, P705, DOI 10.1038/264705a0; CHURCH PJ, 1991, J NEUROSCI, V11, P618; COLOMBAIONI L, 1985, J NEUROSCI, V5, P2533; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; COOPER BF, 1989, J COMP PHYSIOL B, V159, P225, DOI 10.1007/BF00691743; COTTRELL GA, 1989, COMP BIOCHEM PHYS A, V93, P41, DOI 10.1016/0300-9629(89)90189-8; CRITZ SD, 1991, J NEUROPHYSIOL, V66, P1912, DOI 10.1152/jn.1991.66.6.1912; DALE N, 1987, J NEUROSCI, V7, P2232; DALE N, 1990, J PHYSIOL-LONDON, V421, P203, DOI 10.1113/jphysiol.1990.sp017941; DALE N, 1988, SCIENCE, V239, P282, DOI 10.1126/science.2892269; DAN Y, 1992, SCIENCE, V256, P1570, DOI 10.1126/science.1317971; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; Doherty P, 1989, CURR OPIN CELL BIOL, V1, P1102, DOI 10.1016/S0955-0674(89)80057-2; EDELMAN GM, 1990, COLD SH Q B, V55, P303; EVANS BD, 1989, CELL TISSUE RES, V257, P187; FORSCHER P, 1987, J NEUROSCI, V7, P3600; FUNTE LR, 1993, NEURON, V10, P1069, DOI 10.1016/0896-6273(93)90055-V; GEARY TG, 1992, PEPTIDES, V13, P209, DOI 10.1016/0196-9781(92)90098-N; GHIRARDI M, 1992, NEURON, V9, P479, DOI 10.1016/0896-6273(92)90185-G; GLANZMAN DL, 1989, NEURON, V3, P441, DOI 10.1016/0896-6273(89)90203-1; GLANZMAN DL, 1990, SCIENCE, V249, P799, DOI 10.1126/science.2389145; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; GREENBERG SM, 1987, NATURE, V329, P62, DOI 10.1038/329062a0; Grenningloh G, 1992, Curr Opin Neurobiol, V2, P42, DOI 10.1016/0959-4388(92)90160-M; HARISH OE, 1992, NEURON, V9, P1201, DOI 10.1016/0896-6273(92)90077-Q; HAYDON PG, 1991, J NEUROSCI, V11, P3851; HEBB DO, 1949, ORG BEHAVIOR; HORNBERG U, 1991, J COMP NEUROL, V303, P35; HU YH, 1993, NEURON, V10, P921, DOI 10.1016/0896-6273(93)90207-8; ICHINOSE M, 1989, J NEUROBIOL, V20, P10, DOI 10.1002/neu.480200103; JESSELL TM, 1993, CELL, V72, P1, DOI 10.1016/S0092-8674(05)80025-X; JESSELL TM, 1988, NEURON, V1, P3, DOI 10.1016/0896-6273(88)90204-8; KAANG BK, 1993, NEURON, V10, P427, DOI 10.1016/0896-6273(93)90331-K; KELLER F, 1990, J CELL BIOL, V111, P2637, DOI 10.1083/jcb.111.6.2637; KLEIN M, 1986, P NATL ACAD SCI USA, V83, P7994, DOI 10.1073/pnas.83.20.7994; KRAJNIAK KG, 1992, COMP BIOCHEM PHYS C, V101, P93, DOI 10.1016/0742-8413(92)90205-L; KRAMER RH, 1988, J NEUROPHYSIOL, V60, P1728, DOI 10.1152/jn.1988.60.5.1728; KRONTIRISLITOWITZ JK, 1989, J COMP PHYSIOL B, V159, P211, DOI 10.1007/BF00691742; LANDMESSER L, 1990, NEURON, V4, P655, DOI 10.1016/0896-6273(90)90193-J; LOHOF AM, 1992, J NEUROSCI, V12, P1253; MACKEY SL, 1987, P NATL ACAD SCI USA, V84, P8730, DOI 10.1073/pnas.84.23.8730; MANSONHING H, 1989, NATURE, V341, P237, DOI 10.1038/341237a0; MATTSON MP, 1988, J NEUROSCI, V8, P1704; MAYFORD M, 1992, SCIENCE, V256, P638, DOI 10.1126/science.1585176; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; MONTAROLO PG, 1988, NATURE, V333, P171, DOI 10.1038/333171a0; NAZIF FA, 1991, BRAIN RES, V539, P324, DOI 10.1016/0006-8993(91)91638-H; OCORR KA, 1985, NEUROSCI LETT, V55, P113, DOI 10.1016/0304-3940(85)90004-7; ODELL TJ, 1991, P NATL ACAD SCI USA, V88, P11285, DOI 10.1073/pnas.88.24.11285; PETER N, 1993, IN PRESS J NEUROSCI; PIERONI JP, 1992, J NEUROSCI, V12, P2633; PIOMELLI D, 1987, NATURE, V328, P38, DOI 10.1038/328038a0; PRICE DA, 1977, SCIENCE, V197, P670, DOI 10.1126/science.877582; RAJARATHNAM K, 1989, BIOCHEMISTRY-US, V28, P3168, DOI 10.1021/bi00434a009; RAYPORT SG, 1986, J NEUROSCI, V6, P759; RICH MM, 1989, J NEUROSCI, V9, P1781, DOI 10.1523/jneurosci.09-05-01781.1989; RUTISHAUSER U, 1988, SCIENCE, V240, P53, DOI 10.1126/science.3281256; SCHACHER S, 1991, NEURON, V6, P679, DOI 10.1016/0896-6273(91)90166-W; SCHACHER S, 1983, J NEUROSCI, V3, P2403; SCHACHER S, 1988, SCIENCE, V240, P1667, DOI 10.1126/science.2454509; SCHACHER S, 1993, NEURON, V10, P1079, DOI 10.1016/0896-6273(93)90056-W; SCHACHER S, 1990, J NEUROSCI, V10, P3286; SCHACHER S, 1985, J NEUROSCI, V5, P2028; SCHACHER S, 1990, COLD SPRING HARB SYM, V55, P187; SCHAEFER M, 1985, CELL, V41, P457, DOI 10.1016/S0092-8674(85)80019-2; SCHOLZ KP, 1987, SCIENCE, V235, P685, DOI 10.1126/science.2433766; SCHOLZ KP, 1988, SCIENCE, V240, P1664, DOI 10.1126/science.2837826; SCHUMAN EM, 1991, SCIENCE, V254, P1503, DOI 10.1126/science.1720572; SHIBUKI K, 1991, NATURE, V349, P326, DOI 10.1038/349326a0; SMALL SA, 1992, J NEUROSCI, V12, P1616; SMALL SA, 1989, SCIENCE, V243, P1603, DOI 10.1126/science.2538924; STENT GS, 1973, P NATL ACAD SCI USA, V70, P997, DOI 10.1073/pnas.70.4.997; TANG J, 1992, NEURON, V8, P1031, DOI 10.1016/0896-6273(92)90125-W; TAUSSIG R, 1986, DNA-J MOLEC CELL BIO, V5, P453, DOI 10.1089/dna.1.1986.5.453; THOMPSON KJ, 1992, J NEUROPHYSIOL, V67, P280, DOI 10.1152/jn.1992.67.2.280; YAKEL JL, 1991, J NEUROPHYSIOL, V65, P1517, DOI 10.1152/jn.1991.65.6.1517; ZORAN MJ, 1989, J EXP BIOL, V142, P225	100	22	22	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1994	12	2					407	421		10.1016/0896-6273(94)90281-X	http://dx.doi.org/10.1016/0896-6273(94)90281-X			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MY500	7906529				2022-12-24	WOS:A1994MY50000015
J	JIN, J; CROUCH, RK; CORSON, DW; KATZ, BM; MACNICHOL, EF; CORNWALL, MC				JIN, J; CROUCH, RK; CORSON, DW; KATZ, BM; MACNICHOL, EF; CORNWALL, MC			NONCOVALENT OCCUPANCY OF THE RETINAL-BINDING POCKET OF OPSIN DIMINISHES BLEACHING ADAPTATION OF RETINAL CONES	NEURON			English	Article							VISUAL PIGMENTS; LIGHT ADAPTATION; SKATE RETINA; RHODOPSIN; PHOTORECEPTORS; SENSITIVITY; SALAMANDER; MEMBRANE; PROTEINS; ANALOGS	Bright light bleaches visual pigment and leads to a persistent desensitization of isolated rod and cone photoreceptors called bleaching adaptation. Bleaching adaptation results from the combined effects of pigment depletion and adaptational modulation of certain cellular reactions in the visual transduction cascade. Here, we present evidence that in solitary cone photoreceptors isolated from the salamander retina, the latter effect is due to the presence of free opsin in the outer segment. Also, we demonstrate that this ''opsin adaptation'' can be reversed by treating the cells with synthetic retinoids similar to 11-cis retinal but having polyene chains too short to form protonated Schiff base attachments to opsin.	MED UNIV S CAROLINA, DEPT OPHTHALMOL, CHARLESTON, SC 29425 USA; MED UNIV S CAROLINA, DEPT PATHOL & LAB MED, CHARLESTON, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	JIN, J (corresponding author), BOSTON UNIV, DEPT PHYSIOL, BOSTON, MA 02118 USA.			Cornwall, M./0000-0002-0847-939X	NATIONAL EYE INSTITUTE [R01EY004939, R01EY001157, R01EY007543] Funding Source: NIH RePORTER; NEI NIH HHS [EY07543, EY04939, EY01157] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		APPLEBURY ML, 1986, VISION RES, V26, P1881, DOI 10.1016/0042-6989(86)90115-X; BACKSTROM AC, 1978, J PHYSL, V287, P107; BAUMANN C, 1973, J PHYSIOL-LONDON, V235, P761, DOI 10.1113/jphysiol.1973.sp010415; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P589; BAYLOR DA, 1982, J PHYSIOL-LONDON, V328, P49, DOI 10.1113/jphysiol.1982.sp014252; BERNSTEIN PS, 1987, P NATL ACAD SCI USA, V84, P1849, DOI 10.1073/pnas.84.7.1849; BLATZ PE, 1969, J AM CHEM SOC, V91, P5930, DOI 10.1021/ja01049a069; BOWNDS D, 1967, NATURE, V216, P1178, DOI 10.1038/2161178a0; BRIN KP, 1977, J GEN PHYSIOL, V69, P97, DOI 10.1085/jgp.69.1.97; CATT M, 1982, BIOCHEM SOC T, V10, P343, DOI 10.1042/bst0100343; CORNWALL MC, 1990, J GEN PHYSIOL, V96, P345, DOI 10.1085/jgp.96.2.345; CORSON DW, 1990, P NATL ACAD SCI USA, V87, P6823, DOI 10.1073/pnas.87.17.6823; CROUCH RK, 1992, PHOTOCHEM PHOTOBIOL, V56, P251, DOI 10.1111/j.1751-1097.1992.tb02154.x; CROUCH RK, 1982, VISION RES, V22, P1451, DOI 10.1016/0042-6989(82)90209-7; DAEMEN FJM, 1978, NATURE, V276, P847, DOI 10.1038/276847a0; DALY SJ, 1985, VISION RES, V25, P1197, DOI 10.1016/0042-6989(85)90034-3; DOWLING JE, 1960, NATURE, V188, P114, DOI 10.1038/188114a0; DRATZ EA, 1983, TRENDS BIOCHEM SCI, V8, P128, DOI 10.1016/0968-0004(83)90235-9; FINDLAY JBC, 1986, BIOCHEM J, V238, P625, DOI 10.1042/bj2380625; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HOLLINS M, 1973, J GEN PHYSIOL, V62, P430, DOI 10.1085/jgp.62.4.430; HUBBARD R., 1971, Methods in Enzymology, V18C, P615, DOI 10.1016/S0076-6879(71)18045-7; JOHNSON GL, 1989, ENDOCR REV, V10, P317, DOI 10.1210/edrv-10-3-317; JONES GJ, 1989, P NATL ACAD SCI USA, V86, P9606, DOI 10.1073/pnas.86.23.9606; JONES GJ, 1993, IN PRESS J GEN PHYSL; KROPF A, 1958, ANN NY ACAD SCI, V74, P266, DOI 10.1111/j.1749-6632.1958.tb39550.x; LAMB TD, 1986, MOL MECHANISM PHOTOR, P267; MacNichol E. F.  Jr., 1978, Frontiers in Visual Science, P194; MAKINO CL, 1991, J PHYSIOL-LONDON, V442, P761, DOI 10.1113/jphysiol.1991.sp018818; MATSUMOTO H, 1975, NATURE, V258, P523, DOI 10.1038/258523a0; MATTHEWS HR, 1990, J PHYSIOL-LONDON, V420, P447, DOI 10.1113/jphysiol.1990.sp017922; MATTHEWS RG, 1963, J GEN PHYSIOL, V47, P215, DOI 10.1085/jgp.47.2.215; PEPPERBERG DR, 1984, VISION RES, V24, P357, DOI 10.1016/0042-6989(84)90061-0; PEPPERBERG DR, 1978, J GEN PHYSIOL, V71, P369, DOI 10.1085/jgp.71.4.369; PERLMAN JI, 1982, J GEN PHYSIOL, V80, P885, DOI 10.1085/jgp.80.6.885; RIPPS H, 1987, NEUROSCI RES, pS87, DOI 10.1016/0921-8696(87)90010-7; RUSHTON WA, 1961, J PHYSIOL-LONDON, V156, P193, DOI 10.1113/jphysiol.1961.sp006668; RUSHTON WAH, 1965, PROC R SOC SER B-BIO, V162, P20, DOI 10.1098/rspb.1965.0024; STECHER PG, 1968, MERCK INDEX, P574; SZUTS EZ, 1991, ARCH BIOCHEM BIOPHYS, V287, P297, DOI 10.1016/0003-9861(91)90482-X; TOWNER P, 1981, EUR J BIOCHEM, V117, P353, DOI 10.1111/j.1432-1033.1981.tb06345.x; VONISLER O, 1956, HELV CHIM ACTA, V39, P259; YOSHIKAMI S, 1978, SCIENCE, V200, P1393	43	58	64	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1993	11	3					513	522		10.1016/0896-6273(93)90155-K	http://dx.doi.org/10.1016/0896-6273(93)90155-K			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LY498	8398144				2022-12-24	WOS:A1993LY49800011
J	REGEHR, W; KEHOE, J; ASCHER, P; ARMSTRONG, C				REGEHR, W; KEHOE, J; ASCHER, P; ARMSTRONG, C			SYNAPTICALLY TRIGGERED ACTION-POTENTIALS IN DENDRITES	NEURON			English	Article							NEURONS; RECORDINGS	We tested the hypothesis that action potentials originate in apical dendrites of pyramidal cells. Layer V somata were voltage clamped in thin slices of rat motor cortex. Fibers synapsing in unclamped regions far out on the apical dendrite caused small, slow synaptic currents, as recorded at the soma, and sometimes elicited complex, multicomponent current spikes, beginning with a small first spike. Hyperpolarization, or tetrodotoxin applied to basal dendrites and soma, blocked the later spike components without affecting the synaptic current and the first component, which was a synaptically triggered Na+ spike in the apical dendrite. Similar spikes followed voltage steps or direct stimulation. We conclude that Na+ action potentials are initiated in the apical dendrite in response to synaptic input.	ECOLE NORMALE SUPER,NEUROBIOL LAB,F-75231 PARIS 05,FRANCE	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	REGEHR, W (corresponding author), UNIV PENN,DEPT PHYSIOL,PHILADELPHIA,PA 19104, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS012547] Funding Source: NIH RePORTER; NINDS NIH HHS [NS12547] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Cauller LJ, 1992, SINGLE NEURON COMPUT, P199; COOMBS JS, 1957, J PHYSIOL-LONDON, V139, P198, DOI 10.1113/jphysiol.1957.sp005887; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; FATT P, 1957, J NEUROPHYSIOL, V20, P61, DOI 10.1152/jn.1957.20.1.61; FATT P, 1957, J NEUROPHYSIOL, V20, P27, DOI 10.1152/jn.1957.20.1.27; FOURTES MGF, 1957, J GEN PHYSIOL, V40, P735; HUGUENARD JR, 1989, P NATL ACAD SCI USA, V86, P2473, DOI 10.1073/pnas.86.7.2473; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P197, DOI 10.1113/jphysiol.1980.sp013358; PEINADO A, 1993, NEURON, V10, P103, DOI 10.1016/0896-6273(93)90246-N; PHILLIPS C. G., 1959, QUART JOUR EXPTL PHYSIOL, V44, P1; POCKBERGER H, 1991, BRAIN RES, V539, P181, DOI 10.1016/0006-8993(91)91619-C; RALL W, 1992, PHYSIOL REV, V72, pS159, DOI 10.1152/physrev.1992.72.suppl_4.S159; RALL W, 1962, ANN NY ACAD SCI, V96, P1071, DOI 10.1111/j.1749-6632.1962.tb54120.x; REGEHR WG, 1992, P NATL ACAD SCI USA, V89, P5492, DOI 10.1073/pnas.89.12.5492; SPENCER WA, 1961, J NEUROPHYSIOL, V24, P272, DOI 10.1152/jn.1961.24.3.272; WONG RKS, 1979, P NATL ACAD SCI USA, V76, P986, DOI 10.1073/pnas.76.2.986	16	95	96	1	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1993	11	1					145	151		10.1016/0896-6273(93)90278-Y	http://dx.doi.org/10.1016/0896-6273(93)90278-Y			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LP430	8338663				2022-12-24	WOS:A1993LP43000013
J	VARNUM, MD; MAYLIE, J; BUSCH, A; ADELMAN, JP				VARNUM, MD; MAYLIE, J; BUSCH, A; ADELMAN, JP			PERSISTENT ACTIVATION OF MIN-K CHANNELS BY CHEMICAL CROSS-LINKING	NEURON			English	Article							PROTEIN-KINASE-C; POTASSIUM CHANNEL; XENOPUS OOCYTES; EXPRESSION; CLONING; HEART; ISK; MUTATIONS	Expression of the structurally and functionally distinct min K channel in Xenopus oocytes results in voltage-dependent potassium currents that activate with a characteristic slow time course. Application of a membrane-impermeable chemical cross-linking agent to oocytes expressing min K decreased the time-dependent current, increased its rate of activation, and induced persistently activated inward and outward potassium currents. These effects required membrane depolarization, demonstrating use dependence. Persistently activated channels retained potassium selectivity and sensitivity to block by clofilium and barium. These results suggest that a major conformational change occurs during min K channel gating, which can be stabilized by chemical cross-linking, and are consistent with a model in which min K channels activate by voltage-dependent subunit aggregation.	OREGON HLTH SCI UNIV,DEPT OBSTET & GYNECOL,PORTLAND,OR 97201	Oregon Health & Science University	VARNUM, MD (corresponding author), OREGON HLTH SCI UNIV,VOLLUM INST,L474,PORTLAND,OR 97201, USA.							ABDELLA PM, 1979, BIOCHEM BIOPH RES CO, V87, P734, DOI 10.1016/0006-291X(79)92020-5; ADELMAN JP, 1992, NEURON, V9, P209, DOI 10.1016/0896-6273(92)90160-F; ATTALI B, 1993, NATURE, V365, P850, DOI 10.1038/365850a0; BAUMANN G, 1974, Journal of Supramolecular Structure, V2, P538, DOI 10.1002/jss.400020504; BUSCH AE, 1992, SCIENCE, V255, P1705, DOI 10.1126/science.1553557; CHRISTIE MJ, 1989, SCIENCE, V244, P221, DOI 10.1126/science.2539643; FOLANDER K, 1990, P NATL ACAD SCI USA, V87, P2975, DOI 10.1073/pnas.87.8.2975; FREEMAN LC, 1993, CIRC RES, V73, P968, DOI 10.1161/01.RES.73.5.968; GOLDSTEIN SAN, 1991, NEURON, V7, P403, DOI 10.1016/0896-6273(91)90292-8; HAUSDORFF SF, 1991, BIOCHEMISTRY-US, V30, P3341, DOI 10.1021/bi00227a025; HONORE E, 1991, EMBO J, V10, P2805, DOI 10.1002/j.1460-2075.1991.tb07829.x; MOORMAN JR, 1992, J BIOL CHEM, V267, P14551; PINTO LH, 1992, CELL, V69, P517, DOI 10.1016/0092-8674(92)90452-I; TAKUMI T, 1991, J BIOL CHEM, V266, P22192; TAKUMI T, 1988, SCIENCE, V242, P1042, DOI 10.1126/science.3194754; VARNUM MD, 1993, P NATL ACAD SCI USA, V90, P11528, DOI 10.1073/pnas.90.24.11528; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687	17	18	18	0	0	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1995	14	2					407	412		10.1016/0896-6273(95)90296-1	http://dx.doi.org/10.1016/0896-6273(95)90296-1			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QH294	7857648	Bronze			2022-12-24	WOS:A1995QH29400018
J	RAJENDRA, S; LYNCH, JW; PIERCE, KD; FRENCH, CR; BARRY, PH; SCHOFIELD, PR				RAJENDRA, S; LYNCH, JW; PIERCE, KD; FRENCH, CR; BARRY, PH; SCHOFIELD, PR			MUTATION OF AN ARGININE RESIDUE IN THE HUMAN GLYCINE RECEPTOR TRANSFORMS BETA-ALANINE AND TAURINE FROM AGONISTS INTO COMPETITIVE ANTAGONISTS	NEURON			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; FUNCTIONAL EXPRESSION; ION CHANNEL; BINDING SITES; SUBUNIT; PHARMACOLOGY; CELLS; ACTIVATION; CONDUCTANCE; RESOLUTION	Agonist binding to the inhibitory glycine receptor (GlyR) initiates the opening of a chloride-selective channel that modulates the neuronal membrane potential. Point mutations of the GlyR, substituting Arg-271 with either Leu or Gin, have been shown to underlie the inherited neurological disorder startle disease (hyperekplexia). We show that these substitutions result in the redistribution of GlyR single-channel conductances to lower conductance levels. Additionally, the binding of the glycinergic agonists beta-alanine and taurine to mutated GryRs does not initiate a chloride current, but instead competitively antagonizes currents activated by glycine. These findings are consistent with mutations of Arg-271 resulting in the uncoupling of the agonist binding process from the channel activation mechanism of the receptor.	GARVAN INST MED RES,DARLINGHURST,NSW 2010,AUSTRALIA	Garvan Institute of Medical Research	RAJENDRA, S (corresponding author), UNIV NEW S WALES,SCH PHYSIOL & PHARMACOL,SYDNEY,NSW 2052,AUSTRALIA.		French, Chris/AHA-1801-2022; Pierce, Kerrie D/O-7300-2018; Lynch, Joseph/C-8636-2009; Schofield, Peter/C-9669-2011	Pierce, Kerrie D/0000-0003-0636-4836; French, Christopher/0000-0002-1445-8704; Schofield, Peter/0000-0003-2967-9662				AKAIKE N, 1987, J PHYSIOL-LONDON, V391, P219, DOI 10.1113/jphysiol.1987.sp016735; AMIN J, 1993, NATURE, V366, P565, DOI 10.1038/366565a0; ANDERMANN F, 1988, BRAIN DEV-JPN, V10, P213, DOI 10.1016/S0387-7604(88)80001-9; BARRY PH, 1994, J NEUROSCI METH, V51, P107, DOI 10.1016/0165-0270(94)90031-0; BERTRAND D, 1992, P NATL ACAD SCI USA, V89, P1261, DOI 10.1073/pnas.89.4.1261; BORMANN J, 1993, EMBO J, V12, P3729, DOI 10.1002/j.1460-2075.1993.tb06050.x; CASCIO M, 1993, J BIOL CHEM, V268, P22135; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; COLQUHOUN D, 1993, NATURE, V366, P510, DOI 10.1038/366510b0; DEVILLERSTHIERY A, 1993, J MEMBRANE BIOL, V136, P97, DOI 10.1007/BF02505755; GORMAN CM, 1990, DNA PROTEIN ENG TECH, V2, P3; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; GRENNINGLOH G, 1990, EMBO J, V9, P771, DOI 10.1002/j.1460-2075.1990.tb08172.x; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; KIRSTEIN L, 1958, ACTA PSYCH NEUROL, V33, P471, DOI 10.1111/j.1600-0447.1958.tb03533.x; KUHSE J, 1990, NEURON, V5, P867, DOI 10.1016/0896-6273(90)90346-H; LANGOSCH D, 1993, FEBS LETT, V336, P540, DOI 10.1016/0014-5793(93)80872-R; LANGOSCH D, 1991, BIOCHIM BIOPHYS ACTA, V1063, P36, DOI 10.1016/0005-2736(91)90350-H; LANGOSCH D, 1994, EMBO J, V13, P4223, DOI 10.1002/j.1460-2075.1994.tb06742.x; LEE YH, 1994, BIOPHYS J, V66, P646, DOI 10.1016/S0006-3495(94)80838-0; LI L, 1992, BIOPHYS J, V62, P61, DOI 10.1016/S0006-3495(92)81779-4; LO DC, 1991, NEURON, V6, P31, DOI 10.1016/0896-6273(91)90119-K; MARICQ AV, 1991, SCIENCE, V254, P432, DOI 10.1126/science.1718042; OLEARY ME, 1992, J BIOL CHEM, V267, P8360; RAJENDRA S, 1994, J BIOL CHEM, V269, P18739; SCHMIEDEN V, 1992, EMBO J, V11, P2025, DOI 10.1002/j.1460-2075.1992.tb05259.x; SCHMIEDEN V, 1993, SCIENCE, V262, P256, DOI 10.1126/science.8211147; SCHOFIELD PR, 1987, NATURE, V328, P221, DOI 10.1038/328221a0; SHIANG R, 1993, NAT GENET, V5, P351, DOI 10.1038/ng1293-351; SIEGHART W, 1992, TRENDS PHARMACOL SCI, V13, P446, DOI 10.1016/0165-6147(92)90142-S; SONTHEIMER H, 1989, NEURON, V2, P1491, DOI 10.1016/0896-6273(89)90195-5; SUHREN O, 1966, J NEUROL SCI, V3, P577, DOI 10.1016/0022-510X(66)90047-5; TAKAHASHI T, 1992, NEURON, V9, P1155, DOI 10.1016/0896-6273(92)90073-M; TOMASELLI GF, 1991, BIOPHYS J, V60, P721, DOI 10.1016/S0006-3495(91)82102-6; UNWIN N, 1993, J MOL BIOL, V229, P1101, DOI 10.1006/jmbi.1993.1107; VALENZUELA CF, 1994, BIOPHYS J, V66, P674, DOI 10.1016/S0006-3495(94)80841-0; VANDENBERG RJ, 1992, NEURON, V9, P491, DOI 10.1016/0896-6273(92)90186-H; VANDENBERG RJ, 1993, TODAYS LIFE SCI, V5, P20	40	138	142	0	3	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1995	14	1					169	175		10.1016/0896-6273(95)90251-1	http://dx.doi.org/10.1016/0896-6273(95)90251-1			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QC548	7826634	Bronze			2022-12-24	WOS:A1995QC54800017
J	HARRISON, SD; BROADIE, K; VANDEGOOR, J; RUBIN, GM				HARRISON, SD; BROADIE, K; VANDEGOOR, J; RUBIN, GM			MUTATIONS IN THE DROSOPHILA ROP GENE SUGGEST A FUNCTION IN GENERAL SECRETION AND SYNAPTIC TRANSMISSION	NEURON			English	Article							SACCHAROMYCES-CEREVISIAE; YEAST; CELLS; MELANOGASTER; PROTEINS; ENCODES; FAMILY; FUSION; TRANSPORT; MACHINERY	The Drosophila protein Rop shows similarity with the Sec1p protein of S. cerevisiae. Sec1p has an essential role in secretion, whereas most related proteins from higher organisms are hypothesized to function in neurotransmitter release. We show that, like the latter proteins, Rop is expressed in the nervous system, but it is expressed in other tissues as well, many of which are actively engaged in secretion. We have isolated mutations in the Rop gene and find that the extracellular accumulation of a number of normally secreted cellular products fails to occur in null mutant animals, which subsequently die at a late embryonic stage. Electrophysiological recordings on temperature-sensitive Rop mutants show that reductions in Rop activity result in a loss of the normal synaptic response to a light stimulus. These data suggest that a member of the Sec1p class of proteins has an in vivo function in both general secretion and synaptic transmission.	UNIV CALIF BERKELEY,DEPT MOLEC & CELLULAR BIOL,BERKELEY,CA 94720; UNIV CAMBRIDGE,DEPT ZOOL,CAMBRIDGE CB2 3EJ,ENGLAND; UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,HORMONE RES INST,SAN FRANCISCO,CA 94143	University of California System; University of California Berkeley; University of Cambridge; University of California System; University of California San Francisco; University of California System; University of California San Francisco	HARRISON, SD (corresponding author), UNIV CALIF BERKELEY,HOWARD HUGHES MED INST,BERKELEY,CA 94720, USA.			Rubin, Gerald/0000-0001-8762-8703	NINDS NIH HHS [NS 15927] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015927] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AALTO MK, 1992, CELL, V68, P181, DOI 10.1016/0092-8674(92)90462-L; AALTO MK, 1991, YEAST, V7, P643, DOI 10.1002/yea.320070613; AALTO MK, 1993, EMBO J, V12, P4095, DOI 10.1002/j.1460-2075.1993.tb06093.x; AALTO MK, 1991, YEAST, V8, P587; ASHBURNER M, 1989, DROSOPHILA LABORATOR; BATE M, 1990, DEVELOPMENT, V110, P791; BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2559, DOI 10.1073/pnas.90.7.2559; BROADIE KS, 1993, J NEUROSCI, V13, P144; BROCK HW, 1987, GENE, V51, P129, DOI 10.1016/0378-1119(87)90301-5; BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; CHEN M, 1992, P NATL ACAD SCI USA, V89, P5211, DOI 10.1073/pnas.89.12.5211; COHEN N, 1988, ONCOGENE, V3, P137; COOMBE PE, 1986, J COMP PHYSIOL A, V159, P655, DOI 10.1007/BF00612038; DASCHER C, 1991, MOL CELL BIOL, V11, P872, DOI 10.1128/MCB.11.2.872; DIANTONIO A, 1994, NEURON, V12, P909, DOI 10.1016/0896-6273(94)90342-5; DIEDERICH RJ, 1994, DEVELOPMENT, V120, P473; FELLER R, 1992, J NEUROSCI, V12, P3862; GARCIA EP, 1994, P NATL ACAD SCI USA, V91, P2003, DOI 10.1073/pnas.91.6.2003; GENGYOANDO K, 1993, NEURON, V11, P703, DOI 10.1016/0896-6273(93)90080-B; HARLOW E, 1988, ANTIBODIES LABORATOR; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; HODEL A, 1994, J BIOL CHEM, V269, P8623; HOSONO R, 1992, J NEUROCHEM, V58, P1517, DOI 10.1111/j.1471-4159.1992.tb11373.x; JOHANSEN J, 1989, J NEUROSCI, V9, P4318; KARESS RE, 1984, CELL, V38, P135, DOI 10.1016/0092-8674(84)90534-8; Maniatis T., 1982, MOL CLONING; MOZER B, 1985, MOL CELL BIOL, V5, P885, DOI 10.1128/MCB.5.4.885; NEUFELD TP, 1994, CELL, V77, P371, DOI 10.1016/0092-8674(94)90152-X; NOVICK P, 1993, CELL, V75, P597, DOI 10.1016/0092-8674(93)90478-9; NOVICK P, 1979, P NATL ACAD SCI USA, V76, P1858, DOI 10.1073/pnas.76.4.1858; OCONNOR V, 1994, CELL, V76, P785, DOI 10.1016/0092-8674(94)90352-2; PATEL NH, 1989, GENE DEV, V3, P890, DOI 10.1101/gad.3.6.890; PEVSNER J, 1994, P NATL ACAD SCI USA, V91, P1445, DOI 10.1073/pnas.91.4.1445; PFEFFER SR, 1994, P NATL ACAD SCI USA, V91, P1987, DOI 10.1073/pnas.91.6.1987; POODRY CA, 1980, GENET BIOL DROSOPHIL, P443; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SALZBERG A, 1993, DEVELOPMENT, V117, P1309; Skaer Helen, 1993, P941; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SUDHOF TC, 1993, CELL, V75, P1; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; TOMLINSON A, 1987, DEV BIOL, V120, P366, DOI 10.1016/0012-1606(87)90239-9; WADA Y, 1990, MOL CELL BIOL, V10, P2214, DOI 10.1128/MCB.10.5.2214; XU T, 1993, DEVELOPMENT, V117, P1223; XU T, 1994, IN PRESS DROSOPHILA	46	205	213	1	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1994	13	3					555	566		10.1016/0896-6273(94)90025-6	http://dx.doi.org/10.1016/0896-6273(94)90025-6			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PJ284	7917291				2022-12-24	WOS:A1994PJ28400005
J	STEPHENS, RM; LOEB, DM; COPELAND, TD; PAWSON, T; GREENE, LA; KAPLAN, DR				STEPHENS, RM; LOEB, DM; COPELAND, TD; PAWSON, T; GREENE, LA; KAPLAN, DR			TRK RECEPTORS USE REDUNDANT SIGNAL-TRANSDUCTION PATHWAYS INVOLVING SHC AND PLC-GAMMA-1 TO MEDIATE NGF RESPONSES	NEURON			English	Article							NERVE GROWTH-FACTOR; PROTEIN-TYROSINE PHOSPHORYLATION; SERINE THREONINE KINASE; PDGF BETA-RECEPTOR; PHOSPHATIDYLINOSITOL 3-KINASE; NEURONAL DIFFERENTIATION; PHEOCHROMOCYTOMA CELLS; PHOSPHOLIPASE-C; PC12 CELLS; NEUROTROPHIN RECEPTORS	In response to NCF, the Trk receptor tyrosine kinase forms a complex with SHC, a protein that couples receptor tyrosine kinases to p21(ras). Complex formation between Trk and SHC, SHC tyrosine phosphorylation, and association of SHC with Grb2 were mediated by autophosphorylation at Y490 in Trk (NPQYFSD). To determine the role of SHC and other Trk substrates in NGF signaling, Trk receptors with mutations in Y490 and Y785 (the PLC-gamma 1 association site) were introduced into PC12nnr5 cells. NGF treatment of PC12nnr5 cells expressing Trk with mutations in either substrate-binding site resulted in normal neurite outgrowth and Erk1 activity and tyrosine phosphorylation. However, PC12nnr5 cells expressing Trk with mutations at both sites failed to stably extend neurites and efficiently induce Erk1 activity and tyrosine phosphorylation in response to NGF. We postulate that Trk receptors can activate Erk1 by either SHC- or PLC-gamma 1-dependent signaling pathways. These results suggest a model whereby Trk receptors utilize at least partially redundant signal transduction pathways to mediate NGF responses.	COLUMBIA UNIV, DEPT PATHOL, NEW YORK, NY 10032 USA; COLUMBIA UNIV, CTR NEUROBIOL & BEHAV, NEW YORK, NY 10032 USA; UNIV TORONTO, DEPT MOLEC & MED GENET, TORONTO, ON, CANADA	Columbia University; Columbia University; University of Toronto	STEPHENS, RM (corresponding author), NCI, FREDERICK CANC RES & DEV CTR, ABL BASIC RES PROGRAM, FREDERICK, MD 21702 USA.		Pawson, Tony J/E-4578-2013		OFFICE OF THE DIRECTOR, NCI [N01CO074101] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CO-74101] Funding Source: Medline	OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BACKER JM, 1992, J BIOL CHEM, V267, P1367; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BIEDLER JL, 1973, CANCER RES, V33, P2643; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CHAO MV, 1992, CELL, V68, P995, DOI 10.1016/0092-8674(92)90068-N; CHAO MV, 1992, NEURON, V9, P583, DOI 10.1016/0896-6273(92)90023-7; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; CORDONCARDO C, 1991, CELL, V66, P173, DOI 10.1016/0092-8674(91)90149-S; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; DRUKER BJ, 1992, J VIROL, V66, P5770, DOI 10.1128/JVI.66.10.5770-5776.1992; DUCHESNE M, 1993, SCIENCE, V259, P525, DOI 10.1126/science.7678707; EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0; ELLIS C, 1990, NATURE, V343, P377, DOI 10.1038/343377a0; ESCOBEDO JA, 1991, MOL CELL BIOL, V11, P1125, DOI 10.1128/MCB.11.2.1125; FENG GS, 1993, SCIENCE, V259, P1607, DOI 10.1126/science.8096088; GALE NW, 1993, NATURE, V363, P88, DOI 10.1038/363088a0; GOMEZ N, 1990, FEBS LETT, V271, P119, DOI 10.1016/0014-5793(90)80386-W; GREEN SH, 1986, J BIOL CHEM, V261, P5316; GREEN SH, 1986, J CELL BIOL, V102, P830, DOI 10.1083/jcb.102.3.830; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Greene LA., 1982, ADV CELL NEUROBIOL, V3, P373, DOI [10.1016/B978-0-12-008303-9.50016-5, DOI 10.1016/B978-0-12-008303-9.50016-5]; GREENE LA, 1991, CULTURING NERVE CELL, P207; HALEGOUA S, 1991, CURR TOP MICROBIOL, V165, P119; HEFTI F, 1992, LOCALIZATION FUNCTIO, P25; HEMPSTEAD BL, 1992, NEURON, V9, P883, DOI 10.1016/0896-6273(92)90241-5; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; JING SQ, 1992, NEURON, V9, P1067, DOI 10.1016/0896-6273(92)90066-M; KABURAGI Y, 1994, IN PRESS J BIOL CHEM; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KAPLAN DR, 1990, CELL, V61, P125, DOI 10.1016/0092-8674(90)90220-9; KAPLAN DR, 1993, NEURON, V11, P321, DOI 10.1016/0896-6273(93)90187-V; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KIM UH, 1991, J BIOL CHEM, V266, P1359; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LI BQ, 1992, SCIENCE, V256, P1456, DOI 10.1126/science.1604323; LI N, 1993, NATURE, V363, P85, DOI 10.1038/363085a0; LI W, 1992, MOL CELL BIOL, V12, P5824, DOI 10.1128/MCB.12.12.5824; LOEB DM, 1992, NEURON, V9, P1053, DOI 10.1016/0896-6273(92)90065-L; LOEB DM, 1991, CELL, V66, P961, DOI 10.1016/0092-8674(91)90441-Z; LOEB DM, 1994, IN PRESS J BIOL CHEM; LOEB DM, IN PRESS J NEUROSCI; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; MAHER PA, 1988, P NATL ACAD SCI USA, V85, P6788, DOI 10.1073/pnas.85.18.6788; MARTINZANCA D, 1989, MOL CELL BIOL, V9, P24, DOI 10.1128/MCB.9.1.24; MEDEMA RH, 1992, MOL CELL BIOL, V12, P3425, DOI 10.1128/MCB.12.8.3425; MEISENHELDER J, 1992, MOL CELL BIOL, V12, P5843, DOI 10.1128/MCB.12.12.5843; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; MITRA G, 1991, ONCOGENE, V6, P2237; MIYASAKA T, 1991, P NATL ACAD SCI USA, V88, P2653, DOI 10.1073/pnas.88.7.2653; MOBLEY WC, 1976, BIOCHEMISTRY-US, V15, P5543, DOI 10.1021/bi00670a019; MORRISON DK, 1989, CELL, V58, P649, DOI 10.1016/0092-8674(89)90100-1; OBERMEIER A, 1993, EMBO J, V12, P933, DOI 10.1002/j.1460-2075.1993.tb05734.x; OLIVIER JP, 1993, CELL, V73, P179, DOI 10.1016/0092-8674(93)90170-U; PARK D, 1992, MOL CELL BIOL, V12, P5816, DOI 10.1128/MCB.12.12.5816; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; PRONK GJ, 1993, J BIOL CHEM, V268, P5748; PULIDO D, 1992, EMBO J, V11, P391, DOI 10.1002/j.1460-2075.1992.tb05067.x; RABIN SJ, 1993, MOL CELL BIOL, V13, P2203, DOI 10.1128/MCB.13.4.2203; RAFFIONI S, 1992, P NATL ACAD SCI USA, V89, P9121, DOI 10.1073/pnas.89.19.9121; RHEE SG, 1989, SCIENCE, V244, P546, DOI 10.1126/science.2541501; ROBBINS DJ, 1992, P NATL ACAD SCI USA, V89, P6924, DOI 10.1073/pnas.89.15.6924; ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; RYDEL RE, 1987, J NEUROSCI, V7, P3639; SCHANENKING C, 1991, NEURON, V6, P915, DOI 10.1016/0896-6273(91)90232-O; SIMON MA, 1993, CELL, V73, P169, DOI 10.1016/0092-8674(93)90169-Q; SOLTOFF SP, 1992, J BIOL CHEM, V267, P17472; STEPHENS RM, 1992, MOL CELL BIOL, V12, P3733, DOI 10.1128/MCB.12.9.3733; SUH PG, 1988, J BIOL CHEM, V263, P14497; Summers MD, 1987, MANUAL METHODS BACUL; SZEBERENYI J, 1990, MOL CELL BIOL, V10, P5324, DOI 10.1128/MCB.10.10.5324; THOENEN H, 1991, TRENDS NEUROSCI, V14, P165, DOI 10.1016/0166-2236(91)90097-E; THOMAS SM, 1992, CELL, V68, P1031, DOI 10.1016/0092-8674(92)90075-N; TROPPMAIR J, 1992, ONCOGENE, V7, P1867; VETTER ML, 1991, P NATL ACAD SCI USA, V88, P5650, DOI 10.1073/pnas.88.13.5650; VOGEL W, 1993, SCIENCE, V259, P1611, DOI 10.1126/science.7681217; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O; YATANI A, 1990, CELL, V61, P769, DOI 10.1016/0092-8674(90)90187-J; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	83	498	523	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	1994	12	3					691	705		10.1016/0896-6273(94)90223-2	http://dx.doi.org/10.1016/0896-6273(94)90223-2			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NC769	8155326				2022-12-24	WOS:A1994NC76900019
J	KIEDROWSKI, L; BROOKER, C; COSTA, E; WROBLEWSKI, JT				KIEDROWSKI, L; BROOKER, C; COSTA, E; WROBLEWSKI, JT			GLUTAMATE IMPAIRS NEURONAL CALCIUM EXTRUSION WHILE REDUCING SODIUM-GRADIENT	NEURON			English	Article							EXCITATORY AMINO-ACIDS; CEREBELLAR GRANULE CELLS; HUMAN CORTICAL-NEURONS; SPINAL-CORD NEURONS; PROTEIN-KINASE-C; INTRACELLULAR CALCIUM; NEUROTOXICITY INVITRO; STRIATAL NEURONS; NERVE-TERMINALS; PRIMARY CULTURE	The rate of decrease of neuronal [Ca2+](i) after an elevation induced by a glutamate pulse is much slower than that after a comparable [Ca2+](i) elevation induced by a K+ depolarization. To investigate whether the [Na+](i) increase taking place during the glutamate pulse reduces the rate of Ca2+ extrusion, we monitored simultaneously [Na+](i) and [Ca2+](i) during a K+ depolarization and a glutamate pulse lasting 1 min. The K+ depolarization evoked only a transient increase of [Na+](i) from 4 mM to 13 mM, whereas the glutamate pulse increased [Na+](i) to 60 mM, and this increase persisted after glutamate removal. An application of bepridil immediately after glutamate pulse when [Na+](i) was greatly elevated, but not 14 min after glutamate removal when a basal [Na+](i) was restored, evoked a [Ca2+](i) increase accompanied by a decrease of [Na+](i), indicating a reverse mode of operation of the Na+/Ca2+ exchanger. These data suggest that the glutamate evoked increase in [Na+](i) may play a role in Ca2+ homeostasis destabilization.			KIEDROWSKI, L (corresponding author), GEORGETOWN UNIV, FIDIA GEORGETOWN INST NEUROSCI, WASHINGTON, DC 20007 USA.			Ribeiro, Jessyca/0000-0003-0068-0061	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS028130] Funding Source: NIH RePORTER; NINDS NIH HHS [NS28130] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDREEVA N, 1991, BRAIN RES, V548, P322, DOI 10.1016/0006-8993(91)91141-M; ARMSTRONG CM, 1981, PHYSIOL REV, V61, P644, DOI 10.1152/physrev.1981.61.3.644; BLAUSTEIN MP, 1978, J GEN PHYSIOL, V72, P43, DOI 10.1085/jgp.72.1.43; BLAUSTEIN MP, 1988, TRENDS NEUROSCI, V11, P438, DOI 10.1016/0166-2236(88)90195-6; CANDEO P, 1992, J NEUROCHEM, V59, P1558, DOI 10.1111/j.1471-4159.1992.tb08474.x; CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.biochem.56.1.395; CHOI DW, 1987, J NEUROSCI, V7, P369; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; CONNOR JA, 1988, SCIENCE, V240, P649, DOI 10.1126/science.2452481; COULTER DA, 1992, J NEUROPHYSIOL, V68, P362, DOI 10.1152/jn.1992.68.2.362; CROMPTON M, 1976, EUR J BIOCHEM, V69, P453, DOI 10.1111/j.1432-1033.1976.tb10930.x; CROMPTON M, 1978, EUR J BIOCHEM, V82, P25, DOI 10.1111/j.1432-1033.1978.tb11993.x; FAVARON M, 1990, P NATL ACAD SCI USA, V87, P1983, DOI 10.1073/pnas.87.5.1983; GARCIA ML, 1988, BIOCHEMISTRY-US, V27, P2410, DOI 10.1021/bi00407a024; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAROOTUNIAN AT, 1989, J BIOL CHEM, V264, P19458; HARTLEY DM, 1993, J NEUROSCI, V13, P1993; KACZOROWSKI GJ, 1989, BIOCHIM BIOPHYS ACTA, V988, P287, DOI 10.1016/0304-4157(89)90022-1; KAO JPY, 1989, J BIOL CHEM, V264, P8179; MANEV H, 1989, MOL PHARMACOL, V36, P106; MATTSON MP, 1991, MOL CHEM NEUROPATHOL, V15, P117, DOI 10.1007/BF03159951; MATTSON MP, 1989, FASEB J, V3, P2519, DOI 10.1096/fasebj.3.13.2572500; MATTSON MP, 1991, EXP NEUROL, V112, P95, DOI 10.1016/0014-4886(91)90118-V; MAYER ML, 1987, PROG NEUROBIOL, V28, P197, DOI 10.1016/0301-0082(87)90011-6; MAYER ML, 1987, J NEUROSCI, V7, P3230; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MCCABE MJ, 1992, ANN NY ACAD SCI, V663, P269, DOI 10.1111/j.1749-6632.1992.tb38670.x; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; MELDOLESI J, 1990, BIOCHIM BIOPHYS ACTA, V1055, P130, DOI 10.1016/0167-4889(90)90113-R; MICHAELS RL, 1990, J NEUROSCI, V10, P283; MURPHY SN, 1989, J PHARMACOL EXP THER, V249, P184; MURPHY SN, 1987, J NEUROSCI, V7, P4145; NICOLETTI F, 1986, J NEUROSCI, V6, P1905; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; SANCHEZARMASS S, 1987, AM J PHYSIOL, V252, pC595, DOI 10.1152/ajpcell.1987.252.6.C595; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; SHUTTLEWORTH TJ, 1991, J BIOL CHEM, V266, P1410	38	170	175	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1994	12	2					295	300		10.1016/0896-6273(94)90272-0	http://dx.doi.org/10.1016/0896-6273(94)90272-0			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MY500	7906528	hybrid			2022-12-24	WOS:A1994MY50000006
J	HUGHES, RA; SENDTNER, M; GOLDFARB, M; LINDHOLM, D; THOENEN, H				HUGHES, RA; SENDTNER, M; GOLDFARB, M; LINDHOLM, D; THOENEN, H			EVIDENCE THAT FIBROBLAST GROWTH FACTOR-5 IS A MAJOR MUSCLE-DERIVED SURVIVAL FACTOR FOR CULTURED SPINAL MOTONEURONS	NEURON			English	Article							CILIARY NEUROTROPHIC FACTOR; CHOLINE-ACETYLTRANSFERASE ACTIVITY; NEURONAL DIFFERENTIATION FACTOR; CENTRAL-NERVOUS-SYSTEM; FACTOR RECEPTOR FAMILY; SKELETAL-MUSCLE; MESSENGER-RNA; MOTOR NEURONS; CORD NEURONS; REGIONAL DISTRIBUTION	We examined the potential role of fibroblast growth factor 5 (FGF-5) as a target-derived trophic factor for spinal motoneurons. Northern analysis of total RNA from rat skeletal muscle revealed an FGF-5 mRNA transcript both during the period of embryonic motoneuron death and in the adult. Recombinant human FGF-5 supported the survival of highly enriched cultures of embryonic chick motoneurons. Significant proportions of the motoneuron survival activity of rat skeletal muscle extracts could be immunoprecipitated using an antiserum to FGF-5. The immunoprecipitable activity was present in soluble and matrix-bound forms in embryonic muscle, but bound exclusively to the extracellular matrix in adult muscle. These results, along with the secretory nature of FGF-5, suggest that FGF-5 may act as a target-derived trophic factor for motoneurons.	COLUMBIA UNIV COLL PHYS & SURG,DEPT BIOCHEM & MOLEC BIOPHYS,NEW YORK,NY 10032	Columbia University	HUGHES, RA (corresponding author), MAX PLANCK INST PSYCHIAT,DEPT NEUROCHEM,W-8033 MARTINSRIED,GERMANY.		Sendtner, Michael/J-1542-2012; Sendtner, Michael/M-8137-2014; Lindholm, Dan/B-3777-2014	Sendtner, Michael/0000-0002-4737-2974; Sendtner, Michael/0000-0002-4737-2974; 				ABRAHAM JA, 1986, SCIENCE, V233, P545, DOI 10.1126/science.2425435; ALTERIO J, 1990, BIOCHEM BIOPH RES CO, V166, P1205, DOI 10.1016/0006-291X(90)90994-X; ARAKAWA Y, 1990, J NEUROSCI, V10, P3507; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BATES B, 1991, MOL CELL BIOL, V11, P1840, DOI 10.1128/MCB.11.4.1840; BENNETT MR, 1980, BRAIN RES, V190, P537, DOI 10.1016/0006-8993(80)90295-4; BLOCHGALLEGO E, 1991, DEVELOPMENT, V111, P221; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CALOF AL, 1984, DEV BIOL, V106, P194, DOI 10.1016/0012-1606(84)90075-7; CASTREN E, 1992, IN PRESS P NATL ACAD; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DIONNE CA, 1990, EMBO J, V9, P2685, DOI 10.1002/j.1460-2075.1990.tb07454.x; DOHRMANN U, 1986, DEV BIOL, V118, P209, DOI 10.1016/0012-1606(86)90089-8; FLANIGAN TP, 1985, J NEUROCHEM, V45, P1323, DOI 10.1111/j.1471-4159.1985.tb05563.x; FU YM, 1991, J CELL BIOL, V114, P1261, DOI 10.1083/jcb.114.6.1261; FUKADA K, 1985, P NATL ACAD SCI USA, V82, P8795, DOI 10.1073/pnas.82.24.8795; GONZALEZ AM, 1990, J CELL BIOL, V110, P753, DOI 10.1083/jcb.110.3.753; HAMBURGER V, 1958, AM J ANAT, V102, P365, DOI 10.1002/aja.1001020303; HAUB O, 1991, DEVELOPMENT, V112, P397; HAUB O, 1990, P NATL ACAD SCI USA, V87, P8022, DOI 10.1073/pnas.87.20.8022; HEBERT JM, 1990, DEV BIOL, V138, P454, DOI 10.1016/0012-1606(90)90211-Z; HEBERT JM, 1991, DEVELOPMENT, V112, P407; HOLLYDAY M, 1976, J COMP NEUROL, V170, P311, DOI 10.1002/cne.901700304; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; JEONG SJ, 1991, J NEUROBIOL, V22, P462, DOI 10.1002/neu.480220504; JOHNSON DE, 1990, MOL CELL BIOL, V10, P4728, DOI 10.1128/MCB.10.9.4728; JOHNSON DE, 1991, MOL CELL BIOL, V11, P4627, DOI 10.1128/MCB.11.9.4627; JOSEPHSILVERSTEIN J, 1989, J CELL BIOL, V108, P2459, DOI 10.1083/jcb.108.6.2459; KAUFMAN LM, 1985, J NEUROSCI, V5, P160; KEEGAN K, 1991, P NATL ACAD SCI USA, V88, P1095, DOI 10.1073/pnas.88.4.1095; KLAGSBRUN M, 1991, CELL, V67, P229, DOI 10.1016/0092-8674(91)90173-V; KORNBLUTH S, 1988, MOL CELL BIOL, V8, P5541, DOI 10.1128/MCB.8.12.5541; KUCHEREREHRET A, 1990, DEVELOPMENT, V110, P1285; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEE PL, 1989, SCIENCE, V245, P57, DOI 10.1126/science.2544996; LIN LFH, 1989, SCIENCE, V246, P1023, DOI 10.1126/science.2587985; LINDHOLM D, 1988, J BIOL CHEM, V263, P16348; MARTINOU JC, 1989, J NEUROSCI, V9, P3645; MARTINOU JC, 1992, NEURON, V8, P737, DOI 10.1016/0896-6273(92)90094-T; MASIAKOWSKI P, 1991, J NEUROCHEM, V57, P1003, DOI 10.1111/j.1471-4159.1991.tb08250.x; MCMANAMAN J, 1989, J NEUROCHEM, V53, P1763, DOI 10.1111/j.1471-4159.1989.tb09241.x; MCMANAMAN JL, 1991, J NEUROCHEM, V57, P258, DOI 10.1111/j.1471-4159.1991.tb02123.x; MCMANAMAN JL, 1988, J BIOL CHEM, V263, P5890; MIKI T, 1991, SCIENCE, V251, P72, DOI 10.1126/science.1846048; MORROW NG, 1990, J CLIN INVEST, V85, P1816, DOI 10.1172/JCI114640; OBRIEN RJ, 1986, J NEUROSCI, V6, P3265; OPPENHEIM RW, 1986, J COMP NEUROL, V246, P281, DOI 10.1002/cne.902460211; OPPENHEIM RW, 1991, SCIENCE, V251, P1616, DOI 10.1126/science.2011743; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; PARTANEN J, 1991, EMBO J, V10, P1347, DOI 10.1002/j.1460-2075.1991.tb07654.x; PASQUALE EB, 1990, P NATL ACAD SCI USA, V87, P5812, DOI 10.1073/pnas.87.15.5812; Patterson P H, 1992, Curr Opin Neurobiol, V2, P94, DOI 10.1016/0959-4388(92)90169-L; PATTERSON PH, 1992, CIBA F SYMP, V167, P125; ROHRER H, 1992, DEVELOPMENT, V114, P689; RUTA M, 1988, ONCOGENE, V3, P9; SCHNAAR RL, 1981, J NEUROSCI, V1, P204; SENDTNER M, 1990, NATURE, V345, P440, DOI 10.1038/345440a0; SMITH RG, 1985, J CELL BIOL, V101, P1608, DOI 10.1083/jcb.101.4.1608; STARK KL, 1991, DEVELOPMENT, V113, P641; STOCKLI KA, 1989, NATURE, V342, P920, DOI 10.1038/342920a0; STOCKLI KA, 1991, J CELL BIOL, V115, P447, DOI 10.1083/jcb.115.2.447; VACA K, 1989, J NEUROSCI RES, V23, P55, DOI 10.1002/jnr.490230108; WANAKA A, 1991, DEVELOPMENT, V111, P455; WANAKA A, 1990, NEURON, V5, P267, DOI 10.1016/0896-6273(90)90164-B; WERNER S, 1991, ONCOGENE, V6, P2137; YAMAMORI T, 1989, SCIENCE, V246, P1412, DOI 10.1126/science.2512641; ZHAN X, 1987, ONCOGENE, V1, P369; ZHAN XI, 1988, MOL CELL BIOL, V8, P3487, DOI 10.1128/MCB.8.8.3487	68	127	131	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1993	10	3					369	377		10.1016/0896-6273(93)90327-N	http://dx.doi.org/10.1016/0896-6273(93)90327-N			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KU901	8461132	Green Published			2022-12-24	WOS:A1993KU90100004
J	WILLIAMS, K; RUSSELL, SL; SHEN, YM; MOLINOFF, PB				WILLIAMS, K; RUSSELL, SL; SHEN, YM; MOLINOFF, PB			DEVELOPMENTAL SWITCH IN THE EXPRESSION OF NMDA RECEPTORS OCCURS INVIVO AND INVITRO	NEURON			English	Article							D-ASPARTATE RECEPTOR; MUSCLE ACETYLCHOLINE-RECEPTOR; CENTRAL NERVOUS-SYSTEM; ANTI-ISCHEMIC AGENTS; ANTICONVULSANT MK-801; XENOPUS OOCYTES; VISUAL-CORTEX; RAT-BRAIN; ANTAGONIST; IFENPRODIL	The properties of many ligand-gated ion channels are altered during development. We have characterized a developmental switch in the sensitivity of NMDA receptors to the novel antagonist ifenprodil using ligand binding assays with rat brain membranes and voltage-clamp recording of Xenopus oocytes expressing NMDA receptors after injection of RNA from rat brain and from cloned subunits of the receptor. In neonatal rat brain, NMDA receptors have a uniformly high affinity for ifenprodil. During postnatal development, a second population of receptors having a 100-fold lower affinity for ifenprodil is expressed and represents 50% of NMDA receptors in adult rat brain. This developmental change also occurred in cortical neurons maintained in primary culture. Ifenprodil potently inhibited responses of homomeric NR1 and heteromeric NR1/NR2B receptors but not NR1/NR2A receptors expressed in oocytes, suggesting that inclusion of different NR2 subunits in native NMDA receptors can control the sensitivity to ifenprodil.			WILLIAMS, K (corresponding author), UNIV PENN, SCH MED, DEPT PHARMACOL, PHILADELPHIA, PA 19104 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM034781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS030000] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 34781] Funding Source: Medline; NINDS NIH HHS [NS 30000] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANANTHARAM V, 1992, FEBS LETT, V305, P27, DOI 10.1016/0014-5793(92)80648-Z; ANIS NA, 1983, BRIT J PHARMACOL, V79, P565, DOI 10.1111/j.1476-5381.1983.tb11031.x; AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; BEAR MF, 1990, J NEUROSCI, V10, P909; BENARI Y, 1988, NEUROSCI LETT, V94, P88, DOI 10.1016/0304-3940(88)90275-3; BETTLER B, 1990, NEURON, V5, P583, DOI 10.1016/0896-6273(90)90213-Y; CARTER C, 1989, EUR J PHARMACOL, V164, P611, DOI 10.1016/0014-2999(89)90275-6; CARTER C, 1988, J PHARMACOL EXP THER, V247, P1222; CARTER C, 1991, EXCITATORY AMINO ACI, P130; COLLINGRIDGE GL, 1989, PHARMACOL REV, V41, P143; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; DAUBAS P, 1990, NEURON, V5, P49, DOI 10.1016/0896-6273(90)90032-B; DUMONT JN, 1972, J MORPHOL, V136, P153, DOI 10.1002/jmor.1051360203; FOSTER AC, 1987, BRIT J PHARMACOL, V91, P403, DOI 10.1111/j.1476-5381.1987.tb10295.x; GOTTI B, 1988, J PHARMACOL EXP THER, V247, P1211; HARTMAN DS, 1990, NATURE, V343, P372, DOI 10.1038/343372a0; HESTRIN S, 1992, NATURE, V357, P686, DOI 10.1038/357686a0; KATO N, 1991, DEV BRAIN RES, V60, P43, DOI 10.1016/0165-3806(91)90153-A; KILLISCH I, 1991, NEURON, V7, P927, DOI 10.1016/0896-6273(91)90338-Z; KLECKNER NW, 1991, MOL BRAIN RES, V11, P151; KUHSE J, 1990, NEURON, V5, P867, DOI 10.1016/0896-6273(90)90346-H; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; LEGENDRE P, 1991, MOL PHARMACOL, V40, P289; LEONARD JP, 1990, NEURON, V4, P53, DOI 10.1016/0896-6273(90)90443-J; MAYER ML, 1987, PROG NEUROBIOL, V28, P197, DOI 10.1016/0301-0082(87)90011-6; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MONYER H, 1991, NEURON, V6, P799, DOI 10.1016/0896-6273(91)90176-Z; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; MORRISETT RA, 1990, DEV BRAIN RES, V56, P257, DOI 10.1016/0165-3806(90)90090-L; POULTER MO, 1992, J NEUROSCI, V12, P2888, DOI 10.1523/JNEUROSCI.12-08-02888.1992; QUICK M W, 1992, Biotechniques, V13, P362; REYNOLDS IJ, 1988, MOL PHARMACOL, V33, P581; REYNOLDS IJ, 1989, MOL PHARMACOL, V36, P758; REYNOLDS IJ, 1992, J NEUROSCI, V12, P970; SUGIHARA H, 1992, BIOCHEM BIOPH RES CO, V185, P826, DOI 10.1016/0006-291X(92)91701-Q; TSUMOTO T, 1987, NATURE, V327, P513, DOI 10.1038/327513a0; VERDOORN TA, 1987, SCIENCE, V238, P1114, DOI 10.1126/science.2825347; WILLIAMS K, 1990, NEURON, V5, P199, DOI 10.1016/0896-6273(90)90309-4; WILLIAMS K, 1991, MOL PHARMACOL, V40, P774; WILLIAMS K, 1991, LIFE SCI, V48, P469, DOI 10.1016/0024-3205(91)90463-L; WILLIAMS K, 1992, MOL PHARMACOL, V42, P147; WONG EHF, 1986, P NATL ACAD SCI USA, V83, P7104, DOI 10.1073/pnas.83.18.7104	43	390	396	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1993	10	2					267	278		10.1016/0896-6273(93)90317-K	http://dx.doi.org/10.1016/0896-6273(93)90317-K			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KP685	8439412				2022-12-24	WOS:A1993KP68500014
J	Roche, KW; OBrien, RJ; Mammen, AL; Bernhardt, J; Huganir, RL				Roche, KW; OBrien, RJ; Mammen, AL; Bernhardt, J; Huganir, RL			Characterization of multiple phosphorylation sites on the AMPA receptor GluR1 subunit	NEURON			English	Article							DEPENDENT PROTEIN-KINASE; RETINAL HORIZONTAL CELLS; GLUTAMATE-RECEPTOR; HIPPOCAMPAL-NEURONS; FUNCTIONAL EXPRESSION; MODULATION; CHANNELS; ENHANCEMENT; CLONING	We have characterized the phosphorylation of the glutamate receptor subunit GluR1, using biochemical and electrophysiological techniques. GluR1 is phosphorylated on multiple sites that are all located on the C-terminus of the protein. Cyclic AMP-dependent protein kinase specifically phosphorylates SER-845 of GluR1 in transfected HEK cells and in neurons in culture. Phosphorylation of this residue results in a 40% potentiation of the peak current through GluR1 homo-meric channels. In addition, protein kinase C specifically phosphorylates Ser-831 of GluR1 in HEK-293 cells and in cultured neurons. These results are consistent with the recently proposed transmembrane topology models of glutamate receptors, in which the C-terminus is intracellular. In addition, the modulation of GluR1 by PKA phosphorylation of Ser-845 suggests that phosphorylation of this residue may underlie the PKA-induced potentiation of AMPA receptors in neurons.	JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT NEUROL,BALTIMORE,MD 21205	Howard Hughes Medical Institute; Johns Hopkins University	Roche, KW (corresponding author), JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT NEUROSCI,BALTIMORE,MD 21205, USA.		Roche, Katherine/W-9893-2019; Mammen, Andrew/AAF-2885-2021	Roche, Katherine/0000-0001-7282-6539	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007368] Funding Source: NIH RePORTER; NINDS NIH HHS [1T32NS07368] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BENNETT JA, 1995, NEURON, V14, P373, DOI 10.1016/0896-6273(95)90293-7; BLACKSTONE C, 1994, J NEUROSCI, V14, P7585; BLACKSTONE CD, 1992, J NEUROCHEM, V58, P1118, DOI 10.1111/j.1471-4159.1992.tb09370.x; BLACKSTONE CD, 1992, ANN NEUROL, V31, P680, DOI 10.1002/ana.410310620; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; CHEN L, 1992, NATURE, V356, P521, DOI 10.1038/356521a0; CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U; ESHHAR N, 1993, NEUROSCIENCE, V57, P943, DOI 10.1016/0306-4522(93)90040-M; GREENGARD P, 1991, SCIENCE, V253, P1135, DOI 10.1126/science.1716001; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HOLLMANN M, 1994, NEURON, V13, P1331, DOI 10.1016/0896-6273(94)90419-7; HUGANIR RL, 1984, P NATL ACAD SCI-BIOL, V81, P6968, DOI 10.1073/pnas.81.22.6968; KELLER BU, 1992, EMBO J, V11, P891, DOI 10.1002/j.1460-2075.1992.tb05127.x; KNAPP AG, 1987, NATURE, V325, P437, DOI 10.1038/325437a0; KREBS EG, 1994, TRENDS BIOCHEM SCI, V19, P439, DOI 10.1016/0968-0004(94)90125-2; LIMAN ER, 1989, BRAIN RES, V481, P399, DOI 10.1016/0006-8993(89)90822-6; LINDEN DJ, 1994, NEURON, V12, P457, DOI 10.1016/0896-6273(94)90205-4; MCGLADEMCCULLOH E, 1993, NATURE, V362, P640, DOI 10.1038/362640a0; MOLNAR E, 1993, NEUROSCIENCE, V53, P307, DOI 10.1016/0306-4522(93)90198-O; MOORE KR, 1994, BIOTECHNIQUES, V17, P130; MOSS SJ, 1993, NEUROCHEM RES, V18, P105, DOI 10.1007/BF00966929; NAKAZAW AK, 1995, NEURON, V15, P697; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; RAYMOND LA, 1993, TRENDS NEUROSCI, V16, P147, DOI 10.1016/0166-2236(93)90123-4; RAYMOND LA, 1993, NATURE, V361, P637, DOI 10.1038/361637a0; REIMANN EM, 1983, METHOD ENZYMOL, V99, P51; Roche Katherine W., 1994, Current Opinion in Neurobiology, V4, P383, DOI 10.1016/0959-4388(94)90100-7; ROCHE KW, 1994, J BIOL CHEM, V269, P11679; ROCHE KW, 1995, NEUROSCIENCE, V69, P383, DOI 10.1016/0306-4522(95)00253-F; ROSENMUND C, 1994, NATURE, V368, P853, DOI 10.1038/368853a0; SEEBURG PH, 1993, TRENDS PHARMACOL SCI, V14, P297, DOI 10.1016/0165-6147(93)90047-N; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; SWOPE SL, 1992, FASEB J, V6, P2514, DOI 10.1096/fasebj.6.8.1375568; TAN SE, 1994, J NEUROSCI, V14, P1123, DOI 10.1523/JNEUROSCI.14-03-01123.1994; TAVERNA FA, 1994, J BIOL CHEM, V269, P14159; TINGLEY WG, 1993, NATURE, V364, P70, DOI 10.1038/364070a0; WANG LY, 1993, SCIENCE, V259, P1173, DOI 10.1126/science.8382377; WANG LY, 1991, SCIENCE, V253, P1132, DOI 10.1126/science.1653455; WANG LY, 1994, J PHYSIOL-LONDON, V475, P431, DOI 10.1113/jphysiol.1994.sp020083; WO ZG, 1994, P NATL ACAD SCI USA, V91, P7154, DOI 10.1073/pnas.91.15.7154; WOOD MW, 1995, P NATL ACAD SCI USA, V92, P4882, DOI 10.1073/pnas.92.11.4882; WOODGETT JR, 1987, J BIOL CHEM, V262, P4836; YAKEL JL, 1995, P NATL ACAD SCI USA, V92, P1376, DOI 10.1073/pnas.92.5.1376	45	638	651	2	25	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1996	16	6					1179	1188		10.1016/S0896-6273(00)80144-0	http://dx.doi.org/10.1016/S0896-6273(00)80144-0			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UU118	8663994	Bronze			2022-12-24	WOS:A1996UU11800015
J	Rosenmund, C; Stevens, CF				Rosenmund, C; Stevens, CF			Definition of the readily releasable pool of vesicles at hippocampal synapses	NEURON			English	Article							TRANSMITTER RELEASE; NEUROMUSCULAR-JUNCTION; QUANTAL ANALYSIS; CALCIUM; NEURONS; NEUROSECRETION; CURRENTS	A readily releasable pool of quanta, tentatively identified with docked synaptic vesicles, has been defined by analysis of the neurotransmitter release caused by application of hypertonic solutions. The goal of this work is to determine the relationship of this functionally defined readily releasable pool to the one drawn upon by action potential-evoked release. We find that hypertonic solutions do not act through changes in intracellular calcium. Since the release produced by action potentials and hypertonic solutions varies in parallel as the pool size is changed, we conclude that the same pool is shared by both mechanisms. This conclusion, taken together with other observations in the literature, means that the synaptic release probability depends on the size of the readily releasable pool.	SALK INST BIOL STUDIES,HOWARD HUGHES MED INST,MOLEC NEUROBIOL LAB,LA JOLLA,CA 92037	Howard Hughes Medical Institute; Salk Institute	Rosenmund, C (corresponding author), MAX PLANCK INST BIOPHYS CHEM,AG ZELLULARE NEUROBIOL,D-37077 GOTTINGEN,GERMANY.		Rosenmund, Christian/AAC-3596-2020	Rosenmund, Christian/0000-0002-3905-2444	NINDS NIH HHS [NS 12961] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS012961] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARRETT EF, 1972, J PHYSIOL-LONDON, V227, P691, DOI 10.1113/jphysiol.1972.sp010054; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Bekkers John M., 1992, P150; BLIOCH ZL, 1968, J PHYSIOL-LONDON, V199, P11, DOI 10.1113/jphysiol.1968.sp008637; BORGES S, 1995, P NATL ACAD SCI USA, V92, P6896, DOI 10.1073/pnas.92.15.6896; BROSIUS DC, 1992, J NEUROPHYSIOL, V68, P1229, DOI 10.1152/jn.1992.68.4.1229; COHEN I, 1985, INT REV NEUROBIOL, V27, P299, DOI 10.1016/S0074-7742(08)60560-7; DELANEY K, 1991, J NEUROSCI, V11, P2631; FORSYTHE ID, 1990, J PHYSIOL-LONDON, V429, P1; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; HUBBARD JI, 1968, J PHYSIOL-LONDON, V197, P639, DOI 10.1113/jphysiol.1968.sp008579; KORN H, 1991, TRENDS NEUROSCI, V14, P439, DOI 10.1016/0166-2236(91)90042-S; LESTER RAJ, 1990, NEURON, V4, P741, DOI 10.1016/0896-6273(90)90200-Y; LIU GS, 1995, NATURE, V375, P404, DOI 10.1038/375404a0; Nicoll R A, 1979, Int Rev Neurobiol, V21, P217; QUASTEL DMJ, 1971, SCIENCE, V172, P1034, DOI 10.1126/science.172.3987.1034; REDMAN S, 1990, PHYSIOL REV, V70, P165, DOI 10.1152/physrev.1990.70.1.165; ROSENMUND C, 1995, J NEUROSCI, V15, P2788; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; SHIMONI Y, 1977, NATURE, V267, P170, DOI 10.1038/267170a0; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; THIES RE, 1965, J NEUROPHYSIOL, V28, P427, DOI 10.1152/jn.1965.28.3.427; YANG XC, 1989, SCIENCE, V243, P1068, DOI 10.1126/science.2466333; Yu WF, 1995, J NEUROSCI METH, V62, P159, DOI 10.1016/0165-0270(95)00071-2; ZENCHENKO TA, 1995, PROTEIN SCI, V4, P251; ZUCKER RS, 1973, J PHYSIOL-LONDON, V229, P787, DOI 10.1113/jphysiol.1973.sp010167	28	819	827	1	27	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1996	16	6					1197	1207		10.1016/S0896-6273(00)80146-4	http://dx.doi.org/10.1016/S0896-6273(00)80146-4			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UU118	8663996	Green Published, Bronze			2022-12-24	WOS:A1996UU11800017
J	Impey, S; Mark, M; Villacres, EC; Poser, S; Chavkin, C; Storm, DR				Impey, S; Mark, M; Villacres, EC; Poser, S; Chavkin, C; Storm, DR			Induction of CRE-mediated gene expression by stimuli that generate long-lasting LTP in area CA1 of the hippocampus	NEURON			English	Article							DROSOPHILA LEARNING MUTANT; APLYSIA SENSORY NEURONS; TERM POTENTIATION; CYCLIC-AMP; ADENYLATE-CYCLASE; PROTEIN-SYNTHESIS; SYNAPTIC ACTIVATION; SOMATOSTATIN GENE; PYRAMIDAL CELLS; CA-2+ CHANNELS	Gene expression regulated by the cAMP response element (CRE) has been implicated in synaptic plasticity and long-term memory. It has been proposed that CRE-mediated gene expression is stimulated by signals that induce long-term potentiation (LTP). To test this hypothesis, we made mice transgenic for a CRE-regulated reporter construct. We focused on longlasting long-term potentiation (L-LTP), because it depends on cAMP-dependent protein kinase activity (PKA) and de novo gene expression. CRE-mediated gene expression was markedly increased after L-LTP, but not after decremental LTP (D-LTP). Furthermore, inhibitors of PKA blocked L-LTP and associated increases in CRE-mediated gene expression. These data demonstrate that the signaling required for the generation of L-LTP but not D-LTP is sufficient to stimulate CRE-mediated transcription in the hippocampus.	UNIV WASHINGTON, SCH MED, DEPT PSYCHIAT & BEHAV SCI, SEATTLE, WA 98195 USA	University of Washington; University of Washington Seattle	Impey, S (corresponding author), UNIV WASHINGTON, SCH MED, DEPT PHARMACOL, SEATTLE, WA 98195 USA.		Mark, Melanie/ABF-9102-2020; Chavkin, Charles/G-2797-2010	Mark, Melanie/0000-0002-2788-6003; 	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020498] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 20498] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABRAMS TW, 1991, J NEUROSCI, V11, P2655; ALVAREZ P, 1994, P NATL ACAD SCI USA, V91, P5637, DOI 10.1073/pnas.91.12.5637; ANIKSZTEJN L, 1991, NATURE, V349, P67, DOI 10.1038/349067a0; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; BARONDES SH, 1968, P NATL ACAD SCI USA, V61, P923, DOI 10.1073/pnas.61.3.923; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Blitzer RD, 1995, NEURON, V15, P1403, DOI 10.1016/0896-6273(95)90018-7; BOHM M, 1995, CELL GROWTH DIFFER, V6, P291; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; CAHILL L, 1994, NATURE, V371, P702, DOI 10.1038/371702a0; CASTELLUCCI VF, 1989, J NEUROBIOL, V20, P1, DOI 10.1002/neu.480200102; CHATTON B, 1994, ONCOGENE, V9, P375; Choi EJ, 1993, CURR OPIN CELL BIOL, V5, P269, DOI 10.1016/0955-0674(93)90115-7; CHRISTIE BR, 1995, J NEUROPHYSIOL, V73, P2553, DOI 10.1152/jn.1995.73.6.2553; COLLINGRIDGE GL, 1995, TRENDS NEUROSCI, V18, P54, DOI 10.1016/0166-2236(95)93868-X; CROW T, 1990, P NATL ACAD SCI USA, V87, P4490, DOI 10.1073/pnas.87.12.4490; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; DECESARE D, 1995, ONCOGENE, V11, P365; DEGROOT RP, 1993, EMBO J, V12, P3903, DOI 10.1002/j.1460-2075.1993.tb06068.x; DEGROOT RP, 1994, CELL, V79, P81, DOI 10.1016/0092-8674(94)90402-2; DEUTSCH PJ, 1987, J BIOL CHEM, V262, P12169; ENSLEN H, 1994, J BIOL CHEM, V269, P15520; FEANY MB, 1990, P NATL ACAD SCI USA, V87, P2795, DOI 10.1073/pnas.87.7.2795; FLEXNER LB, 1966, P NATL ACAD SCI USA, V55, P369, DOI 10.1073/pnas.55.2.369; FRANK DA, 1994, CELL, V79, P5, DOI 10.1016/0092-8674(94)90394-8; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; GINTY DD, 1994, CELL, V77, P713, DOI 10.1016/0092-8674(94)90055-8; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; GRECKSCH G, 1980, PHARM BIOCH BEHAV, V12, P613; GROVER LM, 1994, SYNAPSE, V16, P66, DOI 10.1002/syn.890160108; GROVER LM, 1990, NATURE, V347, P477, DOI 10.1038/347477a0; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; HANSE E, 1995, NEUROSCIENCE, V67, P531, DOI 10.1016/0306-4522(95)00090-6; HOEFFLER JP, 1988, SCIENCE, V242, P1430, DOI 10.1126/science.2974179; Huang Y Y, 1994, Learn Mem, V1, P74; HUANG YY, 1995, P NATL ACAD SCI USA, V92, P2446, DOI 10.1073/pnas.92.7.2446; HUANG YY, 1993, J NEUROSCI, V13, P568; HUBER KM, 1995, J NEUROPHYSIOL, V73, P270, DOI 10.1152/jn.1995.73.1.270; IMPEY S, 1994, MOL CELL BIOL, V14, P8272, DOI 10.1128/MCB.14.12.8272; ITO I, 1991, NEUROSCI LETT, V121, P119, DOI 10.1016/0304-3940(91)90663-E; KAANG BK, 1993, NEURON, V10, P427, DOI 10.1016/0896-6273(93)90331-K; KESNER RP, 1972, SCIENCE, V176, P432, DOI 10.1126/science.176.4033.432; KILBOURNE EJ, 1992, J BIOL CHEM, V267, P7563; LEVIN LR, 1992, CELL, V68, P479, DOI 10.1016/0092-8674(92)90185-F; LIU F, 1993, J BIOL CHEM, V268, P6714; LIVINGSTONE MS, 1984, CELL, V37, P205, DOI 10.1016/0092-8674(84)90316-7; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; MATTHIES H, 1993, NEUROREPORT, V4, P712, DOI 10.1097/00001756-199306000-00028; Matthies H, 1990, Adv Exp Med Biol, V268, P359; MEINKOTH J, 1990, CIBA F SYMP, V150, P47; MIYAKAWA H, 1992, NEURON, V9, P1163, DOI 10.1016/0896-6273(92)90074-N; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; MONTMINY MR, 1990, TRENDS NEUROSCI, V13, P184, DOI 10.1016/0166-2236(90)90045-C; MURPHY TH, 1991, NEURON, V7, P625, DOI 10.1016/0896-6273(91)90375-A; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; REDDY R, 1995, J BIOL CHEM, V270, P14340, DOI 10.1074/jbc.270.24.14340; REGEHR WG, 1992, J NEUROSCI, V12, P4202; REYMANN KG, 1989, NEUROSCI LETT, V96, P96, DOI 10.1016/0304-3940(89)90249-8; SCHWANINGER M, 1995, J BIOL CHEM, V270, P8860, DOI 10.1074/jbc.270.15.8860; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; SILVER BJ, 1987, P NATL ACAD SCI USA, V84, P2198, DOI 10.1073/pnas.84.8.2198; Slack JR, 1995, NEUROSCI LETT, V201, P25, DOI 10.1016/0304-3940(94)12121-6; SQUIRE LR, 1973, BRAIN RES, V56, P215, DOI 10.1016/0006-8993(73)90336-3; SQUIRE LR, 1988, TRENDS NEUROSCI, V11, P170, DOI 10.1016/0166-2236(88)90144-0; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; TAUSSIG R, 1995, J BIOL CHEM, V270, P1, DOI 10.1074/jbc.270.1.1; THOMPSON MA, 1995, J BIOL CHEM, V270, P4224, DOI 10.1074/jbc.270.9.4224; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; VALLEJO M, 1993, P NATL ACAD SCI USA, V90, P4679, DOI 10.1073/pnas.90.10.4679; VANNGUYEN T, 1990, J NEUROSCI, V10, P2825; WESTENBROEK RE, 1990, NATURE, V347, P281, DOI 10.1038/347281a0; WU ZL, 1995, P NATL ACAD SCI USA, V92, P220, DOI 10.1073/pnas.92.1.220; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; YOVELL Y, 1987, P NATL ACAD SCI USA, V84, P9285, DOI 10.1073/pnas.84.24.9285	85	489	498	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	1996	16	5					973	982		10.1016/S0896-6273(00)80120-8	http://dx.doi.org/10.1016/S0896-6273(00)80120-8			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UN480	8630255	Bronze			2022-12-24	WOS:A1996UN48000012
J	Brandes, C; Plautz, JD; Stanewsky, R; Jamison, CF; Straume, M; Wood, KV; Kay, SA; Hall, JC				Brandes, C; Plautz, JD; Stanewsky, R; Jamison, CF; Straume, M; Wood, KV; Kay, SA; Hall, JC			Novel features of Drosophila period transcription revealed by real-time luciferase reporting	NEURON			English	Article							MESSENGER-RNA LEVELS; CIRCADIAN CLOCK; GENE; MELANOGASTER; EXPRESSION; MUTATIONS	The rapid turnover of luciferase and the sensitive, noninvasive nature of its assay make this reporter gene uniquely situated for temporal gene expression studies. To determine the in vivo regulatory pattern of the Drosophila clock gene period (per), we generated transgenic strains carrying a luciferase cDNA fused to the promoter region of the per gene. This has allowed us to monitor circadian rhythms of bioluminescence from pacemaker cells within the head for several days in individual living adults. These high time-resolution experiments permitted neuronal per transcription to be accurately measured in single animals. This new technology has revealed a novel feature of per transcription and opens the door to vastly simplified experiments in general chronobiology and studies of temporally regulated transcription in a wide range of experimental systems.	UNIV VIRGINIA,DEPT BIOL,CHARLOTTESVILLE,VA 22903; UNIV VIRGINIA,NATL SCI FDN CTR BIOL TIMING,CHARLOTTESVILLE,VA 22903; BRANDEIS UNIV,DEPT BIOL,WALTHAM,MA 02254; BRANDEIS UNIV,NATL SCI FDN CTR BIOL TIMING,WALTHAM,MA 02254; PROMEGA CORP,MADISON,WI 53711	University of Virginia; National Science Foundation (NSF); NSF - Center for Biological Timing; University of Virginia; Brandeis University; Brandeis University; National Science Foundation (NSF); NSF - Center for Biological Timing; Promega Corporation			Stanewsky, Ralf/ABB-9193-2021; Kay, Steve A/F-6025-2011	Kay, Steve A/0000-0002-0402-2878; Stanewsky, Ralf/0000-0001-8238-6864	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051573] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-33205] Funding Source: Medline; NIMH NIH HHS [MH-51573] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		CARPENTER JM, 1950, DROSOPHILA INFORMATI, V24, P96; DUNLAP JC, 1993, ANNU REV PHYSIOL, V55, P683, DOI 10.1146/annurev.physiol.55.1.683; EDERY I, 1994, SCIENCE, V263, P237, DOI 10.1126/science.8284676; HALL JC, 1995, TRENDS NEUROSCI, V18, P218; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; HARDIN PE, 1992, P NATL ACAD SCI USA, V89, P11711, DOI 10.1073/pnas.89.24.11711; HARDIN PE, 1994, MOL CELL BIOL, V14, P7211, DOI 10.1128/MCB.14.11.7211; JOHNSON ML, 1992, METHOD ENZYMOL, V210, P1; JOHNSON ML, 1985, METHOD ENZYMOL, V117, P301; Kay S A, 1993, Semin Cell Biol, V4, P81, DOI 10.1006/scel.1993.1010; KONDO T, 1993, P NATL ACAD SCI USA, V90, P5672, DOI 10.1073/pnas.90.12.5672; KONDO T, 1994, SCIENCE, V266, P1233, DOI 10.1126/science.7973706; KONOPKA RJ, 1989, J NEUROGENET, V6, P1, DOI 10.3109/01677068909107096; LIU Y, 1995, GENE DEV, V9, P1469, DOI 10.1101/gad.9.12.1469; LOCKETT TJ, 1992, GENE, V114, P187, DOI 10.1016/0378-1119(92)90573-8; LORENZ LJ, 1989, DEVELOPMENT, V107, P869; LOROS JJ, 1989, SCIENCE, V243, P385, DOI 10.1126/science.2563175; LOSSON R, 1979, P NATL ACAD SCI USA, V76, P5134, DOI 10.1073/pnas.76.10.5134; MILLAR AJ, 1992, PLANT CELL, V4, P1075, DOI 10.1105/tpc.4.9.1075; MILLAR AJ, 1995, SCIENCE, V267, P1161, DOI 10.1126/science.7855595; MONSMA SA, 1988, J EXP ZOOL, V247, P279, DOI 10.1002/jez.1402470312; PLAUTZ JD, 1996, IN PRESS GENE; ROBERTSON HM, 1988, GENETICS, V118, P461; RUTTER GA, 1995, CURR BIOL, V5, P890, DOI 10.1016/S0960-9822(95)00179-5; SEHGAL A, 1994, SCIENCE, V263, P1603, DOI 10.1126/science.8128246; Straume M, 1991, TOPICS FLUORESCENCE, P177, DOI DOI 10.1007/B112907; THOMPSON EM, 1995, P NATL ACAD SCI USA, V92, P1317, DOI 10.1073/pnas.92.5.1317; Vetterling W.T., 1989, NUMERICAL RECIPES; WASHBURN T, 1992, GENETICS, V130, P585; Wood Keith V., 1995, Current Opinion in Biotechnology, V6, P50, DOI 10.1016/0958-1669(95)80009-3; WRIGHT NJD, 1995, J NEUROSCI, V15, P1025; YU Q, 1987, P NATL ACAD SCI USA, V84, P784, DOI 10.1073/pnas.84.3.784; ZWIEBEL LJ, 1991, P NATL ACAD SCI USA, V88, P3882, DOI 10.1073/pnas.88.9.3882	33	132	133	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1996	16	4					687	692		10.1016/S0896-6273(00)80088-4	http://dx.doi.org/10.1016/S0896-6273(00)80088-4			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UG611	8607986	Bronze			2022-12-24	WOS:A1996UG61100001
J	RUANO, D; LAMBOLEZ, B; ROSSIER, J; PATERNAIN, AV; LERMA, J				RUANO, D; LAMBOLEZ, B; ROSSIER, J; PATERNAIN, AV; LERMA, J			KAINATE RECEPTOR SUBUNITS EXPRESSED IN SINGLE CULTURED HIPPOCAMPAL-NEURONS - MOLECULAR AND FUNCTIONAL VARIANTS BY RNA EDITING	NEURON			English	Article							HIGH-AFFINITY KAINATE; SELECTIVE GLUTAMATE RECEPTORS; AMINO-ACID RECEPTORS; CA2+ PERMEABILITY; NERVOUS-SYSTEM; RAT-BRAIN; CHANNELS; CLONING; FAMILY; CELLS	To determine the kainate receptor subunits that are found in native kainate receptors, we have applied a multiplex PCR of cDNAs reverse transcribed from mRNA harvested from single cultured hippocampal neurons after electrophysiological recording. We found that all the cells showing rapidly desensitizing currents in response to kainate express the GluR6 subunit mRNA, and that some of them also express the GluRS subunit mRNA. No GluR7, KA-1, or KA-2 subunit mRNAs were detected. Analysis of the editing sites of the GluR6 mRNA demonstrated that the three editing sites present in these subunits are edited to a different extent. Predominant expression of the unedited variant (Q) was observed, but edited and unedited variants may coexist in the same cell. In addition, we show that the Q/R site from the GluR6 subunit controls functional properties of native kainate receptors.	CSIC,INST CAJAL,DEPT PLAST NEURAL,E-28002 MADRID,SPAIN	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC)	RUANO, D (corresponding author), CNRS,INST ALFRED FESSARD,F-91198 GIF SUR YVETTE,FRANCE.		IBIS, ALZHEIMER/O-9867-2015; CABALLERO, DIEGO RUANO/I-4471-2014; Lerma, Juan/G-7907-2015	CABALLERO, DIEGO RUANO/0000-0001-6131-3033; Lerma, Juan/0000-0001-7838-5199; lambolez, bertrand/0000-0002-0653-480X				ALDRICH RW, 1994, CURR BIOL, V4, P839, DOI 10.1016/S0960-9822(00)00187-1; AUDINAT E, 1994, EUR J NEUROSCI, V6, P1792, DOI 10.1111/j.1460-9568.1994.tb00572.x; BETTLER B, 1990, NEURON, V5, P583, DOI 10.1016/0896-6273(90)90213-Y; BETTLER B, 1992, NEURON, V8, P257, DOI 10.1016/0896-6273(92)90292-L; BOCHET P, 1994, NEURON, V12, P383, DOI 10.1016/0896-6273(94)90279-8; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; CATTANEO R, 1991, ANNU REV GENET, V25, P71, DOI 10.1146/annurev.ge.25.120191.000443; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; EGEBJERG J, 1993, P NATL ACAD SCI USA, V90, P755, DOI 10.1073/pnas.90.2.755; EGEBJERG J, 1991, NATURE, V351, P745, DOI 10.1038/351745a0; FELDMEYER D, 1994, CURR BIOL, V4, P82, DOI 10.1016/S0960-9822(00)00021-X; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HERB A, 1992, NEURON, V8, P775, DOI 10.1016/0896-6273(92)90098-X; HUETTNER JE, 1990, NEURON, V5, P255, DOI 10.1016/0896-6273(90)90163-A; JONAS P, 1994, NEURON, V12, P1281, DOI 10.1016/0896-6273(94)90444-8; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; KELLER BU, 1993, P NATL ACAD SCI USA, V90, P605, DOI 10.1073/pnas.90.2.605; KOHLER M, 1993, NEURON, V10, P491, DOI 10.1016/0896-6273(93)90336-P; LAMBOLEZ B, 1992, NEURON, V9, P247, DOI 10.1016/0896-6273(92)90164-9; LERMA J, 1992, NEURON, V8, P343, DOI 10.1016/0896-6273(92)90300-3; LERMA J, 1993, P NATL ACAD SCI USA, V90, P11688, DOI 10.1073/pnas.90.24.11688; LERMA J, 1994, EUR J NEUROSCI, V6, P1080, DOI 10.1111/j.1460-9568.1994.tb00605.x; LOMELI H, 1993, FEBS LETT, V315, P318, DOI 10.1016/0014-5793(93)81186-4; LOMELI H, 1992, FEBS LETT, V307, P139, DOI 10.1016/0014-5793(92)80753-4; MACKLER SA, 1993, MOL PHARMACOL, V44, P308; MONAGHAN DT, 1989, ANNU REV PHARMACOL, V29, P365, DOI 10.1146/annurev.pa.29.040189.002053; NAKANISHI N, 1990, NEURON, V5, P569, DOI 10.1016/0896-6273(90)90212-X; PATERNAIN AV, 1995, NEURON, V14, P185, DOI 10.1016/0896-6273(95)90253-8; PATNEAU DK, 1994, NEURON, V12, P357, DOI 10.1016/0896-6273(94)90277-1; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; RYCHLIK W, 1989, NUCLEIC ACIDS RES, V17, P8543, DOI 10.1093/nar/17.21.8543; SCOTT VES, 1994, P NATL ACAD SCI USA, V91, P1637, DOI 10.1073/pnas.91.5.1637; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; SOMMER B, 1992, EMBO J, V11, P1651, DOI 10.1002/j.1460-2075.1992.tb05211.x; SOMMER B, 1992, TRENDS PHARMACOL SCI, V13, P291, DOI 10.1016/0165-6147(92)90088-N; WATKINS JC, 1990, TRENDS PHARMACOL SCI, V11, P291; WERNER P, 1991, NATURE, V351, P742, DOI 10.1038/351742a0; WISDEN W, 1993, J NEUROSCI, V13, P3582; YAMAZAKI M, 1992, BIOCHEM BIOPH RES CO, V183, P886, DOI 10.1016/0006-291X(92)90566-4	39	127	132	0	2	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1995	14	5					1009	1017		10.1016/0896-6273(95)90339-9	http://dx.doi.org/10.1016/0896-6273(95)90339-9			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QY935	7748549	Bronze			2022-12-24	WOS:A1995QY93500013
J	SHIRASAKI, R; TAMADA, A; KATSUMATA, R; MURAKAMI, F				SHIRASAKI, R; TAMADA, A; KATSUMATA, R; MURAKAMI, F			GUIDANCE OF CEREBELLOFUGAL AXONS IN THE RAT EMBRYO - DIRECTED GROWTH TOWARD THE FLOOR PLATE AND SUBSEQUENT ELONGATION ALONG THE LONGITUDINAL AXIS	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD; CHICK-EMBRYO; BRACHIUM CONJUNCTIVUM; GRASSHOPPER EMBRYOS; NEURITE OUTGROWTH; ZEBRAFISH EMBRYO; CONES; PROJECTIONS; NEURONS	To elucidate guidance mechanisms of brain commissural axons, we examined the navigation of cerebellofugal axons. Axons were labeled by implantation of the fluorescent tracer Dil into the cerebellar plate (CP) of fixed, flat whole-mount embryonic rat brain. Axons initially grew straight toward the ventral midline floor plate (FP) in the rostral hindbrain and then, after crossing it, made a right-angled turn to grow either caudally or rostrally along the longitudinal axis. In collagen gel culture, CP axons showed directed growth toward both FP explants and heterologous cells expressing netrin-1, a FP-derived chemoattractant for spinal commissural axons. These results suggest that CP axons are guided to the midline by FP-derived chemoattractant(s) and then reoriented, possibly by another guidance cue, for longitudinal extension. Considering that the basic structures of the neural tube, including the FP, extend up to the caudal diencephalon, these results suggest that common guidance mechanisms operate for ventrally decussating commissural axons in both the brain and spinal cord.			SHIRASAKI, R (corresponding author), OSAKA UNIV,FAC ENGN SCI,DEPT BIOPHYS ENGN,TOYONAKA,OSAKA 560,JAPAN.			Tamada, Atsushi/0000-0003-3677-6102; Murakami, Fujio/0000-0002-1519-5096				ALTMAN J, 1985, J COMP NEUROL, V231, P1, DOI 10.1002/cne.902310103; ALTMAN J, 1978, J COMP NEUROL, V179, P23, DOI 10.1002/cne.901790104; ALTMAN J, 1985, J COMP NEUROL, V231, P27, DOI 10.1002/cne.902310104; BASTIANI MJ, 1984, J NEUROSCI, V4, P2311; BENTIVOGLIO M, 1982, EXP BRAIN RES, V46, P339; BERNHARDT RR, 1994, J COMP NEUROL, V350, P122, DOI 10.1002/cne.903500109; BOVOLENTA P, 1990, DEVELOPMENT, V109, P435; Brodal P., 1992, CENTRAL NERVOUS SYST, P262; Chan-Palay V, 1977, CEREBELLAR DENTATE N; CHITNIS AB, 1992, J NEUROBIOL, V23, P845, DOI 10.1002/neu.480230706; CHOLLEY B, 1989, DEV BRAIN RES, V45, P185, DOI 10.1016/0165-3806(89)90038-2; CHUANG W, 1990, DEV BIOL, V137, P219, DOI 10.1016/0012-1606(90)90249-I; CLARKE JDW, 1993, DEVELOPMENT, V118, P151; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; EBENDAL T, 1977, EXP CELL RES, V105, P379, DOI 10.1016/0014-4827(77)90135-5; FAULL RLM, 1978, J COMP NEUROL, V178, P495, DOI 10.1002/cne.901780307; FITZGERALD M, 1993, DEVELOPMENT, V117, P1377; FREDETTE BJ, 1991, ANAT EMBRYOL, V184, P225, DOI 10.1007/BF01673258; GLOVER JC, 1993, BRAIN RES BULL, V30, P265, DOI 10.1016/0361-9230(93)90254-9; GODEMENT P, 1987, DEVELOPMENT, V101, P697; HALLONET MER, 1990, DEVELOPMENT, V108, P19; HATTA K, 1992, NEURON, V9, P629, DOI 10.1016/0896-6273(92)90027-B; HEFFNER CD, 1990, SCIENCE, V247, P217, DOI 10.1126/science.2294603; HOLLEY JA, 1987, DEV BIOL, V123, P375, DOI 10.1016/0012-1606(87)90396-4; HOLLEY JA, 1987, DEV BIOL, V123, P389, DOI 10.1016/0012-1606(87)90397-6; HONIG MG, 1989, TRENDS NEUROSCI, V12, P333, DOI 10.1016/0166-2236(89)90040-4; HUNTER DD, 1992, J COMP NEUROL, V323, P238, DOI 10.1002/cne.903230208; Ito M, 1984, CEREBELLUM NEURAL CO; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; KIMMEL CB, 1993, ANNU REV NEUROSCI, V16, P707, DOI 10.1146/annurev.ne.16.030193.003423; Kingsbury BF, 1930, J COMP NEUROL, V50, P177, DOI 10.1002/cne.900500109; KLAR A, 1992, CELL, V69, P95, DOI 10.1016/0092-8674(92)90121-R; KUWADA JY, 1986, SCIENCE, V233, P740, DOI 10.1126/science.3738507; KUWADA JY, 1990, J NEUROSCI, V10, P1299; LUMSDEN A, 1989, NATURE, V337, P424, DOI 10.1038/337424a0; LUMSDEN AGS, 1986, NATURE, V323, P538, DOI 10.1038/323538a0; LUMSDEN AGS, 1983, NATURE, V306, P786, DOI 10.1038/306786a0; MASON CA, 1992, NERVE GROWTH CONE, P405; MCCREA RA, 1978, J COMP NEUROL, V181, P397, DOI 10.1002/cne.901810210; MYERS PZ, 1993, J NEUROSCI, V13, P127; PINI A, 1993, SCIENCE, V261, P95, DOI 10.1126/science.8316861; PLACZEK M, 1990, DEVELOPMENT, V110, P19; PLACZEK M, 1990, COLD SPRING HARB SYM, V55, P279; PUELLES L, 1987, J COMP NEUROL, V266, P247, DOI 10.1002/cne.902660210; RAPER JA, 1984, J NEUROSCI, V4, P2329; SATO M, 1994, NEURON, V13, P791, DOI 10.1016/0896-6273(94)90246-1; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; SHIRASAKI R, 1994, NEUROSCI RES       S, V19, pS117; TAMADA A, 1993, NEUROSCI RES       S, V18, pS108; TAMADA A, 1994, NEUROSCI RES       S, V19, pS117; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; TOLBERT DL, 1978, EXP BRAIN RES, V31, P305; TREVARROW B, 1990, NEURON, V4, P669, DOI 10.1016/0896-6273(90)90194-K; YAGINUMA H, 1991, J COMP NEUROL, V304, P78, DOI 10.1002/cne.903040107; YAGINUMA H, 1991, J NEUROSCI, V11, P2598; YAGINUMA H, 1990, DEVELOPMENT, V108, P705	56	101	103	0	1	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1995	14	5					961	972		10.1016/0896-6273(95)90334-8	http://dx.doi.org/10.1016/0896-6273(95)90334-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QY935	7748563	Bronze			2022-12-24	WOS:A1995QY93500008
J	YANG, J; JAN, YN; JAN, LY				YANG, J; JAN, YN; JAN, LY			CONTROL OF RECTIFICATION AND PERMEATION BY RESIDUES IN 2 DISTINCT DOMAINS IN AN INWARD RECTIFIER K+ CHANNEL	NEURON			English	Article							RECTIFYING POTASSIUM CHANNELS; PIG VENTRICULAR CELLS; FUNCTIONAL EXPRESSION; INTERNAL MG-2+; BLOCK; IONS; SELECTIVITY; CONDUCTANCE; HEART	Inwardly rectifying K+ channels conduct more inward than outward current as a result of voltage-dependent block of the channel pore by intracellular Mg2+ and polyamines. We investigated the molecular mechanism and structural determinants of inward rectification and ion permeation in a strongly rectifying channel, IRK1. Block by Mg2+ and polyamines is found not to conform to one-to-one binding, suggesting that a channel pore can accommodate more than one blocking particle. A negatively charged amino acid in the hydrophilic C-terminal domain is found to be critical for both inward rectification and ion permeation. This residue and a negatively charged residue in the putative second transmembrane segment (M2) contribute independently to high affinity binding of Mg2+ and polyamines. Mutation of this residue also induces Mg2+- and polyamine-independent inward rectification and dramatically alters single-channel behavior. We propose that the hydrophilic C-terminal domain comprises part of the channel pore and that involvement of both hydrophilic and hydrophobic domains in pore lining may provide a molecular basis for the multi-ion, long-pore nature of inwardly rectifying K+ channels.			YANG, J (corresponding author), UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,DEPT PHYSIOL & BIOCHEM,SAN FRANCISCO,CA 94143, USA.			Jan, Lily/0000-0003-3938-8498; Jan, Yuh Nung/0000-0003-1367-6299				ARMSTRON.CM, 1969, J GEN PHYSIOL, V54, P553, DOI 10.1085/jgp.54.5.553; ASHFORD MLJ, 1994, NATURE, V370, P456, DOI 10.1038/370456a0; CONSTANTI A, 1983, J PHYSIOL-LONDON, V385, P153; DASCAL N, 1993, P NATL ACAD SCI USA, V90, P6596, DOI 10.1073/pnas.90.14.6596; FAKLER B, 1995, CELL, V80, P149, DOI 10.1016/0092-8674(95)90459-X; FICKER E, 1994, SCIENCE, V266, P1068, DOI 10.1126/science.7973666; HAGIWARA S, 1974, J MEMBRANE BIOL, V18, P61, DOI 10.1007/BF01870103; HILLE B, 1978, J GEN PHYSIOL, V72, P409, DOI 10.1085/jgp.72.4.409; Hille B., 1992, IONIC CHANNELS EXCIT; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; ISHIHARA K, 1989, J PHYSIOL-LONDON, V419, P297, DOI 10.1113/jphysiol.1989.sp017874; ISOM LL, 1994, NEURON, V12, P1183, DOI 10.1016/0896-6273(94)90436-7; KATZ B, 1949, ARCH SCI PHYSL, V2, P285; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; LOPATIN AN, 1994, NATURE, V372, P356; LU Z, 1994, NATURE, V371, P243, DOI 10.1038/371243a0; MATSUDA H, 1987, NATURE, V325, P156, DOI 10.1038/325156a0; MATSUDA H, 1993, J PHYSIOL-LONDON, V460, P311, DOI 10.1113/jphysiol.1993.sp019473; MATSUDA H, 1988, J PHYSIOL-LONDON, V397, P237, DOI 10.1113/jphysiol.1988.sp016998; MATSUDA H, 1993, J PHYSIOL-LONDON, V470, P295, DOI 10.1113/jphysiol.1993.sp019859; NICHOLS CG, 1994, J PHYSIOL-LONDON, V476, P399, DOI 10.1113/jphysiol.1994.sp020141; NICHOLS CG, 1993, TRENDS PHARMACOL SCI, V14, P320; OSBORNE HB, 1989, BIOCHEM BIOPH RES CO, V158, P520, DOI 10.1016/S0006-291X(89)80080-4; SAKMANN B, 1984, J PHYSIOL-LONDON, V347, P641, DOI 10.1113/jphysiol.1984.sp015088; Sather William A., 1994, Current Opinion in Neurobiology, V4, P313, DOI 10.1016/0959-4388(94)90091-4; SILVER MR, 1990, J GEN PHYSIOL, V96, P109, DOI 10.1085/jgp.96.1.109; Smith RM, 1974, CRITICAL STABILITY C, V1-6; STANFIELD PR, 1994, J PHYSIOL-LONDON, V478, P1; TAGLIALATELA M, 1994, SCIENCE, V264, P844, DOI 10.1126/science.8171340; VANDENBERG CA, 1987, P NATL ACAD SCI USA, V84, P2560, DOI 10.1073/pnas.84.8.2560; WELLS JA, 1990, BIOCHEMISTRY-US, V29, P8509, DOI 10.1021/bi00489a001; WIBLE BA, 1994, NATURE, V371, P246, DOI 10.1038/371246a0; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687; YANG J, 1993, NATURE, V366, P158, DOI 10.1038/366158a0	36	265	268	0	0	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1995	14	5					1047	1054		10.1016/0896-6273(95)90343-7	http://dx.doi.org/10.1016/0896-6273(95)90343-7			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QY935	7748552	Bronze			2022-12-24	WOS:A1995QY93500017
J	CHAPMAN, PF; FRENGUELLI, BG; SMITH, A; CHEN, CM; SILVA, AJ				CHAPMAN, PF; FRENGUELLI, BG; SMITH, A; CHEN, CM; SILVA, AJ			THE ALPHA-CA2+/CALMODULIN KINASE-II - A BIDIRECTIONAL MODULATOR OF PRESYNAPTIC PLASTICITY	NEURON			English	Article							DEPENDENT PROTEIN-KINASE; LONG-TERM POTENTIATION; SQUID GIANT SYNAPSE; NEUROTRANSMITTER RELEASE; MUTANT MICE; CALMODULIN; TRANSMISSION; HIPPOCAMPUS; INDUCTION	The alpha-Ca2+/calmodulin kinase II(alpha CaMKII) is required for long-term potentiation in the CA1 region of the hippocampus. Here, we report that this kinase also has a crucial role in presynaptic plasticity. Paired-pulse facilitation is blunted in the CA1 region of mice heterozygous for a targeted mutation of alpha CaMKII, confirming that this kinase can promote neurotransmitter release. Unexpectedly, field and whole-cell recordings of posttetanic potentiation show that the synaptic responses of mutants are larger than those of controls, indicating that alpha CaMKII can also inhibit transmitter release immediately after tetanic stimulation. Thus, alpha CaMKII has the capacity either to potentiate or to depress excitatory synaptic transmission depending on the pattern of presynaptic activation.	UNIV MINNESOTA,DEPT PSYCHOL,GRAD PROGRAM NEUROSCI,MINNEAPOLIS,MN 55455	University of Minnesota System; University of Minnesota Twin Cities	CHAPMAN, PF (corresponding author), COLD SPRING HARBOR LAB,POB 100,COLD SPRING HARBOR,NY 11724, USA.		Silva, Alcino/ABD-7684-2021; Frenguelli, Bruno/C-5007-2015	Silva, Alcino/0000-0002-1587-4558; Frenguelli, Bruno/0000-0001-7214-3172; Silva, Alcino/0000-0001-5525-0494				BENFENATI F, 1992, NATURE, V359, P417, DOI 10.1038/359417a0; Byrne John H., 1993, V27, P47; DUNKLEY PR, 1991, MOL NEUROBIOL, V5, P179, DOI 10.1007/BF02935545; GLUCK MA, 1993, ANNU REV NEUROSCI, V16, P667, DOI 10.1146/annurev.ne.16.030193.003315; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; HACKETT JT, 1990, J NEUROPHYSIOL, V63, P701, DOI 10.1152/jn.1990.63.4.701; HALEY JE, 1992, NEURON, V8, P211, DOI 10.1016/0896-6273(92)90288-O; HANSON PI, 1992, ANNU REV BIOCHEM, V61, P559, DOI 10.1146/annurev.bi.61.070192.003015; HANSON PI, 1994, NEURON, V12, P943, DOI 10.1016/0896-6273(94)90306-9; HESS G, 1987, NEUROSCI LETT, V77, P187, DOI 10.1016/0304-3940(87)90584-2; LARSON J, 1986, SCIENCE, V232, P985, DOI 10.1126/science.3704635; LIN JW, 1990, P NATL ACAD SCI USA, V87, P8257, DOI 10.1073/pnas.87.21.8257; LLINAS R, 1985, P NATL ACAD SCI USA, V82, P3035, DOI 10.1073/pnas.82.9.3035; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MCNAUGHTON BL, 1982, J PHYSIOL-LONDON, V324, P249, DOI 10.1113/jphysiol.1982.sp014110; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; MULLER D, 1989, BRAIN RES, V479, P290, DOI 10.1016/0006-8993(89)91631-4; NICHOLS RA, 1990, NATURE, V343, P647, DOI 10.1038/343647a0; OTMAKHOV N, 1993, NEURON, V10, P1101, DOI 10.1016/0896-6273(93)90058-Y; Otto T, 1991, Hippocampus, V1, P181, DOI 10.1002/hipo.450010206; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; ROSAHL TW, 1993, CELL, V75, P661, DOI 10.1016/0092-8674(93)90487-B; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; STEVENS CF, 1994, CURR BIOL, V4, P687, DOI 10.1016/S0960-9822(00)00153-6; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	28	101	101	1	5	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1995	14	3					591	597		10.1016/0896-6273(95)90315-1	http://dx.doi.org/10.1016/0896-6273(95)90315-1			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QP230	7695905	Bronze			2022-12-24	WOS:A1995QP23000012
J	DAS, S; POTTER, H				DAS, S; POTTER, H			EXPRESSION OF THE ALZHEIMER AMYLOID-PROMOTING FACTOR ANTICHYMOTRYPSIN IS INDUCED IN HUMAN ASTROCYTES BY IL-1	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; HEPARAN-SULFATE PROTEOGLYCANS; ACUTE PHASE RESPONSE; BETA-PROTEIN; SENILE PLAQUES; PRECURSOR PROTEIN; APOLIPOPROTEIN-E; MESSENGER-RNA; INHIBITOR ALPHA-1-ANTICHYMOTRYPSIN; NEURITIC PLAQUES	The amyloid deposits of Alzheimer's disease contain, in addition to the beta protein (Ap), lesser amounts of other proteins including the protease inhibitor alpha-antichymotrypsin (ACT). We have recently shown that ACT acts as a pathological chaperone, binding to the beta protein and strongly promoting its polymerization into amyloid filaments in vitro. The data of this paper show that ACT synthesis is induced in cultured human astrocytes by IL-1, a lymphokine whose expression is strongly up-regulated in microglial cells in affected areas of Alzheimer's disease brain. Furthermore, unfractionated glial cultures containing both astrocytes and microglia from human cortex (which develops amyloid in Alzheimer's disease) spontaneously express IL-1 and ACT as they reach confluence. In contrast, confluent mixed glial cultures similarly prepared from human cerebellum or brain stem, or from rat brain tissues not prone to amyloid formation-do not express ACT unless supplemented with exogenous IL-1. The same regional difference in IL-1 expression by microglia is seen in vivo in Alzheimer's disease. These results indicate that the IL-1-induced expression of ACT may help direct the region-specific production of mature amyloid filaments in the Alzheimer brain.			DAS, S (corresponding author), HARVARD UNIV, SCH MED, DEPT NEUROBIOL, BOSTON, MA 02115 USA.		Das, Saumya/R-7644-2019	Das, Saumya/0000-0002-4521-4606				ABRAHAM CR, 1990, NEUROBIOL AGING, V11, P123, DOI 10.1016/0197-4580(90)90045-2; ABRAHAM CR, 1989, NEUROSCIENCE, V32, P715, DOI 10.1016/0306-4522(89)90292-3; ABRAHAM CR, 1988, CELL, V52, P487, DOI 10.1016/0092-8674(88)90462-X; ABRAHAM CR, 1989, BIO-TECHNOL, V7, P147, DOI 10.1038/nbt0289-147; ARAUJO DM, 1992, BRAIN RES, V569, P141, DOI 10.1016/0006-8993(92)90380-R; BAUMANN H, 1987, J IMMUNOL, V139, P4122; BAUMANN H, 1989, ANN NY ACAD SCI, V557, P280; BENOWITZ LI, 1989, EXP NEUROL, V106, P237, DOI 10.1016/0014-4886(89)90156-8; BIRECREE E, 1988, J NEUROPATH EXP NEUR, V47, P549, DOI 10.1097/00005072-198809000-00006; CACABELOS R, 1994, METHOD FIND EXP CLIN, V16, P141; CARD JP, 1988, NEURON, V1, P835, DOI 10.1016/0896-6273(88)90131-6; CATALDO AM, 1990, P NATL ACAD SCI USA, V87, P3861, DOI 10.1073/pnas.87.10.3861; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DAVIS KL, 1986, AM J PSYCHIAT, V143, P300; DUFFY PE, 1980, NEUROLOGY, V30, P778, DOI 10.1212/WNL.30.7.778; EIKELENBOOM P, 1989, VIRCHOWS ARCH B, V56, P259; ESIRI MM, 1984, J CLIN PATHOL, V37, P150, DOI 10.1136/jcp.37.2.150; FORLONI G, 1992, MOL BRAIN RES, V16, P128, DOI 10.1016/0169-328X(92)90202-M; GIACCONE G, 1989, NEUROSCI LETT, V97, P232, DOI 10.1016/0304-3940(89)90169-9; GIULIAN D, 1987, J NEUROSCI RES, V18, P155, DOI 10.1002/jnr.490180123; GIULIAN D, 1985, SCIENCE, V228, P497, DOI 10.1126/science.3872478; GLENNER GG, 1980, NEW ENGL J MED, V302, P1283, DOI 10.1056/NEJM198006053022305; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOLDGABER D, 1989, P NATL ACAD SCI USA, V86, P7606, DOI 10.1073/pnas.86.19.7606; GOLDGABER D, 1987, SCIENCE, V235, P877, DOI 10.1126/science.3810169; GRIFFIN WST, 1989, P NATL ACAD SCI USA, V86, P7611; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HIGGINS GA, 1988, P NATL ACAD SCI USA, V85, P1297, DOI 10.1073/pnas.85.4.1297; IKEDA S, 1969, LAB INVEST, V61, P133; ITAGAKI S, 1989, J NEUROIMMUNOL, V24, P173, DOI 10.1016/0165-5728(89)90115-X; JOACHIM CL, 1989, NATURE, V341, P226, DOI 10.1038/341226a0; JOACHIM CL, 1989, AM J PATHOL, V135, P309; JUSTICE DL, 1987, J CELL BIOCHEM, V34, P227, DOI 10.1002/jcb.240340402; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KOO EH, 1991, NEUROBIOL AGING, V12, P495, DOI 10.1016/0197-4580(91)90079-Y; LEE SHC, 1992, LAB INVEST, V67, P465; MA JY, 1994, NATURE, V372, P92, DOI 10.1038/372092a0; MANN DMA, 1985, NEUROPATHOL APPL NEU, V15, P317; MARTIGNONI E, 1990, ACTA NEUROL SCAND, V81, P452; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; MCGEER PL, 1993, GLIA, V7, P84, DOI 10.1002/glia.440070114; MERZ PA, 1983, ACTA NEUROPATHOL, V60, P113, DOI 10.1007/BF00685355; NAMBA Y, 1991, BRAIN RES, V541, P163, DOI 10.1016/0006-8993(91)91092-F; NELSON RB, 1990, J BIOL CHEM, V265, P3836; NELSON RB, 1993, J NEUROCHEM, V61, P567; NIETOSAMPEDRO M, 1988, SCIENCE, V240, P1784, DOI 10.1126/science.3289118; OTSUKA N, 1991, BRAIN RES, V568, P335, DOI 10.1016/0006-8993(91)91422-W; PALMERT MR, 1988, SCIENCE, V241, P1080, DOI 10.1126/science.2457949; PASTERNACK JM, 1989, AM J PATHOL, V135, P827; POTTER H, 1991, ALZHEIMERS DISEASE : BASIC MECHANISMS, DIAGNOSIS AND THERAPEUTIC STRATEGIES, P275; POTTER H, 1992, PROG BRAIN RES, V94, P447; PROBST A, 1987, ACTA NEUROPATHOL, V74, P133, DOI 10.1007/BF00692843; QUON D, 1991, NATURE, V352, P239, DOI 10.1038/352239a0; ROBAKIS NK, 1987, P NATL ACAD SCI USA, V84, P4190, DOI 10.1073/pnas.84.12.4190; ROZEMULLER JM, 1990, NEUROSCI LETT, V119, P75, DOI 10.1016/0304-3940(90)90759-3; ROZEMULLER JM, 1991, ACTA NEUROPATHOL, V82, P200, DOI 10.1007/BF00294446; SANAN DA, 1994, J CLIN INVEST, V94, P860, DOI 10.1172/JCI117407; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; SELKOE DJ, 1987, SCIENCE, V235, P873, DOI 10.1126/science.3544219; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; SHENG JG, 1994, IN PRESS J EXP NEURO; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; SIMAN R, 1989, NEURON, V3, P275, DOI 10.1016/0896-6273(89)90252-3; SNOW AD, 1989, J NEUROPATH EXP NEUR, V48, P352, DOI 10.1097/00005072-198905000-00160; SNOW AD, 1994, NEURON, V12, P219, DOI 10.1016/0896-6273(94)90165-1; SNOW AD, 1988, AM J PATHOL, V133, P456; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; STRUBLE RG, 1985, BRAIN RES, V361, P267, DOI 10.1016/0006-8993(85)91298-3; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; WIRAK DO, 1991, SCIENCE, V253, P323, DOI 10.1126/science.1857970; Wisniewski H M, 1973, Prog Brain Res, V40, P167; WISNIEWSKI T, 1994, AM J PATHOL, V145, P1030; WISNIEWSKI T, 1992, NEUROSCI LETT, V135, P235, DOI 10.1016/0304-3940(92)90444-C; WISNIEWSKI T, 1993, BIOCHEM BIOPH RES CO, V192, P359, DOI 10.1006/bbrc.1993.1423; YAMAGUCHI H, 1988, ACTA NEUROPATHOL, V77, P113; YANKNER BA, 1989, SCIENCE, V245, P417, DOI 10.1126/science.2474201; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531	77	144	148	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1995	14	2					447	456		10.1016/0896-6273(95)90300-3	http://dx.doi.org/10.1016/0896-6273(95)90300-3			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QH294	7857652	Bronze			2022-12-24	WOS:A1995QH29400022
J	TANG, CM; MARGULIS, M; SHI, QY; FIELDING, A				TANG, CM; MARGULIS, M; SHI, QY; FIELDING, A			SATURATION OF POSTSYNAPTIC GLUTAMATE RECEPTORS AFTER QUANTAL RELEASE OF TRANSMITTER	NEURON			English	Article							LONG-TERM POTENTIATION; RAT HIPPOCAMPAL SLICES; SYNAPTIC TRANSMISSION; DENDRITIC SPINES; TIME COURSE; NEURONS; DESENSITIZATION; SYNAPSES; VARIABILITY; AMPLITUDE	Miniature excitatory postsynaptic currents (mEPSCs) were elicited from small numbers of release sites after brief microperfusion of Ba2+ and K+ onto proximal dendritic processes of hippocampal neurons in culture. Temporal summation of closely timed mEPSCs deviated significantly from linearity. The number of instances of closely timed mEPSCs that were also closely matched in terms of peak amplitudes was significantly greater than that expected by chance. Amplitude pairing became statistically more significant after prolongation of mEPSC duration and inhibition of glutamate receptor desensitization with cyclothiazide. These results are best explained by postsynaptic receptors that approach saturation after quantal release of transmitter.	GRAD HOSP PHILADELPHIA,PHILADELPHIA,PA 19146	University of Pennsylvania; Pennsylvania Medicine	TANG, CM (corresponding author), UNIV MARYLAND,SCH MED,DEPT NEUROL,BALTIMORE,MD 21201, USA.				NINDS NIH HHS [R29 NS28158] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS028158] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BEKKERS JM, 1990, P NATL ACAD SCI USA, V87, P5359, DOI 10.1073/pnas.87.14.5359; BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; CLEMENTS J, 1991, NATURE, V353, P396, DOI 10.1038/353396a0; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; COHEN I, 1974, J PHYSIOL-LONDON, V236, P327, DOI 10.1113/jphysiol.1974.sp010437; EDWARDS F, 1991, NATURE, V350, P271, DOI 10.1038/350271a0; EDWARDS FA, 1990, J PHYSIOL-LONDON, V430, P213, DOI 10.1113/jphysiol.1990.sp018289; HARRIS KM, 1993, NEUROSCIENCE, V53, P495, DOI 10.1016/0306-4522(93)90214-Z; HARRIS KM, 1989, J NEUROSCI, V9, P2982; HARRIS KM, 1992, J NEUROSCI, V12, P2685; HESTRIN S, 1993, NEURON, V11, P1083, DOI 10.1016/0896-6273(93)90221-C; HUETTNER JE, 1990, NEURON, V5, P255, DOI 10.1016/0896-6273(90)90163-A; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; KULLMANN DM, 1992, NATURE, V357, P240, DOI 10.1038/357240a0; LARKMAN A, 1991, NATURE, V350, P344, DOI 10.1038/350344a0; LIAO D, 1992, NEURON, V9, P1089, DOI 10.1016/0896-6273(92)90068-O; LISMAN JE, 1993, TRENDS NEUROSCI, V16, P141, DOI 10.1016/0166-2236(93)90122-3; MENNERICK S, 1994, NATURE, V368, P59, DOI 10.1038/368059a0; PATNEAU DK, 1993, J NEUROSCI, V13, P3496; QUASTEL DMJ, 1988, J PHYSIOL-LONDON, V406, P55, DOI 10.1113/jphysiol.1988.sp017368; RAASTAD M, 1992, EUR J NEUROSCI, V4, P113, DOI 10.1111/j.1460-9568.1992.tb00114.x; RAHAMIMOFF R, 1973, J PHYSIOL-LONDON, V228, P241, DOI 10.1113/jphysiol.1973.sp010084; RASGADOFLORES H, 1987, AM J PHYSIOL, V252, P604; REDMAN S, 1990, PHYSIOL REV, V70, P165, DOI 10.1152/physrev.1990.70.1.165; SILINSKY EM, 1978, J PHYSIOL-LONDON, V274, P157, DOI 10.1113/jphysiol.1978.sp012141; STEVENS CF, 1993, CELL, V72, P55, DOI 10.1016/S0092-8674(05)80028-5; STEVENS CF, 1972, BIOPHYS J, V12, P1028, DOI 10.1016/S0006-3495(72)86141-1; TANG CM, 1991, SCIENCE, V254, P288, DOI 10.1126/science.1681589; TONG G, 1994, NEURON, V12, P51, DOI 10.1016/0896-6273(94)90151-1; TRUSSELL LO, 1993, NEURON, V10, P1185, DOI 10.1016/0896-6273(93)90066-Z; USHERWOOD PN, 1972, J PHYSIOL-LONDON, V227, P527, DOI 10.1113/jphysiol.1972.sp010046; YAMADA KA, 1993, J NEUROSCI, V13, P3904; ZHANG JF, 1993, NEUROPHARMACOLOGY, V32, P1075, DOI 10.1016/0028-3908(93)90003-L	34	97	97	0	3	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1994	13	6					1385	1393		10.1016/0896-6273(94)90423-5	http://dx.doi.org/10.1016/0896-6273(94)90423-5			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PZ689	7993629				2022-12-24	WOS:A1994PZ68900012
J	RANGANATHAN, R; BACSKAI, BJ; TSIEN, RY; ZUKER, CS				RANGANATHAN, R; BACSKAI, BJ; TSIEN, RY; ZUKER, CS			CYTOSOLIC CALCIUM TRANSIENTS - SPATIAL LOCALIZATION AND ROLE IN DROSOPHILA PHOTORECEPTOR CELL-FUNCTION	NEURON			English	Article							LIMULUS VENTRAL PHOTORECEPTORS; PROTEIN-KINASE-C; INTRACELLULAR CALCIUM; EXTRACELLULAR CALCIUM; TRANSMITTER RELEASE; GENETIC DISSECTION; DENDRITIC SPINES; LIGHT ADAPTATION; VISUAL-SYSTEM; ARSENAZO-III	Drosophila phototransduction is a phosphoinositide-mediated and Ca2+-regulated signaling cascade ideal for the dissection of feedback regulatory mechanisms. To study the roles of intracellular Ca2+ ([Ca2+](i)) in this process, we developed novel techniques for the measurement of [Ca2+](i) in intact photoreceptors. We genetically engineered flies that express a UV-specific rhodopsin in place of the normal rhodopsin, so that long wavelength light can be used to image [Ca2+](i) changes while minimally exciting the photoreceptor cells. We show that activation with UV generates [Ca2+](i) increases that are spatially localized to the rhabdomeres and that are entirely dependent on the influx of extracellular Ca2+. Application of intracellular Ca2+ chelators of varying affinities demonstrates that the Ca2+ influx initially generates a large-amplitude transient that is crucial for negative regulation. Internal Ca2+ stores were revealed by discharging them with thapsigargin. But, in contrast to proposals that IP3-sensitive stores mediate phototransduction, thapsigargin does not mimic or acutely interfere with photoexcitation. Finally, we identify a photoreceptor-specific PKC as essential for normal kinetics of [Ca2+](i) recovery.	UNIV CALIF SAN DIEGO,DEPT BIOL,LA JOLLA,CA 92093; UNIV CALIF SAN DIEGO,DEPT NEUROSCI,LA JOLLA,CA 92093; UNIV CALIF SAN DIEGO,DEPT PHARMACOL,LA JOLLA,CA 92093; UNIV CALIF SAN DIEGO,HOWARD HUGHES MED INST,LA JOLLA,CA 92093	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego			Bacskai, Brian/AAE-9583-2021					ADAMS SR, 1988, J AM CHEM SOC, V110, P3212, DOI 10.1021/ja00218a034; Augustine G J, 1992, Curr Opin Neurobiol, V2, P302, DOI 10.1016/0959-4388(92)90119-6; AUGUSTINE GJ, 1992, J PHYSIOL-LONDON, V450, P247, DOI 10.1113/jphysiol.1992.sp019126; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; BRITT SG, 1993, NEURON, V11, P29, DOI 10.1016/0896-6273(93)90268-V; BROWN JE, 1977, J PHYSIOL-LONDON, V267, P299, DOI 10.1113/jphysiol.1977.sp011814; BROWN JE, 1974, J GEN PHYSIOL, V64, P643, DOI 10.1085/jgp.64.6.643; BROWN JE, 1986, MOL MECHANISM PHOTOR, P231; BRUNDAGE RA, 1993, AM J PHYSIOL, V265, pC1527, DOI 10.1152/ajpcell.1993.265.6.C1527; CHAD JE, 1984, BIOPHYS J, V45, P993, DOI 10.1016/S0006-3495(84)84244-7; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; DOLPH PJ, 1993, SCIENCE, V260, P1910, DOI 10.1126/science.8316831; FEILER R, 1992, J NEUROSCI, V12, P3862; FEILER R, 1988, NATURE, V333, P737, DOI 10.1038/333737a0; FOGELSON AL, 1985, BIOPHYS J, V48, P1003, DOI 10.1016/S0006-3495(85)83863-7; FRANCESCHINI N, 1979, INVEST OPHTH VIS SCI, P5; GUTHRIE PB, 1991, NATURE, V354, P76, DOI 10.1038/354076a0; HARDIE RC, 1991, P ROY SOC B-BIOL SCI, V245, P203, DOI 10.1098/rspb.1991.0110; HARDIE RC, 1993, TRENDS NEUROSCI, V16, P371, DOI 10.1016/0166-2236(93)90095-4; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; HARDIE RC, 1983, PROGR SENSORY PHYSL; HERNANDEZCRUZ A, 1990, SCIENCE, V247, P858, DOI 10.1126/science.2154851; HOTTA Y, 1970, P NATL ACAD SCI USA, V67, P1156, DOI 10.1073/pnas.67.3.1156; IRVING H, 1963, J CHEM SOC, P3308, DOI 10.1039/jr9630003308; KARESS RE, 1984, CELL, V38, P135, DOI 10.1016/0092-8674(84)90534-8; LAGNADO L, 1990, J MEMBRANE BIOL, V113, P177, DOI 10.1007/BF01870070; LEE YJ, 1990, NEURON, V5, P889, DOI 10.1016/0896-6273(90)90349-K; LEVY S, 1985, J GEN PHYSIOL, V85, P805, DOI 10.1085/jgp.85.6.805; LEVY S, 1993, J GEN PHYSIOL, V101, P67, DOI 10.1085/jgp.101.1.67; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; MEYER T, 1991, CELL, V64, P675, DOI 10.1016/0092-8674(91)90496-L; MINKE B, 1991, PROG RET RES, P11; MULLER W, 1991, NATURE, V354, P73, DOI 10.1038/354073a0; NAGY K, 1983, BIOPHYS STRUCT MECH, V9, P207, DOI 10.1007/BF00537817; NOWYCKY MC, 1993, BIOPHYS J, V64, P77, DOI 10.1016/S0006-3495(93)81342-0; ODAY PM, 1989, J GEN PHYSIOL, V93, P473, DOI 10.1085/jgp.93.3.473; OTOUSA JE, 1985, CELL, V40, P839, DOI 10.1016/0092-8674(85)90343-5; PAK WL, 1970, NATURE, V227, P518, DOI 10.1038/227518b0; PAYNE R, 1987, J CELL BIOL, V104, P933, DOI 10.1083/jcb.104.4.933; PERETZ A, 1994, NEURON, V12, P1257, DOI 10.1016/0896-6273(94)90442-1; PUTNEY JW, 1993, CELL, V75, P199, DOI 10.1016/0092-8674(93)80061-I; RANGANATHAN R, 1991, NATURE, V354, P230, DOI 10.1038/354230a0; RANGANATHAN R, 1994, IN PRESS ANN REV NEU; RATTO GM, 1988, J NEUROSCI, V8, P3240; REHDER V, 1992, J NEUROSCI, V12, P3175, DOI 10.1523/JNEUROSCI.12-08-03175.1992; SANDLER C, 1991, J COMP PHYSIOL A, V169, P299; SCHAEFFER E, 1989, CELL, V57, P403, DOI 10.1016/0092-8674(89)90915-X; SIMON SM, 1985, BIOPHYS J, V48, P485, DOI 10.1016/S0006-3495(85)83804-2; SMITH DP, 1991, SCIENCE, V254, P1478, DOI 10.1126/science.1962207; SMITH DP, 1991, ANNU REV CELL BIOL, V7, P161; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; THOMAS P, 1990, NEURON, V5, P723, DOI 10.1016/0896-6273(90)90226-6; TSIEN RW, 1990, ANNU REV CELL BIOL, V6, P715, DOI 10.1146/annurev.cb.06.110190.003435; TSIEN RY, 1989, ANNU REV NEUROSCI, V12, P227, DOI 10.1146/annurev.neuro.12.1.227; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; TSIEN RY, 1994, IN PRESS HDB BIOL CO; WALZ B, 1994, J COMP PHYSIOL A, V174, P421, DOI 10.1007/BF00191708; WALZ B, 1992, J COMP PHYSL, V1, P605; ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0; Zuker Charles S., 1992, Current Opinion in Neurobiology, V2, P622, DOI 10.1016/0959-4388(92)90029-K; ZUKER CS, 1985, CELL, V40, P851, DOI 10.1016/0092-8674(85)90344-7	63	123	124	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1994	13	4					837	848		10.1016/0896-6273(94)90250-X	http://dx.doi.org/10.1016/0896-6273(94)90250-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PP533	7946332				2022-12-24	WOS:A1994PP53300007
J	SATO, M; LOPEZMASCARAQUE, L; HEFFNER, CD; OLEARY, DDM				SATO, M; LOPEZMASCARAQUE, L; HEFFNER, CD; OLEARY, DDM			ACTION OF A DIFFUSIBLE TARGET-DERIVED CHEMOATTRACTANT ON CORTICAL AXON BRANCH INDUCTION AND DIRECTED GROWTH	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; NEURONS; GUIDANCE; PROJECTIONS; COLLATERALS; CHEMOTAXIS; COLLAPSE; PROTEIN; FIBERS; CELLS	Cortical axons innervate their brainstem target, the basilar pens, by the initiation and extension of collateral branches interstitially along their length. To address whether a diffusible pens-derived chemoattractant controls these events, we used cocultures in collagen matrices and time-lapse microscopy. Pontine explants enhanced by 5-fold the de novo initiation of transient branches along cortical axons; most branches were directed toward pens. Of the branches extended toward pens, 2%-3% were stabilized; those extended away were not. Pontine explants also enhanced the stable bifurcation of growth cones and prompted directional changes by growth cone turning and collateral extension. These effects were distance dependent and mimicked by pens-conditioned medium. This evidence indicates that the pens activity promotes branch initiation interstitially along cortical axons, a novel property for a chemoattractant, and provides a directional cue for their growth. These findings suggest that the pens chemoattractant serves as a diffusible target-recognition molecule.	SALK INST BIOL STUDIES,MOLEC NEUROBIOL LAB,LA JOLLA,CA 92037	Salk Institute			Lopez-Mascaraque, Laura/M-2448-2014	Lopez-Mascaraque, Laura/0000-0002-7154-5687				Cajal S. R., 1952, HISTOLOGIE SYSTEME N; Cussler E. L., 1984, DIFFUSION MASS TRANS; DAVIES AM, 1987, NATURE, V326, P353, DOI 10.1038/326353a0; DEVREOTES PN, 1988, ANNU REV CELL BIOL, V4, P649, DOI 10.1146/annurev.cb.04.110188.003245; DODD J, 1988, SCIENCE, V242, P692, DOI 10.1126/science.3055291; ENDO K, 1973, BRAIN RES, V57, P484, DOI 10.1016/0006-8993(73)90154-6; GODEMENT P, 1987, DEVELOPMENT, V101, P697; GUNDERSEN RW, 1979, SCIENCE, V206, P1079, DOI 10.1126/science.493992; GUNDERSEN RW, 1980, J CELL BIOL, V87, P546, DOI 10.1083/jcb.87.3.546; HEFFNER CD, 1990, SCIENCE, V247, P217, DOI 10.1126/science.2294603; HONIG MG, 1986, J CELL BIOL, V103, P171, DOI 10.1083/jcb.103.1.171; HONIG MG, 1989, TRENDS NEUROSCI, V12, P333, DOI 10.1016/0166-2236(89)90040-4; ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E; Jones E. G., 1984, CELLULAR COMPONENTS, P521; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; LUMSDEN AGS, 1986, NATURE, V323, P538, DOI 10.1038/323538a0; LUMSDEN AGS, 1983, NATURE, V306, P786, DOI 10.1038/306786a0; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; MEAKIN SO, 1992, TRENDS NEUROSCI, V15, P323, DOI 10.1016/0166-2236(92)90047-C; OLEARY DDM, 1993, NEURON, V10, P991, DOI 10.1016/0896-6273(93)90049-W; OLEARY DDM, 1988, NEURON, V1, P901, DOI 10.1016/0896-6273(88)90147-X; OLEARY DDM, 1985, BRAIN RES, V336, P326, DOI 10.1016/0006-8993(85)90661-4; PINI A, 1993, SCIENCE, V261, P95, DOI 10.1126/science.8316861; PLACZEK M, 1990, DEVELOPMENT, V110, P1930; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; STANFIELD BB, 1988, EXP BRAIN RES, V72, P185, DOI 10.1007/BF00248514; STANFIELD BB, 1987, J NEUROSCI, V7, P3350, DOI 10.1523/jneurosci.07-10-03350.1987; TESSIERLAVIGNE M, 1991, TRENDS NEUROSCI, V14, P303, DOI 10.1016/0166-2236(91)90142-H; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; UGOLINI G, 1986, BRAIN RES, V365, P211, DOI 10.1016/0006-8993(86)91632-X; WALTER J, 1990, TRENDS NEUROSCI, V13, P447, DOI 10.1016/0166-2236(90)90097-T; WIESENDANGER R, 1982, J COMP NEUROL, V208, P215, DOI 10.1002/cne.902080302	32	77	77	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1994	13	4					791	803		10.1016/0896-6273(94)90246-1	http://dx.doi.org/10.1016/0896-6273(94)90246-1			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PP533	7946329				2022-12-24	WOS:A1994PP53300003
J	ROTHSTEIN, JD; MARTIN, L; LEVEY, AI; DYKESHOBERG, M; JIN, L; WU, D; NASH, N; KUNCL, RW				ROTHSTEIN, JD; MARTIN, L; LEVEY, AI; DYKESHOBERG, M; JIN, L; WU, D; NASH, N; KUNCL, RW			LOCALIZATION OF NEURONAL AND GLIAL GLUTAMATE TRANSPORTERS	NEURON			English	Article							RAT-BRAIN; RECEPTOR SUBUNITS; PATHWAYS; NEUROTRANSMITTERS; NEUROTOXICITY; ASTROCYTES; PLASTICITY; EXPRESSION; INHIBITION; SODIUM	The cellular and subcellular distributions of the glutamate transporter subtypes EAAC1, GLT-1, and GLAST in the rat CNS were demonstrated using anti-peptide antibodies that recognize the C-terminal domains of each transporter. On immunoblots, the antibodies specifically recognize proteins of 65-73 kDa in total brain homogenates, Immunocytochemistry shows that glutamate transporter subtypes are distributed differentially within neurons and astroglia. EAAC1 is specific for certain neurons, such as large pyramidal cortical neurons and Purkinje cells, but does not appear to be selective for glutamatergic neurons. GLT-1 is localized only to astroglia. GLAST is found in both neurons and astroglia. The regional localizations are unique to each transporter subtype. EAAC1 is highly enriched in the cortex, hippocampus, and caudate-putamen and is confined to pre- and postsynaptic elements. GLT-1 is distributed in astrocytes throughout the brain and spinal cord. CLAST is most abundant in Bergmann glia in the cerebellar molecular layer brain, but is also present in the cortex, hippocampus, and deep cerebellar nuclei.	JOHNS HOPKINS UNIV,DEPT NEUROSCI,BALTIMORE,MD 21287; JOHNS HOPKINS UNIV,DEPT PATHOL,BALTIMORE,MD 21287; JOHNS HOPKINS UNIV,GRAD PROGRAM CELLULAR & MOLEC BIOL,BALTIMORE,MD 21287; EMORY UNIV,SCH MED,DEPT NEUROL,ATLANTA,GA 30322; SCIOS NOVA,BALTIMORE,MD 21224	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Emory University; Scios	ROTHSTEIN, JD (corresponding author), JOHNS HOPKINS UNIV,DEPT NEUROL,BALTIMORE,MD 21287, USA.		Levey, Allan/F-2104-2011; rothstein, jeffrey d/C-9470-2013	Levey, Allan/0000-0002-3153-502X; 	NIA NIH HHS [NIA AG 07914] Funding Source: Medline; NINDS NIH HHS [NINDS K08NS01355, NINDS NS30086] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS001355, R01NS030086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R35AG007914] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BLACKSTONE CD, 1992, J NEUROCHEM, V58, P1118, DOI 10.1111/j.1471-4159.1992.tb09370.x; CHANPALAY V, 1982, EXP BRAIN RES S, V6, P554; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.ne.13.030190.001131; COTMAN CW, 1987, TRENDS NEUROSCI, V10, P273, DOI 10.1016/0166-2236(87)90172-X; DANBOLT NC, 1992, NEUROSCIENCE, V51, P295, DOI 10.1016/0306-4522(92)90316-T; FAGG GE, 1983, NEUROSCIENCE, V9, P701, DOI 10.1016/0306-4522(83)90263-4; HERTZ L, 1979, PROG NEUROBIOL, V13, P277, DOI 10.1016/0301-0082(79)90018-2; Iversen L. L., 1975, HDB PSYCHOPHARMACOLO, V2, P381; KANAI Y, 1993, FASEB J, V7, P1450, DOI 10.1096/fasebj.7.15.7903261; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; KANNER BI, 1987, CRIT REV BIOCHEM MOL, V22, P1, DOI 10.3109/10409238709082546; KRNJEVIC K, 1982, EXPL BRAIN RES S, V6, P533; KUHAR MJ, 1973, LIFE SCI, V13, P1623, DOI 10.1016/0024-3205(73)90110-0; LEVY LM, 1993, FEBS LETT, V317, P79, DOI 10.1016/0014-5793(93)81495-L; MARTIN LJ, 1993, J NEUROSCI, V13, P782; MARTIN LJ, 1993, NEUROSCIENCE, V53, P327, DOI 10.1016/0306-4522(93)90199-P; MARTIN LJ, 1992, NEURON, V9, P259, DOI 10.1016/0896-6273(92)90165-A; MCBEAN GJ, 1985, J NEUROCHEM, V44, P247, DOI 10.1111/j.1471-4159.1985.tb07137.x; MULLER CM, 1992, INT REV NEUROBIOL, V34, P215, DOI 10.1016/S0074-7742(08)60099-9; MULLER CM, 1989, NATURE, V342, P427, DOI 10.1038/342427a0; NICHOLLS D, 1990, TRENDS PHARMACOL SCI, V11, P462, DOI 10.1016/0165-6147(90)90129-V; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; ROBINSON MB, 1993, J NEUROCHEM, V60, P167, DOI 10.1111/j.1471-4159.1993.tb05835.x; ROBINSON MB, 1991, BRAIN RES, V544, P196, DOI 10.1016/0006-8993(91)90054-Y; ROBINSON MB, 1993, J NEUROCHEM, V61, P2099, DOI 10.1111/j.1471-4159.1993.tb07447.x; ROTHSTEIN JD, 1993, P NATL ACAD SCI USA, V90, P6591, DOI 10.1073/pnas.90.14.6591; ROTHSTEIN JD, 1992, NEW ENGL J MED, V326, P1464, DOI 10.1056/NEJM199205283262204; STORCK T, 1992, P NATL ACAD SCI USA, V89, P10955, DOI 10.1073/pnas.89.22.10955	28	1423	1448	0	40	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1994	13	3					713	725		10.1016/0896-6273(94)90038-8	http://dx.doi.org/10.1016/0896-6273(94)90038-8			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PJ284	7917301	hybrid			2022-12-24	WOS:A1994PJ28400018
J	SALZBERG, A; DEVELYN, D; SCHULZE, KL; LEE, JK; STRUMPF, D; TSAI, L; BELLEN, HJ				SALZBERG, A; DEVELYN, D; SCHULZE, KL; LEE, JK; STRUMPF, D; TSAI, L; BELLEN, HJ			MUTATIONS AFFECTING THE PATTERN OF THE PNS IN DROSOPHILA REVEAL NOVEL ASPECTS OF NEURONAL DEVELOPMENT	NEURON			English	Article							PERIPHERAL NERVOUS-SYSTEM; SCUTE GENE-COMPLEX; SENSORY ORGAN DEVELOPMENT; LOOP-HELIX PROTEINS; CELL FATES; SHOWS HOMOLOGY; CYCLIN-A; MELANOGASTER; ACHAETE; EXPRESSION	Through a systematic genetic screen, we have identified 55 mutations that affect the development of the PNS of Drosophila embryos. These mutations specify 13 novel and 5 previously characterized genes and define new phenotypes for 2 other known genes. Five classes of mutant phenotypes were identified in the screen: gain of neurons, loss of neurons, abnormal position of chordotonal neurons, aberrant neuronal trajectories, and abnormal morphology of neurons. Phenotypic analyses of mutations identified in this study revealed three novel aspects of PNS development. First, we have identified a novel gene that may be required to define glial versus neuronal cell identity. Second, our data indicate that neuronal migration plays an important role in pattern formation in the embryonic PNS. Third, we have identified mutations that cause a lack of sensory organs, but unlike mutations in proneural genes, do not affect the formation of sensory organ precursors. These genes may be required for key aspects of neuronal differentiation. Our studies suggest that approximately 70 essential genes are required for proper PNS development in Drosophila embryos.	BAYLOR COLL MED,DIV NEUROSCI,HOUSTON,TX 77030	Baylor College of Medicine	SALZBERG, A (corresponding author), BAYLOR COLL MED,HOWARD HUGHES MED INST,DEPT HUMAN MOLEC GENET,HOUSTON,TX 77030, USA.		Salzberg, Adi/A-9986-2014; Salzberg, Adi/O-1198-2019	Salzberg, Adi/0000-0002-0427-9809; Salzberg, Adi/0000-0002-0427-9809; Bellen, Hugo/0000-0001-5992-5989; Tsai, Linus/0000-0002-0134-6949				ALTON AK, 1988, GENETICS, V118, P235; ARTAVANISTSAKONAS S, 1991, TRENDS GENET, V7, P403, DOI 10.1016/0168-9525(91)90264-Q; ASHBURNER M, 1991, DROS INF SER, V69, P1; BANG AG, 1992, GENE DEV, V6, P1752, DOI 10.1101/gad.6.9.1752; BELLEN HJ, 1992, GENE DEV, V6, P2125, DOI 10.1101/gad.6.11.2125; BELLEN HJ, 1989, GENE DEV, V3, P1288, DOI 10.1101/gad.3.9.1288; BIER E, 1989, GENE DEV, V3, P1273, DOI 10.1101/gad.3.9.1273; BIER E, 1990, GENE DEV, V4, P190, DOI 10.1101/gad.4.2.190; BIER E, 1992, GENE DEV, V6, P2137, DOI 10.1101/gad.6.11.2137; BLOCHLINGER K, 1990, GENE DEV, V4, P1322, DOI 10.1101/gad.4.8.1322; BLOCHLINGER K, 1991, GENE DEV, V5, P1124, DOI 10.1101/gad.5.7.1124; BLOCHLINGER K, 1988, NATURE, V333, P629, DOI 10.1038/333629a0; BODMER R, 1987, CELL, V51, P293, DOI 10.1016/0092-8674(87)90156-5; BODMER R, 1989, NEURON, V3, P21, DOI 10.1016/0896-6273(89)90112-8; BOULIANNE GL, 1991, EMBO J, V10, P2975, DOI 10.1002/j.1460-2075.1991.tb07848.x; BRAND M, 1993, DEVELOPMENT, V119, P1; CABRERA CV, 1987, CELL, V50, P425, DOI 10.1016/0092-8674(87)90496-X; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; CAMPOSORTEGA JA, 1988, TRENDS NEUROSCI, V11, P400, DOI 10.1016/0166-2236(88)90077-X; CAMPUZANO S, 1985, CELL, V40, P327, DOI 10.1016/0092-8674(85)90147-3; CAMPUZANO S, 1992, TRENDS GENET, V8, P202, DOI 10.1016/0168-9525(92)90234-U; CAUDY M, 1988, CELL, V55, P1061, DOI 10.1016/0092-8674(88)90250-4; CUBAS P, 1991, GENE DEV, V5, P996, DOI 10.1101/gad.5.6.996; DAMBLYCHAUDIERE C, 1992, CELL, V69, P159, DOI 10.1016/0092-8674(92)90127-X; DAMBLYCHAUDIERE C, 1987, GENE DEV, V1, P297, DOI 10.1101/gad.1.3.297; DELIDAKIS C, 1992, P NATL ACAD SCI USA, V89, P8731, DOI 10.1073/pnas.89.18.8731; DOE CQ, 1991, CELL, V65, P451, DOI 10.1016/0092-8674(91)90463-9; FUJITA SC, 1982, P NATL ACAD SCI-BIOL, V79, P7929, DOI 10.1073/pnas.79.24.7929; GARRELL J, 1990, CELL, V61, P39, DOI 10.1016/0092-8674(90)90213-X; GHYSEN A, 1988, GENE DEV, V2, P495, DOI 10.1101/gad.2.5.495; GHYSEN A, 1989, TRENDS GENET, V5, P251, DOI 10.1016/0168-9525(89)90097-8; GHYSEN A, 1986, ROUX ARCH DEV BIOL, V195, P281, DOI 10.1007/BF00376060; GHYSEN A, 1993, GENE DEV, V7, P723, DOI 10.1101/gad.7.5.723; GHYSEN A, 1989, DEVELOPMENT, V105, P35; GINIGER E, 1993, DEVELOPMENT, V117, P431; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; GOODMAN CS, 1984, SCIENCE, V225, P1271, DOI 10.1126/science.6474176; GORIELY A, 1991, DEVELOPMENT, V113, P1395; HARRISON SD, 1990, EMBO J, V9, P207, DOI 10.1002/j.1460-2075.1990.tb08097.x; HARTENSTEIN V, 1988, DEVELOPMENT, V102, P869; HARTENSTEIN V, 1987, ROUX ARCH DEV BIOL, V196, P101, DOI 10.1007/BF00402031; HEUER JG, 1992, DEVELOPMENT, V115, P35; HIGASHIJIMA S, 1992, GENE DEV, V6, P1005, DOI 10.1101/gad.6.6.1005; INGHAM PW, 1991, NATURE, V353, P184, DOI 10.1038/353184a0; JAN LY, 1993, DEV DROSOPHILA MELAN, P1207; JARMAN AP, 1993, CELL, V73, P1307, DOI 10.1016/0092-8674(93)90358-W; JIMENEZ F, 1993, CURR OPIN GENET DEV, V3, P626, DOI 10.1016/0959-437X(93)90099-B; JURGENS G, 1984, ROUX ARCH DEV BIOL, V193, P283, DOI 10.1007/BF00848157; KANIA A, 1993, NEURON, V11, P673, DOI 10.1016/0896-6273(93)90078-6; KLAMBT C, 1989, EMBO J, V8, P203, DOI 10.1002/j.1460-2075.1989.tb03365.x; KNUST E, 1992, GENETICS, V132, P505; LEHNER CF, 1989, CELL, V56, P957, DOI 10.1016/0092-8674(89)90629-6; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; LEWIS EB, 1968, DROSOPHILA INFORM SE, V43, P193; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; NOTTEBOHM E, 1994, NEURON, V12, P25, DOI 10.1016/0896-6273(94)90149-X; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; PATEL NH, 1989, GENE DEV, V3, P890, DOI 10.1101/gad.3.6.890; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; ROMANI S, 1989, GENE DEV, V3, P997, DOI 10.1101/gad.3.7.997; RUSHLOW CA, 1989, EMBO J, V8, P3095, DOI 10.1002/j.1460-2075.1989.tb08461.x; SCHWEISGUTH F, 1992, CELL, V69, P1199, DOI 10.1016/0092-8674(92)90641-O; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; UEDA R, 1992, EMBO J, V11, P2935, DOI 10.1002/j.1460-2075.1992.tb05363.x; UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0; VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; VILLARES R, 1987, CELL, V50, P415, DOI 10.1016/0092-8674(87)90495-8; XIONG WC, 1993, GENE DEV, V7, P1085, DOI 10.1101/gad.7.6.1085; YOUNOSSIHARTENSTEIN A, 1993, DEV BIOL, V158, P430, DOI 10.1006/dbio.1993.1201	70	126	126	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1994	13	2					269	287		10.1016/0896-6273(94)90346-8	http://dx.doi.org/10.1016/0896-6273(94)90346-8			19	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PD430	8060613				2022-12-24	WOS:A1994PD43000002
J	HANSON, PI; MEYER, T; STRYER, L; SCHULMAN, H				HANSON, PI; MEYER, T; STRYER, L; SCHULMAN, H			DUAL ROLE OF CALMODULIN IN AUTOPHOSPHORYLATION OF MULTIFUNCTIONAL CAM KINASE MAY UNDERLIE DECODING OF CALCIUM SIGNALS	NEURON			English	Article							DEPENDENT PROTEIN-KINASE; CA-2+ CALMODULIN; POSTSYNAPTIC DENSITY; HIPPOCAMPAL SLICES; PEPTIDE COMPLEX; PC12 CELLS; MECHANISM; EXPRESSION; ACTIVATION; BINDING	Autophosphorylation of multifunctional Ca2+/calmodulin-dependent protein kinase makes it Ca2+ independent by trapping bound calmodulin and by enabling the kinase to remain partially active even after calmodulin dissociates. We show that autophosphorylation is an intersubunit reaction between neighbors in the multimeric kinase which requires two molecules of calmodulin. Ca2+/calmodulin acts not only to activate the ''kinase'' subunit but also to present effectively the ''substrate'' subunit for autophosphorylation. Conversion of the kinase to the potentiated or trapped state is a cooperative process that is inefficient at low occupancy of calmodulin. Simulations show that repetitive Ca2+ pulses at limiting calmodulin lead to the recruitment of calmodulin to the holoenzyme, which further stimulates autophosphorylation and trapping. This cooperative, positive feedback loop will potentiate the response of the kinase to sequential Ca2+ transients and establish a threshold frequency at which the enzyme becomes highly active.	STANFORD UNIV,SCH MED,DEPT NEUROBIOL,STANFORD,CA 94305	Stanford University			Hanson, Phyllis/E-9420-2012	Meyer, Tobias/0000-0003-4339-3804	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024032, R01GM030179, R37GM024032, R37GM030179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH045324] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM30179, GM24032] Funding Source: Medline; NIMH NIH HHS [MH45324] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BERRIDGE MJ, 1990, J BIOL CHEM, V265, P9583; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Colbran R J, 1990, Curr Top Cell Regul, V31, P181; CRUZALEGUI FH, 1992, P NATL ACAD SCI USA, V89, P12127, DOI 10.1073/pnas.89.24.12127; DUPONT G, 1992, BIOESSAYS, V14, P485, DOI 10.1002/bies.950140711; Estep R P, 1990, Curr Top Cell Regul, V31, P161; FIELD J, 1988, MOL CELL BIOL, V8, P2159, DOI 10.1128/MCB.8.5.2159; FONG YL, 1989, J BIOL CHEM, V264, P16759; FUKUNAGA K, 1993, J BIOL CHEM, V268, P7863; FUKUNAGA K, 1989, J BIOL CHEM, V264, P21830; GOUGH AH, 1993, J CELL BIOL, V121, P1095, DOI 10.1083/jcb.121.5.1095; HANSON PI, 1992, ANNU REV BIOCHEM, V61, P559, DOI 10.1146/annurev.bi.61.070192.003015; HANSON PI, 1992, J BIOL CHEM, V267, P17216; HANSON PI, 1989, NEURON, V3, P59, DOI 10.1016/0896-6273(89)90115-3; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; IP NY, 1984, NATURE, V311, P472, DOI 10.1038/311472a0; KANASEKI T, 1991, J CELL BIOL, V115, P1049, DOI 10.1083/jcb.115.4.1049; KLEE CB, 1991, NEUROCHEM RES, V16, P1059, DOI 10.1007/BF00965851; KURET J, 1984, BIOCHEMISTRY-US, V23, P5495, DOI 10.1021/bi00318a018; KURET J, 1985, J BIOL CHEM, V260, P6427; LAI Y, 1986, P NATL ACAD SCI USA, V83, P4253, DOI 10.1073/pnas.83.12.4253; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; LISMAN JE, 1985, P NATL ACAD SCI USA, V82, P3055, DOI 10.1073/pnas.82.9.3055; LISMAN JE, 1988, P NATL ACAD SCI USA, V85, P5320, DOI 10.1073/pnas.85.14.5320; LOU LL, 1986, P NATL ACAD SCI USA, V83, P9497, DOI 10.1073/pnas.83.24.9497; LOU LL, 1989, J NEUROSCI, V9, P2020; MACNICOL M, 1992, FEBS LETT, V304, P237, DOI 10.1016/0014-5793(92)80627-S; MACNICOL M, 1990, J BIOL CHEM, V265, P18055; MACNICOL M, 1992, J BIOL CHEM, V267, P12197; MARTIN RG, 1961, J BIOL CHEM, V236, P1372; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; MEYER T, 1990, P NATL ACAD SCI USA, V87, P3841, DOI 10.1073/pnas.87.10.3841; MEYER T, 1991, ANNU REV BIOPHYS BIO, V20, P153, DOI 10.1146/annurev.bb.20.060191.001101; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; MILLER SG, 1985, J BIOL CHEM, V260, P9039; MOLLOY SS, 1991, P NATL ACAD SCI USA, V88, P4756, DOI 10.1073/pnas.88.11.4756; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; OCORR KA, 1991, NEURON, V6, P907, DOI 10.1016/0896-6273(91)90231-N; PATTON BL, 1990, J BIOL CHEM, V265, P11204; SCHOLZ WK, 1988, J NEUROSCI, V8, P1039; SCHULMAN H, 1992, CELL CALCIUM, V13, P401, DOI 10.1016/0143-4160(92)90053-U; Skene J H, 1990, Neurosci Res Suppl, V13, pS112, DOI 10.1016/0921-8696(90)90040-A; SMITH MK, 1992, J BIOL CHEM, V267, P1761; STUMPO DJ, 1989, P NATL ACAD SCI USA, V86, P4012, DOI 10.1073/pnas.86.11.4012; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; WALDMANN R, 1990, BIOCHEMISTRY-US, V29, P1679, DOI 10.1021/bi00459a002; WAXHAM MN, 1990, P NATL ACAD SCI USA, V87, P1273, DOI 10.1073/pnas.87.4.1273; WILSON IA, 1984, CELL, V37, P767, DOI 10.1016/0092-8674(84)90412-4; YAMAUCHI T, 1989, J BIOL CHEM, V264, P19108	51	381	386	0	15	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1994	12	5					943	956		10.1016/0896-6273(94)90306-9	http://dx.doi.org/10.1016/0896-6273(94)90306-9			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NM831	8185953				2022-12-24	WOS:A1994NM83100002
J	DIANTONIO, A; SCHWARZ, TL				DIANTONIO, A; SCHWARZ, TL			THE EFFECT ON SYNAPTIC PHYSIOLOGY OF SYNAPTOTAGMIN MUTATIONS IN DROSOPHILA	NEURON			English	Article							SQUID GIANT SYNAPSE; NEUROTRANSMITTER RELEASE; NEUROMUSCULAR-JUNCTION; TRANSMITTER RELEASE; PROTEIN; EXCITABILITY; INHIBITION; MUTANTS; BINDING; TETANUS	Synaptotagmin is a synaptic vesicle protein implicated in neurotransmitter release. Molecular characterization of four mutant alleles of this protein in Drosophila melanogaster has permitted an investigation of synaptotagmin's role in synaptic physiology and of some of the structural requirements for its function. Reduced levels of synaptotagmin resulted in a substantial alteration in synaptic function in the eye and at larval neuromuscular junctions. Decreased neurotransmitter release caused smaller evoked synaptic potentials. However, the frequency, but not the size, of spontaneous quantal events was simultaneously increased. These abnormalities do not appear to be secondary to a detectable morphological change in the arborization of the synapse. The increased frequency of spontaneous events was insufficient to deplete significantly the vesicle supply and thereby account for reduced transmission. These data are discussed in the context of models in which synaptotagmin's function includes a role in vesicle docking.			DIANTONIO, A (corresponding author), STANFORD UNIV,MED CTR,DEPT CELLULAR & MOLEC PHYSIOL,STANFORD,CA 94305, USA.			DiAntonio, Aaron/0000-0002-7262-0968	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007365] Funding Source: NIH RePORTER; NIGMS NIH HHS [5T32 GM07365] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADLER EM, 1991, J NEUROSCI, V11, P1496; AUGUSTINE GJ, 1984, J PHYSIOL-LONDON, V346, P257, DOI 10.1113/jphysiol.1984.sp015020; BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2559, DOI 10.1073/pnas.90.7.2559; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; BOMMERT K, 1993, NATURE, V363, P163, DOI 10.1038/363163a0; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; BUDNIK V, 1990, J NEUROSCI, V10, P3754; BUDNIK V, 1989, J NEUROSCI, V9, P2866; BURG MG, 1993, EMBO J, V12, P911, DOI 10.1002/j.1460-2075.1993.tb05732.x; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; COHEN GA, 1992, NEURON, V9, P325, DOI 10.1016/0896-6273(92)90171-9; COUTEAUX R, 1973, ARCH ITAL BIOL, V3, P231; DEBELLO WM, 1993, CELL, V74, P947, DOI 10.1016/0092-8674(93)90716-4; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P574, DOI 10.1113/jphysiol.1954.sp005130; DIANTONIO A, 1993, J NEUROSCI, V73, P1281; ELFERINK LA, 1993, CELL, V72, P153, DOI 10.1016/0092-8674(93)90059-Y; JAN LY, 1982, P NATL ACAD SCI-BIOL, V79, P2700, DOI 10.1073/pnas.79.8.2700; JAN LY, 1976, J PHYSIOL-LONDON, V262, P189, DOI 10.1113/jphysiol.1976.sp011592; JOHANSEN J, 1989, J NEUROSCI, V9, P710; KELLY RB, 1993, CELL, V72, P43, DOI 10.1016/S0092-8674(05)80027-3; LITTLETON JT, 1993, DEVELOPMENT, V118, P1077; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; MARTIN AR, 1955, J PHYSIOL-LONDON, V130, P114, DOI 10.1113/jphysiol.1955.sp005397; MEIRI U, 1971, J PHYSIOL-LONDON, V215, P709, DOI 10.1113/jphysiol.1971.sp009493; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; PAK WL, 1991, MOL BIOL RETINA BASI, P1; PERIN MS, 1991, J BIOL CHEM, V266, P615; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; PETRENKO AG, 1991, NATURE, V353, P65, DOI 10.1038/353065a0; POPOV SV, 1993, CELL, V73, P1247, DOI 10.1016/0092-8674(93)90352-Q; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; SCHIAVO G, 1992, EMBO J, V11, P3577, DOI 10.1002/j.1460-2075.1992.tb05441.x; SHIRATAKI H, 1993, MOL CELL BIOL, V13, P2061, DOI 10.1128/MCB.13.4.2061; SHOJIKASAI Y, 1992, SCIENCE, V256, P1820, DOI 10.1126/science.256.5065.1820; SINGH S, 1990, J EXP BIOL, V152, P59; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; VONRUDEN L, 1993, SCIENCE, V262, P1061, DOI 10.1126/science.8235626; WENDLAND B, 1991, NEURON, V6, P993, DOI 10.1016/0896-6273(91)90239-V; YAO KM, 1994, IN PRESS J NEUROCHEM	42	208	212	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1994	12	4					909	920		10.1016/0896-6273(94)90342-5	http://dx.doi.org/10.1016/0896-6273(94)90342-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NH253	7909234				2022-12-24	WOS:A1994NH25300018
J	MCCORMACK, K; JOINER, WJ; HEINEMANN, SH				MCCORMACK, K; JOINER, WJ; HEINEMANN, SH			A CHARACTERIZATION OF THE ACTIVATING STRUCTURAL REARRANGEMENTS IN VOLTAGE-DEPENDENT SHAKER K+ CHANNELS	NEURON			English	Article							POTASSIUM CHANNEL; SODIUM-CHANNEL; XENOPUS-OOCYTES; COOPERATIVE INTERACTIONS; SUBUNIT STOICHIOMETRY; GATING CURRENTS; SKELETAL-MUSCLE; INACTIVATION; DROSOPHILA; MUTATIONS	In response to changes in membrane potential, voltage-dependent ion channel proteins undergo conformational rearrangements that lead to channel opening. These rearrangements move a net charge, measured as ''gating current,'' across the membrane. Here we characterize the effects of the pharmacological blocker 4-aminopyridine on both the K+ and gating currents of wild-type and mutant Shaker K+ channels. Our results indicate that the activation of these channels involves two distinct types of structural rearrangement. In addition to independent Hodgkin and Huxley type rearrangements for each of the four subunits, which are responsible for most of the gating charge movement, Shaker channels interconvert between two quaternary conformations during activation. The transition between the two quaternary states moves about 10% of the total gating charge, and it is selectively blocked by 4-aminopyridine.	YALE UNIV,SCH MED,DEPT PHYSIOL,NEW HAVEN,CT 06510; MAX PLANCK INST BIOPHYS CHEM,D-37077 GOTTINGEN,GERMANY	Yale University; Max Planck Society	MCCORMACK, K (corresponding author), MAX PLANCK INST EXPTL MED,ABT 11,D-37075 GOTTINGEN,GERMANY.			Heinemann, Stefan H./0000-0002-4144-0251	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072431] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS072431] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ACKERS GK, 1992, SCIENCE, V255, P54, DOI 10.1126/science.1553532; Almers W, 1978, Rev Physiol Biochem Pharmacol, V82, P96, DOI 10.1007/BFb0030498; ARMSTRONG CM, 1973, NATURE, V242, P459, DOI 10.1038/242459a0; AULD VJ, 1990, P NATL ACAD SCI USA, V87, P323, DOI 10.1073/pnas.87.1.323; BEZANILLA F, 1991, SCIENCE, V254, P679, DOI 10.1126/science.1948047; CHOI KL, 1993, NEURON, V10, P533, DOI 10.1016/0896-6273(93)90340-W; CONTI F, 1982, J MEMBRANE BIOL, V69, P35, DOI 10.1007/BF01871239; HEINEMANN SH, 1992, METHOD ENZYMOL, V207, P353; Hille B., 1992, IONIC CHANNELS EXCIT; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HURST RS, 1992, J BIOL CHEM, V267, P23742; IVERSON LE, 1990, J NEUROSCI, V10, P2903; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; KASAI H, 1986, BIOPHYS J, V49, P1243, DOI 10.1016/S0006-3495(86)83754-7; KIRSCH GE, 1993, NEURON, V11, P503, DOI 10.1016/0896-6273(93)90154-J; KOREN G, 1990, NEURON, V4, P39, DOI 10.1016/0896-6273(90)90442-I; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P364; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; LIMAN ER, 1991, NATURE, V353, P752, DOI 10.1038/353752a0; MACKINNON R, 1990, NEURON, V5, P767, DOI 10.1016/0896-6273(90)90335-D; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; MCCORMACK K, 1989, NATURE, V340, P103, DOI 10.1038/340103a0; MCCORMACK K, 1991, P NATL ACAD SCI USA, V88, P2931, DOI 10.1073/pnas.88.7.2931; MEVES H, 1977, J PHYSIOL-LONDON, V268, P511, DOI 10.1113/jphysiol.1977.sp011869; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; NODA M, 1986, NATURE, V320, P188, DOI 10.1038/320188a0; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3; PUSCH M, 1991, EUR BIOPHYS J, V20, P127, DOI 10.1007/BF01561134; RUDY B, 1988, NEUROSCIENCE, V25, P729, DOI 10.1016/0306-4522(88)90033-4; SCHNEIDER MF, 1973, NATURE, V242, P244, DOI 10.1038/242244a0; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; Stryer L, 1981, BIOCHEMISTRY; STUHMER W, 1991, PFLUG ARCH EUR J PHY, V418, P423, DOI 10.1007/BF00550881; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; STUHMER W, 1992, METHOD ENZYMOL, V207, P319; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; TERLAU H, 1991, FEBS LETT, V293, P93, DOI 10.1016/0014-5793(91)81159-6; THOMPSON SH, 1977, J PHYSIOL-LONDON, V265, P465, DOI 10.1113/jphysiol.1977.sp011725; TYTGAT J, 1992, NATURE, V359, P420, DOI 10.1038/359420a0; YEH JZ, 1976, J GEN PHYSIOL, V68, P519, DOI 10.1085/jgp.68.5.519; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; ZAGOTTA WN, 1990, J GEN PHYSIOL, V95, P29, DOI 10.1085/jgp.95.1.29	45	105	106	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1994	12	2					301	315		10.1016/0896-6273(94)90273-9	http://dx.doi.org/10.1016/0896-6273(94)90273-9			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MY500	8110460				2022-12-24	WOS:A1994MY50000007
J	PASSAFARO, M; CLEMENTI, F; POLLO, A; CARBONE, E; SHER, E				PASSAFARO, M; CLEMENTI, F; POLLO, A; CARBONE, E; SHER, E			OMEGA-CONOTOXIN AND CD2+ STIMULATE THE RECRUITMENT TO THE PLASMAMEMBRANE OF AN INTRACELLULAR POOL OF VOLTAGE-OPERATED CA2+ CHANNELS	NEURON			English	Article							HUMAN NEURO-BLASTOMA; CALCIUM CHANNELS; TRANSMITTER RELEASE; GLUCOSE-TRANSPORT; VERTEBRATE CELLS; RAT-BRAIN; MODULATION; RECEPTORS; MECHANISM; MEMBRANE	I-125-omega-conotoxin binding to neuroblastoma cells at 37 degrees C continously increased, reaching a plateau after 6-8 hr; this was up to 6 times higher than that observed at lower temperatures. The same effect was induced by short pulses with omega-conotoxin followed by a chase period at 37 degrees C in control medium. Cd2+ also induced up-regulation of surface I-125-omega-conotoxin-binding sites. Fura-2 and patch-clamp experiments showed that the recruited binding sites corresponded to functional voltage-operated Ca2+ channels. Permeabilization experiments revealed a large intracellular pool of I-125-omega-conotoxin-binding sites, whose recruitment to the plasmamembrane was prevented by brefeldin A and nocodazole. These data suggest that specific stimuli might induce voltage-operated Ca2+ channel translocation to plasmamembrane and, in this way, modulate presynaptic events.	UNIV MILAN, CNR, CTR CYTOPHARMACOL, MILAN, ITALY; UNIV ROMA TOR VERGATA, DEPT BIOL, I-00173 ROME, ITALY; UNIV TURIN, DEPT HUMAN ANAT & PHYSIOL, TURIN, ITALY	Consiglio Nazionale delle Ricerche (CNR); University of Milan; University of Rome Tor Vergata; University of Turin	PASSAFARO, M (corresponding author), UNIV MILAN, DEPT MED PHARMACOL, MILAN, ITALY.		Carbone, Emilio/W-5763-2019	Carbone, Emilio/0000-0003-2239-6280	Fondazione Telethon Funding Source: Custom	Fondazione Telethon(Fondazione Telethon)		ANWYL R, 1991, BRAIN RES REV, V16, P265, DOI 10.1016/0165-0173(91)90010-6; BEAN BP, 1989, ANNU REV PHYSIOL, V51, P367, DOI 10.1146/annurev.physiol.51.1.367; BERTOLINO M, 1992, ANNU REV PHARMACOL, V32, P399, DOI 10.1146/annurev.pa.32.040192.002151; CARBONE E, 1990, PFLUG ARCH EUR J PHY, V416, P170, DOI 10.1007/BF00370239; CARBONE E, 1989, PROG BIOPHYS MOL BIO, V54, P31, DOI 10.1016/0079-6107(89)90008-4; CLEMENTI F, 1986, J NEUROCHEM, V47, P291; COHEN MW, 1991, J NEUROSCI, V11, P1032; CUSHMAN SW, 1980, J BIOL CHEM, V255, P4758; FERRANTE J, 1990, BIOCHEM PHARMACOL, V39, P1267, DOI 10.1016/0006-2952(90)90001-2; GRIFFITHS G, 1986, SCIENCE, V234, P438, DOI 10.1126/science.2945253; JACOB MH, 1986, J CELL BIOL, V103, P205, DOI 10.1083/jcb.103.1.205; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; KNOX RJ, 1992, NEURON, V8, P883, DOI 10.1016/0896-6273(92)90202-O; KONO T, 1981, J BIOL CHEM, V256, P6400; MILLER RJ, 1992, J BIOL CHEM, V267, P1403; PASSAFARO M, 1992, J NEUROSCI, V12, P3372; ROBITAILLE R, 1990, NEURON, V5, P773, DOI 10.1016/0896-6273(90)90336-E; ROSA P, 1992, EUR J CELL BIOL, V59, P265; SCHMIDT J, 1985, P NATL ACAD SCI USA, V82, P4847, DOI 10.1073/pnas.82.14.4847; SCHMIDT JW, 1986, CELL, V46, P437, DOI 10.1016/0092-8674(86)90664-1; SCOTT RH, 1991, PROG NEUROBIOL, V36, P485, DOI 10.1016/0301-0082(91)90014-R; SHER E, 1989, J CELL BIOL, V108, P2291, DOI 10.1083/jcb.108.6.2291; SHER E, 1990, CANCER RES, V50, P3892; SHER E, 1988, FEBS LETT, V235, P178, DOI 10.1016/0014-5793(88)81258-4; SHER E, 1991, NEUROSCIENCE, V42, P301, DOI 10.1016/0306-4522(91)90376-Y; SHER E, 1992, EUR J PHARMACOL, V216, P407, DOI 10.1016/0014-2999(92)90438-A; SMITH SJ, 1988, TRENDS NEUROSCI, V11, P458, DOI 10.1016/0166-2236(88)90199-3; STOLLBERG J, 1987, J NEUROSCI, V7, P1809; TARELLI FT, 1991, BRAIN RES, V547, P331, DOI 10.1016/0006-8993(91)90981-Z; VANDERSLUIJS P, 1990, J CELL SCI, V95, P545; VANDEURS B, 1989, INT REV CYTOL, V117, P131; WOOD MR, 1992, J NEUROSCI, V12, P2948, DOI 10.1523/JNEUROSCI.12-08-02948.1992	32	36	36	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1994	12	2					317	326		10.1016/0896-6273(94)90274-7	http://dx.doi.org/10.1016/0896-6273(94)90274-7			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MY500	8110461				2022-12-24	WOS:A1994MY50000008
J	WILKBLASZCZAK, MA; GUTOWSKI, S; STERNWEIS, PC; BELARDETTI, F				WILKBLASZCZAK, MA; GUTOWSKI, S; STERNWEIS, PC; BELARDETTI, F			BRADYKININ MODULATES POTASSIUM AND CALCIUM CURRENTS IN NEUROBLASTOMA HYBRID-CELLS VIA DIFFERENT PERTUSSIS TOXIN-INSENSITIVE PATHWAYS	NEURON			English	Article							G-PROTEINS; PHOSPHOLIPASE-C; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; INOSITOL 1,4,5-TRISPHOSPHATE; ALPHA-SUBUNITS; INHIBITION; HYDROLYSIS; ACTIVATION; RESPONSES; RECEPTORS	In NG108-15 cells, bradykinin (BK) activates a potassium current (I(K,BK)) and inhibits the voltage-dependent calcium current(I(Ca,V)). BK also stimulates a phosphatidylinositol-specific phospholipase C (PI-PLC). The subsequent release of inositol 1,4,5-trisphosphate and increase in intracellular calcium contribute to IK,BK, through activation of a calcium-dependent potassium current. In membranes from these cells, stimulation of PI-PLC by BK is mediated by G(q) and/or G11, two homologous, pertussis toxin-insensitive G proteins. Here, we have investigated the role of G(q/11), in the electrical responses to BK. GTPgammaS mimicked and occluded both actions of BK, and both effects were insensitive to pertussis toxin. Perfusion of an anti-G(q/11alpha) antibody into the pipette suppressed I(K,BK), but not the inhibition of I(Ca,V) by BK. Thus, BK couples to I(K,BK) via G(q/11), but coupling to I(Ca,V) is most likely via a different, pertussis toxin-insensitive G protein.			WILKBLASZCZAK, MA (corresponding author), UNIV TEXAS,SW MED CTR,DEPT PHARMACOL,DALLAS,TX 75235, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047721, R01GM031954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS025186] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM31954, GM47721] Funding Source: Medline; NINDS NIH HHS [NS25186] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BIRNBAUMER L, 1992, CELL, V71, P1069, DOI 10.1016/S0092-8674(05)80056-X; BIRNBAUMER L, 1990, ANNU REV PHARMACOL, V30, P675; BROWN AM, 1990, ANNU REV PHYSIOL, V52, P197, DOI 10.1146/annurev.ph.52.030190.001213; BROWN DA, 1988, J PHYSIOL-LONDON, V397, P167, DOI 10.1113/jphysiol.1988.sp016994; BROWN DA, 1988, J PHYSIOL-LONDON, V397, P185, DOI 10.1113/jphysiol.1988.sp016995; BROWN DA, 1988, J PHYSIOL-LONDON, V397, P149, DOI 10.1113/jphysiol.1988.sp016993; DIVERSEPIERLUISSI M, 1993, NEURON, V10, P753, DOI 10.1016/0896-6273(93)90175-Q; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GRANDT R, 1986, FEBS LETT, V196, P279, DOI 10.1016/0014-5793(86)80263-0; GUTOWSKI S, 1991, J BIOL CHEM, V266, P20519; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HAMPRECHT B, 1985, METHOD ENZYMOL, V109, P316; HARLOW E, 1988, ANTIBODIES LABORATOR; HEPLER JR, 1993, J BIOL CHEM, V268, P14367; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; HESCHELER J, 1987, NATURE, V325, P445, DOI 10.1038/325445a0; HIGASHIDA H, 1986, P NATL ACAD SCI USA, V83, P942, DOI 10.1073/pnas.83.4.942; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; Iniguez-Lluhi Jorge, 1993, Trends in Cell Biology, V3, P230, DOI 10.1016/0962-8924(93)90122-H; JACKSON TR, 1987, EMBO J, V6, P49, DOI 10.1002/j.1460-2075.1987.tb04717.x; KRAMER RH, 1991, NEURON, V6, P557, DOI 10.1016/0896-6273(91)90058-8; LAMORTE VJ, 1993, J CELL BIOL, V121, P91, DOI 10.1083/jcb.121.1.91; LLEDO PM, 1992, NEURON, V8, P455, DOI 10.1016/0896-6273(92)90273-G; MCGEHEE DS, 1992, NEURON, V9, P315, DOI 10.1016/0896-6273(92)90170-I; PRESSMAN BC, 1976, ANNU REV BIOCHEM, V45, P501, DOI 10.1146/annurev.bi.45.070176.002441; RASENICK MM, 1989, BRAIN RES, V488, P105, DOI 10.1016/0006-8993(89)90698-7; ROBBINS J, 1993, J PHYSIOL-LONDON, V469, P153, DOI 10.1113/jphysiol.1993.sp019809; ROBBINS J, 1992, J PHYSIOL-LONDON, V451, P159, DOI 10.1113/jphysiol.1992.sp019159; ROSS EM, 1989, NEURON, V3, P141, DOI 10.1016/0896-6273(89)90027-5; SCHAFER S, 1991, PFLUG ARCH EUR J PHY, V418, P581, DOI 10.1007/BF00370575; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; STERNWEIS PC, 1992, TRENDS BIOCHEM SCI, V17, P502, DOI 10.1016/0968-0004(92)90340-F; STERNWEIS PC, 1990, TRENDS NEUROSCI, V13, P122, DOI 10.1016/0166-2236(90)90002-R; TANG JM, 1990, PFLUG ARCH EUR J PHY, V416, P347, DOI 10.1007/BF00392072; TAUSSIG R, 1992, NEURON, V8, P799, DOI 10.1016/0896-6273(92)90100-R; TAYLOR SJ, 1991, NATURE, V350, P516, DOI 10.1038/350516a0; YANO K, 1984, J BIOL CHEM, V259, P201	38	44	44	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1994	12	1					109	116		10.1016/0896-6273(94)90156-2	http://dx.doi.org/10.1016/0896-6273(94)90156-2			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MU493	8292355				2022-12-24	WOS:A1994MU49300010
J	ANGLESON, JK; WENSEL, TG				ANGLESON, JK; WENSEL, TG			A GTPASE-ACCELERATING FACTOR FOR TRANSDUCIN, DISTINCT FROM ITS EFFECTOR CGMP PHOSPHODIESTERASE, IN ROD OUTER SEGMENT MEMBRANES	NEURON			English	Article							CYCLIC-GMP PHOSPHODIESTERASE; RETINAL RODS; INHIBITORY SUBUNIT; BINDING-SITES; G-PROTEIN; PHOSPHOLIPASE C-BETA-1; MOLECULAR MECHANISM; VISUAL TRANSDUCTION; HYDROLYSIS; BOVINE	Hydrolysis of GTP by the photoreceptor G protein transducin (G(talpha)) was found to occur with kinetics identical to the inactivation of its effector cGMP phosphodiesterase (PDE), but was too slow (tens of seconds) in dilute rod outer segment (ROS) suspensions to account for subsecond recovery of the light response. Raising the concentration of ROS membranes increased the rates of GTP hydrolysis and PDE inactivation in parallel as much as 6-fold. Holo-PDE and its gamma subunit had weak effects on GTPase kinetics (<1.6-fold and <1.3-fold, respectively). ROS membranes stripped of PDE retained approximately 90% of a GTPase accelerating activity that was protease sensitive, indicating that they contain a GTPase-accelerating factor distinct from PDE.			ANGLESON, JK (corresponding author), BAYLOR COLL MED, VERNA & MARRS MCLEAN DEPT BIOCHEM, HOUSTON, TX 77030 USA.			Wensel, Theodore/0000-0003-3518-9352	NEI NIH HHS [EY07001, EY07981] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY007981] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ANTONNY B, 1993, BIOCHEMISTRY-US, V32, P8646, DOI 10.1021/bi00084a036; ARSHAVSKY VY, 1989, FEBS LETT, V250, P353, DOI 10.1016/0014-5793(89)80754-9; ARSHAVSKY VY, 1992, J BIOL CHEM, V267, P24501; ARSHAVSKY VY, 1987, FEBS LETT, V224, P19, DOI 10.1016/0014-5793(87)80414-3; ARSHAVSKY VY, 1991, J BIOL CHEM, V266, P18530; ARSHAVSKY VY, 1992, NATURE, V357, P416, DOI 10.1038/357416a0; BAEHR W, 1979, J BIOL CHEM, V254, P1669; BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; BENNETT N, 1989, BIOCHEMISTRY-US, V28, P7418, DOI 10.1021/bi00444a040; BERSTEIN G, 1992, J BIOL CHEM, V267, P8081; BERSTEIN G, 1992, CELL, V70, P411, DOI 10.1016/0092-8674(92)90165-9; BIGAY J, 1987, EMBO J, V6, P2907, DOI 10.1002/j.1460-2075.1987.tb02594.x; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; BOURNE HR, 1992, NATURE, V358, P541, DOI 10.1038/358541a0; BRANDT DR, 1986, J BIOL CHEM, V261, P1656; BROWN RL, 1992, BIOCHEMISTRY-US, V31, P5918, DOI 10.1021/bi00140a031; BROWN RL, 1989, P NATL ACAD SCI USA, V86, P4922, DOI 10.1073/pnas.86.13.4922; CASEY PJ, 1990, J BIOL CHEM, V265, P2383; CATTY P, 1992, J BIOL CHEM, V267, P19489; CLERC A, 1992, J BIOL CHEM, V267, P6620; DETERRE P, 1988, P NATL ACAD SCI USA, V85, P2424, DOI 10.1073/pnas.85.8.2424; DRATZ EA, 1987, BIOCHEM BIOPH RES CO, V146, P379, DOI 10.1016/0006-291X(87)90540-7; ERICKSON MA, 1992, SCIENCE, V257, P1255, DOI 10.1126/science.1519062; FUNG BKK, 1983, J BIOL CHEM, V258, P503; FUNG BKK, 1980, P NATL ACAD SCI-BIOL, V77, P2500, DOI 10.1073/pnas.77.5.2500; GILLESPIE PG, 1989, P NATL ACAD SCI USA, V86, P4311, DOI 10.1073/pnas.86.11.4311; GUY PM, 1990, BIOCHEMISTRY-US, V29, P6954, DOI 10.1021/bi00482a003; HAMM HE, 1986, BIOCHEMISTRY-US, V25, P4512, DOI 10.1021/bi00364a010; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P757; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P3597; HODGKIN AL, 1988, J PHYSIOL-LONDON, V403, P439, DOI 10.1113/jphysiol.1988.sp017258; HURLEY JB, 1982, J BIOL CHEM, V257, P1094; KAHLERT M, 1991, BIOPHYS J, V59, P375, DOI 10.1016/S0006-3495(91)82231-7; KAUPP UB, 1992, ANNU REV PHYSIOL, V54, P153; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; LAGNADO L, 1992, NEURON, V8, P995, DOI 10.1016/0896-6273(92)90122-T; LAMB TD, 1988, J PHYSIOL-LONDON, V407, P463, DOI 10.1113/jphysiol.1988.sp017426; LAMB TD, 1986, J PHYSIOL-LONDON, V372, P315, DOI 10.1113/jphysiol.1986.sp016011; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; LIEBMAN PA, 1982, METHOD ENZYMOL, V81, P532; LOLLEY RN, 1982, VISION RES, V22, P1481, DOI 10.1016/0042-6989(82)90213-9; MALINSKI JA, 1992, BIOCHEMISTRY-US, V31, P9502, DOI 10.1021/bi00154a024; NAVON SE, 1984, J BIOL CHEM, V259, P6686; NEAL SE, 1988, J BIOL CHEM, V263, P19718; OHGURO H, 1993, BIOCHEMISTRY-US, V32, P5718, DOI 10.1021/bi00072a030; PAGES F, 1992, J BIOL CHEM, V267, P22018; PAPERMASTER DS, 1974, BIOCHEMISTRY-US, V13, P2438, DOI 10.1021/bi00708a031; PUGH EN, 1993, BIOCHIM BIOPHYS ACTA, V1141, P111, DOI 10.1016/0005-2728(93)90038-H; SATHER WA, 1987, P NATL ACAD SCI USA, V84, P9290, DOI 10.1073/pnas.84.24.9290; SITARAMAYYA A, 1988, BIOCHEMISTRY-US, V27, P4880, DOI 10.1021/bi00413a044; STRYER L, 1991, J BIOL CHEM, V266, P10711; TING TD, 1991, BIOCHEMISTRY-US, V30, P8996, DOI 10.1021/bi00101a013; TYMINSKI PN, 1984, BIOCHEMISTRY-US, V23, P3986, DOI 10.1021/bi00312a028; VUONG TM, 1990, NATURE, V346, P71, DOI 10.1038/346071a0; VUONG TM, 1991, P NATL ACAD SCI USA, V88, P9813, DOI 10.1073/pnas.88.21.9813; WENSEL T G, 1986, Proteins Structure Function and Genetics, V1, P90, DOI 10.1002/prot.340010114; WENSEL TG, 1990, BIOCHEMISTRY-US, V29, P2155, DOI 10.1021/bi00460a028; YAMAZAKI A, 1990, J BIOL CHEM, V265, P11539; YAMAZAKI A, 1993, J BIOL CHEM, V268, P8899; YAMAZAKI A, 1980, J BIOL CHEM, V255, P1619; YEE R, 1978, J BIOL CHEM, V253, P8902; ZUCKERMAN R, 1986, FEBS LETT, V207, P35, DOI 10.1016/0014-5793(86)80008-4	63	83	85	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1993	11	5					939	949		10.1016/0896-6273(93)90123-9	http://dx.doi.org/10.1016/0896-6273(93)90123-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MJ041	8240815				2022-12-24	WOS:A1993MJ04100015
J	SHAO, XM; PAPAZIAN, DM				SHAO, XM; PAPAZIAN, DM			S4 MUTATIONS ALTER THE SINGLE-CHANNEL GATING KINETICS OF SHAKER K+ CHANNELS	NEURON			English	Article							SODIUM-CHANNEL; POTASSIUM CHANNELS; INACTIVATION GATE; XENOPUS OOCYTES; RECEPTOR; DROSOPHILA; CURRENTS; CHARGE; MUSCLE; CDNA	The S4 sequence comprises at least part of the voltage sensor in Shaker K+ channels. Two site-directed mutations in the Shaker S4 sequence, R368Q and R377K, which decrease the voltage dependence of the whole-cell current, alter voltage-dependent gating at the single-channel level. Compared with the wild-type channel, they increase the latency to first opening, destabilize the open state, and alter the equilibria of voltage-dependent transitions, so that some of the charge movement occurs after the first opening. Whether these changes reflect a new mechanism of activation is a key question. Although the mutations alter the kinetics of many steps in the gating process, we conclude that the mutant channels are likely to activate using the same fundamental mechanism as wild-type channels.	UNIV CALIF LOS ANGELES,INST MOLEC BIOL,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles	SHAO, XM (corresponding author), UNIV CALIF LOS ANGELES,SCH MED,DEPT PHYSIOL,LOS ANGELES,CA 90024, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043459] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM043459-14, R01 GM043459-17, R01 GM043459-13, R01 GM043459-15, R01 GM043459, R01 GM043459-12, R01 GM043459-10, R01 GM043459-16, R01 GM043459-11, GM43459, R01 GM043459-09, R01 GM043459-15S1] Funding Source: Medline; NINDS NIH HHS [NS07101] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALDRICH RW, 1987, J NEUROSCI, V7, P418; ALDRICH RW, 1983, NATURE, V306, P436, DOI 10.1038/306436a0; BENDAT JS, 1971, MEASUREMETN ANAL RAN, P123; BEZANILLA F, 1991, SCIENCE, V254, P679, DOI 10.1126/science.1948047; CATTERALL WA, 1986, ANNU REV BIOCHEM, V55, P953, DOI 10.1146/annurev.biochem.55.1.953; Colquhoun D, 1983, SINGLE CHANNEL RECOR, P191; DEMO SD, 1991, NEURON, V7, P743, DOI 10.1016/0896-6273(91)90277-7; GREENBLATT RE, 1985, FEBS LETT, V193, P125, DOI 10.1016/0014-5793(85)80136-8; GUY HR, 1986, P NATL ACAD SCI USA, V83, P508, DOI 10.1073/pnas.83.2.508; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; ISACOFF EY, 1991, NATURE, V353, P86, DOI 10.1038/353086a0; JAN LY, 1989, CELL, V56, P13, DOI 10.1016/0092-8674(89)90979-3; LIMAN ER, 1991, NATURE, V353, P752, DOI 10.1038/353752a0; LOGOTHETIS DE, 1992, NEURON, V8, P531, DOI 10.1016/0896-6273(92)90281-H; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; MCCORMACK K, 1991, P NATL ACAD SCI USA, V88, P2931, DOI 10.1073/pnas.88.7.2931; METHFESSEL C, 1986, PFLUG ARCH EUR J PHY, V407, P577, DOI 10.1007/BF00582635; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; NODA M, 1986, NATURE, V320, P188, DOI 10.1038/320188a0; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; PEROZO E, 1992, BIOPHYS J, V62, P160, DOI 10.1016/S0006-3495(92)81802-7; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; TANABE T, 1988, NATURE, V336, P134, DOI 10.1038/336134a0; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; TIMPE LC, 1988, NATURE, V331, P143, DOI 10.1038/331143a0; TIMPE LC, 1988, NEURON, V1, P659, DOI 10.1016/0896-6273(88)90165-1; TYTGAT J, 1992, NATURE, V359, P420, DOI 10.1038/359420a0; ZAGOTTA WH, 1989, P NATL ACAD SCI USA, V76, P7243; ZAGOTTA WN, 1990, J GEN PHYSIOL, V95, P29, DOI 10.1085/jgp.95.1.29; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520	34	27	27	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1993	11	2					343	352		10.1016/0896-6273(93)90189-X	http://dx.doi.org/10.1016/0896-6273(93)90189-X			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LU065	8352942				2022-12-24	WOS:A1993LU06500013
J	WALTON, KM; MARTELL, KJ; KWAK, SP; DIXON, JE; LARGENT, BL				WALTON, KM; MARTELL, KJ; KWAK, SP; DIXON, JE; LARGENT, BL			A NOVEL RECEPTOR-TYPE PROTEIN-TYROSINE-PHOSPHATASE IS EXPRESSED DURING NEUROGENESIS IN THE OLFACTORY NEUROEPITHELIUM	NEURON			English	Article							CELL-ADHESION MOLECULES; CENTRAL-NERVOUS-SYSTEM; LEUKOCYTE-COMMON ANTIGEN; GROWTH CONE MEMBRANES; IMMUNOGLOBULIN SUPERFAMILY; TRK PROTOONCOGENE; NEURAL DEVELOPMENT; DROSOPHILA EMBRYO; MARKER PROTEIN; BINDING-SITE	Tyrosine phosphorylation plays a central role in the control of neuronal cell development and function. Yet, few neuronal protein tyrosine phosphatases (PTPs) have been identified. We examined rat olfactory neuroepithelium for expression of novel PTPs potentially important in neuronal development and regeneration. Using the polymerase chain reaction with degenerate DNA oligomers directed to the conserved tyrosine phosphatase domain, we identified 6 novel tyrosine phosphatases. One of these, PTP NE-3, is a receptor-type PTP expressed selectively in both rat brain and olfactory neuroepithelium. In the olfactory neuroepithelium, PTP NE-3 expression is restricted to neurons and describes a novel pattern of expression with a high level in the immature neurons and a lower level in mature olfactory sensory neurons.	UNIV MICHIGAN, NEUROSCI PROGRAM, ANN ARBOR, MI 48109 USA; UNIV MICHIGAN, DEPT ANAT & CELL BIOL, ANN ARBOR, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	WALTON, KM (corresponding author), UNIV MICHIGAN, DEPT BIOL CHEM, ANN ARBOR, MI 48109 USA.				NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK018024, R37DK018024] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR00042] Funding Source: Medline; NIDCD NIH HHS [DC-01964] Funding Source: Medline; NIDDK NIH HHS [DK-18024] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANHOLT RRH, 1993, CRIT REV NEUROBIOL, V7, P1; ATASHI JR, 1992, NEURON, V8, P831, DOI 10.1016/0896-6273(92)90197-L; BARBACID M, 1991, BIOCHIM BIOPHYS ACTA, V1072, P115, DOI 10.1016/0304-419X(91)90010-I; BENOWITZ LI, 1988, J NEUROSCI, V8, P339; CAMARA CG, 1984, BRAIN RES, V308, P63, DOI 10.1016/0006-8993(84)90917-X; CHAO MV, 1992, NEURON, V9, P583, DOI 10.1016/0896-6273(92)90023-7; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHUONG CM, 1987, J CELL BIOL, V104, P331, DOI 10.1083/jcb.104.2.331; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; DELAMONTE SM, 1989, DEV BRAIN RES, V46, P161, DOI 10.1016/0165-3806(89)90279-4; DUNPHY WG, 1991, CELL, V67, P189, DOI 10.1016/0092-8674(91)90582-J; ELICES MJ, 1990, CELL, V60, P577, DOI 10.1016/0092-8674(90)90661-W; ELKINS T, 1990, CELL, V60, P565, DOI 10.1016/0092-8674(90)90660-7; Frohman M.A., 1990, PCR PROTOCOLS GUIDE, P28; GERTLER FB, 1989, CELL, V58, P103, DOI 10.1016/0092-8674(89)90407-8; GIERASCH LM, 1989, BIOCHEMISTRY-US, V28, P923, DOI 10.1021/bi00429a001; Graziadei P. P., 1978, DEV SENSORY SYSTEMS, V9, P55; GRENNINGLOH G, 1990, COLD SH Q B, V55, P327; GRUNSTEIN M, 1975, P NATL ACAD SCI USA, V72, P3961, DOI 10.1073/pnas.72.10.3961; GU MX, 1991, P NATL ACAD SCI USA, V88, P5867, DOI 10.1073/pnas.88.13.5867; GUAN KL, 1990, P NATL ACAD SCI USA, V87, P1501, DOI 10.1073/pnas.87.4.1501; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; HARIHARAN IK, 1991, P NATL ACAD SCI USA, V88, P11266, DOI 10.1073/pnas.88.24.11266; HOWARD PK, 1992, CELL, V71, P637, DOI 10.1016/0092-8674(92)90597-6; HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O; IBANEZ CF, 1992, CELL, V69, P329, DOI 10.1016/0092-8674(92)90413-7; JIRIK FR, 1992, CYTOGENET CELL GENET, V61, P266, DOI 10.1159/000133418; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KLEIN R, 1990, DEVELOPMENT, V109, P845; KLEIN R, 1989, EMBO J, V8, P3701, DOI 10.1002/j.1460-2075.1989.tb08545.x; KOZAK M, 1991, J BIOL CHEM, V266, P19867; KREMER NE, 1991, J CELL BIOL, V115, P809, DOI 10.1083/jcb.115.3.809; KRUEGER NX, 1990, EMBO J, V9, P3241, DOI 10.1002/j.1460-2075.1990.tb07523.x; LAI C, 1987, P NATL ACAD SCI USA, V84, P4337, DOI 10.1073/pnas.84.12.4337; LARGENT BL, 1993, J NEUROSCI, V13, P300; LEBEAU JM, 1991, J NEUROSCI RES, V28, P299, DOI 10.1002/jnr.490280217; LEVEY MS, 1991, J NEUROSCI, V11, P3556; LINDNER J, 1983, NATURE, V305, P427, DOI 10.1038/305427a0; LOMBROSO PJ, 1991, P NATL ACAD SCI USA, V88, P7242, DOI 10.1073/pnas.88.16.7242; MANESS PF, 1990, CIBA F SYMP, V150, P57; MANESS PF, 1988, P NATL ACAD SCI USA, V85, P5001, DOI 10.1073/pnas.85.14.5001; MARGOLIS FL, 1985, TRENDS NEUROSCI, V8, P542, DOI 10.1016/0166-2236(85)90192-4; MARTINZANCA D, 1990, GENE DEV, V4, P683, DOI 10.1101/gad.4.5.683; MATTEN WT, 1990, J CELL BIOL, V111, P1959, DOI 10.1083/jcb.111.5.1959; MATTHEWS RJ, 1990, P NATL ACAD SCI USA, V87, P4444, DOI 10.1073/pnas.87.12.4444; MIRAGALL F, 1988, DEV BIOL, V129, P516, DOI 10.1016/0012-1606(88)90397-1; MORRISON EE, 1990, J COMP NEUROL, V297, P1, DOI 10.1002/cne.902970102; NEF P, 1992, P NATL ACAD SCI USA, V89, P8948, DOI 10.1073/pnas.89.19.8948; NEVE RL, 1988, P NATL ACAD SCI USA, V85, P3638, DOI 10.1073/pnas.85.10.3638; NGAI J, 1993, CELL, V72, P667, DOI 10.1016/0092-8674(93)90396-8; OAKLEY B, 1992, EXP NEUROL, V115, P50, DOI 10.1016/0014-4886(92)90220-K; OKAYAMA H, 1987, METHOD ENZYMOL, V154, P3; PATTHY L, 1990, CELL, V61, P13, DOI 10.1016/0092-8674(90)90208-V; PERKINS LA, 1992, CELL, V70, P225, DOI 10.1016/0092-8674(92)90098-W; PINGEL JT, 1989, CELL, V58, P1055, DOI 10.1016/0092-8674(89)90504-7; POT DA, 1991, J BIOL CHEM, V266, P19688; RAMAKERS GJA, 1992, J NEUROCYTOL, V21, P853, DOI 10.1007/BF01191683; RAMAKERS GJA, 1992, J NEUROCYTOL, V8, P205; REED RR, 1992, NEURON, V8, P205, DOI 10.1016/0896-6273(92)90287-N; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; RITISHAUSER U, 1908, PHYSIOL REV, V68, P819; RODRIGUEZTEBAR A, 1991, PHILOS T ROY SOC B, V331, P255, DOI 10.1098/rstb.1991.0013; SAMANEN DW, 1984, J COMP NEUROL, V225, P201, DOI 10.1002/cne.902250206; Sambrook J, 1989, MOL CLONING LABORATO; SCHWOB JE, 1992, J NEUROSCI, V12, P3896; SCHWOB JE, 1986, J NEUROSCI, V6, P208; SHEN SH, 1991, NATURE, V352, P736, DOI 10.1038/352736a0; STAUNTON DE, 1988, CELL, V52, P925, DOI 10.1016/0092-8674(88)90434-5; STJOHNSTON D, 1992, CELL, V68, P201; STREULI M, 1988, J EXP MED, V168, P1523, DOI 10.1084/jem.168.5.1523; STREULI M, 1992, EMBO J, V11, P897, DOI 10.1002/j.1460-2075.1992.tb05128.x; STREULI M, 1989, P NATL ACAD SCI USA, V86, P8698, DOI 10.1073/pnas.86.22.8698; SWARUP G, 1991, FEBS LETT, V280, P65, DOI 10.1016/0014-5793(91)80205-H; TIAN SS, 1991, CELL, V67, P675, DOI 10.1016/0092-8674(91)90063-5; TROWBRIDGE IS, 1991, J BIOL CHEM, V266, P23517; VERHAAGEN J, 1989, J NEUROSCI, V9, P683; VERHAAGEN J, 1990, J NEUROSCI RES, V26, P31, DOI 10.1002/jnr.490260105; VIERECK C, 1989, J NEUROSCI, V9, P3547; VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; YANG Q, 1991, P NATL ACAD SCI USA, V88, P5949, DOI 10.1073/pnas.88.14.5949; YANG XH, 1991, CELL, V67, P661, DOI 10.1016/0092-8674(91)90062-4; YU Q, 1992, ONCOGENE, V7, P1051; ZHANG ZY, 1992, J BIOL CHEM, V267, P23759; ZHAO ZZ, 1993, J BIOL CHEM, V268, P2816	86	91	93	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	1993	11	2					387	400		10.1016/0896-6273(93)90193-U	http://dx.doi.org/10.1016/0896-6273(93)90193-U			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LU065	8352946	Green Submitted			2022-12-24	WOS:A1993LU06500017
J	OBERDICK, J; SCHILLING, K; SMEYNE, RJ; CORBIN, JG; BOCCHIARO, C; MORGAN, JI				OBERDICK, J; SCHILLING, K; SMEYNE, RJ; CORBIN, JG; BOCCHIARO, C; MORGAN, JI			CONTROL OF SEGMENT-LIKE PATTERNS OF GENE-EXPRESSION IN THE MOUSE CEREBELLUM	NEURON			English	Article							TRANSGENE EXPRESSION; OLIVOCEREBELLAR PROJECTION; PARASAGITTAL ORGANIZATION; VISUAL-CORTEX; PURKINJE; RAT; CAT; TRANSCRIPTION; COMPARTMENTS; PROMOTER	A Purkinje cell-specific transgene, L7-lacZ, is expressed in a series of parasagitally oriented stripes in the mouse cerebellum. This banding pattern can be perturbed by promoter mutation, showing that a combination of positive and negative control elements contributes to the temporal and spatial map of L7 gene expression. In addition to the parasagittal stripes, certain mutations reveal Purkinje cells organized into compartments oriented in the transverse plane of the cerebellum. Transcription factors of the POU or homeobox families appear to be involved in controlling L7 expression in the transverse orientation. Strikingly, some of the domains of gene expression revealed by the mutations appear to correspond to functional compartments of Purkinje cells, thereby suggesting an underlying genetic principle used to orchestrate functional organization in the nervous system.	OHIO STATE UNIV, CTR BIOTECHNOL, COLUMBUS, OH 43210 USA	University System of Ohio; Ohio State University	OBERDICK, J (corresponding author), ROCHE INST MOLEC BIOL, DEPT NEUROSCI, ROCHE RES CTR, NUTLEY, NJ 07110 USA.		Morgan, James/N-8104-2018; Morgan, James/GRO-2905-2022	Morgan, James/0000-0002-8920-1065; Smeyne, Richard/0000-0002-8459-5472	PHS HHS [08-08601] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AKAIKE T, 1992, J COMP NEUROL, V320, P398, DOI 10.1002/cne.903200311; ALLEN N D, 1987, P217; ARMSTRONG DM, 1974, J COMP NEUROL, V154, P287, DOI 10.1002/cne.901540305; BROCHU G, 1990, J COMP NEUROL, V291, P538, DOI 10.1002/cne.902910405; BUISSERETDELMAS C, 1988, NEUROSCI RES, V5, P494, DOI 10.1016/0168-0102(88)90039-9; DESPLAN C, 1988, CELL, V54, P1081, DOI 10.1016/0092-8674(88)90123-7; EISENMAN LM, 1989, NEUROSCIENCE, V31, P231, DOI 10.1016/0306-4522(89)90045-6; GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2; GRAVEL C, 1987, J COMP NEUROL, V265, P294, DOI 10.1002/cne.902650211; GRAVEL C, 1990, J COMP NEUROL, V291, P79, DOI 10.1002/cne.902910107; GROENEWEGEN HJ, 1977, J COMP NEUROL, V174, P417, DOI 10.1002/cne.901740304; HAWKES R, 1987, J COMP NEUROL, V256, P29, DOI 10.1002/cne.902560104; HAWKES R, 1991, PROG NEUROBIOL, V36, P309, DOI 10.1016/0301-0082(91)90004-K; HIROMI Y, 1987, CELL, V50, P963, DOI 10.1016/0092-8674(87)90523-X; HORTON JC, 1984, PHILOS T ROY SOC B, V304, P255, DOI 10.1098/rstb.1984.0022; INMNIS MA, 1990, PCR PROTOCOLS GUIDE; JONES KA, 1985, CELL, V42, P559, DOI 10.1016/0092-8674(85)90113-8; KAWAMURA K, 1979, NEUROSCIENCE, V4, P1615, DOI 10.1016/0306-4522(79)90024-1; LECLERC N, 1992, P NATL ACAD SCI USA, V89, P5006, DOI 10.1073/pnas.89.11.5006; LIVINGSTONE MS, 1984, J NEUROSCI, V4, P309; MARANI E, 1979, ACTA MORPHOL NEER SC, V17, P33; MARTINEZ S, 1989, EUR J NEUROSCI, V1, P549, DOI 10.1111/j.1460-9568.1989.tb00362.x; OBERDICK J, 1990, SCIENCE, V248, P223, DOI 10.1126/science.2109351; OBERDICK J, 1988, NEURON, V1, P367, DOI 10.1016/0896-6273(88)90186-9; OSCARSSON O, 1979, TRENDS NEUROSCI, V2, P143, DOI 10.1016/0166-2236(79)90057-2; RAUSCHER FJ, 1988, GENE DEV, V2, P1687, DOI 10.1101/gad.2.12b.1687; ROBERTSON LT, 1982, EXP BRAIN RES, V46, P281; ROSS ME, 1990, P NATL ACAD SCI USA, V87, P4189, DOI 10.1073/pnas.87.11.4189; RUVKUN G, 1991, CELL, V64, P475, DOI 10.1016/0092-8674(91)90227-P; SCHILLING K, 1991, NEURON, V7, P891, DOI 10.1016/0896-6273(91)90335-W; SMEYNE RJ, 1991, SCIENCE, V254, P719, DOI 10.1126/science.1948052; SOTELO C, 1991, PHILOS T R SOC B, V331, P307, DOI 10.1098/rstb.1991.0022; STANOJEVIC D, 1991, SCIENCE, V254, P1385, DOI 10.1126/science.1683715; TANO D, 1992, J COMP NEUROL, V323, P128, DOI 10.1002/cne.903230111; VANDAELE S, 1991, GENE DEV, V5, P1136, DOI 10.1101/gad.5.7.1136; Voogd J., 1980, INFERIOR OLIVARY NUC, P207; WASSEF M, 1990, J COMP NEUROL, V294, P223, DOI 10.1002/cne.902940207; WASSEF M, 1992, J COMP NEUROL, V323, P519, DOI 10.1002/cne.903230405; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; XI H, 1989, NATURE, V340, P35, DOI 10.1038/340035a0	40	143	143	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	1993	10	6					1007	1018		10.1016/0896-6273(93)90050-2	http://dx.doi.org/10.1016/0896-6273(93)90050-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LK373	8318226				2022-12-24	WOS:A1993LK37300002
J	GILBERTSON, TA; ROPER, SD; KINNAMON, SC				GILBERTSON, TA; ROPER, SD; KINNAMON, SC			PROTON CURRENTS THROUGH AMILORIDE-SENSITIVE NA+ CHANNELS IN ISOLATED HAMSTER TASTE CELLS - ENHANCEMENT BY VASOPRESSIN AND CAMP	NEURON			English	Article							ACTIVE ION-TRANSPORT; SODIUM-CHANNELS; CHORDA TYMPANI; FUNGIFORM PAPILLA; NEURAL RESPONSES; K+ CHANNELS; TRANSDUCTION; INHIBITION; RAT; MEMBRANE	Amiloride has been suggested to inhibit responses to a variety of taste stimuli, including salty, sweet, and sour (acid). To test for the involvement of amiloride-sensitive Na+ channels in the transduction of acid stimuli, fungiform taste receptor cells were examined using patch-clamp techniques. Approximately one-half of all cells had amiloride-sensitive Na+ currents (I(Na)) with a K(i) value near 0.2 muM amiloride. After blocking voltage-gated conductances, cells having amiloride sensitivity were tested for responses to acid stimuli. Over three-fourths of cells showed an inward proton current (I(H+)) with an extrapolated reversal potential near approximately +150 mV, which was completely blocked by amiloride (30 muM). Treatment of isolated taste cells with arginine8-vasopressin caused equivalent increases in both I(Na) and I(H+); each effect was mimicked by 8-Br-cAMP. Taken together, these results indicate that protons permeate amiloride-sensitive Na+ channels in hamster fungiform taste cells and contribute to acid transduction.	UNIV COLORADO, HLTH SCI CTR, ROCKY MT TASTE & SMELL CTR, DENVER, CO 80262 USA; COLORADO STATE UNIV, DEPT ANAT & NEUROBIOL, FT COLLINS, CO 80523 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Colorado State University			Gilbertson, Timothy/G-7147-2011	Gilbertson, Timothy/0000-0003-2569-3096; Roper, Stephen/0000-0001-6049-8320	NIDCD NIH HHS [DC-00374, DC-00766, DC-00244] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000766] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		AKABAS M, 1990, J MEMBRANE BIOL, V114, P71, DOI 10.1007/BF01869386; AVENET P, 1988, J MEMBRANE BIOL, V105, P245, DOI 10.1007/BF01871001; AVENET P, 1991, J MEMBRANE BIOL, V124, P33, DOI 10.1007/BF01871362; AVENET P, 1992, SOC GEN PHY, V47, P271; Avenet P, 1991, Curr Opin Neurobiol, V1, P198, DOI 10.1016/0959-4388(91)90078-L; AVENET P, 1992, PENNINGTON CTR NUTRI, V2, P374; BEHE P, 1990, J GEN PHYSIOL, V96, P1061, DOI 10.1085/jgp.96.5.1061; BEHE P, 1990, 10TH P INT S OLF TAS, P270; BENOS DJ, 1982, AM J PHYSIOL, V242, pC131, DOI 10.1152/ajpcell.1982.242.3.C131; BESTERMAN JM, 1985, J BIOL CHEM, V260, P1155; BRAND JG, 1985, BRAIN RES, V334, P207, DOI 10.1016/0006-8993(85)90212-4; CUMMINGS TA, 1992, J GEN PHYSIOL, V99, P591, DOI 10.1085/jgp.99.4.591; DESIMONE JA, 1981, SCIENCE, V214, P1039, DOI 10.1126/science.7302576; DESIMONE JA, 1985, AM J PHYSIOL, V249, pR52, DOI 10.1152/ajpregu.1985.249.1.R52; DESIMONE JA, 1984, J GEN PHYSIOL, V83, P633, DOI 10.1085/jgp.83.5.633; FRELIN C, 1988, BIOCHIMIE, V70, P1285, DOI 10.1016/0300-9084(88)90196-4; GARCIA ML, 1990, J BIOL CHEM, V265, P3763; GARTY H, 1983, J GEN PHYSIOL, V81, P785, DOI 10.1085/jgp.81.6.785; GARTY H, 1988, PHYSIOL REV, V68, P309, DOI 10.1152/physrev.1988.68.2.309; GARTY H, 1986, J MEMBRANE BIOL, V90, P193, DOI 10.1007/BF01870126; GILBERTSON TA, 1992, J GEN PHYSIOL, V100, P803, DOI 10.1085/jgp.100.5.803; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HECK GL, 1985, CHEM SENSES, V10, P427; HECK GL, 1984, SCIENCE, V223, P403, DOI 10.1126/science.6691151; HELLEMANN U, 1992, INT J FOOD SCI TECH, V27, P201; HELMAN SI, 1983, J GEN PHYSIOL, V82, P201, DOI 10.1085/jgp.82.2.201; HERNESS MS, 1992, COMP BIOCHEM PHYS A, V103, P269, DOI 10.1016/0300-9629(92)90578-E; HETTINGER TP, 1990, BRAIN RES, V513, P24, DOI 10.1016/0006-8993(90)91085-U; HILL DL, 1985, DEV BRAIN RES, V20, P310, DOI 10.1016/0165-3806(85)90121-X; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; HYMAN AM, 1980, J GEN PHYSIOL, V76, P143, DOI 10.1085/jgp.76.2.143; INOMATA N, 1988, BRIT J PHARMACOL, V93, P679, DOI 10.1111/j.1476-5381.1988.tb10326.x; KINNAMON SC, 1988, P NATL ACAD SCI USA, V85, P7023, DOI 10.1073/pnas.85.18.7023; KINNAMON SC, 1988, CHEM SENSES, V13, P115, DOI 10.1093/chemse/13.1.115; KINNAMON SC, 1988, J GEN PHYSIOL, V91, P351, DOI 10.1085/jgp.91.3.351; KINNAMON SC, 1988, TRENDS NEUROSCI, V11, P491, DOI 10.1016/0166-2236(88)90010-0; KINTER LB, 1988, AM J PHYSIOL, V254, pF165, DOI 10.1152/ajprenal.1988.254.2.F165; Korn S.J., 1991, METHODS NEUROSCIENCE, VVolume 4, P364; KOSTEN T, 1985, BEHAV NEUROSCI, V99, P734, DOI 10.1037/0735-7044.99.4.734; LESTER DS, 1988, AM J PHYSIOL, V254, pC802, DOI 10.1152/ajpcell.1988.254.6.C802; MANEV H, 1990, NEUROPHARMACOLOGY, V29, P1103, DOI 10.1016/0028-3908(90)90033-N; MARUNAKA Y, 1991, AM J PHYSIOL, V260, pC1071, DOI 10.1152/ajpcell.1991.260.5.C1071; MCBURNEY DH, 1973, PHYSIOL BEHAV, V10, P1101, DOI 10.1016/0031-9384(73)90194-7; MCCUTCHEON NB, 1986, PHYSIOL BEHAV, V36, P1081, DOI 10.1016/0031-9384(86)90483-X; MCPHEETERS M, 1985, CHEM SENSES, V10, P341, DOI 10.1093/chemse/10.3.341; MENDOZA SA, 1970, AM J PHYSIOL, V219, P1440, DOI 10.1152/ajplegacy.1970.219.5.1440; MIERSON S, 1988, J GEN PHYSIOL, V92, P87, DOI 10.1085/jgp.92.1.87; MIYAMOTO T, 1988, J PHYSIOL-LONDON, V405, P699, DOI 10.1113/jphysiol.1988.sp017356; OKADA Y, 1991, COMP BIOCHEM PHYS A, V100, P693; OKADA Y, 1990, COMP BIOCHEM PHYS A, V97, P535; ORLOFF J, 1962, J CLIN INVEST, V41, P702, DOI 10.1172/JCI104528; OZEKI M, 1971, J GEN PHYSIOL, V58, P688, DOI 10.1085/jgp.58.6.688; PALATY V, 1989, MOL PHARMACOL, V36, P296; Palmer L G, 1981, Ann N Y Acad Sci, V372, P1, DOI 10.1111/j.1749-6632.1981.tb15453.x; PALMER LG, 1982, J MEMBRANE BIOL, V64, P91, DOI 10.1007/BF01870771; PALMER LG, 1992, ANNU REV PHYSIOL, V54, P51, DOI 10.1146/annurev.ph.54.030192.000411; PANGBORN RM, 1967, PERCEPT PSYCHOPHYS, V2, P503, DOI 10.3758/BF03210255; ROPER S, 1983, SCIENCE, V220, P1311, DOI 10.1126/science.6857254; SARIBANSOHRABY S, 1986, AM J PHYSIOL, V250, pC175, DOI 10.1152/ajpcell.1986.250.2.C175; SCHELLENBERG GD, 1983, MOL PHARMACOL, V24, P251; SCHELLENBERG GD, 1985, MOL PHARMACOL, V27, P537; SCHIFFMAN SS, 1983, P NATL ACAD SCI-BIOL, V80, P6136, DOI 10.1073/pnas.80.19.6136; Schulkin J., 1991, SODIUM HUNGER SEARCH; SETTLE RG, 1986, PHYSIOL BEHAV, V36, P619, DOI 10.1016/0031-9384(86)90343-4; SIMON SA, 1986, AM J PHYSIOL, V251, pR598, DOI 10.1152/ajpregu.1986.251.3.R598; STRICKER E M, 1992, P451; TANG CM, 1988, SCIENCE, V240, P213, DOI 10.1126/science.2451291; TEETER JH, 1989, CHEM SENSES, V1, P151; TONASAKI K, 1984, COMP BIOCH PHYSL A, V78, P651; TONASAKI K, 1989, COMP BIOCH PHYSL A, V94, P659; TRAVERS SP, 1984, J GEN PHYSIOL, V84, P221, DOI 10.1085/jgp.84.2.221; VANDRIESSCHE W, 1985, PHYSIOL REV, V65, P833, DOI 10.1152/physrev.1985.65.4.833	72	130	136	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY	1993	10	5					931	942		10.1016/0896-6273(93)90208-9	http://dx.doi.org/10.1016/0896-6273(93)90208-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LD322	8388226				2022-12-24	WOS:A1993LD32200015
J	JOHNSON, BD; BYERLY, L				JOHNSON, BD; BYERLY, L			A CYTOSKELETAL MECHANISM FOR CA2+ CHANNEL METABOLIC DEPENDENCE AND INACTIVATION BY INTRACELLULAR CA2+	NEURON			English	Article							SQUID GIANT-AXONS; CALCIUM CURRENTS; LYMNAEA-STAGNALIS; PERFUSED NEURONS; HIPPOCAMPAL-NEURONS; PROTEIN-KINASES; SODIUM CURRENT; HELIX NEURONS; MEMBRANE; MICROTUBULES	Many different types of voltage-dependent Ca2+ channels inactivate when intracellular ATP declines or intracellular Ca2+ rises. An inside-out, patch-clamp technique was applied to the Ca2+ channels of Lymnaea neurons to determine the mechanism(s) underlying these two phenomena. Although no evidence was found for a phosphorylation mechanism, agents that act on the cytoskeleton were found to alter Ca2+ channel activity. The cytoskeletal disrupters colchicine and cytochalasin B were found to speed Ca2+ channel decline in ATP, whereas the cytoskeletal stabilizers taxol and phalloidin were found to prolong Ca2+ channel activity without ATP. In addition, cytoskeletal stabilizers reduced Ca2+-dependent channel inactivation, suggesting that both channel metabolic dependence and Ca2+-dependent inactivation result from a cytoskeletal interaction.			JOHNSON, BD (corresponding author), UNIV SO CALIF, DEPT BIOL SCI, NEUROBIOL SECT, LOS ANGELES, CA 90089 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028484] Funding Source: NIH RePORTER; NINDS NIH HHS [NS28484] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKAIKE N, 1988, NEUROSCI LETT, V84, P46, DOI 10.1016/0304-3940(88)90335-7; ANDERSON MP, 1992, SCIENCE, V257, P1701, DOI 10.1126/science.1382316; ARMSTRONG D, 1987, P NATL ACAD SCI USA, V84, P2518, DOI 10.1073/pnas.84.8.2518; BELLES B, 1988, PFLUG ARCH EUR J PHY, V411, P353, DOI 10.1007/BF00587713; BYERLY L, 1986, J PHYSIOL-LONDON, V370, P631, DOI 10.1113/jphysiol.1986.sp015955; BYERLY L, 1989, J PHYSIOL-LONDON, V413, P75, DOI 10.1113/jphysiol.1989.sp017642; BYERLY L, 1984, J PHYSIOL-LONDON, V352, P637, DOI 10.1113/jphysiol.1984.sp015314; BYERLY L, 1988, BIOMED RES-TOKYO, V9, P1; CANTIELLO HF, 1991, AM J PHYSIOL, V261, pC882, DOI 10.1152/ajpcell.1991.261.5.C882; CAPUTO CB, 1989, BIOCHIM BIOPHYS ACTA, V1012, P299, DOI 10.1016/0167-4889(89)90112-2; CHAD JE, 1986, J PHYSIOL-LONDON, V378, P31, DOI 10.1113/jphysiol.1986.sp016206; CHEN QX, 1990, J PHYSIOL-LONDON, V420, P207, DOI 10.1113/jphysiol.1990.sp017908; COLLINS A, 1992, J PHYSIOL-LONDON, V454, P27, DOI 10.1113/jphysiol.1992.sp019253; DEWEILLE JR, 1992, J BIOL CHEM, V267, P4557; DOLPHIN AC, 1992, PFLUG ARCH EUR J PHY, V421, P138, DOI 10.1007/BF00374820; DOROSHENKO PA, 1982, NEUROSCIENCE, V7, P2125, DOI 10.1016/0306-4522(82)90124-5; DUPONT JL, 1986, PFLUG ARCH EUR J PHY, V406, P433, DOI 10.1007/BF00590950; FUKUDA J, 1981, NATURE, V294, P82, DOI 10.1038/294082a0; FURUHASHI K, 1990, J CELL BIOL, V111, P1081, DOI 10.1083/jcb.111.3.1081; HAGIWARA S, 1966, J GEN PHYSIOL, V49, P807, DOI 10.1085/jgp.49.4.807; HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V171, P189, DOI 10.1016/0006-291X(90)91375-3; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; HILGEMANN DW, 1989, PFLUG ARCH EUR J PHY, V415, P247, DOI 10.1007/BF00370601; HILGEMANN DW, 1992, J PHYSIOL-LONDON, V454, P59, DOI 10.1113/jphysiol.1992.sp019254; JOHNSON BD, 1993, J PHYSIOL-LONDON, V462, P321, DOI 10.1113/jphysiol.1993.sp019558; KOSTYUK PG, 1992, PFLUG ARCH EUR J PHY, V420, P9, DOI 10.1007/BF00378635; MATSUMOTO G, 1979, J MEMBRANE BIOL, V50, P15, DOI 10.1007/BF01868785; MATSUMOTO G, 1984, J MEMBRANE BIOL, V77, P93; MATSUMOTO G, 1984, J MEMBRANE BIOL, V77, P77; MATSUMOTO G, 1979, J MEMBRANE BIOL, V50, P1, DOI 10.1007/BF01868784; MEJILLANO MR, 1990, BIOCHEM BIOPH RES CO, V166, P653, DOI 10.1016/0006-291X(90)90859-L; MODY I, 1988, NEUROSCI LETT, V93, P73, DOI 10.1016/0304-3940(88)90015-8; MUKAI M, 1992, AM J PHYSIOL, V262, pC84, DOI 10.1152/ajpcell.1992.262.1.C84; Neher E., 1986, EXPT BRAIN RES SERIE, P80; OHYA Y, 1988, CIRC RES, V62, P375, DOI 10.1161/01.RES.62.2.375; OROURKE B, 1992, SCIENCE, V257, P245, DOI 10.1126/science.1321495; PLANT TD, 1983, J PHYSIOL-LONDON, V334, P189, DOI 10.1113/jphysiol.1983.sp014489; ROSENBERG RL, 1988, J GEN PHYSIOL, V92, P27, DOI 10.1085/jgp.92.1.27; RUKNUDIN A, 1991, J CELL BIOL, V112, P125, DOI 10.1083/jcb.112.1.125; SAHYOUN N, 1985, J BIOL CHEM, V260, P1230; SHIRASAKI T, 1992, J PHYSIOL-LONDON, V449, P551, DOI 10.1113/jphysiol.1992.sp019101; SIMON SM, 1985, BIOPHYS J, V48, P485, DOI 10.1016/S0006-3495(85)83804-2; TSIEN RY, 1980, BIOCHIM BIOPHYS ACTA, V599, P623, DOI 10.1016/0005-2736(80)90205-9; TUAZON PT, 1991, ADV 2ND MESSENGER PH, V23, P123; Wang YL, 1991, CURR OPIN CELL BIOL, V3, P27, DOI 10.1016/0955-0674(91)90162-R; WELSH MJ, 1992, NEURON, V8, P821, DOI 10.1016/0896-6273(92)90196-K	46	209	214	1	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	1993	10	5					797	804		10.1016/0896-6273(93)90196-X	http://dx.doi.org/10.1016/0896-6273(93)90196-X			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LD322	8098608				2022-12-24	WOS:A1993LD32200003
J	BRUNS, D; ENGERT, F; LUX, HD				BRUNS, D; ENGERT, F; LUX, HD			A FAST ACTIVATING PRESYNAPTIC REUPTAKE CURRENT DURING SEROTONERGIC TRANSMISSION IN IDENTIFIED NEURONS OF HIRUDO	NEURON			English	Article							PLASMA-MEMBRANE VESICLES; SQUID GIANT SYNAPSE; LEECH NEURONS; NEUROTRANSMITTER RELEASE; RETZIUS CELLS; TIME COURSE; PLATELET 5-HYDROXYTRYPTAMINE; TRANSMITTER RELEASE; VOLTAGE HYPOTHESIS; SENSORY NEURONS	An electrogenic serotonin (5-HT) uptake process was characterized in the serotonergic Retzius-P cell synapse of the leech, and the simultaneous activation of this presynaptic reuptake and the postsynaptic response was monitored during evoked transmitter release. A presynaptic, Na+-dependent inward current upon application of 5-HT was isolated at membrane potentials between -80 and +60 mV. Its identification as a transmitter uptake current was confirmed by monitoring accumulation of the autofluorescent 5-HT analog 5,7-dihydroxytryptamine during activation of this current. To study the kinetics of 5-HT reuptake in functional synapses, transmitter release was stimulated by flash photolysis of the Ca2+-caging DM-nitrophen. The results demonstrate that re-uptake activates with a minimal delay of less than a millisecond during synaptic transmission. It acts as a rapid transmitter removal system to determine the time course of the postsynaptic response and monitors the kinetics of transmitter clearance at the synaptic site.			BRUNS, D (corresponding author), MAX PLANCK INST PSYCHIAT,DEPT NEUROPHYSIOL,KLOPFERSPITZ 18A,W-8033 MARTINSRIED,GERMANY.							Baumgarten H G, 1978, Ann N Y Acad Sci, V305, P3, DOI 10.1111/j.1749-6632.1978.tb31507.x; BLAUSTEIN MP, 1975, J MEMBRANE BIOL, V22, P285, DOI 10.1007/BF01868176; BOGDANSKI DF, 1970, BIOCHIM BIOPHYS ACTA, V219, P189, DOI 10.1016/0005-2736(70)90074-X; BORLINGHAUS R, 1987, J MEMBRANE BIOL, V97, P161, DOI 10.1007/BF01869220; BREW H, 1987, NATURE, V327, P707, DOI 10.1038/327707a0; CARBONE E, 1987, J PHYSIOL-LONDON, V386, P547, DOI 10.1113/jphysiol.1987.sp016551; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; DEITMER JW, 1981, J EXP BIOL, V91, P87; DELANEY KR, 1990, J PHYSIOL-LONDON, V426, P473, DOI 10.1113/jphysiol.1990.sp018150; DELATORRE JC, 1976, HISTOCHEMISTRY, V49, P81, DOI 10.1007/BF00495672; DIETZEL ID, 1988, DEV BIOL, V128, P277, DOI 10.1016/0012-1606(88)90290-4; DIETZEL ID, 1986, J PHYSIOL-LONDON, V372, P191, DOI 10.1113/jphysiol.1986.sp016004; DRAPEAU P, 1989, J NEUROSCI, V9, P2502; DRAPEAU P, 1988, J NEUROSCI, V8, P4718; DUDEL J, 1988, NEUROMUSCULAR JUNCTI, P149; ECCLES JC, 1958, PROC R SOC SER B-BIO, V148, P38, DOI 10.1098/rspb.1958.0003; FUCHS PA, 1982, J PHYSIOL-LONDON, V323, P195, DOI 10.1113/jphysiol.1982.sp014068; GERSCHENFELD HM, 1974, J PHYSIOL-LONDON, V243, P427, DOI 10.1113/jphysiol.1974.sp010761; GERSCHENFELD HM, 1978, J PHYSIOL-LONDON, V274, P265; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HENDERSON LP, 1983, J PHYSIOL-LONDON, V339, P309, DOI 10.1113/jphysiol.1983.sp014718; HIGASHI H, 1982, J PHYSIOL-LONDON, V323, P543, DOI 10.1113/jphysiol.1982.sp014091; HOFMEIER G, 1981, PFLUG ARCH EUR J PHY, V391, P242, DOI 10.1007/BF00596178; HORN AS, 1973, J NEUROCHEM, V21, P233; IVERSEN LL, 1973, BRIT MED BULL, V29, P130, DOI 10.1093/oxfordjournals.bmb.a070982; IVERSEN LL, 1971, BRIT J PHARMACOL, V41, P571, DOI 10.1111/j.1476-5381.1971.tb07066.x; KANNER BI, 1987, CRIT REV BIOCHEM MOL, V22, P1, DOI 10.3109/10409238709082546; KANNER BI, 1985, BIOCHIM BIOPHYS ACTA, V816, P403, DOI 10.1016/0005-2736(85)90508-5; KAPLAN JH, 1988, P NATL ACAD SCI USA, V85, P6571, DOI 10.1073/pnas.85.17.6571; KEYES SR, 1982, J BIOL CHEM, V257, P1172; KUFFLER DP, 1987, J COMP NEUROL, V256, P516, DOI 10.1002/cne.902560404; KUHAR MJ, 1978, J NEUROCHEM, V31, P251, DOI 10.1111/j.1471-4159.1978.tb12456.x; LENT CM, 1984, BRAIN RES, V300, P167, DOI 10.1016/0006-8993(84)91353-2; LESSMANN V, 1991, J NEUROSCI, V11, P800; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; LIU Y, 1989, PROC R SOC SER B-BIO, V236, P253, DOI 10.1098/rspb.1989.0023; LLINAS R, 1981, BIOPHYS J, V33, P323, DOI 10.1016/S0006-3495(81)84899-0; MAGLEBY KL, 1972, J PHYSIOL-LONDON, V223, P151, DOI 10.1113/jphysiol.1972.sp009839; MCCAMAN MW, 1973, BRAIN RES, V53, P129, DOI 10.1016/0006-8993(73)90772-5; MORAD M, 1988, SCIENCE, V241, P842, DOI 10.1126/science.2457253; NELSON PJ, 1979, J BIOL CHEM, V254, P84; NELSON PJ, 1982, J BIOL CHEM, V257, P6151; NIGGLI E, 1991, NATURE, V349, P621, DOI 10.1038/349621a0; OREILLY CA, 1988, J BIOL CHEM, V263, P6115; PAN ZZ, 1989, J PHARMACOL EXP THER, V251, P56; PARNAS H, 1986, PFLUG ARCH EUR J PHY, V406, P121, DOI 10.1007/BF00586672; PARNAS I, 1986, J PHYSIOL-PARIS, V81, P289; PARTRIDGE LD, 1988, TRENDS NEUROSCI, V11, P69, DOI 10.1016/0166-2236(88)90167-1; REITH MEA, 1989, BIOCHEM PHARMACOL, V38, P2091, DOI 10.1016/0006-2952(89)90062-2; ROSS SB, 1977, NEUROPHARMACOLOGY, V16, P57, DOI 10.1016/0028-3908(77)90048-X; RUDNICK G, 1980, J BIOL CHEM, V255, P3638; RUDNICK G, 1977, J BIOL CHEM, V252, P2170; RUDNICK G, 1978, BIOCHEMISTRY-US, V17, P4739, DOI 10.1021/bi00615a021; SILVA NL, 1988, P NATL ACAD SCI USA, V85, P7346, DOI 10.1073/pnas.85.19.7346; STEWART RR, 1989, J EXP BIOL, V141, P1; TALVENHEIMO J, 1983, J BIOL CHEM, V258, P6115; THOMPSON SM, 1992, J NEUROPHYSIOL, V67, P1698, DOI 10.1152/jn.1992.67.6.1698; ZUCKER RS, 1986, SCIENCE, V231, P574, DOI 10.1126/science.2868525; ZUCKER RS, 1988, NATURE, V335, P360, DOI 10.1038/335360a0	59	66	67	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1993	10	4					559	572		10.1016/0896-6273(93)90159-O	http://dx.doi.org/10.1016/0896-6273(93)90159-O			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KY501	8386524				2022-12-24	WOS:A1993KY50100001
J	LUCAS, JJ; MELLSTROM, B; COLADO, MI; NARANJO, JR				LUCAS, JJ; MELLSTROM, B; COLADO, MI; NARANJO, JR			MOLECULAR MECHANISMS OF PAIN - SEROTONIN(1A) RECEPTOR AGONISTS TRIGGER TRANSACTIVATION BY C-FOS OF THE PRODYNORPHIN GENE IN SPINAL-CORD NEURONS	NEURON			English	Article							DORSAL HORN NEURONS; MULTIPLE SEQUENCE ELEMENTS; PIG HIPPOCAMPAL MEMBRANES; CENTRAL NERVOUS-SYSTEM; CHRONIC ARTHRITIC RATS; IMMEDIATE EARLY GENES; CHI-OPIOID RECEPTOR; ADENYLATE-CYCLASE; MESSENGER-RNA; PHARMACOLOGICAL CHARACTERIZATION	By using spinal cord neurons cultured in chemically defined medium, a double labeling procedure, and blockage with antisense oligonucleotides, we show that induction of c-fos and the subsequent transactivation of the prodynorphin gene are coupled events, triggered by serotonin1A receptor agonists. Addition of the specific 1A agonist 8-hydroxy-2-(di-n-propylamino)-tetralin (8-OH-DPAT) to the culture, at concentrations similar to that needed for transactivation of the prodynorphin gene, also significantly increases cAMP levels. Furthermore, in rats depleted of serotonin by intrathecal administration of 5,7-dihydroxytryptamine, the induction of prodynorphin after noxious stimulation is dramatically decreased compared with the induction in sham-operated rats. These results suggest that the expression of the prodynorphin gene in spinal cord is under the control of the raphe-spinal efferents containing serotonin.	UNIV COMPLUTENSE MADRID, FAC MED, DEPT FARMACOL, MADRID 3, SPAIN	Complutense University of Madrid	LUCAS, JJ (corresponding author), CSIC, INST CAJAL NEUROCIENCIA, AV DR ARCE 37, E-28002 MADRID, SPAIN.		NARANJO, Jose R/K-1950-2014; Lucas, Jose J./U-6543-2019	NARANJO, Jose R/0000-0002-0270-3469; Lucas, Jose J./0000-0003-1597-3916				ALBERT PR, 1990, J BIOL CHEM, V265, P5825; BALSINDE J, 1988, BIOCHEM BIOPH RES CO, V154, P502, DOI 10.1016/0006-291X(88)90168-4; BERKOWITZ LA, 1989, MOL CELL BIOL, V9, P4272, DOI 10.1128/MCB.9.10.4272; Besson J M, 1981, Adv Exp Med Biol, V133, P153; BOCKAERT J, 1990, MOL PHARMACOL, V37, P408; CARTER MS, 1990, J NEUROSCI, V10, P2203; CAUDLE RM, 1988, J PHARMACOL EXP THER, V246, P508; CHEN L, 1992, NATURE, V356, P521, DOI 10.1038/356521a0; CIVELLI O, 1985, P NATL ACAD SCI USA, V82, P4291, DOI 10.1073/pnas.82.12.4291; COMB M, 1988, EMBO J, V7, P3793, DOI 10.1002/j.1460-2075.1988.tb03264.x; CORBETT AD, 1982, NATURE, V299, P79, DOI 10.1038/299079a0; CRAIN SM, 1990, TRENDS PHARMACOL SCI, V11, P77, DOI 10.1016/0165-6147(90)90322-Y; CURRAN T, 1987, BIOESSAYS, V7, P255, DOI 10.1002/bies.950070606; CURRAN T, 1985, MOL CELL BIOL, V5, P167, DOI 10.1128/MCB.5.1.167; DIGBY J, 1985, MUSCLE NERVE, V8, P595, DOI 10.1002/mus.880080709; DOUGLASS J, 1989, MOL ENDOCRINOL, V3, P2070, DOI 10.1210/mend-3-12-2070; DRAISCI G, 1989, MOL BRAIN RES, V6, P31, DOI 10.1016/0169-328X(89)90025-9; DUBNER R, 1992, TRENDS NEUROSCI, V15, P96, DOI 10.1016/0166-2236(92)90019-5; DUBUISSON D, 1980, BRAIN RES, V199, P283, DOI 10.1016/0006-8993(80)90690-3; DUMUIS A, 1988, MOL PHARMACOL, V34, P880; EMILSSON A, 1984, J BIOL CHEM, V259, P3111; FIELDS HL, 1977, BRAIN RES, V126, P441, DOI 10.1016/0006-8993(77)90596-0; FIELDS HL, 1991, ANNU REV NEUROSCI, V14, P219, DOI 10.1146/annurev.neuro.14.1.219; FISCH TM, 1989, GENE DEV, V3, P198, DOI 10.1101/gad.3.2.198; FRAZER A, 1990, ANNU REV PHARMACOL, V30, P307; GIZANGGINSBERG E, 1990, GENE DEV, V4, P477, DOI 10.1101/gad.4.4.477; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; GOZLAN H, 1983, NATURE, V305, P140, DOI 10.1038/305140a0; GREUEL JM, 1992, EUR J PHARMACOL, V211, P211, DOI 10.1016/0014-2999(92)90531-8; HAUN RS, 1990, J BIOL CHEM, V265, P15455; HENGERER B, 1990, P NATL ACAD SCI USA, V87, P3899, DOI 10.1073/pnas.87.10.3899; HOLLT V, 1987, NEUROSCI LETT, V73, P90, DOI 10.1016/0304-3940(87)90037-1; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; HYLDEN JLK, 1992, J NEUROSCI, V12, P1716; HYLDEN JLK, 1991, PAIN, V44, P187, DOI 10.1016/0304-3959(91)90136-L; Iadarola M J, 1986, NIDA Res Monogr, V75, P406; IADAROLA MJ, 1988, BRAIN RES, V455, P205, DOI 10.1016/0006-8993(88)90078-9; IADAROLA MJ, 1988, 5TH P WORLD C PAIN, P61; Jessell TM, 1989, TXB PAIN, P82; JONES SL, 1990, BRAIN RES, V530, P335, DOI 10.1016/0006-8993(90)91306-2; JONES SL, 1990, J COMP NEUROL, V297, P267, DOI 10.1002/cne.902970209; JULIUS D, 1991, ANNU REV NEUROSCI, V14, P335, DOI 10.1146/annurev.neuro.14.1.335; KAKIUCHI S, 1968, MOL PHARMACOL, V4, P367; KNOX RJ, 1987, BRAIN RES, V415, P21, DOI 10.1016/0006-8993(87)90265-4; LEAH J, 1988, NEUROSCIENCE, V24, P195; MAROTEAUX L, 1992, P NATL ACAD SCI USA, V89, P3020, DOI 10.1073/pnas.89.7.3020; MELLSTROM B, 1991, MOL ENDOCRINOL, V5, P1339, DOI 10.1210/mend-5-9-1339; MILLAN MJ, 1985, BRAIN RES, V340, P156, DOI 10.1016/0006-8993(85)90786-3; MILLAN MJ, 1989, NEUROSCI LETT, V107, P227, DOI 10.1016/0304-3940(89)90822-7; MILLAN MJ, 1991, J PHARMACOL EXP THER, V256, P983; MILLER KE, 1987, J COMP NEUROL, V255, P293, DOI 10.1002/cne.902550212; MOLINEAUX SM, 1989, P NATL ACAD SCI USA, V86, P6793, DOI 10.1073/pnas.86.17.6793; MORRIS BJ, 1987, N-S ARCH PHARMACOL, V336, P240, DOI 10.1007/BF00165811; MORRIS BJ, 1988, MOL BRAIN RES, V4, P15, DOI 10.1016/0169-328X(88)90013-7; NARANJO JR, 1989, NEUROPHARMACOLOGY, V28, P291, DOI 10.1016/0028-3908(89)90106-8; NARANJO JR, 1991, NEURON, V6, P607, DOI 10.1016/0896-6273(91)90063-6; NARANJO JR, 1991, ONCOGENE, V6, P223; NOGUCHI K, 1992, NEUROSCIENCE, V46, P561, DOI 10.1016/0306-4522(92)90144-Q; PAZOS A, 1985, BRAIN RES, V346, P205, DOI 10.1016/0006-8993(85)90856-X; PRETEL S, 1991, PEPTIDES, V12, P1243, DOI 10.1016/0196-9781(91)90202-Z; PRZEWLOCKI R, 1988, MOL BRAIN RES, V4, P37, DOI 10.1016/0169-328X(88)90016-2; RUDA MA, 1988, P NATL ACAD SCI USA, V85, P622, DOI 10.1073/pnas.85.2.622; SASEK CA, 1984, NEUROSCIENCE, V12, P855, DOI 10.1016/0306-4522(84)90175-1; SASSONECORSI P, 1988, GENE DEV, V2, P1529, DOI 10.1101/gad.2.12a.1529; SCHMAUSS C, 1984, J PHARMACOL EXP THER, V228, P1; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; SHENKER A, 1987, MOL PHARMACOL, V31, P357; SONNENBERG JL, 1989, SCIENCE, V246, P1622, DOI 10.1126/science.2512642; STERNBERGER LA, 1986, IMMUNOCYTOCHEMISTRY; TAKAHASHI O, 1990, PEPTIDES, V11, P1233, DOI 10.1016/0196-9781(90)90157-Z; WISDEN W, 1990, NEURON, V4, P603, DOI 10.1016/0896-6273(90)90118-Y; WOOLF CJ, 1986, J NEUROSCI, V6, P1433; YAKSH TL, 1976, PHYSIOL BEHAV, V17, P1031, DOI 10.1016/0031-9384(76)90029-9	73	86	86	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1993	10	4					599	611		10.1016/0896-6273(93)90163-L	http://dx.doi.org/10.1016/0896-6273(93)90163-L			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KY501	8476611				2022-12-24	WOS:A1993KY50100005
J	CANNON, SC; STRITTMATTER, SM				CANNON, SC; STRITTMATTER, SM			FUNCTIONAL EXPRESSION OF SODIUM-CHANNEL MUTATIONS IDENTIFIED IN FAMILIES WITH PERIODIC PARALYSIS	NEURON			English	Article							ADYNAMIA EPISODICA HEREDITARIA; ALPHA-SUBUNIT; MESSENGER-RNA; MUSCLE; INACTIVATION; GENE; MEMBRANE; CELLS; MODES; RAT	Two mutations in the sodium channel alpha subunit that have been implicated as the cause of periodic paralysis were studied by functional expression in a mammalian cell line. Both mutations disrupted inactivation without affecting the time course of the onset of the sodium current or the single-channel conductance. This is the same functional defect that was observed in myotubes cultured from affected patients and proves that these mutations are not benign polymorphisms. Unlike the currents in the myotubes, however, there was no consistent potassium dependence for the noninactivating component. These mutations also define new regions of the sodium channel alpha subunit that are involved in the process of inactivation.	MASSACHUSETTS GEN HOSP E,DEPT NEUROL,BOSTON,MA 02129		CANNON, SC (corresponding author), MASSACHUSETTS GEN HOSP,HOWARD HUGHES MED INST,DEPT NEUROL,BOSTON,MA 02114, USA.		Cannon, Stephen/V-5343-2019; Strittmatter, Stephen/F-5739-2011	Strittmatter, Stephen/0000-0001-8188-3092; Cannon, Stephen/0000-0001-8428-3690				ALDRICH RW, 1987, J NEUROSCI, V7, P418; CANNON SC, 1991, NEURON, V6, P619, DOI 10.1016/0896-6273(91)90064-7; CANNON SC, 1993, IN PRESS J PHYSL; CREUTZFELDT O, 1963, ELECTROEN CLIN NEURO, V15, P508, DOI 10.1016/0013-4694(63)90071-3; CUMMINS TR, 1993, IN PRESS NEURON; EBERS GC, 1991, ANN NEUROL, V30, P810, DOI 10.1002/ana.410300610; FONTAINE B, 1990, SCIENCE, V250, P1000, DOI 10.1126/science.2173143; GAMSTORP I, 1956, ACTA PAEDIATR STOC S, V108, P1; GEORGE AL, 1992, ANN NEUROL, V31, P131, DOI 10.1002/ana.410310203; GUY HR, 1986, P NATL ACAD SCI USA, V83, P508, DOI 10.1073/pnas.83.2.508; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; ISACOFF EY, 1991, NATURE, V353, P86, DOI 10.1038/353086a0; ISOM LL, 1992, SCIENCE, V256, P839, DOI 10.1126/science.1375395; KRAFTE DS, 1988, J NEUROSCI, V8, P2859; KRANER SD, 1985, J BIOL CHEM, V260, P6341; LEHMANNHORN F, 1987, MUSCLE NERVE, V10, P363, DOI 10.1002/mus.880100414; LEHMANNHORN F, 1983, MUSCLE NERVE, V6, P113, DOI 10.1002/mus.880060206; MOORMAN JR, 1990, NEURON, V4, P243, DOI 10.1016/0896-6273(90)90099-2; NODA M, 1986, NATURE, V322, P826, DOI 10.1038/322826a0; PARDO LA, 1992, P NATL ACAD SCI USA, V89, P2466, DOI 10.1073/pnas.89.6.2466; PATLAK JB, 1986, J GEN PHYSIOL, V87, P305, DOI 10.1085/jgp.87.2.305; PTACEK LJ, 1991, CELL, V67, P1021; PTACEK LJ, 1991, AM J HUM GENET, V49, P378; ROJAS CV, 1991, NATURE, V354, P387, DOI 10.1038/354387a0; Sambrook J, 1989, MOL CLONING LABORATO; SCHEUER T, 1990, SCIENCE, V247, P854, DOI 10.1126/science.2154850; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; TRIMMER JS, 1989, NEURON, V3, P33, DOI 10.1016/0896-6273(89)90113-X; UKOMADU C, 1992, NEURON, V8, P663, DOI 10.1016/0896-6273(92)90088-U; WANG JZ, 1992, BIOCHEM BIOPH RES CO, V182, P794, DOI 10.1016/0006-291X(92)91802-W; ZHOU JY, 1991, NEURON, V7, P775, DOI 10.1016/0896-6273(91)90280-D	31	190	192	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1993	10	2					317	326		10.1016/0896-6273(93)90321-H	http://dx.doi.org/10.1016/0896-6273(93)90321-H			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KP685	8382500				2022-12-24	WOS:A1993KP68500018
J	PEARCE, RA				PEARCE, RA			PHYSIOLOGICAL EVIDENCE FOR 2 DISTINCT GABA(A) RESPONSES IN RAT HIPPOCAMPUS	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; LACUNOSUM-MOLECULARE INTERNEURONS; CIRCUIT SYNAPTIC-INTERACTIONS; SPINAL-CORD NEURONS; PYRAMIDAL CELLS; RECURRENT INHIBITION; RECEPTOR SUBTYPES; BRAIN-SLICES; CA1 NEURONS; A RECEPTORS	The gamma-aminobutyric acid(A) (GABA(A)) receptor is a ligand-gated ionophore involved in synaptic inhibition. Biochemical and molecular biological studies indicate that considerable receptor heterogeneity exists, but physiological differences between inhibitory GABA(A) synaptic responses have not been identified in the brain. The present report describes two anatomically segregated GABA(A)-mediated synaptic currents in the hippocampal CA1 region that have distinct physiological, pharmacological, and functional properties. GABA(A,fast) enters at or near the cell body, decays rapidly (3-8 ms), is blocked by furosemide, and rapidly curtails the excitatory response. GABA(A,slow) enters far from the cell body, decays slowly (30-70 ms), is not blocked by furosemide, and underlies the conventionally recognized early inhibitory postsynaptic potential. The receptors producing these responses may represent subtypes of the GABA(A) receptor.	UNIV WISCONSIN,DEPT ANAT,MADISON,WI 53706; UNIV WISCONSIN,NEUROSCI TRAINING PROGRAM,MADISON,WI 53706	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	PEARCE, RA (corresponding author), UNIV WISCONSIN,DEPT ANESTHESIOL,MADISON,WI 53706, USA.		Pearce, Robert/B-4044-2011	Pearce, Robert/0000-0002-1516-6260	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS001548] Funding Source: NIH RePORTER; NINDS NIH HHS [NS01548] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALGER BE, 1982, J PHYSIOL-LONDON, V328, P105, DOI 10.1113/jphysiol.1982.sp014255; BORMANN J, 1988, TRENDS NEUROSCI, V11, P112, DOI 10.1016/0166-2236(88)90156-7; BUSCH C, 1990, COLD SH Q B, V55, P69; CHEN QX, 1990, J PHYSIOL-LONDON, V420, P207, DOI 10.1113/jphysiol.1990.sp017908; COLLINGRIDGE GL, 1984, J PHYSIOL-LONDON, V356, P551, DOI 10.1113/jphysiol.1984.sp015482; DAVIES CH, 1991, NATURE, V349, P609, DOI 10.1038/349609a0; DAVIES CH, 1990, J PHYSIOL-LONDON, V424, P513, DOI 10.1113/jphysiol.1990.sp018080; DUNWIDDIE TV, 1986, J PHARMACOL EXP THER, V238, P564; DUTAR P, 1988, NATURE, V332, P156, DOI 10.1038/332156a0; EDWARDS FA, 1990, J PHYSIOL-LONDON, V430, P213, DOI 10.1113/jphysiol.1990.sp018289; HARA M, 1992, NEUROSCI LETT, V143, P135, DOI 10.1016/0304-3940(92)90250-B; INOMATA N, 1988, BRIT J PHARMACOL, V93, P679, DOI 10.1111/j.1476-5381.1988.tb10326.x; ISHIZUKA N, 1990, J COMP NEUROL, V295, P580, DOI 10.1002/cne.902950407; JOHNSTON D, 1983, J NEUROPHYSIOL, V50, P464, DOI 10.1152/jn.1983.50.2.464; KANDEL ER, 1961, J NEUROPHYSIOL, V24, P225, DOI 10.1152/jn.1961.24.3.225; KAPUR J, 1989, J NEUROPHYSIOL, V61, P417, DOI 10.1152/jn.1989.61.2.417; KERR DIB, 1988, NEUROSCI LETT, V92, P92, DOI 10.1016/0304-3940(88)90748-3; KERR DIB, 1987, BRAIN RES, V405, P150, DOI 10.1016/0006-8993(87)90999-1; KNOWLES WD, 1981, J NEUROSCI, V1, P318; KRASZEWSKI K, 1992, NEUROSCIENCE, V47, P555, DOI 10.1016/0306-4522(92)90165-X; LACAILLE JC, 1988, J NEUROSCI, V8, P1411; LACAILLE JC, 1988, J NEUROSCI, V8, P1400; LACAILLE JC, 1987, J NEUROSCI, V7, P1979; LERMA J, 1992, MOL PHARMACOL, V41, P217; MACDONALD RL, 1989, J PHYSIOL-LONDON, V410, P479, DOI 10.1113/jphysiol.1989.sp017545; MATHERS DA, 1988, SYNAPSE, V2, P627, DOI 10.1002/syn.890020608; MILES R, 1990, J PHYSIOL-LONDON, V428, P61, DOI 10.1113/jphysiol.1990.sp018200; MISGELD U, 1986, SCIENCE, V232, P1413, DOI 10.1126/science.2424084; MODY I, 1991, BRAIN RES, V538, P319, DOI 10.1016/0006-8993(91)90447-4; NATHAN T, 1990, NEUROSCI LETT, V110, P309, DOI 10.1016/0304-3940(90)90865-7; NATHAN T, 1991, J NEUROPHYSIOL, V66, P1704, DOI 10.1152/jn.1991.66.5.1704; NEWBERRY NR, 1984, J PHYSIOL-LONDON, V348, P239, DOI 10.1113/jphysiol.1984.sp015107; NICOLL RA, 1981, J NEUROSCI METH, V4, P153, DOI 10.1016/0165-0270(81)90049-2; NICOLL RA, 1972, J PHYSIOL-LONDON, V223, P803, DOI 10.1113/jphysiol.1972.sp009875; NICOLL RA, 1990, PHYSIOL REV, V70, P513, DOI 10.1152/physrev.1990.70.2.513; NICOLL RA, 1978, J PHYSIOL-LONDON, V283, P121, DOI 10.1113/jphysiol.1978.sp012491; OLPE HR, 1990, EUR J PHARMACOL, V187, P27, DOI 10.1016/0014-2999(90)90337-6; OLSEN RW, 1990, FASEB J, V4, P1469, DOI 10.1096/fasebj.4.5.2155149; PEARCE RA, 1989, ANESTHESIOLOGY, V71, P591, DOI 10.1097/00000542-198910000-00019; PROCTOR WR, 1986, J NEUROSCI, V6, P3161; RALL W, 1985, VOLTAGE PATCH CLAMPI, P191; ROCK DM, 1986, NEUROSCI LETT, V65, P265, DOI 10.1016/0304-3940(86)90272-7; SIEGHART W, 1989, TRENDS PHARMACOL SCI, V10, P407, DOI 10.1016/0165-6147(89)90189-2; SIVILOTTI L, 1991, PROG NEUROBIOL, V36, P35, DOI 10.1016/0301-0082(91)90036-Z; SOMOGYI P, 1983, BRAIN RES, V259, P137, DOI 10.1016/0006-8993(83)91076-4; THOMPSON SM, 1989, J NEUROPHYSIOL, V61, P512, DOI 10.1152/jn.1989.61.3.512; THOMPSON SM, 1988, J NEUROPHYSIOL, V60, P105, DOI 10.1152/jn.1988.60.1.105; VERDOORN TA, 1990, NEURON, V4, P919, DOI 10.1016/0896-6273(90)90145-6; VU ET, 1992, SCIENCE, V255, P1710, DOI 10.1126/science.1553559; WILLIAMS S, 1992, SYNAPSE, V11, P249, DOI 10.1002/syn.890110309; WISDEN W, 1992, J NEUROSCI, V12, P1040; WOLF P, 1977, N-S ARCH PHARMACOL, V299, P211, DOI 10.1007/BF00500313	52	286	289	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1993	10	2					189	200		10.1016/0896-6273(93)90310-N	http://dx.doi.org/10.1016/0896-6273(93)90310-N			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KP685	8382497				2022-12-24	WOS:A1993KP68500007
J	Gale, NW; Holland, SJ; Valenzuela, DM; Flenniken, A; Pan, L; Ryan, TE; Henkemeyer, M; Strebhardt, K; Hirai, H; Wilkinson, DG; Pawson, T; Davis, S; Yancopoulos, GD				Gale, NW; Holland, SJ; Valenzuela, DM; Flenniken, A; Pan, L; Ryan, TE; Henkemeyer, M; Strebhardt, K; Hirai, H; Wilkinson, DG; Pawson, T; Davis, S; Yancopoulos, GD			Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalized during embryogenesis	NEURON			English	Article							PROTEIN-TYROSINE KINASE; PATTERN-FORMATION; LIMB DEVELOPMENT; GENE; EXPRESSION; HINDBRAIN; FAMILY; BRAIN; ECK; ELK	We report that the many Eph-related receptor tyrosine kinases, and their numerous membrane-bound ligands, can each be grouped into only two major specificity subclasses. Receptors in a given subclass bind most members of a corresponding ligand subclass. The physiological relevance of these groupings is suggested by viewing the collective distributions of all members of a subclass. These composite distributions, in contrast with less informative patterns seen with individual members of the family, reveal that the developing embryo is subdivided into domains defined by reciprocal and apparently mutually exclusive expression of a receptor subclass and its corresponding ligands. Receptors seem to encounter their ligands only at the interface between these domains. This reciprocal compartmentalization implicates the Eph family in the formation of spatial boundaries that may help to organize the developing body plan.	REGENERON PHARMACEUT INC,TARRYTOWN,NY 10591; MT SINAI HOSP,SAMUEL LUNENFELD RES INST,TORONTO,ON M5G 1X5,CANADA; NATL INST MED RES,MRC,LONDON NW7 1AA,ENGLAND; CHEMOTHERAPEUT FORSCHUNGSINST,D-6000 FRANKFURT,GERMANY; UNIV TOKYO,FAC MED,DEPT INTERNAL MED 3,TOKYO 113,JAPAN	Regeneron; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; MRC National Institute for Medical Research; University of Tokyo			Pawson, Tony J/E-4578-2013; Strebhardt, Klaus/E-8765-2011	Henkemeyer, Mark/0000-0002-7525-1061; Wilkinson, David/0000-0001-6757-7080; Strebhardt, Klaus/0000-0003-2173-9763				BARTLEY TD, 1994, NATURE, V368, P558, DOI 10.1038/368558a0; BECKMANN MP, 1994, EMBO J, V13, P3757, DOI 10.1002/j.1460-2075.1994.tb06685.x; BENNETT BD, 1995, P NATL ACAD SCI USA, V92, P1866, DOI 10.1073/pnas.92.6.1866; BERGEMANN AD, 1995, MOL CELL BIOL, V15, P4921; BOUILLET P, 1995, DEV BIOL, V170, P420, DOI 10.1006/dbio.1995.1226; BRAMBILLA R, 1995, EMBO J, V14, P3116, DOI 10.1002/j.1460-2075.1995.tb07314.x; Cerretti DP, 1995, MOL IMMUNOL, V32, P1197, DOI 10.1016/0161-5890(95)00108-5; CHENG HJ, 1994, CELL, V79, P157, DOI 10.1016/0092-8674(94)90408-1; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; CLOSSEK T, 1995, ONCOGENE, V10, P97; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; DEALY CN, 1993, MECH DEVELOP, V43, P175, DOI 10.1016/0925-4773(93)90034-U; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; ELLIS J, 1995, MECH DEVELOP, V52, P319, DOI 10.1016/0925-4773(95)00411-S; ESPESETH A, 1995, MOL CELL NEUROSCI, V6, P199, DOI 10.1006/mcne.1995.1017; GALE NW, 1996, IN PRESS ONCOGENE; GANJU P, 1994, ONCOGENE, V9, P1613; GILARDIHEBENSTREIT P, 1992, ONCOGENE, V7, P2499; HENKEMEYER M, 1994, ONCOGENE, V9, P1001; HIRAI H, 1987, SCIENCE, V238, P1717, DOI 10.1126/science.2825356; HOLZMAN LB, 1990, MOL CELL BIOL, V10, P5830, DOI 10.1128/MCB.10.11.5830; KOZLOSKY CJ, 1995, ONCOGENE, V10, P299; Lackmann M, 1996, P NATL ACAD SCI USA, V93, P2523, DOI 10.1073/pnas.93.6.2523; LHOTAK V, 1991, MOL CELL BIOL, V11, P2496, DOI 10.1128/MCB.11.5.2496; LHOTAK V, 1993, MOL CELL BIOL, V13, P7071, DOI 10.1128/MCB.13.11.7071; MAISONPIERRE PC, 1993, ONCOGENE, V8, P3277; NIETO MA, 1992, DEVELOPMENT, V116, P1137; RUIZ JC, 1994, MECH DEVELOP, V46, P87; SCHLESSINGER J, 1992, NEURON, V9, P383, DOI 10.1016/0896-6273(92)90177-F; SHAO HN, 1994, J BIOL CHEM, V269, P26606; SHAO HN, 1995, J BIOL CHEM, V270, P3467, DOI 10.1074/jbc.270.8.3467; TABIN CJ, 1991, CELL, V66, P199, DOI 10.1016/0092-8674(91)90612-3; TAYLOR V, 1994, NEUROSCIENCE, V63, P163, DOI 10.1016/0306-4522(94)90014-0; TESSIERLAVIGNE M, 1995, CELL, V82, P345, DOI 10.1016/0092-8674(95)90421-2; TUZI NL, 1994, BRIT J CANCER, V69, P417, DOI 10.1038/bjc.1994.77; VALENZUELA DM, 1995, ONCOGENE, V10, P1573; WINSLOW JW, 1995, NEURON, V14, P973, DOI 10.1016/0896-6273(95)90335-6; Xu QL, 1995, DEVELOPMENT, V121, P4005; ZHOU R, 1994, J NEUROSCI RES, V37, P129, DOI 10.1002/jnr.490370117	39	735	759	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1996	17	1					9	19		10.1016/S0896-6273(00)80276-7	http://dx.doi.org/10.1016/S0896-6273(00)80276-7			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UY981	8755474	Bronze			2022-12-24	WOS:A1996UY98100003
J	XIONG, WC; MONTELL, C				XIONG, WC; MONTELL, C			DEFECTIVE GLIA INDUCE NEURONAL APOPTOSIS IN THE REPO VISUAL-SYSTEM OF DROSOPHILA	NEURON			English	Article							PROGRAMMED CELL-DEATH; GROWTH CONES; COMPOUND EYE; NINAC KINASE; OPTIC-LOBES; SURVIVAL; GLIA; MELANOGASTER; ENDONUCLEASE; DEGENERATION	The role of glia in suppressing neuronal cell death was investigated in the visual system of the Drosophila mutant, reversed polarity (repo). The repo locus encodes a glial-specific homeodomain protein expressed in the optic lobes. Here, we show that survival of the laminar neurons in the optic lobe depends on repo expression in the laminar glia, indicating that the laminar glia supply factors required for neuronal survival. The repo glia also underwent cell death, suggesting that the laminar neurons are required for survival of the glia or that repo expression is required to suppress an intrinsic cell suicide program. Subsequent to the laminar cell death, the retinal cells in the repo visual system also degenerated, indicating that the retinal cell death was due to retrograde degeneration.			XIONG, WC (corresponding author), JOHNS HOPKINS UNIV, SCH MED, DEPT NEUROSCI, DEPT BIOL CHEM, BALTIMORE, MD 21205 USA.		Montell, Craig/AAH-3357-2021	Montell, Craig/0000-0001-5637-1482; Xiong, Wen-Cheng/0000-0001-9071-7598	NEI NIH HHS [EY08117] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY008117] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ARENDS MJ, 1990, AM J PATHOL, V136, P593; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; BARRES BA, 1991, J NEUROSCI, V11, P3685; BARRES BA, 1993, DEVELOPMENT, V118, P283; BASTIANI MJ, 1986, J NEUROSCI, V6, P3542; BONINI NM, 1993, CELL, V72, P379, DOI 10.1016/0092-8674(93)90115-7; BUCHANAN RL, 1993, NEURON, V10, P839, DOI 10.1016/0896-6273(93)90200-B; CAGAN RL, 1989, DEV BIOL, V136, P346, DOI 10.1016/0012-1606(89)90261-3; CAMPBELL G, 1994, DEVELOPMENT, V120, P2957; CAMPOS AR, 1992, DEVELOPMENT, V114, P355; CARLSON SD, 1990, ANNU REV ENTOMOL, V35, P597, DOI 10.1146/annurev.en.35.010190.003121; COHEN JJ, 1984, J IMMUNOL, V132, P38; COLLINS MKL, 1993, TRENDS BIOCHEM SCI, V18, P307, DOI 10.1016/0968-0004(93)90042-L; COOMBE PE, 1986, J COMP PHYSIOL A, V159, P655, DOI 10.1007/BF00612038; COWAN WM, 1970, CONT RES METHODS NEU, P215; EBENS AJ, 1993, CELL, V74, P15, DOI 10.1016/0092-8674(93)90291-W; FAWCETT JW, 1990, ANNU REV NEUROSCI, V13, P43, DOI 10.1146/annurev.neuro.13.1.43; FISCHBACH KF, 1984, DEV BIOL, V104, P219, DOI 10.1016/0012-1606(84)90050-2; FISCHBACH KF, 1983, DEV BIOL, V95, P1, DOI 10.1016/0012-1606(83)90002-7; FREDIEU JR, 1989, DEVELOPMENT, V106, P739; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; HATTEN ME, 1991, GLIA, V4, P233, DOI 10.1002/glia.440040215; HEISENBERG M, 1971, J EXP BIOL, V55, P85; HOTTA Y, 1972, NATURE, V240, P527, DOI 10.1038/240527a0; JACOBS JR, 1989, J NEUROSCI, V9, P2402; JESSEN KR, 1994, NEURON, V12, P509, DOI 10.1016/0896-6273(94)90209-7; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; KOKILEVA L, 1989, MOL BIOL REP, V13, P139, DOI 10.1007/BF00444309; LOUIS JC, 1993, SCIENCE, V259, P689, DOI 10.1126/science.8430320; MARTIN SJ, 1994, TRENDS BIOCHEM SCI, V19, P26, DOI 10.1016/0968-0004(94)90170-8; MASU Y, 1993, NATURE, V365, P27, DOI 10.1038/365027a0; MEYEROWITZ EM, 1978, DEV BIOL, V62, P112, DOI 10.1016/0012-1606(78)90096-9; MONTELL C, 1988, CELL, V52, P757, DOI 10.1016/0092-8674(88)90413-8; OPPENHEIM RW, 1989, TRENDS NEUROSCI, V12, P252, DOI 10.1016/0166-2236(89)90021-0; POLLARD TD, 1984, J CELL BIOL, V99, P1970, DOI 10.1083/jcb.99.6.1970; PORTER JA, 1992, J CELL BIOL, V116, P683, DOI 10.1083/jcb.116.3.683; PORTER JA, 1993, J CELL BIOL, V122, P601, DOI 10.1083/jcb.122.3.601; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; RAFF MC, 1993, SCIENCE, V262, P695, DOI 10.1126/science.8235590; RAMOS RGP, 1993, GENE DEV, V7, P2533, DOI 10.1101/gad.7.12b.2533; ROBINOW S, 1993, DEVELOPMENT, V119, P1251; ROITBAK AI, 1983, NEUROGLIA; SAINTMARIE RL, 1983, J NEUROCYTOL, V12, P213, DOI 10.1007/BF01148463; SHAW SR, 1975, NATURE, V255, P480, DOI 10.1038/255480a0; STEPHENSON RS, 1980, J GEN PHYSIOL, V75, P353, DOI 10.1085/jgp.75.4.353; STITT TN, 1991, ANN NY ACAD SCI, V633, P113; THIRY M, 1992, J HISTOCHEM CYTOCHEM, V40, P411, DOI 10.1177/40.3.1552179; TRUJILLOCENOZ O, 1973, J ULTRA MOL STRUCT R, V42, P554, DOI 10.1016/S0022-5320(73)80027-9; VERNADAKIS A, 1988, INT REV NEUROBIOL, V30, P149; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; WILLIAMS GT, 1993, CELL, V74, P777, DOI 10.1016/0092-8674(93)90457-2; WINBERG ML, 1992, DEVELOPMENT, V115, P903; WOLFF T, 1991, DEVELOPMENT, V113, P825; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; XIONG WC, 1994, GENE DEV, V8, P981, DOI 10.1101/gad.8.8.981	56	90	93	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	1995	14	3					581	590		10.1016/0896-6273(95)90314-3	http://dx.doi.org/10.1016/0896-6273(95)90314-3			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QP230	7695904	hybrid			2022-12-24	WOS:A1995QP23000011
J	COVARRUBIAS, M; WEI, AA; SALKOFF, L; VYAS, TB				COVARRUBIAS, M; WEI, AA; SALKOFF, L; VYAS, TB			ELIMINATION OF RAPID POTASSIUM CHANNEL INACTIVATION BY PHOSPHORYLATION OF THE INACTIVATION GATE	NEURON			English	Article							PROTEIN-KINASE-C; APLYSIA SENSORY NEURONS; SHAKER K+ CHANNEL; SODIUM-CHANNEL; RAT-BRAIN; XENOPUS OOCYTES; IK(A) CHANNELS; ION CHANNELS; MODULATION; CAMP	The effect of protein kinase C (PKC) on rapid N-type inactivation of K+ channels has not been reported previously. We found that PKC specifically eliminates rapid inactivation of a cloned human A-type K+ channel (hKv3.4), converting this channel from a rapidly inactivating A type to a noninactivating delayed rectifier type. Biochemical analysis showed that the N-terminal domain of hKv3.4 is phosphorylated in vitro by PKC, and mutagenesis experiments revealed that two serines within the inactivation gate at the N-terminus are sites of direct PKC action. Moreover, mutating one of these serines to aspartic acid mimics the action of PKC. Serine phosphorylation may thus prevent rapid inactivation by shielding basic residues known to be critical to the function of the inactivation gate. The regulatory mechanism reported here may have substantial effects on signal coding in the nervous system.	WASHINGTON UNIV, SCH MED, DEPT ANAT & NEUROBIOL, ST LOUIS, MO 63110 USA; WASHINGTON UNIV, SCH MED, DEPT GENET, ST LOUIS, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	COVARRUBIAS, M (corresponding author), THOMAS JEFFERSON UNIV, JEFFERSON MED COLL, DEPT ANAT PATHOL & CELL BIOL, PHILADELPHIA, PA 19107 USA.			Covarrubias, Manuel/0000-0002-0881-4143	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032337, R29NS032337, R01NS024785] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA007186] Funding Source: NIH RePORTER; NIAAA NIH HHS [P50 AA007186, T32 AA007463, AA07186] Funding Source: Medline; NINDS NIH HHS [R01 NS032337-10, R01 NS032337-08, NS32337, R01 NS032337, R01 NS032337-06, R01 NS032337-07, R01 NS032337-09A1, R01 NS032337-12, R01 NS032337-11, NS24785] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARMSTRONG D, 1987, P NATL ACAD SCI USA, V84, P2518, DOI 10.1073/pnas.84.8.2518; AUGUSTINE CK, 1990, J GEN PHYSIOL, V95, P245, DOI 10.1085/jgp.95.2.245; BEZANILLA F, 1977, J GEN PHYSIOL, V70, P549, DOI 10.1085/jgp.70.5.549; BUSCH AE, 1992, SCIENCE, V255, P1705, DOI 10.1126/science.1553557; CHUNG SK, 1991, SCIENCE, V253, P560, DOI 10.1126/science.1857986; DEMO SD, 1991, NEURON, V7, P743, DOI 10.1016/0896-6273(91)90277-7; DRAIN P, 1994, NEURON, V12, P1097, DOI 10.1016/0896-6273(94)90317-4; GOLDIN AL, 1992, METHOD ENZYMOL, V207, P279; GOLDSMITH BA, 1992, P NATL ACAD SCI USA, V89, P11481, DOI 10.1073/pnas.89.23.11481; Hille B., 1992, IONIC CHANNELS EXCIT; HOCHNER B, 1992, P NATL ACAD SCI USA, V89, P11476, DOI 10.1073/pnas.89.23.11476; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1994, J GEN PHYSIOL, V103, P249, DOI 10.1085/jgp.103.2.249; HUANG KP, 1986, J BIOL CHEM, V261, P2134; ISACOFF EY, 1991, NATURE, V353, P86, DOI 10.1038/353086a0; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; KOBAYASHI E, 1989, BIOCHEM BIOPH RES CO, V159, P548, DOI 10.1016/0006-291X(89)90028-4; KRISHEK BJ, 1994, NEURON, V12, P1081, DOI 10.1016/0896-6273(94)90316-6; LEVITAN IB, 1990, ADV SEC MESS PHOSPH, V24, P36; Levitan IB, 1991, NEURON CELL MOL BIOL; LI M, 1993, SCIENCE, V261, P1439, DOI 10.1126/science.8396273; MACKINNON R, 1993, SCIENCE, V262, P757, DOI 10.1126/science.7694359; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; MARAIS RM, 1990, FEBS LETT, V277, P151, DOI 10.1016/0014-5793(90)80831-3; MORAN O, 1991, FEBS LETT, V279, P256, DOI 10.1016/0014-5793(91)80162-V; MURRELLLAGNADO RD, 1993, J GEN PHYSIOL, V102, P977, DOI 10.1085/jgp.102.6.977; MURRELLLAGNADO RD, 1993, J GEN PHYSIOL, V102, P949, DOI 10.1085/jgp.102.6.949; NICOLL RA, 1988, SCIENCE, V241, P545, DOI 10.1126/science.2456612; NUMANN R, 1991, SCIENCE, V254, P115, DOI 10.1126/science.1656525; PAK MD, 1991, P NATL ACAD SCI USA, V88, P4386, DOI 10.1073/pnas.88.10.4386; PATTON DE, 1992, P NATL ACAD SCI USA, V89, P10905, DOI 10.1073/pnas.89.22.10905; PEROZO E, 1990, NEURON, V5, P685, DOI 10.1016/0896-6273(90)90222-2; RETTIG J, 1992, EMBO J, V11, P2473, DOI 10.1002/j.1460-2075.1992.tb05312.x; RUDY B, 1991, J NEUROSCI RES, V29, P401, DOI 10.1002/jnr.490290316; RUKNUDIN A, 1991, J CELL BIOL, V112, P125, DOI 10.1083/jcb.112.1.125; RUPPERSBERG JP, 1991, NATURE, V352, P711, DOI 10.1038/352711a0; RUPPERSBERG JP, 1991, NATURE, V353, P657, DOI 10.1038/353657a0; SCHROTER KH, 1991, FEBS LETT, V278, P211, DOI 10.1016/0014-5793(91)80119-N; SCULPTOREANU A, 1993, NATURE, V364, P240, DOI 10.1038/364240a0; SHEARMAN MS, 1989, PHARMACOL REV, V41, P211; SHUSTER MJ, 1985, NATURE, V313, P392, DOI 10.1038/313392a0; SIGEL E, 1988, P NATL ACAD SCI USA, V85, P6192, DOI 10.1073/pnas.85.16.6192; SLATER SJ, 1993, NATURE, V364, P82, DOI 10.1038/364082a0; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; STUHMER W, 1992, METHOD ENZYMOL, V207, P319; SWOPE SL, 1992, FASEB J, V6, P2514, DOI 10.1096/fasebj.6.8.1375568; VASSILEV PM, 1988, SCIENCE, V241, P1658, DOI 10.1126/science.2458625; WALSH KB, 1988, SCIENCE, V242, P67, DOI 10.1126/science.2845575; WEI A, 1990, SCIENCE, V248, P599, DOI 10.1126/science.2333511; WEISER M, 1994, J NEUROSCI, V14, P949, DOI 10.1523/JNEUROSCI.14-03-00949.1994; WEST JW, 1991, SCIENCE, V254, P866, DOI 10.1126/science.1658937; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; ZAGOTTA WN, 1990, J GEN PHYSIOL, V95, P29, DOI 10.1085/jgp.95.1.29; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520	54	129	132	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1994	13	6					1403	1412		10.1016/0896-6273(94)90425-1	http://dx.doi.org/10.1016/0896-6273(94)90425-1			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PZ689	7993631	Green Accepted			2022-12-24	WOS:A1994PZ68900014
J	LEE, YJ; SHAH, S; SUZUKI, E; ZARS, T; ODAY, PM; HYDE, DR				LEE, YJ; SHAH, S; SUZUKI, E; ZARS, T; ODAY, PM; HYDE, DR			THE DROSOPHILA DGQ GENE ENCODES A G(ALPHA)-PROTEIN THAT MEDIATES PHOTOTRANSDUCTION	NEURON			English	Article							RETINAL-DEGENERATION-B; BETA-GAMMA-SUBUNITS; PHOSPHOLIPASE-C; ALPHA-SUBUNITS; NORPA GENE; PHOTORECEPTOR CELLS; SIGNAL TRANSDUCTION; MOLECULAR-CLONING; NERVOUS-SYSTEM; VISUAL-SYSTEM	We examined the roles of the Drosophila G(q alpha) proteins (DG(q)) in the phototransduction pathway. The DG(q) proteins immunolocalized to the ocelli and all eight retinular photoreceptor cell rhabdomeres. An affinity-purified anti-DG(q alpha) immunoglobulin blocked the light-dependent GTP hydrolysis activity associated with Drosophila head membranes in vitro, suggesting that rhodopsin stimulated DG(q). Dominantly active DG(q1) mutants exhibited a light-independent GTPase activity and abnormal electrophysiological light responses, such as reduced retinal sensitivity and slow response kinetics compared with wild-type flies. Dominant DG(q2) mutants exhibited a light-independent GTPase activity with normal electrophysiological light responses. Retinas of double mutants of DG(q1), but not DG(q2), with the light-dependent retinal degeneration mutant rdgB degenerated even in the dark. DG(q1) stimulation of rdgB retinal degeneration in the dark was norpA-dependent. These results indicate that DG(q1) mediates the stimulation by light-activated rhodopsin of the norpA-encoded phospholipase C in the visual transduction cascade.	UNIV TOKYO,INST MED SCI,DEPT FINE MORPHOL,MINATO KU,TOKYO 108,JAPAN; UNIV OREGON,INST NEUROSCI,EUGENE,OR 97403	University of Tokyo; University of Oregon	LEE, YJ (corresponding author), UNIV NOTRE DAME,DEPT BIOL SCI,NOTRE DAME,IN 46556, USA.			Suzuki, Emiko/0000-0002-4005-0542; Zars, Troy/0000-0003-4114-9322	NEI NIH HHS [EY08058, EY09388] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY009388, R01EY008058] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ASHBURNER M, 1989, DROSOPHILA LABORATOR; BERLOT CH, 1992, CELL, V68, P911, DOI 10.1016/0092-8674(92)90034-A; BLAKE A, 1991, J NEUROGENET, V7, P213, DOI 10.3109/01677069109167434; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; BLUMENFELD A, 1985, P NATL ACAD SCI USA, V82, P7116, DOI 10.1073/pnas.82.20.7116; BONINI NM, 1993, CELL, V72, P379, DOI 10.1016/0092-8674(93)90115-7; Catty D., 1988, ANTIBODIES, V1, P19; DEVARY O, 1987, P NATL ACAD SCI USA, V84, P6939, DOI 10.1073/pnas.84.19.6939; DEVIVO M, 1992, J BIOL CHEM, V267, P18263; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; FERREIRA PA, 1993, P NATL ACAD SCI USA, V90, P6042, DOI 10.1073/pnas.90.13.6042; FESENKO EE, 1985, NATURE, V313, P310, DOI 10.1038/313310a0; Franceschini N., 1972, INFORMATION PROCESSI, P75; FUJITA SC, 1982, P NATL ACAD SCI-BIOL, V79, P7929, DOI 10.1073/pnas.79.24.7929; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GRAZIANO MP, 1989, J BIOL CHEM, V264, P15475; HANANI M, 1977, J PHYSL, V270, P152; HARRIS WA, 1977, J GEN PHYSIOL, V69, P261, DOI 10.1085/jgp.69.3.261; HOTTA Y, 1970, P NATL ACAD SCI USA, V67, P1156, DOI 10.1073/pnas.67.3.1156; HURLEY JB, 1992, J BIOENERG BIOMEMBR, V24, P219, DOI 10.1007/BF00762680; JHON DY, 1993, J BIOL CHEM, V268, P6654; JIANG HP, 1994, J BIOL CHEM, V269, P7593; KARESS RE, 1984, CELL, V38, P135, DOI 10.1016/0092-8674(84)90534-8; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKO PF, 1988, GENETICS, V120, P495; LEE CW, 1993, J BIOL CHEM, V268, P21318; LEE YJ, 1990, NEURON, V5, P889, DOI 10.1016/0896-6273(90)90349-K; MASTERS SB, 1989, J BIOL CHEM, V264, P15457; MINKE B, 1990, P NATL ACAD SCI USA, V87, P113, DOI 10.1073/pnas.87.1.113; MISMER D, 1987, GENETICS, V116, P565; NOBES C, 1992, BIOCHEM J, V287, P545, DOI 10.1042/bj2870545; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; ODAY PM, 1982, J GEN PHYSIOL, V79, P211, DOI 10.1085/jgp.79.2.211; PAK WL, 1976, ANNU REV BIOPHYS BIO, V5, P397, DOI 10.1146/annurev.bb.05.060176.002145; PARK DG, 1993, J BIOL CHEM, V268, P4573; POLLOCK JA, 1988, NATURE, V333, P779, DOI 10.1038/333779a0; RAPORT CJ, 1994, INVEST OPHTH VIS SCI, V35, P2932; RARICK HM, 1992, SCIENCE, V256, P1031, DOI 10.1126/science.1317058; RUBINSTEIN CT, 1989, VISUAL NEUROSCI, V2, P541, DOI 10.1017/S0952523800003485; RYBA NJ, 1993, BIOCHEM J, V292, P333, DOI 10.1042/bj2920333; SCHNEUWLY S, 1991, J BIOL CHEM, V266, P24314; SMITH DP, 1991, SCIENCE, V254, P1478, DOI 10.1126/science.1962207; SMITH DP, 1991, ANNU REV CELL BIOL, V7, P161; SMRCKA AV, 1993, J BIOL CHEM, V268, P9667; STARK WS, 1983, J INSECT PHYSIOL, V29, P123, DOI 10.1016/0022-1910(83)90135-X; STRATHMANN M, 1990, P NATL ACAD SCI USA, V87, P9113, DOI 10.1073/pnas.87.23.9113; STRYER L, 1986, ANNU REV NEUROSCI, V9, P87, DOI 10.1146/annurev.ne.09.030186.000511; SUZUKI E, 1991, J ELECTRON MICROSC, V40, P187; Sved J, 1986, DROSOPH INF SERV, V63, P169; TERAKITA A, 1993, FEBS LETT, V330, P197, DOI 10.1016/0014-5793(93)80272-V; VIHTELIC TS, 1993, J CELL BIOL, V122, P1013, DOI 10.1083/jcb.122.5.1013; WOLFGANG WJ, 1990, J NEUROSCI, V10, P1014; WU DQ, 1992, J BIOL CHEM, V267, P1811; YARFITZ S, 1991, NEURON, V7, P429, DOI 10.1016/0896-6273(91)90295-B; ZHU LQ, 1993, J BIOL CHEM, V268, P15994	56	106	107	1	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1994	13	5					1143	1157		10.1016/0896-6273(94)90052-3	http://dx.doi.org/10.1016/0896-6273(94)90052-3			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PU763	7946351				2022-12-24	WOS:A1994PU76300010
J	SCHULZE, KL; LITTLETON, JT; SALZBERG, A; HALACHMI, N; STERN, M; LEV, Z; BELLEN, HJ				SCHULZE, KL; LITTLETON, JT; SALZBERG, A; HALACHMI, N; STERN, M; LEV, Z; BELLEN, HJ			ROP, A DROSOPHILA HOMOLOG OF YEAST SEC1 AND VERTEBRATE N-SEC1 MUNC-18 PROTEINS, IS A NEGATIVE REGULATOR OF NEUROTRANSMITTER RELEASE IN-VIVO	NEURON			English	Article							SYNAPTOTAGMIN; GENE; EXPRESSION; NEURONS; FUSION	The mammalian homolog of the yeast Sec1p, n-Sec1/l Munc-18 has been demonstrated to bind the presynaptic membrane protein syntaxin, a putative synaptic vesicle docking protein. To determine the role of n-Sec1/Munc-18 in neurotransmitter release in vivo, we have overexpressed the Drosophila homolog, rep, in third instar larvae and measured the electrophysiological consequences at the neuromuscular junction. A 3- to 5-fold induction of the rop protein causes a dramatic decrease in neurotransmitter release, suggesting rop may restrict the ability of vesicles to dock or of docked vesicles to fuse. Consistent with this hypothesis, rop overexpression also reduces the number of spontaneous vesicle fusions by more than 50%, and repetitive stimulation results in significant decreases in evoked responses similar to those observed in rab3a mutant mice. However, rop overexpression does not alter significantly the Ca2+ dependence of neurotransmitter release. We propose that the Drosophila n-Sec1/Munc-18 homolog plays a negative role in neurotransmitter release in vivo, in addition to its previously identified positive function, possibly by modulation of docking of synaptic vesicles or activation of a pre-fusion complex at the active zone.	BAYLOR COLL MED,DIV NEUROSCI,HOUSTON,TX 77030; TECHNION ISRAEL INST TECHNOL,DEPT BIOL,IL-32000 HAIFA,ISRAEL; RICE UNIV,DEPT BIOCHEM & CELL BIOL,HOUSTON,TX 77251	Baylor College of Medicine; Technion Israel Institute of Technology; Rice University	SCHULZE, KL (corresponding author), BAYLOR COLL MED,HOWARD HUGHES MED INST,DEPT MOLEC & HUMAN GENET,HOUSTON,TX 77030, USA.		Salzberg, Adi/A-9986-2014; Salzberg, Adi/O-1198-2019	Salzberg, Adi/0000-0002-0427-9809; Salzberg, Adi/0000-0002-0427-9809; Bellen, Hugo/0000-0001-5992-5989				BELLEN HJ, 1989, GENE DEV, V3, P1288, DOI 10.1101/gad.3.9.1288; BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2559, DOI 10.1073/pnas.90.7.2559; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; CHAPMAN ER, 1994, J BIOL CHEM, V269, P5735; COHEN N, 1988, ONCOGENE, V3, P137; DASCHER C, 1991, MOL CELL BIOL, V11, P872, DOI 10.1128/MCB.11.2.872; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; GARCIA EP, 1994, P NATL ACAD SCI USA, V91, P2003, DOI 10.1073/pnas.91.6.2003; GENGYOANDO K, 1993, NEURON, V11, P703, DOI 10.1016/0896-6273(93)90080-B; GEPPERT M, 1994, NATURE, V369, P493, DOI 10.1038/369493a0; HARRISON SD, 1994, NEURON, V13, P555, DOI 10.1016/0896-6273(94)90025-6; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; HUNT JM, 1994, NEURON, V12, P1269, DOI 10.1016/0896-6273(94)90443-X; JAHN R, 1994, ANNU REV NEUROSCI, V17, P219, DOI 10.1146/annurev.ne.17.030194.001251; JAN LY, 1976, J PHYSIOL-LONDON, V262, P189, DOI 10.1113/jphysiol.1976.sp011592; KATZ B, 1967, PROC R SOC SER B-BIO, V167, P23, DOI 10.1098/rspb.1967.0011; KLEMENZ R, 1987, NUCLEIC ACIDS RES, V15, P3947, DOI 10.1093/nar/15.10.3947; KNIPPLE DC, 1988, NUCLEIC ACIDS RES, V16, P7748, DOI 10.1093/nar/16.15.7748; LITTLETON JT, 1993, DEVELOPMENT, V118, P1077; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; LITTLETON JT, 1994, IN PRESS P NATL ACAD; MARTIN AR, 1955, J PHYSIOL-LONDON, V130, P114, DOI 10.1113/jphysiol.1955.sp005397; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; PEVSNER J, 1994, P NATL ACAD SCI USA, V91, P1445, DOI 10.1073/pnas.91.4.1445; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; RIVOSECCHI R, 1994, J PHYSIOL-LONDON, V474, P223, DOI 10.1113/jphysiol.1994.sp020015; SALZBERG A, 1993, DEVELOPMENT, V117, P1309; SALZBERG A, 1994, NEURON, V13, P269, DOI 10.1016/0896-6273(94)90346-8; Sambrook J, 1989, MOL CLONING LABORATO; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0	32	159	165	0	13	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1994	13	5					1099	1108		10.1016/0896-6273(94)90048-5	http://dx.doi.org/10.1016/0896-6273(94)90048-5			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PU763	7946348				2022-12-24	WOS:A1994PU76300006
J	LEVINE, JD; CASEY, CI; KALDERON, DD; JACKSON, FR				LEVINE, JD; CASEY, CI; KALDERON, DD; JACKSON, FR			ALTERED CIRCADIAN PACEMAKER FUNCTIONS AND CYCLIC-AMP RHYTHMS IN THE DROSOPHILA LEARNING MUTANT DUNCE	NEURON			English	Article							DEPENDENT PROTEIN-KINASE; CHICK PINEAL CELLS; MUSHROOM BODIES; CLOCK; CAMP; MELANOGASTER; PHOSPHODIESTERASE; PHOSPHORYLATION; EXPRESSION; MUTATION	Neural circadian pacemakers can be reset by light, and the resetting mechanism may involve cyclic nucleotide second messengers. We have examined pacemaker resetting and free-running activity rhythms in Drosophila dunce (dnc) and DC0 mutants, which identify a cAMP-specific phosphodiesterase and the catalytic subunit of cAMP-dependent protein kinase, respectively. dnc mutants exhibit augmented light-induced phase delays and shortened circadian periods, which indicate altered pace maker function. Interestingly, however, light-induced phase advances are normal in dnc, suggesting a selective effect on one component of the pacemaker resetting response. Furthermore, we demonstrate the presence of circadian rhythms in cAMP content in head tissues and show that dnc mutations increase the amplitude of daily cAMP peaks. These results show that cAMP levels are not chronically elevated in the dnc mutant. A role for cAMP signaling in circadian processes is also suggested by an analysis of DC0 mutants, which have severe kinase deficits and display arrhythmic locomotor activity.	WORCESTER FDN EXPTL BIOL INC,NEUROBIOL GRP,SHREWSBURY,MA 01545; COLUMBIA UNIV,DEPT BIOL SCI,NEW YORK,NY 10027	Worcester Foundation for Biomedical Research; Columbia University					NIGMS NIH HHS [F32 GM15907] Funding Source: Medline; NINDS NIH HHS [NS30386] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM015907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030386] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ASCHOFF J, 1965, CIRCADIAN CLOCKS, P94; Brindle PK, 1992, CURR OPIN GENET DEV, V2, P199, DOI 10.1016/S0959-437X(05)80274-6; BRUGGEMANN A, 1993, NATURE, V365, P445, DOI 10.1038/365445a0; BYERS D, 1981, NATURE, V289, P79, DOI 10.1038/289079a0; CARRE IA, 1993, J CELL SCI, V104, P1163; Cowan T.M., 1984, Journal of Neurogenetics, V1, P333, DOI 10.3109/01677068409107095; DAVIS RL, 1981, J CELL BIOL, V90, P101, DOI 10.1083/jcb.90.1.101; DAVIS RL, 1993, NEURON, V11, P1, DOI 10.1016/0896-6273(93)90266-T; DUSHAY MS, 1990, GENETICS, V125, P557; EDERY I, 1994, P NATL ACAD SCI USA, V91, P2260, DOI 10.1073/pnas.91.6.2260; ESKIN A, 1983, SCIENCE, V220, P82, DOI 10.1126/science.6298939; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; GRIFFITH LC, 1993, NEURON, V10, P501, DOI 10.1016/0896-6273(93)90337-Q; GUY HR, 1991, SCIENCE, V254, P730, DOI 10.1126/science.1658932; HAMBLENCOYLE M, 1989, J NEUROGENET, V5, P229, DOI 10.3109/01677068909066210; KONOPKA RJ, 1991, J NEUROGENET, V7, P103, DOI 10.3109/01677069109066214; LANE ME, 1993, GENE DEV, V7, P1229, DOI 10.1101/gad.7.7a.1229; NIKAIDO SS, 1989, NEURON, V3, P609, DOI 10.1016/0896-6273(89)90271-7; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P291, DOI 10.1007/BF01417859; PROSSER RA, 1991, BRAIN RES, V568, P185, DOI 10.1016/0006-8993(91)91396-I; PROSSER RA, 1989, J NEUROSCI, V9, P1073; RALPH MR, 1992, COMP BIOCHEM PHYS A, V101, P813, DOI 10.1016/0300-9629(92)90363-U; SKOULAKIS EMC, 1993, NEURON, V11, P197, DOI 10.1016/0896-6273(93)90178-T; TAKAHASHI JS, 1993, ANNU REV PHYSIOL, V55, P729, DOI 10.1146/annurev.physiol.55.1.729; TAKAHASHI JS, 1993, CURR OPIN GENET DEV, V3, P301, DOI 10.1016/0959-437X(93)90038-Q; TECHEL D, 1990, J COMP PHYSIOL B, V159, P695, DOI 10.1007/BF00691715; ZATZ M, 1992, J BIOL RHYTHM, V7, P301, DOI 10.1177/074873049200700404	27	105	106	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1994	13	4					967	974		10.1016/0896-6273(94)90262-3	http://dx.doi.org/10.1016/0896-6273(94)90262-3			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PP533	7946340				2022-12-24	WOS:A1994PP53300019
J	PARSONS, TD; LENZI, D; ALMERS, W; ROBERTS, WM				PARSONS, TD; LENZI, D; ALMERS, W; ROBERTS, WM			CALCIUM-TRIGGERED EXOCYTOSIS AND ENDOCYTOSIS IN AN ISOLATED PRESYNAPTIC CELL - CAPACITANCE MEASUREMENTS IN SACCULAR HAIR-CELLS	NEURON			English	Article							ADRENAL CHROMAFFIN CELLS; SYNAPSIN-I; AFFERENT SYNAPSE; FINE-STRUCTURE; NERVE-ENDINGS; RAT PITUITARY; SECRETION; TRANSDUCTION; GOLDFISH; MEMBRANE	Depolarization of isolated frog saccular hair cells caused Ca2+-dependent increases in membrane capacitance that we interpret as the fusion of synaptic vesicles with the plasma membrane. During a maintained depolarization to -10 mV, the capacitance increased at a rate corresponding to the fusion of similar to 500 vesicles per second at each active zone. Release continued at this high rate for up to 2 s, long enough to exhaust >5 times the number of vesicles initially in close apposition to the plasma membrane at active zones. We therefore propose that hair cells are specialized for rapid replenishment of vesicles at release sites. Upon repolarization to -70 mV, the capacitance returned exponentially (time constant, similar to 14 s) to near the prestimulus level in perforated-patch recordings, but not in whole-cell recordings, suggesting that a mobile intracellular factor is required for membrane retrieval.	UNIV OREGON, INST NEUROSCI, EUGENE, OR 97403 USA	University of Oregon	PARSONS, TD (corresponding author), MAX PLANCK INST MED RES, MOLEK ZELLFORSCH ABT, D-69120 HEIDELBERG, GERMANY.			Roberts, William/0000-0001-9762-4255; Lenzi, David/0000-0003-4802-1444	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS027142, R01NS027142] Funding Source: NIH RePORTER; NINDS NIH HHS [NS27142] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AUGUSTINE GJ, 1991, ANN NY ACAD SCI, V635, P365, DOI 10.1111/j.1749-6632.1991.tb36505.x; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; DELCASTILLO J, 1956, PROG BIOPHYS MOL BIO, V6, P122, DOI 10.1016/S0096-4174(18)30106-9; DILGER JP, 1982, CHEM PHYS LIPIDS, V30, P159, DOI 10.1016/0009-3084(82)90050-0; FAVRE D, 1986, BRAIN RES, V384, P379, DOI 10.1016/0006-8993(86)91176-5; Fesce Riccardo, 1994, Trends in Cell Biology, V4, P1, DOI 10.1016/0962-8924(94)90025-6; FURUKAWA T, 1978, J PHYSIOL-LONDON, V276, P211, DOI 10.1113/jphysiol.1978.sp012229; GLEISNER L, 1973, ACTA OTO-LARYNGOL, V76, P199, DOI 10.3109/00016487309121500; HAMA K, 1980, J NEUROCYTOL, V9, P845, DOI 10.1007/BF01205023; HAMA K, 1977, J NEUROCYTOL, V6, P361, DOI 10.1007/BF01178223; HAMILL OP, 1981, PFLUGERS ARCH, V391, P88; HEINEMANN C, 1993, PFLUG ARCH EUR J PHY, V424, P105, DOI 10.1007/BF00374600; Hille B., 1992, IONIC CHANNELS EXCIT; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; JACOBS RA, 1990, COLD SPRING HARB SYM, V55, P547; KOENIG JH, 1989, J NEUROSCI, V9, P1937; KROESE ABA, 1989, HEARING RES, V37, P203, DOI 10.1016/0378-5955(89)90023-3; LARKIN JM, 1983, CELL, V33, P273, DOI 10.1016/0092-8674(83)90356-2; LENZI D, 1994, IN PRESS CURR OPIN N; LEWIS RS, 1983, NATURE, V304, P538, DOI 10.1038/304538a0; LINDAU M, 1992, BIOPHYS J, V61, P19, DOI 10.1016/S0006-3495(92)81812-X; LINDAU M, 1991, Q REV BIOPHYS, V24, P75, DOI 10.1017/S0033583500003279; LUTHER PK, 1988, ULTRAMICROSCOPY, V24, P7, DOI 10.1016/0304-3991(88)90322-1; MANDELL JW, 1990, NEURON, V5, P19, DOI 10.1016/0896-6273(90)90030-J; MILLER TM, 1984, J CELL BIOL, V98, P685, DOI 10.1083/jcb.98.2.685; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; PUSCH M, 1988, PFLUG ARCH EUR J PHY, V411, P204, DOI 10.1007/BF00582316; ROBERTS WM, 1991, ANN NY ACAD SCI, V635, P221, DOI 10.1111/j.1749-6632.1991.tb36494.x; ROBERTS WM, 1993, NATURE, V363, P74, DOI 10.1038/363074a0; ROBERTS WM, 1988, ANNU REV CELL BIOL, V4, P63, DOI 10.1146/annurev.cellbio.4.1.63; ROBERTS WM, 1994, J NEUROSCI, V14, P3246; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; SCARFONE E, 1991, J NEUROSCI, V11, P1173; SCARFONE E, 1988, J NEUROSCI, V8, P4640; SIEGEL JH, 1986, J NEUROCYTOL, V15, P311, DOI 10.1007/BF01611434; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; TATSUOKA H, 1989, J COMP NEUROL, V290, P343, DOI 10.1002/cne.902900304; THOMAS P, 1994, J CELL BIOL, V124, P667, DOI 10.1083/jcb.124.5.667; THOMAS P, 1993, NEURON, V11, P93, DOI 10.1016/0896-6273(93)90274-U; THOMAS P, 1993, EMBO J, V12, P303, DOI 10.1002/j.1460-2075.1993.tb05657.x; THOMAS P, 1990, NEURON, V5, P723, DOI 10.1016/0896-6273(90)90226-6; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; VONRUDEN L, 1993, SCIENCE, V262, P1061, DOI 10.1126/science.8235626	45	220	222	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	1994	13	4					875	883		10.1016/0896-6273(94)90253-4	http://dx.doi.org/10.1016/0896-6273(94)90253-4			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PP533	7946334				2022-12-24	WOS:A1994PP53300010
J	KOTZBAUER, PT; LAMPE, PA; ESTUS, S; MILBRANDT, J; JOHNSON, EM				KOTZBAUER, PT; LAMPE, PA; ESTUS, S; MILBRANDT, J; JOHNSON, EM			POSTNATAL-DEVELOPMENT OF SURVIVAL RESPONSIVENESS IN RAT SYMPATHETIC NEURONS TO LEUKEMIA INHIBITORY FACTOR AND CILIARY NEUROTROPHIC FACTOR	NEURON			English	Article							CHOLINERGIC DIFFERENTIATION FACTOR; NEUROTRANSMITTER PLASTICITY INVIVO; SWEAT GLAND INNERVATION; IL-6 SIGNAL TRANSDUCER; MOLECULAR-CLONING; MESSENGER-RNA; GROWTH-FACTOR; NEURONOTROPHIC FACTOR; NUCLEOTIDE-SEQUENCE; CONDITIONED MEDIUM	Embryonic rat sympathetic neurons undergo programmed cell death upon NGF deprivation. We show that during postnatal development, these neurons acquire the ability to be supported in vitro by LIF and CNTF as well as NGF. LIF and CNTF do not promote the long-term survival of embryonic day 21 sympathetic neurons in vitro. However, after 5 days of culture in the presence of NGF, the majority of embryonic day 21 sympathetic neurons can be supported by either of these factors. Furthermore, postnatal day 6 sympathetic neurons can be immediately supported by LIF and CNTF, indicating that acquisition of survival responsiveness occurs in vivo as well as in vitro. During this period, neuronal expression of LIF and CNTF receptor mRNAs remains constant, suggesting that sympathetic neurons alter their responsiveness to LIF and CNTF by allowing additional intracellular signaling pathways to promote survival.	WASHINGTON UNIV,SCH MED,DEPT INTERNAL MED,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT MOLEC BIOL & PHARMACOL,ST LOUIS,MO 63110	Washington University (WUSTL); Washington University (WUSTL)	KOTZBAUER, PT (corresponding author), WASHINGTON UNIV,SCH MED,DEPT PATHOL,DIV LAB MED,ST LOUIS,MO 63110, USA.		Lampe, Patricia/AAH-9545-2020	Milbrandt, Jeffrey/0000-0002-5477-7689	NIA NIH HHS [P50-AG05681] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P50AG005681] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ADLER R, 1979, SCIENCE, V204, P1434, DOI 10.1126/science.451576; BARBIN G, 1984, J NEUROCHEM, V43, P1468, DOI 10.1111/j.1471-4159.1984.tb05410.x; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BOCCHINI V, 1969, P NATL ACAD SCI USA, V64, P787, DOI 10.1073/pnas.64.2.787; BORNSTEIN MB, 1958, LAB INVEST, V7, P134; COUGHLIN MD, 1981, DEV BIOL, V82, P56, DOI 10.1016/0012-1606(81)90428-0; COUGHLIN MD, 1977, P NATL ACAD SCI USA, V74, P3438, DOI 10.1073/pnas.74.8.3438; DANIELSON PE, 1988, DNA-J MOLEC CELL BIO, V7, P261, DOI 10.1089/dna.1988.7.261; DAVIS S, 1993, SCIENCE, V260, P1805, DOI 10.1126/science.8390097; DAVIS S, 1991, SCIENCE, V253, P59, DOI 10.1126/science.1648265; DOBREA GM, 1992, DEV BRAIN RES, V66, P209, DOI 10.1016/0165-3806(92)90082-8; FRIEDMAN B, 1992, NEURON, V9, P295, DOI 10.1016/0896-6273(92)90168-D; FUKADA K, 1985, P NATL ACAD SCI USA, V82, P8795, DOI 10.1073/pnas.82.24.8795; GEARING DP, 1991, EMBO J, V10, P2839, DOI 10.1002/j.1460-2075.1991.tb07833.x; HENDRY IA, 1992, J NEUROSCI, V12, P3427; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; IP NY, 1993, NEURON, V10, P89, DOI 10.1016/0896-6273(93)90245-M; KESSLER JA, 1993, NEURON, V11, P1123, DOI 10.1016/0896-6273(93)90225-G; KESSLER JA, 1986, P NATL ACAD SCI USA, V83, P3528, DOI 10.1073/pnas.83.10.3528; KUWANO R, 1984, NUCLEIC ACIDS RES, V12, P7455, DOI 10.1093/nar/12.19.7455; LANDIS SC, 1988, DEV BIOL, V126, P129, DOI 10.1016/0012-1606(88)90246-1; LANDIS SC, 1983, DEV BIOL, V98, P349, DOI 10.1016/0012-1606(83)90365-2; LEBLANC G, 1986, J NEUROSCI, V6, P260; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; LIN LFH, 1989, SCIENCE, V246, P1023, DOI 10.1126/science.2587985; MANTHORPE M, 1986, BRAIN RES, V367, P282, DOI 10.1016/0006-8993(86)91603-3; MARTIN DP, 1988, J CELL BIOL, V106, P829, DOI 10.1083/jcb.106.3.829; MARTINOU JC, 1992, NEURON, V8, P737, DOI 10.1016/0896-6273(92)90094-T; MASU Y, 1993, NATURE, V365, P27, DOI 10.1038/365027a0; MURPHY M, 1993, DEVELOPMENT, V117, P1173; MURPHY M, 1991, P NATL ACAD SCI USA, V88, P3498, DOI 10.1073/pnas.88.8.3498; NAPOLITANO EW, 1987, J NEUROSCI, V7, P2590; NAWA H, 1991, J NEUROCHEM, V56, P2147, DOI 10.1111/j.1471-4159.1991.tb03479.x; OPPENHEIM RW, 1991, SCIENCE, V251, P1616, DOI 10.1126/science.2011743; PATTERSON PH, 1977, DEV BIOL, V56, P263, DOI 10.1016/0012-1606(77)90269-X; RAO MS, 1992, DEVELOPMENT, V116, P731; RAO MS, 1990, NEURON, V5, P899, DOI 10.1016/0896-6273(90)90350-O; RAO MS, 1992, DEV BIOL, V150, P281, DOI 10.1016/0012-1606(92)90242-9; RAO MS, 1993, J NEUROBIOL, V24, P215, DOI 10.1002/neu.480240208; ROHRER H, 1992, DEVELOPMENT, V114, P689; SAADAT S, 1989, J CELL BIOL, V108, P1807, DOI 10.1083/jcb.108.5.1807; SAITO M, 1992, J IMMUNOL, V148, P4066; SAKIMURA K, 1985, P NATL ACAD SCI USA, V82, P7453, DOI 10.1073/pnas.82.21.7453; SCHOTZINGER RJ, 1990, CELL TISSUE RES, V260, P575, DOI 10.1007/BF00297238; SCHOTZINGER RJ, 1990, NEURON, V5, P91, DOI 10.1016/0896-6273(90)90037-G; SENDTNER M, 1990, NATURE, V345, P440, DOI 10.1038/345440a0; STEVENS LM, 1990, DEV BIOL, V137, P109, DOI 10.1016/0012-1606(90)90012-8; STEVENS LM, 1987, DEV BIOL, V123, P179, DOI 10.1016/0012-1606(87)90440-4; STEVENS LM, 1988, DEV BIOL, V130, P703, DOI 10.1016/0012-1606(88)90362-4; STOCKLI KA, 1989, NATURE, V342, P920, DOI 10.1038/342920a0; URE DR, 1992, DEV BIOL, V154, P388, DOI 10.1016/0012-1606(92)90077-T; YAMAMORI T, 1991, P NATL ACAD SCI USA, V88, P7298, DOI 10.1073/pnas.88.16.7298; YAMAMORI T, 1989, SCIENCE, V246, P1412, DOI 10.1126/science.2512641	53	53	60	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1994	12	4					763	773		10.1016/0896-6273(94)90329-8	http://dx.doi.org/10.1016/0896-6273(94)90329-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NH253	8161448				2022-12-24	WOS:A1994NH25300005
J	JESSEN, KR; BRENNAN, A; MORGAN, L; MIRSKY, R; KENT, A; HASHIMOTO, Y; GAVRILOVIC, J				JESSEN, KR; BRENNAN, A; MORGAN, L; MIRSKY, R; KENT, A; HASHIMOTO, Y; GAVRILOVIC, J			THE SCHWANN-CELL PRECURSOR AND ITS FATE - A STUDY OF CELL-DEATH AND DIFFERENTIATION DURING GLIOGENESIS IN RAT EMBRYONIC NERVES	NEURON			English	Article							PERIPHERAL NERVOUS-SYSTEM; FIBROBLAST GROWTH-FACTOR; MAMMALIAN NEURAL CREST; AVIAN EMBRYOS; CYCLIC-AMP; N-CAM; MONOCLONAL-ANTIBODY; MYELIN PROTEIN; SCIATIC-NERVE; NEURONS	We have characterized a cell, the Schwann cell precursor, that represents a distinct intermediate differentiation stage in the process by which Schwann cells are generated from neural crest cells. The Schwann cell precursor shows radical differences from Schwann cells which include death regulation, antigenic phenotype, pattern of cell-cell interaction, migratory behavior, and morphology. In the nerves of the rat hind limb, Schwann cells are irreversibly generated from these during a brief period, essentially embryonic days 15-17. We also provide evidence that the survival of Schwann cell precursors is regulated by neurons and identify basic fibroblast growth factor as a potential key regulator of apoptosis in Schwann cell precursors and of precursor to Schwann cell conversion. These findings have implications for our understanding of gliogenesis in the peripheral nervous system.	UDMS, DEPT ANAT, LONDON SE1 9RT, ENGLAND	University of London; King's College London	JESSEN, KR (corresponding author), UCL, DEPT ANAT & DEV BIOL, GOWER ST, LONDON WC1E 6BT, ENGLAND.		Gavrilovic, Jelena/J-7754-2013	Gavrilovic, Jelena/0000-0002-5312-1784	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Anderson D J, 1993, Curr Opin Neurobiol, V3, P8, DOI 10.1016/0959-4388(93)90028-W; ANDERSON DJ, 1989, NEURON, V3, P1, DOI 10.1016/0896-6273(89)90110-4; BANNERMAN PG, 1993, J NEUROSCI RES, V36, P46, DOI 10.1002/jnr.490360106; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; BARTLETT PF, 1981, BRAIN RES, V204, P339, DOI 10.1016/0006-8993(81)90593-X; Battey, 1986, BASIC METHODS MOL BI; BHATTACHARYYA A, 1991, NEURON, V7, P831, DOI 10.1016/0896-6273(91)90285-8; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; BRILL G, 1992, DEVELOPMENT, V115, P1059; BUNGE RP, 1986, ANNU REV NEUROSCI, V9, P305; CHRISTIE GA, 1964, J MORPHOL, V114, P263, DOI 10.1002/jmor.1051140207; CIMENT G, 1986, DEV BIOL, V118, P392, DOI 10.1016/0012-1606(86)90009-6; CIMENT G, 1990, COMMENTS DEV NEUROBI, V1, P207; COMPTON MM, 1992, TRENDS ENDOCRIN MET, V3, P17, DOI 10.1016/1043-2760(92)90087-H; CURTIS R, 1992, J CELL BIOL, V116, P1455, DOI 10.1083/jcb.116.6.1455; CURTIS R, 1991, EUR J NEUROSCI, V3, P876, DOI 10.1111/j.1460-9568.1991.tb00099.x; DELEON M, 1991, J NEUROSCI RES, V29, P155; DELOULME JC, 1990, J CELL BIOL, V111, P1559, DOI 10.1083/jcb.111.4.1559; DIEPERINK ME, 1992, J NEUROSCI, V12, P2177; DUBAND JL, 1988, J CELL BIOL, V107, P1385, DOI 10.1083/jcb.107.4.1385; DULAC C, 1992, NEURON, V8, P323, DOI 10.1016/0896-6273(92)90298-R; ECCLESTON PA, 1990, EUR J NEUROSCI, V2, P985, DOI 10.1111/j.1460-9568.1990.tb00011.x; ECCLESTON PA, 1989, EXP CELL RES, V182, P173, DOI 10.1016/0014-4827(89)90289-9; ECCLESTON PA, 1987, DEV BRAIN RES, V35, P249, DOI 10.1016/0165-3806(87)90049-6; ELLIS RE, 1991, ANNU REV CELL BIOL, V7, P663, DOI 10.1146/annurev.cb.07.110191.003311; ERICKSON CA, 1993, DEV BIOL, V159, P60, DOI 10.1006/dbio.1993.1221; FLANDERS KC, 1991, DEVELOPMENT, V113, P183; FRANK E, 1991, DEVELOPMENT, V111, P895; FRASER SE, 1991, DEVELOPMENT, V112, P913; GENNARINI G, 1984, EUR J BIOCHEM, V142, P65, DOI 10.1111/j.1432-1033.1984.tb08251.x; GONZALEZ AM, 1990, J CELL BIOL, V110, P753, DOI 10.1083/jcb.110.3.753; GOULD RM, 1992, MYELIN BIOL CHEM; HOLTON B, 1982, DEV BIOL, V89, P64, DOI 10.1016/0012-1606(82)90294-9; HOLTON B, 1982, DEV BIOL, V89, P72, DOI 10.1016/0012-1606(82)90295-0; Jessen K R, 1992, Curr Opin Neurobiol, V2, P575, DOI 10.1016/0959-4388(92)90021-C; JESSEN KR, 1990, DEVELOPMENT, V109, P91; JESSEN KR, 1987, J NEUROSCI, V7, P3362; JESSEN KR, 1985, J CELL BIOL, V101, P1135, DOI 10.1083/jcb.101.3.1135; JESSEN KR, 1991, GLIA, V4, P185, DOI 10.1002/glia.440040210; JESSEN KR, 1991, ANN NY ACAD SCI, V633, P78; KALCHEIM C, 1990, DEVELOPMENT, V109, P203; KALCHEIM C, 1989, DEV BIOL, V134, P1, DOI 10.1016/0012-1606(89)90072-9; LEDOUARIN N, 1991, GLIA, V4, P175; LEMKE G, 1988, DEVELOPMENT, V102, P499; MARTINI R, 1986, J CELL BIOL, V103, P2439, DOI 10.1083/jcb.103.6.2439; Marusich MF, 1991, CURR OPIN GENET DEV, V1, P221, DOI 10.1016/S0959-437X(05)80074-7; MIRSKY R, 1985, CELL TISSUE RES, V240, P723, DOI 10.1007/BF00216361; MIRSKY R, 1990, DEVELOPMENT, V109, P105; MIRSKY R, 1980, J CELL BIOL, V84, P483, DOI 10.1083/jcb.84.3.483; MONUKI ES, 1989, NEURON, V3, P783, DOI 10.1016/0896-6273(89)90247-X; MORGAN L, 1991, J CELL BIOL, V112, P457, DOI 10.1083/jcb.112.3.457; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NICHOLS DH, 1977, DEV BIOL, V60, P217, DOI 10.1016/0012-1606(77)90120-8; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; OWENS GC, 1989, GLIA, V2, P119, DOI 10.1002/glia.440020208; RANSCHT B, 1982, P NATL ACAD SCI-BIOL, V79, P2709, DOI 10.1073/pnas.79.8.2709; RYDEL RE, 1988, P NATL ACAD SCI USA, V85, P1257, DOI 10.1073/pnas.85.4.1257; SASAHARA M, 1991, CELL, V64, P217, DOI 10.1016/0092-8674(91)90223-L; SCHUMAN S, 1988, J NEUROCHEM, V50, P190; SKENE JHP, 1989, ANNU REV NEUROSCI, V12, P127, DOI 10.1146/annurev.ne.12.030189.001015; SMITHTHOMAS LC, 1989, DEVELOPMENT, V105, P251; SMITHTHOMAS LC, 1990, DEVELOPMENT, V109, P925; SNIPES GJ, 1992, J CELL BIOL, V117, P225, DOI 10.1083/jcb.117.1.225; SOBUE G, 1984, SCIENCE, V224, P72, DOI 10.1126/science.6322307; SOMMER I, 1981, DEV BIOL, V83, P311, DOI 10.1016/0012-1606(81)90477-2; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; STOCKER KM, 1991, DEVELOPMENT, V111, P635; THOENEN H, 1991, TRENDS NEUROSCI, V14, P165, DOI 10.1016/0166-2236(91)90097-E; TRAPP BD, 1984, J NEUROCHEM, V43, P944, DOI 10.1111/j.1471-4159.1984.tb12828.x; VARON SS, 1978, ANNU REV NEUROSCI, V1, P327, DOI 10.1146/annurev.ne.01.030178.001551; WEBSTER HD, 1984, PERIPHERAL NEUROPATH, P329; WEINBERG HJ, 1976, BRAIN RES, V113, P363, DOI 10.1016/0006-8993(76)90947-1; WINNINGHAMMAJOR F, 1989, J CELL BIOL, V109, P3063, DOI 10.1083/jcb.109.6.3063; Wyllie A H, 1980, Int Rev Cytol, V68, P251; YEH HJ, 1991, CELL, V64, P209, DOI 10.1016/0092-8674(91)90222-K	75	241	243	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR	1994	12	3					509	527		10.1016/0896-6273(94)90209-7	http://dx.doi.org/10.1016/0896-6273(94)90209-7			19	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NC769	8155318				2022-12-24	WOS:A1994NC76900005
J	EYER, J; PETERSON, A				EYER, J; PETERSON, A			NEUROFILAMENT-DEFICIENT AXONS AND PERIKARYAL AGGREGATES IN VIABLE TRANSGENIC MICE EXPRESSING A NEUROFILAMENT-BETA-GALACTOSIDASE FUSION PROTEIN	NEURON			English	Article							INTERMEDIATE FILAMENT PROTEIN; MOTOR-NEURON DISEASE; MONOCLONAL-ANTIBODIES DISTINGUISH; HEREDITARY HYPOTROPHIC AXONOPATHY; CARBOXY-TERMINAL EXTENSION; PERIPHERAL NERVOUS-SYSTEM; NF-M; DIFFERENTIAL EXPRESSION; GENE-EXPRESSION; ELECTROPHORETIC TRANSFER	Interactions between neurofilament side arms may modulate axon caliber. To investigate this hypothesis, we derived transgenic mice expressing a fusion protein in which the carboxyl terminus of the high molecular weight neurofilament protein (NFH) was replaced by beta-galactosidase. The transgene, regulated by NFH sequences, was expressed in projection neurons. However, the fusion protein remained in perikarya precipitating large filamentous aggregates. Axons were not invested with neurofilaments and developed only small calibers. Perikaryal aggregates, with similar structural features, are associated with neurodegenerative diseases, but these mice showed few ill effects and their neurons rarely degenerated. We conclude that an organized neurofilament cytoskeleton is required by axons to achieve large calibers but is not essential for neuronal function or extended survival.	MCGILL UNIV, ROYAL VICTORIA HOSP, DEPT NEUROL & NEUROSURG, MONTREAL H3A 1A1, PQ, CANADA	McGill University; Royal Victoria Hospital			Eyer, Joel/V-8679-2019; Eyer, Joel/K-4265-2015	Eyer, Joel/0000-0001-6301-7465; Eyer, Joel/0000-0001-6301-7465				BALCAREK JM, 1985, NUCLEIC ACIDS RES, V13, P5527, DOI 10.1093/nar/13.15.5527; BEAUDET L, 1992, GENE, V116, P205, DOI 10.1016/0378-1119(92)90517-S; BERTHOLD CH, 1978, PHYSL PATHOBIOLOGY A, P3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRADY ST, 1993, CELL, V73, P1, DOI 10.1016/0092-8674(93)90151-F; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CARDEN MJ, 1985, J BIOL CHEM, V260, P9805; CARDEN MJ, 1986, NEUROCHEM PATHOL, V5, P25, DOI 10.1007/BF03028034; CARDEN MJ, 1987, NEUROCHEM PATHOL, V7, P189; CARDEN MJ, 1987, J NEUROSCI, V7, P3489; CARPENTER S, 1968, NEUROLOGY, V18, P841, DOI 10.1212/WNL.18.9.841; COCHARD P, 1984, J NEUROSCI, V4, P2080; CORBO M, 1992, J NEUROPATH EXP NEUR, V51, P531, DOI 10.1097/00005072-199209000-00008; COTE F, 1993, CELL, V73, P35, DOI 10.1016/0092-8674(93)90158-M; DEWAEGH SM, 1992, CELL, V68, P451, DOI 10.1016/0092-8674(92)90183-D; ELDER GA, 1992, MOL BRAIN RES, V15, P99, DOI 10.1016/0169-328X(92)90156-6; ELDER GA, 1992, MOL BRAIN RES, V15, P85, DOI 10.1016/0169-328X(92)90155-5; ESCURAT M, 1990, J NEUROSCI, V10, P764; EYER J, 1988, BIOCHEM J, V252, P655, DOI 10.1042/bj2520655; FLIEGNER KH, 1990, EMBO J, V9, P749, DOI 10.1002/j.1460-2075.1990.tb08169.x; FLIEGNER KH, 1991, INT REV CYTOL, V131, P109, DOI 10.1016/S0074-7696(08)62018-5; FRANKE WW, 1987, CELL, V48, P3, DOI 10.1016/0092-8674(87)90345-X; FRIEDE RL, 1970, ANAT REC, V167, P379, DOI 10.1002/ar.1091670402; GEISLER N, 1984, EMBO J, V3, P2701, DOI 10.1002/j.1460-2075.1984.tb02196.x; GEISLER N, 1983, EMBO J, V2, P1295, DOI 10.1002/j.1460-2075.1983.tb01584.x; GEISLER N, 1985, EMBO J, V4, P57, DOI 10.1002/j.1460-2075.1985.tb02317.x; GLICKSMAN MA, 1985, ANN NY ACAD SCI, V455, P479, DOI 10.1111/j.1749-6632.1985.tb50430.x; GOLDMAN JE, 1986, ANN NEUROL, V19, P209, DOI 10.1002/ana.410190302; GOLDSTEIN ME, 1988, MOL BRAIN RES, V3, P287, DOI 10.1016/0169-328X(88)90051-4; GOLDSTEIN ME, 1987, J NEUROIMMUNOL, V14, P149, DOI 10.1016/0165-5728(87)90049-X; GOTOW T, 1992, EUR J CELL BIOL, V58, P331; GRIFFIN JW, 1978, SCIENCE, V202, P633, DOI 10.1126/science.81524; GRIFFIN JW, 1980, EXPT CLIN NEUROTOXIC, P161; HIROKAWA N, 1982, J CELL BIOL, V94, P129, DOI 10.1083/jcb.94.1.129; HIROKAWA N, 1984, J CELL BIOL, V98, P1523, DOI 10.1083/jcb.98.4.1523; HIROKAWA N, 1991, NEURONAL CYTOSKELETO, P5; HISANAGA S, 1989, J NEUROSCI, V9, P959; HOFFMAN PN, 1983, J NEUROSCI, V3, P1694; HOFFMAN PN, 1984, J CELL BIOL, V99, P705, DOI 10.1083/jcb.99.2.705; HOFFMAN PN, 1987, P NATL ACAD SCI USA, V84, P3472, DOI 10.1073/pnas.84.10.3472; HOFFMAN PN, 1985, J NEUROSCI, V5, P2920; HOFFMAN PN, 1985, J CELL BIOL, V101, P1332, DOI 10.1083/jcb.101.4.1332; JULIEN JP, 1982, J BIOL CHEM, V257, P467; JULIEN JP, 1988, GENE, V68, P307, DOI 10.1016/0378-1119(88)90033-9; JULIEN JP, 1987, GENE DEV, V1, P1085, DOI 10.1101/gad.1.10.1085; JULIEN JP, 1986, MOL BRAIN RES, V1, P243, DOI 10.1016/0169-328X(86)90030-6; KAPLAN MP, 1990, J NEUROSCI, V10, P2735; KELLY BM, 1992, J CELL BIOL, V118, P397, DOI 10.1083/jcb.118.2.397; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANGLEY KE, 1976, BIOCHEMISTRY-US, V15, P4866, DOI 10.1021/bi00667a018; LASEK RJ, 1983, COLD SPRING HARB SYM, V48, P731, DOI 10.1101/SQB.1983.048.01.076; LEE VMY, 1987, J NEUROSCI, V7, P3474; LEE VMY, 1988, P NATL ACAD SCI USA, V85, P1998, DOI 10.1073/pnas.85.6.1998; LEMOUELLIC H, 1990, P NATL ACAD SCI USA, V87, P4712, DOI 10.1073/pnas.87.12.4712; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; LETERRIER JF, 1987, BIOCHEM J, V245, P93, DOI 10.1042/bj2450093; Liem RKH, 1993, CURR OPIN CELL BIOL, V5, P12, DOI 10.1016/S0955-0674(05)80003-1; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; MITCHISON T, 1988, NEURON, V1, P761, DOI 10.1016/0896-6273(88)90124-9; MONACO S, 1989, J NEUROPATH EXP NEUR, V48, P23, DOI 10.1097/00005072-198901000-00003; MONTEIRO MJ, 1990, J CELL BIOL, V111, P1543, DOI 10.1083/jcb.111.4.1543; MUMA NA, 1990, EXP NEUROL, V107, P230, DOI 10.1016/0014-4886(90)90140-N; OBLINGER MM, 1988, J NEUROSCI, V8, P1747; OSAMU O, 1993, J CELL BIOL, V121, P387; PACHTER JS, 1984, DEV BIOL, V103, P200, DOI 10.1016/0012-1606(84)90021-6; PANT HC, 1988, BIOCHEM J, V256, P665, DOI 10.1042/bj2560665; PARRY D A D, 1992, Current Opinion in Cell Biology, V4, P94, DOI 10.1016/0955-0674(92)90064-J; ROOTS BI, 1983, SCIENCE, V221, P971, DOI 10.1126/science.6192501; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; SAKAGUCHI T, 1993, NEUROSCI LETT, V153, P65, DOI 10.1016/0304-3940(93)90078-Y; Sambrook J, 1989, MOL CLONING LABORATO; SCHMIDT ML, 1989, LAB INVEST, V60, P513; SCHMIDT ML, 1987, LAB INVEST, V56, P282; SCHMIDT ML, 1991, AM J PATHOL, V139, P53; SHAW G, 1982, NATURE, V298, P277, DOI 10.1038/298277a0; STEINERT PM, 1988, ANNU REV BIOCHEM, V57, P593, DOI 10.1146/annurev.bi.57.070188.003113; STERNBERGER LA, 1983, P NATL ACAD SCI-BIOL, V80, P6126, DOI 10.1073/pnas.80.19.6126; SZARO BG, 1991, J COMP NEUROL, V308, P576, DOI 10.1002/cne.903080406; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TOYOSHIMA I, 1989, J NEUROL SCI, V89, P269, DOI 10.1016/0022-510X(89)90028-2; TRONCOSO JC, 1986, BRAIN RES, V364, P295, DOI 10.1016/0006-8993(86)90842-5; TRONCOSO JC, 1985, BRAIN RES, V342, P172, DOI 10.1016/0006-8993(85)91369-1; TUCKER RP, 1989, NEURON, V2, P1245, DOI 10.1016/0896-6273(89)90309-7; VOYVODIC JT, 1989, NATURE, V342, P430, DOI 10.1038/342430a0; WATSON DF, 1989, J NEUROCHEM, V53, P1818, DOI 10.1111/j.1471-4159.1989.tb09248.x; WILLARD M, 1983, CELL, V35, P551, DOI 10.1016/0092-8674(83)90189-7; WONG J, 1987, METAB BRAIN DIS, V2, P291, DOI 10.1007/BF00999699; WUIEK IR, 1986, J NEUROSCI, V15, P75; XU ZS, 1993, CELL, V73, P23, DOI 10.1016/0092-8674(93)90157-L; YAMASAKI H, 1991, ACTA NEUROPATHOL, V82, P427, DOI 10.1007/BF00293376; YAMASAKI H, 1992, LAB INVEST, V66, P734; ZABIN I, 1982, MOL CELL BIOCHEM, V49, P87	92	260	267	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1994	12	2					389	405		10.1016/0896-6273(94)90280-1	http://dx.doi.org/10.1016/0896-6273(94)90280-1			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MY500	8110465				2022-12-24	WOS:A1994MY50000014
J	PFRIEGER, FW; GOTTMANN, K; LUX, HD				PFRIEGER, FW; GOTTMANN, K; LUX, HD			KINETICS OF GABA(B) RECEPTOR-MEDIATED INHIBITION OF CALCIUM CURRENTS AND EXCITATORY SYNAPTIC TRANSMISSION IN HIPPOCAMPAL-NEURONS IN-VITRO	NEURON			English	Article							GAMMA-AMINOBUTYRIC-ACID; CENTRAL-NERVOUS-SYSTEM; ROOT GANGLION NEURONS; B RECEPTORS; G-PROTEINS; PRESYNAPTIC INHIBITION; SYMPATHETIC NEURONS; RAT HIPPOCAMPUS; PERTUSSIS TOXIN; PHARMACOLOGICAL CHARACTERIZATION	The time courses of the gamma-aminobutyric acid type B (GABA(B)) receptor-mediated inhibition of excitatory synaptic transmission and of action potential-evoked calcium currents were studied in hippocampal neurons in vitro with step-like changes of a saturating baclofen concentration. Inhibition mediated by postsynaptic GABA(B) receptors was excluded pharmacologically. Both presynaptic inhibition and reduction of calcium currents developed and declined exponentially with similar time constants of about 0.2 and 3 s, respectively. The close correlation of the time courses indicates that fast, G protein-mediated depression of voltage-gated calcium channels and thus direct reduction of the presynaptic calcium influx may contribute to the GABA(B) receptor-induced inhibition of excitatory synaptic transmission in hippocampal neurons in vitro.			PFRIEGER, FW (corresponding author), MAX PLANCK INST PSYCHIAT,DEPT NEUROPHYSIOL,KLOPFERSPITZ 18A,D-82152 PLANEGG,GERMANY.		Pfrieger, Frank/AAX-3208-2020	Pfrieger, Frank/0000-0001-7085-1431				ALFORD S, 1991, J NEUROSCI, V11, P3718; ANDRADE R, 1991, EUR J PHARMACOL, V199, P259, DOI 10.1016/0014-2999(91)90467-5; ANDRADE R, 1986, SCIENCE, V234, P1261, DOI 10.1126/science.2430334; ANWYL R, 1991, BRAIN RES REV, V16, P265, DOI 10.1016/0165-0173(91)90010-6; ARMSTRONG CM, 1992, METHOD ENZYMOL, V207, P100; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; BERNHEIM L, 1991, NEURON, V6, P859, DOI 10.1016/0896-6273(91)90226-P; BIRNBAUMER L, 1990, BIOCHIM BIOPHYS ACTA, V1031, P163, DOI 10.1016/0304-4157(90)90007-Y; BOLAND LM, 1993, J NEUROSCI, V13, P516; BOWERY N, 1989, TRENDS PHARMACOL SCI, V10, P401, DOI 10.1016/0165-6147(89)90188-0; BOWERY NG, 1993, ANNU REV PHARMACOL, V33, P109, DOI 10.1146/annurev.pa.33.040193.000545; BREITWIESER GE, 1988, J GEN PHYSIOL, V91, P469, DOI 10.1085/jgp.91.4.469; BROWN AM, 1984, J GEN PHYSIOL, V83, P751, DOI 10.1085/jgp.83.5.751; BROWN AM, 1993, J MEMBRANE BIOL, V131, P93, DOI 10.1007/BF02791318; CARBONE E, 1989, PROG BIOPHYS MOL BIO, V54, P31, DOI 10.1016/0079-6107(89)90008-4; COLMERS WF, 1989, BRAIN RES, V498, P99, DOI 10.1016/0006-8993(89)90403-4; CONNORS BW, 1982, J PHARMACOL EXP THER, V220, P476; CRUNELLI V, 1991, TRENDS NEUROSCI, V14, P16, DOI 10.1016/0166-2236(91)90178-W; DAVIES CH, 1990, J PHYSIOL-LONDON, V424, P513, DOI 10.1113/jphysiol.1990.sp018080; DIVERSEPIERLUISSI M, 1993, NEURON, V10, P753, DOI 10.1016/0896-6273(93)90175-Q; DOLPHIN AC, 1990, ANNU REV PHYSIOL, V52, P243; DUTAR P, 1988, NEURON, V1, P585, DOI 10.1016/0896-6273(88)90108-0; ELMSLIE KS, 1990, NEURON, V5, P75, DOI 10.1016/0896-6273(90)90035-E; FORSYTHE ID, 1990, J PHYSIOL-LONDON, V429, P1; FRYER MW, 1993, J PHYSIOL-LONDON, V464, P501, DOI 10.1113/jphysiol.1993.sp019648; GAGE PW, 1992, TRENDS NEUROSCI, V15, P46, DOI 10.1016/0166-2236(92)90025-4; GAHWILER BH, 1985, P NATL ACAD SCI USA, V82, P1558, DOI 10.1073/pnas.82.5.1558; GRASSI F, 1989, NEUROSCI LETT, V105, P113, DOI 10.1016/0304-3940(89)90021-9; GREEN KA, 1988, BRIT J PHARMACOL, V94, P235, DOI 10.1111/j.1476-5381.1988.tb11520.x; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARRISON NL, 1990, J PHYSIOL-LONDON, V422, P433, DOI 10.1113/jphysiol.1990.sp017993; HOLZ GG, 1989, J NEUROSCI, V9, P657; HOLZ GG, 1986, NATURE, V319, P670, DOI 10.1038/319670a0; HOWE JR, 1987, J PHYSIOL-LONDON, V384, P539, DOI 10.1113/jphysiol.1987.sp016469; HUSTON E, 1990, NEUROSCIENCE, V38, P721, DOI 10.1016/0306-4522(90)90065-C; INOMATA N, 1989, AM J PHYSIOL, V257, pC646, DOI 10.1152/ajpcell.1989.257.4.C646; ISAAC JT, 1993, NEUROSCI LETT, V150, P227, DOI 10.1016/0304-3940(93)90542-S; JACKSON MB, 1992, BIOPHYS J, V61, P756, DOI 10.1016/S0006-3495(92)81880-5; JANIGRO D, 1988, DEV BRAIN RES, V41, P171, DOI 10.1016/0165-3806(88)90180-0; JENKS BG, 1991, LIFE SCI, V48, P1633, DOI 10.1016/0024-3205(91)90123-S; JONES SW, 1991, BIOPHYS J, V60, P502, DOI 10.1016/S0006-3495(91)82077-X; KASAI H, 1992, J PHYSIOL-LONDON, V448, P189, DOI 10.1113/jphysiol.1992.sp019036; LAMBERT NA, 1993, J NEUROPHYSIOL, V69, P630, DOI 10.1152/jn.1993.69.2.630; LESSMANN V, 1992, NEUROSCI LETT, V146, P13; MANSONHING H, 1989, NATURE, V341, P237, DOI 10.1038/341237a0; MCCOBB DP, 1991, NEURON, V7, P119, DOI 10.1016/0896-6273(91)90080-J; MILLER RJ, 1990, FASEB J, V4, P3291, DOI 10.1096/fasebj.4.15.1979294; MILLIGAN G, 1988, BIOCHEM J, V255, P1; MINTZ IM, 1993, NEURON, V10, P889, DOI 10.1016/0896-6273(93)90204-5; MORAD M, 1988, SCIENCE, V241, P842, DOI 10.1126/science.2457253; MORISHITA R, 1990, FEBS LETT, V271, P231, DOI 10.1016/0014-5793(90)80413-D; NARGEOT J, 1982, J GEN PHYSIOL, V79, P657, DOI 10.1085/jgp.79.4.657; NATHAN T, 1990, NEUROSCI LETT, V110, P309, DOI 10.1016/0304-3940(90)90865-7; NICOLL RA, 1990, PHYSIOL REV, V70, P513, DOI 10.1152/physrev.1990.70.2.513; OLPE HR, 1990, EUR J PHARMACOL, V187, P27, DOI 10.1016/0014-2999(90)90337-6; OTIS TS, 1993, J PHYSIOL-LONDON, V463, P391, DOI 10.1113/jphysiol.1993.sp019600; PFRIEGER FW, 1992, J NEUROSCI, V12, P4347; POLLO A, 1992, PFLUG ARCH EUR J PHY, V422, P75; REKLING JC, 1993, J NEUROSCI, V13, P1954; SAHARA Y, 1993, J NEUROSCI, V13, P3041; SAINT DA, 1990, NEUROSCI LETT, V118, P9, DOI 10.1016/0304-3940(90)90236-3; SCANZIANI M, 1992, NEURON, V9, P919, DOI 10.1016/0896-6273(92)90244-8; SCHOLZ KP, 1991, J PHYSIOL-LONDON, V444, P669, DOI 10.1113/jphysiol.1991.sp018900; SCHOLZ KP, 1992, NEURON, V8, P1139, DOI 10.1016/0896-6273(92)90134-Y; SCHULTZ G, 1990, ANNU REV PHYSIOL, V52, P275, DOI 10.1146/annurev.ph.52.030190.001423; SCOTT RH, 1991, PROG NEUROBIOL, V36, P485, DOI 10.1016/0301-0082(91)90014-R; SCROGGS RS, 1992, J NEUROSCI, V12, P1789; SEABROOK GR, 1990, BRIT J PHARMACOL, V101, P949, DOI 10.1111/j.1476-5381.1990.tb14186.x; SIVILOTTI L, 1991, PROG NEUROBIOL, V36, P35, DOI 10.1016/0301-0082(91)90036-Z; SOLIS JM, 1992, J NEUROSCI, V12, P3466; SPENCER AN, 1989, NATURE, V340, P636, DOI 10.1038/340636a0; STREIT J, 1989, J NEUROSCI, V9, P4190; SWARTZ KJ, 1992, J NEUROSCI, V12, P4358; THOMPSON SM, 1992, J PHYSIOL-LONDON, V451, P329, DOI 10.1113/jphysiol.1992.sp019167; THOMPSON SM, 1993, TRENDS NEUROSCI, V16, P222, DOI 10.1016/0166-2236(93)90160-N; TRAVAGLI RA, 1991, J PHARMACOL EXP THER, V258, P903; UI M, 1984, TRENDS PHARMACOL SCI, V5, P277, DOI 10.1016/0165-6147(84)90444-9; YATANI A, 1987, SCIENCE, V235, P207, DOI 10.1126/science.2432660; YOON KW, 1991, J PHYSIOL-LONDON, V442, P377, DOI 10.1113/jphysiol.1991.sp018798	79	97	99	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1994	12	1					97	107		10.1016/0896-6273(94)90155-4	http://dx.doi.org/10.1016/0896-6273(94)90155-4			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MU493	8292363	Green Published			2022-12-24	WOS:A1994MU49300009
J	ARTINGER, KB; BRONNERFRASER, M				ARTINGER, KB; BRONNERFRASER, M			DELAYED FORMATION OF THE FLOOR PLATE AFTER ABLATION OF THE AVIAN NOTOCHORD	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; CHICK-EMBRYO; NEURAL-TUBE; DIFFERENTIATION; PATTERN; AXONS; CELLS	We have examined the long-term effects of notochord ablation at chick stages 9-10 on formation of the floor plate and motor neurons. Although missing or reduced 2 days postablation, the floor plate and motor neurons were morphologically normal by 4 postoperative days. When isolated whole or ventral, but not lateral, neural plate fragments from stage 9 embryos were cultured for 4 days in collagen gels, floor plate and neural markers were observed. Our results suggest that floor plate and motor neurons can form in a delayed fashion in vivo after notochord ablation and in vitro from isolated neural plates. This suggests that either there is an early induction of floor plate by the chordamesoderm of Hensen's node, or only limited interactions between the neural plate and notochord immediately after neurulation are required for floor plate determination.			ARTINGER, KB (corresponding author), UNIV CALIF IRVINE,CTR DEV BIOL,IRVINE,CA 92717, USA.			Bronner, Marianne/0000-0003-4274-1862	NICHD NIH HHS [NICHD NO1-HD-2-3144, HD-25138] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD025138] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ARTINGER KB, 1992, DEVELOPMENT, V116, P877; BURNS FR, 1991, NEURON, V7, P209, DOI 10.1016/0896-6273(91)90259-3; DARNELL DK, 1992, DEV DYNAM, V193, P389, DOI 10.1002/aja.1001930411; GOULDING MD, 1993, DEVELOPMENT, V117, P1001; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HAMILTON HL, 1952, ILLIES DEV CHICK; HATTA K, 1992, NEURON, V9, P629, DOI 10.1016/0896-6273(92)90027-B; HATTA K, 1991, NATURE, V350, P339, DOI 10.1038/350339a0; LEDOUARIAN N, 1982, NEURAL CREST; LUMSDEN AGS, 1983, NATURE, V306, P786, DOI 10.1038/306786a0; PLACZEK M, 1990, DEVELOPMENT, V110, P19; PLACZEK M, 1993, DEVELOPMENT, V117, P205; SCHOENWOLF GC, 1985, DEV BIOL, V109, P127, DOI 10.1016/0012-1606(85)90353-7; SCHOENWOLF GC, 1989, J EXP ZOOL, V249, P271, DOI 10.1002/jez.1402490305; SCHOENWOLF GC, 1984, DEV BIOL, V105, P257, DOI 10.1016/0012-1606(84)90284-7; SELLECK MAJ, 1991, DEVELOPMENT, V112, P615; SMITH G, 1989, FILM COMMENT, V25, P49; TANAKA H, 1984, DEV BIOL, V106, P26, DOI 10.1016/0012-1606(84)90057-5; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; VANSTRAATEN HWM, 1989, DEVELOPMENT, V107, P793; VANSTRAATEN HWM, 1988, ANAT EMBRYOL, V177, P317; VANSTRAATEN HWM, 1991, ANAT EMBRYOL, V184, P55; YAMADA T, 1991, CELL, V64, P635, DOI 10.1016/0092-8674(91)90247-V; YAMADA T, 1993, CELL, V73, P673, DOI 10.1016/0092-8674(93)90248-O	24	45	46	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1993	11	6					1147	1161		10.1016/0896-6273(93)90227-I	http://dx.doi.org/10.1016/0896-6273(93)90227-I			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MP548	8274280				2022-12-24	WOS:A1993MP54800015
J	MURALIDHAR, MG; THOMAS, JB				MURALIDHAR, MG; THOMAS, JB			THE DROSOPHILA BENDLESS GENE ENCODES A NEURAL PROTEIN RELATED TO UBIQUITIN-CONJUGATING ENZYMES	NEURON			English	Article							NEURONAL GROWTH CONES; VISUAL-SYSTEM; IDENTIFIED NEURONS; CELL-ADHESION; MOTO-NEURONS; WHITE GENE; PATHWAY; EMBRYOS; DNA; GLYCOPROTEIN	The bendless (ben) mutation of Drosophila alters synaptic connectivity between a subset of CNS neurons. Here, we show that ben also causes morphological abnormalities within the visual system, suggesting that ben functions in a number of different developmental processes. We show that the ben gene encodes a protein which is closely related to ubiquitin-conjugating enzymes and that a missense mutation in the highly conserved active site region is associated with the ben mutation. High levels of ben expression are restricted to the nervous system during development. These results suggest a role for ubiquitin-mediated protein modification in nervous system development, including, but not exclusive to, the regulation of synaptic connectivity.			MURALIDHAR, MG (corresponding author), SALK INST BIOL STUDIES,MOLEC NEUROBIOL LAB,SAN DIEGO,CA 92186, USA.							BAINBRIDGE SP, 1981, J EMBRYOL EXP MORPH, V66, P57; BALL E, 1987, CELL, V51, P221, DOI 10.1016/0092-8674(87)90149-8; BASTIANI MJ, 1986, J NEUROSCI, V6, P3518; BENZER S, 1991, DEV VISUAL SYSTEM, P9; BOURGOUIN C, 1992, NEURON, V9, P549, DOI 10.1016/0896-6273(92)90192-G; BUCKLES GR, 1992, NEURON, V8, P1015, DOI 10.1016/0896-6273(92)90124-V; CAMPOS AR, 1992, DEVELOPMENT, V114, P355; CAVENER DR, 1987, NUCLEIC ACIDS RES, V15, P1353, DOI 10.1093/nar/15.4.1353; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; EDGECOMB RS, 1993, IN PRESS J NEUROGENE; FINLEY D, 1985, TRENDS BIOCHEM SCI, V10, P343, DOI 10.1016/0968-0004(85)90108-2; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; FRIEDBERG EC, 1988, MICROBIOL REV, V52, P70, DOI 10.1128/MMBR.52.1.70-102.1988; FURLEY AJ, 1990, CELL, V61, P157, DOI 10.1016/0092-8674(90)90223-2; GOEBL MG, 1988, SCIENCE, V241, P1331, DOI 10.1126/science.2842867; GREEN SH, 1981, NATURE, V292, P152, DOI 10.1038/292152a0; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; Grigliati T., 1986, DROSOPHILA PRACTICAL, P39; HARTE PJ, 1982, GENETICS, V101, P477; HERSHKO A, 1984, P NATL ACAD SCI-BIOL, V81, P1619, DOI 10.1073/pnas.81.6.1619; ITOH N, 1985, DROS INF SERVICE, V61, P89; Jentsch S, 1992, Trends Cell Biol, V2, P98, DOI 10.1016/0962-8924(92)90013-D; JENTSCH S, 1991, BIOCHIM BIOPHYS ACTA, V1089, P127, DOI 10.1016/0167-4781(91)90001-3; JIANG J, 1991, GENE DEV, V5, P1881, DOI 10.1101/gad.5.10.1881; JOHANSEN J, 1989, J NEUROSCI, V9, P4318; KING DG, 1980, J NEUROCYTOL, V9, P753, DOI 10.1007/BF01205017; KLEMENZ R, 1987, NUCLEIC ACIDS RES, V15, P3947, DOI 10.1093/nar/15.10.3947; KOKEN M, 1991, P NATL ACAD SCI USA, V88, P3832, DOI 10.1073/pnas.88.9.3832; KOTO M, 1981, BRAIN RES, V221, P213, DOI 10.1016/0006-8993(81)90772-1; KRETZ KA, 1989, NUCLEIC ACIDS RES, V17, P5864, DOI 10.1093/nar/17.14.5864; LANCEJONES C, 1981, PROC R SOC SER B-BIO, V214, P19, DOI 10.1098/rspb.1981.0080; LANDMESSER LT, 1980, ANNU REV NEUROSCI, V3, P279, DOI 10.1146/annurev.ne.03.030180.001431; LAWRENCE PA, 1986, CELL, V45, P505, DOI 10.1016/0092-8674(86)90282-5; LEVIS R, 1985, SCIENCE, V229, P558, DOI 10.1126/science.2992080; Lewis E B, 1982, Prog Clin Biol Res, V85 Pt A, P269; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; Maniatis T., 1982, MOL CLONING; MEINERTZHAGEN IA, 1983, TRENDS NEUROSCI, V6, P223, DOI 10.1016/0166-2236(83)90099-1; MEYEROWITZ EM, 1978, DEV BIOL, V62, P112, DOI 10.1016/0012-1606(78)90096-9; NOSE A, 1992, CELL, V70, P553, DOI 10.1016/0092-8674(92)90426-D; PAOLINI R, 1993, EMBO J, V12, P779, DOI 10.1002/j.1460-2075.1993.tb05712.x; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; POOLE SJ, 1985, CELL, V40, P37, DOI 10.1016/0092-8674(85)90306-X; RAPER JA, 1984, J NEUROSCI, V4, P2329; RATHJEN FG, 1984, EMBO J, V3, P1; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; SELLECK SB, 1991, NEURON, V6, P83, DOI 10.1016/0896-6273(91)90124-I; SEUFERT W, 1990, EMBO J, V9, P4535, DOI 10.1002/j.1460-2075.1990.tb07905.x; SIEGELMAN M, 1986, SCIENCE, V231, P823, DOI 10.1126/science.3003913; SINK H, 1991, DEVELOPMENT, V113, P701; SINK H, 1991, DEVELOPMENT, V112, P307; SPRADLING AC, 1983, CELL, V34, P47, DOI 10.1016/0092-8674(83)90135-6; STELLER H, 1987, CELL, V50, P1139, DOI 10.1016/0092-8674(87)90180-2; STEWART WW, 1978, CELL, V14, P741, DOI 10.1016/0092-8674(78)90256-8; Strausfeld NJ., 1976, ATLAS INSECT BRAIN, DOI 10.1007/978-3-642-66179-2; TANOUYE MA, 1980, J NEUROPHYSIOL, V44, P405, DOI 10.1152/jn.1980.44.2.405; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; THOMAS JB, 1984, DEV BIOL, V102, P531, DOI 10.1016/0012-1606(84)90222-7; THOMAS JB, 1983, TRENDS NEUROSCI, V6, P214, DOI 10.1016/0166-2236(83)90097-8; THOMAS JB, 1982, NATURE, V298, P650, DOI 10.1038/298650a0; THOMAS JB, 1984, J NEUROSCI, V4, P530; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; TREIER M, 1992, EMBO J, V11, P367, DOI 10.1002/j.1460-2075.1992.tb05059.x; VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8; VANVACTOR D, 1993, CELL, V73, P1155; WIEBEL FF, 1992, NATURE, V359, P73, DOI 10.1038/359073a0	71	120	123	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1993	11	2					253	266		10.1016/0896-6273(93)90182-Q	http://dx.doi.org/10.1016/0896-6273(93)90182-Q			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LU065	8394720				2022-12-24	WOS:A1993LU06500006
J	SWARTZ, KJ				SWARTZ, KJ			MODULATION OF CA2+ CHANNELS BY PROTEIN-KINASE-C IN RAT CENTRAL AND PERIPHERAL NEURONS - DISRUPTION OF G-PROTEIN-MEDIATED INHIBITION	NEURON			English	Article							DEPENDENT CALCIUM CURRENT; CHICK SENSORY NEURONS; GTP-BINDING PROTEIN; FROG SYMPATHETIC NEURONS; ADENYLATE-CYCLASE; PHORBOL-ESTER; HUMAN-PLATELETS; HIPPOCAMPUS INVITRO; POSTSYNAPTIC RECEPTORS; SYNAPTIC TRANSMISSION	Activation of protein kinase C (PKC) reduced G protein-dependent inhibition of Ca2+ channels by glutamate, GABA(B), adenosine, muscarinic, alpha-adrenergic, and LHRH receptors in a variety of central and peripheral neurons. PKC stimulation also relieved the inhibitory effect of internal GTPgammaS and reduced tonic G protein-mediated inhibition observed with internal GTP in the absence of transmitter receptor agonist. Basal Ca2+ channel currents were enhanced by PKC stimulation in most neurons studied. The PKC-induced enhancement of basal current was voltage dependent, and enhanced currents displayed altered kinetics. Inhibition of G proteins with GDPbetaS attenuated the PKC-induced enhancement of basal Ca2+ channel current. These results show that PKC regulates the inhibitory effects of G proteins, possibly by disrupting the coupling of G proteins to Ca2+ channels. The PKC-induced enhancement of Ca2+ channel current results, at least in part, from the removal of tonic G protein-mediated inhibition.			SWARTZ, KJ (corresponding author), HARVARD UNIV, SCH MED, DEPT NEUROBIOL, BOSTON, MA 02115 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035034] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 35034] Funding Source: Medline; NINDS NIH HHS [NS 02253] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AHLIJANIAN MK, 1991, J BIOL CHEM, V266, P20192; ANDRADE R, 1986, SCIENCE, V234, P1261, DOI 10.1126/science.2430334; BASKYS A, 1991, J PHYSIOL-LONDON, V444, P687, DOI 10.1113/jphysiol.1991.sp018901; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; BEECH DJ, 1992, NEURON, V8, P97, DOI 10.1016/0896-6273(92)90111-P; BELL JD, 1990, MOL PHARMACOL, V37, P535; BELL JD, 1986, J BIOL CHEM, V261, P2036; BERNHEIM L, 1991, NEURON, V6, P859, DOI 10.1016/0896-6273(91)90226-P; BLEY KR, 1990, NEURON, V4, P379, DOI 10.1016/0896-6273(90)90050-P; BOLAND LM, 1991, J NEUROSCI, V11, P1140; BOLAND LM, 1993, J NEUROSCI, V13, P516; BOSMA MM, 1989, P NATL ACAD SCI USA, V86, P2943, DOI 10.1073/pnas.86.8.2943; BROWN AM, 1990, ANNU REV PHYSIOL, V52, P197, DOI 10.1146/annurev.ph.52.030190.001213; BUSHFIELD M, 1990, BIOCHEM J, V268, P449, DOI 10.1042/bj2680449; CARLSON KE, 1989, J BIOL CHEM, V264, P13298; DERIEMER SA, 1985, NATURE, V313, P313, DOI 10.1038/313313a0; DIVERSEPIERLUISSI M, 1993, NEURON, V10, P753, DOI 10.1016/0896-6273(93)90175-Q; DOERNER D, 1990, J NEUROSCI, V10, P1699; DOLPHIN AC, 1987, J PHYSIOL-LONDON, V386, P1; DUNNWIDDIE TV, 1985, J PHYSL, V369, P365; DUTAR P, 1988, NEURON, V1, P585, DOI 10.1016/0896-6273(88)90108-0; ECKSTEIN F, 1979, J BIOL CHEM, V254, P9829; ELMSLIE KS, 1992, J PHYSIOL-LONDON, V456, P107, DOI 10.1113/jphysiol.1992.sp019329; ELMSLIE KS, 1992, J PHYSIOL-LONDON, V451, P229, DOI 10.1113/jphysiol.1992.sp019162; ELMSLIE KS, 1990, NEURON, V5, P75, DOI 10.1016/0896-6273(90)90035-E; FARLEY J, 1986, NATURE, V319, P220, DOI 10.1038/319220a0; FORSCHER P, 1986, J PHYSIOL-LONDON, V379, P131, DOI 10.1113/jphysiol.1986.sp016244; GARCIASAINZ JA, 1989, FEBS LETT, V257, P427, DOI 10.1016/0014-5793(89)81588-1; GRASSI F, 1989, NEUROSCI LETT, V105, P113, DOI 10.1016/0304-3940(89)90021-9; GREEN KA, 1988, BRIT J PHARMACOL, V94, P235, DOI 10.1111/j.1476-5381.1988.tb11520.x; GUSTAFSSON B, 1988, NEUROSCI LETT, V85, P77, DOI 10.1016/0304-3940(88)90432-6; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HAMMOND C, 1987, NATURE, V325, P809, DOI 10.1038/325809a0; HARRIS EW, 1983, EXP BRAIN RES, V52, P455; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; HOCKBERGER P, 1989, NATURE, V338, P340, DOI 10.1038/338340a0; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; HUGANIR RL, 1990, NEURON, V5, P555, DOI 10.1016/0896-6273(90)90211-W; IKEDA SR, 1991, J PHYSIOL-LONDON, V439, P181, DOI 10.1113/jphysiol.1991.sp018663; IKEDA SR, 1989, J PHYSIOL-LONDON, V409, P221, DOI 10.1113/jphysiol.1989.sp017494; IKEDA SR, 1992, J PHYSIOL-LONDON, V458, P339, DOI 10.1113/jphysiol.1992.sp019421; JAKOBS KH, 1985, EUR J BIOCHEM, V151, P425, DOI 10.1111/j.1432-1033.1985.tb09119.x; JONES SW, 1991, BIOPHYS J, V60, P502, DOI 10.1016/S0006-3495(91)82077-X; KASAI H, 1989, PFLUG ARCH EUR J PHY, V414, P145, DOI 10.1007/BF00580956; KASAI H, 1991, P NATL ACAD SCI USA, V88, P8855, DOI 10.1073/pnas.88.19.8855; KATADA T, 1985, EUR J BIOCHEM, V151, P431, DOI 10.1111/j.1432-1033.1985.tb09120.x; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; LESTER RAJ, 1990, NEURON, V4, P741, DOI 10.1016/0896-6273(90)90200-Y; LEWIS DL, 1986, P NATL ACAD SCI USA, V83, P9035, DOI 10.1073/pnas.83.23.9035; LIPSCOMBE D, 1989, NATURE, V340, P639, DOI 10.1038/340639a0; LOPEZ HS, 1991, NEURON, V7, P1061, DOI 10.1016/0896-6273(91)90350-9; LOUNSBURY KM, 1991, J BIOL CHEM, V266, P22051; MALENKA RC, 1986, NATURE, V321, P175, DOI 10.1038/321175a0; MARCHETTI C, 1989, BIOPHYS J, V56, P1267, DOI 10.1016/S0006-3495(89)82774-2; MARCHETTI C, 1986, PFLUG ARCH EUR J PHY, V406, P104, DOI 10.1007/BF00586670; ODELL TJ, 1991, J PHYSIOL-LONDON, V436, P739, DOI 10.1113/jphysiol.1991.sp018577; PENINGTON NJ, 1991, J NEUROSCI, V11, P3594, DOI 10.1523/jneurosci.11-11-03594.1991; PLUMMER MR, 1991, J NEUROSCI, V11, P2339; POLLO A, 1992, PFLUG ARCH EUR J PHY, V422, P75; PYNE NJ, 1989, FEBS LETT, V243, P77, DOI 10.1016/0014-5793(89)81221-9; PYNE NJ, 1992, BIOCHEM J, V285, P333, DOI 10.1042/bj2850333; RANE SG, 1989, NEURON, V3, P239, DOI 10.1016/0896-6273(89)90037-8; RANE SG, 1986, P NATL ACAD SCI USA, V83, P184, DOI 10.1073/pnas.83.1.184; SAGIEISENBERG R, 1989, CELL SIGNAL, V1, P519, DOI 10.1016/0898-6568(89)90036-3; SAHARA Y, 1993, J NEUROSCI, V13, P3041; SCHOLZ KP, 1992, NEURON, V8, P1139, DOI 10.1016/0896-6273(92)90134-Y; SCOTT RH, 1990, BRIT J PHARMACOL, V99, P629, DOI 10.1111/j.1476-5381.1990.tb12981.x; SHAPIRA R, 1987, NATURE, V325, P58, DOI 10.1038/325058a0; SHAPIRO MS, 1993, NEURON, V10, P11, DOI 10.1016/0896-6273(93)90237-L; SIGEL E, 1988, P NATL ACAD SCI USA, V85, P6192, DOI 10.1073/pnas.85.16.6192; SILINSKY EM, 1984, J PHYSIOL-LONDON, V346, P243, DOI 10.1113/jphysiol.1984.sp015019; STRONG JA, 1987, NATURE, V325, P714, DOI 10.1038/325714a0; SURPRENANT A, 1990, J PHYSIOL-LONDON, V431, P585, DOI 10.1113/jphysiol.1990.sp018349; SWARTZ KJ, 1992, J NEUROSCI, V12, P4358; SWARTZ KJ, 1993, NATURE, V361, P165, DOI 10.1038/361165a0; THOMPSON SM, 1992, J PHYSIOL-LONDON, V451, P347, DOI 10.1113/jphysiol.1992.sp019168; THOMPSON SM, 1992, J PHYSIOL-LONDON, V451, P329, DOI 10.1113/jphysiol.1992.sp019167; TOSELLI M, 1989, PFLUG ARCH EUR J PHY, V415, P255, DOI 10.1007/BF00370874; TROMBLEY PQ, 1992, J NEUROSCI, V12, P2043; WANKE E, 1987, P NATL ACAD SCI USA, V84, P4313, DOI 10.1073/pnas.84.12.4313; WATANABE Y, 1985, FEBS LETT, V192, P23, DOI 10.1016/0014-5793(85)80035-1; WILLIAMS ME, 1992, SCIENCE, V257, P389, DOI 10.1126/science.1321501; WORLEY PF, 1987, P NATL ACAD SCI USA, V84, P3467, DOI 10.1073/pnas.84.10.3467; YANG J, 1993, NEURON, V10, P127, DOI 10.1016/0896-6273(93)90305-B; YOSHIMASA T, 1987, NATURE, V327, P67, DOI 10.1038/327067a0; ZICK Y, 1986, P NATL ACAD SCI USA, V83, P9294, DOI 10.1073/pnas.83.24.9294	86	192	198	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	1993	11	2					305	320		10.1016/0896-6273(93)90186-U	http://dx.doi.org/10.1016/0896-6273(93)90186-U			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LU065	8102534				2022-12-24	WOS:A1993LU06500010
J	CALABRESI, P; PISANI, A; MERCURI, NB; BERNARDI, G				CALABRESI, P; PISANI, A; MERCURI, NB; BERNARDI, G			LITHIUM TREATMENT BLOCKS LONG-TERM SYNAPTIC DEPRESSION IN THE STRIATUM	NEURON			English	Article							MUSCARINIC RECEPTOR SUBTYPES; CYCLIC-AMP ACCUMULATION; PHOSPHOINOSITIDE HYDROLYSIS; INOSITOL TRISPHOSPHATE; HIPPOCAMPAL-NEURONS; NEOSTRIATAL NEURONS; MEMBRANE-PROPERTIES; SUPER-SENSITIVITY; RAT NEOSTRIATUM; BASAL GANGLIA	We have studied the effect of acute and chronic lithium treatment on the activity of striatal neurons recorded from corticostriatal slices. Under control conditions, tetanic stimulation of glutamatergic corticostriatal terminals caused long-term depression (LTD) of excitatory synaptic potentials. Acute lithium treatment did not affect the peak of the induction phase, but it reduced the following phases of LTD. LTD was completely blocked in slices obtained from rats chronically injected with LiCl. Lithium treatment failed to affect the intrinsic membrane properties of striatal neurons and the presynaptic inhibitory effects of carbachol and t-ACPD. We suggest that the lithium-induced blockade of LTD may contribute to the therapeutic action of lithium salts in mania and depression.			CALABRESI, P (corresponding author), UNIV ROMA TOR VERGATA,DIPARTIMENTO SANITA,NEUROL CLIN,VIA O RAIMONDO,I-00173 ROME,ITALY.		Mercuri, Nicola Biagio/K-5348-2016; Pisani, Antonio/G-2492-2012; Calabresi, Paolo/G-8496-2011	Mercuri, Nicola Biagio/0000-0001-6700-7491; Pisani, Antonio/0000-0002-8432-594X; Calabresi, Paolo/0000-0003-0326-5509				AKAIKE A, 1988, J PHARMACOL EXP THER, V246, P1129; AKINS PT, 1990, J NEUROCHEM, V54, P266, DOI 10.1111/j.1471-4159.1990.tb13310.x; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALDENHOFF JB, 1985, NEUROSCI LETT, V54, P103, DOI 10.1016/S0304-3940(85)80125-7; ALGER BE, 1976, BRAIN RES, V110, P463, DOI 10.1016/0006-8993(76)90858-1; AMBROSINI A, 1989, J NEUROCHEM, V53, P825; ARAMORI I, 1992, NEURON, V8, P757, DOI 10.1016/0896-6273(92)90096-V; ARONICA E, 1991, J NEUROCHEM, V57, P376, DOI 10.1111/j.1471-4159.1991.tb03763.x; AVISSAR S, 1988, NATURE, V331, P440, DOI 10.1038/331440a0; BEAUGE L, 1975, J PHYSIOL-LONDON, V246, P397, DOI 10.1113/jphysiol.1975.sp010896; BERRIDGE MJ, 1984, BIOCHEM J, V220, P345, DOI 10.1042/bj2200345; BERRIDGE MJ, 1989, JAMA-J AM MED ASSOC, V262, P1834; BERRIDGE MJ, 1982, BIOCHEM J, V206, P587, DOI 10.1042/bj2060587; BLAUSTEIN MP, 1975, REV PHYSL BIOCH PHAR, V70, P34; BRANCHEY MH, 1976, AM J PSYCHIAT, V133, P444; BROCHER S, 1992, P NATL ACAD SCI USA, V89, P123, DOI 10.1073/pnas.89.1.123; BUNNEY WE, 1987, PSYCHOPHARMACOLOGY 3, P553; CALABRESI P, 1991, J PHYSIOL-LONDON, V440, P581, DOI 10.1113/jphysiol.1991.sp018726; CALABRESI P, 1992, NEUROSCI LETT, V142, P95, DOI 10.1016/0304-3940(92)90628-K; CALABRESI P, 1987, NEUROSCIENCE, V20, P293, DOI 10.1016/0306-4522(87)90021-2; CALABRESI P, 1990, J NEUROPHYSIOL, V63, P663, DOI 10.1152/jn.1990.63.4.663; CALABRESI P, 1992, J NEUROSCI, V12, P4224; CALABRESI P, 1992, EUR J NEUROSCI, V4, P929, DOI 10.1111/j.1460-9568.1992.tb00119.x; CALABRESI P, 1992, NEUROSCI LETT, V139, P41, DOI 10.1016/0304-3940(92)90852-X; CALABRESI P, 1991, EUR J NEUROSCI, V4, P116; CALDECOTTHAZARD S, 1991, SYNAPSE, V9, P251, DOI 10.1002/syn.890090404; COCKCROFT S, 1987, TRENDS BIOCHEM SCI, V12, P75, DOI 10.1016/0968-0004(87)90035-1; Crepel F, 1990, Neuroreport, V1, P133, DOI 10.1097/00001756-199010000-00013; EBSTEIN RP, 1980, J PHARMACOL EXP THER, V213, P161; FLORU L, 1979, INT PHARMACOPSYCHIAT, V14, P149, DOI 10.1159/000468373; GALLAGER DW, 1978, NATURE, V273, P309, DOI 10.1038/273309a0; GARCIAMUNOZ M, 1992, NEUROREPORT, V3, P357, DOI 10.1097/00001756-199204000-00017; GEISLER A, 1978, LIFE SCI, V23, P635, DOI 10.1016/0024-3205(78)90045-0; GOTTBERG E, 1988, SYNAPSE, V2, P442, DOI 10.1002/syn.890020412; GRAYBIEL AM, 1990, TRENDS NEUROSCI, V13, P244, DOI 10.1016/0166-2236(90)90104-I; GROVES PM, 1983, BRAIN RES REV, V5, P109, DOI 10.1016/0165-0173(83)90011-5; HIRSCH JC, 1990, J PHYSL, V432, P123; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; IZQUIERDO I, 1992, TRENDS PHARMACOL SCI, V13, P7, DOI 10.1016/0165-6147(92)90004-P; JIANG ZG, 1991, J PHYSIOL-LONDON, V443, P533, DOI 10.1113/jphysiol.1991.sp018850; KITA T, 1984, BRAIN RES, V109, P601; KUBA K, 1990, PROG NEUROBIOL, V34, P197, DOI 10.1016/0301-0082(90)90012-6; LINDEN DJ, 1991, SCIENCE, V254, P1656, DOI 10.1126/science.1721243; LOVINGER DM, 1991, NEUROSCI LETT, V129, P17, DOI 10.1016/0304-3940(91)90710-B; MADISON DV, 1991, ANNU REV NEUROSCI, V14, P379, DOI 10.1146/annurev.ne.14.030191.002115; MULLER W, 1989, NEUROSCI LETT, V100, P135, DOI 10.1016/0304-3940(89)90673-3; NAHORSKI SR, 1991, TRENDS PHARMACOL SCI, V12, P297, DOI 10.1016/0165-6147(91)90581-C; NICOLETTI F, 1986, J NEUROCHEM, V46, P40, DOI 10.1111/j.1471-4159.1986.tb12922.x; PANDEY GN, 1978, J GEN PHYSIOL, V72, P233, DOI 10.1085/jgp.72.2.233; PERALTA EG, 1988, NATURE, V334, P434, DOI 10.1038/334434a0; SCHORDERET M, 1977, BIOCHEM PHARMACOL, V26, P167, DOI 10.1016/0006-2952(77)90392-6; SHIBUKI K, 1991, NATURE, V349, P326, DOI 10.1038/349326a0; SLADECZEK F, 1985, NATURE, V317, P717, DOI 10.1038/317717a0; SLADECZEK F, 1988, TRENDS NEUROSCI, V11, P545, DOI 10.1016/0166-2236(88)90183-X; STANTON PK, 1989, NATURE, V339, P215, DOI 10.1038/339215a0; SUGITA S, 1991, P NATL ACAD SCI USA, V88, P2608, DOI 10.1073/pnas.88.6.2608; SVENSSON A, 1992, J NEURAL TRANSM-GEN, V88, P235, DOI 10.1007/BF01244735; TANABE Y, 1992, NEURON, V8, P169, DOI 10.1016/0896-6273(92)90118-W; TEYLER TJ, 1984, BRAIN RES REV, V7, P15, DOI 10.1016/0165-0173(84)90027-4; TYRER S, 1980, BRIT J PSYCHIAT, V136, P191; WHITWORTH P, 1990, BRIT J PHARMACOL, V101, P39, DOI 10.1111/j.1476-5381.1990.tb12085.x; WHORLEY PF, 1988, SCIENCE, V239, P1428; WOOD AJ, 1987, PSYCHOL MED, V17, P579, DOI 10.1017/S0033291700025836	64	42	42	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1993	10	5					955	962		10.1016/0896-6273(93)90210-I	http://dx.doi.org/10.1016/0896-6273(93)90210-I			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LD322	8494646				2022-12-24	WOS:A1993LD32200017
J	Kim, E; Cho, KO; Rothschild, A; Sheng, M				Kim, E; Cho, KO; Rothschild, A; Sheng, M			Heteromultimerization and NMDA receptor-clustering activity of chapsyn-110, a member of the PSD-95 family of proteins	NEURON			English	Article							TUMOR-SUPPRESSOR GENE; MOLECULAR CHARACTERIZATION; SUBCELLULAR-LOCALIZATION; CHANNEL PROTEINS; K+ CHANNELS; RAT-BRAIN; SUBUNIT; HOMOLOG; NEURONS; CLONING	Chapsyn-110, a novel membrane-associated putative guanylate kinase (MAGUK) that binds directly to N-methyl-D-aspartate (NMDA) receptor and Shaker K+ channel subunits, is 70%-80% identical to, and shares an identical domain organization with, PSD-95/SAP90 and SAP97. In rat brain, chapsyn-110 protein shows a somatodendritic expression pattern that overlaps partly with PSD-95 but that contrasts with the axonal distribution of SAP97. Chapsyn-110 associates tightly with the postsynaptic density in brain, and mediates the clustering of both NMDA receptors and K+ channels in heterologous cells. Indeed, chapsyn-110 and PSD-95 can heteromultimerize with each other and are recruited into the same NMDA receptor and K, channel clusters. Thus, chapsyn-110 and PSD-95 may interact at postsynaptic sites to form a multimeric scaffold for the clustering of receptors, ion channels, and associated signalling proteins.	BAYLOR COLL MED,DEPT CELL BIOL,HOUSTON,TX 77030	Baylor College of Medicine	Kim, E (corresponding author), HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,DEPT NEUROBIOL,HOWARD HUGHES MED INST,BOSTON,MA 02114, USA.		Cho, Kyung-Ok/C-1705-2011; Kim, Eunjoon/C-1566-2011	Sheng, Morgan/0000-0002-8703-5366; Cho, Kyung-Ok/0000-0002-0760-2560				AOKI C, 1994, J NEUROSCI, V14, P5202; Apel Elizabeth D., 1995, Current Opinion in Neurobiology, V5, P62, DOI 10.1016/0959-4388(95)80088-3; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; FROEHNER SC, 1993, ANNU REV NEUROSCI, V16, P347, DOI 10.1146/annurev.ne.16.030193.002023; Gomperts SN, 1996, CELL, V84, P659, DOI 10.1016/S0092-8674(00)81043-0; GUMBINER B, 1991, P NATL ACAD SCI USA, V88, P3460, DOI 10.1073/pnas.88.8.3460; HALL ZW, 1993, NEURON S, V10, P99; Hunt CA, 1996, J NEUROSCI, V16, P1380; ISHII T, 1993, J BIOL CHEM, V268, P2836; JESAITIS LA, 1994, J CELL BIOL, V124, P949, DOI 10.1083/jcb.124.6.949; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KISTNER U, 1993, J BIOL CHEM, V268, P4580; KOMAU HC, 1995, SCIENCE, V269, P1737; LAHEY T, 1994, NEURON, V13, P823, DOI 10.1016/0896-6273(94)90249-6; LIU H, 1994, P NATL ACAD SCI USA, V91, P8383, DOI 10.1073/pnas.91.18.8383; LUE RA, 1994, P NATL ACAD SCI USA, V91, P9818, DOI 10.1073/pnas.91.21.9818; MALETICSAVATIC M, 1995, J NEUROSCI, V15, P3840; MEGURO H, 1992, NATURE, V357, P70, DOI 10.1038/357070a0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; MULLER BM, 1995, J NEUROSCI, V15, P2354, DOI 10.1523/JNEUROSCI.15-03-02354.1995; Niethammer M, 1996, J NEUROSCI, V16, P2157; PETRALIA RS, 1994, J NEUROSCI, V14, P667; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; SHENG M, 1994, J NEUROSCI, V14, P2408; SHENG M, 1993, NATURE, V365, P72, DOI 10.1038/365072a0; SHENG M, 1992, NEURON, V9, P271, DOI 10.1016/0896-6273(92)90166-B; SIEGEL SJ, 1994, P NATL ACAD SCI USA, V91, P564, DOI 10.1073/pnas.91.2.564; SUGIHARA H, 1992, BIOCHEM BIOPH RES CO, V185, P826, DOI 10.1016/0006-291X(92)91701-Q; THODES KJ, 1995, J NEUROSCI, V15, P5360; WANG H, 1993, NATURE, V365, P75, DOI 10.1038/365075a0; WANG H, 1994, J NEUROSCI, V14, P4588; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X	36	474	484	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1996	17	1					103	113		10.1016/S0896-6273(00)80284-6	http://dx.doi.org/10.1016/S0896-6273(00)80284-6			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UY981	8755482	Bronze			2022-12-24	WOS:A1996UY98100011
J	Gillis, KD; Mossner, R; Neher, E				Gillis, KD; Mossner, R; Neher, E			Protein kinase C enhances exocytosis from chromaffin cells by increasing the size of the readily releasable pool of secretory granules	NEURON			English	Article							HIGH-VOLTAGE DISCHARGE; PANCREATIC B-CELLS; PHORBOL ESTER; INSULIN-SECRETION; CALCIUM; CA-2+; CA2+; PHOSPHORYLATION; ACTIVATION; CURRENTS	We have used membrane capacitance measurements to assay Ca2+-triggered exocytosis in single bovine adrenal chromaffin cells. Brief application of phorbol ester (PMA) enhances depolarization-evoked exocytosis severalfold while actually decreasing the Ca2+ current. Ca2+ metabolism is unchanged. Three different protocols were used to show that PMA increases the size of the readily releasable pool of secretory granules. PMA treatment leads to a large increase in amplitude, but little change in the time course of the exocytic burst that results from rapid elevation of [Ca2+](i) upon photolysis of DM-Nitrophen. Thus, PKC appears to affect a late step in secretion but not the Ca2+ sensitivity of the final step.			Gillis, KD (corresponding author), MAX PLANCK INST BIOPHYS CHEM, DEPT MEMBRANE BIOPHYS, FASSBERG, D-37077 GOTTINGEN, GERMANY.		Neher, Erwin/A-2109-2013					AMMALA C, 1993, J PHYSIOL-LONDON, V472, P665, DOI 10.1113/jphysiol.1993.sp019966; AMMALA C, 1993, NATURE, V363, P356, DOI 10.1038/363356a0; AMMALA C, 1994, P NATL ACAD SCI USA, V91, P4343, DOI 10.1073/pnas.91.10.4343; BARNETT DW, 1994, J MEMBRANE BIOL, V138, P113; BITTNER MA, 1992, J BIOL CHEM, V267, P16226; BITTNER MA, 1992, J BIOL CHEM, V267, P16219; BITTNER MA, 1993, CELL MOL NEUROBIOL, V13, P649, DOI 10.1007/BF00711564; BURGOYNE RD, 1991, BIOCHIM BIOPHYS ACTA, V1071, P174, DOI 10.1016/0304-4157(91)90024-Q; CAPOGNA M, 1995, J NEUROSCI, V15, P1249; Fujita Y, 1996, J BIOL CHEM, V271, P7265, DOI 10.1074/jbc.271.13.7265; GILLIS KD, 1993, PFLUG ARCH EUR J PHY, V424, P195, DOI 10.1007/BF00374612; GILLIS KD, 1991, PFLUG ARCH EUR J PHY, V418, P611, DOI 10.1007/BF00370579; GILLIS KD, 1992, PFLUG ARCH EUR J PHY, V420, P121, DOI 10.1007/BF00378654; Gillis Kevin D., 1995, P155; GOLDBERG AL, 1969, P NATL ACAD SCI USA, V64, P134, DOI 10.1073/pnas.64.1.134; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HARTWIG JH, 1992, NATURE, V356, P618, DOI 10.1038/356618a0; HAY JC, 1992, J CELL BIOL, V119, P139, DOI 10.1083/jcb.119.1.139; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HEINEMANN C, 1994, BIOPHYS J, V67, P2546, DOI 10.1016/S0006-3495(94)80744-1; HEINEMANN C, 1993, PFLUG ARCH EUR J PHY, V424, P105, DOI 10.1007/BF00374600; HOLZ RW, 1989, J BIOL CHEM, V264, P5412; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; HORRIGAN FT, 1994, NEURON, V13, P1119, DOI 10.1016/0896-6273(94)90050-7; JOHNSTONE SA, 1992, J BIOL CHEM, V267, P25976; JONES PM, 1985, FEBS LETT, V191, P102, DOI 10.1016/0014-5793(85)81002-4; JONES PM, 1986, FEBS LETT, V205, P205, DOI 10.1016/0014-5793(86)80898-5; KAPLAN JH, 1988, P NATL ACAD SCI USA, V85, P6571, DOI 10.1073/pnas.85.17.6571; KNIGHT DE, 1983, FEBS LETT, V160, P98, DOI 10.1016/0014-5793(83)80944-2; KULLMANN DM, 1995, NEURON, V15, P997, DOI 10.1016/0896-6273(95)90089-6; LIM NF, 1990, NATURE, V344, P449, DOI 10.1038/344449a0; LIN LF, 1994, J NEUROCHEM, V63, P1941; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; LLANO I, 1993, J PHYSIOL-LONDON, V468, P201, DOI 10.1113/jphysiol.1993.sp019767; MORGAN A, 1992, BIOCHEM J, V286, P807, DOI 10.1042/bj2860807; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; NISHIZAKI T, 1992, J BIOL CHEM, V267, P23972; OYLER GA, 1989, J CELL BIOL, V109, P3039, DOI 10.1083/jcb.109.6.3039; PARSONS TD, 1995, NEURON, V15, P1085, DOI 10.1016/0896-6273(95)90097-7; PIPELEERS D, 1987, DIABETOLOGIA, V30, P277, DOI 10.1007/BF00299019; POCOTTE SL, 1985, P NATL ACAD SCI USA, V82, P930, DOI 10.1073/pnas.82.3.930; Seward EP, 1996, J NEUROSCI, V16, P553; Sillen L.G., 1971, STABILITY CONSTANTS; TAMAGAWA T, 1985, FEBS LETT, V183, P433, DOI 10.1016/0014-5793(85)80825-5; TERBUSH DR, 1990, J BIOL CHEM, V265, P21179; THOMAS P, 1993, NEURON, V11, P93, DOI 10.1016/0896-6273(93)90274-U; THOMAS P, 1993, EMBO J, V12, P303, DOI 10.1002/j.1460-2075.1993.tb05657.x; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; TRIFARO JM, 1993, TRENDS NEUROSCI, V16, P466, DOI 10.1016/0166-2236(93)90079-2; VITALE ML, 1995, NEURON, V14, P353, DOI 10.1016/0896-6273(95)90291-0; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; VONRUDEN L, 1993, SCIENCE, V262, P1061, DOI 10.1126/science.8235626; WEI W, 1992, BIOCHEMISTRY-US, V31, P9934, DOI 10.1021/bi00156a011; WHITEHEART SW, 1993, NATURE, V362, P353, DOI 10.1038/362353a0; ZHOU ZA, 1993, J PHYSIOL-LONDON, V469, P245, DOI 10.1113/jphysiol.1993.sp019813	57	345	349	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	1996	16	6					1209	1220		10.1016/S0896-6273(00)80147-6	http://dx.doi.org/10.1016/S0896-6273(00)80147-6			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UU118	8663997	Bronze, Green Published			2022-12-24	WOS:A1996UU11800018
J	Seoh, SA; Sigg, D; Papazian, DM; Bezanilla, F				Seoh, SA; Sigg, D; Papazian, DM; Bezanilla, F			Voltage-sensing residues in the S2 and S4 segments of the Shaker K+ channel	NEURON			English	Article							POTASSIUM-CHANNEL; SODIUM-CHANNEL; GATING CHARGE; INACTIVATION; CURRENTS; REGION; CDNA	The activation of Shaker K+ channels is steeply voltage dependent. To determine whether conserved charged amino acids in putative transmembrane segments S2, S3, and S4 contribute to the gating charge of the channel, the total gating charge movement per channel was measured in channels containing neutralization mutations. Of eight residues tested, four contributed significantly to the gating charge: E293, an acidic residue in S2, and R365, R368, and R371, three basic residues in the S4 segment. The results indicate that these residues are a major component of the voltage sensor. Furthermore, the S4 segment is not solely resposible for gating charge movement in Shaker K+ channels.	UNIV CALIF LOS ANGELES,SCH MED,DEPT ANESTHESIOL,LOS ANGELES,CA 90095	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Seoh, SA (corresponding author), UNIV CALIF LOS ANGELES,SCH MED,DEPT PHYSIOL,LOS ANGELES,CA 90095, USA.				NIGMS NIH HHS [R01 GM043459-11, R01 GM043459-14, R01 GM043459-13, R01 GM043459-09, R01 GM043459-17, GM 30376, R01 GM043459-15S1, R01 GM043459-16, R01 GM043459-10, R01 GM043459, R01 GM043459-12, R01 GM043459-15] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030376, R37GM030376, R01GM043459] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Almers W, 1978, Rev Physiol Biochem Pharmacol, V82, P96, DOI 10.1007/BFb0030498; ARMSTRONG CM, 1973, NATURE, V242, P459, DOI 10.1038/242459a0; BEZANILLA F, 1991, SCIENCE, V254, P679, DOI 10.1126/science.1948047; BEZANILLA F, 1994, BIOPHYS J, V66, P1011, DOI 10.1016/S0006-3495(94)80882-3; CATTERALL WA, 1986, ANNU REV BIOCHEM, V55, P953, DOI 10.1146/annurev.biochem.55.1.953; CHANDY GK, 1995, HDB RECEPTORS CHANNE, P1; GUY HR, 1986, P NATL ACAD SCI USA, V83, P508, DOI 10.1073/pnas.83.2.508; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; LI M, 1994, CURR BIOL, V4, P110, DOI 10.1016/S0960-9822(94)00026-6; LIMAN ER, 1991, NATURE, V353, P752, DOI 10.1038/353752a0; LOGOTHETIS DE, 1992, NEURON, V8, P531, DOI 10.1016/0896-6273(92)90281-H; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; PEROZO E, 1994, BIOPHYS J, V66, P345, DOI 10.1016/S0006-3495(94)80783-0; PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3; PLANELLSCASES R, 1995, P NATL ACAD SCI USA, V92, P9422, DOI 10.1073/pnas.92.20.9422; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; SCHWARZ TL, 1988, NATURE, V331, P137, DOI 10.1038/331137a0; SIGG D, 1994, SCIENCE, V264, P578, DOI 10.1126/science.8160016; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; STEFANI E, 1994, BIOPHYS J, V66, P996, DOI 10.1016/S0006-3495(94)80881-1; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; TIMPE LC, 1988, NATURE, V331, P143, DOI 10.1038/331143a0; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8	33	571	582	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1996	16	6					1159	1167		10.1016/S0896-6273(00)80142-7	http://dx.doi.org/10.1016/S0896-6273(00)80142-7			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UU118	8663992	Bronze			2022-12-24	WOS:A1996UU11800013
J	Deisseroth, K; Bito, H; Tsien, RW				Deisseroth, K; Bito, H; Tsien, RW			Signaling from synapse to nucleus: Postsynaptic CREB phosphorylation during multiple forms of hippocampal synaptic plasticity	NEURON			English	Article							LONG-TERM POTENTIATION; IMMEDIATE-EARLY GENES; CAMP-RESPONSIVE ELEMENT; APLYSIA SENSORY NEURONS; MESSENGER-RNA; ADENYLATE-CYCLASE; CA1 NEURONS; HAIR-CELLS; AREA CA1; CALCIUM	Phosphorylation of the transcription factor CREB is thought to be important in processes underlying long-term memory. It is unclear whether CREB phosphorylation can carry information about the sign of changes in synaptic strength, whether CREB pathways are equally activated in neurons receiving or providing synaptic input, or how synapse-to-nucleus communication is mediated. We found that Ca2+-dependent nuclear CREB phosphorylation was rapidly evoked by synaptic stimuli including, but not limited to, those that induced potentiation and depression of synaptic strength. In striking contrast, high frequency action potential firing alone failed to trigger CREB phosphorylation. Activation of a submembranous Ca2+ sensor, just beneath sites of Ca2+ entry, appears critical for triggering nuclear CREB phosphorylation via calmodulin and a Ca2+/calmodulin-dependent protein kinase.			Deisseroth, K (corresponding author), STANFORD UNIV,SCH MED,BECKMAN CTR MOLEC & GENET MED,DEPT CELLULAR & MOLEC PHYSIOL,STANFORD,CA 94305, USA.		Bito, Haruhiko/A-8635-2008	Bito, Haruhiko/0000-0001-6315-9594				ABRAHAM WC, 1994, P NATL ACAD SCI USA, V91, P10049, DOI 10.1073/pnas.91.21.10049; ADLER EM, 1991, J NEUROSCI, V11, P1496; ALBERINI CM, 1994, CELL, V76, P1099, DOI 10.1016/0092-8674(94)90386-7; ARANCIO O, 1995, NATURE, V376, P74, DOI 10.1038/376074a0; BEAR MF, 1995, NEURON, V15, P1, DOI 10.1016/0896-6273(95)90056-X; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Brindle PK, 1992, CURR OPIN GENET DEV, V2, P199, DOI 10.1016/S0959-437X(05)80274-6; CACERES A, 1983, NEUROSCIENCE, V10, P449, DOI 10.1016/0306-4522(83)90145-8; CALI JJ, 1994, J BIOL CHEM, V269, P12190; Choi EJ, 1993, CURR OPIN CELL BIOL, V5, P269, DOI 10.1016/0955-0674(93)90115-7; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; COLE AJ, 1989, NATURE, V340, P474, DOI 10.1038/340474a0; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; DASH PK, 1991, P NATL ACAD SCI USA, V88, P5061, DOI 10.1073/pnas.88.11.5061; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Deisseroth K, 1995, CURR BIOL, V5, P1334, DOI 10.1016/S0960-9822(95)00262-4; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; EBIHARA S, 1993, J PHYSIOL-LONDON, V472, P689, DOI 10.1113/jphysiol.1993.sp019967; ENSLEN H, 1994, J BIOL CHEM, V269, P15520; FIOL CJ, 1994, J BIOL CHEM, V269, P32187; FRANK DA, 1994, CELL, V79, P5, DOI 10.1016/0092-8674(94)90394-8; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; Goda Y, 1996, NEURON, V16, P103, DOI 10.1016/S0896-6273(00)80027-6; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; HAGIWARA M, 1993, MOL CELL BIOL, V13, P4852, DOI 10.1128/MCB.13.8.4852; HUANG CF, 1994, NEURON, V13, P167, DOI 10.1016/0896-6273(94)90467-7; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; IMREDY JP, 1992, NEURON, V9, P197, DOI 10.1016/0896-6273(92)90159-B; IRVING AJ, 1992, J PHYSIOL-LONDON, V456, P667, DOI 10.1113/jphysiol.1992.sp019360; KAANG BK, 1993, NEURON, V10, P427, DOI 10.1016/0896-6273(93)90331-K; LALLI E, 1994, J BIOL CHEM, V269, P17359; LEE KAW, 1993, BIOCHIM BIOPHYS ACTA, V1174, P221, DOI 10.1016/0167-4781(93)90191-F; Lisman J, 1995, J NIH RES, V7, P43; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; MACKLER SA, 1992, NEURON, V9, P539, DOI 10.1016/0896-6273(92)90191-F; MALENKA RC, 1992, NEURON, V9, P121, DOI 10.1016/0896-6273(92)90227-5; MALENKA RC, 1994, CELL, V78, P535, DOI 10.1016/0092-8674(94)90517-7; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; MAYFORD M, 1995, CURR OPIN NEUROBIOL, V5, P141, DOI 10.1016/0959-4388(95)80019-0; MAYFORD M, 1995, CELL, V81, P891, DOI 10.1016/0092-8674(95)90009-8; MELLSTROM B, 1993, NEURON, V10, P655, DOI 10.1016/0896-6273(93)90167-P; MORGAN JI, 1989, TRENDS NEUROSCI, V12, P459, DOI 10.1016/0166-2236(89)90096-9; MORI Y, 1993, J BIOL CHEM, V268, P26482; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; Neher E., 1986, EXPT BRAIN RES SERIE, P80; OLSON NJ, 1995, P NATL ACAD SCI USA, V92, P1659, DOI 10.1073/pnas.92.5.1659; PETTIT DL, 1994, SCIENCE, V266, P1081; ROBERTS WM, 1993, NATURE, V363, P74, DOI 10.1038/363074a0; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; SAKAMOTO KM, 1991, ONCOGENE, V6, P867; SASSONECORSI P, 1988, GENE DEV, V2, P1529, DOI 10.1101/gad.2.12a.1529; SAUERWALD A, 1990, J BIOL CHEM, V265, P14932; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; SIEGELBAUM SA, 1980, J PHYSIOL-LONDON, V299, P485, DOI 10.1113/jphysiol.1980.sp013138; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Silva Alcino J., 1994, Current Opinion in Neurobiology, V4, P413, DOI 10.1016/0959-4388(94)90104-X; STERN MD, 1992, CELL CALCIUM, V13, P183, DOI 10.1016/0143-4160(92)90046-U; STEVENS CF, 1994, CURR BIOL, V4, P687, DOI 10.1016/S0960-9822(00)00153-6; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; STEVENS CF, 1994, NEURON, V13, P769, DOI 10.1016/0896-6273(94)90244-5; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; SWANDULLA D, 1991, NEURON, V7, P915, DOI 10.1016/0896-6273(91)90337-Y; THOMAS KL, 1994, NEURON, V13, P737, DOI 10.1016/0896-6273(94)90040-X; THOMPSON MA, 1995, J BIOL CHEM, V270, P4224, DOI 10.1074/jbc.270.9.4224; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; WISDEN W, 1990, NEURON, V4, P603, DOI 10.1016/0896-6273(90)90118-Y; WORLEY PF, 1993, J NEUROSCI, V13, P4776; WYLLIE DJA, 1994, NEURON, V13, P635, DOI 10.1016/0896-6273(94)90031-0; XIA ZG, 1991, NEURON, V6, P431, DOI 10.1016/0896-6273(91)90251-T; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9	83	599	641	0	28	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1996	16	1					89	101		10.1016/S0896-6273(00)80026-4	http://dx.doi.org/10.1016/S0896-6273(00)80026-4			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TT307	8562094	Bronze			2022-12-24	WOS:A1996TT30700012
J	Marrion, NV				Marrion, NV			Calcineurin regulates M channel modal gating in sympathetic neurons	NEURON			English	Article							M-CURRENTS; PROTEIN-PHOSPHORYLATION; MUSCARINIC SUPPRESSION; POTASSIUM CURRENTS; INTRACELLULAR CA2+; K+-CURRENT; INHIBITION; CELLS; IDENTIFICATION; MODULATION	The M current regulates neuronal excitability, with its amplitude resulting from high open probability modal M channel behavior. The M current is affected by changing intracellular calcium levels. It is proposed that internal calcium acts by regulating M channel modal gating. Intracellular application of a preactivated form of the calcium-dependent phosphatase calcineurin (CaN420) inhibited the macroscopic M current, while its application to excised inside-out patches reduced high open probability M channel activity. Addition of ATP reversed the action of CaN420 on excised patches. The change in M channel gating induced by CaN420 was different from the effect of muscarine. A kinetic model supports the proposition that shifts in channel gating induced by calcium-dependent phosphorylation and dephosphorylation control M current amplitude.			Marrion, NV (corresponding author), OREGON HLTH SCI UNIV,VOLLUM INST,L474,PORTLAND,OR 97201, USA.				NINDS NIH HHS [NS 29806] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029806, R29NS029806, R55NS029806] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS PR, 1982, J PHYSIOL-LONDON, V332, P263, DOI 10.1113/jphysiol.1982.sp014412; ADAMS PR, 1982, J PHYSIOL-LONDON, V330, P537, DOI 10.1113/jphysiol.1982.sp014357; ADAMS PR, 1982, J PHYSIOL-LONDON, V332, P223, DOI 10.1113/jphysiol.1982.sp014411; AKASU T, 1993, NEURON, V11, P1133, DOI 10.1016/0896-6273(93)90226-H; BEECH DJ, 1991, P NATL ACAD SCI USA, V88, P652, DOI 10.1073/pnas.88.2.652; BOSMA MM, 1989, P NATL ACAD SCI USA, V86, P2943, DOI 10.1073/pnas.86.8.2943; Brown D A, 1988, Ion Channels, V1, P55; BROWN DA, 1989, J PHYSIOL-LONDON, V413, P469, DOI 10.1113/jphysiol.1989.sp017664; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; BROWN DA, 1987, CELL MOL NEUROBIOL, V7, P255, DOI 10.1007/BF00711303; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; COHEN P, 1988, PROC R SOC SER B-BIO, V234, P115, DOI 10.1098/rspb.1988.0040; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HASHIMOTO Y, 1990, J BIOL CHEM, V265, P1924; HORN R, 1991, BIOPHYS J, V60, P433, DOI 10.1016/S0006-3495(91)82069-0; JONES SW, 1989, J GEN PHYSIOL, V94, P151, DOI 10.1085/jgp.94.1.151; KIRKWOOD A, 1992, BRAIN RES, V580, P281, DOI 10.1016/0006-8993(92)90955-9; KIRKWOOD A, 1991, NEURON, V6, P1009, DOI 10.1016/0896-6273(91)90240-Z; KLEE CB, 1991, NEUROCHEM RES, V16, P1059, DOI 10.1007/BF00965851; KLEE CB, 1988, ADV ENZYMOL RAMB, V61, P149; MACINTOSH C, 1990, FEBS LETT, V264, P187; MARRION NV, 1992, J PHYSIOL-LONDON, V445, P515, DOI 10.1113/jphysiol.1992.sp018937; MARRION NV, 1991, NEURON, V6, P533, DOI 10.1016/0896-6273(91)90056-6; MARRION NV, 1993, NEURON, V11, P77, DOI 10.1016/0896-6273(93)90272-S; MARRION NV, 1994, PFLUG ARCH EUR J PHY, V426, P296, DOI 10.1007/BF00374785; MARRION NV, 1992, P ROY SOC B-BIOL SCI, V248, P207, DOI 10.1098/rspb.1992.0063; MUNAKATA M, 1993, J PHYSIOL-LONDON, V471, P599, DOI 10.1113/jphysiol.1993.sp019918; PERRINO BA, 1995, J BIOL CHEM, V270, P340, DOI 10.1074/jbc.270.1.340; PFAFFINGER P, 1988, J NEUROSCI, V8, P3343; PFAFFINGER PJ, 1988, NEURON, V1, P477, DOI 10.1016/0896-6273(88)90178-X; ROSENMUND C, 1994, NATURE, V368, P853, DOI 10.1038/368853a0; SCHAFER S, 1991, PFLUG ARCH EUR J PHY, V418, P581, DOI 10.1007/BF00370575; SELYANKO AA, 1993, J PHYSIOL-LONDON, V472, P711, DOI 10.1113/jphysiol.1993.sp019968; SELYANKO AA, 1992, P ROY SOC B-BIOL SCI, V250, P119, DOI 10.1098/rspb.1992.0139; Selyanko AA, 1996, NEURON, V16, P151, DOI 10.1016/S0896-6273(00)80032-X; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; STANSFELD CE, 1993, NEURON, V10, P639, DOI 10.1016/0896-6273(93)90166-O; TOKIMASA T, 1995, BRIT J PHARMACOL, V114, P489, DOI 10.1111/j.1476-5381.1995.tb13253.x; TOKIMASA T, 1985, BRAIN RES, V337, P386, DOI 10.1016/0006-8993(85)90081-2; YU SP, 1994, J NEUROSCI, V14, P3487	41	45	45	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1996	16	1					163	173		10.1016/S0896-6273(00)80033-1	http://dx.doi.org/10.1016/S0896-6273(00)80033-1			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TT307	8562080	Bronze			2022-12-24	WOS:A1996TT30700019
J	Wadsworth, WG; Bhatt, H; Hedgecock, EM				Wadsworth, WG; Bhatt, H; Hedgecock, EM			Neuroglia and pioneer neurons express UNC-6 to provide global and local netrin cues for guiding migrations in C-elegans	NEURON			English	Article							CAENORHABDITIS-ELEGANS; AXON MIGRATIONS; NERVOUS-SYSTEM; GUIDES CELL; LAMININ; GUIDANCE; POLYMORPHISMS; GENETICS; PROTEIN; DOMAINS	Netrins are laminin-related proteins that guide circumferential migrations on the ectoderm. To understand how netrin cues direct cell movements, we examined the expression of nematode netrin UNC-6 from embryo to adult. UNC-6 is expressed in 12 types of neuroglia and neurons, creating a hierarchy of netrin cues in the developing nervous system. Comparing gene expression pattern with in vivo phenotypes, we suggest how multiple netrin cues, each with a characteristic role, guide cells and axons during development. We also present the molecular analysis of selective loss-of-function and null alleles. The results indicate that the biological activities of netrins are mediated through distinct protein domains. Subtle mutations in domain VI can produce selective defects in both direction- and tissue-specific guidance. EGF-like module V-2 is essential for dorsal guidance activity; we infer this module is important for interactions between UNC-6 and the dorsal guidance receptor UNC-5.	ROCHE INST MOLEC BIOL,NUTLEY,NJ 07110; JOHNS HOPKINS UNIV,DEPT BIOL,BALTIMORE,MD 21218	Johns Hopkins University	Wadsworth, WG (corresponding author), ROBERT WOOD JOHNSON MED SCH,DEPT PATHOL,PISCATAWAY,NJ 08854, USA.		Wadsworth, William G/N-7866-2014	Wadsworth, William G/0000-0003-3824-2948	NINDS NIH HHS [NS26295, NS33156] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033156, R56NS033156, R37NS026295, R01NS026295] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALBERTSON DG, 1976, PHILOS T ROY SOC B, V275, P299, DOI 10.1098/rstb.1976.0085; BECK K, 1990, FASEB J, V4, P148, DOI 10.1096/fasebj.4.2.2404817; BRENNER S, 1974, GENETICS, V77, P71; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; DUBBIN R, 1987, THESIS U CAMBRIDGE E; FIELD J, 1988, MOL CELL BIOL, V8, P2159, DOI 10.1128/MCB.8.5.2159; FIRE A, 1986, EMBO J, V5, P2673, DOI 10.1002/j.1460-2075.1986.tb04550.x; HAMELIN M, 1993, NATURE, V364, P327, DOI 10.1038/364327a0; HEDGECOCK EM, 1987, DEVELOPMENT, V100, P365; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O; ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E; Jacobson M., 1991, DEV NEUROBIOLOGY; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PODBILEWICZ B, 1994, DEV BIOL, V161, P408, DOI 10.1006/dbio.1994.1041; PRIESS JR, 1986, DEV BIOL, V117, P156, DOI 10.1016/0012-1606(86)90358-1; Sambrook J, 1989, MOL CLONING LABORATO; SCHITTNY JC, 1990, J CELL BIOL, V110, P825, DOI 10.1083/jcb.110.3.825; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; STROME S, 1982, P NATL ACAD SCI-BIOL, V79, P1558, DOI 10.1073/pnas.79.5.1558; STROME S, 1986, J EMBRYOL EXP MORPH, V97, P15; SULSTON JE, 1980, DEV BIOL, V78, P577, DOI 10.1016/0012-1606(80)90353-X; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; VILLENEUVE AM, 1987, CELL, V48, P25, DOI 10.1016/0092-8674(87)90352-7; Wadsworth William G., 1992, Current Opinion in Neurobiology, V2, P36, DOI 10.1016/0959-4388(92)90159-I; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; YURCHENCO PD, 1993, J BIOL CHEM, V268, P17286	31	280	288	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1996	16	1					35	46		10.1016/S0896-6273(00)80021-5	http://dx.doi.org/10.1016/S0896-6273(00)80021-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TT307	8562088	Bronze			2022-12-24	WOS:A1996TT30700007
J	PATERNAIN, AV; MORALES, M; LERMA, J				PATERNAIN, AV; MORALES, M; LERMA, J			SELECTIVE ANTAGONISM OF AMPA RECEPTORS UNMASKS KAINATE RECEPTOR-MEDIATED RESPONSES IN HIPPOCAMPAL-NEURONS	NEURON			English	Article							DEPENDENT PROTEIN-KINASE; NMDA GLUTAMATE RECEPTOR; CENTRAL NERVOUS-SYSTEM; AMINO-ACID RECEPTORS; MESSENGER-RNA; HIGH-AFFINITY; SUBUNIT; GLUR6; 2,3-BENZODIAZEPINE; PHOSPHORYLATION	Although both protein and mRNAs for kainate receptor subunits are abundant in several brain regions, the responsiveness of AMPA receptors to kainate has made it difficult to demonstrate the presence of functional kainate-type receptors in native cells. Recently, however, we have shown that many hippocampal neurons in culture express glutamate receptors of the kainate type. The large nondesensitizing response that kainate induces at AMPA receptors precludes detection and analysis of smaller, rapidly desensitizing currents induced by kainate at kainate receptors. Consequently, the functional significance of these strongly desensitizing glutamate receptors remains enigmatic. We report here that the family of new noncompetitive antagonists of AMPA receptors (GYKI 52466 and 53655) minimally affects kainate-induced responses at kainate receptors while completely blocking AMPA receptor-mediated currents, making it possible to separate the responses mediated by each receptor. These compounds will allow determination of the role played by kainate receptors in synaptic transmission and plasticity in the mammalian brain, as well as evaluation of their involvement in neurotoxicity.			PATERNAIN, AV (corresponding author), CSIC,INST CAJAL,DEPT PLASTICIDAD NEURAL,AV DOCTOR ARCE 37,E-28002 MADRID,SPAIN.		Morales, Miguel/G-8995-2014; Lerma, Juan/G-7907-2015	Morales, Miguel/0000-0002-8885-2333; Lerma, Juan/0000-0001-7838-5199				BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; BERGOLD PJ, 1993, P NATL ACAD SCI USA, V90, P6165, DOI 10.1073/pnas.90.13.6165; COLLINGRIDGE GL, 1989, PHARMACOL REV, V41, P143; COYLE JT, 1983, J NEUROCHEM, V41, P1; CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U; DONEVAN SD, 1993, NEURON, V10, P51, DOI 10.1016/0896-6273(93)90241-I; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HERB A, 1992, NEURON, V8, P775, DOI 10.1016/0896-6273(92)90098-X; HIKIJI M, 1993, LIFE SCI, V53, P857, DOI 10.1016/0024-3205(93)90508-Z; HONORE T, 1988, SCIENCE, V241, P701, DOI 10.1126/science.2899909; HUNTLEY GW, 1993, J NEUROSCI, V13, P2965; ITO I, 1990, J PHYSIOL-LONDON, V424, P533, DOI 10.1113/jphysiol.1990.sp018081; LAMBOLEZ B, 1990, NATURE, V347, P26, DOI 10.1038/347026b0; LERMA J, 1992, NEURON, V8, P343, DOI 10.1016/0896-6273(92)90300-3; LERMA J, 1993, P NATL ACAD SCI USA, V90, P11688, DOI 10.1073/pnas.90.24.11688; MACKLER SA, 1993, MOL PHARMACOL, V44, P308; MAYER ML, 1987, PROG NEUROBIOL, V28, P197, DOI 10.1016/0301-0082(87)90011-6; OUARDOUZ M, 1991, NEUROSCI LETT, V125, P5, DOI 10.1016/0304-3940(91)90115-A; PATNEAU DK, 1991, NEURON, V6, P785, DOI 10.1016/0896-6273(91)90175-Y; PATNEAU DK, 1993, J NEUROSCI, V13, P3496; PATNEAU DK, 1994, NEURON, V12, P357, DOI 10.1016/0896-6273(94)90277-1; RAYMOND LA, 1993, NATURE, V361, P637, DOI 10.1038/361637a0; SOMMER B, 1992, EMBO J, V11, P1651, DOI 10.1002/j.1460-2075.1992.tb05211.x; SOMMER B, 1992, TRENDS PHARMACOL SCI, V13, P291, DOI 10.1016/0165-6147(92)90088-N; TARNAWA I, 1989, EUR J PHARMACOL, V167, P193, DOI 10.1016/0014-2999(89)90579-7; WANG LY, 1993, SCIENCE, V259, P1173, DOI 10.1126/science.8382377; Westbrook Gary L., 1994, Current Opinion in Neurobiology, V4, P337, DOI 10.1016/0959-4388(94)90094-9; WISDEN W, 1993, J NEUROSCI, V13, P3582; ZORUMSKI CF, 1993, NEURON, V10, P61, DOI 10.1016/0896-6273(93)90242-J	29	333	336	0	4	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1995	14	1					185	189		10.1016/0896-6273(95)90253-8	http://dx.doi.org/10.1016/0896-6273(95)90253-8			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QC548	7826635	Bronze			2022-12-24	WOS:A1995QC54800019
J	VANBERKUM, MFA; GOODMAN, CS				VANBERKUM, MFA; GOODMAN, CS			TARGETED DISRUPTION OF CA2+-CALMODULIN SIGNALING IN DROSOPHILA GROWTH CONES LEADS TO STALLS IN AXON EXTENSION AND ERRORS IN AXON GUIDANCE	NEURON			English	Article							LIGHT CHAIN KINASE; GENE FUSHI-TARAZU; INTRACELLULAR CALCIUM; SMOOTH-MUSCLE; CALMODULIN-BINDING; NEURITE OUTGROWTH; PEPTIDE COMPLEX; NERVOUS-SYSTEM; ACTIVATION; PROTEIN	Ca2+-calmodulin (CaM) function was selectively disrupted in a specific subset of growth cones in transgenic Drosophila embryos in which a specific enhancer element drives the expression of the kinesin motor domain fused to a CaM antagonist peptide (kinesin-antagonist or KA, which blacks CaM binding to target proteins) or CaM itself (kinesin-CaM or KC, which acts as a Ca2+-binding protein). In both KA and KC mutant embryos, specific growth cones exhibit dosage-dependent stalls in axon extension and errors in axon guidance, including both defects in fasciculation and abnormal crossings of the midline. These results demonstrate an in vivo function for Ca2+-CaM signaling in growth cone extension and guidance and suggest that Ca2+-CaM may in part regulate specific growth cone decisions, including when to defasciculate and whether or not to cross the midline.			VANBERKUM, MFA (corresponding author), UNIV CALIF BERKELEY,HOWARD HUGHES MED INST,DEPT MOLEC & CELL BIOL,DIV NEUROBIOL,BERKELEY,CA 94720, USA.							BAGCHI IC, 1992, J BIOL CHEM, V267, P3024; BANDTLOW CE, 1993, SCIENCE, V259, P80, DOI 10.1126/science.8418499; BECKINGHAM K, 1991, J BIOL CHEM, V266, P6027; BENTLEY D, 1991, J NEUROSCI, V11, P1300; BOWMAN BF, 1992, J BIOL CHEM, V267, P5346; CALLAHAN CA, 1994, P NATL ACAD SCI USA, V91, P5972, DOI 10.1073/pnas.91.13.5972; CHATTOPADHYAYA R, 1992, J MOL BIOL, V228, P1177, DOI 10.1016/0022-2836(92)90324-D; CYPHER C, 1992, Current Opinion in Cell Biology, V4, P4, DOI 10.1016/0955-0674(92)90051-D; DAVENPORT RW, 1992, NEURON, V9, P405, DOI 10.1016/0896-6273(92)90179-H; DOE CQ, 1988, SCIENCE, V239, P170, DOI 10.1126/science.2892267; Doherty Patrick, 1994, Current Opinion in Neurobiology, V4, P49, DOI 10.1016/0959-4388(94)90031-0; DOYLE KE, 1990, J MOL BIOL, V213, P599, DOI 10.1016/S0022-2836(05)80245-1; GAO ZH, 1993, J BIOL CHEM, V268, P20096; GINIGER E, 1993, ROUX ARCH DEV BIOL, V202, P112, DOI 10.1007/BF00636536; GNEGY ME, 1993, ANNU REV PHARMACOL, V33, P45, DOI 10.1146/annurev.pa.33.040193.000401; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; GOODMAN CS, 1994, CELL, V78, P353, DOI 10.1016/0092-8674(94)90413-8; GOSHIMA Y, 1993, J NEUROSCI, V13, P559; GOUGH AH, 1993, J CELL BIOL, V121, P1095, DOI 10.1083/jcb.121.5.1095; HANSON PI, 1992, ANNU REV BIOCHEM, V61, P559, DOI 10.1146/annurev.bi.61.070192.003015; HENDEY B, 1992, SCIENCE, V258, P296, DOI 10.1126/science.1384129; HINRICHSEN RD, 1993, BIOCHIM BIOPHYS ACTA, V1155, P277, DOI 10.1016/0304-419X(93)90010-A; HIROMI Y, 1985, CELL, V43, P603, DOI 10.1016/0092-8674(85)90232-6; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; IVINS JK, 1991, J NEUROSCI, V11, P1597; JANMEY PA, 1994, ANNU REV PHYSIOL, V56, P169, DOI 10.1146/annurev.ph.56.030194.001125; KATER SB, 1991, J NEUROSCI, V11, P891; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; KLAMBT C, 1991, CELL, V64, P801, DOI 10.1016/0092-8674(91)90509-W; KNIGHTON DR, 1992, SCIENCE, V258, P130, DOI 10.1126/science.1439761; KOLODKIN AL, 1992, NEURON, V9, P831, DOI 10.1016/0896-6273(92)90237-8; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; KOVALICK GE, 1992, DEV BIOL, V150, P33, DOI 10.1016/0012-1606(92)90005-2; Lee G, 1993, CURR OPIN CELL BIOL, V5, P88, DOI 10.1016/S0955-0674(05)80013-4; LIN DM, 1994, NEURON, V13, P1055, DOI 10.1016/0896-6273(94)90045-0; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; MCCARRON JG, 1992, NATURE, V357, P74, DOI 10.1038/357074a0; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; MEANS AR, 1991, ADV EXP MED BIOL, V304, P11; MENNE TV, 1994, DEVELOPMENT, V120, P123; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; PERSECHINI A, 1994, J BIOL CHEM, V269, P16148; POLAK KA, 1991, J NEUROSCI, V11, P534; REHDER V, 1992, J NEUROSCI, V12, P3175, DOI 10.1523/JNEUROSCI.12-08-03175.1992; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; SAXTON WM, 1988, P NATL ACAD SCI USA, V85, P1109, DOI 10.1073/pnas.85.4.1109; SCHUCH U, 1989, NEURON, V3, P13, DOI 10.1016/0896-6273(89)90111-6; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; SILVER RA, 1990, NATURE, V343, P751, DOI 10.1038/343751a0; Skoufias DA, 1993, CURR OPIN CELL BIOL, V5, P95, DOI 10.1016/S0955-0674(05)80014-6; Tear G, 1993, Perspect Dev Neurobiol, V1, P183; TREWHELLA J, 1992, CELL CALCIUM, V13, P377, DOI 10.1016/0143-4160(92)90051-S; VALE RD, 1985, CELL, V40, P559, DOI 10.1016/0092-8674(85)90204-1; VANBERKUM MFA, 1991, J BIOL CHEM, V266, P21488; WEINSTEIN H, 1994, ANNU REV PHYSIOL, V56, P213, DOI 10.1146/annurev.ph.56.030194.001241; ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0; ZOT HG, 1990, J BIOL CHEM, V265, P14796	59	68	68	0	2	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1995	14	1					43	56		10.1016/0896-6273(95)90239-2	http://dx.doi.org/10.1016/0896-6273(95)90239-2			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QC548	7826640	Bronze			2022-12-24	WOS:A1995QC54800005
J	SUGIYAMA, J; BOWEN, DC; HALL, ZW				SUGIYAMA, J; BOWEN, DC; HALL, ZW			DYSTROGLYCAN BINDS NERVE AND MUSCLE AGRIN	NEURON			English	Article							DYSTROPHIN-GLYCOPROTEIN COMPLEX; ACETYLCHOLINE-RECEPTOR; SKELETAL-MUSCLE; NEUROMUSCULAR-JUNCTIONS; EXTRACELLULAR-MATRIX; CULTURED MYOTUBES; FIBROBLAST GROWTH; ELECTRIC TISSUE; HEPARAN-SULFATE; HIGH-AFFINITY	Neurally released agrin is thought to cluster acetylcholine receptors (AChRs) and other synaptic proteins in the postsynaptic membrane during synaptogenesis at the neuromuscular junction. We have examined the binding of nerve and muscle agrins, which have dramatically different abilities to cluster AChRs, to the membrane proteins of Torpedo electric organ and C2 myotubes. Both bound with approximately nanomolar affinity to a single component identified as alpha-dystroglycan: agrin binding was blocked by antibodies to alpha-dystroglycan, and agrin bound to purified alpha-dystroglycan. Dystroglycan was altered in two genetic variants of C2 muscle cells that fail to form spontaneous clusters of AChRs and that show a diminished response to agrin. Antibodies that blocked alpha-dystroglycan binding, however, failed to block the clustering of AChRs by neural agrin. Although alpha-dystroglycan is the major agrin-binding protein in Torpedo and myotube membranes, its physiological role is unclear.			SUGIYAMA, J (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,PROGRAM NEUROSCI,SAN FRANCISCO,CA 94143, USA.							BEWICK GS, 1992, NEUROREPORT, V3, P857, DOI 10.1097/00001756-199210000-00009; BLOCH RJ, 1989, J CELL BIOL, V108, P481, DOI 10.1083/jcb.108.2.481; BOWE MA, 1994, IN PESS ANN REV NEUR; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; BUTLER MH, 1992, J BIOL CHEM, V267, P6213; CARR C, 1989, J CELL BIOL, V109, P1753, DOI 10.1083/jcb.109.4.1753; CHANG HW, 1989, J BIOL CHEM, V264, P20831; CULLEN MJ, 1990, PROC R SOC SER B-BIO, V240, P197, DOI 10.1098/rspb.1990.0034; ERVASTI JM, 1991, J BIOL CHEM, V266, P9161; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; EVERS J, 1989, J NEUROSCI, V9, P1523; FERNS M, 1992, NEURON, V8, P1079, DOI 10.1016/0896-6273(92)90129-2; FERNS MJ, 1993, NEURON, V11, P491, DOI 10.1016/0896-6273(93)90153-I; FERTUCK HC, 1976, J CELL BIOL, V69, P144, DOI 10.1083/jcb.69.1.144; FLUCHER BE, 1989, NEURON, V3, P163, DOI 10.1016/0896-6273(89)90029-9; FROEHNER SC, 1993, ANNU REV NEUROSCI, V16, P347, DOI 10.1146/annurev.ne.16.030193.002023; GEE SH, 1993, J BIOL CHEM, V268, P14972; GORDON H, 1989, DEV BIOL, V135, P1, DOI 10.1016/0012-1606(89)90152-8; GORDON H, 1993, J NEUROSCI, V13, P586; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; HIRANO Y, 1989, J NEUROSCI, V9, P1555; HOCK W, 1993, NEURON, V11, P479; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; JASMIN BJ, 1990, P NATL ACAD SCI USA, V87, P3938, DOI 10.1073/pnas.87.10.3938; KHURANA TS, 1990, J BIOL CHEM, V265, P16717; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIETH E, 1993, J NEUROSCI, V13, P2509, DOI 10.1523/JNEUROSCI.13-06-02509.1993; LOPEZCASILLAS F, 1994, J CELL BIOL, V124, P557, DOI 10.1083/jcb.124.4.557; LOPEZCASILLAS F, 1993, CELL, V73, P1435, DOI 10.1016/0092-8674(93)90368-Z; LOVE DR, 1989, NATURE, V339, P55, DOI 10.1038/339055a0; LYONS PR, 1991, J NEUROCYTOL, V20, P969, DOI 10.1007/BF01187915; MA JY, 1993, J BIOL CHEM, V268, P25108; MACKETT M, 1985, DNA CLONING PRACTICA, P191; MATSUMURA K, 1992, NATURE, V360, P588, DOI 10.1038/360588a0; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; MITSUMOTO Y, 1992, J BIOL CHEM, V267, P4957; NAEGELE JR, 1991, BRAIN RES, V559, P118, DOI 10.1016/0006-8993(91)90294-6; NASTUK MA, 1991, NEURON, V7, P807, DOI 10.1016/0896-6273(91)90283-6; NGSEE JK, 1990, GENE, V86, P251, DOI 10.1016/0378-1119(90)90286-Z; NITKIN RM, 1990, J CELL BIOL, V111, P1161, DOI 10.1083/jcb.111.3.1161; OHLENDIECK K, 1991, J CELL BIOL, V112, P135, DOI 10.1083/jcb.112.1.135; OHLENDIECK K, 1991, NEURON, V7, P449; PERKUS ME, 1989, J VIROL, V63, P3829, DOI 10.1128/JVI.63.9.3829-3836.1989; PHILLIPS WD, 1993, J CELL BIOL, V123, P729, DOI 10.1083/jcb.123.3.729; PONS F, 1991, FEBS LETT, V282, P161, DOI 10.1016/0014-5793(91)80468-I; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; REIST NE, 1992, NEURON, V8, P865, DOI 10.1016/0896-6273(92)90200-W; RUEGG MA, 1992, NEURON, V8, P691, DOI 10.1016/0896-6273(92)90090-Z; RUPP F, 1992, J NEUROSCI, V12, P3535; RUPP F, 1991, NEURON, V6, P811, DOI 10.1016/0896-6273(91)90177-2; SALTO M, 1993, DEV BRAIN RES, V71, P9; SEALOCK R, 1991, J CELL BIOL, V113, P1133, DOI 10.1083/jcb.113.5.1133; SEALOCK R, 1987, J CELL BIOL, V104, P1633; SMITH MA, 1992, MOL CELL NEUROSCI, V3, P406, DOI 10.1016/1044-7431(92)90052-4; SMITH MA, 1994, NEURON, V12, P795, DOI 10.1016/0896-6273(94)90332-8; TORRES LFB, 1987, BRAIN, V110, P269, DOI 10.1093/brain/110.2.269; TSIM KWK, 1992, NEURON, V8, P677, DOI 10.1016/0896-6273(92)90089-V; WAGNER KR, 1993, NEURON, V10, P511, DOI 10.1016/0896-6273(93)90338-R; WALLACE BG, 1990, J NEUROSCI, V10, P3576; WALLACE BG, 1991, NEURON, V6, P869, DOI 10.1016/0896-6273(91)90227-Q; WATKINS SC, 1988, NATURE, V333, P863, DOI 10.1038/333863a0; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; YOSHIDA M, 1990, J BIOCHEM-TOKYO, V108, P748, DOI 10.1093/oxfordjournals.jbchem.a123276	66	238	241	1	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1994	13	1					103	115		10.1016/0896-6273(94)90462-6	http://dx.doi.org/10.1016/0896-6273(94)90462-6			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NZ247	8043271				2022-12-24	WOS:A1994NZ24700008
J	KERNAN, M; COWAN, D; ZUKER, C				KERNAN, M; COWAN, D; ZUKER, C			GENETIC DISSECTION OF MECHANOSENSORY TRANSDUCTION - MECHANORECEPTION-DEFECTIVE MUTATIONS OF DROSOPHILA	NEURON			English	Article							SITE-SPECIFIC RECOMBINATION; X-CHROMOSOME; MELANOGASTER; LOCALIZATION; NEURONS; TISSUES; MOSAICS; ORGANS; CELL	To identify genes involved in mechanotransduction, Drosophila larvae were screened for X-linked mutations affecting a behavioral response to touch. Many mutations that caused nondevelopmental defects were recovered, among them multiple alleles of the genes uncoordinated (unc) and uncoordinated-like (uncl). Adult flies mutant in these genes showed reduced viability that was associated with behavioral phenotypes ranging from reduced locomotor activity to total uncoordination, Behavioral analysis of mosaic flies indicated that external sensory bristles are a focus of the unc mutant defect. Extracellular recordings from mutant mechanosensory bristles revealed that mechanoreceptor potentials were absent or reduced in both unc and uncl mutants. A second genetic screen, for unc-like uncoordination, yielded mutations in seven genes on the second chromosome; mutations in five of these genes also reduced or eliminated bristle mechanoreceptor potentials. These mutants provide the basis for a genetic, electrophysiological, and molecular dissection of mechanotransduction.	UNIV CALIF SAN DIEGO,DEPT BIOL,LA JOLLA,CA 92093; UNIV CALIF SAN DIEGO,DEPT NEUROSCI,LA JOLLA,CA 92093	University of California System; University of California San Diego; University of California System; University of California San Diego	KERNAN, M (corresponding author), UNIV CALIF SAN DIEGO,HOWARD HUGHES MED INST,LA JOLLA,CA 92093, USA.			Kernan, Maurice/0000-0002-1546-6159				ANHOLT RRH, 1993, CRIT REV NEUROBIOL, V7, P1; ASHBURNER M, 1989, ROUX ARCH DEVEL BIOL, V196, P69; BODMER R, 1987, CELL, V51, P293, DOI 10.1016/0092-8674(87)90156-5; CANESSA CM, 1993, CHAL, V361, P467; CHALFIE M, 1989, SCIENCE, V243, P1027, DOI 10.1126/science.2646709; CORFAS G, 1990, J NEUROSCI, V10, P491; DAMBLYCHAUDIERE C, 1986, ROUX ARCH DEV BIOL, V195, P222, DOI 10.1007/BF02438954; Delcomyn F., 1985, P439; GHYSEN A, 1989, DEVELOPMENT, V105, P35; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; GOLIC KG, 1991, SCIENCE, V252, P958, DOI 10.1126/science.2035025; Grigliati T., 1986, DROSOPHILA PRACTICAL, P39; GRUNERT U, 1987, J COMP PHYSIOL A, V161, P329, DOI 10.1007/BF00615253; HARGRAVE PA, 1992, INT REV CYTOL, V137B, P49; HARTENSTEIN V, 1992, ROUX ARCH DEV BIOL, V201, P194, DOI 10.1007/BF00188752; HARTENSTEIN V, 1989, DEVELOPMENT, V107, P389; HODGSON ES, 1955, SCIENCE, V122, P417, DOI 10.1126/science.122.3166.417-a; HOWARD J, 1988, NEURON, V1, P189, DOI 10.1016/0896-6273(88)90139-0; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; ITO F, 1992, COMP ASPECTS MECHANO; Janning W, 1978, Results Probl Cell Differ, V9, P1; KANKEL DR, 1976, DEV BIOL, V48, P1, DOI 10.1016/0012-1606(76)90041-5; KUIJPERS W, 1970, PFLUG ARCH EUR J PHY, V320, P359, DOI 10.1007/BF00588214; LIFSCHYTZ E, 1968, MUTAT RES, V8, P147; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; LINGUEGLIA E, 1993, FEBS LETT, V318, P95, DOI 10.1016/0014-5793(93)81336-X; Margolskee Robert F., 1993, Current Opinion in Neurobiology, V3, P526, DOI 10.1016/0959-4388(93)90051-Y; McIver S.B., 1985, P71; MIKLOS GLG, 1987, J NEUROGENET, V4, P1, DOI 10.3109/01677068709102329; OSTER II, 1951, DROS INF SERV, V25, P124; PERRIMON N, 1989, GENETICS, V121, P313; PHILLIS RW, 1993, GENETICS, V133, P581; POLLACK JA, 1985, MONOCLONAL ANTIBODY, P203; RANGANATHAN R, 1991, NATURE, V354, P230, DOI 10.1038/354230a0; REARDON W, 1992, J MED GENET, V29, P521, DOI 10.1136/jmg.29.8.521; SAIMI Y, 1987, ANNU REV GENET, V21, P47, DOI 10.1146/annurev.genet.21.1.47; SCHALET A, 1973, CHROMOSOMA, V44, P183, DOI 10.1007/BF00329116; SCHALET A, 1976, GENET BIOL DROSOPHIL, V1, P848; Steel KP, 1991, ANN NY ACAD SCI, V630, P68; Thurm U., 1980, P735; VANDERVORST P, 1980, NATURE, V286, P65, DOI 10.1038/286065a0; VILLARES R, 1987, CELL, V50, P415, DOI 10.1016/0092-8674(87)90495-8; WOLBARSHT ML, 1958, J GEN PHYSIOL, V42, P393, DOI 10.1085/jgp.42.2.393; Wright B.R., 1976, STRUCTURE FUNCTION P, P323; XU T, 1993, DEVELOPMENT, V117, P1223; ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2	46	249	260	2	20	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1994	12	6					1195	1206		10.1016/0896-6273(94)90437-5	http://dx.doi.org/10.1016/0896-6273(94)90437-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NT463	8011334				2022-12-24	WOS:A1994NT46300002
J	WAFFORD, KA; BAIN, CJ; QUIRK, K; MCKERNAN, RM; WINGROVE, PB; WHITING, PJ; KEMP, JA				WAFFORD, KA; BAIN, CJ; QUIRK, K; MCKERNAN, RM; WINGROVE, PB; WHITING, PJ; KEMP, JA			A NOVEL ALLOSTERIC MODULATORY SITE ON THE GABA(A) RECEPTOR-BETA SUBUNIT	NEURON			English	Article							SPECTRUM ANTICONVULSANT LORECLEZOLE; UNCONTROLLED PARTIAL SEIZURES; AMINOBUTYRIC ACID-A; ADD-ON THERAPY; BENZODIAZEPINE RECEPTORS; FUNCTIONAL EXPRESSION; MESSENGER-RNAS; GAMMA-SUBUNIT; RAT-BRAIN; PHARMACOLOGY	Cloning of cDNAs that code for GABA(A) receptor subunits has revealed multiple receptor populations constructed from different subunit combinations. On native rat and cloned human GABA(A) receptors, the anticonvulsant compound loreclezole strongly potentiated GABA-mediated chloride currents. Using different combinations of human GABA(A) receptor subunits expressed in Xenopus oocytes and transfected 293 cells, loreclezole was highly selective for receptors containing the beta 2 or beta 3 subunit over those containing the beta 1 subunit. Loreclezole was demonstrated to act at a site distinct from the benzodiazepine, barbiturate, and steroid sites with a unique subunit dependence. These results describe a previously unidentified modulatory site on the GABA(A) receptor beta subunit that allows pharmacological discrimination of different GABA(A) receptor subpopulations in the brain and provides a new target for putative anticonvulsant/anxiolytic drugs.			WAFFORD, KA (corresponding author), MERCK SHARP & DOHME LTD,RES LABS,TERLINGS PK,EASTWICK RD,HARLOW CM20 2QR,ESSEX,ENGLAND.			Whiting, Paul/0000-0002-4121-1379; Wafford, Keith/0000-0003-4537-4690				ARAKI T, 1992, MOL BRAIN RES, V15, P121, DOI 10.1016/0169-328X(92)90159-9; ASHTON D, 1992, EPILEPSY RES, V11, P27, DOI 10.1016/0920-1211(92)90018-O; ASHTON D, 1992, EPILEPSY RES, V11, P75, DOI 10.1016/0920-1211(92)90042-R; BURT DR, 1991, FASEB J, V5, P2916, DOI 10.1096/fasebj.5.14.1661244; CALLACHAN H, 1987, PROC R SOC SER B-BIO, V231, P359, DOI 10.1098/rspb.1987.0049; CUTTING GR, 1991, P NATL ACAD SCI USA, V88, P2673, DOI 10.1073/pnas.88.7.2673; DAWSON GR, 1994, EUR J PHARMACOL, V252, P325, DOI 10.1016/0014-2999(94)90180-5; HADINGHAM KL, 1993, MOL PHARMACOL, V43, P970; HADINGHAM KL, 1993, MOL PHARMACOL, V44, P1211; HERB A, 1992, P NATL ACAD SCI USA, V89, P1433, DOI 10.1073/pnas.89.4.1433; HORNE AL, 1993, BRIT J PHARMACOL, V108, P711; IM HK, 1993, MOL PHARMACOL, V44, P468; LAURIE DJ, 1992, J NEUROSCI, V12, P1063; LEVITAN ES, 1988, NATURE, V335, P76, DOI 10.1038/335076a0; LUDDENS H, 1990, NATURE, V346, P648, DOI 10.1038/346648a0; MALHERBE P, 1990, J NEUROSCI, V10, P2330; NEWLAND CF, 1992, J PHYSIOL-LONDON, V447, P191, DOI 10.1113/jphysiol.1992.sp018998; PERSOHN E, 1992, J COMP NEUROL, V326, P193, DOI 10.1002/cne.903260204; PRITCHETT DB, 1990, J NEUROCHEM, V54, P1802, DOI 10.1111/j.1471-4159.1990.tb01237.x; PRITCHETT DB, 1989, SCIENCE, V245, P1389, DOI 10.1126/science.2551039; PRITCHETT DB, 1991, P NATL ACAD SCI USA, V88, P1421, DOI 10.1073/pnas.88.4.1421; PRITCHETT DB, 1989, NATURE, V338, P582, DOI 10.1038/338582a0; PUIA G, 1991, MOL PHARMACOL, V39, P691; QUIRK K, 1994, IN PRESS MOL PHARM; RENTMEESTER T, 1991, EPILEPSY RES, V8, P166, DOI 10.1016/0920-1211(91)90085-T; RENTMEESTER T, 1991, EPILEPSY RES, V9, P65, DOI 10.1016/0920-1211(91)90048-K; RENTMEESTER T, 1991, EPILEPSY RES, V9, P59, DOI 10.1016/0920-1211(91)90047-J; SCHOFIELD PR, 1987, NATURE, V328, P221, DOI 10.1038/328221a0; SHIVERS BD, 1989, NEURON, V3, P327, DOI 10.1016/0896-6273(89)90257-2; SMART TG, 1986, PROC R SOC SER B-BIO, V227, P191, DOI 10.1098/rspb.1986.0019; SQUIRES RF, 1983, MOL PHARMACOL, V23, P326; VANRIJN CM, 1993, NEUROSCI RES COMMUN, V12, P57; VAUGHT JL, 1991, DRUG DEVELOP RES, V23, P181, DOI 10.1002/ddr.430230209; WAFFORD KA, 1993, MOL PHARMACOL, V43, P240; WAFFORD KA, 1993, MOL PHARMACOL, V44, P437; WAUQUIER A, 1990, DRUG DEVELOP RES, V19, P375, DOI 10.1002/ddr.430190404; WIELAND HA, 1992, J BIOL CHEM, V267, P1426; WILSONSHAW D, 1991, FEBS LETT, V284, P211, DOI 10.1016/0014-5793(91)80687-X; Wisden W, 1992, Curr Opin Neurobiol, V2, P263, DOI 10.1016/0959-4388(92)90113-Y; WISDEN W, 1991, FEBS LETT, V289, P227, DOI 10.1016/0014-5793(91)81076-K; WISDEN W, 1992, J NEUROSCI, V12, P1040; YMER S, 1990, EMBO J, V9, P3261, DOI 10.1002/j.1460-2075.1990.tb07525.x; YMER S, 1989, EMBO J, V8, P1665, DOI 10.1002/j.1460-2075.1989.tb03557.x; ZHANG CL, 1992, N-S ARCH PHARMACOL, V346, P581	44	185	185	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1994	12	4					775	782		10.1016/0896-6273(94)90330-1	http://dx.doi.org/10.1016/0896-6273(94)90330-1			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NH253	8161449				2022-12-24	WOS:A1994NH25300006
J	QUATTROCKI, EA; MARSHALL, J; KACZMAREK, LK				QUATTROCKI, EA; MARSHALL, J; KACZMAREK, LK			A SHAB POTASSIUM CHANNEL CONTRIBUTES TO ACTION-POTENTIAL BROADENING IN PEPTIDERGIC NEURONS	NEURON			English	Article							DELAYED-RECTIFIER PROPERTIES; PROTEIN-CODING SEQUENCES; ACTIVATED K+ CHANNELS; XENOPUS OOCYTES; RAT-BRAIN; MOLECULAR MECHANISMS; APLYSIA NEURONS; MAMMALIAN BRAIN; CALCIUM CURRENT; MESSENGER-RNAS	We have cloned the gene for a potassium channel, Aplysia Shab, that is expressed in the bag cell neurons of Aplysia. The voltage dependence and kinetics of the Aplysia Shab current in oocytes match those of IK2, one of the two delayed rectifiers in these neurons. Like IK2, but in contrast with other members of the Shab subfamily, the Aplysia Shab current inactivates within several hundred milliseconds. This inactivation occurs by a process whose properties do not match those previously described for C-type and N-type mechanisms. Neither truncation of the N-terminus nor block by tetraethylammonium alters the time course of inactivation. By incorporating the characteristics of Aplysia Shab into a computational model, we have shown how this current contributes to the normal enhancement of action potentials that occurs in the bag cell neurons at the onset of neuropeptide secretion.			QUATTROCKI, EA (corresponding author), YALE UNIV, SCH MED, DEPT PHARMACOL, NEW HAVEN, CT 06510 USA.		Quattrocki, Elizabeth/D-5263-2016	Quattrocki, Elizabeth/0000-0003-1164-8606	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS018492] Funding Source: NIH RePORTER; NINDS NIH HHS [NS-18492] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALDRICH RW, 1979, J PHYSIOL-LONDON, V291, P507, DOI 10.1113/jphysiol.1979.sp012828; ALDRICH RW, 1979, J PHYSIOL-LONDON, V291, P531, DOI 10.1113/jphysiol.1979.sp012829; BIBB MJ, 1984, GENE, V30, P157, DOI 10.1016/0378-1119(84)90116-1; BLOCH W, 1991, BIOCHEMISTRY-US, V30, P2735, DOI 10.1021/bi00225a001; BUTLER A, 1990, NUCLEIC ACIDS RES, V18, P2173, DOI 10.1093/nar/18.8.2173; BUTLER A, 1989, SCIENCE, V243, P943, DOI 10.1126/science.2493160; CHANDY KG, 1991, NATURE, V352, P26, DOI 10.1038/352026b0; CHIU AY, 1979, P NATL ACAD SCI USA, V76, P6656, DOI 10.1073/pnas.76.12.6656; CHOI KL, 1991, P NATL ACAD SCI USA, V88, P5092, DOI 10.1073/pnas.88.12.5092; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHRISTIE MJ, 1989, SCIENCE, V244, P221, DOI 10.1126/science.2539643; CONN PJ, 1989, J NEUROSCI, V9, P480; CONN PJ, 1989, MOL NEUROBIOL, V3, P237, DOI 10.1007/BF02740607; DERIEMER SA, 1985, NATURE, V313, P313, DOI 10.1038/313313a0; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; FAWCETT TW, 1991, COMMENTS, V17, P19; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; GRIBSKOV M, 1984, NUCLEIC ACIDS RES, V12, P539, DOI 10.1093/nar/12.1Part2.539; HEGINBOTHAM L, 1992, NEURON, V8, P483, DOI 10.1016/0896-6273(92)90276-J; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HOROWITZ SB, 1989, P NATL ACAD SCI USA, V86, P9652, DOI 10.1073/pnas.86.24.9652; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; HWANG PM, 1992, NEURON, V8, P473, DOI 10.1016/0896-6273(92)90275-I; IVERSON LE, 1990, J NEUROSCI, V10, P2903; KACZMAREK LK, 1978, P NATL ACAD SCI USA, V75, P5200, DOI 10.1073/pnas.75.10.5200; KACZMAREK LK, 1984, J NEUROPHYSIOL, V52, P340, DOI 10.1152/jn.1984.52.2.340; KACZMAREK LK, 1982, BRAIN RES, V238, P105, DOI 10.1016/0006-8993(82)90774-0; Kaczmarek LK, 1987, NEUROMODULATION BIOC; KAMB A, 1987, CELL, V50, P405, DOI 10.1016/0092-8674(87)90494-6; KAVANAUGH MP, 1992, NEURON, V8, P493, DOI 10.1016/0896-6273(92)90277-K; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LOECHNER KJ, 1990, J NEUROPHYSIOL, V63, P738, DOI 10.1152/jn.1990.63.4.738; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MACKINNON R, 1990, NEURON, V5, P767, DOI 10.1016/0896-6273(90)90335-D; Maniatis T., 1982, MOL CLONING; PAK MD, 1991, J NEUROSCI, V11, P869; PAPAZIAN DM, 1987, SCIENCE, V237, P749, DOI 10.1126/science.2441470; PFAFFINGER PJ, 1991, J NEUROSCI, V11, P918; RAJPARA SM, 1992, NEURON, V9, P505, DOI 10.1016/0896-6273(92)90188-J; SIGEL E, 1990, J MEMBRANE BIOL, V117, P201, DOI 10.1007/BF01868451; SPENCER AN, 1989, NATURE, V340, P636, DOI 10.1038/340636a0; STRONG JA, 1986, J NEUROSCI, V6, P814; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; SWANSON R, 1990, NEURON, V4, P929, DOI 10.1016/0896-6273(90)90146-7; TAKUMI T, 1988, SCIENCE, V242, P1042, DOI 10.1126/science.3194754; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; TIMPE LC, 1988, NATURE, V331, P143, DOI 10.1038/331143a0; WEI A, 1990, SCIENCE, V248, P599, DOI 10.1126/science.2333511; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520	53	45	45	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1994	12	1					73	86		10.1016/0896-6273(94)90153-8	http://dx.doi.org/10.1016/0896-6273(94)90153-8			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MU493	8292361				2022-12-24	WOS:A1994MU49300007
J	CAHILL, GM; BESHARSE, JC				CAHILL, GM; BESHARSE, JC			CIRCADIAN CLOCK FUNCTIONS LOCALIZED IN XENOPUS RETINAL PHOTORECEPTORS	NEURON			English	Article							N-ACETYLTRANSFERASE; DOPAMINE-RECEPTORS; MELATONIN; EYE; PINEAL; LIGHT; RHYTHMS; SYSTEM	A circadian oscillator that regulates visual function is located somewhere within the vertebrate eye. To determine whether circadian rhythmicity is generated by retinal photoreceptors, we isolated and cultured photoreceptor layers from Xenopus retina. On average, 94% of the viable cells in these preparations were rod or cone photoreceptors. Photoreceptor layers produced melatonin rhythmically, with an average period of 24.3 hr, in constant darkness. The phase of the melatonin rhythm was reset by in vitro exposure of the photoreceptor layers to cycles of either light or quinpirole, a D2 dopamine receptor agonist. These data indicate that other parts of the eye are not necessary for generation or entrainment of retinal circadian melatonin rhythms and suggest that rod and/or cone photoreceptors are circadian clock cells.			CAHILL, GM (corresponding author), UNIV KANSAS, MED CTR, DEPT ANAT & CELL BIOL, KANSAS CITY, KS 66160 USA.				NEI NIH HHS [R01 EY002414, EY02414] Funding Source: Medline; NIMH NIH HHS [MH49757] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY002414] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Besharse J.C., 1988, PROGR RETINAL RES, V7, P21; BESHARSE JC, 1983, NATURE, V305, P133, DOI 10.1038/305133a0; BESHARSE JC, 1983, EXP EYE RES, V36, P567, DOI 10.1016/0014-4835(83)90051-9; BLOCK GD, 1984, J COMP PHYSIOL, V155, P387, DOI 10.1007/BF00610592; BRANN MR, 1986, NEUROSCI LETT, V69, P221, DOI 10.1016/0304-3940(86)90483-0; CAHILL GM, 1992, VISUAL NEUROSCI, V8, P487, DOI 10.1017/S0952523800005009; CAHILL GM, 1991, J NEUROSCI, V11, P2959; CAHILL GM, 1991, CELL MOL NEUROBIOL, V11, P529, DOI 10.1007/BF00734814; CAHILL GM, 1990, J NEUROCHEM, V54, P716, DOI 10.1111/j.1471-4159.1990.tb01932.x; DEARRY A, 1986, J NEUROCHEM, V46, P1006, DOI 10.1111/j.1471-4159.1986.tb00612.x; IUVONE PM, 1983, BRAIN RES, V273, P111, DOI 10.1016/0006-8993(83)91099-5; KAPLAN MW, 1990, INVEST OPHTH VIS SCI, V31, P1; MEIJER JH, 1989, PHYSIOL REV, V69, P671, DOI 10.1152/physrev.1989.69.3.671; MENAKER M, 1983, P NATL ACAD SCI-BIOL, V80, P6119, DOI 10.1073/pnas.80.19.6119; MURESAN Z, 1993, IN PRESS J COMP NEUR; PIERCE ME, 1993, NEURON, V10, P579, DOI 10.1016/0896-6273(93)90161-J; PIERCE ME, 1985, J GEN PHYSIOL, V86, P671, DOI 10.1085/jgp.86.5.671; Pittendrigh C, 1981, HDB BEHAVIORAL NEURO, V4, P57; REME CE, 1991, J BIOL RHYTHM, V6, P5, DOI 10.1177/074873049100600104; SCHUTTE M, 1991, J NEUROCYTOL, V20, P195, DOI 10.1007/BF01186992; STEINBERG RH, 1985, DOC OPHTHALMOL, V60, P327, DOI 10.1007/BF00158922; TAKAHASHI JS, 1989, RECENT PROG HORM RES, V45, P279; UNDERWOOD H, 1990, J BIOL RHYTHM, V5, P257, DOI 10.1177/074873049000500307; WIECHMANN AF, 1986, EXP EYE RES, V42, P507, DOI 10.1016/0014-4835(86)90042-4	24	262	263	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1993	10	4					573	577		10.1016/0896-6273(93)90160-S	http://dx.doi.org/10.1016/0896-6273(93)90160-S			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KY501	8476609				2022-12-24	WOS:A1993KY50100002
J	GRAYKELLER, MP; POLANS, AS; PALCZEWSKI, K; DETWILER, PB				GRAYKELLER, MP; POLANS, AS; PALCZEWSKI, K; DETWILER, PB			THE EFFECT OF RECOVERIN-LIKE CALCIUM-BINDING PROTEINS ON THE PHOTORESPONSE OF RETINAL RODS	NEURON			English	Article							PHOTORECEPTOR GUANYLATE-CYCLASE; OUTER SEGMENTS; SALAMANDER RODS; PURIFICATION; LIGHT; EXCITATION; CELLS	The rod photoresponse is triggered by an enzyme cascade that stimulates cGMP hydrolysis. The resulting fall in cGMP leads to a decrease in Ca2+, which promotes photoresponse recovery by activating guanylate cyclase, causing cGMP resynthesis. In vitro biochemical studies suggest that Ca2+ activation of guanylate cyclase is mediated by recoverin, a 26 kd Ca2+-binding protein. To evaluate this, exogenous bovine recoverin and two other homologous Ca2+-binding proteins from chicken and Gecko retina were dialyzed into functionally intact Gecko rods using whole-cell recording. All three proteins prolonged the rising phase of the photoresponse without affecting the kinetics of response recovery. These results suggest that recoverin-like proteins affect termination of the transduction cascade, rather than mediate Ca2+-sensitive activation of guanylate cyclase.	GOOD SAMARITAN HOSP, RS DOW NEUROL SCI INST, PORTLAND, OR 97209 USA; UNIV WASHINGTON, SCH MED, DEPT OPHTHALMOL, SEATTLE, WA 98195 USA; UNIV WASHINGTON, SCH MED, DEPT PHARMACOL, SEATTLE, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	GRAYKELLER, MP (corresponding author), UNIV WASHINGTON, SCH MED, DEPT PHYSIOL & BIOPHYS, SEATTLE, WA 98195 USA.			Detwiler, Peter/0000-0003-3910-2023	NEI NIH HHS [T32-EY07031, EY08061, EY07089] Funding Source: Medline; NATIONAL EYE INSTITUTE [R29EY007089, T32EY007031, R29EY008061, R01EY008061, R01EY007089] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BAYLOR DA, 1987, INVEST OPHTH VIS SCI, V28, P34; BIERNBAUM MS, 1985, J GEN PHYSIOL, V85, P83, DOI 10.1085/jgp.85.1.83; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CERVETTO L, 1989, NATURE, V337, P740, DOI 10.1038/337740a0; DEDMAN JR, 1983, METHOD ENZYMOL, V102, P1; DIZHOOR AM, 1989, BIOCHEM BIOPH RES CO, V162, P544, DOI 10.1016/0006-291X(89)92031-7; DIZHOOR AM, 1991, SCIENCE, V251, P915, DOI 10.1126/science.1672047; FAIRBANKS G, 1971, BIOCHEMISTRY-US, V10, P2606, DOI 10.1021/bi00789a030; HAGINS WA, 1974, EXP EYE RES, V18, P299, DOI 10.1016/0014-4835(74)90157-2; HAKKI S, 1990, BIOCHEMISTRY-US, V29, P1088, DOI 10.1021/bi00456a035; HATAKENAKA S, 1985, BRAIN RES, V331, P209, DOI 10.1016/0006-8993(85)91546-X; HAYASHI F, 1991, P NATL ACAD SCI USA, V88, P4746, DOI 10.1073/pnas.88.11.4746; HAYASHI F, 1993, IN PRESS METH NEUROS; HODGKIN AL, 1988, J PHYSIOL-LONDON, V403, P439, DOI 10.1113/jphysiol.1988.sp017258; KAWAMURA S, 1991, NATURE, V349, P420, DOI 10.1038/349420a0; KAWAMURA S, 1992, BIOCHEM BIOPH RES CO, V186, P411, DOI 10.1016/S0006-291X(05)80823-X; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; KOCH KW, 1991, J BIOL CHEM, V266, P8634; KUNO T, 1992, BIOCHEM BIOPH RES CO, V184, P1219, DOI 10.1016/S0006-291X(05)80012-9; KUTUZOV MA, 1991, FEBS LETT, V293, P21, DOI 10.1016/0014-5793(91)81143-V; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMBRECHT HG, 1991, EMBO J, V10, P793, DOI 10.1002/j.1460-2075.1991.tb08011.x; LOLLEY RN, 1982, VISION RES, V22, P1481, DOI 10.1016/0042-6989(82)90213-9; MCNAUGHTON PA, 1986, NATURE, V322, P261, DOI 10.1038/322261a0; MCNAUGHTON PA, 1990, PHYSIOL REV, V70, P847, DOI 10.1152/physrev.1990.70.3.847; MILAM AH, 1992, VISUAL NEUROSCI, V10, P1; OKAZAKI K, 1992, BIOCHEM BIOPH RES CO, V185, P147, DOI 10.1016/S0006-291X(05)80968-4; PALCZEWSKI K, 1992, NEURON, V8, P117, DOI 10.1016/0896-6273(92)90113-R; PALCZEWSKI K, 1993, IN PRESS METH NEUROS; PALCZEWSKI K, 1990, BIOCHEMISTRY-US, V29, P6267; PANNBACKER RG, 1973, SCIENCE, V182, P1138, DOI 10.1126/science.182.4117.1138; PEPE IM, 1986, FEBS LETT, V203, P73, DOI 10.1016/0014-5793(86)81439-9; POLANS AS, 1993, INVEST OPHTH VIS SCI, V34, P81; POLANS AS, 1991, J CELL BIOL, V112, P981, DOI 10.1083/jcb.112.5.981; RATTO GM, 1988, J NEUROSCI, V8, P3240; RAY S, 1992, P NATL ACAD SCI USA, V89, P5705, DOI 10.1073/pnas.89.13.5705; RISPOLI G, 1990, NATO ADV SCI I A-LIF, V194, P157; RISPOLI G, 1993, IN PRESS J PHYSL; RISPOLI G, 1992, SIGNAL TRANSDUCTION, P217; SAKMANN B, 1983, SINGLE CHANNEL RECOR; SATHEL WA, 1988, THESIS U WASHINGTON; STRYER L, 1991, J BIOL CHEM, V266, P10711; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; TAKAMATSU K, 1992, BIOCHEM BIOPH RES CO, V183, P245, DOI 10.1016/0006-291X(92)91635-4; TORRE V, 1986, P NATL ACAD SCI USA, V83, P7109, DOI 10.1073/pnas.83.18.7109; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; YAMAGATA K, 1990, NEURON, V4, P469, DOI 10.1016/0896-6273(90)90059-O; YAU KW, 1984, NATURE, V311, P661, DOI 10.1038/311661a0; Yoshikami S., 1973, BIOCH PHYSL VISUAL P, P245	49	157	157	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR	1993	10	3					523	531		10.1016/0896-6273(93)90339-S	http://dx.doi.org/10.1016/0896-6273(93)90339-S			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KU901	8461139				2022-12-24	WOS:A1993KU90100016
J	SEEGER, M; TEAR, G; FERRESMARCO, D; GOODMAN, CS				SEEGER, M; TEAR, G; FERRESMARCO, D; GOODMAN, CS			MUTATIONS AFFECTING GROWTH CONE GUIDANCE IN DROSOPHILA - GENES NECESSARY FOR GUIDANCE TOWARD OR AWAY FROM THE MIDLINE	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; AXON PATHWAYS; EMBRYONIC-DEVELOPMENT; NUCLEAR-PROTEIN; LARVAL CUTICLE; RETINAL AXONS; ZYGOTIC LOCI; FASCICLIN-I; FLOOR PLATE; PATTERN	We performed a large-scale screen for mutations that affect the development of CNS axon pathways in the Drosophila embryo. We screened embryos from over 13,500 balanced lines and saved over 250 mutant lines whose phenotypes suggest possible defects in growth cone guidance. Here we focus on two new genes: commissureless (comm) and roundabout (robo). Mutations in comm lead to an absence of nearly all CNS axon commissures, such that growth cones that normally project across the midline instead now extend only on their own side. Mutations in robo lead to the opposite misrouting, such that some growth cones that normally extend only on their own side instead now project across the midline. The phenotypes of these two genes suggest that they may encode components of attractive and repulsive signaling systems at the midline that either guide growth cones across the midline or keep them on their own side.			SEEGER, M (corresponding author), UNIV CALIF BERKELEY,HOWARD HUGHES MED INST,DEPT MOLEC & CELL BIOL,BERKELEY,CA 94720, USA.		Tear, Guy/C-5444-2009; Ferres-Marco, Maria/G-8364-2015	Ferres-Marco, Maria/0000-0002-0596-4891	NINDS NIH HHS [NS18366] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS018366] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ASHBURNER M, 1989, DROSOPHILA LABORATOR; BASTIANI MJ, 1987, CELL, V48, P745, DOI 10.1016/0092-8674(87)90072-9; BERNHARDT RR, 1992, NEURON, V8, P869, DOI 10.1016/0896-6273(92)90201-N; BERNHARDT RR, 1990, J COMP NEUROL, V302, P607; BIER E, 1989, GENE DEV, V3, P1273, DOI 10.1101/gad.3.9.1273; Bixby J L, 1992, Curr Opin Neurobiol, V2, P66, DOI 10.1016/0959-4388(92)90164-G; BRENNER S, 1974, GENETICS, V77, P71; CREWS ST, 1988, CELL, V52, P143, DOI 10.1016/0092-8674(88)90538-7; DAVIES JA, 1990, NEURON, V4, P11, DOI 10.1016/0896-6273(90)90439-M; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; DOE CQ, 1991, CELL, V65, P451, DOI 10.1016/0092-8674(91)90463-9; DOE CQ, 1988, SCIENCE, V239, P170, DOI 10.1126/science.2892267; ELKINS T, 1990, CELL, V60, P565, DOI 10.1016/0092-8674(90)90660-7; FUJITA SC, 1982, P NATL ACAD SCI-BIOL, V79, P7929, DOI 10.1073/pnas.79.24.7929; GODEMENT P, 1990, NEURON, V5, P173, DOI 10.1016/0896-6273(90)90307-2; GOODMAN CS, 1993, DEV DROSOPHILA; GREENINGLOH G, 1991, CELL, V67, P45; HATTA K, 1992, NEURON, V9, P629, DOI 10.1016/0896-6273(92)90027-B; HATTA K, 1991, NATURE, V350, P339, DOI 10.1038/350339a0; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; HORTSCH M, 1990, NEURON, V4, P697, DOI 10.1016/0896-6273(90)90196-M; JACOBS JR, 1989, NEURON, V2, P1625; JACOBS JR, 1989, J NEUROSCI, V9, P2412; JACOBS JR, 1989, J NEUROSCI, V9, P2402; JURGENS G, 1984, ROUX ARCH DEV BIOL, V193, P283, DOI 10.1007/BF00848157; KAPFHAMMER JP, 1987, J NEUROSCI, V7, P1595; Keynes R J, 1992, Curr Opin Neurobiol, V2, P55, DOI 10.1016/0959-4388(92)90162-E; KLAMBT C, 1991, CELL, V64, P801, DOI 10.1016/0092-8674(91)90509-W; KLAMBT C, 1991, GLIA, V4, P205, DOI 10.1002/glia.440040212; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; MAYER U, 1988, GENE DEV, V2, P1496, DOI 10.1101/gad.2.11.1496; MCINTIRE SL, 1992, NEURON, V8, P307, DOI 10.1016/0896-6273(92)90297-Q; MOORMAN SJ, 1990, J NEUROSCI, V10, P3158; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; NUSSLEINVOLHARD C, 1984, ROUX ARCH DEV BIOL, V193, P267, DOI 10.1007/BF00848156; PATEL NH, 1992, NATURE, V357, P339, DOI 10.1038/357339a0; PATEL NH, 1989, GENE DEV, V3, P890, DOI 10.1101/gad.3.6.890; PATEL NH, 1987, CELL, V48, P975, DOI 10.1016/0092-8674(87)90706-9; PATEL NH, 1989, CELL, V58, P955, DOI 10.1016/0092-8674(89)90947-1; PLACZEK M, 1990, DEVELOPMENT, V110, P19; RAPER JA, 1990, EXP NEUROL, V109, P70, DOI 10.1016/S0014-4886(05)80009-3; RAPER JA, 1990, NEURON, V4, P21, DOI 10.1016/0896-6273(90)90440-Q; ROBERTSON HM, 1988, GENETICS, V118, P461; ROTHBERG JM, 1990, GENE DEV, V4, P2169, DOI 10.1101/gad.4.12a.2169; ROTHBERG JM, 1988, CELL, V55, P1047, DOI 10.1016/0092-8674(88)90249-8; SCHWAB ME, 1988, J NEUROSCI, V8, P2381; STRETAVAN DW, 1990, J NEUROSCI, V10, P1995; Tessier-Lavigne M, 1992, Curr Opin Neurobiol, V2, P60, DOI 10.1016/0959-4388(92)90163-F; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; THOMAS JB, 1988, CELL, V52, P133, DOI 10.1016/0092-8674(88)90537-5; VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8; WALTER J, 1987, DEVELOPMENT, V101, P909; WIESCHAUS E, 1984, W ROUX ARCH DEV BIOL, V193, P283; YAGINUMA H, 1991, J NEUROSCI, V11, P2598	54	586	600	0	23	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1993	10	3					409	426		10.1016/0896-6273(93)90330-T	http://dx.doi.org/10.1016/0896-6273(93)90330-T			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KU901	8461134				2022-12-24	WOS:A1993KU90100007
J	YANG, J; TSIEN, RW				YANG, J; TSIEN, RW			ENHANCEMENT OF N-TYPE AND L-TYPE CALCIUM-CHANNEL CURRENTS BY PROTEIN-KINASE-C IN FROG SYMPATHETIC NEURONS	NEURON			English	Article							HIPPOCAMPAL-NEURONS; PHORBOL ESTERS; TRANSMITTER RELEASE; PERIPHERAL NEURONS; OMEGA-CONOTOXIN; CA-2+ CHANNELS; RAT; ACTIVATION; MODULATION; PHOSPHORYLATION	The effect of protein kinase C (PKC) stimulation on Ca2+ channels was studied in frog sympathetic neurons. 12,13-Phorbol dibutyrate (PDBu) consistently augmented Ca2+ channel currents in whole-cell recordings. This enhancement was blocked by staurosporine and PKC(19-31), but not produced by 4alpha-phorbol 12,13-didecanoate, indicating that PDBu acts via PKC. Both N- and L-type currents, as isolated pharmacologically, were increased. PKC enhancement was independent of the extent of G protein activation, indicating that it was not caused by removal of tonic G protein inhibition. In unitary recordings PDBu produced dramatic increases in single N- and L-type channel activity by sharply decreasing closed time intervals between adjacent openings, but did not alter the unitary current size or mean open time. This up-modulation by PKC may constitute a positive feedback mechanism in the regulation of neuronal Ca2+ channel activity.			YANG, J (corresponding author), STANFORD UNIV, DEPT MOLEC & CELLULAR PHYSIOL, STANFORD, CA 94305 USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH048108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024067] Funding Source: NIH RePORTER; NIMH NIH HHS [MH48108] Funding Source: Medline; NINDS NIH HHS [NS24067] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AHLIJANIAN MK, 1991, J BIOL CHEM, V266, P20192; ANWYL R, 1991, BRAIN RES REV, V16, P265, DOI 10.1016/0165-0173(91)90010-6; ARTALEJO CR, 1990, NATURE, V348, P239, DOI 10.1038/348239a0; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; BEECH DJ, 1992, J NEUROSCI, V10, P1922; BERNHEIM L, 1991, NEURON, V6, P859, DOI 10.1016/0896-6273(91)90226-P; BLEY KR, 1990, NEURON, V4, P379, DOI 10.1016/0896-6273(90)90050-P; BOLAND LM, 1991, J NEUROSCI, V11, P1140; BOLAND LM, 1993, IN PRESS J NEUROSCI; BROWN AM, 1990, ANNU REV PHYSIOL, V52, P197, DOI 10.1146/annurev.ph.52.030190.001213; BUSCH AE, 1992, SCIENCE, V255, P1705, DOI 10.1126/science.1553557; CHANG CF, 1991, J BIOL CHEM, V266, P16395; DELCOUR A, 1993, IN PRESS SCIENCE; DELCOUR AH, 1993, J NEUROSCI, V13, P181; DOERNER D, 1990, J NEUROSCI, V10, P1699; DUBEL SJ, 1992, P NATL ACAD SCI USA, V89, P5058, DOI 10.1073/pnas.89.11.5058; ELMSLIE KS, 1990, NEURON, V5, P75, DOI 10.1016/0896-6273(90)90035-E; FISHER R, 1990, J NEUROPHYSIOL, V64, P1291, DOI 10.1152/jn.1990.64.4.1291; FRIEL DD, 1992, NEURON, V8, P1109, DOI 10.1016/0896-6273(92)90132-W; GRAY R, 1987, NATURE, V327, P620, DOI 10.1038/327620a0; GURNEY AM, 1989, NATURE, V341, P65, DOI 10.1038/341065a0; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HIRNING LD, 1988, SCIENCE, V239, P57, DOI 10.1126/science.2447647; HOCKBERGER P, 1989, NATURE, V338, P340, DOI 10.1038/338340a0; HULLIN R, 1992, EMBO J, V11, P885, DOI 10.1002/j.1460-2075.1992.tb05126.x; IKEDA SR, 1991, J PHYSIOL-LONDON, V439, P181, DOI 10.1113/jphysiol.1991.sp018663; JAHN H, 1988, EUR J BIOCHEM, V178, P535, DOI 10.1111/j.1432-1033.1988.tb14480.x; JONES SW, 1989, J GEN PHYSIOL, V94, P151, DOI 10.1085/jgp.94.1.151; JONES SW, 1990, J NEUROSCI, V10, P2261; JONES SW, 1989, J GEN PHYSIOL, V94, P169, DOI 10.1085/jgp.94.1.169; KACZMAREK LK, 1987, NEUROMODULATION BIOC, P286; KASAI H, 1991, P NATL ACAD SCI USA, V88, P8855, DOI 10.1073/pnas.88.19.8855; LACERDA AE, 1988, NATURE, V335, P249, DOI 10.1038/335249a0; LIPSCOMBE D, 1989, NATURE, V340, P639, DOI 10.1038/340639a0; MALENKA RC, 1987, BRAIN RES, V403, P198, DOI 10.1016/0006-8993(87)90145-4; MARBAN E, 1982, J PHYSIOL-LONDON, V329, P589, DOI 10.1113/jphysiol.1982.sp014321; MATHIE A, 1992, NEURON, V8, P907, DOI 10.1016/0896-6273(92)90205-R; MCCARRON JG, 1992, NATURE, V357, P74, DOI 10.1038/357074a0; ODELL TJ, 1991, J PHYSIOL-LONDON, V436, P739, DOI 10.1113/jphysiol.1991.sp018577; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; RANE SG, 1989, NEURON, V3, P239, DOI 10.1016/0896-6273(89)90037-8; REGAN LJ, 1991, NEURON, V6, P269, DOI 10.1016/0896-6273(91)90362-4; RYU PD, 1990, J NEUROPHYSIOL, V63, P273, DOI 10.1152/jn.1990.63.2.273; SCHROEDER JE, 1990, J NEUROSCI, V10, P947; SEKIGUCHI K, 1988, J BIOCHEM-TOKYO, V103, P759, DOI 10.1093/oxfordjournals.jbchem.a122343; SHAPIRA R, 1987, NATURE, V325, P58, DOI 10.1038/325058a0; SHEARMAN MS, 1989, PHARMACOL REV, V41, P211; STRONG JA, 1987, NATURE, V325, P714, DOI 10.1038/325714a0; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; VIVAUDOU MB, 1988, FASEB J, V2, P2497, DOI 10.1096/fasebj.2.9.2453389; WAKADE AR, 1985, N-S ARCH PHARMACOL, V331, P122, DOI 10.1007/BF00498863; WEST JW, 1991, SCIENCE, V254, P866, DOI 10.1126/science.1658937; WILLIAMS ME, 1992, SCIENCE, V257, P389, DOI 10.1126/science.1321501; YUE DT, 1990, P NATL ACAD SCI USA, V87, P753, DOI 10.1073/pnas.87.2.753	54	165	171	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1993	10	2					127	136		10.1016/0896-6273(93)90305-B	http://dx.doi.org/10.1016/0896-6273(93)90305-B			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KP685	8382496				2022-12-24	WOS:A1993KP68500002
J	ElShamy, WM; Ernfors, P				ElShamy, WM; Ernfors, P			A local action of neurotrophin-3 prevents the death of proliferating sensory neuron precursor cells	NEURON			English	Article							NERVE GROWTH-FACTOR; EXPRESSING MESSENGER-RNA; TYROSINE KINASE RECEPTOR; AFFINITY NGF RECEPTOR; DORSAL-ROOT GANGLION; FACTOR FAMILY; MOLECULAR-CLONING; TRK PROTOONCOGENE; SYMPATHETIC NEURONS; SPINAL GANGLIA	The role of neurotrophin-3 (NT-3) in early development of the dorsal root ganglion was investigated. Excessive cell death in the dorsal root ganglion of mice that carry a deleted NT-3 gene (NT-3(-/-) mice) preceded the period of programmed cell death, detected by the TUNEL method, and caused a reduction in the number of proliferating precursors without altering the proportion of proliferating cells to total number of neurons. Furthermore, the majority of proliferating cells detected by bromodeoxyuridine incorporation also stained with the TUNEL method. NT-3 mRNA was expressed locally in the embryonic, but not the postnatal dorsal root ganglion. Most cultured early embryonic NT-3(-/-) neurons died in the absence of exogenous NT-3 as did the wild-type neurons when cultured with NT-3 neutralizing antibodies, suggesting that NT-3 acts locally to prevent the death of proliferating sensory precursor cells during neurogenesis. Thus, NT-3 may inflict constraints on the number of proliferating precursor cells and thereby affect the number of neurons generated during development of the peripheral nervous system.			ElShamy, WM (corresponding author), KAROLINSKA INST,DEPT MED BIOCHEM & BIOPHYS,MOLEC NEUROBIOL LAB,DOKTORSRINGEN 12A,S-17177 STOCKHOLM,SWEDEN.		ElShamy, Wael M./L-1090-2018; ElShamy, Wael/AAF-2867-2019	Ernfors, Patrik/0000-0002-1140-3986				ACHESON A, 1995, NATURE, V374, P450, DOI 10.1038/374450a0; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; BERKEMEIER LR, 1991, NEURON, V7, P857, DOI 10.1016/0896-6273(91)90287-A; BIRREN SJ, 1993, DEVELOPMENT, V119, P597; CARR PA, 1993, BRAIN RES BULL, V30, P209, DOI 10.1016/0361-9230(93)90246-8; COPRAY JCVM, 1994, NEUROSCIENCE, V63, P1125, DOI 10.1016/0306-4522(94)90578-9; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; DAVIES AM, 1986, J NEUROSCI, V6, P1897; DECHANT G, 1993, J NEUROSCI, V13, P2610, DOI 10.1523/JNEUROSCI.13-06-02610.1993; DICICCOBLOOM E, 1993, NEURON, V11, P1101, DOI 10.1016/0896-6273(93)90223-E; Elshamy WM, 1996, DEVELOPMENT, V122, P491; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; ERNFORS P, 1992, EUR J NEUROSCI, V4, P1140, DOI 10.1111/j.1460-9568.1992.tb00141.x; ERNFORS P, 1995, NEURON, V14, P1153, DOI 10.1016/0896-6273(95)90263-5; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; ERNFORS P, 1990, P NATL ACAD SCI USA, V87, P5454, DOI 10.1073/pnas.87.14.5454; ERNFORS P, 1990, NEURON, V5, P511, DOI 10.1016/0896-6273(90)90090-3; ERNFORS P, 1991, EUR J NEUROSCI, V3, P953, DOI 10.1111/j.1460-9568.1991.tb00031.x; EVAN GI, 1995, CURR OPIN CELL BIOL, V7, P825, DOI 10.1016/0955-0674(95)80066-2; FARINAS I, 1994, NATURE, V369, P658, DOI 10.1038/369658a0; Farinelli SE, 1996, J NEUROSCI, V16, P1150, DOI 10.1523/jneurosci.16-03-01150.1996; GAESE F, 1994, DEVELOPMENT, V120, P1613; GHOSH A, 1995, NEURON, V15, P89, DOI 10.1016/0896-6273(95)90067-5; GLASS DJ, 1991, CELL, V66, P405, DOI 10.1016/0092-8674(91)90629-D; GOLDSTEIN RS, 1990, P NATL ACAD SCI USA, V87, P4476, DOI 10.1073/pnas.87.12.4476; HALLBOOK F, 1991, NEURON, V6, P845, DOI 10.1016/0896-6273(91)90180-8; HAMBURGER V, 1981, J NEUROSCI, V1, P60, DOI 10.1523/JNEUROSCI.01-01-00060.1981; HAMBURGER V, 1949, J EXP ZOOL, V111, P457, DOI 10.1002/jez.1401110308; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HOFER MM, 1988, NATURE, V331, P261, DOI 10.1038/331261a0; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; HORYLEE F, 1993, P NATL ACAD SCI USA, V90, P2613, DOI 10.1073/pnas.90.7.2613; IBANEZ CF, 1993, DEVELOPMENT, V117, P1345; IP NY, 1992, P NATL ACAD SCI USA, V89, P3060, DOI 10.1073/pnas.89.7.3060; JOHNSON EM, 1980, SCIENCE, V210, P916, DOI 10.1126/science.7192014; JONES KR, 1994, CELL, V76, P989, DOI 10.1016/0092-8674(94)90377-8; JONES KR, 1990, P NATL ACAD SCI USA, V87, P8060, DOI 10.1073/pnas.87.20.8060; KAISHO Y, 1990, FEBS LETT, V266, P187, DOI 10.1016/0014-5793(90)81536-W; KALCHEIM C, 1992, P NATL ACAD SCI USA, V89, P1661, DOI 10.1073/pnas.89.5.1661; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KLEIN R, 1990, DEVELOPMENT, V109, P845; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; LEVIMONTALCINI R, 1987, EMBO J, V6, P1145, DOI 10.1002/j.1460-2075.1987.tb02347.x; LEWIN GR, 1993, TRENDS NEUROSCI, V16, P353, DOI 10.1016/0166-2236(93)90092-Z; LINDSAY RM, 1985, DEV BIOL, V112, P319, DOI 10.1016/0012-1606(85)90402-6; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MARTINZANCA D, 1990, GENE DEV, V4, P683, DOI 10.1101/gad.4.5.683; MCMAHON SB, 1994, NEURON, V12, P1161, DOI 10.1016/0896-6273(94)90323-9; MCMILLANCARR V, 1978, J COMP NEUROL, V182, P727; MEMBERG SP, 1995, MOL CELL NEUROSCI, V6, P323, DOI 10.1006/mcne.1995.1025; MU XJ, 1993, J NEUROSCI, V13, P4029; OAKLEY RA, 1995, DEVELOPMENT, V121, P1341; OPPENHEIM RW, 1989, DEV BIOL, V133, P468, DOI 10.1016/0012-1606(89)90050-X; PHILLIPS HS, 1990, SCIENCE, V250, P290, DOI 10.1126/science.1688328; PIRVOLA U, 1992, P NATL ACAD SCI USA, V89, P9915, DOI 10.1073/pnas.89.20.9915; ROHRER H, 1987, J NEUROSCI, V7, P3739; ROSENTHAL A, 1990, NEURON, V4, P767, DOI 10.1016/0896-6273(90)90203-R; SCHECTERSON LC, 1992, NEURON, V9, P449, DOI 10.1016/0896-6273(92)90183-E; SCHOMCZYSKI P, 1987, ANAL BIOCHEM, V162, P156; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; TESSAROLLO L, 1994, P NATL ACAD SCI USA, V91, P11844, DOI 10.1073/pnas.91.25.11844; THOENEN H, 1980, PHYSIOL REV, V60, P1284, DOI 10.1152/physrev.1980.60.4.1284; VICARIOABEJON C, 1995, NEURON, V15, P105, DOI 10.1016/0896-6273(95)90068-3; VOGEL KS, 1991, NEURON, V7, P819, DOI 10.1016/0896-6273(91)90284-7; WRIGHT EM, 1992, NEURON, V9, P139, DOI 10.1016/0896-6273(92)90229-7; ZHOU XF, 1994, BRAIN RES, V643, P162, DOI 10.1016/0006-8993(94)90022-1	69	80	80	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1996	16	5					963	972		10.1016/S0896-6273(00)80119-1	http://dx.doi.org/10.1016/S0896-6273(00)80119-1			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UN480	8630254	Bronze			2022-12-24	WOS:A1996UN48000011
J	Sereda, M; Griffiths, I; Puhlhofer, A; Stewart, H; Rossner, MJ; Zimmermann, F; Magyar, JP; Schneider, A; Hund, E; Meinck, HM; Suter, U; Nave, KA				Sereda, M; Griffiths, I; Puhlhofer, A; Stewart, H; Rossner, MJ; Zimmermann, F; Magyar, JP; Schneider, A; Hund, E; Meinck, HM; Suter, U; Nave, KA			A transgenic rat model of Charcot-Marie-Tooth disease	NEURON			English	Article							ARREST-SPECIFIC GENE; PERIPHERAL MYELIN; POINT MUTATION; GROWTH ARREST; NERVE-CONDUCTION; SCHWANN-CELLS; PMP22 GENE; TYPE-1A; PROTEIN; DUPLICATION	Charcot-Marie-Tooth disease (CMT) is the most common inherited neuropathy in humans and has been associated with a partial duplication of chromosome 17 (CMT type 1A). We have generated a transgenic rat model of this disease and provide experimental evidence that CMT1A is caused by increased expression of the gene for peripheral myelin protein-22 (PMP22, gas-3). PMP22-transgenic rats develop gait abnormalities caused by a peripheral hypomyelination, Schwann cell hypertrophy (onion bulb formation), and muscle weakness. Reduced nerve conduction velocities closely resemble recordings in human patients with CMT1A. When bred to homozygosity, transgenic animals completely fail to elaborate myelin. We anticipate that the CMT rat model will facilitate the identification of a cellular disease mechanism and serve in the evaluation of potential treatment strategies.	UNIV HEIDELBERG,ZENTRUM MOLEK BIOL,D-69120 HEIDELBERG,GERMANY; UNIV HEIDELBERG,DEPT NEUROL,D-69120 HEIDELBERG,GERMANY; UNIV GLASGOW,DEPT VET CLIN STUDIES,GLASGOW G61 1QH,LANARK,SCOTLAND; ETH ZURICH,ETH HOENGGERBERG,DEPT CELL BIOL,CH-8093 ZURICH,SWITZERLAND	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Glasgow; Swiss Federal Institutes of Technology Domain; ETH Zurich			Nave, Klaus-Armin/C-8883-2011; Suter, Ueli/A-1624-2010	Rossner, Moritz/0000-0002-0667-3420				ADLKOFER K, 1995, NAT GENET, V11, P274, DOI 10.1038/ng1195-274; BAECHNER D, 1995, J NEUROSCI RES, V42, P735; BERGOFFEN J, 1993, SCIENCE, V262, P2039, DOI 10.1126/science.8266101; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; CHANCE PF, 1993, CELL, V72, P143, DOI 10.1016/0092-8674(93)90058-X; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Dyck PJ, 1993, PERIPHERAL NEUROPATH, V2; FABBRETTI E, 1995, GENE DEV, V9, P1846, DOI 10.1101/gad.9.15.1846; GANTEN D, 1991, HYPERTENSION, V17, P843, DOI 10.1161/01.HYP.17.6.843; GARCIA CA, 1996, IN PRESS NEUROLOGY; HANEMANN CO, 1994, J NEUROSCI RES, V37, P654, DOI 10.1002/jnr.490370513; HAYASAKA K, 1993, NAT GENET, V5, P31, DOI 10.1038/ng0993-31; HUDSON LD, 1990, SEMIN NEUROSCI, V2, P483; IONASESCU VV, 1995, NEUROLOGY, V45, P1766, DOI 10.1212/WNL.45.9.1766; IONASESCU VV, 1995, MUSCLE NERVE, V18, P257; KAGAWA T, 1994, NEURON, V13, P427, DOI 10.1016/0896-6273(94)90358-1; KAKU DA, 1993, NEUROLOGY, V43, P1806, DOI 10.1212/WNL.43.9.1806; KAMHOLZ J, 1994, ANN NEUROL, V36, P451, DOI 10.1002/ana.410360326; KITAMURA K, 1976, BIOCHIM BIOPHYS ACTA, V455, P806, DOI 10.1016/0005-2736(76)90050-X; LEMKE G, 1988, NEURON, V1, P535, DOI 10.1016/0896-6273(88)90103-1; LEMKE G, 1985, CELL, V40, P501, DOI 10.1016/0092-8674(85)90198-9; LUPSKI JR, 1993, JAMA-J AM MED ASSOC, V270, P2326, DOI 10.1001/jama.270.19.2326; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; MANFIOLETTI G, 1990, MOL CELL BIOL, V10, P2924, DOI 10.1128/MCB.10.6.2924; MATSUNAMI N, 1992, NAT GENET, V1, P176, DOI 10.1038/ng0692-176; MORGAN L, 1991, J CELL BIOL, V112, P457, DOI 10.1083/jcb.112.3.457; Nave KA, 1996, NEUROSCIENTIST, V2, P33, DOI 10.1177/107385849600200111; Nave Klaus-Armin, 1995, P571; NICHOLSON GA, 1991, NEUROLOGY, V41, P547, DOI 10.1212/WNL.41.4.547; PARMANTIER E, 1995, EUR J NEUROSCI, V7, P1080, DOI 10.1111/j.1460-9568.1995.tb01095.x; PATEL PI, 1994, TRENDS GENET, V10, P128, DOI 10.1016/0168-9525(94)90214-3; PATEL PI, 1992, NAT GENET, V1, P159, DOI 10.1038/ng0692-159; Raeymaekers P, 1991, Neuromuscul Disord, V1, P93, DOI 10.1016/0960-8966(91)90055-W; READHEAD C, 1994, NEURON, V12, P583, DOI 10.1016/0896-6273(94)90214-3; ROA BB, 1993, NAT GENET, V5, P189, DOI 10.1038/ng1093-189; ROA BB, 1993, NEW ENGL J MED, V329, P96, DOI 10.1056/NEJM199307083290205; ROA BB, 1993, NAT GENET, V5, P269, DOI 10.1038/ng1193-269; SCHNEIDER C, 1988, CELL, V54, P787, DOI 10.1016/S0092-8674(88)91065-3; SKRE H, 1974, CLIN GENET, V6, P98; SNIPES GJ, 1995, BRAIN PATHOL, V5, P233, DOI 10.1111/j.1750-3639.1995.tb00600.x; SNIPES GJ, 1995, J ANAT, V186, P483; SNIPES GJ, 1992, J CELL BIOL, V117, P225, DOI 10.1083/jcb.117.1.225; SPREYER P, 1991, EMBO J, V10, P3661, DOI 10.1002/j.1460-2075.1991.tb04933.x; SUTER U, 1992, NATURE, V356, P241, DOI 10.1038/356241a0; SUTER U, 1994, J BIOL CHEM, V269, P1; TIMMERMAN V, 1992, NAT GENET, V1, P171, DOI 10.1038/ng0692-171; TSO JY, 1985, NUCLEIC ACIDS RES, V13, P2485, DOI 10.1093/nar/13.7.2485; VALENTIJN LJ, 1992, NAT GENET, V2, P288, DOI 10.1038/ng1292-288; VALENTIJN LJ, 1992, NAT GENET, V1, P166, DOI 10.1038/ng0692-166; WELCHER AA, 1991, P NATL ACAD SCI USA, V88, P7195, DOI 10.1073/pnas.88.16.7195; WISE CA, 1993, AM J HUM GENET, V53, P853; YOSHIKAWA H, 1994, ANN NEUROL, V35, P445, DOI 10.1002/ana.410350412; ZOIDL G, 1995, EMBO J, V14, P1122, DOI 10.1002/j.1460-2075.1995.tb07095.x	53	280	295	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1996	16	5					1049	1060		10.1016/S0896-6273(00)80128-2	http://dx.doi.org/10.1016/S0896-6273(00)80128-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UN480	8630243	Bronze			2022-12-24	WOS:A1996UN48000020
J	MacKenzie, PJ; Umemiya, M; Murphy, TH				MacKenzie, PJ; Umemiya, M; Murphy, TH			Ca2+ imaging of CNS axons in culture indicates reliable coupling between single action potentials and distal functional release sites	NEURON			English	Article							FROG NEUROMUSCULAR-JUNCTION; LONG-TERM POTENTIATION; SQUID GIANT SYNAPSE; TRANSMITTER RELEASE; CALCIUM CHANNELS; PRESYNAPTIC CALCIUM; HIPPOCAMPAL SLICES; ENHANCEMENT; PROBABILITY; MECHANISM	A combination of Ca2+ imaging and current-clamp recording in cultured cortical neurons was used to evaluate the reliability of coupling between the action potential and rises in Ca2+ at distal release sites as a possible source of variability in CNS synaptic transmission. Local domains of enhanced Ca2+ influx were observed at varicosities on axon collaterals. Functional assay of vesicle turnover using FM1-43 and parallel electron microscopy confirmed that these varicosities were release sites. Single action potentials reliably (>95% of the time) resulted in a presynaptic Ca2+ transient at all presumed release sites including those on distal collaterals. Variability in the amplitude of presynaptic Ca2+ transients at individual boutons was estimated to be on average less than 20%. We conclude that the coupling of somatic action potentials to distal release sites is generally a reliable process, although nonlinearity in the relationship between Ca2+ influx and neurotransmitter release may amplify the effects of relatively small fluctuations in Ca2+ influx.	UNIV BRITISH COLUMBIA,DEPT PSYCHIAT,KINSMEN LAB,VANCOUVER,BC V6T 1Z3,CANADA	University of British Columbia			Murphy, Timothy/AAW-1975-2021; Murphy, Timothy H/I-4982-2014	Murphy, Timothy/0000-0002-0093-4490; Murphy, Timothy H/0000-0002-0093-4490				ADLER EM, 1991, J NEUROSCI, V11, P1496; ALLEN C, 1994, P NATL ACAD SCI USA, V91, P10380, DOI 10.1073/pnas.91.22.10380; AUGUSTINE GJ, 1986, J PHYSIOL-LONDON, V381, P619, DOI 10.1113/jphysiol.1986.sp016347; AUGUSTINE GJ, 1990, CALCIUM ENTRY ACTION, P365; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; BETZ WJ, 1993, J PHYSIOL-LONDON, V460, P287, DOI 10.1113/jphysiol.1993.sp019472; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; Cajal R, 1911, HISTOLOGY NERVOUS SY; CASTILLO PE, 1994, NEURON, V12, P261, DOI 10.1016/0896-6273(94)90269-0; COOPER RL, 1995, J NEUROSCI, V15, P4209; DELANEY K, 1991, J NEUROSCI, V11, P2631; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; FIELDS RD, 1991, J NEUROSCI, V11, P134; FRERKING M, 1995, NEURON, V15, P885, DOI 10.1016/0896-6273(95)90179-5; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARRIS KM, 1995, TRENDS NEUROSCI, V18, P365, DOI 10.1016/0166-2236(95)93930-V; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; HILLE B, 1992, IONIC CHANNELS EXCIT, P321; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; LIU GS, 1995, NATURE, V375, P404, DOI 10.1038/375404a0; LUSCHER C, 1994, J NEUROPHYSIOL, V72, P634, DOI 10.1152/jn.1994.72.2.634; MAGEE JC, 1995, SCIENCE, V268, P301, DOI 10.1126/science.7716525; MALGAROLI A, 1995, SCIENCE, V268, P1624, DOI 10.1126/science.7777862; MALINOW R, 1994, SCIENCE, V266, P1195, DOI 10.1126/science.7973700; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; MALINOW R, 1994, P NATL ACAD SCI USA, V91, P8170, DOI 10.1073/pnas.91.17.8170; MINTA A, 1989, J BIOL CHEM, V264, P8171; MINTZ IM, 1995, NEURON, V15, P675, DOI 10.1016/0896-6273(95)90155-8; MURPHY TH, 1995, NEURON, V15, P159, DOI 10.1016/0896-6273(95)90073-X; MURPHY TH, 1994, SCIENCE, V263, P529, DOI 10.1126/science.7904774; MURPHY TH, 1990, DEV BRAIN RES, V57, P146, DOI 10.1016/0165-3806(90)90195-5; Peters A, 1976, FINE STRUCTURE NERVO, P90; PUMPLIN DW, 1981, P NATL ACAD SCI-BIOL, V78, P7210, DOI 10.1073/pnas.78.11.7210; RAASTAD M, 1992, EUR J NEUROSCI, V4, P113, DOI 10.1111/j.1460-9568.1992.tb00114.x; RAGU B, 1989, AM J PHYSIOL, V256, pC540; REGEHR WG, 1995, BIOPHYS J, V68, P2156, DOI 10.1016/S0006-3495(95)80398-X; REGEHR WG, 1994, J NEUROSCI, V14, P523; REUTER H, 1995, NEURON, V14, P773, DOI 10.1016/0896-6273(95)90221-X; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; ROBITAILLE R, 1990, NEURON, V5, P773, DOI 10.1016/0896-6273(90)90336-E; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; SHENG ZH, 1994, NEURON, V13, P1303, DOI 10.1016/0896-6273(94)90417-0; SMITH SJ, 1988, TRENDS NEUROSCI, V11, P458, DOI 10.1016/0166-2236(88)90199-3; SMITH SJ, 1993, J PHYSIOL-LONDON, V472, P573, DOI 10.1113/jphysiol.1993.sp019963; SORRA KE, 1993, J NEUROSCI, V13, P3736; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; TAKAHASHI T, 1993, NATURE, V366, P156, DOI 10.1038/366156a0; TOTH PT, 1993, NATURE, V364, P635, DOI 10.1038/364635a0; VOLGUSHEV M, 1995, EUR J NEUROSCI, V7, P1751, DOI 10.1111/j.1460-9568.1995.tb00695.x; WALL PD, 1995, TRENDS NEUROSCI, V18, P99, DOI 10.1016/0166-2236(95)93883-Y; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; WU LG, 1994, J NEUROSCI, V14, P645; WU LG, 1994, J NEUROSCI, V14, P5613; WU LG, 1994, NEURON, V12, P1139, DOI 10.1016/0896-6273(94)90321-2; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Zar JH., 1999, BIOSTAT ANAL; ZUCKER RS, 1993, J PHYSIOL-PARIS, V87, P25, DOI 10.1016/0928-4257(93)90021-K	67	85	85	2	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1996	16	4					783	795		10.1016/S0896-6273(00)80098-7	http://dx.doi.org/10.1016/S0896-6273(00)80098-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UG611	8607996	Bronze			2022-12-24	WOS:A1996UG61100011
J	GONG, QH; SHIPLEY, MT				GONG, QH; SHIPLEY, MT			EVIDENCE THAT PIONEER OLFACTORY AXONS REGULATE TELENCEPHALON CELL-CYCLE KINETICS TO INDUCE THE FORMATION OF THE OLFACTORY-BULB	NEURON			English	Article							AXONALLY TRANSPORTED PROTEINS; XENOPUS-LAEVIS; GROWTH; SYSTEM; MOUSE; NEURONS; NEUROGENESIS; GAP-43; IMMUNOHISTOCHEMISTRY; 5-BROMODEOXYURIDINE	Early olfactory axons follow a specific pathway to reach the developing telencephalon. We observed that a subpopulation of these axons, the pioneer olfactory axons, penetrate into the ventricular zone of a highly restricted region of the telencephalon at E13 and E14. At E15, this same telencephalic region evaginates to form the olfactory bulb. To investigate the possibility that the pioneer olfactory axons induce the olfactory bulb by influencing precursor cell populations, we compared cell cycle kinetics and differentiation in the olfactory bulb primordium and the adjacent neocortex using cumulative bromdeoxyuridine labeling. The results showed that, 24 hr after the arrival of the first pioneer axons, the duration of the cell cycle is prolonged significantly in the olfactory bulb primordium. In addition, twice as many cells have exited the mitotic cycle in the olfactory bulb primordium versus the adjacent cortex. These findings suggest that pioneer olfactory axons play a role in the induction of the olfactory bulb by selectively modulating cell cycle kinetics in the olfactory bulb primordium. Afferent axons may influence target morphogenesis by modulating target precursor cell proliferation in other developing neural structures.	UNIV MARYLAND, SCH MED, DEPT ANAT, BALTIMORE, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	GONG, QH (corresponding author), UNIV CINCINNATI, COLL MED, DEPT ANAT CELL BIOL & NEUROBIOL, CINCINNATI, OH 45267 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029218] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC00347] Funding Source: Medline; NINDS NIH HHS [NS29218] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALBERCH P, 1981, J MORPHOL, V167, P249, DOI 10.1002/jmor.1051670208; ANDERSON H, 1980, ANNU REV NEUROSCI, V3, P97, DOI 10.1146/annurev.ne.03.030180.000525; BANNIGAN JG, 1985, TERATOLOGY, V32, P229, DOI 10.1002/tera.1420320211; BANNIGAN JG, 1987, DEV BRAIN RES, V36, P161, DOI 10.1016/0165-3806(87)90020-4; BAPTISTA CA, 1990, NATURE, V346, P855, DOI 10.1038/346855a0; BATE CM, 1976, NATURE, V260, P54, DOI 10.1038/260054a0; Burr HS, 1930, J EXP ZOOL, V55, P171, DOI 10.1002/jez.1400550111; Burr HS, 1924, J COMP NEUROL, V37, P455, DOI 10.1002/cne.900370306; BYRD CA, 1993, J COMP NEUROL, V331, P551, DOI 10.1002/cne.903310410; BYRD CA, 1991, J COMP NEUROL, V314, P79, DOI 10.1002/cne.903140108; EDWARDS JS, 1977, IDENTIFIED NEURONS B, P483; GONG QZ, 1994, J COMP NEUROL, V344, P336, DOI 10.1002/cne.903440303; HINDS JW, 1972, J COMP NEUROL, V146, P253, DOI 10.1002/cne.901460208; HINDS JW, 1968, J COMP NEUROL, V134, P287, DOI 10.1002/cne.901340304; Jacobson M., 1991, DEV NEUROBIOLOGY; KOLLROS JJ, 1982, J COMP NEUROL, V205, P171, DOI 10.1002/cne.902050208; Kosciuszko H., 1958, Folia Biologica Krakow, V6, P117; LUMSDEN A, 1990, TRENDS NEUROSCI, V13, P329, DOI 10.1016/0166-2236(90)90144-Y; LUMSDEN A, 1989, NATURE, V337, P424, DOI 10.1038/337424a0; MACAGNO ER, 1979, DEV BIOL, V73, P206, DOI 10.1016/0012-1606(79)90064-2; MEIRI KF, 1988, J NEUROSCI, V8, P2571; MILLER MW, 1988, BRAIN RES, V457, P44, DOI 10.1016/0006-8993(88)90055-8; MONTIGRAZIADEI GA, 1980, NEUROSCIENCE, V5, P1239; NOWAKOWSKI RS, 1989, J NEUROCYTOL, V18, P311, DOI 10.1007/BF01190834; ONODA N, 1992, NEUROSCI RES, V15, P143, DOI 10.1016/0168-0102(92)90027-A; PINCHING AJ, 1971, J CELL SCI, V9, P347; RAMAKERS GJA, 1992, J NEUROCYTOL, V21, P853, DOI 10.1007/BF01191683; SANDELL JH, 1988, J HISTOCHEM CYTOCHEM, V36, P555, DOI 10.1177/36.5.3356898; SANES JR, 1976, DEV BIOL, V52, P121, DOI 10.1016/0012-1606(76)90012-9; SANTACANA M, 1992, DEV BRAIN RES, V70, P213, DOI 10.1016/0165-3806(92)90200-G; SELLECK SB, 1991, NEURON, V6, P83, DOI 10.1016/0896-6273(91)90124-I; SELLECK SB, 1992, NATURE, V355, P253, DOI 10.1038/355253a0; SKENE JHP, 1986, SCIENCE, V233, P783, DOI 10.1126/science.3738509; SKENE JHP, 1989, ANNU REV NEUROSCI, V12, P127, DOI 10.1146/annurev.ne.12.030189.001015; SKENE JHP, 1981, J CELL BIOL, V89, P86, DOI 10.1083/jcb.89.1.86; SKENE JHP, 1981, J CELL BIOL, V89, P96, DOI 10.1083/jcb.89.1.96; STOUT RP, 1980, NEUROSCIENCE, V5, P2175, DOI 10.1016/0306-4522(80)90134-7; TAKAHASHI T, 1992, J NEUROCYTOL, V21, P185, DOI 10.1007/BF01194977; TAKAHASHI T, 1993, J NEUROSCI, V13, P820; VERHAAGEN J, 1989, J NEUROSCI, V9, P683; VERHAAGEN J, 1990, EUR J NEUROSCI, V2, P397, DOI 10.1111/j.1460-9568.1990.tb00432.x; WILLEY TJ, 1973, J COMP NEUROL, V152, P211, DOI 10.1002/cne.901520302	42	193	193	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1995	14	1					91	101		10.1016/0896-6273(95)90243-0	http://dx.doi.org/10.1016/0896-6273(95)90243-0			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QC548	7826645	Bronze			2022-12-24	WOS:A1995QC54800009
J	BRUZZONE, R; WHITE, TW; SCHERER, SS; FISCHBECK, KH; PAUL, DL				BRUZZONE, R; WHITE, TW; SCHERER, SS; FISCHBECK, KH; PAUL, DL			NULL MUTATIONS OF CONNEXIN32 IN PATIENTS WITH X-LINKED CHARCOT-MARIE-TOOTH DISEASE	NEURON			English	Article							GAP JUNCTION PROTEIN; CULTURED ASTROCYTES; NERVOUS-SYSTEM; SCHWANN-CELLS; MYELIN; TYPE-1A; LIVER; GENE; EXPRESSION; CHANNELS	The X-linked form of Charcot-Marie-Tooth disease (CMTX) is associated with mutations in the gene encoding connexin32, a member of the family of protei ns forming intercellular channels. We have compared the functional properties of three mutant connexin32 genes with those of the wild-type gene by testing their ability to form intercellular channels in the paired oocyte expression system. Whereas wild-type connexin32 induced the development of large junctional conductance between paired oocytes, no functional channels were detected between pairs expressing CMTX mutants. Furthermore, CMTX mutants selectively acted as dominant inhibitors of intercellular communication by interfering with the channel-forming ability of connexin26 but not with that of connexin40. These results demonstrate a functional loss in the product of a candidate gene for a demyelinating form of CMT.	HARVARD UNIV,SCH MED,DEPT NEUROBIOL,BOSTON,MA 02115; UNIV PENN,SCH MED,DEPT NEUROL,PHILADELPHIA,PA 19104	Harvard University; Harvard Medical School; University of Pennsylvania	BRUZZONE, R (corresponding author), HARVARD UNIV,SCH MED,DEPT CELL BIOL,BOSTON,MA 02115, USA.		White, Thomas W./R-3605-2019; Bruzzone, Roberto/G-9355-2017; Bruzzone, Roberto/C-4719-2009; White, Thomas/GPG-4026-2022	Bruzzone, Roberto/0000-0003-4373-1447; Bruzzone, Roberto/0000-0003-4373-1447; White, Thomas/0000-0002-3285-7434	NIGMS NIH HHS [GM18974, GM37751] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM018974, R01GM037751, R01GM018974] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARRIO LC, 1991, P NATL ACAD SCI USA, V88, P8410, DOI 10.1073/pnas.88.19.8410; BENNETT MVL, 1991, NEURON, V6, P305, DOI 10.1016/0896-6273(91)90241-Q; BERGOFFEN J, 1993, SCIENCE, V262, P2039, DOI 10.1126/science.8266101; Beyer E C, 1993, Int Rev Cytol, V137C, P1; BRIGHTMA.MW, 1969, J CELL BIOL, V40, P648, DOI 10.1083/jcb.40.3.648; BRUZZONE R, 1994, J CELL SCI, V107, P955; BRUZZONE R, 1994, J CELL SCI, V17, P955; CHANSON M, 1993, J GEN PHYSIOL, V102, P925, DOI 10.1085/jgp.102.5.925; Charcot JM, 1886, REV MED-PARIS, V6, P97; DAHL G, 1987, SCIENCE, V236, P1290, DOI 10.1126/science.3035715; DERMIETZEL R, 1991, J NEUROSCI, V11, P1421; DERMIETZEL R, 1993, TRENDS NEUROSCI, V16, P186, DOI 10.1016/0166-2236(93)90151-B; Doyle JP, 1993, CURR OPIN CELL BIOL, V5, P779, DOI 10.1016/0955-0674(93)90025-L; DURSO D, 1990, NEURON, V4, P449, DOI 10.1016/0896-6273(90)90057-M; EGHBALI B, 1990, P NATL ACAD SCI USA, V87, P1328, DOI 10.1073/pnas.87.4.1328; FAIRWEATHER N, 1994, HUM MOL GENET, V3, P29, DOI 10.1093/hmg/3.1.29; FILBIN MT, 1990, NATURE, V344, P871, DOI 10.1038/344871a0; GIAUME C, 1991, NEURON, V6, P133, DOI 10.1016/0896-6273(91)90128-M; GOLIGER JA, 1994, DEV DYNAM, V200, P1, DOI 10.1002/aja.1002000102; GOODENOUGH DA, 1988, J CELL BIOL, V107, P1817, DOI 10.1083/jcb.107.5.1817; GOODMAN P, 1993, COMPUT MED IMAG GRAP, V17, P133, DOI 10.1016/0895-6111(93)90055-R; GOW A, 1994, J NEUROSCI RES, V37, P574, DOI 10.1002/jnr.490370504; HAYASAKA K, 1993, NAT GENET, V5, P31, DOI 10.1038/ng0993-31; HOTZWAGENBLATT A, 1993, CRIT REV ONCOGENESIS, V4, P541; IONASESCU V, 1994, HUM MOL GENET, V3, P355, DOI 10.1093/hmg/3.2.355; KETTENMANN H, 1983, J NEUROSCI, V3, P506; KONISHI T, 1990, BRAIN RES, V508, P85, DOI 10.1016/0006-8993(90)91121-V; KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057; KULKENS T, 1993, NAT GENET, V5, P35, DOI 10.1038/ng0993-35; KUMAR NM, 1986, J CELL BIOL, V103, P767, DOI 10.1083/jcb.103.3.767; LEMKE G, 1988, NEURON, V1, P535, DOI 10.1016/0896-6273(88)90103-1; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; MASSA PT, 1982, NEUROSCIENCE, V7, P523; MEDA P, 1993, ENDOCRINOLOGY, V133, P2371, DOI 10.1210/en.133.5.2371; METHFESSEL C, 1986, PFLUG ARCH EUR J PHY, V407, P577, DOI 10.1007/BF00582635; MILKS LC, 1988, EMBO J, V7, P2967, DOI 10.1002/j.1460-2075.1988.tb03159.x; NICHOLSON B, 1987, NATURE, V329, P732, DOI 10.1038/329732a0; PATEL PI, 1994, TRENDS GENET, V10, P128, DOI 10.1016/0168-9525(94)90214-3; PATEL PI, 1992, NAT GENET, V1, P159, DOI 10.1038/ng0692-159; PAUL DL, 1986, J CELL BIOL, V103, P123, DOI 10.1083/jcb.103.1.123; PAUL DL, 1993, PROG CELL R, V3, P15; RAEYMAEKERS P, 1992, J MED GENET, V29, P5, DOI 10.1136/jmg.29.1.5; ROA BB, 1993, NEW ENGL J MED, V329, P96, DOI 10.1056/NEJM199307083290205; SCHNEIDERSCHAULIES J, 1990, J NEUROSCI RES, V27, P286, DOI 10.1002/jnr.490270307; SPRAY DC, 1981, J GEN PHYSIOL, V77, P77, DOI 10.1085/jgp.77.1.77; SU Y, 1993, P NATL ACAD SCI USA, V90, P10856, DOI 10.1073/pnas.90.22.10856; SUTER U, 1993, TRENDS NEUROSCI, V16, P50, DOI 10.1016/0166-2236(93)90015-E; SWENSON KI, 1989, CELL, V57, P145, DOI 10.1016/0092-8674(89)90180-3; Tooth HH, 1886, PERONEAL TYPE PROGRE; TRAUB O, 1989, J CELL BIOL, V108, P1039, DOI 10.1083/jcb.108.3.1039; VALENTIJN LJ, 1992, NAT GENET, V2, P288, DOI 10.1038/ng1292-288; VANCE JM, 1991, J MED GENET, V28, P1, DOI 10.1136/jmg.28.1.1; WHITE TW, 1992, MOL BIOL CELL, V3, P711, DOI 10.1091/mbc.3.7.711; WHITE TW, 1994, J CELL BIOL, V125, P879, DOI 10.1083/jcb.125.4.879; ZHANG JT, 1989, J CELL BIOL, V109, P3391, DOI 10.1083/jcb.109.6.3391	55	173	177	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1994	13	5					1253	1260		10.1016/0896-6273(94)90063-9	http://dx.doi.org/10.1016/0896-6273(94)90063-9			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PU763	7946361				2022-12-24	WOS:A1994PU76300021
J	WYLLIE, DJA; NICOLL, RA				WYLLIE, DJA; NICOLL, RA			A ROLE FOR PROTEIN-KINASES AND PHOSPHATASES IN THE CA2+-INDUCED ENHANCEMENT OF HIPPOCAMPAL AMPA RECEPTOR-MEDIATED SYNAPTIC RESPONSES	NEURON			English	Article							LONG-TERM POTENTIATION; CA2+ CHANNELS; CALMODULIN; NEURONS; INHIBITOR; SLICES; KN-62; PHOSPHORYLATION; TRANSMISSION; MEMORY	We have investigated the effects of inhibitors of protein kinases and protein phosphatases on the NMDA receptor-independent potentiation of evoked and miniature (m) excitatory postsynaptic currents (EPSCs) induced by the entry of Ca2+ via voltage-gated Ca2+ channels in hippocampal CA1 pyramidal neurons. Voltage pulse-induced potentiation was markedly attenuated when evoked in the presence of the protein kinase blockers KN-62, K-252a, or H-7. Bath application of the protein phosphatase inhibitor calyculin A converted the usual transient potentiation of both evoked and spontaneous EPSCs induced by voltage pulses into a more sustained potentiation. Similarly, the introduction of the phosphatase inhibitors microcystin LR or okadaic acid into postsynaptic cells, via patch pipettes, also resulted in a sustained increase in the amplitude of mEPSCs. We propose that entry of Ca2+ into CA1 neurons activates calcium/calmodulin-dependent protein kinase II, which leads to an enhanced responsiveness of synaptic AMPA receptor channels. The enhancement is transient, however, owing to postsynaptic phosphatase activity.	UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco	WYLLIE, DJA (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT PHARMACOL,SAN FRANCISCO,CA 94143, USA.		Wyllie, David J A/AAK-4678-2021	Wyllie, David J A/0000-0002-4957-6049				BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; COLEMAN PA, 1989, J NEUROPHYSIOL, V61, P218, DOI 10.1152/jn.1989.61.1.218; DOESMECI A, 1993, J NEUROCHEM, V61, P550; FIGUROV A, 1993, EUR J NEUROSCI, V5, P1035, DOI 10.1111/j.1460-9568.1993.tb00956.x; FORSCHER P, 1985, J GEN PHYSIOL, V85, P743, DOI 10.1085/jgp.85.5.743; GREENGARD P, 1991, SCIENCE, V253, P1135, DOI 10.1126/science.1716001; HANSE E, 1994, NEUROSCIENCE, V58, P263, DOI 10.1016/0306-4522(94)90033-7; HASHIMOTO Y, 1991, BIOCHEM BIOPH RES CO, V181, P423, DOI 10.1016/S0006-291X(05)81436-6; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; ITO I, 1991, NEUROSCI LETT, V121, P119, DOI 10.1016/0304-3940(91)90663-E; KENNEDY MB, 1983, P NATL ACAD SCI-BIOL, V80, P7357, DOI 10.1073/pnas.80.23.7357; KULLMANN DM, 1992, NEURON, V9, P1175, DOI 10.1016/0896-6273(92)90075-O; LI GD, 1992, MOL PHARMACOL, V42, P489; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; LISMAN JE, 1988, P NATL ACAD SCI USA, V85, P8320; MADISON DV, 1991, ANNU REV NEUROSCI, V14, P379, DOI 10.1146/annurev.ne.14.030191.002115; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MATTHIES H, 1991, NEUROSCI LETT, V121, P259, DOI 10.1016/0304-3940(91)90699-T; MCGLADEMCCULLOH E, 1993, NATURE, V362, P640, DOI 10.1038/362640a0; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; NICOLL RA, 1981, J NEUROSCI METH, V4, P153, DOI 10.1016/0165-0270(81)90049-2; NICOLL RA, 1994, CELLULAR MOL MECHANI, P189; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; SWOPE SL, 1992, FASEB J, V6, P2514, DOI 10.1096/fasebj.6.8.1375568; TOKUMITSU H, 1990, J BIOL CHEM, V265, P4315; WANG JH, 1992, P NATL ACAD SCI USA, V89, P2576, DOI 10.1073/pnas.89.7.2576; WANG LY, 1991, SCIENCE, V253, P1132, DOI 10.1126/science.1653455; WANG LY, 1994, J PHYSIOL-LONDON, V475, P431, DOI 10.1113/jphysiol.1994.sp020083; WYLLIE DJA, 1994, NEURON, V12, P127, DOI 10.1016/0896-6273(94)90158-9	31	91	91	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1994	13	3					635	643		10.1016/0896-6273(94)90031-0	http://dx.doi.org/10.1016/0896-6273(94)90031-0			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PJ284	7917294				2022-12-24	WOS:A1994PJ28400011
J	IMREDY, JP; YUE, DT				IMREDY, JP; YUE, DT			MECHANISM OF CA2+-SENSITIVE INACTIVATION OF L-TYPE CA2+ CHANNELS	NEURON			English	Article							PIG VENTRICULAR MYOCYTES; BETA-ADRENERGIC STIMULATION; SINGLE CALCIUM CHANNELS; DEPENDENT INACTIVATION; SODIUM-CHANNEL; CA-2+ CHANNELS; HEART-CELLS; PROTEIN PHOSPHATASES; MAMMALIAN BRAIN; GATING CURRENTS	Many high threshold, voltage-gated Ca2+ channels, including the dihydropyridine-sensitive class (L-type), inactivate in response not only to voltage, but also to entry of Ca2+. Despite the physiological importance of this Ca2+-sensitive inactivation, its molecular mechanism is understood only in broad outline. We now demonstrate that Ca2+-dependent inactivation transpires by a Ca2+-induced shift of channel gating to a low open probability mode, distinguished by a more than 100-fold reduction of entry rate to the open state. A gating mechanism that explains this shift quantitatively and enables successful separation of Ca2+- and voltage-sensitive forms of inactivation is deduced and tested. Finally, both calmodulin activation and channel (de)phosphorylation are excluded as significant signaling events underlying Ca2+-induced mode shifts, leaving direct binding of Ca2+ to the channel as a likely chemical initiation event for inactivation.	JOHNS HOPKINS UNIV, SCH MED, DEPT BIOMED ENGN, BALTIMORE, MD 21205 USA	Johns Hopkins University					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL043307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007057] Funding Source: NIH RePORTER; NHLBI NIH HHS [R29 HL43307] Funding Source: Medline; NIGMS NIH HHS [5 T32 GM07057] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AHLIJANIAN MK, 1990, NEURON, V4, P819, DOI 10.1016/0896-6273(90)90135-3; ALDRICH RW, 1983, NATURE, V306, P436, DOI 10.1038/306436a0; ARMSTRONG CM, 1977, J GEN PHYSIOL, V70, P567, DOI 10.1085/jgp.70.5.567; ARMSTRONG DL, 1989, TRENDS NEUROSCI, V12, P117, DOI 10.1016/0166-2236(89)90168-9; BABITCH J, 1990, NATURE, V346, P345; BALKE CW, 1991, CIRC RES, V68, P897, DOI 10.1161/01.RES.68.3.897; BEAN BP, 1984, NATURE, V307, P371, DOI 10.1038/307371a0; BECHEM M, 1985, PFLUG ARCH EUR J PHY, V404, P10, DOI 10.1007/BF00581485; BLACKMORE PF, 1985, J BIOL CHEM, V260, P4477; BREHM P, 1978, SCIENCE, V202, P1203, DOI 10.1126/science.103199; BYERLY L, 1988, CALCIUM ION CHANNEL, P3; CAVALIE A, 1983, PFLUG ARCH EUR J PHY, V398, P284, DOI 10.1007/BF00657238; CAVALIE A, 1986, PFLUG ARCH EUR J PHY, V406, P241, DOI 10.1007/BF00640910; CHAD JE, 1986, J PHYSIOL-LONDON, V378, P31, DOI 10.1113/jphysiol.1986.sp016206; CHAD JE, 1984, BIOPHYS J, V45, P993, DOI 10.1016/S0006-3495(84)84244-7; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; COHEN P, 1988, PROC R SOC SER B-BIO, V234, P115, DOI 10.1098/rspb.1988.0040; Colquhoun D, 1983, SINGLE CHANNEL RECOR, P191; ECKERT R, 1984, PROG BIOPHYS MOL BIO, V44, P215, DOI 10.1016/0079-6107(84)90009-9; FRYER MW, 1993, J PHYSIOL-LONDON, V464, P501, DOI 10.1113/jphysiol.1993.sp019648; GUTNICK MJ, 1989, J PHYSIOL-LONDON, V412, P197, DOI 10.1113/jphysiol.1989.sp017611; HADLEY RW, 1987, J PHYSIOL-LONDON, V389, P205, DOI 10.1113/jphysiol.1987.sp016654; HADLEY RW, 1991, J PHYSIOL-LONDON, V444, P257, DOI 10.1113/jphysiol.1991.sp018876; HAGIWARA S, 1983, J PHYSIOL-LONDON, V336, P649, DOI 10.1113/jphysiol.1983.sp014603; HERZIG S, 1993, BIOPHYS J, V65, P1599, DOI 10.1016/S0006-3495(93)81199-8; HESCHELER J, 1988, PFLUG ARCH EUR J PHY, V412, P248, DOI 10.1007/BF00582504; HESCHELER J, 1988, J PHYSIOL-LONDON, V404, P259, DOI 10.1113/jphysiol.1988.sp017289; HESS P, 1984, NATURE, V311, P536; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P497, DOI 10.1113/jphysiol.1952.sp004719; IMREDY JP, 1992, NEURON, V9, P197, DOI 10.1016/0896-6273(92)90159-B; JOHNSON BD, 1993, NEURON, V10, P797, DOI 10.1016/0896-6273(93)90196-X; JOSEPHSON IR, 1991, BIOPHYS J, V60, P491, DOI 10.1016/S0006-3495(91)82075-6; KASS RS, 1984, J GEN PHYSIOL, V84, P705, DOI 10.1085/jgp.84.5.705; KAY AR, 1991, J PHYSIOL-LONDON, V437, P27, DOI 10.1113/jphysiol.1991.sp018581; KEIZER J, 1992, BIOPHYS J, V63, P291, DOI 10.1016/S0006-3495(92)81576-X; KLOCKNER U, 1987, AM J PHYSIOL, V253, pH1601, DOI 10.1152/ajpheart.1987.253.6.H1601; KRAFTE DS, 1988, J GEN PHYSIOL, V91, P641, DOI 10.1085/jgp.91.5.641; LEE KS, 1985, J PHYSIOL-LONDON, V364, P395, DOI 10.1113/jphysiol.1985.sp015752; LIMAN ER, 1991, NATURE, V353, P752, DOI 10.1038/353752a0; LLINAS R, 1989, P NATL ACAD SCI USA, V86, P1689, DOI 10.1073/pnas.86.5.1689; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; MAHAN BH, 1975, U CHEM, P375; MARKS TN, 1992, J GEN PHYSIOL, V99, P367, DOI 10.1085/jgp.99.3.367; MAZZANTI M, 1991, J PHYSIOL-LONDON, V443, P307, DOI 10.1113/jphysiol.1991.sp018835; MAZZANTI M, 1990, BIOPHYS J, V58, P1059, DOI 10.1016/S0006-3495(90)82448-6; MENTRARD D, 1984, J GEN PHYSIOL, V83, P105, DOI 10.1085/jgp.83.1.105; MITCHELL MR, 1984, BRIT J PHARMACOL, V81, P13, DOI 10.1111/j.1476-5381.1984.tb10735.x; NEHER E, 1978, J PHYSIOL-LONDON, V277, P153, DOI 10.1113/jphysiol.1978.sp012267; NEUMANN J, 1993, AM J PHYSIOL, V265, pH257, DOI 10.1152/ajpheart.1993.265.1.H257; OBEJEROPAZ CA, 1991, J GEN PHYSIOL, V98, P1127, DOI 10.1085/jgp.98.6.1127; ONO K, 1992, J PHYSIOL-LONDON, V454, P673, DOI 10.1113/jphysiol.1992.sp019286; PELZER S, 1990, AM J PHYSIOL, V259, pH264, DOI 10.1152/ajpheart.1990.259.1.H264; PIETROBON D, 1990, NATURE, V346, P651, DOI 10.1038/346651a0; PUSCH M, 1988, PFLUG ARCH EUR J PHY, V411, P204, DOI 10.1007/BF00582316; ROMANIN C, 1992, PFLUG ARCH EUR J PHY, V421, P516, DOI 10.1007/BF00370266; ROMANIN C, 1991, PFLUG ARCH EUR J PHY, V418, P86, DOI 10.1007/BF00370456; SATHER WA, 1993, NEURON, V11, P291, DOI 10.1016/0896-6273(93)90185-T; SCHERUBL H, 1993, AM J PHYSIOL, V264, pE354, DOI 10.1152/ajpendo.1993.264.3.E354; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; SCULPTOREANU A, 1993, NATURE, V364, P240, DOI 10.1038/364240a0; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; SHENOLIKAR S, 1991, ADV SEC MESS PHOSPH, V23, P1; SHERMAN A, 1990, BIOPHYS J, V58, P985, DOI 10.1016/S0006-3495(90)82443-7; SHIROKOV R, 1992, J GEN PHYSIOL, V99, P863, DOI 10.1085/jgp.99.6.863; SHIROKOV R, 1993, J GEN PHYSIOL, V102, P1005, DOI 10.1085/jgp.102.6.1005; SIMON SM, 1985, BIOPHYS J, V48, P485, DOI 10.1016/S0006-3495(85)83804-2; SNUTCH TP, 1990, P NATL ACAD SCI USA, V87, P3391, DOI 10.1073/pnas.87.9.3391; SOONG TW, 1993, SCIENCE, V260, P1133, DOI 10.1126/science.8388125; STANDEN NB, 1982, PROC R SOC SER B-BIO, V217, P101, DOI 10.1098/rspb.1982.0097; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; TSIEN RW, 1991, TRENDS PHARMACOL SCI, V12, P349, DOI 10.1016/0165-6147(91)90595-J; TSIEN RW, 1990, ANNU REV CELL BIOL, V6, P715, DOI 10.1146/annurev.cb.06.110190.003435; VANDENBERG CA, 1991, BIOPHYS J, V60, P1511, DOI 10.1016/S0006-3495(91)82186-5; WANG Y, 1993, AM J PHYSIOL, V33, P1473; YATANI A, 1987, SCIENCE, V238, P1288, DOI 10.1126/science.2446390; YUE DT, 1990, J GEN PHYSIOL, V95, P911, DOI 10.1085/jgp.95.5.911; YUE DT, 1990, P NATL ACAD SCI USA, V87, P753, DOI 10.1073/pnas.87.2.753; YUE DT, 1990, SCIENCE, V250, P1735, DOI 10.1126/science.2176745; YUE DT, NEURAL ENG; ZAGOTTA WN, 1994, IN PRESS J GEN PHYSL	80	214	217	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	1994	12	6					1301	1318		10.1016/0896-6273(94)90446-4	http://dx.doi.org/10.1016/0896-6273(94)90446-4			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NT463	8011340				2022-12-24	WOS:A1994NT46300011
J	HUA, SY; TOKIMASA, T; TAKASAWA, S; FURUYA, Y; NOHMI, M; OKAMOTO, H; KUBA, K				HUA, SY; TOKIMASA, T; TAKASAWA, S; FURUYA, Y; NOHMI, M; OKAMOTO, H; KUBA, K			CYCLIC ADP-RIBOSE MODULATES CA2+ RELEASE CHANNELS FOR ACTIVATION BY PHYSIOLOGICAL CA2+ ENTRY IN BULLFROG SYMPATHETIC NEURONS	NEURON			English	Article							FREE CALCIUM-CONCENTRATION; ROOT GANGLION NEURONS; CELLS; CAFFEINE; OSCILLATION; AFTERHYPERPOLARIZATION; CONDUCTANCE; GENERATION; HYDROLYSIS; DYNAMICS	Although Ca2+-induced Ca2+ release (CICR) via ryanodine receptors has been found to occur in intact neurons, little is known about the physiological processes that regulate it. We studied the effects of cyclic ADP-ribose (cADPR) on CICR in cultured bullfrog sympathetic neurons by fura-2 fluorescence recording and patch-clamp techniques. cADPR applied through a patch pipette augmented action potential- or depolarizing pulse-induced rises in intracellular Ca2+ without a change in Ca2+ entry initiating the responses, but not in the presence of ryanodine. Likewise, cADPR enhanced a single or oscillatory rise(s) in intracellular Ca2+ induced by caffeine. These results strongly suggest that cADPR tan be an endogenous modulator of ryanodine receptors in neurons.	SAGA MED SCH,CENT LABS MSRE,SAGA 849,JAPAN; KURUME UNIV,SCH MED,DEPT PHYSIOL,KURUME,FUKUOKA 830,JAPAN; TOHOKU UNIV,SCH MED,DEPT BIOCHEM,SENDAI,MIYAGI 98077,JAPAN	Saga University; Kurume University; Tohoku University	HUA, SY (corresponding author), SAGA MED SCH,DEPT PHYSIOL,SAGA 849,JAPAN.							BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BERRIDGE MJ, 1993, NATURE, V365, P388, DOI 10.1038/365388a0; CURRIE KPM, 1992, MOL BIOL CELL, V3, P1415, DOI 10.1091/mbc.3.12.1415; ENDO M, 1970, NATURE, V249, P469; FORD LE, 1970, SCIENCE, V167, P58, DOI 10.1126/science.167.3914.58; FRIEL DD, 1992, J PHYSIOL-LONDON, V450, P217, DOI 10.1113/jphysiol.1992.sp019125; GALIONE A, 1993, NATURE, V365, P456, DOI 10.1038/365456a0; GALIONE A, 1991, SCIENCE, V253, P1143, DOI 10.1126/science.1909457; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HUA SY, 1993, J PHYSIOL-LONDON, V464, P245, DOI 10.1113/jphysiol.1993.sp019633; JASSAR BS, 1991, PFLUG ARCH EUR J PHY, V419, P478, DOI 10.1007/BF00370792; KOSHIYAMA H, 1991, J BIOL CHEM, V266, P16985; KUBA K, 1992, CAN J PHYSIOL PHARM, V70, pS64, DOI 10.1139/y92-245; KUBA K, 1983, PFLUG ARCH EUR J PHY, V399, P194, DOI 10.1007/BF00656714; KUBA K, 1981, J THEOR BIOL, V93, P1009, DOI 10.1016/0022-5193(81)90352-0; KUBA K, 1980, J PHYSIOL-LONDON, V298, P251, DOI 10.1113/jphysiol.1980.sp013079; KUBA K, 1976, J NEUROPHYSIOL, V39, P547, DOI 10.1152/jn.1976.39.3.547; KUWAJIMA G, 1992, NEURON, V9, P1133, DOI 10.1016/0896-6273(92)90071-K; LEE HC, 1993, BIOCHEM BIOPH RES CO, V191, P639, DOI 10.1006/bbrc.1993.1265; LEE HC, 1989, J BIOL CHEM, V264, P1608; LEE HC, 1993, J BIOL CHEM, V268, P293; LIPSCOMBE D, 1988, NEURON, V1, P355, DOI 10.1016/0896-6273(88)90185-7; LOPEZ HS, 1992, NEURON, V8, P725, DOI 10.1016/0896-6273(92)90093-S; MARION MNV, 1992, J PHYSL, V445, P515; MESZAROS LG, 1993, NATURE, V364, P76, DOI 10.1038/364076a0; MORITA K, 1980, NATURE, V283, P204, DOI 10.1038/283204a0; NOHMI M, 1992, J PHYSIOL-LONDON, V450, P513, DOI 10.1113/jphysiol.1992.sp019140; NOHMI M, 1992, J PHYSIOL-LONDON, V458, P171, DOI 10.1113/jphysiol.1992.sp019412; SALA F, 1990, BIOPHYS J, V57, P313, DOI 10.1016/S0006-3495(90)82533-9; TAKASAWA S, 1993, J BIOL CHEM, V268, P26052; TAKASAWA S, 1993, SCIENCE, V259, P370, DOI 10.1126/science.8420005; THAYER SA, 1988, MOL PHARMACOL, V34, P664; THAYER SA, 1990, J PHYSIOL-LONDON, V425, P85, DOI 10.1113/jphysiol.1990.sp018094; WALSETH TF, 1993, J BIOL CHEM, V268, P26686; WHITE AM, 1993, FEBS LETT, V318, P259, DOI 10.1016/0014-5793(93)80524-X	36	134	135	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1994	12	5					1073	1079		10.1016/0896-6273(94)90315-8	http://dx.doi.org/10.1016/0896-6273(94)90315-8			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NM831	8185944				2022-12-24	WOS:A1994NM83100011
J	MACONOCHIE, DJ; ZEMPEL, JM; STEINBACH, JH				MACONOCHIE, DJ; ZEMPEL, JM; STEINBACH, JH			HOW QUICKLY CAN GABA(A) RECEPTORS OPEN	NEURON			English	Article							SPINAL-CORD NEURONS; FROG NEUROMUSCULAR-JUNCTION; INDUCED CHLORIDE CURRENT; SINGLE-CHANNEL ANALYSIS; MAIN CONDUCTANCE STATE; ACETYLCHOLINE-RECEPTOR; PATCH-CLAMP; TIME-COURSE; SYNAPTIC TRANSMISSION; STOCHASTIC PROPERTIES	We have examined GABA(A) receptor activation by making rapid applications of GABA to outside-out patches excised from cultured postnatal rat cerebellar neurons. The rate of development of current increases with increasing GABA concentration from a low to a high concentration asymptote. The low concentration asymptote is about 10 s-1 for patches taken from granule cells and 4 s-1 for patches from Purkinje cells. The high concentration asymptote is about 6000 s-1 for patches taken from either granule cells or Purkinje cells. The high concentration asymptote gives an estimate of the fastest rate at which these channels can open and indicates that agonist binding steps are not rate limiting. The concentration dependence of the development of current indicates that more than one GABA molecule is bound to most receptors with open channels and that the final binding step is of low affinity (about 500 muM). A comparison with GABA-mediated postsynaptic currents suggests that the properties of the GABA(A) receptor play a major role in determining the shape of inhibitory synaptic responses and that the cleft concentration of GABA reaches at least 500 muM.			MACONOCHIE, DJ (corresponding author), WASHINGTON UNIV,SCH MED,DEPT ANESTHESIOL,ST LOUIS,MO 63110, USA.				NIGMS NIH HHS [P01 GM047969, P01 GM47969] Funding Source: Medline; NINDS NIH HHS [R01 NS22356] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM047969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022356] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKAIKE N, 1986, J PHYSIOL-LONDON, V379, P171, DOI 10.1113/jphysiol.1986.sp016246; AUERBACH A, 1992, BIOPHYS J, V62, P72, DOI 10.1016/S0006-3495(92)81783-6; BARTOL TM, 1991, BIOPHYS J, V59, P1290, DOI 10.1016/S0006-3495(91)82344-X; BLATZ AL, 1986, BIOPHYS J, V49, P967, DOI 10.1016/S0006-3495(86)83725-0; BORMANN J, 1985, P NATL ACAD SCI USA, V82, P2168, DOI 10.1073/pnas.82.7.2168; CACHELIN AB, 1989, J PHYSIOL-LONDON, V415, P159, DOI 10.1113/jphysiol.1989.sp017717; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; COLQUHOUN D, 1981, NATURE, V294, P464, DOI 10.1038/294464a0; COLQUHOUN D, 1982, PHILOS T ROY SOC B, V300, P1, DOI 10.1098/rstb.1982.0156; COLQUHOUN D, 1985, J PHYSIOL-LONDON, V369, P501, DOI 10.1113/jphysiol.1985.sp015912; COLQUHOUN D, 1977, PROC R SOC SER B-BIO, V199, P231, DOI 10.1098/rspb.1977.0137; COLQUHOUN D, 1981, PROC R SOC SER B-BIO, V211, P205, DOI 10.1098/rspb.1981.0003; CROUZY SC, 1990, BIOPHYS J, V58, P731, DOI 10.1016/S0006-3495(90)82416-4; DELCASTILLO J, 1957, PROC R SOC SER B-BIO, V146, P369; DILGER JP, 1990, BIOPHYS J, V57, P723, DOI 10.1016/S0006-3495(90)82593-5; DUDEL J, 1990, BIOPHYS J, V57, P533, DOI 10.1016/S0006-3495(90)82569-8; EDMONDS B, 1992, P ROY SOC B-BIOL SCI, V250, P279, DOI 10.1098/rspb.1992.0160; EDWARDS FA, 1990, J PHYSIOL-LONDON, V430, P213, DOI 10.1113/jphysiol.1990.sp018289; FELTZ A, 1982, J PHYSIOL-LONDON, V322, P257, DOI 10.1113/jphysiol.1982.sp014036; FRANKE C, 1991, BIOPHYS J, V60, P1008, DOI 10.1016/S0006-3495(91)82138-5; FRANKE C, 1987, NEUROSCI LETT, V88, P405; HAMILL OP, 1983, NATURE, V305, P805, DOI 10.1038/305805a0; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P449, DOI 10.1113/jphysiol.1952.sp004717; JACKSON MB, 1986, BIOPHYS J, V49, P663, DOI 10.1016/S0006-3495(86)83693-1; KANEDA M, 1989, AM J PHYSIOL, V256, pC1153, DOI 10.1152/ajpcell.1989.256.6.C1153; KATZ B, 1957, J PHYSIOL-LONDON, V138, P63, DOI 10.1113/jphysiol.1957.sp005838; LAURIE DJ, 1992, J NEUROSCI, V12, P1063; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; LESTER RAJ, 1992, J NEUROSCI, V12, P635; LINGLE CJ, 1992, J MEMBRANE BIOL, V126, P195; LIU Y, 1991, BIOPHYS J, V60, P424, DOI 10.1016/S0006-3495(91)82068-9; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; MACDONALD RL, 1989, J PHYSIOL-LONDON, V410, P479, DOI 10.1113/jphysiol.1989.sp017545; MACDONALD RL, 1992, ION CHANNELS, P315; MACONOCHIE DJ, 1989, PFLUG ARCH EUR J PHY, V414, P589, DOI 10.1007/BF00580996; MACONOCHIE DJ, 1992, J PHYSIOL-LONDON, V454, P129, DOI 10.1113/jphysiol.1992.sp019257; MACONOCHIE DJ, 1992, J PHYSL, V454, P154; MAGLEBY KL, 1972, J PHYSIOL-LONDON, V223, P151, DOI 10.1113/jphysiol.1972.sp009839; MARICQ AV, 1991, SCIENCE, V254, P432, DOI 10.1126/science.1718042; MATHERS DA, 1988, SYNAPSE, V2, P627, DOI 10.1002/syn.890020608; NEHER E, 1975, P NATL ACAD SCI USA, V72, P2140, DOI 10.1073/pnas.72.6.2140; NEWLAND CF, 1991, J PHYSIOL-LONDON, V432, P203, DOI 10.1113/jphysiol.1991.sp018382; ROUX B, 1985, BIOPHYS J, V48, P149, DOI 10.1016/S0006-3495(85)83768-1; Sakmann B, 1983, J Neural Transm Suppl, V18, P83; SCHNEGGENBURGER R, 1992, PFLUG ARCH EUR J PHY, V421, P364, DOI 10.1007/BF00374225; SIEGEL RE, 1988, NEURON, V1, P579, DOI 10.1016/0896-6273(88)90107-9; SILVER RA, 1992, NATURE, V355, P163, DOI 10.1038/355163a0; TWYMAN RE, 1990, J PHYSIOL-LONDON, V423, P193, DOI 10.1113/jphysiol.1990.sp018018; VERDOORN TA, 1990, NEURON, V4, P919, DOI 10.1016/0896-6273(90)90145-6; WEISS DS, 1989, J NEUROSCI, V9, P1314; Wisden W, 1992, Curr Opin Neurobiol, V2, P263, DOI 10.1016/0959-4388(92)90113-Y; [No title captured]	52	207	209	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1994	12	1					61	71		10.1016/0896-6273(94)90152-X	http://dx.doi.org/10.1016/0896-6273(94)90152-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MU493	8292360				2022-12-24	WOS:A1994MU49300006
J	THOMAS, P; WONG, JG; LEE, AK; ALMERS, W				THOMAS, P; WONG, JG; LEE, AK; ALMERS, W			A LOW-AFFINITY CA2+ RECEPTOR CONTROLS THE FINAL STEPS IN PEPTIDE SECRETION FROM PITUITARY MELANOTROPHS	NEURON			English	Article							ADRENAL CHROMAFFIN CELLS; FLUORESCENT INDICATOR; RAT PITUITARY; CALCIUM; EXOCYTOSIS; RELEASE; CURRENTS; TEMPERATURE; ENDOCYTOSIS; MAGNESIUM	Using flash photolysis of caged Ca2+ and the membrane capacitance to monitor exocytosis, we have studied the response of single melanotrophs to a step rise in cytosolic Ca2+ concentration ([Ca2+]i). Exocytosis begins with a rapid burst. This burst is followed by a slower phase, which is inhibited at cytosolic pH 6.2, and an ultraslow phase, which is strongly temperature sensitive. The exocytic burst starts with a delay of 6-11 ms and continues at a rate that grows steeply with [Ca2+]i and is half-maximal at [Ca2+]i = 27 muM. At least 3 Ca2+ ions are required to trigger exocytosis. The rate constant at saturating [Ca2+]i suggests that exocytosis of a dense core vesicle takes 40 ms after all Ca2+ ions have bound to the irregulatory sites. If docked dense core vesicles cause the exocytic burst, they must decorate the plasma membrane at a mean density of 0.5/mum2.	UNIV WASHINGTON,DEPT PHYSIOL & BIOPHYS,SEATTLE,WA 98195; MAX PLANCK INST MED RES,MOLEK ZELLFORSCH ABT,W-6900 HEIDELBERG 1,GERMANY	University of Washington; University of Washington Seattle; Max Planck Society	THOMAS, P (corresponding author), UNIV CALIF DAVIS,SCH MED,DEPT HUMAN PHYSIOL,DAVIS,CA 95616, USA.		Thomas, Paul/B-1244-2009	Thomas, Paul/0000-0002-0883-9068	NIAMS NIH HHS [AR-17803] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR017803, R37AR017803] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALMERS W, 1985, FEBS LETT, V192, P13, DOI 10.1016/0014-5793(85)80033-8; Augustine G J, 1992, Curr Opin Neurobiol, V2, P302, DOI 10.1016/0959-4388(92)90119-6; AUGUSTINE GJ, 1992, J PHYSIOL-LONDON, V450, P247, DOI 10.1113/jphysiol.1992.sp019126; AUGUSTINE GJ, 1985, J PHYSIOL-LONDON, V369, P163; BACK N, 1989, CELL TISSUE RES, V255, P405; BITTNER MA, 1992, J BIOL CHEM, V267, P16226; BITTNER MA, 1992, J BIOL CHEM, V267, P16219; BLINKS JR, 1982, PROG BIOPHYS MOL BIO, V40, P1, DOI 10.1016/0079-6107(82)90011-6; BRECKENRIDGE LJ, 1987, NATURE, V328, P814, DOI 10.1038/328814a0; BURGOYNE RD, 1990, ANNU REV PHYSIOL, V52, P647; Chronwall B M, 1988, Peptides, V9 Suppl 1, P169, DOI 10.1016/0196-9781(88)90241-0; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; DOUGLAS WW, 1968, BRIT J PHARMACOL, V34, P451, DOI 10.1111/j.1476-5381.1968.tb08474.x; FIDLERLIM N, 1990, NATURE, V344, P449; GRAFENSTEIN HV, 1986, J CELL BIOL, V103, P2343; HAY JC, 1992, J CELL BIOL, V119, P139, DOI 10.1083/jcb.119.1.139; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; JOSHI C, 1988, BIOPHYS J, V53, P885, DOI 10.1016/S0006-3495(88)83169-2; KAPLAN JH, 1988, P NATL ACAD SCI USA, V85, P6571, DOI 10.1073/pnas.85.17.6571; Katz B., 1969, RELEASE NEURAL TRANS; KNIGHT DE, 1982, J MEMBRANE BIOL, V68, P107, DOI 10.1007/BF01872259; KONISHI M, 1991, J GEN PHYSIOL, V97, P271, DOI 10.1085/jgp.97.2.271; LATTANZIO FA, 1991, BIOCHEM BIOPH RES CO, V177, P184, DOI 10.1016/0006-291X(91)91966-G; LATTANZIO FA, 1990, BIOCHEM BIOPH RES CO, V171, P102, DOI 10.1016/0006-291X(90)91362-V; LINDAU M, 1992, BIOPHYS J, V61, P19, DOI 10.1016/S0006-3495(92)81812-X; LUNDBERG JM, 1982, ACTA PHYSIOL SCAND, V115, P525, DOI 10.1111/j.1748-1716.1982.tb07117.x; MAGLEBY KL, 1972, J PHYSIOL-LONDON, V223, P151, DOI 10.1113/jphysiol.1972.sp009839; MARTELL AE, 1974, CRITICAL STABILITY C, V1, P269; MCCRAY JA, 1992, BIOCHEMISTRY-US, V31, P8856, DOI 10.1021/bi00152a023; MIYAMOTO MD, 1975, J PHYSIOL-LONDON, V250, P121, DOI 10.1113/jphysiol.1975.sp011045; NAVONE F, 1986, J CELL BIOL, V103, P2511, DOI 10.1083/jcb.103.6.2511; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; PUSCH M, 1988, PFLUG ARCH EUR J PHY, V411, P204, DOI 10.1007/BF00582316; RAJU B, 1989, AM J PHYSIOL, V256, pC540, DOI 10.1152/ajpcell.1989.256.3.C540; STACK J, 1991, J PHYSIOL-LONDON, V439, P37, DOI 10.1113/jphysiol.1991.sp018655; Steinbach J.H., 1976, P33; THOMAS P, 1993, EMBO J, V12, P303, DOI 10.1002/j.1460-2075.1993.tb05657.x; THOMAS P, 1990, NEURON, V5, P723, DOI 10.1016/0896-6273(90)90226-6; TSE A, 1993, SCIENCE, V260, P82, DOI 10.1126/science.8385366; WALENT JH, 1992, CELL, V70, P765, DOI 10.1016/0092-8674(92)90310-9; WATHEY JC, 1979, BIOPHYS J, V27, P145, DOI 10.1016/S0006-3495(79)85208-X; ZUCKER RS, 1993, CELL CALCIUM, V14, P87, DOI 10.1016/0143-4160(93)90079-L	43	216	218	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1993	11	1					93	104		10.1016/0896-6273(93)90274-U	http://dx.doi.org/10.1016/0896-6273(93)90274-U			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LP430	8393324				2022-12-24	WOS:A1993LP43000009
J	LITMAN, P; BARG, J; RINDZOONSKI, L; GINZBURG, I				LITMAN, P; BARG, J; RINDZOONSKI, L; GINZBURG, I			SUBCELLULAR-LOCALIZATION OF TAU-MESSENGER RNA IN DIFFERENTIATING NEURONAL CELL-CULTURE - IMPLICATIONS FOR NEURONAL POLARITY	NEURON			English	Article							MICROTUBULE-ASSOCIATED PROTEINS; DEVELOPING RAT-BRAIN; INSITU HYBRIDIZATION; HIPPOCAMPAL-NEURONS; PC12 CELLS; SYNTHETIC MACHINERY; NEURITE OUTGROWTH; GROWTH; EXPRESSION; MAP2	A primary neuronal cell culture derived from whole brains of fetal rats was used to analyze the subcellular localization of tau mRNA, employing nonisotopic detection by in situ hybridization. The culture exhibited a developmental differentiation pattern previously described for neuronal cells in vivo; i.e., a transition from immature to mature tau isoforms as well as segregation of tau into the axons. Our results demonstrate that unlike tubulin mRNA, which is confined to cell bodies, or MAP2 mRNA, which extends into dendrites, tau mRNA was observed to enter the proximal portion of the axon. This sorting of tau mRNA might explain how the tau protein could be selectively delivered to the axon and could have important implications for the development of neuronal polarity.			LITMAN, P (corresponding author), WEIZMANN INST SCI,DEPT NEUROL,IL-76100 REHOVOT,ISRAEL.							BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; BINDER LI, 1984, P NATL ACAD SCI-BIOL, V81, P5613, DOI 10.1073/pnas.81.17.5613; BINDER LI, 1986, ANN NY ACAD SCI, V466, P145, DOI 10.1111/j.1749-6632.1986.tb38392.x; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; BLACK MM, 1982, J CELL BIOL, V95, P379, DOI 10.1083/jcb.95.2.379; BRE MH, 1990, CELL MOTIL CYTOSKEL, V15, P88, DOI 10.1002/cm.970150205; BRUCKENSTEIN DA, 1990, NEURON, V5, P809, DOI 10.1016/0896-6273(90)90340-L; BURGIN KE, 1990, J NEUROSCI, V10, P1788; CACERES A, 1990, NATURE, V343, P461, DOI 10.1038/343461a0; CACERES A, 1984, J NEUROSCI, V4, P394; COUCHIE D, 1985, FEBS LETT, V188, P331, DOI 10.1016/0014-5793(85)80397-5; DANIELS M, 1975, ANN NY ACAD SCI, V253, P535, DOI 10.1111/j.1749-6632.1975.tb19227.x; DIRKS RW, 1989, J HISTOCHEM CYTOCHEM, V37, P7, DOI 10.1177/37.1.2642295; DOTTI CG, 1988, J NEUROSCI, V8, P1454; DOTTI CG, 1987, NEUROSCIENCE, V23, P121, DOI 10.1016/0306-4522(87)90276-4; DRUBIN D, 1988, J CELL BIOL, V106, P1583, DOI 10.1083/jcb.106.5.1583; DRUBIN DG, 1986, J CELL BIOL, V103, P2739, DOI 10.1083/jcb.103.6.2739; DRUBIN DG, 1985, J CELL BIOL, V101, P1799, DOI 10.1083/jcb.101.5.1799; FONTAINE B, 1988, EMBO J, V7, P603, DOI 10.1002/j.1460-2075.1988.tb02853.x; FRANCON J, 1982, EUR J BIOCHEM, V129, P465, DOI 10.1111/j.1432-1033.1982.tb07072.x; GARNER CC, 1988, NATURE, V336, P674, DOI 10.1038/336674a0; GARNER CC, 1988, J CELL BIOL, V106, P779, DOI 10.1083/jcb.106.3.779; GINZBURG I, 1980, NUCLEIC ACIDS RES, V8, P3557; GIUDITTA A, 1990, REGULATION GENE EXPR, P205; HANEMAAIJER R, 1991, J NEUROSCI RES, V30, P163, DOI 10.1002/jnr.490300117; HIROKAWA N, 1988, J CELL BIOL, V107, P1449, DOI 10.1083/jcb.107.4.1449; JIRIKOWSKI GF, 1990, P NATL ACAD SCI USA, V87, P7400, DOI 10.1073/pnas.87.19.7400; KANAI Y, 1992, EMBO J, V11, P3953, DOI 10.1002/j.1460-2075.1992.tb05489.x; KANAI Y, 1989, J CELL BIOL, V109, P1173, DOI 10.1083/jcb.109.3.1173; KEATES RAB, 1988, SCIENCE, V241, P1642, DOI 10.1126/science.3420415; KLEIMAN R, 1990, NEURON, V5, P821, DOI 10.1016/0896-6273(90)90341-C; KOSIK KS, 1989, ANN NEUROL, V26, P352, DOI 10.1002/ana.410260308; KOSIK KS, 1989, NEURON, V2, P1389, DOI 10.1016/0896-6273(89)90077-9; LAWRENCE JB, 1986, CELL, V45, P407, DOI 10.1016/0092-8674(86)90326-0; LEE G, 1990, CELL MOTIL CYTOSKEL, V15, P199, DOI 10.1002/cm.970150402; LEWIS SA, 1989, NATURE, V342, P498, DOI 10.1038/342498a0; LIM SS, 1989, J CELL BIOL, V109, P253, DOI 10.1083/jcb.109.1.253; MATUS A, 1981, P NATL ACAD SCI-BIOL, V78, P3010, DOI 10.1073/pnas.78.5.3010; MATUS A, 1988, ANNU REV NEUROSCI, V11, P29, DOI 10.1146/annurev.neuro.11.1.29; MERLIE JP, 1985, NATURE, V317, P66, DOI 10.1038/317066a0; MOHR E, 1991, EMBO J, V10, P2419, DOI 10.1002/j.1460-2075.1991.tb07781.x; PENG I, 1986, J CELL BIOL, V102, P252, DOI 10.1083/jcb.102.1.252; STEWARD O, 1986, J NEUROSCI, V6, P3079; STEWARD O, 1986, J NEUROSCI, V6, P412; TAKEMURA R, 1991, NEUROSCIENCE, V44, P393, DOI 10.1016/0306-4522(91)90064-U; TIEDGE H, 1991, P NATL ACAD SCI USA, V88, P2093, DOI 10.1073/pnas.88.6.2093; TRAPP BD, 1987, P NATL ACAD SCI USA, V84, P7773, DOI 10.1073/pnas.84.21.7773; TUCKER RP, 1989, NEURON, V2, P1245, DOI 10.1016/0896-6273(89)90309-7; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; YAMADA KM, 1970, P NATL ACAD SCI USA, V66, P1206, DOI 10.1073/pnas.66.4.1206; YAVIN E, 1974, J CELL BIOL, V62, P540, DOI 10.1083/jcb.62.2.540	51	162	164	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1993	10	4					627	638		10.1016/0896-6273(93)90165-N	http://dx.doi.org/10.1016/0896-6273(93)90165-N			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KY501	8476613				2022-12-24	WOS:A1993KY50100007
J	Guo, M; Jan, LY; Jan, YN				Guo, M; Jan, LY; Jan, YN			Control of daughter cell fates during asymmetric division: Interaction of numb and notch	NEURON			English	Article							DROSOPHILA NEUROGENIC GENE; LOOP-HELIX PROTEINS; ORGAN FORMATION; NERVOUS-SYSTEM; FUSHI-TARAZU; MELANOGASTER; LOCUS; EXPRESSION; RECEPTOR; EMBRYOS	During development of the Drosophila peripheral nervous system, a sensory organ precursor (SOP) cell undergoes rounds of asymmetric divisions to generate four distinct cells of a sensory organ. Numb, a membrane-associated protein, is asymmetrically segregated into one daughter cell during SOP division and acts as an inherited determinant of cell fate. Here, we show that Notch, a transmembrane receptor mediating cell-cell communication, functions as a binary switch in cell fate specification during asymmetric divisions of the SOP and its daughter cells in embryogenesis. Moreover, numb negatively regulates Notch, probably through direct protein-protein interaction that requires the phosphotyrosine-binding (PTB) domain of Numb and either the RAM23 region or the very C-terminal end of Notch. Notch then positively regulates a transcription factor encoded by tramtrack (ttk). This leads to Ttk expression in the daughter cell that does not inherit Numb. Thus, the inherited determinant Numb bestows a bias in the machinery for cell-cell communication to allow the specification of distinct daughter cell fates.	UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Guo, M (corresponding author), UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,SAN FRANCISCO,CA 94143, USA.			Jan, Yuh Nung/0000-0003-1367-6299; Jan, Lily/0000-0003-3938-8498				ARTAVANISTSAKONAS S, 1991, TRENDS GENET, V7, P403, DOI 10.1016/0168-9525(91)90264-Q; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; ASHBURNER M, 1982, GENETICS, V101, P447; Ashburner M., 1989, DROSOPHILA LAB HDB; Axelrod JD, 1996, SCIENCE, V271, P1826, DOI 10.1126/science.271.5257.1826; BAILEY AM, 1995, GENE DEV, V9, P2609, DOI 10.1101/gad.9.21.2609; Bang AG, 1995, DEV BIOL, V172, P479, DOI 10.1006/dbio.1995.8033; Bartel P. L., 1993, CELLULAR INTERACTION, P153; BATE CM, 1978, HDB SENSORY PHYSL, P1; BIER E, 1988, SCIENCE, V240, P913, DOI 10.1126/science.3129785; BIERKAMP C, 1993, MECH DEVELOP, V43, P87, DOI 10.1016/0925-4773(93)90027-U; BLOCHLINGER K, 1990, GENE DEV, V4, P1322, DOI 10.1101/gad.4.8.1322; BODMER R, 1987, ROUX ARCH DEV BIOL, V196, P69, DOI 10.1007/BF00402027; BODMER R, 1989, NEURON, V3, P21, DOI 10.1016/0896-6273(89)90112-8; BORK P, 1995, CELL, V80, P693, DOI 10.1016/0092-8674(95)90347-X; BRAND AH, 1993, DEVELOPMENT, V118, P401; BRAND M, 1993, DEVELOPMENT, V119, P1; BREWSTER R, 1995, DEVELOPMENT, V121, P2923; BROWN JL, 1991, EMBO J, V10, P665, DOI 10.1002/j.1460-2075.1991.tb07995.x; CAGAN RL, 1989, GENE DEV, V3, P1099, DOI 10.1101/gad.3.8.1099; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; CAMPOSORTEGA JA, 1988, TRENDS NEUROSCI, V11, P400, DOI 10.1016/0166-2236(88)90077-X; CAMPUZANO S, 1992, TRENDS GENET, V8, P202, DOI 10.1016/0168-9525(92)90234-U; CORBIN V, 1991, CELL, V67, P311, DOI 10.1016/0092-8674(91)90183-Y; DELIDAKIS C, 1992, P NATL ACAD SCI USA, V89, P8731, DOI 10.1073/pnas.89.18.8731; DIEDERICH RJ, 1994, DEVELOPMENT, V120, P473; Doherty D, 1996, GENE DEV, V10, P421, DOI 10.1101/gad.10.4.421; FORTINI ME, 1993, NATURE, V365, P555, DOI 10.1038/365555a0; FORTINI ME, 1994, CELL, V79, P273, DOI 10.1016/0092-8674(94)90196-1; GHYSEN A, 1986, ROUX ARCH DEV BIOL, V195, P281, DOI 10.1007/BF00376060; GHYSEN A, 1993, GENE DEV, V7, P723, DOI 10.1101/gad.7.5.723; GINIGER E, 1993, DEVELOPMENT, V117, P431; GUO M, 1995, NEURON, V14, P913, DOI 10.1016/0896-6273(95)90330-5; HARRISON SD, 1990, EMBO J, V9, P207, DOI 10.1002/j.1460-2075.1990.tb08097.x; HARTENSTEIN V, 1990, DEV BIOL, V142, P13, DOI 10.1016/0012-1606(90)90147-B; HARTENSTEIN V, 1989, DEVELOPMENT, V107, P389; HEITZLER P, 1991, CELL, V64, P1083, DOI 10.1016/0092-8674(91)90263-X; HORVITZ HR, 1992, CELL, V68, P237, DOI 10.1016/0092-8674(92)90468-R; Hsieh JJD, 1996, MOL CELL BIOL, V16, P952; JAN YN, 1995, NEURON, V14, P1; KAVANAUGH WM, 1995, SCIENCE, V268, P1177, DOI 10.1126/science.7539155; KAVANAUGH WM, 1994, SCIENCE, V266, P1862, DOI 10.1126/science.7527937; KIDD S, 1986, MOL CELL BIOL, V6, P3094, DOI 10.1128/MCB.6.9.3094; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; KNUST E, 1992, GENETICS, V132, P505; KOPCZYNSKI CC, 1988, GENE DEV, V2, P1723, DOI 10.1101/gad.2.12b.1723; Laminet AA, 1996, J BIOL CHEM, V271, P264, DOI 10.1074/jbc.271.1.264; LECOURTOIS M, 1995, GENE DEV, V9, P2598, DOI 10.1101/gad.9.21.2598; LEHMANN R, 1983, ROUX ARCH DEV BIOL, V192, P62, DOI 10.1007/BF00848482; LIEBER T, 1993, GENE DEV, V7, P1949, DOI 10.1101/gad.7.10.1949; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; LYMAN DF, 1995, GENETICS, V141, P1491; MATSUNO K, 1995, DEVELOPMENT, V121, P2633; PARKS AL, 1993, DEV BIOL, V157, P484, DOI 10.1006/dbio.1993.1151; POSAKONY JW, 1994, CELL, V76, P415, DOI 10.1016/0092-8674(94)90105-8; READ D, 1992, MECH DEVELOP, V38, P183, DOI 10.1016/0925-4773(92)90052-L; READ D, 1992, EMBO J, V11, P1035, DOI 10.1002/j.1460-2075.1992.tb05142.x; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; REBAY I, 1993, CELL, V74, P319, DOI 10.1016/0092-8674(93)90423-N; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; RHYU MS, 1994, THESIS U CALIFORNIA; RUCHOLA H, 1991, CELL, V66, P433; SCHWEISGUTH F, 1994, DEVELOPMENT, V120, P1433; SPANA EP, 1995, DEVELOPMENT, V121, P3187; STRUHL G, 1993, CELL, V74, P331, DOI 10.1016/0092-8674(93)90424-O; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X; TATA F, 1995, MECH DEVELOP, V51, P305, DOI 10.1016/0925-4773(95)00377-0; UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0; VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8; VAESSIN H, 1987, EMBO (European Molecular Biology Organization) Journal, V6, P3431; VANDERGEER P, 1995, TRENDS BIOCHEM SCI, V20, P277, DOI 10.1016/S0968-0004(00)89043-X; WEINMASTER G, 1991, DEVELOPMENT, V113, P199; WEINMASTER G, 1992, DEVELOPMENT, V116, P931; WHARTON KA, 1985, CELL, V43, P567, DOI 10.1016/0092-8674(85)90229-6; XU T, 1990, GENE DEV, V4, P464, DOI 10.1101/gad.4.3.464; XU T, 1992, DEVELOPMENT, V115, P913; ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2	77	534	548	1	27	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1996	17	1					27	41		10.1016/S0896-6273(00)80278-0	http://dx.doi.org/10.1016/S0896-6273(00)80278-0			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UY981	8755476	Bronze			2022-12-24	WOS:A1996UY98100005
J	Boxall, AR; Lancaster, B; Garthwaite, J				Boxall, AR; Lancaster, B; Garthwaite, J			Tyrosine kinase is required for long-term depression in the cerebellum	NEURON			English	Article							METABOTROPIC GLUTAMATE-RECEPTOR; PURKINJE-CELLS; PROTEIN-KINASE; CALCIUM TRANSIENTS; CLIMBING FIBER; LAVENDUSTIN-A; RAT-BRAIN; ACETYLCHOLINE-RECEPTOR; SYNAPTIC CURRENTS; HERBIMYCIN-A	Long-term depression (LTD) at the parallel fiber-Purkinje cell synapse in the cerebellum is a well-known example of synaptic plasticity. Although LTD is thought to reflect an enduring loss of postsynaptic AMPA receptor sensitivity, the underlying mechanisms are unclear. Protein-tyrosine kinases (PTKs) are able to modulate ionotropic receptor function and are enriched in Purkinje cells. Using intracellular recording from Purkinje cells, it is shown that two structurally and mechanistically distinct PTK inhibitors, lavendustin A and herbimycin A, block LTD induced by pairing parallel fiber stimulation with postsynaptic Ca2+ spiking. Intracellular application of the protein kinase C (PKC) activator, (-)-indolactam V, consistently depressed parallel fiber-Purkinje cell EPSPs and occluded pairing-induced LTD. Herbimycin A nullified the run-down produced by (-)-indolactam V. These data suggest that PTKs are necessary for LTD at the parallel fiber-Purkinje cell synapse and that PKC-induced synaptic depression requires PTK activity.	UCL, CRUCIFORM PROJECT, LONDON W1P 91N, ENGLAND	University of London; University College London	Boxall, AR (corresponding author), UCL, RAYNE INST, CRUCIFORM PROJECT, 5 UNIV ST, LONDON WC1E 6JQ, ENGLAND.							ABE K, 1993, BRAIN RES, V621, P167, DOI 10.1016/0006-8993(93)90315-E; AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; ARAKI K, 1993, BIOCHEM BIOPH RES CO, V197, P1267, DOI 10.1006/bbrc.1993.2614; ARAMORI I, 1992, NEURON, V8, P757, DOI 10.1016/0896-6273(92)90096-V; BATCHELOR AM, 1994, NEUROSCIENCE, V63, P911, DOI 10.1016/0306-4522(94)90558-4; BAUDE A, 1993, NEURON, V11, P771, DOI 10.1016/0896-6273(93)90086-7; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; CREPEL F, 1986, J PHYSIOL-LONDON, V372, P1; CREPEL F, 1988, BRAIN RES, V458, P397, DOI 10.1016/0006-8993(88)90486-6; DANIEL H, 1992, EXP BRAIN RES, V90, P327; DUBOIS PM, 1994, EUR J IMMUNOL, V24, P348, DOI 10.1002/eji.1830240212; EKEROT CF, 1985, BRAIN RES, V342, P357, DOI 10.1016/0006-8993(85)91136-9; FALET H, 1994, FEBS LETT, V345, P87, DOI 10.1016/0014-5793(94)00414-5; FUJIKI H, 1984, GANN, V75, P866; FUKUZAWA H, 1994, FEBS LETT, V340, P155; FUKUZAWA H, 1991, BIOCHEM PHARMACOL, V42, P1661; GARTHWAITE J, 1989, NEUROSCI LETT, V107, P151, DOI 10.1016/0304-3940(89)90808-2; GOLARD A, 1993, J NEUROPHYSIOL, V70, P1639, DOI 10.1152/jn.1993.70.4.1639; GRANDALIANO G, 1994, AM J PHYSIOL-RENAL, V267, pF528, DOI 10.1152/ajprenal.1994.267.4.F528; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; GRONROOS E, 1995, CELL CALCIUM, V17, P177, DOI 10.1016/0143-4160(95)90032-2; HARTELL NA, 1994, NEUROREPORT, V5, P913, DOI 10.1097/00001756-199404000-00015; HARTELL NA, 1994, NEUROREPORT, V5, P833, DOI 10.1097/00001756-199403000-00024; HEMART N, 1995, EUR J NEUROSCI, V7, P45, DOI 10.1111/j.1460-9568.1995.tb01019.x; HIRANO AA, 1988, J NEUROCHEM, V50, P1447, DOI 10.1111/j.1471-4159.1988.tb03029.x; HIRANO T, 1995, NEUROREPORT, V6, P524, DOI 10.1097/00001756-199502000-00029; HOPFIELD JF, 1988, NATURE, V336, P677, DOI 10.1038/336677a0; HSU CYJ, 1991, J BIOL CHEM, V266, P21105; HUANG XY, 1993, CELL, V75, P1145, DOI 10.1016/0092-8674(93)90324-J; HUGANIR RL, 1991, ADV EXP MED BIOL, P279; HUNTER T, 1982, J BIOL CHEM, V257, P4843; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; Ito M, 1990, Neuroreport, V1, P129; KANO M, 1988, NEUROSCI RES, V5, P544, DOI 10.1016/0168-0102(88)90041-7; KASHIWABUCHI N, 1995, CELL, V81, P245, DOI 10.1016/0092-8674(95)90334-8; KASONO K, 1994, NEUROREPORT, V6, P17, DOI 10.1097/00001756-199412300-00006; KONNERTH A, 1992, P NATL ACAD SCI USA, V89, P7051, DOI 10.1073/pnas.89.15.7051; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; KOSE A, 1988, J NEUROSCI, V8, P4262; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; LEVRAM V, 1992, J NEUROPHYSIOL, V68, P1167, DOI 10.1152/jn.1992.68.4.1167; LEVY JB, 1993, J BIOL CHEM, V268, P10573; LIEBENHOFF U, 1993, BIOCHEM J, V295, P41, DOI 10.1042/bj2950041; LINDEN DJ, 1993, NEURON, V11, P1093, DOI 10.1016/0896-6273(93)90222-D; LINDEN DJ, 1991, SCIENCE, V254, P1656, DOI 10.1126/science.1721243; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P197, DOI 10.1113/jphysiol.1980.sp013358; LOMELI H, 1993, FEBS LETT, V315, P318, DOI 10.1016/0014-5793(93)81186-4; MALENKA RC, 1987, BRAIN RES, V403, P198, DOI 10.1016/0006-8993(87)90145-4; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; MARTIN LJ, 1992, NEURON, V9, P259, DOI 10.1016/0896-6273(92)90165-A; MIYAKAWA H, 1992, J NEUROPHYSIOL, V68, P1178, DOI 10.1152/jn.1992.68.4.1178; MOSS SJ, 1995, NATURE, V377, P344, DOI 10.1038/377344a0; MOSS SJ, 1993, NEUROCHEM RES, V18, P105, DOI 10.1007/BF00966929; ODELL TJ, 1991, NATURE, V353, P558, DOI 10.1038/353558a0; ONODA T, 1989, J NAT PROD, V52, P1252, DOI 10.1021/np50066a009; PATSCHINSKY T, 1982, P NATL ACAD SCI-BIOL, V79, P973, DOI 10.1073/pnas.79.4.973; PERKEL DJ, 1990, P ROY SOC B-BIOL SCI, V241, P116, DOI 10.1098/rspb.1990.0074; ROSS WN, 1987, J PHYSIOL-LONDON, V389, P319, DOI 10.1113/jphysiol.1987.sp016659; SAKURAI M, 1987, J PHYSIOL-LONDON, V394, P463, DOI 10.1113/jphysiol.1987.sp016881; SAKURAI M, 1990, P NATL ACAD SCI USA, V87, P3383, DOI 10.1073/pnas.87.9.3383; SCHLESSINGER J, 1992, NEURON, V9, P383, DOI 10.1016/0896-6273(92)90177-F; SHEARDOWN MJ, 1990, SCIENCE, V247, P571, DOI 10.1126/science.2154034; SHIGEMOTO R, 1994, NEURON, V12, P1245, DOI 10.1016/0896-6273(94)90441-3; SICILIANO JC, 1994, J NEUROCHEM, V62, P950; SUGRUE MM, 1990, J NEUROSCI, V10, P2513; TERRIAN DM, 1995, J NEUROCHEM, V64, P172; THOMPSON RF, 1986, SCIENCE, V233, P941, DOI 10.1126/science.3738519; UEHARA Y, 1989, BIOCHEM BIOPH RES CO, V163, P803, DOI 10.1016/0006-291X(89)92293-6; VALENZUELA CF, 1995, MOL BRAIN RES, V31, P165, DOI 10.1016/0169-328X(95)00048-W; VANDERGEER P, 1994, ANNU REV CELL BIOL, V10, P251, DOI 10.1146/annurev.cellbio.10.1.251; WANG YT, 1994, NATURE, V369, P223; ZHAO YH, 1991, ONCOGENE, V6, P1725; ZHAO YH, 1992, P NATL ACAD SCI USA, V89, P8298, DOI 10.1073/pnas.89.17.8298	76	60	61	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	APR	1996	16	4					805	813		10.1016/S0896-6273(00)80100-2	http://dx.doi.org/10.1016/S0896-6273(00)80100-2			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UG611	8607998	Bronze			2022-12-24	WOS:A1996UG61100013
J	Inestrosa, NC; Alvarez, A; Perez, CA; Moreno, RD; Vicente, M; Linker, C; Casanueva, OI; Soto, C; Garrido, J				Inestrosa, NC; Alvarez, A; Perez, CA; Moreno, RD; Vicente, M; Linker, C; Casanueva, OI; Soto, C; Garrido, J			Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils: Possible role of the peripheral site of the enzyme	NEURON			English	Article							CORTICAL CHOLINERGIC INNERVATION; HEPARAN-SULFATE PROTEOGLYCANS; MOLECULAR-FORMS; NEURITIC PLAQUES; EXTRACELLULAR-MATRIX; CEREBROSPINAL-FLUID; TORPEDO-CALIFORNICA; SENILE DEMENTIA; CEREBRAL-CORTEX; SELECTIVE LOSS	Acetylcholinesterase (AChE), an important component of cholinergic synapses, colocalizes with amyloid-beta peptide (A beta) deposits of Alzheimer's brain. We report here that bovine brain AChE, as well as the human and mouse recombinant enzyme, accelerates amyloid formation from wild-type A beta and a mutant A beta peptide, which alone produces few amyloid-like fibrils. The action of AChE was independent of the subunit array of the enzyme, was not affected by edrophonium, an active site inhibitor, but it was affected by propidium, a peripheral anionic binding site ligand. Butyrylcholinesterase, an enzyme that lacks the peripheral site, did not affect amyloid formation. Furthermore, AChE is a potent amyloid-promoting factor when compared with other A beta-associated proteins. Thus, in addition to its role in cholinergic synapses, AChE may function by accelerating A beta formation and could play a role during amyloid deposition in Alzheimer's brain.			Inestrosa, NC (corresponding author), PONTIFICIA UNIV CATOLICA CHILE, FAC CIENCIAS BIOL, DEPT BIOL CELULAR & MOLEC, ALAMEDA 340, SANTIAGO, CHILE.		Perez, Cristian A./A-2341-2008; Moreno, Ricardo R/C-6802-2011	Alvarez Rojas, Alejandra/0000-0002-8129-9280				Alvarez A, 1995, NEUROSCI LETT, V201, P49, DOI 10.1016/0304-3940(94)12127-C; Amitai G, 1991, CHOLINESTERASES STRU, V285; ARENDT T, 1992, NEUROCHEM INT, V21, P381, DOI 10.1016/0197-0186(92)90189-X; ATACK JR, 1983, NEUROSCI LETT, V40, P199, DOI 10.1016/0304-3940(83)90302-6; BARAK D, 1994, J BIOL CHEM, V269, P6296; BARROW CJ, 1992, J MOL BIOL, V225, P1075, DOI 10.1016/0022-2836(92)90106-T; BEERI R, 1995, CURR BIOL, V5, P1063, DOI 10.1016/S0960-9822(95)00211-9; BERGMANN F, 1950, BIOCHIM BIOPHYS ACTA, V6, P217, DOI 10.1016/0006-3002(50)90094-1; BERGMANN F, 1954, BIOCHEM J, V58, P692, DOI 10.1042/bj0580692; Bondi Mark W., 1994, P41; BOURNE Y, 1995, CELL, V83, P503, DOI 10.1016/0092-8674(95)90128-0; BRANDAN E, 1993, GEN PHARMACOL, V24, P1063, DOI 10.1016/0306-3623(93)90350-7; BRANDAN E, 1985, J CELL BIOL, V101, P985, DOI 10.1083/jcb.101.3.985; CARSON KA, 1991, BRAIN RES, V540, P204, DOI 10.1016/0006-8993(91)90508-S; CASTANO EM, 1995, BIOCHEM J, V306, P599, DOI 10.1042/bj3060599; CASTANO EM, 1986, BIOCHEM BIOPH RES CO, V141, P782, DOI 10.1016/S0006-291X(86)80241-8; CHANGEUX JP, 1966, MOL PHARMACOL, V2, P369; CHATONNET A, 1989, BIOCHEM J, V260, P625, DOI 10.1042/bj2600625; COYLE JT, 1983, SCIENCE, V219, P1184, DOI 10.1126/science.6338589; DEPREZ PN, 1995, J BIOL CHEM, V270, P11043, DOI 10.1074/jbc.270.19.11043; EICHLER J, 1994, MOL PHARMACOL, V45, P335; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; EVANS KC, 1995, P NATL ACAD SCI USA, V92, P763, DOI 10.1073/pnas.92.3.763; FISHMAN EB, 1986, ANN NEUROL, V19, P246, DOI 10.1002/ana.410190305; FUENTES ME, 1988, BIOCHEM J, V256, P1047, DOI 10.1042/bj2561047; GEULA C, 1989, BRAIN RES, V498, P185, DOI 10.1016/0006-8993(89)90419-8; Geula Changiz, 1994, P263; GHISO J, 1993, BIOCHEM J, V293, P27, DOI 10.1042/bj2930027; GOMEZRAMOS P, 1992, BRAIN RES, V569, P229, DOI 10.1016/0006-8993(92)90634-L; HALL ZW, 1971, NATURE-NEW BIOL, V232, P62, DOI 10.1038/newbio232062a0; Harel M, 1995, STRUCTURE, V3, P1355, DOI 10.1016/S0969-2126(01)00273-8; HAREL M, 1992, MULTIDISCIPLINARY AP, P233; INESTROSA NC, 1988, NEUROSCI LETT, V90, P186, DOI 10.1016/0304-3940(88)90809-9; INESTROSA NC, 1987, J BIOL CHEM, V262, P4441; INESTROSA NC, 1983, EXP CELL RES, V147, P393, DOI 10.1016/0014-4827(83)90221-5; INESTROSA NC, 1990, J MEMBRANE BIOL, V118, P1, DOI 10.1007/BF01872200; INESTROSA NC, 1989, TRENDS PHARMACOL SCI, V10, P325, DOI 10.1016/0165-6147(89)90067-9; IVERSEN LL, 1995, BIOCHEM J, V311, P1; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; KALARIA RN, 1991, NEUROPATH APPL NEURO, V17, P189, DOI 10.1111/j.1365-2990.1991.tb00714.x; Katzman Robert, 1994, P105; KIRSCHNER DA, 1987, P NATL ACAD SCI USA, V84, P6953, DOI 10.1073/pnas.84.19.6953; LANSBURY PT, 1992, BIOCHEMISTRY-US, V31, P6865, DOI 10.1021/bi00145a001; LAYER PG, 1993, CELL TISSUE RES, V273, P219, DOI 10.1007/BF00312823; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; MA JY, 1994, NATURE, V372, P92, DOI 10.1038/372092a0; MAIN AR, 1976, BIOL CHOLINERGIC FUN, P269; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; MESULAM MM, 1987, ANN NEUROL, V22, P683, DOI 10.1002/ana.410220603; MESULAM MM, 1986, NEUROSCIENCE, V17, P275, DOI 10.1016/0306-4522(86)90242-3; MESULAM MM, 1988, ANN NEUROL, V24, P765, DOI 10.1002/ana.410240611; MORAN MA, 1993, ACTA NEUROPATHOL, V85, P362, DOI 10.1007/BF00334445; NAIKI H, 1991, LAB INVEST, V65, P104; Nakamura S, 1990, J Neural Transm Suppl, V30, P13; NAVARATNAM DS, 1991, LANCET, V337, P447, DOI 10.1016/0140-6736(91)93391-L; PERRY EK, 1978, BRIT MED J, V2, P1457, DOI 10.1136/bmj.2.6150.1457; RADIC Z, 1991, MOL PHARMACOL, V39, P98; RADIC Z, 1993, BIOCHEMISTRY-US, V32, P12074, DOI 10.1021/bi00096a018; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SELKOE DJ, 1994, ANNU REV NEUROSCI, V17, P489, DOI 10.1146/annurev.neuro.17.1.489; SHEN ZX, 1994, MED HYPOTHESES, V43, P21, DOI 10.1016/0306-9877(94)90045-0; SILMAN I, 1994, BIOCHEM SOC T, V22, P745, DOI 10.1042/bst0220745; SMITH AD, 1984, LANCET, V1, P513; SNOW AD, 1994, NEURON, V12, P219, DOI 10.1016/0896-6273(94)90165-1; SNOW AD, 1988, AM J PATHOL, V133, P456; SOTO C, 1994, J NEUROCHEM, V63, P1191; SOTO C, 1995, J BIOL CHEM, V270, P3063, DOI 10.1074/jbc.270.7.3063; STRUBLE RG, 1982, SCIENCE, V216, P413, DOI 10.1126/science.6803359; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; Sussman JL, 1992, CURR OPIN STRUC BIOL, V2, P721; TAGLIAVINI F, 1988, NEUROSCI LETT, V93, P191, DOI 10.1016/0304-3940(88)90080-8; TAYLOR P, 1994, ANNU REV PHARMACOL, V34, P281, DOI 10.1146/annurev.pa.34.040194.001433; TAYLOR P, 1975, BIOCHEMISTRY-US, V14, P1989, DOI 10.1021/bi00680a029; Terry Robert D., 1994, P179; VELAN B, 1991, J BIOL CHEM, V266, P23977; VELLOM DC, 1993, BIOCHEMISTRY-US, V32, P12, DOI 10.1021/bi00052a003; WEISE C, 1990, EMBO J, V9, P3885, DOI 10.1002/j.1460-2075.1990.tb07607.x; WHITEHOUSE PJ, 1981, ANN NEUROL, V10, P122, DOI 10.1002/ana.410100203; WILSON IB, 1958, ARCH BIOCHEM BIOPHYS, V73, P131, DOI 10.1016/0003-9861(58)90248-0; WINKLER J, 1995, NATURE, V375, P484, DOI 10.1038/375484a0; WISNIEWSKI T, 1991, BIOCHEM BIOPH RES CO, V179, P1247, DOI 10.1016/0006-291X(91)91706-I; WISNIEWSKI T, 1992, NEUROSCI LETT, V135, P235, DOI 10.1016/0304-3940(92)90444-C; WRIGHT CI, 1993, P NATL ACAD SCI USA, V90, P683, DOI 10.1073/pnas.90.2.683; YOUNKIN SG, 1986, FASEB J, V45, P2982	86	937	960	4	84	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1996	16	4					881	891		10.1016/S0896-6273(00)80108-7	http://dx.doi.org/10.1016/S0896-6273(00)80108-7			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UG611	8608006	hybrid			2022-12-24	WOS:A1996UG61100021
J	Sun, ZP; Akabas, MH; Goulding, EH; Karlin, A; Siegelbaum, SA				Sun, ZP; Akabas, MH; Goulding, EH; Karlin, A; Siegelbaum, SA			Exposure of residues in the cyclic nucleotide-gated channel pore: P region structure and function in gating	NEURON			English	Article							POTASSIUM CHANNELS; ION PERMEATION; K+ CHANNELS; SODIUM-CHANNEL; RECEPTOR; SELECTIVITY; EXPRESSION; DROSOPHILA; MUTATIONS; PATHWAYS	In voltage-gated ion channels and in the homologous cyclic nucleotide-gated (CNG) channels, the loop between the S5 and S6 transmembrane segments (P region) is thought to form the lining of the pore. To investigate the structure and the role in gating of the P region of the bovine retinal CNG channel, we determined the accessibility of 11 cysteine-substituted P region residues to small, charged sulfhydryl reagents applied to the inside and outside of membrane patches in the open and closed states of the channel. The results suggest that the P region forms a loop that extends toward the central axis of the channel, analogous to the L3 loop of bacterial porin channels. Furthermore, the P region, in addition to forming the ion selectivity filter, functions as the channel gate, the structure of which changes when the channel opens.	COLUMBIA UNIV COLL PHYS & SURG,DEPT PHYSIOL,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,DEPT BIOCHEM,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,DEPT MED,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,DEPT NEUROL,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,CTR NEUROBIOL & BEHAV,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,CTR MOLEC RECOGNIT,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,HOWARD HUGHES MED INST,NEW YORK,NY 10032	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute	Sun, ZP (corresponding author), COLUMBIA UNIV COLL PHYS & SURG,DEPT PHARMACOL,630 W 168TH ST,NEW YORK,NY 10032, USA.			Akabas, Myles/0000-0001-8781-7846; KARLIN, ARTHUR/0000-0002-4813-752X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030808] Funding Source: NIH RePORTER; NINDS NIH HHS [NS07065, NS30808] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; CATTERALL WA, 1993, TRENDS NEUROSCI, V16, P500, DOI 10.1016/0166-2236(93)90193-P; CHOI KL, 1993, NEURON, V10, P533, DOI 10.1016/0896-6273(93)90340-W; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; DURELL SR, 1992, BIOPHYS J, V62, P238, DOI 10.1016/S0006-3495(92)81809-X; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; GOULDING EH, 1993, NATURE, V364, P61, DOI 10.1038/364061a0; GOULDING EH, 1992, NEURON, V8, P45, DOI 10.1016/0896-6273(92)90107-O; GOULDING EH, 1994, NATURE, V372, P369, DOI 10.1038/372369a0; GUY HR, 1986, P NATL ACAD SCI USA, V83, P508, DOI 10.1073/pnas.83.2.508; GUY HR, 1991, SCIENCE, V254, P730, DOI 10.1126/science.1658932; HARTMANN HA, 1991, SCIENCE, V251, P942, DOI 10.1126/science.2000495; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; HEGINBOTHAM L, 1992, SCIENCE, V258, P1152, DOI 10.1126/science.1279807; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; HILLE B, 1977, J GEN PHYSIOL, V69, P497, DOI 10.1085/jgp.69.4.497; ISACOFF EY, 1991, NATURE, V353, P86, DOI 10.1038/353086a0; JAN LY, 1990, NATURE, V345, P672, DOI 10.1038/345672a0; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; KIRSCH GE, 1993, NEURON, V11, P503, DOI 10.1016/0896-6273(93)90154-J; KRAMER RH, 1994, NEURON, V12, P655, DOI 10.1016/0896-6273(94)90220-8; KURZ LL, 1995, BIOPHYS J, V68, P900, DOI 10.1016/S0006-3495(95)80266-3; LOPEZ GA, 1994, NATURE, V367, P179, DOI 10.1038/367179a0; LU Q, 1995, SCIENCE, V268, P304, DOI 10.1126/science.7716526; MACKINNON R, 1995, NEURON, V14, P889, DOI 10.1016/0896-6273(95)90327-5; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; MILLER C, 1991, SCIENCE, V252, P1092, DOI 10.1126/science.252.5009.1092; MILLER C, 1995, NEURON, V15, P5, DOI 10.1016/0896-6273(95)90057-8; PASCUAL JM, 1995, NEURON, V14, P1055, DOI 10.1016/0896-6273(95)90344-5; ROOT MJ, 1993, NEURON, V11, P459, DOI 10.1016/0896-6273(93)90150-P; SCHIRMER T, 1995, SCIENCE, V267, P512, DOI 10.1126/science.7824948; SLESINGER PA, 1993, NEURON, V11, P739, DOI 10.1016/0896-6273(93)90083-4; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; WEISS MS, 1991, SCIENCE, V254, P1627, DOI 10.1126/science.1721242; YANG J, 1993, NATURE, V366, P158, DOI 10.1038/366158a0; YAU KW, 1989, ANNU REV NEUROSCI, V12, P289, DOI 10.1146/annurev.ne.12.030189.001445; YELLEN G, 1991, NATURE, V349, P700; YOOL AJ, 1991, NATURE, V349, P700, DOI 10.1038/349700a0	41	101	102	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1996	16	1					141	149		10.1016/S0896-6273(00)80031-8	http://dx.doi.org/10.1016/S0896-6273(00)80031-8			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TT307	8562078	hybrid			2022-12-24	WOS:A1996TT30700017
J	OGAWA, M; MIYATA, T; NAKAJIMA, K; YAGYU, K; SEIKE, M; IKENAKA, K; YAMAMOTO, H; MIKOSHIBA, K				OGAWA, M; MIYATA, T; NAKAJIMA, K; YAGYU, K; SEIKE, M; IKENAKA, K; YAMAMOTO, H; MIKOSHIBA, K			THE REELER GENE-ASSOCIATED ANTIGEN ON CAJAL-RETZIUS NEURONS IS A CRUCIAL MOLECULE FOR LAMINAR ORGANIZATION OF CORTICAL-NEURONS	NEURON			English	Article							EARLIEST GENERATED CELLS; CEREBRAL-CORTEX; MARGINAL ZONE; MUTANT MICE; CEREBELLAR CORTEX; MONKEY NEOCORTEX; EMBRYONIC MOUSE; RAT NEOCORTEX; VISUAL-CORTEX; RHESUS-MONKEY	In the neurological mutant mouse reeler, the histological organization of the neocortex develops abnormally and essentially results in an inversion of the relative positions of the cortical layers. The reeler mutation, therefore, provides an insight into the molecular mechanisms underlying the formation of the cortical layers. We have generated a monoclonal antibody (CR-50) that probes a distinct allelic antigen present in wild-type but not in reeler mutant mice. CR-50 reacted specifically with Cajal-Retzius neurons, one of the first cortical neurons to differentiate in the neocortex, but whose functional role is not known. When dissociated cerebral cortical cells were incubated with CR-50 in reaggregation culture, the genotype-dependent histogenetic assembly of wild-type cortical cells resembled that of reeler mutants. These findings revealed that the selective expression of a distinct molecule on Cajal-Retzius neurons is critical for the normal lamination of cortical neurons in the mammalian neocortex.	KOCHI MED SCH, MED RES LAB, KOCHI 783, JAPAN; RIKEN, INST PHYS & CHEM RES, TSUKUBA LIFE SCI CTR, MOLEC NEUROBIOL LAB, IBARAKI 305, OSAKA, JAPAN; UNIV TOKYO, INST MED SCI, DEPT MOLEC NEUROBIOL, TOKYO 108, JAPAN; NATL INST PHYSIOL SCI, NEURAL INFORMAT LAB, OKAZAKI, AICHI 444, JAPAN; NATL INST NEUROSCI, DEPT IMMUNOL, TOKYO 187, JAPAN	Kochi University; RIKEN; University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); National Center for Neurology & Psychiatry - Japan	OGAWA, M (corresponding author), KOCHI MED SCH, DEPT PHYSIOL, KOCHI 783, JAPAN.		Nakajima, Kazunori/L-3396-2013; MIYATA, TAKAKI/I-7066-2014; Mikoshiba, Katsuhiko/N-7943-2015	Nakajima, Kazunori/0000-0003-1864-9425; 				ALLENDOERFER KL, 1994, ANNU REV NEUROSCI, V17, P185, DOI 10.1146/annurev.neuro.17.1.185; ALTMAN J, 1972, J COMP NEUROL, V145, P353, DOI 10.1002/cne.901450305; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; ANGEVINE JB, 1965, EXP NEUROL        S2, V13, P1; BAYER SA, 1990, EXP NEUROL, V107, P48, DOI 10.1016/0014-4886(90)90062-W; BERRY M, 1965, J ANAT, V99, P691; BOTTENSTEIN JE, 1985, CELL CULTURE NEUROSC, P3; BRADFORD R, 1977, J COMP NEUROL, V176, P121, DOI 10.1002/cne.901760108; CAVINESS VS, 1978, ANNU REV NEUROSCI, V1, P297, DOI 10.1146/annurev.ne.01.030178.001501; CAVINESS VS, 1982, DEV BRAIN RES, V4, P293, DOI 10.1016/0165-3806(82)90141-9; CAVINESS VS, 1973, J COMP NEUROL, V148, P141, DOI 10.1002/cne.901480202; CAVINESS VS, 1988, CEREB CORTEX, V7, P59; CHUN JJM, 1989, J NEUROSCI, V9, P1648; CRANDALL JE, 1986, DEV BRAIN RES, V28, P127, DOI 10.1016/0165-3806(86)90072-6; DELONG GR, 1970, DEV BIOL, V22, P584, DOI 10.1016/0012-1606(70)90170-3; DELONG GR, 1970, DEV BIOL, V22, P563, DOI 10.1016/0012-1606(70)90169-7; DERER P, 1977, BRAIN RES, V123, P27, DOI 10.1016/0006-8993(77)90641-2; DERER P, 1990, NEUROSCIENCE, V36, P839, DOI 10.1016/0306-4522(90)90027-2; DERER P, 1985, NEUROSCI LETT, V54, P1; DERNONCOURT C, 1991, GENOMICS, V11, P1167, DOI 10.1016/0888-7543(91)90049-K; DUCKETT S, 1968, J ANAT, V102, P183; EDMUNDS SM, 1982, J NEUROCYTOL, V11, P427, DOI 10.1007/BF01257987; FALCONER DS, 1951, J GENET, V50, P192, DOI 10.1007/BF02996215; GARBER BB, 1980, BRAIN RES, V201, P255, DOI 10.1016/0006-8993(80)91035-5; GOFFINET AM, 1979, ANAT EMBRYOL, V157, P205, DOI 10.1007/BF00305160; GOFFINET AM, 1984, BRAIN RES REV, V7, P261, DOI 10.1016/0165-0173(84)90013-4; GOFFINET AM, 1984, J ANAT, V138, P207; HUNTLEY GW, 1990, J NEUROCYTOL, V19, P200, DOI 10.1007/BF01217298; KONIG N, 1977, NEUROSCI LETT, V4, P21, DOI 10.1016/0304-3940(77)90118-5; KOSTOVIC I, 1990, J COMP NEUROL, V297, P441, DOI 10.1002/cne.902970309; LARROCHE JC, 1981, ANAT EMBRYOL, V162, P301, DOI 10.1007/BF00299974; LUSKIN MB, 1985, J NEUROSCI, V5, P1062; MARINPADILLA M, 1978, ANAT EMBRYOL, V152, P109, DOI 10.1007/BF00315920; MARINPADILLA M, 1982, ANAT EMBRYOL, V164, P161, DOI 10.1007/BF00318504; MARINPADILLA M, 1971, Z ANAT ENTWICKLUNGS, V134, P117, DOI 10.1007/BF00519296; MARTIN MR, 1981, J COMP NEUROL, V197, P141, DOI 10.1002/cne.901970111; MCCONNELL SK, 1992, DETERMINANTS NEURONA, P391; NIINOBE M, 1988, J NEUROCHEM, V51, P1132, DOI 10.1111/j.1471-4159.1988.tb03078.x; PINTOLORD MC, 1979, J COMP NEUROL, V187, P49, DOI 10.1002/cne.901870104; RAEDLER A, 1976, ANAT EMBRYOL, V149, P173, DOI 10.1007/BF00317896; RAEDLER E, 1978, ANAT EMBRYOL, V154, P267, DOI 10.1007/BF00345657; RAKIC P, 1981, J COMP NEUROL, V196, P99, DOI 10.1002/cne.901960109; RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; RICKMANN M, 1977, ANAT EMBRYOL, V151, P285, DOI 10.1007/BF00318931; RYDER EF, 1994, NEURON, V12, P1011, DOI 10.1016/0896-6273(94)90310-7; SCHLESSINGER AR, 1978, ANAT EMBRYOL, V154, P153, DOI 10.1007/BF00304660; SHATZ CJ, 1988, CEREB CORTEX, V7, P35; SHOUKIMAS GM, 1978, J COMP NEUROL, V179, P795, DOI 10.1002/cne.901790407; SINGER HS, 1983, J NEUROCHEM, V41, P874, DOI 10.1111/j.1471-4159.1983.tb04821.x; SORIANO E, 1994, J COMP NEUROL, V340, P1; STANFIELD BB, 1979, J COMP NEUROL, V185, P423, DOI 10.1002/cne.901850303; WATANABE T, 1990, NEURON, V4, P461, DOI 10.1016/0896-6273(90)90058-N; WOOD JG, 1992, DEV BRAIN RES, V66, P137, DOI 10.1016/0165-3806(92)90150-U; WYSS JM, 1980, BRAIN RES, V188, P566, DOI 10.1016/0006-8993(80)90056-6; WYSS JM, 1983, J COMP NEUROL, V221, P341, DOI 10.1002/cne.902210309	56	739	759	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	1995	14	5					899	912		10.1016/0896-6273(95)90329-1	http://dx.doi.org/10.1016/0896-6273(95)90329-1			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QY935	7748558	Bronze			2022-12-24	WOS:A1995QY93500003
J	MARTIN, PT; SANES, JR				MARTIN, PT; SANES, JR			ROLE FOR A SYNAPSE-SPECIFIC CARBOHYDRATE IN AGRIN-INDUCED CLUSTERING OF ACETYLCHOLINE-RECEPTORS	NEURON			English	Article							BIFLORUS AGGLUTININ RECEPTORS; RAT NEUROMUSCULAR-JUNCTION; CULTURED MUSCLE-CELLS; BASAL LAMINA; MOUSE MUSCLE; FIBROBLAST GROWTH; HEPARAN-SULFATE; SKELETAL-MUSCLE; BINDING-SITES; AGGREGATION	Lectins such as VVA-B-4, which bind N-acetylgalactosaminyl (GalNAc)-terminated saccharides, selectively stain the neuromuscular junction, thus defining a synapse-specific carbohydrate. In seeking roles for this carbohydrate, we asked whether VVA-B-4 affected the distribution of acetylcholine receptors (AChRs) on cultured muscle cells. We found that incubation of myotubes with VVA-B-4 induced formation of AChR clusters and potentiated the effect of a nerve-derived clustering factor, agrin. Additional experiments implicated GalNAc-terminated glycoconjugates as modulators of agrin-induced AChR clustering. Enzymatic removal of GalNAc residues or treatment with a multivalent protein-GalNAc conjugate blocked agrin-induced clustering, whereas enzymatic unmasking of additional GalNAc residues induced clustering in the absence of added agrin. Moreover, incubation with agrin led to redistribution of VVA-B-4-binding material on myotubes. Together, these results suggest that agrin-induced clustering of AChRs involves a GalNAc-dependent step.			MARTIN, PT (corresponding author), WASHINGTON UNIV, SCH MED, DEPT ANAT & NEUROBIOL, ST LOUIS, MO 63110 USA.			Martin, Paul/0000-0002-0674-6191				ACHESON A, 1991, J CELL BIOL, V114, P143, DOI 10.1083/jcb.114.1.143; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; BOWE MA, 1994, NEURON, V12, P1173, DOI 10.1016/0896-6273(94)90324-7; Brown J C, 1978, Int Rev Cytol, V52, P277, DOI 10.1016/S0074-7696(08)60758-5; CAMPANELLI JT, 1992, COLD SPRING HARB SYM, V57, P461, DOI 10.1101/SQB.1992.057.01.051; CAMPANELLI JT, 1994, CELL, V77, P663, DOI 10.1016/0092-8674(94)90051-5; CERI H, 1985, MUSCLE NERVE, V8, P710, DOI 10.1002/mus.880080814; CERI H, 1981, J BIOL CHEM, V256, P390; CHRISTIAN CN, 1978, P NATL ACAD SCI USA, V75, P4011, DOI 10.1073/pnas.75.8.4011; CRNEFINDERLE N, 1993, J NEUROSCI RES, V34, P67, DOI 10.1002/jnr.490340108; DRICKAMER K, 1993, ANNU REV CELL BIOL, V9, P237, DOI 10.1146/annurev.cb.09.110193.001321; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; Feizi Ten, 1993, Current Opinion in Structural Biology, V3, P701, DOI 10.1016/0959-440X(93)90053-N; FERNS M, 1992, NEURON, V8, P1079, DOI 10.1016/0896-6273(92)90129-2; FERNS MJ, 1993, NEURON, V11, P491, DOI 10.1016/0896-6273(93)90153-I; FOX N, 1982, EXP CELL RES, V140, P331, DOI 10.1016/0014-4827(82)90122-7; GEE SH, 1994, CELL, V77, P675, DOI 10.1016/0092-8674(94)90052-3; GODFREY EW, 1984, J CELL BIOL, V99, P615, DOI 10.1083/jcb.99.2.615; GORDON H, 1993, J NEUROSCI, V13, P586; HALL H, 1993, EUR J NEUROSCI, V5, P34, DOI 10.1111/j.1460-9568.1993.tb00202.x; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; HOLTHOFER H, 1983, J HISTOCHEM CYTOCHEM, V31, P531, DOI 10.1177/31.4.6827083; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; IGLESIAS M, 1992, HISTOCHEMISTRY, V97, P125, DOI 10.1007/BF00267302; INESTROSA NC, 1983, EXP CELL RES, V147, P393, DOI 10.1016/0014-4827(83)90221-5; JESSELL TM, 1990, ANNU REV NEUROSCI, V13, P227, DOI 10.1146/annurev.ne.13.030190.001303; KAHN CR, 1978, P NATL ACAD SCI USA, V75, P4209, DOI 10.1073/pnas.75.9.4209; KAUPMANN K, 1988, EUR J CELL BIOL, V46, P419; KAUPMANN K, 1988, EUR J CELL BIOL, V46, P411; LAITINEN L, 1989, ANAT REC, V223, P311, DOI 10.1002/ar.1092230310; LASKY LA, 1992, SCIENCE, V258, P964, DOI 10.1126/science.1439808; Lee Reiko T., 1994, P23; MA JY, 1993, J BIOL CHEM, V268, P25108; MAIMONE MM, 1993, NEURON, V11, P53, DOI 10.1016/0896-6273(93)90270-2; Margolis RU, 1989, NEUROBIOLOGY GLYCOCO; McMahan Uel J., 1992, Current Opinion in Cell Biology, V4, P869, DOI 10.1016/0955-0674(92)90113-Q; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; NASTUK MA, 1993, TRENDS NEUROSCI, V16, P72, DOI 10.1016/0166-2236(93)90020-M; OLEK AJ, 1986, J NEUROSCI, V6, P487; PHILLIPS WD, 1993, J CELL BIOL, V123, P729, DOI 10.1083/jcb.123.3.729; PHILLIPS WD, 1991, SCIENCE, V251, P568, DOI 10.1126/science.1703661; PONDER BAJ, 1985, J EMBRYOL EXP MORPH, V87, P229; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; REIST NE, 1992, NEURON, V8, P865, DOI 10.1016/0896-6273(92)90200-W; RIBERA J, 1987, CELL TISSUE RES, V248, P111, DOI 10.1007/BF01239970; SALPETER MM, 1982, J CELL BIOL, V93, P417, DOI 10.1083/jcb.93.2.417; SANES JR, 1984, J NEUROSCI, V4, P464; SANES JR, 1982, NATURE, V300, P646, DOI 10.1038/300646a0; SCOTT LJC, 1988, J NEUROSCI, V8, P932; SCOTT LJC, 1990, J NEUROSCI, V10, P346; SILBERSTEIN L, 1982, NATURE, V295, P143, DOI 10.1038/295143a0; SUGIYAMA J, 1994, NEURON, V13, P103, DOI 10.1016/0896-6273(94)90462-6; TOLLEFSEN SE, 1983, J BIOL CHEM, V258, P5165; WALLACE BG, 1990, J NEUROSCI, V10, P3576; WALLACE BG, 1992, J NEUROBIOL, V23, P592, DOI 10.1002/neu.480230512; WALLACE BG, 1988, J CELL BIOL, V107, P267, DOI 10.1083/jcb.107.1.267; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W	59	75	75	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1995	14	4					743	754		10.1016/0896-6273(95)90218-X	http://dx.doi.org/10.1016/0896-6273(95)90218-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QU826	7718237	Bronze			2022-12-24	WOS:A1995QU82600008
J	PARTIN, KM; BOWIE, D; MAYER, ML				PARTIN, KM; BOWIE, D; MAYER, ML			STRUCTURAL DETERMINANTS OF ALLOSTERIC REGULATION IN ALTERNATIVELY SPLICED AMPA RECEPTORS	NEURON			English	Article							D-ASPARTATE RECEPTOR; GLUTAMATE RECEPTORS; HIPPOCAMPAL-NEURONS; MOLECULAR-CLONING; PREGNENOLONE SULFATE; SYNAPTIC CURRENTS; DESENSITIZATION; MODULATION; CHANNELS; KAINATE	The flip and flop splice variants of AMPA receptors show strikingly different sensitivity to allosteric regulation by cyclothiazide; heteromers assembled from GluR-A and GluR-B also exhibit splice variant-dependent differences in efficacy for activation by glutamate and kainate. The sensitivity for attenuation of desensitization by cyclothiazide for homomeric GluR-A was solely dependent upon exchange of Ser-750 (flip) and Asn-750 (flop), and was unaffected by mutagenesis of other divergent residues. In contrast, substantial alteration of the relative efficacy of glutamate versus kainate required mutation of multiple residues in the flip/flop region. Modulation by cyclothiazide was abolished by mutation of Ser-750 to Gln, the residue found at the homologous site in kainate-preferring subunits, whereas introduction of Ser at this site in GluR6 imparted sensitivity to cyclothiazide.			PARTIN, KM (corresponding author), NICHHD,CELLULAR & MOLEC NEUROPHYSIOL LAB,BETHESDA,MD 20892, USA.		Partin, Kathryn/A-8706-2015; Mayer, Mark L/H-5500-2013; Mayer, Mark/AAE-7356-2019; Partin, Kathryn/AAI-5412-2021	Partin, Kathryn/0000-0003-3801-3299; Mayer, Mark/0000-0003-4378-8451; Partin, Kathryn/0000-0003-3801-3299; Bowie, Derek/0000-0001-9491-8768				BENNETT JA, 1995, NEURON, V14, P373, DOI 10.1016/0896-6273(95)90293-7; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; BOWLBY MR, 1993, MOL PHARMACOL, V43, P813; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; COLLINGRIDGE GL, 1989, PHARMACOL REV, V41, P143; EGEBJERG J, 1991, NATURE, V351, P745, DOI 10.1038/351745a0; GALLO V, 1992, J NEUROSCI, V12, P1010; HERLITZE S, 1993, NEURON, V10, P1131, DOI 10.1016/0896-6273(93)90061-U; HESTRIN S, 1993, NEURON, V11, P1083, DOI 10.1016/0896-6273(93)90221-C; HOLLMANN M, 1994, NEURON, V13, P1331, DOI 10.1016/0896-6273(94)90419-7; ISAACSON JS, 1991, P NATL ACAD SCI USA, V88, P10936, DOI 10.1073/pnas.88.23.10936; JONAS P, 1994, NEURON, V12, P1281, DOI 10.1016/0896-6273(94)90444-8; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; KOHLER M, 1994, J BIOL CHEM, V269, P17367; KURYATOV A, 1994, NEURON, V12, P1291, DOI 10.1016/0896-6273(94)90445-6; LIVSEY CT, 1992, NEURON, V8, P745, DOI 10.1016/0896-6273(92)90095-U; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; MCBAIN CJ, 1993, J PHYSIOL-LONDON, V462, P373, DOI 10.1113/jphysiol.1993.sp019560; MCGLADEMCCULLOH E, 1993, NATURE, V362, P640, DOI 10.1038/362640a0; MOSBACHER J, 1994, SCIENCE, V266, P1059, DOI 10.1126/science.7973663; Nicoletti F, 1992, Funct Neurol, V7, P413; OH BH, 1993, J BIOL CHEM, V268, P11348; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; PARTIN KM, 1994, MOL PHARMACOL, V46, P129; PARTIN KM, 1993, A NEURON, V11, P1069; PATNEAU DK, 1993, J NEUROSCI, V13, P3496; PAUL SM, 1992, FASEB J, V6, P2311, DOI 10.1096/fasebj.6.6.1347506; RAMAN IM, 1994, J NEUROSCI, V14, P4998; ROCHE KW, 1994, J BIOL CHEM, V269, P11679; SCHALL TJ, 1990, CELL, V61, P361, DOI 10.1016/0092-8674(90)90816-W; SCHREIBMAYER W, 1994, PFLUG ARCH EUR J PHY, V426, P453, DOI 10.1007/BF00388310; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; STAUBLI U, 1994, P NATL ACAD SCI USA, V91, P777, DOI 10.1073/pnas.91.2.777; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; TAVERNA FA, 1994, J BIOL CHEM, V269, P14159; TRUSSELL LO, 1994, SEMIN NEUROSCI, V6, P71; VYKLICKY L, 1990, J PHYSIOL-LONDON, V428, P313, DOI 10.1113/jphysiol.1990.sp018214; VYKLICKY L, 1991, NEURON, V7, P971, DOI 10.1016/0896-6273(91)90342-W; WONG LA, 1993, MOL PHARMACOL, V44, P504; WU FS, 1991, MOL PHARMACOL, V40, P333; YAMADA KA, 1993, J NEUROSCI, V13, P3904; YAMADA KA, 1992, J PHYSIOL-LONDON, V458, P385	44	138	141	0	3	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1995	14	4					833	843		10.1016/0896-6273(95)90227-9	http://dx.doi.org/10.1016/0896-6273(95)90227-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QU826	7718245	Bronze			2022-12-24	WOS:A1995QU82600017
J	RAOMIROTZNIK, R; HARKINS, AB; BUCHSBAUM, G; STERLING, P				RAOMIROTZNIK, R; HARKINS, AB; BUCHSBAUM, G; STERLING, P			MAMMALIAN ROD TERMINAL - ARCHITECTURE OF A BINARY SYNAPSE	NEURON			English	Article							OUTER PLEXIFORM LAYER; BIPOLAR CELLS; CAT RETINA; AXON TERMINALS; RABBIT RETINA; ION CHANNELS; DOMESTIC CAT; ACTIVE ZONES; ULTRASTRUCTURE; PHOTORECEPTORS	The mammalian rod synapse transmits a binary signal (one photon or none) using tonic, rapid exocytosis. We constructed a quantitative, physical model of the synapse. Presynaptically, a single, linear active zone provides docking sites for similar to 130 vesicles, and a ''ribbon'' anchored to the active zone provides a depot for similar to 640 vesicles. Postsynaptically, 4 processes invaginate the terminal: 2 (known to have low affinity glutamate receptors) lie near the active zone (16 nm), and 2 (known to have high affinity glutamate receptors) lie at a distance (130-640 nm). The presynaptic structure seems designed to minimize fluctuations in tonic rate owing to empty docking sites, whereas the postsynaptic geometry may permit 1 vesicle to evoke an all-ornone response at all 4 postsynaptic processes.	UNIV PENN, DEPT BIOENGN, PHILADELPHIA, PA 19104 USA	University of Pennsylvania	RAOMIROTZNIK, R (corresponding author), UNIV PENN, DEPT NEUROSCI, PHILADELPHIA, PA 19104 USA.				NATIONAL EYE INSTITUTE [R01EY008124, R01EY000828] Funding Source: NIH RePORTER; NEI NIH HHS [EY00828, EY08124] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ABE H, 1988, TOHOKU J EXP MED, V156, P381, DOI 10.1620/tjem.156.381; AHNELT P, 1990, J COMP NEUROL, V293, P39, DOI 10.1002/cne.902930104; AKERT K, 1973, BRAIN RES, V49, P511; ATTWELL D, 1986, Q J EXP PHYSIOL CMS, V71, P497; Barlow H B, 1971, Vision Res, VSuppl 3, P87; BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; Berg H. C., 1983, RANDOM WALKS BIOL; BOYCOTT BB, 1973, J COMP NEUROL, V148, P91, DOI 10.1002/cne.901480106; BRANDON C, 1983, J COMP NEUROL, V217, P167, DOI 10.1002/cne.902170205; CALKINS DJ, 1994, NATURE, V371, P70, DOI 10.1038/371070a0; CECCARELLI B, 1988, J PHYSIOL-LONDON, V402, P195, DOI 10.1113/jphysiol.1988.sp017200; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; COHEN AI, 1964, INVEST OPHTH VISUAL, V3, P198; COHEN E, 1990, PHILOS T R SOC B, V330, P305, DOI 10.1098/rstb.1990.0201; DACHEUX RF, 1986, J NEUROSCI, V6, P331; DELAVILLA P, 1995, IN PRESS J NEUROSCI; DOWLING JE, 1991, ENCY HUMAN BIOL, P615; EVANS EM, 1966, Z ZELLFORSCH MIK ANA, V71, P499, DOI 10.1007/BF00349610; FOREHAND CJ, 1984, J NEUROSCI, V4, P1; GRAY EG, 1971, BRAIN RES, V35, P1, DOI 10.1016/0006-8993(71)90591-9; GRUNERT U, 1991, J NEUROSCI, V11, P2742; GULYAS AI, 1993, NATURE, V366, P683, DOI 10.1038/366683a0; HESTRIN S, 1992, NEURON, V9, P991, DOI 10.1016/0896-6273(92)90250-H; HIDAKA S, 1986, J COMP NEUROL, V247, P181, DOI 10.1002/cne.902470205; KOLB H, 1977, J NEUROCYTOL, V6, P131, DOI 10.1007/BF01261502; LADMAN AJ, 1958, J BIOPHYS BIOCHEM CY, V4, P459, DOI 10.1083/jcb.4.4.459; LINBERG KA, 1988, J COMP NEUROL, V268, P281, DOI 10.1002/cne.902680211; MARIANI AP, 1986, PROC R SOC SER B-BIO, V227, P483, DOI 10.1098/rspb.1986.0035; Massey S.C., 1990, Progress in Retinal Research, V9, P399, DOI 10.1016/0278-4327(90)90013-8; MASTRONARDE DN, 1983, J NEUROPHYSIOL, V49, P325, DOI 10.1152/jn.1983.49.2.325; MCCARTNEY MD, 1985, EXP EYE RES, V41, P313, DOI 10.1016/S0014-4835(85)80022-1; MCGUIRE BA, 1984, J NEUROSCI, V4, P2920; Missotten L, 1965, ULTRASTRUCTURE HUMAN; NOMURA A, 1994, CELL, V77, P361, DOI 10.1016/0092-8674(94)90151-1; PIERCE JP, 1993, J NEUROSCI, V13, P4748; PUMPLIN DW, 1978, NEUROSCIENCE, V3, P685, DOI 10.1016/0306-4522(78)90065-9; PUMPLIN DW, 1981, P NATL ACAD SCI-BIOL, V78, P7210, DOI 10.1073/pnas.78.11.7210; Ramon y Cajal S, 1972, STRUCTURE RETINA; RAO R, 1994, BIOPHYS J, V67, P57, DOI 10.1016/S0006-3495(94)80454-0; RAVIOLA E, 1975, J CELL BIOL, V65, P192, DOI 10.1083/jcb.65.1.192; RAVIOLA E, 1976, INVEST OPHTH VISUAL, V15, P881; RIPPS H, 1991, VISUAL NEUROSCI, V7, P597, DOI 10.1017/S0952523800010385; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; SAITO T, 1985, J COMP NEUROL, V236, P141, DOI 10.1002/cne.902360202; SAKITT B, 1972, J PHYSIOL-LONDON, V223, P131, DOI 10.1113/jphysiol.1972.sp009838; SCHAEFFER SF, 1978, J CELL BIOL, V79, P802, DOI 10.1083/jcb.79.3.802; SJOSTRAND FS, 1958, J ULTRA MOL STRUCT R, V2, P122, DOI 10.1016/S0022-5320(58)90050-9; SMITH RG, 1986, J NEUROSCI, V6, P3505; SPADARO A, 1978, ACTA ANAT, V102, P365; STELL WK, 1967, AM J ANAT, V121, P401, DOI 10.1002/aja.1001210213; STERLING P, 1988, J NEUROSCI, V8, P623; STERLING P, 1987, NEUROSCI RES, pS269, DOI 10.1016/0921-8696(87)90022-3; Sterling P., 1990, SYNAPTIC ORG BRAIN, P170; TOWNESANDERSON E, 1988, J NEUROSCI, V8, P320; VOLLRATH L, 1989, J NEUROCYTOL, V18, P115, DOI 10.1007/BF01188430; WAGNER HJ, 1993, TRENDS NEUROSCI, V16, P201, DOI 10.1016/0166-2236(93)90155-F; WALROND JP, 1985, J NEUROSCI, V5, P1118; WILLIAMS RW, 1993, J NEUROSCI, V13, P208; YAMASHITA M, 1991, J NEUROSCI, V11, P2372; YEOW MBL, 1991, J COMP NEUROL, V307, P475, DOI 10.1002/cne.903070310	60	128	129	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	1995	14	3					561	569		10.1016/0896-6273(95)90312-7	http://dx.doi.org/10.1016/0896-6273(95)90312-7			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QP230	7695902	hybrid			2022-12-24	WOS:A1995QP23000009
J	GREENLUND, LJS; DECKWERTH, TL; JOHNSON, EM				GREENLUND, LJS; DECKWERTH, TL; JOHNSON, EM			SUPEROXIDE-DISMUTASE DELAYS NEURONAL APOPTOSIS - A ROLE FOR REACTIVE OXYGEN SPECIES IN PROGRAMMED NEURONAL DEATH	NEURON			English	Article							NERVE GROWTH-FACTOR; AMYOTROPHIC-LATERAL-SCLEROSIS; C-JUN GENE; CELL-DEATH; SYMPATHETIC NEURONS; FACTOR DEPRIVATION; CIS-FOS; PROTEIN; BCL-2; CED-3	Sympathetic neurons in culture die by apoptosis when deprived of nerve growth factor (NGF). We used this model of programmed cell death to study the mechanisms that mediate neuronal apoptosis. Cultured sympathetic neurons were injected with copper/zinc superoxide dismutase protein (SOD) or with an expression vector containing an SOD cDNA. In both cases apoptosis was delayed when the neurons were deprived of NGF. The delay was similar to that seen when a bcl-2 expression vector was injected. SOD, injected 8 hr after NGF deprivation, provided no protection, indicating that superoxide production may occur early in response to trophic factor deprivation. We have demonstrated, with a redox sensitive dye, an increase in reactive oxygen species (ROS) that peaked at 3 hr after sympathetic neurons were deprived of NGF. If NGF was added back to the culture medium after the period of peak ROS generation, apoptosis was completely prevented, suggesting that ROS production serves as an early signal, rather than a toxic agent, to mediate apoptosis.	WASHINGTON UNIV,SCH MED,DEPT MOLEC BIOL & PHARMACOL,ST LOUIS,MO 63110	Washington University (WUSTL)	GREENLUND, LJS (corresponding author), WASHINGTON UNIV,SCH MED,DEPT NEUROL,ST LOUIS,MO 63110, USA.				NATIONAL INSTITUTE ON AGING [P50AG005681] Funding Source: NIH RePORTER; NIA NIH HHS [P50-AG05681] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ADCOCK IM, 1994, BIOCHEM BIOPH RES CO, V199, P1518, DOI 10.1006/bbrc.1994.1403; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; BOCCHINI V, 1969, P NATL ACAD SCI USA, V64, P787, DOI 10.1073/pnas.64.2.787; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; BOSCHART M, 1985, CELL, V41, P521; CRAWFORD D, 1988, ONCOGENE, V3, P27; DECKWERTH TL, 1993, J CELL BIOL, V123, P1207, DOI 10.1083/jcb.123.5.1207; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; DEVARY Y, 1991, MOL CELL BIOL, V11, P2804, DOI 10.1128/MCB.11.5.2804; Edwards S, 1994, J CELL BIOL, V124, P965; EDWARDS SN, 1991, J NEUROCHEM, V57, P2140, DOI 10.1111/j.1471-4159.1991.tb06434.x; ENOKIDO Y, 1993, NEUROSCIENCE, V57, P965, DOI 10.1016/0306-4522(93)90041-D; ESTUS S, 1994, IN PRESS J CELL BIOL; FORLONI G, 1993, NEUROREPORT, V4, P523, DOI 10.1097/00001756-199305000-00015; FRANKLIN JL, 1994, IN PRESS J NEUROSCI; FREEMAN RS, 1994, NEURON, V12, P343, DOI 10.1016/0896-6273(94)90276-3; GAGLIARDINI V, 1994, SCIENCE, V263, P826, DOI 10.1126/science.8303301; GARCIA I, 1992, SCIENCE, V258, P302, DOI 10.1126/science.1411528; HENGARTNER MO, 1994, CELL, V76, P665, DOI 10.1016/0092-8674(94)90506-1; HENGARTNER MO, 1992, NATURE, V356, P494, DOI 10.1038/356494a0; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; JACOBSON M, 1991, DEV NEUROBIOL, P348; JOHNSON MI, 1983, METHOD ENZYMOL, V103, P334; KANE DJ, 1993, SCIENCE, V262, P1274, DOI 10.1126/science.8235659; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; KESSLER JA, 1993, NEURON, V11, P1123, DOI 10.1016/0896-6273(93)90225-G; KEYSE SM, 1992, NATURE, V359, P644, DOI 10.1038/359644a0; KLEENE KC, 1985, BIOCHEMISTRY-US, V24, P719, DOI 10.1021/bi00324a027; KUMAR S, 1994, GENE DEV, V8, P1613, DOI 10.1101/gad.8.14.1613; LAZARUS KJ, 1976, BRAIN RES, V113, P159, DOI 10.1016/0006-8993(76)90013-5; LINNIK MD, 1993, STROKE, V24, P2002, DOI 10.1161/01.STR.24.12.2002; LOO DT, 1993, P NATL ACAD SCI USA, V90, P7951, DOI 10.1073/pnas.90.17.7951; MACMANUS JP, 1994, NEUROREPORT, V5, P493, DOI 10.1097/00001756-199401120-00031; MANOME Y, 1993, BIOCHEMISTRY-US, V32, P10607, DOI 10.1021/bi00091a010; MARTIN DP, 1988, J CELL BIOL, V106, P829, DOI 10.1083/jcb.106.3.829; MARTIN DP, 1990, J NEUROSCI, V10, P184; MARTIN DP, 1992, J NEUROBIOL, V23, P1205, DOI 10.1002/neu.480230911; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MIURA M, 1993, CELL, V75, P653, DOI 10.1016/0092-8674(93)90486-A; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; ROBBERECHT W, 1994, J NEUROCHEM, V62, P384; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; ROTHSTEIN JD, 1994, P NATL ACAD SCI USA, V91, P4155, DOI 10.1073/pnas.91.10.4155; RYDEL RE, 1988, P NATL ACAD SCI USA, V85, P1257, DOI 10.1073/pnas.85.4.1257; SHIBANUMA M, 1988, ONCOGENE, V3, P17; STAMLER JS, 1992, SCIENCE, V258, P1898, DOI 10.1126/science.1281928; TROY CM, 1994, P NATL ACAD SCI USA, V91, P6384, DOI 10.1073/pnas.91.14.6384; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; WANG L, 1994, CELL, V78, P739, DOI 10.1016/S0092-8674(94)90422-7; WRIGHT LL, 1983, J NEUROCYTOL, V12, P727, DOI 10.1007/BF01258147; XANTHOUDAKIS S, 1992, EMBO J, V11, P653, DOI 10.1002/j.1460-2075.1992.tb05097.x; YUAN JY, 1992, DEVELOPMENT, V116, P309; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9; YUAN JY, 1990, DEV BIOL, V138, P33, DOI 10.1016/0012-1606(90)90174-H	56	702	716	1	16	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1995	14	2					303	315		10.1016/0896-6273(95)90287-2	http://dx.doi.org/10.1016/0896-6273(95)90287-2			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QH294	7857640	Bronze			2022-12-24	WOS:A1995QH29400009
J	ULLRICH, B; LI, C; ZHANG, JZ; MCMAHON, H; ANDERSON, RGW; GEPPERT, M; SUDHOF, TC				ULLRICH, B; LI, C; ZHANG, JZ; MCMAHON, H; ANDERSON, RGW; GEPPERT, M; SUDHOF, TC			FUNCTIONAL-PROPERTIES OF MULTIPLE SYNAPTOTAGMINS IN BRAIN	NEURON			English	Article							SYNAPTIC VESICLES; BINDING; EXOCYTOSIS; EXPRESSION; PROTEINS; DOCKING; DOMAIN; FUSION; P65	At least four forms of synaptotagmin are expressed in neurons. Of these, synaptotagmin I has an essential function in mediating Ca2+-triggered neurotransmitter release at hippocampal synapses, but the functional implications of multiple synaptotagmins are unknown. Synaptotagmins I-III exhibit a strikingly differential distribution between synapses, with most neurons coexpressing either synaptotagmins I or II with III, Synaptotagmin IV is present uniformly throughout the brain at low levels. Synaptotagmins III and IV are both coexpressed with synaptotagmin I in hippocampal synapses, suggesting that these synaptotagmins are not functionally redundant. The first C-2 domains of synaptotagmins I-III exhibit similar Ca2+ affinities in phospholipid-binding assays, whereas that of synaptotagmin IV is unable to bind Ca2+. All synaptotagmins tested bind the clathrin-adaptor protein AP-2 with high affinity. Our results suggest that different synaptotagmins serve distinct but overlapping functions in neuronal membrane traffic, with synaptotagmins I and II representing alternative Ca2+ sensors in exocytosis and all synaptotagmins functioning as AP-2 receptors in endocytosis.	UNIV TEXAS,SW MED CTR,DEPT CELL BIOL & NEUROSCI,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,HOWARD HUGHES MED INST,DALLAS,TX 75235	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	ULLRICH, B (corresponding author), UNIV TEXAS,SW MED CTR,DEPT MOLEC GENET,DALLAS,TX 75235, USA.							BENNETT MK, 1994, ANNU REV BIOCHEM, V63, P63, DOI 10.1146/annurev.bi.63.070194.000431; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; BLASI J, 1993, EMBO J, V12, P4821, DOI 10.1002/j.1460-2075.1993.tb06171.x; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; FYKSE EM, 1993, J NEUROSCI, V13, P4997; GEPPERT M, 1991, J BIOL CHEM, V266, P13548; GEPPERT M, 1994, NATURE, V369, P493, DOI 10.1038/369493a0; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; GERFEN CR, 1992, EXPT NEUROANATOMY, P173; GODA Y, 1994, IN PRESS P NATL ACAD; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; HATA Y, 1993, NEURON, V10, P307, DOI 10.1016/0896-6273(93)90320-Q; HILBUSH BS, 1994, P NATL ACAD SCI USA, V91, P8195, DOI 10.1073/pnas.91.17.8195; JOHNSTON PA, 1989, J BIOL CHEM, V264, P1268; LAEMMLI UK, 1971, NATURE, V227, P680; MIZUTA M, 1994, J BIOL CHEM, V269, P11675; PERIN MS, 1994, J BIOL CHEM, V269, P8576; PERIN MS, 1991, J BIOL CHEM, V266, P623; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; PETRENKO AG, 1991, NATURE, V353, P65, DOI 10.1038/353065a0; ROSAHL TW, 1993, CELL, V75, P661, DOI 10.1016/0092-8674(93)90487-B; Sambrook J, 1989, MOL CLONING LABORATO; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SUDHOF TC, 1991, NEURON, V6, P665, DOI 10.1016/0896-6273(91)90165-V; SUDHOF TC, 1989, SCIENCE, V238, P1142; TRIMBLE WS, 1990, J NEUROSCI, V10, P1380; WENDLAND B, 1991, NEURON, V6, P993, DOI 10.1016/0896-6273(91)90239-V; ZHANG JZ, 1994, CELL, V78, P751, DOI 10.1016/S0092-8674(94)90442-1	29	179	182	0	7	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1994	13	6					1281	1291		10.1016/0896-6273(94)90415-4	http://dx.doi.org/10.1016/0896-6273(94)90415-4			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PZ689	7993622				2022-12-24	WOS:A1994PZ68900004
J	KEHOE, J				KEHOE, J			GLUTAMATE ACTIVATES A K+ CONDUCTANCE INCREASE IN APLYSIA NEURONS THAT APPEARS TO BE INDEPENDENT OF G-PROTEINS	NEURON			English	Article							MOLLUSK PLANORBARIUS-CORNEUS; ACETYLCHOLINE-RECEPTORS; POTASSIUM CHANNEL; BINDING PROTEINS; SENSORY NEURONS; SMOOTH-MUSCLE; CELLS; GTP; INHIBITION; MECHANISM	A study was made of the role of G proteins in the K+ conductance increases elicited by cholinergic and glutamatergic agonists in identified Aplysia neurons. The cholinergic response, previously shown to be G protein mediated, was occluded by dialysis with either nonhydrolyzable GTP analogs (GTP gamma S or Gpp(NH)p) or beryllium fluoride and was blocked by pertussis toxin as well as by dialysis with a nonhydrolyzable GDP analog (GDP beta S). In contrast, the glutamatergic response, studied simultaneously in the same cell, persisted throughout all of the above manipulations and hence does not appear to depend upon G protein activation. This characteristic differentiates the glutamatergic response from most other transmitter- or hormone-induced increases in K+ conductance elicited in either neurons or other cell types, whether vertebrate or invertebrate.			KEHOE, J (corresponding author), ECOLE NORMALE SUPER, NEUROBIOL LAB, 46 RUE ULM, F-75005 PARIS, FRANCE.							ASCHER P, 1982, J PHYSIOL-LONDON, V324, P67, DOI 10.1113/jphysiol.1982.sp014101; ASCHER P, 1986, ION CHANNELS NEURAL, P283; BIGAY J, 1987, EMBO J, V6, P2907, DOI 10.1002/j.1460-2075.1987.tb02594.x; BOLSHAKOV VY, 1991, J PHYSIOL-LONDON, V439, P15, DOI 10.1113/jphysiol.1991.sp018654; BOLSHAKOV VY, 1993, J PHYSIOL-LONDON, V468, P11, DOI 10.1113/jphysiol.1993.sp019757; BOLSHAKOV VY, 1992, J PHYSIOL-LONDON, V455, P33, DOI 10.1113/jphysiol.1992.sp019289; BREITWIESER GE, 1988, J GEN PHYSIOL, V91, P469, DOI 10.1085/jgp.91.4.469; BREITWIESER GE, 1985, NATURE, V317, P538, DOI 10.1038/317538a0; BREZINA V, 1988, J PHYSIOL-LONDON, V407, P15, DOI 10.1113/jphysiol.1988.sp017401; BROWN AM, 1990, ANNU REV PHYSIOL, V52, P197, DOI 10.1146/annurev.ph.52.030190.001213; BROWN DA, 1990, ANNU REV PHYSIOL, V52, P215; BURGEN ASV, 1953, J PHYSIOL-LONDON, V120, P449, DOI 10.1113/jphysiol.1953.sp004910; CLAPHAM DE, 1993, NATURE, V365, P403, DOI 10.1038/365403a0; DELCASTILLO J, 1955, NATURE, V175, P1035, DOI 10.1038/1751035a0; ECCLES JC, 1979, TRENDS NEUROSCI, V2, P39, DOI 10.1016/0166-2236(79)90017-1; ENDOH M, 1985, AM J PHYSIOL, V249, pH309, DOI 10.1152/ajpheart.1985.249.2.H309; GARDNER D, 1971, SCIENCE, V173, P550, DOI 10.1126/science.173.3996.550; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; KATZ PS, 1993, J NEUROPHYSIOL, V69, P143, DOI 10.1152/jn.1993.69.1.143; KEHOE J, 1972, J PHYSIOL-LONDON, V225, P115, DOI 10.1113/jphysiol.1972.sp009931; KEHOE J, 1985, J PHYSIOL-LONDON, V369, P399, DOI 10.1113/jphysiol.1985.sp015909; KEHOE JS, 1978, NATURE, V274, P866, DOI 10.1038/274866a0; KOMORI S, 1990, J PHYSIOL-LONDON, V427, P395, DOI 10.1113/jphysiol.1990.sp018178; LIM SP, 1988, BRIT J PHARMACOL, V95, P325, DOI 10.1111/j.1476-5381.1988.tb11649.x; LOWAGIE C, 1973, J PHYSIOL-PARIS, V67, P350; MARTY A, 1985, J PHYSIOL-LONDON, V367, P117, DOI 10.1113/jphysiol.1985.sp015817; NORTH RA, 1989, BRIT J PHARMACOL, V98, P13, DOI 10.1111/j.1476-5381.1989.tb16855.x; OLESEN SP, 1988, CIRC RES, V62, P1059, DOI 10.1161/01.RES.62.6.1059; OOMURA Y, 1974, J PHYSIOL-LONDON, V243, P321, DOI 10.1113/jphysiol.1974.sp010756; PFAFFINGER P, 1988, J NEUROSCI, V8, P3343; PFAFFINGER PJ, 1985, NATURE, V317, P536, DOI 10.1038/317536a0; Pfaffinger PJ, 1990, POTASSIUM CHANNELS S, P117; SASAKI K, 1987, JPN J PHYSIOL, V37, P551, DOI 10.2170/jjphysiol.37.551; SASAKI K, 1987, NATURE, V325, P259, DOI 10.1038/325259a0; SIEGELBAUM SA, 1982, NATURE, V299, P413, DOI 10.1038/299413a0; SOROTA S, 1985, CIRC RES, V57, P748, DOI 10.1161/01.RES.57.5.748; SZABO G, 1990, ANNU REV PHYSIOL, V52, P293; SZCZEPAN.AC, 1973, NATURE-NEW BIOL, V241, P62, DOI 10.1038/newbio241062a0; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; TRAUTWEIN W, 1958, PFLUG ARCH GES PHYS, V266, P324, DOI 10.1007/BF00416781; VOLTERRA A, 1988, P NATL ACAD SCI USA, V85, P7810, DOI 10.1073/pnas.85.20.7810; WHITE RE, 1991, NATURE, V351, P570, DOI 10.1038/351570a0; WHITE RE, 1993, NATURE, V361, P263, DOI 10.1038/361263a0	45	32	32	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1994	13	3					691	702		10.1016/0896-6273(94)90036-1	http://dx.doi.org/10.1016/0896-6273(94)90036-1			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PJ284	7917299				2022-12-24	WOS:A1994PJ28400016
J	NOSE, A; TAKEICHI, M; GOODMAN, CS				NOSE, A; TAKEICHI, M; GOODMAN, CS			ECTOPIC EXPRESSION OF CONNECTIN REVEALS A REPULSIVE FUNCTION DURING GROWTH CONE GUIDANCE AND SYNAPSE FORMATION	NEURON			English	Article							DROSOPHILA; TARGET; EMBRYO; AXON; MECHANISMS; COLLAPSE; NEURITES; ADHESION; PROTEIN; PATTERN	Connectin, a cell surface protein of the leucine-rich repeat family in Drosophila, is expressed on the surface of a subset of embryonic muscles (primarily lateral muscles), on the growth cones and axons of the motoneurons that innervate these muscles (primarily SNa motoneurons), and on several associated glial cells. When coupled with its ability to mediate homophilic cell adhesion, these results led to the suggestion that Connectin functions as an attractive signal for SNa pathfinding and targeting. In the present study, we ectopically expressed Connectin on ventral muscles normally innervated by SNb motoneurons. The SNb growth cones change both their morphology and their trajectory when they encounter ectopic Connectin positive ventral muscles, displaying "bypass," "detour," and "stall" phenotypes. Moreover, SNb synapse formation is prevented by Connectin expression on ventral muscles. These results reveal a repulsive function for Connectin during motoneuron growth cone guidance and synapse formation.	NATL INST BASIC BIOL, OKAZAKI, AICHI 444, JAPAN; KYOTO UNIV, FAC SCI, DEPT BIOPHYS, SAKYO KU, KYOTO 606, JAPAN	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Kyoto University	NOSE, A (corresponding author), UNIV CALIF BERKELEY, HOWARD HUGHES MED INST, DIV CELL & MOLEC BIOL, BERKELEY, CA 94720 USA.		Takeichi, Masatoshi/G-5903-2012	Takeichi, Masatoshi/0000-0002-9931-3378	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS018366] Funding Source: NIH RePORTER; NINDS NIH HHS [NS18366] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAIER H, 1992, SCIENCE, V255, P472, DOI 10.1126/science.1734526; BROADIE K, 1993, DEVELOPMENT, P227; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; COX EC, 1990, NEURON, V2, P31; DAVIES JA, 1990, NEURON, V2, P11; FUJITA SC, 1982, P NATL ACAD SCI-BIOL, V79, P7929, DOI 10.1073/pnas.79.24.7929; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; GOULD AP, 1992, DEVELOPMENT, V116, P1163; HASHIMOTO C, 1991, DEVELOPMENT, V111, P1021; JOHANSEN J, 1989, J NEUROSCI, V9, P710; KAPFHAMMER JP, 1986, J NEUROSCI, V6, P2527; KAPFHAMMER JP, 1987, J NEUROSCI, V7, P201; KESHISHIAN H, 1993, J NEUROBIOL, V24, P757, DOI 10.1002/neu.480240606; KOLODKIN AL, 1992, NEURON, V9, P831, DOI 10.1016/0896-6273(92)90237-8; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; LETOURNEAU PC, 1975, DEV BIOL, V44, P92, DOI 10.1016/0012-1606(75)90379-6; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; NOSE A, 1992, CELL, V70, P553, DOI 10.1016/0092-8674(92)90426-D; PATEL NH, 1987, CELL, V48, P975, DOI 10.1016/0092-8674(87)90706-9; Pirrotta V, 1988, Biotechnology, V10, P437; SINK H, 1991, DEVELOPMENT, V113, P701; SINK H, 1991, J NEUROBIOL, V22, P298, DOI 10.1002/neu.480220309; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; TAGHERT PH, 1982, DEV BIOL, V94, P391, DOI 10.1016/0012-1606(82)90356-6; TOSNEY KW, 1988, DEV BIOL, V127, P266, DOI 10.1016/0012-1606(88)90314-4; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; WALTER J, 1987, DEVELOPMENT, V101, P909; WHARTON KA, 1993, MECH DEVELOP, V40, P141, DOI 10.1016/0925-4773(93)90072-6	30	125	126	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1994	13	3					525	539		10.1016/0896-6273(94)90023-X	http://dx.doi.org/10.1016/0896-6273(94)90023-X			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PJ284	7917289				2022-12-24	WOS:A1994PJ28400003
J	YU, XM; HALL, ZW				YU, XM; HALL, ZW			A SEQUENCE IN THE MAIN CYTOPLASMIC LOOP OF THE A SUBUNIT IS REQUIRED FOR ASSEMBLY OF MOUSE MUSCLE NICOTINIC ACETYLCHOLINE-RECEPTOR	NEURON			English	Article							BUNGAROTOXIN BINDING-SITE; ALPHA-SUBUNIT; MONOCLONAL-ANTIBODIES; TORPEDO-CALIFORNICA; MAMMALIAN MUSCLE; LIGAND-BINDING; DELTA-SUBUNIT; CDNA SEQUENCE; COS CELLS; EXPRESSION	We have investigated the role of intracellular cytoplasmic sequences in the assembly of the mouse muscle nicotinic acetylcholine receptor (AChR) transiently expressed in COS cells. A chimeric protein in which the region from M1 to M4 of the a subunit was replaced by the corresponding region in the beta subunit was unable to support AChR assembly when substituted for the alpha subunit; a chimeric alpha subunit containing only the long cytoplasmic loop from the beta subunit was likewise inactive. Systematic mutation of short segments of the loop identified a sequence of 17 amino acids near the C-terminal end of the loop for which the beta sequence could not be substituted. Each of the inactive chimeric and mutated alpha subunits bound alpha-bungarotoxin when expressed alone and formed a heterodimer when expressed with the delta subunit. An alpha subunit truncated after M1 formed both an alpha delta heterodimer and an alpha delta beta heterotrimer, demonstrating that the cytoplasmic loop is dispensible for the early steps of assembly. A sequence in the long cytoplasmic loop of the alpha subunit thus appears to play a role in a late step of AChR assembly.	UNIV CALIF SAN FRANCISCO, DEPT PHYSIOL, SAN FRANCISCO, CA 94143 USA	University of California System; University of California San Francisco								ANDERSON DJ, 1981, P NATL ACAD SCI-BIOL, V78, P5598, DOI 10.1073/pnas.78.9.5598; BETZ H, 1990, NEURON, V5, P383, DOI 10.1016/0896-6273(90)90077-S; BLOUNT P, 1990, J CELL BIOL, V111, P2613, DOI 10.1083/jcb.111.6.2613; BLOUNT P, 1990, J CELL BIOL, V111, P2601, DOI 10.1083/jcb.111.6.2601; BLOUNT P, 1988, J BIOL CHEM, V263, P1072; BLOUNT P, 1989, NEURON, V3, P349, DOI 10.1016/0896-6273(89)90259-6; BRODSKY MH, 1990, J IMMUNOL, V144, P3078; BUONANNO A, 1986, J BIOL CHEM, V261, P6451; CHAVEZ RA, 1992, J CELL BIOL, V116, P385, DOI 10.1083/jcb.116.2.385; CHAVEZ RA, 1991, J BIOL CHEM, V266, P15532; CLAUDIO T, 1989, FRONTIERS MOL BIOL M, P63; DEVILLERSTHIERY A, 1983, P NATL ACAD SCI-BIOL, V80, P2067, DOI 10.1073/pnas.80.7.2067; FINERMOORE J, 1984, P NATL ACAD SCI-BIOL, V81, P155, DOI 10.1073/pnas.81.1.155; FROEHNER SC, 1983, J BIOL CHEM, V258, P7112; GEISSELSODER J, 1987, BIOTECHNIQUES, V5, P786; GERSHONI JM, 1987, P NATL ACAD SCI USA, V84, P4318, DOI 10.1073/pnas.84.12.4318; GREEN WN, 1993, CELL, V74, P57, DOI 10.1016/0092-8674(93)90294-Z; GU Y, 1991, J CELL BIOL, V114, P799, DOI 10.1083/jcb.114.4.799; GU Y, 1988, J BIOL CHEM, V263, P12878; GU Y, 1990, NEURON, V5, P147, DOI 10.1016/0896-6273(90)90305-Y; GULLICK WJ, 1983, BIOCHEMISTRY-US, V22, P3312, DOI 10.1021/bi00283a003; Hall Z W, 1992, Trends Cell Biol, V2, P66, DOI 10.1016/0962-8924(92)90058-U; ISENBERG KE, 1986, NUCLEIC ACIDS RES, V14, P5111, DOI 10.1093/nar/14.12.5111; KARLIN A, 1983, J BIOL CHEM, V258, P6678; KISTLER J, 1982, BIOPHYS J, V37, P371, DOI 10.1016/S0006-3495(82)84685-7; KUBALEK E, 1987, J CELL BIOL, V105, P9, DOI 10.1083/jcb.105.1.9; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAPOLLA RJ, 1984, P NATL ACAD SCI-BIOL, V81, P7970, DOI 10.1073/pnas.81.24.7970; MERLIE JP, 1983, CELL, V34, P747, DOI 10.1016/0092-8674(83)90531-7; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; NEUMANN D, 1986, P NATL ACAD SCI USA, V83, P9250, DOI 10.1073/pnas.83.23.9250; NODA M, 1982, NATURE, V299, P793, DOI 10.1038/299793a0; SAEDI MS, 1991, J CELL BIOL, V112, P1007, DOI 10.1083/jcb.112.5.1007; SEED B, 1987, P NATL ACAD SCI USA, V84, P3365, DOI 10.1073/pnas.84.10.3365; SMITH MM, 1987, J BIOL CHEM, V262, P4367; TAKAI T, 1985, NATURE, V315, P761, DOI 10.1038/315761a0; TZARTOS SJ, 1981, J BIOL CHEM, V256, P8635; TZARTOS SJ, 1981, J NEUROIMMUNOL, V10, P235; VERRALL S, 1992, CELL, V68, P23, DOI 10.1016/0092-8674(92)90203-O; WILSON PT, 1985, P NATL ACAD SCI USA, V82, P8790, DOI 10.1073/pnas.82.24.8790; YONG G, 1989, J CELL BIOL, V109, P729, DOI 10.1083/jcb.109.2.729; YU L, 1986, NUCLEIC ACIDS RES, V14, P3539, DOI 10.1093/nar/14.8.3539; YU XM, 1991, NATURE, V352, P64, DOI 10.1038/352064a0; YU XM, 1994, J NEUROSCI, V14, P785; ZINGSHEIM HP, 1982, NATURE, V299, P81, DOI 10.1038/299081a0	45	42	42	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	1994	13	1					247	255		10.1016/0896-6273(94)90473-1	http://dx.doi.org/10.1016/0896-6273(94)90473-1			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NZ247	8043279				2022-12-24	WOS:A1994NZ24700019
J	TAIRA, E; TAKAHA, N; TANIURA, H; KIM, CH; MIKI, N				TAIRA, E; TAKAHA, N; TANIURA, H; KIM, CH; MIKI, N			MOLECULAR-CLONING AND FUNCTIONAL EXPRESSION OF GICERIN, A NOVEL CELL-ADHESION MOLECULE THAT BINDS TO NEURITE OUTGROWTH FACTOR	NEURON			English	Article							IMMUNOGLOBULIN-LIKE DOMAINS; INTERCELLULAR-ADHESION; NERVOUS-SYSTEM; SUPERFAMILY; EXTENSION; RECEPTOR; PROTEIN; GLYCOPROTEINS; PURIFICATION; RECOGNITION	Gicerin is an integral membrane glycoprotein of about 82 kd that is transiently expressed in the developing CNS. Gicerin was first identified as a binding protein for neurite outgrowth factor (NOF), a member of the laminin family of extracellular matrix proteins. By isolating and sequencing a gicerin cDNA, we have found that this protein is a novel member of the immunoglobulin superfamily. The deduced protein (584 amino acids) consists of five immunoglobulin-like loop structures in an extracellular domain, a single transmembrane region, and a short cytoplasmic tail. Cells transfected stably with gicerin cDNA adhered to NOF and aggregated with each other, indicating that gicerin exhibits both heterophilic and hemophilic adhesion activities.			TAIRA, E (corresponding author), OSAKA UNIV,SCH MED,DEPT PHARMACOL,2-2 YAMADAOKA,SUITA,OSAKA 565,JAPAN.			Kim, Cheol-Hee/0000-0002-3019-0699				BEAUCHEMIN N, 1989, CANCER RES, V49, P2017; BOZYCZKO D, 1986, J NEUROSCI, V6, P1241; BRUMMENDORF T, 1993, NEURON, V10, P711; BURNS FR, 1991, NEURON, V7, P209, DOI 10.1016/0896-6273(91)90259-3; CHANG S, 1987, J CELL BIOL, V104, P355, DOI 10.1083/jcb.104.2.355; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COLE GJ, 1986, J CELL BIOL, V102, P403, DOI 10.1083/jcb.102.2.403; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; DODD J, 1988, SCIENCE, V242, P692, DOI 10.1126/science.3055291; EDELMAN GM, 1986, ANNU REV PHYSIOL, V48, P417; ELKINS T, 1990, J CELL BIOL, V110, P1825, DOI 10.1083/jcb.110.5.1825; EVERCOOREN AB, 1982, J NEUROSCI RES, V8, P179; GOAD WB, 1982, NUCLEIC ACIDS RES, V10, P247, DOI 10.1093/nar/10.1.247; HAYASHI Y, 1987, DEV BRAIN RES, V35, P11, DOI 10.1016/0165-3806(87)90003-4; HAYASHI Y, 1985, J BIOL CHEM, V260, P4269; HESSION C, 1992, BIOCHEM BIOPH RES CO, V183, P163, DOI 10.1016/0006-291X(92)91623-X; HIGGINS DG, 1992, COMPUT APPL BIOSCI, V8, P189; Huynh TV, 1985, DNA CLONING TECHNIQU, V1, P49; KATO S, 1992, NEUROSCI LETT, V140, P78, DOI 10.1016/0304-3940(92)90686-2; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEMMON V, 1989, NEURON, V2, P1597, DOI 10.1016/0896-6273(89)90048-2; MAKGOBA MW, 1988, NATURE, V331, P86, DOI 10.1038/331086a0; Maniatis T., 1982, MOL CLONING; MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8; MAURO VP, 1992, J CELL BIOL, V119, P191, DOI 10.1083/jcb.119.1.191; MIKI N, 1981, J NEUROCHEM, V37, P627; MIURA M, 1992, J BIOL CHEM, V267, P10752; PESHEVA P, 1993, NEURON, V10, P69, DOI 10.1016/0896-6273(93)90243-K; RATHJEN FG, 1987, J CELL BIOL, V104, P343, DOI 10.1083/jcb.104.2.343; REICHARDT LF, 1991, ANNU REV NEUROSCI, V14, P531, DOI 10.1146/annurev.neuro.14.1.531; RUTISHAUSER U, 1982, P NATL ACAD SCI-BIOL, V79, P685, DOI 10.1073/pnas.79.2.685; RUTISHAUSER U, 1988, SCIENCE, V240, P53, DOI 10.1126/science.3281256; SALZER JL, 1989, DEV NEUROSCI-BASEL, V11, P377, DOI 10.1159/000111914; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SANTONI MJ, 1988, J NEUROSCI RES, V20, P304, DOI 10.1002/jnr.490200304; SATO S, 1989, BIOCHEM BIOPH RES CO, V163, P1473, DOI 10.1016/0006-291X(89)91145-5; SCHACHNER M, 1991, NERVE GROWTH CONE, P237; TAKEICHI M, 1988, DEVELOPMENT, V102, P639; TAKEICHI M, 1977, J CELL BIOL, V75, P464, DOI 10.1083/jcb.75.2.464; TANAKA H, 1991, NEURON, V7, P535, DOI 10.1016/0896-6273(91)90366-8; TANIURA H, 1991, J CELL BIOL, V112, P313, DOI 10.1083/jcb.112.2.313; TOMASELLI KJ, 1986, J CELL BIOL, V103, P2659, DOI 10.1083/jcb.103.6.2659; URUSHIHARA H, 1979, DEV BIOL, V70, P206, DOI 10.1016/0012-1606(79)90017-4; WEINBERGER C, 1985, SCIENCE, V228, P740, DOI 10.1126/science.2581314; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; ZISCH AH, 1992, J CELL BIOL, V119, P203, DOI 10.1083/jcb.119.1.203	47	92	96	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1994	12	4					861	872		10.1016/0896-6273(94)90338-7	http://dx.doi.org/10.1016/0896-6273(94)90338-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NH253	8161457				2022-12-24	WOS:A1994NH25300014
J	ZHENG, X; ZHANG, L; DURAND, GM; BENNETT, MVL; ZUKIN, RS				ZHENG, X; ZHANG, L; DURAND, GM; BENNETT, MVL; ZUKIN, RS			MUTAGENESIS RESCUES SPERMINE AND ZN2+ POTENTIATION OF RECOMBINANT NMDA RECEPTORS	NEURON			English	Article							METHYL-D-ASPARTATE; XENOPUS OOCYTES; REGIONAL DISTRIBUTION; ENDOGENOUS ZN-2+; CHANNEL CURRENTS; CORTICAL-NEURONS; POLYAMINES; RAT; BRAIN; RELEASE	Alternative splicing generates distinct forms of the NMDA receptor subunit NR1. NR1 subunits with an N-terminal insert (termed N1) form receptors in Xenopus oocytes with greatly reduced potentiation by spermine and Zn2+. Oocytes expressing NR1 receptors with N1 exhibited larger NMDA currents than oocytes expressing corresponding receptors without N1. In the present study, we used mutational analysis to investigate structural features of the N1 insert that control current amplitude and spermine and Zn2+ potentiation. Neutralization of positive charges in N1 rescued spermine and Zn2+ potentiation. Positive charges in N1 did not affect spermine or Zn2+ affinity. Neutralization of positive charges in N1 diminished the responses to the level of NR1 receptors lacking N1. The positively charged N1 may increase NMDA currents by causing a conformational change similar to that produced by spermine and Zn2+ in NR1 receptors lacking N1.			ZHENG, X (corresponding author), YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT NEUROSCI,BRONX,NY 10461, USA.				NICHD NIH HHS [HD 04248] Funding Source: Medline; NINDS NIH HHS [NS 07412, NS 20752] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD004248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007412, R01NS020752] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANANTHARAM V, 1992, FEBS LETT, V305, P27, DOI 10.1016/0014-5793(92)80648-Z; ANIKSZTEJN L, 1987, BRAIN RES, V404, P58, DOI 10.1016/0006-8993(87)91355-2; ARANEDA RC, 1993, NEUROSCI LETT, V152, P107, DOI 10.1016/0304-3940(93)90495-7; ASSAF SY, 1984, NATURE, V308, P734, DOI 10.1038/308734a0; BENVENISTE M, 1993, J PHYSIOL-LONDON, V464, P131, DOI 10.1113/jphysiol.1993.sp019627; BRACKLEY P, 1990, NEUROSCI LETT, V114, P51, DOI 10.1016/0304-3940(90)90427-B; CHARTON G, 1985, EXP BRAIN RES, V58, P202; CHRISTINE CW, 1990, J NEUROSCI, V10, P108; DONALDSON J, 1973, CAN J BIOCHEM CELL B, V51, P87, DOI 10.1139/o73-010; DREOSTI IE, 1984, NEUROBIOLOGY ZINC, P1; DURAND GM, 1992, P NATL ACAD SCI USA, V89, P9359, DOI 10.1073/pnas.89.19.9359; DURAND GM, 1993, P NATL ACAD SCI USA, V90, P6731, DOI 10.1073/pnas.90.14.6731; HOLLMANN M, 1993, NEURON, V10, P943, DOI 10.1016/0896-6273(93)90209-A; HOWELL GA, 1984, NATURE, V308, P736, DOI 10.1038/308736a0; IKEDA K, 1992, FEBS LETT, V313, P34, DOI 10.1016/0014-5793(92)81178-O; ISHII T, 1993, J BIOL CHEM, V268, P2836; KUSHNER L, 1988, P NATL ACAD SCI USA, V85, P3250, DOI 10.1073/pnas.85.9.3250; KUSHNER L, 1989, METHODS NEUROSCIENCE, P3; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; LERMA J, 1992, NEURON, V8, P343, DOI 10.1016/0896-6273(92)90300-3; MCGURK JF, 1990, P NATL ACAD SCI USA, V87, P9971, DOI 10.1073/pnas.87.24.9971; MEGURO H, 1992, NATURE, V357, P70, DOI 10.1038/357070a0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; NAKANISHI N, 1992, P NATL ACAD SCI USA, V89, P8552, DOI 10.1073/pnas.89.18.8552; RANSOM RW, 1988, J NEUROCHEM, V51, P830, DOI 10.1111/j.1471-4159.1988.tb01818.x; REYNOLDS IJ, 1989, MOL PHARMACOL, V36, P758; ROCK DM, 1992, MOL PHARMACOL, V42, P157; ROCK DM, 1992, MOL PHARMACOL, V41, P83; SEILER N, 1990, INT J BIOCHEM, V22, P211, DOI 10.1016/0020-711X(90)90332-W; SEILER N, 1975, J NEUROCHEM, V24, P791, DOI 10.1111/j.1471-4159.1975.tb03866.x; SHAW GG, 1973, J NEUROCHEM, V20, P1225, DOI 10.1111/j.1471-4159.1973.tb00091.x; SPROSEN TS, 1990, EUR J PHARMACOL, V179, P477, DOI 10.1016/0014-2999(90)90193-A; STANDAERT DG, 1993, NEUROSCI LETT, V152, P161, DOI 10.1016/0304-3940(93)90508-I; SUGIHARA H, 1992, BIOCHEM BIOPH RES CO, V185, P826, DOI 10.1016/0006-291X(92)91701-Q; WESTBROOK GL, 1987, NATURE, V328, P640, DOI 10.1038/328640a0; WILLIAMS K, 1989, MOL PHARMACOL, V36, P575; YAMAZAKI M, 1992, FEBS LETT, V300, P39, DOI 10.1016/0014-5793(92)80160-I	38	70	71	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1994	12	4					811	818						8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NH253	8161453				2022-12-24	WOS:A1994NH25300010
J	BAUERFEIND, R; REGNIERVIGOUROUX, A; FLATMARK, T; HUTTNER, WB				BAUERFEIND, R; REGNIERVIGOUROUX, A; FLATMARK, T; HUTTNER, WB			SELECTIVE STORAGE OF ACETYLCHOLINE, BUT NOT CATECHOLAMINES, IN NEUROENDOCRINE SYNAPTIC-LIKE MICROVESICLES OF EARLY ENDOSOMAL ORIGIN	NEURON			English	Article							VESICULAR MONOAMINE TRANSPORTER; PHEOCHROMOCYTOMA CELL-LINE; IMMATURE SECRETORY GRANULE; CHROMOGRANINS SECRETOGRANINS; BIOCHEMICAL-EVIDENCE; CHROMAFFIN GRANULES; REGULATED PATHWAY; PC12 CELLS; VESICLES; SYNAPTOPHYSIN	We have defined, in the neuroendocrine cell line PC12, the catecholamine- and acetylcholine-storing organelles in the context of the biogenesis of secretory granules and synaptic-like microvesicles (SLMVs). SLMVs were found to originate directly from early endosomes. Both early endosomes and SLMVs exhibited uptake and storage of biosynthetic acetylcholine. Surprisingly, however, despite the presence of a reserpine-sensitive vesicular amine transporter in early endosomes, SLMVs lacked detectable uptake and storage of catecholamines. This was confined to two populations of mature secretory granules, referred to as small and large mature secretory granules, which both derived from immature secretory granules. Our results show that PC 12 cells lack small dense core vesicles, i.e., the catecholamine-storing, but secretory protein-lacking, vesicles found in sympathetic neurons and imply that the biogenesis of these vesicles requires the expression of a distinct type of vesicular amine transporter and/or a change in endosomal protein sorting.			BAUERFEIND, R (corresponding author), UNIV HEIDELBERG, INST NEUROBIOL, NEUENHEIMER FELD 364, D-69120 HEIDELBERG, GERMANY.		Huttner, Wieland B./P-4080-2018					CAMERON PL, 1991, J CELL BIOL, V115, P151, DOI 10.1083/jcb.115.1.151; CLIFTOGRADY L, 1990, J CELL BIOL, V110, P1693, DOI 10.1083/jcb.110.5.1693; CUTLER DF, 1990, J CELL BIOL, V110, P721, DOI 10.1083/jcb.110.3.721; DECAMILLI P, 1990, ANNU REV PHYSIOL, V52, P625, DOI 10.1146/annurev.ph.52.030190.003205; Edwards R H, 1992, Curr Opin Neurobiol, V2, P586, DOI 10.1016/0959-4388(92)90023-E; ERICKSON JD, 1992, P NATL ACAD SCI USA, V89, P10993, DOI 10.1073/pnas.89.22.10993; FRIEDERICH E, 1988, J CELL BIOL, V107, P1655, DOI 10.1083/jcb.107.5.1655; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; GRUENBERG J, 1989, ANNU REV CELL BIOL, V5, P453; HELL JW, 1990, J BIOL CHEM, V265, P2111; HENRY JP, 1989, BIOCHEM PHARMACOL, V38, P2395, DOI 10.1016/0006-2952(89)90082-8; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; HUTTNER WB, 1984, METHOD ENZYMOL, V107, P200; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; HUTTNER WB, 1991, MARKERS NEURAL ENDOC, P93; ISAMBERT MF, 1989, BIOCHEMISTRY-US, V28, P2265, DOI 10.1021/bi00431a044; JOHNSON RG, 1987, ANN NY ACAD SCI, V493, P162, DOI 10.1111/j.1749-6632.1987.tb27198.x; JOHNSTON PA, 1989, EMBO J, V8, P2863, DOI 10.1002/j.1460-2075.1989.tb08434.x; KELLY RB, 1993, CELL, V72, P43, DOI 10.1016/S0092-8674(05)80027-3; KLEIN RL, 1982, NEUROTRANSMITTER VES; LEE RWH, 1983, J BIOL CHEM, V258, P1326; LINSTEDT AD, 1991, NEURON, V7, P309, DOI 10.1016/0896-6273(91)90269-6; LIU Y, 1992, P NATL ACAD SCI USA, V89, P9074, DOI 10.1073/pnas.89.19.9074; LIU YJ, 1992, CELL, V70, P539, DOI 10.1016/0092-8674(92)90425-C; LOWE AW, 1988, J CELL BIOL, V106, P51, DOI 10.1083/jcb.106.1.51; MELEGA WP, 1984, P NATL ACAD SCI-BIOL, V81, P6535, DOI 10.1073/pnas.81.20.6535; NAVONE F, 1986, J CELL BIOL, V103, P2511, DOI 10.1083/jcb.103.6.2511; NEUMAN B, 1984, NEUROSCIENCE, V13, P921, DOI 10.1016/0306-4522(84)90106-4; NORSETH J, 1982, BIOCHIM BIOPHYS ACTA, V719, P569, DOI 10.1016/0304-4165(82)90247-1; PATZAK A, 1986, J CELL BIOL, V102, P510, DOI 10.1083/jcb.102.2.510; REBOIS RV, 1980, BIOCHEMISTRY-US, V19, P1240, DOI 10.1021/bi00547a031; REETZ A, 1991, EMBO J, V10, P1275, DOI 10.1002/j.1460-2075.1991.tb08069.x; REGNIERVIGOUROUX A, 1991, EMBO J, V10, P3589, DOI 10.1002/j.1460-2075.1991.tb04925.x; REGNIERVIGOUROUX A, 1993, NEUROCHEM RES, V18, P59, DOI 10.1007/BF00966923; ROSA P, 1989, J CELL BIOL, V109, P17, DOI 10.1083/jcb.109.1.17; ROSA P, 1985, J CELL BIOL, V101, P1999, DOI 10.1083/jcb.101.5.1999; ROSA P, 1992, J HISTOCHEM CYTOCHEM, V40, P523, DOI 10.1177/40.4.1552186; SCHUBERT D, 1977, P NATL ACAD SCI USA, V74, P5184, DOI 10.1073/pnas.74.11.5184; SLINDE E, 1973, ANAL BIOCHEM, V56, P324, DOI 10.1016/0003-2697(73)90198-X; SLINDE E, 1978, ANAL BIOCHEM, V90, P516, DOI 10.1016/0003-2697(78)90145-8; SMITH AD, 1972, PHARMACOL REV, V24, P435; SMITH AD, 1973, BRIT MED BULL, V29, P123, DOI 10.1093/oxfordjournals.bmb.a070981; SUDHOF TC, 1991, NEURON, V6, P665, DOI 10.1016/0896-6273(91)90165-V; TOOZE J, 1989, EUR J CELL BIOL, V49, P259; TOOZE J, 1991, J CELL BIOL, V115, P635, DOI 10.1083/jcb.115.3.635; TOOZE SA, 1990, CELL, V60, P837, DOI 10.1016/0092-8674(90)90097-X; TOOZE SA, 1992, METHOD ENZYMOL, V219, P81; TOOZE SA, 1991, FEBS LETT, V285, P220, DOI 10.1016/0014-5793(91)80805-D; TOOZE SA, 1991, J CELL BIOL, V115, P1491, DOI 10.1083/jcb.115.6.1491; TOOZE SA, 1993, MECHANISMS INTRACELL, P157; TOUTANT JP, 1988, HDB EXP PHARM, V86, P225; Tuek S., 1988, HDB EXPT PHARM, P125; WAGNER JA, 1985, J NEUROCHEM, V45, P1244, DOI 10.1111/j.1471-4159.1985.tb05549.x; WIEDENMANN B, 1988, FEBS LETT, V240, P71, DOI 10.1016/0014-5793(88)80342-9; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9; WIEDENMANN B, 1989, VIRCHOWS ARCH B, V58, P95, DOI 10.1007/BF02890062; WINKLER H, 1987, ANN NY ACAD SCI, V493, P3, DOI 10.1111/j.1749-6632.1987.tb27176.x	58	131	132	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	1993	11	1					105	121		10.1016/0896-6273(93)90275-V	http://dx.doi.org/10.1016/0896-6273(93)90275-V			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LP430	8338662				2022-12-24	WOS:A1993LP43000010
J	MARRION, NV				MARRION, NV			SELECTIVE REDUCTION OF ONE-MODE OF M-CHANNEL GATING BY MUSCARINE IN SYMPATHETIC NEURONS	NEURON			English	Article							FREE MEMBRANE PATCHES; POTASSIUM-M-CURRENT; CALCIUM CHANNELS; INTRACELLULAR CALCIUM; GANGLION CELLS; KINETIC STATES; INHIBITION; MODULATION; VOLTAGE; PROTEIN	M-current is widespread in the nervous system. It stabilizes cell excitability, and its suppression by muscarinic receptor activation underlies slow synaptic transmission in sympathetic neurons. Suppression of M-current was one of the first examples of neuromodulation of a potassium current, but the mechanism is not understood. Single-channel recording was used to study this issue. An M-channel with two conductance states, which exhibited appropriate voltage-dependent kinetics with two modes of gating, has been resolved. Mode 1 comprises short open time, low open probability events, and mode 2 openings represent long open time, high open probability behavior. Muscarine decreased M-channel activity by selectively reducing mode 2 M-channel gating through a diffusible second messenger. It is suggested that control of modal gating may be a widespread mechanism for neuromodulation.			MARRION, NV (corresponding author), SUNY,DEPT NEUROBIOL & BEHAV,STONY BROOK,NY 11794, USA.				NINDS NIH HHS [NS 29806] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029806, R29NS029806, R55NS029806] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS PR, 1982, J PHYSIOL-LONDON, V332, P263, DOI 10.1113/jphysiol.1982.sp014412; ADAMS PR, 1986, J EXP BIOL, V124, P259; ADAMS PR, 1982, J PHYSIOL-LONDON, V330, P537, DOI 10.1113/jphysiol.1982.sp014357; ADAMS PR, 1982, J PHYSIOL-LONDON, V332, P223, DOI 10.1113/jphysiol.1982.sp014411; AUERBACH A, 1986, J PHYSIOL-LONDON, V378, P119, DOI 10.1113/jphysiol.1986.sp016211; BEECH DJ, 1991, P NATL ACAD SCI USA, V88, P652, DOI 10.1073/pnas.88.2.652; Brown D A, 1988, Ion Channels, V1, P55; BROWN DA, 1989, J PHYSIOL-LONDON, V413, P469, DOI 10.1113/jphysiol.1989.sp017664; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; DELCOUR AH, 1993, J NEUROSCI, V13, P181; DELCOUR AH, 1993, SCIENCE, V259, P980, DOI 10.1126/science.8094902; GRUNER W, 1991, THESIS SUNY STONY BR; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HESS P, 1984, NATURE, V311, P538, DOI 10.1038/311538a0; HORN R, 1991, BIOPHYS J, V60, P433, DOI 10.1016/S0006-3495(91)82069-0; JONES SW, 1991, BIOPHYS J, V60, P502, DOI 10.1016/S0006-3495(91)82077-X; KASAI H, 1991, P NATL ACAD SCI USA, V88, P8855, DOI 10.1073/pnas.88.19.8855; KOYANO K, 1992, J PHYSIOL-LONDON, V454, P231, DOI 10.1113/jphysiol.1992.sp019262; LANSMAN JB, 1986, J GEN PHYSIOL, V88, P321, DOI 10.1085/jgp.88.3.321; LOPEZ HS, 1992, NEURON, V8, P725, DOI 10.1016/0896-6273(92)90093-S; LOPEZ HS, 1989, EUR J NEUROSCI, V1, P529, DOI 10.1111/j.1460-9568.1989.tb00360.x; MARRION NV, 1992, J PHYSIOL-LONDON, V445, P515, DOI 10.1113/jphysiol.1992.sp018937; MARRION NV, 1991, NEURON, V6, P533, DOI 10.1016/0896-6273(91)90056-6; MARRION NV, 1992, P ROY SOC B-BIOL SCI, V248, P207, DOI 10.1098/rspb.1992.0063; MCMANUS OB, 1988, J PHYSIOL-LONDON, V402, P79, DOI 10.1113/jphysiol.1988.sp017195; NEHER E, 1988, FEBS LETT, V240, P88, DOI 10.1016/0014-5793(88)80345-4; NILIUS B, 1988, BIOPHYS J, V53, P857, DOI 10.1016/S0006-3495(88)83166-7; NOWYCKY MC, 1985, P NATL ACAD SCI USA, V82, P2178, DOI 10.1073/pnas.82.7.2178; OWEN DG, 1990, J PHYSIOL-LONDON, V431, P269, DOI 10.1113/jphysiol.1990.sp018330; PATLAK JB, 1979, NATURE, V278, P643, DOI 10.1038/278643a0; PFAFFINGER P, 1988, J NEUROSCI, V8, P3343; SELYANKO AA, 1992, P ROY SOC B-BIOL SCI, V250, P119, DOI 10.1098/rspb.1992.0139; SIEGELBAUM SA, 1982, NATURE, V299, P413, DOI 10.1038/299413a0; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; TSIEN RW, 1986, J MOL CELL CARDIOL, V18, P691, DOI 10.1016/S0022-2828(86)80941-5; YUE DT, 1990, P NATL ACAD SCI USA, V87, P753, DOI 10.1073/pnas.87.2.753	36	45	45	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1993	11	1					77	84		10.1016/0896-6273(93)90272-S	http://dx.doi.org/10.1016/0896-6273(93)90272-S			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LP430	8338670				2022-12-24	WOS:A1993LP43000007
J	PAN, ZZ; TONG, G; JAHR, CE				PAN, ZZ; TONG, G; JAHR, CE			A FALSE TRANSMITTER AT EXCITATORY SYNAPSES	NEURON			English	Article							METHYL-D-ASPARTATE; SYNAPTIC VESICLES; GLUTAMATE UPTAKE; TIME COURSE; HIPPOCAMPAL-NEURONS; CEREBRAL-CORTEX; BINDING-SITES; BRAIN-SLICES; CELL-CULTURE; RECEPTORS	We used the low affinity N-methyl-D-aspartate (NMDA) receptor agonist D-glutamate to study the time course of synaptic activation of NMDA receptors. Repetitive stimulation of cultured hippocampal neurons loaded with D-glutamate caused a dramatic shortening of both the rising and decaying phases of NMDA receptor excitatory postsynaptic currents (EPSCs) evoked by autaptic stimulation. The EPSC time course was mimicked by NMDA receptor currents evoked in outside-out patches by 1-4 ms applications of D-glutamate. Thus, D-glutamate can be released as a false transmitter. The results show that both the rise and fall of the NMDA receptor EPSCs are normally controlled by the slow unbinding rate of the natural neurotransmitter and that the concentration of free transmitter is elevated in the cleft for only a few milliseconds after release.	OREGON HLTH SCI UNIV,DEPT PHYSIOL,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DEPT CELL BIOL & ANAT,PORTLAND,OR 97201	Oregon Health & Science University; Oregon Health & Science University	PAN, ZZ (corresponding author), OREGON HLTH SCI UNIV,VOLLUM INST,L474,PORTLAND,OR 97201, USA.		Tong, Gary/AAC-9426-2022		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021419] Funding Source: NIH RePORTER; NINDS NIH HHS [NS21419] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BALCAR VJ, 1972, J NEUROCHEM, V19, P2657, DOI 10.1111/j.1471-4159.1972.tb01325.x; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; BENVENISTE M, 1991, BIOPHYS J, V59, P560, DOI 10.1016/S0006-3495(91)82272-X; CLEMENTS JD, 1991, NEURON, V7, P605, DOI 10.1016/0896-6273(91)90373-8; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; COLQUHOUN D, 1977, J PHYSIOL-LONDON, V266, P361, DOI 10.1113/jphysiol.1977.sp011772; CURTIS DR, 1960, J NEUROCHEM, V6, P117, DOI 10.1111/j.1471-4159.1960.tb13458.x; DALE N, 1985, J PHYSIOL-LONDON, V363, P35, DOI 10.1113/jphysiol.1985.sp015694; ELIASOF S, 1993, J NEUROSCI, V13, P402; FORSYTHE ID, 1988, J PHYSIOL-LONDON, V396, P515, DOI 10.1113/jphysiol.1988.sp016975; FYKSE EM, 1992, NEUROSCI LETT, V135, P125, DOI 10.1016/0304-3940(92)90151-V; GARTHWAITE J, 1985, BRIT J PHARMACOL, V85, P297, DOI 10.1111/j.1476-5381.1985.tb08860.x; GIBB AJ, 1992, J PHYSIOL-LONDON, V456, P143, DOI 10.1113/jphysiol.1992.sp019331; GRIMWOOD S, 1991, BRIT J PHARMACOL, V103, P1385, DOI 10.1111/j.1476-5381.1991.tb09799.x; HESTRIN S, 1990, NEURON, V5, P247, DOI 10.1016/0896-6273(90)90162-9; Hille B., 1992, IONIC CHANNELS EXCIT; HOWE JR, 1988, PROC R SOC SER B-BIO, V233, P407, DOI 10.1098/rspb.1988.0030; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; KEMP JA, 1991, MOL PHARMACOL, V39, P666; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; LESTER RAJ, 1993, J NEUROSCI, V13, P1088; LESTER RAJ, 1989, MOL PHARMACOL, V35, P565; LESTER RAJ, 1992, J NEUROSCI, V12, P635; MAYCOX PR, 1988, J BIOL CHEM, V263, P15423; MONAGHAN DT, 1986, P NATL ACAD SCI USA, V83, P7532, DOI 10.1073/pnas.83.19.7532; NAITO S, 1985, J NEUROCHEM, V44, P99, DOI 10.1111/j.1471-4159.1985.tb07118.x; OLVERMAN HJ, 1988, NEUROSCIENCE, V26, P17, DOI 10.1016/0306-4522(88)90124-8; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; RANDALL AD, 1990, NEUROSCI LETT, V114, P191, DOI 10.1016/0304-3940(90)90070-P; ROSENBERG PA, 1992, J NEUROSCI, V12, P56; SATHER W, 1992, J PHYSIOL-LONDON, V450, P643, DOI 10.1113/jphysiol.1992.sp019148; SEGAL MM, 1990, J NEUROPHYSIOL, V64, P1390, DOI 10.1152/jn.1990.64.5.1390; TABB JS, 1991, J NEUROSCI, V11, P1822; VILLANUEVA S, 1990, NEUROSCIENCE, V37, P23, DOI 10.1016/0306-4522(90)90188-A; WIGSTROM H, 1985, ACTA PHYSL SCAND, V124, P175	35	37	37	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1993	11	1					85	91						7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LP430	8101712				2022-12-24	WOS:A1993LP43000008
J	PONGS, O; LINDEMEIER, J; ZHU, XR; THEIL, T; ENGELKAMP, D; KRAHJENTGENS, I; LAMBRECHT, HG; KOCH, KW; SCHWEMER, J; RIVOSECCHI, R; MALLART, A; GALCERAN, J; CANAL, I; BARBAS, JA; FERRUS, A				PONGS, O; LINDEMEIER, J; ZHU, XR; THEIL, T; ENGELKAMP, D; KRAHJENTGENS, I; LAMBRECHT, HG; KOCH, KW; SCHWEMER, J; RIVOSECCHI, R; MALLART, A; GALCERAN, J; CANAL, I; BARBAS, JA; FERRUS, A			FREQUENIN - A NOVEL CALCIUM-BINDING PROTEIN THAT MODULATES SYNAPTIC EFFICACY IN THE DROSOPHILA NERVOUS-SYSTEM	NEURON			English	Article							ROD GUANYLATE-CYCLASE; NEUROMUSCULAR-JUNCTION; INSITU HYBRIDIZATION; SHAKER COMPLEX; OUTER SEGMENTS; EF-HAND; GENE; MELANOGASTER; RECOVERIN; CHANNELS	The T(X;Y)V7 rearrangement in Drosophila has originally been recognized as a Shaker-like mutant because of its behavioral and electrophysiological phenotype. The gene whose expression is altered by the V7 rearrangement has been characterized. It encodes a novel Ca2+-binding protein named frequenin, which is related to recoverin and visinin. In vitro, the frequenin protein functions like recoverin as a Ca2+-sensitive guanylyl cyclase activator. Anti-frequenin antibodies stain the central and peripheral nervous system in Drosophila embryos and in larval and adult tissue sections. Frequenin appears to be particularly enriched in synapses, such as the motor nerve endings at neuromuscular junctions. Neuromuscular junctions of transgenic flies, which overexpress frequenin upon heat shock, exhibit an extraordinarily enhanced, frequency-dependent facilitation of neurotransmitter release, with properties identical to those observed in V7 junctions. We propose that frequenin represents a new element for the Ca2+-dependent modulation of synaptic efficacy.	FORSCHUNGSZENTRUM JULICH, FORSCHUNGSZENTRUM, W-5170 JULICH 1, GERMANY; RUHR UNIV BOCHUM, AG SEHPHYSIOL, W-4630 BOCHUM 1, GERMANY; CNRS, NEUROBIOL CELLULAIRE & MOLEC LAB, F-91198 GIF SUR YVETTE, FRANCE; CSIC, INST CAJAL, E-28002 MADRID, SPAIN	Helmholtz Association; Research Center Julich; Ruhr University Bochum; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC)	PONGS, O (corresponding author), INST NEURALE SIGNALVERARBEITUNG, ZENTRUM MOLEK NEUROBIOL, W-2000 HAMBURG 20, GERMANY.		Barbas, Julio/R-8122-2017; Galceran, Juan/K-6744-2014; Koch, Karl-Wilhelm/C-9551-2015	Barbas, Julio/0000-0003-4588-720X; Galceran, Juan/0000-0002-5247-2726; Koch, Karl-Wilhelm/0000-0003-1501-0044; Theil, Thomas/0000-0001-6590-8309				ADELMAN JP, 1992, NEURON, V9, P209, DOI 10.1016/0896-6273(92)90160-F; ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; Ausubel M., 1987, CURRENT PROTOCOLS MO; BABU A, 1992, J BIOL CHEM, V267, P15469; BAUMANN A, 1987, EMBO J, V6, P3419, DOI 10.1002/j.1460-2075.1987.tb02665.x; BRAWERMAN G, 1989, CELL, V57, P9, DOI 10.1016/0092-8674(89)90166-9; BRIGANT JL, 1982, J PHYSIOL-LONDON, V333, P619, DOI 10.1113/jphysiol.1982.sp014472; CATTY D, 1988, ANTIBODIES, V1; DIZHOOR AM, 1992, J BIOL CHEM, V267, P16033; DIZHOOR AM, 1991, SCIENCE, V251, P915, DOI 10.1126/science.1672047; ELKINS T, 1986, P NATL ACAD SCI USA, V83, P8415, DOI 10.1073/pnas.83.21.8415; FERRUS A, 1990, GENETICS, V125, P383; FRANKEL AD, 1991, CELL, V67, P1041, DOI 10.1016/0092-8674(91)90282-4; Ganetzky B, 1983, J NEUROGENET, V1, P17, DOI 10.3109/01677068309107069; GEISER JR, 1991, CELL, V65, P949, DOI 10.1016/0092-8674(91)90547-C; GISSELMANN G, 1989, EMBO J, V8, P2359, DOI 10.1002/j.1460-2075.1989.tb08364.x; HARLOW E, 1988, P NATL ACAD SCI USA, V66, P765; JAN LY, 1976, J PHYSIOL-LONDON, V262, P189, DOI 10.1113/jphysiol.1976.sp011592; JAN YN, 1977, PROC R SOC SER B-BIO, V198, P87, DOI 10.1098/rspb.1977.0087; JAN YN, 1978, P NATL ACAD SCI USA, V75, P515, DOI 10.1073/pnas.75.1.515; KATZ B, 1965, PROC R SOC SER B-BIO, V161, P483, DOI 10.1098/rspb.1965.0016; KINK JA, 1990, CELL, V62, P165, DOI 10.1016/0092-8674(90)90250-I; KLEMENZ R, 1987, NUCLEIC ACIDS RES, V15, P3947, DOI 10.1093/nar/15.10.3947; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; KRAHJENTGENS I, 1989, THESIS RUHR U BOCHUM; KRAMER RH, 1992, NEURON, V9, P897, DOI 10.1016/0896-6273(92)90242-6; KRETSINGER RH, 1980, CRC CR REV BIOCH MOL, V8, P119, DOI 10.3109/10409238009105467; KUNO T, 1992, BIOCHEM BIOPH RES CO, V184, P1219, DOI 10.1016/S0006-291X(05)80012-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAGNADO L, 1992, NEURON, V8, P995, DOI 10.1016/0896-6273(92)90122-T; LAMBRECHT HG, 1991, EMBO J, V10, P793, DOI 10.1002/j.1460-2075.1991.tb08011.x; LENZ SE, 1992, MOL BRAIN RES, V15, P133, DOI 10.1016/0169-328X(92)90160-D; LICHTINGHAGEN R, 1990, EMBO J, V9, P4399, DOI 10.1002/j.1460-2075.1990.tb07890.x; MALLART A, 1991, J NEUROGENET, V7, P75, DOI 10.3109/01677069109066212; MALLART A, 1967, J PHYSIOL-LONDON, V193, P679, DOI 10.1113/jphysiol.1967.sp008388; MATSUOKA I, 1992, J NEUROSCI, V12, P3350; MCGINNIS JF, 1992, FEBS LETT, V302, P172, DOI 10.1016/0014-5793(92)80433-H; MURAKAMI A, 1992, BIOCHEM BIOPH RES CO, V187, P234, DOI 10.1016/S0006-291X(05)81483-4; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; NELSON RM, 1989, ANAL BIOCHEM, V180, P147, DOI 10.1016/0003-2697(89)90103-6; PELHAM HRB, 1982, CELL, V30, P517, DOI 10.1016/0092-8674(82)90249-5; PERSECHINI A, 1989, TRENDS NEUROSCI, V12, P462, DOI 10.1016/0166-2236(89)90097-0; PONGS O, 1992, PHYSIOL REV, V72, pS69, DOI 10.1152/physrev.1992.72.suppl_4.S69; PONGS O, 1988, EMBO J, V7, P1087, DOI 10.1002/j.1460-2075.1988.tb02917.x; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Sambrook J, 1989, MOL CLONING LABORATO; SCHAEFER WH, 1987, P NATL ACAD SCI USA, V84, P3931, DOI 10.1073/pnas.84.11.3931; SCHNETKAMP PPM, 1982, METHOD ENZYMOL, V81, P110; SHYJAN AW, 1992, NEURON, V9, P727, DOI 10.1016/0896-6273(92)90035-C; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; STERN M, 1989, J NEUROGENET, V5, P215, DOI 10.3109/01677068909066209; STOCKER M, 1991, P ROY SOC B-BIOL SCI, V245, P101, DOI 10.1098/rspb.1991.0094; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; TANOUYE MA, 1981, P NATL ACAD SCI-BIOL, V78, P6548, DOI 10.1073/pnas.78.10.6548; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; THIRKILL CE, 1992, INVEST OPHTH VIS SCI, V33, P2768; TOWLER DA, 1988, ANNU REV BIOCHEM, V57, P69, DOI 10.1146/annurev.bi.57.070188.000441; WARMKE J, 1991, SCIENCE, V252, P1560, DOI 10.1126/science.1840699; YAMAGATA K, 1990, NEURON, V4, P469, DOI 10.1016/0896-6273(90)90059-O; ZHONG Y, 1991, SCIENCE, V252, P1562, DOI 10.1126/science.2047864	60	287	294	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	1993	11	1					15	28		10.1016/0896-6273(93)90267-U	http://dx.doi.org/10.1016/0896-6273(93)90267-U			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LP430	8101711				2022-12-24	WOS:A1993LP43000002
J	MOONEY, R; MADISON, DV; SHATZ, CJ				MOONEY, R; MADISON, DV; SHATZ, CJ			ENHANCEMENT OF TRANSMISSION AT THE DEVELOPING RETINOGENICULATE SYNAPSE	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; LONG-TERM POTENTIATION; MEDIATING EXCITATORY INPUT; THALAMIC NEURONS INVITRO; OCULAR DOMINANCE COLUMNS; PRENATAL DEVELOPMENT; NMDA RECEPTORS; VISUAL-CORTEX; HIPPOCAMPAL SLICES; GANGLION-CELLS	Axon terminals from retinal ganglion cells in the left and right eyes initially overlap with each other in the lateral geniculate nucleus of the neonatal ferret, then segregate into eye-specific layers via an activity-dependent process. Brain slices were used to show that, during this period of reorganization, retinal terminals within the lateral geniculate nucleus evoke excitatory postsynaptic currents composed of both NMDA and non-NMDA receptor-mediated currents. The amplitude of these currents could be enhanced for several tens of minutes to more than an hour by several bursts of high frequency synaptic stimulation, and the induction of enhancement appears to depend on NMDA receptor activation. Synaptic enhancement such as this could provide one of the physiological mechanisms by which retinal terminals segregate into eye-specific layers during development.	UNIV CALIF BERKELEY,DEPT MOLEC & CELL BIOL,BERKELEY,CA 94720	University of California System; University of California Berkeley	MOONEY, R (corresponding author), STANFORD UNIV,MED CTR,SCH MED,DEPT MOLEC & CELLULAR PHYSIOL,STANFORD,CA 94305, USA.		; Madison, Daniel/F-9341-2017	Mooney, Richard/0000-0002-3308-1367; Madison, Daniel/0000-0002-0718-5373	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH048108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007158, T32NS007280] Funding Source: NIH RePORTER; NIMH NIH HHS [MH 48108] Funding Source: Medline; NINDS NIH HHS [5 T32 NS07158, 5 T32 NS07280] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARCHER SM, 1982, SCIENCE, V217, P743, DOI 10.1126/science.7100921; ARTOLA A, 1987, NATURE, V330, P649, DOI 10.1038/330649a0; BARRIONUEVO G, 1983, P NATL ACAD SCI-BIOL, V80, P7347, DOI 10.1073/pnas.80.23.7347; BEAR MF, 1986, NATURE, V320, P172, DOI 10.1038/320172a0; CAMPBELL G, 1992, J NEUROSCI, V12, P1847; CLINE HT, 1987, P NATL ACAD SCI USA, V84, P4342, DOI 10.1073/pnas.84.12.4342; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; DAVIES J, 1981, NEUROSCI LETT, V21, P77, DOI 10.1016/0304-3940(81)90061-6; DESCHENES M, 1984, J NEUROPHYSIOL, V51, P1196, DOI 10.1152/jn.1984.51.6.1196; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; ESGUERRA M, 1992, VISUAL NEUROSCI, V8, P545, DOI 10.1017/S0952523800005642; FRIEDLANDER MJ, 1981, J NEUROPHYSIOL, V46, P80, DOI 10.1152/jn.1981.46.1.80; GRAHAM J, 1977, J COMP NEUROL, V173, P629, DOI 10.1002/cne.901730403; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; HAHM JO, 1991, NATURE, V351, P368; HARTVEIT E, 1990, J NEUROPHYSIOL, V63, P1361, DOI 10.1152/jn.1990.63.6.1361; HEGGELUND P, 1990, J NEUROPHYSIOL, V63, P1347, DOI 10.1152/jn.1990.63.6.1347; HICKEY TL, 1974, J COMP NEUROL, V156, P239, DOI 10.1002/cne.901560207; HONORE T, 1988, SCIENCE, V241, P701, DOI 10.1126/science.2899909; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P227, DOI 10.1113/jphysiol.1984.sp015154; KANDEL ER, 1992, SCIENCE, V258, P243, DOI 10.1126/science.1411522; KEMP JA, 1982, J PHYSIOL-LONDON, V323, P377, DOI 10.1113/jphysiol.1982.sp014078; KOMATSU Y, 1988, J NEUROPHYSIOL, V59, P124, DOI 10.1152/jn.1988.59.1.124; KWON YH, 1991, J NEUROPHYSIOL, V66, P414, DOI 10.1152/jn.1991.66.2.414; LEVAY S, 1978, J COMP NEUROL, V179, P223, DOI 10.1002/cne.901790113; LEVAY S, 1980, J COMP NEUROL, V191, P1, DOI 10.1002/cne.901910102; LINDEN DC, 1981, J COMP NEUROL, V203, P189, DOI 10.1002/cne.902030204; LLINAS R, 1982, NATURE, V297, P406, DOI 10.1038/297406a0; LO YJ, 1991, SCIENCE, V254, P1019, DOI 10.1126/science.1658939; MAFFEI L, 1990, P NATL ACAD SCI USA, V87, P2861, DOI 10.1073/pnas.87.7.2861; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; MCCORMICK DA, 1988, NATURE, V334, P246, DOI 10.1038/334246a0; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; O'Leary JL, 1940, J COMP NEUROL, V73, P405, DOI 10.1002/cne.900730304; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; REH TA, 1985, J NEUROSCI, V5, P1132; SCHARFMAN HE, 1990, P NATL ACAD SCI USA, V87, P4548, DOI 10.1073/pnas.87.12.4548; SCHMIDT JT, 1990, J NEUROSCI, V10, P233; SHATZ CJ, 1984, J NEUROSCI, V4, P1378; SHATZ CJ, 1983, J NEUROSCI, V3, P482; SHATZ CJ, 1988, SCIENCE, V242, P87, DOI 10.1126/science.3175636; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; SILLITO AM, 1990, J NEUROPHYSIOL, V63, P347, DOI 10.1152/jn.1990.63.2.347; SILLITO AM, 1983, BRAIN RES, V280, P299, DOI 10.1016/0006-8993(83)90059-8; SILLITO AM, 1990, NEUROSCIENCE, V34, P273, DOI 10.1016/0306-4522(90)90137-S; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; SRETAVAN DW, 1986, J NEUROSCI, V6, P234; SRETAVAN DW, 1988, NATURE, V336, P468, DOI 10.1038/336468a0; WHITE CA, 1992, P NATL ACAD SCI USA, V89, P9820; WIGSTROM H, 1986, ACTA PHYSIOL SCAND, V126, P317, DOI 10.1111/j.1748-1716.1986.tb07822.x	53	85	87	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1993	10	5					815	825		10.1016/0896-6273(93)90198-Z	http://dx.doi.org/10.1016/0896-6273(93)90198-Z			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LD322	8388224				2022-12-24	WOS:A1993LD32200005
J	Dudek, SM; Friedlander, MJ				Dudek, SM; Friedlander, MJ			Developmental down-regulation of LTD in cortical layer IV and its independence of modulation by inhibition	NEURON			English	Article							LONG-TERM POTENTIATION; RAT VISUAL-CORTEX; LATERAL GENICULATE-NUCLEUS; OCULAR DOMINANCE COLUMNS; MONOCULARLY DEPRIVED KITTENS; MUSCIMOL BINDING-SITES; STRIATE CORTEX; NMDA RECEPTORS; BINOCULAR COMPETITION; SLICE PREPARATION	For in vitro LTD to remain viable as a model for synaptic weakening in visual cortical plasticity, it is crucial that it display a critical period for its induction within layer IV. A complicating factor, however, is that LTD in layer IV is modulated by inhibitory postsynaptic potentials (IPSPs); postsynaptic responses characterized as containing IPSPs do not depress in response to 1 Hz afferent stimulation. By blocking IPSPs intracellularly, we find that the ability to induce LTD in layer IV neurons is restored in juvenile, but not in mature animals. This developmental down-regulation of LTD induction is specific for layer IV when compared with LTD induction in layers II/III. These data are consistent with the hypothesis that an LTD-like phenomenon is involved in critical period plasticity and is apparently independent of developmental changes in inhibitory circuitry.	UNIV ALABAMA,NEUROBIOL RES CTR,BIRMINGHAM,AL 35294	University of Alabama System; University of Alabama Birmingham			Dudek, Serena/C-6561-2009	Dudek, Serena/0000-0003-4094-8368	NEI NIH HHS [F32 EY06509, EY 05116] Funding Source: Medline; NATIONAL EYE INSTITUTE [F32EY006509] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AGMON A, 1992, J NEUROPHYSIOL, V68, P345, DOI 10.1152/jn.1992.68.1.345; ANDERSON JC, 1992, P ROY SOC B-BIOL SCI, V250, P187, DOI 10.1098/rspb.1992.0148; ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; ARTOLA A, 1990, NATURE, V347, P69, DOI 10.1038/347069a0; BEAR MF, 1987, SCIENCE, V237, P42, DOI 10.1126/science.3037696; BEAR MF, 1985, J NEUROSCI, V5, P1262; BEAR MF, 1990, J NEUROSCI, V10, P909; BEAR MF, 1990, P NATL ACAD SCI USA, V87, P9246, DOI 10.1073/pnas.87.23.9246; BEAR MF, 1992, J NEUROPHYSIOL, V67, P1; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; BODEGREUEL KM, 1989, DEV BRAIN RES, V46, P197, DOI 10.1016/0165-3806(89)90283-6; BURGARD EC, 1993, J NEUROPHYSIOL, V69, P230, DOI 10.1152/jn.1993.69.1.230; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; CLOTHIAUX EE, 1991, J NEUROPHYSIOL, V399, P301; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Dudek SM, 1995, DEV BRAIN RES, V90, P54, DOI 10.1016/0165-3806(96)83486-9; Dudek SM, 1996, J NEUROPHYSIOL, V75, P2167, DOI 10.1152/jn.1996.75.5.2167; DUFFY FH, 1976, NATURE, V260, P256, DOI 10.1038/260256a0; FOX K, 1992, J NEUROSCI, V12, P2672; FOX K, 1995, NEURON, V15, P485, DOI 10.1016/0896-6273(95)90136-1; FOX K, 1991, NATURE, V350, P342, DOI 10.1038/350342a0; FREEMAN RD, 1988, J NEUROSCI, V8, P2491; FREGNAC Y, 1988, NATURE, V333, P367, DOI 10.1038/333367a0; FRIEDLANDER MJ, 1984, EXP BRAIN RES, V53, P451; FRIEDLANDER MJ, 1989, J PHYSIOL-LONDON, V416, P183, DOI 10.1113/jphysiol.1989.sp017756; FRIEDLANDER MJ, 1991, J NEUROSCI, V11, P3268; GUILLERY RW, 1972, J COMP NEUROL, V144, P117, DOI 10.1002/cne.901440106; HENDRY SHC, 1986, NATURE, V320, P750, DOI 10.1038/320750a0; HENDRY SHC, 1988, NEURON, V1, P701, DOI 10.1016/0896-6273(88)90169-9; HICKEY TL, 1980, J COMP NEUROL, V189, P467, DOI 10.1002/cne.901890304; HIRSCH JA, 1995, J PHYSIOL-LONDON, V483, P183, DOI 10.1113/jphysiol.1995.sp020577; HORIKAWA K, 1988, J NEUROSCI METH, V25, P1, DOI 10.1016/0165-0270(88)90114-8; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; Johnson RR, 1996, J COMP NEUROL, V368, P335, DOI 10.1002/(SICI)1096-9861(19960506)368:3<335::AID-CNE2>3.0.CO;2-6; KALIL R, 1980, J COMP NEUROL, V189, P483, DOI 10.1002/cne.901890305; KATO N, 1991, DEV BRAIN RES, V60, P43, DOI 10.1016/0165-3806(91)90153-A; KIRKWOOD A, 1994, J NEUROSCI, V14, P3404; KIRKWOOD A, 1995, NATURE, V375, P328, DOI 10.1038/375328a0; KIRKWOOD A, 1993, SCIENCE, V260, P1518, DOI 10.1126/science.8502997; KIRKWOOD A, 1994, J NEUROSCI, V14, P1534; KLEINSCHMIDT A, 1987, SCIENCE, V238, P355, DOI 10.1126/science.2443978; KOMATSU Y, 1981, NEUROSCI LETT, V26, P269, DOI 10.1016/0304-3940(81)90144-0; KOMATSU Y, 1983, DEV BRAIN RES, V8, P136, DOI 10.1016/0165-3806(83)90165-7; LAURIE DJ, 1994, J NEUROSCI, V14, P3180; LEHMKUHLE S, 1980, J NEUROPHYSIOL, V43, P542, DOI 10.1152/jn.1980.43.2.542; LEVAY S, 1978, J COMP NEUROL, V179, P223, DOI 10.1002/cne.901790113; LEVAY S, 1976, BRAIN RES, V113, P1, DOI 10.1016/0006-8993(76)90002-0; LEVAY S, 1980, J COMP NEUROL, V191, P1, DOI 10.1002/cne.901910102; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; LUHMANN HJ, 1990, DEV BRAIN RES, V54, P287, DOI 10.1016/0165-3806(90)90152-O; LUND JS, 1979, J COMP NEUROL, V184, P599, DOI 10.1002/cne.901840402; MAYFORD M, 1995, CELL, V81, P891, DOI 10.1016/0092-8674(95)90009-8; Montague PR, 1991, CEREB CORTEX, V1, P199, DOI 10.1093/cercor/1.3.199; MOWER GD, 1984, BRAIN RES, V309, P168, DOI 10.1016/0006-8993(84)91024-2; MOWER GD, 1985, J COMP NEUROL, V235, P448, DOI 10.1002/cne.902350404; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; NEEDLER MC, 1984, BRAIN RES, V308, P347, DOI 10.1016/0006-8993(84)91076-X; NELSON S, 1994, SCIENCE, V265, P774, DOI 10.1126/science.8047882; O'Leary JL, 1941, J COMP NEUROL, V75, P131, DOI 10.1002/cne.900750107; OLSON CR, 1980, EXP BRAIN RES, V39, P17; OUIMET CC, 1995, P NATL ACAD SCI USA, V92, P3396, DOI 10.1073/pnas.92.8.3396; PERKINS AT, 1988, BRAIN RES, V439, P222; PETERS A, 1985, J COMP NEUROL, V238, P263, DOI 10.1002/cne.902380303; REYNOLDS IJ, 1991, EXP BRAIN RES, V85, P611; SHAPLEY R, 1980, EXP BRAIN RES, V39, P41; SHATZ CJ, 1977, BRAIN RES, V131, P103, DOI 10.1016/0006-8993(77)90031-2; SHATZ CJ, 1978, J PHYSIOL-LONDON, V281, P267, DOI 10.1113/jphysiol.1978.sp012421; SHAW C, 1984, BRAIN RES BULL, V13, P331, DOI 10.1016/0361-9230(84)90134-5; SHERMAN SM, 1973, BRAIN RES, V40, P224; SILLITO AM, 1981, NATURE, V291, P318, DOI 10.1038/291318a0; SINGER W, 1995, SCIENCE, V270, P758, DOI 10.1126/science.270.5237.758; TIEMAN SB, 1985, CELL MOL NEUROBIOL, V5, P35, DOI 10.1007/BF00711084; TSUMOTO T, 1978, BRAIN RES, V153, P150, DOI 10.1016/0006-8993(78)91137-X; TSUMOTO T, 1987, NATURE, V327, P513, DOI 10.1038/327513a0; WAGNER JJ, 1995, J NEUROSCI, V15, P1577; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; WIESEL TN, 1965, J NEUROPHYSIOL, V28, P1060, DOI 10.1152/jn.1965.28.6.1060; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P978, DOI 10.1152/jn.1963.26.6.978	81	83	83	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1996	16	6					1097	1106		10.1016/S0896-6273(00)80136-1	http://dx.doi.org/10.1016/S0896-6273(00)80136-1			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UU118	8663986	Bronze			2022-12-24	WOS:A1996UU11800007
J	Zitt, C; Zobel, A; Obukhov, AG; Harteneck, C; Kalkbrenner, F; Luckhoff, A; Schultz, G				Zitt, C; Zobel, A; Obukhov, AG; Harteneck, C; Kalkbrenner, F; Luckhoff, A; Schultz, G			Cloning and functional expression of a human Ca2+-permeable cation channel activated by calcium store depletion	NEURON			English	Article							PHOTOTRANSDUCTION; PROTEIN; CELLS	Depletion of intracellular calcium stores generates a signal that activates Ca2+-permeable channels in the plasma membrane. We have identified a human cDNA, TRPC1A, from a human fetal brain cDNA library. TRPC1A is homologous to the cation channels trp and trpl in Drosophila and is a splice variant of the recently identified cDNA Htrp-1. Expression of TRPC1A in CHO cells induced nonselective cation currents with similar permeabilities for Na+, Ca2+, and Cs+. The currents were activated by intracellular infusion of myo inositol-1,4,5-trisphosphate or thapsigargin. Expression of TRPC1A significantly enhanced increases in the intracellular free calcium concentration induced by Ca2+ restitution after prolonged depletion. Similar results were obtained in Sf9 cells. We conclude that TRPC1A encodes a Ca2+-permeable cation channel activated by depletion of intracellular calcium stores.	FREE UNIV BERLIN,INST PHARMAKOL,D-14195 BERLIN,GERMANY	Free University of Berlin			Obukhov, Alexander G/C-7246-2008	Obukhov, Alexander G/0000-0002-3862-6004				BERRIDGE MJ, 1995, BIOCHEM J, V312, P1, DOI 10.1042/bj3120001; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Dippel E, 1996, P NATL ACAD SCI USA, V93, P1391, DOI 10.1073/pnas.93.4.1391; FASOLATO C, 1994, TRENDS PHARMACOL SCI, V15, P77, DOI 10.1016/0165-6147(94)90282-8; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARDIE RC, 1993, TRENDS NEUROSCI, V16, P371, DOI 10.1016/0166-2236(93)90095-4; HARTENECK C, 1995, FEBS LETT, V358, P297, DOI 10.1016/0014-5793(94)01455-A; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; HU YF, 1995, BIOCHEM J, V305, P605, DOI 10.1042/bj3050605; HU YF, 1994, AM J PHYSIOL, V266, pC1736, DOI 10.1152/ajpcell.1994.266.6.C1736; KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057; LUCKHOFF A, 1994, BIOPHYS J, V67, P177, DOI 10.1016/S0006-3495(94)80467-9; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; NEHER E, 1977, ANNU REV BIOPHYS BIO, V6, P345, DOI 10.1146/annurev.bb.06.060177.002021; OReilly D.R., 1992, BACULOVIRUS EXPRESSI; Penner R, 1993, Curr Opin Neurobiol, V3, P368, DOI 10.1016/0959-4388(93)90130-Q; PETERSEN CCH, 1995, BIOCHEM J, V311, P41, DOI 10.1042/bj3110041; PHILLIPS AM, 1992, NEURON, V8, P631, DOI 10.1016/0896-6273(92)90085-R; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; VACA L, 1994, AM J PHYSIOL-CELL PH, V267, pC1501, DOI 10.1152/ajpcell.1994.267.5.C1501; WES PD, 1995, P NATL ACAD SCI USA, V92, P9652, DOI 10.1073/pnas.92.21.9652; ZHU X, 1995, FEBS LETT, V373, P193, DOI 10.1016/0014-5793(95)01038-G; ZUCKER CS, 1996, P NATL ACAD SCI USA, V93, P571; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	26	330	343	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1996	16	6					1189	1196		10.1016/S0896-6273(00)80145-2	http://dx.doi.org/10.1016/S0896-6273(00)80145-2			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UU118	8663995	Bronze			2022-12-24	WOS:A1996UU11800016
J	Kofuji, P; Hofer, M; Millen, KJ; Millonig, JH; Davidson, N; Lester, HA; Hatten, ME				Kofuji, P; Hofer, M; Millen, KJ; Millonig, JH; Davidson, N; Lester, HA; Hatten, ME			Functional analysis of the weaver mutant GIRK2 K+ channel and rescue of weaver granule cells	NEURON			English	Article							NEURONAL DIFFERENTIATION; MOUSE CEREBELLUM; GENE-ACTION; EXPRESSION; MIGRATION; INVITRO; CHIMERAS; PATTERNS; SITE; MICE	In the neurological mutant mouse weaver, granule cell precursors proliferate normally in the external germinal layer of the cerebellar cortex, but fail to differentiate. Granule neurons purified from weaver cerebella have greatly reduced G protein-activated inwardly rectifying K+ currents; instead, they display a constitutive Na+ conductance. Expression of the weaver GIRK2 channel in oocytes confirms that the mutation leads to constitutive activation, loss of monovalent cation selectivity, and increased sensitivity to three channel blockers. Pharmacological blockade of the Na+ influx in weaver granule cells restores their ability to differentiate normally. Thus, Na+ flux through the weaver GIRK2 channel underlies the failure of granule cell development in situ.	ROCKEFELLER UNIV,DEV NEUROBIOL LAB,NEW YORK,NY 10021	Rockefeller University	Kofuji, P (corresponding author), CALTECH,DIV BIOL,PASADENA,CA 91125, USA.		Kofuji, Paulo/AAR-7835-2021	Kofuji, Paulo/0000-0002-4840-9986; Millen, Kathleen/0000-0001-9978-675X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH049176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034469] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 29836] Funding Source: Medline; NIMH NIH HHS [MH 49176] Funding Source: Medline; NINDS NIH HHS [NS 34469] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDRADE R, 1991, EUR J PHARMACOL, V199, P259, DOI 10.1016/0014-2999(91)90467-5; Bormann Joachim, 1992, P136; BREITWIESER GE, 1988, J GEN PHYSIOL, V91, P469, DOI 10.1085/jgp.91.4.469; CHAVIS P, 1994, J NEUROSCI, V14, P7067; CHEN Y, 1994, J BIOL CHEM, V269, P7839; CLAPHAM DE, 1994, ANNU REV NEUROSCI, V17, P441; DASCAL N, 1993, P NATL ACAD SCI USA, V90, P10235, DOI 10.1073/pnas.90.21.10235; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; DOUPNIK CA, 1995, CURR OPIN NEUROBIOL, V5, P268, DOI 10.1016/0959-4388(95)80038-7; FAKLER B, 1995, CELL, V80, P149, DOI 10.1016/0092-8674(95)90459-X; GAO WQ, 1992, CELL, V68, P841, DOI 10.1016/0092-8674(92)90028-B; GAO WQ, 1991, NEURON, V6, P705, DOI 10.1016/0896-6273(91)90168-Y; GAO WQ, 1993, SCIENCE, V260, P367, DOI 10.1126/science.8469990; GOLDOWITZ D, 1989, NEURON, V2, P1565, DOI 10.1016/0896-6273(89)90045-7; GOLDOWITZ D, 1982, J NEUROSCI, V2, P1474; GRAYBIEL AM, 1990, J NEUROSCI, V10, P720; GUPTA M, 1987, BRAIN RES, V402, P379, DOI 10.1016/0006-8993(87)90050-3; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HATTEN ME, 1981, DEV BIOL, V87, P102, DOI 10.1016/0012-1606(81)90064-6; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; HATTEN ME, 1986, J NEUROSCI, V6, P2676; Hedin KE, 1996, NEURON, V16, P423, DOI 10.1016/S0896-6273(00)80060-4; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; HERRUP K, 1987, NEUROSCIENCE, V23, P871, DOI 10.1016/0306-4522(87)90164-3; Hille B., 1992, IONIC CHANNELS EXCIT; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HUANG CL, 1995, NEURON, V15, P1133, DOI 10.1016/0896-6273(95)90101-9; KOBAYASHI T, 1995, BIOCHEM BIOPH RES CO, V208, P1166, DOI 10.1006/bbrc.1995.1456; KOFUJI P, 1995, P NATL ACAD SCI USA, V92, P6542, DOI 10.1073/pnas.92.14.6542; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; KUHAR SG, 1993, DEVELOPMENT, V117, P97; KUNKEL MT, 1995, CELL, V83, P443, DOI 10.1016/0092-8674(95)90122-1; KURACHI Y, 1995, AM J PHYSIOL-CELL PH, V269, pC821, DOI 10.1152/ajpcell.1995.269.4.C821; LESAGE F, 1995, J BIOL CHEM, V270, P28660, DOI 10.1074/jbc.270.48.28660; LESAGE F, 1994, FEBS LETT, V353, P37, DOI 10.1016/0014-5793(94)01007-2; LIM NF, 1995, J GEN PHYSIOL, V105, P421, DOI 10.1085/jgp.105.3.421; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; Millen Kathleen J., 1996, P339; Millen KJ, 1995, DEVELOPMENT, V121, P3935; MILTONIG JH, 1996, IN PRESS MAMMALIAN G; Mjaatvedt AE, 1995, GENOME RES, V5, P453, DOI 10.1101/gr.5.5.453; NICHOLS CG, 1993, TRENDS PHARMACOL SCI, V14, P320; NORTH RA, 1989, BRIT J PHARMACOL, V98, P13, DOI 10.1111/j.1476-5381.1989.tb16855.x; PATIL N, 1995, NAT GENET, V11, P126, DOI 10.1038/ng1095-126; QUICK MW, 1994, ION CHANNELS EXCITAB, P261; RAKIC P, 1973, P NATL ACAD SCI USA, V70, P240, DOI 10.1073/pnas.70.1.240; RANDALL A, 1995, J NEUROSCI, V15, P2995; REEVES RH, 1989, GENOMICS, V5, P522, DOI 10.1016/0888-7543(89)90018-9; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; REZAI Z, 1972, DEV BIOL, V29, P17, DOI 10.1016/0012-1606(72)90039-5; RofflerTarlov S, 1996, J NEUROSCI, V16, P1819; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; SEKIGUCHI M, 1995, BRAIN RES, V696, P262, DOI 10.1016/0006-8993(95)00974-U; Slesinger PA, 1996, NEURON, V16, P321, DOI 10.1016/S0896-6273(00)80050-1; SOTELO C, 1974, BRAIN RES, V77, P484, DOI 10.1016/0006-8993(74)90636-2; STEWART RR, 1995, J NEUROBIOL, V28, P419, DOI 10.1002/neu.480280403; TAKANO K, 1995, NEURON, V14, P999, DOI 10.1016/0896-6273(95)90338-0; TRIARHOU LC, 1988, EXP BRAIN RES, V70, P256; Velimirovic BM, 1996, FEBS LETT, V379, P31, DOI 10.1016/0014-5793(95)01465-9; WILLINGER M, 1985, DEV BIOL, V107, P156, DOI 10.1016/0012-1606(85)90384-7; ZERR P, 1993, J PHYSIOL-LONDON, V459, pP281	62	172	174	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1996	16	5					941	952		10.1016/S0896-6273(00)80117-8	http://dx.doi.org/10.1016/S0896-6273(00)80117-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UN480	8630252	Bronze			2022-12-24	WOS:A1996UN48000009
J	Cash, S; Dan, Y; Poo, MM; Zucker, R				Cash, S; Dan, Y; Poo, MM; Zucker, R			Postsynaptic elevation of calcium induces persistent depression of developing neuromuscular synapses	NEURON			English	Article							LONG-TERM POTENTIATION; NERVE-MUSCLE INTERACTIONS; XENOPUS CELL-CULTURE; SYNAPTIC TRANSMISSION; PROTEIN-KINASE; NITRIC-OXIDE; SKELETAL-MUSCLE; AREA CA1; HIPPOCAMPUS; ACETYLCHOLINE	Synaptic activity is known to modulate neuronal connectivity in the nervous system. At developing Xenopus neuromuscular synapses in culture, repetitive postsynaptic application of ACh near the synapse leads to immediate and persistent synaptic depression, which was shown to be caused by reduction of presyaptic evoked transmitter release. However, little depression was found when ACh was applied to the muscle 20 mu m or further from the synapse. Fluorescence imaging of cytosolic Ca2+ ([Ca2+](i)) showed that each ACh pulse induced a transient elevation of myocyte [Ca2+], that spread approximately 20 mu m. Local photoactivated release of Ca2+ from the caged Ca2+ chelators nitr-5 or nitrophen in the postsynaptic cell was sufficient to induce persistent synaptic depression. These results support a model in which localized Ca2+ influx into the postsynaptic myocyte initiates transsynaptic retrograde modulation of presynaptic secretion mechanisms.	UNIV CALIF BERKELEY,DIV NEUROBIOL,BERKELEY,CA 94720	University of California System; University of California Berkeley	Cash, S (corresponding author), COLUMBIA UNIV,DEPT BIOL SCI,NEW YORK,NY 10027, USA.		Zucker, Robert S/J-9995-2012	Zucker, Robert S/0000-0003-1068-2343; Dan, Yang/0000-0002-3818-877X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015114] Funding Source: NIH RePORTER; NINDS NIH HHS [NS15114] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKERS RF, 1986, SCIENCE, V231, P587, DOI 10.1126/science.3003904; ANDERSON MJ, 1977, J PHYSIOL-LONDON, V268, P731, DOI 10.1113/jphysiol.1977.sp011879; BALICEGORDON RJ, 1994, NATURE, V372, P519, DOI 10.1038/372519a0; BALICEGORDON RJ, 1993, J NEUROSCI, V13, P834; BETZ WJ, 1990, J NEUROBIOL, V21, P1, DOI 10.1002/neu.480210102; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOHME GA, 1991, EUR J PHARMACOL, V199, P379, DOI 10.1016/0014-2999(91)90505-K; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; BOURNE HR, 1993, CELL, V72, P65, DOI 10.1016/S0092-8674(05)80029-7; BROWN MC, 1976, J PHYSIOL-LONDON, V261, P387, DOI 10.1113/jphysiol.1976.sp011565; BUCHANAN J, 1989, J NEUROSCI, V9, P1540; Cash Sydney, 1995, Seminars in Developmental Biology, V6, P185, DOI 10.1016/S1044-5781(06)80028-9; CLINE HT, 1987, P NATL ACAD SCI USA, V84, P4342, DOI 10.1073/pnas.84.12.4342; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; DAN Y, 1992, SCIENCE, V256, P1570, DOI 10.1126/science.1317971; DAN Y, 1992, NATURE, V359, P733, DOI 10.1038/359733a0; Dan Yang, 1994, Current Opinion in Neurobiology, V4, P95, DOI 10.1016/0959-4388(94)90037-X; DANIEL H, 1992, EXP BRAIN RES, V90, P327; DECKER ER, 1990, J NEUROSCI, V10, P3413; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; EVERS J, 1989, J NEUROSCI, V9, P1523; GIROD R, 1995, J NEUROSCI, V15, P2826; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; GORDON T, 1974, CELL TISSUE RES, V155, P13; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARRIS EW, 1984, BRAIN RES, V323, P132, DOI 10.1016/0006-8993(84)90275-0; HEBB DO, 1949, ORG BEHAVIOR; HU GY, 1987, NATURE, V328, P426, DOI 10.1038/328426a0; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; KIDOKORO Y, 1982, P NATL ACAD SCI-BIOL, V79, P6727, DOI 10.1073/pnas.79.21.6727; KUFFLER D, 1977, BRAIN RES, V138, P353, DOI 10.1016/0006-8993(77)90752-1; KULLBERG RW, 1977, DEV BIOL, V60, P101, DOI 10.1016/0012-1606(77)90113-0; LANDO L, 1994, J NEUROPHYSIOL, V72, P825, DOI 10.1152/jn.1994.72.2.825; LANDO L, 1989, J GEN PHYSIOL, V93, P1017, DOI 10.1085/jgp.93.6.1017; LINDEN DJ, 1991, SCIENCE, V254, P1656, DOI 10.1126/science.1721243; LISMAN JE, 1985, P NATL ACAD SCI USA, V82, P3055, DOI 10.1073/pnas.82.9.3055; LO YJ, 1994, J NEUROSCI, V14, P4684; LO YJ, 1991, SCIENCE, V254, P1019, DOI 10.1126/science.1658939; LYNCH G, 1984, SCIENCE, V224, P1057, DOI 10.1126/science.6144182; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; MINTA A, 1989, J BIOL CHEM, V264, P8171; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; OBRIEN RAD, 1980, NEUROSCIENCE, V5, P1367, DOI 10.1016/0306-4522(80)90209-2; OLIVER MW, 1989, BRAIN RES, V505, P233, DOI 10.1016/0006-8993(89)91448-0; POO MM, 1982, NATURE, V295, P332, DOI 10.1038/295332a0; POO MM, 1995, IN PRESS COLD SPRING, V60; PURVES D, 1985, PRINCIPLES NEURAL DE; RABACCHI S, 1992, SCIENCE, V256, P1823, DOI 10.1126/science.1352066; RICH MM, 1989, J NEUROSCI, V9, P1781, DOI 10.1523/jneurosci.09-05-01781.1989; SAKURAI M, 1990, P NATL ACAD SCI USA, V87, P3383, DOI 10.1073/pnas.87.9.3383; SCHUMAN EM, 1991, SCIENCE, V254, P1503, DOI 10.1126/science.1720572; SPITZER NC, 1976, P NATL ACAD SCI USA, V73, P1641, DOI 10.1073/pnas.73.5.1641; SRIHARI T, 1978, J NEUROCYTOL, V7, P529, DOI 10.1007/BF01260887; STAUBLI U, 1988, BRAIN RES, V444, P153, DOI 10.1016/0006-8993(88)90922-5; STEVENS CF, 1993, NATURE, V364, P147, DOI 10.1038/364147a0; SUN YA, 1987, P NATL ACAD SCI USA, V84, P2540, DOI 10.1073/pnas.84.8.2540; Tabti N., 1991, CULTURING NERVE CELL, P137; VANESSEN DC, 1990, J NEUROBIOL, V21, P223, DOI 10.1002/neu.480210115; WANG T, 1995, NATURE, V374, P262, DOI 10.1038/374262a0; WILLIAMS JH, 1989, NATURE, V341, P739, DOI 10.1038/341739a0; ZHUO M, 1993, SCIENCE, V260, P1946, DOI 10.1126/science.8100368; ZUCKER RS, 1993, CELL CALCIUM, V14, P87, DOI 10.1016/0143-4160(93)90079-L	68	33	33	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1996	16	4					745	754		10.1016/S0896-6273(00)80095-1	http://dx.doi.org/10.1016/S0896-6273(00)80095-1			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UG611	8607993	Bronze			2022-12-24	WOS:A1996UG61100008
J	RYAN, TA; SMITH, SJ				RYAN, TA; SMITH, SJ			VESICLE POOL MOBILIZATION DURING ACTION-POTENTIAL FIRING AT HIPPOCAMPAL SYNAPSES	NEURON			English	Article							FROG NEUROMUSCULAR-JUNCTION; MOTOR-NERVE TERMINALS; RELEASE; TRANSMITTER	Using the fluorescent membrane label FM 1-43, we have measured the release, reuptake, and repriming of synaptic vesicles in response to action potential stimulation of cultured hippocampal neurons. We find that similar to 90% of a recycling vesicle pool is released during 60 s of 10 Hz action potential firing, and that a single action potential releases approximately 0.5% of that pool. Our data also indicate that endocytic reuptake of vesicle membrane externalized by 10 Hz action potentials lags exocytosis, with a half-time on the order of 20 s, and that the minimum time for repriming of an endocytosed vesicle is on the order of 15 s. Finally, we find that once vesicles have undergone this repriming period, they become functionally mixed in the vesicle pool within a few minutes; the probability of release for recently recycled vesicles is indistinguishable from that of vesicles that have resided within the bouton for much longer periods.			RYAN, TA (corresponding author), STANFORD UNIV,DEPT MOLEC & CELLULAR PHYSIOL,STANFORD,CA 94305, USA.		Ryan, Timothy/AAO-8286-2020	Ryan, Timothy/0000-0003-2533-9548	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH048108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028587] Funding Source: NIH RePORTER; NIMH NIH HHS [MH48108] Funding Source: Medline; NINDS NIH HHS [NS 28587] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; HARRIS KM, 1989, J NEUROSCI, V9, P2982; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; KELLY RB, 1993, CELL, V72, P43, DOI 10.1016/S0092-8674(05)80027-3; Malgaroli Antonio, 1994, Seminars in Cell Biology, V5, P231, DOI 10.1006/scel.1994.1029; PARSONS TD, 1994, NEURON, V13, P875, DOI 10.1016/0896-6273(94)90253-4; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; SEARL T, 1991, J PHYSIOL-LONDON, V444, P99, DOI 10.1113/jphysiol.1991.sp018868; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0	12	244	249	0	3	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1995	14	5					983	989		10.1016/0896-6273(95)90336-4	http://dx.doi.org/10.1016/0896-6273(95)90336-4			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QY935	7748565	Bronze			2022-12-24	WOS:A1995QY93500010
J	SHARP, AH; LOEV, SJ; SCHILLING, G; LI, SH; LI, XJ; BAO, J; WAGSTER, MV; KOTZUK, JA; STEINER, JP; LO, A; HEDREEN, J; SISODIA, S; SNYDER, SH; DAWSON, TM; RYUGO, DK; ROSS, CA				SHARP, AH; LOEV, SJ; SCHILLING, G; LI, SH; LI, XJ; BAO, J; WAGSTER, MV; KOTZUK, JA; STEINER, JP; LO, A; HEDREEN, J; SISODIA, S; SNYDER, SH; DAWSON, TM; RYUGO, DK; ROSS, CA			WIDESPREAD EXPRESSION OF HUNTINGTONS-DISEASE GENE (IT15) PROTEIN PRODUCT	NEURON			English	Article							TRINUCLEOTIDE CAG REPEAT; D-ASPARTATE RECEPTOR; STRIATAL NEURONS; QUINOLINIC ACID; KAINIC ACID; GLUTAMATE; LENGTH; CORTEX; DEGENERATION; EXPANSION	Huntington's Disease (HD) is caused by expansion of a CAG repeat within a putative open reading frame of a recently identified gene, IT15. We have examined the expression of the gene's protein product using antibodies developed against the N-terminus and an internal epitope. Both antisera recognize a 350 kDa protein, the predicted size, indicating that the CAG repeat is translated into polyglutamine. The HD protein product is widely expressed, most highly in neurons in the brain. There is no enrichment in the striatum, the site of greatest pathology in HD. Within neurons, the protein is diminished in nuclei and mitochondria and is present in the soluble cytoplasmic compartment, as well as loosely associated with membranes or cytoskeleton, in cell bodies, dendrites, and axons. It is concentrated in nerve terminals, including terminals within the caudate and putamen. Thus, the normal HD gene product may be involved in common intracellular functions, and possibly in regulation of nerve terminal function. The product of the expanded allele is expressed, consistent with a gain of function mechanism for HD at the protein level.	JOHNS HOPKINS UNIV,SCH MED,DEPT PSYCHIAT,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT PATHOL,NEUROPATHOL LAB,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROL,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT PHARMACOL,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT OTOLARYNGOL HEAD & NECK SURG,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	SHARP, AH (corresponding author), JOHNS HOPKINS UNIV,SCH MED,MOLEC NEUROBIOL LAB,BALTIMORE,MD 21205, USA.		Ross, Christopher A/H-8395-2013; Ryugo, David K./G-1940-2012; Lo, Amy C. Y./C-1195-2009	Ryugo, David K./0000-0002-5250-7503; Lo, Amy C. Y./0000-0003-4239-6851	NIDCD NIH HHS [DC00232] Funding Source: Medline; NINDS NIH HHS [P01 NS16375, NS 01578] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS016375, K08NS001578] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000232] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ADAMS JC, 1992, J HISTOCHEM CYTOCHEM, V40, P1457, DOI 10.1177/40.10.1527370; ALBIN RL, 1992, NEUROLOGY, V42, P733, DOI 10.1212/WNL.42.4.733; ALBIN RL, 1995, TRENDS NEUROSCI, V18, P11, DOI 10.1016/0166-2236(95)93943-R; AMBROSE CM, 1994, SOMAT CELL MOLEC GEN, V20, P27, DOI 10.1007/BF02257483; ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; AYLWARD EH, 1994, NEUROLOGY, V44, P823, DOI 10.1212/WNL.44.5.823; BEAL MF, 1991, J NEUROSCI, V11, P1649; BEAL MF, 1993, TRENDS NEUROSCI, V16, P125, DOI 10.1016/0166-2236(93)90117-5; BEAL MF, 1986, NATURE, V321, P168, DOI 10.1038/321168a0; BEAL MF, 1993, J NEUROSCI, V13, P4181; BIRD ED, 1974, ANN HUM GENET, V37, P255, DOI 10.1111/j.1469-1809.1974.tb01833.x; BIZIERE K, 1979, J NEUROSCI RES, V4, P383, DOI 10.1002/jnr.490040507; BRAAK H, 1982, CELL TISSUE RES, V227, P319, DOI 10.1007/BF00210889; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; CHOI DW, 1992, SCIENCE, V258, P241, DOI 10.1126/science.1357748; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; COYLE JT, 1976, NATURE, V263, P244, DOI 10.1038/263244a0; CUDKOWICZ M, 1990, ANN NEUROL, V27, P200, DOI 10.1002/ana.410270217; DELAMONTE SM, 1988, J NEUROPATH EXP NEUR, V47, P516, DOI 10.1097/00005072-198809000-00003; DIFIGLIA M, 1976, BRAIN RES, V114, P245, DOI 10.1016/0006-8993(76)90669-7; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; FERRANTE RJ, 1987, J NEUROPATH EXP NEUR, V46, P12, DOI 10.1097/00005072-198701000-00002; FERRANTE RJ, 1985, SCIENCE, V230, P561, DOI 10.1126/science.2931802; FOLSTEIN SE, 1989, HUNTINGTONS DISEASE; GRAVELAND GA, 1985, SCIENCE, V227, P770, DOI 10.1126/science.3155875; GRAY EG, 1962, J ANAT, V96, P79; GREEN H, 1993, CELL, V74, P955, DOI 10.1016/0092-8674(93)90718-6; HARLOW E, 1988, ANTIBODIES LABORATOR; HEDREEN JC, 1991, NEUROSCI LETT, V133, P257, DOI 10.1016/0304-3940(91)90583-F; HEDREEN JC, 1995, HUNTINGTON DISEASE P, P1; HOOGEVEEN AT, 1993, HUM MOL GENET, V12, P2069; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; KAWAGUCHI Y, 1995, NAT GENET, V8, P221; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANGE H W, 1981, Verhandlungen der Anatomischen Gesellschaft, V75, P923; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LEE WS, 1993, ENDOCRINOLOGY, V133, P2248, DOI 10.1210/en.133.5.2248; LI SH, 1993, NEURON, V11, P985, DOI 10.1016/0896-6273(93)90127-D; LIN BY, 1994, HUM MOL GENET, V3, P85, DOI 10.1093/hmg/3.1.85; MARTIN JB, 1986, NEW ENGL J MED, V315, P1267; MCGEER EG, 1978, BRAIN RES, V139, P381, DOI 10.1016/0006-8993(78)90941-1; MCPHERSON PS, 1994, J BIOL CHEM, V269, P30132; MYERS RH, 1988, NEUROLOGY, V38, P341, DOI 10.1212/WNL.38.3.341; NAGAFUCHI S, 1994, NAT GENET, V8, P177, DOI 10.1038/ng1094-177; NOVELLI A, 1988, BRAIN RES, V451, P205, DOI 10.1016/0006-8993(88)90765-2; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; RIDLEY RM, 1988, J MED GENET, V25, P589, DOI 10.1136/jmg.25.9.589; ROSS CA, 1993, TRENDS NEUROSCI, V16, P254, DOI 10.1016/0166-2236(93)90175-L; RYUGO DK, 1991, J COMP NEUROL, V308, P209, DOI 10.1002/cne.903080208; SOTREL A, 1991, NEUROLOGY, V41, P1117, DOI 10.1212/WNL.41.7.1117; STINE OC, 1993, HUM MOL GENET, V2, P1547, DOI 10.1093/hmg/2.10.1547; STRONG TV, 1993, NAT GENET, V5, P259, DOI 10.1038/ng1193-259; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VERHEIJ C, 1993, NATURE, V363, P722, DOI 10.1038/363722a0; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; WEXLER NS, 1987, NATURE, V326, P194, DOI 10.1038/326194a0; 1993, CELL, V72, P971	58	403	417	0	17	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1995	14	5					1065	1074		10.1016/0896-6273(95)90345-3	http://dx.doi.org/10.1016/0896-6273(95)90345-3			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QY935	7748554	hybrid			2022-12-24	WOS:A1995QY93500019
J	KREIENKAMP, HJ; MAEDA, RK; SINE, SM; TAYLOR, P				KREIENKAMP, HJ; MAEDA, RK; SINE, SM; TAYLOR, P			INTERSUBUNIT CONTACTS GOVERNING ASSEMBLY OF THE MAMMALIAN NICOTINIC ACETYLCHOLINE-RECEPTOR	NEURON			English	Article							TORPEDO-CALIFORNICA; SUBUNIT INTERFACES; EPSILON SUBUNIT; LIGAND-BINDING; AMINO-ACIDS; COS CELLS; IDENTIFICATION; SITE; MUTAGENESIS; RESIDUES	Through specific intersubunit contacts, the four subunits of the nicotinic acetylcholine receptor assemble into an alpha(2) beta gamma delta pentamer, The specificity of subunit association leads to formation of proper ligand binding sites and to transport of assembled pentamers to the cell surface. To identify determinants of subunit association, we constructed chimeric subunits, transfected them into HEK 293 cells, and studied their association with wild-type subunits. We used py chimeras to determine sequences that associate with the a subunit to form a ligand binding site and found residues 21-131 of the gamma subunit sufficient to form the site. Residues 51-131 of the beta subunit do not farm a binding site, but do promote surface expression of pentamers; of these residues, R117 is key for surface expression. We studied formation of tetramers by alpha and gamma subunits and dimers by alpha and delta subunits, and used gamma delta chimeras to identify sequences that result in either dimers or tetramers. The conserved residues 1145 and T150 of the gamma subunit promote alpha gamma alpha gamma tetramer formation, whereas the corresponding residues in the delta subunit, K145 and K150, allow only alpha delta dimer formation.	MAYO CLIN & MAYO FDN,DEPT PHYSIOL & BIOPHYS,ROCHESTER,MN 55905	Mayo Clinic	KREIENKAMP, HJ (corresponding author), UNIV CALIF SAN DIEGO,DEPT PHARMACOL 0636,LA JOLLA,CA 92093, USA.			Kreienkamp, Hans-Jurgen/0000-0002-8871-9970	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031744, R37NS031744] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 24437] Funding Source: Medline; NINDS NIH HHS [NS 31744] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BETZ H, 1990, NEURON, V5, P383, DOI 10.1016/0896-6273(90)90077-S; BLOUNT P, 1990, J CELL BIOL, V111, P2601, DOI 10.1083/jcb.111.6.2601; BLOUNT P, 1988, J BIOL CHEM, V263, P1072; BLOUNT P, 1989, NEURON, V3, P349, DOI 10.1016/0896-6273(89)90259-6; COUTURIER S, 1990, J BIOL CHEM, V265, P17560; COUTURIER S, 1990, NEURON, V5, P847, DOI 10.1016/0896-6273(90)90344-F; DENNIS M, 1988, BIOCHEMISTRY-US, V27, P2346, DOI 10.1021/bi00407a016; FU DX, 1994, J BIOL CHEM, V269, P26152; GALZI JL, 1991, FEBS LETT, V294, P198, DOI 10.1016/0014-5793(91)80668-S; GREEN WN, 1993, CELL, V74, P57, DOI 10.1016/0092-8674(93)90294-Z; GU Y, 1991, NEURON, V6, P879, DOI 10.1016/0896-6273(91)90228-R; GU Y, 1991, J CELL BIOL, V114, P799, DOI 10.1083/jcb.114.4.799; GULLICK WJ, 1983, BIOCHEMISTRY-US, V22, P3312, DOI 10.1021/bi00283a003; Karlin A, 1993, Curr Opin Neurobiol, V3, P299, DOI 10.1016/0959-4388(93)90121-E; KARLIN A, 1983, J BIOL CHEM, V258, P6678; KREIENKAMP HJ, 1994, J BIOL CHEM, V269, P8108; KUHSE J, 1993, NEURON, V11, P1049, DOI 10.1016/0896-6273(93)90218-G; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; MERLIE JP, 1983, CELL, V34, P747, DOI 10.1016/0092-8674(83)90531-7; PAULSON HL, 1991, J CELL BIOL, V110, P1705; PEDERSEN SE, 1990, P NATL ACAD SCI USA, V87, P2785, DOI 10.1073/pnas.87.7.2785; RAFTERY MA, 1980, SCIENCE, V208, P1454, DOI 10.1126/science.7384786; SAEDI MS, 1991, J CELL BIOL, V112, P1007, DOI 10.1083/jcb.112.5.1007; SINE SM, 1991, J BIOL CHEM, V266, P19369; SINE SM, 1993, P NATL ACAD SCI USA, V90, P9436, DOI 10.1073/pnas.90.20.9436; SINE SM, 1981, J BIOL CHEM, V256, P6692; UNWIN N, 1993, NEURON S, V10, P31; VERNALLIS AB, 1993, NEURON, V10, P451, DOI 10.1016/0896-6273(93)90333-M; VERRALL S, 1992, CELL, V68, P23, DOI 10.1016/0092-8674(92)90203-O; YU XM, 1991, NATURE, V352, P64, DOI 10.1038/352064a0	30	89	90	0	2	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1995	14	3					635	644		10.1016/0896-6273(95)90320-8	http://dx.doi.org/10.1016/0896-6273(95)90320-8			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QP230	7695910	Bronze			2022-12-24	WOS:A1995QP23000017
J	PITLER, TA; ALGER, BE				PITLER, TA; ALGER, BE			DEPOLARIZATION-INDUCED SUPPRESSION OF GABAERGIC INHIBITION IN RAT HIPPOCAMPAL PYRAMIDAL CELLS - G-PROTEIN INVOLVEMENT IN A PRESYNAPTIC MECHANISM	NEURON			English	Article							CEREBELLAR PURKINJE-CELLS; SYNAPTIC POTENTIALS; NEURONS; RESPONSES; CALCIUM; RECEPTORS; ADENOSINE; CURRENTS; INVITRO; SLICES	Following postsynaptic activation of a pyramidal cell, the degree of GABAergic synaptic inhibition that the cell receives is reduced dramatically for many seconds. Previously, we found that induction of depolarization induced suppression of inhibition (DSI) required postsynaptic increases in intracellular [Ca2+], but absence of a decrease in responsiveness to iontophoretically applied GABA left the mechanism of DSI expression uncertain. We investigated DSI with whole-cell voltage-clamp recordings in rat hippocampal slices. Bath-applied carbachol was ordinarily used to increase the spontaneous action potential-induced IPSCs (sIPSCs) and enhance detectability of DSI; synaptically released ACh has the same effects. TTX-sensitive sIPSCs are markedly reduced by DSI, whereas TTX-insensitive miniature IPSC amplitudes do not change, suggesting that DSI represents a retrograde influence on presynaptic GABA release. A lag (similar to 1 s) prior to maximal DSI and prevention of DSI by pertussis toxin pointed to a G protein-linked second messenger that may be presynaptic, since perturbation of postsynaptic G protein function did not alter DSI.			PITLER, TA (corresponding author), UNIV MARYLAND, SCH MED, DEPT PHYSIOL, BALTIMORE, MD 21201 USA.				NINDS NIH HHS [NS22010, NS30219, NS27968] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027968, R01NS022010, R01NS030219] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALGER BE, 1991, ANN NY ACAD SCI, V627, P249; ALGER BE, 1980, BRAIN RES, V200, P195, DOI 10.1016/0006-8993(80)91108-7; ANDERSEN P, 1964, J NEUROPHYSIOL, V27, P608, DOI 10.1152/jn.1964.27.4.608; ANDRADE R, 1986, SCIENCE, V234, P1261, DOI 10.1126/science.2430334; ANWYL R, 1991, BRAIN RES REV, V16, P265, DOI 10.1016/0165-0173(91)90010-6; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; BOWERY NG, 1993, ANNU REV PHARMACOL, V33, P109, DOI 10.1146/annurev.pa.33.040193.000545; COLE AE, 1983, SCIENCE, V221, P1299, DOI 10.1126/science.6612345; DAVIES CH, 1990, J PHYSIOL-LONDON, V424, P513, DOI 10.1113/jphysiol.1990.sp018080; DUNWIDDIE TV, 1984, J PHYSIOL-LONDON, V350, P545, DOI 10.1113/jphysiol.1984.sp015217; DUNWIDDIE TV, 1984, LIFE SCI, V34, P37, DOI 10.1016/0024-3205(84)90328-X; EDWARDS FA, 1990, J PHYSIOL-LONDON, V430, P213, DOI 10.1113/jphysiol.1990.sp018289; GAHWILER BH, 1985, P NATL ACAD SCI USA, V82, P1558, DOI 10.1073/pnas.82.5.1558; GULYAS AI, 1993, NATURE, V366, P683, DOI 10.1038/366683a0; HALLIWELL JV, 1982, BRAIN RES, V250, P71, DOI 10.1016/0006-8993(82)90954-4; HARTZELL HC, 1981, NATURE, V291, P539, DOI 10.1038/291539a0; HILLE B, 1992, IONIC CHANNELS EXCIT, P1; HOSMER DW, 1989, APPLIED REGRESSION; LLANO I, 1991, NEURON, V6, P565, DOI 10.1016/0896-6273(91)90059-9; MILES R, 1984, J PHYSIOL-LONDON, V356, P97, DOI 10.1113/jphysiol.1984.sp015455; NATHAN T, 1990, NEUROSCI LETT, V110, P309, DOI 10.1016/0304-3940(90)90865-7; NEWBERRY NR, 1985, J PHYSIOL-LONDON, V360, P161, DOI 10.1113/jphysiol.1985.sp015610; NICOLL RA, 1981, J NEUROSCI METH, V4, P153, DOI 10.1016/0165-0270(81)90049-2; PITLER TA, 1992, J PHYSIOL-LONDON, V450, P127, DOI 10.1113/jphysiol.1992.sp019119; PITLER TA, 1992, J NEUROSCI, V12, P4122; ROPERT N, 1990, J PHYSIOL-LONDON, V428, P707, DOI 10.1113/jphysiol.1990.sp018236; SCANZIANI M, 1992, NEURON, V9, P919, DOI 10.1016/0896-6273(92)90244-8; SCHWARTZKROIN PA, 1977, BRAIN RES, V135, P157, DOI 10.1016/0006-8993(77)91060-5; STELZER A, 1992, INT REV NEUROBIOL, V33, P195, DOI 10.1016/S0074-7742(08)60693-5; VINCENT P, 1993, NEURON, V11, P885, DOI 10.1016/0896-6273(93)90118-B; WORLEY PF, 1987, P NATL ACAD SCI USA, V84, P3467, DOI 10.1073/pnas.84.10.3467; WU LG, 1994, NEURON, V12, P1139, DOI 10.1016/0896-6273(94)90321-2	32	156	160	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1994	13	6					1447	1455						9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PZ689	7993636				2022-12-24	WOS:A1994PZ68900019
J	UMEMIYA, M; BERGER, AJ				UMEMIYA, M; BERGER, AJ			ACTIVATION OF ADENOSINE A(1) AND A(2) RECEPTORS DIFFERENTIALLY MODULATES CALCIUM CHANNELS AND GLYCINERGIC SYNAPTIC TRANSMISSION IN RAT BRAIN-STEM	NEURON			English	Article							CA2+ CHANNELS; TRANSMITTER RELEASE; NEURONS; INHIBITION; CURRENTS; HIPPOCAMPUS; BACLOFEN; PROTEIN; INFLUX	Multiple types of calcium channels are responsible for calcium influx that triggers transmitter release in the mammalian CNS. To test the contribution of each calcium channel type an synaptic modulation, we recorded calcium currents from somata of presynaptic interneurons and unitary glycinergic postsynaptic currents in the rat brainstem. In interneuron somata, A(1) receptor activation inhibited predominantly N-type (omega-conotoxin GVIA-sensitive) and, to a lesser extent, P-type (omega-agatoxin IVA-sensitive) channels. At the presynaptic terminal N- and P-type channels mediated synaptic transmission. omega-CgTx occluded synaptic inhibition by A(1) receptor activation, suggesting that synaptic inhibition was mediated predominantly by N-type channel inhibition. A(2) receptor activation facilitated synaptic transmission, probably through potentiation of P-type channels at the presynaptic terminal.			UMEMIYA, M (corresponding author), UNIV WASHINGTON, SCH MED, DEPT PHYSIOL & BIOPHYS, SJ-40, SEATTLE, WA 98195 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS014857] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-49657] Funding Source: Medline; NINDS NIH HHS [NS-14857] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AUGUSTINE GJ, 1991, ANN NY ACAD SCI, V635, P365, DOI 10.1111/j.1749-6632.1991.tb36505.x; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; CASTILLO PE, 1994, NEURON, V12, P261, DOI 10.1016/0896-6273(94)90269-0; CLAPHAM DE, 1994, ANNU REV NEUROSCI, V17, P441; COLLIS MG, 1993, TRENDS PHARMACOL SCI, V14, P360; DOROSHENKO P, 1991, PFLUG ARCH EUR J PHY, V419, P444, DOI 10.1007/BF00370786; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; FORT P, 1993, NEUROREPORT, V4, P1123; KASAI H, 1989, PFLUG ARCH EUR J PHY, V414, P145, DOI 10.1007/BF00580956; MINTZ IM, 1993, NEURON, V10, P889, DOI 10.1016/0896-6273(93)90204-5; MOGUL DJ, 1993, NEURON, V10, P327, DOI 10.1016/0896-6273(93)90322-I; OCONNOR VM, 1993, FEBS LETT, V326, P255, DOI 10.1016/0014-5793(93)81802-7; REGEHR WG, 1994, NEURON, V12, P605, DOI 10.1016/0896-6273(94)90216-X; SCANZIANI M, 1992, NEURON, V9, P919, DOI 10.1016/0896-6273(92)90244-8; SCHOLZ KP, 1991, J PHYSIOL-LONDON, V435, P373, DOI 10.1113/jphysiol.1991.sp018515; SCHOLZ KP, 1992, NEURON, V8, P1139, DOI 10.1016/0896-6273(92)90134-Y; SIMON SM, 1985, BIOPHYS J, V48, P485, DOI 10.1016/S0006-3495(85)83804-2; TAKAHASHI T, 1993, NATURE, V366, P156, DOI 10.1038/366156a0; TAKAHASHI T, 1992, J PHYSIOL-LONDON, V450, P593, DOI 10.1113/jphysiol.1992.sp019145; THOMPSON SM, 1992, J PHYSIOL-LONDON, V451, P347, DOI 10.1113/jphysiol.1992.sp019168; UMEMIYA M, 1994, J NEUROSCI, V14, P5652; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; WU LG, 1994, NEURON, V12, P1139, DOI 10.1016/0896-6273(94)90321-2; YAWO H, 1993, NATURE, V365, P256, DOI 10.1038/365256a0; ZHU Y, 1993, J NEUROPHYSIOL, V70, P610, DOI 10.1152/jn.1993.70.2.610	25	96	98	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1994	13	6					1439	1446		10.1016/0896-6273(94)90429-4	http://dx.doi.org/10.1016/0896-6273(94)90429-4			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PZ689	7993635				2022-12-24	WOS:A1994PZ68900018
J	HORRIGAN, FT; BOOKMAN, RJ				HORRIGAN, FT; BOOKMAN, RJ			RELEASABLE POOLS AND THE KINETICS OF EXOCYTOSIS IN ADRENAL CHROMAFFIN CELLS	NEURON			English	Article							PATCH-CLAMP TECHNIQUES; CAPACITANCE MEASUREMENTS; TRANSMITTER RELEASE; CALCIUM DIFFUSION; RAT PITUITARY; SECRETION; CATECHOLAMINES; MELANOTROPHS; ENDOCYTOSIS; CURRENTS	Using high resolution capacitance (C-m) measurement techniques, we mapped the kinetics of exocytosis evoked by brief (5-100 ms) depolarizations that activate voltage-dependent Ca2+ channels in rat adrenal chromaffin cells. After correcting the C-m signal for contributions from Na+ channel-gating charge movements, the initial kinetics of exocytosis were consistent with depolarization-triggered release occurring initially from an immediately releasable pool of only similar to 17 secretory vesicles. In contrast, repetitive application of longer depolarizations evoked release from a distinct, larger readily releasable pool of similar to 170 vesicles. Our results suggest that the secretory response of a chromaffin cell to an action potential is limited by the size of the immediately releasable pool rather than by a fusion mechanism that is stower than that at synapses.			HORRIGAN, FT (corresponding author), UNIV MIAMI,SCH MED,DEPT MOLEC & CELLULAR PHARMACOL,MIAMI,FL 33101, USA.		Oka, Yoshitaka/C-9670-2010	Oka, Yoshitaka/0000-0002-3482-3051; Bookman, Richard/0000-0003-3481-6844; Horrigan, Frank/0000-0001-6703-9581				AUGUSTINE GJ, 1992, J PHYSIOL-LONDON, V450, P247, DOI 10.1113/jphysiol.1992.sp019126; BAUERFEIND R, 1993, NEURON, V11, P105, DOI 10.1016/0896-6273(93)90275-V; BITTNER MA, 1992, J BIOL CHEM, V267, P16219; BOOKMAN RJ, 1988, J GEN PHYSIOL, V92, P4; BURGOYNE RD, 1982, PROC R SOC SER B-BIO, V216, P111, DOI 10.1098/rspb.1982.0064; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; CLAPHAM DE, 1984, J PHYSIOL-LONDON, V353, P541, DOI 10.1113/jphysiol.1984.sp015350; COUPLAND RE, 1965, J ANAT, V99, P231; FERRONOVICK S, 1994, NATURE, V370, P191, DOI 10.1038/370191a0; FIDLER N, 1989, BIOPHYS J, V56, P1153, DOI 10.1016/S0006-3495(89)82762-6; FOGELSON AL, 1985, BIOPHYS J, V48, P1003, DOI 10.1016/S0006-3495(85)83863-7; GILLY WF, 1980, BIOPHYS J, V29, P485, DOI 10.1016/S0006-3495(80)85147-2; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HEINEMANN C, 1993, PFLUG ARCH EUR J PHY, V424, P105, DOI 10.1007/BF00374600; HERRINGTON J, 1994, PULSE CONTROL; HEUSER JE, 1979, J CELL BIOL, V81, P275, DOI 10.1083/jcb.81.2.275; JOSHI C, 1988, BIOPHYS J, V53, P885, DOI 10.1016/S0006-3495(88)83169-2; KADO RT, 1993, METHOD ENZYMOL, V221, P273, DOI 10.1016/0076-6879(93)21024-3; LIM NF, 1990, NATURE, V344, P449, DOI 10.1038/344449a0; LINDAU M, 1992, BIOPHYS J, V61, P19, DOI 10.1016/S0006-3495(92)81812-X; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; MONCK JR, 1994, BIOPHYS J, V67, P505, DOI 10.1016/S0006-3495(94)80554-5; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; SALA F, 1990, BIOPHYS J, V57, P313, DOI 10.1016/S0006-3495(90)82533-9; SCHWEIZER FE, 1989, NATURE, V339, P709; SIMON SM, 1985, BIOPHYS J, V48, P485, DOI 10.1016/S0006-3495(85)83804-2; THOMAS P, 1993, NEURON, V11, P93, DOI 10.1016/0896-6273(93)90274-U; THOMAS P, 1993, EMBO J, V12, P303, DOI 10.1002/j.1460-2075.1993.tb05657.x; THOMAS P, 1990, NEURON, V5, P723, DOI 10.1016/0896-6273(90)90226-6; UNSICKER K, 1977, CELL TISSUE RES, V177, P247; VONGERSDORFFH, 1994, NATURE, V367, P735; VONRUDEN L, 1993, SCIENCE, V262, P1061, DOI 10.1126/science.8235626	33	223	223	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1994	13	5					1119	1129		10.1016/0896-6273(94)90050-7	http://dx.doi.org/10.1016/0896-6273(94)90050-7			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PU763	7946349				2022-12-24	WOS:A1994PU76300008
J	LAHEY, T; GORCZYCA, M; JIA, XX; BUDNIK, V				LAHEY, T; GORCZYCA, M; JIA, XX; BUDNIK, V			THE DROSOPHILA TUMOR-SUPPRESSOR GENE DLG IS REQUIRED FOR NORMAL SYNAPTIC BOUTON STRUCTURE	NEURON			English	Article							NEUROMUSCULAR-JUNCTIONS; SEPTATE JUNCTIONS; GUANYLATE KINASE; SH3 DOMAINS; MUTANTS; PROTEIN; DISKS; RECEPTOR; ONCOGENE; LARVAE	The Drosophila tumor suppressor gene lethal (1) discs large (dlg) encodes a protein necessary for normal cell growth in epithelial and brain tissue. It shares high sequence identity to the mammalian synaptic proteins PSD-95 and SAP-70, whose functions are unknown. To determine the localization and role of dig at synapses, we investigated its distribution and the effects of dig mutations on Drosophila neuromuscular junctions. We show that dig immunoreactivity is expressed at one type of glutamatergic synapse and is associated with both presynaptic and postsynaptic membranes. Mutations in dig alter the expression of dig and cause striking changes in the structure of the subsynaptic reticulum, a postsynaptic specialization at these synapses. These results indicate that dig is required for normal synaptic structure and offer insights regarding the role of dig homologs at vertebrate synapses.			LAHEY, T (corresponding author), UNIV MASSACHUSETTS,NEUROSCI & BEHAV PROGRAM,DEPT BIOL,AMHERST,MA 01003, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030072] Funding Source: NIH RePORTER; NINDS NIH HHS [NS30072, R01 NS030072] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON MS, 1988, J NEUROSCI, V8, P242; ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; BERGER A, 1989, EUR J BIOCHEM, V184, P433, DOI 10.1111/j.1432-1033.1989.tb15035.x; BERNSTEIN SI, 1983, NATURE, V302, P393, DOI 10.1038/302393a0; BROADIE K, 1993, NATURE, V361, P350, DOI 10.1038/361350a0; BUDNIK V, 1990, J NEUROSCI, V10, P3754; CANTERA R, 1992, CELL TISSUE RES, V269, P459, DOI 10.1007/BF00353901; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Crossley AC, 1978, GENETICS BIOL DROS B, V2, P499; DIANTONIO A, 1993, CELL, V73, P1281, DOI 10.1016/0092-8674(93)90356-U; GENISMAN Y, 1993, HIPPOCAMPUS, V3, P435; GORCZYCA M, 1993, J NEUROSCI, V13, P3692; HALL ZW, 1993, NEURON S, V10, P99; JAN LY, 1982, P NATL ACAD SCI-BIOL, V79, P2700, DOI 10.1073/pnas.79.8.2700; JAN LY, 1976, J PHYSIOL-LONDON, V262, P215, DOI 10.1113/jphysiol.1976.sp011593; JIA XX, 1993, J NEUROBIOL, V24, P1025, DOI 10.1002/neu.480240804; JOHANSEN J, 1989, J NEUROSCI, V9, P710; KESHISHIAN H, 1993, TRENDS NEUROSCI, V16, P278, DOI 10.1016/0166-2236(93)90182-L; KISTNER U, 1993, J BIOL CHEM, V268, P4580; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; MAYER BJ, 1988, NATURE, V332, P272, DOI 10.1038/332272a0; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; PERIN MS, 1991, J BIOL CHEM, V266, P615; PERRIMON N, 1988, DEV BIOL, V127, P392, DOI 10.1016/0012-1606(88)90326-0; RAMIREZ F, 1990, ANN NY ACAD SCI, V580, P74, DOI 10.1111/j.1749-6632.1990.tb17919.x; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; SMITH MR, 1993, PHARMACOL THERAPEUT, V58, P211, DOI 10.1016/0163-7258(93)90050-N; STEWART M, 1972, DEV BIOL, V27, P71, DOI 10.1016/0012-1606(72)90113-3; SUDHOF TC, 1991, NEURON, V6, P665, DOI 10.1016/0896-6273(91)90165-V; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; WILLOTT E, 1993, P NATL ACAD SCI USA, V90, P7834, DOI 10.1073/pnas.90.16.7834; Woods D F, 1993, J Cell Sci Suppl, V17, P171; WOODS DF, 1989, DEV BIOL, V134, P222, DOI 10.1016/0012-1606(89)90092-4; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; WOODS DF, 1993, MECH DEVELOP, V44, P85, DOI 10.1016/0925-4773(93)90059-7	37	253	254	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1994	13	4					823	835		10.1016/0896-6273(94)90249-6	http://dx.doi.org/10.1016/0896-6273(94)90249-6			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PP533	7946331	Green Accepted			2022-12-24	WOS:A1994PP53300006
J	WEI, A; SOLARO, C; LINGLE, C; SALKOFF, L				WEI, A; SOLARO, C; LINGLE, C; SALKOFF, L			CALCIUM SENSITIVITY OF BK-TYPE K-CA CHANNELS DETERMINED BY A SEPARABLE DOMAIN	NEURON			English	Article							ACTIVATED POTASSIUM CHANNELS; RAT SKELETAL-MUSCLE; GATED CHANNEL; FUNCTIONAL EXPRESSION; INACTIVATION; DROSOPHILA; MOUSE; COMPONENT; KINETICS; CLONING	High conductance, Ca2+-activated (BK-type) K+ channels from mouse (mSlo) and Drosophila (dSlo) differ in their functional properties but share a conserved core resembling voltage-gated K+ channels and a tail appended to the core by a nonconserved linker. We have found that the channel subunit is physically divisible into these two conserved domains and that the core determines such properties as channel open time, conductance, and, probably, voltage dependence, whereas the tail determines apparent Ca2+ sensitivity. Both domains are required for function. We demonstrated the different roles of the core and tail by taking advantage of the functional differences between mSlo and dSlo. Heterologous pairing of cores and tails from mSlo and dSlo showed that single-channel properties were always characteristic of the core species, but that apparent Ca2+ sensitivity was adjusted up or down depending on the species of the tail. Thus, the tail is implicated in the Ca2+ sensing role of BK channels.	WASHINGTON UNIV,SCH MED,DEPT ANESTHESIOL,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT GENET,ST LOUIS,MO 63110	Washington University (WUSTL); Washington University (WUSTL)	WEI, A (corresponding author), WASHINGTON UNIV,SCH MED,DEPT ANAT & NEUROBIOL,ST LOUIS,MO 63110, USA.			Lingle, Christopher/0000-0002-9916-3795				ADELMAN JP, 1992, NEURON, V9, P209, DOI 10.1016/0896-6273(92)90160-F; ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; BARRETT JN, 1982, J PHYSIOL-LONDON, V331, P211, DOI 10.1113/jphysiol.1982.sp014370; BLATZ AL, 1987, TRENDS NEUROSCI, V10, P463, DOI 10.1016/0166-2236(87)90101-9; BRUGGEMANN A, 1993, NATURE, V365, P445, DOI 10.1038/365445a0; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; GOLOWASCH J, 1986, J EXP BIOL, V124, P5; GOULDING EH, 1992, NEURON, V8, P45, DOI 10.1016/0896-6273(92)90107-O; HARTMANN HA, 1991, SCIENCE, V251, P942, DOI 10.1126/science.2000495; Hille B., 1992, IONIC CHANNELS EXCIT; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; JAN LY, 1992, CELL, V69, P715, DOI 10.1016/0092-8674(92)90280-P; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; KOZAK M, 1987, J MOL BIOL, V196, P947, DOI 10.1016/0022-2836(87)90418-9; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; LATORRE R, 1989, ANNU REV PHYSIOL, V51, P385, DOI 10.1146/annurev.ph.51.030189.002125; LOGOTHETIS DE, 1993, NEURON, V10, P1121, DOI 10.1016/0896-6273(93)90060-5; MCMANUS OB, 1991, J PHYSIOL-LONDON, V443, P739, DOI 10.1113/jphysiol.1991.sp018861; MCMANUS OB, 1991, J BIOENERG BIOMEMBR, V23, P537, DOI 10.1007/BF00785810; MEECH RW, 1978, ANNU REV BIOPHYS BIO, V7, P1, DOI 10.1146/annurev.bb.07.060178.000245; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; Miller C., 1987, NEUROMODULATION BIOC, P39; MOCZYDLOWSKI E, 1983, J GEN PHYSIOL, V82, P511, DOI 10.1085/jgp.82.4.511; NAYAL M, 1994, P NATL ACAD SCI USA, V91, P817, DOI 10.1073/pnas.91.2.817; PALLOTTA BS, 1985, J GEN PHYSIOL, V86, P601, DOI 10.1085/jgp.86.5.601; SALKOFF L, 1992, TRENDS NEUROSCI, V15, P161, DOI 10.1016/0166-2236(92)90165-5; SOLARO CR, 1992, SCIENCE, V257, P1694, DOI 10.1126/science.1529355; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; VERGARA C, 1983, J GEN PHYSIOL, V82, P542; WARMKE J, 1991, SCIENCE, V252, P1560, DOI 10.1126/science.1840699; WEI A, 1990, SCIENCE, V248, P599, DOI 10.1126/science.2333511	33	226	231	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1994	13	3					671	681		10.1016/0896-6273(94)90034-5	http://dx.doi.org/10.1016/0896-6273(94)90034-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PJ284	7917297				2022-12-24	WOS:A1994PJ28400014
J	ASENJO, AB; RIM, J; OPRIAN, DD				ASENJO, AB; RIM, J; OPRIAN, DD			MOLECULAR DETERMINANTS OF HUMAN RED/GREEN COLOR DISCRIMINATION	NEURON			English	Article							AMINO-ACID SUBSTITUTIONS; VISUAL PIGMENT GENES; ABSORPTION-SPECTRA; MONOCLONAL-ANTIBODIES; WAVELENGTH REGULATION; CONE PIGMENTS; HUMAN RED; VISION; RHODOPSIN; GREEN	The human red and green color vision pigments are identical at all but 15 of their 364 amino acids, and yet their absorption maxima differ by 31 nm. In an extensive mutagenesis study, including a set of 28 chimeric proteins modeled after pigments in the color-deficient human population and an additional 30 single and multiple point mutants, the spectral difference between these 2 pigments is shown to be determined by 7 and only 7 amino acid residues. In going from the red pigment to the green pigment, the 7 residues are Ser(116) --> Tyr, Ser(180) --> Ala, Ile(230) --> Thr, Ala(233) --> Ser, Tyr(277) --> Phe, Thr(285) --> Ala, and Tyr(309) --> Phe.			ASENJO, AB (corresponding author), BRANDEIS UNIV,GRAD DEPT BIOCHEM,WALTHAM,MA 02254, USA.				NEI NIH HHS [EY09514] Funding Source: Medline; NIGMS NIH HHS [5T32 GM0796] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY009514] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Boynton R. M., 1979, HUMAN COLOR VISION; CHAN T, 1992, J BIOL CHEM, V267, P9478; CHEN JG, 1989, BIOPHYS J, V55, P725, DOI 10.1016/S0006-3495(89)82871-1; CUATRECASAS P, 1970, J BIOL CHEM, V245, P3059; DEEB SS, 1992, AM J HUM GENET, V51, P687; HENDERSON R, 1990, PHILOS T ROY SOC B, V326, P379, DOI 10.1098/rstb.1990.0019; HONIG B, 1979, J AM CHEM SOC, V101, P7084, DOI 10.1021/ja00517a060; LO KM, 1984, P NATL ACAD SCI-BIOL, V81, P2285, DOI 10.1073/pnas.81.8.2285; MACKENZIE D, 1984, BIOCHEMISTRY-US, V23, P6544, DOI 10.1021/bi00321a041; MATHIES R, 1976, P NATL ACAD SCI USA, V73, P2169, DOI 10.1073/pnas.73.7.2169; MERBS SL, 1992, SCIENCE, V258, P464, DOI 10.1126/science.1411542; MERBS SL, 1993, PHOTOCHEM PHOTOBIOL, V58, P706, DOI 10.1111/j.1751-1097.1993.tb04956.x; MERBS SL, 1992, NATURE, V356, P433, DOI 10.1038/356433a0; MOLDAY RS, 1983, BIOCHEMISTRY-US, V22, P653, DOI 10.1021/bi00272a020; NATHANS J, 1986, SCIENCE, V232, P203, DOI 10.1126/science.3485310; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; NEITZ J, 1989, NATURE, V342, P679, DOI 10.1038/342679a0; NEITZ J, 1986, NATURE, V323, P623, DOI 10.1038/323623a0; NEITZ M, 1991, SCIENCE, V252, P971, DOI 10.1126/science.1903559; OPRIAN DD, 1991, BIOCHEMISTRY-US, V30, P11367, DOI 10.1021/bi00112a002; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; POKORNY J., 1979, CONGENITAL ACQUIRED; ROBINSON PR, 1992, NEURON, V9, P719, DOI 10.1016/0896-6273(92)90034-B; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; VOLLRATH D, 1988, SCIENCE, V240, P1669, DOI 10.1126/science.2837827; WANG ZY, 1993, BIOCHEMISTRY-US, V32, P2125, DOI 10.1021/bi00060a001; WILLIAMS AJ, 1992, EMBO J, V11, P2039, DOI 10.1002/j.1460-2075.1992.tb05261.x; WINDERICKX J, 1992, NATURE, V356, P431, DOI 10.1038/356431a0; YOKOYAMA R, 1990, P NATL ACAD SCI USA, V87, P9315, DOI 10.1073/pnas.87.23.9315; ZHUKOVSKY EA, 1991, SCIENCE, V251, P558, DOI 10.1126/science.1990431; ZHUKOVSKY EA, 1989, SCIENCE, V246, P928, DOI 10.1126/science.2573154; ZHUKOVSKY EA, 1992, BIOCHEMISTRY-US, V31, P10400, DOI 10.1021/bi00157a030	33	347	354	3	41	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1994	12	5					1131	1138		10.1016/0896-6273(94)90320-4	http://dx.doi.org/10.1016/0896-6273(94)90320-4			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NM831	8185948				2022-12-24	WOS:A1994NM83100016
J	REGEHR, WG; MINTZ, IM				REGEHR, WG; MINTZ, IM			PARTICIPATION OF MULTIPLE CALCIUM-CHANNEL TYPES IN TRANSMISSION AT SINGLE CLIMBING FIBER TO PURKINJE-CELL SYNAPSES	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; OMEGA-CONOTOXIN GVIA; SYNAPTIC TRANSMISSION; PERIPHERAL NEURONS; CA2+ CHANNELS; FUNCTIONAL EXPRESSION; VERTEBRATE CELLS; SENSORY NEURONS; AGA-IVA; CURRENTS	The sensitivity of synaptic transmission to antagonists of different calcium channels was examined at the powerful climbing fiber synapse between neurons from the inferior olive and cerebellar Purkinje cells. In rat brain slices, climbing fibers were activated with extracellular electrodes, and synaptic currents were recorded with whole-cell patch clamp. Dihydropyridines did not discernibly affect synaptic strength. omega-Conotoxin GVIA, a potent antagonist of N-type calcium channels, reduced synaptic currents by an average of 29%. omega-Agatoxin-IVA, a high affinity blocker of P-type calcium channels, reduced synaptic strength by an average of 77%. Together, the two toxins virtually eliminated synaptic transmission (91% inhibition). These results indicate that omega-agatoxin-IVA-sensitive calcium channels play an important role in transmission at the climbing fiber synapse. They also suggest that in single climbing fibers, release is evoked by at least two pharmacologically distinct calcium currents, one sensitive to omega-agatoxin-IVA, the other to omega-conotoxin GVIA.			REGEHR, WG (corresponding author), HARVARD UNIV,SCH MED,DEPT NEUROBIOL,BOSTON,MA 02115, USA.							BEAN BP, 1991, AM J HYPERTENS, V4, pS406, DOI 10.1093/ajh/4.7.406S; BEAN BP, 1989, ANNU REV PHYSIOL, V51, P367, DOI 10.1146/annurev.physiol.51.1.367; Cajal SR, HISTOLOGIE SYSTEME N; CARBONE E, 1984, NATURE, V310, P501, DOI 10.1038/310501a0; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; DUTAR P, 1989, EUR J PHARMACOL, V174, P261, DOI 10.1016/0014-2999(89)90318-X; ECCLES JC, 1966, J PHYSIOL-LONDON, V182, P268, DOI 10.1113/jphysiol.1966.sp007824; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; ELLINOR PT, 1993, NATURE, V363, P455, DOI 10.1038/363455a0; FOX AP, 1987, J PHYSIOL-LONDON, V394, P173, DOI 10.1113/jphysiol.1987.sp016865; FUJITA Y, 1993, NEURON, V10, P585, DOI 10.1016/0896-6273(93)90162-K; GRAY WR, 1988, ANNU REV BIOCHEM, V57, P665, DOI 10.1146/annurev.bi.57.070188.003313; HEIDELBERGER R, 1992, J PHYSIOL-LONDON, V447, P235, DOI 10.1113/jphysiol.1992.sp019000; HESS P, 1990, ANNU REV NEUROSCI, V13, P337, DOI 10.1146/annurev.ne.13.030190.002005; HILLMAN D, 1991, P NATL ACAD SCI USA, V88, P7076, DOI 10.1073/pnas.88.16.7076; HOF RP, 1985, J CARDIOVASC PHARM, V7, P689, DOI 10.1097/00005344-198507000-00012; HORNE AL, 1991, BRIT J PHARMACOL, V103, P1733, DOI 10.1111/j.1476-5381.1991.tb09855.x; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; ITO M, 1980, INFERIOR OLIVARY NUC, P367; KATZ B, 1967, J PHYSIOL-LONDON, V189, P535, DOI 10.1113/jphysiol.1967.sp008183; KERR LM, 1984, NATURE, V308, P282, DOI 10.1038/308282a0; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; LEMOS JR, 1989, NEURON, V2, P1419, DOI 10.1016/0896-6273(89)90187-6; Linden D J, 1993, Curr Opin Neurobiol, V3, P401, DOI 10.1016/0959-4388(93)90133-J; LINDGREN CA, 1989, J PHYSIOL-LONDON, V414, P201, DOI 10.1113/jphysiol.1989.sp017684; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; LLINAS R, 1982, P NATL ACAD SCI-BIOL, V79, P2415, DOI 10.1073/pnas.79.7.2415; LLINAS R, 1989, P NATL ACAD SCI USA, V86, P1689, DOI 10.1073/pnas.86.5.1689; LUEBKE JI, 1993, NEURON, V11, P895, DOI 10.1016/0896-6273(93)90119-C; MCCOBB DP, 1991, NEURON, V7, P119, DOI 10.1016/0896-6273(91)90080-J; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; MILLER RJ, 1992, J BIOL CHEM, V267, P1403; MINTZ IM, 1992, NEURON, V9, P85, DOI 10.1016/0896-6273(92)90223-Z; MINTZ IM, 1993, NEUROPHARMACOLOGY, V32, P1161, DOI 10.1016/0028-3908(93)90010-Z; MINTZ IM, 1992, NATURE, V355, P827, DOI 10.1038/355827a0; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; NOWYCKY MC, 1985, NATURE, V316, P440, DOI 10.1038/316440a0; OBAID AL, 1989, J GEN PHYSIOL, V93, P715, DOI 10.1085/jgp.93.4.715; Palay S. L., 1974, CEREBELLAR CORTEX CY; PFRIEGER FW, 1992, J NEUROSCI, V12, P4347; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; RAMPE D, 1989, TRENDS PHARMACOL SCI, V10, P507; REGAN LJ, 1991, NEURON, V6, P269, DOI 10.1016/0896-6273(91)90362-4; REGEHR WG, 1992, P NATL ACAD SCI USA, V89, P5492, DOI 10.1073/pnas.89.12.5492; SATHER WA, 1993, NEURON, V11, P291, DOI 10.1016/0896-6273(93)90185-T; Snutch T P, 1992, Curr Opin Neurobiol, V2, P247, DOI 10.1016/0959-4388(92)90111-W; SOONG TW, 1993, SCIENCE, V260, P1133, DOI 10.1126/science.8388125; STANLEY EF, 1990, P NATL ACAD SCI USA, V87, P9683, DOI 10.1073/pnas.87.24.9683; TAKAHASHI T, 1993, NATURE, V366, P156, DOI 10.1038/366156a0; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; TURNER TJ, 1992, SCIENCE, V258, P310, DOI 10.1126/science.1357749; UCHITEL OD, 1992, P NATL ACAD SCI USA, V89, P3330, DOI 10.1073/pnas.89.8.3330; WILLIAMS ME, 1992, SCIENCE, V257, P3	53	173	173	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1994	12	3					605	613		10.1016/0896-6273(94)90216-X	http://dx.doi.org/10.1016/0896-6273(94)90216-X			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NC769	8155322				2022-12-24	WOS:A1994NC76900012
J	VONBARTHELD, CS; KINOSHITA, Y; PREVETTE, D; YIN, QW; OPPENHEIM, RW; BOTHWELL, M				VONBARTHELD, CS; KINOSHITA, Y; PREVETTE, D; YIN, QW; OPPENHEIM, RW; BOTHWELL, M			POSITIVE AND NEGATIVE EFFECTS OF NEUROTROPHINS ON THE ISTHMO-OPTIC NUCLEUS IN CHICK-EMBRYOS	NEURON			English	Article							NERVE GROWTH-FACTOR; AFFINITY NGF RECEPTOR; RETROGRADE AXONAL-TRANSPORT; PRIMARY SENSORY NEURONS; DEVELOPMENTAL EXPRESSION; PHEOCHROMOCYTOMA CELLS; PROPRIOCEPTIVE NEURONS; TRK PROTOONCOGENE; FACTOR PREVENTS; MESSENGER-RNA	The survival of neurons in the developing isthmo-optic nucleus (ION) is believed to depend on the retrograde transport of trophic molecules from the target, the contralateral retina. We now show that ION neurons transport nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and neurotrophin-3 (NT-3) retrogradely and that BDNF and NT-3 support the survival of ION neurons in vivo and promote neurite outgrowth in vitro. Surprisingly, NGF enhanced normal developmental cell death in vivo in a dose-dependent way. These findings show that increased levels of NGF can have adverse effects on differentiated neurons. The negative effect of NCF could be mimicked by intraocular injection of antibodies that block binding of neurotrophins to the 75 kd neurotrophin receptor (p75). These data implicate a role for the p75 receptor in NCF's neurotoxicity and indicate that this receptor is involved in the mechanism by which ION neurons respond to BDNF and NT-3 in the target.	WAKE FOREST UNIV, BOWMAN GRAY SCH MED, DEPT NEUROBIOL & ANAT, WINSTON SALEM, NC 27157 USA; WAKE FOREST UNIV, BOWMAN GRAY SCH MED, NEUROSCI PROGRAM, WINSTON SALEM, NC 27157 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	VONBARTHELD, CS (corresponding author), UNIV WASHINGTON, DEPT PHYSIOL & BIOPHYS, SEATTLE, WA 98195 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R29HD029177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020402, P50NS030305] Funding Source: NIH RePORTER; NICHD NIH HHS [HD 29177] Funding Source: Medline; NINDS NIH HHS [NS 20402, NS 30305] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		[Anonymous], [No title captured]; BALLARIN M, 1991, EXP NEUROL, V114, P35, DOI 10.1016/0014-4886(91)90082-N; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BERND P, 1984, J BIOL CHEM, V259, P5509; BOTHWELL M, 1991, CELL, V65, P915, DOI 10.1016/0092-8674(91)90540-F; CATSICAS S, 1987, J COMP NEUROL, V262, P523, DOI 10.1002/cne.902620406; CATSICAS S, 1987, P NATL ACAD SCI USA, V84, P8165, DOI 10.1073/pnas.84.22.8165; CATSICAS S, 1987, J COMP NEUROL, V262, P512, DOI 10.1002/cne.902620405; CHUWANG IW, 1978, J COMP NEUROL, V177, P59, DOI 10.1002/cne.901770106; CLARKE PGH, 1976, J COMP NEUROL, V167, P143, DOI 10.1002/cne.901670203; CLARKE PGH, 1976, J COMP NEUROL, V167, P125, DOI 10.1002/cne.901670202; CLARKE PGH, 1985, J COMP NEUROL, V234, P365, DOI 10.1002/cne.902340307; CLARKE PGH, 1985, TRENDS NEUROSCI, V8, P345, DOI 10.1016/0166-2236(85)90120-1; CLARKE PGH, 1992, J NEUROBIOL, V23, P1140, DOI 10.1002/neu.480230907; CLARKE PGH, 1992, TRENDS NEUROSCI, V15, P211, DOI 10.1016/0166-2236(92)90036-8; CLARKE PGH, 1982, NEUROSCI LETT, V30, P223, DOI 10.1016/0304-3940(82)90403-7; CLARKE PGH, 1989, J COMP NEUROL, V283, P438, DOI 10.1002/cne.902830311; CLARKE PGH, 1982, ANAT EMBRYOL, V165, P389, DOI 10.1007/BF00305575; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; COWAN WM, 1984, SCIENCE, V225, P1258, DOI 10.1126/science.6474175; COWAN WM, 1961, J ANAT, V95, P545; COWAN WM, 1968, J COMP NEUROL, V133, P207, DOI 10.1002/cne.901330205; CROSSLAND WJ, 1974, J COMP NEUROL, V155, P127, DOI 10.1002/cne.901550202; DAVIES AM, 1986, DEV BIOL, V115, P56, DOI 10.1016/0012-1606(86)90227-7; DAVIES AM, 1987, NEUROSCIENCE, V20, P37, DOI 10.1016/0306-4522(87)90004-2; DECHANT G, 1993, DEVELOPMENT, V119, P545; DISTEFANO PS, 1992, NEURON, V8, P983, DOI 10.1016/0896-6273(92)90213-W; DOHERTY P, 1988, NEUROSCI LETT, V92, P222, DOI 10.1016/0304-3940(88)90065-1; ERIKSDOTTERNILSSON M, 1989, NEUROSCIENCE, V30, P755, DOI 10.1016/0306-4522(89)90167-X; FRITZSCH B, 1990, J COMP NEUROL, V300, P405; GAGE FH, 1989, NEURON, V2, P1177, DOI 10.1016/0896-6273(89)90184-0; GLASS DJ, 1991, CELL, V66, P405, DOI 10.1016/0092-8674(91)90629-D; HALLBOOK F, 1991, NEURON, V6, P845, DOI 10.1016/0896-6273(91)90180-8; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HAYES BP, 1983, EXP BRAIN RES, V49, P189; HEFTI F, 1991, CLIN NEUROPHARMACOL, V14, pS62, DOI 10.1097/00002826-199114001-00008; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HEUER JG, 1990, DEV BIOL, V137, P287, DOI 10.1016/0012-1606(90)90255-H; HOFER MM, 1988, NATURE, V331, P261, DOI 10.1038/331261a0; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; HONIG MG, 1986, J CELL BIOL, V103, P171, DOI 10.1083/jcb.103.1.171; HOSANG M, 1987, EMBO J, V6, P1197, DOI 10.1002/j.1460-2075.1987.tb02354.x; JING SQ, 1992, NEURON, V9, P1067, DOI 10.1016/0896-6273(92)90066-M; JOHNSON EM, 1987, J NEUROSCI, V7, P923; JOHNSON EM, 1989, BRAIN RES, V478, P166, DOI 10.1016/0006-8993(89)91491-1; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; KOJIMA M, 1992, MOL BRAIN RES, V16, P267, DOI 10.1016/0169-328X(92)90235-4; KORSCHING S, 1983, P NATL ACAD SCI-BIOL, V80, P3513, DOI 10.1073/pnas.80.11.3513; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; LARGE TH, 1989, NEURON, V2, P1123, DOI 10.1016/0896-6273(89)90179-7; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; MATURANA HR, 1965, SCIENCE, V150, P359, DOI 10.1126/science.150.3694.359; MCGILL JI, 1966, J ANAT, V100, P35; MILES FA, 1972, BRAIN RES, V48, P93, DOI 10.1016/0006-8993(72)90172-2; MOBLEY WC, 1976, BIOCHEMISTRY-US, V15, P5543, DOI 10.1021/bi00670a019; NURCOMBE V, 1991, ANAT RECORD, V231, P416, DOI 10.1002/ar.1092310404; OLEARY DDM, 1982, J COMP NEUROL, V212, P399, DOI 10.1002/cne.902120407; OLEARY DDM, 1984, DEV BRAIN RES, V12, P293, DOI 10.1016/0165-3806(84)90051-8; OPPENHEIM RW, 1992, NATURE, V360, P755, DOI 10.1038/360755a0; OPPENHEIM RW, 1991, SCIENCE, V251, P1616, DOI 10.1126/science.2011743; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; OPPENHEIM RW, 1988, SCIENCE, V240, P919, DOI 10.1126/science.3363373; PEQUIGNOT Y, 1991, DEV BRAIN RES, V60, P94, DOI 10.1016/0165-3806(91)90159-G; REPERANT J, 1989, INT REV CYTOL, V118, P115, DOI 10.1016/S0074-7696(08)60874-8; RODRIGUEZTEBAR A, 1990, NEURON, V4, P487, DOI 10.1016/0896-6273(90)90107-Q; SAFFRAN BN, 1992, PERSPECT BIOL MED, V35, P471; SCHWAB ME, 1979, BRAIN RES, V168, P473, DOI 10.1016/0006-8993(79)90303-2; SEGAL RA, 1992, NEURON, V9, P1041, DOI 10.1016/0896-6273(92)90064-K; SENDTNER M, 1992, NATURE, V360, P757, DOI 10.1038/360757a0; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; STRAZNICKY C, 1985, ANAT EMBRYOL, V171, P91, DOI 10.1007/BF00319058; SUTTER A, 1979, J BIOL CHEM, V254, P5972; TISCHLER AS, 1975, NATURE, V258, P341, DOI 10.1038/258341a0; VERGE VMK, 1992, J NEUROSCI, V12, P4011; VONBARTHELD CS, 1992, J COMP NEUROL, V320, P479, DOI 10.1002/cne.903200406; VONBARTHELD CS, 1991, J COMP NEUROL, V310, P103, DOI 10.1002/cne.903100110; WESKAMP G, 1991, NEURON, V6, P649, DOI 10.1016/0896-6273(91)90067-A; YAN Q, 1993, J NEUROBIOL, V24, P1555, DOI 10.1002/neu.480241202	80	126	126	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	1994	12	3					639	654		10.1016/0896-6273(94)90219-4	http://dx.doi.org/10.1016/0896-6273(94)90219-4			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NC769	8155324				2022-12-24	WOS:A1994NC76900015
J	HALL, GF; KOSIK, KS				HALL, GF; KOSIK, KS			AXOTOMY-INDUCED NEUROFILAMENT PHOSPHORYLATION IS INHIBITED INSITU BY MICROINJECTION OF PKA AND PKC INHIBITORS INTO IDENTIFIED LAMPREY NEURONS	NEURON			English	Article							PROTEIN-KINASE-C; NERVE GROWTH-FACTOR; CYTOSKELETAL PROTEINS; SPINAL-CORD; CENTRAL CHROMATOLYSIS; GANGLION NEURONS; GENE-EXPRESSION; CYTOCHALASIN-B; CLOSE AXOTOMY; AXON REACTION	Close axotomy of identified lamprey neurons induces phosphorylation of somatodendritic neurofilaments (NFs), followed by ectopic regeneration of neurofilamentous sprouts from the dendrites. We used in situ intracellular microinjection to study the mechanism of axotomy-induced NF phosphorylation. We found that inhibitors of protein kinase C (PKC) and protein kinase A (PKA) block somatodendritic NF phosphorylation for up to 15 days when injected at the time of axotomy. Injection of PKA catalytic subunit, diacylglycerol, or okadaic acid induces somatodendritic NF phosphorylation in intact neurons with the same time course as close axotomy. These results suggest that transient activation of PKC, PKA, and/or serine phosphatase inhibition by axotomy triggers persistent intracellular changes that may be related to polarity loss in these neurons.	CHILDRENS HOSP MED CTR,DEPT NEUROL,BOSTON,MA 02115; BRIGHAM & WOMENS HOSP,DEPT MED,F13G,CTR NEUROL,BOSTON,MA 02115	Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital	HALL, GF (corresponding author), HARVARD UNIV,SCH MED,DEPT NEUROL NEUROSCI,BOSTON,MA 02115, USA.				NIA NIH HHS [AG 06601] Funding Source: Medline; NINDS NIH HHS [NS 29031, NS 29281] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029031, R29NS029281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG006601] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BENNETT GS, 1985, J CELL BIOL, V100, P1799, DOI 10.1083/jcb.100.5.1799; BENTLEY D, 1986, NATURE, V323, P712, DOI 10.1038/323712a0; BLACK MM, 1986, J NEUROSCI, V6, P1004; BORGENS RB, 1980, P NATL ACAD SCI-BIOL, V77, P1209, DOI 10.1073/pnas.77.2.1209; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; BRIDGMAN PC, 1989, J CELL BIOL, V108, P95, DOI 10.1083/jcb.108.1.95; CACERES A, 1990, NATURE, V343, P461, DOI 10.1038/343461a0; COHEN P, 1988, PROC R SOC SER B-BIO, V234, P115, DOI 10.1098/rspb.1988.0040; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; DRAGER UC, 1984, NATURE, V309, P624, DOI 10.1038/309624a0; FINE RE, 1971, NATURE-NEW BIOL, V234, P115, DOI 10.1038/newbio234115a0; GOLDSTEIN ME, 1987, J NEUROSCI, V7, P1586; HALL GF, 1983, SCIENCE, V222, P518, DOI 10.1126/science.6623092; HALL GF, 1989, J NEUROSCI, V9, P588; HALL GF, 1991, P NATL ACAD SCI USA, V88, P5016, DOI 10.1073/pnas.88.11.5016; HALL GF, 1988, J NEUROSCI, V8, P3584; HANNUN YA, 1986, J BIOL CHEM, V261, P2604; HAYSTEAD TAJ, 1990, J BIOL CHEM, V265, P16571; HEACOCK AM, 1976, P NATL ACAD SCI USA, V73, P828, DOI 10.1073/pnas.73.3.828; HEASLEY LE, 1989, J BIOL CHEM, V264, P8646; HISANAGA S, 1990, CELL REGUL, V1, P237, DOI 10.1091/mbc.1.2.237; HOFFMAN PN, 1980, BRAIN RES, V202, P317, DOI 10.1016/0006-8993(80)90144-4; HOFFMAN PN, 1987, P NATL ACAD SCI USA, V84, P3472, DOI 10.1073/pnas.84.10.3472; HOLLIDAY J, 1991, NEURON, V7, P787, DOI 10.1016/0896-6273(91)90281-4; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; KLUMPP S, 1990, EMBO J, V9, P685, DOI 10.1002/j.1460-2075.1990.tb08160.x; KNOPS J, 1991, J CELL BIOL, V114, P725, DOI 10.1083/jcb.114.4.725; KOIZUMI S, 1988, J NEUROSCI, V8, P715; LANNERS HN, 1980, J NEUROCYTOL, V9, P733, DOI 10.1007/BF01205016; LEE VMY, 1986, J NEUROSCI, V6, P850; LEE VMY, 1988, P NATL ACAD SCI USA, V85, P1998, DOI 10.1073/pnas.85.6.1998; LETOURNEAU PC, 1987, CELL MOTIL CYTOSKEL, V8, P193, DOI 10.1002/cm.970080302; LETOURNEAU PC, 1981, DEV BIOL, V85, P113, DOI 10.1016/0012-1606(81)90240-2; Lieberman A R, 1971, Int Rev Neurobiol, V14, P49, DOI 10.1016/S0074-7742(08)60183-X; LINDA H, 1985, BRAIN RES, V358, P329, DOI 10.1016/0006-8993(85)90978-3; MARSH L, 1984, J CELL BIOL, V99, P2041, DOI 10.1083/jcb.99.6.2041; MCKERRACHER L, 1990, J NEUROSCI, V10, P641; MURPHY AD, 1980, BRAIN RES, V186, P251, DOI 10.1016/0006-8993(80)90974-9; NEL AE, 1990, J IMMUNOL, V144, P2683; NIXON RA, 1991, TRENDS NEUROSCI, V14, P501, DOI 10.1016/0166-2236(91)90062-Y; NORDLANDER RH, 1982, DEV BRAIN RES, V4, P181, DOI 10.1016/0165-3806(82)90041-4; OBLINGER MM, 1989, J NEUROSCI, V9, P2645; PLEASURE SJ, 1989, J NEUROSCI, V9, P698; ROEDERER E, 1983, J NEUROSCI, V3, P1835; SCHACHER S, 1983, J NEUROSCI, V3, P2403; SHAW G, 1988, BRAIN RES, V460, P227, DOI 10.1016/0006-8993(88)90367-8; SIHAG RK, 1989, J BIOL CHEM, V264, P457; SINICROPI DV, 1983, J CELL BIOL, V96, P240, DOI 10.1083/jcb.96.1.240; SKOFF RP, 1974, J COMP NEUROL, V153, P107, DOI 10.1002/cne.901530202; SMITH MK, 1990, J BIOL CHEM, V265, P1837; STRAUTMAN AF, 1990, J NEUROSCI, V10, P3564; SZARO BG, 1991, J COMP NEUROL, V308, P576, DOI 10.1002/cne.903080406; TORVIK A, 1976, NEUROPATH APPL NEURO, V2, P423, DOI 10.1111/j.1365-2990.1976.tb00516.x; WESSELLS NK, 1978, EXP CELL RES, V117, P335, DOI 10.1016/0014-4827(78)90147-7; WICKELGREN WO, 1977, J PHYSIOL-LONDON, V270, P89, DOI 10.1113/jphysiol.1977.sp011940	55	39	39	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1993	10	4					613	625		10.1016/0896-6273(93)90164-M	http://dx.doi.org/10.1016/0896-6273(93)90164-M			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KY501	8476612				2022-12-24	WOS:A1993KY50100006
J	PENG, YY; ZUCKER, RS				PENG, YY; ZUCKER, RS			RELEASE OF LHRH IS LINEARLY RELATED TO THE TIME INTEGRAL OF PRESYNAPTIC CA2+ ELEVATION ABOVE A THRESHOLD LEVEL IN BULLFROG SYMPATHETIC-GANGLIA	NEURON			English	Article							SQUID GIANT SYNAPSE; TRANSMITTER RELEASE; CALCIUM DIFFUSION; MEDIAN-EMINENCE; NERVE-TERMINALS; CELLS; CA-2+; FROG; FACILITATION; EXOCYTOSIS	To study the Ca2+ dependency of luteinizing hormone-releasing hormone (LHRH) release in the bullfrog sympathetic ganglia, a method was developed to fill the preganglionic nerve terminal boutons with membrane-impermeant fura-2. We found that as stimulation frequency increased from 0.5 to 40 Hz, the peak [Ca2+]i ([Ca2+]p) and the rate of rise in [Ca2+]i increased, the decay of [Ca2+]i, transients followed up to three exponentials, and release of LHRH was linearly related to integral([Ca2+]i - [Ca2+]t)dt. The threshold level of [Ca2+]i for LHRH release for a given set of boutons on a C cell, [Ca2+]t, was estimated by the [Ca2+]p, evoked by 0.5 Hz stimulation that does not induce LHRH release.			PENG, YY (corresponding author), UNIV CALIF BERKELEY,DEPT MOLEC & CELL BIOL,BERKELEY,CA 94720, USA.		Zucker, Robert S/J-9995-2012	Zucker, Robert S/0000-0003-1068-2343	NINDS NIH HHS [NS15114] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015114] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADLER EM, 1991, J NEUROSCI, V11, P1496; AUGUSTINE GJ, 1986, J PHYSIOL-LONDON, V381, P619, DOI 10.1113/jphysiol.1986.sp016347; BALUK P, 1986, J NEUROCYTOL, V15, P85, DOI 10.1007/BF02057907; BAYLOR SM, 1988, J PHYSIOL-LONDON, V403, P151, DOI 10.1113/jphysiol.1988.sp017244; BELHUMEUR C, 1986, NEUROSCIENCE, V17, P1267, DOI 10.1016/0306-4522(86)90093-X; BUMA P, 1988, CELL TISSUE RES, V252, P107; BUMA P, 1987, NEUROSCI LETT, V74, P151, DOI 10.1016/0304-3940(87)90141-8; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; DODD J, 1983, J PHYSIOL-LONDON, V334, P255, DOI 10.1113/jphysiol.1983.sp014493; DODD J, 1983, J PHYSIOL-LONDON, V334, P271, DOI 10.1113/jphysiol.1983.sp014494; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; FENWICK EM, 1978, J CELL BIOL, V76, P12, DOI 10.1083/jcb.76.1.12; FILLENZ M, 1971, PHILOS T ROY SOC B, V261, P319, DOI 10.1098/rstb.1971.0063; FOGELSON AL, 1985, BIOPHYS J, V48, P1003, DOI 10.1016/S0006-3495(85)83863-7; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HEUSER JE, 1979, J CELL BIOL, V81, P275, DOI 10.1083/jcb.81.2.275; HEUSER JE, 1974, J NEUROCYTOL, V3, P109, DOI 10.1007/BF01111936; HEUSER JE, 1981, J CELL BIOL, V88, P564, DOI 10.1083/jcb.88.3.564; JACKSON MB, 1991, P NATL ACAD SCI USA, V88, P380, DOI 10.1073/pnas.88.2.380; JAN LY, 1982, J PHYSIOL-LONDON, V327, P219, DOI 10.1113/jphysiol.1982.sp014228; JONES SW, 1984, J NEUROSCI, V4, P420; KAO JPY, 1988, BIOPHYS J, V53, P635, DOI 10.1016/S0006-3495(88)83142-4; LEE CJ, 1992, NEURON, V8, P335, DOI 10.1016/0896-6273(92)90299-S; LINDAU M, 1992, BIOPHYS J, V61, P19, DOI 10.1016/S0006-3495(92)81812-X; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; MONCK JR, 1988, J BIOL CHEM, V263, P4569; PENG YY, 1991, J NEUROSCI, V11, P85; POW DV, 1989, NEUROSCIENCE, V32, P435, DOI 10.1016/0306-4522(89)90091-2; PUSCH M, 1988, PFLUG ARCH EUR J PHY, V411, P204, DOI 10.1007/BF00582316; SALA F, 1990, BIOPHYS J, V57, P313, DOI 10.1016/S0006-3495(90)82533-9; STANLEY EF, 1986, J NEUROSCI, V6, P782; STRAUTMAN AF, 1990, J NEUROSCI, V10, P3564; TAXI J, 1967, NEURON, P221; THOMAS P, 1990, NEURON, V5, P723, DOI 10.1016/0896-6273(90)90226-6; THURESONKLEIN A, 1981, CHEM NEUROTRANSMISSI, P153; THURESONKLEIN A, 1979, CATECHOLAMINES BASIC, P262; UCHIZONO K, 1964, JPN J PHYSIOL, V14, P210; VERHAGE M, 1991, NEURON, V6, P517, DOI 10.1016/0896-6273(91)90054-4; YAMADA WM, 1992, BIOPHYS J, V61, P671, DOI 10.1016/S0006-3495(92)81872-6	39	84	87	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1993	10	3					465	473		10.1016/0896-6273(93)90334-N	http://dx.doi.org/10.1016/0896-6273(93)90334-N			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KU901	8461136				2022-12-24	WOS:A1993KU90100011
J	Aggarwal, SK; MacKinnon, R				Aggarwal, SK; MacKinnon, R			Contribution of the S4 segment to gating charge in the Shaker K+ channel	NEURON			English	Article							POTASSIUM CHANNEL; SODIUM-CHANNEL; ELECTROPHORUS-ELECTRICUS; COOPERATIVE INTERACTIONS; SUBUNIT STOICHIOMETRY; MOLECULAR-MODEL; RAT-BRAIN; VOLTAGE; EXPRESSION; MOVEMENT	Voltage-activated ion channels respond to changes in membrane voltage by coupling the movement of charges to channel opening. A K+ channel-specific radioligand was designed and used to determine the origin of these gating charges in the Shaker K+ channel. Opening of a Shaker K+ channel is associated with a displacement of 13.6 electron charge units. Gating charge contributions were determined for six of the seven positive charges in the S4 segment, an unusual amino acid sequence in voltage-activated cation channels consisting of repeating basic residues at every third position. Charge-neutralizing mutations of the first four positive charges led to large decreases (similar to 4 electron charge units each) in the gating charge; however, the gating charge of Shaker Delta 10, a Shaker K+ channel with 10 altered nonbasic residues in its S4 segment, was found to be identical to the wild-type channel. These findings show that movement of the NH2-terminal half but not the CO2H-terminal end of the S4 segment underlies gating charge, and that this portion of the S4 segment appears to move across the entire transmembrane voltage difference in association with channel activation.			Aggarwal, SK (corresponding author), HARVARD UNIV,SCH MED,DEPT NEUROBIOL,BOSTON,MA 02115, USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH010989] Funding Source: NIH RePORTER; NIMH NIH HHS [MH 10989] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Almers W, 1978, Rev Physiol Biochem Pharmacol, V82, P96, DOI 10.1007/BFb0030498; ARMSTRONG CM, 1974, J GEN PHYSIOL, V63, P533, DOI 10.1085/jgp.63.5.533; ARMSTRONG CM, 1973, NATURE, V242, P459, DOI 10.1038/242459a0; BEZANILLA F, 1991, SCIENCE, V254, P679, DOI 10.1126/science.1948047; CATTERALL WA, 1986, ANNU REV BIOCHEM, V55, P953, DOI 10.1146/annurev.biochem.55.1.953; DURELL SR, 1992, BIOPHYS J, V62, P238, DOI 10.1016/S0006-3495(92)81809-X; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; GARCIA ML, 1994, BIOCHEMISTRY-US, V33, P6834, DOI 10.1021/bi00188a012; GREENBLATT RE, 1985, FEBS LETT, V193, P125, DOI 10.1016/0014-5793(85)80136-8; GUY HR, 1986, P NATL ACAD SCI USA, V83, P508, DOI 10.1073/pnas.83.2.508; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HURST RS, 1992, J BIOL CHEM, V267, P23742; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; KEYNES RD, 1974, J PHYSIOL-LONDON, V239, P393, DOI 10.1113/jphysiol.1974.sp010575; KOSOWER EM, 1985, FEBS LETT, V182, P234, DOI 10.1016/0014-5793(85)80306-9; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; LI M, 1994, CURR BIOL, V4, P110, DOI 10.1016/S0960-9822(94)00026-6; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; LIMAN ER, 1991, NATURE, V353, P752, DOI 10.1038/353752a0; LOGOTHETIS DE, 1993, NEURON, V10, P1121, DOI 10.1016/0896-6273(93)90060-5; LOGOTHETIS DE, 1992, NEURON, V8, P531, DOI 10.1016/0896-6273(92)90281-H; LOPEZ GA, 1991, NEURON, V7, P327, DOI 10.1016/0896-6273(91)90271-Z; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; MIKA YH, 1994, BIOPHYS J, V67, P1455, DOI 10.1016/S0006-3495(94)80619-8; NEWMAN M, 1995, SCIENCE, V269, P656, DOI 10.1126/science.7624794; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; NODA M, 1986, NATURE, V320, P188, DOI 10.1038/320188a0; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; PARK CS, 1991, P NATL ACAD SCI USA, V88, P2046, DOI 10.1073/pnas.88.6.2046; SCHNEIDER MF, 1973, NATURE, V242, P244, DOI 10.1038/242244a0; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; SHIMONY E, 1994, PROTEIN ENG, V7, P503, DOI 10.1093/protein/7.4.503; SIGG D, 1994, SCIENCE, V264, P578, DOI 10.1126/science.8160016; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; SLATIN SL, 1994, NATURE, V371, P158, DOI 10.1038/371158a0; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; TYTGAT J, 1992, NATURE, V359, P420, DOI 10.1038/359420a0; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P279, DOI 10.1085/jgp.103.2.279	40	570	587	0	24	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1996	16	6					1169	1177		10.1016/S0896-6273(00)80143-9	http://dx.doi.org/10.1016/S0896-6273(00)80143-9			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UU118	8663993	Bronze			2022-12-24	WOS:A1996UU11800014
J	COLE, RL; KONRADI, C; DOUGLASS, J; HYMAN, SE				COLE, RL; KONRADI, C; DOUGLASS, J; HYMAN, SE			NEURONAL ADAPTATION TO AMPHETAMINE AND DOPAMINE - MOLECULAR MECHANISMS OF PRODYNORPHIN GENE-REGULATION IN RAT STRIATUM	NEURON			English	Article							FREELY MOVING RATS; KAPPA-OPIOID RECEPTORS; NUCLEUS-ACCUMBENS; CYCLIC-AMP; C-FOS; INVIVO MICRODIALYSIS; DIFFERENTIAL EXPRESSION; BINDING PROTEIN; COCAINE; RELEASE	Induction of prodynorphin gene expression by psychostimulant drugs may re present a compensatory adaptation to excessive dopamine stimulation and may contribute to the aversive aspects of withdrawal. We therefore investigated the molecular mechanisms by which dopamine psychostimulant drugs induce prodynorphin gene expression in vivo and in rat primary striatal cultures. We demonstrate that three recently described cAMP response elements (CREs), rather than a previously reported noncanonical AP-1 site, are critical for dopamine induction of the prodynorphin gene in striatal neurons. CRE-binding protein (CREB) binds to these CREs in striatal cell extracts and is phosphorylated on Ser-133 after dopamine stimulation in a D1 dopamine receptor-dependent manner. Surprisingly, following chronic administration of amphetamine, revels of phosphorylated CREB are increased above basal in rat striatum in vivo, whereas c-fos mRNA is suppressed below basal levels. D1 receptor-mediated CREB phosphorylation appears to mediate adaptations to psychostimulant drugs in the striatum.	HARVARD UNIV, SCH MED, PROGRAM NEUROSCI, BOSTON, MA 02115 USA; HARVARD UNIV, MASSACHUSETTS GEN HOSP, SCH MED, DEPT PSYCHIAT, BOSTON, MA 02114 USA; OREGON HLTH SCI UNIV, VOLLUM INST, PORTLAND, OR 97201 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Oregon Health & Science University	COLE, RL (corresponding author), MASSACHUSETTS GEN HOSP, MOLEC & DEV NEUROSCI LAB, CNY-2, BOSTON, MA 02129 USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH044160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007282, R01DA007134] Funding Source: NIH RePORTER; NIDA NIH HHS [DA07282, R01 DA007134-12, T32 DA007282, DA07134] Funding Source: Medline; NIMH NIH HHS [MH44160] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BALSKUBIK R, 1993, J PHARMACOL EXP THER, V264, P489; BERGER SL, 1989, METHOD ENZYMOL, V180, P3; Bergman J., 1990, Behav Pharmacol, V1, P355; BHAT RV, 1992, J PHARMACOL EXP THER, V263, P343; BROWN EE, 1992, J NEUROSCI, V12, P4112; BUTCHER SP, 1988, J NEUROCHEM, V50, P346, DOI 10.1111/j.1471-4159.1988.tb02919.x; CARBONI E, 1989, NEUROSCIENCE, V28, P653, DOI 10.1016/0306-4522(89)90012-2; CHAVKIN C, 1982, SCIENCE, V215, P413, DOI 10.1126/science.6120570; COLE DG, 1994, P NATL ACAD SCI USA, V91, P9631, DOI 10.1073/pnas.91.20.9631; COLLINSHICOK J, 1994, MOL CELL BIOL, V14, P2837, DOI 10.1128/MCB.14.5.2837; COMB M, 1988, EMBO J, V7, P3793, DOI 10.1002/j.1460-2075.1988.tb03264.x; CORBETT AD, 1982, NATURE, V299, P79, DOI 10.1038/299079a0; DANIELSON PE, 1988, DNA-J MOLEC CELL BIO, V7, P261, DOI 10.1089/dna.1988.7.261; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; DICHIARA G, 1988, J PHARMACOL EXP THER, V244, P1067; DOUGLASS J, 1994, MOL ENDOCRINOL, V8, P333, DOI 10.1210/me.8.3.333; ENNULAT DJ, 1995, IN PRESS BRAIN RES; GAWIN FH, 1991, SCIENCE, V251, P1580, DOI 10.1126/science.2011738; GAWIN FH, 1988, NEW ENGL J MED, V318, P1173, DOI 10.1056/NEJM198805053181806; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; GRAYBIEL AM, 1990, P NATL ACAD SCI USA, V87, P6912, DOI 10.1073/pnas.87.17.6912; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; HANSON GR, 1988, EUR J PHARMACOL, V155, P11, DOI 10.1016/0014-2999(88)90397-4; HEIDBREDER CA, 1993, BRAIN RES, V616, P335, DOI 10.1016/0006-8993(93)90228-F; HOEFFLER JP, 1988, SCIENCE, V242, P1430, DOI 10.1126/science.2974179; HURD YL, 1989, BRAIN RES, V498, P199, DOI 10.1016/0006-8993(89)90422-8; HURD YL, 1993, SYNAPSE, V13, P357, DOI 10.1002/syn.890130408; HURD YL, 1992, MOL BRAIN RES, V13, P165, DOI 10.1016/0169-328X(92)90058-J; HYMAN SE, 1988, MOL CELL BIOL, V8, P4225, DOI 10.1128/MCB.8.10.4225; HYMAN SE, 1993, MOL F PSYCHIATRY; KALIVAS PW, 1988, J NEUROCHEM, V50, P1498, DOI 10.1111/j.1471-4159.1988.tb03036.x; KONRADI C, 1994, J NEUROSCI, V14, P5623; KONRADI C, 1993, P NATL ACAD SCI USA, V90, P7005, DOI 10.1073/pnas.90.15.7005; KOOB GF, 1987, NEUROSCI LETT, V79, P315, DOI 10.1016/0304-3940(87)90451-4; LI SJ, 1988, J PHARMACOL EXP THER, V246, P403; LUCAS JJ, 1993, NEURON, V10, P599, DOI 10.1016/0896-6273(93)90163-L; MALDONADO R, 1993, PHARMACOL BIOCHEM BE, V45, P239, DOI 10.1016/0091-3057(93)90112-7; MANSOUR A, 1994, MOL CELL NEUROSCI, V5, P124, DOI 10.1006/mcne.1994.1015; MANSOUR A, 1987, J NEUROSCI, V7, P2445; MESSERSMITH DJ, 1994, MOL CELL NEUROSCI, V5, P238, DOI 10.1006/mcne.1994.1028; MULDER AH, 1984, NATURE, V308, P278, DOI 10.1038/308278a0; NARANJO JR, 1991, NEURON, V6, P607, DOI 10.1016/0896-6273(91)90063-6; NESTLER EJ, 1992, J NEUROSCI, V12, P2439; NESTLER EJ, 1993, NEURON, V11, P995, DOI 10.1016/0896-6273(93)90213-B; NGUYEN TV, 1992, P NATL ACAD SCI USA, V89, P4270, DOI 10.1073/pnas.89.10.4270; PERIS J, 1990, J PHARMACOL EXP THER, V253, P38; PFEIFFER A, 1986, SCIENCE, V233, P774, DOI 10.1126/science.3016896; SIVAM SP, 1989, J PHARMACOL EXP THER, V250, P818; SMILEY PL, 1990, J PHARMACOL EXP THER, V253, P938; SPANAGEL R, 1990, J NEUROCHEM, V55, P1734, DOI 10.1111/j.1471-4159.1990.tb04963.x; STEINER H, 1993, J NEUROSCI, V13, P5066, DOI 10.1523/JNEUROSCI.13-12-05066.1993; TEMPEL A, 1987, P NATL ACAD SCI USA, V84, P4308, DOI 10.1073/pnas.84.12.4308; TERWILLIGER RZ, 1991, BRAIN RES, V548, P100, DOI 10.1016/0006-8993(91)91111-D; TIBERI M, 1991, P NATL ACAD SCI USA, V88, P7491, DOI 10.1073/pnas.88.17.7491; YOUNG ST, 1991, P NATL ACAD SCI USA, V88, P1291, DOI 10.1073/pnas.88.4.1291	57	306	317	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1995	14	4					813	823		10.1016/0896-6273(95)90225-2	http://dx.doi.org/10.1016/0896-6273(95)90225-2			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QU826	7718243	Green Accepted, Bronze			2022-12-24	WOS:A1995QU82600015
J	TREININ, M; CHALFIE, M				TREININ, M; CHALFIE, M			A MUTATED ACETYLCHOLINE-RECEPTOR SUBUNIT CAUSES NEURONAL DEGENERATION IN C-ELEGANS	NEURON			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; NICOTINIC RECEPTOR; LEADER SEQUENCE; CHANNEL DOMAIN; MESSENGER-RNA; CALCIUM; MUTATIONS; GENE; NEURODEGENERATION; ANTAGONISTS	Neurotoxicity through abnormal activation of membrane channels is a potential cause of neurodegenerative disease. Here we show that a gain-of-function mutation, deg 3(u662), leads to the degeneration of a small set of neurons in the nematode C. elegans. The deg-3 gene encodes a nicotinic acetylcholine receptor alpha subunit, which in the region of transmembrane domain II is most similar to the neuronal alpha 7 subunits from rat and chicken. The u662 mutation changes a residue in the second transmembrane domain, the domain thought to form the channel pore. A similar change in the equivalent amino acid in the chick protein produces channels that desensitize slowly. Channel hyperactivity may underlie the degenerations seen in the C. elegans deg-3(u662) mutants, since antagonists of nicotinic acetylcholine receptors suppress the deg-3(u662) mutant phenotypes.			TREININ, M (corresponding author), COLUMBIA UNIV, DEPT BIOL SCI, NEW YORK, NY 10027 USA.			Treinin, Millet/0000-0002-2625-2850	NIGMS NIH HHS [GM34775] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034775] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS RD, 1989, DEGENERATIVE DISEASE, P921; ALKONDON M, 1993, J PHARMACOL EXP THER, V265, P1455; BADIO B, 1994, MOL PHARMACOL, V45, P563; BERTRAND D, 1993, P NATL ACAD SCI USA, V90, P6971, DOI 10.1073/pnas.90.15.6971; BRENNER S, 1974, GENETICS, V77, P71; CALDWELL JH, 1992, NAT GENET, V2, P87, DOI 10.1038/ng1092-87; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; CANESSA CM, 1993, NATURE, V361, P467, DOI 10.1038/361467a0; CHALFIE M, 1990, NATURE, V345, P410, DOI 10.1038/345410a0; CHALFIE M, 1981, DEV BIOL, V82, P358, DOI 10.1016/0012-1606(81)90459-0; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CHANGUEZ JP, 1993, CURR OPIN CELL BIOL, V5, P688; CHOI DW, 1988, J NEUROSCI, V8, P185; COLLINS J, 1987, NATURE, V328, P726, DOI 10.1038/328726a0; COULSON A, 1986, P NATL ACAD SCI USA, V83, P7821, DOI 10.1073/pnas.83.20.7821; COUTURIER S, 1990, NEURON, V5, P847, DOI 10.1016/0896-6273(90)90344-F; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; EMMONS SW, 1983, CELL, V32, P55, DOI 10.1016/0092-8674(83)90496-8; ENGEL AG, 1990, SEMIN NEUROL, V10, P12, DOI 10.1055/s-2008-1041248; ENGEL AG, 1993, ANN NY ACAD SCI, V681, P496, DOI 10.1111/j.1749-6632.1993.tb22933.x; FUCHS PA, 1992, J NEUROSCI, V12, P800; GALZI JL, 1992, NATURE, V359, P500, DOI 10.1038/359500a0; GALZI JL, 1991, ANNU REV PHARMACOL, V31, P37, DOI 10.1146/annurev.pa.31.040191.000345; GIORGUIEFFCHESSELET MF, 1979, LIFE SCI, V25, P1257, DOI 10.1016/0024-3205(79)90469-7; GREENWALD IS, 1980, GENETICS, V96, P147; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; HUANG XY, 1989, P NATL ACAD SCI USA, V86, P8640, DOI 10.1073/pnas.86.22.8640; KAO PN, 1986, J BIOL CHEM, V261, P8085; KRAUSE M, 1987, CELL, V49, P753, DOI 10.1016/0092-8674(87)90613-1; LEONARD JP, 1982, EXP NEUROL, V76, P121, DOI 10.1016/0014-4886(82)90106-6; LEONARD JP, 1979, J CELL BIOL, V82, P811, DOI 10.1083/jcb.82.3.811; LEWIS JA, 1980, NEUROSCIENCE, V5, P967, DOI 10.1016/0306-4522(80)90180-3; LINGUEGLIA E, 1993, FEBS LETT, V318, P95, DOI 10.1016/0014-5793(93)81336-X; LIPTON SA, 1988, SCIENCE, V239, P1293, DOI 10.1126/science.3344435; MITANI S, 1993, DEVELOPMENT, V119, P773; NUMA S, 1983, COLD SPRING HARB SYM, V48, P57, DOI 10.1101/SQB.1983.048.01.008; Sambrook J, 1989, MOL CLONING LABORATO; SCHANNE FAX, 1979, SCIENCE, V206, P700, DOI 10.1126/science.386513; SEGUELA P, 1993, J NEUROSCI, V13, P596; SPIETH J, 1993, CELL, V73, P521, DOI 10.1016/0092-8674(93)90139-H; VOILLEY N, 1994, P NATL ACAD SCI USA, V91, P247, DOI 10.1073/pnas.91.1.247; WARD JM, 1990, FEBS LETT, V270, P45, DOI 10.1016/0014-5793(90)81231-C; WAY JC, 1988, CELL, V54, P5, DOI 10.1016/0092-8674(88)90174-2; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	44	158	164	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1995	14	4					871	877		10.1016/0896-6273(95)90231-7	http://dx.doi.org/10.1016/0896-6273(95)90231-7			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QU826	7718248	hybrid			2022-12-24	WOS:A1995QU82600021
J	TWYMAN, RE; GAHRING, LC; SPIESS, J; ROGERS, SW				TWYMAN, RE; GAHRING, LC; SPIESS, J; ROGERS, SW			GLUTAMATE-RECEPTOR ANTIBODIES ACTIVATE A SUBSET OF RECEPTORS AND REVEAL AN AGONIST BINDING-SITE	NEURON			English	Article							SUBUNIT; CHANNELS; KAINATE; NEURONS; BRAIN	Two rabbits immunized with a portion of glutamate receptor (GluR) subunit GluR3 (amino acids 245-457) exhibited seizure-like behaviors, suggesting that antibodies to GluR3 may modulate neuronal excitability. Using whole-cell recording, rabbit GluR3 antisera were tested on cultured fetal mouse cortical neurons. In a subset of kainate-responsive neurons, miniperfusion of antisera and IgG evoked currents that were blocked by CNQX. Immunoreactivity to synthetic peptides prepared to subregions GluR3A (amino acids 245-274) and GluR3B (amino acids 372-395) was present in both rabbit sera. Peptide GluR3B, but not GluR3A, specifically blocked antisera- and IgG-evoked currents. Similar receptor activation and anti-GluR3 reactivity was present in sera from patients with active Rasmussen's encephalitis, an intractable pediatric epilepsy. Thus, antibodies to GluR3 define a region involved in agonist binding and specific receptor activation. These data suggest that antibodies to neuronal receptors can function as agonists and that autoantibodies to GluRs may be highly specific neurotoxicants in some neurological diseases.	UNIV UTAH,DEPT PHARMACOL,SALT LAKE CITY,UT 84112; UNIV UTAH,DEPT MED,DIV HUMAN DEV & AGING,SALT LAKE CITY,UT 84112; UNIV UTAH,DEPT NEUROBIOL & ANAT,SALT LAKE CITY,UT 84112; VET AFFAIRS MED CTR,CTR GERIATR RES EDUC & CLIN,SALT LAKE CITY,UT 84148; MAX PLANCK INST EXPTL MED,DEPT MOLEC NEUROENDOCRINOL,D-37075 GOTTINGEN,GERMANY	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Max Planck Society	TWYMAN, RE (corresponding author), UNIV UTAH,DEPT NEUROL,SALT LAKE CITY,UT 84112, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS030990, R01NS031519] Funding Source: NIH RePORTER; NINDS NIH HHS [NS31519, NS30990] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AMIN J, 1993, NATURE, V366, P565, DOI 10.1038/366565a0; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; FLORES CM, 1992, MOL PHARMACOL, V42, P31; GAHRING LC, 1995, IN PRESS MOL MED; HERB A, 1992, NEURON, V8, P775, DOI 10.1016/0896-6273(92)90098-X; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HOLLMANN M, 1994, NEURON, V13, P1331, DOI 10.1016/0896-6273(94)90419-7; HUNTLEY GW, 1993, J NEUROSCI, V13, P2965; JUHLER M, 1989, IMPLICATIONS BLOOD B, V1; KIM YI, 1988, SCIENCE, V239, P405, DOI 10.1126/science.2447652; KOPKE AKE, 1993, PROTEIN SCI, V2, P2066; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; Olney J.W., 1978, KAINIC ACID TOOL NEU, P95; PARTIN KM, 1994, MOL PHARMACOL, V46, P129; PATNEAU DK, 1993, J NEUROSCI, V13, P3496; PUCHALSKI RB, 1994, NEURON, V13, P131, DOI 10.1016/0896-6273(94)90464-2; ROGERS SW, 1991, J NEUROSCI, V11, P2713; ROGERS SW, 1994, SCIENCE, V2265, P648; SCHUETZE SM, 1985, P NATL ACAD SCI USA, V82, P2533, DOI 10.1073/pnas.82.8.2533; SIEGEL SJ, 1995, IN PRESS J NEUROSCI; SKEEN GA, 1993, MOL PHARMACOL, V44, P443; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; UCHINO S, 1992, FEBS LETT, V308, P253, DOI 10.1016/0014-5793(92)81286-U; WO ZG, 1994, P NATL ACAD SCI USA, V91, P7154, DOI 10.1073/pnas.91.15.7154	25	184	194	0	1	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1995	14	4					755	762		10.1016/0896-6273(95)90219-8	http://dx.doi.org/10.1016/0896-6273(95)90219-8			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QU826	7718238	Bronze			2022-12-24	WOS:A1995QU82600009
J	BENNETT, JA; DINGLEDINE, R				BENNETT, JA; DINGLEDINE, R			TOPOLOGY PROFILE FOR A GLUTAMATE-RECEPTOR - 3 TRANSMEMBRANE DOMAINS AND A CHANNEL-LINING REENTRANT MEMBRANE LOOP	NEURON			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; DEPENDENT PROTEIN-KINASE; DELTA-SUBUNIT; NMDA RECEPTOR; ALPHA-SUBUNIT; STRUCTURAL DETERMINANTS; CALCIUM PERMEABILITY; LIGAND-BINDING; TEA BLOCKADE; PHOSPHORYLATION	We investigated the transmembrane topology of the GluR3 subunit that was translated in rabbit reticulocytes supplemented with microsomal membranes. A prolactin reporter epitope was fused to GluR3 at six locations, bracketing each of the proposed transmembrane domains. The sidedness of the epitope in the microsomal membrane was then assessed by proteinase K sensitivity. The N terminus and the entire region between M3 and M4 was extracellular, and the C terminus was intracellular by this method. Four native N-linked glycosylation sites in the amino terminus and one introduced site between M3 and M4 were utilized, confirming the extracellular location of these regions. Epitopes inserted upstream and downstream of N12 were protease sensitive and thus intracellular. Our results support a topological model for glutamate receptor subunits that consists of three transmembrane domains, M1, M3, and M4, and another domain, the proposed channel-lining M2, which forms a reentrant membrane segment with both ends facing the cytoplasm.	UNIV N CAROLINA, DEPT PHARMACOL, CHAPEL HILL, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	BENNETT, JA (corresponding author), EMORY UNIV, DEPT PHARMACOL, ATLANTA, GA 30322 USA.		dingledine, Ray/F-5173-2011	Dingledine, Ray/0000-0001-7128-4520				ANAND R, 1993, BIOCHEMISTRY-US, V32, P9975, DOI 10.1021/bi00089a013; ANDERSON DJ, 1981, P NATL ACAD SCI-BIOL, V78, P5598, DOI 10.1073/pnas.78.9.5598; ANDERSON DJ, 1983, J NEUROSCI, V3, P1773; ASCHER P, 1988, J PHYSIOL-LONDON, V399, P247; BEAL MF, 1992, FASEB J, V6, P3338, DOI 10.1096/fasebj.6.15.1464368; BLASCHKE M, 1993, P NATL ACAD SCI USA, V90, P6528, DOI 10.1073/pnas.90.14.6528; BLOBEL G, 1980, P NATL ACAD SCI-BIOL, V77, P1496, DOI 10.1073/pnas.77.3.1496; BLOBEL G, 1975, J CELL BIOL, V67, P852, DOI 10.1083/jcb.67.3.852; BRAELL WA, 1982, CELL, V28, P23, DOI 10.1016/0092-8674(82)90371-3; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; BURNASHEV N, 1992, SCIENCE, V257, P1415, DOI 10.1126/science.1382314; CHAVEZ RA, 1992, J CELL BIOL, V116, P385, DOI 10.1083/jcb.116.2.385; CHAVEZ RA, 1991, J BIOL CHEM, V266, P15532; CRIADO M, 1985, P NATL ACAD SCI USA, V82, P2004, DOI 10.1073/pnas.82.7.2004; CRIADO M, 1985, BIOCHEM BIOPH RES CO, V128, P864, DOI 10.1016/0006-291X(85)90126-3; DEFEA KA, 1994, J BIOL CHEM, V269, P16810; DEISENHOFER J, 1985, NATURE, V318, P618, DOI 10.1038/318618a0; DINGLEDINE R, 1992, J NEUROSCI, V12, P4080; DINGLEDINE R, 1990, TRENDS PHARMACOL SCI, V11, P334, DOI 10.1016/0165-6147(90)90238-4; DIPAOLA M, 1989, J BIOL CHEM, V264, P15457; DOBBERSTEIN B, 1994, CELL, V77, P401; GASIC GP, 1992, ANNU REV PHYSIOL, V54, P507, DOI 10.1146/annurev.physiol.54.1.507; GILL R, 1994, BRAIN METAB REV, V6, P225; GOLDMAN BM, 1981, J CELL BIOL, V90, P236, DOI 10.1083/jcb.90.1.236; HAMPSON DR, 1992, NEUROSCIENCE, V50, P11, DOI 10.1016/0306-4522(92)90378-F; HENDERSON R, 1975, NATURE, V257, P28, DOI 10.1038/257028a0; HENNESSEY ES, 1993, CURR OPIN STRUC BIOL, V3, P524, DOI 10.1016/0959-440X(93)90078-Y; HERLITZE S, 1993, NEURON, V10, P1131, DOI 10.1016/0896-6273(93)90061-U; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; HOLLMANN M, 1994, NEURON, V13, P1331, DOI 10.1016/0896-6273(94)90419-7; HUME RI, 1991, SCIENCE, V253, P1028, DOI 10.1126/science.1653450; JAHR CE, 1990, J NEUROSCI, V10, P1830; KATZ FN, 1977, P NATL ACAD SCI USA, V74, P3278, DOI 10.1073/pnas.74.8.3278; KAWAJIRI S, 1993, NEUROPHARMACOLOGY, V32, P1203; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; KORCGRODZICKI B, 1988, BIOCHEM BIOPH RES CO, V157, P1131; KORCGRODZICKI B, 1988, P NATL ACAD SCI USA, V85, P7541, DOI 10.1073/pnas.85.20.7541; KREUSCH A, 1991, J MOL BIOL, V217, P9, DOI 10.1016/0022-2836(91)90604-5; KURYATOV A, 1994, NEURON, V12, P1291, DOI 10.1016/0896-6273(94)90445-6; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MCCREA PD, 1987, EMBO J, V6, P3619, DOI 10.1002/j.1460-2075.1987.tb02693.x; MCGLADEMCCULLOH E, 1993, NATURE, V362, P640, DOI 10.1038/362640a0; MOLNAR E, 1994, J NEUROCHEM, V63, P683; MOLNAR E, 1993, NEUROSCIENCE, V53, P307, DOI 10.1016/0306-4522(93)90198-O; MORI H, 1992, NATURE, V358, P673, DOI 10.1038/358673a0; MOSS SJ, 1993, NEUROCHEM RES, V18, P105, DOI 10.1007/BF00966929; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; PARKS GD, 1993, J BIOL CHEM, V268, P19101; PARTIN KM, 1993, NEURON, V11, P1069, DOI 10.1016/0896-6273(93)90220-L; PEDEMONTE CH, 1990, P NATL ACAD SCI USA, V87, P9789, DOI 10.1073/pnas.87.24.9789; PEDERSEN SE, 1990, J BIOL CHEM, V265, P569; PERARA E, 1985, J CELL BIOL, V101, P2292, DOI 10.1083/jcb.101.6.2292; RATNAM M, 1986, BIOCHEMISTRY-US, V25, P2621, DOI 10.1021/bi00357a051; RATNAM M, 1986, BIOCHEMISTRY-US, V25, P2633, DOI 10.1021/bi00357a052; RAYMOND LA, 1993, NATURE, V361, P637, DOI 10.1038/361637a0; ROCHE KW, 1994, J BIOL CHEM, V269, P11679; ROTHMAN RE, 1988, J BIOL CHEM, V263, P10470; SAKURADA K, 1993, J BIOL CHEM, V268, P410; SHALTIEL S, 1993, MOL CELL BIOCHEM, V128, P283, DOI 10.1007/BF01076778; SKACH WR, 1994, CANCER RES, V54, P3202; SKACH WR, 1994, J CELL BIOL, V125, P803, DOI 10.1083/jcb.125.4.803; SKACH WR, 1993, J BIOL CHEM, V268, P23552; SKACH WR, 1993, J BIOL CHEM, V268, P6903; SLATIN SL, 1994, NATURE, V371, P158, DOI 10.1038/371158a0; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; STRADER CD, 1987, P NATL ACAD SCI USA, V84, P4384, DOI 10.1073/pnas.84.13.4384; SULLIVAN JM, 1994, NEURON, V13, P929, DOI 10.1016/0896-6273(94)90258-5; TAN S, 1984, J NEUROSCI, V14, P1123; TAVERNA FA, 1994, J BIOL CHEM, V269, P14159; TINGLEY WG, 1993, NATURE, V364, P70, DOI 10.1038/364070a0; UCHINO S, 1992, FEBS LETT, V308, P253, DOI 10.1016/0014-5793(92)81286-U; VILLARROEL A, 1991, P ROY SOC B-BIOL SCI, V243, P69, DOI 10.1098/rspb.1991.0012; WALTER P, 1984, ANN REV CELL BIOL, V1, P115; WANG LY, 1993, SCIENCE, V259, P1173, DOI 10.1126/science.8382377; WEISS MS, 1991, FEBS LETT, V280, P379, DOI 10.1016/0014-5793(91)80336-2; WO ZG, 1994, P NATL ACAD SCI USA, V91, P7154, DOI 10.1073/pnas.91.15.7154; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; YOUNG EF, 1985, P NATL ACAD SCI USA, V82, P626, DOI 10.1073/pnas.82.2.626; ZAREI MM, 1994, J GEN PHYSIOL, V103, P231, DOI 10.1085/jgp.103.2.231	82	246	253	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1995	14	2					373	384		10.1016/0896-6273(95)90293-7	http://dx.doi.org/10.1016/0896-6273(95)90293-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QH294	7857646	Bronze, Green Published			2022-12-24	WOS:A1995QH29400015
J	VITALE, ML; SEWARD, EP; TRIFARO, JM				VITALE, ML; SEWARD, EP; TRIFARO, JM			CHROMAFFIN CELL CORTICAL ACTIN NETWORK DYNAMICS CONTROL THE SIZE OF THE RELEASE-READY VESICLE POOL AND THE INITIAL RATE OF EXOCYTOSIS	NEURON			English	Article							PROTEIN-KINASE-C; NICOTINIC-RECEPTOR STIMULATION; F-ACTIN; FILAMENTOUS ACTIN; CA2+-DEPENDENT SECRETION; CAPACITANCE MEASUREMENTS; CATECHOLAMINE RELEASE; ADRENAL-MEDULLA; PHORBOL ESTERS; MEMBRANE	Morphological, biochemical, and membrane capacitance measurements were used to study the role of cortical filamentous actin (F-actin) in exoctyosis. Fluorescence and electron microscopy of resting chromaffin cells revealed a cortical actin network that excluded secretory vesicles from the subplasmalemmal area. Phorbol ester (PMA) treatment disrupted cortical F-actin and increased both the number of vesicles within the 0-50 nm subplasmalemmal zone and the initial rate of stimulated catecholamine release. In PMA-pretreated cells, membrane capacitance studies showed an increased number of vesicles fusing with the plasmalemma during the first two depolarizations of a train. PMA did not affect voltage-dependent Ca2+ influx. The total number of vesicles fused with the plasma membrane correlated well with the number of vesicles occupying the 0-50 nm cortical zone. Therefore, cortical F-actin disassembly allows translocation of vesicles to the plasmalemma in preparation for exocytosis.	MED COLL PENN, DEPT ANAT & CELL BIOL, PHILADELPHIA, PA 19129 USA	Drexel University	VITALE, ML (corresponding author), UNIV OTTAWA, FAC MED, DEPT PHARMACOL, SECRETORY PROC RES PROGRAM, OTTAWA, ON K1H 8M5, CANADA.			Seward, Elizabeth/0000-0001-5311-1343				ALBERT KA, 1986, P NATL ACAD SCI USA, V83, P2822, DOI 10.1073/pnas.83.9.2822; AUNIS D, 1984, J NEUROCHEM, V42, P1558, DOI 10.1111/j.1471-4159.1984.tb12742.x; BADER MF, 1983, NEUROSCIENCE, V8, P165, DOI 10.1016/0306-4522(83)90036-2; BURGOYNE RD, 1982, PROC R SOC SER B-BIO, V216, P111, DOI 10.1098/rspb.1982.0064; BURGOYNE RD, 1989, CELL SIGNAL, V1, P323, DOI 10.1016/0898-6568(89)90051-X; CARMICHAEL SW, 1987, STIMULUS SECRETION C, V1, P2; CHEEK TR, 1986, FEBS LETT, V207, P110, DOI 10.1016/0014-5793(86)80022-9; COUPLAND RE, 1968, NATURE, V217, P384, DOI 10.1038/217384a0; DELCASTILLO AR, 1992, J CELL BIOL, V119, P797, DOI 10.1083/jcb.119.4.797; DEROBERTIS E, 1957, EXP CELL RES, V12, P568, DOI 10.1016/0014-4827(57)90172-6; FAULSTICH H, 1988, J MUSCLE RES CELL M, V9, P370, DOI 10.1007/BF01774064; FENWICK EM, 1978, J CELL BIOL, V76, P12, DOI 10.1083/jcb.76.1.12; FIDLER N, 1989, BIOPHYS J, V56, P1153, DOI 10.1016/S0006-3495(89)82762-6; FOWLER VM, 1982, NATURE, V295, P336, DOI 10.1038/295336a0; FRIEDMAN JE, 1980, BIOCHEM BIOPH RES CO, V96, P1717, DOI 10.1016/0006-291X(80)91372-8; GRANT NJ, 1990, EUR J CELL BIOL, V52, P36; HARTWIG JH, 1992, NATURE, V356, P818; JOCKUSH BM, 1977, NATURE, V270, P628, DOI 10.1038/270628a0; JOSHI C, 1988, BIOPHYS J, V53, P885, DOI 10.1016/S0006-3495(88)83169-2; KENIGSBERG RL, 1980, NEUROSCIENCE, V5, P1547, DOI 10.1016/0306-4522(80)90019-6; LEE RWH, 1981, NEUROSCIENCE, V6, P2087, DOI 10.1016/0306-4522(81)90048-8; LELKES PI, 1986, FEBS LETT, V208, P357, DOI 10.1016/0014-5793(86)81049-3; MARXEN P, 1991, NEUROREPORT, V2, P33, DOI 10.1097/00001756-199101000-00008; NAKA M, 1983, NATURE, V306, P490, DOI 10.1038/306490a0; NAKATA T, 1992, J NEUROSCI, V12, P2186; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; NISHIZAKI T, 1992, J BIOL CHEM, V267, P23972; PERRIN D, 1985, NATURE, V315, P589, DOI 10.1038/315589a0; PHILLIPS JH, 1982, NEUROSCIENCE, V7, P1595, DOI 10.1016/0306-4522(82)90017-3; PHILLIPS JH, 1987, STIMULUS SECRETION C, V1, P31; SARAFIAN T, 1991, J CELL BIOL, V114, P1135, DOI 10.1083/jcb.114.6.1135; SONTAG JM, 1988, EUR J CELL BIOL, V46, P316; STUMPO DJ, 1989, P NATL ACAD SCI USA, V86, P4012, DOI 10.1073/pnas.86.11.4012; THELEN M, 1991, NATURE, V351, P320, DOI 10.1038/351320a0; THOMAS P, 1993, EMBO J, V12, P303, DOI 10.1002/j.1460-2075.1993.tb05657.x; TRAMEZZANI JH, 1964, CYTOCHEMISTRY, V12, P890; TRIFARO JM, 1989, INT CONGR SER, V839, P15; TRIFARO JM, 1985, CAN J BIOCHEM CELL B, V63, P661, DOI 10.1139/o85-084; TRIFARO JM, 1984, CAN J PHYSIOL PHARM, V62, P493, DOI 10.1139/y84-079; TRIFARO JM, 1992, MOL NEUROBIOL, V6, P339, DOI 10.1007/BF02757940; TRIFARO JM, 1976, MOL PHARMACOL, V12, P536; TRIFARO JM, 1980, NEUROSCIENCE, V5, P1533, DOI 10.1016/0306-4522(80)90018-4; TRIFARO JM, 1993, TRENDS NEUROSCI, V16, P466, DOI 10.1016/0166-2236(93)90079-2; VITALE ML, 1992, NEUROSCIENCE, V51, P463, DOI 10.1016/0306-4522(92)90330-5; VITALE ML, 1991, J CELL BIOL, V113, P1057, DOI 10.1083/jcb.113.5.1057; VITALE ML, 1992, J NEUROCHEM, V59, P1717, DOI 10.1111/j.1471-4159.1992.tb11003.x; VIVEROS OH, 1974, HDB ENDOCRINOLOGY, P389; VONRUDEN L, 1993, SCIENCE, V262, P1061, DOI 10.1126/science.8235626; WANG JKT, 1989, P NATL ACAD SCI USA, V86, P2253, DOI 10.1073/pnas.86.7.2253; WU CSW, 1982, P NATL ACAD SCI USA, V79, P5249; WU YN, 1992, J BIOL CHEM, V267, P8396	52	311	313	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB	1995	14	2					353	363		10.1016/0896-6273(95)90291-0	http://dx.doi.org/10.1016/0896-6273(95)90291-0			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QH294	7857644	Bronze			2022-12-24	WOS:A1995QH29400013
J	ONO, K; TOMASIEWICZ, H; MAGNUSON, T; RUTISHAUSER, U				ONO, K; TOMASIEWICZ, H; MAGNUSON, T; RUTISHAUSER, U			N-CAM MUTATION INHIBITS TANGENTIAL NEURONAL MIGRATION AND IS PHENOCOPIED BY ENZYMATIC REMOVAL OF POLYSIALIC ACID	NEURON			English	Article							GRANULE CELL-MIGRATION; MULTIPLE ADHESION MOLECULES; RAT OLFACTORY-BULB; SUBVENTRICULAR ZONE; EMBRYONIC-DEVELOPMENT; MONOCLONAL-ANTIBODY; CEREBRAL-CORTEX; NCAM; NEUROBLASTS; MOTONEURONS	The mutation of N-CAM in mice produces a phenotype dominated by an undersized olfactory bulb and accumulation of precursors in the subependymal layer. We demonstrate here that this defect can be duplicated by injection of an enzyme that specifically destroys the polysialic acid (PSA) moiety associated with N-CAM. Studies of BrdU-labeled and pyknotic cells suggest that this defect reflects a decrease in the rostral migration of olfactory precursors and not a change in the proliferation or rate of death of these cells. In addition to their ectopic location, these cells had fewer growth cone-like processes oriented along the migration route. In contrast to tangential movement, radial migration of granule cells in the olfactory bulb was not affected by loss of PSA. These results support the proposed role for PSA in cell translocation, discriminate between different mechanisms of cell migration, and provide insight as to the nature of the N-CAM mutant phenotype.	CASE WESTERN RESERVE UNIV,DEPT GENET,CLEVELAND,OH 44106	Case Western Reserve University	ONO, K (corresponding author), CASE WESTERN RESERVE UNIV,DEPT NEUROSCI,CLEVELAND,OH 44106, USA.				NEI NIH HHS [EY06107] Funding Source: Medline; NICHD NIH HHS [HD18369, HD26722] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD026722, R37HD018369, R01HD018369] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY006107] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ACHESON A, 1991, J CELL BIOL, V114, P143, DOI 10.1083/jcb.114.1.143; ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; ASOU H, 1992, NEUROREPORT, V3, P481, DOI 10.1097/00001756-199206000-00006; AUSTIN CP, 1990, DEVELOPMENT, V110, P713; CHUONG CM, 1987, J CELL BIOL, V104, P331, DOI 10.1083/jcb.104.2.331; CHUONG CM, 1990, EXPERIENTIA, V46, P892, DOI 10.1007/BF01939381; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; DOHERTY P, 1990, NEURON, V5, P209, DOI 10.1016/0896-6273(90)90310-C; FREDETTE B, 1993, J CELL BIOL, V123, P1867, DOI 10.1083/jcb.123.6.1867; GADISSEUX JF, 1989, DEV BRAIN RES, V50, P55, DOI 10.1016/0165-3806(89)90126-0; GALILEO DS, 1992, NEURON, V9, P1117, DOI 10.1016/0896-6273(92)90070-T; GENNARINI G, 1984, EUR J BIOCHEM, V142, P57, DOI 10.1111/j.1432-1033.1984.tb08250.x; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; HALLENBECK PC, 1987, J BIOL CHEM, V262, P3553; HATTEN ME, 1990, TRENDS NEUROSCI, V13, P179, DOI 10.1016/0166-2236(90)90044-B; HAWKES R, 1982, ANAL BIOCHEM, V119, P142, DOI 10.1016/0003-2697(82)90677-7; HINDS JW, 1968, J COMP NEUROL, V134, P305, DOI 10.1002/cne.901340305; HINDS JW, 1968, J COMP NEUROL, V134, P287, DOI 10.1002/cne.901340304; HYNES RO, 1986, J NEUROSCI, V6, P867; KISHI K, 1987, J COMP NEUROL, V258, P112, DOI 10.1002/cne.902580109; KUSAKABE M, 1984, STAIN TECHNOL, V59, P127, DOI 10.3109/10520298409113845; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDMESSER L, 1990, NEURON, V4, P655, DOI 10.1016/0896-6273(90)90193-J; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; LEVISON SW, 1993, DEVELOPMENT, V119, P611; LINDNER J, 1986, BRAIN RES, V377, P298, DOI 10.1016/0006-8993(86)90872-3; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; MCKAY SE, 1991, J NEUROBIOL, V22, P721, DOI 10.1002/neu.480220707; MILLHOUSE OE, 1981, NEUROANATOMICAL TRAC, P311; MOODY SA, 1983, J COMP NEUROL, V216, P20, DOI 10.1002/cne.902160104; ONO K, 1990, ANAT EMBRYOL, V182, P11; ONO K, 1989, EXP BRAIN RES, V78, P190; OROURKE NA, 1992, SCIENCE, V258, P299, DOI 10.1126/science.1411527; PHELPS PE, 1993, J COMP NEUROL, V330, P1, DOI 10.1002/cne.903300102; PUELLES L, 1977, ANAT EMBRYOL, V150, P187, DOI 10.1007/BF00316650; RAKIC P, 1971, J COMP NEUROL, V141, P283, DOI 10.1002/cne.901410303; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; RAKIC P, 1990, EXPERIENTIA, V46, P882, DOI 10.1007/BF01939380; RATHJEN FG, 1984, EMBO J, V3, P1; REICHARDT LF, 1991, ANNU REV NEUROSCI, V14, P531, DOI 10.1146/annurev.neuro.14.1.531; RUTISHAUSER U, 1985, J CELL BIOL, V101, P1842, DOI 10.1083/jcb.101.5.1842; RUTISHAUSER U, 1992, DEVELOPMENT, P99; RUTISHAUSER U, 1992, POLYSIALIC ACID, P215; SEKI T, 1993, NEUROSCI RES, V17, P265, DOI 10.1016/0168-0102(93)90111-3; STENSAAS LJ, 1967, J COMP NEUROL, V129, P59, DOI 10.1002/cne.901290105; TANG J, 1992, NEURON, V8, P1031, DOI 10.1016/0896-6273(92)90125-W; TAYLOR JH, 1957, P NATL ACAD SCI USA, V43, P122, DOI 10.1073/pnas.43.1.122; TOMASIEWICZ H, 1993, NEURON, V11, P1163, DOI 10.1016/0896-6273(93)90228-J; VIMR ER, 1984, P NATL ACAD SCI-BIOL, V81, P1971, DOI 10.1073/pnas.81.7.1971; YANG PF, 1992, J CELL BIOL, V116, P1487, DOI 10.1083/jcb.116.6.1487; YOKOTA S, 1993, ARCH HISTOL CYTOL, V56, P27, DOI 10.1679/aohc.56.27; YUASA S, 1991, ANAT EMBRYOL, V184, P195, DOI 10.1007/BF01673256; ZHANG H, 1992, J NEUROSCI, V12, P3107, DOI 10.1523/JNEUROSCI.12-08-03107.1992	55	364	376	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1994	13	3					595	609		10.1016/0896-6273(94)90028-0	http://dx.doi.org/10.1016/0896-6273(94)90028-0			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PJ284	7917293				2022-12-24	WOS:A1994PJ28400008
J	PEVSNER, J; HSU, SC; BRAUN, JEA; CALAKOS, N; TING, AE; BENNETT, MK; SCHELLER, RH				PEVSNER, J; HSU, SC; BRAUN, JEA; CALAKOS, N; TING, AE; BENNETT, MK; SCHELLER, RH			SPECIFICITY AND REGULATION OF A SYNAPTIC VESICLE DOCKING COMPLEX	NEURON			English	Article							SURFACE-PLASMON RESONANCE; YEAST SECRETORY PATHWAY; PROTEIN; FUSION; SYNTAXIN; IDENTIFICATION; RECEPTORS; CLONING; FAMILY; EVENTS	Synaptic vesicles are proposed to dock at the presynaptic plasma membrane through the interaction of two integral membrane proteins of synaptic vesicles, VAMP and synaptotagmin, and two plasma membrane proteins, syntaxin and SNAP-25. We have characterized the binding properties' of these proteins and observed SNAP-25 potentiation of VAMP 2 binding to syntaxins 1a and 4 but not syntaxins 2 or 3. n-sec1, a neuron-specific syntaxin-binding protein, bound syntaxin with nanomolar affinity, forming a complex that is distinct from the previously identified 7S and 20S syntaxin-containing complexes. This suggests that syntaxin exists in at least three states: bound to n-sec1, in a 7S particle, and in a 20S particle. Recombinant n-sec1 inhibited VAMP or SNAP-25 binding to syntaxin. We propose that the specific associations of VAMP, SNAP-25, and syntaxin mediate vesicle docking and that a syntaxin/n-sec 1 complex precedes and/or regulates formation of these complexes.			PEVSNER, J (corresponding author), STANFORD UNIV,MED CTR,HOWARD HUGHES MED INST,DEPT CELLULAR & MOLEC PHYSIOL,STANFORD,CA 94305, USA.			Ting, Anthony/0000-0002-5058-9576				AALTO MK, 1991, YEAST, V7, P643, DOI 10.1002/yea.320070613; Bennett J., 1985, NEUROTRANSMITTER REC, V2nd, P61; BENNETT MK, 1992, J CELL BIOL, V116, P761, DOI 10.1083/jcb.116.3.761; BENNETT MK, 1993, CELL, V74, P863, DOI 10.1016/0092-8674(93)90466-4; BENNETT MK, 1994, ANNU REV BIOCHEM, V63, P63, DOI 10.1146/annurev.bi.63.070194.000431; BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2559, DOI 10.1073/pnas.90.7.2559; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; CALAKOS N, 1994, SCIENCE, V263, P1146, DOI 10.1126/science.8108733; CLARY DO, 1990, CELL, V61, P709, DOI 10.1016/0092-8674(90)90482-T; ELFERINK LA, 1989, J BIOL CHEM, V264, P11061; FAGERSTAM LG, 1992, J CHROMATOGR, V597, P397, DOI 10.1016/0021-9673(92)80137-J; GARCIA EP, 1994, P NATL ACAD SCI USA, V91, P2003, DOI 10.1073/pnas.91.6.2003; HARLOW E, 1988, ANTIBODIES LAB MANUA, P522; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; HOSONO R, 1992, J NEUROCHEM, V58, P1517, DOI 10.1111/j.1471-4159.1992.tb11373.x; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; INOUE A, 1992, J BIOL CHEM, V267, P10613; JAHN R, 1993, J NEUROCHEM, V61, P12, DOI 10.1111/j.1471-4159.1993.tb03533.x; JONSSON U, 1991, BIOTECHNIQUES, V11, P620; KAISER CA, 1990, CELL, V61, P723, DOI 10.1016/0092-8674(90)90483-U; MCMAHON HT, 1993, NATURE, V364, P346, DOI 10.1038/364346a0; NOVICK P, 1981, CELL, V25, P461, DOI 10.1016/0092-8674(81)90064-7; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; OYLER GA, 1989, J CELL BIOL, V109, P3039, DOI 10.1083/jcb.109.6.3039; PEVSNER J, 1994, P NATL ACAD SCI USA, V91, P1445, DOI 10.1073/pnas.91.4.1445; PRYER NK, 1992, ANNU REV BIOCHEM, V61, P471; ROTHMAN JE, 1994, CURR BIOL, V4, P220, DOI 10.1016/S0960-9822(00)00051-8; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0	29	533	538	0	31	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1994	13	2					353	361		10.1016/0896-6273(94)90352-2	http://dx.doi.org/10.1016/0896-6273(94)90352-2			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PD430	8060616				2022-12-24	WOS:A1994PD43000008
J	DEHOOP, MJ; HUBER, LA; STENMARK, H; WILLIAMSON, E; ZERIAL, M; PARTON, RG; DOTTI, CG				DEHOOP, MJ; HUBER, LA; STENMARK, H; WILLIAMSON, E; ZERIAL, M; PARTON, RG; DOTTI, CG			THE INVOLVEMENT OF THE SMALL GTP-BINDING PROTEIN RAB5A IN NEURONAL ENDOCYTOSIS	NEURON			English	Article							SYNAPTIC VESICLE MEMBRANE; CANINE KIDNEY-CELLS; HIPPOCAMPAL-NEURONS; PLASMA-MEMBRANE; CULTURED NEURONS; EPITHELIAL-CELLS; COATED VESICLES; FUSION INVITRO; BREFELDIN-A; MDCK CELLS	Rab5a is a small GTPase that regulates fusion of endocytic vesicles to early endosomes. We investigated whether Rab5a is involved in early endocytic traffic in both the axonal and the somatodendritic domains of polarized neurons. Using immunofluorescence, endogenous Rab5a was detected in axons and dendrites. Its localization in axons strongly overlapped that of the synaptic vesicle protein synaptophysin. Indeed, Rab5a coimmunoisolated with synaptophysin-containing vesicles, and antibodies against Rab5a labeled synaptic vesicle-like structures in nerve terminals, The functional association of Rab5a with dendritic and axonal early endosomes was assayed by electron microscopy after overexpression of wild-type and mutant Rab5a in cultured hippocampal neurons. This induced the formation of abnormal endosomes in both the somatodendritic and the axonal domains. These results show a role for Rab5a in axonal and dendritic endocytosis, and the presence of Rab5a on synaptic vesicles indicates that the axonal endosomes participate in the biogenesis of these vesicles.			DEHOOP, MJ (corresponding author), EUROPEAN MOLEC BIOL LAB, CELL BIOL PROGRAM, D-69012 HEIDELBERG, GERMANY.		Parton, Robert G/C-5673-2009; Dotti, Carlos G/I-5533-2015; Huber, Lukas Alfons/AAM-3499-2021; Stenmark, Harald/B-8868-2008	Parton, Robert G/0000-0002-7494-5248; Dotti, Carlos G/0000-0003-4052-1719; Huber, Lukas Alfons/0000-0003-1116-2120				BARTLETT WP, 1984, J NEUROSCI, V4, P1954; BENNETT MK, 1992, J CELL BIOL, V116, P761, DOI 10.1083/jcb.116.3.761; BOMSEL M, 1989, J CELL BIOL, V109, P3243, DOI 10.1083/jcb.109.6.3243; BOMSEL M, 1990, CELL, V62, P719, DOI 10.1016/0092-8674(90)90117-W; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; BRANDLI AW, 1990, J CELL BIOL, V111, P2909, DOI 10.1083/jcb.111.6.2909; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; BUCCI C, 1994, P NATL ACAD SCI USA, V91, P5061, DOI 10.1073/pnas.91.11.5061; CAMERON PL, 1991, J CELL BIOL, V115, P151, DOI 10.1083/jcb.115.1.151; CELIS JE, 1990, ELECTROPHORESIS, V11, P989, DOI 10.1002/elps.1150111202; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; CHAVRIER P, 1990, MOL CELL BIOL, V10, P6578, DOI 10.1128/MCB.10.12.6578; DOTTI CG, 1988, J NEUROSCI, V8, P1454; DOTTI CG, 1991, NATURE, V349, P158, DOI 10.1038/349158a0; FULLER SD, 1986, J CELL BIOL, V103, P1767, DOI 10.1083/jcb.103.5.1767; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; Goslin K., 1991, CULTURING NERVE CELL, P251; GRIFFITHS G, 1993, FINE STRUCTURE IMMUN; HEUSER J, 1989, CELL BIOL INT REP, V13, P1063, DOI 10.1016/0309-1651(89)90020-9; HOLZMANN E, 1992, CURR OPIN NEUROBIOL, V2, P607; HOPKINS CR, 1992, TRENDS BIOCHEM SCI, V17, P27, DOI 10.1016/0968-0004(92)90423-7; Hubbard AL, 1989, CURR OPIN CELL BIOL, V1, P675, DOI 10.1016/0955-0674(89)90033-1; HUBER LA, 1993, J CELL BIOL, V123, P47, DOI 10.1083/jcb.123.1.47; HUBER LA, 1994, ELECTROPHORESIS, V15, P283, DOI 10.1002/elps.1150150148; HUBER LA, 1993, J CELL BIOL, V123, P35, DOI 10.1083/jcb.123.1.35; HUBER LA, 1994, IN PRESS P NATL ACAD; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; JAHN R, 1993, J NEUROCHEM, V61, P12, DOI 10.1111/j.1471-4159.1993.tb03533.x; KEEN JH, 1990, ANNU REV BIOCHEM, V59, P415, DOI 10.1146/annurev.biochem.59.1.415; KELLY RB, 1993, ANNU REV NEUROSCI, V16, P95, DOI 10.1146/annurev.ne.16.030193.000523; KELLY RB, 1993, NATURE, V364, P487, DOI 10.1038/364487a0; LANDT O, 1990, GENE, V96, P125, DOI 10.1016/0378-1119(90)90351-Q; LILJESTROM P, 1991, BIO-TECHNOL, V9, P1356, DOI 10.1038/nbt1291-1356; LINSTEDT AD, 1991, NEURON, V7, P309, DOI 10.1016/0896-6273(91)90269-6; LUTCKE A, 1993, J CELL BIOL, V121, P553, DOI 10.1083/jcb.121.3.553; MAYCOX PR, 1992, J CELL BIOL, V118, P1379, DOI 10.1083/jcb.118.6.1379; MOSTOV K, 1992, J CELL BIOL, V116, P577, DOI 10.1083/jcb.116.3.577; MUNDIGL O, 1993, J CELL BIOL, V122, P1207, DOI 10.1083/jcb.122.6.1207; NOVICK P, 1993, CELL, V75, P597, DOI 10.1016/0092-8674(93)90478-9; OLKKONEN VM, 1993, J CELL SCI, V106, P1249; OLKKONEN VM, 1993, J NEUROSCI RES, V35, P445, DOI 10.1002/jnr.490350412; Parton R G, 1991, Semin Cell Biol, V2, P387; PARTON RG, 1992, J CELL BIOL, V119, P123, DOI 10.1083/jcb.119.1.123; PARTON RG, 1989, J CELL BIOL, V109, P261; Pfeffer S R, 1992, Trends Cell Biol, V2, P41, DOI 10.1016/0962-8924(92)90161-F; REIZMAN H, 1993, TRENDS CELL BIOL, V3, P330; Rodman JS, 1990, CURR OPIN CELL BIOL, V2, P664, DOI 10.1016/0955-0674(90)90108-Q; SCHACHER S, 1976, J CELL BIOL, V70, P178, DOI 10.1083/jcb.70.1.178; SIMONS K, 1993, NEURON, V11, P789, DOI 10.1016/0896-6273(93)90109-5; STEELEMORTIMER O, 1994, EMBO J, V13, P34, DOI 10.1002/j.1460-2075.1994.tb06232.x; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; SUDHOF TC, 1991, NEURON, V6, P665, DOI 10.1016/0896-6273(91)90165-V; SULZER D, 1989, J NEUROCYTOL, V18, P529, DOI 10.1007/BF01474548; TOOZE J, 1991, J CELL BIOL, V115, P635, DOI 10.1083/jcb.115.3.635; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; VANDERSLUIJS P, 1992, CELL, V70, P729, DOI 10.1016/0092-8674(92)90307-X; VONMOLLARD GF, 1991, NATURE, V349, P79, DOI 10.1038/349079a0; WETZEL R, 1988, PROTEIN ENG, V2, P1, DOI 10.1093/protein/2.1.1; WHITEHEART SW, 1993, NATURE, V362, P353, DOI 10.1038/362353a0; WHITTAKER VP, 1972, METHODS NEUROCHEMIST, V2, P2; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9; WILSON DB, 1992, J CLIN INVEST, V89, P996, DOI 10.1172/JCI115683; WOOD SA, 1992, J CELL BIOL, V119, P273, DOI 10.1083/jcb.119.2.273; Zerial M, 1993, CURR OPIN CELL BIOL, V5, P613, DOI 10.1016/0955-0674(93)90130-I	64	129	132	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	1994	13	1					11	22		10.1016/0896-6273(94)90456-1	http://dx.doi.org/10.1016/0896-6273(94)90456-1			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NZ247	8043272				2022-12-24	WOS:A1994NZ24700002
J	FUJII, H; HAMADA, H				FUJII, H; HAMADA, H			A CNS-SPECIFIC POU TRANSCRIPTION FACTOR, BRN-2, IS REQUIRED FOR ESTABLISHING MAMMALIAN NEURAL CELL LINEAGES	NEURON			English	Article							DEVELOPING NERVOUS-SYSTEM; STEM-CELLS; MOLECULAR CHARACTERIZATION; BINDING-PROTEINS; C-ELEGANS; DOMAIN; GENE; EXPRESSION; BRAIN; OCT-1	The pluripotent embryonal carcinoma cell line P19 can differentiate in vitro into neurons and astrocytes. By employing this neural cell differentiation system, we have studied the expression and function of a POU transcription factor implicated in mammalian neurogenesis. When P19 cells differentiated to the neural cells, one of the CNS-specific POU genes (Brn-2) was selectively induced. The induction of Brn-2 was specific to the neural cell lineages and took place at the early stage of differentiation. When the Brn-2 induction was blocked/delayed by antisense RNA, such cells were unable to differentiate to neurons and astrocytes. Instead they differentiated to nonneural cells, including smooth and skeletal muscle cells. Furthermore, with reduced levels of antisense RNA, differentiation to neural cells occurred. These results indicate that Brn-2 is essential for the neural cell differentiation of P19 cells and suggest that Brn-2 is one of the genes required for establishing neural cell lineages in mammals.	UNIV TOKYO, FAC MED, DEPT BIOCHEM, BUNKYO KU, TOKYO 113, JAPAN	University of Tokyo	FUJII, H (corresponding author), TOKYO METROPOLITAN INST MED SCI, DEPT DEV BIOL & CANC PREVENT, 3-18-22 HONKOMAGOME, BUNKYO KU, TOKYO 113, JAPAN.							AKAZAWA C, 1992, J BIOL CHEM, V267, P21879; AVRAHAM KB, 1993, IN PRESS GENOMICS; BEGLEY CG, 1992, P NATL ACAD SCI USA, V89, P38, DOI 10.1073/pnas.89.1.38; BHAT K, 1988, MOL CELL BIOL, V8, P3251, DOI 10.1128/MCB.8.8.3251; CABRERA CV, 1992, DEVELOPMENT, V115, P893; CAMPOSORTEGA JA, 1991, ANNU REV NEUROSCI, V14, P399, DOI 10.1146/annurev.ne.14.030191.002151; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; FINNEY M, 1988, CELL, V55, P757, DOI 10.1016/0092-8674(88)90132-8; HARA Y, 1992, P NATL ACAD SCI USA, V89, P3280, DOI 10.1073/pnas.89.8.3280; HERR W, 1988, GENE DEV, V2, P1513, DOI 10.1101/gad.2.12a.1513; JONESVILLENEUVE EMV, 1983, MOL CELL BIOL, V3, P2271, DOI 10.1128/MCB.3.12.2271; LEMOINE C, 1992, P NATL ACAD SCI USA, V89, P3285, DOI 10.1073/pnas.89.8.3285; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; LI S, 1990, NATURE, V347, P528, DOI 10.1038/347528a0; LO LC, 1991, GENE DEV, V5, P1524, DOI 10.1101/gad.5.9.1524; MATHIS JM, 1992, EMBO J, V11, P2551, DOI 10.1002/j.1460-2075.1992.tb05320.x; MCKAY RDG, 1989, CELL, V58, P815, DOI 10.1016/0092-8674(89)90934-3; MONUKI ES, 1990, SCIENCE, V249, P1300, DOI 10.1126/science.1975954; OKAMOTO K, 1990, CELL, V60, P461, DOI 10.1016/0092-8674(90)90597-8; OKAMOTO K, 1993, J BIOL CHEM, V268, P7449; OKAZAWA H, 1991, EMBO J, V10, P2997, DOI 10.1002/j.1460-2075.1991.tb07850.x; ROSENFELD MG, 1991, GENE DEV, V5, P897, DOI 10.1101/gad.5.6.897; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; RUDNICKI M, 1991, TERATOCARCINJOMAS EM, V64, P475; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; SCHREIBER E, 1990, NUCLEIC ACIDS RES, V18, P5495, DOI 10.1093/nar/18.18.5495; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SHIMAZAKI T, 1993, IN PRESS EMBO J; STURM RA, 1988, GENE DEV, V2, P1582, DOI 10.1101/gad.2.12a.1582; SUZUKI N, 1990, EMBO J, V9, P3723, DOI 10.1002/j.1460-2075.1990.tb07585.x; XI H, 1989, NATURE, V340, P35, DOI 10.1038/340035a0	31	76	78	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1993	11	6					1197	1206		10.1016/0896-6273(93)90231-F	http://dx.doi.org/10.1016/0896-6273(93)90231-F			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MP548	8274283				2022-12-24	WOS:A1993MP54800019
J	LAMBERT, NA; WILSON, WA				LAMBERT, NA; WILSON, WA			HETEROGENEITY IN PRESYNAPTIC REGULATION OF GABA RELEASE FROM HIPPOCAMPAL INHIBITORY NEURONS	NEURON			English	Article							LACUNOSUM-MOLECULARE INTERNEURONS; GAMMA-AMINOBUTYRIC-ACID; CENTRAL-NERVOUS-SYSTEM; CA3 PYRAMIDAL CELLS; RAT HIPPOCAMPUS; SYNAPTIC TRANSMISSION; AREA CA1; DENDRITIC INHIBITION; GABAERGIC NEURONS; CEREBRAL-CORTEX	Release of GABA from the terminals of hippocampal inhibitory neurons is inhibited by activation of GABA(B) autoreceptors and mu opioid receptors. However, it is not known whether these presynaptic processes affect all inhibitory synapses equally. We examined the effects of the GABA(B) receptor agonist baclofen and the mu opioid receptor agonist DAGO on postsynaptic currents evoked by minimal stimulation of inhibitory fibers (meIPSCs) in area CA3. Baclofen reversibly depressed approximately half of the meIPSCs evoked in the stratum pyramidale. The remaining meIPSCs were unaffected despite a coincident depression of spontaneous IPSCs. In contrast, all meIPSCs were depressed by DAGO. In addition, minimal stimulation in the stratum radiatum evoked meIPSCs that were always depressed by baclofen. These results indicate that regulation of GABA release by GABA(B) autoreceptors occurs at a subset of inhibitory synapses and that GABA(B)-resistant inhibitory synapses are located on pyramidal neuron somata. Hippocampal inhibitory neurons may be heterogeneous with respect to presynaptic receptor-mediated regulation of GABA release.	VET ADM MED CTR,NEUROBIOL RES LAB,DURHAM,NC 27705	US Department of Veterans Affairs; Veterans Health Administration (VHA)	LAMBERT, NA (corresponding author), DUKE UNIV,DEPT PHARMACOL,DURHAM,NC 27710, USA.				NIMH NIH HHS [MH-15177-5] Funding Source: Medline; NINDS NIH HHS [NS-17771] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH015177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS017771] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALGER BE, 1982, J PHYSIOL-LONDON, V328, P105, DOI 10.1113/jphysiol.1982.sp014255; AULT B, 1982, J PHARMACOL EXP THER, V223, P291; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; Cajal S. R., 1911, HISTOLOGIE SYSTEME N; CAPOGNA M, 1993, J PHYSIOL-LONDON, V470, P539, DOI 10.1113/jphysiol.1993.sp019874; COHEN GA, 1992, NEURON, V9, P325, DOI 10.1016/0896-6273(92)90171-9; COLBERT CM, 1992, J NEUROPHYSIOL, V68, P1; DANOS P, 1991, BRAIN RES, V546, P195, DOI 10.1016/0006-8993(91)91481-F; DAVIES CH, 1991, NATURE, V349, P609, DOI 10.1038/349609a0; DAVIES CH, 1990, J PHYSIOL-LONDON, V424, P513, DOI 10.1113/jphysiol.1990.sp018080; de No RL, 1934, J PSYCHOL NEUROL, V46, P113; DEISZ RA, 1989, J PHYSIOL-LONDON, V412, P513, DOI 10.1113/jphysiol.1989.sp017629; DOZE VA, 1991, NEURON, V6, P889, DOI 10.1016/0896-6273(91)90229-S; DUTAR P, 1988, NATURE, V332, P156, DOI 10.1038/332156a0; EDWARDS FA, 1990, J PHYSIOL-LONDON, V430, P213, DOI 10.1113/jphysiol.1990.sp018289; GAHWILER BH, 1985, P NATL ACAD SCI USA, V82, P1558, DOI 10.1073/pnas.82.5.1558; GULYAS AI, 1991, J COMP NEUROL, V312, P371, DOI 10.1002/cne.903120305; HAN ZS, 1993, EUR J NEUROSCI, V5, P395, DOI 10.1111/j.1460-9568.1993.tb00507.x; HARRISON NL, 1990, J PHYSIOL-LONDON, V422, P433, DOI 10.1113/jphysiol.1990.sp017993; HORNE AL, 1991, BRIT J PHARMACOL, V103, P1733, DOI 10.1111/j.1476-5381.1991.tb09855.x; ISAACSON JS, 1993, NEURON, V10, P165, DOI 10.1016/0896-6273(93)90308-E; JOHNSTON D, 1983, J NEUROPHYSIOL, V50, P464, DOI 10.1152/jn.1983.50.2.464; KAWAGUCHI Y, 1987, BRAIN RES, V411, P190, DOI 10.1016/0006-8993(87)90700-1; KUNKEL DD, 1988, SYNAPSE, V2, P382, DOI 10.1002/syn.890020405; LACAILLE JC, 1988, J NEUROSCI, V8, P1411; LACAILLE JC, 1988, J NEUROSCI, V8, P1400; LACAILLE JC, 1989, HIPPOCAMPUS, P287; LAMBERT NA, 1991, EUR J PHARMACOL, V203, P129, DOI 10.1016/0014-2999(91)90801-V; LAMBERT NA, 1993, J NEUROPHYSIOL, V69, P630, DOI 10.1152/jn.1993.69.2.630; LAMBERT NA, 1991, J NEUROPHYSIOL, V66, P1538, DOI 10.1152/jn.1991.66.5.1538; LAMBERT NA, 1991, NEUROSCI LETT, V124, P101, DOI 10.1016/0304-3940(91)90831-D; LANTHORN TH, 1981, BRAIN RES, V225, P171, DOI 10.1016/0006-8993(81)90326-7; MADISON DV, 1988, J PHYSIOL-LONDON, V398, P123, DOI 10.1113/jphysiol.1988.sp017033; MAJOR G, 1993, BIOPHYS J, V65, P469, DOI 10.1016/S0006-3495(93)81039-7; MCBAIN CJ, 1993, J PHYSIOL-LONDON, V462, P373, DOI 10.1113/jphysiol.1993.sp019560; MILES R, 1984, J PHYSIOL-LONDON, V356, P97, DOI 10.1113/jphysiol.1984.sp015455; MILES R, 1990, J PHYSIOL-LONDON, V431, P659, DOI 10.1113/jphysiol.1990.sp018353; MINTZ IM, 1993, NEURON, V10, P889, DOI 10.1016/0896-6273(93)90204-5; MOTT DD, 1990, NEUROSCI LETT, V110, P131, DOI 10.1016/0304-3940(90)90800-O; MOTT DD, 1991, SCIENCE, V252, P1718, DOI 10.1126/science.1675489; MOTT DD, 1993, J NEUROPHYSIOL, V69, P674, DOI 10.1152/jn.1993.69.3.674; NATHAN T, 1990, NEUROSCI LETT, V110, P309, DOI 10.1016/0304-3940(90)90865-7; NATHAN T, 1991, J NEUROPHYSIOL, V66, P1704, DOI 10.1152/jn.1991.66.5.1704; NEWBERRY NR, 1985, J PHYSIOL-LONDON, V360, P161, DOI 10.1113/jphysiol.1985.sp015610; OTIS TS, 1993, J PHYSIOL-LONDON, V463, P391, DOI 10.1113/jphysiol.1993.sp019600; OTIS TS, 1992, J NEUROPHYSIOL, V67, P227, DOI 10.1152/jn.1992.67.1.227; OTIS TS, 1992, NEUROSCIENCE, V49, P13, DOI 10.1016/0306-4522(92)90073-B; PEARCE RA, 1993, NEURON, V10, P189, DOI 10.1016/0896-6273(93)90310-N; PEARCE RA, 1992, PHARM COMM, V2, P157; PITTALUGA A, 1987, EUR J PHARMACOL, V144, P45, DOI 10.1016/0014-2999(87)90007-0; POTIER B, 1993, EUR J PHARMACOL, V231, P427, DOI 10.1016/0014-2999(93)90120-7; REKLING JC, 1993, J NEUROSCI, V13, P1954; SCANZIANI M, 1992, NEURON, V9, P919, DOI 10.1016/0896-6273(92)90244-8; SCHOLZ KP, 1991, J PHYSIOL-LONDON, V444, P669, DOI 10.1113/jphysiol.1991.sp018900; SCHWARTZKROIN PA, 1978, BRAIN RES, V157, P1, DOI 10.1016/0006-8993(78)90991-5; SCHWARTZKROIN PA, 1985, J COMP NEUROL, V232, P205, DOI 10.1002/cne.902320206; SEGAL M, 1990, BRAIN RES, V511, P163, DOI 10.1016/0006-8993(90)90236-5; SIVILOTTI L, 1991, PROG NEUROBIOL, V36, P35, DOI 10.1016/0301-0082(91)90036-Z; SOMOGYI P, 1984, J NEUROSCI, V4, P2590; SOMOGYI P, 1983, J NEUROSCI, V3, P1450; SPRUSTON N, 1993, J NEUROPHYSIOL, V70, P781, DOI 10.1152/jn.1993.70.2.781; SUGITA S, 1992, NEUROSCI LETT, V134, P207, DOI 10.1016/0304-3940(92)90518-C; SWARTZ KJ, 1992, J NEUROSCI, V12, P4358; THOMPSON SM, 1992, J PHYSIOL-LONDON, V451, P329, DOI 10.1113/jphysiol.1992.sp019167; THOMPSON SM, 1992, J NEUROPHYSIOL, V67, P1698, DOI 10.1152/jn.1992.67.6.1698; THOMPSON SM, 1993, TRENDS NEUROSCI, V16, P222, DOI 10.1016/0166-2236(93)90160-N; YOON KW, 1991, J PHYSIOL-LONDON, V442, P377, DOI 10.1113/jphysiol.1991.sp018798	67	83	83	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1993	11	6					1057	1067		10.1016/0896-6273(93)90219-H	http://dx.doi.org/10.1016/0896-6273(93)90219-H			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MP548	8274277				2022-12-24	WOS:A1993MP54800007
J	LUEBKE, JI; DUNLAP, K; TURNER, TJ				LUEBKE, JI; DUNLAP, K; TURNER, TJ			MULTIPLE CALCIUM-CHANNEL TYPES CONTROL GLUTAMATERGIC SYNAPTIC TRANSMISSION IN THE HIPPOCAMPUS	NEURON			English	Article							OMEGA-CONOTOXIN GVIA; PERIPHERAL NEURONS; SODIUM-CHANNELS; AGA-IVA; PEPTIDE; RELEASE; BATRACHOTOXIN; ANTAGONISTS; ACTIVATION; INVITRO	N-type calcium channels play a dominant role in controlling synaptic transmission in many peripheral neurons. Transmitter release from mammalian central nerve terminals, however, is relatively resistant to the N channel antagonist omega-conotoxin GVIA. We studied the sensitivity of glutamatergic synaptic transmission in rat hippocampal slices to omega-conotoxin and to omega-Aga-IVA, a P channel antagonist. Both toxins reduced the amplitude of excitatory postsynaptic potentials in CA1 pyramidal neurons, but omega-Aga-IVA was the more rapid and efficacious. These results were corroborated by biochemical studies measuring subsecond, calcium-dependent [H-3]glutamate release from hippocampal synaptosomes. Thus, at least two calcium channel types trigger glutamate release from hippocampal neurons, but P-type plays a more prominent role. Eliminating synaptic transmission in the CNS, therefore, may require inhibiting more than a single calcium channel type.	TUFTS UNIV, SCH MED, DEPT NEUROSCI, BOSTON, MA 02111 USA	Tufts University	LUEBKE, JI (corresponding author), TUFTS UNIV, SCH MED, DEPT PHYSIOL, BOSTON, MA 02111 USA.			Turner, Timothy/0000-0001-9770-2647; Luebke, Jennifer/0000-0003-1399-6073	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028815, R55NS028815] Funding Source: NIH RePORTER; NINDS NIH HHS [NS28815] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		COLLINGRIDGE GL, 1989, PHARMACOL REV, V41, P143; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; DUNKLEY PR, 1986, BRAIN RES, V372, P115, DOI 10.1016/0006-8993(86)91464-2; DUTAR P, 1989, EUR J PHARMACOL, V174, P261, DOI 10.1016/0014-2999(89)90318-X; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; GREENE RW, 1985, J PHYSIOL-LONDON, V366, P119, DOI 10.1113/jphysiol.1985.sp015788; HORNE AL, 1991, BRIT J PHARMACOL, V103, P1733, DOI 10.1111/j.1476-5381.1991.tb09855.x; HUANG LYM, 1982, P NATL ACAD SCI-BIOL, V79, P2082, DOI 10.1073/pnas.79.6.2082; ITO I, 1990, J PHYSIOL-LONDON, V424, P533, DOI 10.1113/jphysiol.1990.sp018081; JAFFE DB, 1992, NATURE, V357, P244, DOI 10.1038/357244a0; JANIS RA, 1984, DRUG DEVELOP RES, V4, P257, DOI 10.1002/ddr.430040304; KAMIYA H, 1988, NEUROSCI LETT, V91, P84, DOI 10.1016/0304-3940(88)90253-4; KERR LM, 1984, NATURE, V308, P282, DOI 10.1038/308282a0; KHODOROV BI, 1985, PROG BIOPHYS MOL BIO, V45, P57, DOI 10.1016/0079-6107(85)90005-7; KULLMANN DM, 1992, NEURON, V9, P1175, DOI 10.1016/0896-6273(92)90075-O; MAGGI CA, 1988, N-S ARCH PHARMACOL, V338, P107, DOI 10.1007/BF00174856; MILLER RJ, 1987, SCIENCE, V235, P46, DOI 10.1126/science.2432656; MINTZ IM, 1992, NEURON, V9, P85, DOI 10.1016/0896-6273(92)90223-Z; MINTZ IM, 1992, NATURE, V355, P827, DOI 10.1038/355827a0; NOWYCKY MC, 1985, P NATL ACAD SCI USA, V82, P2178, DOI 10.1073/pnas.82.7.2178; OLIVERA BM, 1985, SCIENCE, V230, P1338, DOI 10.1126/science.4071055; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; REGEHR W, 1993, IN PRESS J NEUROSCI; REGEHR WG, 1992, J NEUROSCI, V12, P4202; SEABROOK GR, 1989, BRIT J PHARMACOL, V97, P1125, DOI 10.1111/j.1476-5381.1989.tb12570.x; TRUSSELL LO, 1993, NEURON, V10, P1185, DOI 10.1016/0896-6273(93)90066-Z; TURNER TJ, 1989, ANAL BIOCHEM, V178, P8, DOI 10.1016/0003-2697(89)90347-3; TURNER TJ, 1992, SCIENCE, V258, P310, DOI 10.1126/science.1357749; TURNER TJ, 1993, IN PRESS P NATL ACAD	29	331	339	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1993	11	5					895	902		10.1016/0896-6273(93)90119-C	http://dx.doi.org/10.1016/0896-6273(93)90119-C			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MJ041	7902110				2022-12-24	WOS:A1993MJ04100011
J	RYAN, TA; REUTER, H; WENDLAND, B; SCHWEIZER, FE; TSIEN, RW; SMITH, SJ				RYAN, TA; REUTER, H; WENDLAND, B; SCHWEIZER, FE; TSIEN, RW; SMITH, SJ			THE KINETICS OF SYNAPTIC VESICLE RECYCLING MEASURED AT SINGLE PRESYNAPTIC BOUTONS	NEURON			English	Article							FROG NEUROMUSCULAR-JUNCTION; CULTURED HIPPOCAMPAL-NEURONS; TRANSMITTER RELEASE; MEMBRANE; GLUTAMATE; PROTEINS; EXOCYTOSIS; CELLS	We used the fluorescent membrane probe FM 1-43 to label recycling synaptic vesicles within the presynaptic boutons of dissociated hippocampal neurons in culture. Quantitative time-lapse fluorescence imaging was employed in combination with rapid superfusion techniques to study the dynamics of synaptic vesicles within single boutons. This approach enabled us to measure exocytosis and to analyze the kinetics of endocytosis and the preparation of endocytosed vesicles for re-release (repriming). Our measurements indicate that under sustained membrane depolarization, endocytosis persists much longer than exocytosis, with a t1/2 almost-equal-to 60 s (approximately 24-degrees-C); once internalized, vesicles become reavailable for exocytosis in approximately 30 s. Furthermore, we have shown that endocytosis is not dependent on membrane potential and, unlike exocytosis, that it is independent of extracellular Ca2+.	UNIV BERN,DEPT PHARMACOL,CH-3010 BERN,SWITZERLAND	University of Bern	RYAN, TA (corresponding author), STANFORD UNIV,DEPT MOLEC & CELLULAR PHYSIOL,STANFORD,CA 94305, USA.		Ryan, Timothy/AAO-8286-2020	Smith, Stephen/0000-0002-2290-8701; Ryan, Timothy/0000-0003-2533-9548	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH048108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028587, R01NS024067] Funding Source: NIH RePORTER; NIMH NIH HHS [MH48108] Funding Source: Medline; NINDS NIH HHS [NS 24067, NS 28587] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALMERS W, 1990, NEURON, V4, P813, DOI 10.1016/0896-6273(90)90134-2; BARRETT EF, 1972, J PHYSIOL-LONDON, V227, P691, DOI 10.1113/jphysiol.1972.sp010054; BENNETT MK, 1992, J CELL BIOL, V116, P761, DOI 10.1083/jcb.116.3.761; BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2559, DOI 10.1073/pnas.90.7.2559; BETZ WJ, 1993, J PHYSIOL-LONDON, V460, P287, DOI 10.1113/jphysiol.1993.sp019472; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; BURGER PM, 1989, NEURON, V3, P715, DOI 10.1016/0896-6273(89)90240-7; CECCARELLI B, 1980, J CELL BIOL, V87, P297, DOI 10.1083/jcb.87.1.297; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; DECAMILLI P, 1990, ANNU REV CELL BIOL, V6, P433, DOI 10.1146/annurev.cellbio.6.1.433; DECAMILLI P, 1990, ANNU REV PHYSIOL, V52, P625, DOI 10.1146/annurev.ph.52.030190.003205; DETOLEDO GA, 1993, NATURE, V363, P554, DOI 10.1038/363554a0; FORSCHER P, 1987, J NEUROSCI, V7, P3600; HARRIS KM, 1989, J NEUROSCI, V9, P2982; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; JACOBSON K, 1987, ANNU REV PHYSIOL, V49, P163, DOI 10.1146/annurev.ph.49.030187.001115; Katz B., 1969, RELEASE NEURAL TRANS; KELLY RB, 1993, NEURON S, V10, P43; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; MATTEOLI M, 1992, J CELL BIOL, V117, P849, DOI 10.1083/jcb.117.4.849; MAYCOX PR, 1992, J CELL BIOL, V118, P1379, DOI 10.1083/jcb.118.6.1379; MILLER TM, 1984, J CELL BIOL, V98, P685, DOI 10.1083/jcb.98.2.685; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; PENG YY, 1993, NEURON, V10, P465, DOI 10.1016/0896-6273(93)90334-N; SCHWARTZ EA, 1990, J PHYSIOL-LONDON, V426, P43, DOI 10.1113/jphysiol.1990.sp018126; SUDHOF TC, 1991, NEURON, V6, P665, DOI 10.1016/0896-6273(91)90165-V	27	451	457	1	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1993	11	4					713	724		10.1016/0896-6273(93)90081-2	http://dx.doi.org/10.1016/0896-6273(93)90081-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MD068	8398156				2022-12-24	WOS:A1993MD06800014
J	FERNS, MJ; CAMPANELLI, JT; HOCH, W; SCHELLER, RH; HALL, Z				FERNS, MJ; CAMPANELLI, JT; HOCH, W; SCHELLER, RH; HALL, Z			THE ABILITY OF AGRIN TO CLUSTER ACHRS DEPENDS ON ALTERNATIVE SPLICING AND ON CELL-SURFACE PROTEOGLYCANS	NEURON			English	Article							ACETYLCHOLINE-RECEPTOR CLUSTERS; FIBROBLAST GROWTH-FACTOR; HEPARAN-SULFATE; BASAL LAMINA; EXTRACELLULAR-MATRIX; MOTOR NEURONS; CULTURED MYOTUBES; DEVELOPING MUSCLE; MOLECULES; PROTEINS	Agrin, which induces acetylcholine receptor (AChR) clustering at the developing neuromuscular synapse, occurs in multiple forms generated by alternative splicing. Some of these isoforms are specific to the nervous system; others are expressed in both neural and nonneural tissues, including muscle. We have compared the AChR clustering activity of agrin forms varying at each of the three identified splicing sites, denoted x, y, and z. Agrin isoforms were assayed by applying either transfected COS cells, with agrin bound to their surfaces, or soluble agrin to myotubes of the C2 muscle line, or of two variant lines having defective proteoglycans. Dramatic differences in activity were seen between z site isoforms and lesser differences between y site isoforms. The most active agrin forms contained splicing inserts of 4 amino acids at the y site and 8 amino acids at the z site. These forms are found exclusively in neural tissue. All forms were active on C2 myotubes in cell-attached assays, but muscle forms were less active than neural forms. AChR clustering activity of all agrin forms was decreased when assayed on the proteoglycan-deficient lines, suggesting that proteoglycans may help mediate the action of agrin. As neural agrin forms are more active than muscle forms, they are likely to play a primary role in synaptogenesis.	STANFORD UNIV,HOWARD HUGHES MED INST,DEPT MOLEC & CELLULAR PHYSIOL,STANFORD,CA 94305	Howard Hughes Medical Institute; Stanford University	FERNS, MJ (corresponding author), UNIV CALIF SAN FRANCISCO,SCH MED,DEPT PHYSIOL,SAN FRANCISCO,CA 94143, USA.			Ferns, Michael/0000-0002-1545-3024	NIGMS NIH HHS [GM07276] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON MJ, 1983, J CELL BIOL, V97, P1396, DOI 10.1083/jcb.97.5.1396; BAYNE EK, 1984, J CELL BIOL, V99, P1486, DOI 10.1083/jcb.99.4.1486; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CAMPANELLI JT, 1991, CELL, V67, P909, DOI 10.1016/0092-8674(91)90364-5; CAMPANELLI JT, 1993, COLD SPRING HARB SYM, V57, P461; COHEN MW, 1992, J NEUROSCI, V12, P2982, DOI 10.1523/JNEUROSCI.12-08-02982.1992; FALLON JR, 1989, J CELL BIOL, V108, P1527, DOI 10.1083/jcb.108.4.1527; FERNS M, 1992, NEURON, V8, P1079, DOI 10.1016/0896-6273(92)90129-2; GODFREY EW, 1991, EXP CELL RES, V195, P99, DOI 10.1016/0014-4827(91)90504-N; GODFREY EW, 1988, DEV BIOL, V130, P471, DOI 10.1016/0012-1606(88)90343-0; GORDON H, 1989, DEV BIOL, V135, P1, DOI 10.1016/0012-1606(89)90152-8; GORDON H, 1993, J NEUROSCI, V13, P586; GU Y, 1990, NEURON, V5, P147, DOI 10.1016/0896-6273(90)90305-Y; HIRANO Y, 1989, J NEUROSCI, V9, P1555; HOCH W, 1993, NEURON, V11, P479, DOI 10.1016/0896-6273(93)90152-H; KLAGSBRUN M, 1991, CELL, V67, P229, DOI 10.1016/0092-8674(91)90173-V; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIETH E, 1992, DEV BIOL, V149, P41, DOI 10.1016/0012-1606(92)90262-F; LIETH E, 1993, IN PRESS J NEUROSCI; LOPEZCASILLAS F, 1991, CELL, V67, P785, DOI 10.1016/0092-8674(91)90073-8; MAGILLSOLC C, 1990, J EXP BIOL, V153, P1; MAGILLSOLC C, 1988, J CELL BIOL, V107, P1825, DOI 10.1083/jcb.107.5.1825; MATSUMURA K, 1992, NATURE, V360, P588, DOI 10.1038/360588a0; NASTUK MA, 1991, NEURON, V7, P807, DOI 10.1016/0896-6273(91)90283-6; NGSEE JK, 1990, GENE, V86, P251, DOI 10.1016/0378-1119(90)90286-Z; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; REIST NE, 1992, NEURON, V8, P865, DOI 10.1016/0896-6273(92)90200-W; REIST NE, 1987, J CELL BIOL, V105, P2457, DOI 10.1083/jcb.105.6.2457; RUEGG MA, 1992, NEURON, V8, P691, DOI 10.1016/0896-6273(92)90090-Z; RUPP F, 1992, J NEUROSCI, V12, P3535; RUPP F, 1991, NEURON, V6, P811, DOI 10.1016/0896-6273(91)90177-2; SMITH MA, 1992, MOL CELL NEUROSCI, V3, P406, DOI 10.1016/1044-7431(92)90052-4; TSIM KWK, 1992, NEURON, V8, P677, DOI 10.1016/0896-6273(92)90089-V; WALLACE BG, 1990, J NEUROSCI, V10, P3576; WALLACE BG, 1989, J NEUROSCI, V9, P1294; WANG XF, 1991, CELL, V67, P797, DOI 10.1016/0092-8674(91)90074-9; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W	37	277	279	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1993	11	3					491	502		10.1016/0896-6273(93)90153-I	http://dx.doi.org/10.1016/0896-6273(93)90153-I			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LY498	8398142				2022-12-24	WOS:A1993LY49800009
J	YAN, YM; LAGENAUR, C; NARAYANAN, V				YAN, YM; LAGENAUR, C; NARAYANAN, V			MOLECULAR-CLONING OF M6 - IDENTIFICATION OF A PLP/DM20 GENE FAMILY	NEURON			English	Article							MYELIN PROTEOLIPID PROTEIN; CENTRAL NERVOUS-SYSTEM; WHITE MATTER; CELL-DEATH; BRAIN; HYBRIDIZATION; MUTATION; SEQUENCE; NEURONS; MOUSE	M6 is a membrane glycoprotein that is expressed on central neurons and certain polarized epithelia from early developmental stage. Antibodies against M6 interfere with cerebellar neurite outgrowth in vitro. Two closely related cDNAs were obtained by expression cloning, both of which showed high homology with the major CNS myelin protein PLP/DM20. Although M6 and PLP/DM20 share many molecular characteristics, in situ hybridization revealed nonoverlapping distributions of their mRNAs in mouse CNS. The identification of a gene family including neuron-specific M6 and glia-specific PLP/DM20 in CNS suggests a broader functional role for these molecules than myelination.	CHILDRENS HOSP, DEPT PEDIAT, PITTSBURGH, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	YAN, YM (corresponding author), UNIV PITTSBURGH, SCH MED, DEPT NEUROBIOL, PITTSBURGH, PA 15261 USA.			Narayanan, Vinodh/0000-0002-0658-3847	NINDS NIH HHS [CIDA-NS 01282] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS001282] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AMASINO RM, 1986, ANAL BIOCHEM, V152, P304, DOI 10.1016/0003-2697(86)90413-6; BANDTLOW CE, 1993, SCIENCE, V259, P80, DOI 10.1126/science.8418499; BAUMRIND NL, 1992, DEV DYNAM, V194, P311, DOI 10.1002/aja.1001940407; CAMPAGNONI AT, 1988, J NEUROCHEM, V51, P1, DOI 10.1111/j.1471-4159.1988.tb04827.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DESTGROTH SF, 1980, J IMMUNOL METHODS, V35, P1, DOI 10.1016/0022-1759(80)90146-5; DIAZ RS, 1990, J NEUROCHEM, V55, P1304, DOI 10.1111/j.1471-4159.1990.tb03139.x; DIEHL HJ, 1986, P NATL ACAD SCI USA, V83, P9807, DOI 10.1073/pnas.83.24.9807; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P8; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; HELYNCK G, 1983, EUR J BIOCHEM, V133, P689, DOI 10.1111/j.1432-1033.1983.tb07518.x; HENIKOFF S, 1984, GENE, V28, P357; HUDSON LD, 1989, P NATL ACAD SCI USA, V86, P8128, DOI 10.1073/pnas.86.20.8128; IGARASHI M, 1993, SCIENCE, V259, P77, DOI 10.1126/science.8418498; INOUYE H, 1991, J NEUROSCI RES, V28, P1, DOI 10.1002/jnr.490280102; KITAGAWA K, 1993, NEURON, V11, P433, DOI 10.1016/0896-6273(93)90148-K; KNAPP PE, 1986, J NEUROSCI, V6, P2813; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAGENAUR C, 1992, J NEUROBIOL, V23, P71, DOI 10.1002/neu.480230108; LARMET Y, 1992, NEURON, V9, P563, DOI 10.1016/0896-6273(92)90193-H; Lees M.B., 1984, PROTEINS MYELIN, P197; LEES MB, 1983, ARCH BIOCHEM BIOPHYS, V226, P643, DOI 10.1016/0003-9861(83)90334-X; LIN LFH, 1982, P NATL ACAD SCI-BIOL, V79, P941, DOI 10.1073/pnas.79.3.941; LUND RD, 1986, J COMP NEUROL, V247, P439, DOI 10.1002/cne.902470404; MILNER RJ, 1985, CELL, V42, P931, DOI 10.1016/0092-8674(85)90289-2; MINAMIDE LS, 1990, ANAL BIOCHEM, V190, P66, DOI 10.1016/0003-2697(90)90134-U; NAVE KA, 1987, P NATL ACAD SCI USA, V84, P5665, DOI 10.1073/pnas.84.16.5665; PUCKETT C, 1987, J NEUROSCI RES, V18, P511, DOI 10.1002/jnr.490180402; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHNEIDER A, 1992, NATURE, V358, P758, DOI 10.1038/358758a0; TIMSIT SG, 1992, J NEUROCHEM, V58, P1172, DOI 10.1111/j.1471-4159.1992.tb09378.x; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VERITY AN, 1988, J NEUROSCI RES, V21, P238, DOI 10.1002/jnr.490210216; WAEHNELDT TV, 1987, COMP BIOCHEM PHYS B, V88, P1209, DOI 10.1016/0305-0491(87)90025-3; WAEHNELDT TV, 1990, ANN NY ACAD SCI, V605, P15, DOI 10.1111/j.1749-6632.1990.tb42377.x	37	133	138	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	SEP	1993	11	3					423	431		10.1016/0896-6273(93)90147-J	http://dx.doi.org/10.1016/0896-6273(93)90147-J			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LY498	8398137				2022-12-24	WOS:A1993LY49800003
J	Huang, LYM; Neher, E				Huang, LYM; Neher, E			Ca2+-dependent exocytosis in the somata of dorsal root ganglion neurons	NEURON			English	Article							ADRENAL CHROMAFFIN CELLS; RAT SENSORY NEURONS; PATCH-CLAMP TECHNIQUES; GENE-RELATED PEPTIDE; SUBSTANCE-P; TRANSMITTER RELEASE; CALCIUM CHANNELS; NERVE-TERMINALS; NEUROTRANSMITTER RELEASE; CAPACITANCE MEASUREMENTS	Using capacitance measurements and the single-cell immunoblot assay to study secretion in dorsal root ganglion neurons, we found that the somata underwent robust exocytosis upon depolarization and released substance P, in response to KCI stimulation. The parallel changes between capacitance responses and intracellular Ca2+ concentration ([Ca2+](i)) at different membrane potentials and the inhibition of exocytosis by Ca2+ chelators suggest that soma release is Ca2+-dependent. We also assessed the level of Ca2+ required for exocytosis by raising the average [Ca2+](i) with the Ca2+ ionophore, ionomycin. Capacitance changes were triggered by cytosolic Ca2+ > 0.6 mu M; the [Ca2+](i) at the release sites during depolarizations was estimated to be 3-10 mu M. These Ca2+ levels are similar to those obtained from neuroendocrine cells, but are at least 10 times lower than those required for transmitter release from nerve terminals.	MAX PLANCK INST BIOPHYS CHEM, ABT MEMBRANBIOPHYS, D-37077 GOTTINGEN, GERMANY	Max Planck Society	Huang, LYM (corresponding author), UNIV TEXAS, MED BRANCH, INST MARINE BIOMED, GALVESTON, TX 77555 USA.		Neher, Erwin/A-2109-2013		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030045] Funding Source: NIH RePORTER; NINDS NIH HHS [NS30045] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADLER EM, 1991, J NEUROSCI, V11, P1496; AMMALA C, 1993, J PHYSIOL-LONDON, V472, P665, DOI 10.1113/jphysiol.1993.sp019966; ARITA J, 1991, ENDOCRINOLOGY, V128, P1887, DOI 10.1210/endo-128-4-1887; ARTALEJO CR, 1994, NATURE, V367, P72, DOI 10.1038/367072a0; ARTALEJO CR, 1995, P NATL ACAD SCI USA, V92, P8328, DOI 10.1073/pnas.92.18.8328; AUGUSTINE GJ, 1992, J PHYSIOL-LONDON, V450, P247, DOI 10.1113/jphysiol.1992.sp019126; AUGUSTINE GJ, 1985, J PHYSIOL-LONDON, V367, P163, DOI 10.1113/jphysiol.1985.sp015819; BATTAGLIA G, 1988, J COMP NEUROL, V277, P302, DOI 10.1002/cne.902770210; BEAN AJ, 1994, FASEB J, V8, P630, DOI 10.1096/fasebj.8.9.8005390; Bi GQ, 1995, J CELL BIOL, V131, P1747, DOI 10.1083/jcb.131.6.1747; BOOKMAN RJ, 1991, ANN NY ACAD SCI, V635, P352, DOI 10.1111/j.1749-6632.1991.tb36504.x; BRUNS D, 1995, NATURE, V377, P62, DOI 10.1038/377062a0; CHEN GY, 1995, J NEUROSCI, V15, P7747; CHOW RH, 1994, P NATL ACAD SCI USA, V91, P12765, DOI 10.1073/pnas.91.26.12765; DAN Y, 1994, NEURON, V13, P909, DOI 10.1016/0896-6273(94)90256-9; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; FERNANDEZ JM, 1984, NATURE, V312, P453, DOI 10.1038/312453a0; GANDIA L, 1995, PFLUG ARCH EUR J PHY, V430, P55, DOI 10.1007/BF00373839; GIROD R, 1995, J NEUROSCI, V15, P2826; GLUBEKIAN S, 1986, J NEUROCYTOL, V15, P535; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARPER AA, 1985, J PHYSIOL-LONDON, V359, P47, DOI 10.1113/jphysiol.1985.sp015574; HARPER AA, 1985, J PHYSIOL-LONDON, V359, P31, DOI 10.1113/jphysiol.1985.sp015573; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HEINEMANN C, 1994, BIOPHYS J, V67, P2546, DOI 10.1016/S0006-3495(94)80744-1; HEINEMANN C, 1993, PFLUG ARCH EUR J PHY, V424, P105, DOI 10.1007/BF00374600; HINGTGEN CM, 1994, BRAIN RES, V655, P51, DOI 10.1016/0006-8993(94)91596-2; HOKFELT T, 1994, TRENDS NEUROSCI, V17, P22, DOI 10.1016/0166-2236(94)90031-0; HORRIGAN FT, 1994, NEURON, V13, P1119, DOI 10.1016/0896-6273(94)90050-7; KAYAHARA T, 1981, BRAIN RES, V216, P277, DOI 10.1016/0006-8993(81)90130-X; KENDALL ME, 1987, ENDOCRINOLOGY, V121, P2260, DOI 10.1210/endo-121-6-2260; LEE KH, 1986, J COMP NEUROL, V243, P335, DOI 10.1002/cne.902430305; LIM NF, 1990, NATURE, V344, P449, DOI 10.1038/344449a0; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; Lindau Manfred, 1994, V29, P173; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; LOPEZ MG, 1994, PFLUG ARCH EUR J PHY, V427, P348, DOI 10.1007/BF00374544; MERIGHI A, 1988, CELL TISSUE RES, V254, P101; MUDGE AW, 1979, P NATL ACAD SCI USA, V76, P526, DOI 10.1073/pnas.76.1.526; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; NEHER E, 1989, NEUROMUSCULAR JUNCTI, P65; Neher E., 1986, EXPT BRAIN RES SERIE, P80; NICOL GD, 1992, J NEUROSCI, V12, P1917; NOWYCKY MC, 1993, BIOPHYS J, V64, P77, DOI 10.1016/S0006-3495(93)81342-0; PENNER R, 1988, J EXP BIOL, V139, P329; PLENDERLEITH MB, 1990, SYNAPSE, V6, P344, DOI 10.1002/syn.890060406; RENDT J, 1994, ENDOCRINOLOGY, V135, P501, DOI 10.1210/en.135.2.501; REUTER H, 1995, NEURON, V14, P773, DOI 10.1016/0896-6273(95)90221-X; SCROGGS RS, 1992, J PHYSIOL-LONDON, V445, P639, DOI 10.1113/jphysiol.1992.sp018944; Seward EP, 1996, J NEUROSCI, V16, P553; SMITH SJ, 1988, TRENDS NEUROSCI, V11, P458, DOI 10.1016/0166-2236(88)90199-3; STERN MD, 1992, CELL CALCIUM, V13, P183, DOI 10.1016/0143-4160(92)90046-U; SUN YA, 1987, P NATL ACAD SCI USA, V84, P2540, DOI 10.1073/pnas.84.8.2540; THOMAS P, 1994, J CELL BIOL, V124, P667, DOI 10.1083/jcb.124.5.667; THOMAS P, 1993, NEURON, V11, P93, DOI 10.1016/0896-6273(93)90274-U; THOMAS P, 1990, NEURON, V5, P723, DOI 10.1016/0896-6273(90)90226-6; TSE A, 1993, SCIENCE, V260, P82, DOI 10.1126/science.8385366; VASKO MR, 1994, J NEUROSCI, V14, P4987; VEDDER H, 1991, J NEUROSCI RES, V30, P288, DOI 10.1002/jnr.490300203; VERHAGE M, 1991, NEURON, V6, P517, DOI 10.1016/0896-6273(91)90054-4; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; VONGERSDORFF H, 1994, NATURE, V370, P652, DOI 10.1038/370652a0; VONRUDEN L, 1993, SCIENCE, V262, P1061, DOI 10.1126/science.8235626; WAGONER PK, 1993, P NATL ACAD SCI USA, V90, P9145, DOI 10.1073/pnas.90.19.9145; WILLIS WD, 1991, SENSORY MECHANISMS S, P47; WU LG, 1994, J NEUROSCI, V14, P5613; ZHOU Z, 1995, J BIOL CHEM, V270, P3498, DOI 10.1074/jbc.270.8.3498; ZHOU Z, 1995, P NATL ACAD SCI USA, V92, P6938, DOI 10.1073/pnas.92.15.6938; ZHOU ZA, 1993, J PHYSIOL-LONDON, V469, P245, DOI 10.1113/jphysiol.1993.sp019813; ZHU PC, 1986, NEUROSCIENCE, V19, P43, DOI 10.1016/0306-4522(86)90004-7; ZUCKER RS, 1991, ANN NY ACAD SCI, V635, P191, DOI 10.1111/j.1749-6632.1991.tb36492.x; ZUCKER RS, 1988, NATURE, V335, P360, DOI 10.1038/335360a0	73	245	249	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	1996	17	1					135	145		10.1016/S0896-6273(00)80287-1	http://dx.doi.org/10.1016/S0896-6273(00)80287-1			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UY981	8755485	Bronze, Green Published			2022-12-24	WOS:A1996UY98100014
J	Brundage, L; Avery, L; Katz, A; Kim, UJ; Mendel, JE; Sternberg, PW; Simon, MI				Brundage, L; Avery, L; Katz, A; Kim, UJ; Mendel, JE; Sternberg, PW; Simon, MI			Mutations in a C-elegans G(q)alpha gene disrupt movement, egg laying, and viability	NEURON			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; PROTEIN ALPHA-SUBUNITS; PHOSPHOLIPASE-C; BETA-GAMMA; WILD-TYPE; RECEPTORS; MUTANTS; CELL; ACTIVATION; DIVERSITY	We find that C. elegans egl-30 encodes a heterotrimeric G protein alpha subunit more than 80% identical to mammalian G(q) alpha family proteins, and which can function as a G(q) alpha subunit in COS-7 cells. We have identified new egl-30 alleles in a selection for genes involved in the C. elegans acetylcholine response. Two egl-30 alleles specify premature termination of G(q) alpha and are essentially lethal in homozygotes. Animals homozygous for six other egl-30 alleles are viable and fertile, but exhibit delayed egg laying and leave flattened tracks. Overexpression of the wild-type egl-30 gene produces the opposite behavior. Analysis of these mutants suggest that their phenotypes reflect defects in the muscle or neuromuscular junction.	CALTECH,HOWARD HUGHES MED INST,PASADENA,CA 91125; UNIV TEXAS,SW MED CTR,DEPT BIOCHEM,DALLAS,TX 75235	California Institute of Technology; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Brundage, L (corresponding author), CALTECH,DIV BIOL,PASADENA,CA 91125, USA.		Katz, Arieh/F-5836-2012	Sternberg, Paul/0000-0002-7699-0173	NHLBI NIH HHS [R37 HL046154, R01 HL046154, HL46154] Funding Source: Medline; NINDS NIH HHS [F32 NS009541, F32NS09541-03] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL046154, R37HL046154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS009541] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALFONSO A, 1994, J NEUROSCI, V14, P2290; AROIAN RV, 1993, MOL CELL BIOL, V13, P626, DOI 10.1128/MCB.13.1.626; AVERY L, 1987, CELL, V51, P1071, DOI 10.1016/0092-8674(87)90593-9; AVERY L, 1993, GENETICS, V133, P897; AVERY L, 1990, J EXP ZOOL, V253, P263, DOI 10.1002/jez.1402530305; AVERY L, 1993, J EXP BIOL, V175, P283; BALDWIN JM, 1994, CURR OPIN CELL BIOL, V6, P180, DOI 10.1016/0955-0674(94)90134-1; BARSTEAD RJ, 1989, J BIOL CHEM, V264, P10177; BAYNASH AG, 1994, CELL, V79, P1277, DOI 10.1016/0092-8674(94)90018-3; BRENNER S, 1974, GENETICS, V77, P71; CAMPS M, 1992, NATURE, V360, P684, DOI 10.1038/360684a0; COULSON A, 1986, P NATL ACAD SCI USA, V83, P7821, DOI 10.1073/pnas.83.20.7821; CULOTTI JG, 1983, J NEUROSCI, V3, P359; Davignon I, 1996, GENOMICS, V31, P359, DOI 10.1006/geno.1996.0059; EDGERTON MD, 1994, FEBS LETT, V354, P195, DOI 10.1016/0014-5793(94)01101-X; EGLEN RM, 1994, TRENDS PHARMACOL SCI, V15, P114, DOI 10.1016/0165-6147(94)90047-7; GOLLASCH M, 1991, P NATL ACAD SCI USA, V88, P10262, DOI 10.1073/pnas.88.22.10262; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; KATZ A, 1992, NATURE, V360, P686, DOI 10.1038/360686a0; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; LEE CH, 1992, J BIOL CHEM, V267, P16044; LEE YJ, 1990, NEURON, V5, P889, DOI 10.1016/0896-6273(90)90349-K; LOCHRIE MA, 1991, CELL REGUL, V2, P135, DOI 10.1091/mbc.2.2.135; MCINTIRE SL, 1993, NATURE, V364, P334, DOI 10.1038/364334a0; MCKIM KS, 1993, GENETICS, V134, P749; MENDEL JE, 1995, SCIENCE, V267, P1652, DOI 10.1126/science.7886455; MUMBY SM, 1994, P NATL ACAD SCI USA, V91, P2800, DOI 10.1073/pnas.91.7.2800; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; OFFERMANNS S, 1994, MOL PHARMACOL, V45, P890; OFFERMANNS S, 1991, MOL ENDOCRINOL, V5, P995, DOI 10.1210/mend-5-7-995; OTSUKA AJ, 1991, NEURON, V6, P113, DOI 10.1016/0896-6273(91)90126-K; PARK EC, 1986, GENETICS, V113, P821; RAIZEN DM, 1995, GENETICS, V141, P1365; REINER DJ, 1995, GENETICS, V141, P961; SEGALAT L, 1995, SCIENCE, V267, P1648, DOI 10.1126/science.7886454; SILVA IF, 1990, J MOL BIOL, V215, P483, DOI 10.1016/S0022-2836(05)80160-3; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SLEPAK VZ, 1995, J BIOL CHEM, V270, P4037, DOI 10.1074/jbc.270.8.4037; STRATHMANN M, 1990, P NATL ACAD SCI USA, V87, P9113, DOI 10.1073/pnas.87.23.9113; Sulston J., 1988, NEMATODE CAENORHABDI, P587; SULSTON JE, 1980, DEV BIOL, V78, P577, DOI 10.1016/0012-1606(80)90353-X; TRENT C, 1983, GENETICS, V104, P619; VANDERVOORN L, 1990, J MOL BIOL, V213, P17, DOI 10.1016/S0022-2836(05)80118-4; WATERSTON RH, 1980, DEV BIOL, V77, P271, DOI 10.1016/0012-1606(80)90475-3; Watson S., 1994, G PROTEIN LINKED REC; WEDEGAERTNER PB, 1994, CELL, V77, P1063, DOI 10.1016/0092-8674(94)90445-6; WEINSHENKER D, 1995, J NEUROSCI, V15, P6975; WILKIE TM, 1991, P NATL ACAD SCI USA, V88, P10049, DOI 10.1073/pnas.88.22.10049; WILLIAMS BD, 1994, J CELL BIOL, V124, P475, DOI 10.1083/jcb.124.4.475; WU DQ, 1993, SCIENCE, V261, P101, DOI 10.1126/science.8316840; WU DQ, 1992, J BIOL CHEM, V267, P25798	52	152	157	1	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1996	16	5					999	1009		10.1016/S0896-6273(00)80123-3	http://dx.doi.org/10.1016/S0896-6273(00)80123-3			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UN480	8630258	Green Accepted, Bronze			2022-12-24	WOS:A1996UN48000015
J	Shieh, BH; Zhu, MY				Shieh, BH; Zhu, MY			Regulation of the TRP Ca2+ channel by INAD in Drosophila photoreceptors	NEURON			English	Article							CALCIUM-CHANNEL; PROTEIN; PHOTOTRANSDUCTION; GENE; TRANSDUCTION; EXPRESSION	Drosophila vision involves a G protein-coupled phospholipase C-mediated signaling pathway that leads to membrane depolarization through activation of Na+ and Ca2+ channels. InaD mutant flies have a M442K point mutation and display a slow recovery of the Ca2+-dependent current. We report that anti-INAD antibodies coimmunoprecipitate TRP, identified by its electrophoretic mobility, cross reactivity with anti-TRP antibody, and absence in a null allele trp mutant. This interaction is abolished by the InaD point mutation in vitro and in vivo. Interaction was localized to the 19 amino acid C-terminus of TRP by overlay assays, and to the PDZ domain of INAD, encompassing the point mutation. Given the impaired electrophysiology of the InaD mutant, this novel interaction suggests that INAD functions as a regulatory subunit of the TRP Ca2+ channel.			Shieh, BH (corresponding author), VANDERBILT UNIV,DEPT PHARMACOL,NASHVILLE,TN 37232, USA.				NEI NIH HHS [EY09743] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY009743] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; BROWN PJ, 1993, J BIOL CHEM, V268, P6668; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; COSENS DJ, 1969, NATURE, V224, P285, DOI 10.1038/224285a0; DOOLITTLE RF, 1986, URFS ORFS PRIMER ANA, P561; HARDIE RC, 1993, TRENDS NEUROSCI, V16, P371, DOI 10.1016/0166-2236(93)90095-4; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; HU YF, 1995, BIOCHEM J, V305, P605, DOI 10.1042/bj3050605; HU YF, 1994, BIOCHEM BIOPH RES CO, V201, P1050, DOI 10.1006/bbrc.1994.1808; ISOM LL, 1994, NEURON, V12, P1183, DOI 10.1016/0896-6273(94)90436-7; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; MONTELL C, 1985, SCIENCE, V230, P1040, DOI 10.1126/science.3933112; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; Pak W.L., 1979, P67; Pearn MT, 1996, J BIOL CHEM, V271, P4937; PERETZ A, 1994, J GEN PHYSIOL, V104, P1057, DOI 10.1085/jgp.104.6.1057; PERETZ A, 1994, NEURON, V12, P1257, DOI 10.1016/0896-6273(94)90442-1; PHILLIPS AM, 1992, NEURON, V8, P631, DOI 10.1016/0896-6273(92)90085-R; POLLOCK JA, 1995, J NEUROSCI, V15, P3747; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; RANGANATHAN R, 1995, ANNU REV NEUROSCI, V18, P283; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; Sambrook J., 2002, MOL CLONING LAB MANU; SELINGER Z, 1993, BIOCHIM BIOPHYS ACTA, V1179, P283, DOI 10.1016/0167-4889(93)90084-3; SHIEH BH, 1995, NEURON, V14, P201, DOI 10.1016/0896-6273(95)90255-4; SINGER D, 1991, SCIENCE, V253, P1553, DOI 10.1126/science.1716787; STUDIER FW, 1986, J MOL BIOL, V113, P189; VACA L, 1994, AM J PHYSIOL-CELL PH, V267, pC1501, DOI 10.1152/ajpcell.1994.267.5.C1501; VARADI G, 1991, NATURE, V352, P159, DOI 10.1038/352159a0; WES PD, 1995, P NATL ACAD SCI USA, V92, P9652, DOI 10.1073/pnas.92.21.9652; WOLFNER MF, 1994, DROSOPHILA MELANOGAS, P33; WONG F, 1989, NEURON, V3, P81, DOI 10.1016/0896-6273(89)90117-7	36	228	236	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1996	16	5					991	998		10.1016/S0896-6273(00)80122-1	http://dx.doi.org/10.1016/S0896-6273(00)80122-1			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UN480	8630257	Bronze			2022-12-24	WOS:A1996UN48000014
J	Retaux, S; McNeill, L; Harris, WA				Retaux, S; McNeill, L; Harris, WA			Engrailed, retinotectal targeting, and axonal patterning in the midbrain during Xenopus development: An antisense study	NEURON			English	Article							RETINAL AXONS; ROSTROCAUDAL POLARITY; HOMING BEHAVIOR; VISUAL-SYSTEM; GROWTH CONES; EXPRESSION; HOMEOBOX; BRAIN; GENE; DROSOPHILA	Axonal tracts in the vertebrate brain seem to respect domains of homeobox gene expression. To test the role of engrailed in tract formation in the midbrain, we inhibited its expression using antisense (AS) oligo-nucleotides. Phosphorothioate-modified AS oligos caused navigational errors in both the optic projection (OF) and the intertectal commissure (ITC). These oligos, however, also inhibited bFGF binding to the brain. To determine whether these tract phenotypes were due to inhibition of bFGF function or engrailed expression, we used partially phosphorothioate-modified (pp) oligos, which inhibit engrailed expression but do not affect bFGF binding. These ppAS oligos caused the ITC phenotype but had no effect on the OF. Thus, interference with bFGF function correlates with the OP phenotype, while the ITC phenotype is directly related to engrailed expression.			Retaux, S (corresponding author), UNIV CALIF SAN DIEGO, DEPT BIOL 0366, LA JOLLA, CA 92093 USA.							ALVARADOMALLART RM, 1993, J NEUROBIOL, V24, P1341, DOI 10.1002/neu.480241007; BARTH KA, 1995, DEVELOPMENT, V121, P1755; Boncinelli Edoardo, 1994, Current Opinion in Neurobiology, V4, P29, DOI 10.1016/0959-4388(94)90028-0; BULFONE A, 1993, J NEUROSCI, V13, P3155; CHIEN CB, 1993, NEURON, V11, P237, DOI 10.1016/0896-6273(93)90181-P; CHIEN CB, 1995, DEVELOPMENT, V121, P2621; CONDRON BG, 1994, NEURON, V13, P541, DOI 10.1016/0896-6273(94)90024-8; CORNEL E, 1992, NEURON, V9, P1001, DOI 10.1016/0896-6273(92)90061-H; DAVIS CA, 1991, DEVELOPMENT, V111, P287; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; FIGDOR MC, 1993, NATURE, V363, P630, DOI 10.1038/363630a0; GOULD AP, 1992, DEVELOPMENT, V116, P1163; GUVAKOVA MA, 1995, J BIOL CHEM, V270, P2620, DOI 10.1074/jbc.270.6.2620; HAN KY, 1993, EMBO J, V12, P2723, DOI 10.1002/j.1460-2075.1993.tb05934.x; HARRIS WA, 1986, NATURE, V320, P266, DOI 10.1038/320266a0; HARRIS WA, 1990, ANNU REV NEUROSCI, V13, P155, DOI 10.1146/annurev.ne.13.030190.001103; HARRIS WA, 1989, NATURE, V339, P218, DOI 10.1038/339218a0; HEMMATIBRIVANLOU A, 1991, DEVELOPMENT, V111, P715; HEUER JG, 1992, DEVELOPMENT, V115, P35; HOLT CE, 1983, NATURE, V301, P150, DOI 10.1038/301150a0; ITASAKI N, 1991, DEVELOPMENT, V113, P1133; ITASAKI N, 1992, NEURON, V8, P787, DOI 10.1016/0896-6273(92)90099-Y; JAYNES JB, 1991, EMBO J, V10, P1427, DOI 10.1002/j.1460-2075.1991.tb07663.x; JOLIOT A, 1991, P NATL ACAD SCI USA, V88, P1864, DOI 10.1073/pnas.88.5.1864; JONES FS, 1990, P NATL ACAD SCI USA, V87, P6497, DOI 10.1073/pnas.87.17.6497; JONES FS, 1992, P NATL ACAD SCI USA, V89, P2091, DOI 10.1073/pnas.89.6.2091; JONES FS, 1992, P NATL ACAD SCI USA, V89, P2086, DOI 10.1073/pnas.89.6.2086; JOYNER AL, 1985, CELL, V43, P29, DOI 10.1016/0092-8674(85)90009-1; JOYNER AL, 1991, SCIENCE, V251, P1239, DOI 10.1126/science.1672471; KUWADA JY, 1986, SCIENCE, V233, P740, DOI 10.1126/science.3738507; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MACDONALD R, 1994, NEURON, V13, P1039, DOI 10.1016/0896-6273(94)90044-2; MCFARLANE S, 1995, NEURON, V15, P1017, DOI 10.1016/0896-6273(95)90091-8; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; OHKUMA Y, 1990, P NATL ACAD SCI USA, V87, P2289, DOI 10.1073/pnas.87.6.2289; OROURKE NA, 1990, NEURON, V5, P159, DOI 10.1016/0896-6273(90)90306-Z; PAPALOPULU N, 1993, DEVELOPMENT, V117, P961; PATEL NH, 1989, CELL, V58, P955, DOI 10.1016/0092-8674(89)90947-1; PIPERNO G, 1985, J CELL BIOL, V101, P2085, DOI 10.1083/jcb.101.6.2085; PUELLES L, 1993, TRENDS NEUROSCI, V16, P472, DOI 10.1016/0166-2236(93)90080-6; RUBENSTEIN JLR, 1994, CURR TOP DEV BIOL, V29, P1, DOI 10.1016/S0070-2153(08)60546-3; STAHL B, 1990, NEURON, V5, P735, DOI 10.1016/0896-6273(90)90227-7; TAYLOR JSH, 1990, DEVELOPMENT, V108, P147; TAYLOR JSH, 1991, DEVELOPMENT, P95; WAGNER JSH, 1994, DEVELOPMENT S, V372, P333; WAGNER RW, 1994, NATURE, V372, P333, DOI 10.1038/372333a0; WATANABE M, 1993, NUCLEIC ACIDS RES, V21, P2513, DOI 10.1093/nar/21.10.2513; WILSON SW, 1990, DEVELOPMENT, V108, P121; WILSON SW, 1993, TRENDS NEUROSCI, V16, P316, DOI 10.1016/0166-2236(93)90108-X; WURST W, 1994, DEVELOPMENT, V120, P2065	50	28	28	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1996	16	1					63	75		10.1016/S0896-6273(00)80024-0	http://dx.doi.org/10.1016/S0896-6273(00)80024-0			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TT307	8562092	Bronze			2022-12-24	WOS:A1996TT30700010
J	WINSLOW, JW; MORAN, P; VALVERDE, J; SHIH, A; YUAN, JQ; WONG, SC; TSAI, SP; GODDARD, A; HENZEL, WJ; HEFTI, F; BECK, KD; CARAS, IW				WINSLOW, JW; MORAN, P; VALVERDE, J; SHIH, A; YUAN, JQ; WONG, SC; TSAI, SP; GODDARD, A; HENZEL, WJ; HEFTI, F; BECK, KD; CARAS, IW			CLONING OF AL-1, A LIGAND FOR AN EPH-RELATED TYROSINE KINASE RECEPTOR INVOLVED IN AXON BUNDLE FORMATION	NEURON			English	Article							MICROTUBULE-ASSOCIATED PROTEIN-2; TRK PROTOONCOGENE PRODUCT; HIPPOCAMPAL-NEURONS; GROWTH-FACTOR; SEQUENCE; SIGNAL; EXPRESSION; CULTURE; FAMILY; TAU	REK7 is an Eph-related tyrosine kinase receptor expressed exclusively in the nervous system, predominantly in hippocampus and cortex. A soluble REK7-IgG fusion protein, produced to analyze the biological role of REK7, prevents axon bundling in cocultures of cortical neurons with astrocytes, a model of late stage nervous system development and differentiation. Using REK7-IgG as an affinity reagent, we purified and cloned a novel REK7 ligand called AL-1, a GPI-linked protein homologous to other members of an emerging ligand family. Membrane attachment of AL-1 appears necessary for receptor activation, since REK7 on cortical neurons is efficiently activated by transfected cells expressing GPI-linked AL-1, but not by soluble AL-1. Consistent with this, soluble AL-1 blocks axon bundling. Our findings, together with the observation that both molecules are expressed in the brain, suggest a role in the formation of neuronal pathways, a crucial feature of nervous system development and regeneration.	GENENTECH INC,DEPT MOLEC BIOL,S SAN FRANCISCO,CA 94080; GENENTECH INC,DEPT PROT CHEM,S SAN FRANCISCO,CA 94080	Roche Holding; Genentech; Roche Holding; Genentech	WINSLOW, JW (corresponding author), GENENTECH INC,DEPT NEUROSCI,460 POINT SAN BRUNO BLVD,S SAN FRANCISCO,CA 94080, USA.			Henzel, William/0000-0003-2940-3797; Caras, Ingrid/0000-0002-8902-808X				BARTLEY TD, 1994, NATURE, V368, P558, DOI 10.1038/368558a0; BECKMANN MP, 1994, EMBO J, V13, P3757, DOI 10.1002/j.1460-2075.1994.tb06685.x; BENNETT BD, 1994, J BIOL CHEM, V269, P14211; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; CACERES A, 1986, J NEUROSCI, V6, P714; CAPON DJ, 1989, NATURE, V337, P525, DOI 10.1038/337525a0; CHENG HJ, 1994, CELL, V79, P157, DOI 10.1016/0092-8674(94)90408-1; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; DOTTI CG, 1987, NEUROSCIENCE, V23, P121, DOI 10.1016/0306-4522(87)90276-4; EATON DL, 1986, BIOCHEMISTRY-US, V25, P8343, DOI 10.1021/bi00374a001; FANTL WJ, 1993, ANNU REV BIOCHEM, V62, P453, DOI 10.1146/annurev.bi.62.070193.002321; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; GILARDIHEBENSTREIT, 1992, ONCOGENE, V7, P2499; HATTEN ME, 1990, SEMIN NEUROSCI, V2, P455; HENZEL WJ, 1987, J CHROMATOGR, V404, P41, DOI 10.1016/S0021-9673(01)86835-7; HENZEL WJ, 1990, ANAL BIOCHEM, V187, P228, DOI 10.1016/0003-2697(90)90448-I; IP NY, 1993, NEURON, V10, P137, DOI 10.1016/0896-6273(93)90306-C; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; MAISONPIERRE PC, 1993, ONCOGENE, V8, P3277; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; METZ CN, 1994, EMBO J, V13, P1741, DOI 10.1002/j.1460-2075.1994.tb06438.x; MORAN P, 1991, J CELL BIOL, V115, P1595, DOI 10.1083/jcb.115.6.1595; MORAN P, 1994, J CELL BIOL, V125, P3633; PETERSON C, 1989, DEV BRAIN RES, V48, P187, DOI 10.1016/0165-3806(89)90075-8; RAZ V, 1991, ONCOGENE, V6, P753; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SAJJADI FG, 1993, ONCOGENE, V8, P1807; SCHLESSINGER J, 1992, NEURON, V9, P383, DOI 10.1016/0896-6273(92)90177-F; SHELTON DL, 1995, J NEUROSCI, V15, P477, DOI 10.1523/jneurosci.15-01-00477.1995; SIMONSEN CC, 1983, P NATL ACAD SCI-BIOL, V80, P2495, DOI 10.1073/pnas.80.9.2495; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; TESSIERLAVIGNE M, 1994, CURR OPIN GENET DEV, V4, P596, DOI 10.1016/0959-437X(94)90078-H; TUZI NL, 1994, BRIT J CANCER, V69, P417, DOI 10.1038/bjc.1994.77; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; WONG SC, 1993, TECHNIQUES PROTEIN C, V4, P371; ZHOU R, 1994, J NEUROSCI RES, V37, P129, DOI 10.1002/jnr.490370117	41	252	261	1	6	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1995	14	5					973	981		10.1016/0896-6273(95)90335-6	http://dx.doi.org/10.1016/0896-6273(95)90335-6			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QY935	7748564	Bronze			2022-12-24	WOS:A1995QY93500009
J	COLBERT, HA; BARGMANN, CI				COLBERT, HA; BARGMANN, CI			ODORANT-SPECIFIC ADAPTATION PATHWAYS GENERATE OLFACTORY PLASTICITY IN C-ELEGANS	NEURON			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; SENSITIVE ADENYLATE-CYCLASE; SACCHAROMYCES-CEREVISIAE; PROTEIN METHYLATION; ADAPTIVE PROPERTIES; RHODOPSIN KINASE; RECEPTOR NEURONS; ESCHERICHIA-COLI; PHOSPHORYLATION; DESENSITIZATION	Following prolonged exposure to an odorant, C. elegans exhibits a diminished response to the odorant for several hours. This olfactory adaptation is odorant selective; animals can adapt independently to different odorants sensed by a single pair of olfactory neurons, the AWC neurons. The mechanism of olfactory adaptation is genetically complex, with different genes required for adaptation to different odorants. Animals mutant for the gene adp-1 fail to adapt to a subset of AWC-sensed odorants; adp-1 affects a calcium-dependent process required for adaptation. Mutations in another gene, osm-9 affect adaptation to a different but overlapping subset of AWC-sensed odorants. Mutations in adp-1 and osm-9 do not diminish the ability of unadapted animals to respond to odorants, indicating that odorant sensation and odorant adaptation are distinct processes.	UNIV CALIF SAN FRANCISCO, DEPT ANAT, PROGRAM NEUROSCI, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, DEPT ANAT, GENET PROGRAM, SAN FRANCISCO, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	COLBERT, HA (corresponding author), UNIV CALIF SAN FRANCISCO, DEPT ANAT, PROGRAM DEV BIOL, SAN FRANCISCO, CA 94143 USA.			Bargmann, Cornelia/0000-0002-8484-0618	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001393] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC01393] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; BOEKHOFF I, 1992, P NATL ACAD SCI USA, V89, P471, DOI 10.1073/pnas.89.2.471; BOEKHOFF I, 1990, EMBO J, V9, P2453, DOI 10.1002/j.1460-2075.1990.tb07422.x; BRENNER S, 1974, GENETICS, V77, P71; BROWN NG, 1992, EUR J BIOCHEM, V208, P659, DOI 10.1111/j.1432-1033.1992.tb17232.x; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; CHAN RK, 1982, MOL CELL BIOL, V2, P21, DOI 10.1128/MCB.2.1.21; CHEN TY, 1994, NATURE, V368, P545, DOI 10.1038/368545a0; COLE GM, 1991, CELL, V64, P703, DOI 10.1016/0092-8674(91)90500-X; CULOTTI JG, 1978, GENETICS, V90, P243; DAWSON TM, 1993, SCIENCE, V259, P825, DOI 10.1126/science.8381559; DEAN KR, 1993, EUR J BIOCHEM, V213, P881, DOI 10.1111/j.1432-1033.1993.tb17832.x; Dudai Y., 1989, NEUROBIOLOGY MEMORY; DUSENBERY DB, 1980, J COMP PHYSIOL, V136, P327, DOI 10.1007/BF00657352; EKMAN G, 1967, SCAND J PSYCHOL, V8, P177, DOI 10.1111/j.1467-9450.1967.tb01392.x; FIRESTEIN S, 1991, J NEUROSCI, V11, P3565; GETCHELL TV, 1978, J PHYSIOL-LONDON, V282, P541, DOI 10.1113/jphysiol.1978.sp012480; GOY MF, 1977, P NATL ACAD SCI USA, V74, P4964, DOI 10.1073/pnas.74.11.4964; HADCOCK JR, 1993, J NEUROCHEM, V60, P1, DOI 10.1111/j.1471-4159.1993.tb05816.x; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; KLEENE SJ, 1993, J MEMBRANE BIOL, V131, P237, DOI 10.1007/BF02260112; KONOPKA JB, 1988, CELL, V54, P609, DOI 10.1016/S0092-8674(88)80005-9; KRAMER RH, 1992, NEURON, V9, P897, DOI 10.1016/0896-6273(92)90242-6; KURAHASHI T, 1990, BRAIN RES, V515, P261, DOI 10.1016/0006-8993(90)90605-B; LIU MY, 1994, SCIENCE, V266, P1348, DOI 10.1126/science.266.5189.1348; Murphy C, 1987, NEUROBIOLOGY TASTE S, P251; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; OCHOA ELM, 1990, MOL NEUROBIOL, V4, P251, DOI 10.1007/BF02780343; PACE U, 1985, NATURE, V316, P255, DOI 10.1038/316255a0; Pitt G S, 1990, Semin Cell Biol, V1, P99; RANGANATHAN R, 1991, NATURE, V354, P230, DOI 10.1038/354230a0; RANKIN CH, 1990, BEHAV BRAIN RES, V37, P89, DOI 10.1016/0166-4328(90)90074-O; RAUSCHECKER JP, 1993, J NEUROSCI, V13, P4538; RENEKE JE, 1988, CELL, V55, P221, DOI 10.1016/0092-8674(88)90045-1; SCHLEICHER S, 1993, P NATL ACAD SCI USA, V90, P1420, DOI 10.1073/pnas.90.4.1420; SKLAR PB, 1986, J BIOL CHEM, V261, P5538; SPRINGER MS, 1979, NATURE, V280, P279, DOI 10.1038/280279a0; STRYER L, 1991, J BIOL CHEM, V266, P10711; WANG HW, 1993, SCIENCE, V260, P998, DOI 10.1126/science.8493539; WARD S, 1973, P NATL ACAD SCI USA, V70, P817, DOI 10.1073/pnas.70.3.817; WARD S, 1975, J COMP NEUROL, V160, P313, DOI 10.1002/cne.901600305; WARE RW, 1975, J COMP NEUROL, V162, P71, DOI 10.1002/cne.901620106; WEIS RM, 1988, P NATL ACAD SCI USA, V85, P83, DOI 10.1073/pnas.85.1.83; ZUFALL F, 1991, P ROY SOC B-BIOL SCI, V246, P225, DOI 10.1098/rspb.1991.0148	44	232	242	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1995	14	4					803	812		10.1016/0896-6273(95)90224-4	http://dx.doi.org/10.1016/0896-6273(95)90224-4			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QU826	7718242	Bronze			2022-12-24	WOS:A1995QU82600014
J	BEDLACK, RS; WEI, MD; FOX, SH; GROSS, E; LOEW, LM				BEDLACK, RS; WEI, MD; FOX, SH; GROSS, E; LOEW, LM			DISTINCT ELECTRIC POTENTIALS IN SOMA AND NEURITE MEMBRANES	NEURON			English	Article							SMOOTH-MUSCLE CELLS; MAMMALIAN CEREBELLAR SLICES; NEURONAL GROWTH CONES; CALCIUM INFLUX; PURKINJE-CELLS; PHYSIOLOGICAL PROPERTIES; CHANNELS; CHOLESTEROL; CURRENTS; INCREASES	Structurally similar voltage-dependent ion channels may behave differently in different locations along the surface of a neuron. A possible reason could be that channels experience nonuniform electrical potentials along the plasmalemma. Here, we map the electrical potentials along the membrane of differentiated N1E-115 neuroblastoma cells with a potential-sensitive dye. We find that the intramembrane potential gradient is indeed more positive in the membranes of neurites than in the membranes of somata. This is not attributable to differences in ion conductances or surface charge densities between the membranes of neurites and somata; instead, it can be explained by differences in lipid composition. The spatial variation in intramembrane electrical potential may help account for electrophysiological and functional differences between neurites and somata.			BEDLACK, RS (corresponding author), UNIV CONNECTICUT,CTR HLTH,DEPT PHYSIOL,FARMINGTON,CT 06030, USA.			Loew, Leslie/0000-0002-1851-4646; Bedlack, Richard/0000-0003-4666-7495	NIEHS NIH HHS [ES05973] Funding Source: Medline; NIGMS NIH HHS [GM35063] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES005973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035063] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANGLISTER L, 1982, DEV BIOL, V94, P351, DOI 10.1016/0012-1606(82)90353-0; BEDLACK RS, 1992, NEURON, V9, P393, DOI 10.1016/0896-6273(92)90178-G; BELARDETTI F, 1986, J PHYSIOL-LONDON, V374, P289, DOI 10.1113/jphysiol.1986.sp016080; BIALECKI RA, 1991, J CLIN INVEST, V88, P1894, DOI 10.1172/JCI115512; BIALECKI RA, 1989, AM J PHYSIOL, V257, P306; BOLSOVER SR, 1986, J NEUROSCI, V6, P1934; CATTERALL WA, 1988, SCIENCE, V242, P50, DOI 10.1126/science.2459775; DAVENPORT RW, 1992, NEURON, V9, P405, DOI 10.1016/0896-6273(92)90179-H; DE LAAT SW, 1984, PHYSL MEMBRANE FLUID, P21; FLEWELLING RF, 1986, BIOPHYS J, V49, P541, DOI 10.1016/S0006-3495(86)83664-5; FLUHLER E, 1985, BIOCHEMISTRY-US, V24, P5749, DOI 10.1021/bi00342a010; FRANKLIN JC, 1993, BIOPHYS J, V64, P642, DOI 10.1016/S0006-3495(93)81423-1; GARCIA U, 1990, J EXP BIOL, V150, P1; GLEASON MM, 1991, CIRC RES, V69, P216, DOI 10.1161/01.RES.69.1.216; GROSS E, 1994, BIOPHYS J, V67, P208, DOI 10.1016/S0006-3495(94)80471-0; Hille B., 1992, IONIC CHANNELS EXCIT; HLADKY SB, 1973, BIOCHIM BIOPHYS ACTA, V318, P464, DOI 10.1016/0005-2736(73)90211-3; HONIG BH, 1986, ANNU REV BIOPHYS BIO, V15, P163; IGARASHI M, 1990, DEV BRAIN RES, V51, P1, DOI 10.1016/0165-3806(90)90252-T; KOBAYASHI T, 1992, NATURE, V359, P647, DOI 10.1038/359647a0; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P171, DOI 10.1113/jphysiol.1980.sp013357; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P197, DOI 10.1113/jphysiol.1980.sp013358; LOCHER R, 1984, BIOCHEM BIOPH RES CO, V124, P822, DOI 10.1016/0006-291X(84)91031-3; LOEW LM, 1979, NATURE, V281, P497, DOI 10.1038/281497a0; LOEW LM, 1978, BIOCHEMISTRY-US, V17, P4065, DOI 10.1021/bi00612a030; MA JJ, 1988, BIOPHYS J, V53, P387, DOI 10.1016/S0006-3495(88)83115-1; MASUKAWA LM, 1991, CELL MOL NEUROBIOL, V11, P231, DOI 10.1007/BF00769036; MCLAUGHLIN S, 1989, ANNU REV BIOPHYS BIO, V18, P113, DOI 10.1146/annurev.biophys.18.1.113; MCLAUGHLIN S, 1977, CURR TOP MEMBR TRANS, V9, P71; MEYERS DER, 1993, J NEUROPHYSIOL, V69, P406, DOI 10.1152/jn.1993.69.2.406; MIDTGAARD J, 1993, J NEUROPHYSIOL, V70, P2455, DOI 10.1152/jn.1993.70.6.2455; MILLER C, 1991, SCIENCE, V252, P1092, DOI 10.1126/science.252.5009.1092; MONTANA V, 1989, BIOCHEMISTRY-US, V28, P4536, DOI 10.1021/bi00437a003; SEN LY, 1992, CIRC RES, V71, P1008, DOI 10.1161/01.RES.71.4.1008; SILVER RA, 1990, NATURE, V343, P751, DOI 10.1038/343751a0; STREIT J, 1989, J NEUROSCI, V9, P4190; STRICHARTZ GR, 1980, BIOPHYS J, V31, P229, DOI 10.1016/S0006-3495(80)85053-3; SUGIMORI M, 1990, P NATL ACAD SCI USA, V87, P5084, DOI 10.1073/pnas.87.13.5084; SZABO G, 1974, NATURE, V252, P47, DOI 10.1038/252047a0; TANK DW, 1988, SCIENCE, V242, P773, DOI 10.1126/science.2847315; THOMPSON S, 1988, J NEUROSCI, V8, P1929; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; TSIEN RY, 1986, TRENDS BIOCHEM SCI, V11, P450, DOI 10.1016/0968-0004(86)90245-8; USOWICZ MM, 1992, NEURON, V9, P1185, DOI 10.1016/0896-6273(92)90076-P; WESTENBROEK RE, 1990, NATURE, V347, P281, DOI 10.1038/347281a0; ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0; ZHOU Q, BIOCHIM BIOPHYS ACTA, V1085, P1	47	54	55	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1994	13	5					1187	1193		10.1016/0896-6273(94)90056-6	http://dx.doi.org/10.1016/0896-6273(94)90056-6			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PU763	7946355				2022-12-24	WOS:A1994PU76300014
J	PAOLETTI, P; ASCHER, P				PAOLETTI, P; ASCHER, P			MECHANOSENSITIVITY OF NMDA RECEPTORS IN CULTURED MOUSE CENTRAL NEURONS	NEURON			English	Article							METHYL-D-ASPARTATE; DENDRITIC SPINES; HIPPOCAMPAL-NEURONS; PATCH-CLAMP; ACTIVATED CHANNELS; ION CHANNELS; CELL-VOLUME; CURRENTS; CALCIUM; ACTIN	Changes in osmotic and hydrostatic pressure were found to modulate NMDA responses of cultured embryonic mouse neurons recorded in various patch-clamp configurations. In nucleated patches, NMDA currents were potentiated by reductions in external osmolarity and were reduced in hyper-osmotic solutions. These changes, which were greater for low concentrations of NMDA, were not observed for responses to kainate, glycine, or GABA. They could be mimicked by directly changing the pipette pressure in nucleated, outside-out, inside-out, and cell-attached patches. Osmosensitivity of NMDA responses was also observed in the whole-cell mode, but only after prolonged dialysis. Mechanosensitivity of NMDA receptors could have an important role in neuronal regions experiencing changes in membrane tension, such as spines or growth cones.			PAOLETTI, P (corresponding author), ECOLE NORMALE SUPER,NEUROBIOL LAB,46 RUE ULM,F-75005 PARIS,FRANCE.		Paoletti, Pierre/L-7358-2013	Paoletti, Pierre/0000-0002-3681-4845				ASCHER P, 1988, J PHYSIOL-LONDON, V399, P207; CAMBRAYDEAKIN MA, 1992, DEV BRAIN RES, V66, P25, DOI 10.1016/0165-3806(92)90136-K; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CONDEELIS J, 1993, ANNU REV CELL BIOL, V9, P411, DOI 10.1146/annurev.cb.09.110193.002211; DOROSHENKO P, 1992, J PHYSIOL-LONDON, V449, P197, DOI 10.1113/jphysiol.1992.sp019082; FATIMASHAD K, 1992, P ROY SOC B-BIOL SCI, V250, P99, DOI 10.1098/rspb.1992.0136; FIFKOVA E, 1992, INT REV CYTOL, V139, P267, DOI 10.1016/S0074-7696(08)61414-X; FRENCH AS, 1992, ANNU REV PHYSIOL, V54, P135, DOI 10.1146/annurev.physiol.54.1.135; GIBB AJ, 1992, J PHYSIOL-LONDON, V456, P143, DOI 10.1113/jphysiol.1992.sp019331; GUHARAY F, 1984, J PHYSIOL-LONDON, V352, P685, DOI 10.1113/jphysiol.1984.sp015317; GULLEY RL, 1981, J CELL BIOL, V91, P298, DOI 10.1083/jcb.91.1.298; HALPAIN S, 1990, NEURON, V5, P237, DOI 10.1016/0896-6273(90)90161-8; HAMILL OP, 1992, P NATL ACAD SCI USA, V89, P7462, DOI 10.1073/pnas.89.16.7462; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HOWARD J, 1988, ANNU REV BIOPHYS BIO, V17, P99; JOHNSON JW, 1990, BIOPHYS J, V57, P1085, DOI 10.1016/S0006-3495(90)82626-6; Kennedy M B, 1993, Curr Opin Neurobiol, V3, P732, DOI 10.1016/0959-4388(93)90145-O; KOMURO H, 1993, SCIENCE, V260, P95, DOI 10.1126/science.8096653; LAMOUREUX P, 1989, Nature (London), V340, P159, DOI 10.1038/340159a0; LANGTON PD, 1993, J PHYSIOL-LONDON, V471, P1; LEGENDRE P, 1993, J NEUROSCI, V13, P674; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; MACDONALD JF, 1989, J PHYSIOL-LONDON, V414, P17, DOI 10.1113/jphysiol.1989.sp017674; MARTINAC B, 1990, NATURE, V348, P261, DOI 10.1038/348261a0; MATUS A, 1982, P NATL ACAD SCI-BIOL, V79, P7590, DOI 10.1073/pnas.79.23.7590; MCBAIN CJ, 1994, PHYSIOL REV, V74, P723, DOI 10.1152/physrev.1994.74.3.723; MILLER B, 1992, NATURE, V355, P722, DOI 10.1038/355722a0; MILTON RL, 1990, PFLUG ARCH EUR J PHY, V416, P758, DOI 10.1007/BF00370626; MORALES M, 1989, CELL TISSUE RES, V256, P447; MORALES M, 1989, J COMP NEUROL, V279, P666, DOI 10.1002/cne.902790412; MORRIS CE, 1991, SCIENCE, V251, P1246, DOI 10.1126/science.1706535; MUALLEM S, 1992, J BIOL CHEM, V267, P17658; NISHIKAWA M, 1994, J PHYSIOL-LONDON, V475, P83, DOI 10.1113/jphysiol.1994.sp020051; NITSCHKE R, 1993, PFLUG ARCH EUR J PHY, V423, P274, DOI 10.1007/BF00374406; OLIET SHR, 1993, NATURE, V364, P341, DOI 10.1038/364341a0; OPSAHL LR, 1994, BIOPHYS J, V66, P71, DOI 10.1016/S0006-3495(94)80751-9; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; RASHID NA, 1992, DEV BRAIN RES, V67, P301, DOI 10.1016/0165-3806(92)90231-K; ROSENMUND C, 1993, NEURON, V10, P805, DOI 10.1016/0896-6273(93)90197-Y; Sachs F., 1990, Seminars in the Neurosciences, V2, P49; SACKIN H, 1989, P NATL ACAD SCI USA, V86, P1731, DOI 10.1073/pnas.86.5.1731; SATHER W, 1992, J PHYSIOL-LONDON, V450, P643, DOI 10.1113/jphysiol.1992.sp019148; SOKABE M, 1991, BIOPHYS J, V59, P722, DOI 10.1016/S0006-3495(91)82285-8; SUKHAREV SI, 1993, BIOPHYS J, V65, P177, DOI 10.1016/S0006-3495(93)81044-0; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; UBL J, 1988, J MEMBRANE BIOL, V104, P223, DOI 10.1007/BF01872324; VYKLICKY L, 1993, J PHYSIOL-LONDON, V470, P575, DOI 10.1113/jphysiol.1993.sp019876; WANG YT, 1993, NEUROSCI LETT, V157, P183, DOI 10.1016/0304-3940(93)90732-Z; YAMAGUCHI DT, 1989, J BIOL CHEM, V264, P4383	49	191	202	2	18	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1994	13	3					645	655		10.1016/0896-6273(94)90032-9	http://dx.doi.org/10.1016/0896-6273(94)90032-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PJ284	7917295				2022-12-24	WOS:A1994PJ28400012
J	GEREAU, RW; CONN, PJ				GEREAU, RW; CONN, PJ			POTENTIATION OF CAMP RESPONSES BY METABOTROPIC GLUTAMATE RECEPTORS DEPRESSES EXCITATORY SYNAPTIC TRANSMISSION BY A KINASE-INDEPENDENT MECHANISM	NEURON			English	Article							CYCLIC-AMP ACCUMULATION; RAT HIPPOCAMPUS; ENDOGENOUS ADENOSINE; CA1 REGION; PHOSPHOINOSITIDE HYDROLYSIS; PYRAMIDAL CELLS; CEREBRAL-CORTEX; ACTIVATION; INCREASES; INHIBITION	Coactivation of metabotropic glutamate receptors (mGluRs) and beta-adrenergic receptors causes a synergistic increase in cAMP formation in the rat hippocampus. Increases in cAMP are known to have many actions in the hippocampus via activation of cAMP-dependent protein kinase. We now report that coactivation of mGluRs and beta-adrenergic receptors induces an acute depression of EPSCs at the Schaffer collateral-CA1 synapse. Interestingly, this depression of EPSCs is dependent upon increases in cAMP levels but independent of protein kinase activity. A series of studies suggests that cAMP-mediated depression of EPSCs is dependent on metabolism of cAMP and release of adenosine or 5'-AMP into the extracellular space with resultant activation of presynaptic adenosine receptors. These studies suggest that cAMP can have local hormone-like effects in the hippocampal formation which are independent of cAMP-dependent protein kinase.	EMORY UNIV,SCH MED,PROGRAM NEUROSCI,ATLANTA,GA 30322	Emory University	GEREAU, RW (corresponding author), EMORY UNIV,SCH MED,DEPT PHARMACOL,ATLANTA,GA 30322, USA.		Conn, Peter/D-7848-2012		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS028405, R01NS028405, R01NS031373] Funding Source: NIH RePORTER; NINDS NIH HHS [NS-31373, NS-28405] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BOSS V, 1992, J NEUROCHEM, V59, P2340; BRUNS RF, 1990, ANN NY ACAD SCI, V603, P211; CACIAGLLI F, 1993, FUNCT NEUROL SN, V4, P13; CHAVEZNORIEGA LE, 1992, BRAIN RES, V574, P85, DOI 10.1016/0006-8993(92)90803-H; Conn PJ., 1994, METABOTROPIC GLUTAMA; COSTA M, 1990, N-S ARCH PHARMACOL, V342, P630, DOI 10.1007/BF00175705; DESAI MA, 1992, SYNAPSE, V12, P206, DOI 10.1002/syn.890120305; DESAI MA, 1991, J NEUROPHYSIOL, V66, P40, DOI 10.1152/jn.1991.66.1.40; DESAI MA, 1990, NEUROSCI LETT, V109, P157, DOI 10.1016/0304-3940(90)90555-N; DEVREOTES PN, 1982, DEV DICTYOSTELIUM DI, P117; DIXON D, 1989, J NEUROSCI, V9, P4246; DUNWIDDIE TV, 1980, BRIT J PHARMACOL, V69, P59, DOI 10.1111/j.1476-5381.1980.tb10883.x; DUNWIDDIE TV, 1992, J NEUROSCI, V12, P506; GEREAU RW, 1994, IN PRESS J NEUROSCI; GOLDSMITH BA, 1991, P NATL ACAD SCI USA, V88, P9021, DOI 10.1073/pnas.88.20.9021; GUNTHER T, 1992, FEBS LETT, V307, P333, DOI 10.1016/0014-5793(92)80707-N; HARRIS DN, 1979, J CYCLIC NUCL PROT, V5, P125; JOHNSON RD, 1986, EUR J PHARMACOL, V129, P293, DOI 10.1016/0014-2999(86)90439-5; LAMBERT NA, 1991, NEUROSCI LETT, V122, P50, DOI 10.1016/0304-3940(91)90190-5; MADISON DV, 1986, J PHYSIOL-LONDON, V372, P245, DOI 10.1113/jphysiol.1986.sp016007; MADISON DV, 1988, BRAIN RES, V442, P131, DOI 10.1016/0006-8993(88)91440-0; MITCHELL JB, 1993, J NEUROSCI, V13, P3439; POCKETT S, 1993, NEUROSCIENCE, V52, P229, DOI 10.1016/0306-4522(93)90151-5; PRINCE DA, 1992, P NATL ACAD SCI USA, V89, P8586, DOI 10.1073/pnas.89.18.8586; REDDINGTON M, 1982, NEUROSCI LETT, V28, P275, DOI 10.1016/0304-3940(82)90070-2; ROSENBERG PA, 1992, BRAIN RES BULL, V29, P315, DOI 10.1016/0361-9230(92)90062-3; SCHOEPP DD, 1993, TRENDS PHARMACOL SCI, V14, P13, DOI 10.1016/0165-6147(93)90107-U; SHIMIZU H, 1969, J NEUROCHEM, V16, P1609, DOI 10.1111/j.1471-4159.1969.tb10360.x; SLACK JR, 1991, NEUROSCI LETT, V130, P69, DOI 10.1016/0304-3940(91)90229-M; SUZDAK PD, 1994, IN PRESS METABOTROPI; WINDER DG, 1993, J PHARMACOL EXP THER, V266, P518; WINDER DG, 1992, J NEUROCHEM, V59, P375, DOI 10.1111/j.1471-4159.1992.tb08914.x; WINDER DG, 1993, J NEUROSCI, V13, P38; ZHANG G, 1993, J PHARMACOL EXP THER, V264, P1415	34	67	67	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1994	12	5					1121	1129		10.1016/0896-6273(94)90319-0	http://dx.doi.org/10.1016/0896-6273(94)90319-0			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NM831	8185947				2022-12-24	WOS:A1994NM83100015
J	CHUN, JY; KORNER, J; KREINER, T; SCHELLER, RH; AXEL, R				CHUN, JY; KORNER, J; KREINER, T; SCHELLER, RH; AXEL, R			THE FUNCTION AND DIFFERENTIAL SORTING OF A FAMILY OF APLYSIA PROHORMONE PROCESSING ENZYMES	NEURON			English	Article							SITE-DIRECTED MUTAGENESIS; EGG-LAYING HORMONE; BAG CELL NEURONS; MOLECULAR-CLONING; SECRETORY PATHWAY; XENOPUS OOCYTES; MESSENGER-RNA; HUMAN FURIN; PRECURSOR; CDNA	We have cloned four members of the family of subtilisin-like endoproteases expressed in the bag cell neurons of Aplysia and have demonstrated that two of these enzymes are capable of correctly cleaving the egg-laying hormone precursor. The egg-laying hormone precursor undergoes an ordered series of cleavages, such that different peptides are differentially sorted into distinct secretory vesicles. We have used electron microscopic chemistry to demonstrate that at least one processing enzyme is differentially segregated into a class of secretory vesicles containing the bag cell peptides. The segregation of specific endoproteases, along with specific neuropeptides within a given cell type, may ensure appropriate cleavage and prevent inappropriate cleavage of the polyprotein precursors.	COLUMBIA UNIV,COLL PHYS & SURG,HOWARD HUGHES MED INST,NEW YORK,NY 10032; STANFORD UNIV,DEPT CELLULAR & MOLEC PHYSIOL,STANFORD,CA 94305; STANFORD UNIV,HOWARD HUGHES MED INST,STANFORD,CA 94305	Columbia University; Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University	CHUN, JY (corresponding author), COLUMBIA UNIV,COLL PHYS & SURG,DEPT BIOCHEM & BIOPHYS,NEW YORK,NY 10032, USA.			Axel, Richard/0000-0002-3141-4076				BAILYES EM, 1992, BIOCHEM J, V285, P391, DOI 10.1042/bj2850391; BENJANNET S, 1991, P NATL ACAD SCI USA, V88, P3564, DOI 10.1073/pnas.88.9.3564; BRESNAHAN PA, 1990, J CELL BIOL, V111, P2851, DOI 10.1083/jcb.111.6.2851; BRYAN P, 1986, P NATL ACAD SCI USA, V83, P3743, DOI 10.1073/pnas.83.11.3743; COMB M, 1982, NATURE, V295, P663, DOI 10.1038/295663a0; DOUGLASS J, 1984, ANNU REV BIOCHEM, V53, P665; FISHER JM, 1988, CELL, V54, P813, DOI 10.1016/S0092-8674(88)91131-2; FRAZIER WT, 1967, J NEUROPHYSIOL, V30, P1288, DOI 10.1152/jn.1967.30.6.1288; GUBLER U, 1982, NATURE, V295, P206, DOI 10.1038/295206a0; HELLER E, 1980, P NATL ACAD SCI-BIOL, V77, P2328, DOI 10.1073/pnas.77.4.2328; HOSAKA M, 1991, J BIOL CHEM, V266, P12127; JUNG LJ, 1993, J CELL BIOL, V121, P11, DOI 10.1083/jcb.121.1.11; KAGAN A, 1979, METHOD HORM RADIOIMM, P328; KIEFER MC, 1991, DNA CELL BIOL, V10, P757, DOI 10.1089/dna.1991.10.757; KORNER J, 1991, P NATL ACAD SCI USA, V88, P6834, DOI 10.1073/pnas.88.15.6834; KORNER J, 1991, P NATL ACAD SCI USA, V88, P11393, DOI 10.1073/pnas.88.24.11393; KREINER T, 1984, J NEUROSCI, V4, P2581; KRIEGER DT, 1979, SCIENCE, V205, P366, DOI 10.1126/science.221983; LEDUC R, 1992, J BIOL CHEM, V267, P14304; MISUMI Y, 1991, J BIOL CHEM, V266, P16954; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; MOORE HPH, 1983, CELL, V35, P531, DOI 10.1016/0092-8674(83)90187-3; NAKANISHI S, 1979, NATURE, V278, P423, DOI 10.1038/278423a0; NAKAYAMA K, 1991, J BIOCHEM, V109, P803, DOI 10.1093/oxfordjournals.jbchem.a123461; NAMBU JR, 1988, NEURON, V1, P55, DOI 10.1016/0896-6273(88)90209-7; NEWCOMB R, 1988, J BIOL CHEM, V263, P12514; NEWCOMB R, 1987, J NEUROSCI, V7, P854; NODA M, 1982, NATURE, V295, P202, DOI 10.1038/295202a0; RAJPARA SM, 1992, NEURON, V9, P505, DOI 10.1016/0896-6273(92)90188-J; ROSEN OM, 1987, SCIENCE, V237, P1452, DOI 10.1126/science.2442814; SCHELLER RH, 1982, CELL, V28, P707, DOI 10.1016/0092-8674(82)90050-2; SCHNEIDER LE, 1988, P NATL ACAD SCI USA, V85, P1993, DOI 10.1073/pnas.85.6.1993; SEIDAH NG, 1990, DNA CELL BIOL, V9, P789, DOI 10.1089/dna.1990.9.789; SEIDAH NG, 1991, MOL ENDOCRINOL, V5, P111, DOI 10.1210/mend-5-1-111; SEIDAH NG, 1990, DNA CELL BIOL, V9, P415, DOI 10.1089/dna.1990.9.415; SHENNAN KIJ, 1991, J BIOL CHEM, V266, P24011; SMEEKENS SP, 1991, P NATL ACAD SCI USA, V88, P340, DOI 10.1073/pnas.88.2.340; SMEEKENS SP, 1990, J BIOL CHEM, V265, P2997; SOSSIN WS, 1989, NEURON, V2, P1407, DOI 10.1016/0896-6273(89)90186-4; SOSSIN WS, 1990, J CELL BIOL, V110, P1, DOI 10.1083/jcb.110.1.1; SWEETCORDERO A, 1990, J NEUROCHEM, V55, P1933, DOI 10.1111/j.1471-4159.1990.tb05779.x; THOMAS L, 1991, P NATL ACAD SCI USA, V88, P5297, DOI 10.1073/pnas.88.12.5297; VANDENOUWELAND AMW, 1990, NUCLEIC ACIDS RES, V18, P664, DOI 10.1093/nar/18.3.664; VANDEVEN WJM, 1990, MOL BIOL REP, V14, P265, DOI 10.1007/BF00429896; WELLS JA, 1983, NUCLEIC ACIDS RES, V11, P7911, DOI 10.1093/nar/11.22.7911; WISE RJ, 1990, P NATL ACAD SCI USA, V87, P9378, DOI 10.1073/pnas.87.23.9378; ZHOU A, 1993, J BIOL CHEM, V268, P1763	47	47	48	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1994	12	4					831	844		10.1016/0896-6273(94)90336-0	http://dx.doi.org/10.1016/0896-6273(94)90336-0			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NH253	8161455				2022-12-24	WOS:A1994NH25300012
J	NOTTEBOHM, E; USUI, A; THERIANOS, S; KIMURA, K; DAMBLYCHAUDIERE, C; GHYSEN, A				NOTTEBOHM, E; USUI, A; THERIANOS, S; KIMURA, K; DAMBLYCHAUDIERE, C; GHYSEN, A			THE GENE POXN CONTROLS DIFFERENT STEPS OF THE FORMATION OF CHEMOSENSORY ORGANS IN DROSOPHILA	NEURON			English	Article							MEDIATED ENHANCER DETECTION; SENSE-ORGANS; MELANOGASTER; EXPRESSION; SENSILLA; NEURONS	The gene poxn codes for a transcriptional regulator that specifies poly-innervated (chemosensory), as opposed to mono-innervated (mechanosensory), organs in Drosophila. The ectopic expression of poxn during metamorphosis results in a transformation of the morphology and central projection of adult mechanosensory organs toward those of chemosensory organs. Here we show, by electron microscopy analysis of normal and transformed bristles and by Dil labeling of the innervating neurons, that poxn also controls the number of neurons. To determine whether poxn can transform not only the sense organ precursor cells but also their daughter cells, we examine the effects of the ectopic expression of poxn at different stages of the lineage, and we conclude that poxn can act at a late stage to affect the fate of the undifferentiated neuron.	UNIV LIBRE BRUXELLES,GENET LAB,B-1640 RHODE ST GENESE,BELGIUM; UNIV BASEL,DEPT ZOOL,NEUROBIOL LAB,CH-4051 BASEL,SWITZERLAND; HOKKAIDO UNIV,BIOL LAB,IWAMIZAWA 068,JAPAN	Universite Libre de Bruxelles; University of Basel; Hokkaido University	NOTTEBOHM, E (corresponding author), UNIV LIBRE BRUXELLES,NEUROBIOL LAB,67 RUE CHEVAUX,B-1640 RHODE ST GENESE,BELGIUM.							BATE CM, 1976, HDB SENSORY PHYSL, V11, P8; BELLEN HJ, 1989, GENE DEV, V3, P1288, DOI 10.1101/gad.3.9.1288; BLOCHLINGER K, 1991, GENE DEV, V5, P1124, DOI 10.1101/gad.5.7.1124; BOULIANNE GL, 1991, EMBO J, V10, P2975, DOI 10.1002/j.1460-2075.1991.tb07848.x; BULLOCK TH, 1965, STRUCTURE FUNCTION N, V2, P1030; DAMBLYCHAUDIERE C, 1992, CELL, V69, P159, DOI 10.1016/0092-8674(92)90127-X; GHYSEN A, 1993, BIOESSAYS, V15, P293, DOI 10.1002/bies.950150502; HARTENSTEIN V, 1989, DEVELOPMENT, V107, P389; HONIG MG, 1989, TRENDS NEUROSCI, V12, P333, DOI 10.1016/0166-2236(89)90040-4; HUANG F, 1991, DEVELOPMENT, V111, P1087; JAN YN, 1990, TRENDS NEUROSCI, V13, P493, DOI 10.1016/0166-2236(90)90083-M; MLODZIK M, 1990, GENE DEV, V4, P1848, DOI 10.1101/gad.4.11.1848; NAYAK SV, 1983, INT J INSECT MORPHOL, V12, P273, DOI 10.1016/0020-7322(83)90023-5; NOTTEBOHM E, 1992, NATURE, V359, P829, DOI 10.1038/359829a0; THURM U, 1964, SCIENCE, V145, P1063, DOI 10.1126/science.145.3636.1063; WHITLOCK KE, 1993, DEVELOPMENT, V117, P1251; WIGGLESWORTH VB, 1953, Q J MICROSC SCI, V94, P113; WILSON C, 1989, GENE DEV, V3, P1301, DOI 10.1101/gad.3.9.1301	18	48	49	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1994	12	1					25	34		10.1016/0896-6273(94)90149-X	http://dx.doi.org/10.1016/0896-6273(94)90149-X			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MU493	8292359				2022-12-24	WOS:A1994MU49300003
J	AKASU, T; ITO, M; NAKANO, T; SCHNEIDER, CR; SIMMONS, MA; TANAKA, T; TOKIMASA, T; YOSHIDA, M				AKASU, T; ITO, M; NAKANO, T; SCHNEIDER, CR; SIMMONS, MA; TANAKA, T; TOKIMASA, T; YOSHIDA, M			MYOSIN LIGHT-CHAIN KINASE OCCURS IN BULLFROG SYMPATHETIC NEURONS AND MAY MODULATE VOLTAGE-DEPENDENT POTASSIUM CURRENTS	NEURON			English	Article							NAPHTHALENESULFONAMIDE DERIVATIVES; CALMODULIN ANTAGONISTS; PROTEIN-KINASE; INTRACELLULAR CALCIUM; PRIMARY AFFERENT; K+-CURRENT; INHIBITION; SUPPRESSION; GIZZARD; CELLS	A polyclonal antibody against myosin light chain kinase (MLCK) of chicken gizzard recognized a 130 kd peptide of bullfrog sympathetic ganglia as MLCK. MLCK immunoreactivity was confined to the neuronal cell body. A synthetic peptide corresponding to an inhibitory domain of MLCK (Ala783-Gly804) Was applied intracellularly to isolated sympathetic neurons during whole-cell recordings of ionic currents. The peptide inhibitor reversibly decreased M-type potassium current (I(M)) while not affecting A-type or delayed rectifier-type potassium currents. Intracellular application of an active fragment of MLCK enhanced I(M), whereas application of an inactive MLCK fragment did not. The results suggest that I(M) can be modulated by MLCK-catalyzed phosphorylation.	KURUME UNIV,SCH MED,DEPT PHARMACOL,KURUME,FUKUOKA 830,JAPAN; MIE UNIV,DEPT INTERNAL MED,TSU,MIE 514,JAPAN; MIE UNIV,DEPT MOLEC & CELLULAR PHARMACOL,TSU,MIE 514,JAPAN; MARSHALL UNIV,DEPT PHARMACOL,NEUROPHARMACOL LAB,HUNTINGTON,WV 25755	Kurume University; Mie University; Mie University; Marshall University	AKASU, T (corresponding author), KURUME UNIV,SCH MED,DEPT PHYSIOL,KURUME,FUKUOKA 830,JAPAN.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R55NS025999, R01NS025999, R29NS025999] Funding Source: NIH RePORTER; NINDS NIH HHS [NS-25999] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS PR, 1982, J PHYSIOL-LONDON, V330, P537, DOI 10.1113/jphysiol.1982.sp014357; BOSMA MM, 1989, P NATL ACAD SCI USA, V86, P2943, DOI 10.1073/pnas.86.8.2943; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; BROWN DA, 1987, CELL MOL NEUROBIOL, V7, P255, DOI 10.1007/BF00711303; CAULFIELD MP, 1991, NEUROSCI LETT, V125, P57, DOI 10.1016/0304-3940(91)90130-L; GLASS DB, 1989, J BIOL CHEM, V264, P8802; GODT RE, 1982, J GEN PHYSIOL, V80, P279, DOI 10.1085/jgp.80.2.279; GUERRIERO V, 1986, BIOCHEMISTRY-US, V25, P8372, DOI 10.1021/bi00374a007; GUERRIERO V, 1981, CELL, V27, P449, DOI 10.1016/0092-8674(81)90386-X; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARTSHORNE DJ, 1987, PHYSL GASTROINTESTIN, V1, P423; HIDAKA H, 1981, MOL PHARMACOL, V20, P571; HIDAKA H, 1981, P NATL ACAD SCI-BIOL, V78, P4354, DOI 10.1073/pnas.78.7.4354; IKEBE M, 1990, BIOCHEM BIOPH RES CO, V168, P714, DOI 10.1016/0006-291X(90)92380-I; ITO M, 1989, J BIOL CHEM, V264, P13971; KEMP BE, 1987, J BIOL CHEM, V262, P2542; KIRKWOOD A, 1992, BRAIN RES, V580, P281, DOI 10.1016/0006-8993(92)90955-9; KIRKWOOD A, 1991, NEURON, V6, P1009, DOI 10.1016/0896-6273(91)90240-Z; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIN CT, 1980, J CELL BIOL, V85, P473, DOI 10.1083/jcb.85.2.473; MARRION NV, 1992, J PHYSIOL-LONDON, V445, P515, DOI 10.1113/jphysiol.1992.sp018937; MARRION NV, 1991, NEURON, V6, P533, DOI 10.1016/0896-6273(91)90056-6; MEANS AR, 1980, NATURE, V285, P73, DOI 10.1038/285073a0; NAGATSU I, 1987, BIOPHYS RES COMMUN, V143, P1054; NAGATSU I, 1978, CATECHOLAMINES BASIC, V2, P1330; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; OHARAIMAIZUMI M, 1992, BIOCHEM BIOPH RES CO, V185, P1016, DOI 10.1016/0006-291X(92)91728-9; OLSON NJ, 1990, P NATL ACAD SCI USA, V87, P2284, DOI 10.1073/pnas.87.6.2284; OLWIN BB, 1984, J BIOL CHEM, V259, P949; PFAFFINGER P, 1988, J NEUROSCI, V8, P3343; PFAFFINGER PJ, 1988, NEURON, V1, P477, DOI 10.1016/0896-6273(88)90178-X; SAITOH M, 1986, BIOCHEM BIOPH RES CO, V140, P280, DOI 10.1016/0006-291X(86)91087-9; SAITOH M, 1987, J BIOL CHEM, V262, P7796; SELLERS JR, 1987, ENZYMES, P381; SIMMONS MA, 1990, NEURON, V4, P557, DOI 10.1016/0896-6273(90)90113-T; SIMMONS MA, 1991, J NEUROSCI, V11, P2130; TANAKA T, 1982, MOL PHARMACOL, V22, P403; TANAKA T, 1982, MOL PHARMACOL, V22, P408; TOKIMASA T, 1990, J PHYSIOL-LONDON, V426, P241, DOI 10.1113/jphysiol.1990.sp018136; TOKIMASA T, 1991, J PHYSIOL-LONDON, V435, P585, DOI 10.1113/jphysiol.1991.sp018527; TOKIMASA T, 1990, J PHYSIOL-LONDON, V420, P409, DOI 10.1113/jphysiol.1990.sp017920; TOKIMASA T, 1985, BRAIN RES, V337, P386, DOI 10.1016/0006-8993(85)90081-2; TOKIMASA T, 1990, J AUTONOM NERV SYST, V29, P163, DOI 10.1016/0165-1838(90)90182-I; YAZAWA M, 1987, J BIOL CHEM, V262, P10951; YOSHIDA M, 1988, NEUROSCI LETT, V94, P5, DOI 10.1016/0304-3940(88)90261-3	45	43	43	1	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1993	11	6					1133	1145		10.1016/0896-6273(93)90226-H	http://dx.doi.org/10.1016/0896-6273(93)90226-H			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MP548	7903859				2022-12-24	WOS:A1993MP54800014
J	DIAMOND, P; MALLAVARAPU, A; SCHNIPPER, J; BOOTH, J; PARK, L; OCONNOR, TP; JAY, DG				DIAMOND, P; MALLAVARAPU, A; SCHNIPPER, J; BOOTH, J; PARK, L; OCONNOR, TP; JAY, DG			FASCICLIN-I AND FASCICLIN-II HAVE DISTINCT ROLES IN THE DEVELOPMENT OF GRASSHOPPER PIONEER NEURONS	NEURON			English	Article							CELL-ADHESION MOLECULES; ASSISTED LASER INACTIVATION; PERIPHERAL-NERVE PATHWAYS; GROWTH CONE GUIDANCE; GENETIC-ANALYSIS; PROTEIN FUNCTION; AXON PATHWAYS; DROSOPHILA; MEMBRANE; GLYCOPROTEINS	We have used a new technique, micro-CALI (chromophore-assisted laser inactivation), to investigate the function of the neural cell adhesion molecules fasciclin I and II in the development of the grasshopper Ti1 neurons. Micro-CALI of fasciclin I results in defasciculation of the Ti1 axons similar to that achieved using large scale CALI (Jay and Keshishian, 1990). The initial point of axon separation corresponds to the site of laser irradiation, and defasciculation always continues distal to this point. Micro-CALI of fasciclin II prevents the initiation of Ti1 axon outgrowth but has no effect on fasciculation. This effect is restricted to a 3 hr interval between cytokinesis and growth cone emergence.	UNIV CALIF BERKELEY, DEPT CELLULAR BIOL, BERKELEY, CA 94720 USA	University of California System; University of California Berkeley	DIAMOND, P (corresponding author), HARVARD UNIV, DEPT CELLULAR & DEV BIOL, CAMBRIDGE, MA 02138 USA.							ATASHI JR, 1992, NEURON, V8, P831, DOI 10.1016/0896-6273(92)90197-L; BASTIANI MJ, 1987, CELL, V48, P745, DOI 10.1016/0092-8674(87)90072-9; BATE CM, 1976, NATURE, V260, P54, DOI 10.1038/260054a0; BENTLEY D, 1979, J EMBRYOL EXP MORPH, V54, P47; BIXBY JL, 1991, ANNU REV CELL BIOL, V7, P117, DOI 10.1146/annurev.cellbio.7.1.117; BRAY D, 1973, J CELL BIOL, V56, P702, DOI 10.1083/jcb.56.3.702; BRAY D, 1970, P NATL ACAD SCI USA, V65, P905, DOI 10.1073/pnas.65.4.905; CAUDY M, 1986, J NEUROSCI, V6, P1781; CONDIC ML, 1989, J NEUROSCI, V9, P2678; DOHERTY P, 1991, CELL, V67, P21, DOI 10.1016/0092-8674(91)90569-K; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; EDELMAN GM, 1986, ANNU REV CELL BIOL, V2, P81, DOI 10.1146/annurev.cb.02.110186.000501; EDIDIN M, 1991, SCIENCE, V254, P1379, DOI 10.1126/science.1835798; ELKINS T, 1990, J CELL BIOL, V110, P1825, DOI 10.1083/jcb.110.5.1825; ELKINS T, 1990, CELL, V60, P565, DOI 10.1016/0092-8674(90)90660-7; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; HARRELSON AL, 1988, SCIENCE, V242, P700, DOI 10.1126/science.3187519; HORTSCH M, 1990, J BIOL CHEM, V265, P15104; HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O; JAN LY, 1982, P NATL ACAD SCI-BIOL, V79, P2700, DOI 10.1073/pnas.79.8.2700; JAY DG, 1990, NATURE, V348, P548, DOI 10.1038/348548a0; JAY DG, 1988, P NATL ACAD SCI USA, V85, P5454, DOI 10.1073/pnas.85.15.5454; JESSELL TM, 1988, NEURON, V1, P3, DOI 10.1016/0896-6273(88)90204-8; JOHANSEN J, 1989, J NEUROSCI, V9, P4318; KESHISHIAN H, 1980, DEV BIOL, V80, P388, DOI 10.1016/0012-1606(80)90413-3; KESHISHIAN H, 1983, DEV BIOL, V96, P103, DOI 10.1016/0012-1606(83)90315-9; KESHISHIAN H, 1983, DEV BIOL, V96, P89, DOI 10.1016/0012-1606(83)90314-7; KLOSE M, 1989, SCIENCE, V245, P982, DOI 10.1126/science.2772651; LANDMESSER L, 1988, DEV BIOL, V130, P645, DOI 10.1016/0012-1606(88)90358-2; LEFCORT F, 1989, J CELL BIOL, V108, P1737, DOI 10.1083/jcb.108.5.1737; LINDEN KG, 1992, BIOPHYS J, V61, P956, DOI 10.1016/S0006-3495(92)81902-1; OCONNOR TP, 1990, J NEUROSCI, V10, P3935, DOI 10.1523/JNEUROSCI.10-12-03935.1990; OKABE S, 1992, J CELL BIOL, V117, P105, DOI 10.1083/jcb.117.1.105; PATEL NH, 1987, CELL, V48, P975, DOI 10.1016/0092-8674(87)90706-9; POO MM, 1974, NATURE, V247, P438, DOI 10.1038/247438a0; POPOV S, 1993, SCIENCE, V259, P244, DOI 10.1126/science.7678471; SCHUCH U, 1989, NEURON, V3, P13, DOI 10.1016/0896-6273(89)90111-6; SHEETZ MP, 1990, CELL, V61, P231, DOI 10.1016/0092-8674(90)90804-N; SNOW PM, 1988, P NATL ACAD SCI USA, V85, P5291, DOI 10.1073/pnas.85.14.5291; WHITLOCK KE, 1993, DEVELOPMENT, V117, P1251; ZINN K, 1988, CELL, V53, P577, DOI 10.1016/0092-8674(88)90574-0	41	52	54	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1993	11	3					409	421		10.1016/0896-6273(93)90146-I	http://dx.doi.org/10.1016/0896-6273(93)90146-I			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LY498	8398136				2022-12-24	WOS:A1993LY49800002
J	JASMIN, BJ; LEE, RK; ROTUNDO, RL				JASMIN, BJ; LEE, RK; ROTUNDO, RL			COMPARTMENTALIZATION OF ACETYLCHOLINESTERASE MESSENGER-RNA AND ENZYME AT THE VERTEBRATE NEUROMUSCULAR-JUNCTION	NEURON			English	Article							POLYMERASE CHAIN-REACTION; MULTINUCLEATED MUSCLE-CELLS; CHICK SKELETAL-MUSCLE; RAT SOLEUS MUSCLE; ASYMMETRIC ACETYLCHOLINESTERASE; INSITU HYBRIDIZATION; GENE-EXPRESSION; NUCLEAR DOMAINS; GOLGI-APPARATUS; SINGLE GENE	Acetylcholinesterase (AChE) is concentrated at the vertebrate neuromuscular synapse. To determine whether increased transcript levels could underlie this selective accumulation, we employed a quantitative reverse transcription polymerase chain reaction-based assay to determine mRNA copy number in samples as small as single neuromuscular junctions (NMJs) and a microassay to measure AChE enzyme activity at single synapses. Our results show that AChE mRNA is an intermediate transcript at NMJs, whereas in noninnervated regions of muscle fibers, AChE transcripts are either undetectable or rare. In contrast, alpha-actin transcript levels in the same samples are similar in junctional and extrajunctional regions. However, compared with AChE enzyme activity and alpha-actin mRNA levels, the levels of AChE transcripts at NM)s are highly variable. These results indicate that AChE mRNA and protein expression are compartmentalized at the vertebrate NMJ and provide a direct approach toward dissecting the molecular events leading from synaptic activation to plastic changes in gene expression at single vertebrate synapses.	UNIV MIAMI,SCH MED,DEPT CELL BIOL & ANAT,MIAMI,FL 33101	University of Miami					NATIONAL INSTITUTE ON AGING [R01AG005917] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG005917] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BLOCH RJ, 1988, AM J PHYSIOL, V254, pC345, DOI 10.1152/ajpcell.1988.254.3.C345; BOUABOULA M, 1992, J BIOL CHEM, V267, P21830; BRENNER HR, 1992, DEVELOPMENT, V116, P41; BRENNER HR, 1990, NATURE, V344, P544, DOI 10.1038/344544a0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DAVEY B, 1978, EXP NEUROL, V59, P168; DONALDSON SKB, 1975, J GEN PHYSIOL, V66, P427, DOI 10.1085/jgp.66.4.427; FERNANDEZVALLE C, 1989, J BIOL CHEM, V264, P14043; FONTAINE B, 1988, EMBO J, V7, P603, DOI 10.1002/j.1460-2075.1988.tb02853.x; FONTAINE B, 1989, J CELL BIOL, V108, P1025, DOI 10.1083/jcb.108.3.1025; FROEHNER SC, 1991, J CELL BIOL, V114, P1, DOI 10.1083/jcb.114.1.1; FUENTES ME, 1993, NEURON, V10, P679, DOI 10.1016/0896-6273(93)90169-R; GETMAN DK, 1992, AM J HUM GENET, V51, P170; GILLILAND G, 1990, P NATL ACAD SCI USA, V87, P2725, DOI 10.1073/pnas.87.7.2725; GOLDMAN D, 1991, NEURON, V7, P649, DOI 10.1016/0896-6273(91)90377-C; GOLDMAN D, 1989, NEURON, V3, P219, DOI 10.1016/0896-6273(89)90035-4; GORDON H, 1992, P NATL ACAD SCI USA, V89, P6595, DOI 10.1073/pnas.89.14.6595; HALL ZW, 1989, CELL, V59, P771, DOI 10.1016/0092-8674(89)90597-7; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; HARRIS DA, 1989, NATURE, V337, P173, DOI 10.1038/337173a0; HOROVITZ O, 1989, J CELL BIOL, V108, P1823, DOI 10.1083/jcb.108.5.1823; JASMIN BJ, 1990, NATURE, V344, P673, DOI 10.1038/344673a0; JASMIN BJ, 1989, P NATL ACAD SCI USA, V86, P7218, DOI 10.1073/pnas.86.18.7218; JO SA, 1992, DEVELOPMENT, V115, P673; JOHNSON CD, 1975, ANAL BIOCHEM, V64, P229, DOI 10.1016/0003-2697(75)90423-6; KARNOVSKY MJ, 1964, J HISTOCHEM CYTOCHEM, V12, P219, DOI 10.1177/12.3.219; KLARSFELD A, 1987, BIOCHIMIE, V69, P433, DOI 10.1016/0300-9084(87)90080-0; KLARSFELD A, 1991, EMBO J, V10, P625, DOI 10.1002/j.1460-2075.1991.tb07990.x; LI HH, 1988, NATURE, V335, P414, DOI 10.1038/335414a0; LINKHART TA, 1975, J NEUROL SCI, V26, P193, DOI 10.1016/0022-510X(75)90032-5; MAULET Y, 1990, NEURON, V4, P289, DOI 10.1016/0896-6273(90)90103-M; MERLIE JP, 1985, NATURE, V317, P66, DOI 10.1038/317066a0; METSIKKO K, 1992, J CELL BIOL, V117, P987, DOI 10.1083/jcb.117.5.987; PAVLATH GK, 1989, NATURE, V337, P570, DOI 10.1038/337570a0; RACHINSKY TL, 1990, NEURON, V5, P317, DOI 10.1016/0896-6273(90)90168-F; RALSTON E, 1989, SCIENCE, V244, P1066, DOI 10.1126/science.2543074; ROSSI SG, 1992, J CELL BIOL, V119, P1657, DOI 10.1083/jcb.119.6.1657; ROTUNDO RL, 1988, P NATL ACAD SCI USA, V85, P7805, DOI 10.1073/pnas.85.20.7805; ROTUNDO RL, 1980, CELL, V22, P595, DOI 10.1016/0092-8674(80)90369-4; ROTUNDO RL, 1990, J CELL BIOL, V110, P715, DOI 10.1083/jcb.110.3.715; ROTUNDO RL, 1984, P NATL ACAD SCI-BIOL, V81, P479, DOI 10.1073/pnas.81.2.479; ROTUNDO RL, 1979, J BIOL CHEM, V254, P4790; RUBIN LL, 1985, P NATL ACAD SCI USA, V82, P7121, DOI 10.1073/pnas.82.20.7121; SALPETER MM, 1967, J CELL BIOL, V32, P379, DOI 10.1083/jcb.32.2.379; SANES JR, 1991, DEVELOPMENT, V113, P1181; SCHUMACHER M, 1988, J BIOL CHEM, V263, P18979; SIKORAV JL, 1988, EMBO J, V7, P2983, DOI 10.1002/j.1460-2075.1988.tb03161.x; SIKORAV JL, 1987, EMBO J, V6, P1865, DOI 10.1002/j.1460-2075.1987.tb02445.x; SIMON AM, 1992, DEVELOPMENT, V114, P545; TSIM KWK, 1992, J CELL BIOL, V118, P1201, DOI 10.1083/jcb.118.5.1201; WANG AM, 1989, P NATL ACAD SCI USA, V86, P9717, DOI 10.1073/pnas.86.24.9717; WILSON BW, 1973, DEV BIOL, V33, P285, DOI 10.1016/0012-1606(73)90138-3; WITZEMANN V, 1991, J CELL BIOL, V114, P125, DOI 10.1083/jcb.114.1.125	53	100	104	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1993	11	3					467	477		10.1016/0896-6273(93)90151-G	http://dx.doi.org/10.1016/0896-6273(93)90151-G			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LY498	8398140				2022-12-24	WOS:A1993LY49800007
J	RAYMOND, PA; BARTHEL, LK; ROUNSIFER, ME; SULLIVAN, SA; KNIGHT, JK				RAYMOND, PA; BARTHEL, LK; ROUNSIFER, ME; SULLIVAN, SA; KNIGHT, JK			EXPRESSION OF ROD AND CONE VISUAL PIGMENTS IN GOLDFISH AND ZEBRAFISH - A RHODOPSIN-LIKE GENE IS EXPRESSED IN CONES	NEURON			English	Article							COLOR-VISION; MONOCLONAL-ANTIBODIES; POECILIA-RETICULATA; BRACHYDANIO-RERIO; BOVINE RHODOPSIN; OUTER SEGMENTS; PHOTORECEPTORS; SEQUENCE; POLYMORPHISM; EVOLUTION	The primary purpose of the present study was to determine whether a rhodopsin-like gene, which has been postulated to represent the green cone pigment in several species, is in fact expressed in cone photoreceptors instead of rods. The expression patterns of rod opsin and blue and red cone opsins were also examined in both goldfish and zebrafish retinas using colorimetric in situ hybridization. The results demonstrate that the rhodopsin-like gene is expressed in green cones, as predicted. A subset of small cones that do not hybridize with these cRNA probes are tentatively identified as ultraviolet receptors. The results also demonstrate that opsin message in cones is restricted to the perinuclear region, whereas in rods, it is both perinuclear and adjacent to the ellipsoid.	UNIV MICHIGAN,NEUROSCI PROGRAM,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan	RAYMOND, PA (corresponding author), UNIV MICHIGAN,DEPT ANAT & CELL BIOL,ANN ARBOR,MI 48109, USA.			KNIGHT, JENNY/0000-0002-0041-5500; Raymond, Pamela/0000-0003-1083-5530				APPLEBURY ML, 1986, VISION RES, V26, P1881, DOI 10.1016/0042-6989(86)90115-X; ARAKI M, 1984, CELL STRUCT FUNCT, V9, P1, DOI 10.1247/csf.9.1; ARCHER SN, 1990, VISION RES, V30, P225, DOI 10.1016/0042-6989(90)90038-M; ARCHER SN, 1987, VISION RES, V27, P1243, DOI 10.1016/0042-6989(87)90200-8; BARNSTABLE CJ, 1980, NATURE, V286, P231, DOI 10.1038/286231a0; BARTHEL LK, 1990, J HISTOCHEM CYTOCHEM, V38, P1383, DOI 10.1177/38.9.2201738; BOWMAKER JK, 1987, VISION RES, V27, P2101, DOI 10.1016/0042-6989(87)90124-6; BRANCHEK T, 1984, J COMP NEUROL, V224, P107, DOI 10.1002/cne.902240109; BRIDGES CDB, 1970, VISION RES, V10, P1315, DOI 10.1016/0042-6989(70)90084-2; COHEN AI, 1972, HDB SENSORY PHYSIOLO, V7, P63; CRESCITELLI F, 1977, J PHYSIOL-LONDON, V268, P559, DOI 10.1113/jphysiol.1977.sp011872; ENGSTROM KJELL, 1960, ACTA ZOOL [STOCKHOLM], V41, P277; FALK JD, 1987, PROGR RETINAL RES, V7, P89; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GOLDSMITH TH, 1990, Q REV BIOL, V65, P281, DOI 10.1086/416840; HASHRYSHYN CW, 1988, VIS NEUROSCI, V8, P81; HAWRYSHYN CW, 1991, VISION RES, V31, P567, DOI 10.1016/0042-6989(91)90107-G; HICKS D, 1986, EXP EYE RES, V42, P55, DOI 10.1016/0014-4835(86)90017-5; HISATOMI O, 1991, BIOCHEM BIOPH RES CO, V174, P1125, DOI 10.1016/0006-291X(91)91537-M; JOHNSON RL, 1993, BIOCHEMISTRY-US, V32, P208, DOI 10.1021/bi00052a027; KOJIMA D, 1992, P NATL ACAD SCI USA, V89, P6841, DOI 10.1073/pnas.89.15.6841; KORENBROT JI, 1989, NATURE, V337, P454, DOI 10.1038/337454a0; LEVINE JS, 1979, SENS PROCESS, V3, P95; LYALL AH, 1957, Q J MICROSC SCI, V98, P101; MARC RE, 1976, VISION RES, V16, P1211, DOI 10.1016/0042-6989(76)90044-4; MARC RE, 1976, SCIENCE, V191, P487, DOI 10.1126/science.1246634; MCGINNIS JF, 1992, J NEUROSCI RES, V31, P584, DOI 10.1002/jnr.490310325; MERBS SL, 1992, NATURE, V356, P433, DOI 10.1038/356433a0; NATHANS J, 1984, P NATL ACAD SCI-BIOL, V81, P4851, DOI 10.1073/pnas.81.15.4851; NATHANS J, 1983, CELL, V34, P807, DOI 10.1016/0092-8674(83)90537-8; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; NAWROCKI L, 1985, VISION RES, V25, P1569, DOI 10.1016/0042-6989(85)90127-0; NEITZ M, 1991, SCIENCE, V252, P971, DOI 10.1126/science.1903559; NEUMEYER C, 1985, NATURWISSENSCHAFTEN, V72, P162, DOI 10.1007/BF00490410; NEUMEYER C, 1986, J COMP PHYSIOL A, V158, P203, DOI 10.1007/BF01338563; OHTSUKA T, 1990, EXP EYE RES, V50, P483, DOI 10.1016/0014-4835(90)90036-T; OKANO T, 1989, BIOCHEMISTRY-US, V28, P8848, DOI 10.1021/bi00448a025; OKANO T, 1992, P NATL ACAD SCI USA, V89, P5932, DOI 10.1073/pnas.89.13.5932; PARTRIDGE JC, 1989, J COMP PHYSIOL A, V164, P513, DOI 10.1007/BF00610445; RAYMOND PA, 1985, J COMP NEUROL, V236, P90, DOI 10.1002/cne.902360108; Sambrook J, 1989, MOL CLONING LABORATO; STELL WK, 1976, VISION RES, V16, P647, DOI 10.1016/0042-6989(76)90013-4; TABATA M, 1982, COMP BIOCHEM PHYS A, V73, P125; TAKAO M, 1988, VISION RES, V28, P471, DOI 10.1016/0042-6989(88)90169-1; TOKUNAGA F, 1990, BIOCHEM BIOPH RES CO, V173, P1212, DOI 10.1016/S0006-291X(05)80915-5; TRAVIS DS, 1988, VISION RES, V28, P481, DOI 10.1016/0042-6989(88)90170-8; TSIN ATC, 1981, VISION RES, V21, P943, DOI 10.1016/0042-6989(81)90196-6; WALLS GL, 1967, VERTEBRATE EYE ITS A; WANG SZ, 1992, BIOCHEMISTRY-US, V31, P3309, DOI 10.1021/bi00128a002; YOKOYAMA R, 1990, P NATL ACAD SCI USA, V87, P9315, DOI 10.1073/pnas.87.23.9315; YOKOYAMA R, 1990, VISION RES, V30, P807, DOI 10.1016/0042-6989(90)90049-Q; ZILLES K, 1983, CELL TISSUE RES, V229, P423; [No title captured]	53	149	151	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1993	10	6					1161	1174		10.1016/0896-6273(93)90064-X	http://dx.doi.org/10.1016/0896-6273(93)90064-X			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LK373	8318234	Green Submitted			2022-12-24	WOS:A1993LK37300016
J	BUCHANAN, RL; BENZER, S				BUCHANAN, RL; BENZER, S			DEFECTIVE GLIA IN THE DROSOPHILA BRAIN DEGENERATION MUTANT DROP-DEAD	NEURON			English	Article							RETINAL-DEGENERATION; CELL DEGENERATION; RHODOPSIN GENE; NERVOUS-SYSTEM; FINE-STRUCTURE; OPTIC-LOBES; MELANOGASTER; PROTEIN; DIFFERENTIATION; MOSAICS	To understand better the cellular basis of late-onset neuronal degeneration, we have examined the brain of the drop-dead mutant of Drosophila. This mutant carries an X-chromosomal recessive mutation that causes severe behavioral defects and brain degeneration, manifested a few days after emergence of the adult. Analysis of genetically mosaic flies has indicated that the focus of the drop-dead mutant phenotype is in the brain and that the gene product is non-cell autonomous. We examined the adult drop-dead mutant brain prior to onset of symptoms and found that many glial cells have stunted processes, whereas neuronal morphology is essentially normal. Adult mutant glial cells resemble immature glia found at an earlier stage of normal brain development. These observations suggest that defective glia in the drop-dead brain may disrupt adult nervous system function, contributing to progressive brain degeneration and death. The normal drop-dead gene product may prevent brain degeneration by providing a necessary glial function.			BUCHANAN, RL (corresponding author), CALTECH,DIV BIOL,PASADENA,CA 91125, USA.				NATIONAL EYE INSTITUTE [R01EY009278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM040499] Funding Source: NIH RePORTER; NEI NIH HHS [EYO9278] Funding Source: Medline; NIGMS NIH HHS [GM 40499] Funding Source: Medline; NINDS NIH HHS [5F32NS0881-02] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON DJ, 1989, TRENDS NEUROSCI, V12, P83, DOI 10.1016/0166-2236(89)90160-4; ASHBURNER M, 1989, DROSOPHILA LABORATOR, P179; BARRES BA, 1991, J NEUROSCI, V11, P3685; BENZER S, 1971, J AMER MED ASSOC, V218, P1015, DOI 10.1001/jama.218.7.1015; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; BOSCHEK CB, 1971, Z ZELLFORSCH MIK ANA, V118, P369; CARLSON SD, 1990, ANNU REV ENTOMOL, V35, P597, DOI 10.1146/annurev.en.35.010190.003121; CARTHEW RW, 1990, CELL, V63, P561, DOI 10.1016/0092-8674(90)90452-K; COOMBE PE, 1986, J NEUROGENET, V3, P135, DOI 10.3109/01677068609106845; DRISCOLL M, 1992, TRENDS NEUROSCI, V15, P15, DOI 10.1016/0166-2236(92)90343-7; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; DUVALL E, 1986, IMMUNOL TODAY, V7, P115, DOI 10.1016/0167-5699(86)90152-0; FISCHBACH KF, 1984, DEV BIOL, V104, P219, DOI 10.1016/0012-1606(84)90050-2; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; FLANAGAN JR, 1977, GENETICS, V85, P587; FREEMANM, 1992, CELL, V69, P963; GASSER UE, 1990, J NEUROSCI, V10, P1276; GRENNINGLOH G, 1990, COLD SH Q B, V55, P327; GRIFFITHS GW, 1979, J CELL SCI, V36, P361; Grigliati T., 1986, DROSOPHILA PRACTICAL, P39; HEISENBERG M, 1980, DEV NEUROBIOLOGY DRO, P373; HENKEMEYER MJ, 1987, CELL, V51, P821, DOI 10.1016/0092-8674(87)90105-X; HOFBAUER A, 1990, ROUX ARCH DEV BIOL, V198, P264, DOI 10.1007/BF00377393; HOMYK T, 1986, GENETICS, V113, P367; HOTTA Y, 1972, NATURE, V240, P527, DOI 10.1038/240527a0; HOTTA Y, 1970, P NATL ACAD SCI USA, V67, P1156, DOI 10.1073/pnas.67.3.1156; HOYLE G, 1986, J COMP NEUROL, V246, P85, DOI 10.1002/cne.902460106; INOUE H, 1989, J BIOL CHEM, V264, P5996; JACOBS JR, 1989, NEURON, V2, P1625; Kankel D.R., 1980, Genetics and Biology of Drosophila, V2d, P295; KANKEL DR, 1976, DEV BIOL, V48, P1, DOI 10.1016/0012-1606(76)90041-5; KNAPP PE, 1990, DEV NEUROSCI-BASEL, V12, P145, DOI 10.1159/000111844; KUFFLER SW, 1967, PROC R SOC SER B-BIO, V168, P1, DOI 10.1098/rspb.1967.0047; LANE NJ, 1985, COMPREHENSIVE INSECT, V5, P1; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; McKusick VA, 1990, MENDELIAN INHERITANC; MEYER MR, 1987, J NEUROSCI, V7, P512; Miller A, 1965, BIOL DROSOPHILA, P420; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; NAMBU JR, 1990, CELL, V63, P63, DOI 10.1016/0092-8674(90)90288-P; Nordlander R. H., 1969, Wilhelm Roux Archiv fur Entwicklungsmechanik der Organismen, V163, P197, DOI 10.1007/BF00576929; OTOUSA JE, 1989, J NEUROGENET, V6, P41, DOI 10.3109/01677068909107099; PADGETT RW, 1987, NATURE, V325, P81, DOI 10.1038/325081a0; PAPP MI, 1989, J NEUROL SCI, V94, P79, DOI 10.1016/0022-510X(89)90219-0; PENTREATH VW, 1989, COMP BIOCHEM PHYS A, V93, P77, DOI 10.1016/0300-9629(89)90194-1; RENFRANZ PJ, 1989, DEV BIOL, V136, P411, DOI 10.1016/0012-1606(89)90267-4; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; ROTHBERG JM, 1990, GENE DEV, V4, P2169, DOI 10.1101/gad.4.12a.2169; Sanchez D., 1915, TRAB LAB INVEST BIOL, V13, P1, DOI DOI 10.5962/BHL.TITLE.37839; SIMAN R, 1989, NEURON, V3, P275, DOI 10.1016/0896-6273(89)90252-3; STEELE F, 1990, NEURON, V4, P883, DOI 10.1016/0896-6273(90)90141-2; STEWART BR, 1975, GENETICS, V79, P635; STOCKER RF, 1978, CELL TISSUE RES, V191, P317; Strausfeld NJ., 1980, NEUROANATOMICAL TECH, P132; Strausfeld NJ., 1976, ATLAS INSECT BRAIN, DOI 10.1007/978-3-642-66179-2; TEI H, 1992, IN PRESS P NATL ACAD; TOLBERT LP, 1990, EXP NEUROL, V109, P19, DOI 10.1016/S0014-4886(05)80005-6; TRUJILLO.O, 1965, J ULTRA MOL STRUCT R, V13, P1, DOI 10.1016/S0022-5320(65)80086-7; Trujillo-Cenoz O., 1985, COMPREHENSIVE INSECT, V6, P171; TSACOPOULOS M, 1988, P NATL ACAD SCI USA, V85, P8727, DOI 10.1073/pnas.85.22.8727; VIHTELIC TS, 1991, GENETICS, V127, P761; ZUKER CS, 1985, CELL, V40, P851, DOI 10.1016/0092-8674(85)90344-7	62	120	121	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1993	10	5					839	850		10.1016/0896-6273(93)90200-B	http://dx.doi.org/10.1016/0896-6273(93)90200-B			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LD322	8494644				2022-12-24	WOS:A1993LD32200007
J	LAUGWITZ, KL; OFFERMANNS, S; SPICHER, K; SCHULTZ, G				LAUGWITZ, KL; OFFERMANNS, S; SPICHER, K; SCHULTZ, G			MU AND DELTA OPIOID RECEPTORS DIFFERENTIALLY COUPLE TO G-PROTEIN SUBTYPES IN MEMBRANES OF HUMAN NEUROBLASTOMA SH-SY5Y CELLS	NEURON			English	Article							GTP-BINDING PROTEIN; ADENYLATE-CYCLASE ACTIVITY; GUANINE-NUCLEOTIDE; PERTUSSIS TOXIN; ALPHA-SUBUNIT; SIGNAL TRANSDUCTION; MEDIATED INHIBITION; MOLECULAR-CLONING; HYBRID-CELLS; IDENTIFICATION	Opioids are regarded to act via receptors interacting with heterotrimeric pertussis toxin (PTX)-sensitive G proteins. In membranes of SH-SY5Y cells, the mu-selective agonist [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin (DAGO) and the delta-selective agonist [D-Pen2,Pen5]-enkephalin (DPDPE) stimulated incorporation of the photoreactive GTP analog [alpha-P-32]GTP azidoanilide into proteins comigrating with the alpha subunits of G(i1), G(i2), G(i3), G(o1), and another form of G(o), presumably G(o2). In membranes of PTX-treated cells, both agonists were ineffective. Subtype-specific immunoprecipitation of G protein alpha subunits photolabeled in the absence or presence of agonists revealed profound differences between mu and delta opioid receptors in coupling to PTX-sensitive G proteins. Whereas activated delta opioid receptors preferentially coupled to G(i1), activated mu opioid receptors more effectively coupled to G(i3). Additionally, we provide evidence that G(o) subtypes are also differentially activated by the two receptors. Thus, mu and delta opioid receptors appear to discriminate between PTX-sensitive G proteins and lead to activation of distinct G protein subtypes.			LAUGWITZ, KL (corresponding author), FREE UNIV BERLIN, INST PHARMAKOL, THIELALLEE 69-73, W-1000 BERLIN 33, GERMANY.		Offermanns, Stefan/L-3313-2017	Offermanns, Stefan/0000-0001-8676-6805				ATTALI B, 1989, J NEUROCHEM, V52, P360, DOI 10.1111/j.1471-4159.1989.tb09130.x; BERTRAND P, 1990, J BIOL CHEM, V265, P18576; BIRNBAUMER L, 1990, BIOCHIM BIOPHYS ACTA, V1031, P163, DOI 10.1016/0304-4157(90)90007-Y; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; BROWN DA, 1990, ANNU REV PHYSIOL, V52, P215; CHILDERS SR, 1991, LIFE SCI, V48, P1991, DOI 10.1016/0024-3205(91)90154-4; CLARK MJ, 1986, LIFE SCI, V39, P1721, DOI 10.1016/0024-3205(86)90090-1; FRANKLIN PH, 1984, J NEUROCHEM, V43, P1132, DOI 10.1111/j.1471-4159.1984.tb12853.x; FREY EA, 1984, ENDOCRINOLOGY, V115, P1797, DOI 10.1210/endo-115-5-1797; GOLDSMITH P, 1988, J BIOL CHEM, V263, P6476; GROSS RA, 1987, P NATL ACAD SCI USA, V84, P5469, DOI 10.1073/pnas.84.15.5469; HATTA S, 1986, P NATL ACAD SCI USA, V83, P5439, DOI 10.1073/pnas.83.15.5439; HESCHELER J, 1987, NATURE, V325, P445, DOI 10.1038/325445a0; HINSCH KD, 1988, FEBS LETT, V238, P191, DOI 10.1016/0014-5793(88)80254-0; HINSCH KD, 1989, BIOCHIM BIOPHYS ACTA, V1013, P60, DOI 10.1016/0167-4889(89)90128-6; HSU WH, 1990, J BIOL CHEM, V265, P11220; JONES DT, 1987, J BIOL CHEM, V262, P14241; KAZMI SMI, 1987, MOL PHARMACOL, V32, P109; KLEUSS C, 1991, NATURE, V353, P43, DOI 10.1038/353043a0; KOSKI G, 1981, P NATL ACAD SCI-BIOL, V78, P4185, DOI 10.1073/pnas.78.7.4185; KUROSE H, 1983, J BIOL CHEM, V258, P4870; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOH HH, 1990, ANNU REV PHARMACOL, V30, P123; MCKENZIE FR, 1990, BIOCHEM J, V267, P391, DOI 10.1042/bj2670391; NORTH RA, 1987, P NATL ACAD SCI USA, V84, P5487, DOI 10.1073/pnas.84.15.5487; OFFERMANNS S, 1991, J BIOL CHEM, V266, P3365; OFFERMANNS S, 1991, METHOD ENZYMOL, V195, P286; OFFERMANS S, 1990, FEBS LETT, V260, P14, DOI 10.1016/0014-5793(90)80054-M; PUTTFARCKEN PS, 1988, MOL PHARMACOL, V33, P520; RIBEIRONETO FAP, 1989, P NATL ACAD SCI USA, V86, P2577, DOI 10.1073/pnas.86.8.2577; ROSENTHAL W, 1986, EUR J BIOCHEM, V158, P255, DOI 10.1111/j.1432-1033.1986.tb09745.x; SADEE W, 1987, CANCER RES, V47, P5207; SCHROEDER JE, 1991, NEURON, V6, P13, DOI 10.1016/0896-6273(91)90117-I; SCHULTZ G, 1990, REV PHYSL, V52, P275; SEWARD E, 1991, P ROY SOC B-BIOL SCI, V244, P129, DOI 10.1098/rspb.1991.0061; SEWARD EP, 1989, ADV BIOSCI, V75, P181; SHARMA SK, 1975, P NATL ACAD SCI USA, V72, P590, DOI 10.1073/pnas.72.2.590; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SIMONDS WF, 1989, P NATL ACAD SCI USA, V86, P7809, DOI 10.1073/pnas.86.20.7809; SIMONDS WF, 1988, ENDOCR REV, V9, P200, DOI 10.1210/edrv-9-2-200; SPICHER K, 1992, FEBS LETT, V307, P215, DOI 10.1016/0014-5793(92)80770-H; STRATHMANN M, 1990, P NATL ACAD SCI USA, V87, P6477, DOI 10.1073/pnas.87.17.6477; SUKI WN, 1987, FEBS LETT, V220, P187, DOI 10.1016/0014-5793(87)80900-6; TAUSSIG R, 1992, NEURON, V8, P799, DOI 10.1016/0896-6273(92)90100-R; UEDA H, 1988, P NATL ACAD SCI USA, V85, P7013, DOI 10.1073/pnas.85.18.7013; WERLING LL, 1989, N-S ARCH PHARMACOL, V339, P509, DOI 10.1007/BF00167253; WIMPEY TL, 1991, NEURON, V6, P281, DOI 10.1016/0896-6273(91)90363-5; WONG YH, 1991, NATURE, V351, P63, DOI 10.1038/351063a0; YU VC, 1988, J PHARMACOL EXP THER, V245, P350	49	172	174	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1993	10	2					233	242		10.1016/0896-6273(93)90314-H	http://dx.doi.org/10.1016/0896-6273(93)90314-H			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KP685	8382499				2022-12-24	WOS:A1993KP68500011
J	LEVISON, SW; GOLDMAN, JE				LEVISON, SW; GOLDMAN, JE			BOTH OLIGODENDROCYTES AND ASTROCYTES DEVELOP FROM PROGENITORS IN THE SUBVENTRICULAR ZONE OF POSTNATAL RAT FOREBRAIN	NEURON			English	Article							RADIAL GLIAL-CELLS; OPTIC-NERVE; CEREBRAL-CORTEX; RECOMBINANT RETROVIRUS; MACROGLIAL CELLS; DEVELOPMENT INVITRO; CORPUS-CALLOSUM; WHITE MATTER; YOUNG-RATS; ADULT MICE	The developmental fates of subventricular zone (SVZ) cells of the postnatal rat forebrain were determined by retroviral-mediated gene transfer and immunolabeling for glial antigens. A beta-galactosidase-containing retrovirus injected stereotactically into the SVZ infected small, immature cells. By 28 days post-injection labeled cells had appeared in both gray and white matter of the ipsilateral hemisphere. White matter contained labeled oligodendrocytes, but few astrocytes, while neocortex and striatum contained both glial types, often appearing in tightly knit clusters. An analysis after simultaneously injecting alkaline phosphatase- and beta-galactosidase-containing retroviruses showed that cells in each cortical cluster were related. Most clusters contained a single cell type, but approximately 15% contained both astrocytes and oligodendrocytes. These observations strongly suggest that a single SVZ cell can differentiate into both glial types.	COLUMBIA UNIV COLL PHYS & SURG, CTR NEUROBIOL & BEHAV, NEW YORK, NY 10032 USA	Columbia University	LEVISON, SW (corresponding author), COLUMBIA UNIV COLL PHYS & SURG, DEPT PATHOL, NEW YORK, NY 10032 USA.		Levison, Steven W./Q-6903-2019	Levison, Steven W./0000-0002-1264-7309	NIA NIH HHS [AG 00189] Funding Source: Medline; NIMH NIH HHS [MH 15174] Funding Source: Medline; NINDS NIH HHS [NS17125] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH015174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017125] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALTMAN J, 1966, EXP NEUROL, V16, P263, DOI 10.1016/0014-4886(66)90063-X; ALTMAN J, 1963, ANAT REC, V145, P573, DOI 10.1002/ar.1091450409; Andriezen W L, 1893, Br Med J, V2, P227; ANGEVINE JB, 1970, ANAT REC, V166, P257, DOI 10.1002/ar.1091660214; BENJELLOUNTOUIMI S, 1985, J NEUROIMMUNOL, V9, P87, DOI 10.1016/S0165-5728(85)80009-6; Cajal S. R., 1911, HISTOLOGIE SYSTEME N; CAMMER W, 1988, J NEUROCHEM, V50, P319, DOI 10.1111/j.1471-4159.1988.tb13267.x; CEPKO CL, 1990, COLD SH Q B, V55, P265; CHIU FC, 1984, J NEUROCHEM, V42, P166, DOI 10.1111/j.1471-4159.1984.tb09713.x; CULICAN SM, 1990, J NEUROSCI, V10, P684; CURTIS R, 1988, J NEUROCYTOL, V17, P43, DOI 10.1007/BF01735376; EDWARDS MA, 1990, NEUROSCIENCE, V36, P121, DOI 10.1016/0306-4522(90)90356-9; FFRENCHCONSTANT C, 1986, J CELL BIOL, V102, P844, DOI 10.1083/jcb.102.3.844; FIELDSBERRY SC, 1992, P NATL ACAD SCI USA, V89, P693, DOI 10.1073/pnas.89.2.693; FRANK E, 1991, DEVELOPMENT, V111, P895; GALILEO DS, 1990, P NATL ACAD SCI USA, V87, P458, DOI 10.1073/pnas.87.1.458; GRAY GE, 1992, DEVELOPMENT, V114, P271; HALL PA, 1989, DEVELOPMENT, V106, P619; HALLIDAY AL, 1992, NEURON, V9, P15, DOI 10.1016/0896-6273(92)90216-Z; HARDY R, 1991, DEVELOPMENT, V111, P1061; HELLER A, 1979, J NEUROSCI METH, V1, P41, DOI 10.1016/0165-0270(79)90006-2; IMAMOTO K, 1978, J COMP NEUROL, V180, P115, DOI 10.1002/cne.901800108; KAPLAN MS, 1980, J COMP NEUROL, V193, P711, DOI 10.1002/cne.901930309; KITAMURA T, 1987, BRAIN RES, V423, P189, DOI 10.1016/0006-8993(87)90839-0; KORR H, 1973, J COMP NEUROL, V150, P169, DOI 10.1002/cne.901500205; LEBER SM, 1990, J NEUROSCI, V10, P2451; LEVINE SM, 1988, J NEUROSCI, V8, P3992; LEVINE SM, 1988, J COMP NEUROL, V277, P441, DOI 10.1002/cne.902770309; LEVISON SW, 1993, IN PRESS PHARM ASTRO; LILLIEN LE, 1990, NEURON, V4, P525, DOI 10.1016/0896-6273(90)90110-2; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; MCCARTHY GF, 1988, J COMP NEUROL, V271, P589, DOI 10.1002/cne.902710409; MILLER RH, 1989, ANNU REV NEUROSCI, V12, P517, DOI 10.1146/annurev.ne.12.030189.002505; Misson JP, 1991, CEREB CORTEX, V1, P221, DOI 10.1093/cercor/1.3.221; MISSON JP, 1991, GLIA, V4, P138, DOI 10.1002/glia.440040205; MISSON JP, 1988, DEV BRAIN RES, V44, P95, DOI 10.1016/0165-3806(88)90121-6; NOBLE M, 1991, GLIA, V4, P157, DOI 10.1002/glia.440040207; PATERSON JA, 1973, J COMP NEUROL, V149, P83, DOI 10.1002/cne.901490106; PIXLEY SKR, 1984, DEV BRAIN RES, V15, P201, DOI 10.1016/0165-3806(84)90097-X; Polak M., 1982, HISTOL HISTOPATHOL, P363; PRICE J, 1988, DEVELOPMENT, V104, P473; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; RAFF MC, 1983, J NEUROSCI, V3, P1289; RAMONMOLINER E, 1958, J COMP NEUROL, V110, P157, DOI 10.1002/cne.901100202; REYNOLDS R, 1988, DEVELOPMENT, V102, P409; SANES JR, 1989, TRENDS NEUROSCI, V12, P21, DOI 10.1016/0166-2236(89)90152-5; SCHMECHEL DE, 1979, ANAT EMBRYOL, V156, P115, DOI 10.1007/BF00300010; SKOFF RP, 1991, GLIA, V4, P165, DOI 10.1002/glia.440040208; SKOFF RP, 1990, DEV BIOL, V139, P149, DOI 10.1016/0012-1606(90)90285-Q; SKOFF RP, 1976, J COMP NEUROL, V169, P313, DOI 10.1002/cne.901690304; SMALL RK, 1987, NATURE, V328, P155, DOI 10.1038/328155a0; STURROCK RR, 1980, J ANAT, V130, P391; TURNER M, 1980, NATURE, V284, P13, DOI 10.1038/284013a0; VAYSSE PJJ, 1990, NEURON, V5, P227, DOI 10.1016/0896-6273(90)90160-H; VOIGT T, 1989, J COMP NEUROL, V289, P74, DOI 10.1002/cne.902890106; WALSH C, 1992, SCIENCE, V255, P434, DOI 10.1126/science.1734520; WILKIN GP, 1990, TRENDS NEUROSCI, V13, P43, DOI 10.1016/0166-2236(90)90065-I; WILLIAMS BP, 1991, NEURON, V7, P685, DOI 10.1016/0896-6273(91)90381-9	58	610	615	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1993	10	2					201	212		10.1016/0896-6273(93)90311-E	http://dx.doi.org/10.1016/0896-6273(93)90311-E			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KP685	8439409				2022-12-24	WOS:A1993KP68500008
J	MOGUL, DJ; ADAMS, ME; FOX, AP				MOGUL, DJ; ADAMS, ME; FOX, AP			DIFFERENTIAL ACTIVATION OF ADENOSINE RECEPTORS DECREASES N-TYPE BUT POTENTIATES P-TYPE CA2+ CURRENT IN HIPPOCAMPAL CA3 NEURONS	NEURON			English	Article							LONG-TERM POTENTIATION; MOUSE SENSORY NEURONS; CALCIUM CHANNELS; GUINEA-PIG; PERIPHERAL NEURONS; RAT HIPPOCAMPUS; OMEGA-CONOTOXIN; MULTIPLE TYPES; RELEASE; NEUROTRANSMISSION	Adenosine is released in the brain in significant quantities in response to increased cellular activity. Adenosine has been shown either to decrease synaptic transmission or to produce an excitatory response in hippocampal synapses, resulting in increased glutamate release. Previous reports have shown that adenosine or its analogs reduced Ca2+ current in dorsal root ganglion and hippocampal neurons. Here we show that the selective activation of adenosine receptor subtypes has different effects on Ca2+ channels from acutely isolated pyramidal neurons from the CA3 region of guinea pig hippocampus. Activation of A1 receptors inhibited primarily N-type Ca2+ current. In contrast, activation of A2b receptors resulted in significant potentiation of P-type but not N-type Ca2+ current. This potentiation could be inhibited by blocking the cAMP-dependent protein kinase. Because of the ubiquity of adenosine, the differential effects on Ca2+ channels of adenosine receptor subtype activation may have significant implications for neuronal excitability.	UNIV CHICAGO,DEPT PHARMACOL & PHYSIOL SCI,CHICAGO,IL 60637; UNIV CALIF RIVERSIDE,DEPT ENTOMOL,RIVERSIDE,CA 92521; UNIV CALIF RIVERSIDE,DEPT NEUROSCI,RIVERSIDE,CA 92521	University of Chicago; University of California System; University of California Riverside; University of California System; University of California Riverside			Mogul, David/L-2765-2019					BERNE M, 1982, CEREBRAL HYPOXIA PAT, P82; BOWYER JF, 1990, J PHARMACOL EXP THER, V254, P664; BRUNS RF, 1986, MOL PHARMACOL, V29, P331; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; DOBSON JG, 1971, CIRC RES, V29, P375, DOI 10.1161/01.RES.29.4.375; DOLPHIN AC, 1986, J PHYSIOL-LONDON, V373, P47, DOI 10.1113/jphysiol.1986.sp016034; Drury AN, 1929, J PHYSIOL-LONDON, V68, P213, DOI 10.1113/jphysiol.1929.sp002608; DUNWIDDIE TV, 1984, J PHYSIOL-LONDON, V350, P545, DOI 10.1113/jphysiol.1984.sp015217; DUNWIDDIE TV, 1985, J PHYSIOL-LONDON, V369, P365, DOI 10.1113/jphysiol.1985.sp015907; Fredholm B B, 1983, Acta Physiol Scand Suppl, V515, P7; FREDHOLM BB, 1980, BIOCHEM PHARMACOL, V25, P1583; GINSBORG BL, 1972, J PHYSIOL-LONDON, V224, P629, DOI 10.1113/jphysiol.1972.sp009916; GROSS RA, 1989, J PHYSIOL-LONDON, V411, P585, DOI 10.1113/jphysiol.1989.sp017592; GROVER LM, 1990, NATURE, V347, P477, DOI 10.1038/347477a0; HARRIS EW, 1986, NEUROSCI LETT, V70, P132, DOI 10.1016/0304-3940(86)90451-9; HENNON BK, 1983, J PHYSL, V336, P607; HILLMAN D, 1991, P NATL ACAD SCI USA, V88, P7076, DOI 10.1073/pnas.88.16.7076; KASAI H, 1989, PFLUG ARCH EUR J PHY, V414, P145, DOI 10.1007/BF00580956; KAY AR, 1986, J NEUROSCI METH, V16, P227, DOI 10.1016/0165-0270(86)90040-3; KEEN M, 1989, BIOCHEM PHARMACOL, V38, P3827, DOI 10.1016/0006-2952(89)90592-3; KURODA Y, 1978, J PHYSIOL-PARIS, V74, P463; KURODA Y, 1990, JPN J PHARMACOL, V52, P70; LLINAS RR, 1989, ANN NY ACAD SCI, V560, P103, DOI 10.1111/j.1749-6632.1989.tb24084.x; MACDONALD RL, 1986, J PHYSIOL-LONDON, V370, P75, DOI 10.1113/jphysiol.1986.sp015923; MANGANO TJ, 1990, J PHARMACOL EXP THER, V252, P574; MCCARRON JG, 1992, NATURE, V357, P74, DOI 10.1038/357074a0; MCCLESKEY EW, 1987, P NATL ACAD SCI USA, V84, P4327, DOI 10.1073/pnas.84.12.4327; MINTZ IM, 1992, NATURE, V355, P827, DOI 10.1038/355827a0; MOGUL DJ, 1991, J PHYSIOL-LONDON, V433, P259, DOI 10.1113/jphysiol.1991.sp018425; NISHIMURA S, 1990, BRAIN RES, V525, P165, DOI 10.1016/0006-8993(90)91335-E; OKADA Y, 1990, NEUROSCI LETT, V120, P205, DOI 10.1016/0304-3940(90)90039-C; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; PROCTOR WR, 1983, NEUROSCI LETT, V35, P197, DOI 10.1016/0304-3940(83)90550-5; PULL I, 1972, BIOCHEM J, V130, P975, DOI 10.1042/bj1300975; REGAN LJ, 1991, NEURON, V6, P269, DOI 10.1016/0896-6273(91)90362-4; RIBEIRO JA, 1986, PROG NEUROBIOL, V26, P179, DOI 10.1016/0301-0082(86)90015-8; SAKURAI T, 1992, J PHYSIOL-LONDON, V446, pP380; SCHWABE U, 1974, EUR J BIOCHEM, V46, P537, DOI 10.1111/j.1432-1033.1974.tb03647.x; SILINSKY EM, 1984, J PHYSIOL-LONDON, V346, P243, DOI 10.1113/jphysiol.1984.sp015019; SNYDER SH, 1985, ANNU REV NEUROSCI, V8, P103; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; UKENA D, 1986, LIFE SCI, V39, P743, DOI 10.1016/0024-3205(86)90023-8; ZHOU QY, 1992, P NATL ACAD SCI USA, V89, P7432, DOI 10.1073/pnas.89.16.7432	43	199	202	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1993	10	2					327	334		10.1016/0896-6273(93)90322-I	http://dx.doi.org/10.1016/0896-6273(93)90322-I			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KP685	8382501				2022-12-24	WOS:A1993KP68500019
J	WAKAMATSU, Y; WATANABE, Y; SHIMONO, A; KONDOH, H				WAKAMATSU, Y; WATANABE, Y; SHIMONO, A; KONDOH, H			TRANSITION OF LOCALIZATION OF THE N-MYC PROTEIN FROM NUCLEUS TO CYTOPLASM IN DIFFERENTIATING NEURONS	NEURON			English	Article							B TRANSCRIPTION FACTOR; I-KAPPA-B; DNA-BINDING; DORSAL PROTEIN; CELL-LINES; EXPRESSION; ONCOGENE; EMBRYO; MOUSE; AMPLIFICATION	N-myc is a developmentally regulated proto-oncogene encoding a putative sequence-specific DNA-binding protein. Previous studies on tissue distribution of N-myc transcripts indicated that one of the major sites of N-myc expression is the CNS and neural crest derivatives in developing embryos. We investigated N-Myc protein expression in embryonic neural tissues and found that the protein was usually localized in the nucleus, but accumulated in the cytoplasm upon differentiation of specific classes of neurons, e.g., retinal ganglion cells, neurons of spinal ganglia, and Purkinje cells of the cerebellum. The change of localization of N-Myc from the nucleus to the cytoplasm indicates a novel feature of regulation of myc family proteins and suggests functions of N-myc in the cytoplasm of maturing neurons.			WAKAMATSU, Y (corresponding author), NAGOYA UNIV,SCH SCI,DEPT MOLEC BIOL,NAGOYA 46401,JAPAN.							ACESON A, 1991, NEURON, V7, P265; AKESON R, 1990, MOL CELL BIOL, V10, P2012, DOI 10.1128/MCB.10.5.2012; BAEUERLE PA, 1988, CELL, V53, P211, DOI 10.1016/0092-8674(88)90382-0; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; BERNARDS R, 1986, CELL, V47, P667, DOI 10.1016/0092-8674(86)90509-X; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; CAPOBIANCO AJ, 1990, ONCOGENE, V5, P257; COLLUM RG, 1991, MOL CELL BIOL, V11, P1170; DOWNS KM, 1989, GENE DEV, V3, P861; GHOSH S, 1990, NATURE, V344, P678, DOI 10.1038/344678a0; GUSSE M, 1989, MOL CELL BIOL, V9, P5395, DOI 10.1128/MCB.9.12.5395; JACOBOVITS A, 1985, NATURE, V318, P188; JAFFREDO T, 1989, DEVELOPMENT, V105, P679; JOHNSON GD, 1981, J IMMUNOL METHODS, V43, P349, DOI 10.1016/0022-1759(81)90183-6; KATO K, 1990, MOL CELL BIOL, V10, P486, DOI 10.1128/MCB.10.2.486; KATO K, 1991, DEV GROWTH DIFFER, V33, P29; KOHL NE, 1983, CELL, V35, P359, DOI 10.1016/0092-8674(83)90169-1; MAKELA TP, 1992, SCIENCE, V256, P373, DOI 10.1126/science.256.5055.373; MIYATA Y, 1991, J BIOL CHEM, V266, P8779; MUGRAUER G, 1988, J CELL BIOL, V107, P1325, DOI 10.1083/jcb.107.4.1325; PRENDERGAST GC, 1991, CELL, V65, P395, DOI 10.1016/0092-8674(91)90457-A; ROTH S, 1989, CELL, V59, P1189, DOI 10.1016/0092-8674(89)90774-5; ROUX P, 1990, CELL, V63, P341, DOI 10.1016/0092-8674(90)90167-D; RUSHLOW CA, 1989, CELL, V59, P1165, DOI 10.1016/0092-8674(89)90772-1; SANCHEZ ER, 1992, J BIOL CHEM, V267, P17; SAWAI S, 1990, MOL CELL BIOL, V10, P2017, DOI 10.1128/MCB.10.5.2017; SCHWAB M, 1983, NATURE, V305, P245, DOI 10.1038/305245a0; SIEBERBLUM M, 1991, NEURON, V6, P949, DOI 10.1016/0896-6273(91)90235-R; SLAMON DJ, 1986, SCIENCE, V232, P768, DOI 10.1126/science.3008339; STEWARD R, 1989, CELL, V59, P1179, DOI 10.1016/0092-8674(89)90773-3; SUEMORI H, 1990, CELL DIFFER DEV, V29, P181, DOI 10.1016/0922-3371(90)90120-L; UENO K, 1988, MOL CELL BIOL, V8, P4529, DOI 10.1128/MCB.8.10.4529; WHITESELL L, 1991, MOL CELL BIOL, V11, P1360, DOI 10.1128/MCB.11.3.1360; ZABEL U, 1990, CELL, V61, P255, DOI 10.1016/0092-8674(90)90806-P; ZIMMERMAN KA, 1986, NATURE, V319, P780, DOI 10.1038/319780a0	35	66	66	1	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1993	10	1					1	9		10.1016/0896-6273(93)90236-K	http://dx.doi.org/10.1016/0896-6273(93)90236-K			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KK012	8427698				2022-12-24	WOS:A1993KK01200001
J	Hu, HY; Tomasiewicz, H; Magnuson, T; Rutishauser, U				Hu, HY; Tomasiewicz, H; Magnuson, T; Rutishauser, U			The role of polysialic acid in migration of olfactory bulb interneuron precursors in the subventricular zone	NEURON			English	Article							SUBEPENDYMAL LAYER; CELL-MIGRATION; GRANULE CELLS; NEUROGENESIS; BRAIN; NCAM; RAT; ADHESION	Transplantation studies have been used to show that tangential migration of olfactory bulb interneuron precursors is retarded in NCAM-mutant mice, and that this defect reflects loss of NCAM polysialic acid (PSA). In contrast, radial migration of cells within the bulb did not require PSA. Reciprocal transplantations between wild-type and mutant mice have revealed that the mutation affects the in vivo migration environment in the subventricular zone, and not movement of individual cells. However, in vitro migration of the cells into a PSA-negative collagen matrix environment was also PSA-dependent. The surprisingly similar results obtained in the in vivo and in vitro environments is consistent with the observation that migration of subventricular cells occurs as streams of closely apposed cells in which the PSA-positive cells appear to serve as their own migration substrate.	CASE WESTERN RESERVE UNIV,DEPT NEUROSCI,CLEVELAND,OH 44106	Case Western Reserve University	Hu, HY (corresponding author), CASE WESTERN RESERVE UNIV,DEPT GENET,CLEVELAND,OH 44106, USA.				NICHD NIH HHS [HD26722, HD18369] Funding Source: Medline; NINDS NIH HHS [NS32779] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD018369, R01HD026722, R37HD018369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS032779] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALCARAZ G, 1991, EUR J CELL BIOL, V55, P165; ALTMAN J, 1966, J COMP NEUROL, V127, P337; BAYER SA, 1983, EXP BRAIN RES, V50, P329; COROTTO FS, 1993, NEUROSCI LETT, V149, P111, DOI 10.1016/0304-3940(93)90748-A; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; FREDETTE B, 1993, J CELL BIOL, V123, P1867, DOI 10.1083/jcb.123.6.1867; FUJITA S, 1966, J COMP NEUROL, V128, P191, DOI 10.1002/cne.901280206; HINDS JW, 1968, J COMP NEUROL, V134, P305, DOI 10.1002/cne.901340305; HINDS JW, 1968, J COMP NEUROL, V134, P287, DOI 10.1002/cne.901340304; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; KISHI K, 1987, J COMP NEUROL, V258, P112, DOI 10.1002/cne.902580109; LANDMESSER L, 1990, NEURON, V4, P655, DOI 10.1016/0896-6273(90)90193-J; LEE MK, 1990, CELL MOTIL CYTOSKEL, V17, P118, DOI 10.1002/cm.970170207; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; MENEZES JRL, 1994, J NEUROSCI, V14, P5399; ONO K, 1994, NEURON, V13, P595, DOI 10.1016/0896-6273(94)90028-0; PRICE JL, 1970, J CELL SCI, V7, P91; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; RAKIC P, 1990, EXPERIENTIA, V46, P882, DOI 10.1007/BF01939380; RAKIC P, 1974, NATURE, V250, P31, DOI 10.1038/250031a0; RENFRANZ PJ, 1991, CELL, V66, P713, DOI 10.1016/0092-8674(91)90116-G; ROUSSELOT P, 1995, J COMP NEUROL, V351, P51, DOI 10.1002/cne.903510106; RUTISHAUSER U, 1985, J CELL BIOL, V101, P1842, DOI 10.1083/jcb.101.5.1842; Rutishauser U., 1992, DEVELOPMENT S, V116, P99; RUTISHAUSER U, 1992, POLYSIALIC ACID, P215; SEKI T, 1993, NEUROSCI RES, V17, P265, DOI 10.1016/0168-0102(93)90111-3; TANG J, 1992, NEURON, V8, P1031, DOI 10.1016/0896-6273(92)90125-W; TANG JC, 1994, NEURON, V13, P405, DOI 10.1016/0896-6273(94)90356-5; TOMASIEWICZ H, 1993, NEURON, V11, P1163, DOI 10.1016/0896-6273(93)90228-J	30	314	326	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1996	16	4					735	743		10.1016/S0896-6273(00)80094-X	http://dx.doi.org/10.1016/S0896-6273(00)80094-X			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UG611	8607992	Bronze			2022-12-24	WOS:A1996UG61100007
J	BUSCIGLIO, J; LORENZO, A; YEH, J; YANKNER, BA				BUSCIGLIO, J; LORENZO, A; YEH, J; YANKNER, BA			BETA-AMYLOID FIBRILS INDUCE TAU-PHOSPHORYLATION AND LOSS OF MICROTUBULE-BINDING	NEURON			English	Article							PAIRED HELICAL FILAMENTS; ALZHEIMERS-DISEASE; PROTEIN-TAU; ABNORMAL PHOSPHORYLATION; NEUROFIBRILLARY TANGLES; PRECURSOR PROTEIN; CORTICAL-NEURONS; ALZ-50 EPITOPE; KINASE-I; NEUROTOXICITY	A central issue in the pathogenesis of Alzheimer's disease (AD) is the relationship between amyloid deposition and neurofibrillary tangle formation. To determine whether amyloid fibril formation affects the phosphorylation state of tau, primary cultures of fetal rat hippocampal and human cortical neurons were treated with beta-amyloid (beta A) in a soluble, amorphous-aggregated, or fibrillar form. Fibrillar beta A, but not soluble or amorphous-aggregated beta A, markedly induces the phosphorylation of tau at Ser-202 and Ser-396/Ser-404, resulting in a shift in the tau M(r) in human cortical neurons. Hyperphosphorylated tau accumulates in the somatodendritic compartment of fibrillar beta A-treated neurons in a soluble form that is not associated with microtubules and is incapable of binding to microtubules in vitro. Dephosphorylation of beta A-induced tau restores its capacity to bind to microtubules. Thus, amyloid fibril formation alters the phosphorylation state of tau, resulting in the loss of microtubule binding capacity and somatodendritic accumulation, properties also exhibited by tau in the AD brain. Amyloid fibril formation may therefore be a cause of abnormal tau phosphorylation in AD.	HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,DEPT OBSTET & GYNECOL,BOSTON,MA 02115	Harvard University; Brigham & Women's Hospital; Harvard Medical School	BUSCIGLIO, J (corresponding author), HARVARD UNIV,CHILDRENS HOSP,SCH MED,DEPT NEUROL,BOSTON,MA 02115, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R29AG009229] Funding Source: NIH RePORTER; NIA NIH HHS [AG09229] Funding Source: Medline; NINDS NIH HHS [NS30352] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALONSO AD, 1994, P NATL ACAD SCI USA, V91, P5562, DOI 10.1073/pnas.91.12.5562; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; BIERNAT J, 1992, EMBO J, V11, P1593, DOI 10.1002/j.1460-2075.1992.tb05204.x; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; BUSCIGLIO J, 1993, P NATL ACAD SCI USA, V90, P2092, DOI 10.1073/pnas.90.5.2092; BUSCIGLIO J, 1992, NEUROBIOL AGING, V13, P609, DOI 10.1016/0197-4580(92)90065-6; BUSCIGLIO J, 1993, J NEUROCHEM, V61, P1565, DOI 10.1111/j.1471-4159.1993.tb13658.x; CACERES A, 1986, J NEUROSCI, V6, P714; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; CHAUHAN A, 1991, LIFE SCI, V49, P1555, DOI 10.1016/0024-3205(91)90328-9; CHAUHAN A, 1993, BRAIN RES, V629, P47, DOI 10.1016/0006-8993(93)90479-7; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; DELACOURTE A, 1990, ACTA NEUROPATHOL, V80, P111, DOI 10.1007/BF00308912; FORLONI G, 1993, NATURE, V362, P543, DOI 10.1038/362543a0; GOEDERT M, 1991, NEUROSCI LETT, V126, P149, DOI 10.1016/0304-3940(91)90541-Z; GOEDERT M, 1993, TRENDS NEUROSCI, V16, P460, DOI 10.1016/0166-2236(93)90078-Z; GOEDERT M, 1993, P NATL ACAD SCI USA, V90, P5066, DOI 10.1073/pnas.90.11.5066; GREENBERG SG, 1992, J BIOL CHEM, V267, P564; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; HAASS C, 1993, CELL, V75, P1039, DOI 10.1016/0092-8674(93)90312-E; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HASEGAWA M, 1992, J BIOL CHEM, V267, P17047; IHARA Y, 1988, BRAIN RES, V459, P138, DOI 10.1016/0006-8993(88)90293-4; KANEMARU K, 1992, J NEUROCHEM, V58, P1667, DOI 10.1111/j.1471-4159.1992.tb10039.x; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KENESSEY A, 1963, BRAIN RES, V629, P40; KOSIK KS, 1988, NEURON, V1, P817, DOI 10.1016/0896-6273(88)90129-8; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; KOWALL NW, 1987, ANN NEUROL, V22, P639, DOI 10.1002/ana.410220514; KOWALL NW, 1991, P NATL ACAD SCI USA, V88, P7247, DOI 10.1073/pnas.88.16.7247; KSIEZAKREDING H, 1991, NEURON, V6, P717, DOI 10.1016/0896-6273(91)90169-Z; KSIEZAKREDING H, 1990, J NEUROSCI RES, V25, P412, DOI 10.1002/jnr.490250319; LANG E, 1992, BIOCHEM BIOPH RES CO, V187, P783, DOI 10.1016/0006-291X(92)91264-Q; Lee V M, 1992, Curr Opin Neurobiol, V2, P653, DOI 10.1016/0959-4388(92)90034-I; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; LORENZO A, 1994, NATURE, V368, P756, DOI 10.1038/368756a0; LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243; LU Q, 1993, J NEUROSCI, V13, P508; MANDELKOW EM, 1993, TRENDS BIOCHEM SCI, V18, P480, DOI 10.1016/0968-0004(93)90011-B; MATSUO ES, 1994, NEURON, V13, P989, DOI 10.1016/0896-6273(94)90264-X; MATTSON MP, 1993, BRAIN RES, V621, P35, DOI 10.1016/0006-8993(93)90295-X; MAY PC, 1993, J NEUROCHEM, V61, P2330, DOI 10.1111/j.1471-4159.1993.tb07480.x; MCKEE AC, 1989, ANN NEUROL, V26, P652, DOI 10.1002/ana.410260511; MURTHY ASN, 1983, EUR J BIOCHEM, V137, P37, DOI 10.1111/j.1432-1033.1983.tb07792.x; PIKE CJ, 1991, BRAIN RES, V563, P311, DOI 10.1016/0006-8993(91)91553-D; PIKE CJ, 1992, NEUROREPORT, V3, P769, DOI 10.1097/00001756-199209000-00012; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; SHIN RW, 1993, P NATL ACAD SCI USA, V90, P6825, DOI 10.1073/pnas.90.14.6825; SHOJI M, 1992, SCIENCE, V25, P126; SNOW AD, 1994, NEURON, V12, P219, DOI 10.1016/0896-6273(94)90165-1; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; TAKASHIMA A, 1993, P NATL ACAD SCI USA, V90, P7789, DOI 10.1073/pnas.90.16.7789; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; VALLEE RB, 1982, J CELL BIOL, V92, P435, DOI 10.1083/jcb.92.2.435; WATANABE A, 1993, J BIOL CHEM, V268, P25712; WILLIAMS RC, 1979, BIOCHEMISTRY-US, V18, P2499, DOI 10.1021/bi00579a010; WOLOZIN BL, 1986, SCIENCE, V232, P648, DOI 10.1126/science.3083509; WOOD JG, 1986, P NATL ACAD SCI USA, V83, P4040, DOI 10.1073/pnas.83.11.4040; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; YANKNER BA, 1991, NEW ENGL J MED, V325, P1849; YOSHIDA H, 1993, J NEUROCHEM, V61, P1183, DOI 10.1111/j.1471-4159.1993.tb03642.x	64	547	572	1	28	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1995	14	4					879	888		10.1016/0896-6273(95)90232-5	http://dx.doi.org/10.1016/0896-6273(95)90232-5			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QU826	7718249	Bronze			2022-12-24	WOS:A1995QU82600022
J	CITRON, M; TEPLOW, DB; SELKOE, DJ				CITRON, M; TEPLOW, DB; SELKOE, DJ			GENERATION OF AMYLOID-BETA PROTEIN FROM ITS PRECURSOR IS SEQUENCE-SPECIFIC	NEURON			English	Article							ALZHEIMERS-DISEASE; PEPTIDE; IDENTIFICATION; MUTATION; CLEAVAGE; FRAGMENT; PATHWAY; CELLS	Cerebral deposition of amyloid beta protein (A beta) is an early and critical feature of Alzheimer's disease. Here we analyze the substrate requirements of proteases (''beta-secretases'') that cleave the beta-amyloid precursor protein (beta APP) at the N-terminus of A beta (Asp-597 of beta APP(695)) in intact human cells. The cleavage requires a membrane-bound substrate but tolerates shifts in the distance of the hydrolyzed bond from the membrane. The major protease has a minimum recognition region of Val-594 to Ala-598; most substitutions in this sequence strongly decrease or eliminate AP production. Only the Swedish familial Alzheimer's disease mutation (K595N/M596L) strongly increases A beta production. Moreover, in this mutant but not in the wild type, the entire cytoplasmic tail with its reinternalization signals can be deleted without affecting A beta N-terminal cleavage, consistent with the concept that cleavage of this mutant occurs in a different cellular compartment than that of wild-type molecules. Our results have important implications for current intensive approaches to develop assays for and identify enzymes with beta-secretase activity.			CITRON, M (corresponding author), HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,CTR NEUROL DIS,DEPT NEUROL,PROGRAM NEUROSCI,BOSTON,MA 02115, USA.				NATIONAL INSTITUTE ON AGING [R01AG006173, R35AG007911, R37AG006173] Funding Source: NIH RePORTER; NIA NIH HHS [AG06173, AG07911] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BUSCIGLIO J, 1993, P NATL ACAD SCI USA, V90, P2092, DOI 10.1073/pnas.90.5.2092; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; CITRON M, 1994, P NATL ACAD SCI USA, V91, P11993, DOI 10.1073/pnas.91.25.11993; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOLDE TE, 1990, NEURON, V4, P253, DOI 10.1016/0896-6273(90)90100-T; GOWING E, 1994, J BIOL CHEM, V269, P10987; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HAASS C, 1993, J BIOL CHEM, V268, P3021; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; HAASS C, 1994, P NATL ACAD SCI USA, V91, P1564, DOI 10.1073/pnas.91.4.1564; HUNG AY, 1994, EMBO J, V13, P534, DOI 10.1002/j.1460-2075.1994.tb06291.x; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KITAGUCHI N, 1988, NATURE, V331, P530, DOI 10.1038/331530a0; KOO EH, 1994, J BIOL CHEM, V269, P17386; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; MORI H, 1992, J BIOL CHEM, V267, P17082; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; OLTERSDORF T, 1990, J BIOL CHEM, V265, P4492; PODLISNY MB, 1991, AM J PATHOL, V138, P1423; PONTE P, 1988, NATURE, V331, P525, DOI 10.1038/331525a0; ROHER AE, 1993, P NATL ACAD SCI USA, V90, P10836, DOI 10.1073/pnas.90.22.10836; SELKOE DJ, 1988, P NATL ACAD SCI USA, V85, P7341, DOI 10.1073/pnas.85.19.7341; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; TAMAOKA A, 1992, P NATL ACAD SCI USA, V89, P1345, DOI 10.1073/pnas.89.4.1345; TANZI RE, 1988, NATURE, V331, P528, DOI 10.1038/331528a0; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; ZHONG ZY, 1994, J BIOL CHEM, V269, P627	34	232	252	0	12	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1995	14	3					661	670		10.1016/0896-6273(95)90323-2	http://dx.doi.org/10.1016/0896-6273(95)90323-2			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QP230	7695913	Bronze			2022-12-24	WOS:A1995QP23000020
J	WAID, DK; MCLOON, SC				WAID, DK; MCLOON, SC			IMMEDIATE DIFFERENTIATION OF GANGLION-CELLS FOLLOWING MITOSIS IN THE DEVELOPING RETINA	NEURON			English	Article							NERVE GROWTH-FACTOR; PHOTORECEPTOR DEVELOPMENT INVITRO; LARVAL FROG RETINA; RAT RETINA; AUTORADIOGRAPHIC ANALYSIS; EMBRYONIC RETINA; XENOPUS RETINA; NEURAL RETINA; CHICK RETINA; MOUSE RETINA	The aim of this study is to gain insight into the time during the life history of a retinal neuron that it becomes committed to a particular phenotype. At this paint, it is not possible to identify the time of commitment, but the time that differentiation begins can be identified. Bromodeoxyuridine labeling coupled with immunohistochemistry with a ganglion cell-specific antibody was used to fix the time of the beginning of ganglion cell differentiation relative to the time of mitosis in the developing chick retina. It was found that ganglion cells can begin to differentiate in less than 15 min after the end of mitosis. This suggests that the retinal ganglion cell fate may be determined before or during mitosis.			WAID, DK (corresponding author), UNIV MINNESOTA, DEPT CELL BIOL & NEUROANAT, MINNEAPOLIS, MN 55455 USA.				NATIONAL EYE INSTITUTE [R01EY009537] Funding Source: NIH RePORTER; NEI NIH HHS [EY09537, EY07133] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADLER R, 1993, INVEST OPHTH VIS SCI, V34, P1677; ALTSHULER D, 1993, DEVELOPMENT, V119, P1317; ALTSHULER D, 1992, DEVELOPMENT, V114, P947; ALTSHULER DM, 1991, P RET RES F, V3, P37; BAKER NE, 1990, SCIENCE, V250, P1370, DOI 10.1126/science.2175046; BARNSTABLE CJ, 1985, DEV BRAIN RES, V20, P286, DOI 10.1016/0165-3806(85)90116-6; CURRAN T, 1985, SCIENCE, V229, P1265, DOI 10.1126/science.4035354; DENHAM S, 1967, J EMBRYOL EXP MORPH, V18, P53; DUTTING D, 1983, DEV BRAIN RES, V10, P21, DOI 10.1016/0165-3806(83)90117-7; FUJITA S, 1963, ARCH HISTOL JAPON, V23, P259; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; GREENBERG ME, 1985, J BIOL CHEM, V260, P4101; Greene LA., 1982, ADV CELL NEUROBIOL, V3, P373, DOI [10.1016/B978-0-12-008303-9.50016-5, DOI 10.1016/B978-0-12-008303-9.50016-5]; HARRIS WA, 1992, NEURON, V9, P357, DOI 10.1016/0896-6273(92)90174-C; HARRIS WA, 1991, NEURON, V6, P499, DOI 10.1016/0896-6273(91)90053-3; HARRIS WA, 1993, TRENDS NEUROSCI, V16, P96, DOI 10.1016/0166-2236(93)90130-E; HINDS JW, 1974, DEV BIOL, V37, P381, DOI 10.1016/0012-1606(74)90156-0; HOLT CE, 1988, NEURON, V1, P15, DOI 10.1016/0896-6273(88)90205-X; KAHN AJ, 1974, DEV BIOL, V38, P30, DOI 10.1016/0012-1606(74)90256-5; LEONARD DGB, 1987, MOL CELL BIOL, V7, P3156, DOI 10.1128/MCB.7.9.3156; LINDENBAUM MH, 1988, J BIOL CHEM, V263, P5662; MCCONNELL SK, 1991, SCIENCE, V254, P282, DOI 10.1126/science.1925583; MCLOON SC, 1989, J NEUROSCI, V9, P1424; MCLOON SC, 1984, NEURAL TRANSPLANTS D, P99; REESE BE, 1994, J COMP NEUROL, V341, P464, DOI 10.1002/cne.903410404; REH TA, 1989, J NEUROSCI, V9, P4179; REH TA, 1992, J NEUROBIOL, V23, P1067, DOI 10.1002/neu.480230811; REH TA, 1987, J NEUROSCI, V7, P3317; REH TA, 1986, DEV BIOL, V114, P463, DOI 10.1016/0012-1606(86)90210-1; REINKE R, 1988, CELL, V55, P321, DOI 10.1016/0092-8674(88)90055-4; REPKA A, 1992, DEV BIOL, V153, P242, DOI 10.1016/0012-1606(92)90109-T; Sauer FC, 1935, J COMP NEUROL, V62, P377, DOI 10.1002/cne.900620207; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; SIDMAN RL, 1959, EXP NEUROL, V1, P322, DOI 10.1016/0014-4886(59)90024-X; SNOW RL, 1994, NEUROSCIENCE, V58, P399, DOI 10.1016/0306-4522(94)90046-9; SPARROW JR, 1990, DEV BRAIN RES, V51, P69, DOI 10.1016/0165-3806(90)90259-2; SPENCE SG, 1989, NEUROSCIENCE, V32, P801, DOI 10.1016/0306-4522(89)90300-X; TOMLINSON A, 1987, DEV BIOL, V120, P366, DOI 10.1016/0012-1606(87)90239-9; TURNER DL, 1990, NEURON, V4, P833, DOI 10.1016/0896-6273(90)90136-4; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; WALSH C, 1985, J NEUROSCI, V5, P741; WATANABE T, 1992, DEVELOPMENT, V114, P899; WATANABE T, 1990, NEURON, V4, P461, DOI 10.1016/0896-6273(90)90058-N; WETTS R, 1988, SCIENCE, V239, P1142, DOI 10.1126/science.2449732; WILLIAMS RW, 1992, TRENDS NEUROSCI, V15, P368, DOI 10.1016/0166-2236(92)90181-7	45	117	119	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1995	14	1					117	124		10.1016/0896-6273(95)90245-7	http://dx.doi.org/10.1016/0896-6273(95)90245-7			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QC548	7826629	Bronze			2022-12-24	WOS:A1995QC54800011
J	LIN, DM; FETTER, RD; KOPCZYNSKI, C; GRENNINGLOH, G; GOODMAN, CS				LIN, DM; FETTER, RD; KOPCZYNSKI, C; GRENNINGLOH, G; GOODMAN, CS			GENETIC-ANALYSIS OF FASCICLIN-II IN DROSOPHILA - DEFASCICULATION, REFASCICULATION, AND ALTERED FASCICULATION	NEURON			English	Article							NEURONAL GROWTH CONES; CELL-ADHESION MOLECULE; NERVOUS-SYSTEM; IMMUNOGLOBULIN SUPERFAMILY; GRASSHOPPER EMBRYOS; AXON PATHWAYS; FUSHI-TARAZU; RECOGNITION; EXPRESSION; GLYCOPROTEINS	The Drosophila neural cell adhesion molecule Fasciclin II (Fas II) is expressed dynamically on a subset of embryonic CNS axons, many of which selectively fasciculate in the vMP2, MP1, and FN3 pathways. Here we show complementary fasII loss-of-function and gain-of-function phenotypes. Loss-of-function fadII mutations lead to the complete or partial defasciculation of all three pathways. Cain-of-function conditions, using a specific control element to direct increased levels of Fas II on the axons in these three pathways, rescue the loss-of-function phenotype. Moreover, the gain-of-function can alter fasciculation by abnormally fusing pathways together, in one case apparently by preventing normal defasciculation. These results define an in vivo function for Fas II as a neuronal recognition molecule that controls one mechanism of growth cone guidance-selective axon fasciculation-and genetically separates this function from other aspects of outgrowth and directional guidance.			LIN, DM (corresponding author), UNIV CALIF BERKELEY,HOWARD HUGHES MED INST,DEPT MOLEC & CELL BIOL,DIV NEUROBIOL,BERKELEY,CA 94720, USA.				NICHD NIH HHS [HD21294] Funding Source: Medline; NIGMS NIH HHS [5T32 GM07232] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD021294, R01HD021294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007232] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BASTIANI MJ, 1987, CELL, V48, P745, DOI 10.1016/0092-8674(87)90072-9; BASTIANI MJ, 1984, J NEUROSCI, V4, P2311; BIEBER AJ, 1989, CELL, V59, P447, DOI 10.1016/0092-8674(89)90029-9; BRAND AH, 1993, DEVELOPMENT, V118, P401; CALLAHAN CA, 1994, P NATL ACAD SCI USA, V91, P5972, DOI 10.1073/pnas.91.13.5972; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; DOE CQ, 1988, SCIENCE, V239, P170, DOI 10.1126/science.2892267; Doherty Patrick, 1994, Current Opinion in Neurobiology, V4, P49, DOI 10.1016/0959-4388(94)90031-0; ELKINS T, 1990, CELL, V60, P565, DOI 10.1016/0092-8674(90)90660-7; FISCHER JA, 1988, NATURE, V332, P853, DOI 10.1038/332853a0; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; GOODMAN CS, 1994, CELL, V78, P353, DOI 10.1016/0092-8674(94)90413-8; GOODMAN CS, 1984, SCIENCE, V225, P1271, DOI 10.1126/science.6474176; GOODMAN CS, 1982, S SOC DEV BIOL, V40, P275; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; HARRELSON AL, 1988, SCIENCE, V242, P700, DOI 10.1126/science.3187519; HAWVER DB, 1993, J NEUROBIOL, V24, P368, DOI 10.1002/neu.480240309; HIROMI Y, 1985, CELL, V43, P603, DOI 10.1016/0092-8674(85)90232-6; JACOBS JR, 1989, J NEUROSCI, V9, P2402; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; KUWADA JY, 1986, SCIENCE, V233, P740, DOI 10.1126/science.3738507; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; MAYFORD M, 1992, SCIENCE, V256, P638, DOI 10.1126/science.1585176; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; PINI A, 1993, SCIENCE, V261, P95, DOI 10.1126/science.8316861; RAMOS RGP, 1993, GENE DEV, V7, P2533, DOI 10.1101/gad.7.12b.2533; RAPER JA, 1984, J NEUROSCI, V4, P2329; Rutishauser U, 1993, Curr Opin Neurobiol, V3, P709, DOI 10.1016/0959-4388(93)90142-L; Sato T, 1968, J Electron Microsc (Tokyo), V17, P158; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; SNOW PM, 1988, P NATL ACAD SCI USA, V85, P5291, DOI 10.1073/pnas.85.14.5291; TOMASIEWICZ H, 1993, NEURON, V11, P1163, DOI 10.1016/0896-6273(93)90228-J; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; WHITE JG, 1983, COLD SPRING HARB SYM, V48, P633, DOI 10.1101/SQB.1983.048.01.067; WIGGLESWORTH VB, 1953, Q J MICROSC SCI, V94, P93	38	263	265	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1994	13	5					1055	1069		10.1016/0896-6273(94)90045-0	http://dx.doi.org/10.1016/0896-6273(94)90045-0			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PU763	7946345				2022-12-24	WOS:A1994PU76300003
J	DEWAARD, M; PRAGNELL, M; CAMPBELL, KP				DEWAARD, M; PRAGNELL, M; CAMPBELL, KP			CA2+ CHANNEL REGULATION BY A CONSERVED BETA-SUBUNIT DOMAIN	NEURON			English	Article							NEURONAL CALCIUM-CHANNEL; FUNCTIONAL EXPRESSION; SKELETAL-MUSCLE; BRAIN; CLONING; ALPHA-1-SUBUNIT; FAMILY	The beta subunit is a cytoplasmic component that normalizes the current amplitude, kinetics, and voltage dependence of voltage-gated Ca2+ channels. Here, we identify a 30 amino acid domain of the beta subunit that is sufficient to induce a stimulation and shift in the voltage dependence of activation of the Ca2+ channel currents. This domain is located at the amino terminus of the second region of high conservation among all beta subunit gene products. Single point mutations within this region on the beta(1b) subunit modified or abolished the stimulation of Ca2+ channel currents and the binding of the beta subunit to the alpha(1A) subunit. The binding of this domain is also required for the observed changes in kinetics and voltage dependence of steady-state inactivation induced by beta subunits.	UNIV IOWA,COLL MED,PROGRAM NEUROSCI,IOWA CITY,IA 52242	University of Iowa	DEWAARD, M (corresponding author), UNIV IOWA,COLL MED,HOWARD HUGHES MED INST,DEPT PHYSIOL & BIOPHYS,IOWA CITY,IA 52242, USA.		De Waard, Michel/G-7406-2014	De Waard, Michel/0000-0002-2782-9615; Campbell, Kevin/0000-0003-2066-5889				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; CASTELLANO A, 1993, J BIOL CHEM, V268, P12359; CASTELLANO A, 1993, J BIOL CHEM, V268, P3450; ELLINOR PT, 1993, NATURE, V363, P455, DOI 10.1038/363455a0; HULLIN R, 1992, EMBO J, V11, P885, DOI 10.1002/j.1460-2075.1992.tb05126.x; LACERDA AE, 1991, NATURE, V352, P527, DOI 10.1038/352527a0; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; PEREZREYES E, 1992, J BIOL CHEM, V267, P1792; POWERS PA, 1992, J BIOL CHEM, V267, P22967; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; PRAGNELL M, 1991, FEBS LETT, V291, P253, DOI 10.1016/0014-5793(91)81296-K; SNUTCH TP, 1990, P NATL ACAD SCI USA, V87, P3391, DOI 10.1073/pnas.87.9.3391; SOONG TW, 1993, SCIENCE, V260, P1133, DOI 10.1126/science.8388125; TAKAHASHI M, 1987, P NATL ACAD SCI USA, V84, P5478, DOI 10.1073/pnas.84.15.5478; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; TOMLINSON WJ, 1993, NEUROPHARMACOLOGY, V32, P1117, DOI 10.1016/0028-3908(93)90006-O; VARADI G, 1991, NATURE, V352, P159, DOI 10.1038/352159a0; WEI XY, 1991, J BIOL CHEM, V266, P21943; WILLIAMS ME, 1992, SCIENCE, V257, P389, DOI 10.1126/science.1321501; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; WITCHER DR, 1993, SCIENCE, V261, P486, DOI 10.1126/science.8392754	21	216	219	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1994	13	2					495	503		10.1016/0896-6273(94)90363-8	http://dx.doi.org/10.1016/0896-6273(94)90363-8			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PD430	8060623				2022-12-24	WOS:A1994PD43000019
J	IWATSUBO, T; ODAKA, A; SUZUKI, N; MIZUSAWA, H; NUKINA, N; IHARA, Y				IWATSUBO, T; ODAKA, A; SUZUKI, N; MIZUSAWA, H; NUKINA, N; IHARA, Y			VISUALIZATION OF A-BETA-42(43) AND A-BETA-40 IN SENILE PLAQUES WITH END-SPECIFIC A-BETA MONOCLONALS - EVIDENCE THAT AN INITIALLY DEPOSITED SPECIES IS A-BETA-42(43)	NEURON			English	Article							FAMILIAL ALZHEIMERS-DISEASE; AMYLOID PRECURSOR PROTEIN; DIFFUSE PLAQUES; CORE PROTEIN; MUTATION; PEPTIDE; GENE; PATHOLOGY; CEREBELLUM; TERMINUS	To learn about the carboxy-terminal extent of amyloid beta-protein (A beta) composition of senile plaques (SPs) in the brain affected with Alzheimer's disease (AD), we employed two end-specific monoclonal antibodies as immunocytochemical probes: one is specific for A beta 40, the carboxyl terminus of A beta 1-40, while the other is specific for A beta 42(43). In the AD cortex, all SPs that were labeled with an authentic antibody were A beta 42(43) positive, while only one-third of which, on the average, were A beta 40 positive. There was a strong correlation between A beta 40 positivity and mature plaques. Two familial AD cortices with the mutation of beta-amyloid protein precursor 717 (beta APP717) (Val to Ile) showed a remarkable predominance of A beta 42(43)-positive, A beta 40-negative plaques. Diffuse plaques, representing the earliest stage of A beta deposition, were exclusively positive for A beta 42(43), but completely negative for A beta 40.	UNIV TOKYO,FAC MED,INST BRAIN RES,DEPT NEUROL,BUNKYO KU,TOKYO 113,JAPAN; UNIV TOKYO,FAC MED,INST BRAIN RES,DEPT NEUROPATHOL,BUNKYO KU,TOKYO 113,JAPAN; TAKEDA CHEM IND,DIV DISCOVERY RES,TSUKUBA,IBARAKI 30042,JAPAN; UNIV TSUKUBA,DEPT NEUROL,TSUKUBA,IBARAKI 305,JAPAN	University of Tokyo; University of Tokyo; Takeda Chemical Industries; University of Tsukuba	IWATSUBO, T (corresponding author), UNIV TOKYO,FAC PHARMACEUT SCI,DEPT NEUROPATHOL & NEUROSCI,BUNKYO KU,TOKYO 113,JAPAN.		Nukina, Nobuyuki/GPP-6265-2022					CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; DAVIES CA, 1993, AM J PATHOL, V143, P1594; DOVEY HF, 1993, NEUROREPORT, V4, P1039, DOI 10.1097/00001756-199308000-00011; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HYMAN BT, 1993, J NEUROPATH EXP NEUR, V52, P594, DOI 10.1097/00005072-199311000-00006; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; JOACHIM CL, 1988, BRAIN RES, V474, P100, DOI 10.1016/0006-8993(88)90673-7; JOACHIM CL, 1989, AM J PATHOL, V135, P309; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KHACHATURIAN ZS, 1985, ARCH NEUROL-CHICAGO, V42, P1097, DOI 10.1001/archneur.1985.04060100083029; KITAMOTO T, 1987, LAB INVEST, V57, P230; LANTOS PL, 1992, NEUROSCI LETT, V137, P221, DOI 10.1016/0304-3940(92)90408-Y; MAGGIO JE, 1992, P NATL ACAD SCI USA, V89, P5462, DOI 10.1073/pnas.89.12.5462; MANN DMA, 1989, NEUROBIOL AGING, V10, P397, DOI 10.1016/0197-4580(89)90073-0; MANN DMA, 1988, NEW ENGL J MED, V318, P789; MASLIAH E, 1990, AM J PATHOL, V137, P1293; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; MILLER DL, 1993, ARCH BIOCHEM BIOPHYS, V301, P41, DOI 10.1006/abbi.1993.1112; MORI H, 1992, J BIOL CHEM, V267, P17082; MULLAN M, 1993, TRENDS NEUROSCI, V16, P398, DOI 10.1016/0166-2236(93)90007-9; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; MULLAN M, 1993, NEUROBIOL AGING, V14, P407, DOI 10.1016/0197-4580(93)90099-W; NARUSE S, 1991, LANCET, V337, P978, DOI 10.1016/0140-6736(91)91612-X; OHGAMI T, 1991, ACTA NEUROPATHOL, V81, P242, DOI 10.1007/BF00305864; PRELLI F, 1988, J NEUROCHEM, V51, P648, DOI 10.1111/j.1471-4159.1988.tb01087.x; ROHER AE, 1993, P NATL ACAD SCI USA, V90, P10836, DOI 10.1073/pnas.90.22.10836; ROHER AE, 1993, J BIOL CHEM, V268, P3072; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; SPILLANTINI MG, 1990, P NATL ACAD SCI USA, V87, P3947, DOI 10.1073/pnas.87.10.3947; SUENAGA T, 1990, ACTA NEUROPATHOL, V80, P280, DOI 10.1007/BF00294646; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; TAKASHIMA A, 1993, P NATL ACAD SCI USA, V90, P7789, DOI 10.1073/pnas.90.16.7789; VIGOPELFREY C, 1993, J NEUROCHEM, V61, P1965, DOI 10.1111/j.1471-4159.1993.tb09841.x; YAMAGUCHI H, 1988, ACTA NEUROPATHOL, V77, P113; YAMAGUCHI H, 1989, ACTA NEUROPATHOL, V77, P314, DOI 10.1007/BF00687584; YAMAGUCHI H, 1989, AM J PATHOL, V135, P593	41	1492	1550	2	73	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1994	13	1					45	53		10.1016/0896-6273(94)90458-8	http://dx.doi.org/10.1016/0896-6273(94)90458-8			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NZ247	8043280				2022-12-24	WOS:A1994NZ24700004
J	GILLESPIE, CS; SHERMAN, DL; BLAIR, GE; BROPHY, PJ				GILLESPIE, CS; SHERMAN, DL; BLAIR, GE; BROPHY, PJ			PERIAXIN, A NOVEL PROTEIN OF MYELINATING SCHWANN-CELLS WITH A POSSIBLE ROLE IN AXONAL ENSHEATHMENT	NEURON			English	Article							IMMUNOGLOBULIN GENE SUPERFAMILY; PERIPHERAL NERVOUS-SYSTEM; ADHESION MOLECULES; MESSENGER-RNA; PO PROTEIN; N-CAM; GLYCOPROTEIN; MOUSE; LOCALIZATION; EXPRESSION	We report the cloning and subcellular localization of a novel Schwann cell-specific protein of 147 kd that we have named periaxin. Periaxin has a remarkable domain of repetitive pentameric units in the primary sequence. It is expressed in the first uncompacted whorls of membrane that ensheathe the axon, and further synthesis of the protein in the rat sciatic nerve parallels the deposition of myelin. In mature myelin, periaxin colocalizes with the myelin-associated glycoprotein in the cytoplasm-filled periaxonal regions of the sheath but is excluded from compact myelin. We propose that periaxin has a role in axon-glial interactions, possibly by interacting with the cytoplasmic domains of integral membrane proteins such as myelin-associated glycoprotein in the periaxonal regions of the Schwann cell plasma membrane.	UNIV LEEDS, DEPT BIOCHEM & MOLEC BIOL, LEEDS LS2 9JT, W YORKSHIRE, ENGLAND	University of Leeds	GILLESPIE, CS (corresponding author), UNIV STIRLING, DEPT BIOL & MOLEC SCI, STIRLING FK9 4LA, SCOTLAND.							Ausubel F. M., 1988, CURRENT PROTOCOLS MO; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BRUNDEN KR, 1990, J NEUROSCI RES, V26, P135, DOI 10.1002/jnr.490260202; BUNGE RP, 1986, ANNU REV NEUROSCI, V9, P305; BUNGE RP, 1989, J CELL BIOL, V109, P273, DOI 10.1083/jcb.109.1.273; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DIEPERINK ME, 1992, J NEUROSCI, V12, P2177; Doyle JP, 1993, CURR OPIN CELL BIOL, V5, P779, DOI 10.1016/0955-0674(93)90025-L; DURSO D, 1990, NEURON, V4, P449, DOI 10.1016/0896-6273(90)90057-M; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FIELD EJ, 1969, J NEUROL SCI, V8, P49, DOI 10.1016/0022-510X(69)90040-9; FILBIN MT, 1990, NATURE, V344, P871, DOI 10.1038/344871a0; FRAIL DE, 1985, J NEUROCHEM, V45, P1308, DOI 10.1111/j.1471-4159.1985.tb05559.x; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GIESE KP, 1992, CELL, V71, P565, DOI 10.1016/0092-8674(92)90591-Y; GILLESPIE CS, 1989, BIOCHEM J, V260, P689, DOI 10.1042/bj2600689; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; HUNKAPILLER MW, 1983, METHOD ENZYMOL, V91, P227; JESSEN KR, 1991, GLIA, V4, P185, DOI 10.1002/glia.440040210; KELLY BM, 1992, J CELL BIOL, V118, P397, DOI 10.1083/jcb.118.2.397; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; KROCZEK RA, 1990, ANAL BIOCHEM, V184, P90, DOI 10.1016/0003-2697(90)90017-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEMKE G, 1988, DEVELOPMENT, V102, P499; LEMKE G, 1985, CELL, V40, P501, DOI 10.1016/0092-8674(85)90198-9; LUNA EJ, 1992, SCIENCE, V258, P955, DOI 10.1126/science.1439807; MARTIN JR, 1973, DEV BIOL, V32, P417, DOI 10.1016/0012-1606(73)90251-0; MARTINI R, 1988, J CELL BIOL, V106, P1735, DOI 10.1083/jcb.106.5.1735; MATSUDAIRA P, 1991, TRENDS BIOCHEM SCI, V16, P87, DOI 10.1016/0968-0004(91)90039-X; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; MORGAN L, 1991, J CELL BIOL, V112, P457, DOI 10.1083/jcb.112.3.457; OWENS GC, 1989, GLIA, V2, P119, DOI 10.1002/glia.440020208; OWENS GC, 1991, NEURON, V7, P565, DOI 10.1016/0896-6273(91)90369-B; PETERS A., 1959, QUART JOUR EXPTL PHYSIOL, V44, P117; POLTORAK M, 1987, J CELL BIOL, V105, P1893, DOI 10.1083/jcb.105.4.1893; PORTER S, 1986, J NEUROSCI, V6, P3070; SALZER JL, 1980, J CELL BIOL, V84, P739, DOI 10.1083/jcb.84.3.739; SALZER JL, 1987, J CELL BIOL, V104, P957, DOI 10.1083/jcb.104.4.957; SALZER JL, 1989, DEV NEUROSCI-BASEL, V11, P377, DOI 10.1159/000111914; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHUMAN S, 1988, J NEUROCHEM, V50, P190, DOI 10.1111/j.1471-4159.1988.tb13248.x; SHUMAN S, 1986, J NEUROCHEM, V47, P811; SOBUE G, 1986, NEUROSCI LETT, V72, P253, DOI 10.1016/0304-3940(86)90522-7; SOBUE G, 1984, SCIENCE, V224, P72, DOI 10.1126/science.6322307; SOBUE G, 1985, J NEUROSCI, V5, P379; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRAPP BD, 1988, J CELL BIOL, V107, P675, DOI 10.1083/jcb.107.2.675; TRAPP BD, 1982, J CELL BIOL, V92, P877, DOI 10.1083/jcb.92.3.877; TRAPP BD, 1989, J CELL BIOL, V109, P2417, DOI 10.1083/jcb.109.5.2417; TRAPP BD, 1989, J NEUROCYTOL, V18, P47, DOI 10.1007/BF01188423; TRAPP BD, 1984, J NEUROIMMUNOL, V6, P231, DOI 10.1016/0165-5728(84)90011-0; VOUYIOUKLIS DA, 1993, J NEUROSCI RES, V35, P257, DOI 10.1002/jnr.490350305; WEBSTER HDF, 1973, DEV BIOL, V32, P401, DOI 10.1016/0012-1606(73)90250-9; WEST RR, 1991, J BIOL CHEM, V266, P21886; WILSON R, 1989, J NEUROSCI RES, V22, P439, DOI 10.1002/jnr.490220409; YOUNG RA, 1983, P NATL ACAD SCI-BIOL, V80, P1194, DOI 10.1073/pnas.80.5.1194	57	125	132	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	1994	12	3					497	508		10.1016/0896-6273(94)90208-9	http://dx.doi.org/10.1016/0896-6273(94)90208-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NC769	8155317				2022-12-24	WOS:A1994NC76900004
J	SCHUBIGER, M; FENG, YY; FAMBROUGH, DM; PALKA, J				SCHUBIGER, M; FENG, YY; FAMBROUGH, DM; PALKA, J			MUTATION OF THE DROSOPHILA SODIUM-PUMP ALPHA-SUBUNIT GENE RESULTS IN BANG-SENSITIVE PARALYSIS	NEURON			English	Article							MEDIATED ENHANCER DETECTION; SKELETAL-MUSCLE; MELANOGASTER; EXPRESSION; ATPASE; (NA+; MATURATION; GENOME; FORMS	A bang-sensitive enhancer trap line was isolated in a behavioral screen. The flies show a weak bang-sensitive paralysis, recovering after about 7 s. The P element insert is localized at 93B1-2 on the salivary chromosomes, the site of the (Na+,K+)ATPase alpha subunit gene. Molecular characterization demonstrates that the transposon is inserted into the first intron of this gene. This insertion leads to normal-sized transcripts, but reduced levels of expression. This change is also reflected in lower amounts of a normal-sized a subunit protein. Mutant flies show a much greater sensitivity to ouabain, likewise indicating, on a functional level, a reduction in Na+ pump activity. Furthermore, the bang-sensitive behavior can also be mimicked by injecting sublethal doses of ouabain into wild-type flies. The molecular and functional evidence indicates that the insertion has produced a hypomorphic mutation of the (Na+,K+)ATPase alpha subunit gene, opening the way to future studies of the regulation of the Na+ pump.	JOHNS HOPKINS UNIV, DEPT BIOL, BALTIMORE, MD 21218 USA	Johns Hopkins University	SCHUBIGER, M (corresponding author), UNIV WASHINGTON, DEPT ZOOL, SEATTLE, WA 98195 USA.				NINDS NIH HHS [NS23241] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023241] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARLETBAS C, 1990, J BIOL CHEM, V265, P7799; BELLEN HJ, 1989, GENE DEV, V3, P1288, DOI 10.1101/gad.3.9.1288; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; BIER E, 1989, GENE DEV, V3, P1273, DOI 10.1101/gad.3.9.1273; COOLEY L, 1988, SCIENCE, V239, P1121, DOI 10.1126/science.2830671; GANETZKY B, 1982, GENETICS, V100, P597; GEERING K, 1990, J MEMBRANE BIOL, V115, P109, DOI 10.1007/BF01869450; GICK GG, 1988, NAPLUS KPLUS PUMP B, P277; JAN YN, 1978, P NATL ACAD SCI USA, V75, P515, DOI 10.1073/pnas.75.1.515; Jowett T., 1986, DROSOPHILA, P275; LAMB JF, 1972, J PHYSIOL-LONDON, V225, P599, DOI 10.1113/jphysiol.1972.sp009959; LEBOVITZ RM, 1989, EMBO J, V8, P193, DOI 10.1002/j.1460-2075.1989.tb03364.x; LINDSLEY D, 1990, DROS INF SERV, V68; LYTTON J, 1985, J BIOL CHEM, V260, P1177; McEwen RS, 1918, J EXP ZOOL, V25, P49, DOI 10.1002/jez.1400250103; Mercer R. W., 1991, SODIUM PUMP RECENT D, P37; MLODZIK M, 1992, METHODS NEUROSCIENCE, V9, P397; OCONNELL P, 1984, NUCLEIC ACIDS RES, V12, P5495, DOI 10.1093/nar/12.13.5495; PAPAZIAN DM, 1988, ANNU REV PHYSIOL, V50, P379; POLLACK LR, 1981, AM J PHYSIOL, V241, pC173, DOI 10.1152/ajpcell.1981.241.5.C173; PRESSLEY TA, 1988, J MEMBRANE BIOL, V105, P187, DOI 10.1007/BF01870996; RAYSON BM, 1985, J BIOL CHEM, V260, P2740; ROBERTSON HM, 1988, GENETICS, V118, P461; ROSSIER BC, 1987, TRENDS BIOCHEM SCI, V12, P483, DOI 10.1016/0968-0004(87)90235-0; ROYDEN CS, 1987, CELL, V51, P165, DOI 10.1016/0092-8674(87)90144-9; SALACINSKI PRP, 1981, ANAL BIOCHEM, V117, P136, DOI 10.1016/0003-2697(81)90703-X; Sambrook J, 1989, MOL CLONING LABORATO; SCHMALZING G, 1990, AM J PHYSIOL, V258, pC179, DOI 10.1152/ajpcell.1990.258.1.C179; SHULL GE, 1986, BIOCHEMISTRY-US, V25, P8125, DOI 10.1021/bi00373a001; TAKEYASU K, 1990, AM J PHYSIOL, V259, pC619, DOI 10.1152/ajpcell.1990.259.4.C619; TAKEYASU K, 1989, CURR TOP MEMBR TRANS, V34, P143; TAMKUN JW, 1992, CELL, V68, P561, DOI 10.1016/0092-8674(92)90191-E; TAORMINO JP, 1990, J BIOL CHEM, V265, P4116; WILSON C, 1989, GENE DEV, V3, P1301, DOI 10.1101/gad.3.9.1301; WOLITZKY BA, 1986, J BIOL CHEM, V261, P9990; Wu C F, 1992, Ion Channels, V3, P261	36	56	56	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1994	12	2					373	381		10.1016/0896-6273(94)90278-X	http://dx.doi.org/10.1016/0896-6273(94)90278-X			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MY500	8110464	hybrid			2022-12-24	WOS:A1994MY50000012
J	THOMPSON, RC; MANSOUR, A; AKIL, H; WATSON, SJ				THOMPSON, RC; MANSOUR, A; AKIL, H; WATSON, SJ			CLONING AND PHARMACOLOGICAL CHARACTERIZATION OF A RAT MU-OPIOID RECEPTOR	NEURON			English	Article							INHIBIT ADENYLATE-CYCLASE; SITE-DIRECTED ALKYLATION; KAPPA-OPIATE AGONISTS; NALORPHINE-LIKE DRUGS; CHRONIC SPINAL DOG; BINDING-SITES; HIGH-AFFINITY; HETEROLOGOUS DESENSITIZATION; EXPRESSION CLONING; MORPHINE-LIKE	We have isolated a rat cDNA clone that displays 75% amino acid homology with the mouse delta and rat kappa opioid receptors. The cDNA (designated pRMuR-12) encodes a protein of 398 amino acids comprising, in part, seven hydrophobic domains similar to those described for other G protein-linked receptors. Data from binding assays conducted with COS-1 cells transiently transfected with a CMV mammalian expression vector containing the full coding region of pRMuR-12 demonstrated mu receptor selectivity. In situ hybridization mRNA analysis revealed an mRNA distribution in rat brain that corresponds well to the distribution of binding sites labeled with mu-selective ligands. Based upon these observations, we conclude that pRMuR-12 encodes a mu opioid receptor.			THOMPSON, RC (corresponding author), UNIV MICHIGAN, MENTAL HLTH RES INST, ANN ARBOR, MI 48109 USA.				NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [P30AM034933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA002265] Funding Source: NIH RePORTER; NIADDK NIH HHS [P30-AM34933] Funding Source: Medline; NIDA NIH HHS [NIDA RO1 DA02265] Funding Source: Medline	NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		ATTALI B, 1989, J NEUROCHEM, V52, P360, DOI 10.1111/j.1471-4159.1989.tb09130.x; BARCHFELD CC, 1984, BIOCHEM BIOPH RES CO, V121, P641, DOI 10.1016/0006-291X(84)90230-4; BESSE D, 1990, BRAIN RES, V521, P15, DOI 10.1016/0006-8993(90)91519-M; BESSE D, 1991, BRAIN RES, V548, P287, DOI 10.1016/0006-8993(91)91134-M; BIDLACK JM, 1980, LIFE SCI, V27, P331, DOI 10.1016/0024-3205(80)90201-5; BRAUN T, 1991, EMBO J, V10, P1885, DOI 10.1002/j.1460-2075.1991.tb07714.x; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHEN C, 1993, MOL CELL BIOL, V44, P8; CHEN Y, 1993, MOL PHARMACOL, V44, P8; CHO TM, 1981, LIFE SCI, V28, P2651, DOI 10.1016/0024-3205(81)90723-2; CHO TM, 1986, P NATL ACAD SCI USA, V83, P4138, DOI 10.1073/pnas.83.12.4138; CHOW T, 1983, MOL PHARMACOL, V24, P203; CLARK RB, 1989, MOL PHARMACOL, V36, P343; DEMOLIOUMASON CD, 1984, FEBS LETT, V170, P378, DOI 10.1016/0014-5793(84)81348-4; EVANS CJ, 1992, SCIENCE, V258, P1952, DOI 10.1126/science.1335167; GILBERT PE, 1976, J PHARMACOL EXP THER, V198, P66; GILLAN MGC, 1982, BRIT J PHARMACOL, V77, P461, DOI 10.1111/j.1476-5381.1982.tb09319.x; GOLDSTEIN A, 1989, MOL PHARMACOL, V36, P265; GOLDSTEIN A, 1984, MOL PHARMACOL, V25, P343; HERLING S, 1981, LIFE SCI, V28, P1571, DOI 10.1016/0024-3205(81)90311-8; HOWELLS RD, 1982, J PHARMACOL EXP THER, V222, P629; HSIA JA, 1984, J BIOL CHEM, V259, P1086; IYENGAR S, 1986, LIFE SCI, V39, P637, DOI 10.1016/0024-3205(86)90045-7; JAMES IF, 1984, MOL PHARMACOL, V25, P337; KIEFFER BL, 1992, P NATL ACAD SCI USA, V89, P12048, DOI 10.1073/pnas.89.24.12048; KOSKI G, 1981, P NATL ACAD SCI-BIOL, V78, P4185, DOI 10.1073/pnas.78.7.4185; LEANDER JD, 1985, J PHARMACOL EXP THER, V234, P463; LUTZ RA, 1992, J RECEPTOR RES, V12, P267, DOI 10.3109/10799899209074796; MANECKJEE R, 1985, P NATL ACAD SCI USA, V82, P594, DOI 10.1073/pnas.82.2.594; MANSOUR A, 1988, TRENDS NEUROSCI, V11, P308, DOI 10.1016/0166-2236(88)90093-8; MANSOUR A, 1987, J NEUROSCI, V7, P2445; MANSOUR A, 1993, ANATOMICAL DISTRIBUT; MANZANARES J, 1990, NEUROENDOCRINOLOGY, V52, P200, DOI 10.1159/000125582; MARTIN WR, 1976, J PHARMACOL EXP THER, V197, P517; MCLEAN S, 1986, BRAIN RES, V378, P49, DOI 10.1016/0006-8993(86)90285-4; MENG F, 1993, IN PRESS P NATL ACAD; MORLEY JE, 1983, PEPTIDES, V4, P797, DOI 10.1016/0196-9781(83)90069-4; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; NOCK B, 1988, EUR J PHARMACOL, V154, P27, DOI 10.1016/0014-2999(88)90359-7; PASTERNAK GW, 1986, LIFE SCI, V38, P1889, DOI 10.1016/0024-3205(86)90217-1; PASTERNAK GW, 1975, NATURE, V253, P563, DOI 10.1038/253563a0; PASTERNAK GW, 1993, CLIN NEUROPHARMACOL, V16, P1, DOI 10.1097/00002826-199302000-00001; PUTTFARCKEN PS, 1988, MOL PHARMACOL, V33, P520; ROCHE PC, 1992, ENDOCRINOLOGY, V131, P268, DOI 10.1210/en.131.1.268; ROTHMAN RB, 1987, PEPTIDES, V8, P1015, DOI 10.1016/0196-9781(87)90130-6; RUEGG UT, 1980, EUR J PHARMACOL, V64, P367, DOI 10.1016/0014-2999(80)90247-2; SCHOFIELD PR, 1989, EMBO J, V8, P489, DOI 10.1002/j.1460-2075.1989.tb03402.x; SIMON EJ, 1991, MED RES REV, V11, P357, DOI 10.1002/med.2610110402; SIMON EJ, 1975, SCIENCE, V190, P389, DOI 10.1126/science.1182043; SIMONDS WF, 1980, P NATL ACAD SCI-BIOL, V77, P4623, DOI 10.1073/pnas.77.8.4623; TEMPEL A, 1987, P NATL ACAD SCI USA, V84, P4308, DOI 10.1073/pnas.84.12.4308; UEDA H, 1987, NEUROSCI LETT, V75, P339, DOI 10.1016/0304-3940(87)90546-5; UNTERWALD EM, 1991, BRAIN RES, V562, P57, DOI 10.1016/0006-8993(91)91186-5; WOLOZIN BL, 1981, P NATL ACAD SCI-BIOL, V78, P6181, DOI 10.1073/pnas.78.10.6181; WOOD PL, 1982, NEUROPHARMACOLOGY, V21, P487, DOI 10.1016/0028-3908(82)90038-7; WOOD PL, 1988, PEPTIDES, V1, P49; XIE GX, 1992, P NATL ACAD SCI USA, V89, P4124, DOI 10.1073/pnas.89.9.4124; XIE YB, 1990, J BIOL CHEM, V265, P21411; YASUDA K, 1993, IN PRESS P NATL ACAD; 1991, PROGRAM MANUAL GCG P	60	396	405	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1993	11	5					903	913		10.1016/0896-6273(93)90120-G	http://dx.doi.org/10.1016/0896-6273(93)90120-G			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MJ041	8240812	Green Submitted			2022-12-24	WOS:A1993MJ04100012
J	HOYLE, GW; MERCER, EH; PALMITER, RD; BRINSTER, RL				HOYLE, GW; MERCER, EH; PALMITER, RD; BRINSTER, RL			EXPRESSION OF NGF IN SYMPATHETIC NEURONS LEADS TO EXCESSIVE AXON OUTGROWTH FROM GANGLIA BUT DECREASED TERMINAL INNERVATION WITHIN TISSUES	NEURON			English	Article							NERVE GROWTH-FACTOR; DOPAMINE-BETA-HYDROXYLASE; SUPERIOR CERVICAL-GANGLION; TRANSGENIC MICE; TARGET ORGANS; ADULT-RATS; CELLS; CHICK; PROTEIN; GUANETHIDINE	The effects of nerve growth factor (NGF) on sympathetic axon growth were investigated by generating transgenic mice in which the beta subunit of NGF was expressed in sympathetic neurons using the human dopamine beta-hydroxylase (DBH) promoter. In DBH-NGF mice, the sympathetic trunk and nerves growing to peripheral tissues were enlarged and contained an increased number of sympathetic fibers. Although sympathetic axons reached peripheral tissues, terminal sympathetic innervation within tissues was decreased in DBH-NGF mice. This effect could be reversed in the pancreas by overexpression of NGF in pancreatic islets. The observations are consistent with a model in which NGF gradients are not required to guide sympathetic axons to their targets, but are required for the establishment of the normal density and pattern of sympathetic innervation within target tissues.	UNIV WASHINGTON,HOWARD HUGHES MED INST,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT BIOCHEM,SEATTLE,WA 98195	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	HOYLE, GW (corresponding author), UNIV PENN,SCH VET MED,REPROD PHYSIOL LAB,PHILADELPHIA,PA 19104, USA.		Mercer, Eric H/AAX-6173-2021	Mercer, Eric H/0000-0002-6737-765X; Brinster, Ralph/0000-0003-1408-7656	NICHD NIH HHS [HD 23657, HD 09172] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD009172, R37HD009172, R37HD023657] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALOE L, 1977, BRAIN RES, V133, P358, DOI 10.1016/0006-8993(77)90772-7; BASI GS, 1987, CELL, V49, P785, DOI 10.1016/0092-8674(87)90616-7; BRINSTER RL, 1985, P NATL ACAD SCI USA, V82, P4438, DOI 10.1073/pnas.82.13.4438; CAMPENOT RB, 1977, P NATL ACAD SCI USA, V74, P4516, DOI 10.1073/pnas.74.10.4516; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; CROSSLAND WJ, 1979, J COMP NEUROL, V185, P87, DOI 10.1002/cne.901850106; DELATORRE JC, 1980, J NEUROSCI METH, V3, P1, DOI 10.1016/0165-0270(80)90029-1; DIAMOND J, 1987, P NATL ACAD SCI USA, V84, P6596, DOI 10.1073/pnas.84.18.6596; EDWARDS RH, 1989, CELL, V58, P161, DOI 10.1016/0092-8674(89)90412-1; EDWARDS RH, 1988, MOL CELL BIOL, V8, P2456, DOI 10.1128/MCB.8.6.2456; EMMELIN N, 1961, BRIT J PHARM CHEMOTH, V16, P315, DOI 10.1111/j.1476-5381.1961.tb01090.x; GUNDERSEN RW, 1979, SCIENCE, V206, P1079, DOI 10.1126/science.493992; GUNDERSEN RW, 1980, J CELL BIOL, V87, P546, DOI 10.1083/jcb.87.3.546; HAYASHI M, 1985, DEV BIOL, V108, P49, DOI 10.1016/0012-1606(85)90008-9; HENDRY IA, 1976, J NEUROCYTOL, V5, P351, DOI 10.1007/BF01175120; HENDRY IA, 1977, J NEUROCYTOL, V6, P299, DOI 10.1007/BF01175193; JOHNSON EM, 1976, J PHARMACOL EXP THER, V196, P53; JOHNSON EM, 1975, J PHARMACOL EXP THER, V193, P503; KAPUR RP, 1991, NEURON, V7, P717, DOI 10.1016/0896-6273(91)90275-5; KARASEK M, 1983, PINEAL RES REV, V1, P1; KLINGMAN GERDA I., 1967, INT J NEUROPHARMACOL, V6, P501; KORSCHING S, 1988, DEV BIOL, V126, P40, DOI 10.1016/0012-1606(88)90236-9; KORSCHING S, 1983, NEUROSCI LETT, V39, P1, DOI 10.1016/0304-3940(83)90155-6; KORSCHING S, 1983, P NATL ACAD SCI-BIOL, V80, P3513, DOI 10.1073/pnas.80.11.3513; KOSTRZEWA RM, 1974, PHARMACOL REV, V26, P199; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; Levi-Montalcini R, 1976, Prog Brain Res, V45, P235, DOI 10.1016/S0079-6123(08)60993-0; LEVI-MONTALCINI RITA, 1966, HARVEY LECT, V60, P217; LEVIMONTALCINI R, 1960, P NATL ACAD SCI USA, V46, P373, DOI 10.1073/pnas.46.3.373; LEVIMONTALCINI R, 1960, P NATL ACAD SCI USA, V46, P384, DOI 10.1073/pnas.46.3.384; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; LIU YC, 1991, NEURON, V6, P411, DOI 10.1016/0896-6273(91)90249-Y; LO D, 1988, CELL, V53, P159, DOI 10.1016/0092-8674(88)90497-7; MERCER EH, 1991, NEURON, V7, P703, DOI 10.1016/0896-6273(91)90274-4; NAKAMURA H, 1989, J NEUROSCI, V9, P3776; OLSON L, 1967, Z ZELLFORSCH MIK ANA, V81, P155, DOI 10.1007/BF02075968; OWEN DJ, 1989, BRAIN RES, V476, P248, DOI 10.1016/0006-8993(89)91245-6; PALMITER RD, 1991, P NATL ACAD SCI USA, V88, P478, DOI 10.1073/pnas.88.2.478; PEARCE FL, 1986, J PHYSIOL-LONDON, V372, P379, DOI 10.1113/jphysiol.1986.sp016014; RUBIN E, 1985, J NEUROSCI, V5, P673; SCHECTERSON LC, 1992, NEURON, V9, P449, DOI 10.1016/0896-6273(92)90183-E; STACH RW, 1974, J BIOL CHEM, V249, P6668; TEITELMAN G, 1979, P NATL ACAD SCI USA, V76, P509, DOI 10.1073/pnas.76.1.509; THOENEN H, 1971, P NATL ACAD SCI USA, V68, P1598, DOI 10.1073/pnas.68.7.1598; ULLRICH A, 1983, NATURE, V303, P821, DOI 10.1038/303821a0; UNSICKER K, 1978, P NATL ACAD SCI USA, V75, P3498, DOI 10.1073/pnas.75.7.3498; ZUBER MX, 1989, NATURE, V341, P345, DOI 10.1038/341345a0	48	90	95	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1993	10	6					1019	1034		10.1016/0896-6273(93)90051-R	http://dx.doi.org/10.1016/0896-6273(93)90051-R			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LK373	8318227				2022-12-24	WOS:A1993LK37300003
J	CARSON, MJ; BEHRINGER, RR; BRINSTER, RL; MCMORRIS, FA				CARSON, MJ; BEHRINGER, RR; BRINSTER, RL; MCMORRIS, FA			INSULIN-LIKE GROWTH FACTOR-I INCREASES BRAIN GROWTH AND CENTRAL-NERVOUS-SYSTEM MYELINATION IN TRANSGENIC MICE	NEURON			English	Article							2',3'-CYCLIC NUCLEOTIDE 3'-PHOSPHODIESTERASE; SNELL DWARF MOUSE; RAT-BRAIN; OLIGODENDROCYTE DEVELOPMENT; GENE-EXPRESSION; SOMATOMEDIN-C; CEREBRAL MYELINOGENESIS; CHOROID-PLEXUS; GLIAL-CELLS; IGF-I	Insulin-like growth factor I (IGF-I) is a potent regulator of oligodendrocyte development and myelination in vitro, but its effect on myelination in vivo has never been tested directly. Therefore, we examined brain growth and myelination in a transgenic mouse line that overexpresses IGF-I. By postnatal day 55, when brain growth and myelination are essentially complete in normal mice, the brains of transgenic mice were 55% larger than those of controls owing to an increase in cell size and apparently in cell number. Most or all brain structures appeared to be affected. At the same time, total myelin content of the transgenic mice was 130% greater than that of controls. Oligodendrocyte number as a percentage of total cell number was not increased in the transgenic mouse brains; the increase in myelin content was primarily the result of an increase in myelin production per oligodendrocyte. These findings indicate that IGF-I is a potent inducer of brain growth and myelination in vivo.	WISTAR INST ANAT & BIOL,PHILADELPHIA,PA 19104; UNIV PENN,SCH VET MED,PHILADELPHIA,PA 19104	The Wistar Institute; University of Pennsylvania				Brinster, Ralph/0000-0003-1408-7656	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS011036, R01NS026119, F32NS011036] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 11036, NS 26119] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABNEY ER, 1981, DEV BIOL, V83, P301, DOI 10.1016/0012-1606(81)90476-0; BALLOTTI R, 1987, EMBO J, V6, P3633, DOI 10.1002/j.1460-2075.1987.tb02695.x; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; BASKIN DG, 1988, TRENDS NEUROSCI, V11, P107, DOI 10.1016/0166-2236(88)90155-5; BONDY CA, 1991, J NEUROSCI, V11, P3442; BRAUN PE, 1988, J NEUROSCI, V8, P3057; BRINSTER RL, 1985, P NATL ACAD SCI USA, V82, P4438, DOI 10.1073/pnas.82.13.4438; BROWN AL, 1986, J BIOL CHEM, V261, P3144; DELANEY AJ, 1981, J NUTR, V111, P746, DOI 10.1093/jn/111.4.746; DERCOLE AJ, 1984, P NATL ACAD SCI-BIOL, V81, P935, DOI 10.1073/pnas.81.3.935; EGWIM PO, 1986, COMP BIOCHEM PHYS A, V83, P67, DOI 10.1016/0300-9629(86)90089-7; FAGIN JA, 1989, ENDOCRINOLOGY, V125, P2385, DOI 10.1210/endo-125-5-2385; FROESCH ER, 1985, ANNU REV PHYSIOL, V47, P443; GABBOTT PLA, 1987, NEUROSCIENCE, V21, P833, DOI 10.1016/0306-4522(87)90040-6; GHANDOUR MS, 1980, NEUROSCIENCE, V5, P559, DOI 10.1016/0306-4522(80)90053-6; GRANT DB, 1973, ARCH DIS CHILD, V48, P596, DOI 10.1136/adc.48.8.596; HAN VKM, 1987, J NEUROSCI, V7, P501; HINTZ RL, 1978, J PEDIATR-US, V92, P153, DOI 10.1016/S0022-3476(78)80099-7; HODGKINSON SC, 1991, ENDOCRINOLOGY, V129, P2085, DOI 10.1210/endo-129-4-2085; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; HYNES MA, 1988, MOL ENDOCRINOL, V2, P47, DOI 10.1210/mend-2-1-47; KING RA, 1988, J ENDOCRINOL, V119, P117, DOI 10.1677/joe.0.1190117; KOMOLY S, 1992, P NATL ACAD SCI USA, V89, P1894, DOI 10.1073/pnas.89.5.1894; KRIGMAN MR, 1976, BRAIN RES, V107, P239, DOI 10.1016/0006-8993(76)90224-9; KURIHARA T, 1967, J NEUROCHEM, V14, P1167, DOI 10.1111/j.1471-4159.1967.tb06164.x; LAMSON G, 1989, ENDOCRINOLOGY, V125, P1100, DOI 10.1210/endo-125-2-1100; LEVINE SM, 1988, J NEUROSCI, V8, P3992; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUND PK, 1986, J BIOL CHEM, V261, P4539; MATHEWS LS, 1988, ENDOCRINOLOGY, V123, P2827, DOI 10.1210/endo-123-6-2827; MATHEWS LS, 1986, P NATL ACAD SCI USA, V83, P9343, DOI 10.1073/pnas.83.24.9343; MCMORRIS FA, 1983, J NEUROCHEM, V41, P506, DOI 10.1111/j.1471-4159.1983.tb04768.x; MCMORRIS FA, 1990, ANN NY ACAD SCI, V605, P101, DOI 10.1111/j.1749-6632.1990.tb42385.x; MCMORRIS FA, 1988, J NEUROSCI RES, V21, P199, DOI 10.1002/jnr.490210212; MCMORRIS FA, 1986, P NATL ACAD SCI USA, V83, P822, DOI 10.1073/pnas.83.3.822; MORELL P, 1989, BASIC NEUROCHEMISTRY, P109; MOZELL RL, 1991, J NEUROSCI RES, V30, P382, DOI 10.1002/jnr.490300214; NIELSEN FC, 1991, J NEUROCHEM, V56, P12, DOI 10.1111/j.1471-4159.1991.tb02556.x; NOGUCHI T, 1982, J NEUROCHEM, V38, P257, DOI 10.1111/j.1471-4159.1982.tb10878.x; NOGUCHI T, 1982, J NEUROCHEM, V39, P1693, DOI 10.1111/j.1471-4159.1982.tb08004.x; NOGUCHI T, 1985, NEUROCHEM RES, V10, P1097, DOI 10.1007/BF00965884; Norton W., 1984, OLIGODENDROGLIA; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; OOI GT, 1990, MOL CELL ENDOCRINOL, V71, pC39, DOI 10.1016/0303-7207(90)90243-2; PELTON EW, 1977, NEUROLOGY, V27, P282, DOI 10.1212/WNL.27.3.282; PHILLIPS LS, 1979, AM J CLIN NUTR, V32, P1082, DOI 10.1093/ajcn/32.5.1082; PHILLIPS LS, 1978, ENDOCRINOLOGY, V103, P121, DOI 10.1210/endo-103-1-121; PROHASKA JR, 1973, ANAL BIOCHEM, V56, P275, DOI 10.1016/0003-2697(73)90189-9; ROTWEIN P, 1988, P NATL ACAD SCI USA, V85, P265, DOI 10.1073/pnas.85.1.265; SHEMER J, 1987, J BIOL CHEM, V262, P7693; Sims N.R., 1978, ADV NEUROCHEMISTRY, V3, P1; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STURROCK RR, 1974, J ANAT, V117, P37; STURROCK RR, 1976, J ANAT, V122, P521; STYLIANOPOULOU F, 1988, P NATL ACAD SCI USA, V85, P141, DOI 10.1073/pnas.85.1.141; SUGISAKI T, 1985, NEUROCHEM RES, V10, P767, DOI 10.1007/BF00964534; SWANSON LW, 1985, NATURE, V317, P363, DOI 10.1038/317363a0; VOGEL US, 1988, J NEUROCHEM, V50, P1667, DOI 10.1111/j.1471-4159.1988.tb02461.x; WEST DC, 1985, ANAL BIOCHEM, V147, P289, DOI 10.1016/0003-2697(85)90274-X; WIGGINS RC, 1982, BRAIN RES REV, V4, P151, DOI 10.1016/0165-0173(82)90016-9; WOOD TL, 1990, MOL ENDOCRINOL, V4, P1257, DOI 10.1210/mend-4-8-1257; YOUNG JK, 1991, GLIA, V4, P602, DOI 10.1002/glia.440040607; [No title captured]	63	408	417	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1993	10	4					729	740		10.1016/0896-6273(93)90173-O	http://dx.doi.org/10.1016/0896-6273(93)90173-O			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KY501	8386530				2022-12-24	WOS:A1993KY50100015
J	DIVERSEPIERLUISSI, M; DUNLAP, K				DIVERSEPIERLUISSI, M; DUNLAP, K			DISTINCT, CONVERGENT 2ND MESSENGER PATHWAYS MODULATE NEURONAL CALCIUM CURRENTS	NEURON			English	Article							PROTEIN-KINASE-C; RAT SYMPATHETIC NEURONS; CHICK SENSORY NEURONS; GTP-BINDING PROTEINS; OKADAIC ACID; MEMBRANE CURRENTS; GANGLION NEURONS; CA2+ CHANNELS; CELL-LINE; INHIBITION	Norepinephrine (NE) and gamma-aminobutyric acid (GABA) inhibit N-type calcium channels in embryonic chick sensory neurons. We demonstrate here that the modulatory actions of the two transmitters are mediated through distinct biochemical pathways. Intracellular application of the pseudosubstrate inhibitor for protein kinase C blocks the inhibition produced by NE (and the protein kinase C activator oleoylacetylglycerol), but not that produced by GABA. Calcium current inhibition produced by oleoylacetylglycerol occludes inhibition by subsequent application of NE; GABA-mediated inhibition, however, is not eliminated by prior activation of protein kinase C. These results demonstrate that multiple biochemical pathways converge to control N-type calcium channel function.			DIVERSEPIERLUISSI, M (corresponding author), TUFTS UNIV,SCH MED,DEPT PHYSIOL,BOSTON,MA 02111, USA.				NINDS NIH HHS [NS16483, NS28815] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R55NS028815, R01NS028815, R01NS016483] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARTALEJO CR, 1991, J PHYSIOL-LONDON, V432, P681, DOI 10.1113/jphysiol.1991.sp018406; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; BEECH DJ, 1992, NEURON, V8, P97, DOI 10.1016/0896-6273(92)90111-P; BEECH DJ, 1991, P NATL ACAD SCI USA, V88, P652, DOI 10.1073/pnas.88.2.652; BELL RM, 1991, J BIOL CHEM, V266, P4661; BERNHEIM L, 1991, NEURON, V6, P859, DOI 10.1016/0896-6273(91)90226-P; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; BLEY KR, 1989, NEURON, V4, P379; BOLAND LM, 1991, J NEUROSCI, V11, P1140; BOWERY NG, 1990, ADV BIOCHEM PSYCHOPH, V21, P395; BUSHFIELD M, 1991, BIOCHEM J, V274, P317, DOI 10.1042/bj2740317; BUTTNER N, 1989, NATURE, V342, P553, DOI 10.1038/342553a0; CANFIELD DR, 1984, BRIT J PHARMACOL, V82, P557, DOI 10.1111/j.1476-5381.1984.tb10794.x; COX DH, 1992, J NEUROSCI, V12, P906; DERIEMER SA, 1985, NATURE, V313, P313, DOI 10.1038/313313a0; DOERNER D, 1988, J NEUROSCI, V10, P1669; DOLPHIN AC, 1987, J PHYSIOL-LONDON, V386, P1; DUNLAP K, 1981, BRIT J PHARMACOL, V74, P579, DOI 10.1111/j.1476-5381.1981.tb10467.x; DUNLAP K, 1981, J PHYSIOL-LONDON, V317, P519, DOI 10.1113/jphysiol.1981.sp013841; ELMSLIE KS, 1990, NEURON, V5, P75, DOI 10.1016/0896-6273(90)90035-E; EWALD DA, 1988, P NATL ACAD SCI USA, V85, P3633, DOI 10.1073/pnas.85.10.3633; EWALD DA, 1989, NEURON, V2, P1185, DOI 10.1016/0896-6273(89)90185-2; FORSCHER P, 1985, J GEN PHYSIOL, V85, P743, DOI 10.1085/jgp.85.5.743; FORSCHER P, 1986, J PHYSIOL-LONDON, V379, P131, DOI 10.1113/jphysiol.1986.sp016244; GAGE PW, 1992, TRENDS NEUROSCI, V15, P46, DOI 10.1016/0166-2236(92)90025-4; GRASSI F, 1989, NEUROSCI LETT, V105, P113, DOI 10.1016/0304-3940(89)90021-9; HAMILL OP, 1981, PFLUGERS ARCH, V391, P81; HESCHELER J, 1988, PFLUG ARCH EUR J PHY, V412, P248, DOI 10.1007/BF00582504; HESCHELER J, 1987, NATURE, V325, P445, DOI 10.1038/325445a0; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; HOCKBERGER P, 1989, NATURE, V338, P340, DOI 10.1038/338340a0; HOLZ GG, 1986, NATURE, V319, P670, DOI 10.1038/319670a0; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; ICHINOSE M, 1991, BRAIN RES, V549, P146, DOI 10.1016/0006-8993(91)90611-X; IKEDA SR, 1989, J PHYSIOL-LONDON, V409, P221, DOI 10.1113/jphysiol.1989.sp017494; KASAI H, 1989, PFLUG ARCH EUR J PHY, V414, P145, DOI 10.1007/BF00580956; KASAI H, 1991, P NATL ACAD SCI USA, V88, P8855, DOI 10.1073/pnas.88.19.8855; KASAI H, 1987, Neuroscience Research, V4, P228, DOI 10.1016/0168-0102(87)90014-9; KLEUSS C, 1991, NATURE, V353, P43, DOI 10.1038/353043a0; LEWIS DL, 1986, P NATL ACAD SCI USA, V83, P9035, DOI 10.1073/pnas.83.23.9035; MARCHETTI C, 1986, PFLUG ARCH EUR J PHY, V406, P104, DOI 10.1007/BF00586670; MATHIE A, 1992, NEURON, V8, P907, DOI 10.1016/0896-6273(92)90205-R; MOCHIDA S, 1988, NEUROSCI LETT, V86, P201, DOI 10.1016/0304-3940(88)90571-X; ONO Y, 1989, P NATL ACAD SCI USA, V86, P3099, DOI 10.1073/pnas.86.9.3099; ORR JW, 1992, J BIOL CHEM, V267, P15263; PLUMMER MR, 1991, J NEUROSCI, V11, P2339; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; RANE SG, 1989, NEURON, V3, P239, DOI 10.1016/0896-6273(89)90037-8; RANE SG, 1986, P NATL ACAD SCI USA, V83, P184, DOI 10.1073/pnas.83.1.184; RANE SG, 1990, G PROTEINS, P107; SHEN KZ, 1991, PFLUG ARCH EUR J PHY, V418, P614, DOI 10.1007/BF00370580; SONG SY, 1989, BRAIN RES, V494, P383, DOI 10.1016/0006-8993(89)90609-4; SONG SY, 1991, PFLUG ARCH EUR J PHY, V418, P592, DOI 10.1007/BF00370576; STRONG JA, 1987, NATURE, V325, P714, DOI 10.1038/325714a0; SUGANUMA M, 1988, P NATL ACAD SCI USA, V85, P1768, DOI 10.1073/pnas.85.6.1768; TSIEN RW, 1988, TRENDS NEUROSCI, V14, P46; WANKE E, 1987, P NATL ACAD SCI USA, V84, P4313, DOI 10.1073/pnas.84.12.4313; WHITE RE, 1991, NATURE, V351, P5570; YATANI A, 1987, SCIENCE, V238, P1288, DOI 10.1126/science.2446390	59	69	69	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1993	10	4					753	760		10.1016/0896-6273(93)90175-Q	http://dx.doi.org/10.1016/0896-6273(93)90175-Q			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KY501	8097399				2022-12-24	WOS:A1993KY50100017
J	FUENTES, ME; TAYLOR, P				FUENTES, ME; TAYLOR, P			CONTROL OF ACETYLCHOLINESTERASE GENE-EXPRESSION DURING MYOGENESIS	NEURON			English	Article							MESSENGER-RNA STABILITY; ALPHA-SUBUNIT GENE; SKELETAL-MUSCLE; RECEPTOR GENES; MOUSE MUSCLE; CELLS; ENHANCER; PROTEIN; IDENTIFICATION; DEGRADATION	Acetylcholinesterase (AChE) and the nicotinic acetylcholine receptor show enhanced expression upon differentiation of C2-C12 myoblasts into myotubes. Northern blots and RNAase protection show substantial increases in the mRNAs encoding both proteins. In contrast to transcriptional control of gene expression of acetylcholine receptor subunits during differentiation, Ache mRNA levels increase through stabilization of the transcript. The transcriptional rate remains unchanged during Ache mRNA accumulation, whereas transcription rate increase for the receptor subunits. Inhibition of protein synthesis produces a dramatic superinduction of Ache mRNA in undifferentiated cells without affecting transcription rates, suggesting the presence of labile proteins that uniquely destabilize the mRNA. Hence, Ache mRNA in myoblasts shows rapid turnover, and upon differentiation, its level is increased by slowing the rate of mRNA degradation.			FUENTES, ME (corresponding author), UNIV CALIF SAN DIEGO,DEPT PHARMACOL 0636,LA JOLLA,CA 92093, USA.		Fuentes, Maria/HGA-8617-2022		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM018360, R01GM024337, R01GM018360] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-24337, GM-18360] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANGLISTER L, 1978, J MOL BIOL, V125, P293, DOI 10.1016/0022-2836(78)90404-7; ATWATER JA, 1990, ANNU REV GENET, V24, P519; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BALDWIN TJ, 1988, J CELL BIOL, V107, P2271, DOI 10.1083/jcb.107.6.2271; BROCK ML, 1983, CELL, V34, P207, DOI 10.1016/0092-8674(83)90151-4; BUONANNO A, 1986, J BIOL CHEM, V261, P1452; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLEVELAND D W, 1989, New Biologist, V1, P121; EGYHAZIE E, 1975, P NATL ACAD SCI USA, V72, P946; EISENSTEIN RS, 1988, MOL CELL BIOL, V8, P3183, DOI 10.1128/MCB.8.8.3183; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; EVANS S, 1987, J BIOL CHEM, V262, P4911; FAMBROUGH DM, 1979, PHYSIOL REV, V59, P165, DOI 10.1152/physrev.1979.59.1.165; FRAIL DE, 1989, NEURON, V2, P1077, DOI 10.1016/0896-6273(89)90232-8; FUTERMAN AH, 1985, BIOCHEM J, V226, P369, DOI 10.1042/bj2260369; GENNARI K, 1987, J NEUROCHEM, V49, P12, DOI 10.1111/j.1471-4159.1987.tb03386.x; GENOVESE C, 1990, MOL IMMUNOL, V27, P733, DOI 10.1016/0161-5890(90)90082-B; GILMOUR BP, 1991, J BIOL CHEM, V266, P19871; HAAS R, 1986, BIOCHEMISTRY-US, V25, P3098, DOI 10.1021/bi00359a005; HASTINGS KEM, 1982, P NATL ACAD SCI-BIOL, V79, P1553, DOI 10.1073/pnas.79.5.1553; HENTZE MW, 1991, BIOCHIM BIOPHYS ACTA, V1090, P281, DOI 10.1016/0167-4781(91)90191-N; HOWE JG, 1986, P NATL ACAD SCI USA, V83, P9006, DOI 10.1073/pnas.83.23.9006; INESTROSA NC, 1987, J BIOL CHEM, V262, P4441; INESTROSA NC, 1983, EXP CELL RES, V147, P393, DOI 10.1016/0014-4827(83)90221-5; KHALILI K, 1984, J MOL BIOL, V180, P1007, DOI 10.1016/0022-2836(84)90268-7; KLARSFELD A, 1987, BIOCHIMIE, V69, P433, DOI 10.1016/0300-9084(87)90080-0; LAUFER R, 1989, MOL NEUROBIOL, V3, P1, DOI 10.1007/BF02935587; LI Y, 1993, J BIOL CHEM, V268, P3563; LI Y, 1991, J BIOL CHEM, V266, P23083; LWEBUGAMUKASA JS, 1976, BIOCHEMISTRY-US, V15, P1425, DOI 10.1021/bi00652a012; MASSOULIE J, 1988, HDB EXP PHARM, V86, P167; MERLIE J P, 1986, P75; NEPVEU A, 1987, GENE DEV, V1, P938, DOI 10.1101/gad.1.9.938; OMALLEY K, 1985, MOL CELL BIOL, V5, P3476, DOI 10.1128/MCB.5.12.3476; PONTECORVI A, 1988, EMBO J, V7, P1498; PRODY CA, 1991, J BIOL CHEM, V266, P22588; PRODY CA, 1992, NUCLEIC ACIDS RES, V20, P2367, DOI 10.1093/nar/20.9.2367; RACHINSKY TL, 1990, NEURON, V5, P317, DOI 10.1016/0896-6273(90)90168-F; RUBIN LL, 1985, P NATL ACAD SCI USA, V82, P7121, DOI 10.1073/pnas.82.20.7121; SUBRAMANIAM M, 1989, NATURE, V340, P64, DOI 10.1038/340064a0; TAMM I, 1976, J CELL BIOL, V99, P229; THEODORAKIS NG, 1992, MOL CELL BIOL, V12, P791, DOI 10.1128/MCB.12.2.791; TOUTANT JP, 1988, HDB EXP PHARM, V86, P225; WANG Y, 1988, NEURON, V1, P527, DOI 10.1016/0896-6273(88)90183-3; WILSON T, 1988, NATURE, V336, P396, DOI 10.1038/336396a0; YEN TJ, 1988, MOL CELL BIOL, V8, P1224, DOI 10.1128/MCB.8.3.1224	47	70	71	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1993	10	4					679	687		10.1016/0896-6273(93)90169-R	http://dx.doi.org/10.1016/0896-6273(93)90169-R			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KY501	8386528				2022-12-24	WOS:A1993KY50100011
J	SCHNEIDER, LE; ROBERTS, MS; TAGHERT, PH				SCHNEIDER, LE; ROBERTS, MS; TAGHERT, PH			CELL TYPE-SPECIFIC TRANSCRIPTIONAL REGULATION OF THE DROSOPHILA FMRFAMIDE NEUROPEPTIDE GENE	NEURON			English	Article							DOPA DECARBOXYLASE GENE; INSITU HYBRIDIZATION ANALYSIS; TRANSGENIC MICE; FUSION GENES; EXPRESSION; ELEMENTS; MELANOGASTER; ENHANCER; ORGANIZATION; DIVERSITY	We have used lacZ reporter gene constructs to study the promoter/enhancer regions of the Drosophila FMRFamide neuropeptide gene in germ line transformants. FMRFamide is normally expressed in approximately 60 diverse neurons of the larval CNS that represent approximately 15 distinct cell types. An 8 kb FMRFamide DNA fragment (including 5 kb of 5' upstream sequence) was sufficient to direct a pattern of lacZ expression that mimicked nearly all spatial aspects of the normal pattern. This result indicates that the cell-specific regulation of FMRFamide expression is largely generated by transcriptional mechanisms. Reporter gene expression was lost from selected cell types when smaller fragments were tested, suggesting that multiple control regions are included in the FMRFamide promoter. One region (a 300 bp fragment from -476 to -162) acted as an enhancer for 1 of the approximately 15 FMRFamide-positive cell types, the OL2 neurons. These results suggest that, in the mature nervous system, the complex pattern of FMRFamide neuropeptide gene expression derives from the activity of discrete, cell type-specific enhancers that are independently regulated.	WASHINGTON UNIV,SCH MED,DEPT ANAT & NEUROBIOL,ST LOUIS,MO 63110	Washington University (WUSTL)					PHS HHS [21749] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BEALL CJ, 1987, GENE DEV, V1, P510, DOI 10.1101/gad.1.5.510; BOTWELL DDL, 1989, P NATL ACAD SCI USA, V86, P6245; BOTWELL DDL, 1991, P NATL ACAD SCI USA, V88, P6853; BRAY SJ, 1988, EMBO J, V7, P177, DOI 10.1002/j.1460-2075.1988.tb02798.x; CHIN AC, 1990, DNA CELL BIOL, V9, P263, DOI 10.1089/dna.1990.9.263; DUVE H, 1992, P NATL ACAD SCI USA, V89, P2326, DOI 10.1073/pnas.89.6.2326; EVANS PD, 1986, J EXP BIOL, V126, P403; FISHER JA, 1988, CELL, V53, P451; GARABEDIAN MJ, 1986, CELL, V45, P859, DOI 10.1016/0092-8674(86)90560-X; GOTO T, 1989, CELL, V57, P413, DOI 10.1016/0092-8674(89)90916-1; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; HAMMER RE, 1987, SCIENCE, V235, P53, DOI 10.1126/science.2432657; HARDING K, 1989, EMBO J, V8, P1205, DOI 10.1002/j.1460-2075.1989.tb03493.x; HEBENER JF, 1989, J BIOL CHEM, V264, P18844; HIROMI Y, 1987, CELL, V50, P963, DOI 10.1016/0092-8674(87)90523-X; HIRSH J, 1989, DEV GENET, V10, P232, DOI 10.1002/dvg.1020100312; HOWARD K, 1988, GENE DEV, V2, P1037, DOI 10.1101/gad.2.8.1037; HOWARD KR, 1990, DEVELOPMENT, V110, P1223; JOHNSON WA, 1989, GENE DEV, V3, P676, DOI 10.1101/gad.3.5.676; JOHNSON WA, 1990, NATURE, V343, P467, DOI 10.1038/343467a0; KITAMOTO T, 1992, J NEUROSCI, V12, P1628; KONDOH H, 1987, DEV BIOL, V120, P177, DOI 10.1016/0012-1606(87)90116-3; LOW MJ, 1986, SCIENCE, V231, P1002, DOI 10.1126/science.2868526; MANIATIS T, 1987, SCIENCE, V236, P1237, DOI 10.1126/science.3296191; NAMBU JR, 1988, NEURON, V1, P55, DOI 10.1016/0896-6273(88)90209-7; OBRIEN MA, 1991, J COMP NEUROL, V304, P623, DOI 10.1002/cne.903040409; PANKRATZ MJ, 1990, CELL, V61, P309, DOI 10.1016/0092-8674(90)90811-R; ROBERTSON HM, 1988, GENETICS, V118, P461; SCHNEIDER LE, 1988, P NATL ACAD SCI USA, V85, P1993, DOI 10.1073/pnas.85.6.1993; SCHNEIDER LE, 1990, J BIOL CHEM, V265, P6890; SCHNEIDER LE, 1991, J COMP NEUROL, V304, P608, DOI 10.1002/cne.903040408; SCHOLNICK SB, 1991, DEV BIOL, V146, P423, DOI 10.1016/0012-1606(91)90244-W; SCHOLNICK SB, 1983, CELL, V34, P37, DOI 10.1016/0092-8674(83)90134-4; SCHOLNICK SB, 1986, SCIENCE, V234, P998, DOI 10.1126/science.3095924; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Spradling AC, 1986, DROSOPHILA PRACTICAL, P175; STRUHL K, 1991, NEURON, V7, P177, DOI 10.1016/0896-6273(91)90256-Y; SWANSON LW, 1985, NATURE, V317, P363, DOI 10.1038/317363a0; TAGHERT PH, 1990, J NEUROSCI, V10, P1929; TAMURA T, 1985, P NATL ACAD SCI USA, V82, P700; THUMMEL CS, 1988, GENE, V74, P445, DOI 10.1016/0378-1119(88)90177-1; WHITE K, 1986, J COMP NEUROL, V247, P430, DOI 10.1002/cne.902470403; YOUNG WS, 1990, J NEUROENDOCRINOL, V2, P917, DOI 10.1111/j.1365-2826.1990.tb00660.x	43	67	67	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1993	10	2					279	291		10.1016/0896-6273(93)90318-L	http://dx.doi.org/10.1016/0896-6273(93)90318-L			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KP685	8439413				2022-12-24	WOS:A1993KP68500015
J	Cummings, JA; Mulkey, RM; Nicoll, RA; Malenka, RC				Cummings, JA; Mulkey, RM; Nicoll, RA; Malenka, RC			Ca2+ signaling requirements for long-term depression in the hippocampus	NEURON			English	Article							EXCITATORY SYNAPTIC TRANSMISSION; RAT VISUAL-CORTEX; AREA CA1; BLOCKS INDUCTION; POTENTIATION; SLICES; MECHANISMS; CHANNELS; MEMORY; LTD	It has been hypothesized that the direction of synaptic weight change elicited by synaptic activity depends on the magnitude of the activity-dependent rise in intracellular Ca2+ concentration. Several aspects of this hypothesis were examined at the Schaffer collateral CA1 synapse, where both long-term depression (LTD) and long-term potentiation (LTP) can be elicited and are Ca2+ dependent. Brief tetanic stimulation, which normally generated LTP, could induce LTD when Ca2+ entry via NMDA receptors was limited either by moderate concentrations of D-APV or by voltage clamping cells at negative membrane potentials. Repetitive activation of voltage-dependent Ca2+ channels in the absence of afferent stimulation could also elicit an LTD that was Ca2+ dependent and was occluded by prior generation of homosynaptic LTD using prolonged low frequency stimulation. These results provide strong evidence that the minimal requirements for inducing LTD involve simply a transient influx of Ca2+ into the postsynaptic cell, via either NMDA receptors or voltage-dependent Ca2+ channels.	UNIV CALIF SAN FRANCISCO,DEPT PSYCHIAT,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT CELLULAR & MOLEC PHARMACOL,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Cummings, JA (corresponding author), UNIV CALIF SAN FRANCISCO,GRAD PROGRAM NEUROSCI,SAN FRANCISCO,CA 94143, USA.							ARTOLA A, 1993, TRENDS NEUROSCI, V16, P480, DOI 10.1016/0166-2236(93)90081-V; ARTOLA A, 1990, NATURE, V347, P69, DOI 10.1038/347069a0; BASHIR ZI, 1993, EUR J PHARMACOL, V239, P265, DOI 10.1016/0014-2999(93)91009-C; BASHIR ZI, 1991, NATURE, V349, P156, DOI 10.1038/349156a0; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; BROCHER S, 1992, P NATL ACAD SCI USA, V89, P123, DOI 10.1073/pnas.89.1.123; CHRISTIE BR, 1994, HIPPOCAMPUS, V4, P127, DOI 10.1002/hipo.450040203; CHRISTIE BR, 1995, J NEUROPHYSIOL, V74, P1244, DOI 10.1152/jn.1995.74.3.1244; CHRISTOFI G, 1993, J NEUROPHYSIOL, V69, P219, DOI 10.1152/jn.1993.69.1.219; DEBANNE D, 1994, P NATL ACAD SCI USA, V91, P1148, DOI 10.1073/pnas.91.3.1148; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Goda Y, 1996, NEURON, V16, P103, DOI 10.1016/S0896-6273(00)80027-6; HANSE E, 1995, NEUROSCIENCE, V67, P531, DOI 10.1016/0306-4522(95)00090-6; HUANG YY, 1992, SCIENCE, V255, P730, DOI 10.1126/science.1346729; HUERTA PT, 1995, NEURON, V15, P1053, DOI 10.1016/0896-6273(95)90094-2; KERR DS, 1993, SYNAPSE, V14, P305, DOI 10.1002/syn.890140408; KULLMANN DM, 1992, NEURON, V9, P1175, DOI 10.1016/0896-6273(92)90075-O; LINDEN DJ, 1995, ANNU REV NEUROSCI, V18, P319, DOI 10.1146/annurev.ne.18.030195.001535; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; MALENKA RC, 1992, NEURON, V9, P121, DOI 10.1016/0896-6273(92)90227-5; MALENKA RC, 1991, NEURON, V6, P53, DOI 10.1016/0896-6273(91)90121-F; MALINOW R, 1986, NATURE, V320, P529, DOI 10.1038/320529a0; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; PAULSEN O, 1993, EUR J NEUROSCI, V5, P1241, DOI 10.1111/j.1460-9568.1993.tb00909.x; POCKETT S, 1990, EXP BRAIN RES, V80, P196; REGEHR WG, 1992, J NEUROSCI, V12, P4202; SCANZIANI M, 1996, IN PRESS NATURE; SELIG DK, 1995, NEURON, V15, P417, DOI 10.1016/0896-6273(95)90045-4; STANTON PK, 1989, NATURE, V339, P215, DOI 10.1038/339215a0; STANTON PK, 1991, NEUROSCI LETT, V127, P61, DOI 10.1016/0304-3940(91)90895-Z; STENT GS, 1973, P NATL ACAD SCI USA, V70, P997, DOI 10.1073/pnas.70.4.997; STEVENS CF, 1990, NATURE, V347, P16, DOI 10.1038/347016a0; TEYLER TJ, 1994, HIPPOCAMPUS, V4, P623, DOI 10.1002/hipo.450040602; VOLGUSHEV M, 1994, NEUROREPORT, V5, P2069, DOI 10.1097/00001756-199410270-00020; WICKENS JR, 1991, NEUROSCI LETT, V130, P128, DOI 10.1016/0304-3940(91)90244-N; XIE XP, 1992, J NEUROPHYSIOL, V67, P1009, DOI 10.1152/jn.1992.67.4.1009; YANG XD, 1994, J NEUROPHYSIOL, V71, P1586, DOI 10.1152/jn.1994.71.4.1586	41	343	352	0	23	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1996	16	4					825	833		10.1016/S0896-6273(00)80102-6	http://dx.doi.org/10.1016/S0896-6273(00)80102-6			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UG611	8608000	Bronze			2022-12-24	WOS:A1996UG61100015
J	Tomita, K; Ishibashi, M; Nakahara, K; Ang, SL; Nakanishi, S; Guillemot, F; Kageyama, R				Tomita, K; Ishibashi, M; Nakahara, K; Ang, SL; Nakanishi, S; Guillemot, F; Kageyama, R			Mammalian hairy and Enhancer of split homolog 1 regulates differentiation of retinal neurons and is essential for eye morphogenesis	NEURON			English	Article							C-LIKE IMMUNOREACTIVITY; ROD BIPOLAR CELLS; PHOTORECEPTOR DEVELOPMENT INVITRO; DEVELOPING NERVOUS-SYSTEM; RAT RETINA; MOUSE RETINA; DROSOPHILA-MELANOGASTER; NEUROGENESIS; EXPRESSION; PROTEINS	Mammalian hairy and Enhancer of split homolog 1 (HES1), a basic helix-loop-helix factor gene, is expressed in retinal progenitor cells, and its expression decreases as differentiation proceeds. Retinal progenitor cells infected with HES1-transducing retrovirus did not differentiate into mature retinal cells, suggesting that persistent expression of HES1 blocks retinal development. In contrast, in the retina of HES1-null mutant mice, differentiation was accelerated, and rod and horizontal cells appeared prematurely and formed abnormal rosette-like structures. Lens and cornea development was also severely disturbed. Furthermore, in the mutant retina, bipolar cells extensively died and finally disappeared. These studies provide evidence that HES1 regulates differentiation of retinal neurons and is essential for eye morphogenesis.	UNIV STRASBOURG 1, COLL FRANCE,CNRS,INSERM, INST GENET & BIOL MOLEC & CELLULAIRE, F-67404 ILLKIRCH GRAFFENSTADEN, FRANCE; KYOTO UNIV, FAC MED, DEPT ANAT, SAKYO KU, KYOTO 606, JAPAN; KYOTO UNIV, FAC MED, INST IMMUNOL, SAKYO KU, KYOTO 606, JAPAN; RES DEV CORP JAPAN, INHERITANCE & VARIAT, PRESTO, KYOTO 606, JAPAN	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Kyoto University; Kyoto University; Japan Science & Technology Agency (JST)			Guillemot, Francois/AAV-1482-2021	Nakahara, Kiyoshi/0000-0001-6701-6216				ADLER R, 1989, SCIENCE, V243, P391, DOI 10.1126/science.2911751; AKAZAWA C, 1992, J BIOL CHEM, V267, P21879; AKAZAWA C, 1995, J BIOL CHEM, V270, P8730, DOI 10.1074/jbc.270.15.8730; ALTSHULER D, 1993, DEVELOPMENT, V119, P1317; ALTSHULER D, 1992, DEVELOPMENT, V114, P947; ALTSHULER DM, 1991, P RET RES F, V3, P37; BAILEY AM, 1995, GENE DEV, V9, P2609, DOI 10.1101/gad.9.21.2609; BARNSTABLE CJ, 1985, DEV BRAIN RES, V20, P286, DOI 10.1016/0165-3806(85)90116-6; BARNSTABLE CJ, 1984, NEUROSCIENCE, V11, P847, DOI 10.1016/0306-4522(84)90195-7; BARTHOLOMA A, 1994, MECH DEVELOP, V48, P217, DOI 10.1016/0925-4773(94)90061-2; BROWN NL, 1995, CELL, V80, P879, DOI 10.1016/0092-8674(95)90291-0; CAFFE AR, 1989, CURR EYE RES, V8, P1083, DOI 10.3109/02713688908997401; CAMPOSORTEGA JA, 1991, ANNU REV NEUROSCI, V14, P399, DOI 10.1146/annurev.ne.14.030191.002151; CAMPUZANO S, 1992, TRENDS GENET, V8, P202, DOI 10.1016/0168-9525(92)90234-U; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P263, DOI 10.1002/cne.901880205; CHANG GQ, 1993, NEURON, V11, P595, DOI 10.1016/0896-6273(93)90072-Y; DELAMO FF, 1992, DEVELOPMENT, V115, P737; DELPRADO JM, 1984, W ROUX ARCH DEV BIOL, V193, P242; DORSKY RI, 1995, NEURON, V14, P487, DOI 10.1016/0896-6273(95)90305-4; DRAGER UC, 1983, NATURE, V303, P169, DOI 10.1038/303169a0; FEDER JN, 1993, MOL CELL BIOL, V13, P105, DOI 10.1128/MCB.13.1.105; FURUKAWA T, 1992, CELL, V69, P1191, DOI 10.1016/0092-8674(92)90640-X; GREFERATH U, 1990, J COMP NEUROL, V301, P433, DOI 10.1002/cne.903010308; GUILLEMOT F, 1993, MECH DEVELOP, V42, P171, DOI 10.1016/0925-4773(93)90006-J; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; HARRIS WA, 1991, P RET RES F, V3, P95; HICKS D, 1987, J HISTOCHEM CYTOCHEM, V35, P1317, DOI 10.1177/35.11.3655327; ISHIBASHI M, 1994, EMBO J, V13, P1799, DOI 10.1002/j.1460-2075.1994.tb06448.x; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; JAN YN, 1993, CELL, V75, P827, DOI 10.1016/0092-8674(93)90525-U; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; JOHNSON JE, 1990, NATURE, V346, P858, DOI 10.1038/346858a0; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; MIYACHI K, 1978, J IMMUNOL, V121, P2228; NEGISHI K, 1988, NEUROSCI LETT, V94, P247, DOI 10.1016/0304-3940(88)90025-0; NOMURA A, 1994, CELL, V77, P361, DOI 10.1016/0092-8674(94)90151-1; RAYMOND PA, 1991, P RET RES F, V3, P59; REH TA, 1991, P RET RES F, V3, P79; REPKA A, 1992, DEV BIOL, V153, P242, DOI 10.1016/0012-1606(92)90109-T; SASAI Y, 1992, GENE DEV, V6, P2620, DOI 10.1101/gad.6.12b.2620; SHAW G, 1983, EUR J CELL BIOL, V30, P219; SHIMIZU C, 1995, EUR J BIOCHEM, V229, P239, DOI 10.1111/j.1432-1033.1995.0239l.x; Sidman RL, 1961, STRUCTURE EYE, P487; SPARROW JR, 1990, DEV BRAIN RES, V51, P69, DOI 10.1016/0165-3806(90)90259-2; STEIN R, 1988, NEURON, V1, P463, DOI 10.1016/0896-6273(88)90177-8; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; TAKEBAYASHI K, 1994, J BIOL CHEM, V269, P5150; TURNER DL, 1990, NEURON, V4, P833, DOI 10.1016/0896-6273(90)90136-4; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; WATANABE T, 1992, DEVELOPMENT, V114, P899; WATANABE T, 1990, NEURON, V4, P461, DOI 10.1016/0896-6273(90)90058-N; WEINMASTER G, 1991, DEVELOPMENT, V113, P199; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215; ZHANG DR, 1991, VISUAL NEUROSCI, V6, P429, DOI 10.1017/S0952523800001292	54	286	292	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1996	16	4					723	734		10.1016/S0896-6273(00)80093-8	http://dx.doi.org/10.1016/S0896-6273(00)80093-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UG611	8607991	Bronze			2022-12-24	WOS:A1996UG61100006
J	Itasaki, N; Nakamura, H				Itasaki, N; Nakamura, H			A role for gradient en expression in positional specification on the optic tectum	NEURON			English	Article							CLONALLY RELATED CELLS; RETINAL AXONS; TOPOGRAPHIC ORDER; RETINOTECTAL PROJECTION; ROSTROCAUDAL POLARITY; NERVOUS-SYSTEM; CHICK; HOMEOBOX; GUIDANCE; INVITRO	The optic tectum, the primary visual center in nonmammalian vertebrates, receives retinal fibers in a topographically ordered manner. en (en-1 and en-2, homologs of the Drosophila segment polarity gene engrailed) is expressed in the tectal primordium in a rostrocaudal gradient, around the stage when the polarity of the retinotectal projection map is being determined. Here we report that scattered en expression, caused by retroviral gene transfer, perturbed the retinotopic order. Nasal retinal fibers, which normally recognize the caudal side of the tectum (strong en expression side) as a target, arborized at ectopic sites, as if they found their targets, or degenerated. Temporal retinal fibers, which normally recognize the rostral side of the tectum (weak en expression side) as a target, were also affected in some cases by degeneration or prevention of innervation in the tectum. These results suggest that gradient en expression defines the positional identity of the tectum along the rostrocaudal axis.			Itasaki, N (corresponding author), TOHOKU UNIV,INST DEV AGING & CANC,DEPT MOLEC NEUROBIOL,AOBA KU,SEIRYO MACHI 4-1,SENDAI,MIYAGI 98077,JAPAN.			Itasaki, Nobue/0000-0003-0587-9141				BAIER H, 1992, SCIENCE, V255, P472, DOI 10.1126/science.1734526; BONHOEFFER F, 1982, EMBO J, V1, P427, DOI 10.1002/j.1460-2075.1982.tb01186.x; CEPKO C, 1991, CURR PROT MOL BIOL S, V17; CLINE HT, 1991, TRENDS NEUROSCI, V14, P104, DOI 10.1016/0166-2236(91)90071-2; CROSSLAND WJ, 1979, J COMP NEUROL, V185, P87, DOI 10.1002/cne.901850106; DAVIS CA, 1988, GENE DEV, V2, P1736, DOI 10.1101/gad.2.12b.1736; DAVIS CA, 1991, DEVELOPMENT, V111, P287; FAWCETT JW, 1985, TRENDS NEUROSCI, V8, P201, DOI 10.1016/0166-2236(85)90079-7; FAWCETT JW, 1984, P NATL ACAD SCI-BIOL, V81, P5589, DOI 10.1073/pnas.81.17.5589; GARDNER CA, 1988, J NEUROSCI RES, V21, P426, DOI 10.1002/jnr.490210234; GRAY GE, 1991, NEURON, V6, P211, DOI 10.1016/0896-6273(91)90357-6; GRAY GE, 1988, P NATL ACAD SCI USA, V85, P7356, DOI 10.1073/pnas.85.19.7356; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HOLT CE, 1993, J NEUROBIOL, V24, P1400, DOI 10.1002/neu.480241011; HUGHES SH, 1987, J VIROL, V61, P3004, DOI 10.1128/JVI.61.10.3004-3012.1987; INGHAM PW, 1992, CELL, V68, P221, DOI 10.1016/0092-8674(92)90467-Q; ITASAKI N, 1991, DEVELOPMENT, V113, P1133; ITASAKI N, 1992, NEURON, V8, P787, DOI 10.1016/0896-6273(92)90099-Y; JOYNER AL, 1991, SCIENCE, V251, P1239, DOI 10.1126/science.1672471; KAPRIELIAN Z, 1994, BIOESSAYS, V16, P1, DOI 10.1002/bies.950160102; KOBAYASHI T, 1990, DEV BRAIN RES, V57, P29, DOI 10.1016/0165-3806(90)90181-W; LAVAIL JH, 1971, BRAIN RES, V28, P391, DOI 10.1016/0006-8993(71)90053-9; LOGAN C, 1992, DEV GENET, V13, P345, DOI 10.1002/dvg.1020130505; MARTINEZ S, 1990, DEV BIOL, V139, P432, DOI 10.1016/0012-1606(90)90312-7; MARTINEZ S, 1991, NEURON, V6, P971, DOI 10.1016/0896-6273(91)90237-T; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; MILLEN KJ, 1994, DEVELOPMENT, V120, P695; NAKAMURA H, 1986, CELL DIFFER DEV, V19, P187, DOI 10.1016/0045-6039(86)90095-3; NAKAMURA H, 1989, J NEUROSCI, V9, P3776; PATEL NH, 1989, CELL, V58, P955, DOI 10.1016/0092-8674(89)90947-1; PUELLES L, 1993, TRENDS NEUROSCI, V16, P472, DOI 10.1016/0166-2236(93)90080-6; ROSKIES AL, 1994, SCIENCE, V265, P799, DOI 10.1126/science.8047886; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; SIMON DK, 1990, DEV BIOL, V137, P125, DOI 10.1016/0012-1606(90)90013-9; SIMON DK, 1992, J NEUROSCI, V12, P1212; SIMON DK, 1992, NEURON, V9, P977, DOI 10.1016/0896-6273(92)90249-D; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; THANOS S, 1987, J COMP NEUROL, V261, P155, DOI 10.1002/cne.902610114; VONBOXBERG Y, 1993, NEURON, V10, P345; WALTER J, 1987, DEVELOPMENT, V101, P685; WALTER J, 1987, DEVELOPMENT, V101, P909; WILKINSON DG, 1992, IN SITU HYBRIDIZATIO, P75	42	111	114	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1996	16	1					55	62		10.1016/S0896-6273(00)80023-9	http://dx.doi.org/10.1016/S0896-6273(00)80023-9			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TT307	8562091	Bronze			2022-12-24	WOS:A1996TT30700009
J	LIU, KS; STERNBERG, PW				LIU, KS; STERNBERG, PW			SENSORY REGULATION OF MALE MATING-BEHAVIOR IN CAENORHABDITIS-ELEGANS	NEURON			English	Article							POST-EMBRYONIC DEVELOPMENT; C-ELEGANS; NEURAL NETWORKS; NEMATODE; CELL; DROSOPHILA; NEURONS; MUTANTS	C. elegans male mating behavior comprises a series of steps: response to contact with the hermaphrodite, backing along her body, turning around her head or tail, location of the vulva, insertion of the two copulatory spicules into the vulva, and sperm transfer. By ablation of male-specific copulatory structures and their associated neurons, we have identified sensory structures and neurons that participate in each of these steps: the sensory rays mediate response to contact and turning; the hook, the postcloacal sensilla, and the spicules mediate vulva location; the spicules also mediate spicule insertion and regulate sperm transfer. Generally, successful completion of each step places the male in a position to receive a cue for the next step in the pathway. However, the high degree of sensory regulation allows the mate to execute some steps independently.	CALTECH,DIV BIOL,PASADENA,CA 91125	California Institute of Technology	LIU, KS (corresponding author), CALTECH,HOWARD HUGHES MED INST,PASADENA,CA 91125, USA.			Sternberg, Paul/0000-0002-7699-0173				AROIAN RV, 1991, GENETICS, V128, P251; AVERY L, 1987, CELL, V51, P1071, DOI 10.1016/0092-8674(87)90593-9; AVERY L, 1989, NEURON, V3, P473, DOI 10.1016/0896-6273(89)90206-7; BAIRD SE, 1992, EVOLUTION, V46, P585, DOI [10.2307/2409629, 10.1111/j.1558-5646.1992.tb02067.x]; BAIRD SE, 1991, DEVELOPMENT, V113, P515; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BARKER DM, 1994, ANIM BEHAV, V48, P147, DOI 10.1006/anbe.1994.1221; BREEDLOVE SM, 1986, J NEUROBIOL, V17, P157, DOI 10.1002/neu.480170304; BRENNER S, 1974, GENETICS, V77, P71; CAREW TJ, 1986, ANNU REV NEUROSCI, V9, P435, DOI 10.1146/annurev.ne.09.030186.002251; CHALFIE M, 1985, J NEUROSCI, V5, P956; CHAMBERLIN HM, 1993, DEVELOPMENT, V118, P297; DAVIS BO, 1986, J CHEM ECOL, V12, P1339, DOI 10.1007/BF01012353; DAVIS RL, 1993, NEURON, V11, P1, DOI 10.1016/0896-6273(93)90266-T; DUNLAP JC, 1993, ANNU REV PHYSIOL, V55, P683, DOI 10.1146/annurev.physiol.55.1.683; DUSENBERY DB, 1980, NEMATODES BIOL MODEL, V1, P127; GETTING PA, 1989, ANNU REV NEUROSCI, V12, P185, DOI 10.1146/annurev.neuro.12.1.185; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; HARRISWARRICK RM, 1991, ANNU REV NEUROSCI, V14, P39, DOI 10.1146/annurev.ne.14.030191.000351; HODGKIN J, 1979, GENETICS, V91, P67; HODGKIN J, 1983, GENETICS, V103, P43; Hodgkin JA., 1974, THESIS DARWIN COLLEG; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; LOER CM, 1993, J NEUROSCI, V13, P5407, DOI 10.1523/JNEUROSCI.13-12-05407.1993; QUINN WG, 1984, ANNU REV NEUROSCI, V7, P67, DOI 10.1146/annurev.ne.07.030184.000435; RAIZEN DM, 1994, NEURON, V12, P483, DOI 10.1016/0896-6273(94)90207-0; SCHNEIDERMAN AM, 1985, TRENDS NEUROSCI, V8, P494, DOI 10.1016/0166-2236(85)90176-6; SULSTON J, 1975, J COMP NEUROL, V163, P215, DOI 10.1002/cne.901630207; Sulston J., 1988, NEMATODE CAENORHABDI, P587; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; SULSTON JE, 1980, DEV BIOL, V78, P577, DOI 10.1016/0012-1606(80)90353-X; SULSTON JE, 1980, DEV BIOL, V78, P542, DOI 10.1016/0012-1606(80)90352-8	33	238	243	0	15	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1995	14	1					79	89		10.1016/0896-6273(95)90242-2	http://dx.doi.org/10.1016/0896-6273(95)90242-2			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QC548	7826644	Bronze			2022-12-24	WOS:A1995QC54800008
J	OLCESE, R; QIN, N; SCHNEIDER, T; NEELY, A; WEI, XY; STEFANI, E; BIRNBAUMER, L				OLCESE, R; QIN, N; SCHNEIDER, T; NEELY, A; WEI, XY; STEFANI, E; BIRNBAUMER, L			THE AMINO-TERMINUS OF A CALCIUM-CHANNEL BETA-SUBUNIT SETS RATES OF CHANNEL INACTIVATION INDEPENDENTLY OF THE SUBUNITS EFFECT ON ACTIVATION	NEURON			English	Article							SKELETAL-MUSCLE; FUNCTIONAL EXPRESSION; CA2+ CHANNELS; CLONING; BRAIN; ALPHA-1-SUBUNIT; KINETICS; CURRENTS; MODES	There is molecular diversity in both alpha(1) and beta subunits of voltage-gated Ca2+ channels. Coupling between voltage sensing and pore opening of the C-type alpha(1) (alpha(1C)) is improved by the type 2 beta subunit (beta(2)), and E-type alpha(1) beta complexes inactivate at different rates depending on the nature of beta. We compared the effects of type 1 and 2 beta subunits on activation of the human E-type alpha(1) (alpha(1E)) with the effects they have on inactivation, as seen in Xenopus oocytes. The beta subtypes stimulated activation in similar fashion but affected inactivation differently, and even in opposing directions. beta subunits have a common central core but differ in their N- and C-termini and in a central region. N-terminal chimeras between beta(1) and beta(2) subunits that have opposing effects on inactivation resulted in the reciprocal transfer of their effects. We conclude that regulation of activation and inactivation of alpha(1) by beta are separable events and that the N-terminus of beta is one of the structural determinants important in setting the rate and voltage at which an al inactivates.	BAYLOR COLL MED,DEPT CELL BIOL,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT MOLEC PHYSIOL & BIOPHYS,HOUSTON,TX 77030	Baylor College of Medicine; Baylor College of Medicine			Neely, Alan/A-8715-2009	Neely, Alan/0000-0002-6007-2159				CASTELLANO A, 1993, J BIOL CHEM, V268, P12359; CASTELLANO A, 1993, J BIOL CHEM, V268, P3450; CATTERALL WA, 1991, SCIENCE, V253, P1499, DOI 10.1126/science.1654596; DELCOUR AH, 1993, J NEUROSCI, V13, P181; DELCOUR AH, 1993, SCIENCE, V259, P980, DOI 10.1126/science.8094902; ELLINOR PT, 1993, NATURE, V363, P455, DOI 10.1038/363455a0; HULLIN R, 1992, EMBO J, V11, P885, DOI 10.1002/j.1460-2075.1992.tb05126.x; LACERDA AE, 1991, NATURE, V352, P527, DOI 10.1038/352527a0; NEELY A, 1994, BIOPHYS J, V66, P1895, DOI 10.1016/S0006-3495(94)80983-X; NEELY A, 1993, SCIENCE, V262, P575, DOI 10.1126/science.8211185; NOWYCKY MC, 1985, P NATL ACAD SCI USA, V82, P2178, DOI 10.1073/pnas.82.7.2178; PEREZREYES E, 1989, NATURE, V340, P233, DOI 10.1038/340233a0; PEREZREYES E, 1992, J BIOL CHEM, V267, P1792; POWERS PA, 1992, J BIOL CHEM, V267, P22967; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; PRAGNELL M, 1991, FEBS LETT, V291, P253, DOI 10.1016/0014-5793(91)81296-K; SCHNEIDER T, 1994, IN PRESS RECEPTORS C; SINGER D, 1991, SCIENCE, V253, P1553, DOI 10.1126/science.1716787; SOONG TW, 1993, SCIENCE, V260, P1133, DOI 10.1126/science.8388125; TAGLIALATELA M, 1993, P NATL ACAD SCI USA, V90, P4758, DOI 10.1073/pnas.90.10.4758; TSIEN RW, 1991, TRENDS PHARMACOL SCI, V12, P349, DOI 10.1016/0165-6147(91)90595-J; WEI XY, 1994, J BIOL CHEM, V269, P1635; WEI XY, 1991, J BIOL CHEM, V266, P21943; ZHANG JF, 1993, NEUROPHARMACOLOGY, V90, P3787	24	168	170	0	2	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1994	13	6					1433	1438		10.1016/0896-6273(94)90428-6	http://dx.doi.org/10.1016/0896-6273(94)90428-6			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PZ689	7993634				2022-12-24	WOS:A1994PZ68900017
J	WU, LG; SAGGAU, P				WU, LG; SAGGAU, P			ADENOSINE INHIBITS EVOKED SYNAPTIC TRANSMISSION PRIMARILY BY REDUCING PRESYNAPTIC CALCIUM INFLUX IN AREA CA1 OF HIPPOCAMPUS	NEURON			English	Article							INVITRO RAT HIPPOCAMPUS; CENTRAL-NERVOUS-SYSTEM; PYRAMIDAL NEURONS; GLUTAMATE RELEASE; 8-CYCLOPENTYL-1,3-DIPROPYLXANTHINE DPCPX; POSTTETANIC POTENTIATION; NEUROTRANSMITTER RELEASE; EPILEPTIFORM ACTIVITY; TRANSMITTER RELEASE; ADENYLATE-CYCLASE	Adenosine is a potent modulator of neuronal activity throughout the nervous system. Previous evidence suggests that adenosine presynaptically inhibits synaptic transmission. The mechanism of presynaptic inhibition is uncertain. Adenosine may inhibit transmitter release by reducing voltage-dependent Ca2+ currents, activating K+ currents, or by mechanisms downstream to Ca2+ influx. By simultaneously recording the presynaptic Ca2+ transient ([Ca](t)) and the field excitatory postsynaptic potential (fEPSP) at CA3-CA1 synapses of hippocampal slices, we found that adenosine, through activation of presynaptic A(1) receptors, inhibits the fEPSP primarily by reducing the [Ca](t). Reduced [Ca](t) was due to inhibition of omega-conotoxin GVIA-sensitive and some unidentified Ca2+ channels, probably including Q-type, but not to omega-agatoxin-IVA-sensitive Ca2+ channels. The adenosine A(1) antagonist 8-cyclopentyl-1,3-dipropylxanthine enhanced both the [Ca](t) and the fEPSP, suggesting a tonic inhibition of the [Ca](t) by endogenous adenosine in the hippocampal slice.			WU, LG (corresponding author), BAYLOR COLL MED, DIV NEUROSCI, HOUSTON, TX 77030 USA.							ALZHEIMER C, 1989, NEUROSCI LETT, V99, P107, DOI 10.1016/0304-3940(89)90273-5; AULT B, 1986, BRIT J PHARMACOL, V87, P695, DOI 10.1111/j.1476-5381.1986.tb14587.x; BROWN TH, 1990, SYNAPTIC ORG BRAIN, P34; CHARLTON MP, 1982, J PHYSIOL-LONDON, V323, P173, DOI 10.1113/jphysiol.1982.sp014067; CORRADETTI R, 1984, EUR J PHARMACOL, V104, P19, DOI 10.1016/0014-2999(84)90364-9; DELANEY KR, 1989, J NEUROSCI, V9, P3558; DOLPHIN AC, 1983, NEUROSCI LETT, V43, P49, DOI 10.1016/0304-3940(83)90127-1; DOLPHIN AC, 1985, NATURE, V316, P148, DOI 10.1038/316148a0; DOLPHIN AC, 1986, J PHYSIOL-LONDON, V373, P47, DOI 10.1113/jphysiol.1986.sp016034; DUNWIDDIE TV, 1989, J PHARMACOL EXP THER, V249, P31; DUNWIDDIE TV, 1980, EPILEPSIA, V21, P541, DOI 10.1111/j.1528-1157.1980.tb04305.x; DUNWIDDIE TV, 1980, BRIT J PHARMACOL, V69, P59, DOI 10.1111/j.1476-5381.1980.tb10883.x; DUNWIDDIE TV, 1985, J PHYSIOL-LONDON, V369, P365, DOI 10.1113/jphysiol.1985.sp015907; DUNWIDDIE TV, 1985, INT REV NEUROBIOL, V27, P63, DOI 10.1016/S0074-7742(08)60556-5; DUNWIDDIE TV, 1981, N-S ARCH PHARMACOL, V316, P326, DOI 10.1007/BF00501365; FREDHOLM BB, 1986, ACTA PHYSIOL SCAND, V127, P381, DOI 10.1111/j.1748-1716.1986.tb07918.x; GERBER U, 1989, J PHYSIOL-LONDON, V417, P567, DOI 10.1113/jphysiol.1989.sp017819; GINSBORG BL, 1972, J PHYSIOL-LONDON, V224, P629, DOI 10.1113/jphysiol.1972.sp009916; GREENE RW, 1991, PROG NEUROBIOL, V36, P329, DOI 10.1016/0301-0082(91)90005-L; GREENE RW, 1985, J PHYSIOL-LONDON, V366, P119, DOI 10.1113/jphysiol.1985.sp015788; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; JARVIS MF, 1989, EUR J PHARMACOL, V168, P243, DOI 10.1016/0014-2999(89)90571-2; KAMIYA H, 1991, SYNAPSE, V8, P229, DOI 10.1002/syn.890080309; KASAI H, 1989, PFLUG ARCH EUR J PHY, V414, P145, DOI 10.1007/BF00580956; LOHSE MJ, 1987, N-S ARCH PHARMACOL, V336, P204, DOI 10.1007/BF00165806; LUPICA CR, 1992, J NEUROSCI, V12, P3753; MACDONALD RL, 1986, J PHYSIOL-LONDON, V370, P75, DOI 10.1113/jphysiol.1986.sp015923; MALENKA RC, 1988, J NEUROSCI, V8, P3750; MINTZ IM, 1992, NEURON, V9, P85, DOI 10.1016/0896-6273(92)90223-Z; MINTZ IM, 1992, NATURE, V355, P827, DOI 10.1038/355827a0; MOGUL DJ, 1993, NEURON, V10, P327, DOI 10.1016/0896-6273(93)90322-I; NICOLL RA, 1990, PHYSIOL REV, V70, P513, DOI 10.1152/physrev.1990.70.2.513; OKADA Y, 1980, EUR J PHARMACOL, V68, P483; OLIVERA BM, 1985, SCIENCE, V230, P1338, DOI 10.1126/science.4071055; OLIVERA BM, 1990, SCIENCE, V249, P257, DOI 10.1126/science.2165278; PRINCE DA, 1992, P NATL ACAD SCI USA, V89, P8586, DOI 10.1073/pnas.89.18.8586; PROCTOR WR, 1987, BRAIN RES, V426, P187, DOI 10.1016/0006-8993(87)90441-0; PROCTOR WR, 1983, NEUROSCI LETT, V35, P197, DOI 10.1016/0304-3940(83)90550-5; PULL I, 1972, BIOCHEM J, V130, P975, DOI 10.1042/bj1300975; REDDINGTON M, 1982, NEUROSCI LETT, V28, P275, DOI 10.1016/0304-3940(82)90070-2; REGEHR WG, 1991, J NEUROSCI METH, V37, P111, DOI 10.1016/0165-0270(91)90121-F; RIBEIRO JA, 1975, BRIT J PHARMACOL, V54, P213, DOI 10.1111/j.1476-5381.1975.tb06931.x; SCANZIANI M, 1992, NEURON, V9, P919, DOI 10.1016/0896-6273(92)90244-8; SCHOLFIELD CN, 1978, BRIT J PHARMACOL, V63, P239, DOI 10.1111/j.1476-5381.1978.tb09752.x; SCHOLZ KP, 1991, J PHYSIOL-LONDON, V435, P373, DOI 10.1113/jphysiol.1991.sp018515; SCHOLZ KP, 1992, NEURON, V8, P1139, DOI 10.1016/0896-6273(92)90134-Y; SCHUBERT P, 1986, BRAIN RES, V376, P382, DOI 10.1016/0006-8993(86)90204-0; SCHUBERT P, 1979, BRAIN RES, V172, P186, DOI 10.1016/0006-8993(79)90910-7; SIGGINS GR, 1981, NEUROSCI LETT, V23, P55, DOI 10.1016/0304-3940(81)90186-5; SILINSKY EM, 1984, J PHYSIOL-LONDON, V346, P243, DOI 10.1113/jphysiol.1984.sp015019; SMITH DO, 1991, J PHYSIOL-LONDON, V432, P343, DOI 10.1113/jphysiol.1991.sp018388; SWANDULLA D, 1991, NEURON, V7, P915, DOI 10.1016/0896-6273(91)90337-Y; THOMPSON SM, 1992, J PHYSIOL-LONDON, V451, P347, DOI 10.1113/jphysiol.1992.sp019168; TRUSSELL LO, 1985, P NATL ACAD SCI USA, V82, P4857, DOI 10.1073/pnas.82.14.4857; WHEELER DB, 1994, IN PRESS SCIENCE; WIERASZKO A, 1989, BRAIN RES, V485, P244, DOI 10.1016/0006-8993(89)90567-2; WU LG, 1994, J NEUROSCI, V14, P645; WU LG, 1994, IN PRESS J NEUROSCI; YAMAMOTO C, 1993, HIPPOCAMPUS, V3, P87, DOI 10.1002/hipo.450030109; YAWO H, 1993, NATURE, V365, P256, DOI 10.1038/365256a0; ZHANG JF, 1993, NEUROPHARMACOLOGY, V32, P1075, DOI 10.1016/0028-3908(93)90003-L	61	315	321	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	1994	12	5					1139	1148		10.1016/0896-6273(94)90321-2	http://dx.doi.org/10.1016/0896-6273(94)90321-2			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NM831	8185949				2022-12-24	WOS:A1994NM83100017
J	FENG, L; HATTEN, ME; HEINTZ, N				FENG, L; HATTEN, ME; HEINTZ, N			BRAIN LIPID-BINDING PROTEIN (BLBP) - A NOVEL SIGNALING SYSTEM IN THE DEVELOPING MAMMALIAN CNS	NEURON			English	Article							FATTY-ACID-BINDING; INTRACELLULAR VITAMIN-A; CENTRAL NERVOUS-SYSTEM; RETINOIC ACID; GROWTH INHIBITOR; EXPRESSION; MIGRATION; INVITRO; MOUSE; GENE	Using a polyclonal antibody against postnatal cerebellar cells, we have isolated a new, brain-specific member of the lipid-binding protein family (BLBP). Members of this family, such as cellular retinoic acid-binding protein, have been shown to carry small hydrophobic signaling molecules between cellular compartments. The expression of BLBP is spatially and temporally correlated with neuronal differentiation in many parts of the mouse CNS, including postnatal cerebellum, embryonic spinal cord, and cerebral cortex. In situ hybridization and immunocytochemistry show that BLBP is transiently expressed in radial glia in both the embryonic ventricular zone and the postnatal cerebellum. Subcellular localization studies by immunoelectron microscopy demonstrate that BLBP is present in the nucleus as well as the cytoplasm. Affinity-purified anti-BLBP antibodies block glial and neuronal differentiation in primary cell cultures, but have no effect on cell proliferation or adhesion. Based on these results, we propose that BLBP is required for the establishment of the radial glial fiber system in developing brain, a system that is necessary for the migration of immature neurons to establish cortical layers.			FENG, L (corresponding author), ROCKEFELLER UNIV, HOWARD HUGHES MED INST, NEW YORK, NY 10021 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS030532] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 30532] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BOHMER FD, 1987, J BIOL CHEM, V262, P15137; BROCKES JP, 1989, NEURON, V2, P1285, DOI 10.1016/0896-6273(89)90066-4; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHYTIL F, 1987, ANNU REV NUTR, V7, P321, DOI 10.1146/annurev.nu.07.070187.001541; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; DOLLE P, 1989, NATURE, V342, P702, DOI 10.1038/342702a0; EDMONDSON JC, 1987, J NEUROSCI, V7, P1928; FOURNIER NC, 1990, MOL CELL BIOCHEM, V98, P149; GAO WQ, 1992, CELL, V68, P841, DOI 10.1016/0092-8674(92)90028-B; GAO WQ, 1991, NEURON, V6, P705, DOI 10.1016/0896-6273(91)90168-Y; GAO WQ, 1993, SCIENCE, V260, P367, DOI 10.1126/science.8469990; GODBOUT R, 1993, EXP EYE RES, V56, P95, DOI 10.1006/exer.1993.1014; GORDON JI, 1985, CHEM PHYS LIPIDS, V38, P137, DOI 10.1016/0009-3084(85)90063-5; GORDON JI, 1991, CURR OPIN LIPIDOL, V2, P125; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; GREEN RP, 1992, DNA CELL BIOL, V11, P31, DOI 10.1089/dna.1992.11.31; HARAYANAN V, 1991, J NEUROCHEM, V57, P75; Hatten M E, 1993, Curr Opin Neurobiol, V3, P38, DOI 10.1016/0959-4388(93)90033-U; HATTEN ME, 1990, TRENDS NEUROSCI, V13, P179, DOI 10.1016/0166-2236(90)90044-B; HATTEN ME, 1984, DEV BRAIN RES, V13, P309, DOI 10.1016/0165-3806(84)90166-4; HATTEN ME, 1987, J CELL BIOL, V104, P1353, DOI 10.1083/jcb.104.5.1353; HEYMAN RA, 1992, CELL, V68, P397, DOI 10.1016/0092-8674(92)90479-V; JESSELL TM, 1992, CELL, V68, P257, DOI 10.1016/0092-8674(92)90469-S; KLEIN KL, 1981, J EXP ZOOL, V216, P107, DOI 10.1002/jez.1402160111; KUHAR SG, 1993, DEVELOPMENT, V117, P97; KURTZ A, 1990, J CELL BIOL, V110, P1779, DOI 10.1083/jcb.110.5.1779; MADEN M, 1991, DEVELOPMENT, P87; MISSON JP, 1988, DEV BRAIN RES, V44, P95, DOI 10.1016/0165-3806(88)90121-6; MIYAMOTO M, 1993, MOL CELL BIOL, V13, P4251, DOI 10.1128/MCB.13.7.4251; PIECHACZYK M, 1984, NUCLEIC ACIDS RES, V12, P6951, DOI 10.1093/nar/12.18.6951; PLACZEK M, 1991, DEVELOPMENT, P105; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; Ramon y Cajal S., 1955, HISTOLOGIE SYSTEME N; ROSS AC, 1993, FASEB J, V7, P317, DOI 10.1096/fasebj.7.2.8440409; SIDMAN RL, 1973, BRAIN RES, V62, P1, DOI 10.1016/0006-8993(73)90617-3; SIDMAN RL, 1983, GENETICS NEUROLOGICA, P379; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; TWEEDIE S, 1989, NUCLEIC ACIDS RES, V17, P4374, DOI 10.1093/nar/17.11.4374; WEI LN, 1990, DNA CELL BIOL, V9, P471, DOI 10.1089/dna.1990.9.471; WOLF G, 1991, NUTR REV, V49, P1, DOI 10.1111/j.1753-4887.1991.tb07349.x; YAMADA T, 1993, CELL, V73, P673, DOI 10.1016/0092-8674(93)90248-O	42	459	472	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1994	12	4					895	908		10.1016/0896-6273(94)90341-7	http://dx.doi.org/10.1016/0896-6273(94)90341-7			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NH253	8161459				2022-12-24	WOS:A1994NH25300017
J	AHMAD, FJ; JOSHI, HC; CENTONZE, VE; BAAS, PW				AHMAD, FJ; JOSHI, HC; CENTONZE, VE; BAAS, PW			INHIBITION OF MICROTUBULE NUCLEATION AT THE NEURONAL CENTROSOME COMPROMISES AXON GROWTH	NEURON			English	Article							GAMMA-TUBULIN; ASPERGILLUS-NIDULANS; COMPONENT	We tested the dependence of axon growth on microtubule (MT) nucleation from the neuronal centrosome. Nocodazole diminished MTs in freshly plated neurons by >99%. Within 5 min of drug removal, MTs reassembled at the centrosome. This response was inhibited in cells microinjected with gamma-tubulin antibody. Within 2 hr of drug removal, uninjected neurons grew >500 mu m of axon. In roughly half of the antibody-injected cells, axon growth was abolished and MT levels were reduced by similar to 87% compared with uninjected cells. In the other antibody-injected cells, axon growth was compromised but not abolished, and MT levels were reduced by similar to 38%. Thus inhibition of MT nucleation at the centrosome hindered MT reassembly, and depending on the severity of this response, axon growth was either compromised or abolished.	EMORY UNIV,SCH MED,DEPT ANAT & CELL BIOL,ATLANTA,GA 30322; UNIV WISCONSIN,INTEGRATED MICROSCOPY RESOURCE,MADISON,WI 53706	Emory University; University of Wisconsin System; University of Wisconsin Madison	AHMAD, FJ (corresponding author), UNIV WISCONSIN,SCH MED,DEPT ANAT,MADISON,WI 53706, USA.			Ahmad, Farhan/0000-0002-0740-8573	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000570] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00570] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		AHMAD FJ, 1993, J NEUROSCI, V13, P856; BAAS PW, 1992, J CELL BIOL, V116, P1231, DOI 10.1083/jcb.116.5.1231; BAAS PW, 1992, J CELL BIOL, V119, P171, DOI 10.1083/jcb.119.1.171; BAAS PW, 1993, J CELL BIOL, V120, P1427, DOI 10.1083/jcb.120.6.1427; BAAS PW, 1986, J CELL BIOL, V103, P917, DOI 10.1083/jcb.103.3.917; BRANDT R, 1993, J NEUROCHEM, V61, P997, DOI 10.1111/j.1471-4159.1993.tb03613.x; BRAY D, 1981, J NEUROCYTOL, V10, P589, DOI 10.1007/BF01262592; Bray D., 1991, CULTURING NERVE CELL, P119; BRINKLEY BR, 1985, ANNU REV CELL BIOL, V1, P145, DOI 10.1146/annurev.cellbio.1.1.145; BROWN A, 1992, J CELL BIOL, V119, P867, DOI 10.1083/jcb.119.4.867; DIAZNIDO J, 1990, MICROTUBULE PROTEINS, P193; EVANS L, 1985, J CELL BIOL, V100, P1185, DOI 10.1083/jcb.100.4.1185; Higgins D., 1991, CULTURING NERVE CELL, P177; HORIO T, 1991, J CELL SCI, V99, P661; JOSHI HC, 1992, NATURE, V356, P80, DOI 10.1038/356080a0; JOSHI HC, 1993, J CELL BIOL, V121, P1191, DOI 10.1083/jcb.121.6.1191; JOSHI HC, 1993, BIOESSAYS, V15, P1; Kirschner M W, 1978, Int Rev Cytol, V54, P1, DOI 10.1016/S0074-7696(08)60164-3; Lasec R, 1988, INTRINSIC DETERMINAN, P1; Oakley B R, 1992, Trends Cell Biol, V2, P1, DOI 10.1016/0962-8924(92)90125-7; OAKLEY BR, 1990, CELL, V61, P1289, DOI 10.1016/0092-8674(90)90693-9; OAKLEY CE, 1989, NATURE, V338, P662, DOI 10.1038/338662a0; STEARNS T, 1991, CELL, V65, P825, DOI 10.1016/0092-8674(91)90390-K; WHITLON DS, 1991, J CYTOCHEM HISTOCHEM, V97, P1476; YU WQ, 1993, J CELL BIOL, V122, P349, DOI 10.1083/jcb.122.2.349; ZHENG YX, 1991, CELL, V65, P817, DOI 10.1016/0092-8674(91)90389-G	26	69	70	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1994	12	2					271	280		10.1016/0896-6273(94)90270-4	http://dx.doi.org/10.1016/0896-6273(94)90270-4			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MY500	8110458				2022-12-24	WOS:A1994MY50000004
J	JOHNSON, MD				JOHNSON, MD			SYNAPTIC GLUTAMATE RELEASE BY POSTNATAL RAT SEROTONERGIC NEURONS IN MICROCULTURE	NEURON			English	Article							DORSAL RAPHE NUCLEUS; EXCITATORY AMINO-ACID; GAMMA-AMINOBUTYRIC ACID; SUBSTANCE P-LIKE; HIPPOCAMPAL-NEURONS; SYMPATHETIC NEURONS; SPINAL-CORD; 5-HYDROXYTRYPTAMINE; RECEPTORS; POTENTIALS	Serotonergic neurons are thought to play a role in depression and obsessive compulsive disorder. However, their functional transmitter repertoire is incompletely known. To investigate this repertoire, intracellular recordings were obtained from 132 cytochemically identified rat mesopontine serotonergic neurons that had reestablished synapses in microcultures. Approximately 60% of the neurons evoked excitatory glutamatergic potentials in themselves or in target neurons. Glutamatergic transmission was frequently observed in microcultures containing a solitary serotonergic neuron. Evidence for co-release of serotonin and glutamate from single raphe neurons was also obtained. However, evidence for gamma-aminobutyric acid release by serotonergic neurons was observed in only two cases. These findings indicate that many cultured serotonergic neurons form glutamatergic synapses and may explain several observations in slices and in vivo.			JOHNSON, MD (corresponding author), HARVARD UNIV,SCH MED,DEPT NEUROBIOL,BOSTON,MA 02115, USA.				NINDS NIH HHS [NS02253-32] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALHAIDER AA, 1991, J NEUROSCI, V11, P1881; ANDRADE R, 1986, SCIENCE, V234, P1261, DOI 10.1126/science.2430334; ASTONJONES G, 1991, J NEUROSCI, V11, P760; BEART PM, 1990, NEUROSCIENCE, V34, P163, DOI 10.1016/0306-4522(90)90310-Z; BELIN MF, 1983, BRAIN RES, V275, P329, DOI 10.1016/0006-8993(83)90994-0; BERNAYS RL, 1988, NEUROSCIENCE, V26, P601, DOI 10.1016/0306-4522(88)90168-6; BLAKELY RD, 1991, NATURE, V354, P66, DOI 10.1038/354066a0; BOBKER DH, 1990, J PHYSIOL-LONDON, V422, P447, DOI 10.1113/jphysiol.1990.sp017994; BOBKER DH, 1989, J PHARMACOL EXP THER, V250, P37; CHANPALAY V, 1978, P NATL ACAD SCI USA, V75, P1582, DOI 10.1073/pnas.75.3.1582; DELREE P, 1992, NEUROSCIENCE, V51, P401, DOI 10.1016/0306-4522(92)90324-U; FORNAL CA, 1988, NEURONAL SEROTONIN, P305; FUNG SJ, 1989, NEUROSCI LETT, V103, P185, DOI 10.1016/0304-3940(89)90573-9; FURSHPAN EJ, 1986, J NEUROSCI, V6, P1061; FURSHPAN EJ, 1989, NEURON, V3, P199, DOI 10.1016/0896-6273(89)90033-0; GLAZER EJ, 1981, J PHYSIOLOGY PARIS, V77, P241; GUAN XM, 1992, MOL PHARMACOL, V41, P695; HARANDI M, 1987, NEUROSCIENCE, V21, P237, DOI 10.1016/0306-4522(87)90336-8; HOLTMAN JR, 1986, J NEUROSCI, V6, P1185; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; JOHANSSON O, 1981, NEUROSCIENCE, V6, P1857, DOI 10.1016/0306-4522(81)90028-2; JOHNSON MD, 1989, Q J EXP PHYSIOL CMS, V74, P1043, DOI 10.1113/expphysiol.1989.sp003332; JOHNSON MD, 1993, J COMP NEUROL, V332, P391, DOI 10.1002/cne.903320402; JOHNSON SW, 1992, J NEUROSCI, V12, P2000; KOMBIAN SB, 1992, J NEUROSCI, V12, P1086; LEVINE ES, 1992, J NEUROSCI, V12, P4037; MELANDER T, 1986, J NEUROSCI, V6, P3640; MICELI MO, 1987, BRAIN RES, V412, P381, DOI 10.1016/0006-8993(87)91147-4; MOORE RY, 1981, SEROTONIN NEUROTRANS, P35; NEDERGAARD S, 1987, CELL MOL NEUROBIOL, V7, P367, DOI 10.1007/BF00733789; NICHOLAS AP, 1992, NEUROSCIENCE, V48, P545, DOI 10.1016/0306-4522(92)90401-M; NISHI R, 1988, NEUROSCIENCE, V25, P759, DOI 10.1016/0306-4522(88)90035-8; OSBORNE NN, 1988, NEUR0NAL SEROTONIN, P125; PAN ZZ, 1989, J NEUROPHYSIOL, V62, P481, DOI 10.1152/jn.1989.62.2.481; PARK MR, 1982, BRAIN RES, V243, P49, DOI 10.1016/0006-8993(82)91119-2; RASMUSSEN K, 1990, SYNAPSE, V5, P324, DOI 10.1002/syn.890050409; REYNOLDS JN, 1988, BRAIN RES, V456, P286, DOI 10.1016/0006-8993(88)90230-2; SAH DWY, 1987, J NEUROSCI, V7, P391; SEGAL MM, 1990, J NEUROPHYSIOL, V64, P1390, DOI 10.1152/jn.1990.64.5.1390; SILVA NL, 1988, P NATL ACAD SCI USA, V85, P7346, DOI 10.1073/pnas.85.19.7346; STRAHLENDORF JC, 1991, EUR J PHARMACOL, V201, P239, DOI 10.1016/0014-2999(91)90352-Q; STRATFORD TR, 1990, BRAIN RES, V511, P173, DOI 10.1016/0006-8993(90)90239-8; SUGITA S, 1992, NEURON, V8, P199, DOI 10.1016/0896-6273(92)90121-S; VANWIJNGAARDEN I, 1990, EUR J PHARM-MOLEC PH, V188, P301, DOI 10.1016/0922-4106(90)90190-9; WANG RY, 1982, J NEUROSCI, V2, P11; WHITAKERAZMITIA PM, 1990, ANN NY ACAD SCI, V5, P600; YOSHIMURA M, 1985, NEUROSCI LETT, V53, P69, DOI 10.1016/0304-3940(85)90099-0	47	106	117	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1994	12	2					433	442		10.1016/0896-6273(94)90283-6	http://dx.doi.org/10.1016/0896-6273(94)90283-6			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MY500	7906530				2022-12-24	WOS:A1994MY50000017
J	ZIMMERMAN, L; LENDAHL, U; CUNNINGHAM, M; MCKAY, R; PARR, B; GAVIN, B; MANN, J; VASSILEVA, G; MCMAHON, A				ZIMMERMAN, L; LENDAHL, U; CUNNINGHAM, M; MCKAY, R; PARR, B; GAVIN, B; MANN, J; VASSILEVA, G; MCMAHON, A			INDEPENDENT REGULATORY ELEMENTS IN THE NESTIN GENE DIRECT TRANSGENE EXPRESSION TO NEURAL STEM-CELLS OR MUSCLE PRECURSORS	NEURON			English	Article							FIBRILLARY ACIDIC PROTEIN; INTERMEDIATE FILAMENT PROTEIN; ASTROCYTE-SPECIFIC EXPRESSION; NEUROFILAMENT GENE; DIFFERENTIATION; PROMOTER; ENHANCER; IDENTIFICATION; HYBRIDIZATION; PROLIFERATION	Changes in intermediate filament gene expression occur at key steps in the differentiation of cell types in the mammalian CNS. Neuroepithelial stem cells express the intermediate filament protein nestin and down-regulate it sharply at the transition from proliferating stem cell to postmitotic neuron. Nestin is also expressed in muscle precursors but not in mature muscle cells. We show here that in transgenic mice, independent cell type-specific elements in the first and second introns of the nestin gene consistently direct reporter gene expression to developing muscle and neural precursors, respectively. The second intron contains an enhancer that functions in CNS stem cells, suggesting that there may be a single transcriptional mechanism regulating the CNS stem cell state. This enhancer is much less active in the PNS. The identification of these elements facilitates analysis of mechanisms controlling the switch in gene expression that occurs when muscle and brain precursors terminally differentiate.	MIT,DEPT BRAIN & COGNIT SCI,CAMBRIDGE,MA 02139; ROCHE INST MOLEC BIOL,NUTLEY,NJ 07110	Massachusetts Institute of Technology (MIT)			Vassileva, Galya/A-6807-2009					BALCAREK JM, 1985, NUCLEIC ACIDS RES, V13, P5527, DOI 10.1093/nar/13.15.5527; BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; BAYER SA, 1987, PROG NEUROBIOL, V29, P57, DOI 10.1016/0301-0082(87)90015-3; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BESNARD F, 1991, J BIOL CHEM, V266, P18877; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; CHING GY, 1991, J BIOL CHEM, V266, P19459; DAHLSTRAND J, 1992, J CELL SCI, V103, P589; FREDERIKSEN K, 1988, J NEUROSCI, V8, P1144; FREDERIKSEN K, 1988, NEURON, V1, P439, DOI 10.1016/0896-6273(88)90175-4; GALILEO DS, 1990, P NATL ACAD SCI USA, V87, P458, DOI 10.1073/pnas.87.1.458; HAYES TE, 1991, NEW BIOL, V3, P259; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; HOGAN B, 1986, MANIPULATING MOUSE E; HOLT CE, 1988, NEURON, V1, P15, DOI 10.1016/0896-6273(88)90205-X; HUNT P, 1991, DEVELOPMENT S, V1, P187; JULIEN JP, 1987, BIOCHIM BIOPHYS ACTA, V909, P10, DOI 10.1016/0167-4781(87)90041-8; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; MIURA M, 1990, J NEUROCHEM, V55, P1180, DOI 10.1111/j.1471-4159.1990.tb03123.x; MUCKE L, 1991, NEW BIOL, V3, P465; NAKAHIRA K, 1990, J BIOL CHEM, V265, P19786; NORNES HO, 1974, BRAIN RES, V73, P121, DOI 10.1016/0006-8993(74)91011-7; OSHIMA RG, 1990, GENE DEV, V4, P835, DOI 10.1101/gad.4.5.835; RENFRANZ PJ, 1991, CELL, V66, P713, DOI 10.1016/0092-8674(91)90116-G; Sambrook J, 1989, MOL CLONING LABORATO; TAKEMOTO Y, 1991, NUCLEIC ACIDS RES, V19, P2761, DOI 10.1093/nar/19.10.2761; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; WETTS R, 1988, SCIENCE, V239, P1142, DOI 10.1126/science.2449732; ZENKE M, 1986, EMBO J, V5, P387, DOI 10.1002/j.1460-2075.1986.tb04224.x; ZOPF D, 1990, NUCLEIC ACIDS RES, V18, P521, DOI 10.1093/nar/18.3.521	31	486	526	0	21	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1994	12	1					11	24		10.1016/0896-6273(94)90148-1	http://dx.doi.org/10.1016/0896-6273(94)90148-1			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MU493	8292356				2022-12-24	WOS:A1994MU49300002
J	TOMASIEWICZ, H; ONO, K; YEE, DL; THOMPSON, C; GORIDIS, C; RUTISHAUSER, U; MAGNUSON, T				TOMASIEWICZ, H; ONO, K; YEE, DL; THOMPSON, C; GORIDIS, C; RUTISHAUSER, U; MAGNUSON, T			GENETIC DELETION OF A NEURAL CELL-ADHESION MOLECULE VARIANT (N-CAM-180) PRODUCES DISTINCT DEFECTS IN THE CENTRAL-NERVOUS-SYSTEM	NEURON			English	Article							EMBRYONIC STEM-CELLS; GERM-LINE TRANSMISSION; N-CAM; NEURITE OUTGROWTH; POLYSIALIC ACID; TRANSMEMBRANE DISPOSITION; RETINOTECTAL PROJECTION; SURFACE MODULATION; CYTOPLASMIC DOMAIN; 180-KD COMPONENT	N-CAM is abundantly expressed in the nervous system in the form of numerous structural variants with characteristic distribution patterns and functional properties. N-CAM-180, the variant having the largest cytoplasmic domain, is expressed by all neurons. The N-CAM-180-specific exon 18 has been deleted to generate homozygous mice unable to express this N-CAM form. The most conspicuous mutant phenotype was in the olfactory bulb, where granule cells were both reduced in number and disorganized. In addition, precursors of these cells were found to be accumulated at their origin in the subependymal zone at the lateral ventricle. Analysis of the mutant in this region suggests that the mutant phenotype involves a defect in cell migration, possibly through specific loss of the polysialylated form of N-CAM-180, which is expressed in the migration pathway. Subtle but distinct abnormalities also were observed in other regions of the brain.	CNRS,CTR IMMUNOL,INSERM,F-13288 MARSEILLE 9,FRANCE	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	TOMASIEWICZ, H (corresponding author), CASE WESTERN RESERVE UNIV,DEPT GENET,CLEVELAND,OH 44106, USA.				NEI NIH HHS [EY06107] Funding Source: Medline; NICHD NIH HHS [HD26722, HD18369] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD018369, R37HD018369, R01HD026722] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY006107] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ACHESON A, 1991, J CELL BIOL, V114, P143, DOI 10.1083/jcb.114.1.143; ALTMAN J, 1969, J COMP NEUROL, V136, P269, DOI 10.1002/cne.901360303; BARBAS JA, 1988, EMBO J, V7, P625, DOI 10.1002/j.1460-2075.1988.tb02856.x; BIXBY JL, 1987, P NATL ACAD SCI USA, V84, P2555, DOI 10.1073/pnas.84.8.2555; Bradley A, 1987, TERATOCARCINOMAS EMB, P113; BRONNERFRASER M, 1992, DEV BIOL, V153, P291, DOI 10.1016/0012-1606(92)90114-V; BRUNJES PC, 1986, BRAIN RES REV, V11, P1, DOI 10.1016/0165-0173(86)90008-1; BUSKIRK DR, 1980, NATURE, V285, P488, DOI 10.1038/285488a0; CALEY DW, 1973, AM J ANAT, V133, P179; CAVINESS VS, 1978, ANNU REV NEUROSCI, V1, P297, DOI 10.1146/annurev.ne.01.030178.001501; CHUONG CM, 1984, J NEUROSCI, V4, P2354; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; DOETSCHMAN T, 1988, P NATL ACAD SCI USA, V85, P8583, DOI 10.1073/pnas.85.22.8583; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; DOHERTY P, 1992, J NEUROCHEM, V58, P2338, DOI 10.1111/j.1471-4159.1992.tb10984.x; DOHERTY P, 1990, NATURE, V343, P464, DOI 10.1038/343464a0; DOHERTY P, 1990, NEURON, V5, P209, DOI 10.1016/0896-6273(90)90310-C; EDELMAN GM, 1982, P NATL ACAD SCI-BIOL, V79, P7036, DOI 10.1073/pnas.79.22.7036; FRASER SE, 1988, DEV BIOL, V129, P217, DOI 10.1016/0012-1606(88)90176-5; FREDETTE B, 1993, IN PRESS J CELL BIOL; FREI T, 1992, J CELL BIOL, V118, P177, DOI 10.1083/jcb.118.1.177; GENNARINI G, 1984, EUR J BIOCHEM, V142, P65, DOI 10.1111/j.1432-1033.1984.tb08251.x; GENNARINI G, 1984, EUR J BIOCHEM, V142, P57, DOI 10.1111/j.1432-1033.1984.tb08250.x; GENNARINI G, 1986, J NEUROSCI, V6, P1983; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; HAWKES R, 1982, ANAL BIOCHEM, V119, P142, DOI 10.1016/0003-2697(82)90677-7; HINDS JW, 1968, J COMP NEUROL, V134, P305, DOI 10.1002/cne.901340305; HINDS JW, 1968, J COMP NEUROL, V134, P287, DOI 10.1002/cne.901340304; HOFFMAN S, 1983, P NATL ACAD SCI-BIOL, V80, P5762, DOI 10.1073/pnas.80.18.5762; INOUYE M, 1980, J COMP NEUROL, V190, P357, DOI 10.1002/cne.901900209; KEY B, 1991, NEURON, V6, P381, DOI 10.1016/0896-6273(91)90247-W; KISHI K, 1987, J COMP NEUROL, V258, P112, DOI 10.1002/cne.902580109; KOHLER BH, 1989, P NATL ACAD SCI USA, V86, P8927; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDMESSER L, 1990, NEURON, V4, P655, DOI 10.1016/0896-6273(90)90193-J; LANDMESSER L, 1988, DEV BIOL, V130, P645, DOI 10.1016/0012-1606(88)90358-2; LINDNER J, 1986, BRAIN RES, V377, P298, DOI 10.1016/0006-8993(86)90872-3; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; MAXWELL IH, 1986, CANCER RES, V46, P4660; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; MIRAGALL F, 1990, J NEUROCYTOL, V19, P889; MURRAY BA, 1986, J CELL BIOL, V103, P1431, DOI 10.1083/jcb.103.4.1431; NOBLE M, 1985, NATURE, V316, P725, DOI 10.1038/316725a0; PALMITER RD, 1987, CELL, V50, P435, DOI 10.1016/0092-8674(87)90497-1; PERSOHN E, 1990, J NEUROCYTOL, V19, P807, DOI 10.1007/BF01186812; POLLERBERG EG, 1985, J CELL BIOL, V101, P1921, DOI 10.1083/jcb.101.5.1921; POLLERBERG GE, 1987, CELL TISSUE RES, V250, P227, DOI 10.1007/BF00214676; RUTISHAUSER U, 1985, J CELL BIOL, V101, P1842, DOI 10.1083/jcb.101.5.1842; RUTISHAUSER U, 1980, J CELL BIOL, V87, P370, DOI 10.1083/jcb.87.2.370; RUTISHAUSER U, 1983, J CELL BIOL, V97, P145, DOI 10.1083/jcb.97.1.145; RUTISHAUSER U, 1988, SCIENCE, V240, P53, DOI 10.1126/science.3281256; RUTISHAUSER U, 1991, RECEPTORS EXTRACELLU, P132; RUTISHAUSER U, 1993, CURR OPIN NEUROBIOL, V3, P7096; SADOUL R, 1983, NATURE, V304, P347, DOI 10.1038/304347a0; SANTONI MJ, 1987, NUCLEIC ACIDS RES, V15, P8621, DOI 10.1093/nar/15.21.8621; SCHWARTZBERG PL, 1989, SCIENCE, V246, P799, DOI 10.1126/science.2554496; SEKI T, 1993, J NEUROSCI, V13, P2351, DOI 10.1523/JNEUROSCI.13-06-02351.1993; SHIGA T, 1983, ANAT EMBRYOL, V167, P203, DOI 10.1007/BF00298511; SILVER J, 1984, DEV BIOL, V106, P485, DOI 10.1016/0012-1606(84)90248-3; SMALL SJ, 1988, NEURON, V1, P1007, DOI 10.1016/0896-6273(88)90158-4; THANOS S, 1984, P NATL ACAD SCI-BIOL, V81, P1906, DOI 10.1073/pnas.81.6.1906; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; THOMPSON J, 1989, GENE DEV, V3, P348, DOI 10.1101/gad.3.3.348; THOMPSON S, 1989, CELL, V56, P313, DOI 10.1016/0092-8674(89)90905-7; TOSNEY KW, 1986, DEV BIOL, V114, P468; WYSS JM, 1980, BRAIN RES, V188, P566, DOI 10.1016/0006-8993(80)90056-6; YAGI T, 1990, P NATL ACAD SCI USA, V87, P9918, DOI 10.1073/pnas.87.24.9918; ZHANG H, 1992, J NEUROSCI, V12, P3107, DOI 10.1523/JNEUROSCI.12-08-03107.1992	68	434	446	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1993	11	6					1163	1174		10.1016/0896-6273(93)90228-J	http://dx.doi.org/10.1016/0896-6273(93)90228-J			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MP548	8274281				2022-12-24	WOS:A1993MP54800016
J	TAKEUCHI, J; SHANNON, W; ARONIN, N; SCHWARTZ, WJ				TAKEUCHI, J; SHANNON, W; ARONIN, N; SCHWARTZ, WJ			COMPOSITIONAL CHANGES OF AP-1 DNA-BINDING PROTEINS ARE REGULATED BY LIGHT IN A MAMMALIAN CIRCADIAN CLOCK	NEURON			English	Article							TRANSCRIPTION FACTOR AP-1; EARLY GENE-EXPRESSION; IMMEDIATE EARLY GENES; C-JUN; SUPRACHIASMATIC NUCLEUS; DIFFERENTIAL EXPRESSION; MESSENGER-RNAS; PHOTIC REGULATION; INDUCED SEIZURES; FOS EXPRESSION	Recent reports have shown that the nuclear phosphoprotein Fos is induced by light in a mammalian circadian clock, the suprachiasmatic nucleus. To learn how light and circadian phase affect the binding of Fos to DNA, we analyzed the photic and temporal regulation of immunoreactive Jun protein expression and AP-1 DNA-binding activity in the rat suprachiasmatic nucleus. Immunohistochemistry and gel mobility shift assays suggest that AP-1 activity during the night and after a light pulse consists of constant, as well as variable, protein components; JunD could be identified as a constituent of both dark- and light-activated binding complexes, whereas binding by JunB and Fos could be implicated only after photic stimulation. Since JunD or JunB could be colocalized with Fos in individual suprachiasmatic nucleus cell nuclei, light may be acting in at least some suprachiasmatic nucleus cells by altering AP-1 protein composition rather than binding site occupancy.	UNIV MASSACHUSETTS,SCH MED,DEPT MED,WORCESTER,MA 01655	University of Massachusetts System; University of Massachusetts Worcester	TAKEUCHI, J (corresponding author), UNIV MASSACHUSETTS,SCH MED,DEPT NEUROL,WORCESTER,MA 01655, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024542] Funding Source: NIH RePORTER; NINDS NIH HHS [NINDS R01 NS 24542] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AN G, 1993, ANN NEUROL, V33, P457, DOI 10.1002/ana.410330508; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; ANGEL P, 1988, NATURE, V332, P166, DOI 10.1038/332166a0; ARONIN N, 1990, P NATL ACAD SCI USA, V87, P5959, DOI 10.1073/pnas.87.15.5959; ARONIN N, 1991, SUPRACHIASMATIC NUCL, P445; AUWERX J, 1991, CELL, V64, P983, DOI 10.1016/0092-8674(91)90322-P; BARTEL DP, 1989, GENE DEV, V3, P304, DOI 10.1101/gad.3.3.304; BENBROOK DM, 1990, ONCOGENE, V5, P295; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; BRIATA P, 1993, EXP CELL RES, V204, P136, DOI 10.1006/excr.1993.1018; CARTER DA, 1992, MOL BRAIN RES, V16, P111, DOI 10.1016/0169-328X(92)90200-U; CARTER MS, 1990, J NEUROSCI, V10, P2203; CHIU R, 1989, CELL, V59, P979, DOI 10.1016/0092-8674(89)90754-X; COLE AJ, 1990, J NEUROCHEM, V55, P1920, DOI 10.1111/j.1471-4159.1990.tb05777.x; COLWELL CS, 1993, J NEUROSCI, V13, P1454; CUTRERA RA, 1993, BRAIN RES, V602, P14, DOI 10.1016/0006-8993(93)90235-F; DENG TL, 1993, GENE DEV, V7, P479, DOI 10.1101/gad.7.3.479; DIAMOND MI, 1990, SCIENCE, V249, P1266, DOI 10.1126/science.2119054; EARNEST DJ, 1990, EXP NEUROL, V109, P353, DOI 10.1016/S0014-4886(05)80027-5; GASS P, 1992, NEUROSCIENCE, V48, P315, DOI 10.1016/0306-4522(92)90493-L; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; HERDEGEN T, 1991, NEUROSCIENCE, V45, P413, DOI 10.1016/0306-4522(91)90237-I; HERDEGEN T, 1991, J COMP NEUROL, V313, P178, DOI 10.1002/cne.903130113; HIRAI SI, 1989, EMBO J, V8, P1433, DOI 10.1002/j.1460-2075.1989.tb03525.x; IVASHKIV LB, 1990, MOL CELL BIOL, V10, P1609, DOI 10.1128/MCB.10.4.1609; JANIK D, 1992, NEUROREPORT, V3, P575, DOI 10.1097/00001756-199207000-00007; JOHNSON RF, 1988, BRAIN RES, V462, P301, DOI 10.1016/0006-8993(88)90558-6; KERPPOLA TK, 1991, CELL, V66, P317, DOI 10.1016/0092-8674(91)90621-5; KILDUFF TS, 1992, MOL BRAIN RES, V16, P47, DOI 10.1016/0169-328X(92)90192-E; Klein D.C., 1991, SUPRACHIASMATIC NUCL; KOBIERSKI LA, 1991, P NATL ACAD SCI USA, V88, P10222, DOI 10.1073/pnas.88.22.10222; KORNHAUSER JM, 1992, SCIENCE, V255, P1581, DOI 10.1126/science.1549784; KORNHAUSER JM, 1990, NEURON, V5, P127, DOI 10.1016/0896-6273(90)90303-W; Kornhauser JM, 1993, MOL GENETICS BIOL RH, P271; KOVARY K, 1991, MOL CELL BIOL, V11, P2451, DOI 10.1128/MCB.11.5.2451; MACGREGOR PF, 1990, ONCOGENE, V5, P451; MASQUILIER D, 1992, J BIOL CHEM, V267, P22460; MEAD S, 1992, J NEUROSCI, V12, P2516; MELLSTROM B, 1991, ONCOGENE, V6, P1959; MORATALLA R, 1993, J NEUROSCI, V13, P423; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; MURPHY TH, 1991, J NEUROCHEM, V57, P1862, DOI 10.1111/j.1471-4159.1991.tb06396.x; NARANJO JR, 1991, ONCOGENE, V6, P223; PENNYPACKER KR, 1992, J BIOL CHEM, V267, P20148; RANSONE LJ, 1990, ANNU REV CELL BIOL, V6, P539, DOI 10.1146/annurev.cellbio.6.1.539; REA MA, 1989, BRAIN RES BULL, V23, P577, DOI 10.1016/0361-9230(89)90204-9; ROSEN KM, 1992, P NATL ACAD SCI USA, V89, P5437, DOI 10.1073/pnas.89.12.5437; RUSAK B, 1992, MOL BRAIN RES, V14, P124, DOI 10.1016/0169-328X(92)90019-8; RUSAK B, 1990, SCIENCE, V248, P1237, DOI 10.1126/science.2112267; RUSAK B, 1992, SCIENCE, V14, P124; RYDER K, 1988, P NATL ACAD SCI USA, V85, P1487, DOI 10.1073/pnas.85.5.1487; RYDER K, 1989, P NATL ACAD SCI USA, V86, P1500, DOI 10.1073/pnas.86.5.1500; RYSECK RP, 1991, ONCOGENE, V6, P533; SCHUTTE J, 1989, CELL, V59, P987, DOI 10.1016/0092-8674(89)90755-1; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; SONNENBERG JL, 1989, NEURON, V3, P359, DOI 10.1016/0896-6273(89)90260-2; SONNENBERG JL, 1989, SCIENCE, V246, P1622, DOI 10.1126/science.2512642; SONNENBERG JL, 1989, J NEUROSCI RES, V24, P72, DOI 10.1002/jnr.490240111; TAKATSUJI K, 1991, BRAIN RES, V568, P223, DOI 10.1016/0006-8993(91)91401-L; UHL GR, 1991, MOL BRAIN RES, V11, P133, DOI 10.1016/0169-328X(91)90115-E; Vogt P K, 1990, Adv Cancer Res, V55, P1, DOI 10.1016/S0065-230X(08)60466-2; WISDEN W, 1990, NEURON, V4, P603, DOI 10.1016/0896-6273(90)90118-Y	63	77	78	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1993	11	5					825	836		10.1016/0896-6273(93)90112-5	http://dx.doi.org/10.1016/0896-6273(93)90112-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MJ041	8240806				2022-12-24	WOS:A1993MJ04100004
J	CHANG, GQ; HAO, Y; WONG, F				CHANG, GQ; HAO, Y; WONG, F			APOPTOSIS - FINAL COMMON PATHWAY OF PHOTORECEPTOR DEATH IN RD, RDS, AND RHODOPSIN MUTANT MICE	NEURON			English	Article							PROGRAMMED CELL-DEATH; DEGENERATION SLOW RDS; DOMINANT RETINITIS-PIGMENTOSA; RETINAL DEGENERATION; ENDONUCLEASE ACTIVATION; CGMP-PHOSPHODIESTERASE; BETA-SUBUNIT; MOUSE RETINA; ONE FORM; GENE	Mutations in the retinal degeneration, retinal degeneration slow(/peripherin) and rhodopsin genes cause photoreceptor degeneration in humans and mice. Although the phenotypes arising from these mutations are different, suggesting different mechanisms of pathogenesis, we present evidence that apoptosis may be the final common pathway of the disease process linking genotype to phenotype. We observed internucleosomal cleavage of retinal DNA by gel electrophoresis and fragmented DNA at the single cell level by labeling the nicked DNA ends with biotinylated poly(dU). In retinal degeneration mice, DNA fragmentation occurred during the period of photoreceptor degeneration. In retinal degeneration slow mice and in transgenic mice expressing a mutant (Pro347Ser) rhodopsin gene, DNA fragmentation occurred after normal histogenetic cell death (also apoptosis) had ceased. Since DNA fragmentation by internucleosomal cleavage is a cardinal feature of apoptosis, our data suggest that all three of these genetic mutations lead to apoptosis.	DUKE UNIV, SCH MED, DEPT NEUROBIOL, DURHAM, NC 27710 USA	Duke University	CHANG, GQ (corresponding author), DUKE UNIV, SCH MED, DEPT OPHTHALMOL, DURHAM, NC 27710 USA.				NEI NIH HHS [NEI R55 EY09047, NEI RO1 EY06862] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY006862, R55EY009047] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Allen T.D., 1987, P39; ALLES A, 1991, FASEB J, V5, P2127, DOI 10.1096/fasebj.5.8.2022310; ARENDS MJ, 1990, AM J PATHOL, V136, P593; Battey, 1986, BASIC METHODS MOL BI; BERSON EL, 1993, INVEST OPHTH VIS SCI, V34, P1659; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; BRUNE B, 1991, EXP CELL RES, V195, P323, DOI 10.1016/0014-4827(91)90380-D; CARTERDAWSON LD, 1978, INVEST OPHTH VIS SCI, V17, P489; CHADER GJ, 1988, RETINAL DISEASES BIO, P80; COHEN JJ, 1991, ADV IMMUNOL, V50, P55; COHEN JJ, 1984, J IMMUNOL, V132, P38; CONNELL G, 1991, P NATL ACAD SCI USA, V88, P723, DOI 10.1073/pnas.88.3.723; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; DRYJA TP, 1990, NEW ENGL J MED, V323, P1302, DOI 10.1056/NEJM199011083231903; DUKE RC, 1983, P NATL ACAD SCI-BIOL, V80, P6361, DOI 10.1073/pnas.80.20.6361; ELLIS RE, 1991, ANNU REV CELL BIOL, V7, P663, DOI 10.1146/annurev.cb.07.110191.003311; FARBER DB, 1974, SCIENCE, V186, P449, DOI 10.1126/science.186.4162.449; FARRAR GJ, 1991, NATURE, V354, P478, DOI 10.1038/354478a0; FINLAY BL, 1992, J NEUROBIOL, V23, P1159, DOI 10.1002/neu.480230908; GARCIA I, 1992, SCIENCE, V258, P302, DOI 10.1126/science.1411528; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GERSCHENSON LE, 1992, FASEB J, V6, P2450, DOI 10.1096/fasebj.6.7.1563596; GLUCKSMANN A, 1951, BIOL REV, V26, P59, DOI 10.1111/j.1469-185X.1951.tb00774.x; GLUCKSMANN A., 1965, AFCH BIOL, V76, P419; HAWKINS RK, 1985, EXP EYE RES, V41, P701, DOI 10.1016/0014-4835(85)90179-4; Heckenlively J. R., 1988, RETINITIS PIGMENTOSA; HEINTZ N, 1993, TRENDS BIOCHEM SCI, V18, P157, DOI 10.1016/0968-0004(93)90103-T; HOGAN B, 1986, MANIPULATING MOUSE G, P176; HUANG PC, 1993, P NATL ACAD SCI USA, V90, P8484, DOI 10.1073/pnas.90.18.8484; HUMPHRIES P, 1992, SCIENCE, V256, P804, DOI 10.1126/science.1589761; KAJIWARA K, 1991, NATURE, V354, P480, DOI 10.1038/354480a0; Kerr J. F., 1991, APOPTOSIS MOL BASIS, V3, P5; Kerr J.F.R., 1987, P93; LOCKSHIN RA, 1992, ANN NY ACAD SCI, V663, P234, DOI 10.1111/j.1749-6632.1992.tb38667.x; Martin Seamus J., 1993, Trends in Cell Biology, V3, P141, DOI 10.1016/0962-8924(93)90128-N; MCCONKEY DJ, 1989, ARCH BIOCHEM BIOPHYS, V269, P365, DOI 10.1016/0003-9861(89)90119-7; MCCONKEY DJ, 1990, FASEB J, V4, P2661, DOI 10.1096/fasebj.4.9.2347464; MCLAUGHLIN ME, 1993, NAT GENET, V4, P130, DOI 10.1038/ng0693-130; NICOLAOU KC, 1993, P NATL ACAD SCI USA, V90, P3142, DOI 10.1073/pnas.90.8.3142; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; PITTLER SJ, 1991, P NATL ACAD SCI USA, V88, P8322, DOI 10.1073/pnas.88.19.8322; RUBIN LL, 1993, CURR BIOL, V3, P391, DOI 10.1016/0960-9822(93)90211-6; SANYAL S, 1980, J COMP NEUROL, V194, P193, DOI 10.1002/cne.901940110; SCHMIDT SY, 1973, J CELL BIOL, V57, P117, DOI 10.1083/jcb.57.1.117; SCHWARTZ LM, 1993, P NATL ACAD SCI USA, V90, P980, DOI 10.1073/pnas.90.3.980; SCHWARTZMAN RA, 1993, ENDOCR REV, V14, P133, DOI 10.1210/er.14.2.133; SHAHINFAR S, 1991, CURR EYE RES, V10, P47, DOI 10.3109/02713689109007610; TRAVIS GH, 1992, NEURON, V9, P113, DOI 10.1016/0896-6273(92)90226-4; TRAVIS GH, 1989, NATURE, V338, P70, DOI 10.1038/338070a0; TRAVIS GH, 1991, NEURON, V6, P61, DOI 10.1016/0896-6273(91)90122-G; VAUX DL, 1992, SCIENCE, V258, P1955, DOI 10.1126/science.1470921; WONG F, 1993, ARCH OPHTHALMOL-CHIC, V111, P754, DOI 10.1001/archopht.1993.01090060042020; Wyllie A.H., 1981, CELL DEATH BIOL PATH, P9; WYLLIE AH, 1984, J PATHOL, V142, P67, DOI 10.1002/path.1711420112; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; YAU KW, 1989, ANNU REV NEUROSCI, V12, P289, DOI 10.1146/annurev.ne.12.030189.001445; YOUNG RW, 1984, J COMP NEUROL, V229, P362, DOI 10.1002/cne.902290307	57	559	578	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	1993	11	4					595	605		10.1016/0896-6273(93)90072-Y	http://dx.doi.org/10.1016/0896-6273(93)90072-Y			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MD068	8398150				2022-12-24	WOS:A1993MD06800005
J	LOVENBERG, TW; BARON, BM; DELECEA, L; MILLER, JD; PROSSER, RA; REA, MA; FOYE, PE; RACKE, M; SLONE, AL; SIEGEL, BW; DANIELSON, PE; SUTCLIFFE, JG; ERLANDER, MG				LOVENBERG, TW; BARON, BM; DELECEA, L; MILLER, JD; PROSSER, RA; REA, MA; FOYE, PE; RACKE, M; SLONE, AL; SIEGEL, BW; DANIELSON, PE; SUTCLIFFE, JG; ERLANDER, MG			A NOVEL ADENYLYL CYCLASE-ACTIVATING SEROTONIN RECEPTOR (5-HT7) IMPLICATED IN THE REGULATION OF MAMMALIAN CIRCADIAN-RHYTHMS	NEURON			English	Article							SUPRACHIASMATIC NUCLEI INVITRO; MESSENGER-RNA; FUNCTIONAL EXPRESSION; MOLECULAR-CLONING; FIRING RATE; AGONIST; FAMILY; PHASE; GENE; ACID	We report the cloning and characterization of a novel serotonin receptor, designated as 5-HT7, which is coupled to the stimulation of adenylyl cyclase. 5-HT7 mRNA is expressed discretely throughout the CNS, predominantly in the thalamus and hypothalamus. 5-HT7 has a unique pharmacological profile that redefines agonist and antagonist classification of ligands previously thought to be ''selective.'' The circadian phase of spontaneous neuronal activity of the rat suprachiasmatic nucleus of the hypothalamus advances in response to serotonin ligands with a pharmacological profile consistent exclusively with that of 5-HT7. These findings suggest a physiological role in the regulation of circadian rhythms for one subtype of serotonin receptor, 5-HT7, and provide a pharmacological test to evaluate its role in other neuronal systems.	MARION MERRELL DOW RES INST, CINCINNATI, OH 45215 USA; STANFORD UNIV, MED CTR, SCH MED, CTR SLEEP & CIRCADIAN NEUROBIOL, STANFORD, CA 94305 USA; ARMSTRONG LAB, CIRCADIAN NEUROBIOL RES GRP, BROOKS AFB, TX 78235 USA	Dow Chemical Company; Stanford University; United States Department of Defense; United States Air Force	LOVENBERG, TW (corresponding author), Scripps Res Inst, RES INST, DEPT MOLEC BIOL, LA JOLLA, CA 92037 USA.		de Lecea, Luis/B-3171-2009; de Lecea, Luis/ABE-4005-2021	de Lecea, Luis/0000-0002-8921-5942; de Lecea, Luis/0000-0002-8921-5942; Prosser, Rebecca/0000-0003-1636-7272	NINDS NIH HHS [R01 NS22347, NS08905] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS008905] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADHAM N, 1993, P NATL ACAD SCI USA, V90, P408, DOI 10.1073/pnas.90.2.408; ALBERT PR, 1990, J BIOL CHEM, V265, P5825; AMLAIKY N, 1992, J BIOL CHEM, V267, P19761; ARUNLAKSHANA O, 1959, BRIT J PHARM CHEMOTH, V14, P48, DOI 10.1111/j.1476-5381.1959.tb00928.x; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BARON BM, 1989, J NEUROCHEM, V53, P602, DOI 10.1111/j.1471-4159.1989.tb07376.x; BARON BM, 1990, MOL PHARMACOL, V38, P348; BOCKAERT J, 1992, TRENDS PHARMACOL SCI, V13, P141, DOI 10.1016/0165-6147(92)90051-7; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DANIELSON PE, 1988, DNA-J MOLEC CELL BIO, V7, P261, DOI 10.1089/dna.1988.7.261; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; EDGAR DM, 1993, J BIOL RHYTHM, V8, P17, DOI 10.1177/074873049300800102; ERLANDER MG, 1993, P NATL ACAD SCI USA, V90, P3452, DOI 10.1073/pnas.90.8.3452; FARGIN A, 1989, J BIOL CHEM, V264, P14848; FOGUET M, 1992, EMBO J, V11, P3481, DOI 10.1002/j.1460-2075.1992.tb05427.x; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GALL CM, 1989, SCIENCE, V245, P758, DOI 10.1126/science.2549634; Gillette MU, 1991, SUPRACHIASMATIC NUCL, P125; GLENNON RA, 1988, EUR J PHARMACOL, V154, P339, DOI 10.1016/0014-2999(88)90212-9; GREEN DJ, 1982, BRAIN RES, V245, P198, DOI 10.1016/0006-8993(82)90361-4; GUAN XM, 1992, MOL PHARMACOL, V41, P695; HUMPHREY PPA, 1993, IN PRESS TRENDS PHAR; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; JULIUS D, 1988, SCIENCE, V241, P558, DOI 10.1126/science.3399891; KOBILKA BK, 1987, NATURE, V329, P75, DOI 10.1038/329075a0; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; LIBERT F, 1989, SCIENCE, V244, P569, DOI 10.1126/science.2541503; LOVENBERG TW, 1993, P NATL ACAD SCI USA, V90, P2184, DOI 10.1073/pnas.90.6.2184; MARICQ AV, 1991, SCIENCE, V254, P432, DOI 10.1126/science.1718042; MCALLISTER G, 1992, P NATL ACAD SCI USA, V89, P5517, DOI 10.1073/pnas.89.12.5517; MEDANIC M, 1992, J PHYSIOL-LONDON, V450, P629, DOI 10.1113/jphysiol.1992.sp019147; MEIJER JH, 1989, PHYSIOL REV, V69, P671, DOI 10.1152/physrev.1989.69.3.671; MONSMA FJ, 1993, MOL PHARMACOL, V43, P320; PAZOS A, 1984, EUR J PHARMACOL, V106, P539, DOI 10.1016/0014-2999(84)90057-8; PLASSAT JL, 1992, EMBO J, V11, P4779, DOI 10.1002/j.1460-2075.1992.tb05583.x; PRITCHETT DB, 1988, EMBO J, V7, P4135, DOI 10.1002/j.1460-2075.1988.tb03308.x; PROSSER RA, 1990, BRAIN RES, V534, P336, DOI 10.1016/0006-8993(90)90153-3; PROSSER RA, 1993, J BIOL RHYTHM, V8, P1, DOI 10.1177/074873049300800101; PROSSER RA, 1989, J NEUROSCI, V9, P1073; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; RUSAK B, 1979, PHYSIOL REV, V59, P449, DOI 10.1152/physrev.1979.59.3.449; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAUDOU F, 1992, EMBO J, V11, P7, DOI 10.1002/j.1460-2075.1992.tb05021.x; SCHWARTZ WJ, 1993, ADV INTERNAL MED, V38, P8107; SHIBATA S, 1992, BRAIN RES, V582, P353, DOI 10.1016/0006-8993(92)90156-4; TOMINAGA K, 1992, EUR J PHARMACOL, V214, P79, DOI 10.1016/0014-2999(92)90099-P; TRUMPPKALLMEYER S, 1992, J MED CHEM, V35, P3448, DOI 10.1021/jm00097a002; VOIGT MM, 1991, EMBO J, V10, P4017, DOI 10.1002/j.1460-2075.1991.tb04977.x; WITZ P, 1990, P NATL ACAD SCI USA, V87, P8940, DOI 10.1073/pnas.87.22.8940; ZGOMBICK JM, 1991, MOL PHARMACOL, V40, P1036; ZIFA E, 1992, PHARMACOL REV, V44, P401	52	643	676	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1993	11	3					449	458		10.1016/0896-6273(93)90149-L	http://dx.doi.org/10.1016/0896-6273(93)90149-L			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LY498	8398139				2022-12-24	WOS:A1993LY49800005
J	CHIEN, CB; ROSENTHAL, DE; HARRIS, WA; HOLT, CE				CHIEN, CB; ROSENTHAL, DE; HARRIS, WA; HOLT, CE			NAVIGATIONAL ERRORS MADE BY GROWTH CONES WITHOUT FILOPODIA IN THE EMBRYONIC XENOPUS BRAIN	NEURON			English	Article							APPLIED ELECTRIC-FIELD; CYTOCHALASIN-B; GRASSHOPPER EMBRYOS; ACTIN-FILAMENTS; NEURITE GROWTH; RETINAL AXONS; NERVE GROWTH; AFFINITY; BEHAVIOR; NEURONS	We have developed an exposed brain preparation for observing growth cone pathfinding behavior while performing in vivo pharmacological manipulations, and we used it to test whether Xenopus retinal growth cones need filopodia to navigate. Time-lapse video observation showed that cytochalasin B acted quickly and reversibly when applied; cytochalasin B-treated growth cones lacked filopodia, but had active lamellipodia and continued to advance slowly. Whereas normal retinotectal axons visualized with horseradish peroxidase turn caudally in the mid-diencephalon to reach the tectum, cytochalasin B-treated axons grew past the normal turning point and, instead, continued straight within the diencephalon. In dose-response experiments, pathfinding became abnormal in the same concentration range in which filopodia disappeared. These results suggest that filopodia are necessary for retinal growth cones to respond to guidance signals in the diencephalon.	UNIV CALIF SAN DIEGO,CTR MOLEC GENET,LA JOLLA,CA 92093	University of California System; University of California San Diego	CHIEN, CB (corresponding author), UNIV CALIF SAN DIEGO,DEPT BIOL,LA JOLLA,CA 92093, USA.			Holt, Christine Elizabeth/0000-0003-2829-121X				BANDTLOW C, 1990, J NEUROSCI, V10, P3837, DOI 10.1523/JNEUROSCI.10-12-03837.1990; BASTIANI MJ, 1984, J NEUROSCI, V4, P2311; BENTLEY D, 1986, NATURE, V323, P712, DOI 10.1038/323712a0; BOVOLENTA P, 1987, J NEUROSCI, V7, P1447; BRAY D, 1985, J NEUROSCI, V5, P3204; CAUDY M, 1986, J NEUROSCI, V6, P1781; CAUDY M, 1986, J NEUROSCI, V6, P364; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; DAVENPORT RW, 1992, NEURON, V9, P405, DOI 10.1016/0896-6273(92)90179-H; EASTER SS, 1989, DEVELOPMENT, V107, P553; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; GUNDERSEN RW, 1980, J CELL BIOL, V87, P546, DOI 10.1083/jcb.87.3.546; HARRIS WA, 1985, J NEUROSCI RES, V13, P101, DOI 10.1002/jnr.490130108; HARRIS WA, 1986, NATURE, V320, P266, DOI 10.1038/320266a0; HARRIS WA, 1989, NATURE, V339, P218, DOI 10.1038/339218a0; HARRIS WA, 1987, DEVELOPMENT, V101, P123; Heidemann S R, 1991, Curr Opin Neurobiol, V1, P339, DOI 10.1016/0959-4388(91)90050-H; HEIDEMANN SR, 1990, J CELL BIOL, V111, P1949, DOI 10.1083/jcb.111.5.1949; HOLT CE, 1989, J NEUROSCI, V9, P3123; HOLT CE, 1984, J NEUROSCI, V4, P1130; Holtfreter J, 1943, J EXP ZOOL, V93, P251, DOI 10.1002/jez.1400930205; HONIG MG, 1986, J CELL BIOL, V103, P171, DOI 10.1083/jcb.103.1.171; KATZ MJ, 1985, J NEUROSCI, V5, P589; LETOURNEAU PC, 1987, CELL MOTIL CYTOSKEL, V8, P193, DOI 10.1002/cm.970080302; LETOURNEAU PC, 1991, NERVE GROWTH CONE; MARSH L, 1984, J CELL BIOL, V99, P2041, DOI 10.1083/jcb.99.6.2041; MCCAIG CD, 1986, J PHYSIOL-LONDON, V375, P55, DOI 10.1113/jphysiol.1986.sp016105; MCCAIG CD, 1989, J CELL SCI, V93, P715; NIUWKOOP PD, 1967, NORMAL TABLE XENOPUS; OCONNOR TP, 1990, J NEUROSCI, V10, P3935, DOI 10.1523/JNEUROSCI.10-12-03935.1990; RAMPAL AL, 1980, BIOCHEMISTRY-US, V19, P679, DOI 10.1021/bi00545a011; RAPER JA, 1983, J NEUROSCI, V3, P20; SABRY JH, 1991, J CELL BIOL, V115, P381, DOI 10.1083/jcb.115.2.381; SAMPATH P, 1991, BIOCHEMISTRY-US, V30, P1973, DOI 10.1021/bi00221a034; STRITTMATTER SM, 1991, BIOESSAYS, V13, P127, DOI 10.1002/bies.950130306; SUZUKI N, 1991, J BIOCHEM, V110, P514, DOI 10.1093/oxfordjournals.jbchem.a123612; TOSNEY KW, 1985, J NEUROSCI, V5, P2345; WESSELLS NK, 1978, EXP CELL RES, V115, P111, DOI 10.1016/0014-4827(78)90408-1	38	220	222	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1993	11	2					237	251		10.1016/0896-6273(93)90181-P	http://dx.doi.org/10.1016/0896-6273(93)90181-P			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LU065	8352941				2022-12-24	WOS:A1993LU06500005
J	LAMANTIA, AS; COLBERT, MC; LINNEY, E				LAMANTIA, AS; COLBERT, MC; LINNEY, E			RETINOIC ACID INDUCTION AND REGIONAL DIFFERENTIATION PREFIGURE OLFACTORY PATHWAY FORMATION IN THE MAMMALIAN FOREBRAIN	NEURON			English	Article							NERVOUS-SYSTEM; MOUSE EMBRYOS; NEURAL-TUBE; FLOOR PLATE; POLARIZING ACTIVITY; BINDING-PROTEINS; EXPRESSION; PATTERN; MORPHOGENESIS; HINDBRAIN	We have used an in vitro assay to identify sources of retinoic acid (RA) and transgenic mice to identify target domains in the developing forebrain. RA participates in a sequence of events that leads to the establishment of the olfactory pathway. First, the lateral cranial mesoderm activates an RA-inducible transgene in neuroepithelial cells in the olfactory placode and the ventrolateral forebrain. Then, neurons and neurites begin to differentiate in these two regions. Finally, olfactory axons grow specifically into the ventrolateral forebrain and subsequently are limited to the olfactory bulb rudiment. The coordination of these events, perhaps by common signals, implies that retinoid induction and retinoid-activated region-specific transcriptional regulation may help to define a forebrain subdivision and the peripheral neurons that provide its primary innervation.	DUKE UNIV, MED CTR, DEPT MICROBIOL, DURHAM, NC 27710 USA	Duke University	LAMANTIA, AS (corresponding author), DUKE UNIV, MED CTR, DEPT CHEM & NUCL ENGN, DURHAM, NC 27710 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD007637, R29HD029178, R01HD029178] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA039066] Funding Source: NIH RePORTER; NCI NIH HHS [CA39066] Funding Source: Medline; NICHD NIH HHS [HD07637, HD29178-01A1] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALTABA ARI, 1991, DEVELOPMENT, V112, P945; BALKAN W, 1992, P NATL ACAD SCI USA, V89, P3347, DOI 10.1073/pnas.89.8.3347; Bartelmez G. W., 1962, CONTRIB EMBRYOL CARN, V37, P13; BOVOLENTA P, 1990, DEVELOPMENT, V109, P435; BROCKES JP, 1989, NEURON, V2, P1285, DOI 10.1016/0896-6273(89)90066-4; BRYANT SV, 1992, DEV BIOL, V152, P1, DOI 10.1016/0012-1606(92)90152-7; BULFONE A, 1993, IN PRESS J NEUROSCI; CHISAKA O, 1992, NATURE, V355, P516, DOI 10.1038/355516a0; COLBERT MC, 1993, P NATL ACAD SCI US; CONLON RA, 1992, DEVELOPMENT, V116, P357; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; DOLLE P, 1990, DEVELOPMENT, V110, P1133; EASTER SS, 1993, J NEUROSCI, V13, P285; EPSTEIN DJ, 1991, CELL, V67, P767, DOI 10.1016/0092-8674(91)90071-6; ESPESETH AS, 1989, GENE DEV, V3, P1647, DOI 10.1101/gad.3.11.1647; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; GLASER T, 1990, SCIENCE, V250, P823, DOI 10.1126/science.2173141; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; GURDON JB, 1987, DEVELOPMENT, V99, P285; GUSTAFSON AL, 1993, DEVELOPMENT, V117, P451; HOGAN BLM, 1988, DEVELOPMENT, V103, P115; JESSELL TM, 1992, CELL, V68, P257, DOI 10.1016/0092-8674(92)90469-S; JONES FS, 1992, P NATL ACAD SCI USA, V89, P2086, DOI 10.1073/pnas.89.6.2086; KAPRONBRAS CM, 1985, TERATOLOGY, V32, P87, DOI 10.1002/tera.1420320112; KESSEL M, 1993, NEURON, V10, P379, DOI 10.1016/0896-6273(93)90328-O; KESSEL M, 1990, SCIENCE, V249, P374, DOI 10.1126/science.1974085; KEYNES RJ, 1984, NATURE, V310, P786, DOI 10.1038/310786a0; LAMMER EJ, 1985, NEW ENGL J MED, V313, P837, DOI 10.1056/NEJM198510033131401; LINNEY E, 1992, CURR TOP DEV BIOL, V27, P309, DOI 10.1016/S0070-2153(08)60538-4; LUMSDEN A, 1989, NATURE, V337, P424, DOI 10.1038/337424a0; MADEN M, 1991, DEVELOPMENT, P87; MANGELSDORF DJ, 1992, GENE DEV, V6, P329, DOI 10.1101/gad.6.3.329; MARSHALL H, 1992, NATURE, V360, P737, DOI 10.1038/360737a0; MCBURNEY MW, 1982, NATURE, V299, P165, DOI 10.1038/299165a0; MCCAFFERY P, 1992, DEVELOPMENT, V115, P371; MENDELSOHN C, 1991, DEVELOPMENT, V113, P723; MOASE CE, 1991, DEVELOPMENT, V113, P1049; MORRISSKAY GM, 1991, EMBO J, V10, P2985, DOI 10.1002/j.1460-2075.1991.tb07849.x; PAPALOPULU N, 1991, NUCLEIC ACIDS RES, V19, P5497, DOI 10.1093/nar/19.20.5497; PEREZCASTRO AV, 1989, P NATL ACAD SCI USA, V86, P8813, DOI 10.1073/pnas.86.22.8813; POPPERL H, 1993, MOL CELL BIOL, V13, P257; PORTEUS MH, 1991, NEURON, V7, P221, DOI 10.1016/0896-6273(91)90260-7; PRICE M, 1991, NATURE, V351, P748, DOI 10.1038/351748a0; PRICE M, 1992, NEURON, V8, P241, DOI 10.1016/0896-6273(92)90291-K; REYNOLDS K, 1991, MECH DEVELOP, V36, P15, DOI 10.1016/0925-4773(91)90068-H; RICHMAN JM, 1992, DEV BIOL, V154, P299, DOI 10.1016/0012-1606(92)90069-S; RICHMAN JM, 1989, DEV BIOL, V136, P201, DOI 10.1016/0012-1606(89)90142-5; ROSS LS, 1992, J NEUROSCI, V12, P467; ROSSANT J, 1991, GENE DEV, V5, P1333, DOI 10.1101/gad.5.8.1333; RUBERTE E, 1991, DEVELOPMENT, V111, P45; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; SHARPE CR, 1991, NEURON, V7, P239, DOI 10.1016/0896-6273(91)90262-X; SHENEFELT RE, 1972, TERATOLOGY, V5, P103, DOI 10.1002/tera.1420050115; SIMEONE A, 1992, NATURE, V358, P687, DOI 10.1038/358687a0; SNYDER DC, 1991, J NEUROBIOL, V22, P897, DOI 10.1002/neu.480220903; STOUT RP, 1980, NEUROSCIENCE, V5, P2175, DOI 10.1016/0306-4522(80)90134-7; SULIK KK, 1988, DEVELOPMENT, V103, P213; USMANN M, 1989, DEV BIOL, V136, P194; WAGNER M, 1990, NATURE, V345, P819, DOI 10.1038/345819a0; WAGNER M, 1992, DEVELOPMENT, V116, P55; WALTHER C, 1991, DEVELOPMENT, V113, P1435; WESTERFIELD M, 1986, J NEUROSCI, V6, P2267; WILKINSON DG, 1989, NATURE, V341, P405, DOI 10.1038/341405a0; WILSON SW, 1990, DEVELOPMENT, V108, P121; Windle WF., 1970, EXP NEUROL S, V28, P44; YAMADA T, 1991, CELL, V64, P635, DOI 10.1016/0092-8674(91)90247-V; ZIMMER A, 1992, DEVELOPMENT, V116, P977	67	136	139	1	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	1993	10	6					1035	1048		10.1016/0896-6273(93)90052-S	http://dx.doi.org/10.1016/0896-6273(93)90052-S			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LK373	8318228				2022-12-24	WOS:A1993LK37300004
J	FUJITA, Y; MYNLIEFF, M; DIRKSEN, RT; KIM, MS; NIIDOME, T; NAKAI, J; FRIEDRICH, T; IWABE, N; MIYATA, T; FURUICHI, T; FURUTAMA, D; MIKOSHIBA, K; MORI, Y; BEAM, KG				FUJITA, Y; MYNLIEFF, M; DIRKSEN, RT; KIM, MS; NIIDOME, T; NAKAI, J; FRIEDRICH, T; IWABE, N; MIYATA, T; FURUICHI, T; FURUTAMA, D; MIKOSHIBA, K; MORI, Y; BEAM, KG			PRIMARY STRUCTURE AND FUNCTIONAL EXPRESSION OF THE OMEGA-CONOTOXIN-SENSITIVE N-TYPE CALCIUM-CHANNEL FROM RABBIT BRAIN	NEURON			English	Article							CHICK SENSORY NEURONS; DYSGENIC SKELETAL-MUSCLE; DIHYDROPYRIDINE RECEPTOR; SODIUM-CHANNEL; BETA-SUBUNIT; ACETYLCHOLINE-RECEPTOR; PERIPHERAL NEURONS; COMPLEMENTARY-DNA; GVIA RECEPTOR; CA2+ CHANNELS	The complete amino acid sequence of a rabbit brain calcium channel (BIII) has been deduced by cloning and sequencing the cDNA. The open reading frame encodes 2339 amino acids, which corresponds to an M(r) of 261,167. A phylogenetic tree representing evolutionary relationships indicates that BIII is grouped together with the other rabbit brain calcium channels, BI and BII, into a subfamily that is distinct from the dihydropyridine-sensitive L-type subfamily. Transient expression in cultured skeletal muscle myotubes derived from muscular dysgenic mice demonstrates that the BIII channel mediates an omega-conotoxin-sensitive calcium current with kinetics and voltage dependence like those previously reported for whole-cell N-type current. Cell-attached patch recordings, with isotonic barium as the charge carrier, revealed distinct single channels with an average slope conductance of 14.3 pS.	KYOTO UNIV, FAC MED, DEPT MOLEC GENET, KYOTO 60601, JAPAN; COLORADO STATE UNIV, COLL VET MED & BIOMED SCI, DEPT PHYSIOL, FT COLLINS, CO 80523 USA; KYOTO UNIV, FAC SCI, DEPT BIOPHYS, KYOTO 60601, JAPAN; UNIV TOKYO, INST MED SCI, DEPT MOLEC NEUROBIOL, TOKYO 108, JAPAN	Kyoto University; Colorado State University; Kyoto University; University of Tokyo	FUJITA, Y (corresponding author), KYOTO UNIV, FAC MED, DEPT MED CHEM, KYOTO 60601, JAPAN.		Nakai, Junichi/GQZ-6415-2022; Mikoshiba, Katsuhiko/N-7943-2015; Furuichi, Teiichi/B-5086-2014	Furuichi, Teiichi/0000-0002-9676-1888	NINDS NIH HHS [NS-26416, NS-24444] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026416, R01NS024444] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABE T, 1987, J BIOL CHEM, V262, P9877; ADAMS BA, 1989, J GEN PHYSIOL, V94, P429, DOI 10.1085/jgp.94.3.429; AHLIJANIAN MK, 1990, NEURON, V4, P819, DOI 10.1016/0896-6273(90)90135-3; AOSAKI T, 1989, PFLUG ARCH EUR J PHY, V414, P150, DOI 10.1007/BF00580957; ARTALEJO CR, 1992, NEURON, V8, P85, DOI 10.1016/0896-6273(92)90110-Y; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BEAM KG, 1986, NATURE, V320, P168, DOI 10.1038/320168a0; BEAM KG, 1988, J GEN PHYSIOL, V91, P781, DOI 10.1085/jgp.91.6.781; BIEL M, 1990, FEBS LETT, V269, P409, DOI 10.1016/0014-5793(90)81205-3; CAMPBELL KP, 1988, TRENDS NEUROSCI, V11, P425, DOI 10.1016/0166-2236(88)90193-2; CATTERALL WA, 1988, SCIENCE, V242, P50, DOI 10.1126/science.2459775; CHANG FC, 1988, J BIOL CHEM, V263, P18929; CRUZ LJ, 1987, BIOCHEMISTRY-US, V26, P820, DOI 10.1021/bi00377a024; DIRKSEN RT, 1993, IN PRESS BIOPHYS J; DUBEL SJ, 1992, P NATL ACAD SCI USA, V89, P5058, DOI 10.1073/pnas.89.11.5058; FISHER RE, 1990, J NEUROPHYSIOL, V64, P91, DOI 10.1152/jn.1990.64.1.91; FOX AP, 1987, J PHYSIOL-LONDON, V394, P149, DOI 10.1113/jphysiol.1987.sp016864; FOX AP, 1987, J PHYSIOL-LONDON, V394, P173, DOI 10.1113/jphysiol.1987.sp016865; FURUICHI T, 1993, IN PRESS RECEPTORS C; GUY HR, 1990, TRENDS NEUROSCI, V13, P201; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HILLYARD DR, 1992, NEURON, V9, P69, DOI 10.1016/0896-6273(92)90221-X; HIRNING LD, 1988, SCIENCE, V239, P57, DOI 10.1126/science.2447647; HOFMANN F, 1990, N-S ARCH PHARMACOL, V341, P200; HONG SJ, 1992, NEUROSCIENCE, V48, P727, DOI 10.1016/0306-4522(92)90416-Y; HORNE AL, 1991, BRIT J PHARMACOL, V103, P1733, DOI 10.1111/j.1476-5381.1991.tb09855.x; HUBBARD SC, 1981, ANNU REV BIOCHEM, V50, P555, DOI 10.1146/annurev.bi.50.070181.003011; HUI A, 1991, NEURON, V7, P35, DOI 10.1016/0896-6273(91)90072-8; HULLIN R, 1992, EMBO J, V11, P885, DOI 10.1002/j.1460-2075.1992.tb05126.x; ITAGAKI K, 1992, FEBS LETT, V297, P221, DOI 10.1016/0014-5793(92)80542-O; Kimura M, 1983, NEUTRAL THEORY MOL E, P55; KOMURO H, 1992, SCIENCE, V257, P806, DOI 10.1126/science.1323145; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KREBS EG, 1979, ANNU REV BIOCHEM, V48, P923, DOI 10.1146/annurev.bi.48.070179.004423; LACERDA AE, 1991, NATURE, V352, P527, DOI 10.1038/352527a0; LLINAS R, 1989, P NATL ACAD SCI USA, V86, P1689, DOI 10.1073/pnas.86.5.1689; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MACKINNON R, 1990, NEURON, V5, P767, DOI 10.1016/0896-6273(90)90335-D; MARQUEZE B, 1988, MOL PHARMACOL, V34, P87; MCENERY MW, 1991, P NATL ACAD SCI USA, V88, P11095, DOI 10.1073/pnas.88.24.11095; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; MINTZ IM, 1992, NEURON, V9, P85, DOI 10.1016/0896-6273(92)90223-Z; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; MISHINA M, 1984, NATURE, V307, P604, DOI 10.1038/307604a0; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; MYNLIEFF M, 1992, J NEUROPHYSIOL, V68, P85, DOI 10.1152/jn.1992.68.1.85; NIIDOME T, 1992, FEBS LETT, V308, P7, DOI 10.1016/0014-5793(92)81038-N; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; NODA M, 1989, FEBS LETT, V259, P213, DOI 10.1016/0014-5793(89)81531-5; NOWYCKY MC, 1985, NATURE, V316, P440, DOI 10.1038/316440a0; NUMA S, 1986, ANN NY ACAD SCI, V479, P338, DOI 10.1111/j.1749-6632.1986.tb15580.x; PEREZREYES E, 1989, NATURE, V340, P233, DOI 10.1038/340233a0; PEREZREYES E, 1992, J BIOL CHEM, V267, P1792; PLUMMER MR, 1991, NATURE, V351, P657, DOI 10.1038/351657a0; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; PRAGNELL M, 1991, FEBS LETT, V291, P253, DOI 10.1016/0014-5793(91)81296-K; REGAN LJ, 1991, NEURON, V6, P269, DOI 10.1016/0896-6273(91)90362-4; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SAKAMOTO J, 1991, J BIOL CHEM, V266, P18914; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SATIN J, 1992, SCIENCE, V256, P1202, DOI 10.1126/science.256.5060.1202; SCHNEIDER T, 1988, EUR J BIOCHEM, V174, P369, DOI 10.1111/j.1432-1033.1988.tb14107.x; SCHROEDER JE, 1990, NEURON, V5, P445, DOI 10.1016/0896-6273(90)90083-R; SHER E, 1991, NEUROSCIENCE, V42, P301, DOI 10.1016/0306-4522(91)90376-Y; SINGER D, 1991, SCIENCE, V253, P1553, DOI 10.1126/science.1716787; SMITH SJ, 1988, TRENDS NEUROSCI, V11, P458, DOI 10.1016/0166-2236(88)90199-3; SNUTCH TP, 1991, NEURON, V7, P45, DOI 10.1016/0896-6273(91)90073-9; STARR TVB, 1991, P NATL ACAD SCI USA, V88, P5621, DOI 10.1073/pnas.88.13.5621; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; SWANDULLA D, 1991, TRENDS NEUROSCI, V14, P46, DOI 10.1016/0166-2236(91)90018-P; TAKAHASHI M, 1987, SCIENCE, V236, P88, DOI 10.1126/science.2436296; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; TANABE T, 1990, NATURE, V344, P451, DOI 10.1038/344451a0; TANABE T, 1990, NATURE, V346, P567, DOI 10.1038/346567a0; TANABE T, 1988, NATURE, V336, P134, DOI 10.1038/336134a0; TERLAU H, 1991, FEBS LETT, V293, P93, DOI 10.1016/0014-5793(91)81159-6; TSIEN RW, 1991, TRENDS PHARMACOL SCI, V12, P349, DOI 10.1016/0165-6147(91)90595-J; TSIEN RW, 1990, ANNU REV CELL BIOL, V6, P715, DOI 10.1146/annurev.cb.06.110190.003435; VARADI G, 1991, NATURE, V352, P159, DOI 10.1038/352159a0; WILLIAMS ME, 1992, SCIENCE, V257, P389, DOI 10.1126/science.1321501; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; YOSHIDA A, 1990, J BIOCHEM, V107, P608, DOI 10.1093/oxfordjournals.jbchem.a123094	82	219	223	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1993	10	4					585	598		10.1016/0896-6273(93)90162-K	http://dx.doi.org/10.1016/0896-6273(93)90162-K			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KY501	8386525				2022-12-24	WOS:A1993KY50100004
J	MELLSTROM, B; NARANJO, JR; FOULKES, NS; LAFARGA, M; SASSONECORSI, P				MELLSTROM, B; NARANJO, JR; FOULKES, NS; LAFARGA, M; SASSONECORSI, P			TRANSCRIPTIONAL RESPONSE TO CAMP IN BRAIN - SPECIFIC DISTRIBUTION AND INDUCTION OF CREM ANTAGONISTS	NEURON			English	Article							MULTIPLE SEQUENCE ELEMENTS; IMMEDIATE EARLY GENES; NUCLEAR FACTOR CREB; FOS MESSENGER-RNA; C-FOS; CYCLIC-AMP; BINDING-PROTEINS; NERVOUS-SYSTEM; SPINAL-CORD; EXPRESSION	Changes in cAMP levels are often associated with the modulation of neuronal function. The CREM gene encodes both antagonists and activators of the cAMP-dependent transcriptional response by alternative splicing. CREM transcripts in rat brain show a characteristic pattern of expression, being specific for the inner layer of the cerebral cortex, anterior thalamus, hippocampus, and hypothalamus. Strikingly, the CREM transcripts correspond to the antagonist isoforms in these areas, suggesting a down-regulatory role for CREM in brain; in contrast, the expression of CREMtau and CREB activators is more diffuse and generalized. In the supraoptic nucleus, CREM expression is induced after osmotic stimulus. Importantly, this demonstrates physiological inducibility of CREM, which is novel within the CRE/ATF family.	FAC MED STRASBOURG,CNRS,UA184,GENET MOLEC EUCARYOTES LAB,11 RUE HUMANN,F-67085 STRASBOURG,FRANCE; UNIV CANTABRIA,FAC MED,DEPT ANAT & BIOL CELULAR,E-39011 SANTANDER,SPAIN	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universidad de Cantabria	MELLSTROM, B (corresponding author), CSIC,AVE DR ARCE 37,E-28002 MADRID,SPAIN.		Lafarga, Miguel/K-3733-2014; Foulkes, Nicholas S/K-7003-2013; NARANJO, Jose R/K-1950-2014	Foulkes, Nicholas S/0000-0002-1794-9891; NARANJO, Jose R/0000-0002-0270-3469; Lafarga, Miguel/0000-0003-3402-1152				ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; BERKOWITZ LA, 1989, MOL CELL BIOL, V9, P4272, DOI 10.1128/MCB.9.10.4272; BORRELLI E, 1992, Critical Reviews in Oncogenesis, V3, P321; BULLITT E, 1989, BRAIN RES, V493, P391, DOI 10.1016/0006-8993(89)91177-3; CARTER DA, 1990, CELL MOL NEUROBIOL, V10, P435, DOI 10.1007/BF00711185; CARTER DA, 1989, BRAIN RES, V487, P350, DOI 10.1016/0006-8993(89)90839-1; COMB M, 1987, TRENDS NEUROSCI, V10, P473, DOI 10.1016/0166-2236(87)90103-2; COMB M, 1986, NATURE, V323, P353, DOI 10.1038/323353a0; DELEGEANE AM, 1987, MOL CELL BIOL, V7, P3994, DOI 10.1128/MCB.7.11.3994; DELMAS V, 1992, P NATL ACAD SCI USA, V89, P4226, DOI 10.1073/pnas.89.10.4226; FISCH TM, 1989, GENE DEV, V3, P198, DOI 10.1101/gad.3.2.198; FOULKES NS, 1992, CELL, V68, P411, DOI 10.1016/0092-8674(92)90178-F; FOULKES NS, 1992, NATURE, V355, P80, DOI 10.1038/355080a0; FOULKES NS, 1991, CELL, V64, P739, DOI 10.1016/0092-8674(91)90503-Q; FOULKES NS, 1991, P NATL ACAD SCI USA, V88, P5448, DOI 10.1073/pnas.88.12.5448; FRAZER A, 1990, ANNU REV PHARMACOL, V30, P307; GONZALEZ GA, 1989, NATURE, V337, P749, DOI 10.1038/337749a0; GUBITS RM, 1989, MOL BRAIN RES, V6, P39, DOI 10.1016/0169-328X(89)90026-0; HABENER JF, 1990, MOL ENDOCRINOL, V4, P1087, DOI 10.1210/mend-4-8-1087; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; HO YS, 1988, NUCLEIC ACIDS RES, V16, P7746, DOI 10.1093/nar/16.15.7746; HOEFFLER JP, 1988, SCIENCE, V242, P1430, DOI 10.1126/science.2974179; IVASHKIV LB, 1990, MOL CELL BIOL, V10, P1609, DOI 10.1128/MCB.10.4.1609; KOBILKA B, 1992, ANNU REV NEUROSCI, V15, P87, DOI 10.1146/annurev.ne.15.030192.000511; LAFARGA M, 1992, IN PRESS NEUROSCIENC; LAOIDE BM, 1993, EMBO J, V12, P1179, DOI 10.1002/j.1460-2075.1993.tb05759.x; LEWIN B, 1990, CELL, V61, P1161, DOI 10.1016/0092-8674(90)90675-5; MAEKAWA T, 1989, EMBO J, V8, P2023, DOI 10.1002/j.1460-2075.1989.tb03610.x; MELLSTROM B, 1991, ONCOGENE, V6, P1959; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; MONTMAYEUR JP, 1991, P NATL ACAD SCI USA, V88, P3135, DOI 10.1073/pnas.88.8.3135; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; NARANJO JR, 1991, NEURON, V6, P607, DOI 10.1016/0896-6273(91)90063-6; ODOWD BF, 1989, ANNU REV NEUROSCI, V12, P67, DOI 10.1146/annurev.ne.12.030189.000435; RANSONE LJ, 1990, ANNU REV CELL BIOL, V6, P539, DOI 10.1146/annurev.cellbio.6.1.539; RAYCHAUDHURI P, 1989, GENE DEV, V3, P620, DOI 10.1101/gad.3.5.620; SAGAR SM, 1988, SCIENCE, V240, P1328, DOI 10.1126/science.3131879; SASSONECORSI P, 1988, P NATL ACAD SCI USA, V85, P7192, DOI 10.1073/pnas.85.19.7192; SASSONECORSI P, 1988, GENE DEV, V2, P1529, DOI 10.1101/gad.2.12a.1529; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; SHARP FR, 1991, J NEUROSCI, V11, P2321, DOI 10.1523/jneurosci.11-08-02321.1991; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; SHERMAN TG, 1988, J NEUROSCI, V8, P3785; SHERMAN TG, 1986, J NEUROSCI, V6, P1685; SONNENBERG JL, 1989, SCIENCE, V246, P1622, DOI 10.1126/science.2512642; STRADER CD, 1989, TRENDS PHARMACOL SCI, V89, P26; STRANGE PG, 1990, TRENDS NEUROSCI, V13, P373, DOI 10.1016/0166-2236(90)90022-3; TANABE Y, 1992, NEURON, V8, P169, DOI 10.1016/0896-6273(92)90118-W; VERMA IM, 1986, COLD SPRING HARB SYM, V51, P949, DOI 10.1101/SQB.1986.051.01.108; WISDEN W, 1990, NEURON, V4, P603, DOI 10.1016/0896-6273(90)90118-Y; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0; YOUNG WS, 1987, MOL ENDOCRINOL, V1, P884, DOI 10.1210/mend-1-12-884; [No title captured]	56	85	86	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1993	10	4					655	665		10.1016/0896-6273(93)90167-P	http://dx.doi.org/10.1016/0896-6273(93)90167-P			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KY501	8386526				2022-12-24	WOS:A1993KY50100009
J	PIERCE, ME; SHESHBERADARAN, H; ZHE, Z; FOX, LE; APPLEBURY, ML; TAKAHASHI, JS				PIERCE, ME; SHESHBERADARAN, H; ZHE, Z; FOX, LE; APPLEBURY, ML; TAKAHASHI, JS			CIRCADIAN REGULATION OF IODOPSIN GENE-EXPRESSION IN EMBRYONIC PHOTORECEPTORS IN RETINAL CELL-CULTURE	NEURON			English	Article							MESSENGER-RNA; CHICK RETINA; CLOCK; TRANSCRIPTION; PROTEIN; RHYTHM; OPSIN; LEVEL; ROD	A circadian clock regulates number of diverse physiological functions in the vertebrate eye. In this study, we show that mRNA for the red-sensitive cone pigment, iodopsin, fluctuates with a circadian rhythm in chicken retina. Transcript levels increase in the late afternoon just prior to the time of cone disc shedding. Furthermore, iodopsin mRNA levels are regulated similarly by a circadian oscillator in primary cultures of dispersed embryonic chick retina. Nuclear run-on experiments show that the circadian regulation of iodopsin transcript abundance occurs at the level of gene transcription. Our results provide a demonstration of clock-regulated gene expression in a vertebrate preparation maintained in cell culture.	NORTHWESTERN UNIV,NSF,CTR BIOL TIMING,EVANSTON,IL 60208; UNIV CHICAGO,CTR VISUAL SCI,CHICAGO,IL 60637; UNIV CHICAGO,COMM NEUROBIOL,CHICAGO,IL 60637	National Science Foundation (NSF); NSF - Center for Biological Timing; Northwestern University; University of Chicago; University of Chicago			Takahashi, Joseph S/E-8482-2012; Takahashi, Joseph S./Y-2781-2019	Takahashi, Joseph S/0000-0003-0384-8878; Takahashi, Joseph S./0000-0003-0384-8878	NATIONAL EYE INSTITUTE [R01EY008467, R01EY004801] Funding Source: NIH RePORTER; NEI NIH HHS [EY08467, EY04801, EY06167] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADLER R, 1986, DEV BIOL, V117, P520, DOI 10.1016/0012-1606(86)90319-2; ADLER R, 1986, RETINA MODEL CELL BI, P111; [Anonymous], MOL GENETICS BIOL RH; ARAKI M, 1990, INVEST OPHTH VIS SCI, V31, P1466; BANERJI SS, 1984, MOL CELL BIOL, V4, P2437, DOI 10.1128/MCB.4.11.2437; Besharse J.C., 1988, PROGR RETINAL RES, V7, P21; BOWES C, 1988, EXP EYE RES, V47, P369, DOI 10.1016/0014-4835(88)90049-8; BRANN MR, 1987, SCIENCE, V235, P585, DOI 10.1126/science.3101175; CAHILL GM, 1991, CELL MOL NEUROBIOL, V11, P529, DOI 10.1007/BF00734814; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CRAFT CM, 1990, J NEUROCHEM, V55, P1461, DOI 10.1111/j.1471-4159.1990.tb04927.x; DARNELL JE, 1982, NATURE, V297, P365, DOI 10.1038/297365a0; DUNLAP JC, 1990, TRENDS GENET, V6, P159, DOI 10.1016/0168-9525(90)90151-U; GIULIANO G, 1988, EMBO J, V7, P3635, DOI 10.1002/j.1460-2075.1988.tb03244.x; HALL JC, 1990, ANNU REV GENET, V24, P659; KORENBROT JI, 1989, NATURE, V337, P454, DOI 10.1038/337454a0; KUWATA O, 1990, FEBS LETT, V272, P128, DOI 10.1016/0014-5793(90)80465-U; LOROS JJ, 1991, MOL CELL BIOL, V11, P558, DOI 10.1128/MCB.11.1.558; MILLAR AJ, 1991, PLANT CELL, V3, P541, DOI 10.1105/tpc.3.5.541; MORSE DS, 1990, TRENDS BIOCHEM SCI, V15, P262, DOI 10.1016/0968-0004(90)90050-L; NAGY F, 1988, GENE DEV, V2, P376, DOI 10.1101/gad.2.4.376; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; PITTENDRIGH CS, 1960, COLD SPRING HARB SYM, V25, P159, DOI 10.1101/SQB.1960.025.01.015; REME CE, 1991, J BIOL RHYTHM, V6, P5, DOI 10.1177/074873049100600104; SUGARMAN BJ, 1983, J BIOL CHEM, V258, P9005; Takahashi J S, 1991, Curr Opin Neurobiol, V1, P556, DOI 10.1016/S0959-4388(05)80028-5; WUARIN J, 1990, CELL, V63, P1257, DOI 10.1016/0092-8674(90)90421-A; YOUNG RW, 1978, INVEST OPHTH VIS SCI, V17, P105	28	150	150	1	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1993	10	4					579	584		10.1016/0896-6273(93)90161-J	http://dx.doi.org/10.1016/0896-6273(93)90161-J			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KY501	8476610				2022-12-24	WOS:A1993KY50100003
J	WAGNER, KR; COHEN, JB; HUGANIR, RL				WAGNER, KR; COHEN, JB; HUGANIR, RL			THE 87K-POSTSYNAPTIC MEMBRANE-PROTEIN FROM TORPEDO IS A PROTEIN-TYROSINE KINASE SUBSTRATE HOMOLOGOUS TO DYSTROPHIN	NEURON			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; POSTSYNAPTIC 43-KDA PROTEIN; MARMORATA ELECTRIC ORGAN; CULTURED MUSCLE-CELLS; SKELETAL-MUSCLE; NEUROMUSCULAR-JUNCTIONS; MONOCLONAL-ANTIBODIES; ALKALINE TREATMENT; LEUCINE ZIPPER; RICH MEMBRANES	Postsynaptic peripheral membrane proteins at the neuromuscular junction have been proposed to participate in the immobilization of the nicotinic acetylcholine receptor at the synapse. An 87 kd cytoplasmic peripheral membrane protein has been demonstrated to colocalize with the nicotinic acetylcholine receptor in the Torpedo electric organ and at the mammalian neuromuscular junction. We have cloned the cDNA encoding the 87K protein from Torpedo electric organ, and the predicted protein sequence is homologous to the C-terminal domains of dystrophin, the protein product of the Duchenne muscular dystrophy gene. The 87K protein displays a restricted pattern of expression detected only in electric organ, brain, and skeletal muscle. Analysis of the in vitro and in vivo phosphorylation of the 87K protein indicates that it is multiply phosphorylated on serine, threonine, and tyrosine residues. The 87K protein is in a complex with other proteins associated with the post-synaptic membrane, including dystrophin and a 58 kd protein. These results suggest that the 87K protein is involved in the formation and stability of synapses and is regulated by protein phosphorylation.	HARVARD UNIV,SCH MED,DEPT NEUROBIOL,BOSTON,MA 02115	Harvard University; Harvard Medical School	WAGNER, KR (corresponding author), JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT NEUROSCI,BALTIMORE,MD 21205, USA.				NINDS NIH HHS [NS 24418, NS 29343] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024418, P01NS029343] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS MD, 1992, NATURE, V355, P632, DOI 10.1038/355632a0; BALDWIN TJ, 1988, DEVELOPMENT, V104, P557; BARRANTES FJ, 1980, FEBS LETT, V112, P73, DOI 10.1016/0014-5793(80)80131-1; BERG JM, 1990, J BIOL CHEM, V265, P6513; BLOCH RJ, 1988, AM J PHYSIOL, V254, pC345, DOI 10.1152/ajpcell.1988.254.3.C345; BRIDGMAN PC, 1989, J CELL BIOL, V105, P1829; BUCKLAND R, 1989, NATURE, V338, P547, DOI 10.1038/338547a0; BURDEN SJ, 1983, CELL, V35, P687, DOI 10.1016/0092-8674(83)90101-0; BUTLER MH, 1992, J BIOL CHEM, V267, P6213; CAMPBELL KP, 1989, NATURE, V338, P259, DOI 10.1038/338259a0; CARR C, 1989, J CELL BIOL, V109, P1753, DOI 10.1083/jcb.109.4.1753; CARTAUD J, 1981, J CELL BIOL, V90, P418, DOI 10.1083/jcb.90.2.418; CASNELLIE JE, 1984, P NATL ACAD SCI-BIOL, V81, P6676, DOI 10.1073/pnas.81.21.6676; CHANG HW, 1989, J BIOL CHEM, V264, P20831; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; FERTUCK H C, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1376, DOI 10.1073/pnas.71.4.1376; FLUCHER BE, 1989, NEURON, V3, P163, DOI 10.1016/0896-6273(89)90029-9; FOX GQ, 1978, J COMP NEUROL, V179, P677, DOI 10.1002/cne.901790313; FRAIL DE, 1988, J BIOL CHEM, V263, P15602; FRAIL DE, 1987, P NATL ACAD SCI USA, V84, P6302, DOI 10.1073/pnas.84.17.6302; FROEHNER SC, 1991, J CELL BIOL, V114, P1, DOI 10.1083/jcb.114.1.1; FROEHNER SC, 1987, J CELL BIOL, V104, P1633, DOI 10.1083/jcb.104.6.1633; FROEHNER SC, 1989, FEBS LETT, V249, P229, DOI 10.1016/0014-5793(89)80629-5; FROEHNER SC, 1990, NEURON, V5, P403, DOI 10.1016/0896-6273(90)90079-U; FROEHNER SC, 1984, J CELL BIOL, V99, P88, DOI 10.1083/jcb.99.1.88; HARLOW E, 1988, ANTIBODIES LABORATOR; HELLIWELL TR, 1992, AM J HUM GENET, V50, P508; HIRANO AA, 1988, J NEUROCHEM, V50, P1447, DOI 10.1111/j.1471-4159.1988.tb03029.x; HOFFMAN EP, 1989, NEURON, V2, P1019, DOI 10.1016/0896-6273(89)90226-2; HOPFIELD JF, 1988, NATURE, V336, P677, DOI 10.1038/336677a0; HUGANIR RL, 1982, J BIOL CHEM, V257, P9372; HUGANIR RL, 1984, P NATL ACAD SCI USA, V81, P6963; IBRAGHINOVBESKR, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; KHURANA TS, 1990, J BIOL CHEM, V265, P16717; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P5995; KRAMARCY NR, 1990, FEBS LETT, V274, P171, DOI 10.1016/0014-5793(90)81356-S; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LAROCHELLE WJ, 1987, J BIOL CHEM, V262, P8190; LAROCHELLE WJ, 1986, J BIOL CHEM, V261, P5270; LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033; LEMAIRE C, 1988, EMBO J, V7, P4517; LOVE DR, 1989, NATURE, V339, P55, DOI 10.1038/339055a0; MCMAHAN UJ, 1989, DEV NEUROSCI-BASEL, V11, P227, DOI 10.1159/000111903; MIERENDORF RC, 1987, METHOD ENZYMOL, V152, P458; MILES K, 1988, MOL NEUROBIOL, V2, P91, DOI 10.1007/BF02935341; MUSIL LS, 1989, J CELL BIOL, V108, P1833, DOI 10.1083/jcb.108.5.1833; NEUBIG RR, 1979, P NATL ACAD SCI USA, V76, P690, DOI 10.1073/pnas.76.2.690; NITKIN RM, 1987, J CELL BIOL, V105, P2471, DOI 10.1083/jcb.105.6.2471; PENG HB, 1991, NEURON, V6, P237; PENG HB, 1982, J NEUROSCI, V2, P1760; PHILLIPS WD, 1991, SCIENCE, V251, P568, DOI 10.1126/science.1703661; QU ZC, 1990, NEURON, V4, P367, DOI 10.1016/0896-6273(90)90049-L; REIST NE, 1992, NEURON, V8, P865, DOI 10.1016/0896-6273(92)90200-W; ROUSSELET A, 1981, BIOCHIM BIOPHYS ACTA, V648, P169, DOI 10.1016/0005-2736(81)90032-8; Sambrook J, 1989, MOL CLONING LABORATO; SEALOCK R, 1984, J CELL BIOL, V98, P2239, DOI 10.1083/jcb.98.6.2239; SEALOCK R, 1991, J CELL BIOL, V113, P1133, DOI 10.1083/jcb.113.5.1133; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SOBEL A, 1977, EUR J BIOCHEM, V80, P215, DOI 10.1111/j.1432-1033.1977.tb11874.x; TANK DW, 1982, J CELL BIOL, V92, P207, DOI 10.1083/jcb.92.1.207; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WAGNER K, 1991, J BIOL CHEM, V266, P23784; WALLACE BG, 1991, NEURON, V6, P869, DOI 10.1016/0896-6273(91)90227-Q; YEADON JE, 1991, J CELL BIOL, V115, P1069, DOI 10.1083/jcb.115.4.1069; ZUBRZYCKAGAARN EF, 1988, NATURE, V333, P466, DOI 10.1038/333466a0	69	148	148	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1993	10	3					511	522		10.1016/0896-6273(93)90338-R	http://dx.doi.org/10.1016/0896-6273(93)90338-R			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KU901	8461138				2022-12-24	WOS:A1993KU90100015
J	Currie, KPM; Fox, AP				Currie, KPM; Fox, AP			ATP serves as a negative feedback inhibitor of voltage-gated Ca2+ channel currents in cultured bovine adrenal chromaffin cells	NEURON			English	Article							SENSITIVE CALCIUM CHANNELS; EXTRACELLULAR ATP; OMEGA-CONOTOXIN; RECEPTORS; FACILITATION; SECRETION; NEURONS; ACTIVATION; MODULATION; MECHANISM	Modulation of voltage-gated Ca2+ channel current (I-Ca) regulates secretion of catecholamines from adrenal chromaffin cells. Previous work demonstrated that I-Ca can be augmented by phosphorylation to increase secretion or that inhibition of I-Ca results in diminished catecholamine secretion. In the current manuscript, we show that stimulation of chromaffin cells results in the release of an ''endogenous inhibitor'' that suppresses I-Ca. The inhibition is due to the secretion of ATP, which is stored at high concentrations in secretory granules and is coreleased with catecholamines upon stimulation. The ATP exerts its actions through P-2Y purinoceptors and inhibits both N- and P/Q-type Ca2+ channels in a voltage-dependent manner but with different efficacies. Overall, we have identified and characterized a negative feedback pathway that may serve as an important regulatory mechanism for catecholamine secretion in chromaffin cells.			Currie, KPM (corresponding author), UNIV CHICAGO,DEPT PHARMACOL & PHYSIOL SCI,947 E 58TH ST,CHICAGO,IL 60637, USA.		Currie, Kevin P/J-9561-2019	Currie, Kevin P/0000-0002-0861-423X				ARTALEJO CR, 1990, NATURE, V348, P239, DOI 10.1038/348239a0; ARTALEJO CR, 1992, NEURON, V8, P85, DOI 10.1016/0896-6273(92)90110-Y; ARTALEJO CR, 1994, NATURE, V367, P72, DOI 10.1038/367072a0; ARTALEJO CR, 1992, NATURE, V358, P63, DOI 10.1038/358063a0; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; BEAN BP, 1992, TRENDS PHARMACOL SCI, V13, P87, DOI 10.1016/0165-6147(92)90032-2; BIGORNIA L, 1990, J PHARMACOL EXP THER, V252, P586; BOARDER MR, 1995, TRENDS PHARMACOL SCI, V16, P133, DOI 10.1016/S0165-6147(00)89001-X; BOARDER MR, 1987, BIOCHEM PHARMACOL, V36, P163, DOI 10.1016/0006-2952(87)90394-7; BRAKE AJ, 1994, NATURE, V371, P519, DOI 10.1038/371519a0; CARMICHAEL SW, 1985, SCI AM, V253, P40, DOI 10.1038/scientificamerican0885-40; CASTRO E, 1995, J BIOL CHEM, V270, P5098, DOI 10.1074/jbc.270.10.5098; DALZIEL HH, 1994, PHARMACOL REV, V46, P449; DIVERSEPIERLUISSI M, 1991, P NATL ACAD SCI USA, V88, P1261, DOI 10.1073/pnas.88.4.1261; DOLPHIN AC, 1995, EXP PHYSIOL, V80, P1; DOROSHENKO P, 1991, PFLUG ARCH EUR J PHY, V419, P444, DOI 10.1007/BF00370786; DOUGLAS WW, 1968, BRIT J PHARMACOL, V34, P451, DOI 10.1111/j.1476-5381.1968.tb08474.x; DOUPNIK CA, 1994, J MEMBRANE BIOL, V140, P47; DUBYAK GR, 1993, AM J PHYSIOL, V265, pC577, DOI 10.1152/ajpcell.1993.265.3.C577; ELMSLIE KS, 1990, NEURON, V5, P75, DOI 10.1016/0896-6273(90)90035-E; EVANS RJ, 1995, MOL PHARMACOL, V48, P178; FENWICK EM, 1982, J PHYSIOL-LONDON, V331, P599, DOI 10.1113/jphysiol.1982.sp014394; FREDHOLM BB, 1994, PHARMACOL REV, V46, P143; GANDIA L, 1993, J PHYSIOL-LONDON, V470, P55, DOI 10.1113/jphysiol.1993.sp019847; GANDIA L, 1993, BIOCHEM BIOPH RES CO, V194, P671, DOI 10.1006/bbrc.1993.1874; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HANS M, 1990, NEUROSCI LETT, V114, P63, DOI 10.1016/0304-3940(90)90429-D; HEINEMANN C, 1994, BIOPHYS J, V67, P2546, DOI 10.1016/S0006-3495(94)80744-1; HILLE B, 1994, TRENDS NEUROSCI, V17, P531, DOI 10.1016/0166-2236(94)90157-0; HOSHI T, 1984, P NATL ACAD SCI-BIOL, V81, P5871, DOI 10.1073/pnas.81.18.5871; HOSHI T, 1987, J NEUROSCI, V7, P571; KLEPPISCH T, 1992, PFLUG ARCH EUR J PHY, V421, P131, DOI 10.1007/BF00374819; LIN LF, 1995, NEUROSCI LETT, V183, P147, DOI 10.1016/0304-3940(94)11136-7; LIN WW, 1994, J PHARMACOL EXP THER, V269, P928; LOPEZ MG, 1994, FEBS LETT, V349, P331, DOI 10.1016/0014-5793(94)00696-2; MINTZ IM, 1993, NEURON, V10, P889, DOI 10.1016/0896-6273(93)90204-5; PENINGTON NJ, 1991, J NEUROSCI, V11, P3594, DOI 10.1523/jneurosci.11-11-03594.1991; SASAKAWA N, 1989, J NEUROCHEM, V52, P441, DOI 10.1111/j.1471-4159.1989.tb09140.x; TWITCHELL WA, 1993, NEURON, V10, P701, DOI 10.1016/0896-6273(93)90171-M; TWITCHELL WA, 1994, MOL PHARMACOL, V46, P793; VALERA S, 1994, NATURE, V371, P516, DOI 10.1038/371516a0; WILSON SP, 1988, NEUROPEPTIDES, V11, P17, DOI 10.1016/0143-4179(88)90023-6; WINKLER H, 1980, NEUROSCIENCE, V5, P1803, DOI 10.1016/0306-4522(80)90031-7; WINKLER H, 1988, A BENZON S, V25, P347	44	115	116	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1996	16	5					1027	1036		10.1016/S0896-6273(00)80126-9	http://dx.doi.org/10.1016/S0896-6273(00)80126-9			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UN480	8630241	Bronze			2022-12-24	WOS:A1996UN48000018
J	Gillespie, SKH; Balasubramanian, S; Fung, ET; Huganir, RL				Gillespie, SKH; Balasubramanian, S; Fung, ET; Huganir, RL			Rapsyn clusters and activates the synapse-specific receptor tyrosine kinase MuSK	NEURON			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; MONOCLONAL-ANTIBODIES; PROTEIN-KINASE; POSTSYNAPTIC PROTEIN; POINT MUTATION; 43K PROTEIN; PHOSPHORYLATION; MEMBRANE; DOMAINS; SUBUNITS	Nerve-induced clustering of the nicotinic acetylcholine receptor (AChR) requires rapsyn, a synaptic peripheral membrane protein, as well as protein-tyrosine kinase activity. Here, we show that rapsyn induces the clustering of the synapse-specific receptor-tyrosine kinase MuSK in transfected QT-6 fibroblasts. Furthermore, rapsyn stimulates the autophosphorylation of MUSK, leading to a subsequent MuSK-dependent increase in cellular tyrosine phosphorylation. Moreover, rapsyn-activated MuSK specifically phosphorylated the AChR beta subunit, the same subunit that is tyrosine phosphorylated during innervation or agrin treatment of muscle. These results suggest rapsyn may mediate the synaptic localization of MUSK in muscle and that MuSK may play an important role in the agrin-induced clustering of the ACI IR.			Gillespie, SKH (corresponding author), JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT NEUROSCI,BALTIMORE,MD 21205, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024418] Funding Source: NIH RePORTER; NINDS NIH HHS [NS24418] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		APEL ED, 1995, NEURON, V15, P115, DOI 10.1016/0896-6273(95)90069-1; Apel Elizabeth D., 1995, Current Opinion in Neurobiology, V5, P62, DOI 10.1016/0959-4388(95)80088-3; BLOUNT P, 1988, J BIOL CHEM, V263, P1072; BOWE MA, 1994, NEURON, V12, P1173, DOI 10.1016/0896-6273(94)90324-7; BOWE MA, 1995, ANNU REV NEUROSCI, V18, P443; CAMPANELLI JT, 1994, CELL, V77, P663, DOI 10.1016/0092-8674(94)90051-5; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; EHLERS MD, 1995, SCIENCE, V269, P1734, DOI 10.1126/science.7569904; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Ferns M, 1996, J CELL BIOL, V132, P937, DOI 10.1083/jcb.132.5.937; FERTUCK H C, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1376, DOI 10.1073/pnas.71.4.1376; FROEHNER SC, 1991, J CELL BIOL, V114, P1, DOI 10.1083/jcb.114.1.1; FROEHNER SC, 1990, NEURON, V5, P403, DOI 10.1016/0896-6273(90)90079-U; FROEHNER SC, 1983, J BIOL CHEM, V258, P7112; GANJU P, 1995, ONCOGENE, V11, P281; GAUTAM M, 1995, NATURE, V377, P232, DOI 10.1038/377232a0; GEE SH, 1994, CELL, V77, P675, DOI 10.1016/0092-8674(94)90052-3; Gesemann M, 1996, NEURON, V16, P755, DOI 10.1016/S0896-6273(00)80096-3; GESEMANN M, 1995, J CELL BIOL, V128, P625, DOI 10.1083/jcb.128.4.625; GUITON M, 1994, J BIOL CHEM, V269, P30370; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; HEMPSTEAD BL, 1992, NEURON, V9, P883, DOI 10.1016/0896-6273(92)90241-5; Hopf C, 1996, J BIOL CHEM, V271, P5231; HOPFIELD JF, 1988, NATURE, V336, P677, DOI 10.1038/336677a0; HUGANIR RL, 1982, J BIOL CHEM, V257, P9372; HUGANIR RL, 1984, P NATL ACAD SCI-BIOL, V81, P6968, DOI 10.1073/pnas.81.22.6968; JENNINGS CGB, 1993, P NATL ACAD SCI USA, V90, P2895, DOI 10.1073/pnas.90.7.2895; KOPTA C, 1994, J NEUROSCI, V14, P3922; MAIMONE MM, 1993, NEURON, V11, P53, DOI 10.1016/0896-6273(93)90270-2; MARTINZANCA D, 1986, NATURE, V319, P743, DOI 10.1038/319743a0; MATTHEWS JA, 1985, ANAL BIOCHEM, V151, P205, DOI 10.1016/0003-2697(85)90073-9; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; MEIER T, 1995, J CELL BIOL, V131, P441, DOI 10.1083/jcb.131.2.441; MOSCOVICI C, 1977, CELL, V11, P95, DOI 10.1016/0092-8674(77)90320-8; NOAKES PG, 1993, DEV BIOL, V155, P275, DOI 10.1006/dbio.1993.1025; OHNO S, 1990, J BIOL CHEM, V265, P6296; PENG HB, 1985, J CELL BIOL, V100, P1698, DOI 10.1083/jcb.100.5.1698; PHILLIPS WD, 1993, J CELL BIOL, V123, P729, DOI 10.1083/jcb.123.3.729; PHILLIPS WD, 1991, J CELL BIOL, V115, P1713, DOI 10.1083/jcb.115.6.1713; PHILLIPS WD, 1991, SCIENCE, V251, P568, DOI 10.1126/science.1703661; PHILLIPS WD, 1992, BIOESSAYS, V14, P671, DOI 10.1002/bies.950141005; QU Z, 1994, J NEUROSCI, V14, P6834; QU Z, 1990, NEURON, V2, P367; SEALOCK R, 1984, J CELL BIOL, V98, P2239, DOI 10.1083/jcb.98.6.2239; SHELTON CA, 1993, CELL, V72, P515, DOI 10.1016/0092-8674(93)90071-W; STEINBACH JH, 1981, DEV BIOL, V84, P267, DOI 10.1016/0012-1606(81)90394-8; STJOHNSTON D, 1992, CELL, V68, P201; SUGIYAMA J, 1994, NEURON, V13, P103, DOI 10.1016/0896-6273(94)90462-6; SWOPE SL, 1993, J BIOL CHEM, V268, P25152; SWOPE SL, 1994, J BIOL CHEM, V269, P29817; VALENZUELA DM, 1995, NEURON, V15, P573, DOI 10.1016/0896-6273(95)90146-9; WAGNER K, 1991, J BIOL CHEM, V266, P23784; WALLACE BG, 1991, NEURON, V6, P869, DOI 10.1016/0896-6273(91)90227-Q; WALLACE BG, 1995, J CELL BIOL, V128, P1121, DOI 10.1083/jcb.128.6.1121; WALLACE BG, 1989, J NEUROSCI, V9, P1294; WALLACE BG, 1994, J CELL BIOL, V125, P661, DOI 10.1083/jcb.125.3.661; WEINER DB, 1989, NATURE, V339, P230, DOI 10.1038/339230a0; YU XM, 1994, J NEUROSCI, V14, P785	59	97	97	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1996	16	5					953	962		10.1016/S0896-6273(00)80118-X	http://dx.doi.org/10.1016/S0896-6273(00)80118-X			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UN480	8630253	Bronze			2022-12-24	WOS:A1996UN48000010
J	Hu, HY; Rutishauser, U				Hu, HY; Rutishauser, U			A septum-derived chemorepulsive factor for migrating olfactory interneuron precursors	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; BETA-TUBULIN ISOTYPE; SUBEPENDYMAL LAYER; NEUROGENESIS; RAT; PROLIFERATION; EXPRESSION; NEURONS; BRAIN; CELLS	During mammalian brain development, immature neurons often migrate considerable distances. A dramatic example is the rostral migration of olfactory interneuron precursors from near the septum to the olfactory bulb via a subventricular pathway. Heterotopic transplantations establish that this migration is unidirectional and that guidance cues operate over a considerable distance. The guidance cues for this translocation have not been identified, and the present studies provide evidence that a diffusible chemorepulsive factor, secreted by caudal septum but not by other tissue regions surrounding the pathway, may be involved. This activity is functionally distinct from that produced by factors that influence vertebrate axon outgrowth, such as netrin-1, netrin-2, and collapsin-1/semaphorin-III. The presence of this activity in the floor plate/ventral spinal cord as well as the septum suggests that it may influence other types of cell migration.	CASE WESTERN RESERVE UNIV,SCH MED,DEPT NEUROSCI,CLEVELAND,OH 44106	Case Western Reserve University	Hu, HY (corresponding author), CASE WESTERN RESERVE UNIV,SCH MED,DEPT GENET,CLEVELAND,OH 44106, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD018369, R37HD018369] Funding Source: NIH RePORTER; NEI NIH HHS [EY06107] Funding Source: Medline; NICHD NIH HHS [HD07104, HD18369] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALTMAN J, 1966, J COMP NEUROL, V127, P337; BAYER SA, 1983, EXP BRAIN RES, V50, P329; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; COLAMARINO SA, 1995, ANNU REV NEUROSCI, V18, P497, DOI 10.1146/annurev.ne.18.030195.002433; COROTTO FS, 1993, NEUROSCI LETT, V149, P111, DOI 10.1016/0304-3940(93)90748-A; DODD J, 1995, CELL, V81, P471, DOI 10.1016/0092-8674(95)90066-7; FERREIRA A, 1992, J NEUROSCI RES, V32, P516, DOI 10.1002/jnr.490320407; GATES MA, 1995, J COMP NEUROL, V361, P249, DOI 10.1002/cne.903610205; HINDS JW, 1968, J COMP NEUROL, V134, P305, DOI 10.1002/cne.901340305; HINDS JW, 1968, J COMP NEUROL, V134, P287, DOI 10.1002/cne.901340304; Hu HY, 1996, NEURON, V16, P735, DOI 10.1016/S0896-6273(00)80094-X; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; KISHI K, 1987, J COMP NEUROL, V258, P112, DOI 10.1002/cne.902580109; LEE MK, 1990, CELL MOTIL CYTOSKEL, V17, P118, DOI 10.1002/cm.970170207; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LUMSDEN AGS, 1983, NATURE, V306, P786, DOI 10.1038/306786a0; LUO YL, 1995, NEURON, V14, P1131, DOI 10.1016/0896-6273(95)90261-9; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; LUSKIN MB, 1993, J NIH RES, V5, P60; MCCONNELL SK, 1990, EXPERIENTIA, V46, P922, DOI 10.1007/BF01939385; MENEZES JRL, 1994, J NEUROSCI, V14, P5399; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; MILLER MW, 1988, BRAIN RES, V457, P44, DOI 10.1016/0006-8993(88)90055-8; ONO K, 1994, NEURON, V13, P595, DOI 10.1016/0896-6273(94)90028-0; Paxinos G., 1991, ATLAS DEV RAT BRAIN; PINI A, 1993, SCIENCE, V261, P95, DOI 10.1126/science.8316861; PUSCHEL AW, 1995, NEURON, V14, P941, DOI 10.1016/0896-6273(95)90332-1; RAKIC P, 1990, EXPERIENTIA, V46, P882, DOI 10.1007/BF01939380; ROUSSELOT P, 1995, J COMP NEUROL, V351, P51, DOI 10.1002/cne.903510106	31	114	121	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1996	16	5					933	940		10.1016/S0896-6273(00)80116-6	http://dx.doi.org/10.1016/S0896-6273(00)80116-6			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UN480	8630251	Bronze			2022-12-24	WOS:A1996UN48000008
J	Liu, DT; Tibbs, GR; Siegelbaum, SA				Liu, DT; Tibbs, GR; Siegelbaum, SA			Subunit stoichiometry of cyclic nucleotide-gated channels and effects of subunit order on channel function	NEURON			English	Article							POTASSIUM CHANNELS; ACETYLCHOLINE-RECEPTOR; XENOPUS-OOCYTES; ION CHANNELS; PERMEABILITY; CONDUCTANCE; CATIONS; MUSCLE	Cyclic nucleotide-gated (CNG) ion channels are multimeric structures containing at least two subunits. However, the total number of subunits per functional channel is unknown. To determine the subunit stoichiometry of CNG ion channels, we have coexpressed the 30 pS conductance bovine retinal channel (RET) with an 85 pS conductance chimeric retinal channel containing the catfish olfactory channel P region (R0133). When R0133 and RET monomers are coexpressed, channels with four distinct intermediate conductances are observed. Dimer constructs reveal that two of these conductance levels arise from channels with the same subunit composition (2 R0133:2 RET) but distinct subunit order (like subunits adjacent to each other versus like subunits across from each other). Thus, the data demonstrate that cyclic nucleotide-gated ion channels are tetrameric like the related voltage-gated potassium ion channels; the order of subunits affects the conductance of the channel; and the channel has 4-fold symmetry in which four asymmetric subunits assemble head to tail around a central axis.	COLUMBIA UNIV,CTR NEUROBIOL & BEHAV,NEW YORK,NY 10032; COLUMBIA UNIV,DEPT PHARMACOL,NEW YORK,NY 10032; COLUMBIA UNIV,HOWARD HUGHES MED INST,NEW YORK,NY 10032	Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute	Liu, DT (corresponding author), COLUMBIA UNIV,INTEGRATED PROGRAM CELLULAR MOL & BIOPHYS STUDIES,NEW YORK,NY 10032, USA.							BRADLEY J, 1994, P NATL ACAD SCI USA, V91, P8890, DOI 10.1073/pnas.91.19.8890; CATTERALL WA, 1992, PHYSIOL REV, V72, pS15, DOI 10.1152/physrev.1992.72.suppl_4.S15; CHEN TY, 1993, NATURE, V362, P764, DOI 10.1038/362764a0; CHRISTIE MJ, 1990, NEURON, V4, P405, DOI 10.1016/0896-6273(90)90052-H; COOPER E, 1991, NATURE, V350, P235, DOI 10.1038/350235a0; DWYER TM, 1980, J GEN PHYSIOL, V75, P469, DOI 10.1085/jgp.75.5.469; EISMANN E, 1993, CELL PHYSIOL BIOCHEM, V3, P332, DOI 10.1159/000154697; GORDON SE, 1995, P NATL ACAD SCI USA, V92, P10222, DOI 10.1073/pnas.92.22.10222; GOULDING EH, 1993, NATURE, V364, P61, DOI 10.1038/364061a0; GOULDING EH, 1992, NEURON, V8, P45, DOI 10.1016/0896-6273(92)90107-O; HEGINBOTHAM L, 1992, SCIENCE, V258, P1152, DOI 10.1126/science.1279807; HILLE B, 1973, J GEN PHYSIOL, V61, P669, DOI 10.1085/jgp.61.6.669; HOFMANN F, 1994, ANNU REV NEUROSCI, V17, P399, DOI 10.1146/annurev.neuro.17.1.399; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; ISOM LL, 1994, NEURON, V12, P1183, DOI 10.1016/0896-6273(94)90436-7; JAN LY, 1990, NATURE, V345, P672, DOI 10.1038/345672a0; Karlin A, 1993, Curr Opin Neurobiol, V3, P299, DOI 10.1016/0959-4388(93)90121-E; KORSCHEN HG, 1995, NEURON, V15, P627, DOI 10.1016/0896-6273(95)90151-5; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; LIMAN ER, 1994, NEURON, V13, P611, DOI 10.1016/0896-6273(94)90029-9; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; MCCORMACK K, 1992, BIOPHYS J, V63, P1406, DOI 10.1016/S0006-3495(92)81703-4; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; ROOT MJ, 1994, SCIENCE, V265, P1852, DOI 10.1126/science.7522344; RUPPERSBERG JP, 1990, NATURE, V345, P535, DOI 10.1038/345535a0; YAU KW, 1989, ANNU REV NEUROSCI, V12, P289, DOI 10.1146/annurev.ne.12.030189.001445; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315	28	150	153	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1996	16	5					983	990		10.1016/S0896-6273(00)80121-X	http://dx.doi.org/10.1016/S0896-6273(00)80121-X			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UN480	8630256	hybrid			2022-12-24	WOS:A1996UN48000013
J	PASCUAL, JM; SHIEH, CC; KIRSCH, GE; BROWN, AM				PASCUAL, JM; SHIEH, CC; KIRSCH, GE; BROWN, AM			K+ PORE STRUCTURE REVEALED BY REPORTER CYSTEINES AT INNER AND OUTER SURFACES	NEURON			English	Article							POTASSIUM CHANNELS; TEA BLOCKADE; ION; BINDING; TETRAETHYLAMMONIUM; CHARYBDOTOXIN; SELECTIVITY; INHIBITOR; REGION; SITE	The structure of the carboxyl half of the pore-forming region of Kv2.1 was studied by replacing each of 15 consecutive residues between positions 383 and 369 with a reporter cysteine residue. Extracellular application of charged, membrane-impermeant methanethiosulfonates irreversibly modified currents at four cysteine-substituted positions, K382, Y380, I379, and D378. intracellular exposure to methanethiosulfonate ethyltrimethylammonium revealed another set of reactive mutants (V374, T373, T372, and T370). Our results indicate that positions 378 and 374 are exposed at outer and inner mouths of the channel, respectively, and immersed in the aqueous phase. In contrast to present topological models, the 383-369 region appears to span the pore mainly as a nonperiodic structure.	BAYLOR COLL MED,DEPT MOLEC PHYSIOL & BIOPHYS,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT ANESTHESIOL,HOUSTON,TX 77030; CASE WESTERN RESERVE UNIV,REMMELKAMP CTR RES,CLEVELAND,OH 44109	Baylor College of Medicine; Baylor College of Medicine; Case Western Reserve University				Pascual, Juan/0000-0002-0843-8221	NHLBI NIH HHS [HL37044] Funding Source: Medline; NINDS NIH HHS [NS23877, NS29473] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL037044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023877, R01NS029473] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AIYAR J, 1994, BIOPHYS J, V67, P2261, DOI 10.1016/S0006-3495(94)80710-6; AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; BOGUSZ S, 1992, PROTEIN ENG, V5, P285, DOI 10.1093/protein/5.4.285; DEBIASI M, 1993, BIOPHYS J, V65, P1235, DOI 10.1016/S0006-3495(93)81154-8; DURRELL SR, 1992, BIOPHYS J, V62, P238; GOLDSTEIN SAN, 1994, NEURON, V12, P1377, DOI 10.1016/0896-6273(94)90452-9; HARTMANN HA, 1991, SCIENCE, V251, P942, DOI 10.1126/science.2000495; HEGINBOTHAM L, 1992, NEURON, V8, P483, DOI 10.1016/0896-6273(92)90276-J; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; HEGINBOTHAM L, 1993, BIOPHYS J, V65, P2089, DOI 10.1016/S0006-3495(93)81244-X; HEGINBOTHAM L, 1992, SCIENCE, V258, P1152, DOI 10.1126/science.1279807; HILLE B, 1978, J GEN PHYSIOL, V72, P409, DOI 10.1085/jgp.72.4.409; JAVITCH JA, 1994, P NATL ACAD SCI USA, V91, P10355, DOI 10.1073/pnas.91.22.10355; KAVANAUGH MP, 1991, J BIOL CHEM, V266, P7583; KIRSCH GE, 1992, NEURON, V8, P499, DOI 10.1016/0896-6273(92)90278-L; KIRSCH GE, 1993, NEURON, V11, P503, DOI 10.1016/0896-6273(93)90154-J; KIRSCH GE, 1995, IN PRESS BIOPHYS J; KURZ LL, 1995, BIOPHYS J, V68, P900, DOI 10.1016/S0006-3495(95)80266-3; LOPEZ GA, 1994, NATURE, V367, P179, DOI 10.1038/367179a0; MACKINNON R, 1989, SCIENCE, V245, P1382, DOI 10.1126/science.2476850; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MACKINNON R, 1990, NEURON, V5, P767, DOI 10.1016/0896-6273(90)90335-D; PEREZCORNEJO P, 1994, BIOPHYS J, V66, P1929, DOI 10.1016/S0006-3495(94)80986-5; SHIEH CC, 1994, BIOPHYS J, V67, P2316, DOI 10.1016/S0006-3495(94)80718-0; SLESINGER PA, 1993, NEURON, V11, P739, DOI 10.1016/0896-6273(93)90083-4; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; TAGLIALATELA M, 1994, J BIOL CHEM, V269, P13867; TAGLIALATELA M, 1993, PFLUG ARCH EUR J PHY, V423, P104, DOI 10.1007/BF00374967; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; YELLEN G, 1994, BIOPHYS J, V66, P1068, DOI 10.1016/S0006-3495(94)80888-4; YOOL AJ, 1991, NATURE, V349, P700, DOI 10.1038/349700a0	32	108	108	0	3	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1995	14	5					1055	1063		10.1016/0896-6273(95)90344-5	http://dx.doi.org/10.1016/0896-6273(95)90344-5			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QY935	7748553	Bronze			2022-12-24	WOS:A1995QY93500018
J	MARTIN, KA; POECK, B; ROTH, H; EBENS, AJ; BALLARD, LC; ZIPURSKY, SL				MARTIN, KA; POECK, B; ROTH, H; EBENS, AJ; BALLARD, LC; ZIPURSKY, SL			MUTATIONS DISRUPTING NEURONAL CONNECTIVITY IN THE DROSOPHILA VISUAL-SYSTEM	NEURON			English	Article							1ST OPTIC GANGLION; C-ELEGANS; EARLY DIFFERENTIATION; GENETIC MOSAICS; NERVOUS-SYSTEM; MELANOGASTER; GUIDANCE; AXONS; CELL; PROLIFERATION	The photoreceptor neurons (R cells) of the Drosophila compound eye elaborate a precise array of neuronal connections in the brain. These projections exhibit target specificity and create topographic maps (retinotopy). We have screened histologically for mutations disrupting R cell connectivity in developing tissue. Eighty mutations were isolated from over 6000 ethylmethane sulfonate-mutagenized lines. Characterization of these mutations included genetic mosaic analysis to determine whether the gene is required in the retina or in the optic ganglia. Most mutations were found to affect connectivity indirectly by disrupting development more generally in the eye or brain. Genes were identified as candidates for playing direct roles in R cell connectivity by affecting axonal outgrowth (eddy), target recognition (limbo and nonstop), and retinotopy (limbo).	UNIV CALIF LOS ANGELES, SCH MED, INST MOLEC BIOL, LOS ANGELES, CA 90024 USA; UNIV CALIF LOS ANGELES, SCH MED, HOWARD HUGHES MED INST, LOS ANGELES, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	MARTIN, KA (corresponding author), UNIV CALIF LOS ANGELES, SCH MED, DEPT BIOL CHEM, LOS ANGELES, CA 90024 USA.			Zipursky, Stephen/0000-0001-5630-7181				ASHBURNER M, 1989, DROSOPHILA LABORATOR; BLACKMAN RK, 1991, DEVELOPMENT, V111, P657; CAGAN RL, 1989, DEV BIOL, V136, P346, DOI 10.1016/0012-1606(89)90261-3; CAMPBELL G, 1994, DEVELOPMENT, V120, P2957; CHOI KW, 1994, NEURON, V12, P423, DOI 10.1016/0896-6273(94)90282-8; CREMER H, 1994, NATURE, V367, P456; EBENS AJ, 1993, CELL, V74, P15, DOI 10.1016/0092-8674(93)90291-W; FORTINI ME, 1990, GENE DEV, V4, P444, DOI 10.1101/gad.4.3.444; FUJITA SC, 1982, P NATL ACAD SCI-BIOL, V79, P7929, DOI 10.1073/pnas.79.24.7929; GARRIGA G, 1993, DEVELOPMENT, V117, P1071; GIANGRANDE A, 1994, DEVELOPMENT, V120, P523; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; GREEN P, 1993, CELL TISSUE RES, V273, P583, DOI 10.1007/BF00333712; Gregory G.E., 1980, P75; Grigliati T., 1986, DROSOPHILA PRACTICAL, P39; HAMELIN M, 1993, NATURE, V364, P327, DOI 10.1038/364327a0; HEISENBERG M, 1979, Z NATURFORSCH C, V34, P143; HOFBAUER A, 1990, ROUX ARCH DEV BIOL, V198, P264, DOI 10.1007/BF00377393; ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E; KANKEL DR, 1976, DEV BIOL, V48, P1, DOI 10.1016/0012-1606(76)90041-5; KAPHINGST K, 1994, CELL, V78, P437, DOI 10.1016/0092-8674(94)90422-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; KUNES S, 1993, J NEUROSCI, V13, P752; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; MACAGNO ER, 1978, NATURE, V275, P318, DOI 10.1038/275318a0; MCINTIRE SL, 1992, NEURON, V8, P307, DOI 10.1016/0896-6273(92)90297-Q; Meinertzhagen Ian A., 1993, P1363; MEYEROWITZ EM, 1978, DEV BIOL, V62, P112, DOI 10.1016/0012-1606(78)90096-9; MISMER D, 1987, GENETICS, V116, P565; MOSES K, 1991, GENE DEV, V5, P58; MURALIDHAR MG, 1993, NEURON, V11, P253, DOI 10.1016/0896-6273(93)90182-Q; Power ME, 1943, J EXP ZOOL, V94, P33, DOI 10.1002/jez.1400940103; READY DF, 1976, DEV BIOL, V53, P225; REICHARDT LF, 1991, ANNU REV NEUROSCI, V14, P531, DOI 10.1146/annurev.neuro.14.1.531; SAGA Y, 1992, GENE DEV, V6, P1821, DOI 10.1101/gad.6.10.1821; SALZBERG A, 1994, NEURON, V13, P269, DOI 10.1016/0896-6273(94)90346-8; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; SELLECK SB, 1991, NEURON, V6, P83, DOI 10.1016/0896-6273(91)90124-I; SELLECK SB, 1992, NATURE, V355, P253, DOI 10.1038/355253a0; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; THOMAS JB, 1982, NATURE, V298, P650, DOI 10.1038/298650a0; TOMASIEWICZ H, 1993, NEURON, V11, P1163, DOI 10.1016/0896-6273(93)90228-J; TOMLINSON A, 1987, DEV BIOL, V120, P366, DOI 10.1016/0012-1606(87)90239-9; UDIN SB, 1988, ANNU REV NEUROSCI, V11, P289, DOI 10.1146/annurev.ne.11.030188.001445; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; VANVACTOR DL, 1991, CELL, V67, P1145, DOI 10.1016/0092-8674(91)90291-6; WINBERG ML, 1992, DEVELOPMENT, V115, P903; XU T, 1993, DEVELOPMENT, V117, P1223; ZIPURSKY SL, 1994, ANNU REV NEUROSCI, V17, P373, DOI 10.1146/annurev.neuro.17.1.373	49	72	73	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1995	14	2					229	240		10.1016/0896-6273(95)90281-3	http://dx.doi.org/10.1016/0896-6273(95)90281-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QH294	7857635	Bronze			2022-12-24	WOS:A1995QH29400003
J	LO, DC; MCALLISTER, AK; KATZ, LC				LO, DC; MCALLISTER, AK; KATZ, LC			NEURONAL TRANSFECTION IN BRAIN-SLICES USING PARTICLE-MEDIATED GENE-TRANSFER	NEURON			English	Article							NERVOUS-SYSTEM; MICROPROJECTILES; BOMBARDMENT; RETROVIRUS; TISSUES; LINEAGE; INVIVO; VECTOR; CELLS; MICE	Difficulties in neuronal transfection continue to restrict the applicability of molecular approaches to neurobiology. Conventional transfection techniques have been of limited effectiveness, particularly in intact neural tissues. Viral vectors effectively transfect neurons both in vitro and in vivo but are labor intensive to construct, difficult to control, and often compromise cell viability. We describe here an alternative strategy using particle mediated gene transfer for the transfection of neurons and glia in intact brain slices. This approach is efficient, reliable, and does not require advanced molecular biological facilities for its application.			LO, DC (corresponding author), DUKE UNIV,MED CTR,DEPT NEUROBIOL,DURHAM,NC 27710, USA.			McAllister, A. Kimberley/0000-0001-9177-9889	NEI NIH HHS [EY07690] Funding Source: Medline; NIGMS NIH HHS [T32GM08441] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008441] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARMALEO D, 1990, CURR GENET, V17, P97, DOI 10.1007/BF00312852; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; GALILEO DS, 1992, NEURON, V9, P1117, DOI 10.1016/0896-6273(92)90070-T; GELLER AI, 1988, SCIENCE, V241, P1667, DOI 10.1126/science.2843986; HOLT CE, 1990, NEURON, V4, P203, DOI 10.1016/0896-6273(90)90095-W; JIAO SS, 1993, BIO-TECHNOL, V11, P497, DOI 10.1038/nbt0493-497; KAANG BK, 1993, NEURON, V10, P427, DOI 10.1016/0896-6273(93)90331-K; KATZ LC, 1987, J NEUROSCI, V7, P1223; KLEIN TM, 1987, NATURE, V327, P70, DOI 10.1038/327070a0; KRIEG PA, 1989, DEV BIOL, V133, P93, DOI 10.1016/0012-1606(89)90300-X; LASALLE GL, 1993, SCIENCE, V259, P988, DOI 10.1126/science.8382374; MULLIGAN RC, 1993, SCIENCE, V260, P926, DOI 10.1126/science.8493530; NIRENBERG S, 1993, J NEUROSCI, V13, P3238, DOI 10.1523/jneurosci.13-08-03238.1993; PECORINO L T, 1992, Current Biology, V2, P30, DOI 10.1016/0960-9822(92)90421-6; PRASHER DC, 1992, GENE, V111, P229, DOI 10.1016/0378-1119(92)90691-H; PRICE J, 1987, P NATL ACAD SCI USA, V84, P156, DOI 10.1073/pnas.84.1.156; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; SANFORD J C, 1991, Technique (Philadelphia), V3, P3; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; WILLIAMS RS, 1991, P NATL ACAD SCI USA, V88, P2726, DOI 10.1073/pnas.88.7.2726; YAMAMOTO N, 1992, NEURON, V9, P217, DOI 10.1016/0896-6273(92)90161-6; YANG NS, 1990, P NATL ACAD SCI USA, V87, P9568, DOI 10.1073/pnas.87.24.9568	23	187	188	3	10	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1994	13	6					1263	1268		10.1016/0896-6273(94)90412-X	http://dx.doi.org/10.1016/0896-6273(94)90412-X			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PZ689	7993619				2022-12-24	WOS:A1994PZ68900001
J	KULLMANN, DM				KULLMANN, DM			AMPLITUDE FLUCTUATIONS OF DUAL-COMPONENT EPSCS IN HIPPOCAMPAL PYRAMIDAL CELLS - IMPLICATIONS FOR LONG-TERM POTENTIATION	NEURON			English	Article							EXCITATORY SYNAPTIC CURRENTS; METHYL-D-ASPARTATE; GUINEA-PIG HIPPOCAMPUS; QUANTAL ANALYSIS; NEUROTRANSMITTER RELEASE; RAT HIPPOCAMPUS; NMDA RECEPTORS; CA1 REGION; NEURONS; SLICES	Quantal analysis has provided evidence for a presynaptic contribution to long-term potentiation in hippocampal CA1 cells. This however leaves unexplained the observation that long-term potentiation has little or no effect on the NMDA receptor-mediated component of the synaptic signal. Here, I report that, in baseline conditions, the coefficient of variation of the AMPA/kainate receptor-mediated signal (CVA/K) is consistently larger than that of the NMDA component (CVNMDA), a result which can be explained if AMPA/kainate receptors are absent or nonfunctional at a proportion of synapses. Long-term potentiation is associated with a reduction in CVA/K, but no change in either the average amplitude of the NMDA component or CVNMDA This is consistent with the proposal that long-term potentiation induction uncovers clusters of latent AMPA/kainate receptors, with no change in transmitter release.			KULLMANN, DM (corresponding author), INST NEUROL,DEPT CLIN NEUROL,QUEEN SQ,LONDON WC1N 3BG,ENGLAND.		Kullmann, Dimitri M/A-3162-2009	Kullmann, Dimitri M/0000-0001-6696-3545				ASZTELY F, 1992, EUR J NEUROSCI, V4, P681, DOI 10.1111/j.1460-9568.1992.tb00177.x; BASHIR ZI, 1991, NATURE, V349, P156, DOI 10.1038/349156a0; BEKKERS JM, 1990, P NATL ACAD SCI USA, V87, P5359, DOI 10.1073/pnas.87.14.5359; BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; BERETTA N, 1991, EUR J NEUROSCI, V3, P850; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BROWN TH, 1976, P NATL ACAD SCI USA, V73, P2913, DOI 10.1073/pnas.73.8.2913; CLARK GD, 1990, NEUROSCIENCE, V39, P787, DOI 10.1016/0306-4522(90)90261-2; EDWARDS F, 1991, NATURE, V350, P271, DOI 10.1038/350271a0; FABER DS, 1991, BIOPHYS J, V60, P1288, DOI 10.1016/S0006-3495(91)82162-2; Foster T C, 1991, Hippocampus, V1, P79, DOI 10.1002/hipo.450010108; GULYAS AI, 1993, NATURE, V366, P683, DOI 10.1038/366683a0; GUSTAFSSON B, 1988, NEUROSCI LETT, V85, P77, DOI 10.1016/0304-3940(88)90432-6; HESSLER NA, 1993, NATURE, V366, P568; HESTRIN S, 1990, NEURON, V5, P247, DOI 10.1016/0896-6273(90)90162-9; HESTRIN S, 1992, NEURON, V9, P991, DOI 10.1016/0896-6273(92)90250-H; ISAAC JT, 1993, NEUROSCI LETT, V150, P227, DOI 10.1016/0304-3940(93)90542-S; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; KAMIYA H, 1991, NEUROSCI LETT, V130, P259, DOI 10.1016/0304-3940(91)90410-U; KATO K, 1993, NEUROSCIENCE, V53, P39, DOI 10.1016/0306-4522(93)90282-K; KAUER JA, 1988, NEURON, V1, P911, DOI 10.1016/0896-6273(88)90148-1; KULLMANN DM, 1992, NEURON, V9, P1175, DOI 10.1016/0896-6273(92)90075-O; KULLMANN DM, 1992, NATURE, V357, P240, DOI 10.1038/357240a0; KULLMANN DM, 1993, P ROY SOC B-BIOL SCI, V253, P107, DOI 10.1098/rspb.1993.0088; LARKMAN A, 1992, NATURE, V360, P70, DOI 10.1038/360070a0; LEI SZ, 1992, NEURON, V8, P1087, DOI 10.1016/0896-6273(92)90130-6; LIAO D, 1992, NEURON, V9, P1089, DOI 10.1016/0896-6273(92)90068-O; LISMAN JE, 1993, TRENDS NEUROSCI, V16, P141, DOI 10.1016/0166-2236(93)90122-3; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; MANABE T, 1992, NATURE, V355, P50, DOI 10.1038/355050a0; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451, DOI 10.1152/jn.1993.70.4.1451; MARKRAM H, 1992, J PHYSIOL-LONDON, V457, P491, DOI 10.1113/jphysiol.1992.sp019389; MAYER ML, 1985, J PHYSIOL-LONDON, V361, P65, DOI 10.1113/jphysiol.1985.sp015633; MCBAIN C, 1992, J NEUROPHYSIOL, V68, P16, DOI 10.1152/jn.1992.68.1.16; MCNAUGHTON BL, 1982, J PHYSIOL-LONDON, V324, P249, DOI 10.1113/jphysiol.1982.sp014110; MULLER D, 1988, P NATL ACAD SCI USA, V85, P9346, DOI 10.1073/pnas.85.23.9346; MULLER D, 1988, SCIENCE, V242, P1694, DOI 10.1126/science.2904701; MULLER D, 1992, HIPPOCAMPUS, V2, P29, DOI 10.1002/hipo.450020105; MULLER D, 1989, BRAIN RES, V479, P209; OTMAKHOV N, 1993, NEURON, V10, P1101, DOI 10.1016/0896-6273(93)90058-Y; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; PERKEL DJ, 1993, J PHYSIOL-LONDON, V471, P481, DOI 10.1113/jphysiol.1993.sp019911; RAASTAD M, 1992, EUR J NEUROSCI, V4, P113, DOI 10.1111/j.1460-9568.1992.tb00114.x; RADPOUR S, 1991, EUR J NEUROSCI, V3, P602, DOI 10.1111/j.1460-9568.1991.tb00846.x; RAYMOND LA, 1993, TRENDS NEUROSCI, V16, P147, DOI 10.1016/0166-2236(93)90123-4; ROSENMUND C, 1993, J PHYSIOL-LONDON, V470, P705, DOI 10.1113/jphysiol.1993.sp019884; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; STEVENS CF, 1993, CELL, V72, P55, DOI 10.1016/S0092-8674(05)80028-5; VORONIN LL, 1993, NEUROSCIENCE, V56, P275, DOI 10.1016/0306-4522(93)90332-A; VORONIN LL, 1992, EXP BRAIN RES, V89, P275; VORONIN LL, 1990, NEUROSCI RES COMMUN, V6, P149; VYKLICKY L, 1993, J PHYSIOL-LONDON, V470, P575, DOI 10.1113/jphysiol.1993.sp019876; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039	55	218	222	1	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1994	12	5					1111	1120		10.1016/0896-6273(94)90318-2	http://dx.doi.org/10.1016/0896-6273(94)90318-2			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NM831	7910467				2022-12-24	WOS:A1994NM83100014
J	ANGLISTER, L; STILES, JR; SALPETER, MM				ANGLISTER, L; STILES, JR; SALPETER, MM			ACETYLCHOLINESTERASE DENSITY AND TURNOVER NUMBER AT FROG NEUROMUSCULAR-JUNCTIONS, WITH MODELING OF THEIR ROLE IN SYNAPTIC FUNCTION	NEURON			English	Article							MINIATURE ENDPLATE CURRENTS; BASAL LAMINA; REGENERATING MUSCLE; RECEPTORS; BINDING; SITES; CHOLINESTERASE; ACCUMULATION; CHANNEL; INTACT	Acetylcholinesterase (AChE) density at the neuromuscular junction of frog cutaneous pectoris muscle was determined by electron microscope autoradiography and biochemistry to be similar to 600 sites mu m(-2) of postsynaptic area, similar to 4-fold lower than all previous reports (mouse), whereas the hydrolytic turnover number was 9,500 s(-1), well within the range (2,000-16,000 s(-1)) for AChE from other species. Monte Carlo computer simulations of miniature endplate currents showed that for vertebrate neuromuscular junctions with different morphologies, an AChE density of only similar to 400 sites mu m(-2) and a turnover number of only -1,000 s(-1) are sufficient for normal quantal currents. Above these critical lower limits, miniature endplate currents were essentially insensitive to AChE density and turnover number values up to 5,000 sites mu m(-2) and 16,000 s(-1), respectively.	CORNELL UNIV,DIV BIOL SCI,NEUROBIOL & BEHAV SECT,ITHACA,NY 14853	Cornell University	ANGLISTER, L (corresponding author), HEBREW UNIV JERUSALEM,HADASSAH MED SCH,DEPT ANAT & EMBRYOL,IL-91120 JERUSALEM,ISRAEL.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS009126] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM10422] Funding Source: Medline; NINDS NIH HHS [NS09315, NS09126] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS PR, 1987, VERTEBRATE NEUROMUSC, P317; ANDERSON CR, 1973, J PHYSIOL-LONDON, V235, P655, DOI 10.1113/jphysiol.1973.sp010410; ANGLISTER L, 1991, J CELL BIOL, V115, P755, DOI 10.1083/jcb.115.3.755; ANGLISTER L, 1985, J CELL BIOL, V101, P735, DOI 10.1083/jcb.101.3.735; AUSTIN L, 1953, BIOCHEM J, V54, P695, DOI 10.1042/bj0540695; BACHMANN L, 1967, J CELL BIOL, V33, P299, DOI 10.1083/jcb.33.2.299; BARTOL TM, 1991, BIOPHYS J, V59, P1290, DOI 10.1016/S0006-3495(91)82344-X; BARTOL TM, 1991, THESIS CORNELL U ITH; BETZ W, 1973, J PHYSIOL-LONDON, V230, P673, DOI 10.1113/jphysiol.1973.sp010211; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; COLQUHOUN D, 1985, J PHYSIOL-LONDON, V369, P501, DOI 10.1113/jphysiol.1985.sp015912; DIONNE VE, 1981, J PHYSIOL-LONDON, V310, P145, DOI 10.1113/jphysiol.1981.sp013541; ENGEL AG, 1987, VERTEBRATE NEUROMUSC, P361; GAGE PW, 1975, J PHYSIOL-LONDON, V244, P385, DOI 10.1113/jphysiol.1975.sp010805; HALL ZW, 1971, NATURE-NEW BIOL, V232, P62, DOI 10.1038/newbio232062a0; HARTZELL HC, 1975, J PHYSIOL-LONDON, V251, P427, DOI 10.1113/jphysiol.1975.sp011102; HOBBIGER F, 1963, CHOLINESTERASES ANTI, P921; JOHNSON CD, 1975, ANAL BIOCHEM, V64, P229, DOI 10.1016/0003-2697(75)90423-6; KANDEL ER, 1991, PRINCIPLES NEURAL SC, P135; KARNOVSKY MJ, 1964, J CELL BIOL, V23, P217, DOI 10.1083/jcb.23.2.217; KATZ B, 1972, J PHYSIOL-LONDON, V224, P665, DOI 10.1113/jphysiol.1972.sp009918; KATZ B, 1973, J PHYSIOL-LONDON, V231, P549, DOI 10.1113/jphysiol.1973.sp010248; LAND BR, 1980, P NATL ACAD SCI-BIOL, V77, P3736, DOI 10.1073/pnas.77.6.3736; LAND BR, 1984, P NATL ACAD SCI-BIOL, V81, P1594, DOI 10.1073/pnas.81.5.1594; LEONARD JP, 1982, EXP NEUROL, V46, P121; LESTER HA, 1978, BIOPHYS J, V21, P181, DOI 10.1016/S0006-3495(78)85518-0; LETINSKY MS, 1976, J NEUROCYTOL, V5, P691, DOI 10.1007/BF01181582; LOPATE G, 1993, HOSP PRACT, V28, P109, DOI 10.1080/21548331.1993.11442741; MATTHEWSBELLINGER J, 1978, J PHYSIOL-LONDON, V279, P197, DOI 10.1113/jphysiol.1978.sp012340; MCMAHAN UJ, 1978, NATURE, V271, P172, DOI 10.1038/271172a0; MCMAHAN UJ, 1984, J CELL BIOL, V98, P1453, DOI 10.1083/jcb.98.4.1453; MILEDI R, 1984, J PHYSIOL-LONDON, V349, P663, DOI 10.1113/jphysiol.1984.sp015180; ROGERS AW, 1969, J CELL BIOL, V41, P665, DOI 10.1083/jcb.41.3.665; ROSENBERRY TL, 1975, ADV ENZYMOL RAMB, V43, P103; ROTSHENKER S, 1976, J NEUROCYTOL, V5, P719, DOI 10.1007/BF01181583; SALPETER MM, 1984, J ELECTRON MICR TECH, V1, P63, DOI 10.1002/jemt.1060010107; SALPETER MM, 1978, J CELL BIOL, V78, P274, DOI 10.1083/jcb.78.1.274; SALPETER MM, 1972, J HISTOCHEM CYTOCHEM, V20, P1059, DOI 10.1177/20.12.1059; SALPETER MM, 1969, J CELL BIOL, V42, P122, DOI 10.1083/jcb.42.1.122; SALPETER MM, 1979, J NEUROCYTOL, V8, P95, DOI 10.1007/BF01206461; SALPETER MM, 1969, J CELL BIOL, V41, P1, DOI 10.1083/jcb.41.1.1; SALPETER MM, 1967, J CELL BIOL, V32, P379, DOI 10.1083/jcb.32.2.379; Salpeter MM, 1987, VERTEBRATE NEUROMUSC, V23, P1; SALPETER MM, 1982, TECHNIQUES LIFE SC 1, P1; SALPETER MM, 1972, PRINCIPLES TECHNIQUE, V2, P221; STILES JR, 1990, THESIS U KANSAS LAWR; VIGNY M, 1978, EUR J BIOCHEM, V85, P317, DOI 10.1111/j.1432-1033.1978.tb12241.x	48	70	72	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1994	12	4					783	794		10.1016/0896-6273(94)90331-X	http://dx.doi.org/10.1016/0896-6273(94)90331-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NH253	8161450				2022-12-24	WOS:A1994NH25300007
J	WHITE, JA; ALONSO, A; KAY, AR				WHITE, JA; ALONSO, A; KAY, AR			A HEART-LIKE NA+ CURRENT IN THE MEDIAL ENTORHINAL CORTEX	NEURON			English	Article							TETRODOTOXIN-RESISTANT SODIUM; ROOT GANGLION NEURONS; HIPPOCAMPAL REGION; CATION SELECTIVITY; BINDING-SITE; RAT-BRAIN; CHANNELS; CELLS; ZINC; ADULT	Acutely dissociated neurons from the superficial layers of the medial entorhinal cortex of the rat were studied under voltage clamp using the whole-cell patch-clamp configuration. Neurons from the medial entorhinal cortex exhibit a tetrodotoxin (TTX)-resistant Na+ current (I(TTX-R); IC50 almost-equal-to 146 nM), in addition to the normal TTX-sensitive Na+ current (I(TTX-S); IC50 almost-equal-to 6 nM). I(TTX-R) was found in both putative stellate and putative pyramidal neurons from the medial entorhinal cortex. I(TTX-R) is kinetically indistinguishable from I(TTX-S), but can be distinguished from I(TTX-S) based on its enhanced sensitivity to block by Cd2+, La3+, and Zn2+. I(TTX-R) is kinetically and pharmacologically similar to the TTX-resistant Na+ current found in cardiac muscle.	MONTREAL NEUROL HOSP & INST,DEPT NEUROL & NEUROSURG,MONTREAL H3A 2B4,QUEBEC,CANADA	McGill University	WHITE, JA (corresponding author), UNIV IOWA,DEPT BIOL SCI,IOWA CITY,IA 52242, USA.							ALONSO A, 1989, NATURE, V342, P175, DOI 10.1038/342175a0; ALONSO A, 1993, J NEUROPHYSIOL, V70, P128, DOI 10.1152/jn.1993.70.1.128; ALONSO A, 1990, P NATL ACAD SCI USA, V87, P9280, DOI 10.1073/pnas.87.23.9280; ASSAF SY, 1984, NATURE, V308, P734, DOI 10.1038/308734a0; BACKX PH, 1992, SCIENCE, V257, P248, DOI 10.1126/science.1321496; BENZER TI, 1972, P NATL ACAD SCI USA, V69, P3634, DOI 10.1073/pnas.69.12.3634; BOSSU JL, 1984, NEUROSCI LETT, V51, P241, DOI 10.1016/0304-3940(84)90558-5; BROWN AM, 1981, J PHYSIOL-LONDON, V318, P479; BUSSELBERG D, 1992, BRAIN RES, V593, P77, DOI 10.1016/0006-8993(92)91266-H; CHEMERIS NK, 1980, BIOCHIM BIOPHYS ACTA, V599, P731, DOI 10.1016/0005-2736(80)90213-8; DASILVA FHL, 1990, PHYSIOL REV, V70, P453, DOI 10.1152/physrev.1990.70.2.453; DOYLE DD, 1993, J GEN PHYSIOL, V101, P153, DOI 10.1085/jgp.101.2.153; ELLIOTT AA, 1993, J PHYSIOL-LONDON, V463, P39, DOI 10.1113/jphysiol.1993.sp019583; FRELIN C, 1986, EUR J PHARMACOL, V122, P245, DOI 10.1016/0014-2999(86)90109-3; FRIEDMAN B, 1984, J COMP NEUROL, V223, P88, DOI 10.1002/cne.902230108; GONOI T, 1989, J PHYSIOL-LONDON, V414, P159, DOI 10.1113/jphysiol.1989.sp017682; Hamill OP, 1991, CEREB CORTEX, V1, P48, DOI 10.1093/cercor/1.1.48; HARRISON NL, 1993, MOL PHARMACOL, V43, P482; HAUG FMS, 1976, ADV ANAT EMBRYOL CEL, V52, P1; HEINEMANN SH, 1992, PFLUG ARCH EUR J PHY, V422, P90, DOI 10.1007/BF00381519; Hille B., 1992, IONIC CHANNELS EXCIT; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HOEHN K, 1993, NEURON, V10, P543, DOI 10.1016/0896-6273(93)90341-N; HOLM IE, 1989, J COMP NEUROL, V287, P145, DOI 10.1002/cne.902870202; HOWELL GA, 1984, NATURE, V308, P736, DOI 10.1038/308736a0; HUGUENARD JR, 1988, J NEUROPHYSIOL, V59, P778, DOI 10.1152/jn.1988.59.3.778; IKEDA SR, 1986, J NEUROPHYSIOL, V55, P527, DOI 10.1152/jn.1986.55.3.527; IKEDA SR, 1987, J PHYSIOL-LONDON, V389, P255, DOI 10.1113/jphysiol.1987.sp016656; JONES RSG, 1993, TRENDS NEUROSCI, V16, P58, DOI 10.1016/0166-2236(93)90018-H; KANEDA M, 1989, BRAIN RES, V494, P348; KAY AR, 1989, DISSECTION TISSUE CU, P54; KAYANO T, 1988, FEBS LETT, V228, P187, DOI 10.1016/0014-5793(88)80614-8; KLINK R, 1993, J NEUROPHYSIOL, V70, P144, DOI 10.1152/jn.1993.70.1.144; KOSTYUK PG, 1981, NEUROSCIENCE, V6, P2423, DOI 10.1016/0306-4522(81)90088-9; LEE KS, 1977, NATURE, V265, P751, DOI 10.1038/265751a0; Lehninger A.L, 1975, BIOCHEMISTRY-US; MATZNER O, 1992, BRAIN RES, V597, P92, DOI 10.1016/0006-8993(92)91509-D; MEHLER MF, 1993, NATURE, V362, P62, DOI 10.1038/362062a0; NODA M, 1986, NATURE, V320, P188, DOI 10.1038/320188a0; PENINGTON NJ, 1993, J PHYSIOL-LONDON, V464, P33, DOI 10.1113/jphysiol.1993.sp019623; PEREZCLAUSELL J, 1985, BRAIN RES, V337, P91, DOI 10.1016/0006-8993(85)91612-9; RAVINDRAN A, 1991, J GEN PHYSIOL, V97, P89, DOI 10.1085/jgp.97.1.89; RENAUD JF, 1983, J BIOL CHEM, V258, P879; RITCHIE JM, 1977, REV PHYSIOL BIOCH P, V79, P1, DOI 10.1007/BFb0037088; ROGART RB, 1989, P NATL ACAD SCI USA, V86, P8170, DOI 10.1073/pnas.86.20.8170; ROY ML, 1992, J NEUROSCI, V12, P2104; SATIN J, 1992, SCIENCE, V256, P1202, DOI 10.1126/science.256.5060.1202; SCHILD L, 1991, BIOPHYS J, V59, P523, DOI 10.1016/S0006-3495(91)82269-X; SLOMIANKA L, 1992, NEUROSCIENCE, V48, P325, DOI 10.1016/0306-4522(92)90494-M; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; STEINHAUSER C, 1990, PFLUG ARCH EUR J PHY, V415, P756, DOI 10.1007/BF02584017; SWANSON LW, 1986, J NEUROSCI, V6, P3010; VANHOESEN GW, 1982, TRENDS NEUROSCI, V5, P345, DOI 10.1016/0166-2236(82)90201-6; VILLEGAS R, 1973, BIOCHIM BIOPHYS ACTA, V318, P61, DOI 10.1016/0005-2736(73)90336-2; VISENTIN S, 1990, PFLUG ARCH EUR J PHY, V417, P213, DOI 10.1007/BF00370702; WESTBROOK GL, 1987, NATURE, V328, P640, DOI 10.1038/328640a0; YAROWSKY PJ, 1991, P NATL ACAD SCI USA, V88, P9453, DOI 10.1073/pnas.88.21.9453; YOSHIDA S, 1978, J NEUROPHYSIOL, V41, P1096, DOI 10.1152/jn.1978.41.5.1096	58	71	71	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1993	11	6					1037	1047		10.1016/0896-6273(93)90217-F	http://dx.doi.org/10.1016/0896-6273(93)90217-F			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MP548	8274275				2022-12-24	WOS:A1993MP54800005
J	YANG, JS; BENNETT, PB; MAKITA, N; GEORGE, AL; BARCHI, RL				YANG, JS; BENNETT, PB; MAKITA, N; GEORGE, AL; BARCHI, RL			EXPRESSION OF THE SODIUM CHANNEL-BETA(1) SUBUNIT IN RAT SKELETAL-MUSCLE IS SELECTIVELY ASSOCIATED WITH THE TETRODOTOXIN-SENSITIVE ALPHA-SUBUNIT ISOFORM	NEURON			English	Article							FUNCTIONAL EXPRESSION; XENOPUS-OOCYTES; NA+ CHANNEL; BRAIN; PROTEIN; PURIFICATION; CDNA	Transcripts homologous to the rat brain sodium channel beta subunit (beta1) are prominently expressed in both innervated and denervated adult skeletal muscle and in heart, but not in neonatal skeletal or cardiac muscle. Regulation of beta1 mRNA expression closely parallels that of SkM1 alpha during development, after denervation in adult muscle, and in primary muscle culture, but does not follow SkM2 expression under any condition examined. In oocytes, beta1 interacts functionally with SkM1 to modulate the abnormally slow inactivation kinetics observed with this alpha subunit expressed alone. We conclude that a common beta1 subunit is expressed in skeletal muscle, heart, and brain and that in skeletal muscle, this subunit is specifically associated with the SkM1, rather than the SkM2, sodium channel isoform.	UNIV PENN,SCH MED,DEPT NEUROSCI,PHILADELPHIA,PA 19104; VANDERBILT UNIV,MED CTR,SCH MED,DEPT PHARMACOL,NASHVILLE,TN 37232; VANDERBILT UNIV,MED CTR,SCH MED,DEPT MED,NASHVILLE,TN 37232	University of Pennsylvania; Vanderbilt University; Vanderbilt University	YANG, JS (corresponding author), UNIV PENN,SCH MED,MAHONEY INST NEUROL SCI,PHILADELPHIA,PA 19104, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS008075, R01NS018013, P01NS008075] Funding Source: NIH RePORTER; NINDS NIH HHS [NS-08075, NS-18013] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AGNEW WS, 1980, BIOCHEM BIOPH RES CO, V92, P860, DOI 10.1016/0006-291X(80)90782-2; AULD VJ, 1988, NEURON, V1, P449, DOI 10.1016/0896-6273(88)90176-6; BENNETT PB, 1993, IN PRESS FEBS LETT; CANNON SC, 1993, PFLUG ARCH EUR J PHY, V423, P155, DOI 10.1007/BF00374974; CASSADEI JM, 1986, J BIOL CHEM, V261, P4318; Cohen S A, 1993, Int Rev Cytol, V137C, P55; COHEN SA, 1993, IN PRESS CIRC RES; DENNIS MJ, 1981, DEV BIOL, V81, P266, DOI 10.1016/0012-1606(81)90290-6; GELLENS ME, 1992, P NATL ACAD SCI USA, V89, P554, DOI 10.1073/pnas.89.2.554; GEORGE AL, 1992, ANN NEUROL, V31, P131, DOI 10.1002/ana.410310203; GOLDIN AL, 1986, P NATL ACAD SCI USA, V83, P7503, DOI 10.1073/pnas.83.19.7503; HARTSHORNE RP, 1984, J BIOL CHEM, V259, P1667; ISOM LL, 1992, SCIENCE, V256, P839, DOI 10.1126/science.1375395; KALLEN RG, 1990, NEURON, V4, P233, DOI 10.1016/0896-6273(90)90098-Z; KELLY AM, 1991, J NEUROSCI, V11, P1231; KRAFTE DS, 1990, J GEN PHYSIOL, V96, P689, DOI 10.1085/jgp.96.4.689; KRANER SD, 1985, J BIOL CHEM, V260, P6341; MAKITA N, 1993, IN PRESS CIRCULATION; MARTINOU JC, 1991, J NEUROSCI, V11, P1291; MCCLATCHEY AI, 1993, HUM MOL GENET, V2, P745, DOI 10.1093/hmg/2.6.745; MESSNER DJ, 1985, J BIOL CHEM, V260, P597; NODA M, 1986, NATURE, V322, P826, DOI 10.1038/322826a0; ROBERTS RH, 1987, J BIOL CHEM, V262, P2298; ROGART RB, 1989, P NATL ACAD SCI USA, V86, P8170, DOI 10.1073/pnas.86.20.8170; SATIN J, 1992, J MEMBRANE BIOL, V130, P11; SUTKOWSKI EM, 1990, J BIOL CHEM, V265, P12393; TRIMMER JS, 1989, NEURON, V3, P33, DOI 10.1016/0896-6273(89)90113-X; WHITE MM, 1991, MOL PHARMACOL, V39, P604; YANG J, 1990, J NEUROCHEM, V54, P954, DOI 10.1111/j.1471-4159.1990.tb02343.x; YANG JSJ, 1991, NEURON, V7, P421, DOI 10.1016/0896-6273(91)90294-A; ZHOU JY, 1991, NEURON, V7, P775, DOI 10.1016/0896-6273(91)90280-D	31	61	61	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1993	11	5					915	922		10.1016/0896-6273(93)90121-7	http://dx.doi.org/10.1016/0896-6273(93)90121-7			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MJ041	8240813				2022-12-24	WOS:A1993MJ04100013
J	TYMIANSKI, M; WALLACE, MC; SPIGELMAN, I; UNO, M; CARLEN, PL; TATOR, CH; CHARLTON, MP				TYMIANSKI, M; WALLACE, MC; SPIGELMAN, I; UNO, M; CARLEN, PL; TATOR, CH; CHARLTON, MP			CELL-PERMEANT CA2+ CHELATORS REDUCE EARLY EXCITOTOXIC AND ISCHEMIC NEURONAL INJURY IN-VITRO AND IN-VIVO	NEURON			English	Article							FOCAL CEREBRAL-ISCHEMIA; METHYL-D-ASPARTATE; INTRACELLULAR CALCIUM CHELATION; GLUTAMATE ANTAGONIST MK-801; AMINO-ACID RECEPTORS; RAT SPINAL-CORD; HIPPOCAMPAL-NEURONS; CORTICAL-NEURONS; FOREBRAIN ISCHEMIA; POTASSIUM CHANNELS	We report the characterization of the first successful treatment of neuronal ischemic injury in vivo by cell-permeant Ca2+ chelators. The chelators attenuated glutamate-induced intracellular Ca2+ increases and neurotoxicity in neuronal explant cultures. When infused intravenously in rats, permeant fluorescent BAPTA analogs accumulated in neurons in several brain regions. BAPTA-AM, infused in vivo, reduced Ca2+-dependent spike frequency adaptation and post-spike train hyperpolarizations in CA1 neurons taken from treated animals. This effect was reproduced by direct injections of BAPTA into untreated neurons. The effects of three different chelators (BAPTA, 5,5'-difluoro BAPTA, and 4,4'-difluoro BAPTA) on Ca2+-dependent membrane excitability varied with their Ca2+ affinity. When the chelators' permeant forms were used to treat rats prior to the induction of focal cortical ischemia, they were highly neuroprotective, as gauged by significant reductions in cortical infarction volumes and neuronal sparing. The chelators' protective effects in vivo also reflected their affinity for Ca2+. This report provides the most direct evidence to date that intracellular Ca2+ excess triggers early neurodegeneration in vivo and contributes a novel therapeutic approach to neuronal ischemia of potential clinical utility.	UNIV TORONTO, DIV NEUROSURG, TORONTO M5T 2S8, ON, CANADA; UNIV CALIF LOS ANGELES, BRAIN RES INST, LOS ANGELES, CA 90024 USA; UNIV CALIF LOS ANGELES, SCH DENT, LOS ANGELES, CA 90024 USA; UNIV TORONTO, DEPT PHYSIOL, MRC, NERVE CELLS & SYNAPSES GRP, TORONTO M5S 1A8, ONTARIO, CANADA	University of Toronto; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Toronto	TYMIANSKI, M (corresponding author), TORONTO HOSP, RES INST, PLAYFAIR NEUROSCI UNIT, TORONTO M5T 2S8, ON, CANADA.		Carlen, Peter Louis/GLN-7260-2022; Uno, Masatoshi/V-7934-2019	Tymianski, Mike/0000-0002-6311-9565; Carlen, Peter/0000-0002-3339-8102				ADLER EM, 1991, J NEUROSCI, V11, P1496; ARMITAGE P, 1987, STATISTICAL METHODS; AUGUSTINE GJ, 1991, ANN NY ACAD SCI, V635, P365, DOI 10.1111/j.1749-6632.1991.tb36505.x; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; BAIMBRIDGE KG, 1992, TRENDS NEUROSCI, V15, P303, DOI 10.1016/0166-2236(92)90081-I; BAKER PF, 1985, CELL CALCIUM, V6, P5, DOI 10.1016/0143-4160(85)90030-2; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; BLAUSTEIN MP, 1988, TRENDS NEUROSCI, V11, P438, DOI 10.1016/0166-2236(88)90195-6; BRASCHLER UF, 1989, J NEUROSCI METH, V29, P121, DOI 10.1016/0165-0270(89)90023-X; BRINT S, 1988, J CEREBR BLOOD F MET, V8, P474, DOI 10.1038/jcbfm.1988.88; BROWN AW, 1968, BRIT J EXP PATHOL, V49, P87; BUCHAN A, 1991, J NEUROSCI, V11, P1049; BUCHAN A, 1990, J NEUROSCI, V10, P311; BUCHAN AM, 1991, NEUROSCI LETT, V132, P255, DOI 10.1016/0304-3940(91)90314-J; BUCHAN AM, 1992, STROKE, V23, P273, DOI 10.1161/01.STR.23.2.273; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; CHOI DW, 1990, STROKE, V21, P20; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; CHOI DW, 1990, J NEUROSCI, V10, P2493; CONNOR JA, 1987, J NEUROSCI, V7, P1384; CSERMELY P, 1989, BIOCHEM BIOPH RES CO, V165, P838, DOI 10.1016/S0006-291X(89)80042-7; DELFS J, 1989, BRAIN RES, V488, P31, DOI 10.1016/0006-8993(89)90690-2; DUBINSKY JM, 1993, J NEUROSCI, V13, P623; DUBINSKY JM, 1993, NEUROSCI LETT, V150, P129, DOI 10.1016/0304-3940(93)90518-P; FAROOQUI AA, 1991, BRAIN RES REV, V16, P171, DOI 10.1016/0165-0173(91)90004-R; FRANDSEN A, 1991, J NEUROCHEM, V56, P1075, DOI 10.1111/j.1471-4159.1991.tb02031.x; FREUND TF, 1990, EXP BRAIN RES, V83, P55; GAHWILER BH, 1981, J NEUROSCI METH, V4, P329, DOI 10.1016/0165-0270(81)90003-0; GOLA M, 1993, NEURON, V10, P689, DOI 10.1016/0896-6273(93)90170-V; GOODMAN JH, 1993, BRAIN RES, V606, P309, DOI 10.1016/0006-8993(93)90999-4; GOTOH O, 1985, STROKE, V16, P101, DOI 10.1161/01.STR.16.1.101; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAKIM AM, 1992, STROKE, V23, P1138, DOI 10.1161/01.STR.23.8.1138; HAKIM AM, 1991, J CEREBR BLOOD F MET, V11, P762, DOI 10.1038/jcbfm.1991.133; HARRISON SM, 1987, BIOCHIM BIOPHYS ACTA, V925, P133, DOI 10.1016/0304-4165(87)90102-4; HARTLEY DM, 1993, J NEUROSCI, V13, P1993; HATASHITA S, 1990, STROKE, V21, P582, DOI 10.1161/01.STR.21.4.582; HERNANDEZCRUZ A, 1990, SCIENCE, V247, P858, DOI 10.1126/science.2154851; ISAYAMA K, 1991, STROKE, V22, P1394, DOI 10.1161/01.STR.22.11.1394; KOCHHAR A, 1988, ARCH NEUROL-CHICAGO, V45, P148, DOI 10.1001/archneur.1988.00520260034016; KOH J, 1991, BRAIN RES, V548, P318, DOI 10.1016/0006-8993(91)91140-V; KOH JY, 1988, J NEUROSCI, V8, P2164; KOH JY, 1990, J NEUROSCI, V10, P693; KOHR G, 1991, J GEN PHYSIOL, V98, P941, DOI 10.1085/jgp.98.5.941; KUDO Y, 1990, BRAIN RES, V528, P48, DOI 10.1016/0006-8993(90)90193-F; LEREA LS, 1993, NEURON, V10, P31, DOI 10.1016/0896-6273(93)90239-N; LIPSCOMBE D, 1988, P NATL ACAD SCI USA, V85, P2398, DOI 10.1073/pnas.85.7.2398; LLEDO PM, 1992, NEURON, V9, P943, DOI 10.1016/0896-6273(92)90246-A; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; MARTY A, 1985, J PHYSIOL-LONDON, V367, P117, DOI 10.1113/jphysiol.1985.sp015817; MATTSON MP, 1991, NEURON, V6, P41, DOI 10.1016/0896-6273(91)90120-O; MAYER ML, 1989, J PHYSIOL-LONDON, V415, P329, DOI 10.1113/jphysiol.1989.sp017724; MELDRUM B, 1990, CEREBROVAS BRAIN MET, V2, P27; NEGULESCU PA, 1989, AM J PHYSIOL, V256, pC241, DOI 10.1152/ajpcell.1989.256.2.C241; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; Neher E., 1986, EXPT BRAIN RES SERIE, P80; NELLGARD B, 1992, J CEREBR BLOOD F MET, V12, P2, DOI 10.1038/jcbfm.1992.2; NICOLL RA, 1988, SCIENCE, V241, P545, DOI 10.1126/science.2456612; NIESEN C, 1991, BRAIN RES, V555, P319, DOI 10.1016/0006-8993(91)90358-3; OCHS DL, 1985, AM J PHYSIOL, V249, pG389, DOI 10.1152/ajpgi.1985.249.3.G389; OSBORNE KA, 1987, J NEUROL NEUROSUR PS, V50, P402, DOI 10.1136/jnnp.50.4.402; OZYURT E, 1988, J CEREBR BLOOD F MET, V8, P138, DOI 10.1038/jcbfm.1988.18; PARK CK, 1988, ANN NEUROL, V24, P543, DOI 10.1002/ana.410240411; PARK CK, 1988, NEUROPATH APPL NEURO, V14, P289, DOI 10.1111/j.1365-2990.1988.tb00889.x; PARK CK, 1988, J CEREBR BLOOD F MET, V8, P757, DOI 10.1038/jcbfm.1988.124; PETERS S, 1987, SCIENCE, V236, P589, DOI 10.1126/science.2883728; PETHIG R, 1989, CELL CALCIUM, V10, P491, DOI 10.1016/0143-4160(89)90026-2; RANDALL RD, 1992, J NEUROSCI, V12, P1882; REGAN RF, 1991, NEUROSCIENCE, V43, P585, DOI 10.1016/0306-4522(91)90317-H; ROBITAILLE R, 1992, J NEUROSCI, V12, P297; ROTHMAN S, 1984, J NEUROSCI, V4, P1884; ROTHMAN SM, 1987, NEUROSCIENCE, V22, P471, DOI 10.1016/0306-4522(87)90347-2; ROTHMAN SM, 1983, SCIENCE, V220, P536, DOI 10.1126/science.6836300; ROTHMAN SM, 1987, TRENDS NEUROSCI, V10, P299, DOI 10.1016/0166-2236(87)90177-9; SALA F, 1990, BIOPHYS J, V57, P313, DOI 10.1016/S0006-3495(90)82533-9; SCHARFMAN HE, 1989, SCIENCE, V246, P257, DOI 10.1126/science.2508225; SCHWINDT PC, 1992, NEUROSCIENCE, V47, P571, DOI 10.1016/0306-4522(92)90166-Y; SHEARDOWN MJ, 1990, SCIENCE, V247, P571, DOI 10.1126/science.2154034; SIESJO BK, 1989, J CEREBR BLOOD F MET, V9, P127, DOI 10.1038/jcbfm.1989.20; SMITH GA, 1983, P NATL ACAD SCI-BIOL, V80, P7178, DOI 10.1073/pnas.80.23.7178; SPEKSNIJDER JE, 1989, P NATL ACAD SCI USA, V86, P6607, DOI 10.1073/pnas.86.17.6607; SPIGELMAN I, 1992, J NEUROPHYSIOL, V68, P55, DOI 10.1152/jn.1992.68.1.55; STERN MD, 1992, CELL CALCIUM, V13, P183, DOI 10.1016/0143-4160(92)90046-U; STRAUTMAN AF, 1990, J NEUROSCI, V10, P3564; TSIEN RY, 1981, NATURE, V290, P527, DOI 10.1038/290527a0; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; TYMIANSKI M, 1993, BRAIN RES, V607, P319, DOI 10.1016/0006-8993(93)91523-U; TYMIANSKI M, 1993, J NEUROSCI, V13, P2085; WAHLESTEDT C, 1993, NATURE, V363, P260, DOI 10.1038/363260a0; WEISS JH, 1990, SCIENCE, V247, P1474, DOI 10.1126/science.2157282; WEISS JH, 1990, NEUROLOGY, V40, P1288, DOI 10.1212/WNL.40.8.1288; YUSTE R, 1991, NEURON, V6, P333, DOI 10.1016/0896-6273(91)90243-S	92	198	208	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	1993	11	2					221	235		10.1016/0896-6273(93)90180-Y	http://dx.doi.org/10.1016/0896-6273(93)90180-Y			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LU065	8102532				2022-12-24	WOS:A1993LU06500004
J	BOROWSKY, B; MEZEY, E; HOFFMAN, BJ				BOROWSKY, B; MEZEY, E; HOFFMAN, BJ			2 GLYCINE TRANSPORTER VARIANTS WITH DISTINCT LOCALIZATION IN THE CNS AND PERIPHERAL-TISSUES ARE ENCODED BY A COMMON GENE	NEURON			English	Article							MESSENGER-RNAS; RAT-BRAIN; SEROTONIN TRANSPORTER; DOPAMINE TRANSPORTER; GLIAL-CELLS; EXPRESSION; CLONING; NEURONS; NEUROTRANSMITTERS; NORADRENALINE	We have isolated a cDNA encoding a high affinity, Na+/Cl--dependent glycine transporter, GLYT-2, which is distinct from another glycine transporter, GLYT-1. While the 3' sequences of these two cDNAs are identical, the 5' noncoding regions and the N-termini are completely different. GLYT-1 is found only in the white matter of the CNS, while GLYT-2 is found in the gray matter of the CNS as well as in macrophages and mast cells in peripheral tissues. Our findings suggest that tissue-specific alternative splicing or alternative promoter usage from a single gene results in two mRNA products encoding similar but distinct glycine transporters. The anatomic distibution of GLYT-2 mRNA supports the emerging status of glycine as a supraspinal neurotransmitter and suggests that glycine may function as a chemical messenger outside the CNS.	NINCDS,CLIN NEUROSCI BRANCH,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	BOROWSKY, B (corresponding author), NIMH,CELL BIOL LAB,BETHESDA,MD 20892, USA.		Mezey, Eva/A-8105-2008	Mezey, Eva/0000-0002-5907-4691				APRISON MH, 1990, GLYCINE NEUROTRANSMI, P11; AXELROD J, 1971, SCIENCE, V173, P598, DOI 10.1126/science.173.3997.598; BLACK DL, 1992, CELL, V69, P795, DOI 10.1016/0092-8674(92)90291-J; BLAKELY RD, 1991, NATURE, V354, P66, DOI 10.1038/354066a0; BORDEN LA, 1992, J BIOL CHEM, V267, P21098; CHRISTENSEN HN, 1984, BIOCHIM BIOPHYS ACTA, V779, P255, DOI 10.1016/0304-4157(84)90012-1; CHRISTENSEN HN, 1981, BIOCHEM BIOPH RES CO, V98, P102, DOI 10.1016/0006-291X(81)91875-1; CLARK JA, 1992, NEURON, V9, P337, DOI 10.1016/0896-6273(92)90172-A; CURRIE DN, 1981, J EXP BIOL, V95, P181; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; FAGG GE, 1983, NEUROSCIENCE, V9, P701, DOI 10.1016/0306-4522(83)90263-4; FREMEAU RT, 1992, NEURON, V8, P915, DOI 10.1016/0896-6273(92)90206-S; GIROS B, 1991, FEBS LETT, V295, P149, DOI 10.1016/0014-5793(91)81406-X; GUASTELLA J, 1992, P NATL ACAD SCI USA, V89, P7189, DOI 10.1073/pnas.89.15.7189; GUASTELLA J, 1990, SCIENCE, V249, P1303, DOI 10.1126/science.1975955; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HEDGVIST P, 1969, ACTA PHYSL SCAND, V76, P270; HENN FA, 1976, J NEUROSCI RES, V2, P271, DOI 10.1002/jnr.490020404; HOFFMAN BJ, 1991, SCIENCE, V254, P579, DOI 10.1126/science.1948036; HOLOPAINEN I, 1989, J NEUROSCI RES, V24, P374, DOI 10.1002/jnr.490240306; IVERSEN LL, 1971, BRIT J PHARMACOL, V41, P571, DOI 10.1111/j.1476-5381.1971.tb07066.x; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; KANNER BI, 1987, CRIT REV BIOCHEM MOL, V22, P1, DOI 10.3109/10409238709082546; KILPATRICK DL, 1990, MOL CELL BIOL, V10, P3717, DOI 10.1128/MCB.10.7.3717; KILTY JE, 1991, SCIENCE, V254, P578, DOI 10.1126/science.1948035; KITA H, 1982, BRAIN RES, V235, P131, DOI 10.1016/0006-8993(82)90202-5; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LIU QR, 1992, FEBS LETT, V305, P110, DOI 10.1016/0014-5793(92)80875-H; MALOSIO ML, 1991, EMBO J, V10, P2401, DOI 10.1002/j.1460-2075.1991.tb07779.x; MCGREER EG, 1980, NEUROSCI LETT, V17, P85; MEZEY E, 1991, ENDOCRINOLOGY, V129, P1814, DOI 10.1210/endo-129-4-1814; OHTA M, 1979, BRAIN RES BULL, V4, P231, DOI 10.1016/0361-9230(79)90287-9; PACHOLCZYK T, 1991, NATURE, V350, P350, DOI 10.1038/350350a0; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; PURCELL WM, 1990, AGENTS ACTIONS, V30, P38, DOI 10.1007/BF01968992; PYCOCK CJ, 1981, LIFE SCI, V28, P2679, DOI 10.1016/0024-3205(81)90168-5; SATO K, 1992, BRAIN RES, V590, P95, DOI 10.1016/0006-8993(92)91085-S; SEED B, 1987, NATURE, V329, P840, DOI 10.1038/329840a0; SHIMADA S, 1991, SCIENCE, V254, P567; SMITH CWJ, 1989, ANNU REV GENET, V23, P527, DOI 10.1146/annurev.genet.23.1.527; SMITH KE, 1992, NEURON, V8, P927, DOI 10.1016/0896-6273(92)90207-T; SNYDER S H, 1970, Biological Psychiatry, V2, P367; STORCK T, 1992, P NATL ACAD SCI USA, V89, P10955, DOI 10.1073/pnas.89.22.10955; TAKADA M, 1987, J COMP NEUROL, V262, P465, DOI 10.1002/cne.902620402; USDIN TB, 1991, P NATL ACAD SCI USA, V88, P11168, DOI 10.1073/pnas.88.24.11168; YAMAUCHI A, 1992, J BIOL CHEM, V267, P649; YOUNG WS, 1986, MOL BRAIN RES, V1, P231, DOI 10.1016/0169-328X(86)90029-X; ZAFRA F, 1989, BIOCHEM J, V258, P403, DOI 10.1042/bj2580403	50	187	191	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1993	10	5					851	863		10.1016/0896-6273(93)90201-2	http://dx.doi.org/10.1016/0896-6273(93)90201-2			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LD322	8494645				2022-12-24	WOS:A1993LD32200008
J	CUMMINS, TR; ZHOU, JY; SIGWORTH, FJ; UKOMADU, C; STEPHAN, M; PTACEK, LJ; AGNEW, WS				CUMMINS, TR; ZHOU, JY; SIGWORTH, FJ; UKOMADU, C; STEPHAN, M; PTACEK, LJ; AGNEW, WS			FUNCTIONAL CONSEQUENCES OF A NA+ CHANNEL MUTATION CAUSING HYPERKALEMIC PERIODIC PARALYSIS	NEURON			English	Article							ADYNAMIA EPISODICA HEREDITARIA; SODIUM-CHANNEL; SKELETAL-MUSCLE; INTRACELLULAR PH; ALPHA-SUBUNIT; GATING PROPERTIES; K+ CHANNELS; INACTIVATION; FIBERS; GENE	Hyperkalemic periodic paralysis (HYPP), one of several inheritable myotonic diseases, results from genetic defects in the human skeletal muscle Na+ channel. In some pedigrees, HYPP is correlated with a single base pair substitution resulting in a Met replacing Thr704 in the fifth transmembrane segment of the second domain. This region is totally conserved between the human and rat channels. We have introduced the human mutation into the corresponding region of the rat muscle Na+ channel cDNA and expressed it in human embryonic kidney 293 cells. Patch-clamp recordings show that this mutation shifts the voltage dependence of activation by 10-15 mV in the negative direction. The shift results in a persistent Na+ current that activates near -70 mV; this phenomenon could underlie the abnormal muscle activity observed in patients with HYPP.	UNIV UTAH,HLTH SCI CTR,DEPT HUMAN GENET,SALT LAKE CITY,UT 84132; JOHNS HOPKINS UNIV,SCH MED,DEPT PHYSIOL,BALTIMORE,MD 21205	Utah System of Higher Education; University of Utah; Johns Hopkins University	CUMMINS, TR (corresponding author), YALE UNIV,SCH MED,DEPT CELLULAR & MOLEC PHYSIOL,INTERDEPT NEUROSCI PROGRAM,NEW HAVEN,CT 06510, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K11HD000940] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL038156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017928] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 38156] Funding Source: Medline; NICHD NIH HHS [K11 HD00940-01] Funding Source: Medline; NINDS NIH HHS [NS 17928] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AICKIN CC, 1977, J PHYSIOL-LONDON, V267, P791; AULD VJ, 1990, P NATL ACAD SCI USA, V87, P323, DOI 10.1073/pnas.87.1.323; AULD VJ, 1988, NEURON, V1, P449, DOI 10.1016/0896-6273(88)90176-6; BIRNBERGER KL, 1979, J NEUROL, V22, P23; CANNON SC, 1991, NEURON, V6, P619, DOI 10.1016/0896-6273(91)90064-7; CANNON SC, 1993, NEURON, V10, P317, DOI 10.1016/0896-6273(93)90321-H; CRUZ LJ, 1985, J BIOL CHEM, V260, P9280; DAVIES NW, 1990, NATURE, V343, P375, DOI 10.1038/343375a0; FONTAINE B, 1990, SCIENCE, V250, P1000, DOI 10.1126/science.2173143; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; ISACOFF EY, 1991, NATURE, V353, P86, DOI 10.1038/353086a0; LEHMANNHORN F, 1987, MUSCLE NERVE, V10, P363, DOI 10.1002/mus.880100414; LEHMANNHORN F, 1983, MUSCLE NERVE, V6, P113, DOI 10.1002/mus.880060206; LEHMANNHORN F, 1991, PFLUG ARCH EUR J PHY, V418, P297, DOI 10.1007/BF00370530; MCCORMACK K, 1991, P NATL ACAD SCI USA, V88, P2931, DOI 10.1073/pnas.88.7.2931; MOORMAN JR, 1990, NEURON, V4, P243, DOI 10.1016/0896-6273(90)90099-2; PAN JW, 1988, P NATL ACAD SCI USA, V85, P7836, DOI 10.1073/pnas.85.21.7836; PAPPONE PA, 1980, J PHYSIOL-LONDON, V306, P377, DOI 10.1113/jphysiol.1980.sp013403; PTACEK LJ, 1991, CELL, V67, P1021; PTACEK LJ, 1991, AM J HUM GENET, V49, P378; RENAUD JM, 1989, J PHYSIOL-LONDON, V416, P31, DOI 10.1113/jphysiol.1989.sp017747; ROJAS CV, 1991, NATURE, V354, P387, DOI 10.1038/354387a0; RUDEL R, 1985, PHYSIOL REV, V65, P310, DOI 10.1152/physrev.1985.65.2.310; Sambrook J, 1989, MOL CLONING LABORATO; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; STREIB EW, 1987, MUSCLE NERVE, V10, P603, DOI 10.1002/mus.880100704; SUBRAMONY SH, 1986, NEUROLOGY, V36, P173, DOI 10.1212/WNL.36.2.173; TRIMMER JS, 1989, NEURON, V3, P333; UKOMADU C, 1992, NEURON, V8, P663, DOI 10.1016/0896-6273(92)90088-U; ZAGOTTA WN, 1990, J NEUROSCI, V10, P1799; ZHOU JY, 1991, NEURON, V7, P775, DOI 10.1016/0896-6273(91)90280-D	31	131	132	0	13	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1993	10	4					667	678		10.1016/0896-6273(93)90168-Q	http://dx.doi.org/10.1016/0896-6273(93)90168-Q			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KY501	8386527				2022-12-24	WOS:A1993KY50100010
J	MERRITT, DJ; HAWKEN, A; WHITINGTON, PM				MERRITT, DJ; HAWKEN, A; WHITINGTON, PM			THE ROLE OF THE CUT GENE IN THE SPECIFICATION OF CENTRAL PROJECTIONS BY SENSORY AXONS IN DROSOPHILA	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; MANDUCA-SEXTA; CELL FATES; NEURONS; MELANOGASTER; EMBRYO; EXPRESSION; SENSILLA; PATTERN; INSECT	Mutations in the cut gene transform sense organs in Drosophila embryos from external sensory (es) receptors to chordotonal (ch) organs. We have investigated whether their central axonal projections are also transformed. Following Lucifer yellow injection of the sensory neuron, wild-type es and ch organs show characteristic, different projection patterns in the CNS. Transformed es neurons in cut embryos are variable in their projection patterns: some resemble wild-type es neurons, others ch neurons, while yet others are unlike either of these. We conclude that the cut gene influences axonal projections, although its action as a simple modality switch is open to question. Additional genes could be involved in the specification of the central axonal projection of the transformed neurons.			MERRITT, DJ (corresponding author), UNIV NEW ENGLAND, DEPT ZOOL, ARMIDALE, NSW 2351, AUSTRALIA.		Merritt, David J/D-2318-2010	Merritt, David J/0000-0002-8573-7508; Whitington, Paul/0000-0002-9683-0433				BLOCHL R, 1988, CELL TISSUE RES, V252, P669, DOI 10.1007/BF00216655; BLOCHLINGER K, 1990, GENE DEV, V4, P1322, DOI 10.1101/gad.4.8.1322; BLOCHLINGER K, 1988, NATURE, V333, P629, DOI 10.1038/333629a0; BODMER R, 1987, ROUX ARCH DEV BIOL, V196, P69, DOI 10.1007/BF00402027; BODMER R, 1987, CELL, V51, P293, DOI 10.1016/0092-8674(87)90156-5; BOO K S, 1975, International Journal of Insect Morphology and Embryology, V4, P549, DOI 10.1016/0020-7322(75)90031-8; BOWNES M, 1975, J EMBRYOL EXP MORPH, V33, P789; BURT R, 1982, DEV BIOL, V90, P99, DOI 10.1016/0012-1606(82)90215-9; CAGAN RL, 1989, DEV BIOL, V136, P346, DOI 10.1016/0012-1606(89)90261-3; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; CASH S, 1992, J NEUROSCI, V12, P2051; DAMBLYCHAUDIERE C, 1992, CELL, V69, P159, DOI 10.1016/0092-8674(92)90127-X; DOE CQ, 1991, CELL, V65, P451, DOI 10.1016/0092-8674(91)90463-9; DOE CQ, 1988, NATURE, V333, P376, DOI 10.1038/333376a0; DOE CQ, 1988, SCIENCE, V239, P170, DOI 10.1126/science.2892267; GHYSEN A, 1980, DEV BIOL, V78, P521, DOI 10.1016/0012-1606(80)90351-6; GHYSEN A, 1986, ROUX ARCH DEV BIOL, V195, P281, DOI 10.1007/BF00376060; GHYSEN A, 1983, DEV BIOL, V99, P7, DOI 10.1016/0012-1606(83)90249-X; HARRELSON AL, 1992, J EXP ZOOL, V261, P310, DOI 10.1002/jez.1402610310; HARTENSTEIN V, 1988, DEVELOPMENT, V102, P869; HARTENSTEIN V, 1989, DEVELOPMENT, V107, P389; HIGASHIJIMA S, 1992, GENE DEV, V6, P1005, DOI 10.1101/gad.6.6.1005; JAN YN, 1990, TRENDS NEUROSCI, V13, P493, DOI 10.1016/0166-2236(90)90083-M; KENT KS, 1988, J COMP NEUROL, V271, P559, DOI 10.1002/cne.902710407; LAKESHARLAN R, 1991, J COMP NEUROL, V308, P188, DOI 10.1002/cne.903080206; LEVINE RB, 1985, J COMP PHYSIOL A, V157, P1; LIENHARD MC, 1987, J EXP ZOOL, V244, P187, DOI 10.1002/jez.1402440203; LIU S, 1991, GENETICS, V127, P151; McIver S.B., 1985, P71; MILLER DM, 1992, NATURE, V355, P841, DOI 10.1038/355841a0; Milliken G. A., 1984, ANAL MESSY DATA; Moulins M., 1976, STRUCTURE FUNCTION P; MURPHEY RK, 1989, J COMP NEUROL, V290, P185, DOI 10.1002/cne.902900203; MURPHEY RK, 1989, J NEUROSCI, V9, P3209; MURPHEY RK, 1985, J COMP PHYSIOL A, V156, P381, DOI 10.1007/BF00610730; NOTTEBOHM E, 1992, NATURE, V359, P829, DOI 10.1038/359829a0; PALKA J, 1982, TRENDS NEUROSCI, V5, P382, DOI 10.1016/0166-2236(82)90218-1; PETERSON BA, 1988, J COMP NEUROL, V275, P128, DOI 10.1002/cne.902750111; PFLUGER HJ, 1988, PHILOS T R SOC B, V321, P1, DOI 10.1098/rstb.1988.0090; SINK H, 1991, DEVELOPMENT, V113, P701; SINK H, 1991, J NEUROBIOL, V22, P298, DOI 10.1002/neu.480220309; UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0; VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8; WHITINGTON PM, 1984, DEV BIOL, V106, P438, DOI 10.1016/0012-1606(84)90243-4; Wieschaus E., 1986, P199; WOLFRUM U, 1990, CELL TISSUE RES, V261, P85, DOI 10.1007/BF00329441	46	21	21	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1993	10	4					741	752		10.1016/0896-6273(93)90174-P	http://dx.doi.org/10.1016/0896-6273(93)90174-P			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KY501	8386531				2022-12-24	WOS:A1993KY50100016
J	KOLIATSOS, VE; CLATTERBUCK, RE; WINSLOW, JW; CAYOUETTE, MH; PRICE, DL				KOLIATSOS, VE; CLATTERBUCK, RE; WINSLOW, JW; CAYOUETTE, MH; PRICE, DL			EVIDENCE THAT BRAIN-DERIVED NEUROTROPHIC FACTOR IS A TROPHIC FACTOR FOR MOTOR NEURONS INVIVO	NEURON			English	Article							NERVE GROWTH-FACTOR; AMYOTROPHIC LATERAL SCLEROSIS; HIGH-AFFINITY RECEPTORS; FACTOR NGF; SKELETAL-MUSCLE; SPINAL-CORD; CHOLINERGIC NEURONS; BIOLOGICAL-ACTIVITY; DEVELOPING RATS; MESSENGER-RNA	The neurotrophins nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and neurotrophin-3 (NT-3) act upon populations of neurons that express specific receptors. The present study demonstrates that BDNF rescues motor neurons from degeneration and may also play a role in the normal physiology of these cells. BDNF is expressed in the local environment and in muscle targets of motor neurons; muscle expression is up-regulated by denervation. The alpha motor neurons express the gene encoding p145trkB, a receptor involved in BDNF signal transduction, whereas a subset of motor neurons express p75NGFR. BDNF is transported selectively to a motor neurons from skeletal muscles. Finally, BDNF prevents motor neuron death in the axotomized facial nucleus of the neonatal rat. The effects of BDNF on motor neurons raise the possibility that some neurotrophins may be useful in treating patients with motor neuropathies and amyotrophic lateral sclerosis.	JOHNS HOPKINS UNIV, SCH MED, DEPT NEUROL, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT NEUROSCI, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, NEUROPATHOL LAB, BALTIMORE, MD 21205 USA; GENENTECH INC, S SAN FRANCISCO, CA 94080 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Roche Holding; Genentech	KOLIATSOS, VE (corresponding author), JOHNS HOPKINS UNIV, SCH MED, DEPT PATHOL, BALTIMORE, MD 21205 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS020471, T32NS007179, P50NS020471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005146] Funding Source: NIH RePORTER; NIA NIH HHS [AG05146] Funding Source: Medline; NINDS NIH HHS [NS07179, NS20471] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ACHESON A, 1991, NEURON, V7, P265, DOI 10.1016/0896-6273(91)90265-2; APPEL SH, 1989, PROG BRAIN RES, V79, P251; BANDTLOW CE, 1987, EMBO J, V6, P891, DOI 10.1002/j.1460-2075.1987.tb04835.x; BENNETT MR, 1974, J PHYSIOL-LONDON, V241, P515, DOI 10.1113/jphysiol.1974.sp010670; BERKEMEIER LR, 1991, NEURON, V7, P857, DOI 10.1016/0896-6273(91)90287-A; BERND P, 1984, J BIOL CHEM, V259, P5509; BROWN MC, 1976, J PHYSIOL-LONDON, V261, P387, DOI 10.1113/jphysiol.1976.sp011565; BURLS A, 1991, EUR J NEUROSCI, V3, P216, DOI 10.1111/j.1460-9568.1991.tb00082.x; CAMMERMEYER JAN, 1963, ACTA NEUROPATHOL, V2, P213; CARROLL SL, 1992, NEURON, V9, P779, DOI 10.1016/0896-6273(92)90040-K; CHAO MV, 1992, NEURON, V9, P583, DOI 10.1016/0896-6273(92)90023-7; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CORK LC, 1979, J NEUROPATH EXP NEUR, V38, P209, DOI 10.1097/00005072-197905000-00002; DAVIES AM, 1987, NATURE, V326, P353, DOI 10.1038/326353a0; DISTEFANO PS, 1992, NEURON, V8, P983, DOI 10.1016/0896-6273(92)90213-W; DOHRMANN U, 1987, DEV BIOL, V124, P145, DOI 10.1016/0012-1606(87)90467-2; DOHRMANN U, 1986, DEV BIOL, V118, P209, DOI 10.1016/0012-1606(86)90089-8; ERNFORS P, 1989, NEURON, V2, P1605, DOI 10.1016/0896-6273(89)90049-4; GASSER UE, 1986, BRAIN RES, V376, P351, DOI 10.1016/0006-8993(86)90198-8; HEFTI F, 1986, J NEUROSCI, V6, P2155; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HERRUP K, 1973, P NATL ACAD SCI USA, V70, P3884, DOI 10.1073/pnas.70.12.3884; HOSANG M, 1987, EMBO J, V6, P1197, DOI 10.1002/j.1460-2075.1987.tb02354.x; IBANEZ CF, 1992, CELL, V69, P329, DOI 10.1016/0092-8674(92)90413-7; IP NY, 1992, P NATL ACAD SCI USA, V89, P3060, DOI 10.1073/pnas.89.7.3060; IWATA M, 1966, J CELL BIOL, V31, P113; KELLY AM, 1968, J NEUROPATHOL EXP NE, V27, P100; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; KNUSEL B, 1990, EXP NEUROL, V110, P274, DOI 10.1016/0014-4886(90)90039-U; KOLIATSOS VE, 1991, BRAIN RES, V549, P297, DOI 10.1016/0006-8993(91)90471-7; KOLIATSOS VE, 1993, ANIMAL MODELS NEUR A, V25, P247; KREUTZBERG GW, 1986, FACIAL NERVE, P75; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; MANNEN T, 1977, J NEUROL NEUROSUR PS, V40, P464, DOI 10.1136/jnnp.40.5.464; MANNEN T, 1982, ACTA NEUROPATHOL, V58, P255, DOI 10.1007/BF00688606; MARCHALONIS JJ, 1969, BIOCHEM J, V113, P299, DOI 10.1042/bj1130299; MIYATA Y, 1986, J NEUROSCI, V6, P2012; NURCOMBE V, 1984, BRAIN RES, V291, P19, DOI 10.1016/0006-8993(84)90646-2; OPPENHEIM RW, 1991, SCIENCE, V251, P1616, DOI 10.1126/science.2011743; OPPENHEIM RW, 1982, J COMP NEUROL, V210, P174, DOI 10.1002/cne.902100208; ROSENTHAL A, 1991, ENDOCRINOLOGY, V129, P1289, DOI 10.1210/endo-129-3-1289; ROSENTHAL A, 1990, NEURON, V4, P767, DOI 10.1016/0896-6273(90)90203-R; SCHMALBRUCH H, 1991, J NEUROPATH EXP NEUR, V50, P192, DOI 10.1097/00005072-199105000-00002; SCHMALBRUCH H, 1984, J COMP NEUROL, V224, P252, DOI 10.1002/cne.902240206; SCHWAB ME, 1979, BRAIN RES, V168, P473, DOI 10.1016/0006-8993(79)90303-2; SCOTT J, 1983, NATURE, V302, P538, DOI 10.1038/302538a0; SENDTNER M, 1990, NATURE, V345, P440, DOI 10.1038/345440a0; SHELTON DL, 1986, P NATL ACAD SCI USA, V83, P2714, DOI 10.1073/pnas.83.8.2714; SMITH RG, 1986, J NEUROSCI, V6, P439; SNIDER WD, 1989, J COMP NEUROL, V279, P489, DOI 10.1002/cne.902790312; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; TERAVAINEN H, 1968, Z ZELLFORSCH MIK ANA, V87, P249, DOI 10.1007/BF00319723; YAN H, 1991, SCIENCE, V252, P561, DOI 10.1126/science.1850551; YAN Q, 1988, NEURON, V1, P335; YAN Q, 1988, J NEUROSCI, V8, P3481	56	495	513	2	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	1993	10	3					359	367		10.1016/0896-6273(93)90326-M	http://dx.doi.org/10.1016/0896-6273(93)90326-M			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KU901	8080464				2022-12-24	WOS:A1993KU90100003
J	KILPATRICK, TJ; BARTLETT, PF				KILPATRICK, TJ; BARTLETT, PF			CLONING AND GROWTH OF MULTIPOTENTIAL NEURAL PRECURSORS - REQUIREMENTS FOR PROLIFERATION AND DIFFERENTIATION	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; CLONALLY RELATED CELLS; MEDIATED GENE-TRANSFER; CHICKEN OPTIC TECTUM; RECOMBINANT RETROVIRUS; LINEAGE ANALYSIS; CREST CELLS; OLIGODENDROCYTE DEVELOPMENT; NEUROEPITHELIAL CELLS; COMMON PROGENITOR	The importance of intrinsic commitments and epigenetic influence to the development of mature neural cell phenotypes was assessed using embryonic day 10 murine neuroepithelial cells, isolated from telencephalon and mesencephalon. Two types of clones were generated with fibroblast growth factor: type-A clones consisted of large, amorphous cells, and type-B clones contained epithelial-like cells. In many type-B clones, very large numbers of precursor cells were produced. Twenty-four percent of type-B clones contained small numbers of neurons, and 59% of clones containing neurons also contained astrocytes, indicating that this clonal type was derived from a bipotential precursor cell. Neuronal differentiation was enhanced by culturing precursor cells with conditioned medium derived from an immortalized astroglial-like cell line. These results indicate that neuroepithelial precursors have discrete epigenetic requirements for their proliferation and differentiation.			KILPATRICK, TJ (corresponding author), ROYAL MELBOURNE HOSP,WALTER & ELIZA HALL INST MED RES,ROYAL PARADE,PARKVILLE,VIC 3050,AUSTRALIA.		Bartlett, Perry/F-3813-2012	Kilpatrick, Trevor/0000-0003-3999-085X				ABNEY ER, 1981, DEV BIOL, V83, P301, DOI 10.1016/0012-1606(81)90476-0; ANCHAN RM, 1991, NEURON, V6, P923, DOI 10.1016/0896-6273(91)90233-P; BAROFFIO A, 1988, P NATL ACAD SCI USA, V85, P5325, DOI 10.1073/pnas.85.14.5325; BARTLETT PF, 1988, P NATL ACAD SCI USA, V85, P3255, DOI 10.1073/pnas.85.9.3255; BARTLETT PF, 1991, TODAYS LIFE SCI, V3, P12; BERNARD O, 1989, J NEUROSCI RES, V24, P9, DOI 10.1002/jnr.490240104; BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8; BOGLER O, 1990, P NATL ACAD SCI USA, V87, P6368, DOI 10.1073/pnas.87.16.6368; BRONNERFRASER M, 1988, NATURE, V335, P161, DOI 10.1038/335161a0; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; COWA WM, 1979, SCI AM, V241, P107; DEVITRY F, 1980, P NATL ACAD SCI-BIOL, V77, P4165, DOI 10.1073/pnas.77.7.4165; DRAGO J, 1991, P NATL ACAD SCI USA, V88, P2199, DOI 10.1073/pnas.88.6.2199; DRAGO J, 1991, EXP CELL RES, V196, P246, DOI 10.1016/0014-4827(91)90258-V; DRAGO J, 1991, EXP CELL RES, V37, P251; FRANK E, 1991, DEVELOPMENT, V111, P895; FREDERIKSEN K, 1988, NEURON, V1, P439, DOI 10.1016/0896-6273(88)90175-4; GALILEO DS, 1990, P NATL ACAD SCI USA, V87, P458, DOI 10.1073/pnas.87.1.458; GAO WQ, 1991, NEURON, V6, P705, DOI 10.1016/0896-6273(91)90168-Y; GRAY GE, 1990, EXPERIENTIA, V46, P929, DOI 10.1007/BF01939386; GRAY GE, 1988, P NATL ACAD SCI USA, V85, P7356, DOI 10.1073/pnas.85.19.7356; HATTEN ME, 1988, DEV BIOL, V125, P280, DOI 10.1016/0012-1606(88)90211-4; HOLT CE, 1988, NEURON, V1, P15, DOI 10.1016/0896-6273(88)90205-X; HUGHES SM, 1988, NATURE, V335, P70, DOI 10.1038/335070a0; KILPATRICK TJ, 1993, IN PRESS NEUROSCI RE; LEBER SM, 1990, J NEUROSCI, V10, P2451; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; MCKINNON RD, 1990, NEURON, V5, P603, DOI 10.1016/0896-6273(90)90215-2; METCALF D, 1971, HAEMOPOIETIC CELLS, P70; MURPHY M, 1990, J NEUROSCI RES, V25, P463, DOI 10.1002/jnr.490250404; PRICE J, 1988, DEVELOPMENT, V104, P473; PRICE J, 1987, P NATL ACAD SCI USA, V84, P156, DOI 10.1073/pnas.84.1.156; RAFF MC, 1989, SCIENCE, V243, P1450, DOI 10.1126/science.2648568; RAFF MC, 1978, NATURE, V274, P813, DOI 10.1038/274813a0; RANSCHT B, 1982, P NATL ACAD SCI-BIOL, V79, P2709, DOI 10.1073/pnas.79.8.2709; RENFRANZ PJ, 1991, CELL, V66, P713, DOI 10.1016/0092-8674(91)90116-G; RICHARDSON WD, 1988, CELL, V53, P309, DOI 10.1016/0092-8674(88)90392-3; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; SIEBERBLUM M, 1989, SCIENCE, V243, P1608, DOI 10.1126/science.2564699; SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P; TEMPLE S, 1986, CELL, V44, P773, DOI 10.1016/0092-8674(86)90843-3; TEMPLE S, 1989, NATURE, V340, P471, DOI 10.1038/340471a0; TEMPLE S, 1985, NATURE, V313, P223, DOI 10.1038/313223a0; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; WALSH C, 1988, SCIENCE, V241, P1342, DOI 10.1126/science.3137660; WALSH C, 1992, SCIENCE, V255, P434, DOI 10.1126/science.1734520; WATANABE T, 1990, NEURON, V2, P461; WETTS R, 1988, SCIENCE, V239, P1142, DOI 10.1126/science.2449732; WILLIAMS BP, 1991, NEURON, V7, P685, DOI 10.1016/0896-6273(91)90381-9	49	320	338	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1993	10	2					255	265		10.1016/0896-6273(93)90316-J	http://dx.doi.org/10.1016/0896-6273(93)90316-J			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KP685	8439411				2022-12-24	WOS:A1993KP68500013
J	TCHELINGERIAN, JL; QUINONERO, J; BOOSS, J; JACQUE, C				TCHELINGERIAN, JL; QUINONERO, J; BOOSS, J; JACQUE, C			LOCALIZATION OF TNF-ALPHA AND IL-1-ALPHA IMMUNOREACTIVITIES IN STRIATAL NEURONS AFTER SURGICAL INJURY TO THE HIPPOCAMPUS	NEURON			English	Article							TUMOR-NECROSIS-FACTOR; ADULT-RAT BRAIN; MOUSE-BRAIN; INTERLEUKIN-1 RECEPTORS; PREFRONTAL CORTEX; CYTO-TOXICITY; ASTROCYTES; REJECTION; MICROGLIA; MACROPHAGES	Since the inflammatory process develops after transplantation to the brain, we sought to determine the presence of cytokines following a surgical trauma to the brain of an adult mouse. We report the early and marked presence of tumor necrosis factor-alpha and interleukin-1alpha in neuronal somata of the striatum following a surgical injury to the hippocampus. The expression of cytokines later extends to neuronal cells of the hippocampus, thalamus, cerebral cortex, brain stem, and cerebellum and to glial cells of the corpus callosum. By contrast, these cytokines are not expressed by neuronal cells following injury to other regions, such as the striatum, cerebellum, and cortex. This study suggests a possible role for certain neurons in the brain's early reaction to a penetrating injury.	YALE UNIV,SCH MED,VET ADM,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,DEPT NEUROL,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,DEPT LAB MED,NEW HAVEN,CT 06510	Yale University; Yale University; Yale University	TCHELINGERIAN, JL (corresponding author), HOP LA PITIE SALPETRIERE,INSERM,U134,F-75651 PARIS 13,FRANCE.							ARBUSTINI E, 1991, AM J PATHOL, V139, P709; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; BACKES MG, 1990, J COMP NEUROL, V295, P428, DOI 10.1002/cne.902950307; BALKWILL FR, 1989, IMMUNOL TODAY, V10, P299, DOI 10.1016/0167-5699(89)90085-6; BAN E, 1992, CYTOKINE, V4, P48, DOI 10.1016/1043-4666(92)90036-Q; BAN E, 1991, NEUROSCIENCE, V43, P21, DOI 10.1016/0306-4522(91)90412-H; BANDTLOW CE, 1990, J CELL BIOL, V111, P1701, DOI 10.1083/jcb.111.4.1701; BARKER CF, 1977, ADV IMMUNOL, V25, P1; BEUTLER B, 1986, NATURE, V320, P584, DOI 10.1038/320584a0; BEUTLER B, 1988, ANNU REV BIOCHEM, V57, P505, DOI 10.1146/annurev.bi.57.070188.002445; BOOSS J, 1991, J NEUROSCI RES, V30, P455, DOI 10.1002/jnr.490300302; BREDER CD, 1988, SCIENCE, V240, P321, DOI 10.1126/science.3258444; CHUNG IY, 1990, J IMMUNOL, V144, P2999; COLLINS VP, 1983, ACTA PATH MICRO IM A, V91, P269; CUNNINGHAM ET, 1992, J NEUROSCI, V12, P1101; DANI JW, 1992, NEURON, V8, P429, DOI 10.1016/0896-6273(92)90271-E; DELCERRO M, 1979, NEUROSCIENCE, V4, P1399, DOI 10.1016/0306-4522(79)90167-2; FARRAR WL, 1987, J IMMUNOL, V139, P459; FINSEN BR, 1991, J NEUROIMMUNOL, V32, P159, DOI 10.1016/0165-5728(91)90008-U; FONTANA A, 1982, J IMMUNOL, V129, P2413; FREI K, 1987, EUR J IMMUNOL, V17, P1271, DOI 10.1002/eji.1830170909; GERFEN CR, 1992, TRENDS NEUROSCI, V15, P133, DOI 10.1016/0166-2236(92)90355-C; GIULIAN D, 1986, J EXP MED, V164, P594, DOI 10.1084/jem.164.2.594; GIULIAN D, 1985, SCIENCE, V228, P497, DOI 10.1126/science.3872478; GRAYBIEL AM, 1990, TRENDS NEUROSCI, V13, P244, DOI 10.1016/0166-2236(90)90104-I; GRIFFIN WST, 1989, P NATL ACAD SCI USA, V86, P7611; HETIER E, 1988, J NEUROSCI RES, V21, P391, DOI 10.1002/jnr.490210230; HOFMAN FM, 1989, J EXP MED, V170, P607, DOI 10.1084/jem.170.2.607; JAY TM, 1991, J COMP NEUROL, V313, P574, DOI 10.1002/cne.903130404; KLEIN J, 1983, IMMUNOGENETICS, V17, P553, DOI 10.1007/BF00366126; LAWRENCE JM, 1990, NEUROSCIENCE, V37, P431, DOI 10.1016/0306-4522(90)90413-X; LECHAN RM, 1990, BRAIN RES, V514, P135, DOI 10.1016/0006-8993(90)90445-H; LIEBERMAN AP, 1989, P NATL ACAD SCI USA, V86, P6348, DOI 10.1073/pnas.86.16.6348; MASON DW, 1986, NEUROSCIENCE, V19, P685, DOI 10.1016/0306-4522(86)90292-7; NICHOLAS MK, 1987, J NEUROSCI RES, V18, P245, DOI 10.1002/jnr.490180135; NIETOSAMPEDRO M, 1987, NEUROCHEM RES, V12, P723, DOI 10.1007/BF00970528; OPPENHEIM JJ, 1986, IMMUNOL TODAY, V7, P45, DOI 10.1016/0167-5699(86)90124-6; PHILIP R, 1986, NATURE, V323, P86, DOI 10.1038/323086a0; POLTORAK M, 1989, EXP NEUROL, V103, P222, DOI 10.1016/0014-4886(89)90046-0; RAGSDALE CW, 1990, P NATL ACAD SCI USA, V87, P6196, DOI 10.1073/pnas.87.16.6196; SAWADA M, 1989, BRAIN RES, V491, P394, DOI 10.1016/0006-8993(89)90078-4; SLOAN DJ, 1991, TRENDS NEUROSCI, V14, P341, DOI 10.1016/0166-2236(91)90159-R; STREIT WJ, 1988, GLIA, V1, P301, DOI 10.1002/glia.440010502; SUARD IM, 1989, J NEUROSCI RES, V23, P172, DOI 10.1002/jnr.490230207; SWANSON LW, 1981, BRAIN RES, V217, P150, DOI 10.1016/0006-8993(81)90192-X; SWANSON LW, 1977, J COMP NEUROL, V172, P49, DOI 10.1002/cne.901720104; TAKAO T, 1990, ENDOCRINOLOGY, V127, P3070, DOI 10.1210/endo-127-6-3070; TYOR WR, 1992, ANN NEUROL, V31, P349, DOI 10.1002/ana.410310402	48	164	164	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1993	10	2					213	224		10.1016/0896-6273(93)90312-F	http://dx.doi.org/10.1016/0896-6273(93)90312-F			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KP685	8439410				2022-12-24	WOS:A1993KP68500009
J	ANDRADE, R				ANDRADE, R			ENHANCEMENT OF BETA-ADRENERGIC RESPONSES BY GI-LINKED RECEPTORS IN RAT HIPPOCAMPUS	NEURON			English	Article							GTP-BINDING PROTEINS; PYRAMIDAL CELLS; ADENYLATE-CYCLASE; CALCIUM CURRENT; GUINEA-PIG; NORADRENALINE; SEROTONIN; CHANNELS; NEURONS; TRANSDUCTION	Many excitable cells express a class of neurotransmitter receptors functionally defined by their ability to increase potassium conductance through G proteins of the G(i)/G(o) class that directly activate the potassium channels. Biochemical studies have shown that these same receptors can also inhibit forskolin-stimulated adenylyl cyclase, although the functional significance of this effect remains unclear. In this study electrophysiological techniques were used to examine how activation of serotonin and gamma-aminobutyric acid receptors belonging to this class affect beta-adrenergic responses signaled through adenylyl cyclase. Surprisingly, activation of these receptors not only failed to inhibit but actually enhanced beta-adrenergic responses. These observations are consistent with evidence indicating that G(i)-linked receptors can enhance the ability of G(s) to stimulate certain adenylyl cyclases.			ANDRADE, R (corresponding author), ST LOUIS UNIV,SCH MED,DEPT PHARMACOL & PHYSIOL SCI,ST LOUIS,MO 63104, USA.				NIMH NIH HHS [MH 43985] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH043985, R01MH043985] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANDRADE R, 1991, EUR J PHARMACOL, V199, P259, DOI 10.1016/0014-2999(91)90467-5; ANDRADE R, 1987, J PHYSIOL-LONDON, V394, P99, DOI 10.1113/jphysiol.1987.sp016862; ANDRADE R, 1986, SCIENCE, V234, P1261, DOI 10.1126/science.2430334; ANDRADE R, 1991, J PHARMACOL EXP THER, V40, P399; BIRNBAUMER L, 1990, BIOCHIM BIOPHYS ACTA, V1031, P163, DOI 10.1016/0304-4157(90)90007-Y; DEVIVO M, 1986, J PHARMACOL EXP THER, V238, P248; DOLPHIN AC, 1990, GABAB RECEPTORS IN MAMMALIAN FUNCTION, P259; FEDERMAN AD, 1992, NATURE, V356, P159, DOI 10.1038/356159a0; FISCHMEISTER R, 1986, J PHYSIOL-LONDON, V376, P183, DOI 10.1113/jphysiol.1986.sp016148; HAAS HL, 1983, NATURE, V302, P432, DOI 10.1038/302432a0; HIRAYAMA T, 1991, BRAIN RES, V539, P320, DOI 10.1016/0006-8993(91)91637-G; KARBON EW, 1985, MOL PHARMACOL, V27, P53; KURACHI Y, 1986, PFLUG ARCH EUR J PHY, V407, P264, DOI 10.1007/BF00585301; MADISON DV, 1986, J PHYSIOL-LONDON, V372, P221, DOI 10.1113/jphysiol.1986.sp016006; MADISON DV, 1986, J PHYSIOL-LONDON, V372, P245, DOI 10.1113/jphysiol.1986.sp016007; MARKSTEIN R, 1986, N-S ARCH PHARMACOL, V333, P335, DOI 10.1007/BF00500006; MCALLISTER G, 1992, P NATL ACAD SCI USA, V89, P5517, DOI 10.1073/pnas.89.12.5517; NEWBERRY NR, 1984, NATURE, V308, P450, DOI 10.1038/308450a0; NICOLL RA, 1990, PHYSIOL REV, V70, P513, DOI 10.1152/physrev.1990.70.2.513; NORTH RA, 1987, P NATL ACAD SCI USA, V84, P5487, DOI 10.1073/pnas.84.15.5487; PALMER JM, 1987, J PHYSIOL-LONDON, V387, P371, DOI 10.1113/jphysiol.1987.sp016578; PENINGTON NJ, 1990, NEURON, V4, P751, DOI 10.1016/0896-6273(90)90201-P; PFAFFINGER PJ, 1985, NATURE, V317, P536, DOI 10.1038/317536a0; SCHAAD NC, 1989, J NEUROCHEM, V53, P1941, DOI 10.1111/j.1471-4159.1989.tb09265.x; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; TANG WJ, 1991, SCIENCE, V254, P1500, DOI 10.1126/science.1962211; TANG WJ, 1991, J BIOL CHEM, V266, P8595; VOIGT MM, 1991, EMBO J, V10, P4017, DOI 10.1002/j.1460-2075.1991.tb04977.x; WOJCIK WJ, 1990, GABAB RECEPTORS IN MAMMALIAN FUNCTION, P141	29	59	59	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1993	10	1					83	88		10.1016/0896-6273(93)90244-L	http://dx.doi.org/10.1016/0896-6273(93)90244-L			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KK012	8381289				2022-12-24	WOS:A1993KK01200009
J	Han, KA; Millar, NS; Grotewiel, MS; Davis, RL				Han, KA; Millar, NS; Grotewiel, MS; Davis, RL			DAMB, a novel dopamine receptor expressed specifically in Drosophila mushroom bodies	NEURON			English	Article							ADENYLATE-CYCLASE; PREFERENTIAL EXPRESSION; POINT MUTATIONS; PROTEIN-KINASE; GENE; MEMORY; RUTABAGA; APLYSIA; CLONING; TRANSFORMATION	The modulatory neurotransmitters that trigger biochemical cascades underlying olfactory learning in Drosophila mushroom bodies have remained unknown. To identify molecules that may perform this role, putative biogenic amine receptors were cloned using the polymerase chain reaction (PCR) and single-strand conformation polymorphism analysis. One new receptor, DAMB, was identified as a dopamine D1 receptor by sequence analysis and pharmacological characterization. In situ hybridization and immunohistochemical analyses revealed highly enriched expression of DAMB in mushroom bodies, in a pattern coincident with the rutabaga-encoded adenylyl cyclase. The spatial coexpression of DAMB and the cyclase, along with DAMB's capacity to mediate dopamine-induced increases in cAMP make this receptor an attractive candidate for initiating biochemical cascades underlying learning.	BAYLOR COLL MED, DEPT NEUROL, HOUSTON, TX 77030 USA; UCL, DEPT PHARMACOL, WELLCOME LAB MOL PHARMACOL, LONDON WC1E 6BT, ENGLAND	Baylor College of Medicine; University of London; University College London	Han, KA (corresponding author), BAYLOR COLL MED, DEPT CELL BIOL, 1 BAYLOR PLAZA, HOUSTON, TX 77030 USA.		Davis, Ronald/J-4998-2013; Grotewiel, Mike/AAX-4094-2020	Davis, Ronald/0000-0002-5986-7608; Grotewiel, Mike/0000-0001-7302-3252	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ABRAMS TW, 1991, J NEUROSCI, V11, P2655; ARAKAWA S, 1990, NEURON, V4, P343, DOI 10.1016/0896-6273(90)90047-J; BAILEY CH, 1994, ADV SEC MESS PHOSPH, V29, P529; BARD JA, 1993, J BIOL CHEM, V268, P23422; BICKER G, 1989, NATURE, V337, P33, DOI 10.1038/337033a0; BOURNE HR, 1993, CELL, V72, P65, DOI 10.1016/S0092-8674(05)80029-7; BYRNE JH, 1993, ADV SEC MESS PHOSPH, V27, P47; CAHILL L, 1994, NATURE, V371, P702, DOI 10.1038/371702a0; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; DAVIS RL, 1986, MOL CELL BIOL, V6, P1464, DOI 10.1128/MCB.6.5.1464; DAVIS RL, 1993, NEURON, V11, P1, DOI 10.1016/0896-6273(93)90266-T; Davis RL, 1996, CURR BIOL, V6, P146, DOI 10.1016/S0960-9822(02)00447-5; DAVIS RL, 1996, IN PRESS PHYSL REV, V76; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; DRAIN P, 1991, NEURON, V6, P71, DOI 10.1016/0896-6273(91)90123-H; DUDAI Y, 1976, P NATL ACAD SCI USA, V73, P1684, DOI 10.1073/pnas.73.5.1684; DUDAI Y, 1987, J COMP PHYSIOL A, V161, P739, DOI 10.1007/BF00605015; DUDAI Y, 1983, P NATL ACAD SCI-BIOL, V80, P5445, DOI 10.1073/pnas.80.17.5445; EMPTAGE NJ, 1993, SCIENCE, V262, P253, DOI 10.1126/science.8211146; FENG G, 1996, IN PRESS J NEUROSCI; FORTE M, 1993, GTPASE BIOL, P319; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; GOTZES F, 1994, RECEPTOR CHANNEL, V2, P131; HAN KA, 1992, CANCER RES, V52, P749; HAN PL, 1992, NEURON, V9, P619, DOI 10.1016/0896-6273(92)90026-A; Harlow E., 1988, ANTIBODIES LAB MANUA; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; LEVIN LR, 1992, CELL, V68, P479, DOI 10.1016/0092-8674(92)90185-F; LIVINGSTONE MS, 1984, CELL, V37, P205, DOI 10.1016/0092-8674(84)90316-7; MCGAUGH JL, 1993, BEHAV BRAIN RES, V58, P81, DOI 10.1016/0166-4328(93)90092-5; MILLAR NS, 1994, P ROY SOC B-BIOL SCI, V258, P307, DOI 10.1098/rspb.1994.0178; NASSEL DR, 1992, CELL TISSUE RES, V267, P147, DOI 10.1007/BF00318701; NG GYK, 1994, EUR J PHARM-MOLEC PH, V267, P7, DOI 10.1016/0922-4106(94)90219-4; NIGHORN A, 1994, COMP BIOCHEM PHYS B, V108, P1, DOI 10.1016/0305-0491(94)90157-0; NIGHORN A, 1991, NEURON, V6, P455, DOI 10.1016/0896-6273(91)90253-V; ODOWD BF, 1993, J NEUROCHEM, V60, P804, DOI 10.1111/j.1471-4159.1993.tb03224.x; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; Restifo L.L., 1990, Advances in Insect Physiology, V22, P115, DOI 10.1016/S0065-2806(08)60006-5; Sambrook J., 2002, MOL CLONING LAB MANU; SAUDOU F, 1990, EMBO J, V9, P3611, DOI 10.1002/j.1460-2075.1990.tb07572.x; SAWAGUCHI T, 1994, J NEUROPHYSIOL, V71, P515, DOI 10.1152/jn.1994.71.2.515; Schurmann F.-W., 1987, P231; SKOULAKIS EMC, 1993, NEURON, V11, P197, DOI 10.1016/0896-6273(93)90178-T; SMITH RF, 1992, PROTEIN ENG, V5, P35, DOI 10.1093/protein/5.1.35; SPINARDI L, 1991, NUCLEIC ACIDS RES, V19, P4009, DOI 10.1093/nar/19.14.4009; STEPHENSON RM, 1994, PHARMACOL BIOCHEM BE, V48, P971, DOI 10.1016/0091-3057(94)90207-0; STRAUSFELD N, 1976, ATLAS INSECT BRAIN, P69; SUGAMORI KS, 1995, FEBS LETT, V362, P131, DOI 10.1016/0014-5793(95)00224-W; TECHNAU G, 1982, NATURE, V295, P405, DOI 10.1038/295405a0; TEJEDOR F, 1995, NEURON, V14, P287, DOI 10.1016/0896-6273(95)90286-4; TEMPEL BL, 1984, P NATL ACAD SCI-BIOL, V81, P3577, DOI 10.1073/pnas.81.11.3577; VERNIER P, 1993, EXS, V13, P297	52	219	222	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUN	1996	16	6					1127	1135		10.1016/S0896-6273(00)80139-7	http://dx.doi.org/10.1016/S0896-6273(00)80139-7			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UU118	8663989	Bronze			2022-12-24	WOS:A1996UU11800010
J	Meffert, MK; Calakos, NC; Scheller, RH; Schulman, H				Meffert, MK; Calakos, NC; Scheller, RH; Schulman, H			Nitric oxide modulates synaptic vesicle docking/fusion reactions	NEURON			English	Article							CASEIN KINASE-II; PROTEIN; PHOSPHORYLATION; SYNAPTOTAGMIN; SYNAPTOSOMES; NEUROTOXINS; RELEASE; SNAP-25; TETANUS; FUSION	Nitric oxide (NO) stimulates calcium-independent neurotransmitter release from synaptosomes. NO-stimulated release was found to be inhibited by Botulinum neurotoxins that inactivate the core complex of synaptic proteins involved in the docking and fusion of synaptic vesicles. In experiments using recombinant proteins, NO donors increased formation of the VAMP/SNAP-25/syntaxin 1a core complex and inhibited the binding of n-sec1 to syntaxin 1a. The combined effects of these activities is predicted to promote vesicle docking/fusion. The sulfhydryl reagent NEM inhibited the binding of n-sec1 to syntaxin 1a, while beta-ME could reverse the NO-enhanced association of VAMP/SNAP-25/syntaxin 1a. These data suggest that post-translational modification of sulfhydryl groups by a nitrogen monoxide (likely to be NO+) alters the synaptic protein interactions that regulate neurotransmitter release and synaptic plasticity.	STANFORD UNIV,SCH MED,DEPT CELLULAR & MOLEC PHYSIOL,STANFORD,CA 94305; STANFORD UNIV,SCH MED,HOWARD HUGHES MED INST,STANFORD,CA 94305	Stanford University; Howard Hughes Medical Institute; Stanford University	Meffert, MK (corresponding author), STANFORD UNIV,SCH MED,DEPT NEUROBIOL,STANFORD,CA 94305, USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH048108] Funding Source: NIH RePORTER; NIMH NIH HHS [MH48108] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ARNELLE DR, 1995, ARCH BIOCHEM BIOPHYS, V318, P279, DOI 10.1006/abbi.1995.1231; Bennett J., 1985, NEUROTRANSMITTER REC, V2nd, P61; BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2559, DOI 10.1073/pnas.90.7.2559; BENNETT MK, 1993, J NEUROSCI, V13, P1701; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; BLASI J, 1993, EMBO J, V12, P4821, DOI 10.1002/j.1460-2075.1993.tb06171.x; BOLOTINA VM, 1994, NATURE, V368, P850, DOI 10.1038/368850a0; BROADIE K, 1995, NEURON, V15, P663, DOI 10.1016/0896-6273(95)90154-X; CALAKOS N, 1994, SCIENCE, V263, P1146, DOI 10.1126/science.8108733; CASELLI A, 1994, J BIOL CHEM, V269, P24878; DAVLETOV B, 1993, J BIOL CHEM, V268, P6816; DEBELLO WM, 1995, NATURE, V373, P626, DOI 10.1038/373626a0; DIMMELER S, 1993, FEBS LETT, V315, P21, DOI 10.1016/0014-5793(93)81124-I; DUHE RJ, 1994, J BIOL CHEM, V269, P7290; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; FYKSE EM, 1995, J NEUROSCI, V15, P2385, DOI 10.1523/JNEUROSCI.15-03-02385.1995; GOPALAKRISHNA R, 1993, J BIOL CHEM, V268, P27180; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; HESS DT, 1994, NEUROPHARMACOLOGY, V33, P1283, DOI 10.1016/0028-3908(94)90028-0; HUNT JM, 1994, NEURON, V12, P1269, DOI 10.1016/0896-6273(94)90443-X; KRUSZYNA H, 1993, BIOCHEM PHARMACOL, V46, P95, DOI 10.1016/0006-2952(93)90352-W; LEI SZ, 1992, NEURON, V8, P1087, DOI 10.1016/0896-6273(92)90130-6; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; MCDONALD LJ, 1966, P SOC EXP BIOL MED, V211, P1; MCMAHON HT, 1992, J BIOL CHEM, V267, P21338; MEFFERT MK, 1994, NEURON, V12, P1235, DOI 10.1016/0896-6273(94)90440-5; MONTECUCCO C, 1993, TRENDS BIOCHEM SCI, V18, P324, DOI 10.1016/0968-0004(93)90065-U; NAGY A, 1984, J NEUROCHEM, V43, P1114, DOI 10.1111/j.1471-4159.1984.tb12851.x; NGUYEN T, 1992, P NATL ACAD SCI USA, V89, P3030, DOI 10.1073/pnas.89.7.3030; OYLER GA, 1989, J CELL BIOL, V109, P3039, DOI 10.1083/jcb.109.6.3039; PEVSNER J, 1994, P NATL ACAD SCI USA, V91, P1445, DOI 10.1073/pnas.91.4.1445; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; POPOLI M, 1993, FEBS LETT, V317, P85, DOI 10.1016/0014-5793(93)81496-M; PRYOR WA, 1982, J ORG CHEM, V47, P156, DOI 10.1021/jo00340a038; RUBENSTEIN JL, 1993, SYNAPSE, V13, P161, DOI 10.1002/syn.890130207; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; SCHIAVO G, 1992, J BIOL CHEM, V267, P23479; SCHULZE KL, 1994, NEURON, V13, P1099, DOI 10.1016/0896-6273(94)90048-5; SOLLNER T, 1994, TRENDS NEUROSCI, V17, P344, DOI 10.1016/0166-2236(94)90178-3; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P444, DOI 10.1073/pnas.89.1.444; STAMLER JS, 1994, CELL, V78, P931, DOI 10.1016/0092-8674(94)90269-0; VANDERVLIET A, 1995, ARCH BIOCHEM BIOPHYS, V319, P341, DOI 10.1006/abbi.1995.1303; YAMASAKI S, 1994, J BIOL CHEM, V269, P12764	46	208	211	1	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1996	16	6					1229	1236		10.1016/S0896-6273(00)80149-X	http://dx.doi.org/10.1016/S0896-6273(00)80149-X			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UU118	8663999	Bronze			2022-12-24	WOS:A1996UU11800020
J	Herrington, J; Park, YB; Babcock, DF; Hille, B				Herrington, J; Park, YB; Babcock, DF; Hille, B			Dominant role of mitochondria in clearance of large Ca2+ loads from rat adrenal chromaffin cells	NEURON			English	Article							INTRACELLULAR CALCIUM; CARDIAC MYOCYTES; SECRETION; TRANSPORT; CA-2+; FLUORESCENCE; MELANOTROPHS; PITUITARY; EXCHANGE; NEURONS	Cytosolic Ca2+ (Ca-c(2+)) clearance from adrenal chromaffin cells was studied by whole-cell patch clamp and indo-1 Ca2+ photometry after influx of Ca2+ through voltage-dependent Ca2+ channels. We isolated the rates of Ca-c(2+) clearance by several mechanisms using combinations of the following agents (with their expected targets): Li+ or TEA substituted for Na+ (Na+-Ca2+ exchange), 1 mM La3+ applied after the depolarization (Na+-Ca2+ exchange and plasma membrane Ca2+-ATPase), 1 mu M thapsigargin (pumping into reticular stores), and 2 mu M carbonyl cyanide m-chlorophenylhydrazone (uptake into mitochondria). Remarkably, whenever [Ca2+](c) rose above similar to 500 nM, Ca-c(2+) clearance by mitochondria exceeded clearance by either Na+-Ca2+ exchange or the Ca2+ pumps of the plasma and reticular membranes. As [Ca2+](c) fell again, Ca2+ re-emerged from mitochondria, prolonging the final return to basal levels.			Herrington, J (corresponding author), UNIV WASHINGTON, DEPT PHYSIOL & BIOPHYS, SEATTLE, WA 98195 USA.			Babcock, Donner/0000-0002-4461-4544	NIAMS NIH HHS [AR17803] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR017803, R37AR017803] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AUGUSTINE GJ, 1992, J PHYSIOL-LONDON, V450, P247, DOI 10.1113/jphysiol.1992.sp019126; BASSANI JWM, 1994, J PHYSIOL-LONDON, V476, P279, DOI 10.1113/jphysiol.1994.sp020130; BASSANI RA, 1992, J PHYSIOL-LONDON, V453, P591, DOI 10.1113/jphysiol.1992.sp019246; CARAFOLI E, 1992, J BIOL CHEM, V267, P2115; CHOW RH, 1994, P NATL ACAD SCI USA, V91, P12765, DOI 10.1073/pnas.91.26.12765; CROMPTON M, 1985, CURR TOP MEMBR TRANS, V25, P231; CROMPTON M, 1990, INTRACELLULAR CALCIU, P181; DUCHEN MR, 1990, J PHYSIOL-LONDON, V424, P411, DOI 10.1113/jphysiol.1990.sp018074; FRIEL DD, 1995, BIOPHYS J, V68, P1752, DOI 10.1016/S0006-3495(95)80352-8; FRIEL DD, 1994, J NEUROSCI, V14, P4007; GANDIA L, 1995, PFLUG ARCH EUR J PHY, V430, P55, DOI 10.1007/BF00373839; GARRAHAN PJ, 1990, INTRACELLULAR CALCIU, P271; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HEINEMANN C, 1994, BIOPHYS J, V67, P2546, DOI 10.1016/S0006-3495(94)80744-1; HEINEMANN C, 1993, PFLUG ARCH EUR J PHY, V424, P105, DOI 10.1007/BF00374600; HERRINGTON J, 1995, J PHYSIOL-LONDON, V485, P297, DOI 10.1113/jphysiol.1995.sp020731; HOLMAN ME, 1994, J PHYSIOL-LONDON, V478, P115, DOI 10.1113/jphysiol.1994.sp020235; HORRIGAN FT, 1994, NEURON, V13, P1119, DOI 10.1016/0896-6273(94)90050-7; KIMURA J, 1986, NATURE, V319, P596, DOI 10.1038/319596a0; KLEIN MG, 1991, J PHYSIOL-LONDON, V441, P639, DOI 10.1113/jphysiol.1991.sp018771; LAI FA, 1988, NATURE, V331, P315, DOI 10.1038/331315a0; LOEW LM, 1994, P NATL ACAD SCI USA, V91, P12579, DOI 10.1073/pnas.91.26.12579; MALGAROLI A, 1990, J BIOL CHEM, V265, P3005; MIYATA H, 1991, AM J PHYSIOL, V261, pH1123, DOI 10.1152/ajpheart.1991.261.4.H1123; MONCK JR, 1994, BIOPHYS J, V67, P505, DOI 10.1016/S0006-3495(94)80554-5; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; PARK Y, 1994, J PHYSIOL-LONDON, V481, P555, DOI 10.1113/jphysiol.1994.sp020463; PARK YB, 1996, IN PRESS J PHYSL; PEETERS GA, 1989, AM J PHYSIOL, V256, pC351, DOI 10.1152/ajpcell.1989.256.2.C351; POULSEN JCJ, 1995, BIOCHEM J, V307, P749, DOI 10.1042/bj3070749; POWIS DA, 1994, CELL CALCIUM, V16, P377, DOI 10.1016/0143-4160(94)90031-0; POWIS DA, 1991, CELL CALCIUM, V12, P493, DOI 10.1016/0143-4160(91)90031-9; REEVES JP, 1990, INTRACELLULAR CALCIU, P305; RIZZUTO R, 1994, J CELL BIOL, V126, P1183, DOI 10.1083/jcb.126.5.1183; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; SCHWEIZER FE, 1995, NEURON, V14, P689, DOI 10.1016/0896-6273(95)90213-9; SHEU SS, 1994, J BIOENERG BIOMEMBR, V26, P487, DOI 10.1007/BF00762733; SIPIDO KR, 1991, J PHYSIOL-LONDON, V435, P605, DOI 10.1113/jphysiol.1991.sp018528; Sommer J.R., 1979, HDB PHYSL 2, VVolume 1, P113; TANAKA Y, 1993, BIOCHEMISTRY-US, V32, P12062, DOI 10.1021/bi00096a017; THAYER SA, 1990, J PHYSIOL-LONDON, V425, P85, DOI 10.1113/jphysiol.1990.sp018094; THOMAS D, 1994, METHOD CELL BIOL, V40, P65; THOMAS P, 1993, NEURON, V11, P93, DOI 10.1016/0896-6273(93)90274-U; THOMAS P, 1990, NEURON, V5, P723, DOI 10.1016/0896-6273(90)90226-6; TOMLINSON A, 1987, NEUROSCIENCE, V20, P895, DOI 10.1016/0306-4522(87)90250-8; TRIBE RM, 1994, P NATL ACAD SCI USA, V91, P5908, DOI 10.1073/pnas.91.13.5908; TSE A, 1994, J PHYSIOL-LONDON, V477, P511, DOI 10.1113/jphysiol.1994.sp020212; VILLALBA M, 1994, J BIOL CHEM, V269, P2468; WERTH JL, 1994, J NEUROSCI, V14, P348; WHITE RJ, 1995, J NEUROSCI, V15, P1318; WIER WG, 1992, HEART CARDIOVASCULAR, P1223; ZHOU Z, 1995, J BIOL CHEM, V270, P3498, DOI 10.1074/jbc.270.8.3498; ZHOU ZA, 1993, J PHYSIOL-LONDON, V469, P245, DOI 10.1113/jphysiol.1993.sp019813	56	311	315	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1996	16	1					219	228		10.1016/S0896-6273(00)80038-0	http://dx.doi.org/10.1016/S0896-6273(00)80038-0			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TT307	8562086	Bronze			2022-12-24	WOS:A1996TT30700024
J	MORSHEAD, CM; REYNOLDS, BA; CRAIG, CG; MCBURNEY, MW; STAINES, WA; MORASSUTTI, D; WEISS, S; VANDERKOOY, D				MORSHEAD, CM; REYNOLDS, BA; CRAIG, CG; MCBURNEY, MW; STAINES, WA; MORASSUTTI, D; WEISS, S; VANDERKOOY, D			NEURAL STEM-CELLS IN THE ADULT MAMMALIAN FOREBRAIN - A RELATIVELY QUIESCENT SUBPOPULATION OF SUBEPENDYMAL CELLS	NEURON			English	Article							TRANSFORMING GROWTH-FACTOR; SUBVENTRICULAR ZONE; NEURONS; RAT; NEUROGENESIS; LAYER; BRAIN; 5-FLUOROURACIL; PROLIFERATION; GENERATION	Dissection of the subependyma from the lateral ventricle of the adult mouse forebrain is necessary and sufficient for the in vitro formation of clonally derived spheres of cells that exhibit stem cell properties such as self-maintenance and the generation of a large number of progeny comprising the major cell types found in the central nervous system. Killing the constitutively proliferating cells of the subependyma in vivo has no effect on the number of stem cells isolated in vitro and induces a complete repopulation of the subependyma in vivo by relatively quiescent stem cells found within the subependyma. Depleting the relatively quiescent cell population within the subependyma in vivo results in a corresponding decrease in spheres formed in vitro and in the final number of constitutively proliferating cells in vivo, suggesting that a relatively quiescent subependymal cell is the in vivo source of neural stem cells.	UNIV CALGARY, DEPT ANAT, CALGARY T2N 4N1, AB, CANADA; UNIV CALGARY, DEPT THERAPEUT & PHARMACOL, CALGARY T2N 4N1, AB, CANADA; UNIV OTTAWA, DEPT MED, OTTAWA K1H 8M5, ON, CANADA	University of Calgary; University of Calgary; University of Ottawa	MORSHEAD, CM (corresponding author), UNIV TORONTO, DEPT ANAT & CELL BIOL, NEUROCHEM RES GRP, TORONTO M5S 1A8, ON, CANADA.			Staines, Willim/0000-0002-7288-5026				ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; ALTMAN J, 1963, ANAT REC, V145, P573, DOI 10.1002/ar.1091450409; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; BAYER SA, 1982, SCIENCE, V216, P890, DOI 10.1126/science.7079742; BECKER AJ, 1965, BLOOD-J HEMATOL, V26, P296, DOI 10.1182/blood.V26.3.296.296; BROWN PI, 1990, AM J PHYSIOL, V259, pE256, DOI 10.1152/ajpendo.1990.259.2.E256; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; CHADWICK M, 1972, CANCER RES, V32, P1045; CRAIG CG, 1994, J CELL BIOCHEM, V18, P176; Fallon JH, 1990, GROWTH FACTORS, V2, P241, DOI 10.3109/08977199009071510; HALL PA, 1989, DEVELOPMENT, V106, P619; HARRISON DE, 1991, BLOOD, V78, P1237; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; KIEFER R, 1993, EUR J NEUROSCI, V5, P775, DOI 10.1111/j.1460-9568.1993.tb00929.x; KORN A P, 1973, Experimental Hematology (Charlottesville), V1, P362; KUDLOW JE, 1989, J BIOL CHEM, V264, P3880; LAJTHA LG, 1969, CELL TISSUE KINET, V2, P39, DOI 10.1111/j.1365-2184.1969.tb00336.x; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; MARQUARDT H, 1984, SCIENCE, V223, P1079, DOI 10.1126/science.6320373; MASSAGUE J, 1983, J BIOL CHEM, V258, P3614; MCCONNELL SK, 1988, BRAIN RES REV, V13, P1, DOI 10.1016/0165-0173(88)90002-1; MORSHEAD CM, 1992, J NEUROSCI, V12, P249; OKANO HJ, 1993, J NEUROSCI, V13, P2930; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; RAEDLER E, 1978, ANAT EMBRYOL, V154, P267, DOI 10.1007/BF00345657; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; REYNOLDS BA, 1993, RESTORATIVE NEUROLOG, V6, P247; SMART I, 1961, J COMP NEUROL, V116, P325, DOI 10.1002/cne.901160306; SMART I, 1961, J COMP NEUROL, V116, P349, DOI 10.1002/cne.901160307; SPANGRUDE GJ, 1991, BLOOD, V78, P1395; STREIT WJ, 1988, J COMP NEUROL, V268, P248, DOI 10.1002/cne.902680209; STURROCK RR, 1980, J ANAT, V130, P391; WEN JYM, 1994, J CELL BIOL, V124, P1005, DOI 10.1083/jcb.124.6.1005	36	1139	1206	2	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1994	13	5					1071	1082		10.1016/0896-6273(94)90046-9	http://dx.doi.org/10.1016/0896-6273(94)90046-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PU763	7946346				2022-12-24	WOS:A1994PU76300004
J	MARTINOU, JC; DUBOISDAUPHIN, M; STAPLE, JK; RODRIGUEZ, I; FRANKOWSKI, H; MISSOTTEN, M; ALBERTINI, P; TALABOT, D; CATSICAS, S; PIETRA, C; HUARTE, J				MARTINOU, JC; DUBOISDAUPHIN, M; STAPLE, JK; RODRIGUEZ, I; FRANKOWSKI, H; MISSOTTEN, M; ALBERTINI, P; TALABOT, D; CATSICAS, S; PIETRA, C; HUARTE, J			OVEREXPRESSION OF BCL-2 IN TRANSGENIC MICE PROTECTS NEURONS FROM NATURALLY-OCCURRING CELL-DEATH AND EXPERIMENTAL-ISCHEMIA	NEURON			English	Article							NERVOUS-SYSTEM; SUPEROXIDE-DISMUTASE; PROTOONCOGENE BCL-2; SEQUENCE SIMILARITY; GENE; APOPTOSIS; EXPRESSION; SURVIVAL; CLONING; MECHANISMS	Naturally occurring cell death (NOCD) is a prominent feature of the developing nervous system. During this process, neurons express bcl-2, a major regulator of cell death whose expression may determine whether a neuron dies or survives. To gain insight into the possible role of bcl-2 during NOCD in vivo, we generated lines of transgenic mice in which neurons overexpress the human BCL-2 protein under the control of the neuron-specific enolase (NSE) or phosphoglycerate kinase (PCK) promoters. BCL-2 overexpression reduced neuronal loss during the NOCD period, which led to hypertrophy of the nervous system. For instance, the facial nucleus and the ganglion cell layer of the retina had, respectively, 40% and 50% more neurons than normal. Consistent with this finding, more axons than normal were found in the facial and optic nerves. We also tested whether neurons overexpressing BCL-2 were more resistant to permanent ischemia induced by middle cerebral artery occlusion; in transgenic mice, the volume of the brain infarction was reduced by 50% as compared with wildtype mice. These animals represent an invaluable tool for studying the effects of increased neuronal numbers on brain function as well as the mechanisms that control the survival of neurons during development and adulthood.	UNIV GENEVA,CTR MED,DEPT PHYSIOL,CH-1211 GENEVA,SWITZERLAND; UNIV GENEVA,CTR MED,DEPT PATHOL,CH-1211 GENEVA,SWITZERLAND; UNIV GENEVA,CTR MED,DEPT MORPHOL,CH-1211 GENEVA,SWITZERLAND; GLAXO SPA,DEPT PHARMACOL,I-37100 VERONA,ITALY	University of Geneva; University of Geneva; University of Geneva; GlaxoSmithKline	MARTINOU, JC (corresponding author), GLAXO INST MOLEC BIOL SA,14 CHEMIN AULX,CH-1228 PLAN LES OUATES,SWITZERLAND.			rodriguez, ivan/0000-0002-6468-0565; martinou, Jean-claude/0000-0002-9847-2051				ADRA CN, 1987, GENE, V60, P65, DOI 10.1016/0378-1119(87)90214-9; ALDSKOGIUS H, 1993, ADV STRUCTURAL BIOL, V2, P191; ALLSOPP TE, 1993, CELL, V73, P295, DOI 10.1016/0092-8674(93)90230-N; ARNOLD AP, 1984, ANNU REV NEUROSCI, V7, P413, DOI 10.1146/annurev.ne.07.030184.002213; ASHWELL KW, 1983, J EMBRYOL EXP MORPH, V77, P117; BAKHSHI A, 1985, CELL, V41, P899, DOI 10.1016/S0092-8674(85)80070-2; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; CARSON KA, 1980, NEUROPATH APPL NEURO, V6, P361, DOI 10.1111/j.1365-2990.1980.tb00672.x; CATSICAS S, 1987, J COMP NEUROL, V262, P512, DOI 10.1002/cne.902620405; CHAN PH, 1993, NEUROREPORT, V5, P293, DOI 10.1097/00001756-199312000-00028; CHEDID A, 1980, AM J GASTROENTEROL, V73, P319; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; CLARKE PGH, 1985, TRENDS NEUROSCI, V8, P345, DOI 10.1016/0166-2236(85)90120-1; CLEARY ML, 1986, CELL, V47, P19, DOI 10.1016/0092-8674(86)90362-4; Cowan W.M., 1973, DEV AGING NERVOUS SY, P19; CUNNINGHAM TJ, 1982, INT REV CYTOL, V74, P163, DOI 10.1016/S0074-7696(08)61172-9; DODSON RE, 1993, J NEUROBIOL, V24, P80, DOI 10.1002/neu.480240107; DUBOISDAUPHIN M, 1994, P NATL ACAD SCI USA, V91, P2459; ELLIS RE, 1991, ANNU REV CELL BIOL, V7, P663, DOI 10.1146/annurev.cb.07.110191.003311; FORSSPETTER S, 1990, NEURON, V5, P187, DOI 10.1016/0896-6273(90)90308-3; GARCIA I, 1992, SCIENCE, V258, P302, DOI 10.1126/science.1411528; GLUCKSMANN A, 1951, BIOL REV, V26, P59, DOI 10.1111/j.1469-185X.1951.tb00774.x; HENGARTNER MO, 1994, CELL, V76, P665, DOI 10.1016/0092-8674(94)90506-1; HENGARTNER MO, 1992, NATURE, V356, P494, DOI 10.1038/356494a0; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; JACOBSON MD, 1993, NATURE, V361, P365, DOI 10.1038/361365a0; JOHNSON EM, 1993, ANNU REV NEUROSCI, V16, P31, DOI 10.1146/annurev.ne.16.030193.000335; KANE DJ, 1993, SCIENCE, V262, P1274, DOI 10.1126/science.8235659; KINOUCHI H, 1991, P NATL ACAD SCI USA, V88, P11158, DOI 10.1073/pnas.88.24.11158; KORSMEYER SJ, 1992, IMMUNOL TODAY, V13, P285, DOI 10.1016/0167-5699(92)90037-8; KOZOPAS KM, 1993, P NATL ACAD SCI USA, V90, P3516, DOI 10.1073/pnas.90.8.3516; LEBRUN DP, 1993, AM J PATHOL, V142, P743; LIN EY, 1993, J IMMUNOL, V151, P1979; LIU TH, 1989, AM J PHYSIOL, V256, pH589, DOI 10.1152/ajpheart.1989.256.2.H589; MAH SP, 1993, J NEUROCHEM, V60, P1183, DOI 10.1111/j.1471-4159.1993.tb03275.x; MARTINOU JC, 1994, J PHYSIOLOGY-PARIS, V88, P209, DOI 10.1016/0928-4257(94)90007-8; MASANGKAY JS, 1983, EXP ANIM TOKYO, V32, P139, DOI 10.1538/expanim1978.32.3_139; MERRY DE, 1994, DEVELOPMENT, V120, P301; MONAGHAN P, 1992, J HISTOCHEM CYTOCHEM, V40, P1819, DOI 10.1177/40.12.1453000; NANDY K, 1968, MOTOR NEURON DISEASE, P319; NUNEZ G, 1990, J IMMUNOL, V144, P3602; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; PRAVTCHEVA DD, 1991, DEVELOPMENT, V111, P1109; PROUDFOOT NJ, 1986, NATURE, V322, P562, DOI 10.1038/322562a0; PURVES D, 1980, NATURE, V287, P585, DOI 10.1038/287585a0; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; RAFF MC, 1993, SCIENCE, V262, P695, DOI 10.1126/science.8235590; RAMI A, 1993, BRAIN RES, V609, P67, DOI 10.1016/0006-8993(93)90856-I; REED JC, 1994, J CELL BIOL, V124, P1, DOI 10.1083/jcb.124.1.1; REIK W, 1987, NATURE, V328, P248, DOI 10.1038/328248a0; SAPIENZA C, 1987, NATURE, V328, P251, DOI 10.1038/328251a0; SCHMECHEL DE, 1987, NEUROSCI LETT, V76, P233, DOI 10.1016/0304-3940(87)90721-X; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; SIEGEL RM, 1992, P NATL ACAD SCI USA, V89, P7003, DOI 10.1073/pnas.89.15.7003; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; STRASSER A, 1994, P NATL ACAD SCI USA, V91, P1376, DOI 10.1073/pnas.91.4.1376; SULKIN NM, 1967, J GERONTOL, V22, P485; SUZUKI Y, 1986, EXP NEUROL, V94, P241, DOI 10.1016/0014-4886(86)90287-6; TSUJIMOTO Y, 1984, SCIENCE, V226, P1097, DOI 10.1126/science.6093263; TSUJIMOTO Y, 1986, P NATL ACAD SCI USA, V83, P5214, DOI 10.1073/pnas.83.14.5214; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; WHITEHEAD MC, 1982, DEV NEUROSCI-BASEL, V5, P298, DOI 10.1159/000112689; WILLIAMS GT, 1993, CELL, V74, P777, DOI 10.1016/0092-8674(93)90457-2; WOOD KA, 1993, NEURON, V11, P621, DOI 10.1016/0896-6273(93)90074-2; YANG GY, 1994, STROKE, V25, P165, DOI 10.1161/01.STR.25.1.165; YOSHIDA H, 1983, EXP ANIM TOKYO, V32, P93, DOI 10.1538/expanim1978.32.2_93; YUAN JY, 1992, DEVELOPMENT, V116, P309; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9; YUAN JY, 1990, DEV BIOL, V138, P33, DOI 10.1016/0012-1606(90)90174-H	73	1005	1046	0	25	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1994	13	4					1017	1030		10.1016/0896-6273(94)90266-6	http://dx.doi.org/10.1016/0896-6273(94)90266-6			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PP533	7946326				2022-12-24	WOS:A1994PP53300023
J	PERETZ, A; SUSSTOBY, E; ROMGLAS, A; ARNON, A; PAYNE, R; MINKE, B				PERETZ, A; SUSSTOBY, E; ROMGLAS, A; ARNON, A; PAYNE, R; MINKE, B			THE LIGHT RESPONSE OF DROSOPHILA PHOTORECEPTORS IS ACCOMPANIED BY AN INCREASE IN CELLULAR CALCIUM - EFFECTS OF SPECIFIC MUTATIONS	NEURON			English	Article							LIMULUS VENTRAL PHOTORECEPTORS; SMOOTH ENDOPLASMIC-RETICULUM; INTRACELLULAR CALCIUM; EXTRACELLULAR CALCIUM; FLY PHOTORECEPTORS; INOSITOL TRISPHOSPHATE; HONEYBEE DRONE; BLOWFLY RETINA; ARSENAZO-III; ADAPTATION	Photoreceptors of dissociated Drosophila retinae were loaded with the fluorescent Ca2+ indicators, fluo-3 and Calcium Green-5N. In fluo-3-loaded, wild-type photoreceptors, a rapid increase in fluorescence (Ca2+ signal) accompanied the light-evoked inward current. Removal of extracellular Ca2+ greatly reduced the Ca2+ signal, indicating Ca2+ influx as its major cause. In Calcium Green-SN-loaded trp mutants, which lack a large fraction of the Ca2+ permeability underlying the light-evoked inward current, the Ca2+ signal was smaller relative to wild-type photoreceptors. Fluo-3-loaded norpA mutant photoreceptors, which lack a light-activated phospholipase C, generated no light-evoked inward current and no Ca2+ signal. The phosphoinositide pathway therefore appears necessary for both excitation and changes in cytosolic free Ca2+ concentration.	HEBREW UNIV JERUSALEM,HADASSAH MED SCH,MINERVA CTR STUDIES VISUAL TRANSDUCT,IL-91120 JERUSALEM,ISRAEL; UNIV MARYLAND,DEPT ZOOL,COLL PK,MD 20742	Hebrew University of Jerusalem; University System of Maryland; University of Maryland College Park	PERETZ, A (corresponding author), HEBREW UNIV JERUSALEM,HADASSAH MED SCH,DEPT PHYSIOL,IL-91120 JERUSALEM,ISRAEL.				NATIONAL EYE INSTITUTE [R01EY003529, R01EY007743] Funding Source: NIH RePORTER; NEI NIH HHS [EY 03529, EY 07743] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BAUMANN O, 1989, J COMP PHYSIOL A, V165, P627, DOI 10.1007/BF00610994; BAUMANN O, 1989, CELL TISSUE RES, V255, P511, DOI 10.1007/BF00218786; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; BOLSOVER SR, 1985, J PHYSIOL-LONDON, V364, P381, DOI 10.1113/jphysiol.1985.sp015751; BROWN HM, 1988, CELL CALCIUM, V9, P105, DOI 10.1016/0143-4160(88)90014-0; BROWN JE, 1977, J PHYSIOL-LONDON, V267, P299, DOI 10.1113/jphysiol.1977.sp011814; BROWN JE, 1974, J GEN PHYSIOL, V64, P643, DOI 10.1085/jgp.64.6.643; COLES JA, 1985, J PHYSIOL-LONDON, V362, P415, DOI 10.1113/jphysiol.1985.sp015686; DECKERT A, 1991, J PHYSIOL-LONDON, V433, P467, DOI 10.1113/jphysiol.1991.sp018438; HANANI M, 1976, J GEN PHYSIOL, V67, P235, DOI 10.1085/jgp.67.2.235; HARARY HH, 1984, SCIENCE, V224, P292, DOI 10.1126/science.6710144; HARDIE RC, 1993, P ROY SOC B-BIOL SCI, V252, P223, DOI 10.1098/rspb.1993.0069; HARDIE RC, 1991, J NEUROSCI, V11, P3079; HARDIE RC, 1991, P ROY SOC B-BIOL SCI, V245, P203, DOI 10.1098/rspb.1991.0110; HARDIE RC, 1994, J GEN PHYSIOL, V103, P389, DOI 10.1085/jgp.103.3.389; HARDIE RC, 1993, TRENDS NEUROSCI, V16, P371, DOI 10.1016/0166-2236(93)90095-4; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; Hille B., 1992, IONIC CHANNELS EXCIT; HOCHSTRATE P, 1991, CELL CALCIUM, V12, P695, DOI 10.1016/0143-4160(91)90039-H; JOHNSON EC, 1986, J GEN PHYSIOL, V88, P651, DOI 10.1085/jgp.88.5.651; KIRSCHFELD K, 1980, NATURWISSENSCHAFTEN, V67, P516, DOI 10.1007/BF01047639; LISMAN JE, 1972, J GEN PHYSIOL, V59, P701, DOI 10.1085/jgp.59.6.701; MATSUMOTOSUZUKI E, 1989, J NEUROCYTOL, V18, P87, DOI 10.1007/BF01188427; MINKE B, 1986, VISION RES, V26, P679, DOI 10.1016/0042-6989(86)90082-9; MINKE B, 1991, J NEUROSCI, V11, P900; MINKE B, 1992, SENSORY TRANSDUCTION, P202; MINKE B, 1986, MOL MECHANISM PHOTOR, P241; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; OSTROY SE, 1978, J GEN PHYSIOL, V72, P717, DOI 10.1085/jgp.72.5.717; OTOUSA JE, 1985, CELL, V40, P839, DOI 10.1016/0092-8674(85)90343-5; Pak W.L., 1979, P67; PAYNE R, 1988, PHILOS T ROY SOC B, V320, P359, DOI 10.1098/rstb.1988.0082; PAYNE R, 1986, J GEN PHYSIOL, V88, P127, DOI 10.1085/jgp.88.1.127; PERRY MM, 1968, J MORPHOL, V124, P227, DOI 10.1002/jmor.1051240208; PHILLIPS AM, 1992, NEURON, V8, P631, DOI 10.1016/0896-6273(92)90085-R; RANGANATHAN R, 1991, NATURE, V354, P230, DOI 10.1038/354230a0; ROMGLAS A, 1992, J GEN PHYSIOL, V100, P767, DOI 10.1085/jgp.100.5.767; SAHLY I, 1992, P NATL ACAD SCI USA, V89, P435, DOI 10.1073/pnas.89.1.435; SAHLY I, 1994, IN PRESS VIS NEUROSC; SANDLER C, 1988, NATURWISSENSCHAFTEN, V75, P256, DOI 10.1007/BF00378019; SELINGER Z, 1988, COLD SPRING HARB SYM, V53, P333, DOI 10.1101/SQB.1988.053.01.040; STARK WS, 1976, J COMP PHYSIOL, V105, P15, DOI 10.1007/BF01380050; STIEVE H, 1980, BIOPHYS STRUCT MECH, V6, P271, DOI 10.1007/BF00538228; WALZ B, 1979, EUR J CELL BIOL, V20, P83; WALZ B, 1994, J COMP PHYSIOL A, V174, P421, DOI 10.1007/BF00191708; WALZ B, 1982, J ULTRA MOL STRUCT R, V81, P240, DOI 10.1016/S0022-5320(82)90079-X; YOSHIOKA T, 1985, J BIOCHEM-TOKYO, V97, P1251, DOI 10.1093/oxfordjournals.jbchem.a135171; ZIEGLER A, 1989, J COMP PHYSIOL A, V165, P697, DOI 10.1007/BF00611001	49	125	125	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1994	12	6					1257	1267		10.1016/0896-6273(94)90442-1	http://dx.doi.org/10.1016/0896-6273(94)90442-1			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NT463	8011336				2022-12-24	WOS:A1994NT46300007
J	KLEENE, SJ				KLEENE, SJ			ORIGIN OF THE CHLORIDE CURRENT IN OLFACTORY TRANSDUCTION	NEURON			English	Article							SENSITIVE ADENYLATE-CYCLASE; RAT EXOCRINE PANCREAS; RECEPTOR NEURONS; CALCIUM CHANNELS; GATED CHANNELS; CYCLIC-AMP; CILIA; MEMBRANE; CONDUCTANCE; ACTIVATION	In the cilia of amphibian olfactory receptor neurons, odorants elicit a receptor current that has two components: a cationic current through cAMP-gated channels and a Cl- current. Here, a cascade of ciliary currents that accounts for the total receptor current is demonstrated. In isolated olfactory cilia, cAMP sequentially activates two currents. The first is a primary cationic current through channels directly gated by cAMP. Part of this current is carried by Ca2+, which in turn activates a Cl- current. This secondary current is eliminated by the presence of Cl- channel inhibitors, replacement of Cl- with methanesulfonate-, removal of external Ca2+, or blockers of the cAMP-gated cationic channels. When cytoplasmic Ca2+ buffering is low, small cationic currents can activate Cl- currents that are 20 times larger.			KLEENE, SJ (corresponding author), UNIV CINCINNATI,DEPT ANAT & CELL BIOL,CINCINNATI,OH 45267, USA.				NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000352, R55DC000926, P01DC000347] Funding Source: NIH RePORTER; NIDCD NIH HHS [P01 DC00347, R55 DC00926, R01 DC00352] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BOEKHOFF I, 1990, EMBO J, V9, P2453, DOI 10.1002/j.1460-2075.1990.tb07422.x; BRUCH RC, 1990, CHEM SENSES, V15, P419, DOI 10.1093/chemse/15.4.419; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; DUBIN AE, 1993, J GEN PHYSIOL, V101, P469, DOI 10.1085/jgp.101.4.469; FIRESTEIN S, 1989, SCIENCE, V244, P79, DOI 10.1126/science.2704991; FIRESTEIN S, 1991, J NEUROSCI, V11, P3565; FIRESTEIN S, 1990, J PHYSIOL-LONDON, V430, P135, DOI 10.1113/jphysiol.1990.sp018286; FRINGS S, 1992, J GEN PHYSIOL, V100, P45, DOI 10.1085/jgp.100.1.45; GARCIA ML, 1990, J BIOL CHEM, V265, P3763; GOGELEIN H, 1990, FEBS LETT, V268, P79, DOI 10.1016/0014-5793(90)80977-Q; GOGELEIN H, 1989, PFLUG ARCH EUR J PHY, V413, P287, DOI 10.1007/BF00583543; HAGIWARA S, 1982, J PHYSIOL-LONDON, V331, P231, DOI 10.1113/jphysiol.1982.sp014371; HAYNES LW, 1992, J GEN PHYSIOL, V100, P783, DOI 10.1085/jgp.100.5.783; HIRONO J, 1992, J NEUROSCI METH, V42, P185, DOI 10.1016/0165-0270(92)90098-X; JOSHI H, 1987, NEUROSCI LETT, V82, P321, DOI 10.1016/0304-3940(87)90276-X; KLEENE SJ, 1992, PFLUG ARCH EUR J PHY, V421, P374, DOI 10.1007/BF00374226; KLEENE SJ, 1991, J MEMBRANE BIOL, V120, P75, DOI 10.1007/BF01868593; KLEENE SJ, 1993, J MEMBRANE BIOL, V131, P237, DOI 10.1007/BF02260112; KLEENE SJ, 1991, J NEUROSCI, V11, P3624; KOLESNIKOV SS, 1990, FEBS LETT, V266, P96, DOI 10.1016/0014-5793(90)81515-P; KURAHASHI T, 1991, NEUROREPORT, V2, P5, DOI 10.1097/00001756-199101000-00001; KURAHASHI T, 1990, J PHYSIOL-LONDON, V430, P355, DOI 10.1113/jphysiol.1990.sp018295; KURAHASHI T, 1990, BRAIN RES, V515, P261, DOI 10.1016/0006-8993(90)90605-B; KURAHASHI T, 1989, J PHYSIOL-LONDON, V419, P177, DOI 10.1113/jphysiol.1989.sp017868; KURAHASHI T, 1993, NATURE, V363, P71, DOI 10.1038/363071a0; LOWE G, 1991, J PHYSIOL-LONDON, V442, P147, DOI 10.1113/jphysiol.1991.sp018787; LOWE G, 1993, J PHYSIOL-LONDON, V462, P175, DOI 10.1113/jphysiol.1993.sp019550; MCCLINTOCK TS, 1989, P NATL ACAD SCI USA, V86, P8137, DOI 10.1073/pnas.86.20.8137; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; NICOL GD, 1987, J GEN PHYSIOL, V90, P651, DOI 10.1085/jgp.90.5.651; PACE U, 1985, NATURE, V316, P255, DOI 10.1038/316255a0; RESTREPO D, 1990, SCIENCE, V249, P1166, DOI 10.1126/science.2168580; SHIRLEY SG, 1986, BIOCHEM J, V240, P605, DOI 10.1042/bj2400605; SKLAR PB, 1986, J BIOL CHEM, V261, P5538; TANG JM, 1990, PFLUG ARCH EUR J PHY, V416, P347, DOI 10.1007/BF00392072; WHITE MM, 1990, MOL PHARMACOL, V37, P720; ZUFALL F, 1993, J NEUROPHYSIOL, V69, P1758, DOI 10.1152/jn.1993.69.5.1758	37	189	190	1	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1993	11	1					123	132		10.1016/0896-6273(93)90276-W	http://dx.doi.org/10.1016/0896-6273(93)90276-W			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LP430	8393322				2022-12-24	WOS:A1993LP43000011
J	OZAKI, K; NAGATANI, H; OZAKI, M; TOKUNAGA, F				OZAKI, K; NAGATANI, H; OZAKI, M; TOKUNAGA, F			MATURATION OF MAJOR DROSOPHILA RHODOPSIN, NINAE, REQUIRES CHROMOPHORE 3-HYDROXY-RETINAL	NEURON			English	Article							A-BINDING-PROTEIN; VISUAL PIGMENT; MELANOGASTER; GENE; PHOTORECEPTORS; ENCODES; OPSIN; FLY; RHABDOMERES; DEPRIVATION	Opsin expression is extremely suppressed by carotenoid deprivation in Drosophila. Carotenoid replacement in deprived flies promotes the recovery of visual pigment with an increase in opsin, as well as the chromophore 11-cis-3-hydroxyretinal. Here, we show that opsin mRNA and opsin peptide in an intermediate step of posttranslational processing were present in carotenoid-deprived flies. By supplementing chromophore to photoreceptor cells, intermediate opsin was made mature. During this process, opsin peptide underwent multiple modifications involving glycosylation. Based on these results, we present a novel mechanism of protein regulatory expression; that is, chromophore posttranslationally controls the expression of apoprotein by promoting its maturation.			OZAKI, K (corresponding author), OSAKA UNIV,FAC SCI,DEPT BIOL,TOYONAKA,OSAKA 560,JAPAN.		Ozaki, Koichi/O-2798-2015	Ozaki, Koichi/0000-0001-7268-5377				COLLEY NJ, 1991, CELL, V67, P255, DOI 10.1016/0092-8674(91)90177-Z; DECOUET HG, 1987, EUR J CELL BIOL, V44, P50; GROENENDIJK GWT, 1980, BIOCHIM BIOPHYS ACTA, V617, P430, DOI 10.1016/0005-2760(80)90009-0; HARRIS WA, 1977, NATURE, V266, P648, DOI 10.1038/266648a0; HUBER A, 1990, J BIOL CHEM, V265, P17906; ISHIZAKI T, 1989, Zoological Science (Tokyo), V6, P1083; ISONO K, 1988, J GEN PHYSIOL, V92, P587, DOI 10.1085/jgp.92.5.587; KORENBROT JI, 1989, NATURE, V337, P454, DOI 10.1038/337454a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MATSUMOTO H, 1987, P NATL ACAD SCI USA, V84, P985, DOI 10.1073/pnas.84.4.985; MONTELL C, 1988, CELL, V52, P757, DOI 10.1016/0092-8674(88)90413-8; OTOUSA JE, 1992, VISUAL NEUROSCI, V8, P385, DOI 10.1017/S0952523800004910; OTOUSA JE, 1985, CELL, V40, P439; PAULSEN R, 1983, EUR J BIOCHEM, V137, P609, DOI 10.1111/j.1432-1033.1983.tb07869.x; SAPP RJ, 1991, EXP EYE RES, V53, P73, DOI 10.1016/0014-4835(91)90147-7; SCHNEUWLY S, 1989, P NATL ACAD SCI USA, V86, P5390, DOI 10.1073/pnas.86.14.5390; SCHOLNICK SB, 1983, CELL, V34, P37, DOI 10.1016/0092-8674(83)90134-4; SCHWEMER J, 1984, CELL TISSUE RES, V236, P293, DOI 10.1007/BF00214230; SEKI T, 1986, VISION RES, V26, P255, DOI 10.1016/0042-6989(86)90020-9; SHIEH BH, 1989, NATURE, V338, P67, DOI 10.1038/338067a0; STEPHENSON RS, 1983, BIOL PHOTORECEPTION, P477; TANIMURA T, 1986, PHOTOCHEM PHOTOBIOL, V43, P225, DOI 10.1111/j.1751-1097.1986.tb09519.x; VOGT K, 1984, NATURWISSENSCHAFTEN, V71, P211, DOI 10.1007/BF00490436; WASHBURN T, 1989, J BIOL CHEM, V264, P15464; WHITE RH, 1989, CELL TISSUE RES, V257, P519, DOI 10.1007/BF00221461; ZUKER CS, 1985, CELL, V40, P851, DOI 10.1016/0092-8674(85)90344-7	26	77	77	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1993	10	6					1113	1119		10.1016/0896-6273(93)90059-Z	http://dx.doi.org/10.1016/0896-6273(93)90059-Z			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LK373	8318232				2022-12-24	WOS:A1993LK37300011
J	MINTZ, IM; BEAN, BP				MINTZ, IM; BEAN, BP			GABA-B RECEPTOR INHIBITION OF P-TYPE CA2+ CHANNELS IN CENTRAL NEURONS	NEURON			English	Article							CHICK SENSORY NEURONS; GAMMA-AMINOBUTYRIC-ACID; RAT SYMPATHETIC NEURONS; GATED CALCIUM CHANNELS; HIPPOCAMPAL-NEURONS; VERTEBRATE CELLS; NEUROTRANSMITTER MODULATION; CURRENTS; NORADRENALINE; LOCALIZATION	P-type Ca2+ channels in cerebellar Purkinje neurons were inhibited by GABA and the GABA(B) receptor agonist baclofen. Inhibition of P-type Ca2+ channel current involved changes in voltage dependence and kinetics. Baclofen induced a slow phase of activation and altered tail current kinetics, and inhibition could be partly overcome by large depolarizations. These effects were mimicked by internal application of GTPgammaS, which also made the action of baclofen irreversible. In spinal cord neurons, use of selective channel blockers showed that baclofen inhibited both P-type and N-type Ca2+ channels, but not L-type Ca2+ channels; a high threshold current resistant to blockers of P-type, N-type, and L-type channels was also modulated by baclofen. These results show that stimulation of GABA(B) receptors in central neurons can modulate P-type Ca2+ channels through a G protein-mediated mechanism similar to the one linked to N-type Ca2+ channels.			MINTZ, IM (corresponding author), HARVARD UNIV,SCH MED,DEPT NEUROBIOL,BOSTON,MA 02115, USA.				NHLBI NIH HHS [HL 350334] Funding Source: Medline; NINDS NIH HHS [NS 24472, NS 02253] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024472] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANWYL R, 1991, BRAIN RES REV, V16, P265, DOI 10.1016/0165-0173(91)90010-6; BEAN BP, 1989, ANNU REV PHYSIOL, V51, P367, DOI 10.1146/annurev.physiol.51.1.367; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; BEECH DJ, 1992, NEURON, V8, P97, DOI 10.1016/0896-6273(92)90111-P; BERNHEIM L, 1991, NEURON, V6, P959; BOLAND LM, 1993, J NEUROSCI, V13, P516; BOWERY N, 1989, TRENDS PHARMACOL SCI, V10, P401, DOI 10.1016/0165-6147(89)90188-0; BROWN AM, 1990, ANNU REV PHYSIOL, V52, P197, DOI 10.1146/annurev.ph.52.030190.001213; CARBONE E, 1989, PROG BIOPHYS MOL BIO, V54, P31, DOI 10.1016/0079-6107(89)90008-4; COX DH, 1992, J NEUROSCI, V12, P906; DEISZ RA, 1985, NEUROSCI LETT, V56, P205, DOI 10.1016/0304-3940(85)90130-2; DOLPHIN AC, 1987, J PHYSIOL-LONDON, V386, P1; DUBEL SJ, 1992, P NATL ACAD SCI USA, V89, P5058, DOI 10.1073/pnas.89.11.5058; ELMSLIE KS, 1990, NEURON, V5, P75, DOI 10.1016/0896-6273(90)90035-E; FISHER R, 1990, J NEUROPHYSIOL, V64, P1291, DOI 10.1152/jn.1990.64.4.1291; FORSCHER P, 1986, J PHYSIOL-LONDON, V379, P131, DOI 10.1113/jphysiol.1986.sp016244; FURSHPAN EJ, 1989, NEURON, V3, P199, DOI 10.1016/0896-6273(89)90033-0; GRASSI F, 1989, NEUROSCI LETT, V105, P113, DOI 10.1016/0304-3940(89)90021-9; GREEN KA, 1988, BRIT J PHARMACOL, V94, P235, DOI 10.1111/j.1476-5381.1988.tb11520.x; GUNDERSEN CB, 1992, NEURON, V9, P527, DOI 10.1016/0896-6273(92)90190-O; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HEIDELBERGER R, 1991, P NATL ACAD SCI USA, V88, P7135, DOI 10.1073/pnas.88.16.7135; HEIDELBERGER R, 1992, J PHYSIOL-LONDON, V447, P235, DOI 10.1113/jphysiol.1992.sp019000; HESS P, 1990, ANNU REV NEUROSCI, V13, P337, DOI 10.1146/annurev.ne.13.030190.002005; HESS P, 1984, NATURE, V311, P538, DOI 10.1038/311538a0; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; HILLMAN D, 1991, P NATL ACAD SCI USA, V88, P7076, DOI 10.1073/pnas.88.16.7076; HOLZ GG, 1986, NATURE, V319, P670, DOI 10.1038/319670a0; IKEDA SR, 1991, J PHYSIOL-LONDON, V439, P181, DOI 10.1113/jphysiol.1991.sp018663; KASAI H, 1989, PFLUG ARCH EUR J PHY, V414, P145, DOI 10.1007/BF00580956; KASAI H, 1992, J PHYSIOL-LONDON, V448, P189, DOI 10.1113/jphysiol.1992.sp019036; KISKIN NI, 1990, EUR J NEUROSCI, V2, P461, DOI 10.1111/j.1460-9568.1990.tb00437.x; KRAMER RH, 1991, NEURON, V6, P557, DOI 10.1016/0896-6273(91)90058-8; LESTER RAJ, 1990, NEURON, V4, P741, DOI 10.1016/0896-6273(90)90200-Y; LIPSCOMBE D, 1989, NATURE, V340, P639, DOI 10.1038/340639a0; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P197, DOI 10.1113/jphysiol.1980.sp013358; LLINAS R, 1992, TRENDS NEUROSCI, V15, P351, DOI 10.1016/0166-2236(92)90053-B; LLINAS R, 1989, P NATL ACAD SCI USA, V86, P1689, DOI 10.1073/pnas.86.5.1689; LOPEZ HS, 1991, NEURON, V7, P1061, DOI 10.1016/0896-6273(91)90350-9; MAGUIRE G, 1989, P NATL ACAD SCI USA, V86, P10144, DOI 10.1073/pnas.86.24.10144; MARCHETTI C, 1989, BIOPHYS J, V56, P1267, DOI 10.1016/S0006-3495(89)82774-2; MARCHETTI C, 1986, PFLUG ARCH EUR J PHY, V406, P104, DOI 10.1007/BF00586670; MATHIE A, 1992, NEURON, V8, P907, DOI 10.1016/0896-6273(92)90205-R; MILLER RJ, 1992, J BIOL CHEM, V267, P1403; MINTZ IM, 1992, NEURON, V9, P85, DOI 10.1016/0896-6273(92)90223-Z; MINTZ IM, 1992, NATURE, V355, P827, DOI 10.1038/355827a0; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; NOWYCKY MC, 1985, P NATL ACAD SCI USA, V82, P2178, DOI 10.1073/pnas.82.7.2178; PENNINGTON NJ, 1991, J NEUROSCI, V11, P3594; PLUMMER MR, 1991, J NEUROSCI, V11, P2339; POLLO A, 1992, PFLUG ARCH EUR J PHY, V422, P75; REGAN LJ, 1991, J NEUROSCI, V11, P2259; RYU PD, 1990, J NEUROPHYSIOL, V63, P273, DOI 10.1152/jn.1990.63.2.273; SAH DWY, 1990, J NEUROSCI, V10, P136; SAHARA Y, 1993, IN PRESS J NEUROSCI; SAYER RJ, 1992, J NEUROPHYSIOL, V68, P833, DOI 10.1152/jn.1992.68.3.833; SCHOLZ KP, 1991, J PHYSIOL-LONDON, V444, P669, DOI 10.1113/jphysiol.1991.sp018900; SCHROEDER JE, 1991, NEURON, V6, P13, DOI 10.1016/0896-6273(91)90117-I; SCOTT RH, 1990, NEUROSCIENCE, V38, P285, DOI 10.1016/0306-4522(90)90028-3; SHAPIRO MS, 1993, NEURON, V10, P11, DOI 10.1016/0896-6273(93)90237-L; SHER E, 1991, NEUROSCIENCE, V42, P301, DOI 10.1016/0306-4522(91)90376-Y; Snutch T P, 1992, Curr Opin Neurobiol, V2, P247, DOI 10.1016/0959-4388(92)90111-W; STARR TVB, 1991, P NATL ACAD SCI USA, V88, P5621, DOI 10.1073/pnas.88.13.5621; SWANDULLA D, 1991, TRENDS NEUROSCI, V14, P46, DOI 10.1016/0166-2236(91)90018-P; SWARTZ KJ, 1992, J NEUROSCI, V12, P4358; SWARTZ KJ, 1993, NATURE, V361, P165, DOI 10.1038/361165a0; TSIEN RW, 1991, TRENDS PHARMACOL SCI, V12, P349, DOI 10.1016/0165-6147(91)90595-J; TURNER TJ, 1992, SCIENCE, V258, P310, DOI 10.1126/science.1357749; USOWICZ MM, 1992, NEURON, V9, P1185, DOI 10.1016/0896-6273(92)90076-P; WILKIN GP, 1981, NATURE, V294, P584, DOI 10.1038/294584a0; WILLIAMS ME, 1992, SCIENCE, V257, P389, DOI 10.1126/science.1321501; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q	72	237	243	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1993	10	5					889	898		10.1016/0896-6273(93)90204-5	http://dx.doi.org/10.1016/0896-6273(93)90204-5			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LD322	8388225				2022-12-24	WOS:A1993LD32200011
J	Schafer, M; Fruttiger, M; Montag, D; Schachner, M; Martini, R				Schafer, M; Fruttiger, M; Montag, D; Schachner, M; Martini, R			Disruption of the gene for the myelin-associated glycoprotein improves axonal regrowth along myelin in C57BL/Wld(s) mice	NEURON			English	Article							NERVE GROWTH-FACTOR; SCIATIC-NERVE; WALLERIAN DEGENERATION; NEUROTROPHIC FACTOR; PERIPHERAL-NERVES; MESSENGER-RNA; REGENERATION; NGF; LOCALIZATION; MACROPHAGES	The myelin-associated glycoprotein (MAG) has been shown to be inhibitory for certain neurons in vitro (Mukhopadhyay et al., 1994; McKerracher et al., 1994). To investigate whether MAG is an inhibitory component in peripheral myelin in vivo, MAG-deficient mutant mice were cross-bred with C57BL/Wld(s) mice that have delayed lesion-induced myelin degeneration and axon regrowth. While in crushed nerves of C57BL/Wld(s) mice expressing MAG, only 16% of myelin sheaths were associated with regrowing axons, this number was doubled in MAG-deficient C57BL/Wld(s) mice. These observations suggest that the absence of MAG may contribute to the improved axonal regrowth in the double mutants. Therefore, degeneration of MAG-containing myelin might be an important prerequisite to optimize axonal regrowth after peripheral nerve injury.	SWISS FED INST TECHNOL, DEPT NEUROBIOL, CH-8093 ZURICH, SWITZERLAND	Swiss Federal Institutes of Technology Domain; ETH Zurich			Fruttiger, Marcus/C-1899-2008; Montag, Dirk/D-3925-2014	Montag, Dirk/0000-0002-4964-1330; Martini, Rudolf/0000-0002-5463-5592; Fruttiger, Marcus/0000-0002-6962-5485				ACHESON A, 1991, NEURON, V7, P265, DOI 10.1016/0896-6273(91)90265-2; BANDTLOW CE, 1987, EMBO J, V6, P891, DOI 10.1002/j.1460-2075.1987.tb04835.x; Bartsch U, 1995, NEURON, V15, P1375, DOI 10.1016/0896-6273(95)90015-2; BARTSCH U, 1995, GLIA, V14, P115, DOI 10.1002/glia.440140206; BEDI KS, 1992, EUR J NEUROSCI, V4, P193, DOI 10.1111/j.1460-9568.1992.tb00867.x; BROWN MC, 1991, NEURON, V6, P359, DOI 10.1016/0896-6273(91)90245-U; BROWN MC, 1991, EUR J NEUROSCI, V3, P1366, DOI 10.1111/j.1460-9568.1991.tb00069.x; DAVID S, 1995, J NEUROSCI RES, V42, P594, DOI 10.1002/jnr.490420417; FAWCETT JW, 1990, ANNU REV NEUROSCI, V13, P43, DOI 10.1146/annurev.neuro.13.1.43; FRUTTIGER M, 1995, J NEUROCYTOL, V24, P1, DOI 10.1007/BF01370156; FRUTTIGER M, 1995, EUR J NEUROSCI, V7, P511, DOI 10.1111/j.1460-9568.1995.tb00347.x; FUNAKOSHI H, 1993, BIOCHEM BIOPH RES CO, V194, P1317; GIESE KP, 1992, CELL, V71, P565, DOI 10.1016/0092-8674(92)90591-Y; HALL SM, 1993, J NEUROCYTOL, V22, P480, DOI 10.1007/BF01181567; HEUMANN R, 1987, P NATL ACAD SCI USA, V84, P8735, DOI 10.1073/pnas.84.23.8735; JOHNSON PW, 1989, NEURON, V3, P377, DOI 10.1016/0896-6273(89)90262-6; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; MARTINI R, 1990, J NEUROCYTOL, V19, P601, DOI 10.1007/BF01257247; MARTINI R, 1986, J CELL BIOL, V103, P2439, DOI 10.1083/jcb.103.6.2439; MARTINI R, 1994, J NEUROCYTOL, V23, P1, DOI 10.1007/BF01189813; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; MEYER M, 1992, J CELL BIOL, V119, P45, DOI 10.1083/jcb.119.1.45; MONTAG D, 1994, NEURON, V13, P229, DOI 10.1016/0896-6273(94)90472-3; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; PERRY VH, 1990, EUR J NEUROSCI, V2, P408, DOI 10.1111/j.1460-9568.1990.tb00433.x; RAIVICH G, 1991, NEURON, V7, P151, DOI 10.1016/0896-6273(91)90083-C; SCHACHNER M, 1994, PERSPECT DEV NEUROBI, V2, P33; SCHERER SS, 1984, J NEUROCYTOL, V13, P519, DOI 10.1007/BF01148079; SCHWAB ME, 1993, ANNU REV NEUROSCI, V16, P565, DOI 10.1146/annurev.ne.16.030193.003025; ZHANG Y, 1995, J COMP NEUROL, V361, P193, DOI 10.1002/cne.903610202; ZHANG Y, 1995, J COMP NEUROL, V361, P210, DOI 10.1002/cne.903610203	31	148	150	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	1996	16	6					1107	1113		10.1016/S0896-6273(00)80137-3	http://dx.doi.org/10.1016/S0896-6273(00)80137-3			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UU118	8663987	Bronze			2022-12-24	WOS:A1996UU11800008
J	ZACKENFELS, K; OPPENHEIM, RW; ROHRER, H				ZACKENFELS, K; OPPENHEIM, RW; ROHRER, H			EVIDENCE FOR AN IMPORTANT ROLE OF IGF-I AND IGF-II FOR THE EARLY DEVELOPMENT OF CHICK SYMPATHETIC NEURONS	NEURON			English	Article							GROWTH FACTOR-I; CENTRAL-NERVOUS-SYSTEM; RECEPTOR GENE-EXPRESSION; DORSAL-ROOT GANGLIA; CHROMAFFIN CELLS; PRECURSOR CELLS; EARLY ORGANOGENESIS; BINDING-PROPERTIES; CELLULAR-PATTERN; SENSORY GANGLIA	The ability of immature neurons from chick lumbosacral sympathetic ganglia to proliferate in vitro was used to identify factors that affect neurogenesis. Under serum-free culture conditions, insulin-like growth factor I (IGF-I), IGF-II, or insulin caused an increase in the proportion of cells that incorporated [H-3]thymidine. In addition, IGFs also stimulated neurite outgrowth from these immature sympathetic neurons. IGF-I and IGF-II mRNA was found to be expressed in E7 sympathetic ganglia during the period of neurogenesis. IGF-I was detectable in fibroblasts, whereas IGF-II mRNA was expressed by neurons, glia, and fibroblasts. Elimination of endogenous IGFs by neutralizing antibodies resulted in a reduction of neuron proliferation and neuron number, whereas elevation of IGF levels by treatment with IGF-I increased sympathetic neuron proliferation in vivo. These findings suggest an important role of IGFs for the development of sympathetic neurons and imply a general role of IGFs in the control of neurogenesis and neurite outgrowth.	WAKE FOREST UNIV, BOWMAN GRAY SCH MED, DEPT NEUROBIOL & ANAT, WINSTON SALEM, NC 27157 USA	Wake Forest University; Wake Forest Baptist Medical Center	ZACKENFELS, K (corresponding author), MAX PLANCK INST HIRNFORSCH, NEUROCHEM ABT, DEUTSCHORDENSTR 46, D-60528 FRANKFURT, GERMANY.				NINDS NIH HHS [NS20402] Funding Source: Medline; PHS HHS [N31380] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020402] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALVAREZBUYLLA A, 1990, NEURON, V5, P101, DOI 10.1016/0896-6273(90)90038-H; ANCHAN RM, 1991, NEURON, V6, P923, DOI 10.1016/0896-6273(91)90233-P; AYERLELIEVRE C, 1991, DEVELOPMENT, V111, P105; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; BALLARD FJ, 1986, BIOCHEM J, V233, P223, DOI 10.1042/bj2330223; BARRES BA, 1994, NATURE, V367, P371, DOI 10.1038/367371a0; BARRES BA, 1993, DEVELOPMENT, V118, P283; BARTLETT WP, 1991, DEV BIOL, V147, P239, DOI 10.1016/S0012-1606(05)80021-1; BIRREN SJ, 1993, DEVELOPMENT, V119, P597; BONDY C, 1992, NEUROSCIENCE, V46, P909, DOI 10.1016/0306-4522(92)90193-6; BONDY CA, 1990, MOL ENDOCRINOL, V4, P1386, DOI 10.1210/mend-4-9-1386; BONDY CA, 1991, J NEUROSCI, V11, P3442; CARLSSONSKWIRUT C, 1989, BIOCHIM BIOPHYS ACTA, V1011, P192, DOI 10.1016/0167-4889(89)90209-7; CARONI P, 1990, J CELL BIOL, V110, P1307, DOI 10.1083/jcb.110.4.1307; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLAIRMONT KB, 1989, J BIOL CHEM, V264, P16390; CLAUDE P, 1988, NEURON, V1, P783, DOI 10.1016/0896-6273(88)90126-2; COHICK WS, 1993, ANNU REV PHYSIOL, V55, P131, DOI 10.1146/annurev.ph.55.030193.001023; COUGHLIN MD, 1985, DEV BIOL, V110, P392, DOI 10.1016/0012-1606(85)90098-3; DAVIES AM, 1987, NATURE, V326, P353, DOI 10.1038/326353a0; DICICCOBLOOM E, 1990, J CELL BIOL, V110, P2073, DOI 10.1083/jcb.110.6.2073; DICICCOBLOOM E, 1988, P NATL ACAD SCI USA, V85, P4066, DOI 10.1073/pnas.85.11.4066; DICICCOBLOOM E, 1993, NEURON, V11, P1101, DOI 10.1016/0896-6273(93)90223-E; DRAGO J, 1991, P NATL ACAD SCI USA, V88, P2199, DOI 10.1073/pnas.88.6.2199; DUCLOS MJ, 1990, J ENDOCRINOL, V125, P199, DOI 10.1677/joe.0.1250199; ERNSBERGER U, 1989, DEV BIOL, V135, P250, DOI 10.1016/0012-1606(89)90177-2; ERNSBERGER U, 1988, DEV BIOL, V126, P420, DOI 10.1016/0012-1606(88)90151-0; ERNSBERGER U, 1989, NEURON, V2, P1275, DOI 10.1016/0896-6273(89)90312-7; GAO WQ, 1991, NEURON, V6, P705, DOI 10.1016/0896-6273(91)90168-Y; GENSBURGER C, 1987, FEBS LETT, V217, P1, DOI 10.1016/0014-5793(87)81230-9; GERMAINLEE EL, 1992, BIOCHEM J, V281, P413, DOI 10.1042/bj2810413; GLAZNER GW, 1993, NEUROSCIENCE, V54, P791, DOI 10.1016/0306-4522(93)90248-E; KAJIMOTO Y, 1989, MOL ENDOCRINOL, V3, P1907, DOI 10.1210/mend-3-12-1907; KAJIMOTO Y, 1991, J BIOL CHEM, V266, P9724; KANJE M, 1989, BRAIN RES, V486, P396, DOI 10.1016/0006-8993(89)90531-3; KIKUCHI K, 1991, ENDOCRINOLOGY, V128, P1323, DOI 10.1210/endo-128-3-1323; KIRBY ML, 1978, ANAT REC, V191, P311, DOI 10.1002/ar.1091910304; LENOIR D, 1983, DEV BRAIN RES, V7, P205, DOI 10.1016/0165-3806(83)90177-3; LILLIEN L, 1992, DEVELOPMENT, V115, P253; LILLIEN LE, 1985, EXP CELL RES, V161, P255, DOI 10.1016/0014-4827(85)90083-7; METCALF D, 1991, SCIENCE, V254, P529, DOI 10.1126/science.1948028; NEAR SL, 1992, P NATL ACAD SCI USA, V89, P11716, DOI 10.1073/pnas.89.24.11716; OPPENHEIM RW, 1989, DEV BIOL, V133, P468, DOI 10.1016/0012-1606(89)90050-X; PFEIFFER F, 1984, P NATL ACAD SCI-BIOL, V81, P7224, DOI 10.1073/pnas.81.22.7224; PURVES D, 1988, BODY BRAIN; RECIOPINTO E, 1986, J NEUROSCI, V6, P1211; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; ROHRER H, 1988, DEVELOPMENT, V103, P545; ROHRER H, 1987, J NEUROSCI, V7, P3739; ROHRER H, 1985, EMBO J, V4, P1709, DOI 10.1002/j.1460-2075.1985.tb03840.x; ROHRER H, 1990, EUR J NEUROSCI, V2, P1005, DOI 10.1111/j.1460-9568.1990.tb00013.x; ROHRER H, 1985, DEV BIOL, V111, P95, DOI 10.1016/0012-1606(85)90438-5; ROTHMAN TP, 1987, DEV BIOL, V124, P331, DOI 10.1016/0012-1606(87)90486-6; ROTHMAN TP, 1978, DEV BIOL, V65, P322, DOI 10.1016/0012-1606(78)90030-1; ROTWEIN P, 1987, ENDOCRINOLOGY, V121, P2141, DOI 10.1210/endo-121-6-2141; ROTWEIN P, 1988, P NATL ACAD SCI USA, V85, P265, DOI 10.1073/pnas.85.1.265; RUSSELL WE, 1984, P NATL ACAD SCI-BIOL, V81, P2389, DOI 10.1073/pnas.81.8.2389; SARA VR, 1990, PHYSIOL REV, V70, P591, DOI 10.1152/physrev.1990.70.3.591; SERRANO J, 1990, ENDOCRINOLOGY, V127, P1547, DOI 10.1210/endo-127-3-1547; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; STEMPLE DL, 1988, NEURON, V1, P517, DOI 10.1016/0896-6273(88)90182-1; TAYLOR ER, 1991, J MOL ENDOCRINOL, V7, P145, DOI 10.1677/jme.0.0070145; VANSTRAATEN HWM, 1989, DEVELOPMENT, V107, P793; XUE ZG, 1985, P NATL ACAD SCI USA, V82, P8800, DOI 10.1073/pnas.82.24.8800	64	102	102	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1995	14	4					731	741		10.1016/0896-6273(95)90217-1	http://dx.doi.org/10.1016/0896-6273(95)90217-1			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QU826	7718236	Bronze			2022-12-24	WOS:A1995QU82600007
J	SONG, J; ZIPSER, B				SONG, J; ZIPSER, B			TARGETING OF NEURONAL SUBSETS MEDIATED BY THEIR SEQUENTIALLY EXPRESSED CARBOHYDRATE MARKERS	NEURON			English	Article							CELL-ADHESION MOLECULES; CHICK VISUAL-SYSTEM; RAT SPINAL-CORD; NERVOUS-SYSTEM; L2/HNK-1 CARBOHYDRATE; MONOCLONAL-ANTIBODIES; CHONDROITIN SULFATE; SURFACE MOLECULES; AXONAL GUIDANCE; SKELETAL-MUSCLE	The targeting of sensory afferent neurons in the leech CNS occurs in two discrete steps that are mediated via different carbohydrate recognitions, as shown by molecular perturbations of cultured embryos. A constitutive carbohydrate marker that is generic to all of these neurons mediates their initial defasciculation and arborization across the entire target region via mannose-specific recognition. Subsequently, two subsets of these same neurons can be differentiated by their expression of other markers that are located on hybrid or complex type carbohydrate chains. These developmentally regulated carbohydrate markers then mediate the target assembly of their respective neuronal subsets into discrete subregions. Thus, by performing opposing functions in a temporal sequence, constitutive and developmentally regulated carbohydrate markers collaborate in the targeting of neuronal subsets in the CNS.	MICHIGAN STATE UNIV, DEPT PHYSIOL, E LANSING, MI 48824 USA	Michigan State University					NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025117] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAIRD RA, 1993, HEARING RES, V65, P151, DOI 10.1016/0378-5955(93)90210-R; BAJT ML, 1990, J NEUROCHEM, V55, P2117, DOI 10.1111/j.1471-4159.1990.tb05804.x; BARAKAT I, 1989, BIOL CELL, V66, P317, DOI 10.1016/0248-4900(89)90185-8; BONNERFRASER M, 1985, J CELL BIOL, V101, P610; BRITTIS PA, 1992, SCIENCE, V255, P733, DOI 10.1126/science.1738848; CHOU DKH, 1986, J BIOL CHEM, V261, P1717; COLE RN, 1994, J NEUROCHEM, V63, P66; COLE RN, 1994, J NEUROCHEM, V63, P75; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; COX EC, 1990, NEURON, V4, P31, DOI 10.1016/0896-6273(90)90441-H; DODD J, 1985, J NEUROSCI, V5, P3278; FERNANDEZ J, 1978, J COMP NEUROL, V180, P165, DOI 10.1002/cne.901800110; FLASTER MS, 1983, BRAIN RES, V277, P196, DOI 10.1016/0006-8993(83)90927-7; GRUMET M, 1993, J CELL BIOL, V120, P815, DOI 10.1083/jcb.120.3.815; HABECKER BA, 1994, SCIENCE, V264, P1602, DOI 10.1126/science.8202714; HAKOMORI SI, 1992, HISTOCHEM J, V24, P771, DOI 10.1007/BF01046348; HALL H, 1993, EUR J NEUROSCI, V5, P34, DOI 10.1111/j.1460-9568.1993.tb00202.x; HARLOW E, 1988, ANTIBODIES LABORATOR; HOFFMAN S, 1983, P NATL ACAD SCI-BIOL, V80, P5762, DOI 10.1073/pnas.80.18.5762; HOGG N, 1983, J NEUROSCI RES, V9, P445, DOI 10.1002/jnr.490090410; HORSTKORTE R, 1993, J CELL BIOL, V121, P1409, DOI 10.1083/jcb.121.6.1409; KEY B, 1991, NEURON, V6, P381, DOI 10.1016/0896-6273(91)90247-W; KIVELA T, 1990, CURR EYE RES, V9, P1195, DOI 10.3109/02713689009003476; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KUNEMUND V, 1988, J CELL BIOL, V106, P213, DOI 10.1083/jcb.106.1.213; LANDMESSER L, 1990, NEURON, V4, P655, DOI 10.1016/0896-6273(90)90193-J; LEHMANN S, 1990, P NATL ACAD SCI USA, V87, P6455, DOI 10.1073/pnas.87.16.6455; LIENER RE, 1986, LECTINS PROPERTIES F; MARTINI R, 1992, EUR J NEUROSCI, V4, P628, DOI 10.1111/j.1460-9568.1992.tb00171.x; MAYFORD M, 1992, SCIENCE, V256, P638, DOI 10.1126/science.1585176; MCGLADEMCCULLOH E, 1990, J COMP NEUROL, V299, P123, DOI 10.1002/cne.902990109; MCKAY RDG, 1983, SCIENCE, V222, P788, DOI 10.1126/science.6356361; MISEVIC GN, 1993, J BIOL CHEM, V268, P4922; NAEGELE JR, 1990, J NEUROSCI, V10, P540; NAWA H, 1990, P247; OUDEGA M, 1992, HISTOCHEM J, V24, P869, DOI 10.1007/BF01046358; PEINADO A, 1987, BRAIN RES, V410, P335, DOI 10.1016/0006-8993(87)90333-7; PEINADO A, 1990, J COMP NEUROL, V301, P232, DOI 10.1002/cne.903010207; RIDDLE DR, 1993, J NEUROSCI, V13, P3018; ROSKIES AL, 1994, SCIENCE, V265, P799, DOI 10.1126/science.8047886; RUTISHAUSER U, 1988, SCIENCE, V240, P53, DOI 10.1126/science.3281256; SANES JR, 1982, NATURE, V300, P646, DOI 10.1038/300646a0; SCHWARTING GA, 1992, J NEUROBIOL, V23, P130, DOI 10.1002/neu.480230204; SCOTT LJC, 1990, J NEUROSCI, V10, P346; SCOTT SA, 1990, J NEUROSCI, V10, P336; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; SONG J, 1995, IN PRESS DEV BIOL; STAHL B, 1990, NEURON, V5, P735, DOI 10.1016/0896-6273(90)90227-7; STREIT A, 1993, J CELL BIOL, V120, P799, DOI 10.1083/jcb.120.3.799; STREIT WJ, 1985, J HISTOCHEM CYTOCHEM, V33, P1042, DOI 10.1177/33.10.4045182; WANG LS, 1992, NEURON, V8, P701, DOI 10.1016/0896-6273(92)90091-Q; ZIPSER B, 1981, NATURE, V289, P549, DOI 10.1038/289549a0; ZIPSER B, 1989, NEURON, V3, P621, DOI 10.1016/0896-6273(89)90272-9; ZIPSER B, 1979, J NEUROPHYSIOL, V42, P465, DOI 10.1152/jn.1979.42.2.465; ZIPSER B, 1991, J NEUROSCI, V11, P3471; ZIPSER K, 1994, J NEUROSCI, V14, P4481	56	35	35	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	1995	14	3					537	547		10.1016/0896-6273(95)90310-0	http://dx.doi.org/10.1016/0896-6273(95)90310-0			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QP230	7695900	Bronze			2022-12-24	WOS:A1995QP23000007
J	TOLEDOARAL, JJ; BREHM, P; HALEGOUA, S; MANDEL, G				TOLEDOARAL, JJ; BREHM, P; HALEGOUA, S; MANDEL, G			A SINGLE-PULSE OF NERVE GROWTH-FACTOR TRIGGERS LONG-TERM NEURONAL EXCITABILITY THROUGH SODIUM-CHANNEL GENE INDUCTION	NEURON			English	Article							PC12 CELLS; DIFFERENTIATION; PATHWAY; EXPRESSION; INHIBITION; RECEPTOR; KINASE; LINE	The continuous presence of nerve growth factor (NGF) is thought to be required for the elaboration of neuronal-like traits in PC12 cells. Surprisingly, we find that a 1 min exposure to NGF is sufficient to engage a longer-term genetic program leading to the acquisition of membrane excitability. Whereas continuous exposure to NGF causes the induction of a family of sodium channels, the effect of a brief exposure is to induce selectively expression of the peripheral nerve-type sodium channel gene PN1, through a distinct signaling pathway requiring immediate-early genes. A 1 min exposure of PC12 cells to interferon-gamma also causes PN1 gene induction, suggesting that the ''triggered'' NGF and interferon-gamma signaling pathways share common molecular intermediates.			TOLEDOARAL, JJ (corresponding author), SUNY STONY BROOK, DEPT NEUROBIOL & BEHAV, STONY BROOK, NY 11794 USA.		IBIS, TERAPIA CELULA/P-3297-2015; Toledo-Aral, Juan J/F-2613-2015	Toledo-Aral, Juan J/0000-0001-7512-7135				BONNI A, 1993, SCIENCE, V262, P1575, DOI 10.1126/science.7504325; CATHALA G, 1983, DNA-J MOLEC CELL BIO, V2, P329, DOI 10.1089/dna.1983.2.329; COOPERMAN SS, 1987, P NATL ACAD SCI USA, V84, P8721, DOI 10.1073/pnas.84.23.8721; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; DANIELSON PE, 1988, DNA-J MOLEC CELL BIO, V7, P261, DOI 10.1089/dna.1988.7.261; DARCANGELO G, 1993, MOL CELL BIOL, V13, P3146, DOI 10.1128/MCB.13.6.3146; DARCANGELO G, 1993, J CELL BIOL, V122, P915, DOI 10.1083/jcb.122.4.915; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DAVIES AM, 1987, NATURE, V326, P353, DOI 10.1038/326353a0; DICHTER MA, 1977, NATURE, V268, P501, DOI 10.1038/268501a0; FANGER GR, 1993, J NEUROCHEM, V61, P1977, DOI 10.1111/j.1471-4159.1993.tb09844.x; FU XY, 1993, CELL, V74, P1135, DOI 10.1016/0092-8674(93)90734-8; GINTY DD, 1992, J CELL BIOL, V116, P1465, DOI 10.1083/jcb.116.6.1465; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Greene LA., 1982, ADV CELL NEUROBIOL, V3, P373, DOI [10.1016/B978-0-12-008303-9.50016-5, DOI 10.1016/B978-0-12-008303-9.50016-5]; HAGAG N, 1986, NATURE, V319, P680, DOI 10.1038/319680a0; HALEGOUA S, 1991, CURR TOP MICROBIOL, V165, P119; HAMILL OP, 1981, PFLUGERS ARCH, V391, P95; JONAKAIT GM, 1994, NEURON, V12, P1149; KENGAKU M, 1993, DEVELOPMENT, V119, P1067; LEVIMONTALCINI R, 1968, PHYSIOL REV, V48, P534, DOI 10.1152/physrev.1968.48.3.534; MACHIDA CM, 1989, NEURON, V2, P1587, DOI 10.1016/0896-6273(89)90047-0; MANDEL G, 1988, P NATL ACAD SCI USA, V85, P924, DOI 10.1073/pnas.85.3.924; MOBLEY WC, 1976, BIOCHEMISTRY-US, V15, P5543, DOI 10.1021/bi00670a019; ODOWD DK, 1983, NATURE, V303, P619, DOI 10.1038/303619a0; OLAGUE PH, 1985, J NEUROSCI RES, V13, P301, DOI 10.1002/jnr.490130120; RABIN SJ, 1993, MOL CELL BIOL, V13, P2203, DOI 10.1128/MCB.13.4.2203; RIBERA AB, 1989, NEURON, V2, P1055, DOI 10.1016/0896-6273(89)90229-8; RUDY B, 1987, J NEUROSCI, V7, P1613; RUFFJAMISON S, 1993, SCIENCE, V261, P1733, DOI 10.1126/science.8378774; SADOWSKI HB, 1993, SCIENCE, V261, P1739, DOI 10.1126/science.8397445; SEHGAL PB, 1976, CELL, V9, P473, DOI 10.1016/0092-8674(76)90092-1; SILVENNOINEN O, 1993, SCIENCE, V261, P1736, DOI 10.1126/science.8378775; SISLER HD, 1967, ANTIBIOTICS, P238; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0	35	140	142	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	1995	14	3					607	611		10.1016/0896-6273(95)90317-8	http://dx.doi.org/10.1016/0896-6273(95)90317-8			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QP230	7695907	Bronze			2022-12-24	WOS:A1995QP23000014
J	LEE, MK; MARSZALEK, JR; CLEVELAND, DW				LEE, MK; MARSZALEK, JR; CLEVELAND, DW			A MUTANT NEUROFILAMENT SUBUNIT CAUSES MASSIVE, SELECTIVE MOTOR-NEURON DEATH - IMPLICATIONS FOR THE PATHOGENESIS OF HUMAN MOTOR-NEURON DISEASE	NEURON			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; WERDNIG-HOFFMANN DISEASE; TRANSGENIC MICE; NF-L; AXONAL-TRANSPORT; PHOSPHORYLATED NEUROFILAMENTS; CYTOPLASMIC INCLUSIONS; SUPEROXIDE-DISMUTASE; CORTICOSPINAL TRACT; NONNEURONAL CELLS	A direct role of aberrant neurofilament accumulation in the etiology of human motor neuron diseases, including amyotrophic lateral sclerosis, is suggested by the presence of abnormal accumulations of neurofilaments as an early hallmark of the pathogenic process. Furthermore, forcing increased expression of neurofilament subunits in transgenic mouse models leads to motor neuron dysfunction, albeit without the widespread motor neuron death typical of human disease. We now show that accumulation of a modest level of a point mutant in the smallest neurofilament subunit (NF-L) causes massive, selective degeneration of spinal motor neurons accompanied by abnormal accumulations of neurofilaments and severe neurogenic atrophy of skeletal muscles. As in hu man disease, sensory neurons show only a modest level of degenerative changes. Thus, neurofilament mutations can cause selective motor neuron death, and neurofilamentous abnormalities may be a common toxic intermediate that significantly contributes to the motor neuron death in human disease.	JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205	Johns Hopkins University	LEE, MK (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT BIOL CHEM,BALTIMORE,MD 21205, USA.		Lee, Michael K/D-9491-2013; Cleveland, Don/AAN-9783-2021	Lee, Michael K/0000-0001-5865-9682; Cleveland, Don/0000-0002-1934-3682	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS027036, R01NS027036] Funding Source: NIH RePORTER; NINDS NIH HHS [NS27036] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ASBURY AK, 1972, ACTA NEUROPATHOL, V20, P237, DOI 10.1007/BF00686905; BANKER BQ, 1986, MYOLOGY 2, P2031; BRADY ST, 1993, CELL, V73, P1, DOI 10.1016/0092-8674(93)90151-F; BROWN LT, 1974, J COMP NEUROL, V154, P169, DOI 10.1002/cne.901540205; BROWN LT, 1971, EXP BRAIN RES, V13, P432; BROWN RHJ, 1991, AMYOTROPHIC LATERAL, P215; BROWNELL B, 1970, J NEUROL NEUROSUR PS, V33, P338, DOI 10.1136/jnnp.33.3.338; BRZUSTOWICZ LM, 1990, NATURE, V344, P540, DOI 10.1038/344540a0; BYERS RK, 1961, ARCH NEUROL-CHICAGO, V5, P140, DOI 10.1001/archneur.1961.00450140022003; CARPENTER S, 1968, NEUROLOGY, V18, P841, DOI 10.1212/WNL.18.9.841; CHING GY, 1993, J CELL BIOL, V122, P1323, DOI 10.1083/jcb.122.6.1323; CHOU SHI-MING, 1965, ACTA NEUROPATHOL, V4, P590; CHOU SM, 1971, J NEUROPATH EXP NEUR, V30, P368, DOI 10.1097/00005072-197107000-00005; CLARK AW, 1980, J NEUROPATH EXP NEUR, V39, P42, DOI 10.1097/00005072-198001000-00004; CLEVELAND DW, 1991, J CELL SCI S, V15, P85; CORK LC, 1988, J NEUROPATH EXP NEUR, V47, P420, DOI 10.1097/00005072-198807000-00003; COTE F, 1993, CELL, V73, P35, DOI 10.1016/0092-8674(93)90158-M; Coulombe PA, 1993, CURR OPIN CELL BIOL, V5, P17, DOI 10.1016/S0955-0674(05)80004-3; DELISLE MB, 1984, J NEUROL SCI, V63, P241, DOI 10.1016/0022-510X(84)90199-0; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; Dyck P.J, 1993, PNP, P1094; EKBLOM J, 1993, GLIA, V8, P122, DOI 10.1002/glia.440080208; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; EYER J, 1994, NEURON, V12, P389, DOI 10.1016/0896-6273(94)90280-1; FIGLEWICZ DA, 1994, IN PRESS HUM MOL GEN; FRIEDE RL, 1970, ANAT REC, V167, P379, DOI 10.1002/ar.1091670402; FUCHS E, 1992, CELL, V69, P899, DOI 10.1016/0092-8674(92)90607-E; GILL SR, 1990, J CELL BIOL, V111, P2005, DOI 10.1083/jcb.111.5.2005; GRIFFIN JW, 1978, SCIENCE, V202, P633, DOI 10.1126/science.81524; GRIFFIN JW, 1983, J NEUROSCI, V3, P557; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Harding AE, 1993, PERIPHERAL NEUROPATH, P1051; HIRANO A, 1984, J NEUROPATH EXP NEUR, V43, P461, DOI 10.1097/00005072-198409000-00001; HIRANO A, 1991, ADV NEUROL, V56, P91; HIRANO A, 1984, J NEUROPATH EXP NEUR, V43, P471, DOI 10.1097/00005072-198409000-00002; HIRANO A, 1967, ARCH NEUROL-CHICAGO, V16, P232, DOI 10.1001/archneur.1967.00470210008002; HOFFMAN PN, 1975, J CELL BIOL, V66, P351, DOI 10.1083/jcb.66.2.351; HOFFMAN PN, 1987, P NATL ACAD SCI USA, V84, P3472, DOI 10.1073/pnas.84.10.3472; HURST J, 1987, CYTOGENET CELL GENET, V45, P30, DOI 10.1159/000132421; KATO S, 1990, ACTA NEUROPATHOL, V80, P334, DOI 10.1007/BF00294653; KAWAMURA Y, 1981, J NEUROPATH EXP NEUR, V40, P667, DOI 10.1097/00005072-198111000-00008; KURLAND LT, 1955, NEUROLOGY, V5, P249, DOI 10.1212/WNL.5.4.249; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE MK, 1990, CELL MOTIL CYTOSKEL, V17, P118, DOI 10.1002/cm.970170207; LEE MK, 1993, J CELL BIOL, V122, P1337, DOI 10.1083/jcb.122.6.1337; LEE MK, 1994, CURR OPIN CELL BIOL, V6, P34, DOI 10.1016/0955-0674(94)90113-9; LIEBERBURG I, 1989, P NATL ACAD SCI USA, V86, P2463, DOI 10.1073/pnas.86.7.2463; LOPATA MA, 1987, J CELL BIOL, V105, P1707, DOI 10.1083/jcb.105.4.1707; LOPATA MA, 1984, NUCLEIC ACIDS RES, V12, P5707, DOI 10.1093/nar/12.14.5707; MANETTO V, 1988, J NEUROPATH EXP NEUR, V47, P642, DOI 10.1097/00005072-198811000-00007; MELKI J, 1990, NATURE, V344, P767, DOI 10.1038/344767a0; MONTEIRO MJ, 1989, J CELL BIOL, V108, P579, DOI 10.1083/jcb.108.2.579; MONTEIRO MJ, 1990, J CELL BIOL, V111, P1543, DOI 10.1083/jcb.111.4.1543; MUNOZ DG, 1988, J NEUROPATH EXP NEUR, V47, P9, DOI 10.1097/00005072-198801000-00002; MURAYAMA S, 1991, ACTA NEUROPATHOL, V82, P456, DOI 10.1007/BF00293379; MURAYAMA S, 1991, ACTA NEUROPATHOL, V81, P408, DOI 10.1007/BF00293462; NELSON JS, 1972, ARCH NEUROL-CHICAGO, V27, P300, DOI 10.1001/archneur.1972.00490160028004; NEZNANOV N, 1993, MOL CELL BIOL, V13, P2214, DOI 10.1128/MCB.13.4.2214; NORRIS FH, 1992, HDB AMYOTROPHIC LATE, P3; ODA M, 1978, ACTA NEUROPATHOL, V44, P211, DOI 10.1007/BF00691069; OHARA O, 1993, J CELL BIOL, V121, P387, DOI 10.1083/jcb.121.2.387; OLSSON JE, 1992, NEURON, V9, P815, DOI 10.1016/0896-6273(92)90236-7; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; ROTHSTEIN JD, 1993, P NATL ACAD SCI USA, V90, P6591, DOI 10.1073/pnas.90.14.6591; ROWLAND LP, 1991, AMYOTROPH LATERAL SC, P3; SAKAGUCHI T, 1993, NEUROSCI LETT, V153, P65, DOI 10.1016/0304-3940(93)90078-Y; SASAKI S, 1988, NEUROLOGY, V38, P1114, DOI 10.1212/WNL.38.7.1114; SCHMALBRUCH H, 1991, J NEUROPATH EXP NEUR, V50, P192, DOI 10.1097/00005072-199105000-00002; SCHMIDT ML, 1987, LAB INVEST, V56, P282; SOBUE G, 1987, NEUROLOGY, V37, P529, DOI 10.1212/WNL.37.3.529; SOBUE G, 1990, ACTA NEUROPATHOL, V79, P402, DOI 10.1007/BF00308716; STERNBERGER LA, 1983, P NATL ACAD SCI-BIOL, V80, P6126, DOI 10.1073/pnas.80.19.6126; TAKAHASHI K, 1972, ARCH NEUROL-CHICAGO, V27, P292, DOI 10.1001/archneur.1972.00490160020003; WILEY CA, 1987, ACTA NEUROPATHOL, V72, P369, DOI 10.1007/BF00687269; WILLIAMS DB, 1993, PERIPHERAL NEUROPATH, P1028; WONG PC, 1990, J CELL BIOL, V111, P1987, DOI 10.1083/jcb.111.5.1987; XU ZS, 1993, CELL, V73, P23, DOI 10.1016/0092-8674(93)90157-L; YAMASAKI H, 1992, LAB INVEST, V66, P734	78	322	330	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1994	13	4					975	988		10.1016/0896-6273(94)90263-1	http://dx.doi.org/10.1016/0896-6273(94)90263-1			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PP533	7946341				2022-12-24	WOS:A1994PP53300020
J	OKAMURA, Y; ONO, F; OKAGAKI, R; CHONG, JA; MANDEL, G				OKAMURA, Y; ONO, F; OKAGAKI, R; CHONG, JA; MANDEL, G			NEURAL EXPRESSION OF A SODIUM-CHANNEL GENE REQUIRES CELL-SPECIFIC INTERACTIONS	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; EARLY ASCIDIAN EMBRYOS; CIONA-INTESTINALIS L; ION CHANNELS; SKELETAL-MUSCLE; RAT-BRAIN; DIFFERENTIATION; BLASTOMERES; LINEAGE; EXCITABILITY	In the protochordate Halocynthia roretzi, voltage-activated sodium current undergoes a change in kinetics within 48 hr of fertilization. Molecular cloning and microinjection of antisense DNA into single cells suggest that the kinetic changes are due to the increased expression of a putative neural-specific sodium channel gene, TuNa I. TuNa I gene transcription is first induced in late stage gastrulae, preceding the appearance of the rapidly inactivating sodium current unique to neural cells. In cleavage-arrested and intact embryos, cell interactions between specific animal and vegetal blastomeres are required for induction of TuNa I gene expression. Our results implicate cell contact, prior to neurulation, as a mechanism for selectively activating the TuNa I gene expressed in cells of the neural lineage.	SUNY STONY BROOK,DEPT NEUROBIOL & BEHAV,STONY BROOK,NY 11794	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	OKAMURA, Y (corresponding author), UNIV TOKYO,FAC MED,INST BRAIN RES,DEPT NEUROBIOL,BUNKYO KU,HONGO 7-3-1,TOKYO 113,JAPAN.		ono, fumihito/A-6570-2008	ono, fumihito/0000-0001-7532-5262				CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Conklin E.G., 1905, J ACAD NAT SCI PHILA, V12, P1, DOI DOI 10.5962/BHL.TITLE.4801; COOPERMAN SS, 1987, P NATL ACAD SCI USA, V84, P8721, DOI 10.1073/pnas.84.23.8721; DIERKS P, 1981, P NATL ACAD SCI-BIOL, V78, P1411, DOI 10.1073/pnas.78.3.1411; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GOODMAN CS, 1981, J PHYSIOL-LONDON, V313, P385, DOI 10.1113/jphysiol.1981.sp013672; GUY HR, 1990, TRENDS NEUROSCI, V13, P201; HARLAND RM, 1991, METHOD CELL BIOL, V36, P385; HECHT P M, 1992, Trends in Cell Biology, V2, P197, DOI 10.1016/0962-8924(92)90246-J; HEIN J, 1989, MOL BIOL EVOL, V6, P649; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; HIRANO T, 1984, J PHYSIOL-LONDON, V347, P301, DOI 10.1113/jphysiol.1984.sp015067; HIRANO T, 1987, J PHYSIOL-LONDON, V386, P113, DOI 10.1113/jphysiol.1987.sp016525; JEFFERY WR, 1992, DEVELOPMENT, P53; KINTNER C, 1992, ANNU REV NEUROSCI, V15, P251, DOI 10.1146/annurev.neuro.15.1.251; KUBO Y, 1989, J PHYSIOL-LONDON, V409, P497, DOI 10.1113/jphysiol.1989.sp017510; LOUGHNEY K, 1989, CELL, V58, P1143, DOI 10.1016/0092-8674(89)90512-6; MAKABE KW, 1990, ROUX ARCH DEV BIOL, V199, P307, DOI 10.1007/BF01709509; MANDEL G, 1992, J MEMBRANE BIOL, V125, P193; MOODY WJ, 1991, J NEUROBIOL, V22, P674, DOI 10.1002/neu.480220703; NELSON P, 1969, P NATL ACAD SCI USA, V64, P1004, DOI 10.1073/pnas.64.3.1004; NICOL D, 1991, J COMP NEUROL, V309, P415, DOI 10.1002/cne.903090402; NICOL D, 1988, DEV BIOL, V130, P721, DOI 10.1016/0012-1606(88)90363-6; NISHIDA H, 1987, DEV BIOL, V121, P526, DOI 10.1016/0012-1606(87)90188-6; NISHIDA H, 1986, DEV GROWTH DIFFER, V28, P191; NISHIDA H, 1991, DEVELOPMENT, V112, P389; NISHIDA H, 1989, DEV BIOL, V132, P355, DOI 10.1016/0012-1606(89)90232-7; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; NODA M, 1986, NATURE, V320, P188, DOI 10.1038/320188a0; OHMORI H, 1977, J PHYSIOL-LONDON, V269, P221, DOI 10.1113/jphysiol.1977.sp011900; OKADO H, 1993, J PHYSIOL-LONDON, V463, P269, DOI 10.1113/jphysiol.1993.sp019594; OKADO H, 1990, J PHYSIOL-LONDON, V427, P603, DOI 10.1113/jphysiol.1990.sp018190; OKADO H, 1990, J PHYSIOL-LONDON, V427, P583, DOI 10.1113/jphysiol.1990.sp018189; OKAMOTO H, 1976, J PHYSIOL-LONDON, V254, P607, DOI 10.1113/jphysiol.1976.sp011249; OKAMURA Y, 1993, J PHYSIOL-LONDON, V463, P245, DOI 10.1113/jphysiol.1993.sp019593; OKAMURA Y, 1990, J PHYSIOL-LONDON, V431, P39, DOI 10.1113/jphysiol.1990.sp018320; OKAMURA Y, 1993, BIOESSAYS, V15, P723, DOI 10.1002/bies.950151105; PINOHEISS S, 1989, DEV BIOL, V132, P282, DOI 10.1016/0012-1606(89)90225-X; REVERBERI G., 1960, ACTA EMBRYOL MORPHOL EXPTL, V3, P296; RIBERA AB, 1990, NEURON, V5, P691, DOI 10.1016/0896-6273(90)90223-3; ROSENTHAL JJC, 1993, P NATL ACAD SCI USA, V90, P10026, DOI 10.1073/pnas.90.21.10026; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SATO C, 1992, BIOCHEM BIOPH RES CO, V186, P61, DOI 10.1016/S0006-291X(05)80775-2; SCHMIDT JW, 1986, CELL, V46, P437, DOI 10.1016/0092-8674(86)90664-1; SHIDARA M, 1991, J PHYSIOL-LONDON, V443, P277, DOI 10.1113/jphysiol.1991.sp018834; SIMONCINI L, 1988, SCIENCE, V242, P1572, DOI 10.1126/science.2849207; SLACK JMW, 1994, CURR BIOL, V4, P116, DOI 10.1016/S0960-9822(94)00027-8; Spemann H., 1938, EMBRYONIC DEV INDUCT; SPITZER NC, 1979, ANNU REV NEUROSCI, V2, P363, DOI 10.1146/annurev.ne.02.030179.002051; TAKAHASH.K, 1971, SCIENCE, V171, P415, DOI 10.1126/science.171.3969.415; TORRENCE SA, 1982, ZOOMORPHOLOGY, V99, P103, DOI 10.1007/BF00310303; TRIMMER JS, 1989, NEURON, V3, P33, DOI 10.1016/0896-6273(89)90113-X; WHITTAKER JR, 1979, DEV BIOL, V73, P76, DOI 10.1016/0012-1606(79)90139-8; WHITTAKER JR, 1973, P NATL ACAD SCI USA, V70, P2096, DOI 10.1073/pnas.70.7.2096	55	71	72	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1994	13	4					937	948		10.1016/0896-6273(94)90259-3	http://dx.doi.org/10.1016/0896-6273(94)90259-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PP533	7946338				2022-12-24	WOS:A1994PP53300016
J	SHIN, JH; RICHARD, EA; LISMAN, JE				SHIN, JH; RICHARD, EA; LISMAN, JE			CA2+ IS AN OBLIGATORY INTERMEDIATE IN THE EXCITATION CASCADE OF LIMULUS PHOTORECEPTORS	NEURON			English	Article							VENTRAL PHOTORECEPTORS; INOSITOL-TRISPHOSPHATE; INTRACELLULAR CALCIUM; INVERTEBRATE PHOTORECEPTORS; VISUAL EXCITATION; MICROVILLAR PHOTORECEPTORS; DROSOPHILA PHOTORECEPTORS; DEPENDENT CONDUCTANCES; ENDOPLASMIC-RETICULUM; LIGHT ADAPTATION	We have investigated the role of Ca2+ in the excitation of Limulus photoreceptors by intracellular injection of the Ca2+ buffer, 5,5'-dibromo-BAPTA. Buffer with free Ca2+ of 0.5 or 5 muM slowed the rising edge of the light response over 100-fold and greatly reduced both the transient and plateau phases of the light response, as expected if Ca2+ elevation is necessary for all phases of excitation. Injection of buffers with free Ca2+ of 5 or 45 muM, levels normally reached during light, evoked sustained inward current as expected if Ca2+ is sufficient for excitation. The transduction cascade appears due to a single pathway that sequentially involves 1,4,5-trisphosphate inositol, Ca2+, and cyclic GMP.	BRANDEIS UNIV, CTR COMPLEX SYST, WALTHAM, MA 02254 USA	Brandeis University	SHIN, JH (corresponding author), BRANDEIS UNIV, DEPT BIOL, WALTHAM, MA 02254 USA.				NEI NIH HHS [EY01496] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY001496, R37EY001496] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADLER EM, 1991, J NEUROSCI, V11, P1496; BACIGALUPO J, 1990, SER CENT ES, P27; BACIGALUPO J, 1991, P NATL ACAD SCI USA, V88, P7938, DOI 10.1073/pnas.88.18.7938; BACIGALUPO J, 1992, VISUAL NEUROSCI, V8, P41, DOI 10.1017/S0952523800006477; BAER KM, 1988, J BIOL CHEM, V263, P17; BAUMANN O, 1989, J COMP PHYSIOL A, V165, P627, DOI 10.1007/BF00610994; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; BLUMENFELD A, 1985, P NATL ACAD SCI USA, V82, P7116, DOI 10.1073/pnas.82.20.7116; BOLSOVER SR, 1985, J PHYSIOL-LONDON, V364, P381, DOI 10.1113/jphysiol.1985.sp015751; BROWN JE, 1984, NATURE, V311, P160, DOI 10.1038/311160a0; BROWN JE, 1984, BIOCHEM BIOPH RES CO, V125, P1137, DOI 10.1016/0006-291X(84)91402-5; BROWN JE, 1974, J GEN PHYSIOL, V64, P643, DOI 10.1085/jgp.64.6.643; DECKERT A, 1992, J PHYSIOL-LONDON, V453, P69, DOI 10.1113/jphysiol.1992.sp019219; DEVARY O, 1987, P NATL ACAD SCI USA, V84, P6939, DOI 10.1073/pnas.84.19.6939; EDWARDS SC, 1989, VISUAL NEUROSCI, V3, P95, DOI 10.1017/S0952523800004417; FEIN A, 1975, SCIENCE, V187, P1094, DOI 10.1126/science.1114339; FEIN A, 1984, NATURE, V311, P157, DOI 10.1038/311157a0; FEIN A, 1975, J GEN PHYSIOL, V66, P823, DOI 10.1085/jgp.66.6.823; FEIN A, 1986, SCIENCE, V232, P1543, DOI 10.1126/science.3487116; FEIN A, 1975, NATURE, V258, P250, DOI 10.1038/258250a0; FINCH EA, 1991, SCIENCE, V252, P443, DOI 10.1126/science.2017683; FRANK TM, 1991, J GEN PHYSIOL, V97, P697, DOI 10.1085/jgp.97.4.697; GRZYWACZ NM, 1992, BIOL CYBERN, V66, P429, DOI 10.1007/BF00197723; HARDIE RC, 1991, P ROY SOC B-BIOL SCI, V245, P203, DOI 10.1098/rspb.1991.0110; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; JOHNSON EC, 1986, NATURE, V324, P468, DOI 10.1038/324468a0; KAWAMURA S, 1993, NATURE, V362, P855, DOI 10.1038/362855a0; LEVINE H, 1990, MECH DEVELOP, V33, P19, DOI 10.1016/0925-4773(90)90131-5; LEVY S, 1985, J GEN PHYSIOL, V85, P805, DOI 10.1085/jgp.85.6.805; Lino Masamitsu, 1992, Nature (London), V360, P76; LISMAN JE, 1982, J GEN PHYSIOL, V79, P187, DOI 10.1085/jgp.79.2.187; LISMAN JE, 1971, J GEN PHYSIOL, V58, P544, DOI 10.1085/jgp.58.5.544; LISMAN JE, 1972, J GEN PHYSIOL, V59, P701, DOI 10.1085/jgp.59.6.701; LISMAN JE, 1975, J GEN PHYSIOL, V66, P489, DOI 10.1085/jgp.66.4.489; MILLECCHIA R, 1969, J GEN PHYSIOL, V54, P310, DOI 10.1085/jgp.54.3.310; MILLER RJ, 1991, PROG NEUROBIOL, V37, P255, DOI 10.1016/0301-0082(91)90028-Y; MINKE B, 1992, SOC GEN PHY, V47, P201; NAGY K, 1991, Q REV BIOPHYS, V24, P165, DOI 10.1017/S0033583500003401; NASI E, 1991, J GEN PHYSIOL, V97, P55, DOI 10.1085/jgp.97.1.55; ODAY PM, 1989, J GEN PHYSIOL, V93, P473, DOI 10.1085/jgp.93.3.473; PAK WL, 1969, NATURE, V222, P351, DOI 10.1038/222351a0; PAYNE R, 1988, PHILOS T ROY SOC B, V320, P359, DOI 10.1098/rstb.1988.0082; PAYNE R, 1986, J GEN PHYSIOL, V88, P107, DOI 10.1085/jgp.88.1.107; PAYNE R, 1986, J GEN PHYSIOL, V87, P243, DOI 10.1085/jgp.87.2.243; PAYNE R, 1987, J CELL BIOL, V104, P933, DOI 10.1083/jcb.104.4.933; PAYNE R, 1986, PHOTOBIOCH PHOTOBIOP, V13, P373; PAYNE R, 1986, J GEN PHYSIOL, V88, P127, DOI 10.1085/jgp.88.1.127; PAYNE R, 1990, NEURON, V4, P547, DOI 10.1016/0896-6273(90)90112-S; RICHARD EA, 1992, NATURE, V356, P336, DOI 10.1038/356336a0; SMITH DP, 1991, SCIENCE, V254, P1478, DOI 10.1126/science.1962207; STERN J, 1982, J GEN PHYSIOL, V80, P825, DOI 10.1085/jgp.80.6.825; STIEVE H, 1992, VISION RES, V32, P403, DOI 10.1016/0042-6989(92)90232-8; SZUTS EZ, 1986, BIOCHEM J, V240, P929, DOI 10.1042/bj2400929; WIEBE EM, 1989, VISUAL NEUROSCI, V3, P107, DOI 10.1017/S0952523800004429; YAMADA T, 1990, SCIENCE, V248, P483, DOI 10.1126/science.2158671	56	67	67	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1993	11	5					845	855		10.1016/0896-6273(93)90114-7	http://dx.doi.org/10.1016/0896-6273(93)90114-7			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MJ041	8240808				2022-12-24	WOS:A1993MJ04100006
J	DIXON, DB; TAKAHASHI, KI; COPENHAGEN, DR				DIXON, DB; TAKAHASHI, KI; COPENHAGEN, DR			L-GLUTAMATE SUPPRESSES HVA CALCIUM CURRENT IN CATFISH HORIZONTAL CELLS BY RAISING INTRACELLULAR PROTON CONCENTRATION	NEURON			English	Article							TRANSMITTER CANDIDATES; HIPPOCAMPAL-NEURONS; GOLDFISH RETINA; NERVOUS-SYSTEM; AMINO-ACIDS; TOAD RETINA; GUINEA-PIG; PH; RECEPTOR; MODULATION	Catfish horizontal cells exhibit a high voltage-activated, slowly inactivating calcium (HVA) current. In isolated cells, this current underlies a sustained action potential that can be evoked by depolarization. L-Glutamate at concentrations as low as 1 muM suppressed HVA current and shortened the duration of action potentials. pH indicator dye measurements revealed that L-glutamate acidified cells by up to 0.3 pH units. pH/HVA current dose-response curves indicated that the EC50 for pH inhibition of HVA current was 7.1 and the Hill coefficient was 1.98. L-Glutamate's suppression of HVA current was eliminated when the patch pipette solution contained a high concentration of proton buffer, but was not affected when pipettes contained GTPgammaS. These results support the hypothesis that L-glutamate can modulate HVA current by changing intracellular pH.	UNIV CALIF SAN FRANCISCO, DEPT PHYSIOL, SAN FRANCISCO, CA 94143 USA	University of California System; University of California San Francisco	DIXON, DB (corresponding author), UNIV CALIF SAN FRANCISCO, DEPT OPHTHALMOL, SAN FRANCISCO, CA 94143 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS016033, P01NS016033] Funding Source: NIH RePORTER; NEI NIH HHS [EY01896] Funding Source: Medline; NINDS NIH HHS [NS16033] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARMSTRONG D, 1987, P NATL ACAD SCI USA, V84, P2518, DOI 10.1073/pnas.84.8.2518; AYOUB GS, 1987, VISION RES, V27, P2027, DOI 10.1016/0042-6989(87)90117-9; BARNES S, 1991, J NEUROSCI, V11, P4015; Bass L., 1973, Progress Biophys Molec Biol, V27, P145; BAYLOR DA, 1971, J PHYSIOL-LONDON, V214, P265, DOI 10.1113/jphysiol.1971.sp009432; BOUVIER M, 1992, NATURE, V360, P471, DOI 10.1038/360471a0; CHAD JE, 1986, J PHYSIOL-LONDON, V378, P31, DOI 10.1113/jphysiol.1986.sp016206; CHESLER M, 1992, TRENDS NEUROSCI, V15, P396, DOI 10.1016/0166-2236(92)90191-A; CHESLER M, 1990, PROG NEUROBIOL, V34, P401, DOI 10.1016/0301-0082(90)90034-E; CHOI DW, 1990, CEREBROVAS BRAIN MET, V2, P105; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; COPENHAGEN DR, 1989, NATURE, V341, P536, DOI 10.1038/341536a0; DIXON DB, 1992, NEUROSCI LETT, V147, P147, DOI 10.1016/0304-3940(92)90581-Q; ERECINSKA M, 1991, J NEUROSCI, V11, P2410; HEISLER N, 1979, ENV PHYSL FISHES, P123; JOHNSON JL, 1978, PROG NEUROBIOL, V10, P155; KAIBARA M, 1988, J PHYSIOL-LONDON, V403, P621, DOI 10.1113/jphysiol.1988.sp017268; KAILA K, 1987, NATURE, V330, P163, DOI 10.1038/330163a0; KATZKA DA, 1989, J PHYSIOL-LONDON, V413, P175, DOI 10.1113/jphysiol.1989.sp017648; LASATER EM, 1986, J NEUROPHYSIOL, V55, P499, DOI 10.1152/jn.1986.55.3.499; LESTER RAJ, 1990, NEURON, V4, P741, DOI 10.1016/0896-6273(90)90200-Y; LINN CP, 1992, J NEUROSCI, V12, P2156; MAGUIRE G, 1989, P NATL ACAD SCI USA, V86, P10144, DOI 10.1073/pnas.86.24.10144; MILLER AM, 1983, J PHYSIOL-LONDON, V334, P325, DOI 10.1113/jphysiol.1983.sp014497; MIRONOV SL, 1991, PFLUG ARCH EUR J PHY, V419, P138, DOI 10.1007/BF00372999; MOODY W, 1984, ANNU REV NEUROSCI, V7, P257; MORAD M, 1988, CIBA F SYMP, V139, P187; MURAKAMI M, 1987, J PHYSIOL-LONDON, V386, P165, DOI 10.1113/jphysiol.1987.sp016528; NAKA KI, 1975, J NEUROPHYSIOL, V38, P53, DOI 10.1152/jn.1975.38.1.53; NISTRI A, 1991, J PHYSIOL-LONDON, V435, P465, DOI 10.1113/jphysiol.1991.sp018519; PARADISO AM, 1987, AM J PHYSIOL, V253, pC30, DOI 10.1152/ajpcell.1987.253.1.C30; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; PLANT TD, 1988, J PHYSIOL-LONDON, V404, P731, DOI 10.1113/jphysiol.1988.sp017316; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; SCHWARTZ EA, 1982, J PHYSIOL-LONDON, V323, P211, DOI 10.1113/jphysiol.1982.sp014069; SHARP AP, 1981, J PHYSIOL-LONDON, V312, P71, DOI 10.1113/jphysiol.1981.sp013616; SHINGAI R, 1986, J NEUROPHYSIOL, V56, P32, DOI 10.1152/jn.1986.56.1.32; SWARTZ KJ, 1992, J NEUROSCI, V12, P4358; SZATKOWSKI MS, 1989, J PHYSIOL-LONDON, V409, P89, DOI 10.1113/jphysiol.1989.sp017486; TACHIBANA M, 1981, J PHYSIOL-LONDON, V321, P141, DOI 10.1113/jphysiol.1981.sp013976; TAKAHASHI KI, 1992, J NEUROPHYSIOL, V67, P1633, DOI 10.1152/jn.1992.67.6.1633; TAKAHASHI KI, 1993, J GEN PHYSIOL, V101, P695, DOI 10.1085/jgp.101.5.695; TRAYNELIS SF, 1991, J PHYSIOL-LONDON, V433, P727, DOI 10.1113/jphysiol.1991.sp018453; TROMBLEY PQ, 1991, J NEUROSCI, V11, P435; TROMBLEY PQ, 1992, J NEUROSCI, V12, P2043; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; UMBACH JA, 1982, PROC R SOC SER B-BIO, V216, P209, DOI 10.1098/rspb.1982.0071; WINSLOW RL, 1989, J NEUROPHYSIOL, V62, P738, DOI 10.1152/jn.1989.62.3.738; YAMAMOTO F, 1992, EXP EYE RES, V54, P685, DOI 10.1016/0014-4835(92)90023-L	49	60	60	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	1993	11	2					267	277		10.1016/0896-6273(93)90183-R	http://dx.doi.org/10.1016/0896-6273(93)90183-R			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LU065	8102533				2022-12-24	WOS:A1993LU06500007
J	TAKIMOTO, K; FOMINA, AF; GEALY, R; TRIMMER, JS; LEVITAN, ES				TAKIMOTO, K; FOMINA, AF; GEALY, R; TRIMMER, JS; LEVITAN, ES			DEXAMETHASONE RAPIDLY INDUCES KV1.5 K+ CHANNEL GENE-TRANSCRIPTION AND EXPRESSION IN CLONAL PITUITARY-CELLS	NEURON			English	Article							POTASSIUM-CHANNEL; RAT-BRAIN; MESSENGER-RNA; HETEROMULTIMERIC CHANNELS; DEVELOPMENTAL EXPRESSION; MOLECULAR-CLONING; XENOPUS-OOCYTES; DOWN-REGULATION; SUBUNITS; PROTEIN	Glucocorticoids specifically increase Kv1.5 K+ channel mRNA in normal and clonal (GH3) rat pituitary cells. Here, we demonstrate that dexamethasone, a glucocorticoid agonist, rapidly induces Kv1.5 gene transcription, but does not affect Kv1.5 mRNA turnover (t1/2 almost-equal-to 0.5 hr) in GH3 cells. Immunoblots indicate that the steroid also increases the expression of the 76 kd Kv1.5 protein approximately 3-fold within 12 hr without altering its half-life (t1/2 almost-equal-to 4 hr). In contrast, Kv1.4 protein expression is unaffected. Finally, we find that the induction of Kv1.5 protein is associated with an increase in a noninactivating component of the voltage-gated K+ current. Our results indicate that hormones and neurotransmitters may act within hours to regulate excitability by controlling K+ channel gene expression.	SUNY,DEPT BIOCHEM & CELL BIOL,STONY BROOK,NY 11794	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; SUNY Maritime College	TAKIMOTO, K (corresponding author), UNIV PITTSBURGH,DEPT PHARMACOL,PITTSBURGH,PA 15261, USA.				NINDS NIH HHS [NS 29804, NS29876] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS029804, R55NS029876] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABRAMS TW, 1988, TRENDS NEUROSCI, V11, P128, DOI 10.1016/0166-2236(88)90137-3; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BECKH S, 1990, EMBO J, V9, P777, DOI 10.1002/j.1460-2075.1990.tb08173.x; BONINI JA, 1991, BIOTECHNIQUES, V11, P708; BOYLE MB, 1987, NATURE, V330, P373, DOI 10.1038/330373a0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHRISTIE MJ, 1990, NEURON, V4, P405, DOI 10.1016/0896-6273(90)90052-H; COSLOW ME, 1982, J BIOL CHEM, V257, P9330; DEKLOET ER, 1991, FRONT NEUROENDOCRIN, V12, P95; DREWE JA, 1992, J NEUROSCI, V12, P538; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FOLANDER K, 1990, P NATL ACAD SCI USA, V87, P2975, DOI 10.1073/pnas.87.8.2975; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; GANGULY S, 1985, J BIOL CHEM, V260, P2167; GERTZ BJ, 1987, MOL ENDOCRINOL, V1, P933, DOI 10.1210/mend-1-12-933; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARGROVE JL, 1989, FASEB J, V3, P2360, DOI 10.1096/fasebj.3.12.2676679; HWANG PM, 1992, NEURON, V8, P473, DOI 10.1016/0896-6273(92)90275-I; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; JAN LY, 1992, CELL, V69, P715, DOI 10.1016/0092-8674(92)90280-P; JOELS M, 1992, TRENDS NEUROSCI, V15, P25, DOI 10.1016/0166-2236(92)90345-9; KACZMAREK LK, 1991, NEW BIOL, V3, P315; KELLERWOOD ME, 1984, ENDOCR REV, V5, P1, DOI 10.1210/edrv-5-1-1; LESAGE F, 1992, FEBS LETT, V310, P162, DOI 10.1016/0014-5793(92)81320-L; LEVITAN ES, 1991, MOL ENDOCRINOL, V5, P1903, DOI 10.1210/mend-5-12-1903; MATSUBARA H, 1991, J BIOL CHEM, V266, P13324; MCCORMACK K, 1990, BIOCHEM BIOPH RES CO, V171, P1361, DOI 10.1016/0006-291X(90)90836-C; MEYERHOF W, 1992, J NEUROENDOCRINOL, V4, P245, DOI 10.1111/j.1365-2826.1992.tb00166.x; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; PASSAFARO M, 1992, J NEUROSCI, V12, P3372; PRAGNELL M, 1990, NEURON, V4, P807, DOI 10.1016/0896-6273(90)90207-V; REHM H, 1989, FEBS LETT, V249, P224, DOI 10.1016/0014-5793(89)80628-3; RIBERA AB, 1990, NEURON, V5, P691, DOI 10.1016/0896-6273(90)90223-3; ROBERDS SL, 1991, P NATL ACAD SCI USA, V88, P1798, DOI 10.1073/pnas.88.5.1798; ROBERDS SL, 1991, FEBS LETT, V284, P152, DOI 10.1016/0014-5793(91)80673-Q; RUDY B, 1992, P NATL ACAD SCI USA, V89, P4603, DOI 10.1073/pnas.89.10.4603; RUPPERSBERG JP, 1990, NATURE, V345, P535, DOI 10.1038/345535a0; SALKOFF L, 1992, TRENDS NEUROSCI, V15, P161, DOI 10.1016/0166-2236(92)90165-5; Sambrook J, 1989, MOL CLONING LABORATO; SCHMIDT J, 1985, P NATL ACAD SCI USA, V82, P4847, DOI 10.1073/pnas.82.14.4847; SEQUIER JM, 1990, FEBS LETT, V263, P163, DOI 10.1016/0014-5793(90)80729-3; SHENG M, 1992, NEURON, V9, P271, DOI 10.1016/0896-6273(92)90166-B; SHOLZ KP, 1987, SCIENCE, V235, P685; SIMASKO SM, 1991, AM J PHYSIOL, V261, pE66, DOI 10.1152/ajpendo.1991.261.1.E66; STOLLBERG J, 1987, J NEUROSCI, V7, P1809; SWANSON R, 1990, NEURON, V4, P929, DOI 10.1016/0896-6273(90)90146-7; TAKIMOTO K, 1991, BIOCHEM BIOPH RES CO, V180, P953, DOI 10.1016/S0006-291X(05)81158-1; TORRES M, 1992, BIOCHIM BIOPHYS ACTA, V1105, P291, DOI 10.1016/0005-2736(92)90207-3; TRIMMER JS, 1991, P NATL ACAD SCI USA, V88, P10764, DOI 10.1073/pnas.88.23.10764; TSAUR ML, 1992, NEURON, V8, P1055, DOI 10.1016/0896-6273(92)90127-Y; TSENGCRANK JCL, 1990, FEBS LETT, V268, P63, DOI 10.1016/0014-5793(90)80973-M; WAECHTER CJ, 1983, J BIOL CHEM, V258, P5117	54	97	98	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1993	11	2					359	369		10.1016/0896-6273(93)90191-S	http://dx.doi.org/10.1016/0896-6273(93)90191-S			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LU065	8352944				2022-12-24	WOS:A1993LU06500015
J	TWITCHELL, WA; RANE, SG				TWITCHELL, WA; RANE, SG			OPIOID PEPTIDE MODULATION OF CA2+-DEPENDENT K+ AND VOLTAGE-ACTIVATED CA2+ CURRENTS IN BOVINE ADRENAL CHROMAFFIN CELLS	NEURON			English	Article							ACTION-POTENTIAL DURATION; POTASSIUM CONDUCTANCE; BINDING-SITES; CATECHOLAMINE SECRETION; OPIATE RECEPTORS; CALCIUM CHANNELS; SENSORY NEURONS; INHIBITION; MEDULLA; RELEASE	Opioid peptides are abundantly expressed in the adrenal medulla, and there is evidence that they may be released presynaptically or as medullary paracrine agents. To assess the physiological relevance of these observations, we investigated opioid effects on ionic currents from cultured bovine adrenal chromaffin cells. Under whole-cell path-clamp conditions, opioid peptides, acting via a mu-type opioid receptor, strongly potentiated the large conductance Ca2+-dependent K+ (BK) channel current. Opioids also inhibited voltage-activated Ca2+ currents. Application of opioid peptides to the extracellular face of outside-out patches also increased opening activity of single BK channels, suggestive of tight receptor-channel coupling. This potentiating effect on BK current, combined with the inhibition of Ca2+ current, indicates that opioids may have an inhibitory influence on secretory activity of the adrenal medulla. The widespread distribution of the BK channel class suggests that the significance of its modulation by opioids could also extend beyond the adrenal gland.			TWITCHELL, WA (corresponding author), PURDUE UNIV,DEPT BIOL SCI,W LAFAYETTE,IN 47907, USA.							CASTANAS E, 1985, J NEUROCHEM, V45, P677, DOI 10.1111/j.1471-4159.1985.tb04046.x; CASTANAS E, 1985, J NEUROCHEM, V45, P688, DOI 10.1111/j.1471-4159.1985.tb04047.x; CHAMINADE M, 1984, J PHYSIOL-LONDON, V353, P157, DOI 10.1113/jphysiol.1984.sp015329; CHAVKIN C, 1988, OPIATE RECEPTORS, P273; CHERUBINI E, 1985, P NATL ACAD SCI USA, V82, P1860, DOI 10.1073/pnas.82.6.1860; DEAN DM, 1982, J NEUROCHEM, V38, P606, DOI 10.1111/j.1471-4159.1982.tb08674.x; EWALD DA, 1985, NATURE, V315, P503, DOI 10.1038/315503a0; FENWICK EM, 1982, J PHYSIOL-LONDON, V331, P599, DOI 10.1113/jphysiol.1982.sp014394; GREENBERG A, 1982, CELL TISSUE RES, V226, P655; GROSS RA, 1990, P NATL ACAD SCI USA, V87, P7025, DOI 10.1073/pnas.87.18.7025; HEYM C, 1988, PROG HISTOCHEM CYTOC, V18, P1; HOLZ GG, 1989, J NEUROSCI, V9, P657; KENNEDY C, 1991, MOL PHARMACOL, V40, P1000; KIDOKORO Y, 1980, J PHYSIOL-LONDON, V307, P199, DOI 10.1113/jphysiol.1980.sp013431; KLEPPISCH T, 1992, PFLUG ARCH EUR J PHY, V421, P131, DOI 10.1007/BF00374819; KUMAKURA K, 1980, NATURE, V283, P489, DOI 10.1038/283489a0; LECHLEITER JD, 1988, NEURON, V1, P227, DOI 10.1016/0896-6273(88)90143-2; LEMAIRE S, 1981, J NEUROCHEM, V36, P886, DOI 10.1111/j.1471-4159.1981.tb01677.x; LIVETT BG, 1984, PHYSIOL REV, V64, P1103, DOI 10.1152/physrev.1984.64.4.1103; MARTY A, 1985, J PHYSIOL-LONDON, V367, P117, DOI 10.1113/jphysiol.1985.sp015817; MARTY A, 1981, NATURE, V291, P497, DOI 10.1038/291497a0; MUDGE AW, 1979, P NATL ACAD SCI USA, V76, P526, DOI 10.1073/pnas.76.1.526; NORTH RA, 1983, BRIT J PHARMACOL, V80, P225, DOI 10.1111/j.1476-5381.1983.tb10023.x; NORTH RA, 1986, TRENDS NEUROSCI, V9, P114; REINHART PH, 1989, NEURON, V2, P1031, DOI 10.1016/0896-6273(89)90227-4; SAIANI L, 1982, J NEUROCHEM, V39, P1669, DOI 10.1111/j.1471-4159.1982.tb08001.x; SCHROEDER JE, 1991, NEURON, V6, P13, DOI 10.1016/0896-6273(91)90117-I; SURPRENANT A, 1990, J PHYSIOL-LONDON, V431, P585, DOI 10.1113/jphysiol.1990.sp018349; TORO L, 1990, J GEN PHYSIOL, V96, P373, DOI 10.1085/jgp.96.2.373; TSUNOO A, 1986, P NATL ACAD SCI USA, V83, P9832, DOI 10.1073/pnas.83.24.9832; WAYMIRE JC, 1983, J NEUROSCI METH, V7, P329, DOI 10.1016/0165-0270(83)90026-2; WERZ MA, 1983, NEUROSCI LETT, V42, P173, DOI 10.1016/0304-3940(83)90402-0; WHITE RE, 1991, NATURE, V351, P570, DOI 10.1038/351570a0; WILSON SP, 1982, J NEUROSCI, V2, P1150; WIMPEY TL, 1991, NEURON, V6, P281, DOI 10.1016/0896-6273(91)90363-5	35	49	49	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1993	10	4					701	709		10.1016/0896-6273(93)90171-M	http://dx.doi.org/10.1016/0896-6273(93)90171-M			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KY501	8476614				2022-12-24	WOS:A1993KY50100013
J	VONBOXBERG, Y; DEISS, S; SCHWARZ, U				VONBOXBERG, Y; DEISS, S; SCHWARZ, U			GUIDANCE AND TOPOGRAPHIC STABILIZATION OF NASAL CHICK RETINAL AXONS ON TARGET-DERIVED COMPONENTS INVITRO	NEURON			English	Article							POSITION-SPECIFIC PROPERTIES; TECTAL CELL-MEMBRANES; RETINOTECTAL PROJECTION; BIOCHEMICAL-CHARACTERIZATION; ADHESION MOLECULES; EMBRYONIC CHICK; NERVOUS-SYSTEM; MAP FORMATION; GROWTH CONES; XENOPUS	We studied mechanisms underlying the generation of topographic order within the developing chick retinotectal connection by combining the recently introduced stripe assay with a novel membrane protein fractionation technique. Our experiments show a preference of temporal and nasal retinal fibers for growing on cell membranes prepared from their proper target area. In addition, membrane preparations from posterior tectum were found to prolong substantially the survival of nasal neurites in vitro. We conclude that tropic as well as trophic interactions contribute to the generation of topographic maps during embryogenesis, in our case to the homing of nasal axons within the posterior tectum.			VONBOXBERG, Y (corresponding author), MAX PLANCK INST ENTWICKLUNGSBIOL,W-7400 TUBINGEN,GERMANY.			von Boxberg, Ysander/0000-0001-5886-6155				BAIER H, 1992, SCIENCE, V255, P472, DOI 10.1126/science.1734526; BONHOEFFER F, 1984, TRENDS NEUROSCI, V7, P378, DOI 10.1016/S0166-2236(84)80060-0; CHANGEUX JP, 1976, NATURE, V264, P705, DOI 10.1038/264705a0; CHUONG CM, 1984, J NEUROSCI, V4, P2354; CLINE HT, 1991, TRENDS NEUROSCI, V14, P104, DOI 10.1016/0166-2236(91)90071-2; CONSTANTINEPATON M, 1986, NATURE, V324, P459, DOI 10.1038/324459a0; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; EASTER SS, 1984, J NEUROSCI, V4, P1053; FUJISAWA H, 1987, J COMP NEUROL, V260, P127, DOI 10.1002/cne.902600110; GAZE RM, 1974, PROC R SOC SER B-BIO, V185, P301, DOI 10.1098/rspb.1974.0021; GIERER A, 1987, DEVELOPMENT, V101, P479; GODEMENT P, 1989, DEVELOPMENT, V106, P313; HALFTER W, 1981, NATURE, V292, P67, DOI 10.1038/292067a0; HANKIN M, 1991, TRENDS NEUROSCI, V14, P224, DOI 10.1016/0166-2236(91)90118-E; HARRIS WA, 1987, DEVELOPMENT, V101, P123; HOLT CE, 1983, NATURE, V301, P150, DOI 10.1038/301150a0; ITASAKI N, 1991, DEVELOPMENT, V113, P1133; JESSELL TM, 1988, NEURON, V1, P3, DOI 10.1016/0896-6273(88)90204-8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDER AD, 1989, TRENDS NEUROSCI, V12, P189, DOI 10.1016/0166-2236(89)90070-2; LOW MG, 1989, BIOCHIM BIOPHYS ACTA, V988, P427, DOI 10.1016/0304-4157(89)90014-2; MARCHASE RB, 1977, J CELL BIOL, V75, P237, DOI 10.1083/jcb.75.1.237; MCLOON SC, 1991, J NEUROSCI, V11, P1470; NAKAMURA H, 1989, J NEUROSCI, V9, P3776; NEUKIRCHEN RO, 1982, J BIOL CHEM, V257, P5229; NORRIS CR, 1990, J COMP NEUROL, V293, P268, DOI 10.1002/cne.902930209; OROURKE NA, 1990, NEURON, V5, P159, DOI 10.1016/0896-6273(90)90306-Z; PATTERSON PH, 1988, NEURON, V1, P263, DOI 10.1016/0896-6273(88)90074-8; RABACCHI SA, 1990, DEVELOPMENT, V109, P521; RATHJEN FG, 1987, J CELL BIOL, V104, P343, DOI 10.1083/jcb.104.2.343; RODRIGUEZTEBAR A, 1989, DEV BIOL, V136, P296, DOI 10.1016/0012-1606(89)90256-X; SADOUL K, 1988, J NEUROCHEM, V50, P510, DOI 10.1111/j.1471-4159.1988.tb02941.x; SAKAGUCHI DS, 1985, J NEUROSCI, V5, P3228; SIMON DK, 1990, DEV BIOL, V137, P125, DOI 10.1016/0012-1606(90)90013-9; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; STAHL B, 1990, NEURON, V5, P735, DOI 10.1016/0896-6273(90)90227-7; STIRLING RV, 1991, TRENDS NEUROSCI, V14, P509; STUERMER CAO, 1988, J NEUROSCI, V8, P4513; THANOS S, 1987, J COMP NEUROL, V261, P155, DOI 10.1002/cne.902610114; TRISLER D, 1990, J EXP BIOL, V153, P11; TRISLER GD, 1981, P NATL ACAD SCI-BIOL, V78, P2145, DOI 10.1073/pnas.78.4.2145; UDIN SB, 1988, J COMP NEUROL, V203, P575; VIELMETTER J, 1991, J COMP NEUROL, V311, P321, DOI 10.1002/cne.903110303; VIELMETTER J, 1989, NEURON, V2, P1331, DOI 10.1016/0896-6273(89)90071-8; VONBOXBERG Y, 1988, ANAL BIOCHEM, V169, P372; WALTER J, 1987, DEVELOPMENT, V101, P685; WALTER J, 1990, J PHYSIOL-PARIS, V84, P104; WALTER J, 1990, TRENDS NEUROSCI, V13, P447, DOI 10.1016/0166-2236(90)90097-T	48	42	42	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1993	10	3					345	357						13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KU901	8461131				2022-12-24	WOS:A1993KU90100002
J	IP, NY; MCCLAIN, J; BARREZUETA, NX; ALDRICH, TH; PAN, L; LI, YP; WIEGAND, SJ; FRIEDMAN, B; DAVIS, S; YANCOPOULOS, GD				IP, NY; MCCLAIN, J; BARREZUETA, NX; ALDRICH, TH; PAN, L; LI, YP; WIEGAND, SJ; FRIEDMAN, B; DAVIS, S; YANCOPOULOS, GD			THE ALPHA COMPONENT OF THE CNTF RECEPTOR IS REQUIRED FOR SIGNALING AND DEFINES POTENTIAL CNTF TARGETS IN THE ADULT AND DURING DEVELOPMENT	NEURON			English	Article							CILIARY NEUROTROPHIC FACTOR; LEUKEMIA-INHIBITORY FACTOR; NEURONAL DIFFERENTIATION FACTOR; REGIONAL DISTRIBUTION; MOLECULAR-CLONING; RAT-BRAIN; SYMPATHETIC NEURONS; TROPHIC FACTOR; MESSENGER-RNA; SPINAL-CORD	We recently proposed that ciliary neurotrophic factor (CNTF) shares two receptor components with a generally acting cytokine, leukemia inhibitory factor (LIF), but that CNTF also requires a third receptor component (CNTFRalpha) that is mostly restricted to the nervous system in its expression. Here we demonstrate that a transfected CNTFRalpha gene is sufficient to confer CNTF responsiveness upon hemopoietic cells normally responsive only to LIF, providing evidence that CNTFRalpha is a required receptor component that uniquely characterizes CNTF-responding cells. Consistent with this notion, CNTFRalpha expression could be localized to neurons within all known peripheral targets of CNTF. CNTFRalpha was also widely expressed within neurons of the CNS, suggesting that CNTF has broader CNS actions than previously appreciated. However, in vivo localization of CNTFRalpha, as well as of CNTF itself, is consistent with a particularly important role for CNTF in motor function as well as during neuropoiesis.			IP, NY (corresponding author), REGENERON PHARMACEUT INC, 777 OLD SAW MILL RIVER RD, TARRYTOWN, NY 10591 USA.			Ip, Nancy Yuk-Yu/0000-0002-2763-8907				ADLER R, 1979, SCIENCE, V204, P1434, DOI 10.1126/science.451576; ARAKAWA Y, 1990, J NEUROSCI, V10, P3507; BAUMANN M, 1990, J BIOL CHEM, V265, P19853; BAZAN JF, 1991, NEURON, V7, P197, DOI 10.1016/0896-6273(91)90258-2; BLOTTNER D, 1989, NEUROSCI LETT, V105, P316, DOI 10.1016/0304-3940(89)90640-X; Bothwell A., 1990, METHODS CLONING ANAL; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DAVIS S, 1991, SCIENCE, V253, P59, DOI 10.1126/science.1648265; DAVIS S, 1993, IN PRESS CURR OPIN N; DAVIS S, 1993, IN PRESS SCIENCE; ECKENSTEIN FP, 1990, NEURON, V4, P623, DOI 10.1016/0896-6273(90)90120-5; ERNSBERGER U, 1989, NEURON, V2, P1275, DOI 10.1016/0896-6273(89)90312-7; FREDERIKSEN K, 1988, J NEUROSCI, V8, P1144; FRIEDMAN B, 1992, NEURON, V9, P295, DOI 10.1016/0896-6273(92)90168-D; GEARING DP, 1992, SCIENCE, V255, P1434, DOI 10.1126/science.1542794; GEARING DP, 1991, EMBO J, V10, P2839, DOI 10.1002/j.1460-2075.1991.tb07833.x; HAGG T, 1992, NEURON, V8, P145, DOI 10.1016/0896-6273(92)90116-U; HALL AK, 1992, TRENDS NEUROSCI, V15, P35, DOI 10.1016/0166-2236(92)90022-Z; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; Hughes J T, 1982, Adv Neurol, V36, P61; HUGHES SM, 1988, NATURE, V335, P70, DOI 10.1038/335070a0; IP NY, 1991, J NEUROSCI, V11, P3124; IP NY, 1992, CELL, V69, P1121, DOI 10.1016/0092-8674(92)90634-O; IP NY, 1992, P NATL ACAD SCI USA, V89, P3060, DOI 10.1073/pnas.89.7.3060; IP NY, 1992, IN PRESS PROG GROWTH; IP NY, 1993, IN PRESS EUR J NEURO; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; LAVAIL MM, 1992, IN PRESS P NATL ACAD; LILLIEN LE, 1988, NEURON, V1, P485, DOI 10.1016/0896-6273(88)90179-1; LIN LFH, 1989, SCIENCE, V246, P1023, DOI 10.1126/science.2587985; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MAISONPIERRE PC, 1991, GENOMICS, V10, P558, DOI 10.1016/0888-7543(91)90436-I; MARTINOU JC, 1992, NEURON, V8, P737, DOI 10.1016/0896-6273(92)90094-T; MARTINZANCA D, 1990, GENE DEV, V4, P683, DOI 10.1101/gad.4.5.683; MIYAJIMA A, 1992, ANNU REV IMMUNOL, V10, P295, DOI 10.1146/annurev.immunol.10.1.295; MORSHEAD CM, 1992, J NEUROSCI, V12, P249; MURAKAMI M, 1991, P NATL ACAD SCI USA, V88, P11349, DOI 10.1073/pnas.88.24.11349; MURPHY M, 1991, P NATL ACAD SCI USA, V88, P3498, DOI 10.1073/pnas.88.8.3498; OPPENHEIM RW, 1991, SCIENCE, V251, P1616, DOI 10.1126/science.2011743; PARK LS, 1992, P NATL ACAD SCI USA, V89, P4295, DOI 10.1073/pnas.89.10.4295; RAFF MC, 1989, SCIENCE, V243, P1450, DOI 10.1126/science.2648568; RAO MS, 1990, DEV BIOL, V139, P65, DOI 10.1016/0012-1606(90)90279-R; RENDE M, 1992, GLIA, V5, P25, DOI 10.1002/glia.440050105; ROSE TM, 1991, P NATL ACAD SCI USA, V88, P8641, DOI 10.1073/pnas.88.19.8641; SAADAT S, 1989, J CELL BIOL, V108, P1807, DOI 10.1083/jcb.108.5.1807; SENDTNER M, 1992, NATURE, V358, P502, DOI 10.1038/358502a0; SENDTNER M, 1990, NATURE, V345, P440, DOI 10.1038/345440a0; SHELTON DL, 1986, P NATL ACAD SCI USA, V83, P2714, DOI 10.1073/pnas.83.8.2714; SKAPER SD, 1986, DEV BRAIN RES, V24, P39, DOI 10.1016/0165-3806(86)90171-9; SQUINTO SP, 1990, NEURON, V5, P757, DOI 10.1016/0896-6273(90)90334-C; STOCKLI KA, 1989, NATURE, V342, P920, DOI 10.1038/342920a0; STOCKLI KA, 1991, J CELL BIOL, V115, P447, DOI 10.1083/jcb.115.2.447; TAGA T, 1989, CELL, V58, P573, DOI 10.1016/0092-8674(89)90438-8; THOENEN H, 1991, TRENDS NEUROSCI, V14, P165, DOI 10.1016/0166-2236(91)90097-E; YAMAMORI T, 1989, SCIENCE, V246, P1412, DOI 10.1126/science.2512641; YAMASAKI K, 1988, SCIENCE, V241, P825, DOI 10.1126/science.3136546	57	396	408	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1993	10	1					89	102		10.1016/0896-6273(93)90245-M	http://dx.doi.org/10.1016/0896-6273(93)90245-M			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KK012	8381290				2022-12-24	WOS:A1993KK01200010
J	Pennica, D; Arce, V; Swanson, TA; Vejsada, R; Pollock, RA; Armanini, M; Dudley, K; Phillips, HS; Rosenthal, A; Kato, AC; Henderson, CE				Pennica, D; Arce, V; Swanson, TA; Vejsada, R; Pollock, RA; Armanini, M; Dudley, K; Phillips, HS; Rosenthal, A; Kato, AC; Henderson, CE			Cardiotrophin-1, a cytokine present in embryonic muscle, supports long-term survival of spinal motoneurons	NEURON			English	Article							CILIARY NEUROTROPHIC FACTOR; LEUKEMIA INHIBITORY FACTOR; NERVE GROWTH-FACTOR; FACTOR PREVENTS; CNTF RECEPTOR; MOTOR NEURONS; CELL-DEATH; BRAIN; EXPRESSION; DEGENERATION	The muscle-derived factors required for survival of embryonic motoneurons are not clearly identified. Cardiotrophin-1 (CT-1), a cytokine related to ciliary neurotrophic factor (CNTF), is expressed at high levels in embryonic limb bud and is secreted by differentiated myotubes. In vitro, CT-1 kept 43% of purified E14 rat motoneurons alive for 2 weeks (ECS(50) = 20 pM). In vivo, CT-1 protected neonatal sciatic motoneurons against the effects of axotomy. CT-1 action on motoneurons was inhibited by phosphatidylinositol-specific phospholipase C (PIPLC), suggesting that CT-1 may act through a GPI-linked component. Since no binding of CT-1 to CNTFR alpha was detected, CT-1 may use a novel cytokine receptor alpha. subunit. CT-1 may be important in normal motoneuron development and as a potential tool for slowing motoneuron degeneration in human diseases.	GENENTECH INC,DEPT NEUROSCI,S SAN FRANCISCO,CA 94080; UNIV MEDITERRANEE,INSERM,CNRS,IBDM,U382,F-13288 MARSEILLE 09,FRANCE; CTR MED UNIV GENEVA,DIV CLIN NEUROMUSCULAR RES,CH-1211 GENEVA 4,SWITZERLAND; CTR MED UNIV GENEVA,DEPT PHARMACOL,CH-1211 GENEVA 4,SWITZERLAND	Roche Holding; Genentech; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of Geneva; University of Geneva	Pennica, D (corresponding author), GENENTECH INC,DEPT MOL BIOL,S SAN FRANCISCO,CA 94080, USA.			Henderson, Christopher/0000-0002-9936-3279				ARAKAWA Y, 1990, J NEUROSCI, V10, P3507; CATALA F, 1995, MOL CELL BIOL, V15, P4585; CHANDLER CE, 1984, J BIOL CHEM, V259, P6882; DAVIS S, 1993, SCIENCE, V260, P1805, DOI 10.1126/science.8390097; DECHIARA TM, 1995, CELL, V83, P313, DOI 10.1016/0092-8674(95)90172-8; ESCARY JL, 1993, NATURE, V363, P361, DOI 10.1038/363361a0; HAMBURGER V, 1992, J NEUROBIOL, V23, P1116, DOI 10.1002/neu.480230904; Henderson C.E., 1995, NERVE CELL CULTURE P, P69; HENDERSON CE, 1993, NATURE, V363, P266, DOI 10.1038/363266a0; HENDERSON CE, 1993, RESTOR NEUROL NEUROS, V5, P15, DOI 10.3233/RNN-1993-5105; Henderson CE, 1996, CURR OPIN NEUROBIOL, V6, P64, DOI 10.1016/S0959-4388(96)80010-9; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; HENDERSON CE, 1995, ADV NEUROL, V68, P235; IP NY, 1993, NEURON, V10, P89, DOI 10.1016/0896-6273(93)90245-M; KWON YW, 1995, J NEUROBIOL, V28, P35, DOI 10.1002/neu.480280105; LI LX, 1995, P NATL ACAD SCI USA, V92, P9771, DOI 10.1073/pnas.92.21.9771; LI M, 1995, NATURE, V378, P724, DOI 10.1038/378724a0; LOW MG, 1986, TRENDS BIOCHEM SCI, V11, P212, DOI 10.1016/0968-0004(86)90009-5; MARTINOU JC, 1992, NEURON, V8, P737, DOI 10.1016/0896-6273(92)90094-T; MASU Y, 1993, NATURE, V365, P27, DOI 10.1038/365027a0; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; OPPENHEIM RW, 1992, NATURE, V360, P755, DOI 10.1038/360755a0; OPPENHEIM RW, 1991, SCIENCE, V251, P1616, DOI 10.1126/science.2011743; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; OPPENHEIM RW, 1995, NATURE, V373, P344, DOI 10.1038/373344a0; Pennica D, 1996, CYTOKINE, V8, P183, DOI 10.1006/cyto.1996.0026; PENNICA D, 1995, J BIOL CHEM, V270, P10915, DOI 10.1074/jbc.270.18.10915; PENNICA D, 1995, P NATL ACAD SCI USA, V92, P1142, DOI 10.1073/pnas.92.4.1142; PETERS M, 1995, FEBS LETT, V372, P177, DOI 10.1016/0014-5793(95)00972-C; PHILLIPS HS, 1990, SCIENCE, V250, P290, DOI 10.1126/science.1688328; PINCONRAYMOND M, 1991, DEV BIOL, V148, P517, DOI 10.1016/0012-1606(91)90270-D; PINSET C, 1991, EMBO J, V10, P2411, DOI 10.1002/j.1460-2075.1991.tb07780.x; SAGOT Y, 1995, EUR J NEUROSCI, V7, P1313, DOI 10.1111/j.1460-9568.1995.tb01122.x; Sendtner M, 1996, CURR BIOL, V6, P686, DOI 10.1016/S0960-9822(09)00450-3; SENDTNER M, 1990, NATURE, V345, P440, DOI 10.1038/345440a0; SENDTNER M, 1992, NATURE, V360, P757, DOI 10.1038/360757a0; SENDTNER M, 1992, NATURE, V358, P602; Sheng ZL, 1996, DEVELOPMENT, V122, P419; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; STOCKLI KA, 1991, J CELL BIOL, V115, P447, DOI 10.1083/jcb.115.2.447; SUVA LJ, 1987, SCIENCE, V237, P893, DOI 10.1126/science.3616618; TRUPP M, 1995, J CELL BIOL, V130, P137, DOI 10.1083/jcb.130.1.137; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; VEJSADA R, 1995, EUR J NEUROSCI, V7, P108, DOI 10.1111/j.1460-9568.1995.tb01025.x; WONG VV, 1995, J BIOL CHEM, V270, P313, DOI 10.1074/jbc.270.1.313; YAN Q, 1992, NATURE, V360, P753, DOI 10.1038/360753a0; YAN Q, 1995, NATURE, V373, P341, DOI 10.1038/373341a0; YAN Q, 1988, J NEUROSCI, V8, P3481; Yoshida K, 1996, P NATL ACAD SCI USA, V93, P407, DOI 10.1073/pnas.93.1.407	49	194	209	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1996	17	1					63	74		10.1016/S0896-6273(00)80281-0	http://dx.doi.org/10.1016/S0896-6273(00)80281-0			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UY981	8755479	Bronze			2022-12-24	WOS:A1996UY98100008
J	DOHERTY, P; WILLIAMS, E; WALSH, FS				DOHERTY, P; WILLIAMS, E; WALSH, FS			A SOLUBLE CHIMERIC FORM OF THE L1 GLYCOPROTEIN STIMULATES NEURITE OUTGROWTH	NEURON			English	Article							CELL-ADHESION MOLECULES; 2ND MESSENGER SYSTEMS; NEURAL ADHESION; IMMUNOGLOBULIN SUPERFAMILY; NERVOUS-SYSTEM; N-CADHERIN; PROMOTING ACTIVITY; AXONAL GROWTH; OPTIC-NERVE; VASE EXON	Cerebellar neurons, cultured on monolayers of 3T3 fibroblasts or on a polylysine/extracellular matrix-coated substratum, responded to a soluble recombinant L1-Fc chimera by extending longer neurites than controls. The response was inhibited by pretreating neurons with antibodies to Ll or antibodies to the fibroblast growth factor (FGF) receptor. The response could also be inhibited by a range of pharmacological reagents that inhibit various steps in the signal transduction cascade which underlie a neurite outgrowth response to basic FGF. The response was of a similar magnitude and not additive with that induced by L1 expressed in a cellular substrate. These data show that L1 in neurons is capable of directing a neurite outgrowth response to a soluble L1-Fc chimera, and that neuronal FGF receptor function is required for this response. The data also show that the ability of cell adhesion molecules (CAMs) to stimulate neurite outgrowth can be dissociated from their ability to function as substrate-associated adhesion molecules and point to the potential of using CAM-Fc chimeras to promote nerve regeneration.			DOHERTY, P (corresponding author), UNITED MED & DENT SCH,GUYS HOSP,DEPT EXPTL PATHOL,LONDON BRIDGE,LONDON SE1 9RT,ENGLAND.		Doherty, Patrick/A-8752-2008		Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BAILEY CH, 1992, SCIENCE, V256, P645, DOI 10.1126/science.1585177; BIEBER AJ, 1989, CELL, V59, P447, DOI 10.1016/0092-8674(89)90029-9; DAVENPORT RW, 1993, NATURE, V361, P721, DOI 10.1038/361721a0; Doherty P, 1992, Curr Opin Neurobiol, V2, P595, DOI 10.1016/0959-4388(92)90024-F; DOHERTY P, 1990, NATURE, V343, P464, DOI 10.1038/343464a0; DOHERTY P, 1992, NATURE, V356, P791, DOI 10.1038/356791a0; Doherty Patrick, 1994, Current Opinion in Neurobiology, V4, P49, DOI 10.1016/0959-4388(94)90031-0; DURBEC P, 1992, J CELL BIOL, V117, P877, DOI 10.1083/jcb.117.4.877; Edwards Caroline P., 1993, Current Opinion in Biotechnology, V4, P558, DOI 10.1016/0958-1669(93)90077-A; FELSENFELD DP, 1994, NEURON, V12, P675, DOI 10.1016/0896-6273(94)90222-4; FURLEY AJ, 1990, CELL, V61, P157, DOI 10.1016/0092-8674(90)90223-2; GENNARINI G, 1991, NEURON, V6, P595, DOI 10.1016/0896-6273(91)90062-5; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; GRUMET M, 1993, CELL ADHES COMMUN, V1, P177, DOI 10.3109/15419069309095693; GRUMET M, 1991, J CELL BIOL, V113, P1399, DOI 10.1083/jcb.113.6.1399; GRUMET M, 1993, J CELL BIOL, V120, P815, DOI 10.1083/jcb.120.3.815; GUNDERSEN RW, 1987, DEV BIOL, V121, P423, DOI 10.1016/0012-1606(87)90179-5; HARPER SJ, 1994, CELL ADHES COMMUN, V2, P441, DOI 10.3109/15419069409004454; HLAVIN ML, 1991, GENOMICS, V11, P416, DOI 10.1016/0888-7543(91)90150-D; HOLLENBAUGH D, 1992, CURR OPIN IMMUNOL, V4, P216, DOI 10.1016/0952-7915(92)90017-9; JOHNSON PW, 1989, NEURON, V3, P377, DOI 10.1016/0896-6273(89)90262-6; KADMON G, 1990, J CELL BIOL, V110, P209, DOI 10.1083/jcb.110.1.209; KASAI H, 1994, TRENDS NEUROSCI, V17, P95, DOI 10.1016/0166-2236(94)90112-0; KATER SB, 1991, J NEUROSCI, V11, P891; KUHN TB, 1991, J CELL BIOL, V115, P1113, DOI 10.1083/jcb.115.4.1113; LEMMON V, 1992, J NEUROSCI, V12, P818; LEMMON V, 1989, NEURON, V2, P1597, DOI 10.1016/0896-6273(89)90048-2; LIU L, 1993, J NEUROSCI RES, V35, P327, DOI 10.1002/jnr.490350313; MATSUNAGA M, 1988, NATURE, V334, P62, DOI 10.1038/334062a0; MAUREL P, 1994, P NATL ACAD SCI USA, V91, P2512, DOI 10.1073/pnas.91.7.2512; MAYFORD M, 1992, SCIENCE, V256, P638, DOI 10.1126/science.1585176; MULLIGAN MS, 1993, J IMMUNOL, V151, P6410; NEUGEBAUER KM, 1988, J CELL BIOL, V107, P1177, DOI 10.1083/jcb.107.3.1177; Rathjen F. G, 1991, SEMIN NEUROSCI, V3, P297, DOI 10.1016/1044-5765(91)90047-R; REDIES C, 1993, GLIA, V8, P161, DOI 10.1002/glia.440080304; REID RA, 1992, J MOL NEUROSCI, V3, P127, DOI 10.1007/BF02919404; RUEGG MA, 1989, J CELL BIOL, V109, P2363, DOI 10.1083/jcb.109.5.2363; SAFFELL JL, 1994, J CELL BIOL, V125, P427, DOI 10.1083/jcb.125.2.427; SCHUCH U, 1989, NEURON, V3, P13, DOI 10.1016/0896-6273(89)90111-6; SEILHEIMER B, 1988, J CELL BIOL, V107, P341, DOI 10.1083/jcb.107.1.341; SIMMONS DL, 1993, DEVELOPMENT, P193; SONDEREGGER P, 1992, J CELL BIOL, V119, P1387, DOI 10.1083/jcb.119.6.1387; SWEADNER KJ, 1983, J NEUROSCI, V3, P2518; VONBOHLEN F, 1992, EUR J NEUROSCI, V4, P896; WILLIAMS EJ, 1994, NEURON, V13, P583, DOI 10.1016/0896-6273(94)90027-2; WILLIAMS EJ, 1994, J CELL BIOL, V124, P1029, DOI 10.1083/jcb.124.6.1029; WILLIAMS EJ, 1994, DEVELOPMENT, V120, P1585; WILLIAMS EJ, 1994, J NEUROCHEM, V62, P2124; WILLIAMS EJ, 1992, J CELL BIOL, V119, P885; YAZAKI T, 1991, BIOMED RES-TOKYO, V12, P223, DOI 10.2220/biomedres.12.223	50	159	162	0	0	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1995	14	1					57	66		10.1016/0896-6273(95)90240-6	http://dx.doi.org/10.1016/0896-6273(95)90240-6			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QC548	7826641	Bronze			2022-12-24	WOS:A1995QC54800006
J	SHIEH, BH; NIEMEYER, B				SHIEH, BH; NIEMEYER, B			A NOVEL PROTEIN ENCODED BY THE INAD GENE REGULATES RECOVERY OF VISUAL TRANSDUCTION IN DROSOPHILA	NEURON			English	Article							PHOTORECEPTOR DEACTIVATION; SIGNAL TRANSDUCTION; RNA-POLYMERASE; RHODOPSIN GENE; CYCLIC-GMP; KINASE-C; HOMOLOG; CALCIUM; EXPRESSION; BRAIN	lnaD(p215) is a point mutation that affects photoreceptor function in Drosophila. To understand the molecular basis of the defect, we isolated the InaD gene and found it encodes a photoreceptor-specific polypeptide of 674 residues. Within its sequence are two repeats that share remarkable homology with a family of cytoskeleton-associated proteins that are involved in signal transduction. Patch-clamp recordings from isolated photoreceptor cells of InaD(p215) show a slow deactivation of the light-induced current. Th is defective deactivation of InaD appears dependent on calcium influx; removal of extracellular calcium masks its abnormal phenotype. Moreover, InaD photoreceptors show increased sensitivity to dim light. We propose that InaD is involved in the negative feedback regulation of the light-activated signaling cascade in Drosophila photoreceptors.	UNIV CALIF SAN DIEGO,DEPT NEUROSCI,LA JOLLA,CA 92093	University of California System; University of California San Diego	SHIEH, BH (corresponding author), VANDERBILT UNIV,DEPT PHARMACOL,NASHVILLE,TN 37232, USA.		Niemeyer, Barbara A./AAL-8972-2021	Niemeyer, Barbara A./0000-0002-6963-0575	NEI NIH HHS [R01EY09743] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY009743] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ASHBURNER M, 1989, DROSOPHILA LABORATOR; BAER KM, 1988, J BIOL CHEM, V263, P17; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; BIRCHMEIER C, 1990, P NATL ACAD SCI USA, V87, P4799, DOI 10.1073/pnas.87.12.4799; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; CAVENER DR, 1987, NUCLEIC ACIDS RES, V15, P1353, DOI 10.1093/nar/15.4.1353; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; COWMAN AF, 1986, CELL, V44, P705, DOI 10.1016/0092-8674(86)90836-6; DEVARY O, 1987, P NATL ACAD SCI USA, V84, P6939, DOI 10.1073/pnas.84.19.6939; FEIN A, 1986, TRENDS NEUROSCI, V93, P110; FERRIS CD, 1992, J NEUROSCI, V12, P1567; HAFEN E, 1987, SCIENCE, V236, P55, DOI 10.1126/science.2882603; HARDIE RC, 1991, NEURON, V6, P477, DOI 10.1016/0896-6273(91)90255-X; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; HARLOW E, 1988, ANTIBODIES LABORATOR; HENZI V, 1992, NEUROSCIENCE, V46, P251, DOI 10.1016/0306-4522(92)90049-8; HURLEY JB, 1992, J BIOENERG BIOMEMBR, V24, P219, DOI 10.1007/BF00762680; ITO M, 1993, J CELL BIOL, V121, P491; JOHNSON EC, 1986, NATURE, V324, P468, DOI 10.1038/324468a0; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; LAGNADO L, 1992, NEURON, V8, P995, DOI 10.1016/0896-6273(92)90122-T; LEE YJ, 1990, NEURON, V5, P889, DOI 10.1016/0896-6273(90)90349-K; LINDSLEY D, 1992, GENOME DROSOPHILA M; LISMAN JE, 1972, J GEN PHYSIOL, V59, P701, DOI 10.1085/jgp.59.6.701; MONTELL C, 1987, J NEUROSCI, V7, P1558; NISHIZUKA Y, 1986, SCIENCE, V223, P305; OTOUSA JE, 1985, CELL, V40, P839, DOI 10.1016/0092-8674(85)90343-5; Pak W.L., 1979, P67; RANGANATHAN R, 1991, NATURE, V354, P230, DOI 10.1038/354230a0; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHIEH BH, 1989, NATURE, V338, P67, DOI 10.1038/338067a0; SMITH DP, 1990, P NATL ACAD SCI USA, V87, P1003, DOI 10.1073/pnas.87.3.1003; SMITH DP, 1991, SCIENCE, V254, P1478, DOI 10.1126/science.1962207; SONNENBERG E, 1991, EMBO J, V10, P3693, DOI 10.1002/j.1460-2075.1991.tb04937.x; STRYER L, 1986, ANNU REV NEUROSCI, V9, P87, DOI 10.1146/annurev.ne.09.030186.000511; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; SVED J, 1986, DROSOPH INFO SERV, V73, P169; TAKAI Y, 1979, J BIOL CHEM, V254, P3692; TESSAROLLO L, 1992, DEVELOPMENT, V115, P11; THOMAS GMH, 1993, CELL, V74, P919, DOI 10.1016/0092-8674(93)90471-2; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; YARFITZ S, 1991, NEURON, V7, P429, DOI 10.1016/0896-6273(91)90295-B; YOSHIOKA T, 1984, BIOCHEM J, V100, P1015; ZUKER CS, 1987, J NEUROSCI, V7, P1550; ZUKER CS, 1985, CELL, V40, P851, DOI 10.1016/0092-8674(85)90344-7	50	95	97	0	3	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1995	14	1					201	210		10.1016/0896-6273(95)90255-4	http://dx.doi.org/10.1016/0896-6273(95)90255-4			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QC548	7826638	Bronze			2022-12-24	WOS:A1995QC54800021
J	RAMASWAMI, M; KRISHNAN, KS; KELLY, RB				RAMASWAMI, M; KRISHNAN, KS; KELLY, RB			INTERMEDIATES IN SYNAPTIC VESICLE RECYCLING REVEALED BY OPTICAL IMAGING OF DROSOPHILA NEUROMUSCULAR-JUNCTIONS	NEURON			English	Article							WIDOW SPIDER VENOM; MOTOR-NERVE TERMINALS; ALPHA-LATROTOXIN; TRANSMITTER RELEASE; MELANOGASTER; SHIBIRE; CALCIUM; SYNAPTOTAGMIN; SECRETION; DYNAMIN	We show that uptake and release of the styryl dye FM1-43 may be used to monitor synaptic vesicle exocytosis and recycling at Drosophila larval neuromuscular junctions. At Drosophila nerve terminals, FM1-43 specifically labels subsynaptic domains enriched in synaptotagmin, in a manner that requires Ca2+, membrane depolarization, and shibire (shi) function. Endocytosis rates, very low in unstimulated synapses, are induced severalfold by the exocytosis of synaptic vesicles. Using shi(ts1) mutant synapses to separate synaptic vesicle fusion and recycling temporally, we show that recycling events subsequent to the shi block do not require extracellular Ca2+. We suggest that two distinct intermediate stages in vesicle recycling may be trapped and analyzed at Drosophila neuromuscular junctions.	TATA INST FUNDAMENTAL RES,MOLEC BIOL UNIT,BOMBAY 400005,INDIA; UNIV CALIF SAN FRANCISCO,HORMONE RES INST,SAN FRANCISCO,CA 94143	Tata Institute of Fundamental Research (TIFR); University of California System; University of California San Francisco	RAMASWAMI, M (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143, USA.			Ramaswami, Mani/0000-0001-7631-0468	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015927] Funding Source: NIH RePORTER; NINDS NIH HHS [NS15927] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2559, DOI 10.1073/pnas.90.7.2559; BETZ WJ, 1993, J PHYSIOL-LONDON, V460, P287, DOI 10.1113/jphysiol.1993.sp019472; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; BROADIE KS, 1993, J NEUROSCI, V13, P144; CASH S, 1992, J NEUROSCI, V12, P2051; CECCARELLI B, 1980, J CELL BIOL, V87, P297, DOI 10.1083/jcb.87.1.297; CHEN MS, 1991, NATURE, V351, P583, DOI 10.1038/351583a0; DELANEY KR, 1989, J NEUROSCI, V9, P3558; DIANTONIO A, 1993, CELL, V73, P1281, DOI 10.1016/0092-8674(93)90356-U; GRIGLIATTI TA, 1973, MOL GEN GENET, V120, P107, DOI 10.1007/BF00267238; HATA Y, 1993, NEURON, V10, P307, DOI 10.1016/0896-6273(93)90320-Q; HURLBUT WP, 1994, J MEMBRANE BIOL, V138, P91, DOI 10.1007/BF00211072; JAN LY, 1976, J PHYSIOL-LONDON, V262, P189, DOI 10.1113/jphysiol.1976.sp011592; JIA XX, 1993, J NEUROBIOL, V24, P1025, DOI 10.1002/neu.480240804; JOHANSEN J, 1989, J NEUROSCI, V9, P710; KELLY RB, 1993, CELL, V72, P43, DOI 10.1016/S0092-8674(05)80027-3; KESHISHIAN H, 1993, J NEUROBIOL, V24, P757, DOI 10.1002/neu.480240606; KNIPPER M, 1986, NEUROSCIENCE, V19, P55, DOI 10.1016/0306-4522(86)90005-9; KOENIG JH, 1989, J NEUROSCI, V9, P3844; KOSAKA T, 1983, J NEUROBIOL, V14, P207, DOI 10.1002/neu.480140305; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; MAGAZANIK LG, 1992, NEUROSCIENCE, V46, P181, DOI 10.1016/0306-4522(92)90017-V; MASUR SK, 1990, J NEUROGENET, V6, P191, DOI 10.3109/01677069009107110; MATHEWS G, 1994, NATURE, V367, P735; MELDOLESI J, 1986, TRENDS PHARMACOL SCI, V7, P151, DOI 10.1016/0165-6147(86)90293-2; MONTECUCCO C, 1993, TRENDS BIOCHEM SCI, V18, P324, DOI 10.1016/0968-0004(93)90065-U; MULKEY RM, 1991, NATURE, V350, P153, DOI 10.1038/350153a0; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; PETRENKO AG, 1993, FEBS LETT, V325, P81, DOI 10.1016/0014-5793(93)81418-Y; POODRY CA, 1979, J CELL BIOL, V81, P520, DOI 10.1083/jcb.81.3.520; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; SINK H, 1991, J NEUROBIOL, V22, P298, DOI 10.1002/neu.480220309; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; SUDHOF TC, 1991, NEURON, V6, P665, DOI 10.1016/0896-6273(91)90165-V; THOMAS P, 1994, J CELL BIOL, V124, P667, DOI 10.1083/jcb.124.5.667; TORRITARELLI F, 1990, J CELL BIOL, V110, P449, DOI 10.1083/jcb.110.2.449; VALTORTA F, 1988, J CELL BIOL, V107, P2717, DOI 10.1083/jcb.107.6.2717; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297	43	170	172	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1994	13	2					363	375		10.1016/0896-6273(94)90353-0	http://dx.doi.org/10.1016/0896-6273(94)90353-0			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PD430	8060617				2022-12-24	WOS:A1994PD43000009
J	MATHEWS, GC; BOLOSSY, AM; HOLLAND, KD; ISENBERG, KE; COVEY, DF; FERRENDELLI, JA; ROTHMAN, SM				MATHEWS, GC; BOLOSSY, AM; HOLLAND, KD; ISENBERG, KE; COVEY, DF; FERRENDELLI, JA; ROTHMAN, SM			DEVELOPMENTAL ALTERATION IN GABA(A) RECEPTOR STRUCTURE AND PHYSIOLOGICAL-PROPERTIES IN CULTURED CEREBELLAR GRANULE NEURONS	NEURON			English	Article							SUBUNIT MESSENGER-RNAS; A RECEPTOR; RAT-BRAIN; GAMMA-THIOBUTYROLACTONES; PICROTOXIN RECEPTOR; BINDING-SITES; POSTNATAL-DEVELOPMENT; HIPPOCAMPAL-NEURONS; <H-3>RO 15-4513; ALPHA-SUBUNIT	Although we now have extensive knowledge about the GABA(A) receptor subunits determining benzodiazepine modulation of channel function, little is known about subunits influencing other modulatory sites on the GABA(A) receptor-chloride channel complex. We have identified a developmental change in subunit composition of the GABA(A) receptor in cultured cerebellar granule neurons that eliminates benzodiazepine-mediated enhancement of GABA responses and alters modulation by a substituted gamma-butyrolactone. Based on data from sequential PCR experiments, we mimicked the functional properties of early and mature receptors with heterologous expression of specific subunit combinations. This report describes one of the most extensive cell- and site-specific developmental changes for an ion channel seen to date.	ST LOUIS CHILDRENS HOSP,DEPT NEUROL,ST LOUIS,MO 63110; ST LOUIS CHILDRENS HOSP,DIV PEDIAT NEUROL,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT PSYCHIAT,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT MOLEC BIOL & PHARMACOL,ST LOUIS,MO 63110	St. Louis Children's Hospital; Washington University (WUSTL); St. Louis Children's Hospital; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	MATHEWS, GC (corresponding author), ST LOUIS CHILDRENS HOSP,MED SCIENTIST TRAINING PROGRAM,ST LOUIS,MO 63110, USA.		Mathews, Gregory C/A-9660-2009		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007805] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS014834, P50NS014834] Funding Source: NIH RePORTER; NIGMS NIH HHS [5T32GM07805] Funding Source: Medline; NINDS NIH HHS [NS14834] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANGELOTTI TP, 1993, J NEUROSCI, V13, P1429; BAUDE A, 1992, NEUROSCIENCE, V51, P739, DOI 10.1016/0306-4522(92)90513-2; BEATTIE CE, 1993, J NEUROSCI, V13, P1784; BENKE D, 1991, FEBS LETT, V283, P165; BOVOLIN P, 1992, J NEUROCHEM, V59, P62, DOI 10.1111/j.1471-4159.1992.tb08876.x; BOVOLIN P, 1992, P NATL ACAD SCI USA, V89, P9344, DOI 10.1073/pnas.89.19.9344; BURT DR, 1991, FASEB J, V5, P2916, DOI 10.1096/fasebj.5.14.1661244; CANNEY DJ, 1991, J MED CHEM, V34, P1460, DOI 10.1021/jm00108a034; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHOI DW, 1981, J NEUROPHYSIOL, V45, P621, DOI 10.1152/jn.1981.45.4.621; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; FERRENDELLI JA, 1989, EPILEPSIA, V30, P617, DOI 10.1111/j.1528-1157.1989.tb05482.x; FFRENCHCONSTANT RH, 1993, NATURE, V363, P449, DOI 10.1038/363449a0; FRITSCHY JM, 1992, P NATL ACAD SCI USA, V89, P6726, DOI 10.1073/pnas.89.15.6726; GALLO V, 1982, P NATL ACAD SCI-BIOL, V79, P7919, DOI 10.1073/pnas.79.24.7919; GAMBARANA C, 1990, J NEUROBIOL, V21, P1169, DOI 10.1002/neu.480210803; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HOLLAND KD, 1990, J NEUROSCI, V10, P1719; HOLLAND KD, 1990, BRAIN RES, V516, P147, DOI 10.1016/0006-8993(90)90910-4; HOLLAND KD, 1990, J PHARMACOL EXP THER, V254, P578; KHRESTCHATISKY M, 1989, NEURON, V3, P745, DOI 10.1016/0896-6273(89)90243-2; KLEINGOOR C, 1991, NEUROSCI LETT, V130, P169, DOI 10.1016/0304-3940(91)90389-B; KLUNK WE, 1982, SCIENCE, V217, P1040, DOI 10.1126/science.6810462; KORPI ER, 1993, NEUROSCIENCE, V53, P483, DOI 10.1016/0306-4522(93)90212-X; KORPI ER, 1992, EUR J PHARMACOL, V211, P427, DOI 10.1016/0014-2999(92)90402-P; LAURIE DJ, 1992, J NEUROSCI, V12, P4151; LAURIE DJ, 1992, J NEUROSCI, V12, P1063; LEVI G, 1984, BRAIN RES, V290, P77, DOI 10.1016/0006-8993(84)90737-6; LUDDENS H, 1990, NATURE, V346, P648, DOI 10.1038/346648a0; MALHERBE P, 1990, FEBS LETT, V260, P261, DOI 10.1016/0014-5793(90)80118-3; MALMINIEMI O, 1989, EUR J PHARMACOL, V169, P53, DOI 10.1016/0014-2999(89)90816-9; MCKERNAN RM, 1991, FEBS LETT, V286, P44, DOI 10.1016/0014-5793(91)80936-W; OLSEN RW, 1990, J CHEM NEUROANAT, V3, P59; PRIBILLA I, 1992, EMBO J, V11, P4305, DOI 10.1002/j.1460-2075.1992.tb05529.x; Ramon y Cajal S., 1909, HISTOLOGIE SYSTEME N, DOI [DOI 10.5962/BHL.TITLE.48637, 10.5962/bhl.title.48637]; SHIVERS BD, 1989, NEURON, V3, P327, DOI 10.1016/0896-6273(89)90257-2; SIEGHART W, 1987, J NEUROCHEM, V48, P46, DOI 10.1111/j.1471-4159.1987.tb13125.x; VELAZQUEZ JL, 1989, J NEUROSCI, V9, P2163; WHITING P, 1990, P NATL ACAD SCI USA, V87, P9966, DOI 10.1073/pnas.87.24.9966; WISDEN W, 1992, J NEUROSCI, V12, P1040; ZHENG T, 1993, DEV BRAIN RES, V75, P91, DOI 10.1016/0165-3806(93)90068-L	41	80	82	1	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1994	13	1					149	158		10.1016/0896-6273(94)90465-0	http://dx.doi.org/10.1016/0896-6273(94)90465-0			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NZ247	8043274				2022-12-24	WOS:A1994NZ24700011
J	OHISHI, H; OGAWAMEGURO, R; SHIGEMOTO, R; KANEKO, T; NAKANISHI, S; MIZUNO, N				OHISHI, H; OGAWAMEGURO, R; SHIGEMOTO, R; KANEKO, T; NAKANISHI, S; MIZUNO, N			IMMUNOHISTOCHEMICAL LOCALIZATION OF METABOTROPIC GLUTAMATE RECEPTORS, MGLUR2 AND MGLUR3, IN RAT CEREBELLAR CORTEX	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; AMINO-ACID RECEPTORS; MOLECULAR CHARACTERIZATION; SIGNAL TRANSDUCTION; CULTURED ASTROCYTES; BRAIN-FUNCTION; MESSENGER-RNA; EXPRESSION; PROTEIN; IMMUNOREACTIVITY	The distribution of the metabotropic glutamate receptors mGluR2 and mGluR3 was immunohistochemically examined in the rat cerebellar cortex at both light and electron microscope levels. An antibody was raised against a fusion protein containing a C-terminal portion of mGluR2. On immunoblot, the antibody reacted with both mGluR2 and mGluR3 in rat brain. mGluR2/3 immunoreactivity was expressed in cell bodies, dendrites, and axon terminals of Golgi cells, as well as in presumed glial processes. Golgi axon terminals with mGluR2/3 immunoreactivity were often encountered in the vicinity of glutamatergic messy fiber terminals. The results suggest that transmitter glutamate may exert control influences upon Golgi cells not only through dendritic mGluR2/3, but also through axonal mGluR2/3.	KYOTO UNIV, FAC MED, INST IMMUNOL, KYOTO 60601, JAPAN	Kyoto University	OHISHI, H (corresponding author), KYOTO UNIV, FAC MED, DEPT MORPHOL BRAIN SCI, KYOTO 60601, JAPAN.		Shigemoto, Ryuichi/E-3628-2013	Shigemoto, Ryuichi/0000-0001-8761-9444				ABE T, 1992, J BIOL CHEM, V267, P13361; BABA A, 1993, NEUROSCI LETT, V149, P182, DOI 10.1016/0304-3940(93)90766-E; CALABRESI P, 1992, NEUROSCI LETT, V139, P41, DOI 10.1016/0304-3940(92)90852-X; CELIO MR, 1981, NATURE, V293, P300, DOI 10.1038/293300a0; CLEMENTS JR, 1987, BRAIN RES, V421, P343, DOI 10.1016/0006-8993(87)91304-7; COLLINGRIDGE GL, 1990, TRENDS PHARMACOL SCI, V11, P290, DOI 10.1016/0165-6147(90)90011-V; DANGELO E, 1990, NATURE, V346, P467, DOI 10.1038/346467a0; DYER CA, 1991, J NEUROSCI RES, V28, P607, DOI 10.1002/jnr.490280418; Fox C A, 1967, Prog Brain Res, V25, P174; GARTHWAITE J, 1989, NEUROSCIENCE, V29, P401, DOI 10.1016/0306-4522(89)90067-5; GLAUM SR, 1992, J NEUROSCI, V12, P2251; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; GRUOL DL, 1988, DEV BRAIN RES, V41, P135, DOI 10.1016/0165-3806(88)90177-0; GTASIC GP, 1992, ANNU REV PHYSIOL, V54, P507; HAMORI J, 1966, EXP BRAIN RES, V2, P35; HARLOW E, 1988, ANTIBODIES LABORATOR; HAYASHI Y, 1993, NATURE, V366, P687, DOI 10.1038/366687a0; HOUAMED KM, 1991, SCIENCE, V252, P1318, DOI 10.1126/science.1656524; ISAACSON JS, 1993, NEURON, V10, P165, DOI 10.1016/0896-6273(93)90308-E; Ito M, 1984, CEREBELLUM NEURAL CO; KANEKO T, 1989, NEUROSCIENCE, V32, P79, DOI 10.1016/0306-4522(89)90109-7; KOERNER TJ, 1991, METHOD ENZYMOL, V194, P477; MARTIN LJ, 1993, NEUROSCIENCE, V53, P327, DOI 10.1016/0306-4522(93)90199-P; MARTIN LJ, 1992, NEURON, V9, P259, DOI 10.1016/0896-6273(92)90165-A; MASU M, 1991, NATURE, V349, P760, DOI 10.1038/349760a0; MILLER S, 1992, J NEUROCHEM, V58, P1967, DOI 10.1111/j.1471-4159.1992.tb10078.x; MOLNAR E, 1993, NEUROSCIENCE, V53, P307, DOI 10.1016/0306-4522(93)90198-O; MONAGHAN DT, 1989, ANNU REV PHARMACOL, V29, P365, DOI 10.1146/annurev.pa.29.040189.002053; NAKAJIMA Y, 1993, J BIOL CHEM, V268, P11868; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; NICHOLLS D, 1990, TRENDS PHARMACOL SCI, V11, P462, DOI 10.1016/0165-6147(90)90129-V; OERTEL WH, 1981, NEUROSCIENCE, V6, P2689, DOI 10.1016/0306-4522(81)90113-5; OHISHI H, 1993, J COMP NEUROL, V335, P252, DOI 10.1002/cne.903350209; OHISHI H, 1993, NEUROSCIENCE, V53, P1009, DOI 10.1016/0306-4522(93)90485-X; OKAMOTO N, 1994, J BIOL CHEM, V269, P1231; Palay S. L., 1974, CEREBELLAR CORTEX CY; PETRALIA RS, 1992, J COMP NEUROL, V318, P329, DOI 10.1002/cne.903180309; PICKLES HG, 1976, J PHYSIOL-LONDON, V260, P475, DOI 10.1113/jphysiol.1976.sp011526; ROGERS SW, 1991, J NEUROSCI, V11, P2713; Sambrook J, 1989, MOL CLONING LABORATO; SCHOEPP DD, 1993, TRENDS PHARMACOL SCI, V14, P13, DOI 10.1016/0165-6147(93)90107-U; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; SHIGEMOTO R, 1993, NEUROSCI LETT, V163, P53, DOI 10.1016/0304-3940(93)90227-C; SOMOGYI P, 1986, NEUROSCIENCE, V19, P1045, DOI 10.1016/0306-4522(86)90121-1; TANABE Y, 1992, NEURON, V8, P169, DOI 10.1016/0896-6273(92)90118-W; TANABE Y, 1993, J NEUROSCI, V13, P1372	46	198	201	1	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	1994	13	1					55	66		10.1016/0896-6273(94)90459-6	http://dx.doi.org/10.1016/0896-6273(94)90459-6			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NZ247	8043281				2022-12-24	WOS:A1994NZ24700005
J	EAHOLTZ, G; SCHEUER, T; CATTERALL, WA				EAHOLTZ, G; SCHEUER, T; CATTERALL, WA			RESTORATION OF INACTIVATION AND BLOCK OF OPEN SODIUM-CHANNELS BY AN INACTIVATION GATE PEPTIDE	NEURON			English	Article							POTASSIUM CHANNEL; CELLS; EXPRESSION; PRONASE; LINKER; AXONS	Inactivation of sodium channels terminates the sodium current responsible for initiation of action potentials in excitable cells. A hydrophobic sequence (isoleucine-phenylalanine-methionine, IFM), located in the inactivation gate segment connecting homologous domains III and IV of the sodium channel alpha subunit, is required for fast inactivation. A synthetic peptide containing the IFM sequence (acetyl-KIFMK-amide) restores fast inactivation to mutant sodium channels having a defective inactivation gate and to wild-type sodium channels having inactivation slowed by alpha-scorpion toxin. This peptide also competes with the intrinsic inactivation particle and binds to and blocks open sodium channels in a voltage- and frequency-dependent manner. A peptide (acetyl-KIQMK-amide) containing a mutation that prevents fast inactivation is not effective in restoring inactivation or in blocking open sodium channels. The results support the hypothesis that the sequence IFM serves as the inactivation particle of the sodium channel and suggest that it enters the intracellular mouth of the pore and occludes it during the process of inactivation.	UNIV WASHINGTON, DEPT PHARMACOL, SEATTLE, WA 98195 USA	University of Washington; University of Washington Seattle	EAHOLTZ, G (corresponding author), UNIV WASHINGTON, GRAD PROGRAM NEUROBIOL, SEATTLE, WA 98195 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007332, R01NS015751] Funding Source: NIH RePORTER; NINDS NIH HHS [T32 NS07332, NS15751] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALDRICH RW, 1983, NATURE, V306, P436, DOI 10.1038/306436a0; ARMSTRONG CM, 1992, PHYSIOL REV, V72, pS5, DOI 10.1152/physrev.1992.72.suppl_4.S5; ARMSTRONG CM, 1973, J GEN PHYSIOL, V62, P375, DOI 10.1085/jgp.62.4.375; ARMSTRONG CM, 1977, J GEN PHYSIOL, V70, P567, DOI 10.1085/jgp.70.5.567; ARMSTRONG CM, 1982, J GEN PHYSIOL, V80, P641, DOI 10.1085/jgp.80.5.641; BEZANILLA F, 1977, J GEN PHYSIOL, V70, P549, DOI 10.1085/jgp.70.5.549; CAHALAN MD, 1978, BIOPHYS J, V23, P285, DOI 10.1016/S0006-3495(78)85449-6; CATTERALL WA, 1980, ANNU REV PHARMACOL, V20, P15, DOI 10.1146/annurev.pa.20.040180.000311; GUY HR, 1988, CURR TOP MEMBR TRANS, V33, P289; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hille B., 1992, IONIC CHANNELS EXCIT; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; JOSEPH D, 1990, SCIENCE, V249, P1425, DOI 10.1126/science.2402636; MACGREGOR GR, 1987, SOMAT CELL MOLEC GEN, V13, P253, DOI 10.1007/BF01535207; MARGOLSKEE RF, 1993, BIOTECHNIQUES, V15, P906; MOORMAN JR, 1990, SCIENCE, V250, P688; MURRELLLAGNADO RD, 1993, J GEN PHYSIOL, V102, P949, DOI 10.1085/jgp.102.6.949; PATTON DE, 1993, NEURON, V11, P967; PATTON DE, 1992, P NATL ACAD SCI USA, V89, P10905, DOI 10.1073/pnas.89.22.10905; SEED B, 1987, NATURE, V329, P840, DOI 10.1038/329840a0; STRICHARTZ G, 1987, ANNU REV NEUROSCI, V10, P237; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; UKOMADU C, 1992, NEURON, V8, P663, DOI 10.1016/0896-6273(92)90088-U; VASSILEV P, 1989, P NATL ACAD SCI USA, V86, P8147, DOI 10.1073/pnas.86.20.8147; VASSILEV PM, 1988, SCIENCE, V241, P1658, DOI 10.1126/science.2458625; WEST JW, 1992, NEURON, V8, P59, DOI 10.1016/0896-6273(92)90108-P; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520	28	130	131	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	1994	12	5					1041	1048		10.1016/0896-6273(94)90312-3	http://dx.doi.org/10.1016/0896-6273(94)90312-3			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NM831	8185942				2022-12-24	WOS:A1994NM83100008
J	COHENCORY, S; FRASER, SE				COHENCORY, S; FRASER, SE			BDNF IN THE DEVELOPMENT OF THE VISUAL-SYSTEM OF XENOPUS	NEURON			English	Article							NERVE GROWTH-FACTOR; RETINAL GANGLION-CELLS; TYROSINE PROTEIN-KINASE; FACTOR MESSENGER-RNA; NEUROTROPHIC FACTOR; NGF RECEPTOR; MAP FORMATION; MOLECULAR-CLONING; RETINOTECTAL MAP; FACTOR FAMILY	To explore the role of BDNF during Xenopus visual system development, the expression of BDNF and TrkB, as well as the effect of BDNF during retinal ganglion cell (RGC) development in culture, was examined. BDNF mRNA was found to be expressed in both the developing eye and tectum, peaking at stage 45/46. The expression of BDNF coincided with RGC expression of full-length trkB transcripts, suggesting a functional role for BDNF. In culture, BDNF significantly increased the number of RGCs. The ability of BDNF to rescue differentiated RGCs that had projected to the tectum, the time course of the effect, and the lack of mitogenic response indicate that this neurotrophin promotes survival. The expression of BDNF and TrkB and the responsiveness of RGCs to BDNF coincide with retinal axon terminal arborization and patterning. Our results indicate that BDNF is a relevant neurotrophin for Xenopus RGC development and suggest that it plays a role during visual system patterning.			COHENCORY, S (corresponding author), CALTECH,BECKMAN INST,DIV BIOL,PASADENA,CA 91125, USA.		Fraser, Scott/Y-3406-2019	Fraser, Scott/0000-0002-5377-0223	NIMH NIH HHS [NIMH MH49176] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH049176] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; BEACH DH, 1979, J COMP NEUROL, V183, P603, DOI 10.1002/cne.901830308; BERKEMEIER LR, 1991, NEURON, V7, P857, DOI 10.1016/0896-6273(91)90287-A; CARMIGNOTO G, 1989, J NEUROSCI, V9, P1263; CARMIGNOTO G, 1991, EXP NEUROL, V111, P302, DOI 10.1016/0014-4886(91)90097-V; CHAKRABARTI S, 1990, BRAIN RES, V523, P11, DOI 10.1016/0006-8993(90)91630-Y; CHAO MV, 1992, NEURON, V9, P583, DOI 10.1016/0896-6273(92)90023-7; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COHENCORY S, 1991, J NEUROSCI, V11, P462; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; EASTER SS, 1984, J NEUROSCI, V4, P1052; EBENDAL T, 1988, DEVELOPMENT, V102, P101; ERNFORS P, 1992, EUR J NEUROSCI, V4, P1140, DOI 10.1111/j.1460-9568.1992.tb00141.x; ESCANDON E, 1993, J NEUROSCI RES, V34, P601, DOI 10.1002/jnr.490340602; ESCANDON E, 1994, IN PRESS J NEUROSCI; FRASER SE, 1983, DEV BIOL, V95, P505, DOI 10.1016/0012-1606(83)90053-2; FRASER SE, 1990, J NEUROBIOL, V21, P51, DOI 10.1002/neu.480210105; FRIEDMAN WJ, 1991, EUR J NEUROSCI, V3, P688, DOI 10.1111/j.1460-9568.1991.tb00854.x; GAZE RM, 1979, J EMBRYOL EXP MORPH, V53, P103; GAZE RM, 1992, J COMP NEUROL, V315, P264, DOI 10.1002/cne.903150303; GLASS DJ, 1991, CELL, V66, P405, DOI 10.1016/0092-8674(91)90629-D; GRANT P, 1989, DEV BIOL, V133, P502, DOI 10.1016/0012-1606(89)90053-5; HALLBOOK F, 1991, NEURON, V6, P845, DOI 10.1016/0896-6273(91)90180-8; HOFER M, 1990, EMBO J, V9, P2459, DOI 10.1002/j.1460-2075.1990.tb07423.x; HOFER MM, 1988, NATURE, V331, P261, DOI 10.1038/331261a0; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; HOLT CE, 1983, NATURE, V301, P150, DOI 10.1038/301150a0; HOLT CE, 1988, NEURON, V1, P15, DOI 10.1016/0896-6273(88)90205-X; HUMPHREY MF, 1988, J NEUROCYTOL, V17, P293, DOI 10.1007/BF01187852; ISACKSON PJ, 1991, FEBS LETT, V285, P260, DOI 10.1016/0014-5793(91)80812-H; JACOBSON M, 1968, DEV BIOL, V17, P219, DOI 10.1016/0012-1606(68)90062-6; JOHNSON JE, 1986, J NEUROSCI, V6, P3031; KALCHEIM C, 1992, P NATL ACAD SCI USA, V89, P1661, DOI 10.1073/pnas.89.5.1661; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KELLER R, 1991, XENOPUS LAEVIS PRACT, P102; KLEIN R, 1992, NEURON, V8, P947, DOI 10.1016/0896-6273(92)90209-V; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; LARGE TH, 1986, SCIENCE, V234, P352, DOI 10.1126/science.3764415; LEE VMY, 1988, P NATL ACAD SCI USA, V85, P1998, DOI 10.1073/pnas.85.6.1998; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; LU B, 1989, EXP NEUROL, V104, P191, DOI 10.1016/0014-4886(89)90029-0; MACLEISH PR, 1984, J PHYSIOL-LONDON, V348, P645, DOI 10.1113/jphysiol.1984.sp015131; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; OROURKE NA, 1990, NEURON, V5, P159, DOI 10.1016/0896-6273(90)90306-Z; OROURKE NA, 1986, DEV BIOL, V114, P265, DOI 10.1016/0012-1606(86)90191-0; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; REH TA, 1984, J NEUROSCI, V4, P442; RODRIGEUZTEBAR A, 1988, J NEUROSCI, V8, P3337; RODRIGUEZTEBAR A, 1990, NEURON, V4, P487, DOI 10.1016/0896-6273(90)90107-Q; RODRIGUEZTEBAR A, 1989, DEV BIOL, V136, P296, DOI 10.1016/0012-1606(89)90256-X; ROSENTHAL A, 1990, NEURON, V4, P767, DOI 10.1016/0896-6273(90)90203-R; SAKAGUCHI DS, 1985, J NEUROSCI, V5, P3228; SCHECTERSON LC, 1992, NEURON, V9, P449, DOI 10.1016/0896-6273(92)90183-E; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; STAHLE U, 1994, TRENDS GENET, V10, P75; STRAZNICKY K, 1971, J EMBRYOL EXP MORPH, V26, P67; THANOS S, 1989, EUR J NEUROSCI, V1, P19, DOI 10.1111/j.1460-9568.1989.tb00770.x; TSOULFAS P, 1993, NEURON, V10, P975, DOI 10.1016/0896-6273(93)90212-A; TURNER JE, 1979, BRAIN RES, V171, P197, DOI 10.1016/0006-8993(79)90327-5; UDIN SB, 1988, ANNU REV NEUROSCI, V11, P289, DOI 10.1146/annurev.ne.11.030188.001445; VONBARTHELD CS, 1991, J COMP NEUROL, V310, P103, DOI 10.1002/cne.903100110; WETTS R, 1989, DEV BIOL, V136, P254, DOI 10.1016/0012-1606(89)90146-2; WHITTEMORE SR, 1987, BRAIN RES REV, V12, P439, DOI 10.1016/0165-0173(87)90008-7; WRIGHT EM, 1992, NEURON, V9, P139, DOI 10.1016/0896-6273(92)90229-7; YIP HK, 1982, BRAIN RES, V238, P329, DOI 10.1016/0006-8993(82)90108-1	71	135	137	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1994	12	4					747	761		10.1016/0896-6273(94)90328-X	http://dx.doi.org/10.1016/0896-6273(94)90328-X			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NH253	8068082				2022-12-24	WOS:A1994NH25300004
J	PATTON, DE; WEST, JW; CATTERALL, WA; GOLDIN, AL				PATTON, DE; WEST, JW; CATTERALL, WA; GOLDIN, AL			A PEPTIDE SEGMENT CRITICAL FOR SODIUM-CHANNEL INACTIVATION FUNCTIONS AS AN INACTIVATION GATE IN A POTASSIUM CHANNEL	NEURON			English	Article							SHAKER K+ CHANNEL; GATING PROPERTIES; GENE; BRAIN; DROSOPHILA; CLONING	The short cytoplasmic peptide segment connecting domains III and IV of voltage-gated sodium channels (III-IV linker) is essential for fast inactivation. To test the functional similarity between the III-IV linker and the potassium channel inactivation particle, we attached the III-IV linker to the amino terminus of a noninactivating potassium channel. This chimeric channel inactivated rapidly and displayed biophysical properties similar to Shaker A-type potassium channels. Recovery f rom inactivation in the chimeric channels was accelerated by high external potassium, consistent with the idea that potassium ions passing through the channel displaced the III-IV linker inactivation particle. A mutation that completely abolishes fast inactivation in rat brain sodium channels also completely abolished inactivation in the chimera. These results demonstrate that the sodium channel III-IV linker can function as a fast inactivation gate and suggest a functional relationship between the fast inactivation processes of sodium and potassium channels.	UNIV CALIF IRVINE,DEPT MICROBIOL & MOLEC GENET,IRVINE,CA 92717; UNIV WASHINGTON,SCH MED,DEPT PHARMACOL,SEATTLE,WA 98195	University of California System; University of California Irvine; University of Washington; University of Washington Seattle			Goldin, Alan/A-8385-2015	Goldin, Alan/0000-0001-7159-0288	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026729, R01NS025704, R01NS015751] Funding Source: NIH RePORTER; NINDS NIH HHS [NS25704, NS15751, NS26729] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALDRICH RW, 1983, NATURE, V306, P436, DOI 10.1038/306436a0; ARMSTRON.CM, 1969, J GEN PHYSIOL, V54, P553, DOI 10.1085/jgp.54.5.553; ARMSTRONG CM, 1977, J GEN PHYSIOL, V70, P567, DOI 10.1085/jgp.70.5.567; ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; AULD VJ, 1990, P NATL ACAD SCI USA, V87, P323, DOI 10.1073/pnas.87.1.323; AULD VJ, 1988, NEURON, V1, P449, DOI 10.1016/0896-6273(88)90176-6; Barchi R L, 1992, Curr Opin Neurobiol, V2, P631, DOI 10.1016/0959-4388(92)90031-F; BEZANILLA F, 1977, J GEN PHYSIOL, V70, P549, DOI 10.1085/jgp.70.5.549; CANNON SC, 1991, NEURON, V6, P619, DOI 10.1016/0896-6273(91)90064-7; CANNON SC, 1993, NEURON, V10, P3617; CHANDY KG, 1990, SCIENCE, V247, P973, DOI 10.1126/science.2305265; CHOI KL, 1993, NEURON, V10, P533, DOI 10.1016/0896-6273(93)90340-W; DEMO SD, 1991, NEURON, V7, P743, DOI 10.1016/0896-6273(91)90277-7; EATON DC, 1978, NATURE, V271, P473, DOI 10.1038/271473a0; GOLDIN AL, 1991, METHOD CELL BIOL, V36, P487; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; ISACOFF EY, 1991, NATURE, V353, P86, DOI 10.1038/353086a0; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; KIRSCH GE, 1980, J GEN PHYSIOL, V76, P315, DOI 10.1085/jgp.76.3.315; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LEHMANNHORN F, 1991, PFLUG ARCH EUR J PHY, V418, P297, DOI 10.1007/BF00370530; MORELLO R, 1980, BIOPHYS J, V31, P435, DOI 10.1016/S0006-3495(80)85071-5; MURRELLLAGNADO RD, 1993, IN PRESS J GEN PHYSL; PAPAZIAN DM, 1987, SCIENCE, V237, P749, DOI 10.1126/science.2441470; PATTON DE, 1991, NEURON, V7, P637, DOI 10.1016/0896-6273(91)90376-B; PATTON DE, 1992, P NATL ACAD SCI USA, V89, P10910; PTACEK LJ, 1993, ANN NEUROL, V33, P300, DOI 10.1002/ana.410330312; ROJAS E, 1976, J PHYSIOL-LONDON, V262, P501, DOI 10.1113/jphysiol.1976.sp011608; RUPPERSBERG JP, 1991, NATURE, V353, P657, DOI 10.1038/353657a0; STOCKER M, 1991, P ROY SOC B-BIOL SCI, V245, P101, DOI 10.1098/rspb.1991.0094; STUHMER W, 1988, FEBS LETT, V242, P199, DOI 10.1016/0014-5793(88)81015-9; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; TEMPEL BL, 1988, NATURE, V332, P837, DOI 10.1038/332837a0; VASSILEV P, 1989, P NATL ACAD SCI USA, V86, P8147, DOI 10.1073/pnas.86.20.8147; VASSILEV PM, 1988, SCIENCE, V241, P1658, DOI 10.1126/science.2458625; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10905; YEH JZ, 1977, J GEN PHYSIOL, V69, P293, DOI 10.1085/jgp.69.3.293; ZAGOTTA WN, 1990, J GEN PHYSIOL, V95, P29, DOI 10.1085/jgp.95.1.29; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520	40	45	45	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1993	11	5					967	974						8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MJ041	8240817				2022-12-24	WOS:A1993MJ04100017
J	BRITT, SG; FEILER, R; KIRSCHFELD, K; ZUKER, CS				BRITT, SG; FEILER, R; KIRSCHFELD, K; ZUKER, CS			SPECTRAL TUNING OF RHODOPSIN AND METARHODOPSIN IN-VIVO	NEURON			English	Article							SCHIFF-BASE COUNTERION; HUMAN COLOR-VISION; BOVINE RHODOPSIN; OPSIN GENE; PHOTORECEPTOR CELL; AMINO-ACIDS; DROSOPHILA-MELANOGASTER; ABSORPTION-SPECTRA; MOLECULAR-GENETICS; VISUAL PIGMENTS	Color vision is dependent upon the expression of spectrally distinct forms of rhodopsin in different photoreceptor cells. To identify the structural features of rhodopsin that regulate spectral sensitivity and absorption in vivo, we have constructed a series of chimeric Drosophila rhodopsin molecules, derived from a blue- and a violet-sensitive rhodopsin, and used P element-mediated germline transformation to generate transgenic flies that express the modified pigments in the R1-R6 photoreceptor cells of the compound eye. Our analysis of these animals indicates that multiple regions of the opsin protein are involved in regulating rhodopsin spectral sensitivity and that the native and photoactivated forms of rhodopsin can be tuned independently of each other. These results demonstrate the feasibility of designing receptor molecules with specifically modified activated states.	UNIV CALIF SAN DIEGO, HOWARD HUGHES MED INST, LA JOLLA, CA 92093 USA; MAX PLANCK INST BIOL CYBERNET, D-72076 TUBINGEN, GERMANY; UNIV CALIF SAN DIEGO, DEPT NEUROSCI, LA JOLLA, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; Max Planck Society; University of California System; University of California San Diego	BRITT, SG (corresponding author), UNIV CALIF SAN DIEGO, DEPT BIOL, LA JOLLA, CA 92093 USA.		Britt, Steven/GVT-1340-2022	Britt, Steven/0000-0001-7656-7984				BIRGE RR, 1981, ANNU REV BIOPHYS BIO, V10, P315, DOI 10.1146/annurev.bb.10.060181.001531; CHAN T, 1992, J BIOL CHEM, V267, P9478; COLLEY NJ, 1991, CELL, V67, P255, DOI 10.1016/0092-8674(91)90177-Z; COWMAN AF, 1986, CELL, V44, P705, DOI 10.1016/0092-8674(86)90836-6; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; FEILER R, 1992, J NEUROSCI, V12, P3862; FEILER R, 1988, NATURE, V333, P737, DOI 10.1038/333737a0; FISCHER UC, 1981, PHOTOCHEM PHOTOBIOL, V33, P529, DOI 10.1111/j.1751-1097.1981.tb05456.x; FRYXELL KJ, 1987, EMBO J, V6, P443, DOI 10.1002/j.1460-2075.1987.tb04774.x; Hardie R.C., 1985, Progress in Sensory Physiology, V5, P1; HARGRAVE PA, 1983, BIOPHYS STRUCT MECH, V9, P235, DOI 10.1007/BF00535659; HEISENBERG M, 1971, J EXP BIOL, V55, P85; HEISENBERG M, 1984, VISION DROSOPHILA; JOHNSON EC, 1986, J GEN PHYSIOL, V88, P651, DOI 10.1085/jgp.88.5.651; KARESS RE, 1984, CELL, V38, P135, DOI 10.1016/0092-8674(84)90534-8; KHORANA HG, 1992, J BIOL CHEM, V267, P1; KIRSCHFELD K, 1977, NATURE, V269, P386, DOI 10.1038/269386a0; KIRSCHFELD K, 1986, VISION RES, V26, P1771, DOI 10.1016/0042-6989(86)90127-6; KIRSCHFELD K, 1988, J COMP PHYSIOL A, V163, P421, DOI 10.1007/BF00604896; KIRSCHFELD K, 1978, J COMP PHYSIOL, V125, P275, DOI 10.1007/BF00656606; KOBILKA BK, 1988, SCIENCE, V240, P1310, DOI 10.1126/science.2836950; LAGNADO L, 1992, NEURON, V8, P995, DOI 10.1016/0896-6273(92)90122-T; LEWIS JW, 1992, J BIOENERG BIOMEMBR, V24, P201, DOI 10.1007/BF00762678; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; MERBS SL, 1992, SCIENCE, V258, P464, DOI 10.1126/science.1411542; MERBS SL, 1992, NATURE, V356, P433, DOI 10.1038/356433a0; MINKE B, 1986, MOL MECHANISM PHOTOR, P241; MONTELL C, 1987, J NEUROSCI, V7, P1558; NAKAYAMA TA, 1990, J BIOL CHEM, V265, P15762; NAKAYAMA TA, 1991, J BIOL CHEM, V266, P4269; NATHANS J, 1990, BIOCHEMISTRY-US, V29, P937, DOI 10.1021/bi00456a013; NATHANS J, 1990, BIOCHEMISTRY-US, V29, P9746, DOI 10.1021/bi00493a034; NATHANS J, 1992, BIOCHEMISTRY-US, V31, P4923, DOI 10.1021/bi00136a001; NATHANS J, 1986, SCIENCE, V232, P203, DOI 10.1126/science.3485310; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; NEITZ M, 1991, SCIENCE, V252, P971, DOI 10.1126/science.1903559; OPRIAN DD, 1991, BIOCHEMISTRY-US, V30, P11367, DOI 10.1021/bi00112a002; OPRIAN DD, 1992, J BIOENERG BIOMEMBR, V24, P211, DOI 10.1007/BF00762679; OSAWA S, 1990, CELL, V63, P697, DOI 10.1016/0092-8674(90)90136-3; OTOUSA JE, 1985, CELL, V40, P839, DOI 10.1016/0092-8674(85)90343-5; OVCHINNIKOV YA, 1979, FEBS LETT, V100, P219, DOI 10.1016/0014-5793(79)80338-5; POLLOCK JA, 1988, NATURE, V333, P779, DOI 10.1038/333779a0; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SAKMAR TP, 1991, P NATL ACAD SCI USA, V88, P3079, DOI 10.1073/pnas.88.8.3079; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; Schwemer J., 1989, P112; SMITH DP, 1991, ANNU REV CELL BIOL, V7, P161; Stavenga DG, 1989, FACETS VISION, P152; STRYER L, 1986, ANNU REV NEUROSCI, V9, P87, DOI 10.1146/annurev.ne.09.030186.000511; YON J, 1989, NUCLEIC ACIDS RES, V17, P4895, DOI 10.1093/nar/17.12.4895; ZHUKOVSKY EA, 1989, SCIENCE, V246, P928, DOI 10.1126/science.2573154; ZUKER CS, 1987, J NEUROSCI, V7, P1550; ZUKER CS, 1988, CELL, V53, P475, DOI 10.1016/0092-8674(88)90167-5; ZUKER CS, 1985, CELL, V40, P851, DOI 10.1016/0092-8674(85)90344-7	54	40	42	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	1993	11	1					29	39		10.1016/0896-6273(93)90268-V	http://dx.doi.org/10.1016/0896-6273(93)90268-V			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LP430	8338666				2022-12-24	WOS:A1993LP43000003
J	YOSHIDA, K; KAWAMURA, K; IMAKI, J				YOSHIDA, K; KAWAMURA, K; IMAKI, J			DIFFERENTIAL EXPRESSION OF C-FOS MESSENGER-RNA IN RAT RETINAL CELLS - REGULATION BY LIGHT-DARK CYCLE	NEURON			English	Article							N-ACETYLTRANSFERASE ACTIVITY; PROTO-ONCOGENE; NERVOUS-SYSTEM; GENE; STIMULATION; NEURONS; IMMUNOREACTIVITY; TRANSCRIPTION; DEGRADATION; ACTIVATION	The distribution and levels of c-fos expression in response to changes in the light/dark cycle were examined in rat retina by in situ hybridization histochemistry. Under a 12 hr light:l 2 hr dark cycle (LD 12:12), c-fos mRNA levels in the inner nuclear layer and the ganglion cell layer increased transiently for 30 min immediately following the onset of the light period, whereas in the outer nuclear layer, c-fos mRNA expression was observed throughout the dark period. During a period of extended darkness following the dark period of LD 12:12, c-fos mRNA levels in the outer nuclear layer remained cyclic-low during the day and higher during the night-suggesting an endogenously generated rhythm. Furthermore, since a 30 min pulse of light during the dark period decreased c-fos expression in the outer nuclear layer, whereas a similar pulse of darkness during the light period resulted in an increase, environmental light/dark cues are also suggested to influence c-fos gene expression.	NIPPON MED COLL,DEPT ANAT,BUNKYO KU,TOKYO 113,JAPAN	Nippon Medical School	YOSHIDA, K (corresponding author), KEIO UNIV,SCH MED,DEPT ANAT,35 SHINANOMACHI,SHINJUKU KU,TOKYO 160,JAPAN.							BINKLEY S, 1979, NATURE, V281, P479, DOI 10.1038/281479a0; BOWES C, 1988, EXP EYE RES, V47, P369, DOI 10.1016/0014-4835(88)90049-8; BRANN MR, 1987, SCIENCE, V235, P585, DOI 10.1126/science.3101175; CAHILL GM, 1991, CELL MOL NEUROBIOL, V11, P529, DOI 10.1007/BF00734814; DRAGUNOW M, 1987, NATURE, V329, P441, DOI 10.1038/329441a0; EHINGER B, 1987, HDB CHEM NEUROANATOM, V5, P389; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; GREENBERG ME, 1986, SCIENCE, V234, P80, DOI 10.1126/science.3749894; GRIFERATH U, 1990, J COMP NEUROL, V301, P433; IUVONE PM, 1983, BRAIN RES, V273, P111, DOI 10.1016/0006-8993(83)91099-5; JACOBSON L, 1990, ENDOCRINOLOGY, V126, P1709, DOI 10.1210/endo-126-3-1709; KOIBUCHI N, 1991, ENDOCRINOLOGY, V129, P3208, DOI 10.1210/endo-129-6-3208; KORENBROT JI, 1989, NATURE, V337, P454, DOI 10.1038/337454a0; KORNHAUSER JM, 1990, NEURON, V5, P127, DOI 10.1016/0896-6273(90)90303-W; KRUIJER W, 1984, NATURE, V312, P711, DOI 10.1038/312711a0; MORGAN JI, 1986, NATURE, V322, P552, DOI 10.1038/322552a0; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; MULLER R, 1984, NATURE, V312, P716, DOI 10.1038/312716a0; NARANJO JR, 1991, NEURON, V6, P607, DOI 10.1016/0896-6273(91)90063-6; NOWAK JZ, 1990, ADV PINEAL, V4, P81; SAGAR SM, 1990, MOL BRAIN RES, V7, P17, DOI 10.1016/0169-328X(90)90068-O; SASSONECORSI P, 1988, NATURE, V334, P314, DOI 10.1038/334314a0; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; SIMMONS DM, 1989, J HISTOTECHNOL, V12, P169; SONNENBERG JL, 1989, SCIENCE, V246, P1622, DOI 10.1126/science.2512642; TOMITA T, 1967, VISION RES, V7, P519, DOI 10.1016/0042-6989(67)90061-2; WASSLE H, 1991, VISUAL NEUROSCI, V7, P99, DOI 10.1017/S095252380001097X; WILSON T, 1988, NATURE, V336, P396, DOI 10.1038/336396a0	29	110	110	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1993	10	6					1049	1054		10.1016/0896-6273(93)90053-T	http://dx.doi.org/10.1016/0896-6273(93)90053-T			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LK373	8318229				2022-12-24	WOS:A1993LK37300005
J	CORMIER, RJ; MAUK, MD; KELLY, PT				CORMIER, RJ; MAUK, MD; KELLY, PT			GLUTAMATE IONTOPHORESIS INDUCES LONG-TERM POTENTIATION IN THE ABSENCE OF EVOKED PRESYNAPTIC ACTIVITY	NEURON			English	Article							RAT HIPPOCAMPAL SLICE; METHYL-D-ASPARTATE; SYNAPTIC TRANSMISSION; AREA CA1; PERFORANT PATH; NITRIC-OXIDE; RECEPTOR DESENSITIZATION; LASTING POTENTIATION; TRANSMITTER RELEASE; CALCIUM CURRENTS	Protocols that induce long-term potentiation (LTP) typically involve afferent stimulation. We tested the hypothesis that LTP induction does not require presynaptic activity. The significance of this hypothesis is underscored by results suggesting that LTP expression may involve activity-dependent presynaptic changes. An induction protocol using glutamate iontophoresis was developed that reliably induced LTP in hippocampal slices without afferent stimulation. Iontophoresis LTP was Ca2+ dependent, was blocked by MK-801, and occluded tetanus-induced LTP. Iontophoresis LTP was induced when excitatory postsynaptic potentials were completely blocked by adenosine plus tetrodotoxin. Our results suggest constraints on the involvement of presynaptic mechanisms and putative retrograde messengers in LTP induction and expression; namely, these processes must function without many forms of activity-dependent presynaptic processes.			CORMIER, RJ (corresponding author), UNIV TEXAS,DEPT NEUROBIOL & ANAT,HOUSTON,TX 77025, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022452] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 22452] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alger B.E., 1984, BRAIN SLICES, P381; ANDERSEN P, 1977, NATURE, V266, P736, DOI 10.1038/266736a0; ANIKSZTEJN L, 1990, EUR J PHARMACOL, V181, P157, DOI 10.1016/0014-2999(90)90259-9; ANIKSZTEJN L, 1992, EUR J NEUROSCI, V4, P500, DOI 10.1111/j.1460-9568.1992.tb00900.x; ARAI A, 1990, NEUROSCI LETT, V119, P41, DOI 10.1016/0304-3940(90)90750-4; BASKYS A, 1991, J PHYSIOL-LONDON, V444, P687, DOI 10.1113/jphysiol.1991.sp018901; BEKKERS JM, 1990, P NATL ACAD SCI USA, V87, P5359, DOI 10.1073/pnas.87.14.5359; BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; BLISS T V P, 1988, P3; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BOHME GA, 1991, EUR J PHARMACOL, V199, P379, DOI 10.1016/0014-2999(91)90505-K; BONHOEFFER T, 1989, P NATL ACAD SCI USA, V86, P8113, DOI 10.1073/pnas.86.20.8113; BORTOLOTTO ZA, 1993, NEUROPHARMACOLOGY, V32, P1, DOI 10.1016/0028-3908(93)90123-K; BRANISTEANU DD, 1989, NEUROSCI LETT, V98, P96, DOI 10.1016/0304-3940(89)90380-7; CLARK GD, 1990, NEUROSCIENCE, V39, P787, DOI 10.1016/0306-4522(90)90261-2; COAN EJ, 1987, NEUROSCI LETT, V80, P111, DOI 10.1016/0304-3940(87)90505-2; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P19, DOI 10.1113/jphysiol.1983.sp014477; DELCERRO S, 1990, BEHAV NEURAL BIOL, V54, P213, DOI 10.1016/0163-1047(90)90595-W; DOLPHIN AC, 1983, NEUROSCI LETT, V39, P83, DOI 10.1016/0304-3940(83)90169-6; DUDAR JD, 1974, NEUROPHARMACOLOGY, V13, P1083, DOI 10.1016/0028-3908(74)90099-9; DUNWIDDIE T, 1978, J PHYSIOL-LONDON, V276, P353, DOI 10.1113/jphysiol.1978.sp012239; DUNWIDDIE TV, 1985, J PHYSIOL-LONDON, V369, P365, DOI 10.1113/jphysiol.1985.sp015907; DUNWIDDIE TV, 1990, ADENOSINE ADENOSINE, P143; FATT P, 1952, J PHYSIOL-LONDON, V117, P109; Foster T C, 1991, Hippocampus, V1, P79, DOI 10.1002/hipo.450010108; GROSS RA, 1989, J PHYSIOL-LONDON, V411, P585, DOI 10.1113/jphysiol.1989.sp017592; GROVER LM, 1990, BRAIN RES, V506, P53, DOI 10.1016/0006-8993(90)91198-P; GROVER LM, 1990, NATURE, V347, P477, DOI 10.1038/347477a0; GUSTAFSSON B, 1987, J NEUROSCI, V7, P774; HALEY JE, 1992, NEURON, V8, P211, DOI 10.1016/0896-6273(92)90288-O; HARRIS EW, 1985, BRAIN RES, V334, P348, DOI 10.1016/0006-8993(85)90230-6; HUANG YY, 1992, SCIENCE, V255, P730, DOI 10.1126/science.1346729; HUBBARD JI, 1968, J PHYSIOL-LONDON, V194, P355, DOI 10.1113/jphysiol.1968.sp008413; IZUMI Y, 1992, SCIENCE, V257, P1273, DOI 10.1126/science.1519065; JARVIS MF, 1989, J PHARMACOL EXP THER, V251, P888; KAUER JA, 1988, NATURE, V334, P250, DOI 10.1038/334250a0; KULLMAN DM, 1993, NEURON, V9, P1175; KULLMANN DM, 1992, NATURE, V357, P240, DOI 10.1038/357240a0; LAMBERT NA, 1991, NEUROSCI LETT, V122, P50, DOI 10.1016/0304-3940(91)90190-5; LARKMAN A, 1992, NATURE, V360, P70, DOI 10.1038/360070a0; LEE KS, 1982, BRAIN RES, V239, P617, DOI 10.1016/0006-8993(82)90538-8; LESTER RAJ, 1990, NEURON, V4, P741, DOI 10.1016/0896-6273(90)90200-Y; LIAO D, 1992, NEURON, V9, P1089, DOI 10.1016/0896-6273(92)90068-O; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; LYNCH GS, 1977, NATURE, V266, P737, DOI 10.1038/266737a0; MALENKA RC, 1988, J NEUROSCI, V8, P3750; MALENKA RC, 1991, NEURON, V6, P53, DOI 10.1016/0896-6273(91)90121-F; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; MALINOW R, 1986, NATURE, V320, P529, DOI 10.1038/320529a0; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MANABE T, 1992, NATURE, V355, P50, DOI 10.1038/355050a0; MCGUINNESS N, 1991, NEUROREPORT, V2, P688, DOI 10.1097/00001756-199111000-00014; MCGUINNESS N, 1991, NEUROSCI LETT, V131, P13, DOI 10.1016/0304-3940(91)90326-O; MITCHELL J, 1993, HIPPOCAMPUS, V3, P83; MULLER D, 1989, BRAIN RES, V479, P290, DOI 10.1016/0006-8993(89)91631-4; MULLER D, 1990, P NATL ACAD SCI USA, V87, P4073, DOI 10.1073/pnas.87.11.4073; NARAHASHI T, 1964, J GEN PHYSIOL, V47, P965, DOI 10.1085/jgp.47.5.965; ODELL TJ, 1991, P NATL ACAD SCI USA, V88, P11285, DOI 10.1073/pnas.88.24.11285; PROCTOR WR, 1987, BRAIN RES, V426, P187, DOI 10.1016/0006-8993(87)90441-0; SAKMANN B, 1983, SINGLE CHANNEL RECOR; SCHUMAN EM, 1991, SCIENCE, V254, P1503, DOI 10.1126/science.1720572; SLADECZEK F, 1985, NATURE, V317, P717, DOI 10.1038/317717a0; STALLCUP WB, 1979, J NEUROCHEM, V32, P57, DOI 10.1111/j.1471-4159.1979.tb04509.x; SUGIYAMA H, 1989, NEURON, V3, P129, DOI 10.1016/0896-6273(89)90121-9; THIBAULT O, 1989, BRAIN RES, V476, P170, DOI 10.1016/0006-8993(89)91553-9; TROMBLEY PQ, 1992, J NEUROSCI, V12, P2043; TRUSSELL LO, 1985, P NATL ACAD SCI USA, V82, P4857, DOI 10.1073/pnas.82.14.4857; TRUSSELL LO, 1989, NEURON, V3, P209, DOI 10.1016/0896-6273(89)90034-2; VANCALKER D, 1979, J NEUROCHEM, V33, P999, DOI 10.1111/j.1471-4159.1979.tb05236.x; WIGSTROM H, 1986, J PHYSIOL-PARIS, V81, P228; WILLIAMS JH, 1988, NEUROSCI LETT, V88, P81, DOI 10.1016/0304-3940(88)90319-9; WILLIAMS JH, 1989, NATURE, V341, P739, DOI 10.1038/341739a0; WINDER DG, 1993, J NEUROSCI, V13, P38; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039; ZHENG F, 1992, NEURON, V9, P163, DOI 10.1016/0896-6273(92)90231-2; ZUCKER RS, 1987, BIOPHYS J, V52, P347, DOI 10.1016/S0006-3495(87)83222-8	80	44	44	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1993	10	5					907	919		10.1016/0896-6273(93)90206-7	http://dx.doi.org/10.1016/0896-6273(93)90206-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LD322	8098611				2022-12-24	WOS:A1993LD32200013
J	FORTI, L; PIETROBON, D				FORTI, L; PIETROBON, D			FUNCTIONAL DIVERSITY OF L-TYPE CALCIUM CHANNELS IN RAT CEREBELLAR NEURONS	NEURON			English	Article							CA2+ CHANNELS; PERIPHERAL NEURONS; GATING BEHAVIOR; MULTIPLE TYPES; CARDIAC-CELLS; ACTIVATION; POTENTIATION; LOCALIZATION; FACILITATION; INACTIVATION	Single-channel recordings show that functionally different L-type Ca2+ channels coexist in rat cerebellar granules. Besides two different dihydropyridine (DHP)sensitive gating patterns with properties similar to those of cardiac L-type channels, cerebellar granules contain a third DHP-sensitive gating pattern with unusual voltage-dependent properties and slightly different conductance. This ''anomalous gating'' is characterized, on one hand, by rare, short openings with very low open probability even at high positive voltages and, on the other hand, by long openings with high open probability at negative voltages after a predepolarization. L-type channels with anomalous gating appear suited to generate a surge of Ca2+ influx following strong neuronal activity. The anomalous gating can be explained by a model in which voltage controls the equilibrium between two gating modes.			FORTI, L (corresponding author), UNIV PADUA,CNR,CTR PHYSIOL & MITOCHONDRIA,DEPT BIOMED SCI,I-35100 PADUA,ITALY.		Forti, Lia/AAU-8156-2020	Forti, Lia/0000-0003-3979-0284				AHLIJANIAN MK, 1990, NEURON, V4, P819, DOI 10.1016/0896-6273(90)90135-3; ANIKSZTEJN L, 1991, NATURE, V349, P67, DOI 10.1038/349067a0; ARTALEJO CR, 1990, NATURE, V348, P239, DOI 10.1038/348239a0; ARTALEJO CR, 1991, J PHYSIOL-LONDON, V444, P213, DOI 10.1113/jphysiol.1991.sp018874; ARTALEJO CR, 1992, NATURE, V358, P63, DOI 10.1038/358063a0; BONEV A, 1992, PFLUG ARCH EUR J PHY, V420, P219, DOI 10.1007/BF00374994; CAVALIE A, 1986, PFLUG ARCH EUR J PHY, V406, P241, DOI 10.1007/BF00640910; CHIN H, 1992, FEBS LETT, V299, P69, DOI 10.1016/0014-5793(92)80103-N; Colquhoun D, 1983, SINGLE CHANNEL RECOR, P191; FISHER RE, 1990, J NEUROPHYSIOL, V64, P91, DOI 10.1152/jn.1990.64.1.91; GROVER LM, 1990, NATURE, V347, P477, DOI 10.1038/347477a0; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HESS P, 1984, NATURE, V311, P538, DOI 10.1038/311538a0; HORN R, 1983, BIOPHYS J, V43, P207, DOI 10.1016/S0006-3495(83)84341-0; JOHNSTON D, 1992, ANNU REV PHYSIOL, V54, P489; KASAI H, 1991, P NATL ACAD SCI USA, V88, P8855, DOI 10.1073/pnas.88.19.8855; KOKUBUN S, 1984, P NATL ACAD SCI-BIOL, V81, P4824, DOI 10.1073/pnas.81.15.4824; LEVI G, 1984, BRAIN RES, V290, P77, DOI 10.1016/0006-8993(84)90737-6; MCMANUS OB, 1987, PFLUG ARCH EUR J PHY, V410, P530, DOI 10.1007/BF00586537; MILLER RJ, 1987, SCIENCE, V235, P46, DOI 10.1126/science.2432656; MOGUL DJ, 1991, J PHYSIOL-LONDON, V433, P259, DOI 10.1113/jphysiol.1991.sp018425; MURPHY TH, 1991, NEURON, V7, P625, DOI 10.1016/0896-6273(91)90375-A; NOWYCKY MC, 1985, P NATL ACAD SCI USA, V82, P2178, DOI 10.1073/pnas.82.7.2178; PIETROBON D, 1990, NATURE, V346, P651, DOI 10.1038/346651a0; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; RAO CR, 1973, LINEAR STATISTICAL I; REGAN LJ, 1991, NEURON, V6, P269, DOI 10.1016/0896-6273(91)90362-4; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; SLESINGER PA, 1991, NEURON, V7, P755, DOI 10.1016/0896-6273(91)90278-8; SLESINGER PA, 1991, J PHYSIOL-LONDON, V439, P301, DOI 10.1113/jphysiol.1991.sp018668; SNUTCH TP, 1991, NEURON, V7, P45, DOI 10.1016/0896-6273(91)90073-9; TSIEN RW, 1991, TRENDS PHARMACOL SCI, V12, P349, DOI 10.1016/0165-6147(91)90595-J; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; WICKENS JR, 1991, NEUROSCI LETT, V130, P128, DOI 10.1016/0304-3940(91)90244-N; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; YUE DT, 1990, P NATL ACAD SCI USA, V87, P753, DOI 10.1073/pnas.87.2.753	36	93	93	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1993	10	3					437	450		10.1016/0896-6273(93)90332-L	http://dx.doi.org/10.1016/0896-6273(93)90332-L			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KU901	8384858				2022-12-24	WOS:A1993KU90100009
J	Moratalla, R; Elibol, B; Vallejo, M; Graybiel, AM				Moratalla, R; Elibol, B; Vallejo, M; Graybiel, AM			Network-level changes in expression of inducible Fos-Jun proteins in the striatum during chronic cocaine treatment and withdrawal	NEURON			English	Article							C-FOS; DOPAMINE-RECEPTORS; RAT STRIATUM; INDUCTION; DYNORPHIN; IMMUNOREACTIVITY; SENSITIZATION; AMPHETAMINE; ACTIVATION; SYSTEMS	Repeated exposures to psychomotor stimulants produce long-term changes in behavior ranging from addiction to behavioral sensitization. Many of these behaviors depend on the nigrostriatal system of the basal ganglia. We show here that chronic cocaine exposure not only leads to time-varying alterations in the inducibility of bZIP transcription factors in individual striatal neurons, but also to long-lasting network changes in which ensembles of striatal neurons express these proteins. These network-level adaptations suggest that the behavioral sensitization induced by repeated psychomotor stimulant exposure may reflect an enduring functional reorganization of basal ganglia circuits.	HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,REPROD ENDOCRINE UNIT,BOSTON,MA 02114	Harvard University; Harvard Medical School; Massachusetts General Hospital	Moratalla, R (corresponding author), MIT,DEPT BRAIN & COGNIT SCI,E25-618,CAMBRIDGE,MA 02139, USA.		Moratalla, Rosario V/H-9280-2015	Moratalla, Rosario V/0000-0002-7623-8010; Graybiel, Ann/0000-0002-4326-7720; Vallejo, Mario/0000-0002-6422-0323	NIDA NIH HHS [DA08037] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA008037] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		AOSAKI T, 1995, J NEUROPHYSIOL, V73, P1234, DOI 10.1152/jn.1995.73.3.1234; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; BERRETTA S, 1992, J NEUROPHYSIOL, V68, P767, DOI 10.1152/jn.1992.68.3.767; BHAT RV, 1993, J PHARMACOL EXP THER, V267, P496; CADOR M, 1995, NEUROSCIENCE, V65, P385, DOI 10.1016/0306-4522(94)00524-9; CENCI MA, 1992, EUR J NEUROSCI, V4, P376, DOI 10.1111/j.1460-9568.1992.tb00885.x; COLE RL, 1995, NEURON, V14, P813, DOI 10.1016/0896-6273(95)90225-2; DAUNAIS JB, 1995, MOL BRAIN RES, V29, P201, DOI 10.1016/0169-328X(94)00246-B; DILTS RP, 1993, SYNAPSE, V13, P251, DOI 10.1002/syn.890130308; EBLEN F, 1995, J NEUROSCI, V15, P5999; FRANK DA, 1994, CELL, V79, P5, DOI 10.1016/0092-8674(94)90394-8; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; GRAYBIEL AM, 1990, P NATL ACAD SCI USA, V87, P6912, DOI 10.1073/pnas.87.17.6912; Graybiel AM, 1995, CURR OPIN NEUROBIOL, V5, P733, DOI 10.1016/0959-4388(95)80100-6; HOPE BT, 1994, NEURON, V13, P1235, DOI 10.1016/0896-6273(94)90061-2; HUANG YY, 1995, P NATL ACAD SCI USA, V92, P2446, DOI 10.1073/pnas.92.7.2446; JOHANSSON B, 1994, NEUROSCIENCE, V59, P837, DOI 10.1016/0306-4522(94)90288-7; KALIVAS PW, 1991, BRAIN RES REV, V16, P223, DOI 10.1016/0165-0173(91)90007-U; KALIVAS PW, 1993, J NEUROSCI, V13, P266; KAWAGUCHI Y, 1995, TRENDS NEUROSCI, V18, P527, DOI 10.1016/0166-2236(95)98374-8; LAHOSTE GJ, 1993, P NATL ACAD SCI USA, V90, P7451, DOI 10.1073/pnas.90.16.7451; MORATALLA R, 1993, J NEUROSCI, V13, P423; MORATALLA R, 1992, J NEUROSCI, V12, P2609; Nye HE, 1995, J PHARMACOL EXP THER, V275, P1671; PAUL ML, 1992, J NEUROSCI, V12, P3729, DOI 10.1523/jneurosci.12-10-03729.1992; ROBINSON TE, 1986, BRAIN RES REV, V11, P157, DOI 10.1016/0165-0173(86)90002-0; ROSEN JB, 1994, MOL BRAIN RES, V25, P168, DOI 10.1016/0169-328X(94)90295-X; RUSKIN DN, 1994, SYNAPSE, V18, P233, DOI 10.1002/syn.890180309; SELF DW, 1995, ANNU REV NEUROSCI, V18, P463, DOI 10.1146/annurev.neuro.18.1.463; SIVAM SP, 1989, J PHARMACOL EXP THER, V250, P818; SMILEY PL, 1990, J PHARMACOL EXP THER, V253, P938; STEINER H, 1995, J COMP NEUROL, V353, P200, DOI 10.1002/cne.903530204; TORRES G, 1993, BRAIN RES BULL, V30, P173, DOI 10.1016/0361-9230(93)90055-G; WANG JQ, 1994, SYNAPSE, V18, P343, DOI 10.1002/syn.890180410; WIRTSHAFTER D, 1994, BRAIN RES BULL, V35, P85, DOI 10.1016/0361-9230(94)90220-8; Wise RA, 1996, ANNU REV NEUROSCI, V19, P319, DOI 10.1146/annurev.ne.19.030196.001535; XU M, 1994, CELL, V79, P729, DOI 10.1016/0092-8674(94)90557-6; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YOUNG ST, 1991, P NATL ACAD SCI USA, V88, P1291, DOI 10.1073/pnas.88.4.1291; ZHANG WQ, 1992, BRAIN RES, V577, P312, DOI 10.1016/0006-8993(92)90289-L	41	232	235	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1996	17	1					147	156		10.1016/S0896-6273(00)80288-3	http://dx.doi.org/10.1016/S0896-6273(00)80288-3			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UY981	8755486	Bronze			2022-12-24	WOS:A1996UY98100015
J	Subramony, P; Raucher, S; Dryer, L; Dryer, SE				Subramony, P; Raucher, S; Dryer, L; Dryer, SE			Posttranslational regulation of Ca2+-activated K+ currents by a target-derived factor in developing parasympathetic neurons	NEURON			English	Article							CILIARY-GANGLION NEURONS; ACTIVATED POTASSIUM CHANNELS; ACETYLCHOLINE-RECEPTOR; NEUROTROPHIC FACTORS; SYMPATHETIC NEURONS; CELL-SURVIVAL; A-CURRENTS; IN-SITU; DIFFERENTIATION; TRANSMISSION	Macroscopic /(K[Ca) is not expressed at normal levels in chick ciliary ganglion (CG) neurons prior to synapse formation with target tissues, or in neurons developing in vitro or in situ in the absence of target tissues. Here, two chick CG s/o partial cDNAs encoding /(K[Ca) channels were isolated, cloned, and sequenced. Both s/o transcripts were readily detected in developing Co neurons prior to or in the absence of target tissue interactions. When Co neurons developed in vitro in the presence of target tissue (iris) extracts, a normal whole-cell /(K[Ca) was expressed. These effects did not require protein synthesis, and the activity was detectable throughout the stages of synapse formation in the iris. The active component has an apparent molecular weight of 40-60 kDa.	HARVARD UNIV,SCH MED,DEPT NEUROBIOL,BOSTON,MA 02115	Harvard University; Harvard Medical School	Subramony, P (corresponding author), FLORIDA STATE UNIV,PROGRAM NEUROSCI & MOL BIOPHYS,TALLAHASSEE,FL 32306, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037348] Funding Source: NIH RePORTER; NINDS NIH HHS [NS37348] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADELMAN JP, 1992, NEURON, V9, P209, DOI 10.1016/0896-6273(92)90160-F; ARENELLA L, 1993, J NEUROSCI, V13, P4625; ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; CHIAPPINELLI VA, 1978, DEV NEUROSCI-BASEL, V1, P191, DOI 10.1159/000112574; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHUNG SK, 1991, SCIENCE, V253, P560, DOI 10.1126/science.1857986; COLLINS F, 1991, J NEUROSCI, V11, P2582; COULOMBE JN, 1991, J NEUROSCI, V11, P553; COULOMBE JN, 1993, NEURON, V10, P899, DOI 10.1016/0896-6273(93)90205-6; DOURADO MM, 1992, J PHYSIOL-LONDON, V449, P411, DOI 10.1113/jphysiol.1992.sp019093; DOURADO MM, 1994, J NEUROSCI, V14, P3156; DOURADO MM, 1994, J PHYSIOL-LONDON, V474, P367, DOI 10.1113/jphysiol.1994.sp020029; DRYER SE, 1991, J PHYSIOL-LONDON, V443, P601, DOI 10.1113/jphysiol.1991.sp018854; DRYER SE, 1994, PROG NEUROBIOL, V43, P281, DOI 10.1016/0301-0082(94)90003-5; ENGISCH KL, 1992, J NEUROSCI, V12, P1115; FURBER S, 1987, J NEUROSCI, V7, P1816; HABECKER BA, 1995, DEV BIOL, V167, P307, DOI 10.1006/dbio.1995.1025; HALVORSEN SW, 1991, J NEUROSCI, V11, P2177; JACOB MH, 1986, J CELL BIOL, V103, P205, DOI 10.1083/jcb.103.1.205; JACOB MH, 1991, J NEUROSCI, V11, P1701; JOHNSON EM, 1992, EXP NEUROL, V115, P163, DOI 10.1016/0014-4886(92)90242-I; JONES SM, 1994, J NEUROSCI, V14, P2789; LAGRUTTA A, 1994, J BIOL CHEM, V269, P20347; LANDIS SC, 1994, PROG BRAIN RES, V100, P19; LANDMESSER L, 1972, J PHYSIOL-LONDON, V222, P691, DOI 10.1113/jphysiol.1972.sp009822; LANDMESSER L, 1974, J PHYSIOL-LONDON, V241, P737, DOI 10.1113/jphysiol.1974.sp010681; LANDMESSER L, 1978, FED PROC, V37, P2016; LARMET Y, 1992, NEURON, V9, P563, DOI 10.1016/0896-6273(92)90193-H; LEUNG DW, 1992, NEURON, V8, P1045, DOI 10.1016/0896-6273(92)90126-X; LO DC, 1995, NEURON, V15, P979, DOI 10.1016/0896-6273(95)90085-3; MADERDRUT JL, 1988, BRAIN RES, V444, P189, DOI 10.1016/0006-8993(88)90928-6; MARGIOTTA JF, 1987, P NATL ACAD SCI USA, V84, P8155, DOI 10.1073/pnas.84.22.8155; MERINEY SD, 1987, J NEUROSCI, V7, P3827; MERINEY SD, 1987, J NEUROSCI, V7, P3840; NARAYANAN CH, 1978, J EMBRYOL EXP MORPH, V44, P53; NARAYANAN CH, 1981, J EMBRYOL EXP MORPH, V62, P117; NISHI R, 1981, J NEUROSCI, V1, P505; NISHI R, 1981, DEV BIOL, V87, P301, DOI 10.1016/0012-1606(81)90153-6; NISHI R, 1994, J NEUROBIOL, V25, P612, DOI 10.1002/neu.480250604; PILAR G, 1980, J NEUROPHYSIOL, V43, P233, DOI 10.1152/jn.1980.43.1.233; Pilar G, 1982, PROGR CHOLINERGIC BI, P213; RAUCHER S, 1995, J PHYSIOL-LONDON, V486, P605, DOI 10.1113/jphysiol.1995.sp020838; RAUCHER S, 1994, J PHYSIOL-LONDON, V479, P77, DOI 10.1113/jphysiol.1994.sp020279; REINHART PH, 1991, J NEUROSCI, V11, P1627; Sambrook J., 2002, MOL CLONING LAB MANU; SPITZER NC, 1991, J NEUROBIOL, V22, P659, DOI 10.1002/neu.480220702; Spitzer Nicholas C., 1994, Current Opinion in Neurobiology, V4, P70, DOI 10.1016/0959-4388(94)90034-5; Subramony P, 1996, DEV BRAIN RES, V91, P149, DOI 10.1016/0165-3806(95)00174-3; TSENGCRANK J, 1994, NEURON, V13, P1315, DOI 10.1016/0896-6273(94)90418-9; WISGIRDA ME, 1994, P NATL ACAD SCI USA, V91, P2858, DOI 10.1073/pnas.91.7.2858; WRIGHT L, 1981, DEV BRAIN RES, V1, P283, DOI 10.1016/0165-3806(81)90114-0	52	36	37	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1996	17	1					115	124		10.1016/S0896-6273(00)80285-8	http://dx.doi.org/10.1016/S0896-6273(00)80285-8			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UY981	8755483	Bronze			2022-12-24	WOS:A1996UY98100012
J	Salin, PA; Malenka, RC; Nicoll, RA				Salin, PA; Malenka, RC; Nicoll, RA			Cyclic AMP mediates a presynaptic form of LTP at cerebellar parallel fiber synapses	NEURON			English	Article							LONG-TERM POTENTIATION; PURKINJE-CELL TRANSMISSION; ADENYLATE-CYCLASE; SYNAPTIC TRANSMISSION; DEPRESSION; SLICES; FACILITATION; EXPRESSION; NEURONS; HIPPOCAMPUS	The N-methyl-D-aspartate receptor-independent form of long-term potentiation (LTP) at hippocampal messy fiber synapses requires presynaptic Ca2+-dependent activation of adenylyl cyclase. To determine whether this form of LTP might occur at other synapses, we examined cerebellar parallel fibers that, like hippocampal messy fiber synapses, express high levels of the Ca2+/calmodulin-sensitive adenylyl cyclase I. Repetitive stimulation of parallel fibers caused a longlasting increase in synaptic strength that was associated with a decrease in paired-pulse facilitation. Blockade of glutamate receptors did not prevent LTP induction, nor did loading of Purkinje cells with a Ca2+ chelator. LTP was occluded by forskolin-induced potentiation and blocked by the protein kinase A inhibitor Rp-8-CPT-cAMPS. These findings suggest that parallel fiber synapses express a form of LTP that is dependent on the activation of a presynaptic adenylyl cyclase and is indistinguishable from LTP at hippocampal messy fiber synapses.	UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PSYCHIAT,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Salin, PA (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT CELLULAR & MOLEC PHARMACOL,SAN FRANCISCO,CA 94143, USA.			Salin, Paul/0000-0001-5221-9109				BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BRIGGS CA, 1988, J PHYSIOL-LONDON, V404, P129, DOI 10.1113/jphysiol.1988.sp017282; CASTELLUCCI VF, 1982, J NEUROSCI, V2, P1673; CASTILLO PE, 1994, NEURON, V12, P261, DOI 10.1016/0896-6273(94)90269-0; CREPEL F, 1991, J PHYSIOL-LONDON, V432, P123, DOI 10.1113/jphysiol.1991.sp018380; DIXON D, 1989, J NEUROSCI, V9, P4246; DULAC S, 1995, ANNU REV NEUROSCI, V18, P409, DOI 10.1146/annurev.neuro.18.1.409; ECCLES JC, 1966, EXP BRAIN RES, V1, P17; FARRANT M, 1991, P ROY SOC B-BIOL SCI, V244, P179, DOI 10.1098/rspb.1991.0067; GLATT CE, 1993, NATURE, V361, P536, DOI 10.1038/361536a0; HIRANO T, 1990, NEUROSCI LETT, V119, P141, DOI 10.1016/0304-3940(90)90818-T; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; ITO M, 1982, NEUROSCI LETT, V33, P253, DOI 10.1016/0304-3940(82)90380-9; KATSUKI H, 1991, NEUROSCI RES, V12, P393, DOI 10.1016/0168-0102(91)90070-F; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; KUBA K, 1986, J PHYSIOL-LONDON, V374, P515, DOI 10.1113/jphysiol.1986.sp016095; LANGDON RB, 1995, J NEUROBIOL, V26, P370, DOI 10.1002/neu.480260309; LARKMAN AU, 1995, CURR OPIN NEUROBIOL, V5, P324, DOI 10.1016/0959-4388(95)80045-X; LINDEN DJ, 1994, NEURON, V12, P457, DOI 10.1016/0896-6273(94)90205-4; Llinas R, 1993, Curr Opin Neurobiol, V3, P958, DOI 10.1016/0959-4388(93)90168-X; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451, DOI 10.1152/jn.1993.70.4.1451; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; PERKEL DJ, 1990, P ROY SOC B-BIOL SCI, V241, P116, DOI 10.1098/rspb.1990.0074; PERRETT SP, 1995, J NEUROSCI, V15, P2074, DOI 10.1523/JNEUROSCI.15-03-02074.1995; SAKURAI M, 1987, J PHYSIOL-LONDON, V394, P463, DOI 10.1113/jphysiol.1987.sp016881; SAKURAI M, 1990, P NATL ACAD SCI USA, V87, P3383, DOI 10.1073/pnas.87.9.3383; SCOTT TRD, 1993, BRIT J PHARMACOL, V110, P461, DOI 10.1111/j.1476-5381.1993.tb13833.x; SEAMON KB, 1986, ADV CYCLIC NUCL PROT, V20, P1; SHIBUKI K, 1992, NEUROREPORT, V3, P231, DOI 10.1097/00001756-199203000-00003; STAUBLI U, 1990, SYNAPSE, V5, P333, DOI 10.1002/syn.890050410; THOMPSON RF, 1994, ANNU REV NEUROSCI, V17, P519, DOI 10.1146/annurev.neuro.17.1.519; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; WEISSKOPF MG, 1995, NATURE, V376, P256, DOI 10.1038/376256a0; WORLEY PF, 1986, P NATL ACAD SCI USA, V83, P4053, DOI 10.1073/pnas.83.11.4053; XIA ZG, 1991, NEURON, V6, P431, DOI 10.1016/0896-6273(91)90251-T; XIANG ZX, 1994, J NEUROPHYSIOL, V71, P2552, DOI 10.1152/jn.1994.71.6.2552; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	40	325	329	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1996	16	4					797	803		10.1016/S0896-6273(00)80099-9	http://dx.doi.org/10.1016/S0896-6273(00)80099-9			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UG611	8607997	Bronze			2022-12-24	WOS:A1996UG61100012
J	CHU, GC; MOSCOSO, LM; SLIWKOWSKI, MX; MERLIE, JP				CHU, GC; MOSCOSO, LM; SLIWKOWSKI, MX; MERLIE, JP			REGULATION OF THE ACETYLCHOLINE-RECEPTOR EPSILON-SUBUNIT GENE BY RECOMBINANT ARIA - AN IN-VITRO MODEL FOR TRANSYNAPTIC GENE-REGULATION	NEURON			English	Article							VERTEBRATE NEUROMUSCULAR-JUNCTION; PREFERENTIAL SYNAPTIC EXPRESSION; CULTURED MUSCLE-CELLS; RAT SOLEUS MUSCLE; MESSENGER-RNA; ALPHA-SUBUNIT; MOUSE MUSCLE; INSITU HYBRIDIZATION; TRANSGENIC MICE; BETA-SUBUNIT	Structural specialization of the postsynaptic skeletal muscle membrane is in part mediated by the motor neuron-induced transcriptional regulation of synaptic muscle nuclei. ARIA, a factor that stimulates production of acetylcholine receptors (AChRs), is a candidate signaling molecule for such regulation. Here we examine the transynaptic inducing potential of this polypeptide factor. ARIA immunoreactivity is detectable at synaptic sites in vivo. In vitro, recombinant heregulin beta 1 (rHRG beta 1), the human homolog of ARIA, induces expression of the AChR epsilon gene, the subunit most sensitive to synaptic input. The inducing property of rHRG beta 1 is demonstrated most dramatically in primary muscle cultures from transgenic mice bearing an epsilon promoter-nuclear lacZ reporter transgene. transient transfection experiment; using the Sol 8 muscle cell line indicate that sequences that confer responsiveness to ARIA are located within a 150 bp epsilon subunit promoter region and are, E box-independent. These results suggest that ARIA performs a vital role by directing spatially restricted gene expression at the neuromuscular junction.	WASHINGTON UNIV,SCH MED,DEPT ANAT & NEUROBIOL,ST LOUIS,MO 63110; GENENTECH INC,S SAN FRANCISCO,CA 94080	Washington University (WUSTL); Roche Holding; Genentech	CHU, GC (corresponding author), WASHINGTON UNIV,SCH MED,DEPT MOLEC BIOL & PHARMACOL,ST LOUIS,MO 63110, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007805] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32GM0780513] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BENBARUCH N, 1994, P SOC EXP BIOL MED, V206, P221; BESSEREAU JL, 1994, P NATL ACAD SCI USA, V91, P1304, DOI 10.1073/pnas.91.4.1304; BRENNER HR, 1992, DEVELOPMENT, V116, P41; BRENNER HR, 1990, NATURE, V344, P544, DOI 10.1038/344544a0; BURSZTAJN S, 1989, P NATL ACAD SCI USA, V86, P2928, DOI 10.1073/pnas.86.8.2928; CARRAWAY KL, 1994, J BIOL CHEM, V269, P14303; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CORFAS G, 1993, J NEUROSCI, V13, P2118; COVAULT J, 1986, J CELL BIOL, V102, P716, DOI 10.1083/jcb.102.3.716; DUCLERT A, 1993, P NATL ACAD SCI USA, V90, P3043, DOI 10.1073/pnas.90.7.3043; FALLS DL, 1993, CELL, V72, P801, DOI 10.1016/0092-8674(93)90407-H; FERNS MJ, 1993, NEURON, V11, P491, DOI 10.1016/0896-6273(93)90153-I; FONTAINE B, 1987, J CELL BIOL, V105, P1337, DOI 10.1083/jcb.105.3.1337; FONTAINE B, 1988, EMBO J, V7, P603, DOI 10.1002/j.1460-2075.1988.tb02853.x; FONTAINE B, 1989, J CELL BIOL, V108, P1025, DOI 10.1083/jcb.108.3.1025; GOLDMAN D, 1991, NEURON, V7, P649, DOI 10.1016/0896-6273(91)90377-C; GOLDMAN D, 1989, NEURON, V3, P219, DOI 10.1016/0896-6273(89)90035-4; GORMAN CM, 1985, DNA CLONING PRACTICA, P143; GU Y, 1988, NEURON, V1, P117, DOI 10.1016/0896-6273(88)90195-X; GUNDERSEN K, 1993, J CELL BIOL, V123, P1535, DOI 10.1083/jcb.123.6.1535; HALL ZW, 1993, NEURON S, V10, P99; HARRIS DA, 1989, NATURE, V337, P173, DOI 10.1038/337173a0; HARRIS DA, 1988, P NATL ACAD SCI USA, V85, P1983, DOI 10.1073/pnas.85.6.1983; HINTERBERGER TJ, 1991, DEV BIOL, V147, P144, DOI 10.1016/S0012-1606(05)80014-4; HOLMES WE, 1992, SCIENCE, V256, P1205, DOI 10.1126/science.256.5060.1205; HOROVITZ O, 1989, J CELL BIOL, V108, P1823, DOI 10.1083/jcb.108.5.1823; JASMIN BJ, 1993, NEURON, V11, P467, DOI 10.1016/0896-6273(93)90151-G; JO SA, 1992, DEVELOPMENT, V115, P673; KITA YA, 1994, FEBS LETT, V349, P139, DOI 10.1016/0014-5793(94)00644-X; KLARSFELD A, 1991, EMBO J, V10, P625, DOI 10.1002/j.1460-2075.1991.tb07990.x; LUPA MT, 1993, J NEUROSCI, V13, P1326; MARCHIONNI MA, 1993, NATURE, V362, P312, DOI 10.1038/362312a0; MARTINOU JC, 1991, J NEUROSCI, V11, P1291; MARTINOU JC, 1991, P NATL ACAD SCI USA, V88, P7669, DOI 10.1073/pnas.88.17.7669; MERLIE JP, 1985, NATURE, V317, P66, DOI 10.1038/317066a0; MEYER D, 1994, P NATL ACAD SCI USA, V91, P1064, DOI 10.1073/pnas.91.3.1064; MICHEL RN, 1994, J CELL BIOL, V127, P1061, DOI 10.1083/jcb.127.4.1061; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; MIWA T, 1987, MOL CELL BIOL, V7, P2803, DOI 10.1128/MCB.7.8.2803; MOSCOSO LM, 1995, IN PRESS MOL CELL NE; MULLE C, 1988, P NATL ACAD SCI USA, V85, P5728, DOI 10.1073/pnas.85.15.5728; PIETTE J, 1990, NATURE, V345, P353, DOI 10.1038/345353a0; PINKASKRAMARSKI R, 1994, P NATL ACAD SCI USA, V91, P9387, DOI 10.1073/pnas.91.20.9387; PINSET C, 1991, EMBO J, V10, P2411, DOI 10.1002/j.1460-2075.1991.tb07780.x; PLOWMAN GD, 1993, P NATL ACAD SCI USA, V90, P1746, DOI 10.1073/pnas.90.5.1746; PLOWMAN GD, 1993, NATURE, V366, P473, DOI 10.1038/366473a0; PRODY CA, 1992, NUCLEIC ACIDS RES, V20, P2367, DOI 10.1093/nar/20.9.2367; PRONIN AN, 1992, P NATL ACAD SCI USA, V89, P6220, DOI 10.1073/pnas.89.13.6220; RALSTON E, 1989, SCIENCE, V244, P1066, DOI 10.1126/science.2543074; REDDY NS, 1988, GENE, V70, P231, DOI 10.1016/0378-1119(88)90195-3; SALPETER MM, 1983, J CELL BIOL, V96, P1781, DOI 10.1083/jcb.96.6.1781; SALPETER MM, 1988, J CELL BIOL, V106, P2087, DOI 10.1083/jcb.106.6.2087; SANES JR, 1991, DEVELOPMENT, V113, P1181; SHAN NM, 1994, CELL, V77, P349; SIMON AM, 1993, MOL CELL BIOL, V13, P5133, DOI 10.1128/MCB.13.9.5133; SIMON AM, 1992, DEVELOPMENT, V114, P545; SLIWKOWSKI MX, 1994, J BIOL CHEM, V269, P14661; SUNYER T, 1993, J NEUROSCI RES, V36, P224, DOI 10.1002/jnr.490360213; TANG JC, 1994, DEVELOPMENT, V120, P1799; TZAHAR E, 1994, J BIOL CHEM, V269, P25226; USDIN TB, 1986, J CELL BIOL, V103, P493, DOI 10.1083/jcb.103.2.493; VARTANIAN T, 1994, P NATL ACAD SCI USA, V91, P11626, DOI 10.1073/pnas.91.24.11626; VELLECA MA, 1994, MOL CELL BIOL, V14, P7095, DOI 10.1128/MCB.14.11.7095; WEN DZ, 1992, CELL, V69, P559, DOI 10.1016/0092-8674(92)90456-M; WITZEMANN V, 1989, FEBS LETT, V242, P419, DOI 10.1016/0014-5793(89)80514-9; Xie W.Q., 1991, BIOTECHNIQUES, V11, P326	67	129	131	0	1	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1995	14	2					329	339		10.1016/0896-6273(95)90289-9	http://dx.doi.org/10.1016/0896-6273(95)90289-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QH294	7857642	Bronze			2022-12-24	WOS:A1995QH29400011
J	LITMAN, P; BARG, J; GINZBURG, I				LITMAN, P; BARG, J; GINZBURG, I			MICROTUBULES ARE INVOLVED IN THE LOCALIZATION OF TAU-MESSENGER-RNA IN PRIMARY NEURONAL CELL-CULTURES	NEURON			English	Article							MATERNAL MESSENGER-RNA; INSITU HYBRIDIZATION; XENOPUS OOCYTES; DIFFERENTIAL LOCALIZATION; SUBCELLULAR-LOCALIZATION; CEREBELLAR MACRONEURONS; DENDRITIC TRANSPORT; HIPPOCAMPAL-NEURONS; NONNEURONAL CELLS; DEVELOP INVITRO	Subcellular localization of neuronal mRNAs contributes to the development of identifiable microdomains. In differentiated neurons, tau mRNA is localized in the cell body and the proximal portion of the axon, and MAP2 mRNA is localized in the cell body and dendrites, whereas tubulin mRNA is restricted to the cell body. To investigate the mechanism(s) leading to segregation of mictrotubule-associated protein mRNA, we examined the role of the cytoskeleton in this process. Detergent extraction of primary neuronal cells in culture followed by in situ hybridization analysis demonstrated that tau mRNA remains bound to cytoskeleton of the treated cells. In addition, biochemical fractionation showed that tau and MAP2 mRNAs are preferentially associated with the fraction of assembled microtubules. In contrast, mRNAs restricted to the neuronal cell body, such as those of tubulin, the 68 kDa neurofilament, and mouse GAPDH, are preferentially found in the supernatant. Using cytoskeletal inhibitors, we demonstrate that tau mRNA is associated with the microtubule system, and not with the actin filaments, thus supporting the hypothesis that the mechanism of mRNA localization is a multistep pathway in which the microtubules play a crucial role.			LITMAN, P (corresponding author), WEIZMANN INST SCI, DEPT NEUROBIOL, IL-76100 REHOVOT, ISRAEL.							AINGER K, 1993, J CELL BIOL, V123, P431, DOI 10.1083/jcb.123.2.431; BASSELL GJ, 1994, NEURON, V12, P571, DOI 10.1016/0896-6273(94)90213-5; BINDER LI, 1986, ANN NY ACAD SCI, V466, P145, DOI 10.1111/j.1749-6632.1986.tb38392.x; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; BLACK MM, 1983, J CELL BIOL, V97, P1020, DOI 10.1083/jcb.97.4.1020; BRUCKENSTEIN DA, 1990, NEURON, V5, P809, DOI 10.1016/0896-6273(90)90340-L; BULINSKI JC, 1991, BIOESSAYS, V13, P285, DOI 10.1002/bies.950130605; BURGIN KE, 1990, J NEUROSCI, V10, P1788; CACERES A, 1990, NATURE, V343, P461, DOI 10.1038/343461a0; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; DAVIS L, 1987, NATURE, V330, P477, DOI 10.1038/330477a0; DAVIS L, 1990, J NEUROSCI, V10, P3056; DRUBIN D, 1986, ANN NY ACAD SCI, V466, P257, DOI 10.1111/j.1749-6632.1986.tb38398.x; EDSON K, 1993, DEVELOPMENT, V117, P689; FERREIRA A, 1989, DEV BRAIN RES, V49, P215, DOI 10.1016/0165-3806(89)90023-0; FERREIRA A, 1989, DEV BRAIN RES, V49, P205, DOI 10.1016/0165-3806(89)90022-9; FONTAINE B, 1988, EMBO J, V7, P603, DOI 10.1002/j.1460-2075.1988.tb02853.x; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; GARNER CC, 1988, NATURE, V336, P674, DOI 10.1038/336674a0; GARNER CC, 1988, J CELL BIOL, V106, P779, DOI 10.1083/jcb.106.3.779; GAVIS ER, 1992, CELL, V71, P301, DOI 10.1016/0092-8674(92)90358-J; GINZBURG I, 1989, J NEUROSCI, V9, P1961; GINZBURG I, 1980, NUCLEIC ACIDS RES, V8, P3553, DOI 10.1093/nar/8.16.3553; HANEMAAIJER R, 1991, J NEUROSCI RES, V30, P163, DOI 10.1002/jnr.490300117; HESKETH JE, 1991, BIOCHEM J, V277, P1; HILL MA, 1993, J CELL BIOL, V122, P825, DOI 10.1083/jcb.122.4.825; JIRIKOWSKI GF, 1990, P NATL ACAD SCI USA, V87, P7400, DOI 10.1073/pnas.87.19.7400; Kislauskis Edward H., 1992, Current Opinion in Cell Biology, V4, P975, DOI 10.1016/0955-0674(92)90128-Y; KISLAUSKIS EH, 1993, J CELL BIOL, V123, P165, DOI 10.1083/jcb.123.1.165; KLEIMAN R, 1990, NEURON, V5, P821, DOI 10.1016/0896-6273(90)90341-C; KNOPS J, 1991, J CELL BIOL, V114, P725, DOI 10.1083/jcb.114.4.725; KOSIK KS, 1989, NEURON, V2, P1389, DOI 10.1016/0896-6273(89)90077-9; LAWRENCE JB, 1986, CELL, V45, P407, DOI 10.1016/0092-8674(86)90326-0; LEE G, 1992, J CELL SCI, V102, P227; LETOURNEAU PC, 1987, CELL MOTIL CYTOSKEL, V8, P193, DOI 10.1002/cm.970080302; LEWIS SA, 1985, J CELL BIOL, V100, P843, DOI 10.1083/jcb.100.3.843; LITMAN P, 1993, NEURON, V10, P627, DOI 10.1016/0896-6273(93)90165-N; MACDONALD PM, 1992, SEMIN DEV BIOL, V3, P413; MATUS A, 1981, P NATL ACAD SCI-BIOL, V78, P3010, DOI 10.1073/pnas.78.5.3010; MATUS A, 1991, J CELL SCI, P61; MERLIE JP, 1985, NATURE, V317, P66, DOI 10.1038/317066a0; MOHR E, 1991, EMBO J, V10, P2419, DOI 10.1002/j.1460-2075.1991.tb07781.x; MOWRY KL, 1992, SCIENCE, V255, P991, DOI 10.1126/science.1546297; OJAKIAN GK, 1992, J CELL SCI, V103, P677; Okabe S, 1989, CURR OPIN CELL BIOL, V1, P91, DOI 10.1016/S0955-0674(89)80043-2; PENG I, 1986, J CELL BIOL, V102, P252, DOI 10.1083/jcb.102.1.252; POKRYWKA NJ, 1991, DEVELOPMENT, V113, P55; PONDEL MD, 1988, P NATL ACAD SCI USA, V85, P7612, DOI 10.1073/pnas.85.20.7612; RINGEL I, 1988, BIOCHEM PHARMACOL, V37, P2487, DOI 10.1016/0006-2952(88)90380-2; SINGER R H, 1992, Current Opinion in Cell Biology, V4, P15, DOI 10.1016/0955-0674(92)90053-F; SOLOMON F, 1986, METHOD ENZYMOL, V134, P139; STEWARD O, 1992, TRENDS NEUROSCI, V15, P180, DOI 10.1016/0166-2236(92)90170-D; SUNDELL CL, 1991, SCIENCE, V253, P1275, DOI 10.1126/science.1891715; TANEJA KL, 1992, J CELL BIOL, V119, P1245, DOI 10.1083/jcb.119.5.1245; TIEDGE H, 1991, P NATL ACAD SCI USA, V88, P2093, DOI 10.1073/pnas.88.6.2093; TRAPP BD, 1987, P NATL ACAD SCI USA, V84, P7773, DOI 10.1073/pnas.84.21.7773; WALTER P, 1984, CELL, V38, P5, DOI 10.1016/0092-8674(84)90520-8; WILHELM JE, 1993, J CELL BIOL, V123, P269, DOI 10.1083/jcb.123.2.269; WILSON L, 1974, ADV CELL MOL BIOL, V3, P22; YISRAELI JK, 1990, DEVELOPMENT, V108, P289; ZAMBETTI G, 1990, J CELL BIOCHEM, V44, P177, DOI 10.1002/jcb.240440306	61	70	71	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1994	13	6					1463	1474		10.1016/0896-6273(94)90432-4	http://dx.doi.org/10.1016/0896-6273(94)90432-4			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PZ689	7993638				2022-12-24	WOS:A1994PZ68900021
J	NARANJO, D; PLANT, C; DUNLAP, K; BREHM, P				NARANJO, D; PLANT, C; DUNLAP, K; BREHM, P			2 SUBCELLULAR MECHANISMS UNDERLIE CALCIUM-DEPENDENT FACILITATION OF BIOLUMINESCENCE	NEURON			English	Article							COLONIAL HYDROID OBELIA; SQUID GIANT SYNAPSE; PHOTOPROTEIN	Epithelial calcium action potentials in Obelia geniculata trigger brief light flashes from specialized cells by direct activation of cytoplasmic calcium-activated photoprotein obelin. During a series of action potentials, sequential flashes undergo characteristic facilitation and decrement with no change in associated spike waveform. Analysis of the subcellular light distribution shows that facilitation results from two processes: recruitment of calcium entry sites and increased light from previously responding localized sites. We propose a model that accounts for the localized flash facilitation and decrement observed in vivo and is based upon the kinetics of calcium binding and emission of obelin. In this model, obelin emits light only when three calcium ions are bound. Changes in flash intensity during successive action potentials result from calcium bound persistently to unexpended obelin, effectively lowering the number of calcium ions required for subsequent activation. Accordingly, facilitation or decrement results from the time-dependent availability of singly and doubly bound obelin.	TUFTS UNIV,SCH MED,DEPT PHYSIOL,BOSTON,MA 02111; SUNY STONY BROOK,DEPT NEUROBIOL & BEHAV,STONY BROOK,NY 11790	Tufts University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook				Naranjo, David/0000-0003-3482-5126	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS018205, R37NS018205] Funding Source: NIH RePORTER; NINDS NIH HHS [NS18205] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AUGUSTINE GJ, 1986, J PHYSIOL-LONDON, V381, P619, DOI 10.1113/jphysiol.1986.sp016347; BLUNDON JA, 1993, P NATL ACAD SCI USA, V90, P9388, DOI 10.1073/pnas.90.20.9388; BREHM P, 1989, NEURON, V3, P191, DOI 10.1016/0896-6273(89)90032-9; CAMPBELL AK, 1974, BIOCHEM J, V143, P411, DOI 10.1042/bj1430411; CHARLTON MP, 1982, J PHYSIOL-LONDON, V323, P73; DUNLAP K, 1988, NATURE, V325, P60; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; MORIN JG, 1971, J EXP BIOL, V54, P707; MORIN JG, 1971, J CELL PHYSIOL, V77, P313, DOI 10.1002/jcp.1040770305; MORIN JG, 1974, BIOL BULL-US, V147, P397, DOI 10.2307/1540457; MORIN JG, 1971, J EXP BIOL, V54, P723; Pantin CFA, 1935, J EXP BIOL, V12, P119; RAHAMIMOFF R, 1968, J PHYSIOL-LONDON, V195, P471, DOI 10.1113/jphysiol.1968.sp008468; SIVARAMAKRISHNAN S, 1991, J GEN PHYSIOL, V98, P1181, DOI 10.1085/jgp.98.6.1181; STANLEY EF, 1986, J NEUROSCI, V6, P782; STEPHENSON DG, 1981, BIOCHIM BIOPHYS ACTA, V678, P65, DOI 10.1016/0304-4165(81)90048-9; TSUJI FI, 1986, P NATL ACAD SCI USA, V83, P8107, DOI 10.1073/pnas.83.21.8107	17	5	5	0	1	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1994	13	6					1293	1301		10.1016/0896-6273(94)90416-2	http://dx.doi.org/10.1016/0896-6273(94)90416-2			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PZ689	7993623				2022-12-24	WOS:A1994PZ68900005
J	WILKBLASZCZAK, MA; SINGER, WD; GUTOWSKI, S; STERNWEIS, PC; BELARDETTI, F				WILKBLASZCZAK, MA; SINGER, WD; GUTOWSKI, S; STERNWEIS, PC; BELARDETTI, F			THE G-PROTEIN G(13) MEDIATES INHIBITION OF VOLTAGE-DEPENDENT CALCIUM CURRENT BY BRADYKININ	NEURON			English	Article							GTP-BINDING-PROTEIN; GANGLION NEURONS INVITRO; GLIOMA HYBRID-CELLS; BETA-GAMMA-SUBUNITS; ALPHA-SUBUNITS; PHOSPHOLIPASE-C; SENSORY NEURONS; PERTUSSIS TOXIN; VERTEBRATE CELLS; CA2+ CHANNELS	In neuroblastoma-glioma hybrid cells, bradykinin has dual modulatory effects on ion channels: it activates a K+ current as well as inhibits the voltage-dependent Ca2+ current (I-Ca,I-V). Both of these actions are mediated by pertussis toxin-insensitive G proteins. Antibodies raised against the homologous G(q) and G(11) proteins suppress only the activation of the K+ current; this suggested that at least two distinct G protein pathways transduce diverse effects of this transmitter. Here, we show that the inhibition of I-Ca,I-V by bradykinin is suppressed selectively by intracellular application of antibodies specific for G(13). This novel G protein may play a general role in the inhibition of I-Ca,I-V by pathways resistant to pertussis toxin.			WILKBLASZCZAK, MA (corresponding author), UNIV TEXAS, SW MED CTR, DEPT PHARMACOL, DALLAS, TX 75235 USA.				NIGMS NIH HHS [F32 GM15359, GM47721, R01 GM31954] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031954, R01GM047721, F32GM015359] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEAN BP, 1989, ANNU REV PHYSIOL, V51, P367, DOI 10.1146/annurev.physiol.51.1.367; BEECH DJ, 1993, J PHYSIOL-LONDON, V463, P565, DOI 10.1113/jphysiol.1993.sp019611; BIRNBAUMER L, 1990, ANNU REV PHARMACOL, V30, P675; BLEAKMAN D, 1990, MOL PHARMACOL, V38, P785; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; BROWN AM, 1990, ANNU REV PHYSIOL, V52, P197, DOI 10.1146/annurev.ph.52.030190.001213; BROWN DA, 1988, J PHYSIOL-LONDON, V397, P167, DOI 10.1113/jphysiol.1988.sp016994; CAMPS M, 1992, EUR J BIOCHEM, V206, P821, DOI 10.1111/j.1432-1033.1992.tb16990.x; CASEY PJ, 1990, J BIOL CHEM, V265, P2383; CATTERALL WA, 1991, CELL, V64, P871, DOI 10.1016/0092-8674(91)90309-M; CAULFIELD MP, 1992, PFLUG ARCH EUR J PHY, V420, P486, DOI 10.1007/BF00374623; DOLPHIN AC, 1989, BRIT J PHARMACOL, V97, P263, DOI 10.1111/j.1476-5381.1989.tb11950.x; DRAY A, 1993, TRENDS NEUROSCI, V16, P99, DOI 10.1016/0166-2236(93)90133-7; EWALD DA, 1988, P NATL ACAD SCI USA, V85, P3633, DOI 10.1073/pnas.85.10.3633; EWALD DA, 1989, NEURON, V2, P1185, DOI 10.1016/0896-6273(89)90185-2; FONG HKW, 1988, P NATL ACAD SCI USA, V85, P3066, DOI 10.1073/pnas.85.9.3066; GAGNON AW, 1991, BLOOD, V78, P1247; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GUTOWSKI S, 1991, J BIOL CHEM, V266, P20519; HAMPRECHT B, 1985, METHOD ENZYMOL, V109, P316; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; HEPLER JR, 1994, METHOD ENZYMOL, V237, P191; Hescheler J, 1993, Curr Opin Neurobiol, V3, P360, DOI 10.1016/0959-4388(93)90129-M; HESCHELER J, 1987, NATURE, V325, P445, DOI 10.1038/325445a0; HESS P, 1990, ANNU REV NEUROSCI, V13, P337, DOI 10.1146/annurev.ne.13.030190.002005; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; Hille B., 1992, IONIC CHANNELS EXCIT; HOFMANN F, 1994, ANNU REV NEUROSCI, V17, P399, DOI 10.1146/annurev.neuro.17.1.399; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; Kandel E.R., 1991, PRINC NEUROSCI; KASAI H, 1992, J PHYSIOL-LONDON, V448, P189, DOI 10.1113/jphysiol.1992.sp019036; KASAI H, 1992, J PHYSIOL-LONDON, V448, P161, DOI 10.1113/jphysiol.1992.sp019035; Katz B., 1966, NERVE MUSCLE SYNAPSE; KLEUSS C, 1991, NATURE, V353, P43, DOI 10.1038/353043a0; KOCH GG, 1985, ENCY STATISTICAL SCI, V5, P136; KOZASA T, 1993, P NATL ACAD SCI USA, V90, P9176, DOI 10.1073/pnas.90.19.9176; KRAMER RH, 1991, NEURON, V6, P557, DOI 10.1016/0896-6273(91)90058-8; LLEDO PM, 1992, NEURON, V8, P455, DOI 10.1016/0896-6273(92)90273-G; MATSUOKA M, 1988, P NATL ACAD SCI USA, V85, P5384, DOI 10.1073/pnas.85.15.5384; MCFADZEAN I, 1989, NEURON, V3, P177, DOI 10.1016/0896-6273(89)90030-5; MCGEHEE DS, 1992, NEURON, V9, P315, DOI 10.1016/0896-6273(92)90170-I; MILLER RJ, 1987, TRENDS NEUROSCI, V10, P226, DOI 10.1016/0166-2236(87)90161-5; MUMBY SM, 1991, METHOD ENZYMOL, V195, P215; OFFERMANNS S, 1994, P NATL ACAD SCI USA, V91, P504, DOI 10.1073/pnas.91.2.504; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; REISER G, 1982, BRAIN RES, V239, P191, DOI 10.1016/0006-8993(82)90841-1; ROSS EM, 1989, NEURON, V3, P141, DOI 10.1016/0896-6273(89)90027-5; SHAPIRO MS, 1993, NEURON, V10, P11, DOI 10.1016/0896-6273(93)90237-L; SHIMAHARA T, 1990, BRAIN RES, V524, P219, DOI 10.1016/0006-8993(90)90694-7; SIEGELBAUM SA, 1983, TRENDS NEUROSCI, V6, P307, DOI 10.1016/0166-2236(83)90145-5; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SINGER WD, 1994, J BIOL CHEM, V269, P19796; SMRCKA AV, 1993, J BIOL CHEM, V268, P9667; SPICHER K, 1994, BIOCHEM BIOPH RES CO, V198, P906, DOI 10.1006/bbrc.1994.1129; STERNWEIS PC, 1990, TRENDS NEUROSCI, V13, P122, DOI 10.1016/0166-2236(90)90002-R; STRATHMANN M, 1990, P NATL ACAD SCI USA, V87, P9113, DOI 10.1073/pnas.87.23.9113; STRATHMANN MP, 1991, P NATL ACAD SCI USA, V88, P5582, DOI 10.1073/pnas.88.13.5582; TANG JM, 1990, PFLUG ARCH EUR J PHY, V416, P347, DOI 10.1007/BF00392072; TAUSSIG R, 1992, NEURON, V8, P799, DOI 10.1016/0896-6273(92)90100-R; TSIEN RW, 1991, TRENDS PHARMACOL SCI, V12, P349, DOI 10.1016/0165-6147(91)90595-J; TSUNOO A, 1986, P NATL ACAD SCI USA, V83, P9832, DOI 10.1073/pnas.83.24.9832; VOYNOYASENETSKAYA T, 1994, J BIOL CHEM, V269, P4721; WILKBLASZCZAK MA, 1994, NEURON, V12, P109, DOI 10.1016/0896-6273(94)90156-2; WU DQ, 1992, J BIOL CHEM, V267, P1811	65	37	37	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1994	13	5					1215	1224		10.1016/0896-6273(94)90059-0	http://dx.doi.org/10.1016/0896-6273(94)90059-0			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PU763	7946358				2022-12-24	WOS:A1994PU76300017
J	SHIGEMOTO, R; ABE, T; NOMURA, S; NAKANISHI, S; HIRANO, T				SHIGEMOTO, R; ABE, T; NOMURA, S; NAKANISHI, S; HIRANO, T			ANTIBODIES INACTIVATING MGLUR1 METABOTROPIC GLUTAMATE-RECEPTOR BLOCK LONG-TERM DEPRESSION IN CULTURED PURKINJE-CELLS	NEURON			English	Article							RAT CEREBELLAR CULTURE; PROTEIN KINASE-C; SYNAPTIC TRANSMISSION; SIGNAL TRANSDUCTION; GRANULE CELL; BETA-2-ADRENERGIC RECEPTORS; MOLECULAR CHARACTERIZATION; AGONIST SELECTIVITY; CLIMBING FIBER; CALCIUM	Antibodies were raised against two distinct extracellular sequences of the rat mGluR1 metabotropic glutamate receptor expressed as bacterial fusion proteins. Both antibodies specifically reacted with mGluR1 in the rat cerebellum and inhibited the mGluR1 activity as assessed by the analysis of glutamate-stimulated inositol phosphate formation in CHO cells expressing mGluR1. Using these antibodies, we examined the role of mGluR1 in the induction of long-term depression in cultured Purkinje cells. in voltage-clamped Purkinje cells, current induced by iontophoretically applied glutamate was persistently depressed by depolarization of the Purkinje cells in conjunction with the glutamate application. The mGluR1 antibodies completely blocked the depression of glutamate-induced current. The results indicate that activation of mGluR1 is necessary for the induction of cerebellar long-term depression and that these mGluR1 antibodies can be used as selective antagonists.	KYOTO UNIV, FAC MED, INST IMMUNOL, KYOTO 606, JAPAN; KYOTO UNIV, COLL MED TECHNOL, FAC MED, KYOTO 606, JAPAN; KYOTO UNIV, FAC MED, DEPT PHYSIOL, KYOTO 606, JAPAN	Kyoto University; Kyoto University; Kyoto University	SHIGEMOTO, R (corresponding author), KYOTO UNIV, FAC MED, DEPT MORPHOL BRAIN SCI, KYOTO 606, JAPAN.		Shigemoto, Ryuichi/E-3628-2013	Shigemoto, Ryuichi/0000-0001-8761-9444				ABE T, 1992, J BIOL CHEM, V267, P13361; ARAMORI I, 1992, NEURON, V8, P757, DOI 10.1016/0896-6273(92)90096-V; BLACKSTONE CD, 1989, P NATL ACAD SCI USA, V86, P4316, DOI 10.1073/pnas.86.11.4316; CREPEL F, 1991, J PHYSIOL-LONDON, V432, P123, DOI 10.1113/jphysiol.1991.sp018380; CREPEL F, 1988, BRAIN RES, V458, P397, DOI 10.1016/0006-8993(88)90486-6; DANIEL H, 1992, EXP BRAIN RES, V90, P327; FOTUHI M, 1993, J NEUROSCI, V13, P2001; FRIELLE T, 1988, P NATL ACAD SCI USA, V85, P9494, DOI 10.1073/pnas.85.24.9494; HAYASHI Y, 1994, IN PRESS J NEUROSCI; HIRANO T, 1990, NEUROSCI LETT, V119, P141, DOI 10.1016/0304-3940(90)90818-T; HIRANO T, 1990, NEUROSCI LETT, V119, P145, DOI 10.1016/0304-3940(90)90819-U; HIRANO T, 1986, P NATL ACAD SCI USA, V83, P1945, DOI 10.1073/pnas.83.6.1945; HIRANO T, 1988, P NATL ACAD SCI USA, V85, P934, DOI 10.1073/pnas.85.3.934; HIRANO T, 1993, J NEUROPHYSIOL, V70, P1316, DOI 10.1152/jn.1993.70.4.1316; HIRANO T, 1991, SYNAPSE, V7, P321, DOI 10.1002/syn.890070408; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; Ito M, 1990, Neuroreport, V1, P129; Ito M, 1984, CEREBELLUM NEURAL CO; KANO M, 1987, NATURE, V325, P276, DOI 10.1038/325276a0; KOBILKA BK, 1988, SCIENCE, V240, P1310, DOI 10.1126/science.2836950; KOERNER TJ, 1991, METHOD ENZYMOL, V194, P477; KONNERTH A, 1992, P NATL ACAD SCI USA, V89, P7051, DOI 10.1073/pnas.89.15.7051; KUBO T, 1988, FEBS LETT, V241, P119, DOI 10.1016/0014-5793(88)81043-3; LINDEN DJ, 1993, NEURON, V11, P1093, DOI 10.1016/0896-6273(93)90222-D; LINDEN DJ, 1991, SCIENCE, V254, P1656, DOI 10.1126/science.1721243; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; LLANO I, 1991, NEURON, V7, P577, DOI 10.1016/0896-6273(91)90370-F; MARTIN LJ, 1992, NEURON, V9, P259, DOI 10.1016/0896-6273(92)90165-A; MASU M, 1991, NATURE, V349, P760, DOI 10.1038/349760a0; NAKAJIMA Y, 1993, J BIOL CHEM, V268, P11868; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; OKAMOTO N, 1994, J BIOL CHEM, V269, P1231; Palay S. L., 1974, CEREBELLAR CORTEX CY; PICKERING DS, 1993, J NEUROCHEM, V61, P85, DOI 10.1111/j.1471-4159.1993.tb03540.x; PIN JP, 1992, P NATL ACAD SCI USA, V89, P10331, DOI 10.1073/pnas.89.21.10331; SAKURAI M, 1987, J PHYSIOL-LONDON, V394, P463, DOI 10.1113/jphysiol.1987.sp016881; SAKURAI M, 1990, P NATL ACAD SCI USA, V87, P3383, DOI 10.1073/pnas.87.9.3383; SCHOEPP D, 1990, TRENDS PHARMACOL SCI, V11, P508, DOI 10.1016/0165-6147(90)90052-A; SHIGEMOTO R, 1992, J COMP NEUROL, V322, P121, DOI 10.1002/cne.903220110; SHIGEMOTO R, 1993, NEUROSCI LETT, V163, P53, DOI 10.1016/0304-3940(93)90227-C; TAKAHASHI K, 1993, J BIOL CHEM, V268, P19341; TANABE Y, 1992, NEURON, V8, P169, DOI 10.1016/0896-6273(92)90118-W; TANABE Y, 1993, J NEUROSCI, V13, P1372; THOMSEN C, 1993, BRAIN RES, V619, P22, DOI 10.1016/0006-8993(93)91592-G; VRANESIC I, 1991, NEUROREPORT, V2, P759, DOI 10.1097/00001756-199112000-00007; YUZAKI M, 1992, J NEUROSCI, V12, P4253	50	229	234	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	1994	12	6					1245	1255		10.1016/0896-6273(94)90441-3	http://dx.doi.org/10.1016/0896-6273(94)90441-3			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NT463	7912091				2022-12-24	WOS:A1994NT46300006
J	FRISCH, B; HARDIN, PE; HAMBLENCOYLE, MJ; ROSBASH, M; HALL, JC				FRISCH, B; HARDIN, PE; HAMBLENCOYLE, MJ; ROSBASH, M; HALL, JC			A PROMOTERLESS PERIOD GENE MEDIATES BEHAVIORAL RHYTHMICITY AND CYCLICAL PER EXPRESSION IN A RESTRICTED SUBSET OF THE DROSOPHILA NERVOUS-SYSTEM	NEURON			English	Article							MESSENGER-RNA LEVELS; CIRCADIAN-RHYTHMS; MOSAIC ANALYSIS; VISUAL-SYSTEM; CLOCK GENE; MELANOGASTER; MUTANTS; PROTEIN; ADULT; LOCUS	Transgenic flies carrying a 7.2 kb piece of DNA from the period (per) gene were analyzed for the presence of circadian locomotor activity rhythms and fluctuations of per-encoded mRNA and protein. The 5' end of this genomic fragment is within the first intron, which precedes the coding region. This promotorless fragment could rescue circadian behavioral rhythms and mediate spatial expression of PER in a subset of wild-type per cells within the CNS and PNS. In one behaviorally rhythmic line, PER protein was found in only ''per lateral neurons.'' In the rhythmic transgenics, per mRNA and protein levels undergo circadian cycling, as previously described for wild type. Cycling of PER in brain cells of flies carrying the same 7.2 kb piece of per DNA under the control of a heat shock promotor corroborated the hypothesis that per's molecular cyclings and behavioral rhythmicity are causally related.	BRANDEIS UNIV,HOWARD HUGHES MED INST,WALTHAM,MA 02254; BRANDEIS UNIV,NSF CTR BIOL TIMING,WALTHAM,MA 02254	Brandeis University; Howard Hughes Medical Institute; Brandeis University; National Science Foundation (NSF)	FRISCH, B (corresponding author), BRANDEIS UNIV,DEPT BIOL,WALTHAM,MA 02254, USA.			Hardin, Paul/0000-0002-3370-9011	NIGMS NIH HHS [GM-33205] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM033205] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BONINI NM, 1993, CELL, V72, P379, DOI 10.1016/0092-8674(93)90115-7; BOWTELL DDL, 1989, P NATL ACAD SCI USA, V86, P6245, DOI 10.1073/pnas.86.16.6245; BOWTELL DDL, 1991, P NATL ACAD SCI USA, V88, P6853, DOI 10.1073/pnas.88.15.6853; CITRI Y, 1987, NATURE, V326, P42, DOI 10.1038/326042a0; EDERY I, IN PRESS P NATL ACAD; EWER J, 1992, J NEUROSCI, V12, P3321; EWER J, 1988, NATURE, V333, P82, DOI 10.1038/333082a0; EWER J, 1990, J NEUROGENET, V7, P31, DOI 10.3109/01677069009084151; FREEMAN M, 1991, Current Biology, V1, P378, DOI 10.1016/0960-9822(91)90199-7; GRABA Y, 1992, EMBO J, V11, P3375, DOI 10.1002/j.1460-2075.1992.tb05416.x; Hall J.C., 1990, Advances in Insect Physiology, V22, P221, DOI 10.1016/S0065-2806(08)60007-7; HAMBLEN M, 1986, J NEUROGENET, V3, P249, DOI 10.3109/01677068609106855; HAMBLENCOYLE M, 1989, J NEUROGENET, V5, P229, DOI 10.3109/01677068909066210; HAMBLENCOYLE MJ, 1992, J INSECT BEHAV, V5, P417, DOI 10.1007/BF01058189; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; HARDIN PE, 1992, EMBO J, V11, P1; HARDIN PE, 1992, P NATL ACAD SCI USA, V89, P11711, DOI 10.1073/pnas.89.24.11711; HELFRICH C, 1986, J NEUROGENET, V3, P321, DOI 10.3109/01677068609106857; HUANG ZJ, 1993, NATURE, V364, P259, DOI 10.1038/364259a0; KONOPKA R, 1983, MOL GEN GENET, V190, P284, DOI 10.1007/BF00330652; KONOPKA RJ, 1987, ANNU REV GENET, V21, P227, DOI 10.1146/annurev.genet.21.1.227; KONOPKA RJ, 1989, J NEUROGENET, V6, P1, DOI 10.3109/01677068909107096; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; LIU X, 1992, J NEUROSCI, V12, P2735; LIU X, 1991, NEURON, V6, P753, DOI 10.1016/0896-6273(91)90172-V; LIU X, 1988, GENE DEV, V2, P228, DOI 10.1101/gad.2.2.228; LUCKOW VA, 1988, BIO-TECHNOL, V6, P47, DOI 10.1038/nbt0188-47; MLODZIK M, 1992, METHODS NEUROSCIENCE, V9, P387; RUTILA JE, 1992, J NEUROGENET, V8, P101, DOI 10.3109/01677069209084155; SAEZ L, 1988, MOL CELL BIOL, V8, P5378, DOI 10.1128/MCB.8.12.5378; SIWICKI KK, 1988, NEURON, V1, P141, DOI 10.1016/0896-6273(88)90198-5; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; STEHLE JH, 1993, NATURE, V365, P314, DOI 10.1038/365314a0; TAKAHASHI JS, 1992, SCIENCE, V258, P238, DOI 10.1126/science.1384127; WHEELER DA, 1993, J BIOL RHYTHM, V8, P67, DOI 10.1177/074873049300800106; YU Q, 1987, P NATL ACAD SCI USA, V84, P784, DOI 10.1073/pnas.84.3.784; YU Q, 1987, NATURE, V326, P765, DOI 10.1038/326765a0; ZEHRING WA, 1984, CELL, V39, P369, DOI 10.1016/0092-8674(84)90015-1; ZERR DM, 1990, J NEUROSCI, V10, P2749; ZWIEBEL LJ, 1991, P NATL ACAD SCI USA, V88, P3882, DOI 10.1073/pnas.88.9.3882	40	225	226	0	13	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1994	12	3					555	570		10.1016/0896-6273(94)90212-7	http://dx.doi.org/10.1016/0896-6273(94)90212-7			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NC769	8155319				2022-12-24	WOS:A1994NC76900008
J	STANLEY, EF				STANLEY, EF			SINGLE CALCIUM CHANNELS AND ACETYLCHOLINE-RELEASE AT A PRESYNAPTIC NERVE-TERMINAL	NEURON			English	Article							SQUID GIANT SYNAPSE; TRANSMITTER RELEASE; NEUROTRANSMITTER RELEASE; ACTIVE ZONES; TIME COURSE; VESICLE; FACILITATION; EXOCYTOSIS; DIFFUSION; CURRENTS	The relationship between calcium influx and the gating of transmitter release was examined at the release face of a cholinergic presynaptic nerve terminal using a technique that allows the simultaneous recording of both calcium channels at the single-channel level and quantal acetylcholine secretion. Acetylcholine release occurred during large inward calcium currents through many simultaneously open channels but was also gated by very small calcium transients, admitting less than 200 ions, when only one channel was open at a time. These findings provide functional support for a highly structured model of the transmitter release face in which the synaptic vesicle release mechanism is closely tethered to one or more presynaptic calcium channels and the opening of only one of these may be sufficient to trigger quantal secretion.			STANLEY, EF (corresponding author), NINCDS, SYNAPT MECH SECT, BETHESDA, MD 20892 USA.							ADLER EM, 1991, J NEUROSCI, V11, P1496; AKIMOTO K, 1990, ANAL BIOCHEM, V189, P182, DOI 10.1016/0003-2697(90)90104-H; AUGUSTINE GJ, 1991, ANN NY ACAD SCI, V635, P365, DOI 10.1111/j.1749-6632.1991.tb36505.x; AUGUSTINE GJ, 1986, J PHYSIOL-LONDON, V381, P619, DOI 10.1113/jphysiol.1986.sp016347; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; BRECKENRIDGE LJ, 1987, NATURE, V328, P814, DOI 10.1038/328814a0; CHAD JE, 1984, BIOPHYS J, V45, P993, DOI 10.1016/S0006-3495(84)84244-7; DELCOUR AH, 1993, J NEUROSCI, V13, P181; DRYER SE, 1987, NEUROSCIENCE, V20, P905, DOI 10.1016/0306-4522(87)90251-X; FOGELSON AL, 1985, BIOPHYS J, V48, P1003, DOI 10.1016/S0006-3495(85)83863-7; HEUSER JE, 1979, J CELL BIOL, V81, P275, DOI 10.1083/jcb.81.2.275; HORIKAWA HPM, 1993, FEBS LETT, V330, P236, DOI 10.1016/0014-5793(93)80281-X; ISRAEL M, 1981, Neurochemistry International, V3, P81, DOI 10.1016/0197-0186(81)90052-8; KATZ B, 1969, J PHYSIOL-LONDON, V203, P459, DOI 10.1113/jphysiol.1969.sp008875; KOSTYUK PG, 1989, J PHYSIOL-LONDON, V409, P343, DOI 10.1113/jphysiol.1989.sp017501; LEVEQUE C, 1992, P NATL ACAD SCI USA, V89, P3625, DOI 10.1073/pnas.89.8.3625; LLINAS R, 1982, P NATL ACAD SCI-BIOL, V79, P2415, DOI 10.1073/pnas.79.7.2415; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; LLINAS R, 1981, BIOPHYS J, V33, P323, DOI 10.1016/S0006-3495(81)84899-0; MARTIN AR, 1963, J PHYSIOL-LONDON, V168, P443, DOI 10.1113/jphysiol.1963.sp007202; MARTIN AR, 1964, J PHYSIOL-LONDON, V175, P1; OCONNOR VM, 1993, FEBS LETT, V326, P255, DOI 10.1016/0014-5793(93)81802-7; PARNAS H, 1986, PFLUG ARCH EUR J PHY, V406, P121, DOI 10.1007/BF00586672; PUMPLIN DW, 1981, P NATL ACAD SCI-BIOL, V78, P7210, DOI 10.1073/pnas.78.11.7210; SILINSKY EM, 1978, J PHYSIOL-LONDON, V274, P157, DOI 10.1113/jphysiol.1978.sp012141; SIMON SM, 1985, BIOPHYS J, V48, P485, DOI 10.1016/S0006-3495(85)83804-2; SMITH SJ, 1988, TRENDS NEUROSCI, V11, P458, DOI 10.1016/0166-2236(88)90199-3; STANLEY EF, 1992, CAN J PHYSIOL PHARM, V70, pS73, DOI 10.1139/y92-246; STANLEY EF, 1991, J NEUROSCI, V11, P985; STANLEY EF, 1991, NEURON, V7, P585, DOI 10.1016/0896-6273(91)90371-6; STANLEY EF, 1990, P NATL ACAD SCI USA, V87, P9683, DOI 10.1073/pnas.87.24.9683; YAMADA WM, 1992, BIOPHYS J, V61, P671, DOI 10.1016/S0006-3495(92)81872-6; YAWO H, 1993, J PHYSIOL-LONDON, V460, P153, DOI 10.1113/jphysiol.1993.sp019464; YOSHIKAMI D, 1989, ANN NY ACAD SCI, V560, P230, DOI 10.1111/j.1749-6632.1989.tb24100.x; ZUCKER RS, 1986, P NATL ACAD SCI USA, V83, P3032, DOI 10.1073/pnas.83.9.3032; ZUCKER RS, 1989, PRESYNAPTIC REGULATI, P153	36	217	222	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1993	11	6					1007	1011		10.1016/0896-6273(93)90214-C	http://dx.doi.org/10.1016/0896-6273(93)90214-C			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MP548	8274272				2022-12-24	WOS:A1993MP54800002
J	VOROBJEV, VS; SHARONOVA, IN; WALSH, IB; HAAS, HL				VOROBJEV, VS; SHARONOVA, IN; WALSH, IB; HAAS, HL			HISTAMINE POTENTIATES N-METHYL-D-ASPARTATE RESPONSES IN ACUTELY ISOLATED HIPPOCAMPAL-NEURONS	NEURON			English	Article							RECEPTOR DESENSITIZATION; NMDA RECEPTOR; POTASSIUM CONDUCTANCE; DIVALENT-CATIONS; RAT HIPPOCAMPUS; PYRAMIDAL CELLS; XENOPUS-OOCYTES; POLYAMINES; BRAIN; GLYCINE	N-methyl-D-aspartate (NMDA-evoked currents were recorded from acutely isolated rat hippocampal neurons, using the whole-cell patch-clamp technique and a rapid perfusion system. Histamine, at concentrations from 0.5 to 100 muM, reversibly enhanced NMDA currents by up to 50%. The effect cannot be ascribed to activation of the known histamine receptors (H-1, H-2, H-3) but is occluded by spermine. These results suggest an interaction of histamine with the polyamine-binding site on the NMDA receptor complex. This modulatory action could allow the histaminergic system to determine time and loci of NMDA receptor-mediated events, such as memory formation according to behavioral state.			VOROBJEV, VS (corresponding author), HEINRICH HEINE UNIV, INST PHYSIOL 2, D-40001 DUSSELDORF, GERMANY.		Sharonova, Irina/B-5288-2012	Sharonova, Irina/0000-0001-9955-1870				ASCHER P, 1990, PROG CELL R, V1, P149; ASCHER P, 1988, J PHYSIOL-LONDON, V399, P247; BEKKERS JM, 1993, SCIENCE, V261, P104, DOI 10.1126/science.8391168; BENARI Y, 1992, TRENDS NEUROSCI, V15, P333, DOI 10.1016/0166-2236(92)90049-E; BENVENISTE M, 1990, J PHYSIOL-LONDON, V428, P333, DOI 10.1113/jphysiol.1990.sp018215; BENVENISTE M, 1993, J PHYSIOL-LONDON, V464, P131, DOI 10.1113/jphysiol.1993.sp019627; BERRIDGE MJ, 1987, ANN NY ACAD SCI, V494, P39, DOI 10.1111/j.1749-6632.1987.tb29479.x; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; CLARK GD, 1990, NEUROSCIENCE, V39, P787, DOI 10.1016/0306-4522(90)90261-2; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; FAGE D, 1992, J NEUROCHEM, V58, P2170, DOI 10.1111/j.1471-4159.1992.tb10960.x; GREENE RW, 1990, NEUROSCIENCE, V34, P299, DOI 10.1016/0306-4522(90)90140-Y; HAAS HL, 1983, NATURE, V302, P432, DOI 10.1038/302432a0; HAAS HL, 1984, AGENTS ACTIONS, V14, P534, DOI 10.1007/BF01973865; HAAS HL, 1992, HISTAMINE RECEPTOR, P161; HAAS HL, 1991, HISTAMINERGIC NEURON, P196; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; INAGAKI N, 1988, J COMP NEUROL, V273, P283, DOI 10.1002/cne.902730302; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; KOSTOPOULOS G, 1988, EXP BRAIN RES, V72, P45, DOI 10.1007/BF00248499; KREMZNER LT, 1965, BIOCHEM PHARMACOL, V14, P1189; LERMA J, 1992, NEURON, V8, P343, DOI 10.1016/0896-6273(92)90300-3; LERMA J, 1990, P NATL ACAD SCI USA, V87, P2354, DOI 10.1073/pnas.87.6.2354; LIN JS, 1988, NEUROPHARMACOLOGY, V27, P111, DOI 10.1016/0028-3908(88)90159-1; MADISON DV, 1986, J PHYSIOL-LONDON, V372, P245, DOI 10.1113/jphysiol.1986.sp016007; MARKRAM H, 1992, J PHYSIOL-LONDON, V447, P513, DOI 10.1113/jphysiol.1992.sp019015; MARKRAM H, 1990, J PHYSIOL-LONDON, V427, P381, DOI 10.1113/jphysiol.1990.sp018177; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; MAYER ML, 1989, NATURE, V338, P425, DOI 10.1038/338425a0; MCGURK JF, 1990, P NATL ACAD SCI USA, V87, P9971, DOI 10.1073/pnas.87.24.9971; Monnier M, 1970, Int Rev Neurobiol, V12, P265; PANULA P, 1989, NEUROSCIENCE, V28, P585, DOI 10.1016/0306-4522(89)90007-9; PASCHEN W, 1988, NEUROCHEM PATHOL, V9, P1; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; PRELL GD, 1986, ANNU REV NEUROSCI, V9, P209; RANSOM RW, 1988, J NEUROCHEM, V51, P830, DOI 10.1111/j.1471-4159.1988.tb01818.x; ROCK DM, 1992, MOL PHARMACOL, V42, P157; ROCK DM, 1992, MOL PHARMACOL, V41, P83; SCHWARTZ JC, 1986, TRENDS PHARMACOL SCI, V7, P24, DOI 10.1016/0165-6147(86)90236-1; SCHWARTZ JC, 1991, PHYSIOL REV, V71, P1, DOI 10.1152/physrev.1991.71.1.1; SPECIALE C, 1992, MOL NEUROPHARMACOL, V2, P121; VOROBJEV VS, 1991, J NEUROSCI METH, V38, P145, DOI 10.1016/0165-0270(91)90164-U; WADA H, 1991, TRENDS NEUROSCI, V14, P415, DOI 10.1016/0166-2236(91)90034-R; WILLIAMS K, 1990, NEURON, V5, P199, DOI 10.1016/0896-6273(90)90309-4; WILLIAMS K, 1991, LIFE SCI, V48, P469, DOI 10.1016/0024-3205(91)90463-L; 1992, CHEN L, V356, P521	46	146	153	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1993	11	5					837	844		10.1016/0896-6273(93)90113-6	http://dx.doi.org/10.1016/0896-6273(93)90113-6			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MJ041	8240807				2022-12-24	WOS:A1993MJ04100005
J	KIRSCH, GE; SHIEH, CC; DREWE, JA; VENER, DF; BROWN, AM				KIRSCH, GE; SHIEH, CC; DREWE, JA; VENER, DF; BROWN, AM			SEGMENTAL EXCHANGES DEFINE 4-AMINOPYRIDINE BINDING AND THE INNER MOUTH OF K+ PORES	NEURON			English	Article							DELAYED-RECTIFIER PROPERTIES; POTASSIUM CHANNEL; SQUID AXON; GATING CURRENTS; BLOCK; AMINOPYRIDINES; CONDUCTANCE; EXPRESSION; DROSOPHILA; REGION	4-Aminopyridine (4AP) blocks the intracellular mouth of voltage-gated K+ channels. We identified critical regions for 4AP binding with chimeric channels in which segments of a low affinity clone (Kv2.1, IC50 = 18 mM) were replaced with those of a high affinity clone (Kv3.1, IC50 = 0.1 mM). 4AP sensitivity was not tranferred with the S5-S6 linker (pore or P region). Instead, a chimera of the cytoplasmic half of S6 increased block 20-fold, without affecting gating. A double chimera of the cytoplasmic halves of S5 and S6 fully transferred 4AP sensitivity. Because 4AP block was inhibited by tetrapentylammonium, we conclude that determinants of 4AP binding lie in the S6 segment that forms the cytoplasmic vestibule of the pore and that this site may overlap a quaternary ammonium site.	BAYLOR COLL MED,DEPT MOLEC PHYSIOL & BIOPHYS,HOUSTON,TX 77030	Baylor College of Medicine	KIRSCH, GE (corresponding author), BAYLOR COLL MED,DEPT ANESTHESIOL,HOUSTON,TX 77030, USA.		Vener, David F/AAI-8975-2020		NHLBI NIH HHS [HL37044] Funding Source: Medline; NINDS NIH HHS [NS29473, NS23877] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL037044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023877, R01NS029473] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P859; CHOI KL, 1993, NEURON, V10, P533, DOI 10.1016/0896-6273(93)90340-W; CHOQUET D, 1992, J GEN PHYSIOL, V99, P217, DOI 10.1085/jgp.99.2.217; DEBIASI M, 1993, PFLUG ARCH EUR J PHY, V422, P354, DOI 10.1007/BF00374291; DREWE JA, IN PRESS METH NEUROS; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; FRENCH RJ, 1981, BIOPHYS J, V34, P271, DOI 10.1016/S0006-3495(81)84849-7; HARTMANN HA, 1991, SCIENCE, V251, P942, DOI 10.1126/science.2000495; HEGINBOTHAM L, 1992, SCIENCE, V258, P1152, DOI 10.1126/science.1279807; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; KIRSCH GE, 1991, AM J PHYSIOL, V261, pC583, DOI 10.1152/ajpcell.1991.261.4.C583; KIRSCH GE, 1992, NEURON, V8, P499, DOI 10.1016/0896-6273(92)90278-L; KIRSCH GE, 1992, BIOPHYS J, V62, P136, DOI 10.1016/S0006-3495(92)81800-3; KIRSCH GE, 1986, BIOPHYS J, V50, P637, DOI 10.1016/S0006-3495(86)83503-2; KIRSCH GE, 1983, J PHARMACOL EXP THER, V226, P174; KIRSCH GE, 1978, BIOPHYS J, V22, P507, DOI 10.1016/S0006-3495(78)85503-9; KIRSCH GE, 1993, IN PRESS J GEN PHYSL; KUBO Y, 1993, NATURE, V362, P137; MILLER C, 1982, J GEN PHYSIOL, V79, P869, DOI 10.1085/jgp.79.5.869; PAK MD, 1991, J NEUROSCI, V11, P869; PELHATE M, 1989, Pfluegers Archiv European Journal of Physiology, V414, pS140, DOI 10.1007/BF00582271; Sambrook J, 1989, MOL CLONING LABORATO; SPIRES S, 1989, J GEN PHYSIOL, V93, P263, DOI 10.1085/jgp.93.2.263; STOCKER M, 1991, P ROY SOC B-BIOL SCI, V245, P101, DOI 10.1098/rspb.1991.0094; TAGLIALATELA M, 1992, BIOPHYS J, V62, P34, DOI 10.1016/S0006-3495(92)81770-8; TAGLIALATELA M, 1993, PFLUG ARCH EUR J PHY, V423, P104, DOI 10.1007/BF00374967; TAGLIALATELA M, 1991, MOL PHARMACOL, V40, P299; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; THOMPSON S, 1982, J GEN PHYSIOL, V80, P1, DOI 10.1085/jgp.80.1.1; VILLARROEL A, 1988, PFLUG ARCH EUR J PHY, V413, P118, DOI 10.1007/BF00582521; WAGONER PK, 1990, BIOPHYS J, V58, P1481, DOI 10.1016/S0006-3495(90)82493-0; YEH JZ, 1976, J GEN PHYSIOL, V68, P519, DOI 10.1085/jgp.68.5.519; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; YOKOYAMA S, 1989, FEBS LETT, V259, P37, DOI 10.1016/0014-5793(89)81488-7; YOOL AJ, 1991, NATURE, V349, P700, DOI 10.1038/349700a0	35	104	105	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1993	11	3					503	512		10.1016/0896-6273(93)90154-J	http://dx.doi.org/10.1016/0896-6273(93)90154-J			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LY498	8398143				2022-12-24	WOS:A1993LY49800010
J	KAPLAN, DR; MATSUMOTO, K; LUCARELLI, E; THIELE, CJ				KAPLAN, DR; MATSUMOTO, K; LUCARELLI, E; THIELE, CJ			INDUCTION OF TRKB BY RETINOIC ACID MEDIATES BIOLOGIC RESPONSIVENESS TO BDNF AND DIFFERENTIATION OF HUMAN NEUROBLASTOMA-CELLS	NEURON			English	Article							HUMAN NEURO-BLASTOMA; NERVE GROWTH-FACTOR; ACUTE PROMYELOCYTIC LEUKEMIA; TYROSINE PROTEIN-KINASE; NEUROTROPHIC FACTOR; BINDING PROTEIN; SPINAL-CORD; PROTOONCOGENE PRODUCT; NGF RESPONSIVENESS; MYC GENE	Retinoic acid (RA) induces the neuronal differentiation of many human neuroblastoma cell lines. In this study, we show that RA treatment of neuroblastoma cells induces the expression of TrkB, the receptor for the neurotrophins BDNF, NT-3, and NT-415. BDNF addition to RA-treated SH-SY5Y neuroblastoma cells stimulated the tyrosine phosphorylation of TrkB and neuronal differentiation. RA treatment of KCNR neuroblastoma cells, which constitutively express BDNF mRNA, resulted in the expression of TrkB and differentiation in the absence of added BDNF. Finally, in 15N neuroblastoma cells, which express BDNF mRNA but do not differentiate in response to RA, RA induced only a truncated form of TrkB. 15N cells transfected with full-length TrkB differentiated in the absence of RA. These results indicate that RA induces the neuronal differentiation of neuroblastoma cells by modulating the expression of neurotrophin receptors.	NCI, PEDIAT BRANCH, CELLULAR & MOLEC BIOL SECT, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	KAPLAN, DR (corresponding author), NCI, FREDERICK CANC RES & DEV CTR, ABL BASIC RES PROGRAM, MMCL, EUKARYOT SIGNAL TRANSDUCT GRP, FREDERICK, MD 21702 USA.		Enrico, Lucarelli/G-3588-2015; Lucarelli, Enrico/AAF-1612-2021	Enrico, Lucarelli/0000-0002-6681-6374; Lucarelli, Enrico/0000-0002-6681-6374	NCI NIH HHS [N01-CO-74101] Funding Source: Medline; OFFICE OF THE DIRECTOR, NCI [N01CO074101] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABEMAYOR E, 1989, ENVIRON HEALTH PERSP, V80, P3, DOI 10.2307/3430727; AZAR C, 1991, PROG CLIN BIOL RES, V366, P219; BAKER DL, 1989, CANCER RES, V49, P4142; BARBACID M, 1991, BIOCHIM BIOPHYS ACTA, V1072, P115, DOI 10.1016/0304-419X(91)90010-I; BARDE Y-A, 1990, Progress in Growth Factor Research, V2, P237, DOI 10.1016/0955-2235(90)90021-B; BERKEMEIER LR, 1991, NEURON, V7, P857, DOI 10.1016/0896-6273(91)90287-A; BIEDLER JL, 1973, CANCER RES, V33, P2643; BIRREN SJ, 1992, SCIENCE, V257, P395, DOI 10.1126/science.1321502; BRAND N, 1988, NATURE, V332, P850, DOI 10.1038/332850a0; BRODEUR GM, 1977, CANCER-AM CANCER SOC, V40, P2256, DOI 10.1002/1097-0142(197711)40:5<2256::AID-CNCR2820400536>3.0.CO;2-1; CASTAIGNE S, 1990, BLOOD, V76, P1704; CHAO MV, 1992, NEURON, V9, P583, DOI 10.1016/0896-6273(92)90023-7; CICCARONE V, 1989, CANCER RES, V49, P219; DELEEUW AM, 1990, J NEUROCYTOL, V19, P253, DOI 10.1007/BF01217303; DURSTON AJ, 1989, NATURE, V340, P140, DOI 10.1038/340140a0; FELTNER DE, 1989, J IMMUNOL, V143, P4292; FISCHER I, 1986, DEV BRAIN RES, V25, P99, DOI 10.1016/0165-3806(86)90156-2; FOX F, 1959, CANCER, V12, P108, DOI 10.1002/1097-0142(195901/02)12:1<108::AID-CNCR2820120116>3.0.CO;2-H; GAETANO C, 1992, CANCER RES, V52, P4402; GAETANO C, 1991, CELL GROWTH DIFFER, V2, P487; GAETANO C, 1991, ADV NEUROBLASTOMA RE, V3, P165; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; GLASS DJ, 1991, CELL, V66, P405, DOI 10.1016/0092-8674(91)90629-D; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; HALEGOUA S, 1991, CURR TOP MICROBIOL, V165, P119; HASKELL BE, 1987, CELL TISSUE RES, V247, P67, DOI 10.1007/BF00216548; HEFTI F, 1992, LOCALIZATION FUNCTIO, P25; HELSON L, 1984, CANC DRUG DEL, V1, P303, DOI 10.1089/cdd.1984.1.303; HEMPSTEAD BL, 1992, NEURON, V9, P883, DOI 10.1016/0896-6273(92)90241-5; HOLTZMAN DM, 1992, NEURON, V9, P465, DOI 10.1016/0896-6273(92)90184-F; HUANG ME, 1988, BLOOD, V72, P567, DOI 10.1182/blood.V72.2.567.567; HUNTER K, 1991, P NATL ACAD SCI USA, V88, P3666, DOI 10.1073/pnas.88.9.3666; HYATT GA, 1992, P NATL ACAD SCI USA, V89, P8293, DOI 10.1073/pnas.89.17.8293; IP NY, 1992, P NATL ACAD SCI USA, V89, P3060, DOI 10.1073/pnas.89.7.3060; JONES KR, 1990, P NATL ACAD SCI USA, V87, P8060, DOI 10.1073/pnas.87.20.8060; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; LOEB DM, 1991, CELL, V66, P961, DOI 10.1016/0092-8674(91)90441-Z; MADEN M, 1990, DEVELOPMENT, V109, P75; MADEN M, 1989, DEV BIOL, V135, P124, DOI 10.1016/0012-1606(89)90163-2; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; MARTINZANCA D, 1989, MOL CELL BIOL, V9, P24, DOI 10.1128/MCB.9.1.24; MATSUMOTO K, 1992, ENDOCRINOLOGY, V130, P3669, DOI 10.1210/en.130.6.3669; MCCAFFERY P, 1992, DEVELOPMENT, V115, P371; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; MITRA G, 1991, ONCOGENE, V6, P2237; NAKAGAWARA A, 1992, CANCER RES, V52, P1364; ONG DE, 1982, J BIOL CHEM, V257, P13385; PEREZCASTRO AV, 1989, P NATL ACAD SCI USA, V86, P8813, DOI 10.1073/pnas.86.22.8813; REYNOLDS CP, 1986, J NATL CANCER I, V76, P375; RODRIGUEZTEBAR A, 1991, DEVELOPMENT, V112, P813; SCHEIBE RJ, 1992, J BIOL CHEM, V267, P17611; SCHWAB M, 1985, NATURE, V316, P160, DOI 10.1038/316160a0; SIDELL N, 1982, J NATL CANCER I, V68, P589; SIVE HL, 1990, GENE DEV, V4, P932, DOI 10.1101/gad.4.6.932; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; STEPHENS RM, 1992, MOL CELL BIOL, V12, P3733, DOI 10.1128/MCB.12.9.3733; THALLER C, 1987, NATURE, V327, P625, DOI 10.1038/327625a0; THIELE CJ, 1988, ONCOGENE, V3, P281; THIELE CJ, 1985, NATURE, V313, P404, DOI 10.1038/313404a0; TSOULFAS P, 1993, NEURON, V10, P975, DOI 10.1016/0896-6273(93)90212-A; WAGNER M, 1990, NATURE, V345, P819, DOI 10.1038/345819a0; WARRELL RP, 1991, NEW ENGL J MED, V324, P1385, DOI 10.1056/NEJM199105163242002; WEST GJ, 1977, CANCER RES, V37, P1372; WUARIN L, 1991, DEV BIOL, V144, P429, DOI 10.1016/0012-1606(91)90435-6; WUARIN L, 1990, INT J DEV NEUROSCI, V8, P317, DOI 10.1016/0736-5748(90)90038-4	72	318	328	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	1993	11	2					321	331		10.1016/0896-6273(93)90187-V	http://dx.doi.org/10.1016/0896-6273(93)90187-V			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LU065	8394722				2022-12-24	WOS:A1993LU06500011
J	SKOULAKIS, EMC; KALDERON, D; DAVIS, RL				SKOULAKIS, EMC; KALDERON, D; DAVIS, RL			PREFERENTIAL EXPRESSION IN MUSHROOM BODIES OF THE CATALYTIC SUBUNIT OF PROTEIN KINASE-A AND ITS ROLE IN LEARNING AND MEMORY	NEURON			English	Article							CYCLIC-AMP PHOSPHODIESTERASE; MEDIATED ENHANCER DETECTION; APLYSIA SENSORY NEURONS; LONG-TERM FACILITATION; DROSOPHILA-MELANOGASTER; GENE; DUNCE; PHOSPHORYLATION; TRANSCRIPTION; SENSITIZATION	Involvement of the cAMP cascade in Drosophila learning and memory is suggested by the aberrant behavioral phenotypes of the mutants dunce (cAMP phosphodiesterase) and rutabaga (adenylyl cyclase). Line DCO581, isolated via an enhancer detector screen for genes preferentially expressed in the mushroom bodies, contains a transposon in the first exon of the catalytic subunit gene (DCO) of protein kinase A (PKA). RNA in situ hybridization and immunohistochemistry show that DCO is preferentially expressed in the mushroom bodies. The DCO581 insertion and an independently isolated hypomorphic allele (DCO(B10)) each produce homozygous lethality and a 40% decrease in PKA activity in heterozygotes. This decrease has mild effects on learning but no effect on memory. However, the 80% reduction in activity obtained by constructing heteroallelic yet viable DCO581/DCO(B10) animals results in a dramatic learning and memory deficit. These results suggest that PKA plays a crucial role in the cAMP cascade in mushroom bodies to mediate learning and memory processes.	COLUMBIA UNIV,FAIRCHILD CTR,DEPT BIOL SCI,NEW YORK,NY 10027	Columbia University	SKOULAKIS, EMC (corresponding author), COLD SPRING HARBOR LAB,CTR LEARNING & MEMORY,COLD SPRING HARBOR,NY 11724, USA.		Davis, Ronald/J-4998-2013	Davis, Ronald/0000-0002-5986-7608	NIGMS NIH HHS [GM15406, GM 41815] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041815, F32GM015406] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BELLEN HJ, 1989, GENE DEV, V3, P1288, DOI 10.1101/gad.3.9.1288; BYERS D, 1981, NATURE, V289, P79, DOI 10.1038/289079a0; BYRNE JH, 1987, PHYSIOL REV, V67, P329, DOI 10.1152/physrev.1987.67.2.329; DAVIS RL, 1981, J CELL BIOL, V90, P101, DOI 10.1083/jcb.90.1.101; DAVIS RL, 1991, TRENDS GENET, V7, P224, DOI 10.1016/0168-9525(91)90369-2; DELGADO R, 1991, P NATL ACAD SCI USA, V88, P557, DOI 10.1073/pnas.88.2.557; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; DRAIN P, 1991, NEURON, V6, P71, DOI 10.1016/0896-6273(91)90123-H; DUDAI Y, 1988, ANNU REV NEUROSCI, V11, P537, DOI 10.1146/annurev.ne.11.030188.002541; FOSTER JL, 1984, J BIOL CHEM, V259, P3049; FOSTER JL, 1988, J BIOL CHEM, V263, P1676; FOSTER JL, 1988, METHOD ENZYMOL, V159, P215; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; GROSSNIKLAUS U, 1992, GENE DEV, V6, P1030, DOI 10.1101/gad.6.6.1030; HAN PL, 1992, NEURON, V9, P619, DOI 10.1016/0896-6273(92)90026-A; HAN PL, 1992, THESIS BAYLOR COLLEG; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; HEISENBERG M, 1989, FUNDAMENTALS MEMORY, P3; KALDERON D, 1988, GENE DEV, V2, P1539, DOI 10.1101/gad.2.12a.1539; KANDEL ER, 1983, COLD SPRING HARB SYM, V48, P821, DOI 10.1101/SQB.1983.048.01.085; KOBIERSKI LA, 1991, P NATL ACAD SCI USA, V88, P10222, DOI 10.1073/pnas.88.22.10222; LANE ME, 1993, GENE DEV, V7, P1229, DOI 10.1101/gad.7.7a.1229; LEFKOWITZ RJ, 1990, TRENDS PHARMACOL SCI, V11, P190, DOI 10.1016/0165-6147(90)90113-M; LEVIN LR, 1992, CELL, V68, P479, DOI 10.1016/0092-8674(92)90185-F; LIVINGSTONE MS, 1984, CELL, V37, P67; MELLON PL, 1989, P NATL ACAD SCI USA, V86, P4887, DOI 10.1073/pnas.86.13.4887; MENZEL R, 1991, BEHAVIOR PHYSL BEES; NIGHORN A, 1991, NEURON, V6, P455, DOI 10.1016/0896-6273(91)90253-V; QIU YH, 1991, J MOL BIOL, V222, P553, DOI 10.1016/0022-2836(91)90496-S; SCHACHER S, 1988, SCIENCE, V240, P1667, DOI 10.1126/science.2454509; SCHOLZ KP, 1988, SCIENCE, V240, P1664, DOI 10.1126/science.2837826; SCHWARTZ JH, 1983, COLD SPRING HARB SYM, V48, P811, DOI 10.1101/SQB.1983.048.01.084; Sokal R. R., 1981, BIOMETRY; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; Strausfeld NJ., 1976, ATLAS INSECT BRAIN, DOI 10.1007/978-3-642-66179-2; SWEATT JD, 1989, NATURE, V339, P51, DOI 10.1038/339051a0; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; TULLY T, 1987, TRENDS NEUROSCI, V10, P330, DOI 10.1016/0166-2236(87)90090-7; WALAAS SI, 1991, PHARMACOL REV, V43, P299; WILSON C, 1989, GENE DEV, V3, P1301, DOI 10.1101/gad.3.9.1301	44	242	248	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1993	11	2					197	208		10.1016/0896-6273(93)90178-T	http://dx.doi.org/10.1016/0896-6273(93)90178-T			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LU065	8352940				2022-12-24	WOS:A1993LU06500002
J	SHEN, NV; CHEN, XH; BOYER, MM; PFAFFINGER, PJ				SHEN, NV; CHEN, XH; BOYER, MM; PFAFFINGER, PJ			DELETION ANALYSIS OF K+ CHANNEL ASSEMBLY	NEURON			English	Article							POTASSIUM CHANNEL; XENOPUS-OOCYTES; EXPRESSION; SUBUNITS; SEQUENCE; RECEPTOR	An understanding of K+ channel structure is a critical step in developing an appreciation of the function and regulation of these proteins. We have begun a biochemical analysis of the early steps in K+ channel formation following translation into endoplasmic reticulum membranes. In our experiments, a series of K+ channel subunit protein deletions were constructed and then tested for posttranslational processing and assembly. We find that all deletions containing the S1 domain are inserted into the membrane. The loop between S1 and S2 is glycosylated; thus, this segment is topologically extracellular. Translated subunit proteins mix in the membrane, then assemble into tetramers. This subunit assembly is critically driven by a conserved, self-tetramerizing sequence in the N-terminal cytoplasmic region, which we have named the tetramerization 1 domain.			SHEN, NV (corresponding author), BAYLOR COLL MED,DIV NEUROSCI,HOUSTON,TX 77030, USA.				NICHD NIH HHS [P30-HD24064] Funding Source: Medline; NINDS NIH HHS [NINDS T32-NS07352] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007352] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		CHANDY KG, 1991, NATURE, V352, P26, DOI 10.1038/352026b0; CHRISTIE MJ, 1990, NEURON, V4, P405, DOI 10.1016/0896-6273(90)90052-H; ELROYSTEIN O, 1989, P NATL ACAD SCI USA, V86, P6126, DOI 10.1073/pnas.86.16.6126; GUY HR, 1990, TRENDS NEUROSCI, V13, P201; GUY HR, 1990, MONOVALENT CATIONS B, P31; HARLOW E, 1988, ANTIBODIES LABORATOR, P635; HARTMANN HA, 1991, SCIENCE, V251, P942, DOI 10.1126/science.2000495; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; KAANG BK, 1992, P NATL ACAD SCI USA, V89, P1133, DOI 10.1073/pnas.89.3.1133; KRIEGLER M, 1990, GENE TANSFER EXPRESS, P213; LAUE TM, 1990, GUIDE PROTEIN PURIFI, P566; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; MIGNERY GA, 1990, J BIOL CHEM, V265, P12679; PERIN MS, 1991, J BIOL CHEM, V266, P3877; PFAFFINGER PJ, 1991, J NEUROSCI, V11, P918; STRONG M, 1993, IN PRESS MOL BIOL EV; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; TITUS DE, 1991, PROMEGA PROTOCOL APP, P155; VERRALL S, 1992, CELL, V68, P23, DOI 10.1016/0092-8674(92)90203-O; WESSELS HP, 1989, LABORATORY METHODS V, P3	21	220	221	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1993	11	1					67	76						10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LP430	8338669				2022-12-24	WOS:A1993LP43000006
J	BRAMBLETT, GT; GOEDERT, M; JAKES, R; MERRICK, SE; TROJANOWSKI, JQ; LEE, VMY				BRAMBLETT, GT; GOEDERT, M; JAKES, R; MERRICK, SE; TROJANOWSKI, JQ; LEE, VMY			ABNORMAL TAU-PHOSPHORYLATION AT SER(396) IN ALZHEIMERS-DISEASE RECAPITULATES DEVELOPMENT AND CONTRIBUTES TO REDUCED MICROTUBULE-BINDING	NEURON			English	Article							PAIRED HELICAL FILAMENTS; NERVOUS-SYSTEM; PROTEIN-KINASE; LIVING CELLS; EXPRESSION; ANTIBODIES; TUBULIN; BRAIN; CDNA; CORE	Abnormally phosphorylated tau proteins (A68) are the building blocks of Alzheimer's disease (AD) paired helical filaments. The biological consequences of the conversion of normal adult tau to A68 remain unknown. Here we demonstrate that native A68 does not bind to microtubules (MTs), yet dephosphorylated A68 regains the ability to bind to MTs. Ser396 is phosphorylated in A68, but not in normal adult tau, whereas fetal tau is phosphorylated transiently at this site. Phosphorylation of tau at Ser396 by protein kinases in CHO cells and rat brain produces an electrophoretic mobility similar to that of A68. Using CHO cells transfected with an Ala396 mutant, we show that the phosphorylation of tau at Ser396 reduces its affinity for MTs and its ability to stabilize MTs against nocodazole-induced depolymerization. Our results demonstrate that the abnormal phosphorylation of tau in AD involves Ser396, and we suggest that this may be mediated by the inappropriate activation of fetal kinases or the reduced activity of tau protein phosphatases. Thus, phosphorylation of Ser396 may destabilize MTs in AD, resulting in the degeneration of affected cells.	MRC,MOLEC BIOL LAB,CAMBRIDGE CB2 2QH,ENGLAND	MRC Laboratory Molecular Biology	BRAMBLETT, GT (corresponding author), UNIV PENN,SCH MED,DEPT PATHOL & LAB MED,PHILADELPHIA,PA 19104, USA.							BIERNAT J, 1992, EMBO J, V11, P1593, DOI 10.1002/j.1460-2075.1992.tb05204.x; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; BLOSE SH, 1984, J CELL BIOL, V98, P847, DOI 10.1083/jcb.98.3.847; BRAMBLETT GT, 1992, LAB INVEST, V66, P212; BROWN A, 1992, J CELL BIOL, V119, P867, DOI 10.1083/jcb.119.4.867; BUTNER KA, 1991, J CELL BIOL, V115, P717, DOI 10.1083/jcb.115.3.717; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CROWTHER RA, 1992, FEBS LETT, V309, P199, DOI 10.1016/0014-5793(92)81094-3; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; DREWES G, 1992, EMBO J, V11, P2131, DOI 10.1002/j.1460-2075.1992.tb05272.x; DRUBIN DG, 1986, J CELL BIOL, V103, P2739, DOI 10.1083/jcb.103.6.2739; Goedert M, 1991, BRAIN PATHOL, V1, P279, DOI 10.1111/j.1750-3639.1991.tb00671.x; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; GOEDERT M, 1988, P NATL ACAD SCI USA, V85, P4051, DOI 10.1073/pnas.85.11.4051; GOEDERT M, 1992, NEURON, V8, P159, DOI 10.1016/0896-6273(92)90117-V; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; GOEDERT M, 1992, FEBS LETT, V312, P95, DOI 10.1016/0014-5793(92)81418-L; GOEDERT M, 1993, IN PRESS P NATL ACAD; GREEN S, 1988, NUCLEIC ACIDS RES, V16, P369, DOI 10.1093/nar/16.1.369; GREENBERG SG, 1992, J BIOL CHEM, V267, P564; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; HANGER DP, 1992, NEUROSCI LETT, V147, P58, DOI 10.1016/0304-3940(92)90774-2; HASEGAWA M, 1992, J BIOL CHEM, V267, P17047; ISHIGURO K, 1992, J BIOL CHEM, V267, P10897; KANAI Y, 1989, J CELL BIOL, V109, P1173, DOI 10.1083/jcb.109.3.1173; KANEMARU K, 1992, J NEUROCHEM, V58, P1667, DOI 10.1111/j.1471-4159.1992.tb10039.x; KILMARTIN JV, 1982, J CELL BIOL, V93, P576, DOI 10.1083/jcb.93.3.576; KONDO J, 1988, NEURON, V1, P827, DOI 10.1016/0896-6273(88)90130-4; KOSIK KS, 1989, NEURON, V2, P1389, DOI 10.1016/0896-6273(89)90077-9; KOSIK KS, 1988, NEURON, V1, P817, DOI 10.1016/0896-6273(88)90129-8; LANG E, 1992, BIOCHEM BIOPH RES CO, V187, P783, DOI 10.1016/0006-291X(92)91264-Q; Lee V M, 1992, Curr Opin Neurobiol, V2, P653, DOI 10.1016/0959-4388(92)90034-I; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; LEE VMY, 1987, J NEUROSCI, V7, P3474; LINDWALL G, 1984, J BIOL CHEM, V259, P5301; LIU WK, 1991, J BIOL CHEM, V266, P21723; MANDELKOW EM, 1992, FEBS LETT, V314, P315, DOI 10.1016/0014-5793(92)81496-9; MURTHY ASN, 1983, EUR J BIOCHEM, V137, P37, DOI 10.1111/j.1432-1033.1983.tb07792.x; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; TROJANOWSKI JQ, 1993, BRAIN PATHOL, V3, P45, DOI 10.1111/j.1750-3639.1993.tb00725.x; TROJANOWSKI JQ, 1989, J HISTOCHEM CYTOCHEM, V37, P209, DOI 10.1177/37.2.2492045; VALLEE RB, 1982, J CELL BIOL, V92, P435, DOI 10.1083/jcb.92.2.435; VULLIET R, 1992, J BIOL CHEM, V267, P22570; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; WILLE H, 1992, J CELL BIOL, V118, P573, DOI 10.1083/jcb.118.3.573; WILLIAMS RC, 1979, BIOCHEMISTRY-US, V18, P2499, DOI 10.1021/bi00579a010; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4884, DOI 10.1073/pnas.85.13.4884; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; WOLOZIN BL, 1986, SCIENCE, V232, P648, DOI 10.1126/science.3083509; YANG SD, 1991, J PROTEIN CHEM, V10, P171, DOI 10.1007/BF01024781	51	761	788	0	46	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1993	10	6					1089	1099		10.1016/0896-6273(93)90057-X	http://dx.doi.org/10.1016/0896-6273(93)90057-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LK373	8318230				2022-12-24	WOS:A1993LK37300009
J	OTMAKHOV, N; SHIRKE, AM; MALINOW, R				OTMAKHOV, N; SHIRKE, AM; MALINOW, R			MEASURING THE IMPACT OF PROBABILISTIC TRANSMISSION ON NEURONAL OUTPUT	NEURON			English	Article							LONG-TERM POTENTIATION; CENTRAL-NERVOUS-SYSTEM; GUINEA-PIG HIPPOCAMPUS; PYRAMIDAL CELLS; SYNAPTIC PLASTICITY; RAT HIPPOCAMPUS; NEURAL NETWORK; INVITRO; SLICES; CONDUCTANCE	We have investigated the impact of stochastic transmission on the input-output relations of neurons in hippocampal slices. A synaptic input that fires a cell has a significant trial-to-trial variability in amplitude, reflecting the probabilistic release of transmitter. By measuring miniature excitatory postsynaptic currents, we estimate that synchronous release of a few vesicles can fire a CA1 cell. The firing threshold and variability can be physiologically modulated. Different cell types have distinct firing thresholds and variabilities. Long-term potentiation (LTP) decreases trial-to-trial variability. If after LTP, the stimulus is reduced to produce a threshold response, the variability returns to that observed before LTP. Thus, for a threshold input, the trial-to-trial variability is maintained with LTP. This may be important for the proper functioning of a plastic nervous system.			OTMAKHOV, N (corresponding author), UNIV IOWA,DEPT PHYSIOL & BIOPHYS,IOWA CITY,IA 52242, USA.							AMIT DJ, 1989, P NATL ACAD SCI USA, V86, P7871, DOI 10.1073/pnas.86.20.7871; ANDERSEN P, 1987, J PHYSIOL-LONDON, V383, P509; ANDERSEN P, 1980, J PHYSIOL-LONDON, V307, P273, DOI 10.1113/jphysiol.1980.sp013435; ANDERSEN PO, 1987, SYNAPTIC FUNCTION, P403; BARRIONUEVO G, 1986, J NEUROPHYSIOL, V55, P540, DOI 10.1152/jn.1986.55.3.540; BEKKERS JM, 1990, P NATL ACAD SCI USA, V87, P5359, DOI 10.1073/pnas.87.14.5359; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; BERNANDER O, 1991, P NATL ACAD SCI USA, V88, P11569, DOI 10.1073/pnas.88.24.11569; BRESSLOFF PC, 1990, PHYS REV A, V41, P1126, DOI 10.1103/PhysRevA.41.1126; BUHMANN J, 1987, BIOL CYBERN, V56, P313, DOI 10.1007/BF00319512; BURNOD Y, 1989, P NATL ACAD SCI USA, V86, P352, DOI 10.1073/pnas.86.1.352; DASILVA FHL, 1990, PHYSIOL REV, V70, P453, DOI 10.1152/physrev.1990.70.2.453; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P574, DOI 10.1113/jphysiol.1954.sp005130; EICHENBAUM H, 1992, BEHAV NEURAL BIOL, V57, P2, DOI 10.1016/0163-1047(92)90724-I; FABER DS, 1991, BIOPHYS J, V60, P1288, DOI 10.1016/S0006-3495(91)82162-2; FENWICK EM, 1982, J PHYSIOL-LONDON, V331, P577, DOI 10.1113/jphysiol.1982.sp014393; FERSTER D, 1992, J NEUROSCI, V12, P1262; GIBSON WG, 1991, PHILOS T ROY SOC B, V332, P199, DOI 10.1098/rstb.1991.0050; GUSTAFSSON B, 1988, NEUROSCI LETT, V85, P77, DOI 10.1016/0304-3940(88)90432-6; Hinton GE., 1984, BOLTZMANN MACHINES C; HU GY, 1992, J PHYSIOL-LONDON, V453, P663, DOI 10.1113/jphysiol.1992.sp019250; Katz B., 1969, RELEASE NEURAL TRANS; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Korn H., 1987, SYNAPTIC FUNCTION, P57; KRNJEVIC K, 1982, NEUROSCIENCE, V7, P2165, DOI 10.1016/0306-4522(82)90128-2; KULLMANN DM, 1992, NATURE, V357, P240, DOI 10.1038/357240a0; LANGMOEN IA, 1983, J NEUROPHYSIOL, V50, P1320, DOI 10.1152/jn.1983.50.6.1320; LARKMAN A, 1992, NATURE, V360, P70, DOI 10.1038/360070a0; LIAO D, 1992, NEURON, V9, P1089, DOI 10.1016/0896-6273(92)90068-O; LITTLE WA, 1975, BEHAV BIOL, V14, P115, DOI 10.1016/S0091-6773(75)90122-4; LYNCH JW, 1989, BIOPHYS J, V55, P755, DOI 10.1016/S0006-3495(89)82874-7; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; MALINOW R, 1991, SCIENCE, V252, P722, DOI 10.1126/science.1850871; MANABE T, 1992, NATURE, V355, P50, DOI 10.1038/355050a0; MCBAIN C, 1992, J NEUROPHYSIOL, V68, P16, DOI 10.1152/jn.1992.68.1.16; MCNAUGHTON BL, 1981, J NEUROPHYSIOL, V46, P952, DOI 10.1152/jn.1981.46.5.952; MECKLINGER A, 1992, PSYCHOPHYSIOLOGY, V29, P104, DOI 10.1111/j.1469-8986.1992.tb02021.x; MILES R, 1986, J PHYSIOL-LONDON, V373, P397, DOI 10.1113/jphysiol.1986.sp016055; NICOLL RA, 1990, PHYSIOL REV, V70, P513, DOI 10.1152/physrev.1990.70.2.513; PITLER TA, 1992, J PHYSIOL-LONDON, V450, P127, DOI 10.1113/jphysiol.1992.sp019119; RAASTAD M, 1992, EUR J NEUROSCI, V4, P113, DOI 10.1111/j.1460-9568.1992.tb00114.x; RICE JA, 1988, MATH STATISTICS DATA; ROPERT N, 1990, J PHYSIOL-LONDON, V428, P707, DOI 10.1113/jphysiol.1990.sp018236; ROVIRA C, 1983, EXP BRAIN RES, V49, P151; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; SCHOLZ KP, 1992, NEURON, V8, P1139, DOI 10.1016/0896-6273(92)90134-Y; SHAW G L, 1974, Mathematical Biosciences, V21, P207, DOI 10.1016/0025-5564(74)90015-7; SIGGINS GR, 1981, NEUROSCI LETT, V23, P55, DOI 10.1016/0304-3940(81)90186-5; SPRUSTON N, 1992, J NEUROPHYSIOL, V67, P508, DOI 10.1152/jn.1992.67.3.508; STALEY KJ, 1992, J NEUROPHYSIOL, V67, P1346, DOI 10.1152/jn.1992.67.5.1346; TAYLOR JG, 1972, J THEOR BIOL, V36, P513, DOI 10.1016/0022-5193(72)90006-9; TRUSSELL LO, 1985, P NATL ACAD SCI USA, V82, P4857, DOI 10.1073/pnas.82.14.4857; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	54	85	86	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1993	10	6					1101	1111		10.1016/0896-6273(93)90058-Y	http://dx.doi.org/10.1016/0896-6273(93)90058-Y			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LK373	8318231				2022-12-24	WOS:A1993LK37300010
J	FAHLKE, C; ZACHAR, E; RUDEL, R				FAHLKE, C; ZACHAR, E; RUDEL, R			CHLORIDE CHANNELS WITH REDUCED SINGLE-CHANNEL CONDUCTANCE IN RECESSIVE MYOTONIA-CONGENITA	NEURON			English	Article							MUSCLE-FIBERS; SKELETAL-MUSCLE; MEMBRANE; CURRENTS; BECKER	Myoballs were cultured from muscle biopsies of patients having Becker-type recessive generalized myotonia (RGM). Single-channel recordings showed that the conductance of the ''intermediate'' Cl- channel, the Cl- channel having the highest membrane density and accounting for most of the Cl- conductance in myoballs, was reduced to about 50%. All other channel parameters tested, such as gating properties, ion selectivity, and regulatory pathways, were not different from controls. Two other Cl- channel types were only rarely observed and did not seem different from controls. Also, the macroscopic Cl- conductance measured with tight-seal whole-cell recording was smaller than controls, particularly in the positive membrane potential domain. These results might explain myotonia in RGM on the single-channel level.			FAHLKE, C (corresponding author), UNIV ULM,DEPT GEN PHYSIOL,W-7900 ULM,GERMANY.		Fahlke, Christoph/G-3635-2013	Fahlke, Christoph/0000-0001-8602-9952				ADRIAN RH, 1976, J PHYSIOL-LONDON, V258, P125, DOI 10.1113/jphysiol.1976.sp011410; Becker PE, 1973, NEW DEV ELECTROMYOGR, P407; BRETAG AH, 1987, PHYSIOL REV, V67, P618, DOI 10.1152/physrev.1987.67.2.618; BRYANT SH, 1980, J PHYSIOL-LONDON, V307, pP31; BURTON F, 1988, MUSCLE NERVE, V11, P1029, DOI 10.1002/mus.880111004; CHUA M, 1991, BIOPHYS J, V59, P1251, DOI 10.1016/S0006-3495(91)82340-2; Colquhoun D, 1983, SINGLE CHANNEL RECOR, P191; FAHLKE C, 1992, PFLUG ARCH EUR J PHY, V421, P566, DOI 10.1007/BF00375052; FAHLKE C, 1992, PFLUG ARCH EUR J PHY, V421, P108, DOI 10.1007/BF00374816; FAHLKE C, 1992, PFLUG ARCH EUR J PHY, V420, P248, DOI 10.1007/BF00374454; FRANKE C, 1991, MUSCLE NERVE, V14, P762, DOI 10.1002/mus.880140811; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Iaizzo P A, 1991, Neuromuscul Disord, V1, P47, DOI 10.1016/0960-8966(91)90042-Q; JENTSCH TJ, 1990, NATURE, V348, P510, DOI 10.1038/348510a0; KOCH MC, 1992, SCIENCE, V257, P797, DOI 10.1126/science.1379744; KUNZE DL, 1985, J GEN PHYSIOL, V86, P691, DOI 10.1085/jgp.86.5.691; KUNZELMANN K, 1991, PFLUG ARCH EUR J PHY, V418, P479, DOI 10.1007/BF00497776; Lipicky RJ, 1979, HDB CLIN NEUROLOGY 1, V40, P533; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; PALADE PT, 1977, J GEN PHYSIOL, V69, P325, DOI 10.1085/jgp.69.3.325; PROBSTLE T, 1988, PFLUG ARCH EUR J PHY, V412, P264, DOI 10.1007/BF00582507; RUDEL R, 1988, MUSCLE NERVE, V11, P202, DOI 10.1002/mus.880110303; STEINMEYER K, 1991, NATURE, V354, P301, DOI 10.1038/354301a0; STEINMEYER K, 1991, NATURE, V354, P304, DOI 10.1038/354304a0; Trautmann A, 1983, SINGLE CHANNEL RECOR, P473; ZACHAR E, 1992, PFLUG ARCH EUR J PHY, V421, P101, DOI 10.1007/BF00374815	26	19	19	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1993	10	2					225	232		10.1016/0896-6273(93)90313-G	http://dx.doi.org/10.1016/0896-6273(93)90313-G			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KP685	8382498				2022-12-24	WOS:A1993KP68500010
J	Michaelidis, TM; Sendtner, M; Cooper, JD; Airaksinen, MS; Holtmann, B; Meyer, M; Thoenen, H				Michaelidis, TM; Sendtner, M; Cooper, JD; Airaksinen, MS; Holtmann, B; Meyer, M; Thoenen, H			Inactivation of bcl-2 results in progressive degeneration of motoneurons, sympathetic and sensory neurons during early postnatal development	NEURON			English	Article							NEUROTROPHIC FACTOR PREVENTS; DEVELOPING NERVOUS-SYSTEM; PROGRAMMED CELL-DEATH; MOTOR-NEURONS; TRANSGENIC MICE; PROTOONCOGENE BCL-2; TARGETED DISRUPTION; SEQUENCE SIMILARITY; PROTEIN EXPRESSION; LYMPHOID-TISSUES	Bcl-2 is a major regulator of programmed cell death, a critical process in shaping the developing nervous system. To assess whether Bcl-2 is involved in regulating neuronal survival and in mediating the neuroprotective action of neurotrophic factors, we generated Bcl-5-deficient mice. At birth, the number of facial motoneurons, sensory, and sympathetic neurons was not significantly changed, and axotomy-induced degeneration of facial motoneurons could still be prevented by brain-derived neurotrophic factor (BDNF) or ciliary neurotrophic factor (CNTF). Interestingly, substantial degeneration of motoneurons, sensory, and sympathetic neurons occurred after the physiological cell death period. Accordingly, Bcl-2 is not a permissive factor for the action of neurotrophic factors, and although it does not influence prenatal neuronal survival, it is crucial for the maintenance of specific populations of neurons during the early postnatal period.	UNIV WURZBURG,DEPT NEUROL,CLIN RES UNIT,D-97080 WURZBURG,GERMANY	University of Wurzburg	Michaelidis, TM (corresponding author), MAX PLANCK INST PSYCHIAT,DEPT NEUROCHEM,D-82152 PLANEGG,GERMANY.		Sendtner, Michael/M-8137-2014; Cooper, Jonathan/V-9962-2019; Cooper, Jonathan/C-8117-2009; Sendtner, Michael/J-1542-2012	Sendtner, Michael/0000-0002-4737-2974; Cooper, Jonathan/0000-0003-1339-4750; Cooper, Jonathan/0000-0003-1339-4750; Sendtner, Michael/0000-0002-4737-2974; Airaksinen, Matti/0000-0002-7199-4984				ABEDOHMAE S, 1993, BIOCHEM BIOPH RES CO, V191, P915, DOI 10.1006/bbrc.1993.1304; ALLSOPP TE, 1995, EUR J NEUROSCI, V7, P1266, DOI 10.1111/j.1460-9568.1995.tb01116.x; ALLSOPP TE, 1993, CELL, V73, P295, DOI 10.1016/0092-8674(93)90230-N; ASHWELL KW, 1983, J EMBRYOL EXP MORPH, V77, P117; ASHWELL KW, 1982, J ANAT, V135, P531; BAKHSHI A, 1985, CELL, V41, P899, DOI 10.1016/S0092-8674(85)80070-2; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; BORASIO GD, 1993, J CELL BIOL, V121, P665, DOI 10.1083/jcb.121.3.665; BOTHWELL M, 1995, ANNU REV NEUROSCI, V18, P223, DOI 10.1146/annurev.neuro.18.1.223; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHAO MV, 1992, NEURON, V9, P583, DOI 10.1016/0896-6273(92)90023-7; CHAO MV, 1995, TRENDS NEUROSCI, V18, P321, DOI 10.1016/0166-2236(95)93922-K; CHLEQDESCHAMPS CM, 1993, BLOOD, V81, P293; CLEARY ML, 1986, CELL, V47, P19, DOI 10.1016/0092-8674(86)90362-4; COGGESHALL RE, 1994, DEV BRAIN RES, V82, P193, DOI 10.1016/0165-3806(94)90163-5; CONOVER JC, 1995, NATURE, V375, P235, DOI 10.1038/375235a0; CREWS LL, 1990, J NEUROSCI, V10, P1643; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; DAVIES AM, 1994, J NEUROBIOL, V25, P1334, DOI 10.1002/neu.480251103; DeBilbao F, 1996, NEUROSCIENCE, V71, P1111, DOI 10.1016/0306-4522(95)00505-6; DUBOISDAUPHIN M, 1994, P NATL ACAD SCI USA, V91, P3309, DOI 10.1073/pnas.91.8.3309; ELLIS RE, 1991, ANNU REV CELL BIOL, V7, P663, DOI 10.1146/annurev.cb.07.110191.003311; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; FARINAS I, 1994, NATURE, V369, P658, DOI 10.1038/369658a0; FARLIE PG, 1995, P NATL ACAD SCI USA, V92, P4397, DOI 10.1073/pnas.92.10.4397; FRANKOWSKI H, 1995, NEUROREPORT, V6, P1917, DOI 10.1097/00001756-199510020-00023; GARCIA I, 1992, SCIENCE, V258, P302, DOI 10.1126/science.1411528; GILLARDON F, 1995, NEUROSCI LETT, V192, P85, DOI 10.1016/0304-3940(95)11619-8; GONZALEZGARCIA M, 1995, P NATL ACAD SCI USA, V92, P4304, DOI 10.1073/pnas.92.10.4304; GREENLUND LJS, 1995, NEURON, V15, P649, DOI 10.1016/0896-6273(95)90153-1; Hara A, 1996, BRAIN RES, V711, P249, DOI 10.1016/0006-8993(95)01436-5; HEFTI F, 1994, J NEUROBIOL, V25, P1418, DOI 10.1002/neu.480251109; HENDERSON CE, 1993, NATURE, V363, P266, DOI 10.1038/363266a0; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; HOCKENBERY DM, 1991, P NATL ACAD SCI USA, V88, P6961, DOI 10.1073/pnas.88.16.6961; HUGHES RA, 1993, J NEUROSCI RES, V36, P663, DOI 10.1002/jnr.490360607; JOHNSON EM, 1993, ANNU REV NEUROSCI, V16, P31, DOI 10.1146/annurev.ne.16.030193.000335; JONES KR, 1994, CELL, V76, P989, DOI 10.1016/0092-8674(94)90377-8; KOLIATSOS VE, 1993, NEURON, V10, P359, DOI 10.1016/0896-6273(93)90326-M; KOLIATSOS VE, 1994, P NATL ACAD SCI USA, V91, P3304, DOI 10.1073/pnas.91.8.3304; KONDO E, 1992, BLOOD, V80, P2044; KOU SY, 1995, J NEUROBIOL, V27, P561, DOI 10.1002/neu.480270410; KOZOPAS KM, 1993, P NATL ACAD SCI USA, V90, P3516, DOI 10.1073/pnas.90.8.3516; KRAJEWSKI S, 1994, AM J PATHOL, V145, P1323; KRAJEWSKI S, 1995, J NEUROSCI, V15, P6364; KREUTZBERG GW, 1986, FACIAL NERVE, P75; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lawson SN., 1992, SENSORY NEURONS DIVE, P27; LEMOUELLIC H, 1992, CELL, V69, P251, DOI 10.1016/0092-8674(92)90406-3; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; LI LX, 1994, J NEUROBIOL, V25, P759, DOI 10.1002/neu.480250702; LIN EY, 1993, J IMMUNOL, V151, P1979; LINDSAY RM, 1994, TRENDS NEUROSCI, V17, P182, DOI 10.1016/0166-2236(94)90099-X; LIU X, 1995, NATURE, V375, P238, DOI 10.1038/375238a0; MAH SP, 1993, J NEUROCHEM, V60, P1183, DOI 10.1111/j.1471-4159.1993.tb03275.x; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; MEAKIN SO, 1992, TRENDS NEUROSCI, V15, P323, DOI 10.1016/0166-2236(92)90047-C; MERRY DE, 1994, DEVELOPMENT, V120, P301; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; NAKAYAMA K, 1994, P NATL ACAD SCI USA, V91, P3700, DOI 10.1073/pnas.91.9.3700; NEGRINI M, 1987, CELL, V49, P455, DOI 10.1016/0092-8674(87)90448-X; NOBES CD, 1995, EUR J NEUROSCI, V7, P344, DOI 10.1111/j.1460-9568.1995.tb01069.x; Nobes CD, 1996, NEUROSCIENCE, V70, P1067, DOI 10.1016/0306-4522(95)00420-3; NUNEZ G, 1990, J IMMUNOL, V144, P3602; Ohga Y, 1996, NEUROSCIENCE, V73, P913, DOI 10.1016/0306-4522(96)00204-7; OITVAI ZN, 1993, CELL, V74, P609; OPPENHEIM RW, 1992, NATURE, V360, P755, DOI 10.1038/360755a0; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; OPPENHEIM RW, 1988, SCIENCE, V240, P919, DOI 10.1126/science.3363373; POLLIN MM, 1991, DEVELOPMENT, V112, P83; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; RUDNICKI MA, 1992, CELL, V71, P383, DOI 10.1016/0092-8674(92)90508-A; Sambrook J., 2002, MOL CLONING LAB MANU; SCHMALBRUCH H, 1984, J COMP NEUROL, V224, P252, DOI 10.1002/cne.902240206; SENDTNER M, 1990, NATURE, V345, P440, DOI 10.1038/345440a0; SENDTNER M, 1992, NATURE, V360, P757, DOI 10.1038/360757a0; SIEGEL RM, 1992, P NATL ACAD SCI USA, V89, P7003, DOI 10.1073/pnas.89.15.7003; SILOSSANTIAGO I, 1995, J NEUROSCI, V15, P5929; SNIDER WD, 1992, J NEUROBIOL, V23, P1231, DOI 10.1002/neu.480230913; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; THOENEN H, 1994, INT ACAD B, V7, P197; THOENEN H, 1993, EXP NEUROL, V124, P47, DOI 10.1006/exnr.1993.1173; TSUJIMOTO Y, 1984, SCIENCE, V226, P1097, DOI 10.1126/science.6093263; TZIMAGIORGIS G, 1995, IN PRESS NUCL ACIDS; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; WRIGHT LL, 1983, J NEUROCYTOL, V12, P727, DOI 10.1007/BF01258147; YAN Q, 1992, NATURE, V360, P753, DOI 10.1038/360753a0; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; YOUNG RL, 1993, MOL CELL BIOL, V13, P3686, DOI 10.1128/MCB.13.6.3686	92	234	240	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1996	17	1					75	89		10.1016/S0896-6273(00)80282-2	http://dx.doi.org/10.1016/S0896-6273(00)80282-2			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UY981	8755480	Bronze			2022-12-24	WOS:A1996UY98100009
J	Ziv, NE; Smith, SJ				Ziv, NE; Smith, SJ			Evidence for a role of dendritic filopodia in synaptogenesis and spine formation	NEURON			English	Article							FROG NEUROMUSCULAR-JUNCTION; HIPPOCAMPAL-NEURONS; GROWTH CONES; FINE-STRUCTURE; VISUAL-CORTEX; POSTNATAL-DEVELOPMENT; ELECTRON-MICROSCOPE; FORM SYNAPSES; CELL-CULTURE; RAT	Axo-dendritic synaptogenesis was examined in live hippocampal cell cultures using the fluorescent dyes DiO to label dendrites and FM 4-64 to label functional presynaptic boutons. As the first functional synaptic boutons appeared in these cultures, numerous filopodia (up to 10 mu m long) were observed to extend transiently (mean lifetime 9.5 min) from dendritic shafts. With progressively increasing numbers of boutons, there were coincident decreases in numbers of transient filopodia and increases in numbers of stable dendritic spines. Dendritic filopodia were observed to initiate physical contacts with nearby axons. This sometimes resulted in filopodial stabilization and formation of functional presynaptic boutons. These findings suggest that dendritic filopodia may actively initiate synaptogenic contacts with nearby (5-10 mu m) axons and thereafter evolve into dendritic spines.			Ziv, NE (corresponding author), STANFORD UNIV, SCH MED, DEPT CELLULAR & MOLEC PHYSIOL, STANFORD, CA 94305 USA.		Ziv, Noam/ABA-6551-2020	Ziv, Noam/0000-0001-9197-326X; Smith, Stephen/0000-0002-2290-8701	NIMH NIH HHS [MH48108] Funding Source: Medline; NINDS NIH HHS [NS28587] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH048108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028587] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARTLETT WP, 1984, J NEUROSCI, V4, P1954; BASARSKY TA, 1994, J NEUROSCI, V14, P6402; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BETZ WJ, 1993, J PHYSIOLOGY-PARIS, V87, P193, DOI 10.1016/0928-4257(93)90030-W; BUCHANAN J, 1989, J NEUROSCI, V9, P1540; CACERES A, 1984, DEV BRAIN RES, V13, P314, DOI 10.1016/0165-3806(84)90167-6; CONSTANTINEPATON M, 1990, COLD SPRING HARB SYM, V55, P431; COOPER MW, 1992, J NEUROBIOL, V23, P814, DOI 10.1002/neu.480230704; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U; CRAIG AM, 1994, P NATL ACAD SCI USA, V91, P12373, DOI 10.1073/pnas.91.26.12373; DAILEY ME, 1994, J NEUROSCI, V14, P1060, DOI 10.1523/JNEUROSCI.14-03-01060.1994; Dailey ME, 1996, J NEUROSCI, V16, P2983; DALVA MB, 1994, J NEUROSCI, V14, P3588; DOTTI CG, 1988, J NEUROSCI, V8, P1454; FLETCHER TL, 1994, J NEUROSCI, V14, P6695; HARRIS KM, 1992, J NEUROSCI, V12, P2685; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Harris KM., 1989, HIPPOCAMPUS NEW VIST, P33; HAYES BP, 1973, Z ZELLFORSCH MIK ANA, V137, P251, DOI 10.1007/BF00307433; Henkel AW, 1995, J NEUROSCI, V15, P8246; HINDS JW, 1972, J NEUROCYTOL, V1, P169, DOI 10.1007/BF01099183; HONIG MG, 1986, J CELL BIOL, V103, P171, DOI 10.1083/jcb.103.1.171; HONIG MG, 1989, TRENDS NEUROSCI, V12, P333, DOI 10.1016/0166-2236(89)90040-4; HOSOKAWA T, 1995, J NEUROSCI, V15, P5560; HOSOKAWA T, 1992, NEUROREPORT, V3, P477, DOI 10.1097/00001756-199206000-00005; JURASKA JM, 1979, J COMP NEUROL, V183, P247, DOI 10.1002/cne.901830203; LUND JS, 1977, J COMP NEUROL, V176, P149, DOI 10.1002/cne.901760203; MATTEOLI M, 1995, J PHYSL, V89, P1; MILLER M, 1981, J COMP NEUROL, V203, P555, DOI 10.1002/cne.902030402; MOREST DK, 1969, Z ANAT ENTWICKLUNGS, V128, P290, DOI 10.1007/BF00522529; MOREST DK, 1969, Z ANAT ENTWICKLUNGS, V128, P271, DOI 10.1007/BF00522528; PAPA M, 1995, J NEUROSCI, V15, P1; PAPPAS GD, 1975, ADV NEUROL, V12, P163; PHELPS PE, 1983, DEV BRAIN RES, V10, P1, DOI 10.1016/0165-3806(83)90116-5; PURPURA DP, 1975, PHYSL PATHOLOGY DEND, P91; RAMOA AS, 1987, SCIENCE, V237, P522, DOI 10.1126/science.3603038; ROCHA M, 1995, P NATL ACAD SCI USA, V92, P8026, DOI 10.1073/pnas.92.17.8026; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; SAITO Y, 1992, NEUROSCI LETT, V147, P81, DOI 10.1016/0304-3940(92)90779-7; SEGAL M, 1995, NEUROSCI LETT, V193, P73, DOI 10.1016/0304-3940(95)11665-J; SKOFF RP, 1974, J COMP NEUROL, V153, P107, DOI 10.1002/cne.901530202; SMITH SJ, 1992, NERVE GROWTH CONE, P19; STEWARD O, 1988, MOL NEUROBIOL, V2, P227, DOI 10.1007/BF02935634; SWINDALE NV, 1981, TRENDS NEUROSCI, V4, P240, DOI 10.1016/0166-2236(81)90075-8; ULFHAKE B, 1988, J COMP NEUROL, V278, P88, DOI 10.1002/cne.902780106; VAUGHN JE, 1974, J CELL BIOL, V60, P664, DOI 10.1083/jcb.60.3.664; VAUGHN JE, 1989, SYNAPSE, V3, P255, DOI 10.1002/syn.890030312; VERDERIO C, 1995, P NATL ACAD SCI USA, V92, P6449, DOI 10.1073/pnas.92.14.6449; VERDERIO C, 1994, J CELL BIOL, V126, P1527, DOI 10.1083/jcb.126.6.1527	51	669	687	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	1996	17	1					91	102		10.1016/S0896-6273(00)80283-4	http://dx.doi.org/10.1016/S0896-6273(00)80283-4			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UY981	8755481	Bronze			2022-12-24	WOS:A1996UY98100010
J	Tong, G; Malenka, RC; Nicoll, RA				Tong, G; Malenka, RC; Nicoll, RA			Long-term potentiation in cultures of single hippocampal granule cells: A presynaptic form of plasticity	NEURON			English	Article							MOSSY-FIBER SYNAPSES; CRAYFISH NEUROMUSCULAR-JUNCTION; GUINEA-PIG HIPPOCAMPUS; NEURONS; FACILITATION; ENHANCEMENT; MECHANISMS; RESPONSES	We have explored the mechanisms of messy fiber long-term potentiation (LTP) at autapses in single-cell cultures of guinea pig hippocampal dentate granule cells. L-AP4-sensitive, but not insensitive, cells responded to a brief tetanus with a sustained potentiation in the synaptic responses. The induction of this LTP appeared identical to that observed in hippocampal messy fiber synapses in situ, in that it required a rise in presynaptic Ca2+ and activation of protein kinase A. Its expression also appeared to be presynaptic and was due, at least in part, to events that occurred after the entry of Ca2+ and to the switching on of previously silent release sites.	UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PSYCHIAT,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Tong, G (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT MOLEC & CELLULAR PHARMACOL,SAN FRANCISCO,CA 94143, USA.		Oka, Yoshitaka/C-9670-2010; Tong, Gary/AAC-9426-2022	Oka, Yoshitaka/0000-0002-3482-3051; 				ARANCIO O, 1995, NATURE, V376, P74, DOI 10.1038/376074a0; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; CASTILLO PE, 1994, NEURON, V12, P261, DOI 10.1016/0896-6273(94)90269-0; CHARPIER S, 1995, P NATL ACAD SCI USA, V92, P117, DOI 10.1073/pnas.92.1.117; CLAIBORNE BJ, 1993, HIPPOCAMPUS, V3, P115, DOI 10.1002/hipo.450030202; DERRICK BE, 1994, P NATL ACAD SCI USA, V91, P10290, DOI 10.1073/pnas.91.22.10290; FYKSE EM, 1995, J NEUROSCI, V15, P2385, DOI 10.1523/JNEUROSCI.15-03-02385.1995; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; HARRIS EW, 1986, NEUROSCI LETT, V70, P132, DOI 10.1016/0304-3940(86)90451-9; HOPKINS WF, 1988, J NEUROPHYSIOL, V59, P667, DOI 10.1152/jn.1988.59.2.667; Huang YY, 1996, NEURON, V16, P611, DOI 10.1016/S0896-6273(00)80080-X; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; ITO I, 1991, NEUROREPORT, V2, P333, DOI 10.1097/00001756-199106000-00008; JAFFE D, 1990, J NEUROPHYSIOL, V64, P948, DOI 10.1152/jn.1990.64.3.948; JOHNSTON D, 1992, ANNU REV PHYSIOL, V54, P489; KATSUKI H, 1991, NEUROSCI RES, V12, P393, DOI 10.1016/0168-0102(91)90070-F; LANGDON RB, 1995, J NEUROBIOL, V26, P370, DOI 10.1002/neu.480260309; LANTHORN TH, 1984, BRAIN RES, V290, P174, DOI 10.1016/0006-8993(84)90750-9; LARKMAN AU, 1995, CURR OPIN NEUROBIOL, V5, P324, DOI 10.1016/0959-4388(95)80045-X; LESTER RAJ, 1993, J NEUROSCI, V13, P1088; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; ROSENMUND C, 1993, J PHYSIOL-LONDON, V470, P705, DOI 10.1113/jphysiol.1993.sp019884; ROSENMUND C, 1993, NEURON, V10, P805, DOI 10.1016/0896-6273(93)90197-Y; SALIN PA, 1995, J NEUROSCI, V15, P6939; SEGAL MM, 1990, J NEUROPHYSIOL, V64, P1390, DOI 10.1152/jn.1990.64.5.1390; SPILLANE DM, 1995, NEUROPHARMACOLOGY, V34, P1573, DOI 10.1016/0028-3908(95)00107-H; STAUBLI U, 1990, SYNAPSE, V5, P333, DOI 10.1002/syn.890050410; STEVENS CF, 1993, CELL, V72, P55, DOI 10.1016/S0092-8674(05)80028-5; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; TONG G, 1994, NEURON, V12, P51, DOI 10.1016/0896-6273(94)90151-1; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; WEISSKOPF MG, 1995, NATURE, V376, P256, DOI 10.1038/376256a0; WEISSKOPF MG, 1993, NATURE, V362, P423, DOI 10.1038/362423a0; WILLIAMS S, 1989, NEURON, V3, P583, DOI 10.1016/0896-6273(89)90268-7; WOJTOWICZ JM, 1994, J NEUROSCI, V14, P3688; WOJTOWICZ JM, 1988, J NEUROSCI, V8, P4667; WOJTOWICZ JM, 1988, NEUROSCI LETT, V90, P152, DOI 10.1016/0304-3940(88)90803-8; WYLLIE DJA, 1994, NEURON, V12, P127, DOI 10.1016/0896-6273(94)90158-9; XIANG ZX, 1994, J NEUROPHYSIOL, V71, P2552, DOI 10.1152/jn.1994.71.6.2552; YAMAMOTO C, 1983, EXP BRAIN RES, V51, P128; YAMAMOTO C, 1992, NEUROSCI LETT, V138, P111, DOI 10.1016/0304-3940(92)90484-O; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039; ZALUTSKY RA, 1992, NEUROSCI LETT, V138, P193, DOI 10.1016/0304-3940(92)90503-Y	46	125	126	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1996	16	6					1147	1157		10.1016/S0896-6273(00)80141-5	http://dx.doi.org/10.1016/S0896-6273(00)80141-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UU118	8663991	Bronze			2022-12-24	WOS:A1996UU11800012
J	BECK, KD; POWELLBRAXTON, L; WIDMER, HR; VALVERDE, J; HEFTI, F				BECK, KD; POWELLBRAXTON, L; WIDMER, HR; VALVERDE, J; HEFTI, F			IGF1 GENE DISRUPTION RESULTS IN REDUCED BRAIN SIZE, CNS HYPOMYELINATION, AND LOSS OF HIPPOCAMPAL GRANULE AND STRIATAL PARVALBUMIN-CONTAINING NEURONS	NEURON			English	Article							GROWTH FACTOR-I; CENTRAL-NERVOUS-SYSTEM; FACTOR BINDING-PROTEINS; SNELL DWARF MOUSE; RAT-BRAIN; OLIGODENDROCYTE DEVELOPMENT; MOTONEURON SURVIVAL; CEREBRAL MYELINOGENESIS; NEUROTROPHIC FACTOR; CHOROID-PLEXUS	Homozygous Igf1(-/-) mice at 2 months of age had reduced brain weights, with reductions evenly affecting all major brain areas. The gross morphology of the CNS was normal, but the size of white matter structures in brain and spinal cord was strongly reduced, owing to decreased numbers of axons and oligodendrocytes. Myelinated axons were more strongly reduced in number than unmyelinated axons. The volume of the dentate gyrus granule cell layer was reduced in excess of the decrease in brain weight. Among populations of calcium-binding protein-containing neurons, there was a selective reduction in the number of striatal parvalbumin-containing cells. Numbers of mesencephalic dopaminergic neurons, striatal and basal forebrain cholinergic neurons, and spinal cord motoneurons were unaffected. Cerebellar morphology was unaltered. Our findings suggest cell type- and region-specific functions for IGF-I and emphasize prominent roles in axon growth and maturation in CNS myelination.	GENENTECH INC, DEPT ENDOCRINE RES, San Francisco, CA 94080 USA; UNIV SO CALIF, ANDRUS GERONTOL CTR, LOS ANGELES, CA 90089 USA	Roche Holding; Genentech; University of Southern California	BECK, KD (corresponding author), GENENTECH INC, DEPT NEUROSCI, San Francisco, CA 94080 USA.		Widmer, Hans Rudolf/O-5172-2017; Widmer, Hans R./AAC-8948-2022	Widmer, Hans Rudolf/0000-0003-3378-8765; 	NIA NIH HHS [AG09793, AG10480] Funding Source: Medline; NINDS NIH HHS [NS22933] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG009793, P01AG010480] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AIZENMAN Y, 1987, BRAIN RES, V406, P32, DOI 10.1016/0006-8993(87)90766-9; AIZENMAN Y, 1986, P NATL ACAD SCI USA, V83, P2263, DOI 10.1073/pnas.83.7.2263; ALTMAN J, 1990, J COMP NEUROL, V301, P365, DOI 10.1002/cne.903010304; ALTMAN J, 1990, J COMP NEUROL, V301, P325, DOI 10.1002/cne.903010302; ANG LC, 1992, J NEUROL SCI, V109, P168, DOI 10.1016/0022-510X(92)90164-G; BAIMBRIDGE KG, 1992, TRENDS NEUROSCI, V15, P303, DOI 10.1016/0166-2236(92)90081-I; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; BARRES BA, 1994, NEURON, V12, P935, DOI 10.1016/0896-6273(94)90305-0; BARRES BA, 1993, CURR BIOL, V3, P489, DOI 10.1016/0960-9822(93)90039-Q; BARRES BA, 1992, J NEUROBIOL, V23, P1221, DOI 10.1002/neu.480230912; BARRES BA, 1993, NATURE, V361, P258, DOI 10.1038/361258a0; BECK KD, 1993, NEUROSCIENCE, V52, P855, DOI 10.1016/0306-4522(93)90534-M; BELIO MR, 1984, NEUROSCI LETT S, V18, P332; BERGMANN I, 1991, ANAT EMBRYOL, V184, P403, DOI 10.1007/BF00957901; BONDY C, 1992, NEUROSCIENCE, V46, P909, DOI 10.1016/0306-4522(92)90193-6; BONDY C, 1993, J NEUROSCI, V13, P5092, DOI 10.1523/JNEUROSCI.13-12-05092.1993; BONDY CA, 1991, J NEUROSCI, V11, P3442; BOTHWELL M, 1982, J NEUROSCI RES, V8, P225, DOI 10.1002/jnr.490080212; CARONI P, 1990, J CELL BIOL, V110, P1307, DOI 10.1083/jcb.110.4.1307; CARSON MJ, 1993, NEURON, V10, P729, DOI 10.1016/0896-6273(93)90173-O; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; Clark G., 1981, STAINING PROCEDURES; CLEMMONS DR, 1993, ANN NY ACAD SCI, V692, P10; COLLARINI EJ, 1991, J CELL SCI, P117; CZECH MP, 1989, CELL, V59, P235, DOI 10.1016/0092-8674(89)90281-X; DAUGHADAY WH, 1989, PERSPECT BIOL MED, V32, P194; DAUGHADAY WH, 1989, ENDOCR REV, V10, P68, DOI 10.1210/edrv-10-1-68; DERCOLE AJ, 1994, DEV BRAIN RES, V82, P213; DICICCOBLOOM E, 1988, P NATL ACAD SCI USA, V85, P4066, DOI 10.1073/pnas.85.11.4066; EAGLESON KL, 1986, DEV BRAIN RES, V29, P161, DOI 10.1016/0165-3806(86)90092-1; EAGLESON KL, 1985, DEV BRAIN RES, V17, P95, DOI 10.1016/0165-3806(85)90135-X; FAGIN JA, 1989, ENDOCRINOLOGY, V125, P2385, DOI 10.1210/endo-125-5-2385; FROESCH ER, 1985, ANNU REV PHYSIOL, V47, P443; GAO WQ, 1991, NEURON, V6, P705, DOI 10.1016/0896-6273(91)90168-Y; GARCIASEGURA LM, 1991, BRAIN RES, V560, P167, DOI 10.1016/0006-8993(91)91228-S; GHANDOUR MS, 1980, NEUROSCIENCE, V5, P559, DOI 10.1016/0306-4522(80)90053-6; GYLLENSTEN L, 1963, J EMBRYOL EXP MORPH, V11, P255; HENDERSON CE, 1993, NATURE, V363, P266, DOI 10.1038/363266a0; HODGKINSON SC, 1991, ENDOCRINOLOGY, V129, P2085, DOI 10.1210/endo-129-4-2085; HUGHES RA, 1993, J NEUROSCI RES, V36, P663, DOI 10.1002/jnr.490360607; HUGHES SM, 1988, NATURE, V335, P70, DOI 10.1038/335070a0; HYNES MA, 1988, MOL ENDOCRINOL, V2, P47, DOI 10.1210/mend-2-1-47; KING RA, 1988, J ENDOCRINOL, V119, P117, DOI 10.1677/joe.0.1190117; KNUSEL B, 1990, J NEUROSCI, V10, P558; LEE WH, 1992, J NEUROSCI, V12, P4737; LEE WH, 1993, NEUROSCIENCE, V53, P251, DOI 10.1016/0306-4522(93)90303-W; LEVINE SM, 1988, J NEUROSCI, V8, P3992; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; MATHEWS LS, 1986, P NATL ACAD SCI USA, V83, P9343, DOI 10.1073/pnas.83.24.9343; MATTHIEU JM, 1973, BRAIN RES, V55, P391, DOI 10.1016/0006-8993(73)90304-1; MATTSON MP, 1991, NEURON, V6, P41, DOI 10.1016/0896-6273(91)90120-O; MCMORRIS FA, 1990, ANN NY ACAD SCI, V605, P101, DOI 10.1111/j.1749-6632.1990.tb42385.x; MCMORRIS FA, 1988, J NEUROSCI RES, V21, P199, DOI 10.1002/jnr.490210212; MCMORRIS FA, 1986, P NATL ACAD SCI USA, V83, P822, DOI 10.1073/pnas.83.3.822; MORELL P, 1972, J NEUROCHEM, V19, P2545, DOI 10.1111/j.1471-4159.1972.tb01313.x; MOZELL RL, 1991, J NEUROSCI RES, V30, P382, DOI 10.1002/jnr.490300214; NEFF NT, 1993, J NEUROBIOL, V24, P1578, DOI 10.1002/neu.480241203; NOBLE M, 1991, ANN NY ACAD SCI, V633, P35; NOBLE M, 1992, J NEUROIMMUNOL, V40, P287, DOI 10.1016/0165-5728(92)90145-B; NOGUCHI T, 1991, COMP BIOCHEM PHYS C, V98, P239; NOGUCHI T, 1982, J NEUROCHEM, V38, P257, DOI 10.1111/j.1471-4159.1982.tb10878.x; NOGUCHI T, 1982, J NEUROCHEM, V39, P1693, DOI 10.1111/j.1471-4159.1982.tb08004.x; NOGUCHI T, 1985, NEUROCHEM RES, V10, P1097, DOI 10.1007/BF00965884; OCRANT I, 1990, ENDOCRINOLOGY, V127, P1260, DOI 10.1210/endo-127-3-1260; OOI GT, 1990, MOL CELL ENDOCRINOL, V71, pC39, DOI 10.1016/0303-7207(90)90243-2; POWELLBRAXTON L, 1993, GENE DEV, V7, P2609, DOI 10.1101/gad.7.12b.2609; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; RALPHS JR, 1990, DEVELOPMENT, V109, P51; RECHLER MM, 1992, GROWTH REGULAT, V2, P55; RECHLER MM, 1990, HDB EXPT PHARM, V95, P263; RESIBOIS A, 1992, NEUROSCIENCE, V46, P101, DOI 10.1016/0306-4522(92)90012-Q; ROTWEIN P, 1988, P NATL ACAD SCI USA, V85, P265, DOI 10.1073/pnas.85.1.265; SARA VR, 1990, PHYSIOL REV, V70, P591, DOI 10.1152/physrev.1990.70.3.591; Siddle Kenneth, 1992, Progress in Growth Factor Research, V4, P301, DOI 10.1016/0955-2235(92)90013-8; SOLBACH S, 1991, ANAT EMBRYOL, V184, P103, DOI 10.1007/BF00942742; STYLIANOPOULOU F, 1988, P NATL ACAD SCI USA, V85, P141, DOI 10.1073/pnas.85.1.141; SUGISAKI T, 1985, NEUROCHEM RES, V10, P767, DOI 10.1007/BF00964534; TAUBER H, 1980, NEUROSCI LETT, V16, P235, DOI 10.1016/0304-3940(80)90003-8	78	518	531	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1995	14	4					717	730		10.1016/0896-6273(95)90216-3	http://dx.doi.org/10.1016/0896-6273(95)90216-3			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QU826	7718235	Bronze			2022-12-24	WOS:A1995QU82600006
J	JAVITCH, JA; FU, DY; CHEN, JY; KARLIN, A				JAVITCH, JA; FU, DY; CHEN, JY; KARLIN, A			MAPPING THE BINDING-SITE CREVICE OF THE DOPAMINE D2 RECEPTOR BY THE SUBSTITUTED-CYSTEINE ACCESSIBILITY METHOD	NEURON			English	Article							TRANSMEMBRANE PROTEIN-STRUCTURE; SCHIFF-BASE COUNTERION; DIRECTED MUTAGENESIS; ESCHERICHIA-COLI; BOVINE RHODOPSIN; CHANNEL; IDENTIFICATION; RESIDUES; MUTANTS; CLONING	The binding site of the dopamine D2 receptor, like that of other homologous G protein-coupled receptors, is contained within a water-accessible crevice formed among its seven membrane-spanning segments. We have developed a method to map systematically all the residues forming the surface of this binding-site crevice, and we have applied this method to the third membrane-spanning segment (M3). We mutated, one at a time, 23 residues in and flanking M3 to cysteine and expressed the mutant receptors heterologously. Ten of these mutants reacted with charged, hydrophilic, lipophobic, sulfhydryl-specific reagents, added extracellularly, and were protected from reaction by a reversible dopamine antagonist. Thus, the side chains of these residues are exposed in the binding-site crevice, which like M3 extends from the extracellular to the intracellular side of the membrane. The pattern of exposure is consistent with a short loop followed by six turns of an alpha helix.	COLUMBIA UNIV,COLL PHYS & SURG,DEPT PSYCHIAT,NEW YORK,NY 10032; COLUMBIA UNIV,COLL PHYS & SURG,DEPT BIOCHEM & MOLEC BIOPHYS,NEW YORK,NY 10032; COLUMBIA UNIV,COLL PHYS & SURG,DEPT NEUROL,NEW YORK,NY 10032; COLUMBIA UNIV,COLL PHYS & SURG,DEPT PHYSIOL & CELLULAR BIOPHYS,NEW YORK,NY 10032	Columbia University; Columbia University; Columbia University; Columbia University	JAVITCH, JA (corresponding author), COLUMBIA UNIV,COLL PHYS & SURG,CTR MOLEC RECOGNIT,NEW YORK,NY 10032, USA.			Javitch, Jonathan/0000-0001-7395-2967; KARLIN, ARTHUR/0000-0002-4813-752X	NATIONAL INSTITUTE OF MENTAL HEALTH [K21MH001030] Funding Source: NIH RePORTER; NIMH NIH HHS [K21 MH01030] Funding Source: Medline; NINDS NIH HHS [NS07065, NS07258] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; AKABAS MH, 1994, J BIOL CHEM, V269, P14865; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; ALTENBACH C, 1990, SCIENCE, V248, P1088, DOI 10.1126/science.2160734; BALDWIN JM, 1993, EMBO J, V12, P1693, DOI 10.1002/j.1460-2075.1993.tb05814.x; CIVELLI O, 1991, EUR J PHARM-MOLEC PH, V207, P277, DOI 10.1016/0922-4106(91)90001-X; COX BA, 1992, J NEUROCHEM, V59, P627, DOI 10.1111/j.1471-4159.1992.tb09416.x; FALKE JJ, 1988, J BIOL CHEM, V263, P14850; GRANDY DK, 1989, P NATL ACAD SCI USA, V86, P9762, DOI 10.1073/pnas.86.24.9762; JAKES KS, 1990, J BIOL CHEM, V265, P6984; JARVIE KR, 1987, EUR J PHARMACOL, V144, P163, DOI 10.1016/0014-2999(87)90516-4; JAVITCH JA, 1994, P NATL ACAD SCI USA, V91, P10355, DOI 10.1073/pnas.91.22.10355; JUNG K, 1993, BIOCHEMISTRY-US, V32, P12273, DOI 10.1021/bi00097a001; MANSOUR A, 1992, EUR J PHARM-MOLEC PH, V227, P205, DOI 10.1016/0922-4106(92)90129-J; NATHANS J, 1990, BIOCHEMISTRY-US, V29, P9746, DOI 10.1021/bi00493a034; NIZNIK HB, 1985, N-S ARCH PHARMACOL, V329, P333, DOI 10.1007/BF00496365; OPRIAN DD, 1992, J BIOENERG BIOMEMBR, V24, P211, DOI 10.1007/BF00762679; PAKULA AA, 1992, P NATL ACAD SCI USA, V89, P4144, DOI 10.1073/pnas.89.9.4144; PROBST WC, 1992, DNA CELL BIOL, V11, P1, DOI 10.1089/dna.1992.11.1; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; SCHERTLER GFX, 1993, NATURE, V362, P770, DOI 10.1038/362770a0; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; STRADER CD, 1994, ANNU REV BIOCHEM, V63, P101, DOI 10.1146/annurev.bi.63.070194.000533; TODD AP, 1989, PROTEINS, V6, P294, DOI 10.1002/prot.340060312; VANTOL HHM, 1991, NATURE, V350, P610, DOI 10.1038/350610a0; WESS J, 1991, EMBO J, V10, P3729, DOI 10.1002/j.1460-2075.1991.tb04941.x; WONG SKF, 1988, J BIOL CHEM, V263, P7925; XU M, 1993, J BIOL CHEM, V268, P21505; ZHUKOVSKY EA, 1990, SCIENCE, V246, P928	30	160	160	0	6	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1995	14	4					825	831		10.1016/0896-6273(95)90226-0	http://dx.doi.org/10.1016/0896-6273(95)90226-0			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QU826	7718244	hybrid			2022-12-24	WOS:A1995QU82600016
J	JONES, S; BROWN, DA; MILLIGAN, G; WILLER, E; BUCKLEY, NJ; CAULFIELD, MP				JONES, S; BROWN, DA; MILLIGAN, G; WILLER, E; BUCKLEY, NJ; CAULFIELD, MP			BRADYKININ EXCITES RAT SYMPATHETIC NEURONS BY INHIBITION OF M CURRENT THROUGH A MECHANISM INVOLVING B-2 RECEPTORS AND G(ALPHA-Q/11)	NEURON			English	Article							SENSORY NEURONS; CELLS; GANGLION; DEPOLARIZATION; ANTIBODIES; ACTIVATION; TERMINALS; MESSENGER; SUBTYPES; CHANNELS	Bradykinin (BK) is a peptide mediator released in inflammation that potently excites sympathetic neurons. We have studied the mechanism of this excitation in dissociated rat sympathetic neurons and found that at low nanomolar (EC(50) = (1.9 nM) concentrations, BK inhibited the M-type K+ current IK(M). Studies with the selective antagonist Hoe140 revealed that this effect was mediated via the B-2 receptor subtype, and mRNA encoding this receptor was identified in these neurons by RT-PCR. I-K(M) inhibition was unaffected by Pertussis toxin or microinjection of antibodies to G(ao) but was selectively inhibited by microinjection of antibodies to Go(aq/11). Thus, BK is the most potent M current inhibitor yet described in mammalian neurons, and BK inhibition of M current is mediated by a G protein pathway similar to that activated by muscarinic acetylchaline receptors.	UNIV GLASGOW,DEPT BIOCHEM,MOLEC PHARMACOL GRP,GLASGOW G12 8QQ,LANARK,SCOTLAND; UNIV GLASGOW,DEPT PHARMACOL,GLASGOW G12 8QQ,LANARK,SCOTLAND	University of Glasgow; University of Glasgow	JONES, S (corresponding author), UNIV LONDON UNIV COLL,DEPT PHARMACOL,WELLCOME LAB MOLEC PHARMACOL,LONDON WC1E 6BT,ENGLAND.		Buckley, Noel J/B-9675-2012; Brown, David A/J-9019-2012; Milligan, Graeme/F-9426-2011	Buckley, Noel J/0000-0003-1152-0653; Milligan, Graeme/0000-0002-6946-3519	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ADAMS PR, 1975, J PHYSIOL-LONDON, V250, P85, DOI 10.1113/jphysiol.1975.sp011044; ADAMS PR, 1982, J PHYSIOL-LONDON, V332, P223, DOI 10.1113/jphysiol.1982.sp014411; BERNHEIM L, 1992, P NATL ACAD SCI USA, V89, P9544, DOI 10.1073/pnas.89.20.9544; BROWN DA, 1980, BRIT J PHARMACOL, V70, P593, DOI 10.1111/j.1476-5381.1980.tb09778.x; BURGESS GM, 1989, J NEUROSCI, V9, P3314; CAULFIELD MP, 1994, J PHYSIOL-LONDON, V477, P415, DOI 10.1113/jphysiol.1994.sp020203; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CODERRE TJ, 1989, J NEUROPHYSIOL, V62, P48, DOI 10.1152/jn.1989.62.1.48; CONSTANTI A, 1981, NEUROSCI LETT, V24, P289, DOI 10.1016/0304-3940(81)90173-7; DRAY A, 1993, TRENDS NEUROSCI, V16, P99, DOI 10.1016/0166-2236(93)90133-7; DUNN PM, 1990, BRIT J PHARMACOL, V100, P656, DOI 10.1111/j.1476-5381.1990.tb15863.x; DUNN PM, 1991, BRAIN RES, V545, P80, DOI 10.1016/0006-8993(91)91272-3; GOLDSMITH P, 1987, J BIOL CHEM, V262, P14683; GUTOWSKI S, 1991, J BIOL CHEM, V266, P20519; HALL JM, 1992, PHARMACOL THERAPEUT, V56, P131, DOI 10.1016/0163-7258(92)90016-S; HEFELY WE, 1970, BRADYKININ RELATED K, P591; HIGASHIDA H, 1986, NATURE, V323, P333, DOI 10.1038/323333a0; JONES SW, 1985, J PHYSIOL-LONDON, V366, P63, DOI 10.1113/jphysiol.1985.sp015785; LEE A, 1991, BRAIN RES, V557, P146, DOI 10.1016/0006-8993(91)90127-H; LEVINE JD, 1986, NATURE, V323, P158, DOI 10.1038/323158a0; Lewis G.P., 1970, HDB EXP PHARM, P516; LEWIS GP, 1965, J PHYSIOL-LONDON, V179, P538, DOI 10.1113/jphysiol.1965.sp007679; LEWIS GP, 1966, BRIT J PHARM CHEMOTH, V26, P444, DOI 10.1111/j.1476-5381.1966.tb01925.x; MARRION NV, 1989, BRIT J PHARMACOL, V98, P557, DOI 10.1111/j.1476-5381.1989.tb12630.x; MCINTYRE P, 1993, MOL PHARMACOL, V44, P346; MCMAHON SB, 1991, BRIT MED BULL, V47, P584, DOI 10.1093/oxfordjournals.bmb.a072494; NEHER E, 1988, FEBS LETT, V240, P88, DOI 10.1016/0014-5793(88)80345-4; NEUHAUS R, 1991, J NEUROSCI, V11, P3984; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; REGOLI D, 1980, PHARMACOL REV, V32, P1; SELYANKO AA, 1992, P ROY SOC B-BIOL SCI, V250, P119, DOI 10.1098/rspb.1992.0139; SHAPIRO MS, 1994, NEURON, V12, P1319, DOI 10.1016/0896-6273(94)90447-2; STEEL MC, 1993, MOL PHARMACOL, V43, P694; TERTOOLEN LGJ, 1987, FEBS LETT, V214, P365, DOI 10.1016/0014-5793(87)80089-3; TRENDELE.U, 1966, J PHARMACOL EXP THER, V154, P418; VILLARROEL A, 1989, FEBS LETT, V255, P42, DOI 10.1016/0014-5793(89)81057-9; WALLIS DI, 1974, BRIT J PHARMACOL, V51, P521, DOI 10.1111/j.1476-5381.1974.tb09670.x; WEINREICH D, 1986, EUR J PHARMACOL, V132, P61, DOI 10.1016/0014-2999(86)90010-5; WILKBLASZCZAK MA, 1994, NEURON, V12, P109, DOI 10.1016/0896-6273(94)90156-2	39	119	120	0	2	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1995	14	2					399	405		10.1016/0896-6273(95)90295-3	http://dx.doi.org/10.1016/0896-6273(95)90295-3			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QH294	7857647	Bronze			2022-12-24	WOS:A1995QH29400017
J	SON, YJ; THOMPSON, WJ				SON, YJ; THOMPSON, WJ			NERVE SPROUTING IN MUSCLE IS INDUCED AND GUIDED BY PROCESSES EXTENDED BY SCHWANN-CELLS	NEURON			English	Article							CILIARY NEUROTROPHIC FACTOR; ADULT SKELETAL-MUSCLE; NEUROMUSCULAR-JUNCTION; TRANSMISSION BLOCK; PERIPHERAL-NERVE; SCIATIC-NERVE; MESSENGER-RNA; GROWTH-FACTOR; MOTOR-NERVE; RAT	Partial denervation or paralysis with botulinum toxin, manipulations that induce sprouting of nerve terminals in muscle, also induced terminal Schwann cells to extend processes. These processes were associated with every nerve sprout and in some cases were longer than the sprouts that appeared to be growing along them. Following partial denervation, more than 70% of the nerve sprouts that grew to innervate nearby denervated end plates were associated with Schwann cell processes that had extended from the denervated endplates, i.e., in the direction opposite to nerve growth. Implantation of Schwann cells into an innervated muscle induced sprouting upon contact of an axon or nerve terminal by Schwann cell processes. These observations show that Schwann cells induce and guide axonal sprouting in muscle.	UNIV TEXAS,DEPT ZOOL,AUSTIN,TX 78712	University of Texas System; University of Texas Austin	SON, YJ (corresponding author), UNIV TEXAS,CTR DEV BIOL,AUSTIN,TX 78712, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020480, R37NS020480] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 20480] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ASTROW SH, 1994, J NEUROBIOL, V25, P937, DOI 10.1002/neu.480250804; ASTROW SH, 1992, J NEUROSCI, V12, P1602; BROWN MC, 1977, NATURE, V265, P459, DOI 10.1038/265459a0; BROWN MC, 1979, NATURE, V282, P724, DOI 10.1038/282724a0; BROWN MC, 1981, ANNU REV NEUROSCI, V4, P17, DOI 10.1146/annurev.ne.04.030181.000313; BROWN MC, 1981, J PHYSIOL-LONDON, V318, P355; BROWN MC, 1980, J PHYSL, V306, P495; CARONI P, 1990, J CELL BIOL, V110, P1307, DOI 10.1083/jcb.110.4.1307; CHEN LL, 1994, J NEUROSCI, V14, P796; DIAZ J, 1990, J PHYSIOL-LONDON, V421, P123, DOI 10.1113/jphysiol.1990.sp017936; DUCHEN LW, 1968, Q J EXP PHYSIOL CMS, V53, P84, DOI 10.1113/expphysiol.1968.sp001948; DUCHEN LW, 1971, J NEUROL SCI, V14, P47, DOI 10.1016/0022-510X(71)90129-8; FRIEDMAN B, 1992, NEURON, V9, P295, DOI 10.1016/0896-6273(92)90168-D; GEORGIOU J, 1994, NEURON, V12, P443, DOI 10.1016/0896-6273(94)90284-4; GURNEY ME, 1992, J NEUROSCI, V12, P3241, DOI 10.1523/JNEUROSCI.12-08-03241.1992; HEUMANN R, 1987, J CELL BIOL, V104, P1623, DOI 10.1083/jcb.104.6.1623; HOLLAND RL, 1980, SCIENCE, V207, P649, DOI 10.1126/science.6243417; JAHROMI BS, 1992, NEURON, V8, P1069, DOI 10.1016/0896-6273(92)90128-Z; JESSEN KR, 1991, GLIA, V4, P185, DOI 10.1002/glia.440040210; KUFFLER DP, 1989, J COMP NEUROL, V281, P416, DOI 10.1002/cne.902810307; MAGRASSI L, 1987, J NEUROSCI, V7, P1207; MEHTA A, 1993, NEUROSCIENCE, V57, P433, DOI 10.1016/0306-4522(93)90075-Q; MEYER M, 1992, J CELL BIOL, V119, P45, DOI 10.1083/jcb.119.1.45; PAYER AF, 1979, J COMP NEUROL, V183, P365, DOI 10.1002/cne.901830209; REIST NE, 1992, P NATL ACAD SCI USA, V89, P7625, DOI 10.1073/pnas.89.16.7625; REYNOLDS ML, 1992, J NEUROCYTOL, V21, P50, DOI 10.1007/BF01206897; SANES JR, 1986, J CELL BIOL, V102, P420, DOI 10.1083/jcb.102.2.420; SENDTNER M, 1992, J CELL BIOL, V118, P139, DOI 10.1083/jcb.118.1.139; SON YJ, 1995, NEURON, V14; THOMPSON W, 1977, NEUROSCIENCE, V2, P523, DOI 10.1016/0306-4522(77)90049-5; TSUKAHARA N, 1981, ANNU REV NEUROSCI, V4, P351, DOI 10.1146/annurev.ne.04.030181.002031; VANMIER P, 1994, J NEUROSCI, V14, P5672; WEINSTEIN DE, 1991, J CELL BIOL, V112, P1205, DOI 10.1083/jcb.112.6.1205; WERNIG A, 1984, NEUROSCIENCE, V11, P241, DOI 10.1016/0306-4522(84)90227-6; WERNIG A, 1986, PROG NEUROBIOL, V27, P251, DOI 10.1016/0301-0082(86)90023-7	35	241	249	0	7	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1995	14	1					133	141		10.1016/0896-6273(95)90247-3	http://dx.doi.org/10.1016/0896-6273(95)90247-3			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QC548	7826631	Bronze			2022-12-24	WOS:A1995QC54800013
J	ZHAO, B; RASSENDREN, F; KAANG, BK; FURUKAWA, Y; KUBO, T; KANDEL, ER				ZHAO, B; RASSENDREN, F; KAANG, BK; FURUKAWA, Y; KUBO, T; KANDEL, ER			A NEW CLASS OF NONINACTIVATING K+ CHANNELS FROM APLYSIA CAPABLE OF CONTRIBUTING TO THE RESTING POTENTIAL AND FIRING PATTERNS OF NEURONS	NEURON			English	Article							POTASSIUM CHANNEL; FUNCTIONAL EXPRESSION; NERVOUS-SYSTEM; RAT-BRAIN; DROSOPHILA; FAMILY; SHAKER; GENE; CLONING; DIVERSITY	From the nervous system of Aplysia, we have cloned a new class of noninactivating K+ channels (aKv5.1) that are activated at low voltage and are capable of contributing to the resting potential and fi ring patterns of neurons. Expression of aKv5.1 in Aplysia neuron R15 revealed that aKv5.1 exerts an unusual control over cell excitability; it increased the resting potential by more than 20 mV and abolished the spontaneous bursting activity of the cell. In its ability to suppress the endogenous rhythm of R15, aKv5.1 differs in its actions from transient, inactivating K+ channels such as aKv1.1a, an Aplysia homolog of Shaker. aKv1.1a shortens the duration of the spike and increases the afterpotential, but does not suppress bursting. Thus, by expressing different classes of K+ channels, it is possible to redesign, in specific ways, the signaling capabilities of specific, identified neurons.	COLUMBIA UNIV,COLL PHYS & SURG,HOWARD HUGHES MED INST,NEW YORK,NY 10027; COLUMBIA UNIV,COLL PHYS & SURG,CTR NEUROBIOL & BEHAV,NEW YORK,NY 10027	Columbia University; Howard Hughes Medical Institute; Columbia University			Rassendren, Francois/AAA-6190-2021; Kubo, Tai/F-9499-2012	Kubo, Tai/0000-0002-6404-8295; Rassendren, Francois/0000-0003-3320-2461				ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; BENSON JA, 1987, NEUROMODULATION; BrõndÚn CI., 1991, INTRO PROTEIN STRUCT; BUTLER A, 1989, SCIENCE, V243, P943, DOI 10.1126/science.2493160; CANAVIER CC, 1991, J NEUROPHYSIOL, V66, P2107, DOI 10.1152/jn.1991.66.6.2107; CHANDY KG, 1991, NATURE, V352, P26, DOI 10.1038/352026b0; DREWE JA, 1992, J NEUROSCI, V12, P538; FRAZIER WT, 1967, J NEUROPHYSIOL, V30, P1288, DOI 10.1152/jn.1967.30.6.1288; HARTMANN HA, 1991, SCIENCE, V251, P942, DOI 10.1126/science.2000495; Hille B., 1992, IONIC CHANNELS EXCIT; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; KAANG BK, 1992, P NATL ACAD SCI USA, V89, P1133, DOI 10.1073/pnas.89.3.1133; KAMB A, 1987, CELL, V50, P405, DOI 10.1016/0092-8674(87)90494-6; Kandel ER., 1976, CELLULAR BASIS BEHAV; KENNEDY TE, 1992, NEURON, V9, P1013, DOI 10.1016/0896-6273(92)90062-I; Lewis D V, 1986, Adv Neurol, V44, P235; LUNEAU CJ, 1991, P NATL ACAD SCI USA, V88, P3932, DOI 10.1073/pnas.88.9.3932; MCCORMACK T, 1990, P NATL ACAD SCI USA, V87, P5227, DOI 10.1073/pnas.87.13.5227; PAPAZIAN DM, 1987, SCIENCE, V237, P749, DOI 10.1126/science.2441470; PERNEY T M, 1991, Current Opinion in Cell Biology, V3, P663, DOI 10.1016/0955-0674(91)90039-2; PFAFFINGER PJ, 1991, J NEUROSCI, V11, P918; PONGS O, 1988, EMBO J, V7, P1087, DOI 10.1002/j.1460-2075.1988.tb02917.x; RETTIG J, 1992, EMBO J, V11, P2473, DOI 10.1002/j.1460-2075.1992.tb05312.x; RUDY B, 1988, NEUROSCIENCE, V25, P729, DOI 10.1016/0306-4522(88)90033-4; SCHROTER KH, 1991, FEBS LETT, V278, P211, DOI 10.1016/0014-5793(91)80119-N; SIEGELBAUM SA, 1982, NATURE, V299, P413, DOI 10.1038/299413a0; STRUMWASSER F, 1967, INVERTEBRATE NERVOUS, P291; WARMKE J, 1991, SCIENCE, V252, P1560, DOI 10.1126/science.1840699; WEI A, 1990, SCIENCE, V248, P599, DOI 10.1126/science.2333511; YELIEN G, 1991, SCIENCE, V251, P939; YOKOYAMA S, 1989, FEBS LETT, V259, P37, DOI 10.1016/0014-5793(89)81488-7; YOOL AJ, 1991, NATURE, V349, P700, DOI 10.1038/349700a0	32	49	49	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1994	13	5					1205	1213		10.1016/0896-6273(94)90058-2	http://dx.doi.org/10.1016/0896-6273(94)90058-2			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PU763	7946357				2022-12-24	WOS:A1994PU76300016
J	UMBACH, JA; ZINSMAIER, KE; EBERLE, KK; BUCHNER, E; BENZER, S; GUNDERSEN, CB				UMBACH, JA; ZINSMAIER, KE; EBERLE, KK; BUCHNER, E; BENZER, S; GUNDERSEN, CB			PRESYNAPTIC DYSFUNCTION IN DROSOPHILA CSP MUTANTS	NEURON			English	Article							LARVAL NEUROMUSCULAR-JUNCTION; ESCHERICHIA-COLI DNAJ; NEUROTRANSMITTER RELEASE; SYNAPTIC FUNCTION; SYNAPTOTAGMIN; EXOCYTOSIS; MELANOGASTER; HOMOLOGS; PROTEINS	Cysteine string proteins are synapse-specific proteins. In Drosophila, csp deletion mutants exhibit temperature-sensitive paralysis and early death. Here, we report that neuromuscular transmission is impaired presynaptically in these csp mutant larvae. At 22 degrees C, evoked transmitter release is depressed relative to wild type and rescued controls, and high frequency stimulation of the nerve leads to sporadic failures. At 30 degrees C, stimulus-evoked responses decline gradually before failing completely. When the temperature is returned to 22 degrees C, evoked responses recover. Spontaneous release events persist at both 22 degrees C and 30 degrees C. Since nerve conduction and postsynaptic sensitivity are unaffected, these data indicate that csp mutations disrupt depolarization-secretion coupling. This disruption explains the cellular basis of the temperature-sensitive paralysis of these organisms.	CALTECH,DIV BIOL,PASADENA,CA 91125; THEODOR BOVERI INST BIOWISSENSCH,D-97074 WURZBURG,GERMANY	California Institute of Technology	UMBACH, JA (corresponding author), UNIV CALIF LOS ANGELES,SCH MED,DEPT MOLEC & MED PHARMACOL,LOS ANGELES,CA 90024, USA.							ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2539; BRANTON WD, 1987, J NEUROSCI, V7, P4195; BURGOYNE RD, 1993, BIOCHEM J, V293, P305, DOI 10.1042/bj2930305; CAPLAN AJ, 1993, MOL BIOL CELL, V4, P555, DOI 10.1091/mbc.4.6.555; CHANG HG, 1994, J PHYSIOL-LONDON, V476, P1; DEBELLO WM, 1993, CELL, V74, P947, DOI 10.1016/0092-8674(93)90716-4; DIANTONIO A, 1993, CELL, V73, P1281, DOI 10.1016/0092-8674(93)90356-U; DIANTONIO WM, 1994, NEURON, V12, P909; GINSBORG BL, 1976, HDB EXPT PHARM, P229; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; GUNDERSEN CB, 1992, NEURON, V9, P527, DOI 10.1016/0896-6273(92)90190-O; GUNDERSEN CB, 1994, J BIOL CHEM, V269, P19197; JAN LY, 1976, J PHYSIOL-LONDON, V262, P215, DOI 10.1113/jphysiol.1976.sp011593; JAN LY, 1976, J PHYSIOL-LONDON, V262, P189, DOI 10.1113/jphysiol.1976.sp011592; KELLY RB, 1993, CELL, V72, P43, DOI 10.1016/S0092-8674(05)80027-3; KESHISHIAN H, 1993, J NEUROBIOL, V24, P757, DOI 10.1002/neu.480240606; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; MARTIN AR, 1955, J PHYSIOL-LONDON, V130, P114, DOI 10.1113/jphysiol.1955.sp005397; MASTROGIACOMO A, 1994, SCIENCE, V263, P981, DOI 10.1126/science.7906056; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; OHKI R, 1992, J BIOL CHEM, V267, P13180; POPOV SV, 1993, CELL, V73, P1247, DOI 10.1016/0092-8674(93)90352-Q; SILVER PA, 1993, CELL, V74, P5, DOI 10.1016/0092-8674(93)90287-Z; SINGH S, 1990, J EXP BIOL, V152, P59; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; SUDHOF TC, 1991, NEURON, V6, P665, DOI 10.1016/0896-6273(91)90165-V; TRIMBLE V, 1991, ANN REV NEUROSCI, V14, P93; ZHONG Y, 1991, SCIENCE, V251, P198, DOI 10.1126/science.1670967; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297; ZINSMAIER KE, 1990, J NEUROGENET, V7, P15, DOI 10.3109/01677069009084150	32	148	148	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1994	13	4					899	907		10.1016/0896-6273(94)90255-0	http://dx.doi.org/10.1016/0896-6273(94)90255-0			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PP533	7946336				2022-12-24	WOS:A1994PP53300012
J	DARGENT, B; PAILLART, C; CARLIER, E; ALCARAZ, G; MARTINEAUCLAIRE, MF; COURAUD, F				DARGENT, B; PAILLART, C; CARLIER, E; ALCARAZ, G; MARTINEAUCLAIRE, MF; COURAUD, F			SODIUM-CHANNEL INTERNALIZATION IN DEVELOPING NEURONS	NEURON			English	Article							PROTEIN-KINASE-C; MESSENGER-RNAS; GROWTH-FACTOR; RAT-BRAIN; EXPRESSION; CELLS; PATHWAYS; SUBUNITS; CAMP	Neurotoxin-induced activation of voltage-dependent Na+ channels provoked rapid (t(1/2) = 15-20 min) channel down-regulation in cultured rat brain neurons, resulting in a 50%-70% decrease in [H-3]saxitoxin and I-125-alpha-scorpion toxin binding capacities as well as a decrease in Na+ peak current. Experiments using I-125-alpha-scorpion toxin as both a Na+ channel activator and a surface channel probe showed that a fraction of the bound toxin was internalized, since it was not releasable by acidic washing. Internalization was inhibited by tetrodotoxin, abolished in Na+-free medium, and induced by amphotericin B, a Na+ ionophore. Moreover, down-regulation occurred only in immature neuronal tissue, either cultured fetal neurons or postnatal hippocampal slices, but was absent in adult brain. These observations indicate that Na+ channel internalization is triggered by Na+ influx into neurons and may be involved in the control of electrical activity during development.	FAC MED SECTOR NORD, INST JEAN ROCHE, CNRS, URA 1455, F-13916 MARSEILLE 20, FRANCE	Centre National de la Recherche Scientifique (CNRS)	DARGENT, B (corresponding author), FAC MED SECTOR NORD, INST JEAN ROCHE, INSERM, U374, BLVD PIERRE DRAMARD, F-13916 MARSEILLE 20, FRANCE.							BECKH S, 1989, EMBO J, V8, P3611, DOI 10.1002/j.1460-2075.1989.tb08534.x; BEZANILLA F, 1977, J GEN PHYSIOL, V70, P549, DOI 10.1085/jgp.70.5.549; BOUDIER JA, 1985, DEV BRAIN RES, V20, P137, DOI 10.1016/0165-3806(85)90097-5; BRYSCH W, 1991, EXP BRAIN RES, V86, P562; CATTERALL WA, 1980, ANNU REV PHARMACOL, V20, P15, DOI 10.1146/annurev.pa.20.040180.000311; COURAUD F, 1986, J NEUROSCI, V6, P192; DARCANGELO G, 1993, J CELL BIOL, V122, P915, DOI 10.1083/jcb.122.4.915; DARGENT B, 1990, P NATL ACAD SCI USA, V87, P5907, DOI 10.1073/pnas.87.15.5907; DELIMA ME, 1988, BIOCHEM BIOPH RES CO, V151, P187, DOI 10.1016/0006-291X(88)90577-3; GAUTRON S, 1992, P NATL ACAD SCI USA, V89, P7272, DOI 10.1073/pnas.89.15.7272; HAIGLER HT, 1980, J BIOL CHEM, V255, P1239; JOVER E, 1988, J BIOL CHEM, V263, P1542; KIEDROWSKI L, 1994, NEURON, V12, P295, DOI 10.1016/0896-6273(94)90272-0; LI M, 1993, SCIENCE, V261, P1439, DOI 10.1126/science.8396273; LINDEN DJ, 1993, NEURON, V11, P1093, DOI 10.1016/0896-6273(93)90222-D; Maizel JV, 1971, METHOD VIROL, V5, P179; MANDEL G, 1992, J MEMBRANE BIOL, V125, P193; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; MESSNER DJ, 1985, J BIOL CHEM, V260, P597; NODA M, 1986, NATURE, V322, P826, DOI 10.1038/322826a0; NUMANN R, 1991, SCIENCE, V254, P115, DOI 10.1126/science.1656525; OFFORD J, 1989, NEURON, V2, P1447, DOI 10.1016/0896-6273(89)90190-6; PACKER JM, 1990, J BIOL CHEM, V26, P16450; REY M, 1987, NEUROENDOCRINOLOGY, V46, P424, DOI 10.1159/000124856; SRINIVASAN Y, 1988, NATURE, V333, P177, DOI 10.1038/333177a0; SUZUKI H, 1988, FEBS LETT, V228, P195, DOI 10.1016/0014-5793(88)80615-X; Trowbridge IS, 1991, CURR OPIN CELL BIOL, V3, P1062, DOI 10.1016/0955-0674(91)90130-Q	27	55	55	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1994	13	3					683	690		10.1016/0896-6273(94)90035-3	http://dx.doi.org/10.1016/0896-6273(94)90035-3			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PJ284	7917298				2022-12-24	WOS:A1994PJ28400015
J	YUSTE, R; GUTNICK, MJ; SAAR, D; DELANEY, KR; TANK, DW				YUSTE, R; GUTNICK, MJ; SAAR, D; DELANEY, KR; TANK, DW			CA2+ ACCUMULATIONS IN DENDRITES OF NEOCORTICAL PYRAMIDAL NEURONS - AN APICAL BAND AND EVIDENCE FOR 2 FUNCTIONAL COMPARTMENTS	NEURON			English	Article							VISUAL-CORTEX; PURKINJE-CELLS; ELECTROPHYSIOLOGICAL PROPERTIES; CALCIUM-CONCENTRATION; CORTICAL PROJECTIONS; SYNAPTIC ACTIVATION; ACTION-POTENTIALS; INVITRO; RAT; MORPHOLOGY	Apical dendrites constitute a prominent feature of the microcircuitry in the neocortex, yet their function is poorly understood. Using fura-2 imaging of layer 5 pyramidal neurons from slices of rat somatosensory cortex, we have investigated the Ca2+ influx into dendrites under intracellular, antidromic, synaptic, and receptor-agonist stimulation. We find three spatial patterns of Ca2+ accumulations: an apical band in the apical dendrite approximately 500 mu m from the soma, an accumulation restricted to the basal dendrites, soma, and proximal apical dendrite, and a combination of both of these. We show that the epical band can be activated antidromically and synaptically and that, under blocked Na+ and K+ conductances, it generates Ca2+ spikes. Thus, the apical band may serve as a dendritic trigger zone for regenerative Ca2+ spikes or as a current amplifier for distal synaptic events. Our results suggest that the distal apical dendrite should be considered a separate functional compartment from the rest of the cell.	BEN GURION UNIV NEGEV,FAC HLTH SCI,DEPT PHYSIOL,IL-84105 BEER SHEVA,ISRAEL; BEN GURION UNIV NEGEV,FAC HLTH SCI,CTR BRAIN RES,IL-84105 BEER SHEVA,ISRAEL; SIMON FRASER UNIV,DEPT BIOL SCI,BURNABY V5A 1S6,BC,CANADA	Ben Gurion University; Ben Gurion University; Simon Fraser University	YUSTE, R (corresponding author), AT&T BELL LABS,BIOL COMPUTAT RES DEPT,MURRAY HILL,NJ 07974, USA.		Gutnick, Michael/P-7910-2019	Gutnick, Michael/0000-0003-2564-5094				AMITAI Y, 1993, CEREB CORTEX, V3, P26, DOI 10.1093/cercor/3.1.26; BERNARDER O, 1994, ADV NEURAL INFORMATI; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BROWN AM, 1993, J NEUROPHYSIOL, V70, P1530, DOI 10.1152/jn.1993.70.4.1530; CAULLER LJ, 1994, J NEUROSCI, V14, P751; CAULLER LJ, 1991, EXP BRAIN RES, V84, P607; Cauller LJ, 1992, SINGLE NEURON COMPUT, P199; CHAGNACAMITAL Y, 1990, J COMP NEUROL, V296, P598, DOI 10.1002/cne.902960407; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; COOMBS JS, 1955, J PHYSIOL-LONDON, V130, P326, DOI 10.1113/jphysiol.1955.sp005412; DE NO R. L., 1959, PROC NATL ACAD SCI, V45, P592; DESCHENES M, 1981, EXP BRAIN RES, V43, P304; FELDMAN MD, 1984, CEREB CORTEX, P123; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FITZHUGH R, 1960, J GEN PHYSIOL, V43, P867, DOI 10.1085/jgp.43.5.867; FRANZ P, 1986, BRAIN RES, V366, P262, DOI 10.1016/0006-8993(86)91303-X; FRIEDMAN A, 1989, EUR J NEUROSCI, V1, P374, DOI 10.1111/j.1460-9568.1989.tb00802.x; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HIRSCH JA, 1991, J NEUROSCI, V11, P1800; JACK JJB, 1975, ELECTRIC CURRENT FLO, P25; JAFFE DB, 1992, NATURE, V357, P244, DOI 10.1038/357244a0; kandel, 1977, NERVOUS SYSTEM, V1; KIM HG, 1993, J NEUROSCI, V13, P5301, DOI 10.1523/JNEUROSCI.13-12-05301.1993; KISVARDAY ZF, 1987, J COMP NEUROL, V260, P1, DOI 10.1002/cne.902600102; Labakhua T Sh, 1986, Neirofiziologiia, V18, P435; LARKMAN AU, 1991, J COMP NEUROL, V306, P307, DOI 10.1002/cne.903060207; LARKMAN AU, 1991, J COMP NEUROL, V306, P332, DOI 10.1002/cne.903060209; LEONARD JP, 1985, J NEUROPHYSIOL, V53, P171, DOI 10.1152/jn.1985.53.1.171; LLINAS R, 1976, P NATL ACAD SCI USA, V73, P2520, DOI 10.1073/pnas.73.7.2520; LLINAS R, 1971, J NEUROPHYSIOL, V34, P532, DOI 10.1152/jn.1971.34.4.532; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P197, DOI 10.1113/jphysiol.1980.sp013358; LLINAS R, 1981, J PHYSIOL-LONDON, V315, P569, DOI 10.1113/jphysiol.1981.sp013764; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; LLINAS RR, 1991, P NATL ACAD SCI USA, V88, P897, DOI 10.1073/pnas.88.3.897; MACDERMOTT AB, 1986, NATURE, V321, P519, DOI 10.1038/321519a0; MARKRAM H, 1994, IN PRESS P NATL ACAD; MASON A, 1990, J NEUROSCI, V10, P1415; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; NOBLE D, 1969, J PHYSIOL-LONDON, V200, P233, DOI 10.1113/jphysiol.1969.sp008690; POCKBERGER H, 1991, BRAIN RES, V539, P181, DOI 10.1016/0006-8993(91)91619-C; PURPURA DP, 1964, J NEUROPHYSIOL, V27, P117, DOI 10.1152/jn.1964.27.2.117; RAMON P, 1991, ENCEFALO REPTILES; Ramon y Cajal S, 1891, REV CIENCIAS MED, V22, P23; REGEHR W, 1993, NEURON, V11, P145, DOI 10.1016/0896-6273(93)90278-Y; REGEHR WG, 1989, NATURE, V341, P533, DOI 10.1038/341533a0; REGEHR WG, 1992, J NEUROSCI, V12, P4202; REUVENI I, 1993, J NEUROSCI, V13, P4609; ROCKLAND KS, 1989, J COMP NEUROL, V285, P54, DOI 10.1002/cne.902850106; ROSS WN, 1987, J PHYSIOL-LONDON, V389, P319, DOI 10.1113/jphysiol.1987.sp016659; SAH P, 1989, SCIENCE, V246, P815, DOI 10.1126/science.2573153; Segev C, 1989, METHODS NEURONAL MOD, P9; SOBEL EC, 1994, SCIENCE, V263, P823, DOI 10.1126/science.263.5148.823; SPENCER WA, 1961, J NEUROPHYSIOL, V24, P272, DOI 10.1152/jn.1961.24.3.272; STAFSTROM CE, 1984, J NEUROPHYSIOL, V52, P244, DOI 10.1152/jn.1984.52.2.244; STAFSTROM CE, 1982, BRAIN RES, V236, P221, DOI 10.1016/0006-8993(82)90050-6; STAFSTROM CE, 1985, J NEUROPHYSIOL, V53, P153, DOI 10.1152/jn.1985.53.1.153; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; SUTOR B, 1989, J NEUROPHYSIOL, V61, P621, DOI 10.1152/jn.1989.61.3.621; TANK DW, 1988, SCIENCE, V242, P773, DOI 10.1126/science.2847315; TANK DW, 1994, IN PRESS NEUROSCI; WESTENBROEK RE, 1992, NEURON, V9, P1099, DOI 10.1016/0896-6273(92)90069-P; YUSTE R, 1991, NEURON, V6, P333, DOI 10.1016/0896-6273(91)90243-S	65	218	219	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1994	13	1					23	43		10.1016/0896-6273(94)90457-X	http://dx.doi.org/10.1016/0896-6273(94)90457-X			21	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NZ247	8043278				2022-12-24	WOS:A1994NZ24700003
J	DIZHOOR, AM; LOWE, DG; OLSHEVSKAYA, EV; LAURA, RP; HURLEY, JB				DIZHOOR, AM; LOWE, DG; OLSHEVSKAYA, EV; LAURA, RP; HURLEY, JB			THE HUMAN PHOTORECEPTOR MEMBRANE GUANYLYL CYCLASE, RETGC, IS PRESENT IN OUTER SEGMENTS AND IS REGULATED BY CALCIUM AND A SOLUBLE ACTIVATOR	NEURON			English	Article							NATRIURETIC PEPTIDE RECEPTOR; VERTEBRATE PHOTORECEPTORS; BINDING PROTEIN; SIGNAL TRANSDUCTION; RECOVERIN; ATRIAL; EXPRESSION; CLONING; RODS	A human photoreceptor membrane guanylyl cyclase, RetGC, was recently cloned and expressed, but its localization and manner of regulation were not defined. We report here that RetGC is detected primarily in outer segments of human photoreceptor cells. Recombinant RetGC can be stimulated by a soluble retinal-specific factor. Ca2+ interferes with stimulation of RetGC by this factor with a cooperativity coefficient of 1.7 and EC(50) near 200 nM. The Ca2+ sensitivities of recombinant RetCC and of guanylyl cyclase activity from rod outer segment membranes are very similar. Our findings indicate that RetGC is a photoreceptor-specific guanylyl cyclase which is stimulated by a retinal-specific activator and inhibited by physiologically relevant concentrations of free Ca2+. The Ca2+ sensitivity of RetGC may be responsible for some of the previously reported effects of Ca2+ on light adaptation and recovery of the dark state.	UNIV WASHINGTON, HOWARD HUGHES MED INST, SEATTLE, WA 98195 USA; GENENTECH INC, DEPT CARDIOVASC RES, S SAN FRANCISCO, CA 94080 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Roche Holding; Genentech	DIZHOOR, AM (corresponding author), UNIV WASHINGTON, DEPT BIOCHEM, SEATTLE, WA 98195 USA.			Dizhoor, Alexander/0000-0001-6770-9186	NEI NIH HHS [EY06641] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BENNETT BD, 1991, J BIOL CHEM, V266, P23060; CHANG M, 1989, NATURE, V341, P68, DOI 10.1038/341068a0; CHINKERS M, 1989, NATURE, V338, P78, DOI 10.1038/338078a0; CURRIE MG, 1992, P NATL ACAD SCI USA, V89, P947, DOI 10.1073/pnas.89.3.947; DESAUVAGE FJ, 1992, P NATL ACAD SCI USA, V89, P9089, DOI 10.1073/pnas.89.19.9089; DIZHOOR AM, 1991, SCIENCE, V251, P915, DOI 10.1126/science.1672047; FLEISCHMAN D, 1981, CURR TOP MEMBR TRANS, V15, P109; GILLESPIE PG, 1989, MOL PHARMACOL, V36, P773; GORCZYCA WA, 1994, P NATL ACAD SCI USA, V91, P4014, DOI 10.1073/pnas.91.9.4014; GORCZYCA WA, 1994, IN PRESS BIOCHEMISTR; GRAYKELLER MP, 1993, NEURON, V10, P523, DOI 10.1016/0896-6273(93)90339-S; HAYASHI F, 1991, P NATL ACAD SCI USA, V88, P4746, DOI 10.1073/pnas.88.11.4746; HURLEY JB, 1992, J BIOENERG BIOMEMBR, V24, P219, DOI 10.1007/BF00762680; HURLEY JB, 1993, SCIENCE, V260, P740, DOI 10.1126/science.8097896; KAWAMURA S, 1993, J BIOL CHEM, V268, P14579; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; KOCH KW, 1991, J BIOL CHEM, V266, P8634; KOESLING D, 1991, FEBS LETT, V280, P301, DOI 10.1016/0014-5793(91)80317-V; LAGNADO L, 1992, NEURON, V8, P995, DOI 10.1016/0896-6273(92)90122-T; LAMBRECHT HG, 1991, EMBO J, V10, P793, DOI 10.1002/j.1460-2075.1991.tb08011.x; LAMBRECHT HG, 1992, BIOCHIM BIOPHYS ACTA, V1160, P63, DOI 10.1016/0167-4838(92)90038-F; LOLLEY RN, 1982, VISION RES, V22, P1481, DOI 10.1016/0042-6989(82)90213-9; LOWE DG, 1989, EMBO J, V8, P1377, DOI 10.1002/j.1460-2075.1989.tb03518.x; MARGULIS A, 1993, BIOCHEM BIOPH RES CO, V194, P855, DOI 10.1006/bbrc.1993.1900; MCDOWELL JH, 1977, BIOCHEMISTRY-US, V16, P4054, DOI 10.1021/bi00637a018; MCNAUGHTON PA, 1990, PHYSIOL REV, V70, P847, DOI 10.1152/physrev.1990.70.3.847; PONGS O, 1993, NEURON, V11, P15, DOI 10.1016/0896-6273(93)90267-U; SCHULZ S, 1992, J BIOL CHEM, V267, P16019; SCHULZ S, 1990, CELL, V63, P941, DOI 10.1016/0092-8674(90)90497-3; SCHULZ S, 1989, CELL, V58, P1155, DOI 10.1016/0092-8674(89)90513-8; SHYJAN AW, 1992, NEURON, V9, P727, DOI 10.1016/0896-6273(92)90035-C; STRYER L, 1991, J BIOL CHEM, V266, P10711; TSIEN R, 1989, METHOD ENZYMOL, V172, P230; YUEN PST, 1992, ANNU REV NEUROSCI, V15, P193	34	266	270	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	1994	12	6					1345	1352		10.1016/0896-6273(94)90449-9	http://dx.doi.org/10.1016/0896-6273(94)90449-9			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NT463	7912093				2022-12-24	WOS:A1994NT46300014
J	STANDIFER, KM; CHIEN, CC; WAHLESTEDT, C; BROWN, GP; PASTERNAK, GW				STANDIFER, KM; CHIEN, CC; WAHLESTEDT, C; BROWN, GP; PASTERNAK, GW			SELECTIVE LOSS OF DELTA-OPIOID ANALGESIA AND BINDING BY ANTISENSE OLIGODEOXYNUCLEOTIDES TO A DELTA-OPIOID RECEPTOR	NEURON			English	Article							PHARMACOLOGICAL CHARACTERIZATION; OPIATE RECEPTOR; RAT-BRAIN; SUBTYPES; ANTINOCICEPTION; MOUSE; MICE; EXPRESSION; MEDIATION; MORPHINE	Antisense oligodeoxynucleotides (18-20 bases) to a cloned delta opioid receptor (DOR-1) lower delta binding in NG108-15 cells by 40%-50%. Changing 4 bases to generate a mismatch antisense oligodeoxynucleotide or mixing the corresponding sense and antisense oligodeoxynucleotides prior to treatment of the cells eliminates the inhibition of binding, confirming the specificity of the response. In vivo, an antisense oligodeoxynucleotide to DOR-1 given intrathecally lowers delta, but not mu or kappa(1) spinal analgesia. This mismatch antisense oligodeoxynucleotide is inactive. delta analgesic sensitivity gradually returns by 5 days after the last antisense treatment, indicating the lack of irreversible damage or toxicity. These studies demonstrate that DOR-1 mediates delta analgesia at the level of the spinal cord and confirm at the molecular level traditional pharmacological studies implying distinct receptor mechanisms for delta, mu, and kappa(1) analgesia. The use of antisense approaches may prove valuable in understanding the receptors mediating opioid pharmacology.	CORNELL UNIV,COLL MED,DEPT NEUROL & NEUROSCI,NEW YORK,NY 10021; CORNELL UNIV,COLL MED,DEPT PHARMACOL,NEW YORK,NY 10021	Cornell University; Cornell University	STANDIFER, KM (corresponding author), MEM SLOAN KETTERING CANC CTR,COTZIAS LAB NEUROONCOL,NEW YORK,NY 10021, USA.		Wahlestedt, Claes/A-7039-2009		NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA007242, R01DA002615, R37DA007242] Funding Source: NIH RePORTER; NCI NIH HHS [CA08748] Funding Source: Medline; NIDA NIH HHS [DA02615, DA07242] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		BASBAUM AI, 1984, ANNU REV NEUROSCI, V7, P309, DOI 10.1146/annurev.ne.07.030184.001521; BLUME AJ, 1979, P NATL ACAD SCI USA, V76, P5626, DOI 10.1073/pnas.76.11.5626; CHEN Y, 1993, MOL PHARMACOL, V44, P8; CLARK JA, 1988, MOL PHARMACOL, V34, P308; CLARK JA, 1989, J PHARMACOL EXP THER, V251, P461; D'amour FE, 1941, J PHARMACOL EXP THER, V72, P74; EVANS CJ, 1992, SCIENCE, V258, P1952, DOI 10.1126/science.1335167; FANTOZZI R, 1981, MOL PHARMACOL, V20, P8; FUKUDA K, 1993, FEBS LETT, V327, P311, DOI 10.1016/0014-5793(93)81011-N; HARRISON JK, 1991, MOL PHARMACOL, V40, P407; HEYMAN JS, 1988, J PHARMACOL EXP THER, V245, P238; HOLOPAINEN I, 1993, J PHARMACOL EXP THER, V264, P423; HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4; JIANG Q, 1991, J PHARMACOL EXP THER, V257, P1069; KIEFFER BL, 1992, P NATL ACAD SCI USA, V89, P12048, DOI 10.1073/pnas.89.24.12048; KLEE WA, 1974, P NATL ACAD SCI USA, V71, P3474, DOI 10.1073/pnas.71.9.3474; LI SX, 1993, BIOCHEM J, V295, P629, DOI 10.1042/bj2950629; LING GSF, 1983, BRAIN RES, V271, P152, DOI 10.1016/0006-8993(83)91376-8; MATTIA A, 1991, J PHARMACOL EXP THER, V258, P583; MATTIA A, 1992, J PHARMACOL EXP THER, V260, P518; MENG F, 1993, P NATL ACAD SCI USA, V90, P9954, DOI 10.1073/pnas.90.21.9954; MINAMI M, 1993, FEBS LETT, V329, P291, DOI 10.1016/0014-5793(93)80240-U; PASTERNAK GW, 1980, SCIENCE, V208, P514, DOI 10.1126/science.6245448; PASTERNAK GW, 1980, J PHARMACOL EXP THER, V214, P455; PASTERNAK GW, 1993, CLIN NEUROPHARMACOL, V16, P1, DOI 10.1097/00002826-199302000-00001; PAUL D, 1989, EUR J PHARMACOL, V168, P307, DOI 10.1016/0014-2999(89)90792-9; PERT CB, 1973, SCIENCE, V179, P1011, DOI 10.1126/science.179.4077.1011; PORRECA F, 1987, J PHARMACOL EXP THER, V241, P293; SIMON EJ, 1973, P NATL ACAD SCI USA, V70, P1947, DOI 10.1073/pnas.70.7.1947; STEIN CA, 1992, LEUKEMIA, V6, P967; TAKESHIMA H, 1993, FEBS LETT, V330, P77; TERENIUS L, 1973, ACTA PHARMACOL TOX, V33, P377; THOMPSON RC, 1993, NEURON, V11, P903, DOI 10.1016/0896-6273(93)90120-G; UHL GR, 1994, TRENDS NEUROSCI, V17, P89, DOI 10.1016/0166-2236(94)90110-4; WAHLESTEDT C, 1993, NATURE, V363, P260, DOI 10.1038/363260a0; WAHLESTEDT C, 1993, SCIENCE, V259, P528, DOI 10.1126/science.8380941; WANG JB, 1993, P NATL ACAD SCI USA, V90, P10230, DOI 10.1073/pnas.90.21.10230; WARD SJ, 1982, J PHARMACOL EXP THER, V220, P494; WEINTRAUB HM, 1990, SCI AM, V262, P40, DOI 10.1038/scientificamerican0190-40; YAKSH TL, 1977, J PHARMACOL EXP THER, V202, P411; YASUDA K, 1993, P NATL ACAD SCI USA, V90, P6736, DOI 10.1073/pnas.90.14.6736	41	195	198	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1994	12	4					805	810		10.1016/0896-6273(94)90333-6	http://dx.doi.org/10.1016/0896-6273(94)90333-6			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NH253	8161452				2022-12-24	WOS:A1994NH25300009
J	RAIZEN, DM; AVERY, L				RAIZEN, DM; AVERY, L			ELECTRICAL-ACTIVITY AND BEHAVIOR IN THE PHARYNX OF CAENORHABDITIS-ELEGANS	NEURON			English	Article							NEMATODE ASCARIS; NERVOUS-SYSTEM; C-ELEGANS; CELL; GENE	The pharynx of C. elegans, a model system for neural networks and for membrane excitability, has been chiefly studied by observing its behavior in normal worms, in mutant worms, and in worms lacking pharyngeal neurons. To complement this behavioral approach, we devised a method for recording currents produced by changes in pharyngeal muscle membrane potential. The electrical records, called electropharyngeograms, contain transients caused by pharyngeal muscle action potentials and by inhibitory synaptic transmission between pharyngeal neuron M3 and the muscle. Using the electropharyngeograms, we show that gamma-aminobutyric acid is not likely to be the M3 neurotransmitter, that synaptic transmission is present but abnormal in mutants lacking synaptotagmin, and that worms mutant in the eat-4 gene are defective for M3 function or transmission.			RAIZEN, DM (corresponding author), UNIV TEXAS,SOUTHWESTERN MED CTR,DEPT BIOCHEM,DALLAS,TX 75235, USA.		Raizen, David/ABB-1478-2020; PhD/K-3106-2019		NHLBI NIH HHS [R01 HL046154, R37 HL046154, HL46154] Funding Source: Medline; NIGMS NIH HHS [T32 GM008014, GM08014] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL046154, R01HL046154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008014] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBERTSON DG, 1976, PHILOS T ROY SOC B, V275, P299, DOI 10.1098/rstb.1976.0085; AVERY L, 1987, CELL, V51, P1071, DOI 10.1016/0092-8674(87)90593-9; AVERY L, 1993, GENETICS, V133, P897; AVERY L, 1990, J EXP ZOOL, V253, P263, DOI 10.1002/jez.1402530305; AVERY L, 1989, NEURON, V3, P473, DOI 10.1016/0896-6273(89)90206-7; AVERY L, 1993, J EXP BIOL, V175, P283; BAADER AP, 1992, J NEUROSCI METH, V43, P215, DOI 10.1016/0165-0270(92)90031-8; BARGMANN CI, 1993, ANNU REV NEUROSCI, V16, P47, DOI 10.1146/annurev.ne.16.030193.000403; BOMMERT K, 1993, NATURE, V363, P163, DOI 10.1038/363163a0; BOYER HW, 1969, J MOL BIOL, V41, P459, DOI 10.1016/0022-2836(69)90288-5; BRENNER S, 1974, GENETICS, V77, P71; BROOKS CM, 1947, J NEUROPHYSIOL, V10, P251, DOI 10.1152/jn.1947.10.4.251; BYERLY L, 1979, J PHYSIOL-LONDON, V288, P263; COLE KS, 1968, MEMBRANES IONS IMPUL; DAVIS RE, 1989, J NEUROSCI, V9, P403; DAVIS RE, 1992, J COMP PHYSIOL A, V171, P17, DOI 10.1007/BF00195957; DELCASTILLO J, 1967, J GEN PHYSIOL, V50, P603, DOI 10.1085/jgp.50.3.603; DELCOMYN F, 1974, J ELECTROPHYSIOL TEC, V3, P22; DIANTONIO A, 1993, CELL, V73, P1281, DOI 10.1016/0092-8674(93)90356-U; DONCASTER C. C., 1962, NEMATOLOGICA, V8, P313; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; ELFERINK LA, 1993, CELL, V72, P153, DOI 10.1016/0092-8674(93)90059-Y; FATT P, 1952, J PHYSIOL-LONDON, V117, P109; Fleming J.T., 1993, Experientia Supplementum (Basel), V63, P65; GILMAN AG, 1990, PHARM BASIS THERAPEU; GONZALEZ C, 1992, TRENDS NEUROSCI, V15, P146, DOI 10.1016/0166-2236(92)90357-E; GUASTELLA J, 1991, J COMP NEUROL, V307, P584, DOI 10.1002/cne.903070406; HODGKIN AL, 1946, PROC R SOC SER B-BIO, V133, P444, DOI 10.1098/rspb.1946.0024; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; MACLEOD AR, 1977, J MOL BIOL, V114, P133, DOI 10.1016/0022-2836(77)90287-X; MCINTIRE SL, 1993, NATURE, V364, P337, DOI 10.1038/364337a0; MCINTIRE SL, 1993, NATURE, V364, P334, DOI 10.1038/364334a0; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; POPOV SV, 1993, CELL, V73, P1247, DOI 10.1016/0092-8674(93)90352-Q; SEYMOUR MK, 1983, J ZOOL, V201, P527, DOI 10.1111/j.1469-7998.1983.tb05074.x; Sulston J., 1988, NEMATODE CAENORHABDI, P587; SULSTON JE, 1980, DEV BIOL, V78, P577, DOI 10.1016/0012-1606(80)90353-X; WARD S, 1975, J COMP NEUROL, V160, P313, DOI 10.1002/cne.901600305; WARE RW, 1975, J COMP NEUROL, V162, P71, DOI 10.1002/cne.901620106; WENNING A, 1993, J EXP BIOL, V182, P81; White J., 1988, NEMATODE CAENORHABDI, V17, P81	41	162	174	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1994	12	3					483	495		10.1016/0896-6273(94)90207-0	http://dx.doi.org/10.1016/0896-6273(94)90207-0			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NC769	8155316	Green Accepted			2022-12-24	WOS:A1994NC76900003
J	KAANG, BK; KANDEL, ER; GRANT, SGN				KAANG, BK; KANDEL, ER; GRANT, SGN			ACTIVATION OF CAMP-RESPONSIVE GENES BY STIMULI THAT PRODUCE LONG-TERM FACILITATION IN APLYSIA SENSORY NEURONS	NEURON			English	Article							DEPENDENT PROTEIN-KINASE; ELEMENT-BINDING-PROTEIN; GILL-WITHDRAWAL REFLEX; NUCLEAR FACTOR CREB; CYCLIC-AMP; TRANSCRIPTIONAL ACTIVATION; SUBSTRATE-SPECIFICITY; SOMATOSTATIN GENE; ENHANCER ELEMENTS; INDUCIBLE GENES	One of the hallmarks of long-term memory in both vertebrates and invertebrates is the requirement for new protein synthesis. In sensitization of the gill-withdrawal reflex in Aplysia, this requirement can be studied on the cellular level. Here, long-term but not short-term facilitation of the monosynaptic connections between the sensory and motor neurons requires new protein synthesis and is reflected in an altered level of expression of specific proteins regulated through the cAMP second-messenger pathway. Using gene transfer into individual sensory neurons of Aplysia, we find that serotonin (5-HT) induces transcriptional activation of a lacZ reporter gene driven by the cAMP response element (CRE) and that this induction requires CRE-binding proteins (CREBs). The induction by 5-HT does not occur following a single pulse, but becomes progressively more effective following two or more pulses. Moreover, expression of GAL4-CREB fusion genes shows that 5-HT induction requires phosphorylation of CREB on Ser119 by protein kinase A. These data provide direct evidence for CREB-modulated transcriptional activation with long-term facilitation.	COLUMBIA UNIV COLL PHYS & SURG,INTEGRATED PROGRAM CELLULAR MOLEC BIOL & BIOPHYS STUDIES,NEW YORK,NY 10032	Columbia University	KAANG, BK (corresponding author), COLUMBIA UNIV COLL PHYS & SURG,CTR NEUROBIOL & BEHAV,HOWARD HUGHES MED INST,NEW YORK,NY 10032, USA.			Grant, Seth/0000-0001-8732-8735				ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; BACSKAI B, 1993, IN PRESS SCIENCE; BAILEY CH, 1983, SCIENCE, V220, P91, DOI 10.1126/science.6828885; BARONDES SH, 1975, SHORT TERM MEMORY, P379; BARZILAI A, 1989, NEURON, V2, P1577, DOI 10.1016/0896-6273(89)90046-9; BERKOWITZ LA, 1990, P NATL ACAD SCI USA, V87, P5258, DOI 10.1073/pnas.87.14.5258; BYRNE JH, 1978, J NEUROPHYSIOL, V41, P418, DOI 10.1152/jn.1978.41.2.418; CASTELLUCCI VF, 1989, J NEUROBIOL, V20, P1, DOI 10.1002/neu.480200102; CHIU R, 1989, CELL, V59, P979, DOI 10.1016/0092-8674(89)90754-X; COLBRAN RJ, 1989, BIOCHEM J, V258, P313, DOI 10.1042/bj2580313; COLE AJ, 1989, NATURE, V340, P474, DOI 10.1038/340474a0; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; DASH PK, 1991, P NATL ACAD SCI USA, V88, P5061, DOI 10.1073/pnas.88.11.5061; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; DWARKI VJ, 1990, EMBO J, V9, P225, DOI 10.1002/j.1460-2075.1990.tb08099.x; FINK JS, 1991, J BIOL CHEM, V266, P3882; FROST WN, 1985, P NATL ACAD SCI USA, V82, P8266, DOI 10.1073/pnas.82.23.8266; GLANZMAN DL, 1990, SCIENCE, V249, P799, DOI 10.1126/science.2389145; GONZALEZ GA, 1989, NATURE, V337, P749, DOI 10.1038/337749a0; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; Higuchi R., 1989, PCR TECHNOLOGY, P61; HOEFFLER JP, 1988, SCIENCE, V242, P1430, DOI 10.1126/science.2974179; KAANG BK, 1992, P NATL ACAD SCI USA, V89, P1133, DOI 10.1073/pnas.89.3.1133; KANDEL ER, 1982, SCIENCE, V218, P433, DOI 10.1126/science.6289442; KEMP BE, 1977, J BIOL CHEM, V252, P4888; LEE CQ, 1990, EMBO J, V9, P4455, DOI 10.1002/j.1460-2075.1990.tb07896.x; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; Macgregor G R, 1991, Methods Mol Biol, V7, P217, DOI 10.1385/0-89603-178-0:217; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; MONTMINY MR, 1990, TRENDS NEUROSCI, V13, P184, DOI 10.1016/0166-2236(90)90045-C; NAKABEPPU Y, 1988, CELL, V55, P907, DOI 10.1016/0092-8674(88)90146-8; PEARSON RB, 1985, J BIOL CHEM, V260, P4471; QIAN Z, 1993, IN PRESS NATURE; RAYPORT SG, 1986, J NEUROSCI, V6, P759; ROESLER WJ, 1988, J BIOL CHEM, V263, P9063; SASSONECORSI P, 1990, ONCOGENE, V5, P427; SCHACHER S, 1983, J NEUROSCI, V3, P2403; SCHACHER S, 1988, SCIENCE, V240, P1667, DOI 10.1126/science.2454509; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; SOSSIN WS, 1992, J NEUROSCI, V12, P1160; TSUKADA T, 1987, J BIOL CHEM, V262, P8743; WISDEN W, 1990, NEURON, V4, P603, DOI 10.1016/0896-6273(90)90118-Y; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0	46	266	272	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1993	10	3					427	435		10.1016/0896-6273(93)90331-K	http://dx.doi.org/10.1016/0896-6273(93)90331-K			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KU901	8384857				2022-12-24	WOS:A1993KU90100008
J	PEINADO, A; YUSTE, R; KATZ, LC				PEINADO, A; YUSTE, R; KATZ, LC			EXTENSIVE DYE COUPLING BETWEEN RAT NEOCORTICAL NEURONS DURING THE PERIOD OF CIRCUIT FORMATION	NEURON			English	Article							OCULAR DOMINANCE COLUMNS; CAT VISUAL-CORTEX; GAP-JUNCTIONS; PYRAMIDAL NEURONS; SYNAPSE FORMATION; CEREBRAL-CORTEX; MUSCLE-CELLS; INVITRO; CONNECTIONS; BIOCYTIN	A low molecular weight intracellular tracer, Neurobiotin, was injected into single neurons in living slices of rat neocortex made at postnatal days 5-18. Between days 5 and 12, 66% of single-neuron injections labeled clusters of up to 80 neurons surrounding the injected cell. Coupling between neurons occurred primarily through dendrites. Injections done in the presence of halothane, a gap junction blocker, abolished the spread of tracer to surrounding neurons, implying that gap junctions mediate coupling. Injections done after day 16 resulted in little or no dye coupling. We conclude that transient local coupling via gap junctions in developing cortex may provide a pathway for communicating intercellular signals, including subthreshold electrical activity, and thereby enable temporal coordination of local neuronal ensembles during circuit formation.	DUKE UNIV, MED CTR, DEPT NEUROBIOL, DURHAM, NC 27710 USA	Duke University					NATIONAL EYE INSTITUTE [R01EY007960] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH015177] Funding Source: NIH RePORTER; NEI NIH HHS [EY07960] Funding Source: Medline; NIMH NIH HHS [MH15177] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALLEN F, 1991, NEURON, V6, P101, DOI 10.1016/0896-6273(91)90125-J; [Anonymous], [No title captured]; ARMSTRONG DL, 1983, J NEUROSCI, V3, P1414, DOI 10.1523/jneurosci.03-07-01414.1983; Armstrong-James M., 1988, CEREB CORTEX, V7, p237~ 272; ARMSTRONGJAMES M, 1975, J PHYSIOL-LONDON, V246, P501, DOI 10.1113/jphysiol.1975.sp010902; ARMSTRONGJAMES M, 1970, Z ZELLFORSCH MIK ANA, V110, P559, DOI 10.1007/BF00330104; ARTOLA A, 1987, NATURE, V330, P649, DOI 10.1038/330649a0; Bennett M., 1977, HDB PHYSL          1, P357; BENNETT MVL, 1963, SCIENCE, V141, P262, DOI 10.1126/science.141.3577.262; BENNETT MVL, 1988, GAP JUNCTIONS, P287; BENTLEY D, 1982, SCIENCE, V218, P1082, DOI 10.1126/science.218.4577.1082; BLUE ME, 1983, J NEUROCYTOL, V12, P599, DOI 10.1007/BF01181526; BURT JM, 1989, CIRC RES, V65, P829, DOI 10.1161/01.RES.65.3.829; CHRISTIE MJ, 1989, J NEUROSCI, V9, P3584; CONNORS BW, 1983, J NEUROSCI, V3, P773; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; DERMIETZEL R, 1989, P NATL ACAD SCI USA, V86, P10148, DOI 10.1073/pnas.86.24.10148; Dudek F E, 1986, Adv Neurol, V44, P593; FISCHBACH GD, 1972, DEV BIOL, V28, P407, DOI 10.1016/0012-1606(72)90023-1; FURSHPAN EJ, 1959, J PHYSIOL-LONDON, V145, P289, DOI 10.1113/jphysiol.1959.sp006143; GUTNICK MJ, 1985, NEUROSCIENCE, V15, P659, DOI 10.1016/0306-4522(85)90067-3; HADLEY RD, 1983, SCIENCE, V221, P466, DOI 10.1126/science.6867723; HAUSWIRTH O, 1968, J PHYSL, V201, pP42; HEBB DO, 1949, ORG BEHAVIOR; HORIKAWA K, 1988, J NEUROSCI METH, V25, P1, DOI 10.1016/0165-0270(88)90114-8; HUBEL DH, 1963, J NEUROPHYSIOL, V26, P994, DOI 10.1152/jn.1963.26.6.994; JURASKA JM, 1979, J COMP NEUROL, V183, P257, DOI 10.1002/cne.901830204; KATZ LC, 1989, J NEUROSCI, V9, P1389; KATZ LC, 1987, J NEUROSCI, V7, P1223; KESSLER JA, 1985, GAP JUNCTIONS, P231; KITA H, 1991, J NEUROSCI METH, V37, P141, DOI 10.1016/0165-0270(91)90124-I; KRIEGSTEIN AR, 1987, DEV BRAIN RES, V34, P161, DOI 10.1016/0165-3806(87)90206-9; KRISTT DA, 1976, BRAIN RES, V108, P180, DOI 10.1016/0006-8993(76)90175-X; LIN CS, 1986, J COMP NEUROL, V244, P369, DOI 10.1002/cne.902440309; LLINAS RR, 1984, GAP JUNCTIONS, P337; LO YJ, 1991, SCIENCE, V254, P1019, DOI 10.1126/science.1658939; LOPRESTI V, 1974, P NATL ACAD SCI USA, V71, P1098, DOI 10.1073/pnas.71.4.1098; MATSUMOTO A, 1988, J NEUROSCI, V8, P4177; MCCORMICK DA, 1987, J PHYSIOL-LONDON, V393, P743, DOI 10.1113/jphysiol.1987.sp016851; MEINECKE DL, 1987, J COMP NEUROL, V261, P388, DOI 10.1002/cne.902610305; MILLER M, 1981, J NEUROCYTOL, V10, P859, DOI 10.1007/BF01262658; MILLER MW, 1988, CEREB CORTEX, V7, P133; MURPHY AD, 1983, J NEUROSCI, V3, P1422; NELSON PG, 1989, SCIENCE, V244, P585, DOI 10.1126/science.2717942; OLAGUE PH, 1978, DEV BIOL, V67, P404, DOI 10.1016/0012-1606(78)90209-9; PURPURA DP, 1965, J NEUROPHYSIOL, V28, P925, DOI 10.1152/jn.1965.28.5.925; Purves, 1985, PRINCIPLES NEURAL DE; SAEZ JC, 1989, P NATL ACAD SCI USA, V86, P2708, DOI 10.1073/pnas.86.8.2708; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; SLOPER JJ, 1978, PROC R SOC SER B-BIO, V203, P39, DOI 10.1098/rspb.1978.0089; Spray, 1985, GAP JUNCTIONS, P167; SPRAY DC, 1988, GAP JUNCTIONS, P287; STENT GS, 1973, P NATL ACAD SCI USA, V70, P997, DOI 10.1073/pnas.70.4.997; STRYKER MP, 1986, J NEUROSCI, V6, P2117; TERRAR DA, 1988, BRIT J PHARMACOL, V94, P509, DOI 10.1111/j.1476-5381.1988.tb11554.x; TURCO JJL, 1991, SCIENCE, V252, P563; VANDERLO.H, 1973, SCIENCE, V179, P395, DOI 10.1126/science.179.4071.395; VANEY DI, 1991, NEUROSCI LETT, V125, P187, DOI 10.1016/0304-3940(91)90024-N; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0; YUSTE R, 1992, SCIENCE, V257, P666, DOI 10.1126/science.1496379; YUSTE R, 1991, NEURON, V6, P333, DOI 10.1016/0896-6273(91)90243-S	61	345	349	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1993	10	1					103	114		10.1016/0896-6273(93)90246-N	http://dx.doi.org/10.1016/0896-6273(93)90246-N			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KK012	8427699				2022-12-24	WOS:A1993KK01200011
J	Eksioglu, YZ; Scheffer, IE; Cardenas, P; Knoll, J; DiMario, F; Ramsby, G; Berg, M; Kamuro, K; Berkovic, SF; Duyk, GM; Parisi, J; Huttenlocher, PR; Walsh, CA				Eksioglu, YZ; Scheffer, IE; Cardenas, P; Knoll, J; DiMario, F; Ramsby, G; Berg, M; Kamuro, K; Berkovic, SF; Duyk, GM; Parisi, J; Huttenlocher, PR; Walsh, CA			Periventricular heterotopia: An X-linked dominant epilepsy locus causing aberrant cerebral cortical development	NEURON			English	Article							JUVENILE MYOCLONIC EPILEPSY; GENERALIZED EPILEPSY; DINUCLEOTIDE REPEAT; NODULAR HETEROTOPIA; LINKAGE ANALYSIS; KB REGION; GENE; MAP; CHILDHOOD; CORTEX	Periventricular heterotopia (PH) involves dramatic malformations of the human cerebral cortex. Here we show that PH is closely linked to markers in distal Xq28 (maximal two-point lod score = 4.77 for F8C at theta = 0; maximal multipoint lod score = 5.37), so that affected females are obligatory mosaics for the mutation; that PH is lethal to at least some affected males; that PH malformations consist of well-differentiated cortical neurons filling the adult subependymal zone; and that individuals with PH are at high risk for epilepsy, though they have no other neurological or external stigmata. The PH gene may represent an important epilepsy susceptibility locus in addition to playing a key role in normal cortical development.	AUSTIN HOSP,DEPT NEUROL,MELBOURNE,VIC 3084,AUSTRALIA; BETH ISRAEL HOSP,CHILDRENS HOSP,DEPT PATHOL,DIV GENET,BOSTON,MA 02215; UNIV CONNECTICUT,DEPT PEDIAT,FARMINGTON,CT; UNIV CONNECTICUT,DEPT RADIOL,FARMINGTON,CT; UNIV ROCHESTER,DEPT NEUROL,ROCHESTER,NY; KOKUBU SEIKYO HOSP,DEPT NEUROL,KAGOSHIMA,JAPAN; MILLENNIUM PHARMACEUT,CAMBRIDGE,MA; MAYO CLIN,DEPT PATHOL ANAT,ROCHESTER,MN; UNIV CHICAGO,DEPT PEDIAT,DEPT NEUROL,CHICAGO,IL 60637	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Harvard University; Beth Israel Deaconess Medical Center; Boston Children's Hospital; University of Connecticut; University of Connecticut; University of Rochester; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; Mayo Clinic; University of Chicago	Eksioglu, YZ (corresponding author), HARVARD UNIV,BETH ISRAEL HOSP,SCH MED,DEPT NEUROL,DIV NEUROGENET,BOSTON,MA 02115, USA.		jiang, yu/HGU-0029-2022; Scheffer, Ingrid E/G-1668-2013	Scheffer, Ingrid E/0000-0002-2311-2174; Berkovic, Samuel/0000-0003-4580-841X; Knoll, Joan/0000-0001-6691-1710				AICARDI J, 1988, EPILEPSIA, V29, pS1, DOI 10.1111/j.1528-1157.1988.tb05803.x; ALZHEIMER A, 1907, ALLG Z PSYCHIAT, V64, P418; BARKOVICH AJ, 1992, RADIOLOGY, V182, P483; BERRYKRAVIS E, 1994, ANN NEUROL, V36, P229, DOI 10.1002/ana.410360216; BIONE S, 1993, P NATL ACAD SCI USA, V90, P10977, DOI 10.1073/pnas.90.23.10977; DELGADOESCUETA AV, 1994, EPILEPSIA, V35, pS29, DOI 10.1111/j.1528-1157.1994.tb05926.x; DIMARIO FJ, 1993, NEUROLOGY, V43, P1424, DOI 10.1212/WNL.43.7.1424; DOBYNS WB, 1992, NEUROLOGY, V42, P1375, DOI 10.1212/WNL.42.7.1375; DONNELLY A, 1994, GENOMICS, V20, P363, DOI 10.1006/geno.1994.1189; European Chromosome 16 Tuberous Sclerosis C., 1993, CELL, V75, P1305; FAIN PR, 1995, NAT GENET, V9, P261, DOI 10.1038/ng0395-261; FARRELL MA, 1992, ACTA NEUROPATHOL, V83, P246, DOI 10.1007/BF00296786; FASMAN KH, 1994, NUCLEIC ACIDS RES, V22, P3462, DOI 10.1093/nar/22.17.3462; FREIJE D, 1992, SCIENCE, V258, P1784, DOI 10.1126/science.1465614; Gomez MR, 1988, TUBEROUS SCLEROSIS; GREENBERG DA, 1988, AM J MED GENET, V31, P185, DOI 10.1002/ajmg.1320310125; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HARDIMAN O, 1988, NEUROLOGY, V38, P1041, DOI 10.1212/WNL.38.7.1041; HATTORI M, 1994, NATURE, V370, P216, DOI 10.1038/370216a0; HICKS AA, 1991, NUCLEIC ACIDS RES, V19, P4016, DOI 10.1093/nar/19.14.4016; HUTTENLOCHER PR, 1994, NEUROLOGY, V44, P51, DOI 10.1212/WNL.44.1.51; HUTTENLOCHER PR, 1991, ANN NEUROL, V30, P461; JOUET M, 1994, NAT GENET, V7, P402, DOI 10.1038/ng0794-402; KAMURO K, 1993, BRAIN DEV-JPN, V15, P237, DOI 10.1016/0387-7604(93)90073-H; KORNACK DR, 1995, NEURON, V15, P311, DOI 10.1016/0896-6273(95)90036-5; LALLOZ MRA, 1991, LANCET, V338, P207, DOI 10.1016/0140-6736(91)90348-S; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1988, AM J HUM GENET, V42, P498; LINDNER J, 1983, NATURE, V305, P427, DOI 10.1038/305427a0; LITT M, 1993, BIOTECHNIQUES, V15, P280; LUSKIN MB, 1993, J NEUROSCI, V13, P1730; MEENCKE HJ, 1984, EPILEPSIA, V25, P8, DOI 10.1111/j.1528-1157.1984.tb04149.x; NAKATSU Y, 1993, NATURE, V364, P448, DOI 10.1038/364448a0; ODA T, 1993, AM J MED GENET, V47, P268, DOI 10.1002/ajmg.1320470225; OTTMAN R, 1995, NAT GENET, V10, P56, DOI 10.1038/ng0595-56; Parnavelas JG, 1991, CEREB CORTEX, V1, P463, DOI 10.1093/cercor/1.6.463; PHILLIPS HA, 1995, NAT GENET, V10, P117, DOI 10.1038/ng0595-117; PINARD JM, 1994, J NEUROL NEUROSUR PS, V57, P914, DOI 10.1136/jnnp.57.8.914; RAYMOND AA, 1994, J NEUROL NEUROSUR PS, V57, P1195, DOI 10.1136/jnnp.57.10.1195; REID CB, 1995, NEURON, V15, P299, DOI 10.1016/0896-6273(95)90035-7; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; ROSENTHAL A, 1992, NAT GENET, V2, P107, DOI 10.1038/ng1092-107; RYAN SG, 1995, NAT GENET, V10, P4, DOI 10.1038/ng0595-4; SEDLACEK Z, 1993, HUM MOL GENET, V2, P1865; SEFIANI A, 1991, HUM GENET, V86, P297; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI; VITS L, 1994, NAT GENET, V7, P408, DOI 10.1038/ng0794-408; WALSH C, 1992, SCIENCE, V255, P434, DOI 10.1126/science.1734520; WANG LH, 1994, GENOMICS, V22, P590, DOI 10.1006/geno.1994.1432; WEHNERT M, 1993, HUM MOL GENET, V2, P1503, DOI 10.1093/hmg/2.9.1503; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WEISSENBACH J, 1993, GENE, V135, P275, DOI 10.1016/0378-1119(93)90077-G; WHITEHOUSE WP, 1993, AM J HUM GENET, V53, P652; WILLARD HF, 1994, CYTOGENET CELL GENET, V67, P296; ZOLLINO M, 1992, AM J MED GENET, V43, P452, DOI 10.1002/ajmg.1320430168	55	251	256	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1996	16	1					77	87		10.1016/S0896-6273(00)80025-2	http://dx.doi.org/10.1016/S0896-6273(00)80025-2			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TT307	8562093	hybrid			2022-12-24	WOS:A1996TT30700011
J	Selyanko, AA; Brown, DA				Selyanko, AA; Brown, DA			Intracellular calcium directly inhibits potassium M channels in excised membrane patches from rat sympathetic neurons	NEURON			English	Article							PROTEIN-KINASE-C; M-CURRENTS; GANGLION CELLS; MUSCARINIC SUPPRESSION; K+ CURRENTS; CAFFEINE; DESENSITIZATION; IDENTIFICATION; MODULATION; MESSENGER	Complex effects of altering intracellular [Ca2+] on M-type K+ currents have previously been reported using whole-cell current recording. To study the direct effect of Ca2+ on M-channel activity, we have applied Ca2+ to the inside face of membrane patches excised from rat superior cervical sympathetic ganglion cells. Ca2+ rapidly and reversibly inhibited M-channel activity in 28/44 patches by up to 87%, with a mean IC50 of 100 nM. This effect persisted in the absence of ATP, implying that it was not due to phosphorylation/dephosphorylation. A similar effect was observed in 13/13 cell-attached patches when cells were transiently ''Ca2+-loaded'' by adding 2 mM Ca2+ to a 25 mM K+ solution bathing the extrapatch cell membrane. These observations provide new evidence that Ca2+ can directly inhibit M channels, so supporting the view that Ca2+ might mediate M current inhibition following muscarinic receptor activation.			Selyanko, AA (corresponding author), UCL, DEPT PHARMACOL, GOWER ST, LONDON WC1E 6BT, ENGLAND.		Brown, David A/J-9019-2012					ADAMS PR, 1982, J PHYSIOL-LONDON, V330, P537, DOI 10.1113/jphysiol.1982.sp014357; ADAMS PR, 1982, J PHYSIOL-LONDON, V332, P223, DOI 10.1113/jphysiol.1982.sp014411; AKAIKE N, 1989, J PHYSIOL-LONDON, V412, P221, DOI 10.1113/jphysiol.1989.sp017612; AKASU T, 1993, NEURON, V11, P1133, DOI 10.1016/0896-6273(93)90226-H; ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; BEECH DJ, 1991, P NATL ACAD SCI USA, V88, P652, DOI 10.1073/pnas.88.2.652; BOSMA MM, 1989, P NATL ACAD SCI USA, V86, P2943, DOI 10.1073/pnas.86.8.2943; BROWN D, 1988, TRENDS NEUROSCI, V11, P294, DOI 10.1016/0166-2236(88)90089-6; Brown D A, 1988, Ion Channels, V1, P55; BROWN DA, 1989, J PHYSIOL-LONDON, V413, P469, DOI 10.1113/jphysiol.1989.sp017664; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; BROWN DA, 1987, CELL MOL NEUROBIOL, V7, P255, DOI 10.1007/BF00711303; CAULFIELD MP, 1994, J PHYSIOL-LONDON, V477, P415, DOI 10.1113/jphysiol.1994.sp020203; CHEN HY, 1992, BRIT J PHARMACOL, V105, P329, DOI 10.1111/j.1476-5381.1992.tb14254.x; CONSTANTI A, 1981, NEUROSCI LETT, V24, P289, DOI 10.1016/0304-3940(81)90173-7; DUTAR P, 1988, NEUROSCI LETT, V85, P89, DOI 10.1016/0304-3940(88)90434-X; FILIPPOV AK, 1994, PFLUG ARCH EUR J PHY, V429, P223, DOI 10.1007/BF00374316; FOUCART S, 1995, AM J PHYSIOL-CELL PH, V268, pC829, DOI 10.1152/ajpcell.1995.268.4.C829; FUKUDA K, 1988, NATURE, V335, P355, DOI 10.1038/335355a0; HENKART M, 1980, FED PROC, V39, P2783; HIGASHIDA H, 1995, J PHYSIOL-LONDON, V482, P317, DOI 10.1113/jphysiol.1995.sp020520; HIGASHIDA H, 1986, NATURE, V323, P333, DOI 10.1038/323333a0; HILLE B, 1994, TRENDS NEUROSCI, V17, P531, DOI 10.1016/0166-2236(94)90157-0; JONES S, 1995, NEURON, V14, P399, DOI 10.1016/0896-6273(95)90295-3; Jones S. W, 1987, NEUROMODULATION BIOC, P159; KIRKWOOD A, 1991, NEURON, V6, P1009, DOI 10.1016/0896-6273(91)90240-Z; KUBA K, 1994, JPN J PHYSIOL, V44, P613, DOI 10.2170/jjphysiol.44.613; MARRION NV, 1992, J PHYSIOL-LONDON, V445, P515, DOI 10.1113/jphysiol.1992.sp018937; MARRION NV, 1991, NEURON, V6, P533, DOI 10.1016/0896-6273(91)90056-6; MARRION NV, 1987, NEUROSCI LETT, V77, P55, DOI 10.1016/0304-3940(87)90606-9; MARRION NV, 1993, NEURON, V11, P77, DOI 10.1016/0896-6273(93)90272-S; MARRION NV, 1994, PFLUG ARCH EUR J PHY, V426, P296, DOI 10.1007/BF00374785; MARSH SJ, 1995, NEURON, V15, P729, DOI 10.1016/0896-6273(95)90160-4; OWEN DG, 1990, J PHYSIOL-LONDON, V431, P269, DOI 10.1113/jphysiol.1990.sp018330; PFAFFINGER P, 1988, J NEUROSCI, V8, P3343; PFAFFINGER PJ, 1988, NEURON, V1, P477, DOI 10.1016/0896-6273(88)90178-X; QIN D, 1991, JPN J PHYSIOL, V41, P333, DOI 10.2170/jjphysiol.41.333; ROBBINS J, 1993, J PHYSIOL-LONDON, V469, P153, DOI 10.1113/jphysiol.1993.sp019809; ROBBINS J, 1992, J PHYSIOL-LONDON, V451, P159, DOI 10.1113/jphysiol.1992.sp019159; SCHMITT H, 1993, PFLUG ARCH EUR J PHY, V425, P134, DOI 10.1007/BF00374513; SELYANKO AA, 1993, J PHYSIOL-LONDON, V472, P711, DOI 10.1113/jphysiol.1993.sp019968; SELYANKO AA, 1992, P ROY SOC B-BIOL SCI, V250, P119, DOI 10.1098/rspb.1992.0139; SELYANKO AA, 1995, RECEPTOR CHANNEL, V3, P147; SHAPIRO MS, 1994, NEURON, V12, P1319, DOI 10.1016/0896-6273(94)90447-2; SIMMONS MA, 1990, NEURON, V4, P557, DOI 10.1016/0896-6273(90)90113-T; SMART TG, 1987, J PHYSIOL-LONDON, V389, P337, DOI 10.1113/jphysiol.1987.sp016660; STANSFELD CE, 1993, NEURON, V10, P639, DOI 10.1016/0896-6273(93)90166-O; THAYER SA, 1988, MOL PHARMACOL, V34, P664; TOKIMASA T, 1985, BRAIN RES, V337, P386, DOI 10.1016/0006-8993(85)90081-2; TROUSLARD J, 1993, J PHYSIOL-LONDON, V468, P53, DOI 10.1113/jphysiol.1993.sp019759; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; VIANNA AL, 1975, BIOCHIM BIOPHYS ACTA, V410, P389, DOI 10.1016/0005-2744(75)90241-7; WANG HS, 1995, J PHYSIOL-LONDON, V485, P319, DOI 10.1113/jphysiol.1995.sp020732; WANKE E, 1987, P NATL ACAD SCI USA, V84, P4313, DOI 10.1073/pnas.84.12.4313; YU SP, 1994, J NEUROSCI, V14, P3487	55	113	116	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JAN	1996	16	1					151	162		10.1016/S0896-6273(00)80032-X	http://dx.doi.org/10.1016/S0896-6273(00)80032-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TT307	8562079	Bronze			2022-12-24	WOS:A1996TT30700018
J	ROHLICH, P; VANVEEN, T; SZEL, A				ROHLICH, P; VANVEEN, T; SZEL, A			2 DIFFERENT VISUAL PIGMENTS IN ONE RETINAL CONE CELL	NEURON			English	Article							COLOR-VISION; MONOCLONAL-ANTIBODY; GREEN; BLUE; RED; PHOTORECEPTORS; RECEPTORS; LIGHT; GENES	The retina of the mouse, rabbit, and guinea pig is divided into a superior area dominated by green-sensitive (M) cones and an inferior area in which cones possess practically only short wavelength-sensitive (S) photopigments. The present study shows that the transitional zone between these retinal areas is populated by cones labeled by both the M and S cone photopigment-specific antibodies COS-1 and OS-2. It is concluded that the overwhelming majority of the transitional cones express both visual pigments. A small population of the transitional cones was strongly labeled exclusively by OS-2 (genuine S cones). The results indicate that, in contrast to the generally accepted idea of one visual pigment per one cone cell, cones of certain mammalian species can express different opsins simultaneously under natural conditions. We speculate that the coexpression may be due to the overlapping of regulatory factors determining the M and S fields.	GOTHENBURG UNIV,DEPT ZOOL,S-40031 GOTHENBURG,SWEDEN	University of Gothenburg	ROHLICH, P (corresponding author), SEMMELWEIS UNIV MED,DEPT ANAT HISTOL & EMBRYOL 2,ELECTRON MICROSCOPY LAB 1,H-1450 BUDAPEST,HUNGARY.							ARCHER SN, 1990, VISION RES, V30, P225, DOI 10.1016/0042-6989(90)90038-M; ELDRED WD, 1978, VISION RES, V18, P29, DOI 10.1016/0042-6989(78)90073-1; Harlow E., 1988, ANTIBODIES LABORATOR, P353; JACOBS GH, 1991, NATURE, V353, P655, DOI 10.1038/353655a0; JACOBS GH, 1993, BIOL REV, V68, P413, DOI 10.1111/j.1469-185X.1993.tb00738.x; JULIUSSON B, 1994, INVEST OPHTH VIS SCI, V35, P811; KRAFT TW, 1990, COLD SH Q B, V55, P635; LEMMON V, 1986, INVEST OPHTH VIS SCI, V27, P831; LEREA CL, 1989, NEURON, V3, P367, DOI 10.1016/0896-6273(89)90261-4; MINKE B, 1973, J GEN PHYSIOL, V62, P87, DOI 10.1085/jgp.62.1.87; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; NOLTE J, 1969, J GEN PHYSIOL, V54, P636, DOI 10.1085/jgp.54.5.636; NOLTE J, 1972, J GEN PHYSIOL, V59, P186, DOI 10.1085/jgp.59.2.186; NUBOER JFW, 1983, J COMP PHYSIOL, V151, P353, DOI 10.1007/BF00623910; NUBOER JFW, 1986, NETH J ZOOL, V36, P344; ROHLICH P, 1993, CURR EYE RES, V12, P935, DOI 10.3109/02713689309020400; SHICHIDA Y, 1989, EXP EYE RES, V48, P281, DOI 10.1016/S0014-4835(89)80077-6; SOLESSIO E, 1993, NATURE, V364, P442, DOI 10.1038/364442a0; SZEL A, 1989, NEUROBIOLOGY OF SENSORY SYSTEMS, P275; SZEL A, 1986, EXP EYE RES, V43, P871, DOI 10.1016/0014-4835(86)90066-7; SZEL A, 1988, J COMP NEUROL, V273, P593, DOI 10.1002/cne.902730413; SZEL A, 1994, NATURE, V370, P336, DOI 10.1038/370336a0; SZEL A, 1992, J COMP NEUROL, V325, P327, DOI 10.1002/cne.903250302; WANG YS, 1992, NEURON, V9, P429, DOI 10.1016/0896-6273(92)90181-C	24	194	196	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1994	13	5					1159	1166		10.1016/0896-6273(94)90053-1	http://dx.doi.org/10.1016/0896-6273(94)90053-1			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PU763	7946352				2022-12-24	WOS:A1994PU76300011
J	YOSHIHARA, Y; OKA, S; NEMOTO, Y; WATANABE, Y; NAGATA, S; KAGAMIYAMA, H; MORI, K				YOSHIHARA, Y; OKA, S; NEMOTO, Y; WATANABE, Y; NAGATA, S; KAGAMIYAMA, H; MORI, K			AN ICAM-RELATED NEURONAL GLYCOPROTEIN, TELENCEPHALIN, WITH BRAIN SEGMENT-SPECIFIC EXPRESSION	NEURON			English	Article							CELL-ADHESION MOLECULES; MYELIN-ASSOCIATED GLYCOPROTEIN; LONG-TERM POTENTIATION; FIBRONECTIN-TYPE-III; IMMUNOGLOBULIN SUPERFAMILY; INTERCELLULAR-ADHESION; RESTRICTED EXPRESSION; NERVOUS-SYSTEM; MEMBRANE GLYCOPROTEIN; HIPPOCAMPAL-NEURONS	Telencephalin (TLN) is a 130 kd glycoprotein expressed exclusively in neurons of the telencephalon, the most rostral brain segment. In the neurons, TLN is localized to soma-dendritic membrane but not to axonal membrane. In this study, we have cloned cDNA encoding rabbit and mouse TLN. The cDNA-derived primary structure of TLN predicts an integral membrane protein with nine tandem immunoglobulin-like domains in an extracellular region, a transmembrane domain, and a short cytoplasmic tail. The distal eight immunoglobulin-like domains of TLN show highest homology with the immunoglobulin-like domains of intercellular adhesion molecules (ICAMs) 1, 2, and 3/R. The structural similarity of TLN with ICAMs provides a new and strong link between immunoglobulin superfamily molecules in the nervous and immune systems. TLN is an example of a dendrite-associated cell adhesion molecule involved in the brain's segmental organization, cell-cell interactions during dendritic development, and maintenance of functional neuronal networks.	OSAKA BIOSCI INST, DEPT MOLEC BIOL, SUITA, OSAKA 565, JAPAN; OSAKA MED COLL, DEPT MED CHEM, TAKATSUKI, OSAKA 569, JAPAN	Osaka Medical College	YOSHIHARA, Y (corresponding author), OSAKA BIOSCI INST, DEPT NEUROSCI, 6-2-4 FURUEDAI, SUITA, OSAKA 565, JAPAN.		Nagata, Shigekazu/AAG-3203-2019; Yoshihara, Yoshihiro/N-6481-2015	Nagata, Shigekazu/0000-0001-9758-8426; Yoshihara, Yoshihiro/0000-0002-0319-7166; Mori, Kensaku/0000-0001-7853-9370				BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BRISKIN MJ, 1993, NATURE, V363, P461, DOI 10.1038/363461a0; BRUMMENDORF T, 1989, NEURON, V2, P1351, DOI 10.1016/0896-6273(89)90073-1; BURGOON MP, 1991, J CELL BIOL, V112, P1017, DOI 10.1083/jcb.112.5.1017; BURNS FR, 1991, NEURON, V7, P209, DOI 10.1016/0896-6273(91)90259-3; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DESMOND NL, 1986, J COMP NEUROL, V253, P476, DOI 10.1002/cne.902530405; DESMOND NL, 1986, J COMP NEUROL, V253, P466, DOI 10.1002/cne.902530404; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; DODD J, 1988, SCIENCE, V242, P692, DOI 10.1126/science.3055291; DOTTI CG, 1991, NATURE, V349, P158, DOI 10.1038/349158a0; DOTTI CG, 1990, CELL, V62, P63, DOI 10.1016/0092-8674(90)90240-F; FAWCETT J, 1992, NATURE, V360, P481, DOI 10.1038/360481a0; FURLEY AJ, 1990, CELL, V61, P157, DOI 10.1016/0092-8674(90)90223-2; GENNARINI G, 1989, J CELL BIOL, V109, P775, DOI 10.1083/jcb.109.2.775; GRUMET M, 1991, J CELL BIOL, V113, P1399, DOI 10.1083/jcb.113.6.1399; HONG X, 1992, J IMMUNOL, V149, P2650; HORLEY KJ, 1989, EMBO J, V8, P2889, DOI 10.1002/j.1460-2075.1989.tb08437.x; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; IMAMURA K, 1990, NEUROSCI LETT, V119, P118, DOI 10.1016/0304-3940(90)90770-A; Jacobson M., 1991, DEV NEUROBIOLOGY; JOHNSON JP, 1989, P NATL ACAD SCI USA, V86, P641, DOI 10.1073/pnas.86.2.641; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KRUSE J, 1984, NATURE, V311, P153, DOI 10.1038/311153a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAZZARO D, 1991, DEVELOPMENT, V113, P1093; MALTER JS, 1989, SCIENCE, V246, P664, DOI 10.1126/science.2814487; MCGARRY RC, 1983, NATURE, V306, P376, DOI 10.1038/306376a0; MIURA M, 1992, J BIOL CHEM, V267, P10752; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; MOOS M, 1988, NATURE, V334, P701, DOI 10.1038/334701a0; MORI K, 1987, P NATL ACAD SCI USA, V84, P3921, DOI 10.1073/pnas.84.11.3921; MURAKAMI F, 1991, NEUROSCI RES, V11, P141, DOI 10.1016/0168-0102(91)90052-Z; OKA S, 1990, NEUROSCIENCE, V35, P93, DOI 10.1016/0306-4522(90)90124-M; OSBORN L, 1989, CELL, V59, P1203, DOI 10.1016/0092-8674(89)90775-7; PEARLSTONE JR, 1986, J BIOL CHEM, V261, P6795; PORTEUS MH, 1991, NEURON, V7, P221, DOI 10.1016/0896-6273(91)90260-7; PRICE M, 1991, NATURE, V351, P748, DOI 10.1038/351748a0; PRICE M, 1992, NEURON, V8, P241, DOI 10.1016/0896-6273(92)90291-K; RATHJEN FG, 1987, J CELL BIOL, V104, P343, DOI 10.1083/jcb.104.2.343; REDIES C, 1992, J NEUROSCI, V12, P3525; REICHARDT LF, 1991, ANNU REV NEUROSCI, V14, P531, DOI 10.1146/annurev.neuro.14.1.531; RUTISHAUSER U, 1988, PHYSIOL REV, V68, P819, DOI 10.1152/physrev.1988.68.3.819; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SHIMAMURA K, 1992, DEV BIOL, V152, P242, DOI 10.1016/0012-1606(92)90132-Z; SIMEONE A, 1992, EMBO J, V11, P2541, DOI 10.1002/j.1460-2075.1992.tb05319.x; SIMEONE A, 1992, NATURE, V358, P687, DOI 10.1038/358687a0; SIMMONS D, 1988, NATURE, V331, P624, DOI 10.1038/331624a0; SIMMONS DM, 1989, J HISTOTECHNOL, V12, P169; SONDEREGGER P, 1992, J CELL BIOL, V119, P1387, DOI 10.1083/jcb.119.6.1387; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; STAUNTON DE, 1988, CELL, V52, P925, DOI 10.1016/0092-8674(88)90434-5; STAUNTON DE, 1990, CELL, V61, P243, DOI 10.1016/0092-8674(90)90805-O; STAUNTON DE, 1989, NATURE, V339, P61, DOI 10.1038/339061a0; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; TANAKA H, 1991, NEURON, V7, P535, DOI 10.1016/0896-6273(91)90366-8; TAO W, 1992, NEURON, V8, P957, DOI 10.1016/0896-6273(92)90210-5; VAZEUX R, 1992, NATURE, V360, P485, DOI 10.1038/360485a0; VOLKMER H, 1992, J CELL BIOL, V118, P149, DOI 10.1083/jcb.118.1.149; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; YOSHIHARA Y, 1991, J CELL BIOL, V115, P731, DOI 10.1083/jcb.115.3.731; YOSHIHARA Y, 1991, NEUROSCI RES, V10, P83, DOI 10.1016/0168-0102(91)90033-U; ZUELLIG RA, 1992, EUR J BIOCHEM, V204, P453, DOI 10.1111/j.1432-1033.1992.tb16655.x	69	101	105	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	1994	12	3					541	553		10.1016/0896-6273(94)90211-9	http://dx.doi.org/10.1016/0896-6273(94)90211-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NC769	7794412				2022-12-24	WOS:A1994NC76900007
J	KESSLER, JA; LUDLAM, WH; FREIDIN, MM; HALL, DH; MICHAELSON, MD; SPRAY, DC; DOUGHERTY, M; BATTER, DK				KESSLER, JA; LUDLAM, WH; FREIDIN, MM; HALL, DH; MICHAELSON, MD; SPRAY, DC; DOUGHERTY, M; BATTER, DK			CYTOKINE-INDUCED PROGRAMMED DEATH OF CULTURED SYMPATHETIC NEURONS	NEURON			English	Article							NERVE GROWTH-FACTOR; CILIARY NEUROTROPHIC FACTOR; LEUKEMIA INHIBITORY FACTOR; SMOOTH-MUSCLE CELLS; DIFFERENTIAL REGULATION; FACTOR DEPRIVATION; CA-2+; RECEPTOR; GANGLION; INNERVATION	Programmed cell death (PCD) of sympathetic neurons is inhibited by nerve growth factor. However, factors that induce PCD of these cells are unknown. Leukemia inhibitory factor (LIF) and ciliary neurotrophic factor, neuropoietic cytokines known to regulate sympathetic neuron gene expression, were examined for effects on survival of cultured sympathetic neurons. Treatment with LIF or ciliary neurotrophic factor caused neuronal death in a dose-dependent fashion. Inhibition of RNA or protein synthesis, or treatment with potassium, all of which prevent PCD after nerve growth factor deprivation, prevented LIF-induced death. The morphologic and ultrastructural characteristics of the neuronal death induced by LIF and by nerve growth factor deprivation were similar. Furthermore, LIF treatment resulted in DNA fragmentation with a characteristic ''ladder'' on Southern blot analysis. These observations suggest that neuron numbers may be regulated by factors which initiate PCD, as well as by factors which prevent it.	YESHIVA UNIV ALBERT EINSTEIN COLL MED, DEPT NEUROSCI, BRONX, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	KESSLER, JA (corresponding author), YESHIVA UNIV ALBERT EINSTEIN COLL MED, DEPT NEUROL, BRONX, NY 10461 USA.			Spray, David/0000-0001-8368-5073; Freidin, Mona/0000-0002-3162-4858	NINDS NIH HHS [NS20778, NS20013] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020778, R01NS020013] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALTMAN J, 1992, TRENDS NEUROSCI, V15, P278, DOI 10.1016/0166-2236(92)90076-K; ARAKAWA Y, 1990, J NEUROSCI, V10, P3507; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CHRIST GJ, 1992, AM J PHYSIOL, V263, pC373, DOI 10.1152/ajpcell.1992.263.2.C373; COWAN WM, 1984, SCIENCE, V225, P1258, DOI 10.1126/science.6474175; DAVIS S, 1991, SCIENCE, V253, P59, DOI 10.1126/science.1648265; ERNSBERGER U, 1989, NEURON, V2, P1275, DOI 10.1016/0896-6273(89)90312-7; FERRARI G, 1993, J NEUROSCI, V13, P1879; FRANKLIN JL, 1992, TRENDS NEUROSCI, V15, P501, DOI 10.1016/0166-2236(92)90103-F; GOLDMAN WF, 1990, CELL CALCIUM, V11, P221, DOI 10.1016/0143-4160(90)90073-4; GREEN SH, 1986, J BIOL CHEM, V261, P5316; HEMPSTEAD BL, 1989, SCIENCE, V243, P373, DOI 10.1126/science.2536190; HENDRY IA, 1976, J NEUROCYTOL, V5, P351, DOI 10.1007/BF01175120; HENDRY IA, 1992, J NEUROSCI, V12, P3427; IP NY, 1992, CELL, V69, P1121, DOI 10.1016/0092-8674(92)90634-O; KESSLER JA, 1986, DEV BIOL, V113, P77, DOI 10.1016/0012-1606(86)90109-0; KESSLER JA, 1983, J NEUROSCI, V3, P1301; KESSLER JA, 1985, NEUROSCIENCE, V15, P827, DOI 10.1016/0306-4522(85)90081-8; KESSLER JA, 1985, J NEUROSCI, V5, P2719; KOIKE T, 1989, P NATL ACAD SCI USA, V86, P6421, DOI 10.1073/pnas.86.16.6421; LAZARUS KJ, 1976, BRAIN RES, V113, P159, DOI 10.1016/0006-8993(76)90013-5; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; LIN LFH, 1989, SCIENCE, V246, P1023, DOI 10.1126/science.2587985; LOUIS JC, 1993, SCIENCE, V259, P689, DOI 10.1126/science.8430320; MARTIN DP, 1988, J CELL BIOL, V106, P829, DOI 10.1083/jcb.106.3.829; MOBLEY WC, 1976, BIOCHEMISTRY-US, V15, P5543, DOI 10.1021/bi00670a019; MOORE EDW, 1990, CELL CALCIUM, V11, P157, DOI 10.1016/0143-4160(90)90068-6; MURPHY M, 1991, P NATL ACAD SCI USA, V88, P3498, DOI 10.1073/pnas.88.8.3498; NAWA H, 1990, COLD SH Q B, V55, P247; OBERHAMMER FA, 1992, P NATL ACAD SCI USA, V89, P5408, DOI 10.1073/pnas.89.12.5408; OPPENHEIM RW, 1985, TRENDS NEUROSCI, V8, P487, DOI 10.1016/0166-2236(85)90175-4; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; SAADAT S, 1989, J CELL BIOL, V108, P1807, DOI 10.1083/jcb.108.5.1807; SKAPER SD, 1986, DEV BRAIN RES, V24, P39, DOI 10.1016/0165-3806(86)90171-9; SPIEGEL K, 1990, NEURON, V4, P303, DOI 10.1016/0896-6273(90)90104-N; STOCKLI KA, 1989, NATURE, V342, P920, DOI 10.1038/342920a0; VAUX DL, 1993, P NATL ACAD SCI USA, V90, P786, DOI 10.1073/pnas.90.3.786; YAMAMORI T, 1989, SCIENCE, V246, P1412, DOI 10.1126/science.2512641	39	100	101	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1993	11	6					1123	1132		10.1016/0896-6273(93)90225-G	http://dx.doi.org/10.1016/0896-6273(93)90225-G			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MP548	8274279				2022-12-24	WOS:A1993MP54800013
J	MORALES, G; HUBERT, M; BRUMMENDORF, T; TREUBERT, U; TARNOK, A; SCHWARZ, U; RATHJEN, FG				MORALES, G; HUBERT, M; BRUMMENDORF, T; TREUBERT, U; TARNOK, A; SCHWARZ, U; RATHJEN, FG			INDUCTION OF AXONAL GROWTH BY HETEROPHILIC INTERACTIONS BETWEEN THE CELL-SURFACE RECOGNITION PROTEIN-F11 AND PROTEIN-NR-CAM/BRAVO	NEURON			English	Article							FIBRONECTIN-TYPE-III; IMMUNOGLOBULIN SUPERFAMILY; ADHESION MOLECULE; NEURITE OUTGROWTH; NERVOUS-SYSTEM; NG-CAM; PHOSPHATIDYLINOSITOL; GLYCOPROTEINS; DOMAINS; F11	F11 and Nr-CAM/Bravo are two axon-associated glycoproteins belonging to different subgroups of the immunoglobulin superfamily. In this report we have investigated the interaction of both proteins using neurite outgrowth and binding assays. Antibody blocking experiments demonstrate that neurite extension of tectal cells on immobilized F11 is mediated by Nr-CAM/Bravo. Binding studies further reveal a direct heterophilic interaction between F11 and Nr-CAM/Bravo. This activity can be mapped to the amino-terminal second or third immunoglobulin-like domain within F11 with domain-specific monoclonal antibodies and deletion mutant proteins expressed on COS cells. Furthermore, perturbation experiments with domain-specific monoclonal antibodies demonstrate that this region is required for adhesion and neurite extension.	MAX PLANCK INST ENTWICKLUNGSBIOL, D-72076 TUBINGEN, GERMANY; ZENTRUM MOLEK NEUROBIOL, D-20246 HAMBURG, GERMANY	Max Planck Society								ANSORGE W, 1985, J BIOCHEM BIOPH METH, V11, P13, DOI 10.1016/0165-022X(85)90037-5; BRUMMENDORF T, 1993, J NEUROCHEM, V61, P1207, DOI 10.1111/j.1471-4159.1993.tb13611.x; BRUMMENDORF T, 1989, NEURON, V2, P1351, DOI 10.1016/0896-6273(89)90073-1; BRUMMENDORF T, 1993, NEURON, V10, P711; BURGOON MP, 1991, J CELL BIOL, V112, P1017, DOI 10.1083/jcb.112.5.1017; CHANG S, 1987, J CELL BIOL, V104, P355, DOI 10.1083/jcb.104.2.355; DAVIS JQ, 1993, J CELL BIOL, V121, P121, DOI 10.1083/jcb.121.1.121; DELAROSA EJ, 1990, J CELL BIOL, V111, P3087, DOI 10.1083/jcb.111.6.3087; FAIVRESARRAILH C, 1992, J NEUROSCI, V12, P257; FURLEY AJ, 1990, CELL, V61, P157, DOI 10.1016/0092-8674(90)90223-2; FUSS B, 1993, J CELL BIOL, V120, P1237, DOI 10.1083/jcb.120.5.1237; GENNARINI G, 1989, J CELL BIOL, V109, P775, DOI 10.1083/jcb.109.2.775; GENNARINI G, 1991, NEURON, V6, P595, DOI 10.1016/0896-6273(91)90062-5; GRUMET M, 1991, J CELL BIOL, V113, P1399, DOI 10.1083/jcb.113.6.1399; KAYYEM JF, 1992, J CELL BIOL, V118, P1259, DOI 10.1083/jcb.118.5.1259; KRUSHEL LA, 1993, NEUROSCIENCE, V53, P797, DOI 10.1016/0306-4522(93)90625-P; KUHN TB, 1991, J CELL BIOL, V115, P1113, DOI 10.1083/jcb.115.4.1113; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAGENAUR C, 1987, P NATL ACAD SCI USA, V84, P7753, DOI 10.1073/pnas.84.21.7753; LEMMON V, 1989, NEURON, V2, P1597, DOI 10.1016/0896-6273(89)90048-2; MAURO VP, 1992, J CELL BIOL, V119, P191, DOI 10.1083/jcb.119.1.191; NORENBERG U, 1992, NEURON, V8, P849, DOI 10.1016/0896-6273(92)90199-N; PESHEVA P, 1993, NEURON, V10, P69, DOI 10.1016/0896-6273(93)90243-K; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; RATHJEN FG, 1987, CELL, V51, P841, DOI 10.1016/0092-8674(87)90107-3; RATHJEN FG, 1991, DEVELOPMENT, V113, P151; RATHJEN FG, 1987, J CELL BIOL, V104, P343, DOI 10.1083/jcb.104.2.343; SCHUCH U, 1989, NEURON, V3, P13, DOI 10.1016/0896-6273(89)90111-6; SONDEREGGER P, 1992, J CELL BIOL, V119, P1387, DOI 10.1083/jcb.119.6.1387; VOLKMER H, 1992, J CELL BIOL, V118, P149, DOI 10.1083/jcb.118.1.149; WILLIAMS EJ, 1992, J CELL BIOL, V119, P883, DOI 10.1083/jcb.119.4.883; WOLFF JM, 1989, BIOCHEM BIOPH RES CO, V161, P931, DOI 10.1016/0006-291X(89)92688-0; WOLFF JM, 1987, EUR J BIOCHEM, V168, P551, DOI 10.1111/j.1432-1033.1987.tb13453.x; WOLFF JM, 1988, THESIS U TUBINGEN TU; ZISCH AH, 1992, J CELL BIOL, V119, P203, DOI 10.1083/jcb.119.1.203; ZUELLIG RA, 1992, EUR J BIOCHEM, V204, P453, DOI 10.1111/j.1432-1033.1992.tb16655.x	36	112	114	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1993	11	6					1113	1122		10.1016/0896-6273(93)90224-F	http://dx.doi.org/10.1016/0896-6273(93)90224-F			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MP548	8274278				2022-12-24	WOS:A1993MP54800012
J	WOOD, KA; DIPASQUALE, B; YOULE, RJ				WOOD, KA; DIPASQUALE, B; YOULE, RJ			IN-SITU LABELING OF GRANULE CELLS FOR APOPTOSIS-ASSOCIATED DNA FRAGMENTATION REVEALS DIFFERENT MECHANISMS OF CELL LOSS IN DEVELOPING CEREBELLUM	NEURON			English	Article							QUANTITATIVE-ANALYSIS; MOUSE CHIMERAS; CHICK-EMBRYOS; DEATH; NUMBER; PURKINJE; NEURONS; MICE; DEGRADATION; CORTEX	We have examined the role apoptosis plays during postnatal development of the mouse cerebellum by a new method utilizing T7 DNA polymerase for the in situ detection of DNA fragmentation associated with cell death. Granule cell loss between the third and fifth postnatal weeks, hypothesized to affect the granule cell to Purkinje cell stoichiometry, is not associated with DNA fragmentation. However, cerebellar granule cells undergo extensive nuclear DNA fragmentation between postnatal days 5 and 9. Cell death prior to synaptogenesis may help regulate granule cell number. Our results suggest that different mechanisms of cell death within the same neuronal cell population occur during development.			WOOD, KA (corresponding author), NINCDS,BIOCHEM SECT,SURG NEUROL BRANCH,BETHESDA,MD 20892, USA.							APPLEBY DW, 1977, P NATL ACAD SCI USA, V74, P5579, DOI 10.1073/pnas.74.12.5579; BLACKMAN M, 1990, SCIENCE, V248, P1335, DOI 10.1126/science.1972592; BRUSCH W, 1990, BIOCH CELL BIOL, V88, P1071; CADDY KWT, 1979, PHILOS T ROY SOC B, V287, P167, DOI 10.1098/rstb.1979.0055; CHUN JJM, 1987, NATURE, V325, P617, DOI 10.1038/325617a0; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; COHEN GM, 1992, BIOCHEM J, V286, P331, DOI 10.1042/bj2860331; COWAN WM, 1984, SCIENCE, V225, P1258, DOI 10.1126/science.6474175; CUNNINGHAM TJ, 1982, INT REV CYTOL, V74, P163, DOI 10.1016/S0074-7696(08)61172-9; DIPASQUALE B, 1991, BIOCHEM BIOPH RES CO, V181, P1442, DOI 10.1016/0006-291X(91)92101-O; DRISCOLL M, 1992, TRENDS NEUROSCI, V15, P15, DOI 10.1016/0166-2236(92)90343-7; FESUS L, 1989, FEBS LETT, V245, P150, DOI 10.1016/0014-5793(89)80210-8; FUJITA S, 1966, J COMP NEUROL, V128, P191, DOI 10.1002/cne.901280206; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GIORDANO DL, 1980, J NEUROCYTOL, V9, P603, DOI 10.1007/BF01205028; GLUCKSMANN A, 1951, BIOL REV, V26, P59, DOI 10.1111/j.1469-185X.1951.tb00774.x; HERRUP K, 1987, J NEUROSCI, V7, P829; HERRUP K, 1986, DEV BIOL, V115, P148, DOI 10.1016/0012-1606(86)90236-8; HORNUNG JP, 1989, J COMP NEUROL, V283, P425, DOI 10.1002/cne.902830310; HUBER HE, 1987, ESCHERICHIA COLI THI, V262, P16224; Kerr J.F.R., 1987, P93; LANDIS DMD, 1978, J COMP NEUROL, V179, P831, DOI 10.1002/cne.901790408; MIALE IL, 1961, EXP NEUROL, V4, P277, DOI 10.1016/0014-4886(61)90055-3; MODAK DJ, 1977, EXP CELL RES, V75, P307; OPPENHEIM RW, 1985, TRENDS NEUROSCI, V8, P487, DOI 10.1016/0166-2236(85)90175-4; PILAR G, 1976, J CELL BIOL, V68, P339, DOI 10.1083/jcb.68.2.339; SAMBROOK J, 1987, MOL CLONING LABORATO; SAUNDERS JW, 1966, SCIENCE, V154, P604, DOI 10.1126/science.154.3749.604; SELLINS KS, 1991, J IMMUNOL, V147, P795; SIDMAN RL, 1962, SCIENCE, V137, P610, DOI 10.1126/science.137.3530.610; SONMEZ E, 1984, DEV BRAIN RES, V12, P271, DOI 10.1016/0165-3806(84)90049-X; TABOR S, 1987, J BIOL CHEM, V262, P16212; TOMEI LD, 1991, APOPTOSIS MOL BASIS; WETTS R, 1983, DEV BRAIN RES, V10, P41, DOI 10.1016/0165-3806(83)90119-0; WETTS R, 1982, J NEUROSCI, V2, P1494; WIJSMAN JH, 1993, J HISTOCHEM CYTOCHEM, V41, P7, DOI 10.1177/41.1.7678025; WILLIAMS RW, 1988, ANNU REV NEUROSCI, V11, P423, DOI 10.1146/annurev.neuro.11.1.423; WYLLIE AH, 1984, J PATHOL, V142, P67, DOI 10.1002/path.1711420112; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0	39	328	332	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1993	11	4					621	632		10.1016/0896-6273(93)90074-2	http://dx.doi.org/10.1016/0896-6273(93)90074-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MD068	8398151				2022-12-24	WOS:A1993MD06800007
J	TSOULFAS, P; SOPPET, D; ESCANDON, E; TESSAROLLO, L; MENDOZARAMIREZ, JL; ROSENTHAL, A; NIKOLICS, K; PARADA, LF				TSOULFAS, P; SOPPET, D; ESCANDON, E; TESSAROLLO, L; MENDOZARAMIREZ, JL; ROSENTHAL, A; NIKOLICS, K; PARADA, LF			THE RAT TRKC LOCUS ENCODES MULTIPLE NEUROGENIC RECEPTORS THAT EXHIBIT DIFFERENTIAL RESPONSE TO NEUROTROPHIN-3 IN PC12-CELLS	NEURON			English	Article							NERVE GROWTH-FACTOR; FACTOR MESSENGER-RNA; LEUCINE-RICH ALPHA-2-GLYCOPROTEIN; PLATELET GLYCOPROTEIN-IB; TYROSINE KINASE-ACTIVITY; AMINO-ACID SEQUENCE; MOLECULAR-CLONING; HIGH-AFFINITY; FACTOR FAMILY; PROTOONCOGENE PRODUCT	Members of the Trk tyrosine kinase family have recently been identified as functional receptors of the NGF family of neurotrophins. Here we show the rat trkC locus to be complex, encoding at least four distinct polypeptides. Three of the encoded polypeptides are full-length receptor tyrosine kinases that differ by novel amino acid insertions in the kinase domain. A fourth protein is a truncated receptor that lacks the catalytic domain. Tyrosine phosphorylation, cross-linking, and ligand binding assays indicate that TrkC receptors interact with NT-3 and not with the related neurotrophins NGF, BDNF, xNT-4, or hNT-5. Furthermore, high and low affinity NT-3-binding sites are associated with the TrkC receptors. Stable and transient expression of TrkC receptors in PC12 cells indicates that the neurite outgrowth response elicited by NT-3 is dramatic in receptors lacking the novel kinase insert (gp150trkC) but absent in receptors containing the 14 amino acid insert in the kinase domain (gp150trkC14). These data suggest that the trkC locus encodes receptors that may be capable of mediating different biological responses within the cell. This could have important implications in understanding the role of neurotrophins in the development of the vertebrate nervous system.	GENENTECH INC,S SAN FRANCISCO,CA 94080; UN AM,INST FISIOL CELULAR,MEXICO CITY 04510,DF,MEXICO	Roche Holding; Genentech	TSOULFAS, P (corresponding author), NCI,FREDERICK CANC RES & DEV CTR,MOLEC EMBRYOL SECT,ABL BASIC RES PROGRAM,FREDERICK,MD 21702, USA.		Parada, luis F/B-9400-2014; Tsoulfas, Pantelis/GNH-1922-2022	Tsoulfas, Pantelis/0000-0003-1974-6366	NCI NIH HHS [N01-CO-74101] Funding Source: Medline; OFFICE OF THE DIRECTOR, NCI [N01CO074101] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; BACKER JM, 1992, J CELL BIOL, V118, P831, DOI 10.1083/jcb.118.4.831; BARDE Y-A, 1990, Progress in Growth Factor Research, V2, P237, DOI 10.1016/0955-2235(90)90021-B; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BERKEMEIER LR, 1991, NEURON, V7, P857, DOI 10.1016/0896-6273(91)90287-A; BERND P, 1984, J BIOL CHEM, V259, P5509; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DAVIES AM, 1986, J NEUROSCI, V6, P1897; Ebendal T, 1989, Prog Growth Factor Res, V1, P143, DOI 10.1016/0955-2235(89)90008-2; ERNFORS P, 1990, P NATL ACAD SCI USA, V87, P5454, DOI 10.1073/pnas.87.14.5454; ESCANONYESCANDON E, 1993, IN PRESS J NEUROSCI; GOEDERT M, 1986, MOL BRAIN RES, V1, P85, DOI 10.1016/0169-328X(86)90023-9; GREEN SH, 1986, J CELL BIOL, V102, P830, DOI 10.1083/jcb.102.3.830; HALLBOOK F, 1991, NEURON, V6, P845, DOI 10.1016/0896-6273(91)90180-8; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hanks SK, 1991, CURR OPIN STRUC BIOL, V1, P369, DOI 10.1016/0959-440X(91)90035-R; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HENDERSON CE, 1993, IN PRESS NATURE; HICKEY MJ, 1989, P NATL ACAD SCI USA, V86, P6773, DOI 10.1073/pnas.86.17.6773; HOFER M, 1990, EMBO J, V9, P2459, DOI 10.1002/j.1460-2075.1990.tb07423.x; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; IP NY, 1992, P NATL ACAD SCI USA, V89, P3060, DOI 10.1073/pnas.89.7.3060; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; JONES KR, 1990, P NATL ACAD SCI USA, V87, P8060, DOI 10.1073/pnas.87.20.8060; KAISHO Y, 1990, FEBS LETT, V266, P187, DOI 10.1016/0014-5793(90)81536-W; KALCHEIM C, 1987, EMBO J, V6, P2871, DOI 10.1002/j.1460-2075.1987.tb02589.x; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KATAOKA T, 1985, CELL, V43, P493, DOI 10.1016/0092-8674(85)90179-5; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KLEIN R, 1989, EMBO J, V8, P3701, DOI 10.1002/j.1460-2075.1989.tb08545.x; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; KORSCHING S, 1985, EMBO J, V4, P1389, DOI 10.1002/j.1460-2075.1985.tb03791.x; KRANTZ DD, 1991, J BIOL CHEM, V266, P16801; KTISTAKIS NT, 1990, J CELL BIOL, V111, P1393, DOI 10.1083/jcb.111.4.1393; KUMA KI, 1991, P JAPAN ACAD, V10, P181; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; LANDRETH GE, 1980, P NATL ACAD SCI-BIOL, V77, P4751, DOI 10.1073/pnas.77.8.4751; LARGE TH, 1989, NEURON, V2, P1123, DOI 10.1016/0896-6273(89)90179-7; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; LEVIMONTALCINI R, 1987, EMBO J, V6, P1145, DOI 10.1002/j.1460-2075.1987.tb02347.x; LINDSAY RM, 1985, DEV BIOL, V112, P319, DOI 10.1016/0012-1606(85)90402-6; LOEB DM, 1991, CELL, V66, P961, DOI 10.1016/0092-8674(91)90441-Z; LOPEZ JA, 1987, P NATL ACAD SCI USA, V84, P5615, DOI 10.1073/pnas.84.16.5615; LOPEZ JA, 1988, P NATL ACAD SCI USA, V85, P2135, DOI 10.1073/pnas.85.7.2135; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; MARTINZANCA D, 1989, MOL CELL BIOL, V9, P24, DOI 10.1128/MCB.9.1.24; MARTINZANCA D, 1986, NATURE, V319, P743, DOI 10.1038/319743a0; MEAKIN SO, 1992, P NATL ACAD SCI USA, V89, P2374, DOI 10.1073/pnas.89.6.2374; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; MORRISON DK, 1989, CELL, V58, P649, DOI 10.1016/0092-8674(89)90100-1; MORRISON DK, 1988, MOL CELL BIOL, V8, P176, DOI 10.1128/MCB.8.1.176; NAKANISHI N, 1990, NEURON, V5, P569, DOI 10.1016/0896-6273(90)90212-X; OBRYAN JP, 1991, MOL CELL BIOL, V11, P5016, DOI 10.1128/MCB.11.10.5016; PHILLIPS HS, 1990, SCIENCE, V250, P290, DOI 10.1126/science.1688328; PULIDO D, 1992, EMBO J, V11, P391, DOI 10.1002/j.1460-2075.1992.tb05067.x; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; RODRIGEUZTEBAR A, 1988, J NEUROSCI, V8, P3337; RODRIGUEZTEBAR A, 1990, NEURON, V4, P487, DOI 10.1016/0896-6273(90)90107-Q; RODRIGUEZTEBAR A, 1992, EMBO J, V11, P917, DOI 10.1002/j.1460-2075.1992.tb05130.x; ROSENTHAL A, 1990, NEURON, V4, P767, DOI 10.1016/0896-6273(90)90203-R; ROTHBERG JM, 1990, GENE DEV, V4, P2169, DOI 10.1101/gad.4.12a.2169; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J, 1989, MOL CLONING LABORATO; SCHECHTER AL, 1981, CELL, V24, P867, DOI 10.1016/0092-8674(81)90112-4; SCHMELZER CH, 1992, J NEUROCHEM, V59, P1675, DOI 10.1111/j.1471-4159.1992.tb10998.x; SCHNEIDER DS, 1991, GENE DEV, V5, P797, DOI 10.1101/gad.5.5.797; SCHNEIDER DS, 1991, ONCOGENE, V6, P1807; SHELTON DL, 1986, P NATL ACAD SCI USA, V83, P2714, DOI 10.1073/pnas.83.8.2714; SONNENFELD KH, 1985, J NEUROSCI, V5, P1717; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; SUTTER A, 1979, J BIOL CHEM, V254, P5972; TAKAHASHI N, 1985, P NATL ACAD SCI USA, V82, P1906, DOI 10.1073/pnas.82.7.1906; TESSAROLLO L, 1992, DEVELOPMENT, V115, P11; TESSAROLLO L, 1993, IN PRESS DEVELOPMENT; THOENEN H, 1987, REV PHYSIOL BIOCH P, V109, P145, DOI 10.1007/BFb0031026; TITANI K, 1987, P NATL ACAD SCI USA, V84, P5610, DOI 10.1073/pnas.84.16.5610; UENO H, 1992, J BIOL CHEM, V267, P1470; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; WHITTEMORE SR, 1986, P NATL ACAD SCI USA, V83, P817, DOI 10.1073/pnas.83.3.817; WILKIE T M, 1991, Methods (Orlando), V2, P32, DOI 10.1016/S1046-2023(05)80123-9; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121	88	273	288	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1993	10	5					975	990		10.1016/0896-6273(93)90212-A	http://dx.doi.org/10.1016/0896-6273(93)90212-A			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LD322	8494648				2022-12-24	WOS:A1993LD32200019
J	GOLA, M; CREST, M				GOLA, M; CREST, M			COLOCALIZATION OF ACTIVE KCA CHANNELS AND CA2+ CHANNELS WITHIN CA2+ DOMAINS IN HELIX NEURONS	NEURON			English	Article							RAT HIPPOCAMPAL-NEURONS; GENERATING NERVE-CELLS; SQUID GIANT SYNAPSE; POTASSIUM CHANNELS; TRANSMITTER RELEASE; DENDRITIC SPINES; CALCIUM; CURRENTS; VOLTAGE; ACTIVATION	Large conductance Ca2+-activated K+ channels (KCa channels) have to be colocalized with Ca2+ channels to be involved in nerve cell firing regulation. KCa channels were detected in cell-attached patches performed in voltage-clamped Helix neurons. This technique allowed Ca2+ entry to occur either within or around the patch. We observed that the submembrane Ca2+ diffusion was sufficiently limited to prevent the KCa channels from being opened by remote Ca2+ entry. The KCa channels located i n areas devoid of Ca2+ channels remained quiescent during cell firing. These crypto channels were detected following either patch excision or intracellular Ca2+ injection. These data provide direct evidence for the existence of functional Ca2+ domains in a nonspecialized neural membrane.			GOLA, M (corresponding author), CNRS,NEUROBIOL LAB,31 CHEMIN JOSEPH AIGUIER,F-13402 MARSEILLE 9,FRANCE.							AUGUSTINE GJ, 1990, J PHYSIOL-LONDON, V431, P343, DOI 10.1113/jphysiol.1990.sp018333; CHAD JE, 1984, BIOPHYS J, V45, P993, DOI 10.1016/S0006-3495(84)84244-7; CHAGNEUX H, 1989, BRAIN RES, V488, P336, DOI 10.1016/0006-8993(89)90726-9; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; CREST M, 1990, BRAIN RES, V518, P299, DOI 10.1016/0006-8993(90)90986-L; CREST M, 1990, J EXP BIOL, V152, P211; CREST M, 1992, J BIOL CHEM, V267, P1640; CREST M, 1993, IN PRESS J PHYSL; FISCHMEISTER R, 1986, PFLUG ARCH EUR J PHY, V406, P73, DOI 10.1007/BF00582957; GOLA M, 1990, J PHYSIOL-LONDON, V420, P73, DOI 10.1113/jphysiol.1990.sp017902; GUTHRIE PB, 1991, NATURE, V354, P76, DOI 10.1038/354076a0; HERMANN A, 1987, J GEN PHYSIOL, V90, P27, DOI 10.1085/jgp.90.1.27; HEYER CB, 1976, J PHYSIOL-LONDON, V262, P349, DOI 10.1113/jphysiol.1976.sp011599; IKEMOTO Y, 1989, BIOPHYS J, V56, P2207; IMREDY JP, 1992, NEURON, V9, P197, DOI 10.1016/0896-6273(92)90159-B; KEIZER J, 1992, BIOPHYS J, V63, P291, DOI 10.1016/S0006-3495(92)81576-X; LANCASTER B, 1991, J NEUROSCI, V11, P23; LANCASTER B, 1987, J PHYSIOL-LONDON, V389, P187, DOI 10.1113/jphysiol.1987.sp016653; LANG DG, 1990, J PHYSIOL-LONDON, V425, P117, DOI 10.1113/jphysiol.1990.sp018095; LANG DG, 1987, PFLUG ARCH EUR J PHY, V410, P614, DOI 10.1007/BF00581321; LATORRE R, 1989, ANNU REV PHYSIOL, V51, P385, DOI 10.1146/annurev.ph.51.030189.002125; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; LLINAS R, 1981, BIOPHYS J, V33, P323, DOI 10.1016/S0006-3495(81)84899-0; LUX HD, 1982, PFLUG ARCH EUR J PHY, V394, P70, DOI 10.1007/BF01108310; MARKWARDT F, 1992, J GEN PHYSIOL, V99, P841, DOI 10.1085/jgp.99.6.841; MAZZANTI M, 1991, J PHYSIOL-LONDON, V443, P307, DOI 10.1113/jphysiol.1991.sp018835; MCMANUS OB, 1991, J BIOENERG BIOMEMBR, V23, P537, DOI 10.1007/BF00785810; MILTON RL, 1990, PFLUG ARCH EUR J PHY, V416, P758, DOI 10.1007/BF00370626; MULLER TH, 1989, J GEN PHYSIOL, V94, P997, DOI 10.1085/jgp.94.6.997; MULLER W, 1991, NATURE, V354, P73, DOI 10.1038/354073a0; PIN T, 1990, J EXP BIOL, V152, P189; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; ROBITAILLE R, 1990, NEURON, V5, P773, DOI 10.1016/0896-6273(90)90336-E; SHERMAN A, 1990, BIOPHYS J, V58, P985, DOI 10.1016/S0006-3495(90)82443-7; SIMON SM, 1985, BIOPHYS J, V48, P485, DOI 10.1016/S0006-3495(85)83804-2; THOMPSON S, 1988, J NEUROSCI, V8, P1929; VERITY MA, 1992, NEUROTOXICOLOGY, V13, P139; WOOLUM JC, 1981, BIOPHYS J, V36, P297, DOI 10.1016/S0006-3495(81)84729-7; YOSHIDA A, 1991, JPN J PHYSIOL, V41, P297, DOI 10.2170/jjphysiol.41.297	39	90	91	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1993	10	4					689	699		10.1016/0896-6273(93)90170-V	http://dx.doi.org/10.1016/0896-6273(93)90170-V			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KY501	8386529				2022-12-24	WOS:A1993KY50100012
J	NEHER, E; ZUCKER, RS				NEHER, E; ZUCKER, RS			MULTIPLE CALCIUM-DEPENDENT PROCESSES RELATED TO SECRETION IN BOVINE CHROMAFFIN CELLS	NEURON			English	Article							ADRENAL-MEDULLARY CELLS; FLUORESCENT INDICATOR; EXOCYTOSIS; RELEASE; FURA-2	We have used the caged calcium compound DM-nitrophen to investigate the kinetics of calcium-dependent secretion in bovine chromaffin cells. Perfusion with partially calcium-loaded nitrophen often caused a loading transient-slow secretion for up to 1 min due to displacement of Ca2+ by cytoplasmic Mg2+. Flash photolysis elicited 100 muM [Ca2+]i steps that evoked intense secretion, lasting a few seconds. In cells experiencing a loading transient, [Ca2+]i steps evoked an especially fast secretion. A persistent, slow secretion often followed these fast phases. Distinct kinetic components may reflect secretion from pools that are differentially capable of release. Both secretion and movement of vesicles between pools appear to be [Ca2+]i sensitive. Later [Ca2+]i steps sometimes evoked a rapid capacitance decrease, indicating a fast, [Ca2+]i-dependent phase of endocytosis.	UNIV CALIF BERKELEY, DEPT MOLEC & CELL BIOL, BERKELEY, CA 94720 USA	University of California System; University of California Berkeley	NEHER, E (corresponding author), MAX PLANCK INST BIOPHYS CHEM, DEPT MEMBRANE BIOPHYS, W-3400 GOTTINGEN, GERMANY.		Neher, Erwin/A-2109-2013; Zucker, Robert S/J-9995-2012	Zucker, Robert S/0000-0003-1068-2343				AUGUSTINE GJ, 1992, J PHYSIOL-LONDON, V450, P247, DOI 10.1113/jphysiol.1992.sp019126; AUNIS D, 1988, J EXP BIOL, V139, P253; BAKER PF, 1986, BRIT MED BULL, V42, P399, DOI 10.1093/oxfordjournals.bmb.a072158; BECKER PL, 1987, AM J PHYSIOL, V253, pC613, DOI 10.1152/ajpcell.1987.253.4.C613; BITTNER MA, 1992, J BIOL CHEM, V267, P16219; BURGOYNE RD, 1991, BIOCHIM BIOPHYS ACTA, V1071, P174, DOI 10.1016/0304-4157(91)90024-Q; CHEEK TR, 1989, J CELL BIOL, V109, P1219, DOI 10.1083/jcb.109.3.1219; DELANEY KR, 1990, J PHYSIOL-LONDON, V426, P473, DOI 10.1113/jphysiol.1990.sp018150; DOUGLAS WW, 1968, BRIT J PHARMACOL, V34, P451, DOI 10.1111/j.1476-5381.1968.tb08474.x; DRUST DS, 1988, NATURE, V331, P88, DOI 10.1038/331088a0; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; KAPLAN JH, 1990, ANNU REV PHYSIOL, V52, P897; KAPLAN JH, 1988, P NATL ACAD SCI USA, V85, P6571, DOI 10.1073/pnas.85.17.6571; Katz B., 1969, RELEASE NEURAL TRANS; KNIGHT DE, 1982, J MEMBRANE BIOL, V68, P107, DOI 10.1007/BF01872259; KNIGHT DE, 1989, TRENDS NEUROSCI, V12, P451, DOI 10.1016/0166-2236(89)90095-7; KNIGHT DE, 1983, PROC R SOC SER B-BIO, V218, P177, DOI 10.1098/rspb.1983.0033; KONISHI M, 1991, J GEN PHYSIOL, V97, P271, DOI 10.1085/jgp.97.2.271; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; MARTY A, 1985, J PHYSIOL-LONDON, V367, P117, DOI 10.1113/jphysiol.1985.sp015817; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; NEHER E, 1989, NEUROMUSCULAR JUNCTI, P65; RAJU B, 1989, AM J PHYSIOL, V256, pC540, DOI 10.1152/ajpcell.1989.256.3.C540; ROE MW, 1990, CELL CALCIUM, V11, P63, DOI 10.1016/0143-4160(90)90060-8; ZUCKER RS, 1992, CELL CALCIUM, V13, P29, DOI 10.1016/0143-4160(92)90027-P; ZUCKER RS, 1991, ANN NY ACAD SCI, V635, P191, DOI 10.1111/j.1749-6632.1991.tb36492.x; ZUCKER RS, 1993, IN PRESS CELL CALCIU	28	472	475	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1993	10	1					21	30		10.1016/0896-6273(93)90238-M	http://dx.doi.org/10.1016/0896-6273(93)90238-M			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KK012	8427700				2022-12-24	WOS:A1993KK01200003
J	Spana, EP; Doe, CQ				Spana, EP; Doe, CQ			Numb antagonizes notch signaling to specify sibling neuron cell fates	NEURON			English	Article							NERVOUS-SYSTEM; DROSOPHILA; GENE; PROTEIN; DELTA; SUPPRESSOR; EXPRESSION; HAIRLESS	Asymmetric cell divisions play a key role in establishing neuronal diversity in the mammalian and Drosophila CNS, but the mechanisms involved are mostly unknown. The Drosophila MP2 precursor divides asymmetrically to generate the dMP2/vMP2 interneurons. Delta-Notch signaling is required to specify vMP2 fate, whereas the localized determinant Numb is segregated into dMP2 and is required to specify dMP2 fate. Notch; numb double mutants have two dMP2 neurons; hence, Numb is not required for dMP2 fate, but antagonizes the Delta-Notch ''vMP2'' signal. In vivo Delta expression and in vitro culture experiments show that vMP2 fate is specified by an ''inductive'' signal from outside the MP2 lineage. Thus, intrinsic and extrinsic cues converge to specify binary cell fates in the MP2 cell lineage.			Spana, EP (corresponding author), UNIV ILLINOIS,DEPT CELL & STRUCT BIOL,HOWARD HUGHES MED INST,URBANA,IL 61801, USA.							ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Axelrod JD, 1996, SCIENCE, V271, P1826, DOI 10.1126/science.271.5257.1826; BATE CM, 1981, J EMBRYOL EXP MORPH, V61, P317; BORK P, 1995, CELL, V80, P693, DOI 10.1016/0092-8674(95)90347-X; Campos-Ortega Jose A., 1993, P1091; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; DOE CQ, 1992, DEVELOPMENT, V116, P855; ETEMADMOGHADAM B, 1995, CELL, V83, P743, DOI 10.1016/0092-8674(95)90187-6; FEHON RG, 1990, CELL, V61, P523, DOI 10.1016/0092-8674(90)90534-L; FORTINI ME, 1994, CELL, V79, P273, DOI 10.1016/0092-8674(94)90196-1; GREENWALD I, 1989, TRENDS GENET, V5, P237, DOI 10.1016/0168-9525(89)90094-2; GRIMWADE BG, 1985, DEV BIOL, V107, P503, DOI 10.1016/0012-1606(85)90331-8; GUO M, 1995, NEURON, V14, P913, DOI 10.1016/0896-6273(95)90330-5; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; HARTENSTEIN V, 1990, DEV BIOL, V142, P13, DOI 10.1016/0012-1606(90)90147-B; HIRATA J, 1995, NATURE, V377, P627, DOI 10.1038/377627a0; JAN YN, 1995, NEURON, V14, P1; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; KOOH PJ, 1993, DEVELOPMENT, V117, P493; KUWADA JY, 1985, DEV BIOL, V110, P114, DOI 10.1016/0012-1606(85)90069-7; MATSUNO K, 1995, DEVELOPMENT, V121, P2633; MENNE TV, 1994, DEVELOPMENT, V120, P123; PARKS AL, 1993, DEV BIOL, V157, P484, DOI 10.1006/dbio.1993.1151; PERRIMON N, 1994, CELL, V76, P781, DOI 10.1016/0092-8674(94)90351-4; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; SCHWEISGUTH F, 1992, CELL, V69, P1199, DOI 10.1016/0092-8674(92)90641-O; SEECOF RL, 1971, EXP CELL RES, V69, P161, DOI 10.1016/0014-4827(71)90321-1; SKEATH JB, 1992, DEVELOPMENT, V114, P939; SKEATH JB, 1994, FASEB J, V8, P714, DOI 10.1096/fasebj.8.10.8050670; SPANA EP, 1995, DEVELOPMENT, V121, P3187; SPANA EP, 1995, DEVELOPMENT, V121, P3489; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X; UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0	33	351	359	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1996	17	1					21	26		10.1016/S0896-6273(00)80277-9	http://dx.doi.org/10.1016/S0896-6273(00)80277-9			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UY981	8755475	Bronze			2022-12-24	WOS:A1996UY98100004
J	Miles, R; Toth, K; Gulyas, AI; Hajos, N; Freund, TF				Miles, R; Toth, K; Gulyas, AI; Hajos, N; Freund, TF			Differences between somatic and dendritic inhibition in the hippocampus	NEURON			English	Article							PYRAMIDAL CELLS; RAT HIPPOCAMPUS; DENTATE GYRUS; RECEPTOR; NEURONS; SYNAPSES; INVITRO; INTERNEURONS; BRAIN	Hippocampal synaptic inhibition is mediated by distinct groups of inhibitory cells. Some contact pyramidal cells perisomatically, while others terminate exclusively on their dendrites. We examined perisomatic and dendritic inhibition by recording from CA3 inhibitory and pyramidal cells and injecting biocytin to visualize both cells in light and electron microscopy. Single perisomatic inhibitory cells made 2-6 terminals clustered around the soma and proximal pyramidal cell processes. Dendritic cells established 5-17 terminals, usually on different dendrites of a pyramidal cell. Perisomatic terminals were larger than those facing dendritic membrane. Perisomatic inhibitory cells initiated the majority of simultaneous IPSPs seen in nearby pyramidal cells. Single IPSPs initiated by perisomatic inhibitory cells could suppress repetitive discharge of sodium-dependent action potentials. Activation of inhibitory fibers terminating on dendrites could suppress calcium-dependent spikes. Thus, distinct inhibitory cells may differentially control dendritic electrogenesis and axonal output of hippocampal pyramidal cells.	HUNGARIAN ACAD SCI,INST EXPTL MED,H-1450 BUDAPEST,HUNGARY	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine	Miles, R (corresponding author), INST PASTEUR,LAB NEUROBIOL CELLULAIRE,25 RUE DR ROUX,F-75724 PARIS,FRANCE.		Hajos, Norbert/U-2640-2019	Hajos, Norbert/0000-0002-4582-2708; Miles, Richard/0000-0001-7303-0233; Gulyas, Attila/0000-0003-4961-636X				ALGER BE, 1982, J PHYSIOL-LONDON, V328, P105, DOI 10.1113/jphysiol.1982.sp014255; ATWOOD HL, 1983, CELL TISSUE RES, V231, P103; BAUDE A, 1993, NEURON, V11, P771, DOI 10.1016/0896-6273(93)90086-7; BLACKSTAD TW, 1963, NATURE, V198, P542, DOI 10.1038/198542a0; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Cajal S. R., 1911, HISTOLOGIE SYSTEME N; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; ECCLES JC, 1969, INHIBITORY PATHWAYS, P101; FREUND TF, 1990, P NATL ACAD SCI USA, V87, P8501, DOI 10.1073/pnas.87.21.8501; FREUND TF, 1988, NATURE, V336, P170, DOI 10.1038/336170a0; GULYAS AI, 1993, EUR J NEUROSCI, V5, P1729, DOI 10.1111/j.1460-9568.1993.tb00240.x; HAN ZS, 1993, EUR J NEUROSCI, V5, P395, DOI 10.1111/j.1460-9568.1993.tb00507.x; HILL JA, 1993, J NEUROSCI, V13, P1551; KULLMANN DM, 1992, NEURON, V9, P1175, DOI 10.1016/0896-6273(92)90075-O; LAMBERT NA, 1993, NEURON, V11, P1057, DOI 10.1016/0896-6273(93)90219-H; LLINAS R, 1971, J NEUROPHYSIOL, V34, P352; MACCAFERRI G, 1995, NEURON, V15, P137, DOI 10.1016/0896-6273(95)90071-3; MAGEE JC, 1995, SCIENCE, V268, P301, DOI 10.1126/science.7716525; MICHELSON H, 1991, SCIENCE, V258, P1420; MILES R, 1990, J PHYSIOL-LONDON, V428, P61, DOI 10.1113/jphysiol.1990.sp018200; MILES R, 1990, J PHYSIOL-LONDON, V431, P659, DOI 10.1113/jphysiol.1990.sp018353; MITGAARD J, 1992, J PHYSL, V457, P355; MULLER W, 1990, J NEUROPHYSIOL, V64, P46, DOI 10.1152/jn.1990.64.1.46; NICOLL RA, 1994, NATURE, V368, P808, DOI 10.1038/368808a0; PEARCE RA, 1993, NEURON, V10, P189, DOI 10.1016/0896-6273(93)90310-N; PIERCE JP, 1994, NEUROSCIENCE, V58, P441, DOI 10.1016/0306-4522(94)90071-X; RALL W, 1967, J NEUROPHYSIOL, V30, P1138, DOI 10.1152/jn.1967.30.5.1138; SOLTESZ I, 1995, NEURON, V14, P1273, DOI 10.1016/0896-6273(95)90274-0; SOMOGYI P, 1983, BRAIN RES, V259, P137, DOI 10.1016/0006-8993(83)91076-4; SPENCER WA, 1961, J NEUROPHYSIOL, V24, P272, DOI 10.1152/jn.1961.24.3.272; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; STALEY KJ, 1992, J NEUROPHYSIOL, V68, P197, DOI 10.1152/jn.1992.68.1.197; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; TECOTT LH, 1993, P NATL ACAD SCI USA, V90, P1430, DOI 10.1073/pnas.90.4.1430; WIGSTROM H, 1983, NATURE, V301, P603, DOI 10.1038/301603a0; WISDEN W, 1992, J NEUROSCI, V12, P1040; WONG RKS, 1979, P NATL ACAD SCI USA, V76, P986, DOI 10.1073/pnas.76.2.986; WONG RKS, 1981, J NEUROPHYSIOL, V45, P86, DOI 10.1152/jn.1981.45.1.86	39	732	741	1	20	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1996	16	4					815	823		10.1016/S0896-6273(00)80101-4	http://dx.doi.org/10.1016/S0896-6273(00)80101-4			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UG611	8607999	Bronze			2022-12-24	WOS:A1996UG61100014
J	GUO, M; BIER, E; JAN, LY; JAN, YN				GUO, M; BIER, E; JAN, LY; JAN, YN			TRAMTRACK ACTS DOWNSTREAM OF NUMB TO SPECIFY DISTINCT DAUGHTER CELL FATES DURING ASYMMETRIC CELL DIVISIONS IN THE DROSOPHILA PNS	NEURON			English	Article							SITE-SPECIFIC RECOMBINATION; PERIPHERAL NERVOUS-SYSTEM; ORGAN FORMATION; SENSILLUM DEVELOPMENT; FUSHI-TARAZU; GENE; EXPRESSION; PATTERN; PROTEIN; EMBRYOS	Asymmetric eel divisions allow a sensory organ precursor (SOP) cell to generate a neuron and its support cells in the Drosophila PNS. We demonstrate a role of tramtrack (ttk), previously identified as a zinc finger-containing putative transcription factor, in the determination of different daughter cell fates. Both loss of function and overexpression of ttk affect the fates of the SOP progeny. Whereas loss of ttk function transforms support cells to neurons, ttk overexpression results in the reverse transformation. ttk is expressed in support cells but not in neurons. It has been shown that numb, a membrane-associated protein asymmetrically distributed during the SOP division, confers different daughter cell fates. Loss of ttk or numb function results in reciprocal cell fate transformation. Epistatic studies suggest that ttk acts downstream of numb. We propose that ttk executes the command dictated by asymmetrically localized numb to specify distinct daughter cell fates during multiple asymmetric divisions.	UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,DEPT BIOCHEM,SAN FRANCISCO,CA 94143; UNIV CALIF SAN DIEGO,DEPT BIOL,LA JOLLA,CA 92093; UNIV CALIF SAN DIEGO,CTR MOLEC GENET,LA JOLLA,CA 92093	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Diego; University of California System; University of California San Diego	GUO, M (corresponding author), UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,DEPT PHYSIOL,SAN FRANCISCO,CA 94143, USA.			Jan, Yuh Nung/0000-0003-1367-6299; Jan, Lily/0000-0003-3938-8498				ASHBURNER M, 1982, GENETICS, V101, P447; ASHBURNER M, 1989, DROSOPHILA LABORATOR; BANG AG, 1991, DEVELOPMENT, V111, P89; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; BATE CM, 1978, HDB SENSORY PHYSL, P1; BIER E, 1989, GENE DEV, V3, P1273, DOI 10.1101/gad.3.9.1273; BIER E, 1988, SCIENCE, V240, P913, DOI 10.1126/science.3129785; BIGGS J, 1988, GENE DEV, V2, P1333, DOI 10.1101/gad.2.10.1333; BLOCHLINGER K, 1990, GENE DEV, V4, P1322, DOI 10.1101/gad.4.8.1322; BODMER R, 1987, ROUX ARCH DEV BIOL, V196, P69, DOI 10.1007/BF00402027; BODMER R, 1989, NEURON, V3, P21, DOI 10.1016/0896-6273(89)90112-8; BRAND M, 1993, DEVELOPMENT, V119, P1; BROU C, 1994, GENE DEV, V8, P2491, DOI 10.1101/gad.8.20.2491; BROWN JL, 1991, EMBO J, V10, P665, DOI 10.1002/j.1460-2075.1991.tb07995.x; BROWN JL, 1993, DEVELOPMENT, V113, P45; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; FORTINI ME, 1994, CELL, V79, P273, DOI 10.1016/0092-8674(94)90196-1; GHYSEN A, 1986, ROUX ARCH DEV BIOL, V195, P281, DOI 10.1007/BF00376060; GODT D, 1993, DEVELOPMENT, V119, P799; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; GOLIC KG, 1991, SCIENCE, V252, P958, DOI 10.1126/science.2035025; HARRISON SD, 1990, EMBO J, V9, P207, DOI 10.1002/j.1460-2075.1990.tb08097.x; HARTENSTEIN V, 1990, DEV BIOL, V142, P13, DOI 10.1016/0012-1606(90)90147-B; HARTENSTEIN V, 1990, DEV BIOL, V138, P147, DOI 10.1016/0012-1606(90)90184-K; HARTENSTEIN V, 1989, DEVELOPMENT, V107, P389; HORVITZ HR, 1992, CELL, V68, P237, DOI 10.1016/0092-8674(92)90468-R; JAN YN, 1990, TRENDS NEUROSCI, V13, P493, DOI 10.1016/0166-2236(90)90083-M; JAN YN, 1995, NEURON, V14, P1; JAN YN, 1994, ANNU REV GENET, V28, P373, DOI 10.1146/annurev.ge.28.120194.002105; JARMAN AP, 1993, CELL, V73, P1307, DOI 10.1016/0092-8674(93)90358-W; Lees AD, 1942, PROC R SOC SER B-BIO, V131, P87, DOI 10.1098/rspb.1942.0019; NAKAMURA M, 1994, NEURON, V13, P67, DOI 10.1016/0896-6273(94)90460-X; PARKS AL, 1993, DEV BIOL, V157, P484, DOI 10.1006/dbio.1993.1151; POSAKONY JW, 1994, CELL, V76, P415, DOI 10.1016/0092-8674(94)90105-8; READ D, 1992, MECH DEVELOP, V38, P183, DOI 10.1016/0925-4773(92)90052-L; READ D, 1992, EMBO J, V11, P1035, DOI 10.1002/j.1460-2075.1992.tb05142.x; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; SALZBERG A, 1994, NEURON, V13, P269, DOI 10.1016/0896-6273(94)90346-8; SCHWEISGUTH F, 1994, DEVELOPMENT, V120, P1433; SHIOMI K, 1994, DEVELOPMENT, V120, P1591; UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0; UEMURA T, 1993, GENE DEV, V7, P429, DOI 10.1101/gad.7.3.429; VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8; XIONG WC, 1993, GENE DEV, V7, P1085, DOI 10.1101/gad.7.6.1085; ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2	45	99	100	0	1	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1995	14	5					913	925		10.1016/0896-6273(95)90330-5	http://dx.doi.org/10.1016/0896-6273(95)90330-5			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QY935	7748559	Bronze			2022-12-24	WOS:A1995QY93500004
J	TAMADA, A; SHIRASAKI, R; MURAKAMI, F				TAMADA, A; SHIRASAKI, R; MURAKAMI, F			FLOOR PLATE CHEMOATTRACTS CROSSED AXONS AND CHEMOREPELS UNCROSSED AXONS IN THE VERTEBRATE BRAIN	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; CHICK-EMBRYO HINDBRAIN; SPINAL-CORD; ZEBRAFISH EMBRYO; GROWTH CONES; NEURONAL DIFFERENTIATION; PRECEREBELLAR NUCLEI; PRENATAL DEVELOPMENT; MIGRATORY PATHWAYS; CEREBELLAR SYSTEM	In the bilaterally symmetrical vertebrate CNS, all developing axons must choose between remaining on the same side of the midline or growing across it. The mechanism underlying this axonal pathfinding is, however, poorly understood. Here we demonstrate that the ventral midline floor plate (FP) chemorepels two types of ipsilaterally projecting axons, one from the alar plate and another from the basal plate in the mesencephalon. We further demonstrate that the FP chemoattracts contralaterally projecting myelencephalic as well as metencephalic axons. The FP at all axial levels displayed both chemoattractive and chemorepellent activities, suggesting that FP chemoattraction and chemorepulsion may be at work throughout the neuraxis. Chemotropic guidance by the FP may therefore play a key role in the establishment of neuronal projection laterality.	OSAKA UNIV, FAC ENGN SCI, DEPT BIOPHYS ENGN, TOYONAKA, OSAKA 560, JAPAN	Osaka University				Murakami, Fujio/0000-0002-1519-5096; Tamada, Atsushi/0000-0003-3677-6102				ALTMAN J, 1987, J COMP NEUROL, V257, P477, DOI 10.1002/cne.902570402; ALTMAN J, 1985, J COMP NEUROL, V231, P1, DOI 10.1002/cne.902310103; ALTMAN J, 1981, J COMP NEUROL, V198, P677, DOI 10.1002/cne.901980409; ALTMAN J, 1978, J COMP NEUROL, V179, P23, DOI 10.1002/cne.901790104; ALTMAN J, 1985, J COMP NEUROL, V231, P27, DOI 10.1002/cne.902310104; ALTMAN J, 1978, J COMP NEUROL, V179, P49, DOI 10.1002/cne.901790105; BERNHARDT RR, 1992, J COMP NEUROL, V326, P263, DOI 10.1002/cne.903260208; BERNHARDT RR, 1992, NEURON, V8, P869, DOI 10.1016/0896-6273(92)90201-N; BOURRAT F, 1990, J COMP NEUROL, V294, P1, DOI 10.1002/cne.902940102; BOURRAT F, 1988, DEV BRAIN RES, V39, P19, DOI 10.1016/0165-3806(88)90064-8; BOVOLENTA P, 1990, DEVELOPMENT, V109, P435; BOVOLENTA P, 1991, DEVELOPMENT, V113, P625; CHANG S, 1994, J NEUROBIOL, V25, P395, DOI 10.1002/neu.480250405; CHANG S, 1992, DEVELOPMENT, V114, P815; CHEDOTAL A, 1995, EUR J NEUROSCI, V7, P198, DOI 10.1111/j.1460-9568.1995.tb01056.x; CHOLLEY B, 1989, DEV BRAIN RES, V45, P185, DOI 10.1016/0165-3806(89)90038-2; CLARKE JDW, 1993, DEVELOPMENT, V118, P151; EASTER SS, 1993, J NEUROSCI, V13, P285; EBENDAL T, 1977, EXP CELL RES, V105, P379, DOI 10.1016/0014-4827(77)90135-5; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; FIGDOR MC, 1993, NATURE, V363, P630, DOI 10.1038/363630a0; FITZGERALD M, 1993, DEVELOPMENT, V117, P1377; GLOVER JC, 1991, J NEUROBIOL, V22, P353, DOI 10.1002/neu.480220405; GODEMENT P, 1987, DEVELOPMENT, V101, P697; GUTHRIE S, 1992, DEVELOPMENT, V114, P663; HANNEMAN E, 1988, DEVELOPMENT, V103, P49; HATTA K, 1994, P NATL ACAD SCI USA, V91, P2061, DOI 10.1073/pnas.91.6.2061; HATTA K, 1992, NEURON, V9, P629, DOI 10.1016/0896-6273(92)90027-B; HATTA K, 1991, NATURE, V350, P339, DOI 10.1038/350339a0; HOLLEY JA, 1987, DEV BIOL, V123, P375, DOI 10.1016/0012-1606(87)90396-4; HONIG MG, 1989, TRENDS NEUROSCI, V12, P333, DOI 10.1016/0166-2236(89)90040-4; HYNES M, 1995, CELL, V80, P95, DOI 10.1016/0092-8674(95)90454-9; KANDLER K, 1993, J COMP NEUROL, V328, P161, DOI 10.1002/cne.903280202; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; KIMMEL CB, 1993, ANNU REV NEUROSCI, V16, P707, DOI 10.1146/annurev.ne.16.030193.003423; Kingsbury BF, 1930, J COMP NEUROL, V50, P177, DOI 10.1002/cne.900500109; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; KROGER S, 1990, J NEUROSCI, V10, P3118; KUWADA JY, 1990, J NEUROSCI, V10, P1299; LUMSDEN A, 1989, NATURE, V337, P424, DOI 10.1038/337424a0; LUMSDEN AGS, 1986, NATURE, V323, P538, DOI 10.1038/323538a0; LUMSDEN AGS, 1983, NATURE, V306, P786, DOI 10.1038/306786a0; MACDONALD R, 1994, NEURON, V13, P1039, DOI 10.1016/0896-6273(94)90044-2; METCALFE WK, 1986, J COMP NEUROL, V251, P147, DOI 10.1002/cne.902510202; PINI A, 1993, SCIENCE, V261, P95, DOI 10.1126/science.8316861; PLACZEK M, 1990, DEVELOPMENT, V110, P19; PLACZEK M, 1990, COLD SPRING HARB SYM, V55, P279; PUELLES L, 1987, J COMP NEUROL, V266, P247, DOI 10.1002/cne.902660210; PUELLES L, 1978, ANAT EMBRYOL, V152, P205, DOI 10.1007/BF00315925; PUELLES L, 1977, ANAT EMBRYOL, V150, P187, DOI 10.1007/BF00316650; PUELLES L, 1993, TRENDS NEUROSCI, V16, P472, DOI 10.1016/0166-2236(93)90080-6; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; ROELINK H, 1994, CELL, V76, P761, DOI 10.1016/0092-8674(94)90514-2; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; SHEPHERD IT, 1995, J COMP NEUROL, V354, P501, DOI 10.1002/cne.903540403; SHIRASAKI R, 1995, NEURON, V14, P961, DOI 10.1016/0896-6273(95)90334-8; SPECHT LA, 1981, J COMP NEUROL, V199, P233, DOI 10.1002/cne.901990207; STAINIER DYR, 1991, J COMP NEUROL, V311, P300, DOI 10.1002/cne.903110210; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; TREVARROW B, 1990, NEURON, V4, P669, DOI 10.1016/0896-6273(90)90194-K; WASSEF M, 1992, J COMP NEUROL, V323, P519, DOI 10.1002/cne.903230405; YAGINUMA H, 1991, J COMP NEUROL, V304, P78, DOI 10.1002/cne.903040107; YAGINUMA H, 1991, J NEUROSCI, V11, P2598	63	70	71	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	1995	14	5					1083	1093		10.1016/0896-6273(95)90347-X	http://dx.doi.org/10.1016/0896-6273(95)90347-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QY935	7748556	Bronze			2022-12-24	WOS:A1995QY93500021
J	HIGAKI, J; QUON, D; ZHONG, ZY; CORDELL, B				HIGAKI, J; QUON, D; ZHONG, ZY; CORDELL, B			INHIBITION OF BETA-AMYLOID FORMATION IDENTIFIES PROTEOLYTIC PRECURSORS AND SUBCELLULAR SITE OF CATABOLISM	NEURON			English	Article							PROTEIN-KINASE-C; PEPTIDE; CELLS; CLEAVAGE; SECRETION; FRAGMENTS; DEGRADATION; COMPARTMENT; DERIVATIVES; ACTIVATION	Cerebral deposition of beta-amyloid protein isa pathological feature central to Alzheimer's disease. Production of beta-amyloid by proteolytic processing of the beta-amyloid precursor protein (beta APP) is a critical initial step in beta-amyloidogenesis. We use an inhibitor of beta APP processing to block beta-amyloid peptide formation. Application of the inhibitor to cultured cells results in an accumulation of proteolytic intermediates of beta APP, enabling a precursor-product relationship between beta APP carboxy-terminal fragments and beta-amyloid peptides to be demonstrated directly. In the presence of inhibitor, these amyloidogenic carboxy-terminal fragments can be degraded to nonamyloidogenic products. The catabolism of beta APP carboxy-terminal intermediates and the formation of beta-amyloid peptides ate likely to involve an early endosomal compartment as the subcellular site of processing.			HIGAKI, J (corresponding author), SCIOS NOVA INC,2450 BAYSHORE PKWY,MT VIEW,CA 94043, USA.							ANDERSON JP, 1991, NEUROSCI LETT, V128, P126, DOI 10.1016/0304-3940(91)90775-O; BUSCIGLIO J, 1993, P NATL ACAD SCI USA, V90, P2092, DOI 10.1073/pnas.90.5.2092; BUXBAUM JD, 1993, P NATL ACAD SCI USA, V90, P9195, DOI 10.1073/pnas.90.19.9195; CAPORASO GL, 1992, P NATL ACAD SCI USA, V89, P2252, DOI 10.1073/pnas.89.6.2252; CATALDO AM, 1990, P NATL ACAD SCI USA, V87, P3861, DOI 10.1073/pnas.87.10.3861; DESTROOPER B, 1993, J CELL BIOL, V121, P295, DOI 10.1083/jcb.121.2.295; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; ESTUS S, 1992, SCIENCE, V255, P726, DOI 10.1126/science.1738846; GABUZDA D, 1991, J ACQ IMMUN DEF SYND, V4, P34; GABUZDA D, 1993, J NEUROCHEM, V61, P2326, DOI 10.1111/j.1471-4159.1993.tb07479.x; GOLDE TE, 1992, SCIENCE, V255, P728, DOI 10.1126/science.1738847; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HAASS C, 1993, J BIOL CHEM, V268, P3021; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; HAYASHI Y, 1992, BIOCHEM BIOPH RES CO, V187, P1249, DOI 10.1016/0006-291X(92)90437-P; HUNG AY, 1993, J BIOL CHEM, V268, P22959; KUENTZEL SL, 1993, BIOCHEM J, V295, P367, DOI 10.1042/bj2950367; LEAVITT J, 1984, MOL CELL BIOL, V4, P1961, DOI 10.1128/MCB.4.10.1961; LIPPINCOTTSCHWA.J, 1988, CELL, V54, P209; MEHDI S, 1988, BIOCHEM BIOPH RES CO, V157, P1117, DOI 10.1016/S0006-291X(88)80989-6; MEHDI S, 1991, TRENDS BIOCHEM SCI, V16, P150, DOI 10.1016/0968-0004(91)90058-4; SAMBAMURTI K, 1992, J NEUROSCI RES, V33, P319, DOI 10.1002/jnr.490330216; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; SEUBERT P, 1993, NATURE, V361, P260, DOI 10.1038/361260a0; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; SIMAN R, 1993, J BIOL CHEM, V268, P16602; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; ZHONG ZY, 1994, J BIOL CHEM, V269, P627	28	160	181	1	8	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1995	14	3					651	659		10.1016/0896-6273(95)90322-4	http://dx.doi.org/10.1016/0896-6273(95)90322-4			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QP230	7695912	Bronze			2022-12-24	WOS:A1995QP23000019
J	MULHARDT, C; FISCHER, M; GASS, P; SIMONCHAZOTTES, D; GUENET, JL; KUHSE, J; BETZ, H; BECKER, CM				MULHARDT, C; FISCHER, M; GASS, P; SIMONCHAZOTTES, D; GUENET, JL; KUHSE, J; BETZ, H; BECKER, CM			THE SPASTIC MOUSE - ABERRANT SPLICING OF GLYCINE RECEPTOR-BETA SUBUNIT MESSENGER-RNA CAUSED BY INTRONIC INSERTION OF L1 ELEMENT	NEURON			English	Article							RAT SPINAL-CORD; MESSENGER-RNA; MUTANT MOUSE; EXPRESSION; CHANNELS; CLONING; BRAIN; MICE; GENE; DNA	Mice homozygous for the spastic mutation (spa) suffer from a complex motor disorder resulting from reduced CNS levels of the adult glycine receptor isoform GlyR(A), which is composed of ligand-binding al and structural beta polypeptides. The beta subunit-encoding gene (Glyrb) was mapped near the spa locus on mouse chromosome 3. in spa/spa mice, aberrant splicing of the beta subunit pre-mRNA strikingly diminishes the CNS contents of full-length transcripts, whereas truncated beta subunit mRNAs accumulate. This is a result of exon skipping, which causes translational frameshifts and premature stop codons. Intron 5 of the spa Glyrb gene contains an L1 transposable element that apparently is causal for the aberrant splicing of beta subunit transcripts.	UNIV HEIDELBERG,NEUROL KLIN,D-69120 HEIDELBERG,GERMANY; MAX PLANCK INST HIRNFORSCH,D-60528 FRANKFURT,GERMANY; INST PASTEUR,UNITE GENET MAMMIFERES,F-75724 PARIS,FRANCE	Ruprecht Karls University Heidelberg; Max Planck Society; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	MULHARDT, C (corresponding author), UNIV HEIDELBERG,ZENTRUM MOLEK BIOL,D-69120 HEIDELBERG,GERMANY.		Kuhse, Jochen/T-3864-2019					ADEY NB, 1994, P NATL ACAD SCI USA, V91, P1569, DOI 10.1073/pnas.91.4.1569; ADEY NB, 1991, NUCLEIC ACIDS RES, V11, P2497; BECKER CM, 1992, NEURON, V8, P283, DOI 10.1016/0896-6273(92)90295-O; BECKER CM, 1988, EMBO J, V7, P3717, DOI 10.1002/j.1460-2075.1988.tb03255.x; BECKER CM, 1990, FASEB J, V4, P2767, DOI 10.1096/fasebj.4.10.2165011; BECKER CM, 1986, J NEUROSCI, V6, P1358; BECKER CM, 1992, HDB EXPT PHARM, P539; BETZ H, 1992, Q REV BIOPHYS, V25, P381, DOI 10.1017/S0033583500004340; BISCOE TJ, 1986, J PHYSIOL-LONDON, V379, P275, DOI 10.1113/jphysiol.1986.sp016253; BORMANN J, 1993, EMBO J, V12, P3729, DOI 10.1002/j.1460-2075.1993.tb06050.x; CHAI CK, 1961, J HERED, V52, P241, DOI 10.1093/oxfordjournals.jhered.a107083; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; EICHER EM, 1980, J HERED, V71, P315, DOI 10.1093/oxfordjournals.jhered.a109378; Finnegan DJ, 1992, CURR OPIN GENET DEV, V2, P861, DOI 10.1016/S0959-437X(05)80108-X; FUJITA M, 1991, BRAIN RES, V560, P23, DOI 10.1016/0006-8993(91)91210-R; GASS P, 1993, J CEREBR BLOOD F MET, V13, P337, DOI 10.1038/jcbfm.1993.42; GRENNINGLOH G, 1990, NEURON, V4, P963, DOI 10.1016/0896-6273(90)90149-A; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; HELLER AH, 1982, BRAIN RES, V234, P299, DOI 10.1016/0006-8993(82)90870-8; HOCH W, 1989, NEURON, V3, P339, DOI 10.1016/0896-6273(89)90258-4; HOROWITZ DS, 1994, TRENDS GENET, V10, P100, DOI 10.1016/0168-9525(94)90233-X; KINGSMORE SF, 1994, NAT GENET, V7, P136, DOI 10.1038/ng0694-136; KRAWCZAK M, 1992, HUM GENET, V90, P41; KRNJEVIC K, 1981, HDB PHYSL, P107; KUHSE J, 1990, NEURON, V5, P867, DOI 10.1016/0896-6273(90)90346-H; KUHSE J, 1991, FEBS LETT, V283, P73, DOI 10.1016/0014-5793(91)80557-J; KUHSE J, 1993, NEURON, V11, P1049, DOI 10.1016/0896-6273(93)90218-G; LANE PW, 1987, J HERED, V78, P353, DOI 10.1093/oxfordjournals.jhered.a110414; LANGOSCH D, 1988, P NATL ACAD SCI USA, V85, P7394, DOI 10.1073/pnas.85.19.7394; LASHAM A, 1991, J NEUROCHEM, V57, P352, DOI 10.1111/j.1471-4159.1991.tb02135.x; MALOSIO ML, 1991, EMBO J, V10, P2401, DOI 10.1002/j.1460-2075.1991.tb07779.x; MATZENBACH B, 1994, J BIOL CHEM, V269, P2607; MONTAGUTELLI X, 1990, J HERED, V81, P490, DOI 10.1093/oxfordjournals.jhered.a111033; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; MUELLER PR, 1992, CURRENT PROTOCOLS MO, V2; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.bi.55.070186.005351; PATTANAKITSAKUL SN, 1992, J BIOL CHEM, V267, P7814; PFEIFFER F, 1982, J BIOL CHEM, V257, P9389; PRIBILLA I, 1992, EMBO J, V11, P4305, DOI 10.1002/j.1460-2075.1992.tb05529.x; RYAN SG, 1994, NAT GENET, V7, P131, DOI 10.1038/ng0694-131; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAUL B, 1994, FEBS LETT, V350, P71, DOI 10.1016/0014-5793(94)00736-5; SCHMIEDEN V, 1989, EMBO J, V8, P695, DOI 10.1002/j.1460-2075.1989.tb03428.x; SELDIN MF, 1993, MAMM GENOME, V4, P47; SHIANG R, 1993, NAT GENET, V5, P351, DOI 10.1038/ng1293-351; SOMMER B, 1990, DNA CELL BIOL, V9, P561, DOI 10.1089/dna.1990.9.561; SONTHEIMER H, 1989, NEURON, V2, P1491, DOI 10.1016/0896-6273(89)90195-5; STEINMEYER K, 1991, NATURE, V354, P304, DOI 10.1038/354304a0; TAKAHASHI T, 1992, NEURON, V9, P1155, DOI 10.1016/0896-6273(92)90073-M; VERRALL S, 1992, CELL, V68, P23, DOI 10.1016/0092-8674(92)90203-O; WHITE WF, 1982, NATURE, V298, P655, DOI 10.1038/298655a0; WHITE WF, 1985, BRAIN RES, V329, P1; WISDEN W, 1991, MOL NEUROBIOLOGY PRA, V2, P205	57	155	159	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1994	13	4					1003	1015		10.1016/0896-6273(94)90265-8	http://dx.doi.org/10.1016/0896-6273(94)90265-8			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PP533	7946325				2022-12-24	WOS:A1994PP53300022
J	CAGGIANO, M; KAUER, JS; HUNTER, DD				CAGGIANO, M; KAUER, JS; HUNTER, DD			GLOBOSE BASAL CELLS ARE NEURONAL PROGENITORS IN THE OLFACTORY EPITHELIUM - A LINEAGE ANALYSIS USING A REPLICATION-INCOMPETENT RETROVIRUS	NEURON			English	Article							CENTRAL NERVOUS-SYSTEM; RECOMBINANT RETROVIRUS; N-CAM; MONOCLONAL-ANTIBODIES; ADHESION MOLECULES; SENSORY NEURONS; MOUSE; RAT; NEUROGENESIS; EXPRESSION	We have used a replication-incompetent retrovirus to analyze the lineage of olfactory receptor neurons in young rats. At 5-40 days after infection, clusters of infected cells comprised two major types: one consisted of 1-2 horizontal basal cells, and a second consisted of variable numbers of globose basal cells and immature and mature sensory neurons. Olfactory nerve lesion (which enhances neuronal turnover) increased the frequency of the globose-sensory neuron clusters as well as the number of cells in such clusters. No clusters contained both horizontal and globose basal cells, and none contained sustentacular cells. These data suggest, at least in young rats, that horizontal basal cells are not precursors of olfactory neurons, that there is a lineage path from globose cells to mature neurons, and that sustentacular cells may arise from a separate lineage.	TUFTS UNIV, NEW ENGLAND MED CTR, SCH MED, DEPT ANAT & CELLULAR BIOL, BOSTON, MA 02111 USA; TUFTS UNIV, NEW ENGLAND MED CTR, SCH MED, DEPT NEUROSURG, BOSTON, MA 02111 USA	Tufts Medical Center; Tufts University; Tufts Medical Center; Tufts University	CAGGIANO, M (corresponding author), TUFTS UNIV, NEW ENGLAND MED CTR, SCH MED, NEUROSCI PROGRAM, BOSTON, MA 02111 USA.							BALIN BJ, 1986, J COMP NEUROL, V251, P260, DOI 10.1002/cne.902510209; BROWN D, 1984, HISTOCHEMISTRY, V80, P307, DOI 10.1007/BF00495782; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; CALOF AL, 1989, NEURON, V3, P115, DOI 10.1016/0896-6273(89)90120-7; CARR VM, 1991, NEUROSCIENCE, V45, P433, DOI 10.1016/0306-4522(91)90239-K; CARR VM, 1992, EXP NEUROL, V115, P55, DOI 10.1016/0014-4886(92)90221-B; COSTANZO RM, 1989, J NEUROCYTOL, V18, P381, DOI 10.1007/BF01190841; CUSCHIERI A, 1975, J ANAT, V119, P277; CUSCHIERI A, 1975, J ANAT, V119, P471; FARBMAN AI, 1985, DEV BRAIN RES, V19, P205, DOI 10.1016/0165-3806(85)90192-0; FARBMAN AI, 1990, TRENDS NEUROSCI, V13, P362, DOI 10.1016/0166-2236(90)90017-5; FARBMAN AI, 1980, DEV BIOL, V74, P205, DOI 10.1016/0012-1606(80)90062-7; FIELDSBERRY SC, 1992, P NATL ACAD SCI USA, V89, P693, DOI 10.1073/pnas.89.2.693; FUCHS E, 1980, CELL, V19, P1033, DOI 10.1016/0092-8674(80)90094-X; Fuchs E, 1990, CURR OPIN CELL BIOL, V2, P1028, DOI 10.1016/0955-0674(90)90152-5; GORHAM JD, 1991, NEURON, V7, P485, DOI 10.1016/0896-6273(91)90300-O; GRAZIADEI PP, 1971, Z ZELLFORSCH MIK ANA, V116, P305, DOI 10.1007/BF00330630; GRAZIADEI PP, 1973, TISSUE CELL, V5, P113, DOI 10.1016/S0040-8166(73)80010-2; GRAZIADEI PPC, 1979, J NEUROCYTOL, V8, P1, DOI 10.1007/BF01206454; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; HARDING J, 1977, BRAIN RES, V132, P11, DOI 10.1016/0006-8993(77)90703-X; HEMPSTEAD JL, 1985, J NEUROSCI, V5, P438; HEMPSTEAD JL, 1983, BRAIN RES, V288, P289, DOI 10.1016/0006-8993(83)90105-1; HITCHCOCK PF, 1992, TRENDS NEUROSCI, V15, P103, DOI 10.1016/0166-2236(92)90020-9; HURTT ME, 1988, TOXICOL APPL PHARM, V94, P311, DOI 10.1016/0041-008X(88)90273-6; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; KEY B, 1990, J CELL BIOL, V110, P1729, DOI 10.1083/jcb.110.5.1729; LEVEY MJ, 1991, CELL LINEAGE ANAL OL; LEVEY MS, 1991, J NEUROSCI, V11, P3556; LEVEY MS, 1992, NEUROSCI LETT, V140, P265, DOI 10.1016/0304-3940(92)90117-P; MAHANTHAPPA NK, 1993, NEURON, V10, P293, DOI 10.1016/0896-6273(93)90319-M; MARGOLIS FL, 1972, P NATL ACAD SCI USA, V69, P1221, DOI 10.1073/pnas.69.5.1221; MIRAGALL F, 1989, DEV BIOL, V135, P272, DOI 10.1016/0012-1606(89)90179-6; MIRAGALL F, 1988, DEV BIOL, V129, P516, DOI 10.1016/0012-1606(88)90397-1; MONATH TP, 1983, LAB INVEST, V48, P399; Moulton D. G, 1970, P227; MOULTON DG, 1974, ANN NY ACAD SCI, V237, P52, DOI 10.1111/j.1749-6632.1974.tb49843.x; MULVANEY BD, 1971, AM J ANAT, V131, P241, DOI 10.1002/aja.1001310208; PITTACK C, 1991, DEVELOPMENT, V113, P577; POTTEN CS, 1974, CELL TISSUE KINET, V7, P77, DOI 10.1111/j.1365-2184.1974.tb00401.x; PRICE J, 1987, P NATL ACAD SCI USA, V84, P156, DOI 10.1073/pnas.84.1.156; ROE TY, 1993, EMBO J, V12, P2099, DOI 10.1002/j.1460-2075.1993.tb05858.x; SANES JR, 1989, TRENDS NEUROSCI, V12, P21, DOI 10.1016/0166-2236(89)90152-5; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; SCHWOB JE, 1992, J NEUROSCI, V12, P3896; SHIPLEY MT, 1985, BRAIN RES BULL, V15, P129, DOI 10.1016/0361-9230(85)90129-7; STEWART WB, 1985, BRAIN RES, V347, P200, DOI 10.1016/0006-8993(85)90914-X; SUZUKI Y, 1993, DEV BRAIN RES, V73, P107, DOI 10.1016/0165-3806(93)90052-C; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; VOLLRATH M, 1985, DIFFERENTIATION, V29, P243, DOI 10.1111/j.1432-0436.1985.tb00323.x; WALKER DG, 1990, CHEM SENSES, V15, P741, DOI 10.1093/chemse/15.6.741	51	258	261	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	1994	13	2					339	352		10.1016/0896-6273(94)90351-4	http://dx.doi.org/10.1016/0896-6273(94)90351-4			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PD430	8060615				2022-12-24	WOS:A1994PD43000007
J	FORREST, D; YUZAKI, M; SOARES, HD; NG, L; LUK, DC; SHENG, M; STEWART, CL; MORGAN, JI; CONNOR, JA; CURRAN, T				FORREST, D; YUZAKI, M; SOARES, HD; NG, L; LUK, DC; SHENG, M; STEWART, CL; MORGAN, JI; CONNOR, JA; CURRAN, T			TARGETED DISRUPTION OF NMDA RECEPTOR-1 GENE ABOLISHES NMDA RESPONSE AND RESULTS IN NEONATAL DEATH	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; CEREBELLAR GRANULE CELLS; EXCITATORY AMINO-ACIDS; D-ASPARTATE NMDA; NUCLEUS-TRACTUS-SOLITARII; HIPPOCAMPAL-NEURONS; GLUTAMATE RECEPTORS; MOLECULAR DIVERSITY; EXPLANT CULTURES; CENTRAL SYNAPSE	In vitro studies have suggested that the NMDA receptor consists of an essential subunit, NR1, and various modulatory NR2 subunits. To test this hypothesis directly in vivo, we generated mice carrying a disrupted NR1 allele. NMDA-inducible increases in intracellular calcium and membrane currents were abolished in neurons from homozygous null mutants (NR1(-/-)). Thus, NR1 has a unique role, which cannot be substituted by any other subunit, in determining the activity of the endogenous NMDA receptor. A concomitant reduction in levels of NR2B but not NR2A occurred in NR1(-/-) mice, demonstrating that there is an interdependence of subunit expression. NR1(-/-) mice died 8-15 hr after birth, indicating a vital neonatal function for the NMDA receptor. Although the NMDA receptor has been implicated in several aspects of neurodevelopment, overall neuroanatomy of NR1(-/-) appeared normal. Pathological evidence suggested that respiratory failure was the ultimate cause of death.	UNIV CALIF SAN FRANCISCO, HOWARD HUGHES MED INST, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, DEPT PHYSIOL, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, DEPT BIOCHEM, SAN FRANCISCO, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	FORREST, D (corresponding author), ROCHE INST MOLEC BIOL, NUTLEY, NJ 07110 USA.		Morgan, James/GRO-2905-2022; Curran, Thomas/AAE-7631-2019; Morgan, James/N-8104-2018; Curran, Tom/D-7515-2011; Curran, Tom/F-5234-2018; Yuzaki, Michisuke/K-5328-2013; Curran, Tom/C-1164-2008	Morgan, James/0000-0002-8920-1065; Curran, Thomas/0000-0003-1444-7551; Curran, Tom/0000-0003-1444-7551; Yuzaki, Michisuke/0000-0002-5750-3544; Curran, Tom/0000-0003-1444-7551; Sheng, Morgan/0000-0002-8703-5366				ABBONDANZO SJ, 1993, METHOD ENZYMOL, V225, P803; ASCHER P, 1988, J PHYSIOL-LONDON, V399, P247; BALAZS R, 1989, NEUROSCI LETT, V101, P241, DOI 10.1016/0304-3940(89)90539-9; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; BAZIL MK, 1990, NEUROPHARMACOLOGY, V29, P923, DOI 10.1016/0028-3908(90)90143-F; BESSHO Y, 1994, NEURON, V12, P87, DOI 10.1016/0896-6273(94)90154-6; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BREWER GJ, 1989, NEUROSCI LETT, V99, P268, DOI 10.1016/0304-3940(89)90458-8; CHERNEVSKAYA NI, 1991, NATURE, V349, P418, DOI 10.1038/349418a0; COLLINGRIDGE GL, 1989, PHARMACOL REV, V41, P143; CONNOR JA, 1987, J NEUROSCI, V7, P1384; CONNOR JA, 1986, P NATL ACAD SCI USA, V83, P6179, DOI 10.1073/pnas.83.16.6179; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; CULLCANDY SG, 1988, J PHYSIOL-LONDON, V400, P189, DOI 10.1113/jphysiol.1988.sp017117; DANGELO E, 1990, NATURE, V346, P467, DOI 10.1038/346467a0; DUGAICZYK A, 1983, BIOCHEMISTRY-US, V22, P1605, DOI 10.1021/bi00276a013; FELDMAN JL, 1992, J PHYSIOL-LONDON, V450, P303, DOI 10.1113/jphysiol.1992.sp019128; FISCHER G, 1982, NEUROSCI LETT, V28, P325, DOI 10.1016/0304-3940(82)90079-9; FOUTZ AS, 1989, BRAIN RES, V500, P199, DOI 10.1016/0006-8993(89)90314-4; FOX K, 1993, TRENDS NEUROSCI, V16, P116, DOI 10.1016/0166-2236(93)90136-A; GRUOL DL, 1988, DEV BRAIN RES, V41, P135, DOI 10.1016/0165-3806(88)90177-0; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HESTRIN S, 1992, NATURE, V357, P686, DOI 10.1038/357686a0; HOCKBERGER PE, 1987, J NEUROSCI, V7, P1370; HOLLMANN M, 1993, NEURON, V10, P943, DOI 10.1016/0896-6273(93)90209-A; ISHII T, 1993, J BIOL CHEM, V268, P2836; KESSLER JP, 1991, EUR J PHARMACOL, V201, P59, DOI 10.1016/0014-2999(91)90323-I; KOMURO H, 1993, SCIENCE, V260, P95, DOI 10.1126/science.8096653; KONIG N, 1992, NEUROREPORT, V3, P738; KUBO T, 1988, NEUROSCI LETT, V87, P69, DOI 10.1016/0304-3940(88)90147-4; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; LOTURCO JJ, 1991, J NEUROSCI, V11, P792; MACDERMOTT AB, 1986, NATURE, V321, P519, DOI 10.1038/321519a0; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MAYER ML, 1987, PROG NEUROBIOL, V28, P197, DOI 10.1016/0301-0082(87)90011-6; MCDONALD JW, 1990, BRAIN RES REV, V15, P41, DOI 10.1016/0165-0173(90)90011-C; MEGURO H, 1992, NATURE, V357, P70, DOI 10.1038/357070a0; MONAGHAN DT, 1989, ANNU REV PHARMACOL, V29, P365, DOI 10.1146/annurev.pa.29.040189.002053; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; RASHID NA, 1992, DEV BRAIN RES, V67, P301, DOI 10.1016/0165-3806(92)90231-K; SAH P, 1989, SCIENCE, V246, P815, DOI 10.1126/science.2573153; SCHWEITZER P, 1990, DEV BRAIN RES, V56, P290, DOI 10.1016/0165-3806(90)90095-G; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; STEWART CL, 1993, METHOD ENZYMOL, V225, P823; TRENKNER E, 1984, J NEUROCHEM, V11, P2850; WATANABE M, 1992, NEUROREPORT, V3, P1138, DOI 10.1097/00001756-199212000-00027; YAMAZAKI M, 1992, FEBS LETT, V300, P39, DOI 10.1016/0014-5793(92)80160-I	55	385	398	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	1994	13	2					325	338		10.1016/0896-6273(94)90350-6	http://dx.doi.org/10.1016/0896-6273(94)90350-6			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PD430	8060614				2022-12-24	WOS:A1994PD43000006
J	TERZIC, A; TUNG, RT; INANOBE, A; KATADA, T; KURACHI, Y				TERZIC, A; TUNG, RT; INANOBE, A; KATADA, T; KURACHI, Y			G-PROTEINS ACTIVATE ATP-SENSITIVE K+ CHANNELS BY ANTAGONIZING ATP-DEPENDENT GATING	NEURON			English	Article							INSULIN-SECRETING CELLS; NUCLEOTIDE-BINDING PROTEINS; PIG VENTRICULAR MYOCYTES; GUINEA-PIG; POTASSIUM CHANNELS; GAMMA-SUBUNIT; MEDIATED ACTIVATION; MEMBRANE PATCHES; PERTUSSIS TOXIN; ALPHA-SUBUNITS	To determine whether G proteins activate cardiac ATP-sensitive K+ (K-ATP) channels by regulating intracellular ATP (ATP(i))-dependent gating, currents were measured in inside-out patches. When ATP(i) closed K-ATP channels, activators of endogenous G proteins, GTP (plus adenosine or acetylcholine), GTP gamma S, or AlF4- stimulated channels, an effect prevented by GDP beta S. In the absence of ATP(i), G protein activators were ineffective. Intracellular nucleoside diphosphates restored K-ATP channel openings after the ''rundown'' of spontaneous activity. Only when ATP(i) suppressed nucleoside diphosphate-induced openings, GTP gamma S or AlF4- enhanced K-ATP channel activity. Active forms of exogenous G protein subunits (G(alpha i-1), G(alpha i-2), or G(alpha o)) activated only K-ATP channels closed by ATP(i). G proteins stimulate cardiac K-ATP channels apparently by antagonizing ATP(i)-dependent inhibitory gating. Regulation of ligand-dependent gating represents a distinct type of G protein modulation of ion channels.	MAYO CLIN & MAYO FDN,DEPT PHARMACOL,ROCHESTER,MN 55905; TOKYO INST TECHNOL,DEPT LIFE SCI,KANAGAWA,JAPAN; UNIV TOKYO,FAC PHARMACEUT SCI,DEPT PHYS CHEM,TOKYO 113,JAPAN; OSAKA UNIV,FAC MED,DEPT PHARMACOL 2,OSAKA 530,JAPAN	Mayo Clinic; Tokyo Institute of Technology; University of Tokyo; Osaka University	TERZIC, A (corresponding author), MAYO CLIN & MAYO FDN,DEPT INTERNAL MED,DIV CARDIOVASC DIS,ROCHESTER,MN 55905, USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047360] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL 47360] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AMOROSO S, 1990, SCIENCE, V247, P852, DOI 10.1126/science.2305257; ASHCROFT SJH, 1990, CELL SIGNAL, V2, P197, DOI 10.1016/0898-6568(90)90048-F; BERNARDI H, 1993, P NATL ACAD SCI USA, V90, P1340, DOI 10.1073/pnas.90.4.1340; BIGAY J, 1987, EMBO J, V6, P2907, DOI 10.1002/j.1460-2075.1987.tb02594.x; BIRNBAUMER L, 1992, CELL, V71, P1069, DOI 10.1016/S0092-8674(05)80056-X; BIRNBAUMER L, 1990, BIOCHIM BIOPHYS ACTA, V1031, P163, DOI 10.1016/0304-4157(90)90007-Y; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BROWN AM, 1990, ANNU REV PHYSIOL, V52, P197, DOI 10.1146/annurev.ph.52.030190.001213; Colquhoun D, 1983, SINGLE CHANNEL RECOR, P191; CONKLIN BR, 1993, CELL, V73, P631, DOI 10.1016/0092-8674(93)90245-L; DEUTSCH N, 1993, J PHYSIOL-LONDON, V465, P163, DOI 10.1113/jphysiol.1993.sp019671; DEWEILLE J, 1988, P NATL ACAD SCI USA, V85, P1312; DEWEILLE JR, 1989, P NATL ACAD SCI USA, V86, P2971; DUNNE MJ, 1989, EMBO J, V8, P413, DOI 10.1002/j.1460-2075.1989.tb03392.x; DUNNE MJ, 1986, PFLUGERS ARCH, V407, P565; EDWARDS G, 1993, ANNU REV PHARMACOL, V33, P597, DOI 10.1146/annurev.pa.33.040193.003121; ESCANDE D, 1992, TRENDS PHARMACOL SCI, V13, P269, DOI 10.1016/0165-6147(92)90083-I; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; FAIVRE JF, 1990, BIOCHIM BIOPHYS ACTA, V1029, P167, DOI 10.1016/0005-2736(90)90450-3; FINDLAY I, 1988, J MEMBRANE BIOL, V101, P83, DOI 10.1007/BF01872823; FINDLAY I, 1987, J PHYSIOL-LONDON, V391, P611, DOI 10.1113/jphysiol.1987.sp016759; FOSSET M, 1988, FEBS LETT, V242, P94, DOI 10.1016/0014-5793(88)80992-X; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GROSS GJ, 1992, CARDIOVASC RES, V26, P1011, DOI 10.1093/cvr/26.11.1011; GROVER GJ, 1992, CIRCULATION, V86, P1310, DOI 10.1161/01.CIR.86.4.1310; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HEIDBUCHEL H, 1990, PFLUG ARCH EUR J PHY, V416, P213, DOI 10.1007/BF00370246; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P762; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; ITO H, 1991, J GEN PHYSIOL, V98, P517, DOI 10.1085/jgp.98.3.517; ITO H, 1992, J GEN PHYSIOL, V99, P961, DOI 10.1085/jgp.99.6.961; KATADA T, 1986, J BIOL CHEM, V261, P8182; KEUNG EC, 1991, J CLIN INVEST, V88, P1772, DOI 10.1172/JCI115497; KIRSCH GE, 1990, AM J PHYSIOL, V259, pH820, DOI 10.1152/ajpheart.1990.259.3.H820; KLEUSS C, 1991, NATURE, V353, P43, DOI 10.1038/353043a0; KOBAYASHI I, 1990, EUR J BIOCHEM, V191, P499, DOI 10.1111/j.1432-1033.1990.tb19149.x; KOYANO T, 1993, J PHYSIOL-LONDON, V463, P747, DOI 10.1113/jphysiol.1993.sp019620; KURACHI Y, 1989, NEWS PHYSIOL SCI, V4, P158; KURACHI Y, 1985, J PHYSIOL-LONDON, V366, P365, DOI 10.1113/jphysiol.1985.sp015803; KURACHI Y, 1986, PFLUG ARCH EUR J PHY, V407, P264, DOI 10.1007/BF00585301; KURACHI Y, 1992, PROG NEUROBIOL, V39, P229, DOI 10.1016/0301-0082(92)90017-9; LEDERER WJ, 1989, J PHYSIOL-LONDON, V419, P193, DOI 10.1113/jphysiol.1989.sp017869; LLEDO PM, 1992, NEURON, V8, P455, DOI 10.1016/0896-6273(92)90273-G; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; MARTIN SC, 1989, EMBO J, V8, P3595, DOI 10.1002/j.1460-2075.1989.tb08532.x; NAKAJIMA T, 1992, J GEN PHYSIOL, V99, P665, DOI 10.1085/jgp.99.5.665; NICHOLS CG, 1991, AM J PHYSIOL, V261, pH1675, DOI 10.1152/ajpheart.1991.261.6.H1675; NOMA A, 1983, NATURE, V305, P147, DOI 10.1038/305147a0; OHNOSHOSAKU T, 1987, PFLUG ARCH EUR J PHY, V408, P133, DOI 10.1007/BF00581342; PARENT L, 1989, J GEN PHYSIOL, V94, P445, DOI 10.1085/jgp.94.3.445; SHEN WK, 1991, CIRC RES, V69, P1152, DOI 10.1161/01.RES.69.4.1152; SHEN WK, 1992, CIRC RES, V70, P1054, DOI 10.1161/01.RES.70.5.1054; Smith RM, 1975, CRITICAL STABILITY C, V2; TERZIC A, 1994, J PHARMACOL EXP THER, V268, P818; TERZIC A, 1993, CARDIOVASC DRUG REV, V11, P223, DOI 10.1111/j.1527-3466.1993.tb00277.x; TERZIC A, 1994, IN PRESS NEURON; TERZIC A, 1994, IN PRESS CARDIOVASC; TUNG RT, 1991, J PHYSIOL-LONDON, V437, P239, DOI 10.1113/jphysiol.1991.sp018593; WEISS JN, 1992, J PHYSIOL-LONDON, V447, P649, DOI 10.1113/jphysiol.1992.sp019022; YAMADA M, 1993, J BIOL CHEM, V268, P24551; YAMADA M, 1993, J PHARMACOL EXP THER, V267, P1544; YAMADA M, 1994, IN PRESS METH ENZYMO; YAO ZH, 1993, CIRCULATION, V88, P235, DOI 10.1161/01.CIR.88.1.235; YAO ZH, 1993, AM J PHYSIOL, V264, pH2221, DOI 10.1152/ajpheart.1993.264.6.H2221	64	76	77	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1994	12	4					885	893		10.1016/0896-6273(94)90340-9	http://dx.doi.org/10.1016/0896-6273(94)90340-9			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NH253	8161458				2022-12-24	WOS:A1994NH25300016
J	KRAMER, RH; GOULDING, E; SIEGELBAUM, SA				KRAMER, RH; GOULDING, E; SIEGELBAUM, SA			POTASSIUM CHANNEL INACTIVATION PEPTIDE BLOCKS CYCLIC NUCLEOTIDE-GATED CHANNELS BY BINDING TO THE CONSERVED PORE DOMAIN	NEURON			English	Article							SHAKER K+ CHANNEL; ION CHANNELS; GMP	Cyclic nucleotide-gated (CNG) channels in photoreceptors and olfactory neurons are activated by intracellular ligands (cAMP and cGMP) rather than voltage. Surprisingly, these channels share amino acid sequence homology with voltage-gated channels. Here we show that the distinct gating mechanisms exhibited by CNG and voltage-gated channels share features that reflect this structural homology. Thus, a 20 amino acid peptide (''ball peptide'') derived from the Shaker-type K+ channel and responsible for its rapid inactivation also blocks CNG channels. Moreover, the peptide selectively blocks open CNG channels and prevents channel closure, showing that CNC channel activation, like activation of voltage-dependent K+ channels, involves the opening of a gate located on the intracellular side of the peptide-binding site. Amino acid substitutions in the peptide cause similar changes in blocking affinity of CNG and K+ channels, suggesting a conserved binding site. Using a chimeric retinal/olfactory channel, we show that the difference in the peptide affinity of the two CNG channels is due to a difference in the amino acid sequence of the conserved pore-forming region, demonstrating that this domain forms part of the peptide receptor.	COLUMBIA UNIV,COLL PHYSICIANS & SURGEONS,CTR NEUROBIOL & BEHAV,NEW YORK,NY 10032; COLUMBIA UNIV,COLL PHYSICIANS & SURGEONS,HOWARD HUGHES MED INST,NEW YORK,NY 10032	Columbia University; Columbia University; Howard Hughes Medical Institute					NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS030685] Funding Source: NIH RePORTER; NINDS NIH HHS [NS30685] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		DEMO SD, 1991, NEURON, V7, P743, DOI 10.1016/0896-6273(91)90277-7; FOSTER CD, 1992, NEURON, V9, P229, DOI 10.1016/0896-6273(92)90162-7; GOULDING EH, 1993, NATURE, V364, P61, DOI 10.1038/364061a0; GOULDING EH, 1992, NEURON, V8, P45, DOI 10.1016/0896-6273(92)90107-O; HEGINBOTHAM L, 1992, SCIENCE, V258, P1152, DOI 10.1126/science.1279807; Hille B., 1992, IONIC CHANNELS EXCIT; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; ISACOFF EY, 1991, NATURE, V353, P86, DOI 10.1038/353086a0; JAN LY, 1990, NATURE, V345, P672, DOI 10.1038/345672a0; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; MATTHEWS G, 1988, J PHYSIOL-LONDON, V403, P389, DOI 10.1113/jphysiol.1988.sp017255; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; RUPPERSBERG JP, 1991, NATURE, V353, P657, DOI 10.1038/353657a0; STOCKER M, 1991, P ROY SOC B-BIOL SCI, V245, P101, DOI 10.1098/rspb.1991.0094; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; TORO L, 1992, NEURON, V9, P237, DOI 10.1016/0896-6273(92)90163-8; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520	17	45	45	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1994	12	3					655	662		10.1016/0896-6273(94)90220-8	http://dx.doi.org/10.1016/0896-6273(94)90220-8			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NC769	8155325	hybrid			2022-12-24	WOS:A1994NC76900016
J	SNOW, AD; SEKIGUCHI, R; NOCHLIN, D; FRASER, P; KIMATA, K; MIZUTANI, A; ARAI, M; SCHREIER, WA; MORGAN, DG				SNOW, AD; SEKIGUCHI, R; NOCHLIN, D; FRASER, P; KIMATA, K; MIZUTANI, A; ARAI, M; SCHREIER, WA; MORGAN, DG			AN IMPORTANT ROLE OF HEPARAN-SULFATE PROTEOGLYCAN (PERLECAN) IN A MODEL SYSTEM FOR THE DEPOSITION AND PERSISTENCE OF FIBRILLAR A-ALPHA-AMYLOID IN RAT-BRAIN	NEURON			English	Article							FIBROBLAST GROWTH-FACTOR; SWARM MOUSE-TUMOR; ALZHEIMERS-DISEASE; BASEMENT-MEMBRANE; CHONDROITIN SULFATE; BETA-PROTEIN; P-COMPONENT; NEUROFIBRILLARY TANGLES; PROTEOLYTIC DEGRADATION; MODIFIED BIELSCHOWSKY	A consistent rat model for the study of the consequences of congophilic and fibrillar Abeta-amyloid in brain has been developed. One hundred percent of animals receiving infusions of synthetic beta-amyloid protein (Abeta 1-40) plus a specific heparan sulfate proteoglycan (HSPG) for 1 week or 7 weeks (following 2 week infusions) demonstrated Congo red and thioflavin S-positive deposits adjacent to the infusion site. Extracellular amyloid fibrils were identified by electron microscopy and were immunogold decorated with Abeta antibody. Significant increases in Congo red staining were observed in animals infused with Abeta plus HSPG versus those infused with only Abeta. Infusion of Abeta alone was variable with respect to congophilic amyloid persistence, which occurred in 50% of animals and only when endogenous HSPGs accumulated at Abeta deposition sites. By 7 weeks, only animals infused with Abeta plus HSPG demonstrated compaction of the Congo red material from amorphous, wispy deposits (at 1 week) to stellate deposits resembling a Maltese cross. These spherical amyloid deposits were very similar to Congo red-stained amyloid plaques in human Alzheimer's disease brain, and in vitro data suggest that they were probably formed in vivo following interactions with endogenous brain components.	UNIV TORONTO,CTR RES NEURODEGENERAT DIS,TORONTO M5S 1A8,ONTARIO,CANADA; AICHI MED UNIV,INST MOLEC SCI MED,NAGAKUTE,AICHI 48011,JAPAN; SEIKAGAKU CORP,TOKYO INST,TOKYO 103,JAPAN; UNIV SO CALIF,DIV NEUROGERONTOL,LOS ANGELES,CA 90089	University of Toronto; Aichi Medical University; Seikagaku Corporation; University of Southern California	SNOW, AD (corresponding author), UNIV WASHINGTON,DEPT PATHOL,NEUROPATHOL LABS RJ05,SEATTLE,WA 98195, USA.		Morgan, David G/J-5989-2012		NATIONAL INSTITUTE ON AGING [R01AG007892, P50AG005136] Funding Source: NIH RePORTER; NIA NIH HHS [AG05136, AG7892] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ABRAHAM CR, 1988, CELL, V52, P487, DOI 10.1016/0092-8674(88)90462-X; BAUER J, 1991, FEBS LETT, V285, P111, DOI 10.1016/0014-5793(91)80737-N; BEYREUTHER K, 1990, NEUROBIOL AGING, V11, P66, DOI 10.1016/0197-4580(90)90067-A; BUEE L, 1993, BRAIN RES, V601, P154, DOI 10.1016/0006-8993(93)91706-X; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; CAUGHEY B, 1993, J VIROL, V67, P643, DOI 10.1128/JVI.67.2.643-650.1993; CLEMENS JA, 1992, NEUROBIOL AGING, V13, P581, DOI 10.1016/0197-4580(92)90059-7; CORIA F, 1988, LAB INVEST, V58, P454; CORK LC, 1988, J NEUROPATH EXP NEUR, V47, P629, DOI 10.1097/00005072-198811000-00006; DAVIES P, 1992, NEUROBIOL AGING, V13, P613, DOI 10.1016/0197-4580(92)90066-7; DEMEDICINA EP, 1990, BIOCHIM BIOPHYS ACTA, V1053, P135; EIKELENBOOM P, 1989, VIRCHOWS ARCH B, V56, P259; ELGHETANY MT, 1988, STAIN TECHNOL, V63, P201, DOI 10.3109/10520298809107185; EMRE M, 1992, NEUROBIOL AGING, V13, P553, DOI 10.1016/0197-4580(92)90055-3; FLUHARTY AL, 1975, J NEUROCHEM, V25, P429, DOI 10.1111/j.1471-4159.1975.tb04345.x; FRASER PE, 1992, BIOCHEMISTRY-US, V31, P10716, DOI 10.1021/bi00159a011; FRASER PE, 1991, BIOPHYS J, V60, P1190, DOI 10.1016/S0006-3495(91)82154-3; FRASER PE, 1992, J NEUROCHEM, V59, P1531, DOI 10.1111/j.1471-4159.1992.tb08470.x; FRAUTSCHY SA, 1991, P NATL ACAD SCI USA, V88, P8362, DOI 10.1073/pnas.88.19.8362; FRAUTSCHY SA, 1992, AM J PATHOL, V140, P1389; FREDERICKSON RCA, 1992, NEUROBIOL AGING, V13, P239, DOI 10.1016/0197-4580(92)90036-W; GAMES D, 1992, NEUROBIOL AGING, V13, P569, DOI 10.1016/0197-4580(92)90057-5; GEULA C, 1989, BRAIN RES, V498, P185, DOI 10.1016/0006-8993(89)90419-8; GIACCONE G, 1989, NEUROSCI LETT, V97, P232, DOI 10.1016/0304-3940(89)90169-9; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; HABUCHI H, 1992, BIOCHEM J, V285, P805, DOI 10.1042/bj2850805; HAMAZAKI H, 1987, J BIOL CHEM, V262, P1456; HASSELL JR, 1980, P NATL ACAD SCI-BIOL, V77, P4494, DOI 10.1073/pnas.77.8.4494; HUSBY G, 1993, B WORLD HEALTH ORGAN, V71, P105; ISEKI E, 1988, NEUROPATH APPL NEURO, V14, P169, DOI 10.1111/j.1365-2990.1988.tb00878.x; ISHIHARA T, 1991, BRAIN RES, V548, P196, DOI 10.1016/0006-8993(91)91122-H; JI ZS, 1993, J BIOL CHEM, V268, P10160; JOACHIM CL, 1989, AM J PATHOL, V135, P309; KALARIA RN, 1991, NEUROPATH APPL NEURO, V17, P189, DOI 10.1111/j.1365-2990.1991.tb00714.x; KATO M, 1988, J CELL BIOL, V106, P2203, DOI 10.1083/jcb.106.6.2203; KATO M, 1987, J BIOL CHEM, V262, P7180; KOLSET SO, 1987, GLYCOCONJUGATE J, V4, P73, DOI 10.1007/BF01048446; KOWALL NW, 1991, P NATL ACAD SCI USA, V88, P7247, DOI 10.1073/pnas.88.16.7247; KOWALL NW, 1992, NEUROBIOL AGING, V13, P537, DOI 10.1016/0197-4580(92)90053-Z; KRUEGER RC, 1987, ANAL BIOCHEM, V167, P295, DOI 10.1016/0003-2697(87)90167-9; MANDYBUR TI, 1990, NEUROLOGY, V40, P635, DOI 10.1212/WNL.40.4.635; MARTIN LJ, 1991, P NATL ACAD SCI USA, V88, P1461, DOI 10.1073/pnas.88.4.1461; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; MCCUBBIN WD, 1988, BIOCHEM J, V256, P775, DOI 10.1042/bj2560775; MORAN MA, 1993, ACTA NEUROPATHOL, V85, P362, DOI 10.1007/BF00334445; NAMBA Y, 1991, BRAIN RES, V541, P163, DOI 10.1016/0006-8993(91)91092-F; NARINDRASORASAK S, 1991, J BIOL CHEM, V266, P12878; NOONAN DM, 1991, J BIOL CHEM, V266, P22939; NOONAN DM, 1988, J BIOL CHEM, V263, P16379; OWENS RT, 1991, ARTERIOSCLER THROMB, V11, P1752, DOI 10.1161/01.ATV.11.6.1752; PIKE CJ, 1991, BRAIN RES, V261, P321; PODLISNY MB, 1992, NEUROBIOL AGING, V13, P561, DOI 10.1016/0197-4580(92)90056-4; PUCHTLER H, 1962, J HISTOCHEM CYTOCHEM, V10, P355, DOI 10.1177/10.3.355; ROZEMULLER JM, 1989, J NEUROPATH EXP NEUR, V48, P674, DOI 10.1097/00005072-198911000-00009; RUSH DK, 1992, NEUROBIOL AGING, V13, P591, DOI 10.1016/0197-4580(92)90061-2; SAKSELA O, 1990, J CELL BIOL, V110, P767, DOI 10.1083/jcb.110.3.767; SAKSELA O, 1988, J CELL BIOL, V107, P743, DOI 10.1083/jcb.107.2.743; SELKOE DJ, 1987, SCIENCE, V235, P873, DOI 10.1126/science.3544219; SNOW AD, 1989, J NEUROPATH EXP NEUR, V48, P352, DOI 10.1097/00005072-198905000-00160; SNOW AD, 1990, AM J PATHOL, V137, P1253; SNOW AD, 1989, NEUROBIOL AGING, V10, P481, DOI 10.1016/0197-4580(89)90108-5; SNOW AD, 1988, AM J PATHOL, V133, P456; SNOW AD, 1989, ALZHEIMERS DISEASE R, P383; SNOW AD, 1994, IN PRESS AM J PATHOL; SOMMER A, 1989, J CELL PHYSIOL, V138, P215, DOI 10.1002/jcp.1041380129; STEINBEHRENS B, 1992, NEUROBIOL AGING, V13, P577, DOI 10.1016/0197-4580(92)90058-6; STRAUSS S, 1992, LAB INVEST, V66, P223; SU JH, 1992, NEUROSCIENCE, V51, P801, DOI 10.1016/0306-4522(92)90521-3; SUENAGA T, 1990, ACTA NEUROPATHOL, V80, P280, DOI 10.1007/BF00294646; THRELKELD A, 1989, DEV BIOL, V132, P559, DOI 10.1016/0012-1606(89)90251-0; UNTERBECK A, 1990, REV BIOL RES AGING, V4, P139; VIJAYAN VK, 1991, EXP NEUROL, V112, P72, DOI 10.1016/0014-4886(91)90115-S; WAITE J, 1992, NEUROBIOL AGING, V13, P595, DOI 10.1016/0197-4580(92)90062-3; WEGIEL J, 1990, ACTA NEUROPATHOL, V81, P116, DOI 10.1007/BF00334499; WISNIEWSKI HM, 1991, NEUROBIOL AGING, V12, P593, DOI 10.1016/0197-4580(91)90091-W; WISNIEWSKI HM, 1989, CAN J NEUROL SCI, V16, P535, DOI 10.1017/S0317167100029887; WISNIEWSKI HM, 1990, AM J MED GENET S, V7, P287; WOLOZIN B, 1987, ANN NEUROL, V22, P521, DOI 10.1002/ana.410220412; WOLOZIN BL, 1986, SCIENCE, V232, P648, DOI 10.1126/science.3083509; WONG CW, 1985, P NATL ACAD SCI USA, V82, P8729, DOI 10.1073/pnas.82.24.8729; YAMAMOTO T, 1986, NEUROPATH APPL NEURO, V12, P3, DOI 10.1111/j.1365-2990.1986.tb00677.x; YANKNER BA, 1992, NEUROBIOL AGING, V13, P615, DOI 10.1016/0197-4580(92)90067-8	82	286	305	1	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1994	12	1					219	234		10.1016/0896-6273(94)90165-1	http://dx.doi.org/10.1016/0896-6273(94)90165-1			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MU493	8292358				2022-12-24	WOS:A1994MU49300019
J	BARBOUR, B				BARBOUR, B			SYNAPTIC CURRENTS EVOKED IN PURKINJE-CELLS BY STIMULATING INDIVIDUAL GRANULE CELLS	NEURON			English	Article							CENTRAL NERVOUS-SYSTEM; CEREBELLAR GRANULE; RAT; SLICES; NEURONS; CULTURE; CORTEX; TRANSMISSION; DEPRESSION	Each cerebellar Purkinje cell receives input from about 160,000 glutamatergic granule cells. In anatomically intact preparations this input has hitherto been studied only as a compound synaptic potential or current. Presented here are simultaneous recordings in cerebellar slices of synaptically connected granule cell-Purkinje cell pairs. The mean amplitude of the excitatory synaptic currents evoked by stimulation of individual granule cells ranged from 2 to 60 pA, whereas the great majority of the spontaneous glutamatergic currents in Purkinje cells in the presence of tetrodotoxin were <40 pA. In several cases, stimulation of a single granule cell evoked a disynaptic inhibitory current. It is estimated that on the order of 50 simultaneously active granule cells are sufficient to excite a Purkinje cell.			BARBOUR, B (corresponding author), ECOLE NORMALE SUPER,NEUROBIOL LAB,46 RUE ULM,F-75230 PARIS 05,FRANCE.			Barbour, Boris/0000-0002-1911-0539				ALBUS JS, 1971, MATH BIOSCI, V10, P318; ALTMAN J, 1972, J COMP NEUROL, V145, P465, DOI 10.1002/cne.901450403; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; CREPEL F, 1978, BRAIN RES, V155, P176, DOI 10.1016/0006-8993(78)90321-9; ECCLES JC, 1966, EXP BRAIN RES, V1, P161; ECCLES JC, 1966, EXP BRAIN RES, V1, P17; ECCLES JC, 1966, J PHYSIOL-LONDON, V182, P268, DOI 10.1113/jphysiol.1966.sp007824; Eccles JC, 1967, CEREBELLUM NEURONAL; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; FARRANT M, 1991, P ROY SOC B-BIOL SCI, V244, P179, DOI 10.1098/rspb.1991.0067; FORSYTHE ID, 1990, J PHYSIOL-LONDON, V429, P1; GAHWILER BH, 1984, NEUROSCI LETT, V45, P311, DOI 10.1016/0304-3940(84)90244-1; GRANIT R, 1956, J PHYSIOL-LONDON, V133, P520, DOI 10.1113/jphysiol.1956.sp005606; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARVEY RJ, 1988, J COMP NEUROL, V274, P151, DOI 10.1002/cne.902740202; HIRANO T, 1986, P NATL ACAD SCI USA, V83, P4957, DOI 10.1073/pnas.83.13.4957; HIRANO T, 1988, P NATL ACAD SCI USA, V85, P934, DOI 10.1073/pnas.85.3.934; HIRANO T, 1991, SYNAPSE, V7, P321, DOI 10.1002/syn.890070408; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; Ito M, 1984, CEREBELLUM NEURAL CO; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; LLINAS R, 1969, J NEUROPHYSIOL, V32, P847, DOI 10.1152/jn.1969.32.6.847; Llinas R., 1992, CEREBELLUM REVISITED, P167; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; MERRILL EG, 1978, J PHYSIOL-LONDON, V284, P127, DOI 10.1113/jphysiol.1978.sp012531; NAPPER RMA, 1988, J COMP NEUROL, V274, P158, DOI 10.1002/cne.902740203; NAPPER RMA, 1988, J COMP NEUROL, V274, P168, DOI 10.1002/cne.902740204; Palay S. L., 1974, CEREBELLAR CORTEX CY; PERKEL DJ, 1990, P ROY SOC B-BIOL SCI, V241, P116, DOI 10.1098/rspb.1990.0074; RAASTAD M, 1992, EUR J NEUROSCI, V4, P113, DOI 10.1111/j.1460-9568.1992.tb00114.x; VINCENT P, 1992, J PHYSIOL-LONDON, V456, P453, DOI 10.1113/jphysiol.1992.sp019346	32	146	146	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1993	11	4					759	769		10.1016/0896-6273(93)90085-6	http://dx.doi.org/10.1016/0896-6273(93)90085-6			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MD068	8398158				2022-12-24	WOS:A1993MD06800018
J	CHOI, KL; MOSSMAN, C; AUBE, J; YELLEN, G				CHOI, KL; MOSSMAN, C; AUBE, J; YELLEN, G			THE INTERNAL QUATERNARY AMMONIUM RECEPTOR-SITE OF SHAKER POTASSIUM CHANNELS	NEURON			English	Article							ACTIVATED K+ CHANNELS; TEA BLOCKADE; SQUID AXON; INACTIVATION; CONDUCTANCE; MUTATIONS; REGION; IONS; MECHANISMS; RESIDUES	Quaternary ammonium (QA) compounds inhibit K+ conductance by entering and occluding the open pore of voltage-activated K+ channels. We characterized the effects of a series of alkyl-triethylammonium blockers on the Shaker K+ channel and tested them on a series of site-directed mutants of the channel protein in order to define the structural features of the binding sites. We found that mutations in two regions of the channel protein, the pore (P) region and the last transmembrane sequence (S6), appear to alter QA binding, not through their effects on gating but perhaps through direct effects on the binding site. Several mutations in the P region affect tetraethylammonium binding but have minimal effects on longer blockers, suggesting that the hydrophobic tail contributes to binding in a nonadditive fashion. Binding of the longer blockers can be affected by varying the hydrophobicity of 1 residue within S6 by site-specific substitution, in a manner consistent with a direct hydrophobic interaction between the side chain at this site and the alkyl chains of the blocker.	JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT BIOPHYS,BALTIMORE,MD 21205; UNIV KANSAS,DEPT MED CHEM,LAWRENCE,KS 66045	Howard Hughes Medical Institute; Johns Hopkins University; University of Kansas	CHOI, KL (corresponding author), JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT NEUROSCI,BALTIMORE,MD 21205, USA.			Yellen, Gary/0000-0003-4228-7866; Aube, Jeffrey/0000-0003-1049-5767	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029693] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS029693, NS29693] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARMSTRON.CM, 1969, J GEN PHYSIOL, V54, P553, DOI 10.1085/jgp.54.5.553; ARMSTRONG CM, 1965, J GEN PHYSIOL, V48, P859, DOI 10.1085/jgp.48.5.859; ARMSTRONG CM, 1966, J GEN PHYSIOL, V50, P491, DOI 10.1085/jgp.50.2.491; ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; ARMSTRONG CM, 1972, J GEN PHYSIOL, V59, P388, DOI 10.1085/jgp.59.4.388; CHOI KL, 1991, P NATL ACAD SCI USA, V88, P5092, DOI 10.1073/pnas.88.12.5092; DEMO SD, 1991, NEURON, V7, P743, DOI 10.1016/0896-6273(91)90277-7; FRENCH RJ, 1981, BIOPHYS J, V34, P271, DOI 10.1016/S0006-3495(81)84849-7; GUY HR, 1990, TRENDS NEUROSCI, V13, P201; HARTMANN HA, 1991, SCIENCE, V251, P942, DOI 10.1126/science.2000495; HEYER EJ, 1976, J GEN PHYSIOL, V67, P703, DOI 10.1085/jgp.67.6.703; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; KELLETT JC, 1966, J PHARM SCI, V55, P414, DOI 10.1002/jps.2600550413; KIRSCH GE, 1992, NEURON, V8, P499, DOI 10.1016/0896-6273(92)90278-L; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LIMAN ER, 1991, NATURE, V353, P752, DOI 10.1038/353752a0; LOGOTHETIS DE, 1992, NEURON, V8, P531, DOI 10.1016/0896-6273(92)90281-H; MACKINNON R, 1988, J GEN PHYSIOL, V91, P335, DOI 10.1085/jgp.91.3.335; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MCCORMACK K, 1991, P NATL ACAD SCI USA, V88, P2931, DOI 10.1073/pnas.88.7.2931; MILLER C, 1982, J GEN PHYSIOL, V79, P869, DOI 10.1085/jgp.79.5.869; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHAPIRO BI, 1977, J GEN PHYSIOL, V69, P897, DOI 10.1085/jgp.69.6.897; SWENSON RP, 1981, J GEN PHYSIOL, V77, P255, DOI 10.1085/jgp.77.3.255; TANFORD C, 1980, HYDROPHOBIC EFFECT; VILLARROEL A, 1988, PFLUG ARCH EUR J PHY, V413, P118, DOI 10.1007/BF00582521; YELLEN G, 1984, J GEN PHYSIOL, V84, P187, DOI 10.1085/jgp.84.2.187; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; YOOL AJ, 1991, NATURE, V349, P700, DOI 10.1038/349700a0; ZAGOTTA WN, 1990, J GEN PHYSIOL, V95, P29, DOI 10.1085/jgp.95.1.29	32	239	241	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1993	10	3					533	541		10.1016/0896-6273(93)90340-W	http://dx.doi.org/10.1016/0896-6273(93)90340-W			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KU901	8461140				2022-12-24	WOS:A1993KU90100017
J	HOSHINO, M; MATSUZAKI, F; NABESHIMA, Y; HAMA, C				HOSHINO, M; MATSUZAKI, F; NABESHIMA, Y; HAMA, C			HIKARU-GENKI, A CNS-SPECIFIC GENE IDENTIFIED BY ABNORMAL LOCOMOTION IN DROSOPHILA, ENCODES A NOVEL TYPE OF PROTEIN	NEURON			English	Article							CELL-ADHESION MOLECULE; HUMAN INTERLEUKIN-2 RECEPTOR; AMINO-ACID-SEQUENCE; MYELIN-ASSOCIATED GLYCOPROTEIN; MEMBRANE-SPANNING REGION; CENTRAL-NERVOUS-SYSTEM; COMPLEMENT FACTOR-B; IMMUNOGLOBULIN SUPERFAMILY; FASCICLIN-I; TYROSINE KINASE	We have identified a gene, hikaru genki (hig), whose mutant phenotype includes abnormal locomotor behavior. Mutant first instar larvae have uncoordinated movements, and both larvae and adults have reduced locomotion. Sequence analyses revealed that this gene encodes a novel type of protein with a signal sequence, but without transmembrane regions. One of its domains has similarities with immunoglobulin domains; three or four regions are similar to a complement-binding domain found in complement-related proteins and selectins. In situ hybridization to embryos revealed that accumulation of the hig transcripts is restricted to subsets of cells in the CNS. Our data suggest that hig has a role in the development of CNS functions involved in locomotor activity.	NIIGATA UNIV,BRAIN RES INST,DEPT NEUROCHEM,NIIGATA 951,JAPAN	Niigata University	HOSHINO, M (corresponding author), NATL INST NEUROSCI,NCNP,DIV MOLEC GENET,4-1-1 OGAWAHIGASHI,KODAIRA,TOKYO 187,JAPAN.							ARQUINT M, 1987, P NATL ACAD SCI USA, V84, P600, DOI 10.1073/pnas.84.2.600; BARTHELS D, 1987, EMBO J, V6, P3202; BARTHELS D, 1987, EMBO J, V6, P907, DOI 10.1002/j.1460-2075.1987.tb04837.x; BEVILACQUA M, 1991, CELL, V67, P233, DOI 10.1016/0092-8674(91)90174-W; BIEBER AJ, 1989, CELL, V59, P447, DOI 10.1016/0092-8674(89)90029-9; CAMPBELL RD, 1983, P NATL ACAD SCI-BIOL, V80, P4464, DOI 10.1073/pnas.80.14.4464; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; CAMPOSORTEGA JA, 1991, ANNU REV NEUROSCI, V14, P399, DOI 10.1146/annurev.ne.14.030191.002151; CAVENER DR, 1987, NUCLEIC ACIDS RES, V15, P1353, DOI 10.1093/nar/15.4.1353; CHRISTIE DL, 1983, BIOCHEM J, V209, P61, DOI 10.1042/bj2090061; COSMAN D, 1984, NATURE, V312, P768, DOI 10.1038/312768a0; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; ELKINS T, 1990, J CELL BIOL, V110, P1825, DOI 10.1083/jcb.110.5.1825; ELKINS T, 1990, CELL, V60, P565, DOI 10.1016/0092-8674(90)90660-7; FERGUSON MAJ, 1988, ANNU REV BIOCHEM, V57, P285; FINKELSTEIN R, 1990, NATURE, V346, P485, DOI 10.1038/346485a0; FURLEY AJ, 1990, CELL, V61, P157, DOI 10.1016/0092-8674(90)90223-2; GERTLER FB, 1989, CELL, V58, P103, DOI 10.1016/0092-8674(89)90407-8; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; GRENNINGLOH G, 1990, COLD SH Q B, V55, P327; HAMBLEN M, 1986, J NEUROGENET, V3, P249, DOI 10.3109/01677068609106855; HARTENSTEIN V, 1987, ROUX ARCH DEV BIOL, V196, P473, DOI 10.1007/BF00399871; HE HT, 1986, EMBO J, V5, P2489, DOI 10.1002/j.1460-2075.1986.tb04526.x; HEMPERLY JJ, 1986, P NATL ACAD SCI USA, V83, P9822, DOI 10.1073/pnas.83.24.9822; HORTSCH M, 1991, ANNU REV CELL BIOL, V7, P505, DOI 10.1146/annurev.cb.07.110191.002445; HORTSCH M, 1990, J BIOL CHEM, V265, P15104; ICHINOSE A, 1986, BIOCHEMISTRY-US, V25, P4633, DOI 10.1021/bi00364a027; ICHINOSE A, 1990, J BIOL CHEM, V265, P13411; JACOBS JR, 1989, NEURON, V2, P1625; KOTWAL GJ, 1988, NATURE, V335, P176, DOI 10.1038/335176a0; KRISTENSEN T, 1987, FASEB J, V46, P2463; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAI C, 1987, P NATL ACAD SCI USA, V84, P4337, DOI 10.1073/pnas.84.12.4337; LEONARD WJ, 1984, NATURE, V311, P626, DOI 10.1038/311626a0; LOZIER J, 1984, P NATL ACAD SCI-BIOL, V81, P3640, DOI 10.1073/pnas.81.12.3640; MOLE JE, 1984, J BIOL CHEM, V259, P3407; MOOS M, 1988, NATURE, V334, P701, DOI 10.1038/334701a0; MULLINS MC, 1989, GENE DEV, V3, P729, DOI 10.1101/gad.3.5.729; MUTA T, 1991, J BIOL CHEM, V266, P6554; NIKAIDO T, 1984, NATURE, V311, P631, DOI 10.1038/311631a0; OKANE CJ, 1987, P NATL ACAD SCI USA, V84, P9123, DOI 10.1073/pnas.84.24.9123; PATEL NH, 1987, CELL, V48, P975, DOI 10.1016/0092-8674(87)90706-9; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PROKOP A, 1991, DEVELOPMENT, V111, P79; PROUDFOOT NJ, 1976, NATURE, V263, P211, DOI 10.1038/263211a0; ROBERTSON HM, 1988, GENETICS, V118, P461; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; SALZER JL, 1987, J CELL BIOL, V104, P957, DOI 10.1083/jcb.104.4.957; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEEGER MA, 1988, CELL, V55, P589, DOI 10.1016/0092-8674(88)90217-6; SIEGELMAN MH, 1989, SCIENCE, V243, P1165, DOI 10.1126/science.2646713; SNOW PM, 1989, CELL, V59, P313, DOI 10.1016/0092-8674(89)90293-6; STOOLMAN LM, 1989, CELL, V56, P907, DOI 10.1016/0092-8674(89)90620-X; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; THOMAS JB, 1984, NATURE, V310, P203, DOI 10.1038/310203a0; TIAN SS, 1991, CELL, V67, P675, DOI 10.1016/0092-8674(91)90063-5; TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X; VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WATSON SR, 1991, J CELL BIOL, V115, P235, DOI 10.1083/jcb.115.1.235; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; YANG XH, 1991, CELL, V67, P661, DOI 10.1016/0092-8674(91)90062-4; YARDEN Y, 1986, NATURE, V323, P226, DOI 10.1038/323226a0; ZINN K, 1988, CELL, V53, P577, DOI 10.1016/0092-8674(88)90574-0	65	36	38	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1993	10	3					395	407		10.1016/0896-6273(93)90329-P	http://dx.doi.org/10.1016/0896-6273(93)90329-P			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KU901	8461133				2022-12-24	WOS:A1993KU90100006
J	MERLIO, JP; ERNFORS, P; KOKAIA, Z; MIDDLEMAS, DS; BENGZON, J; KOKAIA, M; SMITH, ML; SIESJO, BK; HUNTER, T; LINDVALL, O; PERSSON, H				MERLIO, JP; ERNFORS, P; KOKAIA, Z; MIDDLEMAS, DS; BENGZON, J; KOKAIA, M; SMITH, ML; SIESJO, BK; HUNTER, T; LINDVALL, O; PERSSON, H			INCREASED PRODUCTION OF THE TRKB PROTEIN TYROSINE KINASE RECEPTOR AFTER BRAIN INSULTS	NEURON			English	Article							NERVE GROWTH-FACTOR; FACTOR MESSENGER-RNA; HUMAN NEUROTROPHIC FACTOR; AFFINITY NGF RECEPTOR; MOLECULAR-CLONING; FACTOR FAMILY; PROTOONCOGENE PRODUCT; LIMBIC SEIZURES; RAT HIPPOCAMPUS; EXPRESSION	The protein-tyrosine kinases Trk, TrkB, and TrkC are signal-transducing receptors for a family of neurotrophic factors known as the neurotrophins. Here we show that seizures induced by hippocampal kindling lead to a rapid, transient increase of trkB mRNA and protein in the hippocampus. TrkB is a component of a high affinity receptor for brain-derived neurotrophic factor (BDNF). No change was detected in mRNAs for Trk or TrkC, components of the high affinity nerve growth factor or neurotrophin-3 receptors, respectively. trkB mRNA was also transiently increased in the dentate gyrus following cerebral ischemia and hypoglycemic coma; these treatments had no effect on trk and trkC mRNAs. The increase in trkB mRNA and protein showed the same time course and distribution as the increase in BDNF mRNA. These data suggest that BDNF and its receptor may play a local role within the hippocampus in kindling-associated neural plasticity and in neuronal protection following epileptic, ischemic, and hypoglycemic insults.	KAROLINSKA INST,DEPT MED CHEM,MOLEC NEUROBIOL LAB,S-10401 STOCKHOLM 60,SWEDEN; UNIV LUND HOSP,DEPT NEUROL,RESTORAT NEUROL UNIT,S-22185 LUND,SWEDEN; SALK INST BIOL STUDIES,MOLEC BIOL & VIROL LAB,LA JOLLA,CA 92037; UNIV LUND HOSP,S-22185 LUND,SWEDEN	Karolinska Institutet; Lund University; Skane University Hospital; Salk Institute; Lund University; Skane University Hospital			Kokaia, Zaal/AAL-6009-2020; Kokaia, Merab/A-2133-2010	Kokaia, Zaal/0000-0003-2296-2449; Bengzon, Johan/0000-0001-6536-2107	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS009199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG004418] Funding Source: NIH RePORTER; NIA NIH HHS [AG 04418] Funding Source: Medline; NINDS NIH HHS [NS 09199] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AUER RN, 1984, DIABETES, V33, P1090, DOI 10.2337/diabetes.33.11.1090; AYERLELIEVRE C, 1988, SCIENCE, V240, P1339, DOI 10.1126/science.2897715; BALLARIN M, 1991, EXP NEUROL, V114, P35, DOI 10.1016/0014-4886(91)90082-N; BANERJEE SP, 1973, P NATL ACAD SCI USA, V79, P2519; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; BENGZON J, 1992, BRAIN RES, V587, P338, DOI 10.1016/0006-8993(92)91016-8; BERKEMEIER LR, 1991, NEURON, V7, P857, DOI 10.1016/0896-6273(91)90287-A; BUZSAKI G, 1989, EXP BRAIN RES, V78, P268; CHENG B, 1991, NEURON, V7, P1031, DOI 10.1016/0896-6273(91)90347-3; CLARK AJL, 1985, P NATL ACAD SCI USA, V82, P8374, DOI 10.1073/pnas.82.24.8374; CORDONCARDO C, 1991, CELL, V66, P173, DOI 10.1016/0092-8674(91)90149-S; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DISTEFANO PS, 1992, NEURON, V8, P983, DOI 10.1016/0896-6273(92)90213-W; DUGICHDJORDJEVIC MM, 1992, NEUROSCIENCE, V47, P303, DOI 10.1016/0306-4522(92)90246-X; Ebendal T, 1989, Prog Growth Factor Res, V1, P143, DOI 10.1016/0955-2235(89)90008-2; ERNFORS P, 1989, NEURON, V2, P1605, DOI 10.1016/0896-6273(89)90049-4; ERNFORS P, 1988, NEURON, V1, P983, DOI 10.1016/0896-6273(88)90155-9; ERNFORS P, 1990, P NATL ACAD SCI USA, V87, P5454, DOI 10.1073/pnas.87.14.5454; ERNFORS P, 1991, NEURON, V7, P165, DOI 10.1016/0896-6273(91)90084-D; ERNFORS P, 1990, NEURON, V5, P511, DOI 10.1016/0896-6273(90)90090-3; GALL C, 1991, MOL BRAIN RES, V9, P113, DOI 10.1016/0169-328X(91)90136-L; GALL CM, 1989, SCIENCE, V245, P758, DOI 10.1126/science.2549634; GLASS DJ, 1991, CELL, V66, P405, DOI 10.1016/0092-8674(91)90629-D; HADCOCK JR, 1991, TRENDS NEUROSCI, V14, P242, DOI 10.1016/0166-2236(91)90124-D; HALLBOOK F, 1991, NEURON, V6, P845, DOI 10.1016/0896-6273(91)90180-8; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HERRUP K, 1973, P NATL ACAD SCI USA, V70, P3884, DOI 10.1073/pnas.70.12.3884; HOFER M, 1990, EMBO J, V9, P2459, DOI 10.1002/j.1460-2075.1990.tb07423.x; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; IBANEZ CF, 1992, CELL, V69, P329, DOI 10.1016/0092-8674(92)90413-7; IP NY, 1992, P NATL ACAD SCI USA, V89, P3060, DOI 10.1073/pnas.89.7.3060; ISACKSON PJ, 1991, NEURON, V6, P937, DOI 10.1016/0896-6273(91)90234-Q; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; JONES KR, 1990, P NATL ACAD SCI USA, V87, P8060, DOI 10.1073/pnas.87.20.8060; KAISHO Y, 1990, FEBS LETT, V266, P187, DOI 10.1016/0014-5793(90)81536-W; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; KLEIN R, 1989, EMBO J, V8, P3701, DOI 10.1002/j.1460-2075.1989.tb08545.x; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; KOKAIA M, 1989, BRAIN RES, V491, P398, DOI 10.1016/0006-8993(89)90079-6; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; LINDVALL O, 1992, P NATL ACAD SCI USA, V89, P648, DOI 10.1073/pnas.89.2.648; LOTHMAN EW, 1985, BRAIN RES, V360, P83, DOI 10.1016/0006-8993(85)91223-5; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MARTINZANCA D, 1989, MOL CELL BIOL, V9, P24, DOI 10.1128/MCB.9.1.24; MERLIO JP, 1992, NEUROSCIENCE, V51, P513, DOI 10.1016/0306-4522(92)90292-A; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; MIDDLEMAS DS, IN PRESS METH NEUROS; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; PERSSON H, 1993, IN PRESS NEUROMETHOD; PHILLIPS HS, 1990, SCIENCE, V250, P290, DOI 10.1126/science.1688328; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; RODRIGUEZTEBAR A, 1990, NEURON, V4, P487, DOI 10.1016/0896-6273(90)90107-Q; ROSENTHAL A, 1990, NEURON, V4, P767, DOI 10.1016/0896-6273(90)90203-R; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHWAB ME, 1979, BRAIN RES, V168, P473, DOI 10.1016/0006-8993(79)90303-2; SEILER M, 1984, BRAIN RES, V300, P33, DOI 10.1016/0006-8993(84)91338-6; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SHIGENO T, 1991, J NEUROSCI, V11, P2914; SMITH ML, 1984, ACTA NEUROL SCAND, V69, P385, DOI 10.1111/j.1600-0404.1984.tb07822.x; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; SUTTER A, 1979, J BIOL CHEM, V254, P5972; THOENEN H, 1987, REV PHYSIOL BIOCH P, V109, P145, DOI 10.1007/BFb0031026; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; WETMORE C, 1990, EXP NEUROL, V109, P141, DOI 10.1016/0014-4886(90)90068-4; WHITTEMORE SR, 1987, BRAIN RES REV, V12, P439, DOI 10.1016/0165-0173(87)90008-7; ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x	72	251	261	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1993	10	2					151	164		10.1016/0896-6273(93)90307-D	http://dx.doi.org/10.1016/0896-6273(93)90307-D			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KP685	8439408				2022-12-24	WOS:A1993KP68500004
J	Zhong, WM; Feder, JN; Jiang, MM; Jan, LY; Jan, YN				Zhong, WM; Feder, JN; Jiang, MM; Jan, LY; Jan, YN			Asymmetric localization of a mammalian numb homolog during mouse cortical neurogenesis	NEURON			English	Article							RAT CEREBRAL-CORTEX; DROSOPHILA EMBRYOS; ORGAN FORMATION; CELL LINEAGE; NOTCH GENE; EXPRESSION; PROTEIN; DISTINCT; PATTERNS; DOMAIN	During Drosophila neurogenesis, differential segregation of Numb is necessary for daughter cells of asymmetric divisions to adopt distinct fates, at least partly by biasing the Notch-mediated cell-cell interaction. We have isolated a highly conserved mammalian homolog of Drosophila numb, m-numb. During mouse cortical neurogenesis, m-Numb is asymmetrically localized to the apical membrane of dividing ventricular neural progenitors. Depending upon the orientation of the cleavage plane, m-Numb may be distributed into one or both of the daughter cells. When expressed in Drosophila embryos, m-Numb is localized asymmetrically in dividing neural precursors and rescues the numb mutant phenotype. Futhermore, m-Numb can physically interact with mouse Notch1. We propose that some shared molecular mechanisms, both cell-intrinsic and cell-extrinsic, generate asymmetric cell divisions during neurogenesis of vertebrates and invertebrates.	UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Zhong, WM (corresponding author), UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,SAN FRANCISCO,CA 94143, USA.			Jan, Yuh Nung/0000-0003-1367-6299; Jan, Lily/0000-0003-3938-8498				ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Bartel P. L., 1993, CELLULAR INTERACTION, P153; BLAIKIE P, 1994, J BIOL CHEM, V269, P32031; BLOCHLINGER K, 1990, GENE DEV, V4, P1322, DOI 10.1101/gad.4.8.1322; BLOCHLINGER K, 1988, NATURE, V333, P629, DOI 10.1038/333629a0; BORK P, 1995, CELL, V80, P693, DOI 10.1016/0092-8674(95)90347-X; BRAND AH, 1993, DEVELOPMENT, V118, P401; BRAND M, 1993, DEVELOPMENT, V119, P1; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DAVIS AA, 1994, NATURE, V372, P263, DOI 10.1038/372263a0; DELAMO FF, 1993, GENOMICS, V15, P259, DOI 10.1006/geno.1993.1055; DIGNAM JD, 1990, METHOD ENZYMOL, V182, P194; DOE CQ, 1992, DEVELOPMENT, V116, P855; GROVE EA, 1993, DEVELOPMENT, V117, P553; GUO M, 1995, NEURON, V14, P913, DOI 10.1016/0896-6273(95)90330-5; HARTENSTEIN V, 1990, DEV BIOL, V142, P13, DOI 10.1016/0012-1606(90)90147-B; JAN YN, 1995, NEURON, V14, P1; KAVANAUGH WM, 1994, SCIENCE, V266, P1862, DOI 10.1126/science.7527937; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; KOMACK DR, 1995, NEURON, V15, P311; LANGMAN J, 1966, J COMP NEUROL, V127, P399, DOI 10.1002/cne.901270308; LUSKIN MB, 1993, J NEUROSCI, V13, P1730; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; MARTIN AH, 1967, NATURE, V216, P1133, DOI 10.1038/2161133a0; MCCONNELL SK, 1995, NEURON, V15, P761, DOI 10.1016/0896-6273(95)90168-X; MINOE MC, 1994, J NEUROSCI, V14, P107; MUSACCHIO A, 1994, PROG BIOPHYS MOL BIO, V61, P283, DOI 10.1016/0079-6107(94)90003-5; Parnavelas JG, 1991, CEREB CORTEX, V1, P463, DOI 10.1093/cercor/1.6.463; PRICE J, 1988, DEVELOPMENT, V104, P473; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1995, P NATL ACAD SCI USA, V92, P11323, DOI 10.1073/pnas.92.25.11323; REID CB, 1995, NEURON, V15, P299, DOI 10.1016/0896-6273(95)90035-7; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; SMART IHM, 1973, J ANAT, V116, P67; SMART IHM, 1985, J ANAT, V140, P397; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SPANA EP, 1995, DEVELOPMENT, V121, P3489; TAKAHASHI T, 1995, J NEUROSCI, V15, P6058; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0; VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8; VANDERGEER P, 1995, TRENDS BIOCHEM SCI, V20, P277, DOI 10.1016/S0968-0004(00)89043-X; WALSH C, 1988, SCIENCE, V241, P1342, DOI 10.1126/science.3137660; WALSH C, 1992, SCIENCE, V255, P434, DOI 10.1126/science.1734520; WEINMASTER G, 1991, DEVELOPMENT, V113, P199; WEINMASTER G, 1992, DEVELOPMENT, V116, P931; ZAMENHOF S, 1987, DEV BRAIN RES, V31, P143, DOI 10.1016/0165-3806(87)90094-0; ZHONG WM, 1994, MOL CELL BIOL, V14, P7276, DOI 10.1128/MCB.14.11.7276; ZHOU MM, 1995, NATURE, V378, P584, DOI 10.1038/378584a0; ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2	52	384	399	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1996	17	1					43	53		10.1016/S0896-6273(00)80279-2	http://dx.doi.org/10.1016/S0896-6273(00)80279-2			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UY981	8755477	Bronze			2022-12-24	WOS:A1996UY98100006
J	Hyman, SE				Hyman, SE			Addiction to cocaine and amphetamine	NEURON			English	Review									HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,LAB MOL & DEV NEUROSCI,BOSTON,MA 02114	Harvard University; Harvard Medical School; Massachusetts General Hospital								BROWN EE, 1992, J NEUROSCI, V12, P4112; Carew TJ, 1996, NEURON, V16, P5, DOI 10.1016/S0896-6273(00)80016-1; COLE RL, 1995, NEURON, V14, P813, DOI 10.1016/0896-6273(95)90225-2; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; HOPE B, 1992, P NATL ACAD SCI USA, V89, P5764, DOI 10.1073/pnas.89.13.5764; HOPE BT, 1994, NEURON, V13, P1235, DOI 10.1016/0896-6273(94)90061-2; JABER M, 1995, NEUROSCIENCE, V65, P1041, DOI 10.1016/0306-4522(94)00537-F; KOMBIAN SB, 1994, NATURE, V368, P242, DOI 10.1038/368242a0; KONRADI C, 1994, J NEUROSCI, V14, P5623; KOOB GF, 1996, NEURON, V16; KOSOFSKY BE, 1995, J COMP NEUROL, V351, P41, DOI 10.1002/cne.903510105; MARKOU A, 1991, NEUROPSYCHOPHARMACOL, V4, P17; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; SELF DW, 1995, ANNU REV NEUROSCI, V18, P463, DOI 10.1146/annurev.neuro.18.1.463; Self DW, 1996, SCIENCE, V271, P1586, DOI 10.1126/science.271.5255.1586; STEINER H, 1995, J COMP NEUROL, V353, P200, DOI 10.1002/cne.903530204; WOLF ME, 1994, J NEUROSCI, V14, P1735, DOI 10.1523/JNEUROSCI.14-03-01735.1994; XU M, 1994, CELL, V79, P729, DOI 10.1016/0092-8674(94)90557-6	18	190	190	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1996	16	5					901	904		10.1016/S0896-6273(00)80111-7	http://dx.doi.org/10.1016/S0896-6273(00)80111-7			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UN480	8630246	Bronze			2022-12-24	WOS:A1996UN48000003
J	Lin, CH; Espreafico, EM; Mooseker, MS; Forscher, P				Lin, CH; Espreafico, EM; Mooseker, MS; Forscher, P			Myosin drives retrograde F-actin flow in neuronal growth cones	NEURON			English	Article							RABBIT SKELETAL-MUSCLE; 2,3-BUTANEDIONE MONOXIME; CONTRACTILE ACTIVATION; UNCONVENTIONAL MYOSIN; LEADING-EDGE; NERVE GROWTH; MOTILITY; CELLS; FIBROBLASTS; LOCOMOTION	Actin filaments assembled at the leading edge of neuronal growth cones are centripetally transported via retrograde F-actin flow, a process fundamental to growth cone guidance and other forms of directed cell motility. Here we investigated the role of myosins in retrograde flow, using two distinct modes of myosin inhibition: microinjection of NEM inactivated myosin S1 fragments, or treatment with 2,3-butanedione-2-monoxime, an inhibitor of myosin ATPase. Both treatments resulted in dose-dependent attenuation of retrograde F-actin flow and growth of filopodia. Growth was cytochalasin sensitive and directly proportional to the degree of myosin inhibition, suggesting that retrograde flow results from superimposition of two independent processes: actin assembly and myosin-based filament retraction. These results provide the first direct evidence for myosin involvement in neuronal growth cone function.	FAC MED RIBEIRAO PRETO, DEPT MORPHOL, RIBEIRAO PRETO, SP, BRAZIL; YALE UNIV, DEPT BIOL, NEW HAVEN, CT 06511 USA	Yale University	Lin, CH (corresponding author), NATL YANG MING UNIV, TAIPEI, TAIWAN.		Espreafico, Enilza/O-3053-2016; Espreafico, Enilza/AAW-4658-2021	Espreafico, Enilza/0000-0002-7552-4234; Espreafico, Enilza/0000-0002-7552-4234; Forscher, Paul/0000-0003-1988-5155	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK025387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028695] Funding Source: NIH RePORTER; NIDDK NIH HHS [R37-DK25387] Funding Source: Medline; NINDS NIH HHS [NS28695] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABERCROMBIE M, 1970, EXP CELL RES, V62, P389, DOI 10.1016/0014-4827(70)90570-7; ALPERT NR, 1989, J PHYSIOL-LONDON, V414, P433, DOI 10.1113/jphysiol.1989.sp017697; BACKX PH, 1994, J PHYSIOL-LONDON, V476, P487, DOI 10.1113/jphysiol.1994.sp020149; BAHLER M, 1994, J CELL BIOL, V126, P375, DOI 10.1083/jcb.126.2.375; BENTLEY D, 1986, NATURE, V323, P712, DOI 10.1038/323712a0; BRAY D, 1988, SCIENCE, V239, P883, DOI 10.1126/science.3277283; BRAY D, 1970, P NATL ACAD SCI USA, V65, P905, DOI 10.1073/pnas.65.4.905; CANDE WZ, 1986, METHOD ENZYMOL, V134, P473; CHENEY RE, 1993, CELL, V75, P13, DOI 10.1016/0092-8674(93)90675-G; CHENG TPO, 1992, FEBS LETT, V311, P91, DOI 10.1016/0014-5793(92)81374-U; CRAMER LP, 1994, CURR OPIN CELL BIOL, V6, P82, DOI 10.1016/0955-0674(94)90120-1; CRAMER LP, 1995, J CELL BIOL, V131, P179, DOI 10.1083/jcb.131.1.179; DETMERS P, 1981, J BIOL CHEM, V256, P99; ESPREAFICO EM, 1992, J CELL BIOL, V119, P1541, DOI 10.1083/jcb.119.6.1541; FISHER GW, 1988, CELL MOTIL CYTOSKEL, V11, P235, DOI 10.1002/cm.970110403; FORSCHER P, 1992, NATURE, V357, P515, DOI 10.1038/357515a0; FORSCHER P, 1990, OPTICAL MICROSCOPY FOR BIOLOGY, P459; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; FRYER MW, 1988, J PHYSIOL-LONDON, V407, P53, DOI 10.1113/jphysiol.1988.sp017403; GRAZI E, 1980, FEBS LETT, V112, P67, DOI 10.1016/0014-5793(80)80129-3; GWATHMEY JK, 1991, CIRC RES, V69, P1280, DOI 10.1161/01.RES.69.5.1280; HEATH JP, 1991, CELL MOTIL CYTOSKEL, V18, P245, DOI 10.1002/cm.970180402; HERRMANN C, 1992, BIOCHEMISTRY-US, V31, P12227, DOI 10.1021/bi00163a036; HIGUCHI H, 1989, J BIOCHEM-TOKYO, V105, P638, DOI 10.1093/oxfordjournals.jbchem.a122717; HORIUTI K, 1988, J MUSCLE RES CELL M, V9, P156, DOI 10.1007/BF01773737; Kennedy Timothy E., 1995, Current Opinion in Neurobiology, V5, P83, DOI 10.1016/0959-4388(95)80091-3; KIELLEY WW, 1960, BIOCHIM BIOPHYS ACTA, V41, P401; LEE J, 1993, NATURE, V362, P167, DOI 10.1038/362167a0; LEE J, 1994, J CELL BIOL, V127, P1957, DOI 10.1083/jcb.127.6.1957; LEWIS AK, 1992, J CELL BIOL, V119, P1219, DOI 10.1083/jcb.119.5.1219; LIN CH, 1993, J CELL BIOL, V121, P1369, DOI 10.1083/jcb.121.6.1369; LIN CH, 1995, NEURON, V14, P763, DOI 10.1016/0896-6273(95)90220-1; Lin Chi-Hung, 1994, Current Opinion in Neurobiology, V4, P640, DOI 10.1016/0959-4388(94)90004-3; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; MCKILLOP DFA, 1994, J MUSCLE RES CELL M, V15, P309; MEEUSEN RL, 1979, J CELL BIOL, V82, P57, DOI 10.1083/jcb.82.1.57; MILLER L, 1988, J BIOL CHEM, V263, P1996; MILLER M, 1992, NEURON, V8, P25, DOI 10.1016/0896-6273(92)90106-N; MITCHISON T, 1988, NEURON, V1, P761, DOI 10.1016/0896-6273(88)90124-9; Mooseker MS, 1995, ANNU REV CELL DEV BI, V11, P633, DOI 10.1146/annurev.cellbio.11.1.633; POLLARD TD, 1986, ANNU REV BIOCHEM, V55, P987, DOI 10.1146/annurev.bi.55.070186.005011; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; ROCHLIN MW, 1995, J CELL SCI, V108, P3661; RUPPERT C, 1993, J CELL BIOL, V120, P1393, DOI 10.1083/jcb.120.6.1393; SCHRAMM M, 1994, J PHYSIOL-LONDON, V481, P647, DOI 10.1113/jphysiol.1994.sp020471; SMITH SJ, 1988, SCIENCE, V242, P708, DOI 10.1126/science.3055292; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; STEELE DS, 1993, AM J PHYSIOL, V265, pH1493, DOI 10.1152/ajpheart.1993.265.5.H1493; STEINEN GJM, 1995, J PHYSL, V482, P109; SVOBODA K, 1994, ANNU REV BIOPH BIOM, V23, P247, DOI 10.1146/annurev.bb.23.060194.001335; TANAKA E, 1995, CELL, V83, P171, DOI 10.1016/0092-8674(95)90158-2; Tessier-Lavigne M, 1992, Curr Opin Neurobiol, V2, P60, DOI 10.1016/0959-4388(92)90163-F; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; THERIOT JA, 1992, NATURE, V357, P257, DOI 10.1038/357257a0; Theriot Julie A., 1992, Trends in Cell Biology, V2, P219, DOI 10.1016/0962-8924(92)90298-2; TUNG L, 1985, J PHARMACOL EXP THER, V232, P688; WANG YL, 1985, J CELL BIOL, V101, P597, DOI 10.1083/jcb.101.2.597; WEST JM, 1989, PFLUG ARCH EUR J PHY, V413, P546, DOI 10.1007/BF00594187; YAMADA KM, 1973, DEV BIOL, V31, P413, DOI 10.1016/0012-1606(73)90276-5; ZHAO Y, 1994, AM J PHYSIOL, V266, pC437, DOI 10.1152/ajpcell.1994.266.2.C437	60	332	332	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1996	16	4					769	782		10.1016/S0896-6273(00)80097-5	http://dx.doi.org/10.1016/S0896-6273(00)80097-5			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UG611	8607995	hybrid			2022-12-24	WOS:A1996UG61100010
J	Grabner, M; Wang, ZY; Hering, S; Striessnig, J; Glossmann, H				Grabner, M; Wang, ZY; Hering, S; Striessnig, J; Glossmann, H			Transfer of 1,4-dihydropyridine sensitivity from L-type to class A (BI) calcium channels	NEURON			English	Article							SKELETAL-MUSCLE; BETA-SUBUNIT; DIHYDROPYRIDINE RECEPTOR; SMOOTH-MUSCLE; CA2+ CHANNELS; FUNCTIONAL EXPRESSION; DEPENDENT MODULATION; ALPHA-1 SUBUNIT; MESSENGER-RNAS; ACTIVATION	L-type Ca2+ channels are characterized by their unique sensitivity to organic Ca2+ channel modulators like the 1,4-dihydropyridines (DHPs). To identify molecular motifs mediating DHP sensitivity, we transferred this sensitivity from L-type Ca2+ channels to the DHP-insensitive class A brain Ca2+ channel, BI-2. Expression of chimeras revealed minimum sequence stretches conferring DHP sensitivity including segments IIIS5, lllS6, and the connecting linker, as well as the IVS5-IVS6 linker plus segment IVS6. DHP agonist and antagonist effects are determined by different regions within the repeat IV motif. Sequence regions responsible for DHP sensitivity comprise only 9.4% of the overall primary structure of a DHP-sensitive alpha(1A)/alpha(1S) construct. This chimera fully exhibits the DHP sensitivity of channels formed by L-type alpha(1) subunits. In addition, it displays the electrophysiological properties of alpha(1A) as well as its sensitivity toward the peptide toxins omega-agatoxin IVA and omega-conotoxin MVIIC.			Grabner, M (corresponding author), UNIV INNSBRUCK, INST BIOCHEM PHARMAKOL, PETER MAYRSTR 1, A-6020 INNSBRUCK, AUSTRIA.		Striessnig, Joerg/S-9334-2017; Glossmann, Hartmut/AAL-9790-2020	Striessnig, Joerg/0000-0002-9406-7120; glossmann, hartmut h./0000-0002-7392-3266				BEAN BP, 1984, P NATL ACAD SCI-BIOL, V81, P6388, DOI 10.1073/pnas.81.20.6388; BECHEM M, 1993, PFLUG ARCH EUR J PHY, V424, P343, DOI 10.1007/BF00384362; BIRNBAUMER L, 1994, NEURON, V13, P505, DOI 10.1016/0896-6273(94)90021-3; CATTERALL WA, 1988, J BIOL CHEM, V263, P3535; CATTERALL WA, 1992, TRENDS PHARMACOL SCI, V13, P256, DOI 10.1016/0165-6147(92)90079-L; DELEAN A, 1978, AM J PHYSIOL, V235, pE97, DOI 10.1152/ajpendo.1978.235.2.E97; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; ELLINOR PT, 1994, NATURE, V372, P272, DOI 10.1038/372272a0; ELLIS SB, 1988, SCIENCE, V241, P1661, DOI 10.1126/science.2458626; GEORGIADIS MM, 1992, SCIENCE, V257, P1653, DOI 10.1126/science.1529353; GINAP T, 1993, NEUROSCI LETT, V156, P35, DOI 10.1016/0304-3940(93)90433-L; Glossmann H., 1990, REV PHYSL BIOCH PHAR, V114, P1; GRABNER M, 1994, J BIOL CHEM, V269, P23668; GRABNER M, 1991, P NATL ACAD SCI USA, V88, P727, DOI 10.1073/pnas.88.3.727; GROSS A, 1994, NEURON, V13, P961, DOI 10.1016/0896-6273(94)90261-5; GUY HR, 1990, TRENDS NEUROSCI, V13, P201; HERING S, 1989, CIRC RES, V64, P928, DOI 10.1161/01.RES.64.5.928; HESS P, 1990, ANNU REV NEUROSCI, V13, P337, DOI 10.1146/annurev.ne.13.030190.002005; HESS P, 1984, NATURE, V311, P538, DOI 10.1038/311538a0; HILLE B, 1992, IONIC CHANNELS EXCIT, P83; HOFMANN F, 1994, ANNU REV NEUROSCI, V17, P399, DOI 10.1146/annurev.neuro.17.1.399; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; HUGHES AD, 1990, BRIT J PHARMACOL, V101, P3, DOI 10.1111/j.1476-5381.1990.tb12076.x; KAMP TJ, 1989, CIRC RES, V64, P338, DOI 10.1161/01.RES.64.2.338; KASS RS, 1989, J GEN PHYSIOL, V93, P1109, DOI 10.1085/jgp.93.6.1109; KASS RS, 1991, J GEN PHYSIOL, V98, P63, DOI 10.1085/jgp.98.1.63; KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057; KUNZE DL, 1992, MOL PHARMACOL, V42, P666; LACERDA AE, 1989, J GEN PHYSIOL, V93, P1243, DOI 10.1085/jgp.93.6.1243; LACERDA AE, 1991, NATURE, V352, P527, DOI 10.1038/352527a0; MARKS TN, 1992, J GEN PHYSIOL, V99, P367, DOI 10.1085/jgp.99.3.367; METHFESSEL C, 1986, PFLUG ARCH EUR J PHY, V407, P577, DOI 10.1007/BF00582635; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; MITTERDORFER J, 1995, BIOCHEMISTRY-US, V34, P9350, DOI 10.1021/bi00029a010; MITTERDORFER J, 1994, FEBS LETT, V352, P141, DOI 10.1016/0014-5793(94)00938-4; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; NAKAI J, 1994, P NATL ACAD SCI USA, V91, P1014, DOI 10.1073/pnas.91.3.1014; NAKAYAMA H, 1991, P NATL ACAD SCI USA, V88, P9203, DOI 10.1073/pnas.88.20.9203; RAGSDALE DS, 1994, SCIENCE, V265, P1724, DOI 10.1126/science.8085162; RANDALL A, 1995, J NEUROSCI, V15, P2995; RUTH P, 1989, SCIENCE, V245, P1115, DOI 10.1126/science.2549640; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SANGUINETTI MC, 1986, J GEN PHYSIOL, V88, P369, DOI 10.1085/jgp.88.3.369; SATHER WA, 1993, NEURON, V11, P291, DOI 10.1016/0896-6273(93)90185-T; SPRANG S, 1987, SCIENCE, V237, P1012, DOI 10.1126/science.3616621; STEA A, 1994, P NATL ACAD SCI USA, V91, P10576, DOI 10.1073/pnas.91.22.10576; STRIESSNIG J, 1991, P NATL ACAD SCI USA, V88, P10769, DOI 10.1073/pnas.88.23.10769; STRUBING C, 1993, BRIT J PHARMACOL, V108, P884, DOI 10.1111/j.1476-5381.1993.tb13482.x; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; TANABE T, 1991, NATURE, V352, P800, DOI 10.1038/352800a0; TANG SQ, 1993, NEURON, V11, P1013, DOI 10.1016/0896-6273(93)90215-D; TRIGGLE DJ, 1991, ANN NY ACAD SCI, V635, P123, DOI 10.1111/j.1749-6632.1991.tb36487.x; VARADI G, 1991, NATURE, V352, P159, DOI 10.1038/352159a0; WANG Z, 1995, J PHYSL, P131; WEI XY, 1991, J BIOL CHEM, V266, P21943; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; ZHANG JF, 1994, NATURE, V372, P97, DOI 10.1038/372097a0	57	133	133	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1996	16	1					207	218		10.1016/S0896-6273(00)80037-9	http://dx.doi.org/10.1016/S0896-6273(00)80037-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TT307	8562085	Bronze			2022-12-24	WOS:A1996TT30700023
J	WELSH, DK; LOGOTHETIS, DE; MEISTER, M; REPPERT, SM				WELSH, DK; LOGOTHETIS, DE; MEISTER, M; REPPERT, SM			INDIVIDUAL NEURONS DISSOCIATED FROM RAT SUPRACHIASMATIC NUCLEUS EXPRESS INDEPENDENTLY PHASED CIRCADIAN FIRING RHYTHMS	NEURON			English	Article							CULTURED NEURONS; VASOPRESSIN RELEASE; HYPOTHALAMIC SLICE; ACTION-POTENTIALS; MAMMALIAN RETINA; INVITRO; CELLS; CLOCK; GABA; NEUROTRANSMITTER	Within the mammalian hypothalamus, the suprachiasmatic nucleus (SCN) contains a circadian clock for timing of diverse neuronal, endocrine, and behavioral rhythms. By culturing cells from neonatal rat SCN on fixed microelectrode arrays, we have been able to record spontaneous action potentials from individual SCN neurons for days or weeks, revealing prominent circadian rhythms in firing rate. Despite abundant functional synapses, circadian rhythms expressed by neurons in the same culture are not synchronized. After reversible blockade of neuronal firing lasting 2.5 days, circadian firing rhythms re-emerge with unaltered phases. These data suggest that the SCN contains a large population of autonomous, single-cell circadian oscillators, and that synapses formed in vitro are neither necessary for operation of these oscillators nor sufficient for synchronizing them.	HARVARD UNIV, SCH MED, PROGRAM NEUROSCI, BOSTON, MA 02115 USA; CHILDRENS HOSP, DIV CARDIOL, BOSTON, MA 02115 USA; HARVARD UNIV, DEPT MOLEC & CELLULAR BIOL, CAMBRIDGE, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University	WELSH, DK (corresponding author), MASSACHUSETTS GEN HOSP, DEV CHRONOBIOL LAB, BOSTON, MA 02114 USA.		Welsh, David K/G-2277-2011; Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X; Meister, Markus/0000-0003-2136-6506				BANKER G, 1991, CULTURING NERVE CELL, P75; BAUGHMAN RW, 1991, CULTURING NERVE CELL, P227; BLOOMFIELD P, 1976, FOURIER ANAL TIME SE, P9; BOS NPA, 1990, BRAIN RES, V511, P158, DOI 10.1016/0006-8993(90)90235-4; BOUSKILA Y, 1993, P NATL ACAD SCI USA, V90, P3207, DOI 10.1073/pnas.90.8.3207; BUCKLEY K, 1985, J CELL BIOL, V100, P1284, DOI 10.1083/jcb.100.4.1284; CASSONE VM, 1993, J BIOL RHYTHM, V8, pS73; DECAVEL C, 1990, J COMP NEUROL, V302, P1019, DOI 10.1002/cne.903020423; DIERICKX K, 1979, CELL TISSUE RES, V201, P349; DING JM, 1994, SCIENCE, V266, P1713, DOI 10.1126/science.7527589; DROGE MH, 1986, J NEUROSCI, V6, P1583; FORDA SR, 1982, BRAIN RES, V249, P371, DOI 10.1016/0006-8993(82)90071-3; GREEN DJ, 1982, BRAIN RES, V245, P198, DOI 10.1016/0006-8993(82)90361-4; GROOS G, 1982, NEUROSCI LETT, V34, P283, DOI 10.1016/0304-3940(82)90189-6; GROSS GW, 1977, NEUROSCI LETT, V6, P101, DOI 10.1016/0304-3940(77)90003-9; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; INOUYE ST, 1979, P NATL ACAD SCI USA, V76, P5962, DOI 10.1073/pnas.76.11.5962; JOHANSSON S, 1992, BRAIN RES, V580, P185, DOI 10.1016/0006-8993(92)90943-4; KIM YI, 1993, J PHYSIOL-LONDON, V464, P229, DOI 10.1113/jphysiol.1993.sp019632; Klein D.C., 1991, SUPRACHIASMATIC NUCL; KRASZEWSKI K, 1992, NEUROSCIENCE, V47, P555, DOI 10.1016/0306-4522(92)90165-X; MCARTHUR AJ, 1991, BRAIN RES, V565, P158, DOI 10.1016/0006-8993(91)91748-P; MEIJER JH, 1989, PHYSIOL REV, V69, P671, DOI 10.1152/physrev.1989.69.3.671; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; MICHEL S, 1993, SCIENCE, V259, P239, DOI 10.1126/science.8421785; MILLER JD, 1993, AM J PHYSIOL, V264, pR821, DOI 10.1152/ajpregu.1993.264.5.R821; MOORE RY, 1989, J NEUROSCI, V9, P2151; MOORE RY, 1993, NEUROSCI LETT, V150, P112, DOI 10.1016/0304-3940(93)90120-A; MURAKAMI N, 1991, BRAIN RES, V545, P347, DOI 10.1016/0006-8993(91)91312-O; OKAMURA H, 1989, NEUROSCI LETT, V102, P131, DOI 10.1016/0304-3940(89)90067-0; PERKEL DH, 1967, BIOPHYS J, V7, P419, DOI 10.1016/S0006-3495(67)86597-4; PINE J, 1980, J NEUROSCI METH, V2, P19, DOI 10.1016/0165-0270(80)90042-4; PROSSER RA, 1994, BRAIN RES, V643, P296, DOI 10.1016/0006-8993(94)90036-1; REFINETTI R, 1993, PHYSIOL BEHAV, V54, P869, DOI 10.1016/0031-9384(93)90294-P; REGEHR WG, 1989, J NEUROSCI METH, V30, P91, DOI 10.1016/0165-0270(89)90055-1; REPPERT SM, 1994, NEURON, V13, P1177, DOI 10.1016/0896-6273(94)90055-8; REPPERT SM, 1984, J NEUROSCI, V4, P1677; RISKIND PN, 1989, NEUROSCI LETT, V105, P215, DOI 10.1016/0304-3940(89)90040-2; ROBERTS MM, 1993, NEUROENDOCRINOLOGY, V57, P388, DOI 10.1159/000126384; SCHWARTZ WJ, 1987, P NATL ACAD SCI USA, V84, P1694, DOI 10.1073/pnas.84.6.1694; SCHWARTZ WJ, 1980, J COMP NEUROL, V189, P157, DOI 10.1002/cne.901890109; SELVERSTON AI, 1985, ANNU REV PHYSIOL, V47, P29; SHIBATA S, 1984, DEV BRAIN RES, V13, P29, DOI 10.1016/0165-3806(84)90074-9; SHIBATA S, 1982, BRAIN RES, V247, P154, DOI 10.1016/0006-8993(82)91041-1; SHIBATA S, 1993, BRAIN RES, V606, P259, DOI 10.1016/0006-8993(93)90993-W; SILVER R, 1990, BRAIN RES, V525, P45, DOI 10.1016/0006-8993(90)91319-C; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; VANDENPOL AN, 1993, NEUROSCIENCE, V56, P793, DOI 10.1016/0306-4522(93)90128-3; VANDENPOL AN, 1985, NEUROSCIENCE, V15, P1049, DOI 10.1016/0306-4522(85)90254-4; VANDENPOL AN, 1992, J NEUROSCI, V12, P2648; VINCENT SR, 1985, J COMP NEUROL, V238, P169, DOI 10.1002/cne.902380205; WALSH IB, 1992, BRAIN RES, V588, P120, DOI 10.1016/0006-8993(92)91351-E; WATANABE K, 1993, BRAIN RES, V624, P115, DOI 10.1016/0006-8993(93)90067-W; WATTS AG, 1987, J COMP NEUROL, V258, P230, DOI 10.1002/cne.902580205; WHITNALL MH, 1985, J NEUROSCI, V5, P98; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8; ZLOMANCZUK P, 1991, BRAIN RES, V559, P94, DOI 10.1016/0006-8993(91)90291-3	58	1087	1106	1	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1995	14	4					697	706		10.1016/0896-6273(95)90214-7	http://dx.doi.org/10.1016/0896-6273(95)90214-7			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QU826	7718233	Bronze			2022-12-24	WOS:A1995QU82600004
J	CURTIN, KD; HUANG, ZJ; ROSBASH, M				CURTIN, KD; HUANG, ZJ; ROSBASH, M			TEMPORALLY REGULATED NUCLEAR ENTRY OF THE DROSOPHILA PERIOD PROTEIN CONTRIBUTES TO THE CIRCADIAN CLOCK	NEURON			English	Article							MESSENGER-RNA LEVELS; NF-KAPPA-B; TRANSCRIPTION FACTOR; GENE-PRODUCT; AH-RECEPTOR; MELANOGASTER; MUTANTS; RHYTHMS; DNA; EXPRESSION	The Drosophila period protein (PER) is a predominantly nuclear protein and a likely component of a circadian clock. PER is required for daily oscillations in the transcription of its own gene and thus participates in a circadian feedback loop. In this study, key pacemaker neurons of the Drosophila brain were examined to determine whether the subcellular distribution of PER changes with the tire of day. Indeed, PER was found to accumulate in the cytoplasm for several hours before entering the nucleus during a narrow time window. Three long-period mutations (pert) cause a delay in the timing of nuclear translocation and a further delay at elevated temperature. The data indicate that regulation of PER nuclear entry is critical for circadian oscillations by providing a necessary temporal delay between PER synthesis and its effect on transcription.			CURTIN, KD (corresponding author), BRANDEIS UNIV,HOWARD HUGHES MED INST,DEPT BIOL,WALTHAM,MA 02254, USA.			Huang, Z. Josh/0000-0003-0592-028X	NIGMS NIH HHS [GM-33205] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAEUERLE PA, 1988, CELL, V53, P211, DOI 10.1016/0092-8674(88)90382-0; BAYLIES MK, 1987, NATURE, V326, P390, DOI 10.1038/326390a0; BAYLIES MK, 1993, MOL GENETICS BIOL RH, P123; BEG AA, 1992, GENE DEV, V6, P1899, DOI 10.1101/gad.6.10.1899; BURBACH KM, 1992, P NATL ACAD SCI USA, V89, P8185, DOI 10.1073/pnas.89.17.8185; CITRI Y, 1987, NATURE, V326, P42, DOI 10.1038/326042a0; COTE GG, 1986, J THEOR BIOL, V121, P487, DOI 10.1016/S0022-5193(86)80104-7; EDERY I, 1994, P NATL ACAD SCI USA, V91, P2260, DOI 10.1073/pnas.91.6.2260; EDERY I, 1994, SCIENCE, V263, P237, DOI 10.1126/science.8284676; Edmunds LN, 1988, CELLULAR MOL BASES B; EWER J, 1992, J NEUROSCI, V12, P3321; EWER J, 1990, J NEUROGENET, V7, P31, DOI 10.3109/01677069009084151; FRISCH B, 1994, NEURON, V12, P555, DOI 10.1016/0896-6273(94)90212-7; HAMBLEN M, 1986, J NEUROGENET, V3, P249, DOI 10.3109/01677068609106855; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; HARDIN PE, 1992, P NATL ACAD SCI USA, V89, P11711, DOI 10.1073/pnas.89.24.11711; HARDIN PE, 1993, MOL GENETICS BIOL RH, P155; Hastings J. Woodland, 1976, MOL BASIS CIRCADIAN; HELFRICHFORSTER C, 1995, P NATL ACAD SCI USA, V92, P612, DOI 10.1073/pnas.92.2.612; HOFFMAN EC, 1991, SCIENCE, V252, P954, DOI 10.1126/science.1852076; HUANG ZJ, 1993, NATURE, V364, P259, DOI 10.1038/364259a0; HUANG ZJ, 1995, IN PRESS SCIENCE; KING RW, 1994, CELL, V79, P563, DOI 10.1016/0092-8674(94)90542-8; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; KONOPKA RJ, 1989, J NEUROGENET, V6, P1, DOI 10.3109/01677068909107096; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LIU X, 1992, J NEUROSCI, V12, P2735; MOLL T, 1991, CELL, V66, P743, DOI 10.1016/0092-8674(91)90118-I; NAMBU JR, 1991, CELL, V67, P1157, DOI 10.1016/0092-8674(91)90292-7; POLLENZ RS, 1994, MOL PHARMACOL, V45, P428; REYES H, 1992, SCIENCE, V256, P1193, DOI 10.1126/science.256.5060.1193; RUTILA JE, 1992, J NEUROGENET, V8, P101, DOI 10.3109/01677069209084155; SEHGAL A, 1994, SCIENCE, V263, P1603, DOI 10.1126/science.8128246; Takahashi J S, 1991, Curr Opin Neurobiol, V1, P556, DOI 10.1016/S0959-4388(05)80028-5; VOSSHALL LB, 1994, SCIENCE, V263, P1606, DOI 10.1126/science.8128247; YU Q, 1987, P NATL ACAD SCI USA, V84, P784, DOI 10.1073/pnas.84.3.784; ZENG HK, 1994, EMBO J, V13, P3590, DOI 10.1002/j.1460-2075.1994.tb06666.x; ZERR DM, 1990, J NEUROSCI, V10, P2749	38	228	234	0	20	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1995	14	2					365	372		10.1016/0896-6273(95)90292-9	http://dx.doi.org/10.1016/0896-6273(95)90292-9			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QH294	7857645	Bronze			2022-12-24	WOS:A1995QH29400014
J	LIN, YF; BROWNING, MD; DUDEK, EM; MACDONALD, RL				LIN, YF; BROWNING, MD; DUDEK, EM; MACDONALD, RL			PROTEIN-KINASE-C ENHANCES RECOMBINANT BOVINE ALPHA-1-BETA-1-GAMMA-2L GABA(A) RECEPTOR WHOLE-CELL CURRENTS EXPRESSED IN L929 FIBROBLASTS	NEURON			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; AMINOBUTYRIC ACIDA RECEPTOR; A RECEPTOR; CYCLIC-AMP; PHOSPHORYLATION SITES; MOLECULAR-BIOLOGY; ION CHANNELS; DESENSITIZATION; SUBUNIT; ACTIVATION	The beta 1 and gamma 2L subunits of the gamma-aminobutyric acid type A receptor (GABAR) contain phosphorylation sites for PKC. To determine the effect of PKC on GABAR function, whole-cell recordings were obtained from mouse fibroblasts expressing recombinant alpha 1 beta 1 gamma 2L receptors, and catalytically active PKC (PKM) was applied via the recording pipette. The first experiment was a population study. Intracellular application of PKM increased GABAR currents, and the enhancement was antagonized by coapplication of the PKC inhibitory peptide. No acceleration or deceleration of GABAR desensitization was observed. The second experiment was a reimpalement study in which paired recordings were made successively from individual cells. Enhancement of GABAR currents by PKM was again obtained. PKM increased GABAR currents at high (>10 mu M) but not at low (<10 mu M) GABA concentrations, resulting in increases in both EC(50) and maximal GABAR current. Thus, PKC phosphorylation enhanced recombinant alpha 1 beta 1 gamma 2L GABAR current by increasing maximal current without increasing the affinity of GABA for the GABARs.	UNIV MICHIGAN,SCH MED,DEPT NEUROL,ANN ARBOR,MI 48109; UNIV COLORADO,HLTH SCI CTR,DEPT PHARMACOL,DENVER,CO 80262	University of Michigan System; University of Michigan; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	LIN, YF (corresponding author), UNIV MICHIGAN,SCH MED,DEPT PHYSIOL,ANN ARBOR,MI 48109, USA.			Lin, Yu-Fung/0000-0003-1471-949X	NATIONAL INSTITUTE ON AGING [P01AG004418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA003527] Funding Source: NIH RePORTER; NIAAA NIH HHS [AA 03527, AA 09615] Funding Source: Medline; NIA NIH HHS [AG 04418] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ANGELOTTI TP, 1993, J NEUROSCI, V13, P1418; BOLTON S, 1990, PHARM STATISTICS PRA; BROWNING MD, 1985, J NEUROCHEM, V45, P11, DOI 10.1111/j.1471-4159.1985.tb05468.x; BROWNING MD, 1990, P NATL ACAD SCI USA, V87, P1315, DOI 10.1073/pnas.87.4.1315; BURT DR, 1991, FASEB J, V5, P2916, DOI 10.1096/fasebj.5.14.1661244; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHEN QX, 1990, J PHYSIOL-LONDON, V420, P207, DOI 10.1113/jphysiol.1990.sp017908; DASCAL N, 1986, SCIENCE, V321, P1147; DOWNING JEG, 1987, P NATL ACAD SCI USA, V84, P7739, DOI 10.1073/pnas.84.21.7739; FERRERMONTIEL AV, 1991, P NATL ACAD SCI USA, V88, P10213, DOI 10.1073/pnas.88.22.10213; GYENES M, 1988, MOL PHARMACOL, V34, P719; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARRISON NL, 1989, NEUROSCI LETT, V105, P137, DOI 10.1016/0304-3940(89)90025-6; HEMMINGS HC, 1989, FASEB J, V3, P1583, DOI 10.1096/fasebj.3.5.2493406; HUANG KP, 1986, BIOCHEM BIOPH RES CO, V139, P320, DOI 10.1016/S0006-291X(86)80116-4; HUGANIR RL, 1986, NATURE, V321, P774, DOI 10.1038/321774a0; HUGANIR RL, 1990, NEURON, V5, P555, DOI 10.1016/0896-6273(90)90211-W; HUGGENVIK JI, 1991, MOL ENDOCRINOL, V5, P921, DOI 10.1210/mend-5-7-921; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; KELLENBERGER S, 1992, J BIOL CHEM, V267, P25660; KIRKNESS EF, 1989, BIOCHEM J, V259, P613, DOI 10.1042/bj2590613; KRISHEK BJ, 1994, NEURON, V12, P1081, DOI 10.1016/0896-6273(94)90316-6; LEIDENHEIMER NJ, 1992, MOL PHARMACOL, V41, P1116; LEIDENHEIMER NJ, 1991, J NEUROCHEM, V57, P722, DOI 10.1111/j.1471-4159.1991.tb03806.x; LEVITAN IB, 1985, J MEMBRANE BIOL, V87, P177, DOI 10.1007/BF01871217; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; MALENKA RC, 1987, BRAIN RES, V403, P198, DOI 10.1016/0006-8993(87)90145-4; MILES K, 1989, NEURON, V2, P1517, DOI 10.1016/0896-6273(89)90198-0; MILES K, 1988, MOL NEUROBIOL, V2, P91, DOI 10.1007/BF02935341; MORAN O, 1989, MOL BRAIN RES, V5, P193, DOI 10.1016/0169-328X(89)90035-1; MOSS SJ, 1992, J BIOL CHEM, V267, P14470; MOSS SJ, 1992, SCIENCE, V257, P661, DOI 10.1126/science.1323140; MULLE C, 1988, P NATL ACAD SCI USA, V85, P5728, DOI 10.1073/pnas.85.15.5728; Nestler E. J., 1984, PROTEIN PHOSPHORYLAT; OLSEN RW, 1990, FASEB J, V4, P1469, DOI 10.1096/fasebj.4.5.2155149; Olsen RW, 1986, BENZODIAZEPINE GABA; PORTER NM, 1990, NEURON, V5, P789, DOI 10.1016/0896-6273(90)90338-G; RODRIGUEZPENA A, 1984, BIOCHEM BIOPH RES CO, V120, P1053, DOI 10.1016/S0006-291X(84)80213-2; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; SCHOFIELD PR, 1987, NATURE, V328, P221, DOI 10.1038/328221a0; SHINGAI R, 1991, EUR J PHARM-MOLEC PH, V206, P77, DOI 10.1016/0922-4106(91)90149-C; SIGEL E, 1988, P NATL ACAD SCI USA, V85, P6192, DOI 10.1073/pnas.85.16.6192; SIGEL E, 1991, FEBS LETT, V291, P150, DOI 10.1016/0014-5793(91)81124-Q; STELZER A, 1988, SCIENCE, V241, P339, DOI 10.1126/science.2455347; SWEETNAM PM, 1988, J NEUROCHEM, V51, P1274, DOI 10.1111/j.1471-4159.1988.tb03097.x; SWOPE SL, 1992, FASEB J, V6, P2514, DOI 10.1096/fasebj.6.8.1375568; TICKU MK, 1990, MOL PHARMACOL, V38, P719; VICINI S, 1991, NEUROPSYCHOPHARMACOL, V4, P9; WHITING P, 1990, P NATL ACAD SCI USA, V87, P9966, DOI 10.1073/pnas.87.24.9966; WOLF M, 1984, BIOCHEM BIOPH RES CO, V122, P1268, DOI 10.1016/0006-291X(84)91229-4; WOODGETT JR, 1987, J BIOL CHEM, V262, P4836	51	53	54	0	0	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1994	13	6					1421	1431		10.1016/0896-6273(94)90427-8	http://dx.doi.org/10.1016/0896-6273(94)90427-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PZ689	7993633	Green Submitted			2022-12-24	WOS:A1994PZ68900016
J	SHENG, ZH; RETTIG, J; TAKAHASHI, M; CATTERALL, WA				SHENG, ZH; RETTIG, J; TAKAHASHI, M; CATTERALL, WA			IDENTIFICATION OF A SYNTAXIN-BINDING SITE ON N-TYPE CALCIUM CHANNELS	NEURON			English	Article							TRANSMITTER RELEASE; SKELETAL-MUSCLE; CA2+ CHANNELS; SYNAPTIC TRANSMISSION; FUNCTIONAL EXPRESSION; ACTIVE ZONES; VERTEBRATE CELLS; BETA-SUBUNIT; DNA-BINDING; SYNAPTOTAGMIN	Immunochemical studies have suggested a tight association of syntaxin with N-type calcium channels. Syntaxin specifically interacts with the fusion proteins containing the cytoplasmic loop (L(II-III)) between homologous repeats II and III of the alpha(1) subunit of the class B N-type calcium channel (alpha(1B)) from rat brain, but not with those of the class A Q-type (alpha(1A)) or the class S L-type (alpha(1S)) calcium channels. This interaction is mediated by an 87 amino acid sequence (773-859) containing two overlapping predicted helix-loop-helix domains. The 87 amino acid peptide can specifically block binding of native N-type calcium channels to syntaxin, indicating that this binding site is required for stable interaction of these two proteins. Interaction takes place with the C-terminal one-third of syntaxin (residues 181-288), which is thought to be anchored in the presynaptic plasma membrane. Our results suggest a direct interaction between the cytoplasmic domains of these two presynaptic membrane proteins that could have an important role in the targeting and docking of synaptic vesicles near N-type calcium channels, enabling tight structural and functional association of calcium entry sites and neurotransmitter release sites.	MITSUBISHI KASEI INST LIFE SCI,MACHIDA 194,TOKYO,JAPAN		SHENG, ZH (corresponding author), UNIV WASHINGTON,DEPT PHARMACOL,SJ-30,SEATTLE,WA 98195, USA.		Rettig, Jens/K-5103-2013	Rettig, Jens/0000-0001-6160-3954	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022625] Funding Source: NIH RePORTER; NINDS NIH HHS [NS22625, NS07332-05] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AHLIJANIAN MK, 1990, NEURON, V4, P819, DOI 10.1016/0896-6273(90)90135-3; ANTHONYCAHILL SJ, 1992, SCIENCE, V255, P979, DOI 10.1126/science.1312255; BEAN BP, 1989, ANNU REV PHYSIOL, V51, P367, DOI 10.1146/annurev.physiol.51.1.367; BENNETT MK, 1993, CELL, V74, P863, DOI 10.1016/0092-8674(93)90466-4; BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2559, DOI 10.1073/pnas.90.7.2559; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; CALAKOS N, 1994, SCIENCE, V263, P1146, DOI 10.1126/science.8108733; CATTERALL WA, 1991, CELL, V64, P871, DOI 10.1016/0092-8674(91)90309-M; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; COHEN MW, 1991, J NEUROSCI, V1, P1032; COPE TC, 1982, J NEUROPHYSIOL, V47, P469, DOI 10.1152/jn.1982.47.3.469; DAVIS RL, 1990, CELL, V60, P733, DOI 10.1016/0092-8674(90)90088-V; DUBEL SJ, 1992, P NATL ACAD SCI USA, V89, P5058, DOI 10.1073/pnas.89.11.5058; HATA Y, 1993, NEURON, V10, P307, DOI 10.1016/0896-6273(93)90320-Q; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; HESS P, 1990, ANNU REV NEUROSCI, V13, P337, DOI 10.1146/annurev.ne.13.030190.002005; HIRNING LD, 1988, SCIENCE, V239, P57, DOI 10.1126/science.2447647; HORNE AL, 1991, BRIT J PHARMACOL, V103, P1733, DOI 10.1111/j.1476-5381.1991.tb09855.x; INOUE A, 1992, J BIOL CHEM, V267, P10613; JONES N, 1990, CELL, V61, P9, DOI 10.1016/0092-8674(90)90207-U; LEVEQUE C, 1992, P NATL ACAD SCI USA, V89, P3625, DOI 10.1073/pnas.89.8.3625; LEVEQUE C, 1994, J BIOL CHEM, V269, P6306; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; LLINAS R, 1991, BIOPHYS J, V33, P289; LUEBKE JI, 1993, NEURON, V11, P895, DOI 10.1016/0896-6273(93)90119-C; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; MARTY I, 1994, P NATL ACAD SCI USA, V91, P2270, DOI 10.1073/pnas.91.6.2270; MILLER RJ, 1992, J BIOL CHEM, V267, P1403; MINTZ IM, 1992, NEURON, V9, P85, DOI 10.1016/0896-6273(92)90223-Z; MINTZ IM, 1992, NATURE, V355, P827, DOI 10.1038/355827a0; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; OCONNOR VM, 1993, FEBS LETT, V326, P255, DOI 10.1016/0014-5793(93)81802-7; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; PETRENKO AG, 1991, NATURE, V353, P65, DOI 10.1038/353065a0; PUMPLIN DW, 1983, J NEUROCYTOL, V12, P317, DOI 10.1007/BF01148467; PUMPLIN DW, 1981, P NATL ACAD SCI-BIOL, V78, P7210, DOI 10.1073/pnas.78.11.7210; RIOS E, 1987, NATURE, V325, P717, DOI 10.1038/325717a0; ROBITAILLE R, 1990, NEURON, V5, P773, DOI 10.1016/0896-6273(90)90336-E; SATHER WA, 1993, NEURON, V11, P291, DOI 10.1016/0896-6273(93)90185-T; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SMITH SJ, 1988, TRENDS NEUROSCI, V11, P458, DOI 10.1016/0166-2236(88)90199-3; Snutch T P, 1992, Curr Opin Neurobiol, V2, P247, DOI 10.1016/0959-4388(92)90111-W; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; STARR TVB, 1991, P NATL ACAD SCI USA, V88, P5621, DOI 10.1073/pnas.88.13.5621; STEA A, 1993, NEUROPHARMACOLOGY, V32, P1103, DOI 10.1016/0028-3908(93)90005-N; SUN XH, 1991, MOL CELL BIOL, V11, P5603, DOI 10.1128/MCB.11.11.5603; TAKAHASHI T, 1993, NATURE, V366, P156, DOI 10.1038/366156a0; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; TANABE T, 1990, NATURE, V346, P567, DOI 10.1038/346567a0; TANABE T, 1988, NATURE, V344, P451; TSIEN RW, 1991, TRENDS PHARMACOL SCI, V12, P349, DOI 10.1016/0165-6147(91)90595-J; TURNER TJ, 1993, P NATL ACAD SCI USA, V90, P9518, DOI 10.1073/pnas.90.20.9518; UCHITEL OD, 1992, P NATL ACAD SCI USA, V89, P3330, DOI 10.1073/pnas.89.8.3330; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; WESTENBROEK RE, 1992, NEURON, V9, P1099, DOI 10.1016/0896-6273(92)90069-P; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; WILLIAMS ME, 1992, SCIENCE, V257, P389, DOI 10.1126/science.1321501; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; YOSHIDA A, 1992, J BIOL CHEM, V267, P24925; ZHANG JF, 1993, NEUROPHARMACOLOGY, V32, P1075, DOI 10.1016/0028-3908(93)90003-L; ZUCKER RS, 1993, J PHYSIOL-PARIS, V87, P25, DOI 10.1016/0928-4257(93)90021-K	62	358	368	0	4	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1994	13	6					1303	1313		10.1016/0896-6273(94)90417-0	http://dx.doi.org/10.1016/0896-6273(94)90417-0			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PZ689	7993624				2022-12-24	WOS:A1994PZ68900006
J	WANG, J; RENGER, JJ; GRIFFITH, LC; GREENSPAN, RJ; WU, CF				WANG, J; RENGER, JJ; GRIFFITH, LC; GREENSPAN, RJ; WU, CF			CONCOMITANT ALTERATIONS OF PHYSIOLOGICAL AND DEVELOPMENTAL PLASTICITY IN DROSOPHILA CAM KINASE II-INHIBITED SYNAPSES	NEURON			English	Article							CA-2+/CALMODULIN-DEPENDENT PROTEIN-KINASE; LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; NEUROMUSCULAR-JUNCTION; ADENYLATE-CYCLASE; MUTANT MICE; CALMODULIN; MEMORY; MELANOGASTER; MODULATION	Ca2+/calmodulin-dependent protein kinase II (CaM kinase) has been implicated in neural plasticity that underlies learning and memory processes. Transformed strains of Drosophila, ala1 and ala2, expressing a specific inhibitor of CaM kinase are known to be impaired in an associative conditioning behavioral paradigm. We found that these transformants had altered short-term plasticity in synaptic transmission along with abnormal nerve terminal sprouting and directionality of outgrowth. These results represent an interesting parallel with the activity-dependent regulation of synaptic physiology and morphology by the cAMP cascade in Aplysia and Drosophila. In contrast to the learning mutants dunce and rutabaga, which are defective in the cAMP cascade, inhibition of CaM kinase in ala transformants caused increased sprouting at larval neuromuscular junctions near the nerve entry point, rather than altering the higher order branch segments. In addition, synaptic facilitation and potentiation were altered in a manner different from that observed in the cAMP mutants. Furthermore, synaptic currents in ala transformants were characterized by greater variability, suggesting an important role of CaM kinase in the stability of transmission.	BRANDEIS UNIV,DEPT BIOL,WALTHAM,MA 02254; BRANDEIS UNIV,CTR COMPLEX SYST,WALTHAM,MA 02254; NYU,DEPT BIOL,NEW YORK,NY 10003; NYU,CTR NEURAL SCI,NEW YORK,NY 10003	Brandeis University; Brandeis University; New York University; New York University	WANG, J (corresponding author), UNIV IOWA,DEPT BIOL SCI,IOWA CITY,IA 52242, USA.		Wang, Jing W/C-3885-2008	Wang, Jing W/0000-0001-6291-5802; Griffith, Leslie/0000-0003-3164-9876; Wu, Chun-Fang/0000-0002-4973-2021	NICHD NIH HHS [HD18577] Funding Source: Medline; NIGMS NIH HHS [GM33205] Funding Source: Medline; NINDS NIH HHS [NS26528] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD018577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM033205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026528] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; ATWOOD HL, 1990, J EXP BIOL, V153, P105; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; BUDNIK V, 1990, J NEUROSCI, V10, P3754; CHANG FLF, 1984, BRAIN RES, V309, P35, DOI 10.1016/0006-8993(84)91008-4; CHO KO, 1991, NEURON, V7, P439, DOI 10.1016/0896-6273(91)90296-C; CLINE HT, 1990, NEURON, V4, P899, DOI 10.1016/0896-6273(90)90143-4; DAVIS RL, 1993, NEURON, V11, P1, DOI 10.1016/0896-6273(93)90266-T; DIXON D, 1989, J NEUROSCI, V9, P4246; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; DUDAI Y, 1976, P NATL ACAD SCI USA, V73, P1684, DOI 10.1073/pnas.73.5.1684; DUDAI Y, 1988, ANNU REV NEUROSCI, V11, P537, DOI 10.1146/annurev.ne.11.030188.002541; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; GRIFFITH LC, 1993, J NEUROCHEM, V61, P1534, DOI 10.1111/j.1471-4159.1993.tb13650.x; GRIFFITH LC, 1993, NEURON, V10, P501, DOI 10.1016/0896-6273(93)90337-Q; GRIFFITH LC, 1994, IN PRESS P NATL ACAD; HAUGLAND FN, 1985, J NEUROSCI, V5, P2626; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; JAN LY, 1976, J PHYSIOL-LONDON, V262, P215, DOI 10.1113/jphysiol.1976.sp011593; JIA XX, 1993, J NEUROBIOL, V24, P1025, DOI 10.1002/neu.480240804; JOHANSEN J, 1989, J NEUROSCI, V9, P710; KANDEL ER, 1982, SCIENCE, V218, P433, DOI 10.1126/science.6289442; KENNEDY MB, 1989, CELL, V59, P777, DOI 10.1016/0092-8674(89)90601-6; KESHISHIAN H, 1993, J NEUROBIOL, V24, P757, DOI 10.1002/neu.480240606; KIM YT, 1987, J NEUROSCI, V7, P3245; LANDIS SC, 1983, ANNU REV PHYSIOL, V45, P567, DOI 10.1146/annurev.ph.45.030183.003031; LIVINGSTONE MS, 1984, CELL, V37, P205, DOI 10.1016/0092-8674(84)90316-7; LNENICKA GA, 1989, J NEUROBIOL, V20, P339, DOI 10.1002/neu.480200507; LU B, 1992, NEURON, V8, P521, DOI 10.1016/0896-6273(92)90280-Q; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; SAKAKIBARA M, 1986, BIOPHYS J, V50, P319, DOI 10.1016/S0006-3495(86)83465-8; SCHULMAN H, 1984, J CELL BIOL, V99, P11, DOI 10.1083/jcb.99.1.11; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; SINK H, 1991, J NEUROBIOL, V22, P298, DOI 10.1002/neu.480220309; SUDHOF TC, 1991, NEURON, V6, P665, DOI 10.1016/0896-6273(91)90165-V; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; WILLMUND R, 1986, P NATL ACAD SCI USA, V83, P9789, DOI 10.1073/pnas.83.24.9789; ZHONG Y, 1991, SCIENCE, V251, P198, DOI 10.1126/science.1670967; ZHONG Y, 1992, J NEUROSCI, V12, P644; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	43	88	89	0	0	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1994	13	6					1373	1384		10.1016/0896-6273(94)90422-7	http://dx.doi.org/10.1016/0896-6273(94)90422-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PZ689	7993628				2022-12-24	WOS:A1994PZ68900011
J	MACDONALD, R; XU, QL; BARTH, KA; MIKKOLA, I; HOLDER, N; FJOSE, A; KRAUSS, S; WILSON, SW				MACDONALD, R; XU, QL; BARTH, KA; MIKKOLA, I; HOLDER, N; FJOSE, A; KRAUSS, S; WILSON, SW			REGULATORY GENE-EXPRESSION BOUNDARIES DEMARCATE SITES OF NEURONAL DIFFERENTIATION IN THE EMBRYONIC ZEBRAFISH FOREBRAIN	NEURON			English	Article							HOMEOBOX-CONTAINING GENE; CENTRAL-NERVOUS-SYSTEM; PAIRED BOX GENE; TYROSINE KINASE; FLOOR PLATE; REGIONAL EXPRESSION; NEURAL EXPRESSION; MOUSE FOREBRAIN; GROWTH-CONE; BRAIN	During development of the zebrafish forebrain, a simple scaffold of axon pathways is pioneered by a small number of neurons. We show that boundaries of expression domains of members of the eph, forkhead, pax, and wnt gene families correlate with the positions at which these neurons differentiate and extend axons. Analysis of genetically or experimentally altered forebrains indicates that if a boundary is maintained, there is appropriate neural differentiation with respect to the boundary. Conversely, in the absence of a boundary, there is concomitant disruption of neural patterning. We also show that a strip of cells within the dorsal diencephalon shares features with ventral midline cells. This strip of cells fails to develop in mutant fish in which specification of the ventral CNS is disrupted, suggesting that its development may be regulated by the same inductive pathways that pattern the ventral midline.	UNIV TROMSO,DEPT BIOCHEM,N-9037 TROMSO,NORWAY; UNIV BERGEN,DEPT BIOCHEM & MOLEC BIOL,N-5009 BERGEN,NORWAY	UiT The Arctic University of Tromso; University of Bergen	MACDONALD, R (corresponding author), UNIV LONDON KINGS COLL,RANDALL INST,DEV BIOL RES CTR,LONDON WC2B 5RL,ENGLAND.		Wilson, Stephen W/B-9404-2008	Wilson, Stephen W/0000-0002-8557-5940; Mikkola, Ingvild/0000-0001-6442-7626; Krauss, Stefan/0000-0001-6992-8091	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AKIMENKO MA, 1994, J NEUROSCI, V14, P3475; ALTABA ARI, 1993, P NATL ACAD SCI USA, V90, P8268, DOI 10.1073/pnas.90.17.8268; BARTLEY TD, 1994, NATURE, V368, P558, DOI 10.1038/368558a0; BONCINELLI E, 1993, J NEUROBIOL, V24, P1356, DOI 10.1002/neu.480241008; CHALEPAKIS G, 1993, J NEUROBIOL, V24, P1367, DOI 10.1002/neu.480241009; CHITNIS AB, 1990, J NEUROSCI, V10, P1892; COFFMAN CR, 1993, CELL, V73, P659, DOI 10.1016/0092-8674(93)90247-N; DAVID C, 1993, BIOCHEMISTRY-US, V32, P8179, DOI 10.1021/bi00083a018; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; FIGDOR MC, 1993, NATURE, V363, P630, DOI 10.1038/363630a0; FRASER SE, 1993, CURR BIOL, V3, P787, DOI 10.1016/0960-9822(93)90033-K; GOULDING MD, 1993, DEVELOPMENT, V117, P1011; HATTA K, 1994, P NATL ACAD SCI USA, V91, P2061, DOI 10.1073/pnas.91.6.2061; HATTA K, 1991, NATURE, V350, P339, DOI 10.1038/350339a0; HEYMAN I, 1994, DEV DYNAM, V198, P241; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; HIRAI H, 1987, SCIENCE, V238, P1717, DOI 10.1126/science.2825356; HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O; KATZ MJ, 1980, NEUROSCIENCE, V5, P821, DOI 10.1016/0306-4522(80)90151-7; KIMMEL CB, 1993, ANNU REV NEUROSCI, V16, P707, DOI 10.1146/annurev.ne.16.030193.003423; KRAUSS S, 1991, EMBO J, V10, P3609, DOI 10.1002/j.1460-2075.1991.tb04927.x; KRAUSS S, 1991, DEVELOPMENT, V113, P1193; KRAUSS S, 1992, NATURE, V360, P87, DOI 10.1038/360087a0; KRAUSS S, 1991, NATURE, V353, P267, DOI 10.1038/353267a0; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; KRUMLAUF R, 1993, J NEUROBIOL, V24, P1328, DOI 10.1002/neu.480241006; LAI E, 1991, GENE DEV, V5, P416, DOI 10.1101/gad.5.3.416; LAYER PG, 1983, P NATL ACAD SCI-BIOL, V80, P6413, DOI 10.1073/pnas.80.20.6413; MCMAHON AP, 1992, CELL, V69, P581, DOI 10.1016/0092-8674(92)90222-X; MIKKOLA I, 1992, J NEUROBIOL, V23, P933, DOI 10.1002/neu.480230802; MOLVEN A, 1991, EMBO J, V10, P799, DOI 10.1002/j.1460-2075.1991.tb08012.x; NIETO MA, 1992, DEVELOPMENT, V116, P1137; NUSSE R, 1992, CELL, V69, P1073, DOI 10.1016/0092-8674(92)90630-U; OBRYAN JP, 1991, MOL CELL BIOL, V11, P5016, DOI 10.1128/MCB.11.10.5016; PAPALOPULU N, 1994, IN PRESS PERSPECT DE; PASQUALE EB, 1991, CELL REGUL, V2, P523, DOI 10.1091/mbc.2.7.523; PLACZEK M, 1993, DEVELOPMENT, V117, P205; PRICE M, 1992, NEURON, V8, P241, DOI 10.1016/0896-6273(92)90291-K; PUELLES L, 1987, J COMP NEUROL, V266, P247, DOI 10.1002/cne.902660210; PUELLES L, 1993, TRENDS NEUROSCI, V16, P472, DOI 10.1016/0166-2236(93)90080-6; PULIDO D, 1992, EMBO J, V11, P391, DOI 10.1002/j.1460-2075.1992.tb05067.x; PUSCHEL AW, 1992, DEVELOPMENT, V114, P643; PUSCHEL AW, 1992, MECH DEVELOP, V38, P197, DOI 10.1016/0925-4773(92)90053-M; ROELINK H, 1994, CELL, V76, P761, DOI 10.1016/0092-8674(94)90514-2; ROSS LS, 1992, J NEUROSCI, V12, P467; Ruiz i Altaba A., 1993, CURR OPIN GENE DEV, V3, P633; SALINAS PC, 1992, MECH DEVELOP, V39, P151, DOI 10.1016/0925-4773(92)90042-I; SASAKI H, 1994, CELL, V76, P103, DOI 10.1016/0092-8674(94)90176-7; STACHEL SE, 1993, DEVELOPMENT, V117, P1261; STRAHLE U, 1993, GENE DEV, V7, P1436, DOI 10.1101/gad.7.7b.1436; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6; WALTHER C, 1991, DEVELOPMENT, V113, P1435; WESTERFIELD M, 1989, ZEBRAFISH BOOK; WILSON SW, 1990, DEVELOPMENT, V108, P121; WILSON SW, 1993, TRENDS NEUROSCI, V16, P316, DOI 10.1016/0166-2236(93)90108-X; WILSON SW, 1991, P NATL ACAD SCI USA, V88, P2293, DOI 10.1073/pnas.88.6.2293; WILSON SW, 1991, DEVELOPMENT, V112, P121; XU QL, 1994, DEVELOPMENT, V120, P287; YAMADA T, 1993, CELL, V73, P673, DOI 10.1016/0092-8674(93)90248-O; YAMAGUCHI Y, 1989, DEV GROWTH DIFFER, V31, P531	61	217	218	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1994	13	5					1039	1053		10.1016/0896-6273(94)90044-2	http://dx.doi.org/10.1016/0896-6273(94)90044-2			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PU763	7946344				2022-12-24	WOS:A1994PU76300002
J	NOTTERPEK, LM; ROME, LH				NOTTERPEK, LM; ROME, LH			FUNCTIONAL EVIDENCE FOR THE ROLE OF AXOLEMMA IN CNS MYELINATION	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; CULTURED OLIGODENDROCYTES; MONOCLONAL-ANTIBODIES; ENRICHED FRACTION; AXONS MODULATE; SPINAL-CORD; CELL LINE; RAT-BRAIN; EXPRESSION; MEMBRANE	A direct role for neurons in CNS myelination has yet to be demonstrated. CNS myelination can be examined in cerebellar slice cultures, which faithfully reproduce both synthesis and wrapping of myelin. In an attempt to demonstrate a role for axolemma in this process, we generated more than 2000 axolemma-reactive monoclonal antibodies. One clone, G21.3, repeatedly blocked myelination in cerebellar slices, as documented by both biochemistry and morphology. The antibody caused a dramatic reduction in myelin lipid and protein synthesis. CNS white matter, sciatic nerve, and neuronal cultures were positively stained with G21.3, whereas oligodendrocytes and myelin were fully negative. The antibody identified a restricted number of proteins in purified axolemma. These results suggest a direct involvement of axons in CNS myelination.	UNIV CALIF LOS ANGELES, SCH MED, MENTAL RETARDAT RES CTR, LOS ANGELES, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	NOTTERPEK, LM (corresponding author), UNIV CALIF LOS ANGELES, SCH MED, DEPT BIOL CHEM, LOS ANGELES, CA 90024 USA.		Rome, Leonard H/E-8786-2016	Rome, Leonard H/0000-0002-1236-2063	NICHD NIH HHS [HD-06576] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD006576] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ABO T, 1981, J IMMUNOL, V127, P1024; AIZENMAN Y, 1987, BRAIN RES, V406, P32, DOI 10.1016/0006-8993(87)90766-9; BARRES BA, 1993, CURR BIOL, V3, P489, DOI 10.1016/0960-9822(93)90039-Q; BARRES BA, 1993, NATURE, V361, P258, DOI 10.1038/361258a0; BIGBEE JW, 1985, J NEUROIMMUNOL, V7, P221; BOTTENSTEIN JE, 1988, J NEUROSCI RES, V20, P291, DOI 10.1002/jnr.490200303; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; BRADEL EJ, 1983, J NEUROSCI RES, V9, P381, DOI 10.1002/jnr.490090404; BUNGE MB, 1982, DEV BIOL, V92, P449, DOI 10.1016/0012-1606(82)90190-7; CARDWELL MC, 1988, J CELL BIOL, V107, P1551, DOI 10.1083/jcb.107.4.1551; CARDWELL MC, 1988, J CELL BIOL, V107, P1541, DOI 10.1083/jcb.107.4.1541; CHEN SJ, 1989, J NEUROCHEM, V52, P325, DOI 10.1111/j.1471-4159.1989.tb10936.x; DEVRIES GH, 1980, HDB NEUROCHEMISTRY, P341; DYER CA, 1988, J NEUROSCI, V8, P4307; GIULIAN D, 1986, J NEUROSCI, V6, P2163; HAMPSON DR, 1987, J NEUROSCI RES, V17, P277, DOI 10.1002/jnr.490170312; HARDY R, 1993, J NEUROSCI RES, V36, P121, DOI 10.1002/jnr.490360202; HARLOW E, 1988, ANTIBODIES LABORATOR; HILDEBRAND C, 1993, PROG NEUROBIOL, V40, P319, DOI 10.1016/0301-0082(93)90015-K; KIDD GJ, 1990, J NEUROSCI RES, V26, P409, DOI 10.1002/jnr.490260403; KNAPP PE, 1987, DEV BIOL, V120, P356, DOI 10.1016/0012-1606(87)90238-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVINE JM, 1989, NEURON, V3, P103, DOI 10.1016/0896-6273(89)90119-0; MACKLIN WB, 1986, J NEUROSCI RES, V16, P203, DOI 10.1002/jnr.490160118; MALEKHEDAYAT S, 1994, J CELL BIOL, V124, P1039, DOI 10.1083/jcb.124.6.1039; MCPHILEMY K, 1990, J NEUROCYTOL, V19, P494, DOI 10.1007/BF01257239; MIKOSHIBA K, 1980, BRAIN RES, V192, P195, DOI 10.1016/0006-8993(80)91019-7; MILSTEIN C, 1980, SCI AM, V243, P66, DOI 10.1038/scientificamerican1080-66; MURRAY JA, 1980, J NEUROL SCI, V45, P29, DOI 10.1016/S0022-510X(80)80004-9; NOTTERPEK LM, 1993, J NEUROSCI RES, V36, P621, DOI 10.1002/jnr.490360603; RAJU TR, 1982, BRAIN RES, V248, P196, DOI 10.1016/0006-8993(82)91165-9; RANSCHT B, 1987, J NEUROSCI, V7, P2936; RANSCHT B, 1982, P NATL ACAD SCI-BIOL, V79, P2709, DOI 10.1073/pnas.79.8.2709; REICHARDT LF, 1991, ANNU REV NEUROSCI, V14, P531, DOI 10.1146/annurev.neuro.14.1.531; ROME LH, 1986, J NEUROSCI RES, V15, P49, DOI 10.1002/jnr.490150106; SANES JR, 1989, ANNU REV NEUROSCI, V12, P491, DOI 10.1146/annurev.ne.12.030189.002423; SCARPA S, 1992, CANCER LETT, V64, P31; SCHERER SS, 1992, J NEUROSCI RES, V32, P138, DOI 10.1002/jnr.490320203; SCHILLING K, 1989, J HISTOCHEM CYTOCHEM, V37, P241, DOI 10.1177/37.2.2492046; SCHWAB ME, 1989, J NEUROCYTOL, V18, P161, DOI 10.1007/BF01206659; SILBERBERG D, 1972, J NEUROCHEM, V19, P11, DOI 10.1111/j.1471-4159.1972.tb01248.x; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STERNBERGER LA, 1986, IMMUNOCYTOCHEMISTRY; TATUM AH, 1993, J IMMUNOL METHODS, V158, P1, DOI 10.1016/0022-1759(93)90252-3; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VALAT J, 1988, INT J DEV NEUROSCI, V6, P245, DOI 10.1016/0736-5748(88)90005-6; VALENTINO KL, 1985, ANNU REV NEUROSCI, V8, P199; WAXMAN SG, 1985, SCIENCE, V228, P1502, DOI 10.1126/science.2409596; Waxman SG, 1987, PROG BRAIN RES <D>, V71, P121; WOOD PM, 1986, NATURE, V320, P756, DOI 10.1038/320756a0; WOOD PM, 1984, DEV BRAIN RES, V12, P225, DOI 10.1016/0165-3806(84)90045-2; WUARIN L, 1991, DEV BIOL, V144, P429, DOI 10.1016/0012-1606(91)90435-6; YOSHIHARA Y, 1991, J CELL BIOL, V115, P731, DOI 10.1083/jcb.115.3.731	53	37	38	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	1994	13	2					473	485		10.1016/0896-6273(94)90361-1	http://dx.doi.org/10.1016/0896-6273(94)90361-1			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PD430	8060622				2022-12-24	WOS:A1994PD43000017
J	WONG, ROL; MEISTER, M; SHATZ, CJ				WONG, ROL; MEISTER, M; SHATZ, CJ			TRANSIENT PERIOD OF CORRELATED BURSTING ACTIVITY DURING DEVELOPMENT OF THE MAMMALIAN RETINA	NEURON			English	Article							RECEPTIVE-FIELD CHARACTERISTICS; LATERAL GENICULATE-NUCLEUS; GANGLION-CELLS; AMACRINE CELLS; CAT RETINA; RETINOGENICULATE PATHWAY; PRENATAL DEVELOPMENT; IMPULSE ACTIVITY; LUCIFER YELLOW; RABBIT RETINA	The refinement of early connections in the visual pathway requires electrical activity in the retina before the onset of vision. Using a multielectrode array, we have shown that the spontaneous activity of cells in the neonatal ferret retina is correlated by patterns of periodically generated traveling waves. Here, we examine developmental changes in the characteristics of the waves and show that retinal ganglion cells participate in these patterns of activity, which are seen during the same period as synaptic modification in the lateral geniculate nucleus; that the waves subside gradually as the connectivity in the lateral geniculate nucleus stabilizes; and that their spatial structure allows for refinement of the retinotopic map, as well as for eye-specific segregation in the lateral geniculate nucleus.	STANFORD UNIV,MED CTR,SCH MED,DEPT NEUROBIOL,STANFORD,CA 94305	Stanford University				Meister, Markus/0000-0003-2136-6506				AMES A, 1981, J NEUROCHEM, V37, P867, DOI 10.1111/j.1471-4159.1981.tb04473.x; BLOOMFIELD SA, 1992, J NEUROPHYSIOL, V68, P711, DOI 10.1152/jn.1992.68.3.711; BROWN TH, 1990, ANNU REV NEUROSCI, V13, P475, DOI 10.1146/annurev.ne.13.030190.002355; CAMPBELL G, 1992, J NEUROSCI, V12, P1847; CLINE HT, 1991, TRENDS NEUROSCI, V14, P104, DOI 10.1016/0166-2236(91)90071-2; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; CUCCHIARO J, 1984, PROC R SOC SER B-BIO, V223, P141, DOI 10.1098/rspb.1984.0087; DUBIN MW, 1986, J NEUROSCI, V6, P1021; FINKBEINER S, 1992, NEURON, V8, P1101, DOI 10.1016/0896-6273(92)90131-V; GALLI L, 1988, SCIENCE, V242, P90, DOI 10.1126/science.3175637; GREINER JV, 1980, EXP EYE RES, V30, P439, DOI 10.1016/0014-4835(80)90059-7; GREINER JV, 1981, EXP EYE RES, V33, P315, DOI 10.1016/S0014-4835(81)80055-3; GUSTAFSSON B, 1986, J NEUROSCI, V6, P1575; MADISON DV, 1991, ANNU REV NEUROSCI, V14, P379, DOI 10.1146/annurev.ne.14.030191.002115; MAFFEI L, 1990, P NATL ACAD SCI USA, V87, P2861, DOI 10.1073/pnas.87.7.2861; MARANTO AR, 1982, SCIENCE, V217, P953, DOI 10.1126/science.7112109; MASTRONARDE DN, 1983, J NEUROPHYSIOL, V49, P303, DOI 10.1152/jn.1983.49.2.303; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; MEISTER M, 1993, IN PRESS J NEUROSCI; MILLER KD, 1989, SCIENCE, V245, P605, DOI 10.1126/science.2762813; MOONEY R, 1993, NEURON, V10, P815, DOI 10.1016/0896-6273(93)90198-Z; RAPISARDI SC, 1975, EXP BRAIN RES, V22, P295; REDBURN DA, 1992, NEUROCHEM RES, V17, P61, DOI 10.1007/BF00966865; REGEHR WG, 1989, J NEUROSCI METH, V30, P91, DOI 10.1016/0165-0270(89)90055-1; SHATZ CJ, 1988, SCIENCE, V242, P87, DOI 10.1126/science.3175636; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; SINGER W, 1990, J EXP BIOL, V153, P177; SPEAR PD, 1972, BRAIN RES, V45, P67, DOI 10.1016/0006-8993(72)90216-8; SRETAVAN DW, 1986, J NEUROSCI, V6, P234; SRETAVAN DW, 1987, J COMP NEUROL, V255, P386, DOI 10.1002/cne.902550306; SRETAVAN DW, 1988, NATURE, V336, P468, DOI 10.1038/336468a0; SUR M, 1984, NATURE, V310, P246, DOI 10.1038/310246a0; TSO DY, 1986, J NEUROSCI, V6, P1160; UDIN SB, 1988, ANNU REV NEUROSCI, V11, P289, DOI 10.1146/annurev.ne.11.030188.001445; VANEY DI, 1991, NEUROSCI LETT, V125, P187, DOI 10.1016/0304-3940(91)90024-N; VITEK DJ, 1985, J COMP NEUROL, V241, P1, DOI 10.1002/cne.902410102; WASSLE H, 1987, J COMP NEUROL, V265, P391, DOI 10.1002/cne.902650308; WILLSHAW DJ, 1976, PROC R SOC SER B-BIO, V194, P431, DOI 10.1098/rspb.1976.0087; WINGATE RJT, 1992, J COMP NEUROL, V323, P449, DOI 10.1002/cne.903230402; WONG ROL, 1987, J COMP NEUROL, V255, P159, DOI 10.1002/cne.902550202; YANG G, 1992, SCIENCE, V268, P1949	42	415	417	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1993	11	5					923	938		10.1016/0896-6273(93)90122-8	http://dx.doi.org/10.1016/0896-6273(93)90122-8			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MJ041	8240814				2022-12-24	WOS:A1993MJ04100014
J	HASHIMOTO, H; ISHIHARA, T; SHIGEMOTO, R; MORI, K; NAGATA, S				HASHIMOTO, H; ISHIHARA, T; SHIGEMOTO, R; MORI, K; NAGATA, S			MOLECULAR-CLONING AND TISSUE DISTRIBUTION OF A RECEPTOR FOR PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE	NEURON			English	Article							VASOACTIVE INTESTINAL POLYPEPTIDE; BINDING-SITES; RAT-BRAIN; EXPRESSION CLONING; HIGH-AFFINITY; PEPTIDE; PACAP; PROTEIN; CELLS; NEUROPEPTIDE	Pituitary adenylate cyclase-activating polypeptide (PACAP) is a polypeptide hormone related to vasoactive intestinal polypeptide (VIP). Rat PACAP receptor cDNA was isolated from a brain cDNA library by cross-hybridization with rat VIP receptor cDNA. The recombinant PACAP receptor expressed in COS cells bound PACAP with about 1000 times higher affinity than VIP, and PACAP stimulated adenylate cyclase through the cloned PACAP receptor. The rat PACAP receptor consists of 495 amino acids, contains seven transmembrane segments, and has a significant similarity with other G(s)-coupled receptors, such as VIP, glucagon, and secretin receptors. PACAP receptor mRNA was abundantly expressed in the brain, but not in the peripheral tissues except for the adrenal gland. In situ hybridization revealed a high level of expression of PACAP receptor mRNA in the hippocampal dentate gyrus, olfactory bulb, and cerebellar cortex.	OSAKA UNIV,FAC PHARMACEUT SCI,DEPT PHARMACOL,SUITA,OSAKA 565,JAPAN; KYOTO UNIV,FAC MED,DEPT MORPHOL BRAIN SCI,KYOTO 606,JAPAN	Osaka University; Kyoto University	HASHIMOTO, H (corresponding author), OSAKA BIOSCI INST,6-2-4 FURUEDAI,SUITA,OSAKA 565,JAPAN.		Hashimoto, Hitoshi/D-1209-2010; Shigemoto, Ryuichi/E-3628-2013; Nagata, Shigekazu/AAG-3203-2019	Hashimoto, Hitoshi/0000-0001-6548-4016; Shigemoto, Ryuichi/0000-0001-8761-9444; Nagata, Shigekazu/0000-0001-9758-8426; Mori, Kensaku/0000-0001-7853-9370				ARIMURA A, 1991, ENDOCRINOLOGY, V129, P2787, DOI 10.1210/endo-129-5-2787; ARIMURA A, 1992, REGUL PEPTIDES, V37, P287; BABA A, 1993, NEUROSCI LETT, V149, P182, DOI 10.1016/0304-3940(93)90766-E; BUSCAIL L, 1990, FEBS LETT, V262, P77, DOI 10.1016/0014-5793(90)80158-F; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DEUTSCH PJ, 1992, J BIOL CHEM, V267, P5108; FUKUNAGA R, 1990, J BIOL CHEM, V265, P14008; GOTTSCHALL PE, 1991, FASEB J, V5, P194, DOI 10.1096/fasebj.5.2.1848519; ISHIHARA T, 1992, NEURON, V8, P811, DOI 10.1016/0896-6273(92)90101-I; ISHIHARA T, 1991, EMBO J, V10, P1635, DOI 10.1002/j.1460-2075.1991.tb07686.x; JELINEK LJ, 1993, SCIENCE, V259, P1614, DOI 10.1126/science.8384375; JUPPNER H, 1991, SCIENCE, V254, P1024, DOI 10.1126/science.1658941; KATADA T, 1982, J BIOL CHEM, V257, P3739; KIMURA C, 1990, BIOCHEM BIOPH RES CO, V166, P81, DOI 10.1016/0006-291X(90)91914-E; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAM HC, 1990, EUR J BIOCHEM, V193, P725, DOI 10.1111/j.1432-1033.1990.tb19392.x; LIN CJ, 1992, NATURE, V360, P765, DOI 10.1038/360765a0; LIN HY, 1991, SCIENCE, V254, P1022, DOI 10.1126/science.1658940; MASUO Y, 1992, BRAIN RES, V575, P113, DOI 10.1016/0006-8993(92)90430-H; MASUO Y, 1993, BRAIN RES, V602, P57, DOI 10.1016/0006-8993(93)90241-E; MAYO KE, 1992, MOL ENDOCRINOL, V6, P1734, DOI 10.1210/me.6.10.1734; MIYATA A, 1989, BIOCHEM BIOPH RES CO, V164, P567, DOI 10.1016/0006-291X(89)91757-9; MIYATA A, 1990, BIOCHEM BIOPH RES CO, V170, P643, DOI 10.1016/0006-291X(90)92140-U; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; ODOWD BF, 1989, ANNU REV NEUROSCI, V12, P67, DOI 10.1146/annurev.ne.12.030189.000435; OGI K, 1990, BIOCHEM BIOPH RES CO, V173, P1271, DOI 10.1016/S0006-291X(05)80924-6; OHTAKI T, 1990, BIOCHEM BIOPH RES CO, V171, P838, DOI 10.1016/0006-291X(90)91222-E; ROBBERECHT P, 1991, FEBS LETT, V286, P133, DOI 10.1016/0014-5793(91)80958-6; ROSELLIN G, 1986, PEPTIDES S1, V7, P89; SAID SI, 1986, J ENDOCRINOL INVEST, V9, P191, DOI 10.1007/BF03348097; Sambrook J, 1989, MOL CLONING LABORATO; SCHAFER H, 1991, EUR J BIOCHEM, V202, P951, DOI 10.1111/j.1432-1033.1991.tb16455.x; SEED B, 1987, NATURE, V329, P840, DOI 10.1038/329840a0; SHIVERS BD, 1991, ENDOCRINOLOGY, V128, P3055, DOI 10.1210/endo-128-6-3055; SUNDLER F, 1992, NEUROSCIENCE, V46, P439, DOI 10.1016/0306-4522(92)90064-9; TATSUNO I, 1990, BIOCHEM BIOPH RES CO, V168, P1027, DOI 10.1016/0006-291X(90)91132-C; TATSUNO I, 1991, ENDOCRINOLOGY, V129, P1797, DOI 10.1210/endo-129-4-1797; THORENS B, 1992, P NATL ACAD SCI USA, V89, P8641, DOI 10.1073/pnas.89.18.8641; UETSUKI T, 1989, J BIOL CHEM, V264, P5791; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WATANABE T, 1990, BIOCHEM BIOPH RES CO, V173, P252, DOI 10.1016/S0006-291X(05)81049-6; XIE YB, 1990, J BIOL CHEM, V265, P21411; YOKOTA Y, 1992, EMBO J, V11, P3585, DOI 10.1002/j.1460-2075.1992.tb05442.x	43	248	256	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1993	11	2					333	342		10.1016/0896-6273(93)90188-W	http://dx.doi.org/10.1016/0896-6273(93)90188-W			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LU065	8394723				2022-12-24	WOS:A1993LU06500012
J	YAMAGATA, K; ANDREASSON, KI; KAUFMANN, WE; BARNES, CA; WORLEY, PF				YAMAGATA, K; ANDREASSON, KI; KAUFMANN, WE; BARNES, CA; WORLEY, PF			EXPRESSION OF A MITOGEN-INDUCIBLE CYCLOOXYGENASE IN BRAIN NEURONS - REGULATION BY SYNAPTIC ACTIVITY AND GLUCOCORTICOIDS	NEURON			English	Article							LONG-TERM POTENTIATION; PROSTAGLANDIN ENDOPEROXIDE SYNTHASE; RAT PREOVULATORY FOLLICLES; HORMONE-RELEASING HORMONE; ARACHIDONIC-ACID CASCADE; ANTI-INFLAMMATORY DRUGS; NITRIC-OXIDE SYNTHASE; FACTOR MESSENGER-RNAS; DENTATE GYRUS; LUTEINIZING-HORMONE	Prostaglandins play important and diverse roles in the CNS. The first step in prostaglandin synthesis involves enzymatic oxidation of arachidonic acid, which is catalyzed by prostaglandin H(PGH) synthase, also referred to as cyclooxygenase. We have cloned an inducible form of this enzyme from rat brain that is nearly identical to a murine, mitogen-inducible cyclooxygenase identified from fibroblasts. Our studies indicate that this gene, here termed COX-2, is expressed throughout the forebrain in discrete populations of neurons and is enriched in the cortex and hippocampus. Neuronal expression is rapidly and transiently induced by seizures or NMDA-dependent synaptic activity. No expression is detected in glia or vascular endothelial cells. Basal expression of COX-2 appears to be regulated by natural synaptic activity in the developing and adult brain. Both basal and induced expression of COX-2 are inhibited by glucocorticoids, consistent with COX-2 regulation in peripheral tissues. Our studies indicate that COX-2 expression may be important in regulating prostaglandin signaling in brain. The marked inducibility in neurons by synaptic stimuli suggests a role in activity-dependent plasticity.	JOHNS HOPKINS UNIV, SCH MED, DEPT NEUROL, BALTIMORE, MD 21205 USA; UNIV ARIZONA, DEPT PSYCHOL, TUCSON, AZ 85724 USA; UNIV ARIZONA, DEPT NEUROL, TUCSON, AZ 85724 USA; UNIV ARIZONA, DIV NEURAL SYST MEMORY & AGING, TUCSON, AZ 85724 USA	Johns Hopkins University; University of Arizona; University of Arizona; University of Arizona	YAMAGATA, K (corresponding author), JOHNS HOPKINS UNIV, SCH MED, DEPT NEUROSCI, BALTIMORE, MD 21205 USA.		Snyder, Luann/E-8566-2013		NEI NIH HHS [EY09374, EY08900] Funding Source: Medline; NIA NIH HHS [AG09219] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY008900, R01EY009374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG009219] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ABRAHAM WC, 1991, MOL NEUROBIOL, V5, P297, DOI 10.1007/BF02935553; ABRAHAM WC, 1988, BRAIN RES, V462, P40, DOI 10.1016/0006-8993(88)90582-3; BARNES CA, 1985, BEHAV NEUROSCI, V99, P1040, DOI 10.1037/0735-7044.99.6.1040; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BLUE ME, 1983, J NEUROCYTOL, V12, P697, DOI 10.1007/BF01181531; BREDER CD, 1992, J COMP NEUROL, V322, P409, DOI 10.1002/cne.903220309; BREDT DS, 1991, NEURON, V7, P615, DOI 10.1016/0896-6273(91)90374-9; Campbell W. B., 1990, PHARMACOL BASIS THER, P600; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; CECCATELLI S, 1989, P NATL ACAD SCI USA, V86, P9569, DOI 10.1073/pnas.86.23.9569; COLE AJ, 1990, J NEUROCHEM, V55, P1920, DOI 10.1111/j.1471-4159.1990.tb05777.x; DAWSON TM, 1991, P NATL ACAD SCI USA, V88, P7797, DOI 10.1073/pnas.88.17.7797; DEWITT DL, 1988, P NATL ACAD SCI USA, V85, P1412, DOI 10.1073/pnas.85.5.1412; DEWITT DL, 1990, J BIOL CHEM, V265, P5192; DRAGUNOW M, 1989, NEUROSCI LETT, V101, P274, DOI 10.1016/0304-3940(89)90545-4; DUMUIS A, 1988, NATURE, V336, P68, DOI 10.1038/336068a0; FLETCHER BS, 1992, J BIOL CHEM, V267, P4338; FOSTERMANN U, 1982, PROSTAGLANDINS, V27, P913; GALL C, 1991, MOL BRAIN RES, V9, P113, DOI 10.1016/0169-328X(91)90136-L; GALL C, 1992, EPILEPSY RES, P171; GEROZISSIS K, 1983, BRAIN RES, V279, P133, DOI 10.1016/0006-8993(83)90171-3; GREENOUGH WT, 1975, AM SCI, V63, P37; HAYAISHI O, 1988, J BIOL CHEM, V263, P14593; HEMLER ME, 1980, J BIOL CHEM, V255, P6253; HERTTING G, 1989, ANN NY ACAD SCI, V559, P84; HESTRIN S, 1992, NATURE, V357, P686, DOI 10.1038/357686a0; HLA T, 1992, P NATL ACAD SCI USA, V89, P7384, DOI 10.1073/pnas.89.16.7384; JEFFERY KJ, 1990, MOL BRAIN RES, V8, P267, DOI 10.1016/0169-328X(90)90039-G; JORDAN CA, 1990, IN SITU HYBRIDIZATIO, P39; KENT RS, 1983, J CLIN INVEST, V72, P455, DOI 10.1172/JCI110993; KIMURA H, 1985, BRAIN RES, V330, P235, DOI 10.1016/0006-8993(85)90682-1; KUJUBU DA, 1991, J BIOL CHEM, V266, P12866; KUJUBU DA, 1993, J BIOL CHEM, V268, P5425; KUJUBU DA, 1992, J BIOL CHEM, V267, P7991; LANAHAN A, 1992, MOL CELL BIOL, V12, P3919, DOI 10.1128/MCB.12.9.3919; LAPETINA EG, 1979, P NATL ACAD SCI USA, V76, P121, DOI 10.1073/pnas.76.1.121; LEE SH, 1992, J BIOL CHEM, V267, P25934; LINZER DIH, 1983, P NATL ACAD SCI-BIOL, V80, P4271, DOI 10.1073/pnas.80.14.4271; LYNCH MA, 1989, NEUROSCIENCE, V30, P693, DOI 10.1016/0306-4522(89)90162-0; MARKEY CM, 1987, J BIOL CHEM, V262, P6266; MARSHALL PJ, 1987, J BIOL CHEM, V262, P3510; MCEWEN BS, 1986, PHYSIOL REV, V66, P1121, DOI 10.1152/physrev.1986.66.4.1121; MCNAUGHTON BL, 1986, J NEUROSCI, V6, P563; MEADE EA, 1993, J BIOL CHEM, V268, P6610; MERLIE JP, 1988, J BIOL CHEM, V263, P3550; NARUMIYA S, 1982, LIFE SCI, V31, P2093, DOI 10.1016/0024-3205(82)90101-1; NATHANS D, 1991, ORIGINS OF HUMAN CANCER, P353; NICOLL RA, 1988, NEURON, V1, P97, DOI 10.1016/0896-6273(88)90193-6; OBANION MK, 1992, P NATL ACAD SCI USA, V89, P4888, DOI 10.1073/pnas.89.11.4888; OGOROCHI T, 1984, J NEUROCHEM, V43, P71, DOI 10.1111/j.1471-4159.1984.tb06680.x; OJEDA SR, 1986, P NATL ACAD SCI USA, V83, P4932, DOI 10.1073/pnas.83.13.4932; OJEDA SR, 1982, ENDOCRINOLOGY, V110, P409, DOI 10.1210/endo-110-2-409; OJEDA SR, 1982, ENDOCRINOLOGY, V50, P89; OSULLIVAN MG, 1992, J BIOL CHEM, V267, P14547; PIOMELLI D, 1987, NATURE, V328, P38, DOI 10.1038/328038a0; QIAN Z, 1993, NATURE, V361, P453, DOI 10.1038/361453a0; RAZ A, 1988, J BIOL CHEM, V263, P3022; REED GD, 1991, ANN NY ACAD SCI, V627, P381; RETTORI V, 1992, P NATL ACAD SCI USA, V89, P11543, DOI 10.1073/pnas.89.23.11543; RITTENHOUSE PA, 1992, BRAIN RES, V580, P205, DOI 10.1016/0006-8993(92)90946-7; ROME LH, 1975, P NATL ACAD SCI USA, V72, P4863, DOI 10.1073/pnas.72.12.4863; RYSECK RP, 1992, CELL GROWTH DIFFER, V3, P443; SAFFEN DW, 1988, P NATL ACAD SCI USA, V85, P7795, DOI 10.1073/pnas.85.20.7795; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; SHIMIZU T, 1990, J NEUROCHEM, V55, P1, DOI 10.1111/j.1471-4159.1990.tb08813.x; SIROIS J, 1992, J BIOL CHEM, V267, P11586; SMITH WL, 1991, PHARMACOL THERAPEUT, V49, P153, DOI 10.1016/0163-7258(91)90054-P; STERNBERGER LA, 1986, J HISTOCHEM CYTOCHEM, V34, P599, DOI 10.1177/34.5.3517144; STONE EA, 1993, BRAIN RES, V603, P181, DOI 10.1016/0006-8993(93)91236-L; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; TRAPP BD, 1989, J NEUROCYTOL, V18, P47, DOI 10.1007/BF01188423; TSUBOKURA S, 1991, BRAIN RES, V543, P15, DOI 10.1016/0006-8993(91)91043-Z; TURNER AM, 1985, BRAIN RES, V329, P195, DOI 10.1016/0006-8993(85)90525-6; UENO R, 1982, P NATL ACAD SCI-BIOL, V79, P6093, DOI 10.1073/pnas.79.19.6093; URADE Y, 1987, J BIOL CHEM, V262, P15132; VANE J, 1987, FASEB J, V1, P89, DOI 10.1096/fasebj.1.2.3111928; VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0; WATANABE Y, 1989, BRAIN RES, V478, P143, DOI 10.1016/0006-8993(89)91486-8; WATANABE Y, 1986, BRAIN RES, V378, P216, DOI 10.1016/0006-8993(86)90924-8; WONG WYL, 1989, MOL ENDOCRINOL, V3, P1714, DOI 10.1210/mend-3-11-1714; WONG WYL, 1991, MOL ENDOCRINOL, V5, P1269, DOI 10.1210/mend-5-9-1269; WORLEY PF, 1990, COLD SH Q B, V55, P213, DOI 10.1101/SQB.1990.055.01.023; WORLEY PF, 1991, P NATL ACAD SCI USA, V88, P5106, DOI 10.1073/pnas.88.12.5106; WORLEY PF, 1993, IN PRESS J NEUROSCI; XIE WL, 1991, P NATL ACAD SCI USA, V88, P2692, DOI 10.1073/pnas.88.7.2692; YAMASHITA A, 1983, P NATL ACAD SCI-BIOL, V80, P6114, DOI 10.1073/pnas.80.19.6114; YOKOYAMA C, 1988, FEBS LETT, V231, P347, DOI 10.1016/0014-5793(88)80847-0; YOKOYAMA C, 1989, BIOCHEM BIOPH RES CO, V165, P888, DOI 10.1016/S0006-291X(89)80049-X	90	1067	1084	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	1993	11	2					371	386		10.1016/0896-6273(93)90192-T	http://dx.doi.org/10.1016/0896-6273(93)90192-T			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LU065	8352945				2022-12-24	WOS:A1993LU06500016
J	ZEILHOFER, HU; MULLER, TH; SWANDULLA, D				ZEILHOFER, HU; MULLER, TH; SWANDULLA, D			INHIBITION OF HIGH VOLTAGE-ACTIVATED CALCIUM CURRENTS BY L-GLUTAMATE RECEPTOR-MEDIATED CALCIUM INFLUX	NEURON			English	Article							RAT HIPPOCAMPAL-NEURONS; SENSORY NEURONS; CHANNELS; ACID; EXPRESSION; DEPRESSION; KINETICS; CULTURE; CHICK; BLOCK	The modulation of high voltage-activated (HVA) Ca2+ currents by L-glutamate and its agonists was investigated in cultured rat hypothalamic neurons. L-Glutamate and agonists selective for NMDA or non-NMDA receptors reversibly inhibited HVA Ca2+ currents. The putative presynaptic glutamate receptor agonist L-2-amino-4-phosphonobutyric acid and the selective metabotropic agonist trans-ACPD were ineffective. Inhibition was dependent on the presence of extracellular Ca2+ and blocked by internal perfusion of the cells with BAPTA. The calmodulin antagonists trifluoperazine and calmidazolium completely prevented the inhibition. Increases in the intracellular Ca2+ concentration due to Ca2+ influx through non-NMDA receptor channels were visualized using fura-2. These results indicate that not only NMDA but also non-NMDA receptor channels in these neurons are permeable for Ca2+ and that Ca2+ influx through these channels activates a calmodulin-dependent mechanism, which leads to HVA Ca2+ current inhibition.	MAX PLANCK INST BIOPHYS CHEM, MEMBRANBIOPHYS ABT, W-3400 GOTTINGEN, GERMANY	Max Planck Society	ZEILHOFER, HU (corresponding author), UNIV ERLANGEN NURNBERG, INST EXPTL & KLIN PHARMAKOL & TOXIKOL, UNIV STR 22, W-8520 ERLANGEN, GERMANY.		Zeilhofer, Hanns Ulrich/A-4600-2008	Zeilhofer, Hanns Ulrich/0000-0001-6954-4629				AITKEN A, 1982, FEBS LETT, V150, P314, DOI 10.1016/0014-5793(82)80759-X; ANWYL R, 1991, BRAIN RES REV, V16, P265, DOI 10.1016/0165-0173(91)90010-6; ARMSTRONG D, 1987, P NATL ACAD SCI USA, V84, P2518, DOI 10.1073/pnas.84.8.2518; ASCHER P, 1988, J PHYSIOL-LONDON, V399, P247; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; BERNHEIM L, 1991, NEURON, V6, P859, DOI 10.1016/0896-6273(91)90226-P; CARBONE E, 1989, PROG BIOPHYS MOL BIO, V54, P31, DOI 10.1016/0079-6107(89)90008-4; CARBONE E, 1987, J PHYSIOL-LONDON, V386, P547, DOI 10.1113/jphysiol.1987.sp016551; CHAD JE, 1986, J PHYSIOL-LONDON, V378, P31, DOI 10.1113/jphysiol.1986.sp016206; CHERNEVSKAYA NI, 1991, NATURE, V349, P418, DOI 10.1038/349418a0; COLLINGRIDGE GL, 1989, PHARMACOL REV, V41, P143; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; HOUAMED KM, 1991, SCIENCE, V252, P1318, DOI 10.1126/science.1656524; IINO M, 1990, J PHYSIOL-LONDON, V424, P151, DOI 10.1113/jphysiol.1990.sp018060; JONAS P, 1992, J PHYSIOL-LONDON, V455, P143, DOI 10.1113/jphysiol.1992.sp019294; KLEE CB, 1980, ANNU REV BIOCHEM, V49, P489, DOI 10.1146/annurev.bi.49.070180.002421; KONNERTH A, 1987, J PHYSIOL-LONDON, V386, P603, DOI 10.1113/jphysiol.1987.sp016553; KRAMER RH, 1991, NEURON, V6, P557, DOI 10.1016/0896-6273(91)90058-8; LESTER RAJ, 1990, NEURON, V4, P741, DOI 10.1016/0896-6273(90)90200-Y; MARTY A, 1985, J PHYSIOL-LONDON, V367, P117, DOI 10.1113/jphysiol.1985.sp015817; MASU M, 1991, NATURE, V349, P760, DOI 10.1038/349760a0; MULLER TH, 1992, J PHYSIOL-LONDON, V450, P341; NISTRI A, 1991, J PHYSIOL-LONDON, V435, P465, DOI 10.1113/jphysiol.1991.sp018519; OLIET SHR, 1992, J PHYSIOL-LONDON, V455, P291, DOI 10.1113/jphysiol.1992.sp019302; SCOTT RH, 1991, PROG NEUROBIOL, V36, P485, DOI 10.1016/0301-0082(91)90014-R; SWANDULLA D, 1991, TRENDS NEUROSCI, V14, P46, DOI 10.1016/0166-2236(91)90018-P; SWANDULLA D, 1989, P NATL ACAD SCI USA, V86, P1736, DOI 10.1073/pnas.86.5.1736; SWANDULLA D, 1990, J NEUROPHYSIOL, V64, P715, DOI 10.1152/jn.1990.64.3.715; SWANDULLA D, 1993, IN PRESS NEUROSCI LE; VANDENPOL AN, 1990, SCIENCE, V250, P1276, DOI 10.1126/science.1978759	31	33	34	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	1993	10	5					879	887		10.1016/0896-6273(93)90203-4	http://dx.doi.org/10.1016/0896-6273(93)90203-4			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LD322	8098610				2022-12-24	WOS:A1993LD32200010
J	SRETAVAN, DW; REICHARDT, LF				SRETAVAN, DW; REICHARDT, LF			TIME-LAPSE VIDEO ANALYSIS OF RETINAL GANGLION-CELL AXON PATHFINDING AT THE MAMMALIAN OPTIC CHIASM - GROWTH CONE GUIDANCE USING INTRINSIC CHIASM CUES	NEURON			English	Article							PERIPHERAL PIONEER NEURONS; POSTERIOR TECTAL MEMBRANES; CHICK VISUAL-SYSTEM; FASCICLIN-I; NERVOUS-SYSTEM; MOUSE; GRASSHOPPER; PROJECTIONS; COLLAPSE; FIBERS	The specific routing of retinal ganglion cell axons at the mammalian optic chiasm into the ipsilateral or contralateral optic tracts results from axon pathfinding. Using time-lapse microscopy, we show that encounters between axons from opposite eyes at the chiasm induce axon turning, but do not always aim retinal axons into the optic tracts. Following removal of one eye before retinal axons have invaded the chiasm, axons from the remaining eye are still routed into the correct optic tracts. Ipsilaterally projecting axons make turning decisions without pausing over 10-20 min, whereas contralaterally projecting axons occasionally pause before crossing the midline. Thus, initial pathfinding at the chiasm does not depend on binocular axon interactions, but on local cues that trigger differential growth cone responses.	UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,SAN FRANCISCO,CA 94143	Howard Hughes Medical Institute; University of California System; University of California San Francisco	SRETAVAN, DW (corresponding author), UNIV CALIF SAN FRANCISCO,PROGRAM NEUROSCI,SAN FRANCISCO,CA 94143, USA.							ANGEVINE JB, 1970, J COMP NEUROL, V139, P129, DOI 10.1002/cne.901390202; BAIER H, 1992, SCIENCE, V255, P472, DOI 10.1126/science.1734526; BASTIANI MJ, 1987, CELL, V48, P745, DOI 10.1016/0092-8674(87)90072-9; BENTLEY D, 1982, SCIENCE, V218, P1082, DOI 10.1126/science.218.4577.1082; BERLOT J, 1984, SCIENCE, V223, P493, DOI 10.1126/science.223.4635.493; BONHOEFFER F, 1985, NATURE, V315, P409; BUNT SM, 1981, BRAIN RES, V211, P399, DOI 10.1016/0006-8993(81)90712-5; BUNT SM, 1983, DEV BRAIN RES, V6, P149, DOI 10.1016/0165-3806(83)90093-7; CHALUPA LM, 1991, J NEUROSCI, V11, P191; CHANG WS, 1992, DEVELOPMENT, V114, P507; COLELLO RJ, 1990, DEVELOPMENT, V108, P515; COX EC, 1990, NEURON, V4, P31, DOI 10.1016/0896-6273(90)90441-H; DAVIES JA, 1990, NEURON, V4, P11, DOI 10.1016/0896-6273(90)90439-M; DRAGER UC, 1985, PROC R SOC SER B-BIO, V224, P57, DOI 10.1098/rspb.1985.0021; ELKINS T, 1990, CELL, V60, P565, DOI 10.1016/0092-8674(90)90660-7; GODEMENT P, 1981, CR ACAD SCI III-VIE, V293, P625; GODEMENT P, 1990, NEURON, V5, P173, DOI 10.1016/0896-6273(90)90307-2; GODEMENT P, 1987, J COMP NEUROL, V255, P97, DOI 10.1002/cne.902550108; Grenningloh G, 1992, Curr Opin Neurobiol, V2, P42, DOI 10.1016/0959-4388(92)90160-M; Guillery RW., 1982, SENS PHYSL, V7, P39, DOI [10.1016/B978-0-12-151807-3.50008-2, DOI 10.1016/B978-0-12-151807-3.50008-2]; GUNDERSEN RW, 1979, SCIENCE, V206, P1079, DOI 10.1126/science.493992; GUNDERSEN RW, 1980, J CELL BIOL, V87, P546, DOI 10.1083/jcb.87.3.546; HARRIS WA, 1987, DEVELOPMENT, V101, P123; HEFFNER CD, 1990, SCIENCE, V247, P217, DOI 10.1126/science.2294603; JAY DG, 1990, NATURE, V348, P548, DOI 10.1038/348548a0; KAPFHAMMER J, 1987, J NEUROSCI, V7, P2201; KAPFHAMMER JP, 1987, J NEUROSCI, V7, P1595; KLOSE M, 1989, SCIENCE, V245, P982, DOI 10.1126/science.2772651; LUMSDEN AGS, 1986, NATURE, V323, P538, DOI 10.1038/323538a0; LUMSDEN AGS, 1983, NATURE, V306, P786, DOI 10.1038/306786a0; MYERS PZ, 1993, J NEUROSCI, V13, P127; Niimi K, 1962, TOKUSHIMA J EXP MED, V8, P203; NORRIS WE, 1989, DEVELOPMENT, V105, P541; RAPER JA, 1990, EXP NEUROL, V109, P70, DOI 10.1016/S0014-4886(05)80009-3; RUGH R, 1990, MOUSE ITS REPROD DEV, P430; SNOW DM, 1990, DEV BIOL, V138, P359, DOI 10.1016/0012-1606(90)90203-U; SNOW DM, 1991, DEVELOPMENT, V113, P1473; SRETAVAN DW, 1990, J NEUROSCI, V10, P1995; SRETAVAN DW, 1986, J NEUROSCI, V6, P900; STAHL B, 1990, NEURON, V5, P735, DOI 10.1016/0896-6273(90)90227-7; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; WALTER J, 1987, DEVELOPMENT, V101, P909	42	109	109	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1993	10	4					761	777		10.1016/0896-6273(93)90176-R	http://dx.doi.org/10.1016/0896-6273(93)90176-R			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KY501	8386532				2022-12-24	WOS:A1993KY50100018
J	GRIFFITH, LC; VERSELIS, LM; AITKEN, KM; KYRIACOU, CP; DANHO, W; GREENSPAN, RJ				GRIFFITH, LC; VERSELIS, LM; AITKEN, KM; KYRIACOU, CP; DANHO, W; GREENSPAN, RJ			INHIBITION OF CALCIUM CALMODULIN-DEPENDENT PROTEIN-KINASE IN DROSOPHILA DISRUPTS BEHAVIORAL PLASTICITY	NEURON			English	Article							COURTSHIP SONG RHYTHMS; MELANOGASTER AFFECT; ALPHA-SUBUNIT; AUTOPHOSPHORYLATION; MUTATIONS; MUTANTS; MEMORY; BRAIN; PHOSPHORYLATION; EXPRESSION	One of the major mediators of calcium action in neurons is the multifunctional calcium/calmodulin-dependent protein kinase (CaM kinase), an enzyme with the capability of directly regulating its own activity by autophosphorylation. To assess the involvement of CaM kinase in experience-dependent behavior in an intact animal, we have designed a specific peptide inhibitor of CaM kinase and made transgenic Drosophila that express it under control of an inducible promoter. These flies fail to learn normally in two behavioral plasticity paradigms: acoustic priming, a nonassociative measure of sensitization, and courtship conditioning, a measure of associative learning. The magnitude of the learning defect in the associative paradigm appears to be proportional to the level of expression of the peptide gene in the two transgenic lines and can be increased by heat shock induction of gene expression. These results suggest that CaM kinase activity is required for plastic behaviors in an intact animal.	ROCHE INST MOLEC BIOL, DEPT NEUROSCI, NUTLEY, NJ 07110 USA; UNIV LEICESTER, DEPT GENET, LEICESTER LE1 7RH, ENGLAND; HOFFMANN LA ROCHE INC, ROCHE RES CTR, PEPTIDE RES DEPT, NUTLEY, NJ 07110 USA	University of Leicester; Roche Holding				Griffith, Leslie/0000-0003-3164-9876	NINDS NIH HHS [NS08779] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS008779] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARANY G, 1980, PEPTIDES ANAL SYNTHE, V2, P1; BOYNTON S, 1992, GENETICS, V131, P655; CAREW TJ, 1986, ANNU REV NEUROSCI, V9, P435, DOI 10.1146/annurev.ne.09.030186.002251; CHO KO, 1991, NEURON, V7, P439, DOI 10.1016/0896-6273(91)90296-C; DRAIN P, 1991, NEURON, V6, P71, DOI 10.1016/0896-6273(91)90123-H; DUERR JS, 1982, P NATL ACAD SCI-BIOL, V79, P3646, DOI 10.1073/pnas.79.11.3646; FEANY MB, 1990, P NATL ACAD SCI USA, V87, P2795, DOI 10.1073/pnas.87.7.2795; GAILEY DA, 1984, GENETICS, V106, P613; GREENACRE ML, 1993, IN PRESS BEHAV GENET; GRIFFITH LC, 1988, J BIOL CHEM, V263, P9542; HANSON PI, 1989, NEURON, V3, P59, DOI 10.1016/0896-6273(89)90115-3; KURET J, 1988, J BIOL CHEM, V263, P9149; KYRIACOU CP, 1982, ANIM BEHAV, V30, P794, DOI 10.1016/S0003-3472(82)80152-8; KYRIACOU CP, 1980, P NATL ACAD SCI-BIOL, V77, P6729, DOI 10.1073/pnas.77.11.6729; KYRIACOU CP, 1984, NATURE, V308, P62, DOI 10.1038/308062a0; KYRIACOU CP, 1986, SCIENCE, V232, P494, DOI 10.1126/science.3083506; KYRIACOU CP, 1989, ANIM BEHAV, V37, P850, DOI 10.1016/0003-3472(89)90069-9; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MASON PJ, 1982, J MOL BIOL, V156, P21, DOI 10.1016/0022-2836(82)90456-9; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; NICHOLS R, 1992, J MOL NEUROSCI, V3, P213, DOI 10.1007/BF03380141; Pirrotta V, 1988, VECTORS SURVEY MOL C, P437; ROBERTSON HM, 1988, GENETICS, V118, P461; SAKAKIBARA M, 1986, BIOPHYS J, V50, P319, DOI 10.1016/S0006-3495(86)83465-8; Sambrook J, 1989, MOL CLONING; SCHOLZ WK, 1988, J NEUROSCI, V8, P1039; SCHULMAN H, 1984, J CELL BIOL, V99, P11, DOI 10.1083/jcb.99.1.11; SCHULMAN H, 1988, ADV SEC MESS PHOSPH, V22, P39; SCHWORER CM, 1986, J BIOL CHEM, V261, P8581; SIEGEL RW, 1979, P NATL ACAD SCI USA, V76, P3430, DOI 10.1073/pnas.76.7.3430; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; TAKAI Y, 1977, J BIOL CHEM, V252, P7603; THIEL G, 1988, P NATL ACAD SCI USA, V85, P6337, DOI 10.1073/pnas.85.17.6337; TOMPKINS L, 1983, BEHAV GENET, V13, P565, DOI 10.1007/BF01076402; TULLY T, 1984, BEHAV GENET, V14, P527, DOI 10.1007/BF01065446; WILLMUND R, 1986, P NATL ACAD SCI USA, V83, P9789, DOI 10.1073/pnas.83.24.9789; WOODARD C, 1989, GENETICS, V123, P315; ZHONG Y, 1991, SCIENCE, V251, P198, DOI 10.1126/science.1670967; ZIAI R, 1986, P NATL ACAD SCI USA, V83, P8420, DOI 10.1073/pnas.83.21.8420	40	193	198	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	1993	10	3					501	509		10.1016/0896-6273(93)90337-Q	http://dx.doi.org/10.1016/0896-6273(93)90337-Q			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KU901	8384859				2022-12-24	WOS:A1993KU90100014
J	KESSEL, M				KESSEL, M			REVERSAL OF AXONAL PATHWAYS FROM RHOMBOMERE-3 CORRELATES WITH EXTRA HOX EXPRESSION DOMAINS	NEURON			English	Article							SEGMENT-SPECIFIC EXPRESSION; HOMEOBOX-CONTAINING GENES; CENTRAL-NERVOUS-SYSTEM; CHICK LIMB BUD; RETINOIC ACID; TRANSGENIC MICE; VERTEBRATE HEAD; MOUSE HINDBRAIN; XENOPUS EMBRYOS; HOX-1.1	Exposure of midgastrulation mouse embryos to retinoic acid induced anteriorized expression of the Hoxa-1 (Hox-1.6) and Hoxb-1 (Hox-2.9) genes. Separate, extra domains of Hoxb-1 expression were detected as stripes and patches up to the midbrain boundary within rhombomeres r3, r2, and r1. Morphological alterations were studied in embryos of the transgenic line L17, which allowed staining of cranial ganglia, motor neurons, and axons by means of the beta-galactosidase reaction. Axons of motor neurons in r3 normally project laterally, before they turn sharply rostrally to exit with the trigeminal nerve from r2. Altered projection patterns were observed for single neurons, groups of neurons, or the complete set of r3 motor neurons in different embryos exposed to retinoic acid. Here r3 axons turned in the opposite direction and exited as facial nerves from r4. These changes of neuroectodermal fates indicate a linkage between axonal pathfinding and intrinsic neuronal specification by Hox codes.			KESSEL, M (corresponding author), MAX PLANCK INST BIOPHYS CHEM,AM FASSBERG,W-3400 GOTTINGEN,GERMANY.							AKAM M, 1988, DEVELOPMENT, V104, P123; ALTABA ARI, 1991, DEVELOPMENT, V112, P945; BALLING R, 1989, CELL, V58, P337, DOI 10.1016/0092-8674(89)90848-9; BARON A, 1987, EMBO J, V6, P2977, DOI 10.1002/j.1460-2075.1987.tb02603.x; BATESON W, 1984, MATERIALS STUDY VARI; CHANG S, 1992, DEVELOPMENT, V114, P815; CHISAKA O, 1992, NATURE, V355, P516, DOI 10.1038/355516a0; CHISAKA O, 1991, NATURE, V350, P473, DOI 10.1038/350473a0; CHO KWY, 1991, CELL, V65, P55, DOI 10.1016/0092-8674(91)90407-P; DAVIS CA, 1988, GENE DEV, V2, P1736, DOI 10.1101/gad.2.12b.1736; DURSTON AJ, 1989, NATURE, V340, P140, DOI 10.1038/340140a0; FAINSOD A, 1987, DEV BIOL, V124, P125, DOI 10.1016/0012-1606(87)90465-9; FROHMAN MA, 1990, DEVELOPMENT, V110, P589; GARDNER CA, 1988, J NEUROSCI RES, V21, P426, DOI 10.1002/jnr.490210234; GAUNT SJ, 1988, DEVELOPMENT, V103, P135; GUTHRIE S, 1992, NATURE, V356, P157, DOI 10.1038/356157a0; GUTHRIE S, 1992, DEVELOPMENT, V114, P663; HOGAN BLM, 1992, NATURE, V359, P237, DOI 10.1038/359237a0; HOLDER N, 1991, DEVELOPMENT, V113, P1159; HORNBRUCH A, 1986, J EMBRYOL EXP MORPH, V94, P257; HUNT P, 1991, NATURE, V353, P861, DOI 10.1038/353861a0; HUNT P, 1991, DEVELOPMENT, V112, P43; IZPISUABELMONTE JC, 1991, NATURE, V350, P585, DOI 10.1038/350585a0; KESSEL M, 1992, DEVELOPMENT, V115, P487; KESSEL M, 1990, CELL, V61, P301, DOI 10.1016/0092-8674(90)90810-2; KESSEL M, 1990, SCIENCE, V249, P374, DOI 10.1126/science.1974085; KESSEL M, 1991, CELL, V67, P89, DOI 10.1016/0092-8674(91)90574-I; LEMOUELLIC H, 1992, CELL, V69, P251, DOI 10.1016/0092-8674(92)90406-3; LUFKIN T, 1991, CELL, V66, P1105, DOI 10.1016/0092-8674(91)90034-V; LUMSDEN A, 1990, TRENDS NEUROSCI, V13, P329, DOI 10.1016/0166-2236(90)90144-Y; LUMSDEN A, 1989, NATURE, V337, P424, DOI 10.1038/337424a0; LUMSDEN A, 1991, DEVELOPMENT, V113, P1281; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; MORGAN BA, 1992, NATURE, V358, P236, DOI 10.1038/358236a0; MORRISSKAY GM, 1991, EMBO J, V10, P2985, DOI 10.1002/j.1460-2075.1991.tb07849.x; MURPHY P, 1989, NATURE, V341, P156, DOI 10.1038/341156a0; MURPHY P, 1991, DEVELOPMENT, V111, P61; NOHNO T, 1991, CELL, V64, P1197, DOI 10.1016/0092-8674(91)90274-3; NOJI S, 1991, NATURE, V350, P83, DOI 10.1038/350083a0; PAPALOPULU N, 1991, DEVELOPMENT, V113, P1145; PUSCHEL AW, 1990, DEVELOPMENT, V108, P435; PUSCHEL AW, 1991, DEVELOPMENT, V112, P279; SALSER SJ, 1992, NATURE, V355, P255, DOI 10.1038/355255a0; SCOTT MP, 1992, CELL, V71, P551, DOI 10.1016/0092-8674(92)90588-4; SIMEONE A, 1990, NATURE, V346, P736; SIVE HL, 1990, GENE DEV, V4, P932, DOI 10.1101/gad.4.6.932; SUNDIN O, 1992, DEVELOPMENT, V114, P841; SUNDIN OH, 1990, GENE DEV, V4, P1267, DOI 10.1101/gad.4.8.1267; TABIN CJ, 1991, CELL, V66, P199, DOI 10.1016/0092-8674(91)90612-3; TAM PPL, 1989, DEVELOPMENT, V107, P55; Vaage S., 1969, ERG ANAT ENTWICKLU, V41, P1; WANEK N, 1991, NATURE, V350, P81, DOI 10.1038/350081a0; WILKINSON DG, 1989, NATURE, V341, P405, DOI 10.1038/341405a0; WILKINSON DG, 1989, NATURE, V337, P461, DOI 10.1038/337461a0; WRIGHT CVE, 1989, CELL, V59, P81, DOI 10.1016/0092-8674(89)90871-4	55	88	88	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1993	10	3					379	393		10.1016/0896-6273(93)90328-O	http://dx.doi.org/10.1016/0896-6273(93)90328-O			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KU901	8096385				2022-12-24	WOS:A1993KU90100005
J	Ingi, T; Cheng, J; Ronnett, GV				Ingi, T; Cheng, J; Ronnett, GV			Carbon monoxide: An endogenous modulator of the nitric oxide-cyclic GMP signaling system	NEURON			English	Article							CEREBELLAR GRANULE CELLS; HEME OXYGENASE; MESSENGER-RNA; RAT-BRAIN; INSITU HYBRIDIZATION; GUANYLATE-CYCLASE; ERYTHROID-CELLS; SYNTHASE; GLUTAMATE; LOCALIZATION	Carbon monoxide (GO) is an activator of soluble guanylyl cyclase and is implicated as a neuronal messenger. CO production, nitric oxide synthase (NOS) activity, and guanosine 3',5'-monophosphate (cGMP) levels were quantitated in cerebellar granule cell cultures. Metabolic labeling experiments enabled the direct measurement of neuronal CO production in vitro. CO production is significant, and peaked during early stages of culture. NOS activity and cGMP levels synchronously increased as cells matured. Whereas inhibition of NOS depleted cGMP in mature cultures, inhibitors of CO production potentiated the nitric oxide (NO)-mediated cGMP increase. Exogenous CO at similar concentrations to endogenous levels blocked the NO-mediated cGMP increase. These results directly demonstrate that endogenous neuronal CO production is high and indicate that while NO is the major regulator of cGMP in these neurons, CO may modulate the NO-cGMP signaling system.	JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROL,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins University								BESSHO Y, 1993, J NEUROCHEM, V60, P253, DOI 10.1111/j.1471-4159.1993.tb05845.x; BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; BREDT DS, 1994, ANNU REV BIOCHEM, V63, P175, DOI 10.1146/annurev.bi.63.070194.001135; BRUNE B, 1987, MOL PHARMACOL, V32, P497; CASSOLY R, 1975, J MOL BIOL, V91, P301, DOI 10.1016/0022-2836(75)90382-4; CRUSE I, 1988, J BIOL CHEM, V263, P3348; EBERT PS, 1970, BIOCHIM BIOPHYS ACTA, V208, P236, DOI 10.1016/0304-4165(70)90242-4; EWING JF, 1992, MOL CELL NEUROSCI, V3, P559, DOI 10.1016/1044-7431(92)90068-D; FALK JE, 1975, PROPHYRINS METALLOPO, P808; FREEMAN ME, 1983, J NEUROCHEM, V40, P1441, DOI 10.1111/j.1471-4159.1983.tb13588.x; FURCHGOTT RF, 1991, BLOOD VESSELS, V28, P52; GARDNER LC, 1991, J BIOL CHEM, V266, P22010; GARTHWAITE J, 1988, NATURE, V336, P385, DOI 10.1038/336385a0; GARTHWAITE J, 1991, TRENDS NEUROSCI, V14, P60, DOI 10.1016/0166-2236(91)90022-M; GRISCAVAGE JM, 1994, J BIOL CHEM, V269, P21644; GRISCAVAGE JM, 1993, J IMMUNOL, V151, P6329; HALL PV, 1979, NEUROLOGY, V29, P262, DOI 10.1212/WNL.29.2.262; IGNARRO LJ, 1984, J BIOL CHEM, V259, P6201; Ingi T, 1995, J NEUROSCI, V15, P8214; Jing M, 1994, Adv Pharmacol, V31, P459, DOI 10.1016/S1054-3589(08)60635-3; Jing Ming, 1995, Life Sciences, V56, P19; KHARITONOV VG, 1995, P NATL ACAD SCI USA, V92, P2568, DOI 10.1073/pnas.92.7.2568; KIEDROWSKI L, 1992, J NEUROCHEM, V58, P335, DOI 10.1111/j.1471-4159.1992.tb09315.x; KIM TD, 1994, J BIOL CHEM, V269, P15540; KINGSBURY AE, 1985, DEV BRAIN RES, V17, P17, DOI 10.1016/0165-3806(85)90128-2; KRUSZYNA H, 1993, BIOCHEM PHARMACOL, V46, P95, DOI 10.1016/0006-2952(93)90352-W; LABBE RF, 1957, BIOCHIM BIOPHYS ACTA, V26, P437, DOI 10.1016/0006-3002(57)90033-1; LANDAW SA, 1966, J NUCL MED, V7, P696; LEINDERSZUFALL T, 1995, J NEUROPHYSIOL, V74, P1498, DOI 10.1152/jn.1995.74.4.1498; LINCOLN BC, 1989, BIOCHIM BIOPHYS ACTA, V992, P49, DOI 10.1016/0304-4165(89)90049-4; LUO DS, 1994, EUR J PHARM-MOLEC PH, V267, P263, DOI 10.1016/0922-4106(94)90149-X; MAINES MD, 1988, FASEB J, V2, P2557, DOI 10.1096/fasebj.2.10.3290025; MAINES MD, 1981, BIOCHIM BIOPHYS ACTA, V673, P339, DOI 10.1016/0304-4165(81)90465-7; MATSUOKA I, 1992, J NEUROSCI, V12, P3350; MCMILLAN K, 1992, P NATL ACAD SCI USA, V89, P11141, DOI 10.1073/pnas.89.23.11141; MEFFERT MK, 1994, NEURON, V13, P1225, DOI 10.1016/0896-6273(94)90060-4; MONCADA S, 1991, PHARMACOL REV, V43, P109; NATHANSON JA, 1995, NEURON, V14, P781, DOI 10.1016/0896-6273(95)90222-8; PONKA P, 1985, BLOOD, V65, P850; POSS KD, 1995, NEURON, V15, P867, DOI 10.1016/0896-6273(95)90177-9; SASSA S, 1975, ERYTHROPOIESIS, P383; SCHMIDT HHHW, 1992, FEBS LETT, V307, P102, DOI 10.1016/0014-5793(92)80910-9; SCHWARTZ MB, 1990, J NEUROSCI, V26, P217; STEVENS CF, 1993, NATURE, V364, P147, DOI 10.1038/364147a0; STONE JR, 1994, BIOCHEMISTRY-US, V33, P5636, DOI 10.1021/bi00184a036; SUN Y, 1990, J BIOL CHEM, V265, P8212; TAYEH MA, 1989, J BIOL CHEM, V264, P19654; THOM SR, 1994, TOXICOL APPL PHARM, V128, P105, DOI 10.1006/taap.1994.1186; VERMA A, 1993, SCIENCE, V259, P381, DOI 10.1126/science.7678352; VREMAN HJ, 1991, AM J MED SCI, V302, P335, DOI 10.1097/00000441-199112000-00002; WHITE KA, 1992, BIOCHEMISTRY-US, V31, P6627, DOI 10.1021/bi00144a001; WYSS PA, 1993, BIOCHIM BIOPHYS ACTA, V1182, P323, DOI 10.1016/0925-4439(93)90076-D; ZHUO M, 1993, SCIENCE, V260, P1946, DOI 10.1126/science.8100368	55	221	230	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1996	16	4					835	842		10.1016/S0896-6273(00)80103-8	http://dx.doi.org/10.1016/S0896-6273(00)80103-8			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UG611	8608001	hybrid			2022-12-24	WOS:A1996UG61100016
J	Artalejo, CR; Elhamdani, A; Palfrey, HC				Artalejo, CR; Elhamdani, A; Palfrey, HC			Calmodulin is the divalent cation receptor for rapid endocytosis, but not exocytosis, in adrenal chromaffin cells	NEURON			English	Article							DEPENDENT PROTEIN-KINASE; LIGHT-CHAIN KINASE; AUTOINHIBITORY DOMAIN; BINDING; PHOSPHORYLATION; SECRETION; CALCINEURIN; ANTIBODIES; VESICLES; PURIFICATION	Exocytosis and the ensuing rapid endocytosis in adrenal chromaffin cells are both Ca2+-dependent phenomena but differ in their divalent cation specificity, implying distinct Ca2+ receptors for the two processes. To ascertain whether calmodulin is the Ca2+ receptor for either process, we blocked its function by introducing calmodulin-binding peptides or anti-calmodulin antibodies into these cells. Exo/endocytosis was followed by measurement of cell membrane capacitance. Rapid endocytosis, but not exocytosis, was abolished by these treatments, indicating that calmodulin is the Ca2+ receptor for rapid endocytosis but is not involved in exocytosis. The principal calmodulin target is not protein phosphatase-as, as antagonism of this enzyme did not inhibit but accelerated rapid endocytosis. Calmodulin may thus regulate both the rate and extent of rapid endocytosis by distinct pathways.	UNIV CHICAGO,DEPT PHARMACOL & PHYSIOL SCI,CHICAGO,IL 60637	University of Chicago	Artalejo, CR (corresponding author), NORTHWESTERN UNIV,DEPT NEUROBIOL & PHYSIOL,2153 SHERIDAN RD,EVANSTON,IL 60208, USA.							ARTALEJO CR, 1994, NATURE, V367, P72, DOI 10.1038/367072a0; ARTALEJO CR, 1995, P NATL ACAD SCI USA, V92, P8328, DOI 10.1073/pnas.92.18.8328; BRADY MJ, 1993, J BIOL CHEM, V268, P17951; CECCARELLI B, 1980, J CELL BIOL, V87, P297, DOI 10.1083/jcb.87.1.297; CHAO SH, 1984, MOL PHARMACOL, V26, P75; CLAPHAM DE, 1984, J PHYSIOL-LONDON, V353, P541, DOI 10.1113/jphysiol.1984.sp015350; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; Fabiato A., 1988, METHOD ENZYMOL, V157, P387; FIDLER N, 1989, BIOPHYS J, V56, P1153, DOI 10.1016/S0006-3495(89)82762-6; GEISOW MJ, 1983, NATURE, V301, P432, DOI 10.1038/301432a0; GROBLEWSKI GE, 1994, J BIOL CHEM, V269, P15111; HASHIMOTO Y, 1990, J BIOL CHEM, V265, P1924; HAYCOCK JW, 1988, P NATL ACAD SCI USA, V85, P1677, DOI 10.1073/pnas.85.5.1677; HERSKOVITS JS, 1993, J CELL BIOL, V122, P565, DOI 10.1083/jcb.122.3.565; HIKITA T, 1984, J NEUROCHEM, V43, P1087, DOI 10.1111/j.1471-4159.1984.tb12848.x; HULTSCH T, 1991, P NATL ACAD SCI USA, V88, P6229, DOI 10.1073/pnas.88.14.6229; HUNZIKER W, 1994, J BIOL CHEM, V269, P29003; ITOH T, 1989, NATURE, V338, P164, DOI 10.1038/338164a0; KENIGSBERG RL, 1985, NEUROSCIENCE, V14, P335, DOI 10.1016/0306-4522(85)90183-6; KLEE CB, 1988, ADV ENZYMOL RAMB, V61, P149; KOENIG JH, 1983, J CELL BIOL, V96, P1517, DOI 10.1083/jcb.96.6.1517; KUBLER E, 1994, EMBO J, V13, P5539, DOI 10.1002/j.1460-2075.1994.tb06891.x; KURET J, 1984, BIOCHEMISTRY-US, V23, P5495, DOI 10.1021/bi00318a018; LEE YC, 1984, J BIOL CHEM, V259, P1226; LITTLETON JT, 1995, TRENDS NEUROSCI, V18, P177; LIU JP, 1994, SCIENCE, V265, P970, DOI 10.1126/science.8052858; LUKAS TJ, 1986, BIOCHEMISTRY-US, V25, P1458, DOI 10.1021/bi00354a041; MATTHIES HJG, 1988, FEBS LETT, V229, P238, DOI 10.1016/0014-5793(88)81132-3; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; MITSUI K, 1993, J BIOL CHEM, V268, P13422; MOMAYEZI M, 1987, J CELL BIOL, V105, P181, DOI 10.1083/jcb.105.1.181; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; NICHOLS RA, 1994, J BIOL CHEM, V269, P23817; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; PARSONS TD, 1994, NEURON, V13, P875, DOI 10.1016/0896-6273(94)90253-4; PAYNE ME, 1988, J BIOL CHEM, V263, P7190; PEARSON RB, 1986, J BIOL CHEM, V261, P25; PERIN MS, 1991, J BIOL CHEM, V266, P623; REDDY GPV, 1992, BIOCHEMISTRY-US, V31, P10426, DOI 10.1021/bi00158a002; ROBINSON PJ, 1994, TRENDS NEUROSCI, V17, P348, DOI 10.1016/0166-2236(94)90179-1; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; SACKS DB, 1991, ANAL BIOCHEM, V194, P369, DOI 10.1016/0003-2697(91)90243-M; SALISBURY JL, 1980, J CELL BIOL, V87, P132, DOI 10.1083/jcb.87.1.132; SCHELLER RH, 1995, NEURON, V14, P893; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; SMITH MK, 1992, J BIOL CHEM, V267, P1761; SNYDER SH, 1995, NAT MED, V1, P32, DOI 10.1038/nm0195-32; STEINHARDT RA, 1982, NATURE, V295, P154, DOI 10.1038/295154a0; THOMAS P, 1994, J CELL BIOL, V124, P667, DOI 10.1083/jcb.124.5.667; TRIFARO JM, 1989, NEUROSCIENCE, V29, P1, DOI 10.1016/0306-4522(89)90327-8; VANBELLE H, 1984, ADV CYCLIC NUCL PROT, V17, P557; VONGERSDORFF H, 1994, NATURE, V370, P652, DOI 10.1038/370652a0; VONGRAFENSTEIN H, 1992, J PHYSIOL-LONDON, V453, P15, DOI 10.1113/jphysiol.1992.sp019215; WAGNER JA, 1991, NATURE, V349, P793, DOI 10.1038/349793a0; WOLFF DJ, 1977, J BIOL CHEM, V252, P4108; [No title captured]	57	107	108	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1996	16	1					195	205		10.1016/S0896-6273(00)80036-7	http://dx.doi.org/10.1016/S0896-6273(00)80036-7			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TT307	8562084	Bronze			2022-12-24	WOS:A1996TT30700022
J	PUSCHEL, AW; ADAMS, RH; BETZ, H				PUSCHEL, AW; ADAMS, RH; BETZ, H			MURINE SEMAPHORIN-D COLLAPSIN IS A MEMBER OF A DIVERSE GENE FAMILY AND CREATES DOMAINS INHIBITORY FOR AXONAL EXTENSION	NEURON			English	Article							THORACIC SPINAL-CORD; NEURITE OUTGROWTH; EMBRYONIC CHICK; GROWTH CONES; POSTNATAL ORGANIZATION; GUIDANCE; SEQUENCE; EXPRESSION; PATTERNS; PROTEIN	Members of the collapsin/semaphorin gene family have been proposed to act as growth cone guidance signals in vertebrates and invertebrates. To identify candidate molecules involved in axonal pathfinding during mouse embryogenesis, we isolated cDNAs encoding five new members of the semaphorin family (Sem A-Sem E). The murine semaphorin genes are differentially expressed in mesoderm and neuroectoderm before and during the time when axons select their pathways in the embryo. In explant cultures, recombinant Sem D/collapsin converts a matrix permissive for axonal growth into one that is inhibitory for neurites of peripheral ganglia. Our data demonstrate that semaphorins are a diverse family of molecules that may provide local signals to specify territories nonnaccessible for growing axons.			PUSCHEL, AW (corresponding author), MAX PLANCK INST HIRNFORSCH,NEUROCHEM ABT,DEUTSCHORDENSTR 46,D-60528 FRANKFURT,GERMANY.		Adams, Ralf H/AAE-9274-2019					ALTMAN J, 1984, DEV RAT SPINAL CORD; BROWN AG, 1981, ANATOMY PHYSL IDENTI; CARONI P, 1988, J CELL BIOL, V106, P1281, DOI 10.1083/jcb.106.4.1281; COX EC, 1990, NEURON, V4, P31, DOI 10.1016/0896-6273(90)90441-H; DAVIES JA, 1990, NEURON, V4, P11, DOI 10.1016/0896-6273(90)90439-M; EISEN JS, 1994, ANNU REV NEUROSCI, V17, P1; FENG DF, 1987, J MOL EVOL, V25, P351, DOI 10.1007/BF02603120; FITZGERALD M, 1993, DEVELOPMENT, V117, P1377; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; HONIG MG, 1986, DEV BIOL, V118, P532, DOI 10.1016/0012-1606(86)90024-2; HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; KOLODKIN AL, 1992, NEURON, V9, P831, DOI 10.1016/0896-6273(92)90237-8; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; LANCEJONES C, 1991, DEV BIOL, V143, P93, DOI 10.1016/0012-1606(91)90057-A; LANDMESSER L, 1984, TRENDS NEUROSCI, V7, P336, DOI 10.1016/S0166-2236(84)80083-1; LANDMESSER LT, 1980, ANNU REV NEUROSCI, V3, P279, DOI 10.1146/annurev.ne.03.030180.001431; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Luo Yuling, 1994, Current Opinion in Neurobiology, V4, P648, DOI 10.1016/0959-4388(94)90005-1; NICOLA MA, 1992, NEUROSCI LETT, V138, P173, DOI 10.1016/0304-3940(92)90499-W; PINI A, 1993, SCIENCE, V261, P95, DOI 10.1126/science.8316861; PUSCHEL AW, 1992, DEVELOPMENT, V114, P643; RAPER JA, 1990, NEURON, V4, P21, DOI 10.1016/0896-6273(90)90440-Q; REXED B, 1954, J COMP NEUROL, V100, P297, DOI 10.1002/cne.901000205; Sambrook J, 1989, MOL CLONING LABORATO; SERAFINI T, 1974, CELL, V78, P409; SMITH CL, 1983, J COMP NEUROL, V220, P16, DOI 10.1002/cne.902200104; SMITH CL, 1983, J COMP NEUROL, V220, P29, DOI 10.1002/cne.902200105; TOSNEY KW, 1987, DEV BIOL, V122, P540, DOI 10.1016/0012-1606(87)90318-6; TOSNEY KW, 1990, EXP NEUROL, V109, P75, DOI 10.1016/S0014-4886(05)80010-X; TOSNEY KW, 1989, J EXP ZOOL, V251, P232, DOI 10.1002/jez.1402510211; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; Willis WD, 1991, SENSORY MECH SPINAL	33	338	359	0	3	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1995	14	5					941	948		10.1016/0896-6273(95)90332-1	http://dx.doi.org/10.1016/0896-6273(95)90332-1			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QY935	7748561	Bronze			2022-12-24	WOS:A1995QY93500006
J	STEVENS, CF; WANG, YY				STEVENS, CF; WANG, YY			FACILITATION AND DEPRESSION AT SINGLE CENTRAL SYNAPSES	NEURON			English	Article							RAT HIPPOCAMPAL SLICES; QUANTAL ANALYSIS; GLUTAMATE; NEURONS; PROBABILITY; RECEPTORS; RELEASE	Using whole-cell recording from CA1 hippocampal pyramidal neurons and minimal stimulation of Schaffer collaterals, we have studied what seem to be single synapses. Although the transmission at a putative single synapse is quite unreliable, the synapse can be made to release transmitter reliably in response to the second stimulus in a pair of stimuli that are presented in rapid succession (e.g., 50 ms separation). Statistical analysis of transmission failures seen with such paired pulse stimulation reveals that the majority of stimulus-evoked synaptic currents (>90%) are produced by a single synapse under the conditions of minimal stimulation, even if multiple synapses are actually present. individual synapses appear to release either zero or one quantum; that is, a single synapse seems to have only one functional release site at any time. After the release site has been used, similar to 20 ms is required to refill the site so that it can be used again.			STEVENS, CF (corresponding author), SALK INST BIOL STUDIES,HOWARD HUGHES MED INST,MOLEC NEUROBIOL LAB,LA JOLLA,CA 92037, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS012961] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 12961] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLEN C, 1994, P NATL ACAD SCI USA, V91, P10380, DOI 10.1073/pnas.91.22.10380; ANDERSEN P, 1978, BRAIN RES, V144, P11, DOI 10.1016/0006-8993(78)90431-6; COLQUHOUN D, 1992, J PHYSIOL-LONDON, V458, P261, DOI 10.1113/jphysiol.1992.sp019417; EDWARDS FA, 1990, J PHYSL, V117, P109; Feller W., 1950, INTRO PROBABILITY TH; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; HUBBARD JI, 1963, J PHYSL, V169, P6461; Katz B., 1969, RELEASE NEURAL TRANS; KORN H, 1991, TRENDS NEUROSCI, V14, P439, DOI 10.1016/0166-2236(91)90042-S; MAGLEBY KL, 1987, SYNAPTIC FUNCTION, P21; RAASTAD M, 1992, EUR J NEUROSCI, V4, P113, DOI 10.1111/j.1460-9568.1992.tb00114.x; REDMAN S, 1990, PHYSIOL REV, V70, P165, DOI 10.1152/physrev.1990.70.1.165; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; SORRA KE, 1993, J NEUROSCI, V13, P3736; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; THIES RE, 1965, J NEUROPHYSIOL, V28, P427, DOI 10.1152/jn.1965.28.3.427; TRUSSELL LO, 1988, P NATL ACAD SCI USA, V85, P2834, DOI 10.1073/pnas.85.8.2834; ZUKER RS, 1988, ANN REV NEUROSCI, V12, P13	19	401	405	0	11	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1995	14	4					795	802		10.1016/0896-6273(95)90223-6	http://dx.doi.org/10.1016/0896-6273(95)90223-6			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QU826	7718241	Bronze			2022-12-24	WOS:A1995QU82600013
J	KURADA, P; OTOUSA, JE				KURADA, P; OTOUSA, JE			RETINAL DEGENERATION CAUSED BY DOMINANT RHODOPSIN MUTATIONS IN DROSOPHILA	NEURON			English	Article							RETINITIS-PIGMENTOSA; PHOTORECEPTOR DEGENERATION; CYSTEINE RESIDUE-110; VISUAL PIGMENTS; GENE; MUTANTS; MELANOGASTER; PHOTOTRANSDUCTION; NORPA; MAINTENANCE	Dominant mutations of the Drosophila ninaE-encoded rhodopsin are described that reduce the expression of wild-type rhodopsin and cause a slow, age-dependent form of retinal degeneration. A posttranslational event subsequent to the requirement for the nin aA-encoded cyclophilin is disrupted by the dominant mutations. Most of these dominant mutations are missense mutations that affect the physical properties of one of the seven transmembrane domains; another affects the cysteine involved in a disulfide linkage. The results indicate that misfolded or unstable mutant rhodopsin can interfere with maturation of wild-type rhodopsin, and that these cellular conditions may trigger retinal degeneration. In addition, these dominant rhodopsin mutations suppress the rapid degeneration seen in rdgC and norpA flies, indicating that high levels of rhodopsin are required.			KURADA, P (corresponding author), UNIV NOTRE DAME,DEPT BIOL SCI,NOTRE DAME,IN 46556, USA.			O'Tousa, Joseph/0000-0001-9754-6816	NEI NIH HHS [EY06808] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		APPLEBURY ML, 1986, VISION RES, V26, P1881, DOI 10.1016/0042-6989(86)90115-X; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; BYK T, 1993, P NATL ACAD SCI USA, V90, P1907, DOI 10.1073/pnas.90.5.1907; CHEN DM, 1983, J INSECT PHYSIOL, V29, P133, DOI 10.1016/0022-1910(83)90136-1; COLLEY NJ, 1991, CELL, V67, P255, DOI 10.1016/0092-8674(91)90177-Z; DRYJA TP, 1990, NEW ENGL J MED, V323, P1302, DOI 10.1056/NEJM199011083231903; Franceschini N., 1972, INFORMATION PROCESSI, P75; Grigliati T., 1986, DROSOPHILA PRACTICAL, P39; HARRIS WA, 1977, J GEN PHYSIOL, V69, P261, DOI 10.1085/jgp.69.3.261; JOHNSON EC, 1986, J GEN PHYSIOL, V88, P651, DOI 10.1085/jgp.88.5.651; KARNIK SS, 1990, J BIOL CHEM, V265, P17520; KARNIK SS, 1988, P NATL ACAD SCI USA, V85, P8459, DOI 10.1073/pnas.85.22.8459; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE YJ, 1994, NEURON, V13, P1143, DOI 10.1016/0896-6273(94)90052-3; LEONARD DS, 1992, J NEUROBIOL, V23, P605, DOI 10.1002/neu.480230602; MEYERTHOLEN EP, 1987, J COMP PHYSIOL A, V161, P793, DOI 10.1007/BF00610221; MIN KC, 1993, J BIOL CHEM, V268, P9400; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; NATHANS J, 1994, CELL, V78, P357, DOI 10.1016/0092-8674(94)90414-6; NATHANS J, 1992, ANNU REV GENET, V26, P403, DOI 10.1146/annurev.ge.26.120192.002155; OTOUSA JE, 1985, CELL, V40, P839, DOI 10.1016/0092-8674(85)90343-5; OTOUSA JE, 1989, J NEUROGENET, V6, P41, DOI 10.3109/01677068909107099; OTOUSA JE, 1991, VIS NEUROSCI, V8, P385; OZAKI K, 1993, NEURON, V10, P1113, DOI 10.1016/0896-6273(93)90059-Z; Pak W.L., 1979, P67; ROBINSON PR, 1992, NEURON, V9, P719, DOI 10.1016/0896-6273(92)90034-B; SCAVARDA NJ, 1983, P NATL ACAD SCI-BIOL, V80, P4441, DOI 10.1073/pnas.80.14.4441; SCHNEUWLY S, 1991, J BIOL CHEM, V266, P24314; STARK WS, 1983, J INSECT PHYSIOL, V29, P123, DOI 10.1016/0022-1910(83)90135-X; STARK WS, 1987, J NEUROGENET, V4, P227, DOI 10.3109/01677068709102343; STARK WS, 1988, J NEUROCYTOL, V17, P499, DOI 10.1007/BF01189805; STEELE FR, 1992, CELL, V69, P669, DOI 10.1016/0092-8674(92)90230-A; STEPHENSON RS, 1983, BIOL PHOTORECEPTION, P477; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P8840, DOI 10.1073/pnas.88.19.8840; SUNG CH, 1993, J BIOL CHEM, V268, P26645; VANVACTOR D, 1988, CELL, V52, P281, DOI 10.1016/0092-8674(88)90517-X; VIHTELIC TS, 1993, J CELL BIOL, V122, P1013, DOI 10.1083/jcb.122.5.1013; WASHBURN T, 1992, GENETICS, V130, P585; WASHBURN T, 1989, J BIOL CHEM, V264, P15464; ZUKER CS, 1985, CELL, V40, P851, DOI 10.1016/0092-8674(85)90344-7	40	110	110	0	5	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1995	14	3					571	579		10.1016/0896-6273(95)90313-5	http://dx.doi.org/10.1016/0896-6273(95)90313-5			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QP230	7695903	hybrid			2022-12-24	WOS:A1995QP23000010
J	GARNER, AS; LARGE, TH				GARNER, AS; LARGE, TH			ISOFORMS OF THE AVIAN TRKC RECEPTOR - A NOVEL KINASE INSERTION DISSOCIATES TRANSFORMATION AND PROCESS OUTGROWTH FROM SURVIVAL	NEURON			English	Article							NERVE GROWTH-FACTOR; TYROSINE PROTEIN-KINASE; AFFINITY NGF RECEPTOR; NEUROTROPHIC FACTOR; PROTOONCOGENE PRODUCT; SIGNAL-TRANSDUCTION; MOLECULAR-CLONING; RAT TRKC; BIOCHEMICAL-CHARACTERIZATION; ERYTHROBLASTOSIS VIRUS	TrkC receptor isoforms have been identified by cDNA cloning and RT-PCR analysis of embryonic chick brain RNA. An N-terminal truncation motif is missing from the signal sequence and first cysteine cluster of the extracellular domain. Within the cytoplasmic dimain, a kinase truncation motif retains part of the kinase domain, but appeared to lack activity. Finally, a kinase insert (KI) motif introduces a 25 amino acid sequence distinct from the known mammalian inserts. KI receptors, like full-length receptors, were tyrosine phosphorylated in response to NT-3 and mediated the transformation of chick embryo fibroblasts and process outgrowth from rat PC12 cells. However, KI receptors supported little, if any, survival of serum-deprived PC12 cells. These results indicate that alternative splicing of trkC transcripts is an important mechanism for regulating cellular responses to NT-3.	CASE WESTERN RESERVE UNIV, SCH MED, DEPT NEUROSCI, CLEVELAND, OH 44106 USA	Case Western Reserve University	GARNER, AS (corresponding author), CASE WESTERN RESERVE UNIV, SCH MED, MED SCIENTIST TRAINING PROGRAM, CLEVELAND, OH 44106 USA.				NATIONAL CANCER INSTITUTE [P20CA060171] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY008885] Funding Source: NIH RePORTER; NCI NIH HHS [CA60171] Funding Source: Medline; NEI NIH HHS [EY08885] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALLENDOERFER KL, 1994, J NEUROSCI, V14, P1795; ANTCZAK M, 1990, J VIROL, V64, P1451, DOI 10.1128/JVI.64.4.1451-1458.1990; ANTON ES, 1994, P NATL ACAD SCI USA, V91, P2795, DOI 10.1073/pnas.91.7.2795; BENEDETTI M, 1993, P NATL ACAD SCI USA, V90, P7859, DOI 10.1073/pnas.90.16.7859; BUXSER S, 1991, J NEUROCHEM, V56, P1012, DOI 10.1111/j.1471-4159.1991.tb02022.x; CLEGG DO, 1989, NERVE GROWTH FACTORS, P255; COLLAZO D, 1992, NEURON, V9, P643, DOI 10.1016/0896-6273(92)90028-C; CORDONCARDO C, 1991, CELL, V66, P173, DOI 10.1016/0092-8674(91)90149-S; DEBONDT HL, 1993, NATURE, V363, P595, DOI 10.1038/363595a0; DECHANT G, 1993, J NEUROSCI, V13, P2610, DOI 10.1523/JNEUROSCI.13-06-02610.1993; DICICCOBLOOM E, 1993, NEURON, V11, P1101, DOI 10.1016/0896-6273(93)90223-E; EIDE FF, 1993, EXP NEUROL, V121, P200, DOI 10.1006/exnr.1993.1087; ESCANDON E, 1994, J NEUROSCI, V14, P2054; FANTL WJ, 1992, CELL, V69, P413, DOI 10.1016/0092-8674(92)90444-H; GLASS DJ, 1991, CELL, V66, P405, DOI 10.1016/0092-8674(91)90629-D; GREENE LA, 1978, J CELL BIOL, V78, P747, DOI 10.1083/jcb.78.3.747; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HAYMAN MJ, 1984, NATURE, V309, P460, DOI 10.1038/309460a0; HEMPSTEAD BL, 1992, NEURON, V9, P883, DOI 10.1016/0896-6273(92)90241-5; Higuchi R, 1989, PCR TECHNOLOGY PRINC, P31; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; HONEGGER AM, 1990, MOL CELL BIOL, V10, P4035, DOI 10.1128/MCB.10.8.4035; HOU JZ, 1991, SCIENCE, V251, P665, DOI 10.1126/science.1846977; HUGHES SH, 1987, J VIROL, V61, P3004, DOI 10.1128/JVI.61.10.3004-3012.1987; IP NY, 1993, NEURON, V10, P137, DOI 10.1016/0896-6273(93)90306-C; JING SQ, 1992, NEURON, V9, P1067, DOI 10.1016/0896-6273(92)90066-M; JONES KR, 1990, P NATL ACAD SCI USA, V87, P8060, DOI 10.1073/pnas.87.20.8060; KALCHEIM C, 1992, P NATL ACAD SCI USA, V89, P1661, DOI 10.1073/pnas.89.5.1661; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KASHLES O, 1991, MOL CELL BIOL, V11, P1454, DOI 10.1128/MCB.11.3.1454; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KLEIN R, 1992, NEURON, V8, P947, DOI 10.1016/0896-6273(92)90209-V; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; KLEIN R, 1989, EMBO J, V8, P3701, DOI 10.1002/j.1460-2075.1989.tb08545.x; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; KNIGHTON DR, 1993, P NATL ACAD SCI USA, V90, P5001, DOI 10.1073/pnas.90.11.5001; KNUSEL B, 1994, J NEUROSCI, V14, P1542, DOI 10.1523/JNEUROSCI.14-03-01542.1994; KORSCHING S, 1993, J NEUROSCI, V13, P2739; KOZAK M, 1987, J MOL BIOL, V196, P947, DOI 10.1016/0022-2836(87)90418-9; KRIEGLER M, 1984, CELL, V38, P483, DOI 10.1016/0092-8674(84)90503-8; LAMBALLE F, 1993, EMBO J, V12, P3083, DOI 10.1002/j.1460-2075.1993.tb05977.x; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; LARGE TH, 1989, NEURON, V2, P1123, DOI 10.1016/0896-6273(89)90179-7; LARGE TH, 1986, SCIENCE, V234, P352, DOI 10.1126/science.3764415; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MARTINZANCA D, 1989, MOL CELL BIOL, V9, P24, DOI 10.1128/MCB.9.1.24; MEAKIN SO, 1992, P NATL ACAD SCI USA, V89, P2374, DOI 10.1073/pnas.89.6.2374; MERLIO JP, 1992, NEUROSCIENCE, V51, P513, DOI 10.1016/0306-4522(92)90292-A; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; MIKI T, 1992, P NATL ACAD SCI USA, V89, P246, DOI 10.1073/pnas.89.1.246; MILLAUER B, 1994, NATURE, V367, P576, DOI 10.1038/367576a0; MITRA G, 1991, ONCOGENE, V6, P2237; MITRA G, 1987, P NATL ACAD SCI USA, V84, P6707, DOI 10.1073/pnas.84.19.6707; MOHAMMADI M, 1992, NATURE, V358, P681, DOI 10.1038/358681a0; NEGRO A, 1994, J NEUROCHEM, V62, P471; OBERMEIER A, 1993, EMBO J, V12, P933, DOI 10.1002/j.1460-2075.1993.tb05734.x; OHMICHI M, 1992, J BIOL CHEM, V267, P14604; OKAZAWA H, 1993, FEBS LETT, V329, P171, DOI 10.1016/0014-5793(93)80216-H; PETERS KG, 1992, NATURE, V358, P678, DOI 10.1038/358678a0; POTTS WM, 1987, J GEN VIROL, V68, P3177, DOI 10.1099/0022-1317-68-12-3177; PRIVALSKY ML, 1984, VIROLOGY, V135, P356, DOI 10.1016/0042-6822(84)90192-2; REITH AD, 1993, ONCOGENE, V8, P45; ROSENTHAL A, 1990, NEURON, V4, P767, DOI 10.1016/0896-6273(90)90203-R; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SCHANENKING C, 1991, NEURON, V6, P915, DOI 10.1016/0896-6273(91)90232-O; SCHNEIDER R, 1991, ONCOGENE, V6, P1807; SHI E, 1993, MOL CELL BIOL, V13, P3907, DOI 10.1128/MCB.13.7.3907; SHI YB, 1992, J BIOL CHEM, V267, P733; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; TSOULFAS P, 1993, NEURON, V10, P975, DOI 10.1016/0896-6273(93)90212-A; UENO H, 1993, J BIOL CHEM, V268, P22814; UENO H, 1991, SCIENCE, V252, P844, DOI 10.1126/science.1851331; UENO H, 1992, J BIOL CHEM, V267, P1470; VALENZUELA DM, 1993, NEURON, V10, P963, DOI 10.1016/0896-6273(93)90211-9; VETTER ML, 1991, P NATL ACAD SCI USA, V88, P5650, DOI 10.1073/pnas.88.13.5650; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; WERNER S, 1992, MOL CELL BIOL, V12, P82, DOI 10.1128/MCB.12.1.82; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	83	74	80	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	1994	13	2					457	472		10.1016/0896-6273(94)90360-3	http://dx.doi.org/10.1016/0896-6273(94)90360-3			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PD430	8060621				2022-12-24	WOS:A1994PD43000016
J	TANG, JC; RUTISHAUSER, U; LANDMESSER, L				TANG, JC; RUTISHAUSER, U; LANDMESSER, L			POLYSIALIC ACID REGULATES GROWTH CONE BEHAVIOR DURING SORTING OF MOTOR AXONS IN THE PLEXUS REGION	NEURON			English	Article							CELL-ADHESION MOLECULES; NEURITE OUTGROWTH; PATHWAY SELECTION; CHICK HINDLIMB; SPINAL-CORD; N-CAM; MUSCLE; NEURONS; NCAM; INNERVATION	Removal of polysialic acid (PSA) from N-CAM during the time when chick motoneuron axons are segregating into target-specific fascicles at the base of the limb was previously shown to result in motoneuron projection errors. Here, it is established that these errors are associated with altered growth cone behavior in the plexus. In contrast to control embryos, in which individual axons were observed to exhibit dramatic changes in direction and extensive divergence, axonal trajectories following the removal of PSA were relatively straight. To determine whether enhanced axon-axon fasciculation following PSA removal had prevented growth cones from responding appropriately to guidance cues at the base of the limb, we also examined the role of L1, a major mediator of axon-axon fasciculation in this system. Anti-L1 reversed the effects of PSA removal on both growth cone trajectories and projection errors. These results indicate that PSA plays a permissive role, attenuating axon-axon interactions in the plexus and thereby allowing the axonal reorganization that is essential for the formation of specific motoneuron projections.	CASE WESTERN RESERVE UNIV,SCH MED,DEPT NEUROSCI,CLEVELAND,OH 44106; CASE WESTERN RESERVE UNIV,SCH MED,DEPT GENET,CLEVELAND,OH 44106	Case Western Reserve University; Case Western Reserve University	TANG, JC (corresponding author), UNIV CONNECTICUT,DEPT PHYSIOL & NEUROBIOL,STORRS,CT 06269, USA.				NICHD NIH HHS [HD 18369] Funding Source: Medline; NINDS NIH HHS [NS 25557, NS 19640] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD018369, R01HD018369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019640, R01NS025557] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ACHESON A, 1991, J CELL BIOL, V114, P143, DOI 10.1083/jcb.114.1.143; BIXBY JL, 1987, P NATL ACAD SCI USA, V84, P2555, DOI 10.1073/pnas.84.8.2555; COVAULT J, 1986, J CELL BIOL, V102, P716, DOI 10.1083/jcb.102.3.716; DOHERTY P, 1990, NEURON, V5, P209, DOI 10.1016/0896-6273(90)90310-C; FERGUSON BA, 1983, J NEUROSCI, V3, P1760; HOFFMAN S, 1983, P NATL ACAD SCI USA, V80, P5761; LANCEJONES C, 1981, PROC R SOC SER B-BIO, V214, P19, DOI 10.1098/rspb.1981.0080; LANCEJONES C, 1981, PROC R SOC SER B-BIO, V214, P1, DOI 10.1098/rspb.1981.0079; LANCEJONES C, 1980, J PHYSIOL-LONDON, V302, P581; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P371, DOI 10.1113/jphysiol.1978.sp012545; LANDMESSER L, 1990, NEURON, V4, P655, DOI 10.1016/0896-6273(90)90193-J; LANDMESSER L, 1988, DEV BIOL, V130, P645, DOI 10.1016/0012-1606(88)90358-2; RUTISHAUSER U, 1985, J CELL BIOL, V101, P1842, DOI 10.1083/jcb.101.5.1842; RUTISHAUSER U, 1988, PHYSIOL REV, V68, P819, DOI 10.1152/physrev.1988.68.3.819; RUTISHAUSER U, 1983, J CELL BIOL, V97, P145, DOI 10.1083/jcb.97.1.145; RUTISHAUSER U, 1988, SCIENCE, V240, P53, DOI 10.1126/science.3281256; TANG J, 1992, NEURON, V8, P1031, DOI 10.1016/0896-6273(92)90125-W; Tosney K, 1986, DEV BIOL, V114, P1468; TOSNEY KW, 1985, DEV BIOL, V109, P193, DOI 10.1016/0012-1606(85)90360-4; TOSNEY KW, 1985, J NEUROSCI, V5, P2336; TOSNEY KW, 1985, J NEUROSCI, V5, P2345; VIMR ER, 1984, P NATL ACAD SCI-BIOL, V81, P1971, DOI 10.1073/pnas.81.7.1971; ZHANG H, 1992, J NEUROSCI, V12, P3107, DOI 10.1523/JNEUROSCI.12-08-03107.1992	23	228	231	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1994	13	2					405	414		10.1016/0896-6273(94)90356-5	http://dx.doi.org/10.1016/0896-6273(94)90356-5			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PD430	8060618				2022-12-24	WOS:A1994PD43000012
J	MAGER, S; MIN, C; HENRY, DJ; CHAVKIN, C; HOFFMAN, BJ; DAVIDSON, N; LESTER, HA				MAGER, S; MIN, C; HENRY, DJ; CHAVKIN, C; HOFFMAN, BJ; DAVIDSON, N; LESTER, HA			CONDUCTING STATES OF A MAMMALIAN SEROTONIN TRANSPORTER	NEURON			English	Article							PLATELET 5-HYDROXYTRYPTAMINE TRANSPORT; NA+ GLUCOSE COTRANSPORTER; PLASMA-MEMBRANE VESICLES; GAMMA-AMINOBUTYRIC-ACID; HIGH-AFFINITY BINDING; XENOPUS-OOCYTES; ELECTROGENIC UPTAKE; ACTIVE-TRANSPORT; EXTERNAL K+; RAT-BRAIN	We have studied permeation at a cloned rat 5-HT transporter expressed in Xenopus oocytes. [H-3]5-HT uptake and [I-125]RTI-55 binding yield a turnover rate of similar to 1/s that does not depend on membrane potential. However, in voltage-clamp experiments, three distinct currents result from 5-HT transporter expression. First, a steady-state, voltage-dependent transport-associated current is induced by 5-HT application. Second, a transient inward current is activated by voltage jumps to high negative potentials in the absence of 5-HT and is blocked by 5-HT itself. Third, a small leakage current is observed in the absence of 5-HT. All the observed currents are blocked by inhibitors of 5-HT uptake but are differentially affected by Na+, Li+, K+, Ba2+, Cs+, Cl-, and amiloride. The conducting states of the 5-HT transporter may reflect the existence of a permeation pathway similar to that of ionic channels.	CALTECH, DIV ENGN & APPL SCI, PASADENA, CA 91125 USA; UNIV WASHINGTON, DEPT PHARMACOL, SEATTLE, WA 98125 USA; NIMH, CELL BIOL LAB, BETHESDA, MD 20892 USA	California Institute of Technology; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	MAGER, S (corresponding author), CALTECH, DIV BIOL, PASADENA, CA 91125 USA.		Chavkin, Charles/G-2797-2010					AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; BARBOUR B, 1988, NATURE, V335, P433, DOI 10.1038/335433a0; BLAKELY RD, 1991, NATURE, V354, P66, DOI 10.1038/354066a0; BOJA JW, 1992, SYNAPSE, V12, P27, DOI 10.1002/syn.890120104; BRUNS D, 1993, NEURON, V10, P559, DOI 10.1016/0896-6273(93)90159-O; BULLER AL, 1988, P NATL ACAD SCI USA, V85, P8717, DOI 10.1073/pnas.85.22.8717; COREY JL, 1994, P NATL ACAD SCI USA, V91, P1188, DOI 10.1073/pnas.91.3.1188; GADSBY DC, 1993, SCIENCE, V260, P100, DOI 10.1126/science.7682009; GU H, 1994, IN PRESS J BIOL CHEM; Hille B., 1991, IONIC CHANNELS EXCIT; HOFFMAN BJ, 1991, SCIENCE, V254, P579, DOI 10.1126/science.1948036; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; JENNINGS ML, 1990, J GEN PHYSIOL, V96, P991, DOI 10.1085/jgp.96.5.991; KAILA K, 1992, J PHYSIOL-LONDON, V453, P627, DOI 10.1113/jphysiol.1992.sp019248; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; KANNER BI, 1985, BIOCHIM BIOPHYS ACTA, V816, P403, DOI 10.1016/0005-2736(85)90508-5; KAVANAUGH MP, 1992, J BIOL CHEM, V267, P22007; KIM SY, 1991, SODIUM PUMP RECENT D, P505; LAUGER P, 1979, BIOCHIM BIOPHYS ACTA, V552, P143, DOI 10.1016/0005-2736(79)90253-0; LESTER HA, 1992, ANNU REV BIOPH BIOM, V21, P267, DOI 10.1146/annurev.bb.21.060192.001411; LESTER HA, 1994, ANNU REV PHARMACOL, V34, P219; LESTER HA, 1991, ANNU REV PHYSIOL, V53, P477; LOO DDF, 1993, P NATL ACAD SCI USA, V90, P5767, DOI 10.1073/pnas.90.12.5767; MAGER S, 1993, NEURON, V10, P177, DOI 10.1016/0896-6273(93)90309-F; MALCHOW RP, 1990, P NATL ACAD SCI USA, V87, P8945, DOI 10.1073/pnas.87.22.8945; MANN CD, 1992, J NEUROCHEM, V59, P1856, DOI 10.1111/j.1471-4159.1992.tb11020.x; NELSON PJ, 1979, J BIOL CHEM, V254, P84; NELSON PJ, 1982, J BIOL CHEM, V257, P6151; PARENT L, 1992, J MEMBRANE BIOL, V125, P49; QUICK MW, 1994, METH NEUROSCI, V19, P261; RAKOWSKI RF, 1991, J MEMBRANE BIOL, V121, P177, DOI 10.1007/BF01870531; RAKOWSKI RF, 1993, J GEN PHYSIOL, V101, P117, DOI 10.1085/jgp.101.1.117; REITH MEA, 1989, BIOCHEM PHARMACOL, V38, P2091, DOI 10.1016/0006-2952(89)90062-2; RUDNICK G, 1992, BIOCHEMISTRY-US, V31, P6710, DOI 10.1021/bi00144a010; RUDNICK G, 1977, J BIOL CHEM, V252, P2170; RUDNICK G, 1993, BIOCHIM BIOPHYS ACTA, V1144, P249, DOI 10.1016/0005-2728(93)90109-S; RUDNICK G, 1992, P NATL ACAD SCI USA, V89, P1817, DOI 10.1073/pnas.89.5.1817; RUDNICK G, 1978, BIOCHEMISTRY-US, V17, P4739, DOI 10.1021/bi00615a021; SCHWARTZ EA, 1990, J PHYSIOL-LONDON, V426, P43, DOI 10.1113/jphysiol.1990.sp018126; TALVENHEIMO J, 1979, J BIOL CHEM, V254, P4631; TALVENHEIMO J, 1983, J BIOL CHEM, V258, P6115; TANFORD C, 1983, ANNU REV BIOCHEM, V52, P379, DOI 10.1146/annurev.bi.52.070183.002115; UMBACH JA, 1990, BIOPHYS J, V57, P1217, DOI 10.1016/S0006-3495(90)82640-0; VASILETS LA, 1991, J BIOL CHEM, V266, P16285; WOOD MD, 1987, NEUROPHARMACOLOGY, V26, P1081, DOI 10.1016/0028-3908(87)90251-6; WRIGHT EM, 1993, ANNU REV PHYSIOL, V55, P575, DOI 10.1146/annurev.ph.55.030193.003043	46	206	207	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1994	12	4					845	859		10.1016/0896-6273(94)90337-9	http://dx.doi.org/10.1016/0896-6273(94)90337-9			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NH253	8161456				2022-12-24	WOS:A1994NH25300013
J	OROURKE, NA; CLINE, HT; FRASER, SE				OROURKE, NA; CLINE, HT; FRASER, SE			RAPID REMODELING OF RETINAL ARBORS IN THE TECTUM WITH AND WITHOUT BLOCKADE OF SYNAPTIC TRANSMISSION	NEURON			English	Article							RECEPTOR ANTAGONISTS DISRUPT; NERVE-MUSCLE INTERACTIONS; FIBER-TRACING TECHNIQUE; XENOPUS CELL-CULTURE; METHYL-D-ASPARTATE; OPTIC TECTUM; RETINOTECTAL PROJECTION; MAP FORMATION; ZEBRAFISH EMBRYOS; IMPULSE ACTIVITY	Dynamic rearrangements of axon terminal arbors may be critical for establishing appropriate connections in the developing nervous system. Here, the changes in complex retinal axon arbors in the tecta of live Xenopus larvae were followed during the formation of the topographic retinotectal projection. Three-dimensional reconstructions of terminal arbors made with a confocal microscope at hourly intervals revealed rapid remodeling of arbor extensions. Shorter branches were and retracted very rapidly, suggesting that they probe the environment for the optimal sites to form stable branches. About 27% of longer branches were present throughout the entire observation period and may be sites of stabilized synaptic contacts. Treatment of the animals to block postsynaptic activity resulted in increased rates of arbor rearrangements, which may coincide with decreased synapse stability. These studies reveal the dynamic behavior of nerve arbors and provide estimates for the lifetimes of retinotectal branches.	UNIV IOWA,DEPT PHYSIOL & BIOPHYS,IOWA CITY,IA 52242; CALTECH,DIV BIOL,PASADENA,CA 91125	University of Iowa; California Institute of Technology	OROURKE, NA (corresponding author), STANFORD UNIV,DEPT BIOL SCI,STANFORD,CA 94305, USA.		Fraser, Scott/Y-3406-2019	Fraser, Scott/0000-0002-5377-0223	NATIONAL EYE INSTITUTE [R01EY008363] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH049176] Funding Source: NIH RePORTER; NEI NIH HHS [EY06314, EY08363] Funding Source: Medline; NIMH NIH HHS [MH49176] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANTONINI A, 1993, J NEUROSCI, V13, P3549; BAILEY CH, 1992, SCIENCE, V256, P645, DOI 10.1126/science.1585177; BEACH DH, 1979, J COMP NEUROL, V183, P603, DOI 10.1002/cne.901830308; BENTLEY D, 1986, NATURE, V323, P712, DOI 10.1038/323712a0; BUCHANAN J, 1989, J NEUROSCI, V9, P1540; CHIEN CB, 1993, NEURON, V11, P237, DOI 10.1016/0896-6273(93)90181-P; CLINE HT, 1989, NEURON, V3, P413, DOI 10.1016/0896-6273(89)90201-8; CLINE HT, 1991, TRENDS NEUROSCI, V14, P104, DOI 10.1016/0166-2236(91)90071-2; CLINE HT, 1990, J NEUROSCI, V10, P1197; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; DEBSKI EA, 1990, J COMP PHYSIOL A, V167, P377; EASTER SS, 1984, J NEUROSCI, V4, P1052; EDWARDS DL, 1984, BRAIN RES, V299, P190, DOI 10.1016/0006-8993(84)90807-2; EVERS J, 1989, J NEUROSCI, V9, P1523; FRASER SE, 1983, DEV BIOL, V95, P505, DOI 10.1016/0012-1606(83)90053-2; FRASER SE, 1990, J NEUROBIOL, V21, P51, DOI 10.1002/neu.480210105; FRASER SE, 1986, J EMBRYOL EXP MORPH, V94, P149; GAZE RM, 1979, J EMBRYOL EXP MORPH, V53, P103; GAZE RM, 1974, P ROY SOC LOND B BIO, V185, P303; GINSBURG KS, 1984, J PHYSIOL-LONDON, V351, P433, DOI 10.1113/jphysiol.1984.sp015254; HAHM JO, 1991, NATURE, V351, P568, DOI 10.1038/351568a0; HARRIS W, 1990, J COMP NEUROL, V194, P303; HARRIS WA, 1987, DEVELOPMENT, V101, P123; HARRIS WA, 1984, J NEUROSCI, V4, P1153; HICKMOTT PW, 1993, J NEUROSCI, V13, P4339; HOLT CE, 1983, NATURE, V301, P150, DOI 10.1038/301150a0; HOLT CE, 1984, J NEUROSCI, V4, P1130; HUME RI, 1991, J NEUROBIOL, V3, P249; KAETHNER RJ, 1992, J NEUROSCI, V12, P3257, DOI 10.1523/JNEUROSCI.12-08-03257.1992; LANDMESSER L, 1990, NEURON, V4, P655, DOI 10.1016/0896-6273(90)90193-J; LANGDON RB, 1986, BRAIN RES, V398, P169, DOI 10.1016/0006-8993(86)91263-1; LLINAS R, 1974, HDB EEG CLIN NEURO B, V2; MASTRONARDE DN, 1989, TRENDS NEUROSCI, V12, P75, DOI 10.1016/0166-2236(89)90140-9; MAYFORD M, 1992, SCIENCE, V256, P638, DOI 10.1126/science.1585176; MCDONALD JW, 1989, BRAIN RES, V482, P155, DOI 10.1016/0006-8993(89)90553-2; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; OROURKE NA, 1990, NEURON, V5, P159, DOI 10.1016/0896-6273(90)90306-Z; OROURKE NA, 1986, DEV BIOL, V114, P265, DOI 10.1016/0012-1606(86)90191-0; OROURKE NA, 1986, DEV BIOL, V114, P277, DOI 10.1016/0012-1606(86)90192-2; PURVES D, 1985, PRINCIPLES NEURAL DE; RAYMOND PA, 1983, J NEUROSCI, V3, P1077; REH TA, 1984, J NEUROSCI, V4, P422; SAKAGUCHI DS, 1985, J NEUROSCI, V5, P3228; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; SIMON DK, 1992, P NATL ACAD SCI USA, V89, P10593, DOI 10.1073/pnas.89.22.10593; STRAZNICKY K, 1971, J EMBRYOL EXP MORPH, V26, P67; STRAZNICKY K, 1972, J EMBRYOL EXP MORPH, V28, P87; STUERMER CAO, 1990, J NEUROSCI, V10, P3615; UDIN SB, 1988, ANNU REV NEUROSCI, V11, P289, DOI 10.1146/annurev.ne.11.030188.001445; UDIN SB, 1992, NEUROSCIENCE, V49, P739, DOI 10.1016/0306-4522(92)90240-3	50	113	113	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1994	12	4					921	934		10.1016/0896-6273(94)90343-3	http://dx.doi.org/10.1016/0896-6273(94)90343-3			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NH253	8161460				2022-12-24	WOS:A1994NH25300019
J	BASSELL, GJ; SINGER, RH; KOSIK, KS				BASSELL, GJ; SINGER, RH; KOSIK, KS			ASSOCIATION OF POLY(A) MESSENGER-RNA WITH MICROTUBULES IN CULTURED NEURONS	NEURON			English	Article							HIPPOCAMPAL-NEURONS; MESSENGER-RNA; POLARITY ORIENTATION; INSITU HYBRIDIZATION; LOCALIZATION; PROTEINS; MICROFILAMENTS; DENDRITES; MAP2; TRANSPORT	The structural basis for the synthesis of specific proteins within distinct intraneuronal compartments is unknown. We studied the distribution of poly(A) mRNA within cultured cerebrocortical neurons using high resolution in situ hybridization to identify cytoskeletal components that may anchor mRNA. After 1 day in culture, poly(A) mRNA was distributed throughout all of the initial neurites, including the axon-like process. At 4 days in culture, poly(A) mRNA was distributed throughout the cell body and dendritic processes, but confined to the proximal segment of the axon. Poly(A) mRNA was bound to the cytoskeleton as demonstrated by resistance to detergent extraction. Perturbation of microtubules with colchicine resulted in a major reduction of dendritic poly(A) mRNA; however, this distribution was unaffected by cytochalasin. Ultrastructural in situ hybridization revealed that poly(A) mRNA and associated ribosomes were excluded from tightly bundled microtubules.	HARVARD UNIV, SCH MED, BOSTON, MA 02115 USA; UNIV MASSACHUSETTS, MED CTR, DEPT CELL BIOL, WORCESTER, MA 01655 USA	Harvard University; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester	BASSELL, GJ (corresponding author), BRIGHAM & WOMENS HOSP, CTR NEUROL DIS, BOSTON, MA 02115 USA.				NIA NIH HHS [AG06601] Funding Source: Medline; NINDS NIH HHS [NS29031] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG006601] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AINGER K, 1993, J CELL BIOL, V123, P431, DOI 10.1083/jcb.123.2.431; BAAS PW, 1989, J CELL BIOL, V109, P3085, DOI 10.1083/jcb.109.6.3085; BAAS PW, 1987, BRAIN RES, V420, P73, DOI 10.1016/0006-8993(87)90241-1; BAAS PW, 1988, P NATL ACAD SCI USA, V85, P8335, DOI 10.1073/pnas.85.21.8335; BARTLETT WP, 1984, J NEUROSCI, V4, P1944; BASSELL GJ, 1993, J CELL BIOCHEM, V52, P127, DOI 10.1002/jcb.240520203; BLACK MM, 1989, TRENDS NEUROSCI, V12, P211, DOI 10.1016/0166-2236(89)90124-0; BRUCKENSTEIN DA, 1990, NEURON, V5, P809, DOI 10.1016/0896-6273(90)90340-L; BURGOYNE RD, 1988, EMBO J, V7, P2311, DOI 10.1002/j.1460-2075.1988.tb03074.x; BURTON PR, 1981, P NATL ACAD SCI-BIOL, V78, P3269, DOI 10.1073/pnas.78.5.3269; CACERES A, 1984, DEV BRAIN RES, V13, P314, DOI 10.1016/0165-3806(84)90167-6; CARTER KC, 1991, J CELL BIOL, V115, P1191, DOI 10.1083/jcb.115.5.1191; DAVIS L, 1987, NATURE, V330, P477, DOI 10.1038/330477a0; DOTTI CG, 1988, J NEUROSCI, V8, P1454; FERREIRA A, 1989, DEV BRAIN RES, V49, P215, DOI 10.1016/0165-3806(89)90023-0; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; GARNER CC, 1988, NATURE, V336, P674, DOI 10.1038/336674a0; GOLDMAN RD, 1971, J CELL BIOL, V51, P752, DOI 10.1083/jcb.51.3.752; GOLDSCHMIDT RB, 1982, NEUROSCIENCE, V7, P695, DOI 10.1016/0306-4522(82)90075-6; GOSLIN K, CULTURING NERVE CELL; HEIDEMANN SR, 1981, J CELL BIOL, V91, P661, DOI 10.1083/jcb.91.3.661; HESKETH JE, 1991, BIOCHEM J, V277, P1; HILLMAN DH, 1988, INTRINSIC DETERMINAN; HIROKAWA N, 1988, J NEUROSCI, V8, P2769; HORNE Z, 1990, BIOCHEM J, V268, P231, DOI 10.1042/bj2680231; JIRIKOWSKI GF, 1990, P NATL ACAD SCI USA, V87, P7400, DOI 10.1073/pnas.87.19.7400; KLEIMAN R, 1990, NEURON, V5, P821, DOI 10.1016/0896-6273(90)90341-C; KOSIK KS, 1987, J NEUROSCI, V7, P3142; LENK R, 1977, CELL, V10, P67, DOI 10.1016/0092-8674(77)90141-6; LETOURNEAU PC, 1987, CELL MOTIL CYTOSKEL, V8, P193, DOI 10.1002/cm.970080302; LITMAN P, 1993, NEURON, V10, P627, DOI 10.1016/0896-6273(93)90165-N; MATUS A, 1986, NEUROSCIENCE, V17, P371, DOI 10.1016/0306-4522(86)90253-8; MATUS A, 1981, P NATL ACAD SCI-BIOL, V78, P3010, DOI 10.1073/pnas.78.5.3010; MOHR E, 1991, EMBO J, V10, P2419, DOI 10.1002/j.1460-2075.1991.tb07781.x; ORNELLES DA, 1986, MOL CELL BIOL, V6, P1650, DOI 10.1128/MCB.6.5.1650; POKRYWKA NJ, 1991, DEVELOPMENT, V113, P55; RAMAEKERS FCS, 1983, BIOCHIM BIOPHYS ACTA, V740, P441, DOI 10.1016/0167-4781(83)90093-3; RAO A, 1991, J NEUROSCI, V11, P2881; SATOYOSHITAKE R, 1989, NEURON, V3, P229, DOI 10.1016/0896-6273(89)90036-6; SCHRODER HC, 1982, MOL BIOL REP, V8, P233, DOI 10.1007/BF00776585; SCHRODER HC, 1984, MECH AGEING DEV, V24, P101, DOI 10.1016/0047-6374(84)90178-7; SHAW G, 1985, EUR J CELL BIOL, V39, P205; SHEINESS D, 1973, NATURE-NEW BIOL, V241, P265, DOI 10.1038/newbio241265a0; SINGER R H, 1992, Current Opinion in Cell Biology, V4, P15, DOI 10.1016/0955-0674(92)90053-F; SINGER RH, 1989, J CELL BIOL, V108, P2343, DOI 10.1083/jcb.108.6.2343; STEWARD O, 1992, TRENDS NEUROSCI, V15, P180, DOI 10.1016/0166-2236(92)90170-D; STEWARD O, 1982, J NEUROSCI, V2, P284; STEWARD O, 1983, J NEUROSCI, V3, P177; SUNDELL CL, 1991, SCIENCE, V253, P1275, DOI 10.1126/science.1891715; TANEJA KL, 1992, J CELL BIOL, V119, P1245, DOI 10.1083/jcb.119.5.1245; VALE RD, 1992, TRENDS BIOCHEM SCI, V17, P300, DOI 10.1016/0968-0004(92)90440-K; YISRAELI JK, 1990, DEVELOPMENT, V108, P289	52	125	126	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	1994	12	3					571	582		10.1016/0896-6273(94)90213-5	http://dx.doi.org/10.1016/0896-6273(94)90213-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NC769	8155320				2022-12-24	WOS:A1994NC76900009
J	CHAHINE, M; GEORGE, AL; ZHOU, M; JI, S; SUN, WJ; BARCHI, RL; HORN, R				CHAHINE, M; GEORGE, AL; ZHOU, M; JI, S; SUN, WJ; BARCHI, RL; HORN, R			SODIUM-CHANNEL MUTATIONS IN PARAMYOTONIA-CONGENITA UNCOUPLE INACTIVATION FROM ACTIVATION	NEURON			English	Article							HYPERKALEMIC PERIODIC PARALYSIS; ADYNAMIA EPISODICA HEREDITARIA; SHAKER POTASSIUM CHANNEL; SINGLE CHANNEL; MEMBRANE DEFECTS; NA+ CHANNELS; MUSCLE; CURRENTS; NERVE; TEMPERATURE	Mutations in the adult human skeletal muscle Na+ channel a subunit cause the disease paramyotonia congenita. Two paramyotonia congenita mutations, R1448H and R1448C, substitute histidine and cysteine for arginine in the S4 segment of domain 4. These mutations, expressed in a cell line, have only small effects on the activation of Na+ currents, but mutant channels inactivate more slowly with less voltage dependence than wild-type channels and exhibit an enhanced rate of recovery from inactivation. Increase of extracellular pH made the rate of inactivation of R1448H similar to that of R1448C, suggesting that this residue has an extracellular location and that its charge is important for normal inactivation. Analysis of single-channel data reveals that mutant channels inactivate normally from closed states, but poorly from the open state. The data suggest a critical role for the S4 helix of domain 4 in coupling between activation and inactivation.	VANDERBILT UNIV,SCH MED,DEPT MED,NASHVILLE,TN 37232; VANDERBILT UNIV,SCH MED,DEPT PHARMACOL,NASHVILLE,TN 37232; UNIV PENN,DEPT NEUROL,PHILADELPHIA,PA 19104; UNIV PENN,DAVID MAHONEY INST NEUROL SCI,PHILADELPHIA,PA 19104	Vanderbilt University; Vanderbilt University; University of Pennsylvania; University of Pennsylvania	CHAHINE, M (corresponding author), THOMAS JEFFERSON UNIV,COLL MED,DEPT PHYSIOL,PHILADELPHIA,PA 19107, USA.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR001862, R01AR041691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS018013] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR01862, AR41691] Funding Source: Medline; NINDS NIH HHS [NS18013] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADRIAN RH, 1974, J PHYSIOL-LONDON, V240, P505, DOI 10.1113/jphysiol.1974.sp010620; ALDRICH RW, 1983, NATURE, V306, P436, DOI 10.1038/306436a0; [Anonymous], [No title captured]; ARMSTRONG CM, 1977, J GEN PHYSIOL, V70, P567, DOI 10.1085/jgp.70.5.567; BARCHI RL, 1993, CURR OPIN NEUROL NEU, V6, P40; CANNON SC, 1991, NEURON, V6, P619, DOI 10.1016/0896-6273(91)90064-7; CANNON SC, 1993, NEURON, V10, P317, DOI 10.1016/0896-6273(93)90321-H; CANNON SC, 1993, BIOPHYS J, V65, P270, DOI 10.1016/S0006-3495(93)81045-2; CATTERALL WA, 1986, ANNU REV BIOCHEM, V55, P953, DOI 10.1146/annurev.biochem.55.1.953; CHAHINE M, 1993, IN PRESS PFLUGERS AR; CHIU SY, 1979, NATURE, V279, P327, DOI 10.1038/279327a0; CONTI F, 1989, EUR BIOPHYS J BIOPHY, V17, P53, DOI 10.1007/BF00257102; CUMMINS TR, 1993, NEURON, V10, P667, DOI 10.1016/0896-6273(93)90168-Q; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; GEORGE AL, 1992, ANN NEUROL, V31, P131, DOI 10.1002/ana.410310203; Griggs R C, 1977, Adv Neurol, V17, P143; GUY HR, 1986, P NATL ACAD SCI USA, V83, P508, DOI 10.1073/pnas.83.2.508; HILLE B, 1975, PHILOS T R SOC B, V270, P301, DOI 10.1098/rstb.1975.0011; HOEL PG, 1971, INTRO STATISTICAL TH; HORN R, 1991, BIOPHYS J, V60, P433, DOI 10.1016/S0006-3495(91)82069-0; HORN R, 1983, BIOPHYS J, V43, P207, DOI 10.1016/S0006-3495(83)84341-0; HORN R, 1984, J GEN PHYSIOL, V84, P505, DOI 10.1085/jgp.84.4.505; HORN R, 1986, ION CHANNELS NEURAL, P71; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; ISACOFF EY, 1991, NATURE, V353, P86, DOI 10.1038/353086a0; LEHMANNHORN F, 1981, MUSCLE NERVE, V4, P396, DOI 10.1002/mus.880040508; LEHMANNHORN F, 1983, MUSCLE NERVE, V6, P113, DOI 10.1002/mus.880060206; LEHMANNHORN F, 1987, MUSCLE NERVE, V10, P633, DOI 10.1002/mus.880100709; LEHMANNHORN F, 1991, PFLUG ARCH EUR J PHY, V418, P297, DOI 10.1007/BF00370530; MARGOLSKEE RF, 1993, BIOTECHNIQUES, V15, P906; MCCLATCHEY AI, 1992, CELL, V68, P769, DOI 10.1016/0092-8674(92)90151-2; MCCLATCHEY AI, 1992, NAT GENET, V2, P148, DOI 10.1038/ng1092-148; NILIUS B, 1988, BIOPHYS J, V53, P857, DOI 10.1016/S0006-3495(88)83166-7; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; PATLAK J, 1982, J GEN PHYSIOL, V79, P333, DOI 10.1085/jgp.79.3.333; PATLAK J, 1991, PHYSIOL REV, V71, P1047, DOI 10.1152/physrev.1991.71.4.1047; PATLAK JB, 1986, J GEN PHYSIOL, V87, P305, DOI 10.1085/jgp.87.2.305; PTACEK LJ, 1993, ANN NEUROL, V33, P300, DOI 10.1002/ana.410330312; PTACEK LJ, 1991, CELL, V67, P1021; PTACEK LJ, 1992, PTAC, V8, P891; RICKER K, 1989, MUSCLE NERVE, V12, P883, DOI 10.1002/mus.880121103; RIGGS JE, 1988, NEUROL CLIN, V6, P485, DOI 10.1016/S0733-8619(18)30856-9; ROJAS CV, 1991, NATURE, V354, P387, DOI 10.1038/354387a0; RUDEL R, 1985, PHYSIOL REV, V65, P310, DOI 10.1152/physrev.1985.65.2.310; SANCHO J, 1992, BIOCHEMISTRY-US, V31, P2253, DOI 10.1021/bi00123a006; SCANLEY BE, 1990, J GEN PHYSIOL, V95, P411, DOI 10.1085/jgp.95.3.411; SCHWARZ JR, 1986, PFLUG ARCH EUR J PHY, V406, P397, DOI 10.1007/BF00590943; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; UKOMADU C, 1992, NEURON, V8, P663, DOI 10.1016/0896-6273(92)90088-U; VANDENBERG CA, 1984, J GEN PHYSIOL, V84, P535, DOI 10.1085/jgp.84.4.535; VANDENBERG CA, 1991, BIOPHYS J, V60, P1511, DOI 10.1016/S0006-3495(91)82186-5; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687; ZHOU JY, 1991, NEURON, V7, P775, DOI 10.1016/0896-6273(91)90280-D	56	288	290	0	15	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1994	12	2					281	294		10.1016/0896-6273(94)90271-2	http://dx.doi.org/10.1016/0896-6273(94)90271-2			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MY500	8110459	hybrid			2022-12-24	WOS:A1994MY50000005
J	GILLESPIE, PG; WAGNER, MC; HUDSPETH, AJ				GILLESPIE, PG; WAGNER, MC; HUDSPETH, AJ			IDENTIFICATION OF A 120 KD HAIR-BUNDLE MYOSIN LOCATED NEAR STEREOCILIARY TIPS	NEURON			English	Article							VANADATE-DEPENDENT MODIFICATION; SUBFRAGMENT-1 HEAVY-CHAIN; MUSCLE-CONTRACTION; ACTIN-FILAMENTS; SMOOTH-MUSCLE; INNER-EAR; MECHANOELECTRICAL TRANSDUCTION; ADENOSINE-TRIPHOSPHATASE; CROSS-LINKS; CELLS	By adapting to sustained stimuli, hair cells of the internal ear maintain their optimal sensitivity to minute displacements. Biophysical experiments have suggested that adaptation is mediated by a molecular motor, most likely a member of the myosin family. To provide direct evidence for the presence of myosin isozymes in hair bundles, we used photoaffinity labeling with vanadate-trapped uridine and adenine nucleotides to identify proteins of 120, 160, and 230 kd in a preparation of hair bundles purified from the bullfrog's sacculus. The photoaffinity labeling properties of these proteins, particularly the 120 kd protein, resembled those of other well-characterized myosins. A 120 kd hair-bundle protein was also recognized by a monoclonal antibody directed against a vertebrate myosin I isozyme. Immunofluorescence microscopy localized this protein near the beveled top edge of the hair bundle, the site of mechanoelectrical transduction and adaptation.	UNIV TEXAS,SW MED CTR,HOWARD HUGHES MED INST,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,CTR BASIC NEUROSCI RES,DEPT PHARMACOL,DALLAS,TX 75235	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas				Barr-Gillespie, Peter/0000-0002-9787-5860	NIDCD NIH HHS [DC00241] Funding Source: Medline	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ADAMS RJ, 1989, NATURE, V340, P565, DOI 10.1038/340565a0; ADAMS RJ, 1986, NATURE, V322, P754, DOI 10.1038/322754a0; ASSAD JA, 1989, P NATL ACAD SCI USA, V86, P2918, DOI 10.1073/pnas.86.8.2918; ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; ASSAD JA, 1992, J NEUROSCI, V12, P3291; BAINES IC, 1992, J CELL BIOL, V119, P1193, DOI 10.1083/jcb.119.5.1193; BARYLKO B, 1992, P NATL ACAD SCI USA, V89, P490, DOI 10.1073/pnas.89.2.490; CARBONI JM, 1988, J CELL BIOL, V107, P1749, DOI 10.1083/jcb.107.5.1749; CHENEY R E, 1992, Current Opinion in Cell Biology, V4, P27, DOI 10.1016/0955-0674(92)90055-H; CHENEY RE, 1993, CELL MOTIL CYTOSKEL, V24, P215, DOI 10.1002/cm.970240402; COLBURN JC, 1988, J BIOL CHEM, V263, P19166; COOKE R, 1986, CRIT REV BIOCHEM MOL, V21, P53, DOI 10.3109/10409238609113609; CORWIN JT, 1985, P NATL ACAD SCI USA, V82, P3911, DOI 10.1073/pnas.82.11.3911; COUDRIER E, 1983, EMBO J, V2, P469, DOI 10.1002/j.1460-2075.1983.tb01446.x; CREMO CR, 1988, BIOCHEMISTRY-US, V27, P8415, DOI 10.1021/bi00422a018; DANTZIG JA, 1985, J GEN PHYSIOL, V86, P305, DOI 10.1085/jgp.86.3.305; DRENCKHAHN D, 1982, NATURE, V300, P531, DOI 10.1038/300531a0; DRENCKHAHN D, 1991, J CELL BIOL, V112, P641, DOI 10.1083/jcb.112.4.641; DRENCKHAHN D, 1985, AUDITORY BIOCH, P312; EATOCK RA, 1987, J NEUROSCI, V7, P2821; FATH KR, 1993, J CELL BIOL, V120, P117, DOI 10.1083/jcb.120.1.117; FLOCK A, 1981, J NEUROCYTOL, V10, P133, DOI 10.1007/BF01181749; FUKAI Y, 1989, NATURE, V341, P328; FULLER SA, 1988, CURRENT PROTOCOLS MO, V2; FURNESS DN, 1985, HEARING RES, V18, P177, DOI 10.1016/0378-5955(85)90010-3; GARABEDIAN TE, 1990, J BIOL CHEM, V265, P22547; GILLESPIE PG, 1991, J CELL BIOL, V112, P625, DOI 10.1083/jcb.112.4.625; GILLESPIE PG, 1991, P NATL ACAD SCI USA, V88, P2563, DOI 10.1073/pnas.88.6.2563; GILLESPIE PG, 1993, P NATL ACAD SCI USA, V90, P2710, DOI 10.1073/pnas.90.7.2710; GLENNEY JR, 1980, J BIOL CHEM, V255, P551; GOLDMAN YE, 1987, ANNU REV PHYSIOL, V49, P629; GOODNO CC, 1982, METHOD ENZYMOL, V85, P116; GOODNO CC, 1979, P NATL ACAD SCI USA, V76, P2620, DOI 10.1073/pnas.76.6.2620; GOODSON HV, 1993, P NATL ACAD SCI USA, V90, P659, DOI 10.1073/pnas.90.2.659; GOODY R S, 1980, Journal of Muscle Research and Cell Motility, V1, P101, DOI 10.1007/BF00711928; GRAMMER JC, 1988, BIOCHEMISTRY-US, V27, P8408, DOI 10.1021/bi00422a017; HACOHEN N, 1989, J NEUROSCI, V9, P3988; HAYDEN SM, 1990, J CELL BIOL, V111, P443, DOI 10.1083/jcb.111.2.443; HIBBERD MG, 1986, ANNU REV BIOPHYS BIO, V15, P119; HOWARD J, 1987, P NATL ACAD SCI USA, V84, P3064, DOI 10.1073/pnas.84.9.3064; HOWARD J, 1987, SENSORY TRANSDUCTION, P138; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; HUDSPETH AJ, 1982, J NEUROSCI, V2, P1; JACKSON AP, 1988, BIOCHEM J, V251, P515, DOI 10.1042/bj2510515; JARAMILLO F, 1993, P NATL ACAD SCI USA, V90, P1330, DOI 10.1073/pnas.90.4.1330; JARAMILLO F, 1991, NEURON, V7, P409, DOI 10.1016/0896-6273(91)90293-9; JOHNSTON RF, 1990, ELECTROPHORESIS, V11, P355, DOI 10.1002/elps.1150110503; KIEHART DP, 1984, J CELL BIOL, V99, P1002, DOI 10.1083/jcb.99.3.1002; KORN ED, 1988, ANNU REV BIOPHYS BIO, V17, P23; LEWIS ER, 1973, J MORPHOL, V39, P351; MACARTNEY JC, 1980, NATURE, V288, P491, DOI 10.1038/288491a0; MARUTA H, 1981, J BIOL CHEM, V256, P499; MIYATA H, 1989, J CELL BIOL, V109, P1519, DOI 10.1083/jcb.109.4.1519; NAKAMAYE KL, 1985, BIOCHEMISTRY-US, V24, P5226, DOI 10.1021/bi00340a041; PATE E, 1991, BIOPHYS J, V59, P598, DOI 10.1016/S0006-3495(91)82275-5; PICKLES JO, 1984, HEARING RES, V15, P103, DOI 10.1016/0378-5955(84)90041-8; POLLARD TD, 1991, ANNU REV PHYSIOL, V53, P653, DOI 10.1146/annurev.ph.53.030191.003253; ROBERTS WM, 1988, ANNU REV CELL BIOL, V4, P63, DOI 10.1146/annurev.cellbio.4.1.63; RUPPERT C, 1993, J CELL BIOL, V120, P1393, DOI 10.1083/jcb.120.6.1393; SANS A, 1989, HEARING RES, V40, P117, DOI 10.1016/0378-5955(89)90105-6; SELLERS JR, 1985, J BIOL CHEM, V260, P5815; SHEPHERD GMG, 1989, P NATL ACAD SCI USA, V86, P4973, DOI 10.1073/pnas.86.13.4973; SHERR EH, 1993, J CELL BIOL, V120, P1405, DOI 10.1083/jcb.120.6.1405; SHOTWELL SL, 1981, ANN NY ACAD SCI, V374, P1, DOI 10.1111/j.1749-6632.1981.tb30854.x; SLEPECKY N, 1985, HEARING RES, V20, P245, DOI 10.1016/0378-5955(85)90029-2; SLEPECKY NB, 1992, HEARING RES, V57, P201, DOI 10.1016/0378-5955(92)90152-D; SWANLJUNGCOLLINS H, 1991, J BIOL CHEM, V266, P1312; TILNEY LG, 1992, ANNU REV CELL BIOL, V8, P257, DOI 10.1146/annurev.cb.08.110192.001353; WAGNER MC, 1992, J CELL BIOL, V119, P163, DOI 10.1083/jcb.119.1.163; WALKER RG, 1993, P NATL ACAD SCI USA, V90, P2807, DOI 10.1073/pnas.90.7.2807; WARRICK HM, 1987, ANNU REV CELL BIOL, V3, P379, DOI 10.1146/annurev.cb.03.110187.002115; WHITE HD, 1976, BIOCHEMISTRY-US, V15, P5818, DOI 10.1021/bi00671a020	72	135	138	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1993	11	4					581	594		10.1016/0896-6273(93)90071-X	http://dx.doi.org/10.1016/0896-6273(93)90071-X			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MD068	8398149				2022-12-24	WOS:A1993MD06800004
J	RUPPRECHT, R; REUL, JMHM; TRAPP, T; VANSTEENSEL, B; WETZEL, C; DAMM, K; ZIEGLGANSBERGER, W; HOLSBOER, F				RUPPRECHT, R; REUL, JMHM; TRAPP, T; VANSTEENSEL, B; WETZEL, C; DAMM, K; ZIEGLGANSBERGER, W; HOLSBOER, F			PROGESTERONE RECEPTOR-MEDIATED EFFECTS OF NEUROACTIVE STEROIDS	NEURON			English	Article							HUMAN GLUCOCORTICOID RECEPTOR; GABA-A RECEPTORS; RAT-BRAIN; MINERALOCORTICOID RECEPTOR; MAMMALIAN-CELLS; PITUITARY; NEUROSTEROIDS; EXPRESSION; ACID; DNA	Several 3alpha-hydroxysteroids accumulate in the brain after local synthesis or after metabolization of steroids that are provided by the adrenals. The 3alpha-hydroxy ring A-reduced pregnane steroids allopregnanolone and tetrahydrodeoxycorticosterone are believed not to interact with intracellular receptors, but enhance GABA-mediated chloride currents. The present study shows that these neuroactive steroids can regulate gene expression via the progesterone receptor. The induction of DNA binding and transcriptional activation of the progesterone receptor requires intracellular oxidation of the neuroactive steroids into progesterone receptor active 5alpha-pregnane steroids. Thus, at physiological concentrations, these neuroactive steroids regulate neuronal function through their effects on both transmitter-gated ion channels and steroid receptor-regulated gene expression.	EC SLATER INST, AMSTERDAM, NETHERLANDS		RUPPRECHT, R (corresponding author), MAX PLANCK INST PSYCHIAT, INST CLIN, DEPT NEUROENDOCRINOL, W-8000 MUNICH 40, GERMANY.		Reul, Johannes/B-4132-2019; Jansen, Heiko T./A-5770-2008; Wetzel, Christian/F-1366-2018; Wetzel, Christian/C-2501-2009; Wetzel, Christian H/N-9880-2017	Reul, Johannes/0000-0002-8787-4012; Jansen, Heiko T./0000-0003-0178-396X; Wetzel, Christian/0000-0002-5762-0003; Wetzel, Christian H/0000-0002-5762-0003				ARRIZA JL, 1987, SCIENCE, V237, P268, DOI 10.1126/science.3037703; ARRIZA JL, 1988, NEURON, V1, P887, DOI 10.1016/0896-6273(88)90136-5; BAULIEU EE, 1991, BIOL CELL, V71, P3, DOI 10.1016/0248-4900(91)90045-O; CAMPBELL JS, 1990, J STEROID BIOCHEM, V37, P535, DOI 10.1016/0960-0760(90)90398-5; CELOTTI F, 1992, FRONT NEUROENDOCRIN, V13, P163; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CHU G, 1987, NUCLEIC ACIDS RES, V15, P1311, DOI 10.1093/nar/15.3.1311; CONNEELY OM, 1989, J BIOL CHEM, V264, P14062; CRAWLEY JN, 1986, BRAIN RES, V398, P382, DOI 10.1016/0006-8993(86)91500-3; DASH PK, 1991, P NATL ACAD SCI USA, V88, P5051; DENNER LA, 1990, SCIENCE, V250, P1740, DOI 10.1126/science.2176746; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FOX SR, 1990, NEUROENDOCRINOLOGY, V51, P276, DOI 10.1159/000125350; GEE KW, 1988, J PHARMACOL EXP THER, V246, P803; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARRISON NL, 1987, J PHARMACOL EXP THER, V241, P346; HERBOMEL P, 1984, CELL, V39, P653, DOI 10.1016/0092-8674(84)90472-0; HOLLENBERG SM, 1985, NATURE, V318, P635, DOI 10.1038/318635a0; HOLLENBERG SM, 1988, CELL, V55, P899, DOI 10.1016/0092-8674(88)90145-6; JOHNSON GD, 1981, J IMMUNOL METHODS, V43, P349, DOI 10.1016/0022-1759(81)90183-6; KARAVOLAS HJ, 1990, CIBA F SYMP, V153, P22; KASTNER P, 1990, J BIOL CHEM, V265, P12163; KRAUSE JE, 1980, J BIOL CHEM, V255, P1807; LAN NC, 1991, J NEUROCHEM, V57, P1818, DOI 10.1111/j.1471-4159.1991.tb06388.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAJEWSKA MD, 1986, SCIENCE, V232, P1004, DOI 10.1126/science.2422758; MCEWEN BS, 1991, TRENDS PHARMACOL SCI, V12, P141, DOI 10.1016/0165-6147(91)90531-V; MELCANGI RC, 1993, ENDOCRINOLOGY, V132, P1252, DOI 10.1210/en.132.3.1252; MENDELSON WB, 1987, PSYCHOPHARMACOLOGY, V93, P226; MORROW AL, 1990, MOL PHARMACOL, V37, P263; OLSEN RW, 1990, FASEB J, V4, P1469, DOI 10.1096/fasebj.4.5.2155149; PARKER PJ, 1986, SCIENCE, V233, P853, DOI 10.1126/science.3755547; PAUL SM, 1992, FASEB J, V6, P2311, DOI 10.1096/fasebj.6.6.1347506; PERROTAPPLANAT M, 1987, CANCER RES, V47, P2652; POWER RF, 1991, SCIENCE, V254, P1636, DOI 10.1126/science.1749936; PUIA G, 1990, NEURON, V4, P759, DOI 10.1016/0896-6273(90)90202-Q; PURDY RH, 1991, P NATL ACAD SCI USA, V88, P4553, DOI 10.1073/pnas.88.10.4553; PURDY RH, 1990, J MED CHEM, V33, P1572, DOI 10.1021/jm00168a008; REUL JMHM, 1990, ENDOCRINOLOGY, V127, P907, DOI 10.1210/endo-127-2-907; RODRIGUEZ R, 1989, MOL ENDOCRINOL, V3, P356, DOI 10.1210/mend-3-2-356; RUPPRECHT R, 1993, MOL ENDOCRINOL, V7, P597, DOI 10.1210/me.7.4.597; SARRIEAU A, 1986, J STEROID BIOCHEM, V25, P717, DOI 10.1016/0022-4731(86)90300-6; SCHUMACHER M, 1990, TRENDS NEUROSCI, V13, P359, DOI 10.1016/0166-2236(90)90016-4; SHINGAI R, 1991, EUR J PHARM-MOLEC PH, V206, P77, DOI 10.1016/0922-4106(91)90149-C; SMITHGALL TE, 1985, BIOCHEM PHARMACOL, V34, P831, DOI 10.1016/0006-2952(85)90763-4	47	264	268	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1993	11	3					523	530		10.1016/0896-6273(93)90156-L	http://dx.doi.org/10.1016/0896-6273(93)90156-L			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LY498	8398145				2022-12-24	WOS:A1993LY49800012
J	SCHWARTZ, EA				SCHWARTZ, EA			L-GLUTAMATE CONDITIONALLY MODULATES THE K+ CURRENT OF MULLER GLIAL-CELLS	NEURON			English	Article							PROTEIN KINASE-C; ADENYLYL CYCLASE; INHIBITOR; MEMBRANE; CLONING; POTENT	L-Glutamate inhibits the K+ conductance that dominates the electrical behavior of a Muller glial cell. The effect of glutamate is enhanced by simultaneous exposure to dopamine. L-Glutamate acts at a metabotropic receptor that controls the K+ conductance through two pathways. A rapid pathway produces a partial inhibition in less than 2 s. Thereafter, a slow pathway progressively inhibits the conductance with a half-time of minutes. Pathways initiated by L-glutamate and dopamine appear to converge on and stimulate adenylyl cyclase. A subsequent step is the activation of a cAMP-dependent protein kinase, PKA. The local overflow of L-glutamate from active synapses may functionally remove K+ channels from nearby glial membranes. A uniform rise in extracellular L-glutamate concentration, as might occur during pathological conditions, should suppress a glial cell's K+ conductance and allow other voltage-dependent processes to be influenced by depolarization.	UNIV CHICAGO,DEPT PHYSIOL SCI,CHICAGO,IL 60637	University of Chicago	SCHWARTZ, EA (corresponding author), UNIV CHICAGO,DEPT PHARMACOL SCI,CHICAGO,IL 60637, USA.				NEI NIH HHS [EY-02440] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY002440, R37EY002440] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BARRES BA, 1991, J NEUROSCI, V11, P3685; BARRES BA, 1990, ANNU REV NEUROSCI, V13, P441, DOI 10.1146/annurev.neuro.13.1.441; Besharse J.C., 1988, PROGR RETINAL RES, V7, P21; BIRNBAUMER L, 1990, BIOCHIM BIOPHYS ACTA, V1031, P163, DOI 10.1016/0304-4157(90)90007-Y; BREW H, 1987, NATURE, V327, P707, DOI 10.1038/327707a0; CHARPAK S, 1990, NATURE, V347, P765, DOI 10.1038/347765a0; ECKSTEIN F, 1979, J BIOL CHEM, V254, P9829; FEDERMAN AD, 1992, NATURE, V356, P159, DOI 10.1038/356159a0; FEINSTEIN PG, 1991, P NATL ACAD SCI USA, V88, P10173, DOI 10.1073/pnas.88.22.10173; GAO BN, 1991, P NATL ACAD SCI USA, V88, P10178, DOI 10.1073/pnas.88.22.10178; GLASS DB, 1986, J BIOL CHEM, V261, P2166; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HENSHEL DS, 1992, BRAIN RES, V575, P208, DOI 10.1016/0006-8993(92)90081-J; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; KASE H, 1987, BIOCHEM BIOPH RES CO, V142, P436, DOI 10.1016/0006-291X(87)90293-2; KOBAYASHI E, 1989, BIOCHEM BIOPH RES CO, V159, P548, DOI 10.1016/0006-291X(89)90028-4; Kuffler S W, 1966, J Neurophysiol, V29, P768; MAZZONI MR, 1991, J BIOL CHEM, V266, P14072; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; MULLER T, 1992, SCIENCE, V256, P1563, DOI 10.1126/science.1317969; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; NEWMAN EA, 1985, J NEUROSCI, V5, P2225; NEWMAN EA, 1985, NATURE, V317, P809, DOI 10.1038/317809a0; SCHWARTZ EA, 1990, J PHYSIOL-LONDON, V426, P43, DOI 10.1113/jphysiol.1990.sp018126; TANG WJ, 1991, SCIENCE, V254, P1500, DOI 10.1126/science.1962211	25	65	66	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1993	10	6					1141	1149		10.1016/0896-6273(93)90062-V	http://dx.doi.org/10.1016/0896-6273(93)90062-V			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LK373	8100427				2022-12-24	WOS:A1993LK37300014
J	TIMMUSK, T; PALM, K; METSIS, M; REINTAM, T; PAALME, V; SAARMA, M; PERSSON, H				TIMMUSK, T; PALM, K; METSIS, M; REINTAM, T; PAALME, V; SAARMA, M; PERSSON, H			MULTIPLE PROMOTERS DIRECT TISSUE-SPECIFIC EXPRESSION OF THE RAT BDNF-GENE	NEURON			English	Article							NERVE GROWTH-FACTOR; FACTOR MESSENGER-RNA; NEUROTROPHIC FACTOR; FACTOR FAMILY; CHOLINERGIC NEURONS; MOLECULAR-CLONING; HIPPOCAMPAL-NEURONS; ALZHEIMERS-DISEASE; LIMBIC SEIZURES; BASAL FOREBRAIN	Brain-derived neurotrophic factor (BDNF) supports the survival of a specific set of neurons in the vertebrate nervous system. Here we show that the rat BDNF gene consists of four short 5' exons and one 3' exon encoding the mature BDNF protein. Eight different BDNF mRNAs with four different 5' ends and two alternative polyadenylation sites are transcribed from this gene. BDNF mRNAs containing exons I, II, and III are expressed predominantly in the brain, whereas exon IV transcripts predominate in the lung and heart. mRNAs containing exons I, II, and III increase markedly in the brain after kainic acid-induced seizures, whereas exon IV mRNA increases only slightly. Several transcription initiation sites were mapped upstream of the four 5' exons, and transfection of promoter-reporter gene constructs confirmed that these sequences act as promoters. Combined, the data demonstrate that alternative usage of four promoters within the BDNF gene and differential splicing control tissue-specific and seizure-induced expression of BDNF mRNA.	UNIV HELSINKI,INST BIOTECHNOL,SF-00380 HELSINKI,FINLAND; TALLINN CHEM PHYS & BIOPHYS INST,MOLEC GENET LAB,TALLINN,ESTONIA	University of Helsinki	TIMMUSK, T (corresponding author), KAROLINSKA INST,DEPT MED CHEM 2,MOLEC NEUROBIOL LAB,S-10401 STOCKHOLM 60,SWEDEN.		Metsis, Madis/F-7080-2016; Palm, Kaia/AGF-0479-2022; Timmusk, Tonis/H-4889-2015	Metsis, Madis/0000-0003-1667-677X; Timmusk, Tonis/0000-0002-1015-3348	NIA NIH HHS [AG 04418] Funding Source: Medline; NINDS NIH HHS [NS 09199] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS009199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG004418] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALDERSON RF, 1990, NEURON, V5, P297, DOI 10.1016/0896-6273(90)90166-D; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; AYERLELIEVRE C, 1988, SCIENCE, V240, P1339, DOI 10.1126/science.2897715; BALLARIN M, 1991, EXP NEUROL, V114, P35, DOI 10.1016/0014-4886(91)90082-N; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; BERKEMEIER LR, 1991, NEURON, V7, P857, DOI 10.1016/0896-6273(91)90287-A; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P102; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; BUNNEMANN B, 1990, ADV NEUROSCIENCE, V1, P131; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CSANK C, 1990, NUCLEIC ACIDS RES, V18, P5133, DOI 10.1093/nar/18.17.5133; D'MELLO SR, 1991, MOL BRAIN RES, V11, P255, DOI 10.1016/0169-328X(91)90034-U; D'MELLO SR, 1991, J NEUROCHEM, V57, P1570, DOI 10.1111/j.1471-4159.1991.tb06353.x; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DUGICHDJORDJEVIC MM, 1992, NEURON, V8, P1127, DOI 10.1016/0896-6273(92)90133-X; ERNFORS P, 1992, EUR J NEUROSCI, V4, P1140, DOI 10.1111/j.1460-9568.1992.tb00141.x; ERNFORS P, 1990, P NATL ACAD SCI USA, V87, P5454, DOI 10.1073/pnas.87.14.5454; ERNFORS P, 1991, NEURON, V7, P165, DOI 10.1016/0896-6273(91)90084-D; ERNFORS P, 1990, NEURON, V5, P511, DOI 10.1016/0896-6273(90)90090-3; FOYT HL, 1991, J BIOL CHEM, V266, P7300; FRASER P, 1989, MOL CELL BIOL, V9, P3308, DOI 10.1128/MCB.9.8.3308; FRIEDMAN WJ, 1991, EUR J NEUROSCI, V3, P688, DOI 10.1111/j.1460-9568.1991.tb00854.x; GALL C, 1991, MOL BRAIN RES, V9, P113, DOI 10.1016/0169-328X(91)90136-L; GALL CM, 1989, SCIENCE, V245, P758, DOI 10.1126/science.2549634; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; GONZALEZCRESPO S, 1991, P NATL ACAD SCI USA, V88, P8749, DOI 10.1073/pnas.88.19.8749; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; HALLBOOK F, 1991, NEURON, V6, P845, DOI 10.1016/0896-6273(91)90180-8; HAMMOND DN, 1986, SCIENCE, V234, P1237, DOI 10.1126/science.3775382; HENGERER B, 1990, P NATL ACAD SCI USA, V87, P3899, DOI 10.1073/pnas.87.10.3899; HOFER M, 1990, EMBO J, V9, P2459, DOI 10.1002/j.1460-2075.1990.tb07423.x; HOFER MM, 1988, NATURE, V331, P261, DOI 10.1038/331261a0; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; HYMAN C, 1991, NATURE, V350, P230, DOI 10.1038/350230a0; IP NY, 1992, P NATL ACAD SCI USA, V89, P3060, DOI 10.1073/pnas.89.7.3060; ISACKSON PJ, 1991, NEURON, V6, P937, DOI 10.1016/0896-6273(91)90234-Q; JACKSON RJ, 1990, CELL, V62, P15, DOI 10.1016/0092-8674(90)90235-7; JACOBY DB, 1989, J BIOL CHEM, V264, P17623; JOHNSON JE, 1986, J NEUROSCI, V6, P3031; JONES KR, 1990, P NATL ACAD SCI USA, V87, P8060, DOI 10.1073/pnas.87.20.8060; KAISHO Y, 1990, FEBS LETT, V266, P187, DOI 10.1016/0014-5793(90)81536-W; KNUSEL B, 1991, P NATL ACAD SCI USA, V88, P961, DOI 10.1073/pnas.88.3.961; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; KRANER SD, 1992, NEURON, V9, P37, DOI 10.1016/0896-6273(92)90218-3; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; LINDVALL O, 1992, P NATL ACAD SCI USA, V89, P648, DOI 10.1073/pnas.89.2.648; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MAISONPIERRE PC, 1991, GENOMICS, V10, P558, DOI 10.1016/0888-7543(91)90436-I; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; MATHER JP, 1982, ANN NY ACAD SCI, V383, P44, DOI 10.1111/j.1749-6632.1982.tb23161.x; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; MORI N, 1992, NEURON, V9, P45, DOI 10.1016/0896-6273(92)90219-4; NIELSEN FC, 1990, J BIOL CHEM, V265, P13431; PHILLIPS HS, 1991, NEURON, V7, P695, DOI 10.1016/0896-6273(91)90273-3; PHILLIPS HS, 1990, SCIENCE, V250, P290, DOI 10.1126/science.1688328; ROSENTHAL A, 1990, NEURON, V4, P767, DOI 10.1016/0896-6273(90)90203-R; ROY AL, 1991, NATURE, V354, P245, DOI 10.1038/354245a0; Sambrook J, 1989, MOL CLONING LABORATO; SCHIBLER U, 1987, ANNU REV GENET, V21, P237, DOI 10.1146/annurev.ge.21.120187.001321; SELBY MJ, 1987, MOL CELL BIOL, V7, P3057, DOI 10.1128/MCB.7.9.3057; SHAPIRO LH, 1991, J BIOL CHEM, V266, P11999; SHINTANI A, 1992, BIOCHEM BIOPH RES CO, V182, P325, DOI 10.1016/S0006-291X(05)80148-2; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; SPAETE RR, 1985, J VIROL, V56, P135, DOI 10.1128/JVI.56.1.135-143.1985; WETMORE C, 1990, EXP NEUROL, V109, P141, DOI 10.1016/0014-4886(90)90068-4; WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341; XU LC, 1991, NUCLEIC ACIDS RES, V19, P6699, DOI 10.1093/nar/19.24.6699; ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x; ZAFRA F, 1991, P NATL ACAD SCI USA, V88, P10037, DOI 10.1073/pnas.88.22.10037; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	72	713	723	1	38	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1993	10	3					475	489		10.1016/0896-6273(93)90335-O	http://dx.doi.org/10.1016/0896-6273(93)90335-O			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KU901	8461137				2022-12-24	WOS:A1993KU90100012
J	MATTSON, MP; CHENG, B; CULWELL, AR; ESCH, FS; LIEBERBURG, I; RYDEL, RE				MATTSON, MP; CHENG, B; CULWELL, AR; ESCH, FS; LIEBERBURG, I; RYDEL, RE			EVIDENCE FOR EXCITOPROTECTIVE AND INTRANEURONAL CALCIUM-REGULATING ROLES FOR SECRETED FORMS OF THE BETA-AMYLOID PRECURSOR PROTEIN	NEURON			English	Article							FIBROBLAST GROWTH-FACTOR; ALZHEIMERS-DISEASE; MESSENGER-RNA; HIPPOCAMPAL-NEURONS; NERVOUS-SYSTEM; INHIBITORY PROPERTIES; GLUCOSE-METABOLISM; FACTOR INCREASES; CEREBRAL-CORTEX; CULTURED-CELLS	The beta-amyloid precursor protein (betaAPP) is a membrane-spanning glycoprotein that is the source of the beta-amyloid peptide (betaAP) which accumulates as senile plaques in the brains of patients with Alzheimer's disease. BetaAPP is normally processed such that a cleavage occurs within the betaAP, liberating secreted forms of betaAPP (APP(S)s) from the cell. The neuronal functions of these forms are unknown. We now report that APP(S)s have a potent neuro-protective action in cultured rat hippocampal and septal neurons and in human cortical neurons. APP(S)695 and APP(S)751 protected neurons against hypoglycemic damage, and the neuroprotection was abolished by antibodies to a specific region common to both APP(S)695 and APP(S)751. APP(S)s caused a rapid and prolonged reduction in [Ca2+]i and prevented the rise in [Ca2+]i that normally mediated hypoglycemic damage. APP(S)s also protected neurons against glutamate neurotoxicity, effectively raising the excitotoxic threshold. APP(S)s may normally play excitoprotective and neuromodulatory roles. Alternative processing of APP(S)s in Alzheimer's disease may contribute to neuronal degeneration by compromising the normal function of APP(S)s and by promoting the deposition of betaAP.	UNIV KENTUCKY, DEPT ANAT & NEUROBIOL, LEXINGTON, KY 40536 USA; ATHENA NEUROSCI INC, San Francisco, CA 94080 USA	University of Kentucky	MATTSON, MP (corresponding author), UNIV KENTUCKY, SANDERS BROWN RES CTR AGING, LEXINGTON, KY 40536 USA.		Mattson, Mark P/F-6038-2012					ABE K, 1991, NEUROSCI LETT, V125, P172, DOI 10.1016/0304-3940(91)90020-T; ARAKI W, 1991, BIOCHEM BIOPH RES CO, V181, P265, DOI 10.1016/S0006-291X(05)81412-3; BASKIN F, 1991, ALZHEIMERS DISEASE : BASIC MECHANISMS, DIAGNOSIS AND THERAPEUTIC STRATEGIES, P297; BREEN KC, 1991, J NEUROSCI RES, V28, P90, DOI 10.1002/jnr.490280109; BUSCIGLIO J, 1992, NEUROBIOL AGING, V13, P609, DOI 10.1016/0197-4580(92)90065-6; CHEN M, 1991, NEUROSCI LETT, V125, P223, DOI 10.1016/0304-3940(91)90034-Q; CHENG B, 1992, J NEUROSCI, V12, P1558; CHENG B, 1991, NEURON, V7, P1031, DOI 10.1016/0896-6273(91)90347-3; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; DYRKS T, 1988, EMBO J, V7, P949, DOI 10.1002/j.1460-2075.1988.tb02900.x; ELLIOTT EM, 1993, IN PRESS J NEUROCHEM; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; FINKLESTEIN SP, 1988, BRAIN RES, V460, P253, DOI 10.1016/0006-8993(88)90370-8; FUKUCHI K, 1992, J NEUROCHEM, V58, P1863, DOI 10.1111/j.1471-4159.1992.tb10063.x; GIBSON GE, 1987, NEUROBIOL AGING, V8, P329, DOI 10.1016/0197-4580(87)90072-8; GOLDE TE, 1992, SCIENCE, V255, P728, DOI 10.1126/science.1738847; GOLDGABER D, 1989, P NATL ACAD SCI USA, V86, P7606, DOI 10.1073/pnas.86.19.7606; GREENAMYRE JT, 1989, NEUROBIOL AGING, V10, P593, DOI 10.1016/0197-4580(89)90143-7; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HAASS C, 1991, J NEUROSCI, V11, P3783; HENRIKSSON T, 1991, J NEUROCHEM, V56, P1037, DOI 10.1111/j.1471-4159.1991.tb02026.x; HOYER S, 1988, J NEUROL, V235, P143, DOI 10.1007/BF00314304; JAGUST WJ, 1991, J CEREBR BLOOD F MET, V11, P323, DOI 10.1038/jcbfm.1991.65; JOHNSONWOOD KL, 1990, NEUROBIOL AGING, V11, P306; KALARIA RN, 1989, J NEUROCHEM, V53, P1083, DOI 10.1111/j.1471-4159.1989.tb07399.x; KAMETANI F, 1990, J NEUROL SCI, V97, P43, DOI 10.1016/0022-510X(90)90097-7; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KATER SB, 1988, TRENDS NEUROSCI, V11, P315, DOI 10.1016/0166-2236(88)90094-X; KAWARABAYASHI T, 1991, BRAIN RES, V563, P334, DOI 10.1016/0006-8993(91)91558-I; KENNEDY MB, 1989, CELL, V59, P777, DOI 10.1016/0092-8674(89)90601-6; KITAGUCHI N, 1990, BIOCHIM BIOPHYS ACTA, V1038, P105, DOI 10.1016/0167-4838(90)90017-A; KOH JY, 1990, BRAIN RES, V533, P315, DOI 10.1016/0006-8993(90)91355-K; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; LOREZ H, 1989, NEUROSCI LETT, V98, P339, DOI 10.1016/0304-3940(89)90425-4; MATTSON MP, 1988, INT J DEV NEUROSCI, V6, P439, DOI 10.1016/0736-5748(88)90050-0; MATTSON MP, 1990, BRAIN RES, V522, P204, DOI 10.1016/0006-8993(90)91462-P; MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992; MATTSON MP, 1991, MOL CHEM NEUROPATHOL, V15, P117, DOI 10.1007/BF03159951; MATTSON MP, 1988, J NEUROSCI RES, V21, P447, DOI 10.1002/jnr.490210236; MATTSON MP, 1990, NEURON, V4, P105, DOI 10.1016/0896-6273(90)90447-N; MATTSON MP, 1992, NEUROBIOL AGING, V13, P617, DOI 10.1016/0197-4580(92)90068-9; MATTSON MP, 1992, EXP GERONTOL, V27, P29, DOI 10.1016/0531-5565(92)90027-W; MATTSON MP, 1989, J NEUROSCI, V9, P3728; MILWARD EA, 1992, NEURON, V9, P129, DOI 10.1016/0896-6273(92)90228-6; MOBLEY WC, 1988, P NATL ACAD SCI USA, V85, P9811, DOI 10.1073/pnas.85.24.9811; MONYER H, 1989, BRAIN RES, V483, P347, DOI 10.1016/0006-8993(89)90179-0; NAKAMURA Y, 1992, NEUROSCI LETT, V136, P95, DOI 10.1016/0304-3940(92)90656-R; OHGAMI T, 1992, NEUROSCI LETT, V136, P75, DOI 10.1016/0304-3940(92)90651-M; OLTERSDORF T, 1990, J BIOL CHEM, V265, P4492; OLTERSDORF T, 1989, NATURE, V341, P144, DOI 10.1038/341144a0; OTSUKA N, 1991, BRAIN RES, V568, P335, DOI 10.1016/0006-8993(91)91422-W; PIKE CJ, 1991, BRAIN RES, V563, P311, DOI 10.1016/0006-8993(91)91553-D; QUON D, 1990, BIOCHEM BIOPH RES CO, V167, P96, DOI 10.1016/0006-291X(90)91735-B; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; ROCH JM, 1992, J BIOL CHEM, V267, P2214; SAITOH T, 1989, CELL, V58, P615, DOI 10.1016/0092-8674(89)90096-2; SALBAUM JM, 1988, EMBO J, V7, P2807, DOI 10.1002/j.1460-2075.1988.tb03136.x; SCHUBERT D, 1989, BIOCHEM BIOPH RES CO, V162, P83, DOI 10.1016/0006-291X(89)91965-7; SCHUBERT D, 1989, NEURON, V3, P689, DOI 10.1016/0896-6273(89)90237-7; SCHUBERT W, 1991, BRAIN RES, V563, P184, DOI 10.1016/0006-8993(91)91532-6; SELKOE DJ, 1989, ANNU REV NEUROSCI, V12, P463, DOI 10.1146/annurev.ne.12.030189.002335; SELKOE DJ, 1988, P NATL ACAD SCI USA, V85, P7341, DOI 10.1073/pnas.85.19.7341; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; SEUBERT P, 1993, NATURE, V361, P260, DOI 10.1038/361260a0; SHIGENO T, 1991, J NEUROSCI, V11, P2914; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; SIESJO BK, 1989, ANN NY ACAD SCI, V568, P234; SIMS NR, 1990, ANN NEUROL, V27, P691, DOI 10.1002/ana.410270621; SINHA S, 1990, J BIOL CHEM, V265, P8983; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; SMITH RP, 1990, SCIENCE, V248, P1126, DOI 10.1126/science.2111585; SPILLANTINI MG, 1989, MOL BRAIN RES, V6, P143, DOI 10.1016/0169-328X(89)90048-X; TAMAOKA A, 1992, P NATL ACAD SCI USA, V89, P1345, DOI 10.1073/pnas.89.4.1345; VANNOSTRAND WE, 1990, J BIOL CHEM, V265, P9591; VANNOSTRAND WE, 1989, NATURE, V341, P546; VCHENG B, 1992, EXP NEUROL, V117, P114; WIELOCH T, 1985, SCIENCE, V230, P681, DOI 10.1126/science.2996146; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531	79	710	727	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1993	10	2					243	254		10.1016/0896-6273(93)90315-I	http://dx.doi.org/10.1016/0896-6273(93)90315-I			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KP685	8094963				2022-12-24	WOS:A1993KP68500012
J	Wong, ROL; Oakley, DM				Wong, ROL; Oakley, DM			Changing patterns of spontaneous bursting activity of on and off retinal ganglion cells during development	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; PRENATAL DEVELOPMENT; MAMMALIAN RETINA; CAT RETINA; ON-CENTER; RETINOGENICULATE PATHWAY; POSTNATAL-DEVELOPMENT; ACTION-POTENTIALS; BETA-CELLS; FERRET	In adult ferrets, retinal ganglion cells (RGCs) responsive to increased (On) or decreased (Off) illumination convey information to different cellular layers of the dorsal lateral geniculate nucleus (dLGN). These dLGN sublaminae emerge during development when RGCs are found to undergo correlated spontaneous bursting activity. Using Ca2+ imaging and intracellular dye-filling techniques, we demonstrate here that in ferret neonates, morphologically identified On and Off beta RGCs have similar burst frequencies prior to the segregation of their inputs in the dLGN, but during the segregation period, they develop distinct burst frequencies. Although the bursts of On cells and Off cells occur synchronously, On cells burst only 25%-35% of the time that Off cells do. This change in the temporal bursting patterns of On and Off RGCs may underlie the segregation of their inputs on dLGN neurons.			Wong, ROL (corresponding author), WASHINGTON UNIV,SCH MED,DEPT ANAT & NEUROBIOL,ST LOUIS,MO 63110, USA.				NATIONAL EYE INSTITUTE [R01EY010699] Funding Source: NIH RePORTER; NEI NIH HHS [EY10699] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AMES A, 1981, J NEUROCHEM, V37, P867, DOI 10.1111/j.1471-4159.1981.tb04473.x; BALDRIDGE WH, 1995, INVEST OPHTH VIS SCI, V36, pS865; BODNARENKO SR, 1993, NATURE, V364, P144, DOI 10.1038/364144a0; BODNARENKO SR, 1995, J NEUROSCI, V15, P7037; BOYCOTT BB, 1974, J PHYSIOL-LONDON, V240, P397, DOI 10.1113/jphysiol.1974.sp010616; CUCCHIARO J, 1984, PROC R SOC SER B-BIO, V223, P141, DOI 10.1098/rspb.1984.0087; DANN JF, 1988, J NEUROSCI, V8, P1485; DUBIN MW, 1986, J NEUROSCI, V6, P1021; FIELDS RD, 1990, J NEUROSCI, V10, P2950; GALLI L, 1988, SCIENCE, V242, P90, DOI 10.1126/science.3175637; GREINER JV, 1981, EXP EYE RES, V33, P315, DOI 10.1016/S0014-4835(81)80055-3; GUSTAFSSON B, 1986, J NEUROSCI, V6, P1575; HAHM JO, 1991, NATURE, V351, P568, DOI 10.1038/351568a0; HEBB DO, 1949, ORG BEHAVIOR; HENDERSON Z, 1983, J PHYSIOL-LONDON, V345, pP119; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; LINDEN DC, 1981, J COMP NEUROL, V203, P189, DOI 10.1002/cne.902030204; MASLIM J, 1988, DEV BRAIN RES, V44, P87, DOI 10.1016/0165-3806(88)90120-4; MASTRONARDE DN, 1983, J NEUROPHYSIOL, V49, P303, DOI 10.1152/jn.1983.49.2.303; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; MILLER KD, 1994, NEURAL COMPUT, V6, P100, DOI 10.1162/neco.1994.6.1.100; MILLER KD, 1994, J NEUROSCI, V14, P409; MORGAN J, 1993, VISUAL NEUROSCI, V10, P303, DOI 10.1017/S0952523800003709; NELSON R, 1978, J NEUROPHYSIOL, V41, P472, DOI 10.1152/jn.1978.41.2.472; RAMOA AS, 1988, J NEUROSCI, V8, P4239; RAMOA AS, 1989, P NATL ACAD SCI USA, V86, P2061, DOI 10.1073/pnas.86.6.2061; ROBINSON HPC, 1993, J NEUROPHYSIOL, V70, P1606, DOI 10.1152/jn.1993.70.4.1606; ROE AW, 1989, J COMP NEUROL, V288, P208, DOI 10.1002/cne.902880203; SHATZ CJ, 1983, J NEUROSCI, V3, P482; SHATZ CJ, 1988, SCIENCE, V242, P87, DOI 10.1126/science.3175636; SKALIORA I, 1993, J NEUROSCI, V13, P313; SRETAVAN DW, 1986, J NEUROSCI, V6, P234; SRETAVAN DW, 1988, NATURE, V336, P468, DOI 10.1038/336468a0; STRYKER MP, 1983, J NEUROSCI, V3, P1943; VITEK DJ, 1985, J COMP NEUROL, V241, P1, DOI 10.1002/cne.902410102; WASSLE H, 1981, NATURE, V292, P344, DOI 10.1038/292344a0; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; WASSLE H, 1981, PROC R SOC SER B-BIO, V212, P177, DOI 10.1098/rspb.1981.0033; Wassle H., 1982, PROGR RETINAL RES, V1, P125, DOI DOI 10.1016/0278-4327(82)90006-2; WILLSHAW DJ, 1976, PROC R SOC SER B-BIO, V194, P431, DOI 10.1098/rspb.1976.0087; WINGATE RJT, 1992, J COMP NEUROL, V323, P449, DOI 10.1002/cne.903230402; WINGATE RJT, 1995, EUR J NEUROSCI, V7, P723, DOI 10.1111/j.1460-9568.1995.tb00676.x; Wong R O, 1993, Curr Opin Neurobiol, V3, P595, DOI 10.1016/0959-4388(93)90061-3; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8; WONG ROL, 1995, J NEUROSCI, V15, P2696; WONG ROL, 1995, NATURE, V374, P716, DOI 10.1038/374716a0; YUSTE R, 1991, NEURON, V6, P333, DOI 10.1016/0896-6273(91)90243-S	47	124	125	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1996	16	6					1087	1095		10.1016/S0896-6273(00)80135-X	http://dx.doi.org/10.1016/S0896-6273(00)80135-X			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UU118	8663985	Bronze			2022-12-24	WOS:A1996UU11800006
J	Zhang, L; Goldman, JE				Zhang, L; Goldman, JE			Generation of cerebellar interneurons from dividing progenitors in white matter	NEURON			English	Article							RAT CEREBELLUM; GLUTAMATE-DECARBOXYLASE; SUBVENTRICULAR ZONE; CELL LINEAGE; MIGRATION; NEURONS; LOCALIZATION; OLIGODENDROCYTES; DIFFERENTIATION; PROLIFERATION	The traditional view of the external granular layer of the cerebellar cortex giving rise to interneurons has been challenged by recent studies with quail-chick chimeras. To clarify the time and site of origins of interneurons, a retrovirus carrying the beta-galactosidase gene was injected into the deep cerebellar tissue or external granular layer of postnatal day 4/5 rats to label dividing progenitors. After deep cerebellar tissue injection, unipolar cells were found initially in white matter at 2 days postinjection and subsequently in the internal granule and molecular layers 4-6 days postinjection. Morphologically defined basket, stellate, and Golgi neurons were clearly identified by 20 days postinjection. In contrast, retroviral labeling of cells in the external granular layer produced only granule neurons in the internal granule layer. Thus, dividing progenitors in the cerebellar white matter migrate through the white matter into the cortex before differentiating into a variety of cortical interneurons.			Zhang, L (corresponding author), COLUMBIA UNIV COLL PHYS & SURG,CTR NEUROBIOL & BEHAV,DEPT PATHOL,722 W 168TH ST,NEW YORK,NY 10032, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017125] Funding Source: NIH RePORTER; NINDS NIH HHS [NS17125] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allen E, 1912, J COMP NEUROL, V22, P547; ALTMAN J, 1966, EXP NEUROL, V16, P263, DOI 10.1016/0014-4886(66)90063-X; ALTMAN J, 1972, J COMP NEUROL, V145, P353, DOI 10.1002/cne.901450305; ALTMAN J, 1978, J COMP NEUROL, V179, P23, DOI 10.1002/cne.901790104; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; ANGEVINE JAY B., 1965, EXP NEUROL SUPPL, V2, P1; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; BAYER SA, 1987, PROG NEUROBIOL, V29, P57, DOI 10.1016/0301-0082(87)90015-3; Cajal SRY., 1995, HISTOLOGY NERVOUS SY, V1; Eccles JC, 1967, CEREBELLUM NEURONAL; EDMONDSON JC, 1987, J NEUROSCI, V7, P1928; FUJITA S, 1966, J COMP NEUROL, V128, P191, DOI 10.1002/cne.901280206; GAO WQ, 1994, DEVELOPMENT, V120, P1059; GONYE GE, 1994, J NEUROSCI, V14, P5365; HAJIHOSSEINI M, 1993, EMBO J, V12, P4969, DOI 10.1002/j.1460-2075.1993.tb06190.x; HALLONET MER, 1990, DEVELOPMENT, V108, P19; HALLONET MER, 1993, EUR J NEUROSCI, V5, P1145, DOI 10.1111/j.1460-9568.1993.tb00969.x; HANAWAY J, 1968, ANAT REC, V160, P360; HATTEN ME, 1990, TRENDS NEUROSCI, V13, P179, DOI 10.1016/0166-2236(90)90044-B; HEINSEN H, 1977, ANAT EMBRYOL, V151, P201, DOI 10.1007/BF00297481; HINDS JW, 1968, J COMP NEUROL, V134, P305, DOI 10.1002/cne.901340305; HINDS JW, 1968, J COMP NEUROL, V134, P287, DOI 10.1002/cne.901340304; His W., 1904, ENTWICKLUNG MENSCHLI; HOKFELT F, 1972, EXP BRAIN RES, V14, P331; Jacobson M., 1991, DEV NEUROBIOLOGY; KELLY JS, 1975, BRAIN RES, V85, P255, DOI 10.1016/0006-8993(75)90078-5; LEVINE SM, 1988, J COMP NEUROL, V277, P441, DOI 10.1002/cne.902770309; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; MCGEER PL, 1975, EXP NEUROL, V47, P26, DOI 10.1016/0014-4886(75)90234-4; MCLAUGHLIN BJ, 1974, BRAIN RES, V76, P377, DOI 10.1016/0006-8993(74)90815-4; MIALE IL, 1961, EXP NEUROL, V4, P277, DOI 10.1016/0014-4886(61)90055-3; NAKAFUKU M, 1995, J NEUROSCI RES, V41, P153, DOI 10.1002/jnr.490410203; NAPIERALSKI JA, 1993, DEV DYNAM, V197, P244, DOI 10.1002/aja.1001970403; OERTEL WH, 1981, NEUROSCIENCE, V6, P2715, DOI 10.1016/0306-4522(81)90115-9; OTERO RA, 1993, J COMP NEUROL, V333, P597, DOI 10.1002/cne.903330411; PATEL AJ, 1985, BRAIN RES, V237, P203; PRICE J, 1987, DEVELOPMENT, V101, P409; RAKIC P, 1972, J COMP NEUROL, V146, P335, DOI 10.1002/cne.901460304; RAKIC P, 1971, J COMP NEUROL, V141, P283, DOI 10.1002/cne.901410303; RAKIC P, 1973, J COMP NEUROL, V147, P523, DOI 10.1002/cne.901470407; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; REYNOLDS R, 1988, DEVELOPMENT, V102, P409; SAITO K, 1974, P NATL ACAD SCI USA, V71, P269, DOI 10.1073/pnas.71.2.269; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; Sauer FC, 1935, J COMP NEUROL, V62, P377, DOI 10.1002/cne.900620207; SAUER ME, 1959, P SOC EXP BIOL MED, V101, P557; SIDMAN RL, 1959, EXP NEUROL, V1, P322, DOI 10.1016/0014-4886(59)90024-X; SMART I, 1961, J COMP NEUROL, V116, P349, DOI 10.1002/cne.901160307; TURNER DL, 1990, NEURON, V4, P833, DOI 10.1016/0896-6273(90)90136-4; UZMAN LL, 1960, J COMP NEUROL, V114, P137; WARRINGTON AE, 1992, J NEUROSCI RES, V33, P338, DOI 10.1002/jnr.490330218; WILLIAMS BP, 1991, NEURON, V7, P685, DOI 10.1016/0896-6273(91)90381-9; WOOD JG, 1976, GABA NERVOUS SYSTEM, P133; ZERLIN M, 1995, J NEUROSCI, V15, P7238	57	205	210	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1996	16	1					47	54		10.1016/S0896-6273(00)80022-7	http://dx.doi.org/10.1016/S0896-6273(00)80022-7			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TT307	8562089	hybrid			2022-12-24	WOS:A1996TT30700008
J	DIFIGLIA, M; SAPP, E; CHASE, K; SCHWARZ, C; MELONI, A; YOUNG, C; MARTIN, E; VONSATTEL, JP; CARRAWAY, R; REEVES, SA; BOYCE, FM; ARONIN, N				DIFIGLIA, M; SAPP, E; CHASE, K; SCHWARZ, C; MELONI, A; YOUNG, C; MARTIN, E; VONSATTEL, JP; CARRAWAY, R; REEVES, SA; BOYCE, FM; ARONIN, N			HUNTINGTIN IS A CYTOPLASMIC PROTEIN ASSOCIATED WITH VESICLES IN HUMAN AND RAT-BRAIN NEURONS	NEURON			English	Article							DISEASE GENE; CONSTITUENT; GLUTAMATE; MEMBRANE; TISSUES	The gene defective in Huntington's disease encodes a protein, huntingtin, with unknown function. Antisera generated against three separate regions of huntingtin identified a single high molecular weight protein of similar to 320 kDa on immunoblots of human neuroblastoma extracts. The same protein species was detected in human and rat cortex synaptosomes and in sucrose density gradients of vesicle-enriched fractions, where huntingtin immunoreactivity overlapped with the distribution of vesicle membrane proteins (SV2, transferrin receptor, and synaptophysin). Immunohistochemistry in human and rat brain revealed widespread cytoplasmic labeling of huntingtin within neurons, particularly cell bodies and dendrites, rather than the more selective pattern of axon terminal labeling characteristic of many vesicle-associated proteins. At the ultrastructural level, immunoreactivity in cortical neurons was detected in the matrix of the cytoplasm and around the membranes of the vesicles. The ubiquitous cytoplasmic distribution of huntingtin in neurons and its association with vesicles suggest that huntingtin may have a role in vesicle trafficking.	HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,DEPT PATHOL,BOSTON,MA 02114; HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,DEPT NEUROSURG,BOSTON,MA 02114; UNIV MASSACHUSETTS,MED CTR,DEPT MED,WORCESTER,MA 01655; UNIV MASSACHUSETTS,MED CTR,DEPT PHYSIOL,WORCESTER,MA 01655; UNIV MASSACHUSETTS,MED CTR,DEPT CELL BIOL,WORCESTER,MA 01655	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	DIFIGLIA, M (corresponding author), HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,DEPT NEUROL,BOSTON,MA 02114, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS016367, P01NS031579, P01NS016367] Funding Source: NIH RePORTER; NINDS NIH HHS [NS31579, NS16367] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AMARA JF, 1992, TRENDS CELL BIOL, V2, P165; ARONIN N, 1992, J NEUROSCI, V12, P3435; BEAL MF, 1993, J NEUROSCI, V13, P4181; BROSE N, 1990, J BIOL CHEM, V265, P10604; BRUYN GW, 1973, ADV NEUROL, P83; CAMERON PL, 1991, J CELL BIOL, V115, P151, DOI 10.1083/jcb.115.1.151; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; DIFIGLIA M, 1990, TRENDS NEUROSCI, V13, P286, DOI 10.1016/0166-2236(90)90111-M; FOLSTEIN SE, 1989, HUNTINGTONS DISEASE, P1; GERBER HP, 1994, SCIENCE, V263, P808, DOI 10.1126/science.8303297; GRAVELAND GA, 1985, SCIENCE, V227, P770, DOI 10.1126/science.3155875; HOOGEVEEN AT, 1993, HUM MOL GENET, V2, P2069, DOI 10.1093/hmg/2.12.2069; JAHN R, 1993, J NEUROCHEM, V61, P12, DOI 10.1111/j.1471-4159.1993.tb03533.x; KOENIG H, 1974, METHODS ENZYMOLOGY A; LANDWEHRMEYER GB, 1995, ANN NEUROL, V37, P218, DOI 10.1002/ana.410370213; LI SH, 1993, NEURON, V11, P985, DOI 10.1016/0896-6273(93)90127-D; SAPP E, 1995, NEUROSCIENCE, V64, P397, DOI 10.1016/0306-4522(94)00427-7; STRONG TV, 1993, NAT GENET, V5, P259, DOI 10.1038/ng1193-259; VOLKNANDT W, 1995, NEUROSCIENCE, V64, P277, DOI 10.1016/0306-4522(94)00408-W; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; WALCHSOLIMENA C, 1993, J NEUROSCI, V13, P3895; WEXLER NS, 1991, ANNU REV NEUROSCI, V14, P503, DOI 10.1146/annurev.neuro.14.1.503; WHITE S, 1992, BIOCHIM BIOPHYS ACTA, V1136, P28, DOI 10.1016/0167-4889(92)90081-L; 1993, CELL, V72, P971	24	595	611	0	16	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1995	14	5					1075	1081		10.1016/0896-6273(95)90346-1	http://dx.doi.org/10.1016/0896-6273(95)90346-1			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QY935	7748555	Bronze			2022-12-24	WOS:A1995QY93500020
J	KEE, Y; LIN, RC; HSU, SC; SCHELLER, RH				KEE, Y; LIN, RC; HSU, SC; SCHELLER, RH			DISTINCT DOMAINS OF SYNTAXIN ARE REQUIRED FOR SYNAPTIC VESICLE FUSION COMPLEX-FORMATION AND DISSOCIATION	NEURON			English	Article							VESICULAR TRANSPORT; PROTEIN	Membrane fusion resulting in neurotransmitter secretion forms the basis of neural communication. Three multimeric complexes of the protein syntaxin are important in this process: syntaxin and n-sec1; syntaxin, VAMP, and SNAP-25; and syntaxin, VAMP, SNAP-25, alpha SNAP, and NSF(20S complex). In this report, we demonstrate that unique, yet overlapping, domains of syntaxin are required to form these complexes. The formation of higher order heteromultimers has a set of structural requirements distinct from those required for dimeric interactions. Dissociation of the 20S complex by NSF following ATP hydrolysis requires aminoterminal regions of syntaxin that are outside of the binding domains for the 20S constituent proteins. These data are consistent with the hypothesis that conformational changes in syntaxin, resulting from protein-protein interactions and ATP hydrolysis by NSF, mediate neurotransmitter release.			KEE, Y (corresponding author), STANFORD UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT MOLEC & CELLULAR PHYSIOL,STANFORD,CA 94305, USA.							AALTO MK, 1993, EMBO J, V12, P4095, DOI 10.1002/j.1460-2075.1993.tb06093.x; BENNETT MK, 1994, ANNU REV BIOCHEM, V63, P63, DOI 10.1146/annurev.bi.63.070194.000431; BENNETT MK, 1992, SCIENCE, V257, P3535; CALAKOS N, 1994, SCIENCE, V263, P831; CHAPMAN ER, 1994, J BIOL CHEM, V269, P27427; DIANTONIO A, 1994, NEURON, V12, P909, DOI 10.1016/0896-6273(94)90342-5; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; HARDWICK KG, 1992, J CELL BIOL, V119, P513, DOI 10.1083/jcb.119.3.513; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; INOUE A, 1992, J BIOL CHEM, V267, P10613; JAHN R, 1994, ANNU REV NEUROSCI, V17, P219, DOI 10.1146/annurev.ne.17.030194.001251; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; MCMAHON HT, 1995, J BIOL CHEM, V270, P2213, DOI 10.1074/jbc.270.5.2213; Niemann Heiner, 1994, Trends in Cell Biology, V4, P179, DOI 10.1016/0962-8924(94)90203-8; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; OYLER GA, 1989, J CELL BIOL, V109, P3039, DOI 10.1083/jcb.109.6.3039; PEVSNER J, 1994, P NATL ACAD SCI USA, V91, P1445, DOI 10.1073/pnas.91.4.1445; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; SCHELLER RH, 1995, NEURON, V14, P893; Schiavo G, 1993, Trends Microbiol, V1, P170, DOI 10.1016/0966-842X(93)90086-7; SOGAARD M, 1994, CELL, V78, P937, DOI 10.1016/0092-8674(94)90270-4; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; WILSON DW, 1992, J CELL BIOL, V117, P531, DOI 10.1083/jcb.117.3.531	25	198	200	0	2	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1995	14	5					991	998		10.1016/0896-6273(95)90337-2	http://dx.doi.org/10.1016/0896-6273(95)90337-2			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QY935	7748566	Bronze			2022-12-24	WOS:A1995QY93500011
J	MCMANUS, OB; HELMS, LMH; PALLANCK, L; GANETZKY, B; SWANSON, R; LEONARD, RJ				MCMANUS, OB; HELMS, LMH; PALLANCK, L; GANETZKY, B; SWANSON, R; LEONARD, RJ			FUNCTIONAL-ROLE OF THE BETA-SUBUNIT OF HIGH-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS	NEURON			English	Article							K+ CHANNELS; MUSCLE; KINETICS	Mammalian high conductance, calcium-activated potassium (maxi-K) channels are composed of two dissimilar subunits, alpha and beta. We have examined the functional contribution of the beta subunit to the properties of maxi-K channels expressed heterologously in Xenopus oocytes. Channels from oocytes injected with cRNAs encoding both alpha and beta subunits were much more sensitive to activation by voltage and calcium than channels composed of the a subunit alone, while expression levels, single-channel conductance, and ionic selectivity appeared unaffected. Channels from oocytes expressing both subunits were sensitive to DHS-I, a patent agonist of native maxi-K channels, whereas channels composed of the a subunit alone were insensitive. Thus, alpha and beta subunits together contribute to the functional properties of expressed maxi-K channels, Regulation of coassembly might contribute to the functional diversity noted among members of this family of potassium channels.	MERCK & CO INC,MERCK SHARP & DOHME RES LABS,DEPT PHARMACOL,RAHWAY,NJ 07065; UNIV WISCONSIN,GENET LAB,MADISON,WI 53706	Merck & Company; University of Wisconsin System; University of Wisconsin Madison	MCMANUS, OB (corresponding author), MERCK & CO INC,MERCK SHARP & DOHME RES LABS,DEPT MEMBRANE BIOCHEM & BIOPHYS,RAHWAY,NJ 07065, USA.							ADELMAN JP, 1992, NEURON, V9, P209, DOI 10.1016/0896-6273(92)90160-F; ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; CANDIA S, 1993, BIOPHYS J, V63, P583; GALVEZ A, 1990, J BIOL CHEM, V265, P11083; GARCIACALVO M, 1994, J BIOL CHEM, V269, P676; GIANGIACOMO KM, 1992, BIOCHEMISTRY-US, V31, P6719, DOI 10.1021/bi00144a011; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; ISOM LL, 1994, NEURON, V12, P1183, DOI 10.1016/0896-6273(94)90436-7; KNAUS HG, 1994, J BIOL CHEM, V269, P3921; KNAUS HG, 1994, J BIOL CHEM, V269, P17274; LATORRE R, 1989, ANNU REV PHYSIOL, V51, P385, DOI 10.1146/annurev.ph.51.030189.002125; MCMANUS OB, 1991, J PHYSIOL-LONDON, V443, P739, DOI 10.1113/jphysiol.1991.sp018861; MCMANUS OB, 1993, BIOCHEMISTRY-US, V32, P6128, DOI 10.1021/bi00075a002; MCMANUS OB, 1991, J BIOENERG BIOMEMBR, V23, P537, DOI 10.1007/BF00785810; MOCZYDLOWSKI E, 1983, J GEN PHYSIOL, V82, P511, DOI 10.1085/jgp.82.4.511; PALLANCK L, 1994, HUM MOL GENET, V3, P1239, DOI 10.1093/hmg/3.8.1239; PEREZ G, 1994, BIOPHYS J, V66, P1022, DOI 10.1016/S0006-3495(94)80883-5; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0	19	404	410	0	7	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1995	14	3					645	650		10.1016/0896-6273(95)90321-6	http://dx.doi.org/10.1016/0896-6273(95)90321-6			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QP230	7695911	Bronze			2022-12-24	WOS:A1995QP23000018
J	DIVERSEPIERLUISSI, M; GOLDSMITH, PK; DUNLAP, K				DIVERSEPIERLUISSI, M; GOLDSMITH, PK; DUNLAP, K			TRANSMITTER-MEDIATED INHIBITION OF N-TYPE CALCIUM CHANNELS IN SENSORY NEURONS INVOLVES MULTIPLE GTP-BINDING PROTEINS AND SUBUNITS	NEURON			English	Article							RAT SYMPATHETIC NEURONS; ROOT GANGLION NEURONS; MUSCARINIC K+-CHANNEL; BETA-GAMMA-SUBUNITS; VOLTAGE DEPENDENCE; PERTUSSIS-TOXIN; PHOSPHOLIPASE-C; OMEGA-CONOTOXIN; CA2+ CHANNELS; KINASE-C	The modulation of voltage-activated Ca2+ channels by neurotransmitters and peptides is very likely a primary means of regulating Ca2+-dependent physiological functions such as neurosecretion, muscle contraction, and membrane excitability. In neurons, N-type Ca2+ channels (defined as omega-conotoxin GVIA-sensitive) are one prominent target for transmitter-mediated inhibition. This inhibition is widely thought to result from a shift in the voltage dependence of channel gating. Recently, however, voltage-independent inhibition has also been described for N channels. As embryonic chick dorsal root ganglion neurons express both of these biophysically distinct modulatory pathways, we have utilized these cells to test the hypothesis that the voltage-dependent and -independent actions of transmitters are mediated by separate biochemical pathways. We have confirmed this hypothesis by demonstrating that the two modulatory mechanisms activated by a single transmitter involve not only different classes of G protein but also different G protein subunits.	TUFTS UNIV,SCH MED,DEPT NEUROSCI,BOSTON,MA 02111; NIDDKD,METAB DIS BRANCH,BETHESDA,MD 20892	Tufts University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	DIVERSEPIERLUISSI, M (corresponding author), TUFTS UNIV,SCH MED,DEPT PHYSIOL,BOSTON,MA 02111, USA.				NINDS NIH HHS [NS16483] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS016483] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; BEECH DJ, 1992, NEURON, V8, P97, DOI 10.1016/0896-6273(92)90111-P; BEECH DJ, 1991, P NATL ACAD SCI USA, V88, P652, DOI 10.1073/pnas.88.2.652; BERNHEIM L, 1991, NEURON, V6, P859, DOI 10.1016/0896-6273(91)90226-P; BLANK JL, 1992, J BIOL CHEM, V267, P23069; BLEY KR, 1989, NEURON, V4, P379; BOLAND LM, 1991, J NEUROSCI, V11, P1140; BOLAND LM, 1993, J NEUROSCI, V13, P516; BOWERY NG, 1990, ADV BIOCHEM PSYCHOPH, V21, P395; BOYER JL, 1992, J BIOL CHEM, V267, P25451; BOYER JL, 1994, J BIOL CHEM, V269, P2814; BOYER JL, 1989, J BIOL CHEM, V264, P13917; CANFIELD DR, 1984, BRIT J PHARMACOL, V82, P557, DOI 10.1111/j.1476-5381.1984.tb10794.x; CAULFIELD MP, 1994, J PHYSIOL-LONDON, V477, P415, DOI 10.1113/jphysiol.1994.sp020203; CERIONE RA, 1988, J BIOL CHEM, V263, P9345; COX DH, 1992, J NEUROSCI, V12, P906; DELCOUR AH, 1993, SCIENCE, V259, P980, DOI 10.1126/science.8094902; DIVERSEPIERLUIS.M, 1993, NEURON, V10, P753; DIVERSEPIERLUIS.M, 1994, IN PRESS NEUROSCIENC; DOERNER D, 1988, J NEUROSCI, V10, P1669; DUNLAP K, 1981, BRIT J PHARMACOL, V74, P579, DOI 10.1111/j.1476-5381.1981.tb10467.x; DUNLAP K, 1981, J PHYSIOL-LONDON, V317, P519, DOI 10.1113/jphysiol.1981.sp013841; ELMSLIE KS, 1994, NEURON, V13, P217, DOI 10.1016/0896-6273(94)90471-5; ELMSLIE KS, 1990, NEURON, V5, P75, DOI 10.1016/0896-6273(90)90035-E; EWALD DA, 1988, P NATL ACAD SCI USA, V85, P3633, DOI 10.1073/pnas.85.10.3633; EWALD DA, 1989, NEURON, V2, P1185, DOI 10.1016/0896-6273(89)90185-2; FALLOON J, 1986, FEBS LETT, V209, P352, DOI 10.1016/0014-5793(86)81141-3; FORMENTI A, 1993, BIOPHYS J, V64, P1029, DOI 10.1016/S0006-3495(93)81468-1; FUJITA Y, 1993, NEURON, V10, P585, DOI 10.1016/0896-6273(93)90162-K; GIERSCHIK P, 1986, P NATL ACAD SCI USA, V83, P2258, DOI 10.1073/pnas.83.7.2258; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GOLARD A, 1993, J NEUROSCI, V13, P3884; GOLDSMITH P, 1988, BIOCHEMISTRY-US, V27, P7085, DOI 10.1021/bi00418a062; GRASSI F, 1989, NEUROSCI LETT, V105, P113, DOI 10.1016/0304-3940(89)90021-9; HESCHELER J, 1987, NATURE, V325, P445, DOI 10.1038/325445a0; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; HOLZ GG, 1986, NATURE, V319, P670, DOI 10.1038/319670a0; ITO H, 1992, J GEN PHYSIOL, V99, P961, DOI 10.1085/jgp.99.6.961; KASAI H, 1989, PFLUG ARCH EUR J PHY, V414, P145, DOI 10.1007/BF00580956; KASAI H, 1987, Neuroscience Research, V4, P228, DOI 10.1016/0168-0102(87)90014-9; KLEUSS C, 1991, NATURE, V353, P43, DOI 10.1038/353043a0; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; LUEBKE JI, 1994, PFLUG ARCH EUR J PHY, V428, P499, DOI 10.1007/BF00374571; MACKINNON AC, 1994, TRENDS PHARMACOL SCI, V15, P119, DOI 10.1016/0165-6147(94)90048-5; MARCHETTI C, 1986, PFLUG ARCH EUR J PHY, V406, P104, DOI 10.1007/BF00586670; MCFADZEAN I, 1989, NEURON, V3, P177, DOI 10.1016/0896-6273(89)90030-5; MCKENZIE FR, 1988, BIOCHEM J, V249, P653, DOI 10.1042/bj2490653; MENONJOHANSSON AS, 1993, PFLUG ARCH EUR J PHY, V425, P335, DOI 10.1007/BF00374184; PLUMMER MR, 1991, J NEUROSCI, V11, P2339; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; RANE SG, 1989, NEURON, V3, P239, DOI 10.1016/0896-6273(89)90037-8; RANE SG, 1986, P NATL ACAD SCI USA, V83, P184, DOI 10.1073/pnas.83.1.184; RANE SG, 1990, G PROTEINS, P107; REGAN LJ, 1991, NEURON, V6, P269, DOI 10.1016/0896-6273(91)90362-4; SPIEGEL AM, 1990, GWUMC DEPT, P115; SUMMERS RJ, 1993, J NEUROCHEM, V60, P10, DOI 10.1111/j.1471-4159.1993.tb05817.x; TSIEN RW, 1988, TRENDS NEUROSCI, V14, P46; WANKE E, 1987, P NATL ACAD SCI USA, V84, P4313, DOI 10.1073/pnas.84.12.4313; WILLIAMS ME, 1992, SCIENCE, V257, P389, DOI 10.1126/science.1321501; ZHU Y, 1993, J NEUROPHYSIOL, V70, P610, DOI 10.1152/jn.1993.70.2.610	60	121	123	0	4	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1995	14	1					191	200		10.1016/0896-6273(95)90254-6	http://dx.doi.org/10.1016/0896-6273(95)90254-6			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QC548	7826637	Bronze			2022-12-24	WOS:A1995QC54800020
J	LEVEY, MS; BRUMWELL, CL; DRYER, SE; JACOB, MH				LEVEY, MS; BRUMWELL, CL; DRYER, SE; JACOB, MH			INNERVATION AND TARGET TISSUE INTERACTIONS DIFFERENTIALLY REGULATE ACETYLCHOLINE-RECEPTOR SUBUNIT MESSENGER-RNA LEVELS IN DEVELOPING NEURONS IN-SITU	NEURON			English	Article							CHICK CILIARY GANGLION; POLYMERASE CHAIN-REACTION; GABA-ACTIVATED CURRENTS; GENE-RELATED PEPTIDE; SYMPATHETIC NEURONS; SYNAPTIC TRANSMISSION; MESSENGER-RNA; SMOOTH-MUSCLE; CELL-CULTURE; EXPRESSION	Neurons engage in two distinct types of cell-cell interactions: they receive innervation and establish synapses on target tissues. Regulatory events that influence synapse formation and function on developing neurons are largely undefined. We show here that nicotinic acetylcholine receptor (AChR) subunit transcript levels are differentially regulated by innervation and target tissue interactions in developing chick ciliary ganglion neurons in situ. Using ganglia that have developed in the absence of pre- or postganglionic tissues and quantitative RT-PCR, we demonstrate that alpha 3 and beta 4 transcript levels are increased by innervation and target tissue interactions. In contrast, alpha 5 transcript levels are increased by innervation, but target tissues have little effect. Whole-cell ACh-induced currents, used to estimate the number of functional AChRs, change in correlation with alpha 3 and beta 4, but not alpha 5, transcript levels. A model is proposed in which the changes in AChR subunit expression regulate levels of synaptic activity, which Is a critical determinant of synapse stabilization and elimination, and neuronal cell death.	FLORIDA STATE UNIV,DEPT BIOL SCI,PROGRAM NEUROSCI,TALLAHASSEE,FL 32306	State University System of Florida; Florida State University	LEVEY, MS (corresponding author), WORCESTER FDN EXPTL BIOL INC,222 MAPLE AVE,SHREWSBURY,MA 01545, USA.				NINDS NIH HHS [NS-21725, NS-27013] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS027013, R01NS021725] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; ARENELLA LS, 1993, J NEUROSCI, V13, P4525; BECKERANDRE M, 1989, NUCLEIC ACIDS RES, V17, P9437, DOI 10.1093/nar/17.22.9437; BOULTER J, 1990, J BIOL CHEM, V265, P4472; BOYD RT, 1988, NEURON, V1, P495; BRENNER HR, 1976, J PHYSIOL-LONDON, V260, P159, DOI 10.1113/jphysiol.1976.sp011509; CORRIVEAU RA, 1993, J NEUROSCI, V13, P2662, DOI 10.1523/JNEUROSCI.13-06-02662.1993; COUTURIER S, 1990, J BIOL CHEM, V265, P17560; DAUBAS P, 1990, NEURON, V5, P49, DOI 10.1016/0896-6273(90)90032-B; DEVAY P, 1994, DEV BIOL, V162, P56, DOI 10.1006/dbio.1994.1066; DOURADO MM, 1994, J NEUROSCI, V14, P3156; DRYER SE, 1991, NEUROSCIENCE, V44, P663, DOI 10.1016/0306-4522(91)90086-4; ENGISCH KL, 1990, DEV BIOL, V139, P417, DOI 10.1016/0012-1606(90)90310-F; ENGISCH KL, 1992, J NEUROSCI, V12, P1115; FALLS DL, 1993, CELL, V72, P801, DOI 10.1016/0092-8674(93)90407-H; FERAMISCO JR, 1982, J BIOL CHEM, V257, P1024; FURBER S, 1987, J NEUROSCI, V7, P1816; GARDETTE R, 1991, DEV BIOL, V147, P83, DOI 10.1016/S0012-1606(05)80009-0; HALL ZW, 1993, NEURON S, V10, P99; HALVORSEN SW, 1991, J NEUROSCI, V11, P2177; HIEBER V, 1992, J NEUROCHEM, V58, P1009, DOI 10.1111/j.1471-4159.1992.tb09355.x; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; JACOB MH, 1991, J NEUROSCI, V11, P1701; JACOB MH, 1988, J NEUROSCI, V8, P3838; JACOB MH, 1987, J CELL BIOL, V105, P1847, DOI 10.1083/jcb.105.4.1847; JOHNSON DA, 1988, J PHYSIOL-LONDON, V397, P51, DOI 10.1113/jphysiol.1988.sp016987; KARLIN A, 1991, HARVEY LECT, V85, P71; LANDMESSER L, 1974, J PHYSIOL-LONDON, V241, P715, DOI 10.1113/jphysiol.1974.sp010680; LANDMESSER L, 1972, J PHYSIOL-LONDON, V222, P691, DOI 10.1113/jphysiol.1972.sp009822; LANDMESSER L, 1974, J PHYSIOL-LONDON, V241, P737, DOI 10.1113/jphysiol.1974.sp010681; LISTERUD M, 1991, SCIENCE, V254, P1518, DOI 10.1126/science.1720573; MANDELZYS A, 1994, J NEUROSCI, V14, P2357; MARGIOTTA JF, 1982, NATURE, V296, P152, DOI 10.1038/296152a0; MARGIOTTA JF, 1987, P NATL ACAD SCI USA, V84, P8155, DOI 10.1073/pnas.84.22.8155; MARGIOTTA JF, 1987, J NEUROSCI, V7, P3612; MARGIOTTA JF, 1989, DEV BIOL, V135, P326, DOI 10.1016/0012-1606(89)90183-8; MATTER JM, 1990, EMBO J, V9, P1021, DOI 10.1002/j.1460-2075.1990.tb08205.x; MCEACHERN AE, 1989, J NEUROSCI, V9, P3899; MERINEY SD, 1987, J NEUROSCI, V7, P3827; MONTEIRO MJ, 1988, J MOL BIOL, V199, P439, DOI 10.1016/0022-2836(88)90616-X; MOSS BL, 1989, NEURON, V3, P597, DOI 10.1016/0896-6273(89)90270-5; MOSS BL, 1993, J NEUROSCI, V1, P13; NEF P, 1988, EMBO J, V7, P595, DOI 10.1002/j.1460-2075.1988.tb02852.x; NEW HV, 1986, NATURE, V323, P809, DOI 10.1038/323809a0; PERRIN S, 1990, NUCLEIC ACIDS RES, V18, P7433, DOI 10.1093/nar/18.24.7433; PILAR G, 1987, J NEUROSCI, V7, P3813, DOI 10.1523/jneurosci.07-12-03813.1987; ROLE LW, 1988, P NATL ACAD SCI USA, V85, P2825, DOI 10.1073/pnas.85.8.2825; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SMITH MA, 1985, J NEUROSCI, V5, P2726; STOLLBERG J, 1987, J NEUROSCI, V7, P1809; SULLIVAN KF, 1986, MOL CELL BIOL, V6, P4409, DOI 10.1128/MCB.6.12.4409; VERNALLIS AB, 1993, NEURON, V10, P451, DOI 10.1016/0896-6273(93)90333-M; VIJAYARAGHAVAN S, 1990, J NEUROSCI, V10, P3255; VILLAR MJ, 1989, EUR J NEUROSCI, V1, P269, DOI 10.1111/j.1460-9568.1989.tb00795.x	55	63	64	0	1	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1995	14	1					153	162		10.1016/0896-6273(95)90249-X	http://dx.doi.org/10.1016/0896-6273(95)90249-X			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QC548	7826633	Bronze			2022-12-24	WOS:A1995QC54800015
J	MOHIT, AA; MARTIN, JH; MILLER, CA				MOHIT, AA; MARTIN, JH; MILLER, CA			P49(3F12) KINASE - A NOVEL MAP KINASE EXPRESSED IN A SUBSET OF NEURONS IN THE HUMAN NERVOUS-SYSTEM	NEURON			English	Article							PROTEIN-KINASE; ALZHEIMERS-DISEASE; AMYLOID PRECURSOR; GROWTH-FACTOR; NEUROFIBRILLARY TANGLES; PHOSPHORYLATION SITES; TAU; ACTIVATION; TYROSINE; LOCALIZATION	Monoclonal antibody 3F12 identifies a cytoplasmic antigen of 49 kDa in human hippocampus and neocortex. The distribution of 3F12 immunoreactive neurons closely matches that of Alzheimer's disease (AD) targeted neurons in these areas. In some hippocampal neurons of AD patients, this antigen colocalizes with ALZ-50, indicating the presence of AD pathology in these neurons. Molecular characterization of the 3F12 cDNA revealed it to be a member of the MAP kinase family, showing 43% amino acid sequence identity to human extracellular related kinase 2 (p42(mapk)). We have confirmed that p49(3F12) kinase autophosphorylates both threonine and tyrosine residues, as expected for a MAP kinase. The p49 mRNA is expressed exclusively in the nervous system. In the brain, the distribution of these neurons closely corresponds to 3F12 antigen-bearing neurons. The p49(3F12) gene maps to the human chromosome 21q21 region, a region that may be important in the pathogenesis of AD and Down's syndrome.			MOHIT, AA (corresponding author), UNIV SO CALIF,DEPT PATHOL,DEPT NEUROL,PROGRAM NEUROSCI,LOS ANGELES,CA 90033, USA.				NIA NIH HHS [AG00093, AG05142] Funding Source: Medline; NIMH NIH HHS [5-R37-MH39145] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH039145] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ARAI H, 1990, P NATL ACAD SCI USA, V87, P2249, DOI 10.1073/pnas.87.6.2249; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; CHAO TSO, 1992, J BIOL CHEM, V267, P19876; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CREWS CM, 1991, P NATL ACAD SCI USA, V88, P8845, DOI 10.1073/pnas.88.19.8845; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; DREWES G, 1992, EMBO J, V11, P2131, DOI 10.1002/j.1460-2075.1992.tb05272.x; GANDY S, 1988, P NATL ACAD SCI USA, V85, P6218, DOI 10.1073/pnas.85.16.6218; GARDNER AM, 1993, J BIOL CHEM, V268, P17896; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; GOEDERT M, 1992, FEBS LETT, V312, P95, DOI 10.1016/0014-5793(92)81418-L; GONZALEZ FA, 1992, FEBS LETT, V304, P170, DOI 10.1016/0014-5793(92)80612-K; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HINTON DR, 1988, J COMP NEUROL, V267, P398, DOI 10.1002/cne.902670309; HYMAN BT, 1994, AM J PATHOL, V144, P565; KORENBERG JR, 1990, AM J HUM GENET, V47, P236; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; LU Q, 1993, J NEUROSCI RES, V35, P439, DOI 10.1002/jnr.490350411; MILLER CA, 1987, P NATL ACAD SCI USA, V84, P8657, DOI 10.1073/pnas.84.23.8657; MILLER CA, 1983, P NATL ACAD SCI-BIOL, V80, P7641, DOI 10.1073/pnas.80.24.7641; NAKIELNY S, 1992, FEBS LETT, V308, P183, DOI 10.1016/0014-5793(92)81271-M; OHMICHI M, 1992, J BIOL CHEM, V267, P14604; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; RAY LB, 1987, P NATL ACAD SCI USA, V84, P1502, DOI 10.1073/pnas.84.6.1502; REFOLO LM, 1991, J NEUROSCI, V11, P3888; RUDKIN BB, 1989, EMBO J, V8, P3319, DOI 10.1002/j.1460-2075.1989.tb08493.x; Sambrook J, 1989, MOL CLONING LABORATO; SEGER R, 1991, P NATL ACAD SCI USA, V88, P6142, DOI 10.1073/pnas.88.14.6142; SETH A, 1991, J BIOL CHEM, V266, P23521; SHINOHARAGOTOH Y, 1991, EXP CELL RES, V193, P161, DOI 10.1016/0014-4827(91)90551-5; STGEORGEHYSLOP PH, 1987, SCIENCE, V235, P885, DOI 10.1126/science.2880399; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; TRASK BJ, 1991, METHOD CELL BIOL, V35, P3; TROJANOWSKI JQ, 1993, BRAIN RES, V618, P333, DOI 10.1016/0006-8993(93)91286-2; VERLHAC MH, 1993, DEV BIOL, V158, P330, DOI 10.1006/dbio.1993.1192; WOLOZIN BL, 1986, SCIENCE, V232, P648, DOI 10.1126/science.3083509	39	189	200	0	3	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1995	14	1					67	78		10.1016/0896-6273(95)90241-4	http://dx.doi.org/10.1016/0896-6273(95)90241-4			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QC548	7826642	Bronze			2022-12-24	WOS:A1995QC54800007
J	FAKLER, B; BRANDLE, U; GLOWATZKI, E; ZENNER, HP; RUPPERSBERG, JP				FAKLER, B; BRANDLE, U; GLOWATZKI, E; ZENNER, HP; RUPPERSBERG, JP			K(IR)2.1 INWARD RECTIFIER K+ CHANNELS ARE REGULATED INDEPENDENTLY BY PROTEIN-KINASES AND ATP HYDROLYSIS	NEURON			English	Article							POTASSIUM CHANNEL; FUNCTIONAL EXPRESSION; CELLS; CONDUCTANCE; MODULATION; RECEPTORS; ACTIVATE; HEART	Second messenger regulation of IRK1 (K(ir)2.1) inward rectifier K+ channels was investigated in giant inside-out patches from Xenopus oocytes. K(ir)2.1-mediated currents that run down completely within minutes upon excision of the patches could be partly restored by application of Mg-ATP together with >10 mu M free Mg2+ to the cytoplasmic side of the patch. As restoration could not be induced by the ATP analogs AMP-PNP or ATP gamma S, this suggests an ATPase-like mechanism. In addition to ATP, the catalytic subunit of cAMP-dependent protein kinase (PKA) induced an increase in current amplitude, which could, however, only be observed if channels were previously or subsequently stimulated by Mg-ATP and free Mg2+. This indicates that functional activity of K(ir)2.1 channels requires both phosphorylation by PKA and ATP hydrolysis. Moreover, currents could be down-regulated by N-heptyl-5-chloro-1-naphthalenesulfonamide, a specific stimulator of protein kinase C (PKC), suggesting that PKA and PKC mediate inverse effects on K(ir)2.1 channels. Regulation of K(ir)2.1 channels described here may be an important mechanism for regulation of excitability.			FAKLER, B (corresponding author), UNIV TUBINGEN,ENT HOSP,DEPT SENSORY BIOPHYS,RONTGENWEG 11,D-72076 TUBINGEN,GERMANY.			Glowatzki, Elisabeth/0000-0003-3135-658X				ANDERSON MP, 1991, CELL, V67, P775, DOI 10.1016/0092-8674(91)90072-7; BAUKROWITZ T, 1994, NEURON, V12, P473, DOI 10.1016/0896-6273(94)90206-2; BUSCH AE, 1992, J PHYSIOL-LONDON, V450, P491, DOI 10.1113/jphysiol.1992.sp019138; BUSCH AE, 1992, SCIENCE, V255, P1705, DOI 10.1126/science.1553557; CHANDY KG, 1993, TRENDS PHARMACOL SCI, V14, P434, DOI 10.1016/0165-6147(93)90181-I; CHUNG SK, 1991, SCIENCE, V253, P560, DOI 10.1126/science.1857986; CODERRE TJ, 1992, NEUROSCI LETT, V140, P181, DOI 10.1016/0304-3940(92)90097-Q; ECKSTEIN F, 1985, ANNU REV BIOCHEM, V54, P367, DOI 10.1146/annurev.bi.54.070185.002055; ESGUERRA M, 1994, NATURE, V369, P563, DOI 10.1038/369563a0; FABIATO A, 1988, METHOD ENZYMOL, V157, P378; FINDLAY I, 1986, PFLUG ARCH EUR J PHY, V407, P238, DOI 10.1007/BF00580683; HILGEMANN DW, 1991, NATURE, V352, P715, DOI 10.1038/352715a0; Hille B, 1992, IONIC CHANNELS EXCIT, P127; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; HONORE E, 1993, PFLUG ARCH EUR J PHY, V424, P113, DOI 10.1007/BF00374601; HWANG TC, 1994, P NATL ACAD SCI USA, V91, P4698, DOI 10.1073/pnas.91.11.4698; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; MATSUDA H, 1991, J PHYSIOL-LONDON, V435, P83, DOI 10.1113/jphysiol.1991.sp018499; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MING L, 1993, SCIENCE, V261, P1439; NILIUS B, 1993, J PHYSIOL-LONDON, V472, P359, DOI 10.1113/jphysiol.1993.sp019951; NORTH RA, 1989, J PHYSIOL-LONDON, V417, P1; OLESEN SP, 1993, CIRC RES, V73, P492, DOI 10.1161/01.RES.73.3.492; PAYET MD, 1992, J BIOL CHEM, V267, P18270; PFAFFINGER PJ, 1985, NATURE, V317, P536, DOI 10.1038/317536a0; REHM H, 1989, BIOCHEMISTRY-US, V28, P6455, DOI 10.1021/bi00441a044; WANG WH, 1991, P NATL ACAD SCI USA, V88, P9722, DOI 10.1073/pnas.88.21.9722; WICKMAN KD, 1994, NATURE, V368, P255, DOI 10.1038/368255a0; WIMPEY TL, 1991, NEURON, V6, P281, DOI 10.1016/0896-6273(91)90363-5; YAZAWA K, 1990, J PHYSIOL-LONDON, V421, P135, DOI 10.1113/jphysiol.1990.sp017937; YOUNT RG, 1971, BIOCHEMISTRY-US, V10, P2490, DOI 10.1021/bi00789a010	33	135	138	0	3	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1994	13	6					1413	1420		10.1016/0896-6273(94)90426-X	http://dx.doi.org/10.1016/0896-6273(94)90426-X			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PZ689	7993632				2022-12-24	WOS:A1994PZ68900015
J	HAYDON, PG; HENDERSON, E; STANLEY, EF				HAYDON, PG; HENDERSON, E; STANLEY, EF			LOCALIZATION OF INDIVIDUAL CALCIUM CHANNELS AT THE RELEASE FACE OF A PRESYNAPTIC NERVE-TERMINAL	NEURON			English	Article							ATOMIC-FORCE MICROSCOPY; CHICK CILIARY GANGLION; FROG NEUROMUSCULAR-JUNCTIONS; SYNAPTIC VESICLE EXOCYTOSIS; ALPHA-LATROTOXIN RECEPTOR; LIVING GLIAL-CELLS; TRANSMITTER RELEASE; OMEGA-CONOTOXIN; FREEZE-FRACTURE; ACTIVE ZONES	Studies using biophysical techniques suggest a highly structured organization of calcium channels at the presynaptic transmitter release face (Llinas et al., 1981; Stanley, 1993), but it has not as yet proved possible to localize identified channels at tho required nanometer level of resolution. We have used atomic force microscopy on the calyx-type nerve terminal of the chick ciliary ganglion to localize single calcium channels tagged via biotinylated omega-conotoxin GVIA to avidin-coated 30 nm gold particles. Calcium channels were in low (modal value approximately less than or equal to 1 per mu(2)) and high (modal value approximate to 55 per mu m(2)) density areas and exhibited a prominent interchannel spacing of 40 nm, indicating an intermolecular linkage. Particles were observed in clusters and short linear or parallel linear arrays, groupings that may reflect calcium channel organization at the transmitter release site.	NINCDS,DIV INTRAMURAL RES,SYNAPT MECHANISMS SECT,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	HAYDON, PG (corresponding author), IOWA STATE UNIV SCI & TECHNOL,DEPT ZOOL & GENET,CELLULAR SIGNALING LAB,ROOM 339,AMES,IA 50011, USA.				NINDS NIH HHS [NS 24233, NS 26650] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026650, R01NS024233] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABE T, 1993, ANN NY ACAD SCI, V707, P373, DOI 10.1111/j.1749-6632.1993.tb38074.x; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; BUTT HJ, 1990, J STRUCT BIOL, V105, P54, DOI 10.1016/1047-8477(90)90098-W; CECCARELLI B, 1979, J CELL BIOL, V81, P163, DOI 10.1083/jcb.81.1.163; COHEN MW, 1991, J NEUROSCI, V11, P1032; DELORENZO AJ, 1960, J BIOPHYS BIOCHEM CY, V7, P31, DOI 10.1083/jcb.7.1.31; HENDERSON E, 1992, SCIENCE, V257, P1944, DOI 10.1126/science.1411511; HESS A, 1965, J CELL BIOL, V25, P1, DOI 10.1083/jcb.25.3.1; HEUSER JE, 1979, J CELL BIOL, V81, P275, DOI 10.1083/jcb.81.2.275; HEUSER JE, 1974, J NEUROCYTOL, V3, P109, DOI 10.1007/BF01111936; HOH J H, 1992, Trends in Cell Biology, V2, P208, DOI 10.1016/0962-8924(92)90248-L; HOH JH, 1991, SCIENCE, V253, P1405, DOI 10.1126/science.1910206; HORIKAWA HPM, 1993, FEBS LETT, V330, P236, DOI 10.1016/0014-5793(93)80281-X; LANDMESSER L, 1972, J PHYSIOL-LONDON, V222, P691, DOI 10.1113/jphysiol.1972.sp009822; LEVEQUE C, 1992, P NATL ACAD SCI USA, V89, P3625, DOI 10.1073/pnas.89.8.3625; LEVEQUE C, 1994, J BIOL CHEM, V269, P6306; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; LLINAS R, 1981, BIOPHYS J, V33, P323, DOI 10.1016/S0006-3495(81)84899-0; MAGRASSI L, 1987, J NEUROSCI, V7, P1207; MARTIN AR, 1989, NEUROSCI LETT, V105, P14, DOI 10.1016/0304-3940(89)90004-9; MASTROGIACOMO A, 1994, SCIENCE, V263, P981, DOI 10.1126/science.7906056; OCONNOR VM, 1993, FEBS LETT, V326, P255, DOI 10.1016/0014-5793(93)81802-7; PARPURA V, 1993, J CELL SCI, V104, P427; PARPURA V, 1993, J VAC SCI TECHNOL A, V11, P773, DOI 10.1116/1.578346; PETRENKO AG, 1991, NATURE, V353, P65, DOI 10.1038/353065a0; PETRENKO AG, 1993, FEBS LETT, V325, P81, DOI 10.1016/0014-5793(93)81418-Y; PUMPLIN DW, 1981, P NATL ACAD SCI-BIOL, V78, P7210, DOI 10.1073/pnas.78.11.7210; PUTMAN CAJ, 1992, SPIE, V1639, P198; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; ROBITAILLE R, 1990, NEURON, V5, P773, DOI 10.1016/0896-6273(90)90336-E; ROBITAILLE R, 1993, NEURON, V11, P645, DOI 10.1016/0896-6273(93)90076-4; SMITH SJ, 1993, J PHYSIOL-LONDON, V472, P573, DOI 10.1113/jphysiol.1993.sp019963; STANLEY EF, 1991, J NEUROSCI, V11, P985; STANLEY EF, 1989, BRAIN RES, V505, P341, DOI 10.1016/0006-8993(89)91465-0; STANLEY EF, 1991, NEURON, V7, P585, DOI 10.1016/0896-6273(91)90371-6; STANLEY EF, 1990, P NATL ACAD SCI USA, V87, P9683, DOI 10.1073/pnas.87.24.9683; STANLEY EF, 1993, NEURON, V11, P1007, DOI 10.1016/0896-6273(93)90214-C; STANLEY EF, 1992, CAN J PHYSIOL PHARM, V70, P73; TARELLI FT, 1991, BRAIN RES, V547, P331, DOI 10.1016/0006-8993(91)90981-Z; VASENKA J, 1994, REV SCI INSTRUM, V65, P2249; WITCHER DR, 1993, SCIENCE, V261, P486, DOI 10.1126/science.8392754; YAWO H, 1993, J PHYSIOL-LONDON, V460, P153, DOI 10.1113/jphysiol.1993.sp019464; YOSHIDA A, 1992, J BIOL CHEM, V267, P24925	43	104	105	0	2	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1994	13	6					1275	1280		10.1016/0896-6273(94)90414-6	http://dx.doi.org/10.1016/0896-6273(94)90414-6			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PZ689	7993621	Green Published			2022-12-24	WOS:A1994PZ68900003
J	TSUDA, T; MUNTHASSER, S; FRASER, PE; PERCY, ME; RAINERO, I; VAULA, G; PINESSI, L; BERGAMINI, L; VIGNOCCHI, G; MCLACHLAN, DRC; TATTON, WG; SAINTGEORGEHYSLOP, P				TSUDA, T; MUNTHASSER, S; FRASER, PE; PERCY, ME; RAINERO, I; VAULA, G; PINESSI, L; BERGAMINI, L; VIGNOCCHI, G; MCLACHLAN, DRC; TATTON, WG; SAINTGEORGEHYSLOP, P			ANALYSIS OF THE FUNCTIONAL-EFFECTS OF A MUTATION IN SOD1 ASSOCIATED WITH FAMILIAL AMYOTROPHIC-LATERAL-SCLEROSIS	NEURON			English	Article							CU,ZN SUPEROXIDE-DISMUTASE; ALZHEIMER-DISEASE; OXIDATIVE STRESS; MESSENGER-RNA; NITRIC-OXIDE; CELL-DEATH; GENE; INHIBITION; MPTP	Mutations in the Cu, Zn superoxide dismutase (SOD1) gene have been reported in some pedigrees with Familial Amyotrophic Lateral Sclerosis (FALS). We have investigated the functional and structural effects of a Gly-->Ser mutation at codon 41 of SOD1 in a pedigree with FALS and the topography of SOD1 expression in the mammalian CNS. These analyses show that the (41)Gly-->Ser mutation causes a 27% reduction in Cu, Zn SOD activity. SOD1 is transcribed at high levels in rat motoneurons and four other types of neurons homologous to upper motoneurons that degenerate in human ALS. However, SOD1 is transcribed at lower levels in other types of neurons, such as cerebellar Purkinje cells, which are not usually involved significantly in human ALS. On the other hand, immunocytochemical studies indicate that most types of rat neurons contain similar levels of Cu, Zn SOD immunoreactive protein. Nevertheless, these results suggest that the essential feature causing this subtype of ALS is either a reduction in Cu, Zn SOD activity in cell types that presumably critically require Cu, Zn SOD for protect ion against oxidative damage or the fact that the mutation in SOD1 associated with FALS results in a novel gain of function that is particularly deleterious to those cell types expressing SOD1 at high levels.	UNIV TORONTO,DEPT PHYSIOL,CTR RES NEURODEGENERAT DIS,TORONTO M5S 1A8,ON,CANADA; UNIV TORONTO,SURREY PL CTR,TORONTO M5S 2C2,ON,CANADA; UNIV TURIN,DEPT NEUROL,I-10126 TURIN,ITALY; UNIV PISA,DEPT NEUROL,PISA,ITALY	University of Toronto; University of Toronto; University of Turin; University of Pisa	TSUDA, T (corresponding author), UNIV TORONTO,DEPT MED,DIV NEUROL,TORONTO M5S 1A8,ON,CANADA.			St George-Hyslop, Peter/0000-0003-0796-7209				ABOLA EE, 1987, PROTEIN DATA BANK; ANSARI KS, 1993, J NEUROSCI, V13, P4042; APPEL SH, 1993, TRENDS NEUROSCI, V16, P3, DOI 10.1016/0166-2236(93)90039-O; BEAL MF, 1992, FASEB J, V6, P3338, DOI 10.1096/fasebj.6.15.1464368; BECKMAN JS, 1993, NATURE, V364, P584, DOI 10.1038/364584a0; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; BURROW JNC, 1992, AUST NZ J MED, V22, P469; CELLABOS I, 1991, FREE RADIC RES COMM, V12, P571; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; ELSTNER EF, 1976, ANAL BIOCHEM, V70, P616, DOI 10.1016/0003-2697(76)90488-7; EPSTEIN CJ, 1987, P NATL ACAD SCI USA, V84, P8044, DOI 10.1073/pnas.84.22.8044; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Halliwell B, 1992, FREE RADICALS BRAIN, P21; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; JENNER P, 1992, ANN NEUROL, V32, pS82, DOI 10.1002/ana.410320714; JU WJH, 1994, IN PRESS EXP NEUROL; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIEMANHURWITZ J, 1982, P NATL ACAD SCI-BIOL, V79, P2808, DOI 10.1073/pnas.79.9.2808; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; NIEOULLON A, 1988, BEHAV BRAIN RES, V28, P163, DOI 10.1016/0166-4328(88)90093-9; OLANOW CW, 1992, ANN NEUROL, V32, P52; PARGE HE, 1992, P NATL ACAD SCI USA, V89, P6109, DOI 10.1073/pnas.89.13.6109; PERCY ME, 1990, AM J MED GENET, V35, P459, DOI 10.1002/ajmg.1320350403; RAINERO I, 1993, IN PRESS NEUROLOGY; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; SENIUK NA, 1990, BRAIN RES, V527, P7, DOI 10.1016/0006-8993(90)91055-L; SENIUK NA, 1993, J NEUROSCI RES, V37, P278; SNYDER SH, 1993, NATURE, V364, P577, DOI 10.1038/364577a0; SOMERVILLE MJ, 1991, MOL BRAIN RES, V9, P1, DOI 10.1016/0169-328X(91)90123-F; STGEORGEHYSLOP P, 1994, SCIENCE, V263, P537, DOI 10.1126/science.8290965; TATTON WG, 1990, BRAIN RES, V527, P21, DOI 10.1016/0006-8993(90)91056-M; TENDONKELAAR HJ, 1988, BEHAV BRAIN RES, V28, P9, DOI 10.1016/0166-4328(88)90072-1; THAETE LG, 1986, J NEUROCYTOL, V15, P337, DOI 10.1007/BF01611436; VALTSCHANOFF JG, 1993, EXP BRAIN RES, V93, P95; VAULA G, 1992, NEUROSCI LETT, V144, P46, DOI 10.1016/0304-3940(92)90712-G; WILLIAMS DB, 1990, HDB NEUROLOGY DISEAS, P241; WONG L, 1993, NEUROSCI LETT, V152, P96, DOI 10.1016/0304-3940(93)90492-4; ZHANG P, 1993, NEUROSCIENCE, V55, P167, DOI 10.1016/0306-4522(93)90463-P	40	74	74	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1994	13	3					727	736		10.1016/0896-6273(94)90039-6	http://dx.doi.org/10.1016/0896-6273(94)90039-6			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PJ284	7917302				2022-12-24	WOS:A1994PJ28400019
J	PEDARZANI, P; STORM, JF				PEDARZANI, P; STORM, JF			PKA MEDIATES THE EFFECTS OF MONOAMINE TRANSMITTERS ON THE K+ CURRENT UNDERLYING THE SLOW SPIKE FREQUENCY ADAPTATION IN HIPPOCAMPAL-NEURONS	NEURON			English	Article							DEPENDENT PROTEIN-KINASE; CENTRAL-NERVOUS-SYSTEM; METABOTROPIC GLUTAMATE RECEPTORS; ACTIVATED POTASSIUM CHANNELS; LOCUS COERULEUS NEURONS; APLYSIA SENSORY NEURONS; CA1 PYRAMIDAL NEURONS; CYCLIC-AMP; RAT-BRAIN; CATALYTIC SUBUNIT	The Ca2+-activated K+ current I(AHP), which underlies spike frequency adaptation in cortical pyramidal cells, can be modulated by multiple transmitters and probably contributes to state control of the forebrain by ascending monoaminergic fibers. Here, we show that the modulation of this current by norepinephrine, serotonin, and histamine is mediated by protein kinase A in hippocampal CA1 neurons. Two specific protein kinase A inhibitors, Rp-cAMPS and Walsh peptide, suppressed the effects of these transmitters on I(AHP) and spike frequency adaptation. The effects of the cyclic AMP analog 8CPT-cAMP were also inhibited, whereas muscarinic and metabotropic glutamate receptor agonists had full effect. Intracellular application of protein kinase A catalytic subunit or a phosphatase inhibitor mimicked the effects of monoamines or 8CPT-cAMP. These results demonstrate that monoaminergic modulation of neuronal excitability in the mammalian CNS is mediated by protein phosphorylation.			PEDARZANI, P (corresponding author), UNIV OSLO,INST NEUROPHYSIOL,PB 1104 BLINDERN,N-0317 OSLO,NORWAY.							ADAMS WB, 1982, P NATL ACAD SCI-BIOL, V79, P3877, DOI 10.1073/pnas.79.12.3877; ADELMAN JP, 1992, NEURON, V9, P209, DOI 10.1016/0896-6273(92)90160-F; ALGER BE, 1980, SCIENCE, V210, P1122, DOI 10.1126/science.7444438; ANDRADE R, 1993, NEURON, V10, P83, DOI 10.1016/0896-6273(93)90244-L; ANDRADE R, 1987, J PHYSIOL-LONDON, V394, P99, DOI 10.1113/jphysiol.1987.sp016862; ANDRADE R, 1991, J PHARMACOL EXP THER, V257, P930; ASTONJONES G, 1981, J NEUROSCI, V1, P887; Azmitia E. C., 1987, PSYCHOPHARMACOLOGY 3, P61; BARBACCIA ML, 1983, J NEUROCHEM, V40, P1671, DOI 10.1111/j.1471-4159.1983.tb08141.x; BASKYS A, 1990, NEUROSCI LETT, V112, P76, DOI 10.1016/0304-3940(90)90325-4; BERNARDO LS, 1982, BRAIN RES, V249, P333; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; BOCKAERT J, 1992, TRENDS PHARMACOL SCI, V13, P141, DOI 10.1016/0165-6147(92)90051-7; BOLAND LM, 1991, J NEUROSCI, V11, P1140; BOTELHO LHP, 1988, METHOD ENZYMOL, V159, P159; BRUM G, 1983, PFLUG ARCH EUR J PHY, V398, P147, DOI 10.1007/BF00581064; CASTELLUCCI VF, 1980, P NATL ACAD SCI-BIOL, V77, P7492, DOI 10.1073/pnas.77.12.7492; CATTERALL WA, 1992, PHYSIOL REV, V72, pS15, DOI 10.1152/physrev.1992.72.suppl_4.S15; CHAPUT Y, 1990, EUR J PHARMACOL, V182, P441, DOI 10.1016/0014-2999(90)90041-4; CHARPAK S, 1990, NATURE, V347, P765, DOI 10.1038/347765a0; CHENG HC, 1986, J BIOL CHEM, V261, P989; CHU N, 1973, SCIENCE, V179, P908, DOI 10.1126/science.179.4076.908; CHUNG SK, 1991, SCIENCE, V253, P560, DOI 10.1126/science.1857986; COLE AE, 1983, SCIENCE, V221, P1299, DOI 10.1126/science.6612345; COLINO A, 1987, NATURE, V328, P73, DOI 10.1038/328073a0; CONSTANTI A, 1987, J PHYSIOL-LONDON, V387, P173, DOI 10.1113/jphysiol.1987.sp016569; COSTA MRC, 1982, J BIOL CHEM, V257, P7918; DELGADO R, 1991, P NATL ACAD SCI USA, V88, P557, DOI 10.1073/pnas.88.2.557; DERIEMER SA, 1985, NATURE, V313, P313, DOI 10.1038/313313a0; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; DIVERSEPIERLUISSI M, 1993, NEURON, V10, P753, DOI 10.1016/0896-6273(93)90175-Q; DUMUIS A, 1988, MOL PHARMACOL, V34, P880; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; FARLEY J, 1988, BIOPHYS J, V53, P919, DOI 10.1016/S0006-3495(88)83173-4; FESENKO EE, 1985, NATURE, V313, P310, DOI 10.1038/313310a0; FOEHRING RC, 1989, J NEUROPHYSIOL, V61, P245, DOI 10.1152/jn.1989.61.2.245; FOOTE SL, 1980, P NATL ACAD SCI-BIOL, V77, P3033, DOI 10.1073/pnas.77.5.3033; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; GARBARG M, 1974, SCIENCE, V186, P833, DOI 10.1126/science.186.4166.833; GERBER U, 1992, EUR J NEUROSCI, V4, P792, DOI 10.1111/j.1460-9568.1992.tb00189.x; GOLDSMITH BA, 1992, P NATL ACAD SCI USA, V89, P11481, DOI 10.1073/pnas.89.23.11481; GREEN JP, 1983, HDB PSYCHOPHARMACOLO, P385; GREENGARD P, 1978, SCIENCE, V199, P146, DOI 10.1126/science.22932; GREENGARD P, 1991, SCIENCE, V253, P1135, DOI 10.1126/science.1716001; GUY HR, 1991, SCIENCE, V254, P730, DOI 10.1126/science.1658932; HAAS HL, 1985, AGENTS ACTIONS, V16, P234, DOI 10.1007/BF01983148; HAAS HL, 1983, NATURE, V302, P432, DOI 10.1038/302432a0; HAAS HL, 1986, EXP BRAIN RES, V62, P123; HAAS HL, 1987, NEUROSCI LETT, V78, P171, DOI 10.1016/0304-3940(87)90628-8; HIRAYAMA T, 1991, BRAIN RES, V539, P320, DOI 10.1016/0006-8993(91)91637-G; HOCHNER B, 1992, P NATL ACAD SCI USA, V89, P11476, DOI 10.1073/pnas.89.23.11476; HOGER JH, 1991, NEURON, V6, P227, DOI 10.1016/0896-6273(91)90358-7; HOTSON JR, 1980, J NEUROPHYSIOL, V43, P409, DOI 10.1152/jn.1980.43.2.409; HU GY, 1991, BRAIN RES, V568, P339, DOI 10.1016/0006-8993(91)91423-X; KACZMAREK LK, 1980, P NATL ACAD SCI-BIOL, V77, P7487, DOI 10.1073/pnas.77.12.7487; KANDEL ER, 1982, SCIENCE, V218, P433, DOI 10.1126/science.6289442; KLEIN M, 1986, P NATL ACAD SCI USA, V83, P7994, DOI 10.1073/pnas.83.20.7994; KUME H, 1989, NATURE, V341, P152, DOI 10.1038/341152a0; LANCASTER B, 1991, J NEUROSCI, V11, P23; LANCASTER B, 1986, J NEUROPHYSIOL, V55, P1268, DOI 10.1152/jn.1986.55.6.1268; LANCASTER B, 1987, J PHYSIOL-LONDON, V389, P187, DOI 10.1113/jphysiol.1987.sp016653; LEVITAN IB, 1985, J MEMBRANE BIOL, V87, P177, DOI 10.1007/BF01871217; LIVINGSTONE MS, 1981, NATURE, V291, P554, DOI 10.1038/291554a0; MACKINTOSH C, 1990, FEBS LETT, V264, P187, DOI 10.1016/0014-5793(90)80245-E; MADISON DV, 1982, NATURE, V299, P636, DOI 10.1038/299636a0; MADISON DV, 1984, J PHYSIOL-LONDON, V354, P319, DOI 10.1113/jphysiol.1984.sp015378; MADISON DV, 1986, J PHYSIOL-LONDON, V372, P221, DOI 10.1113/jphysiol.1986.sp016006; MADISON DV, 1986, J PHYSIOL-LONDON, V372, P245, DOI 10.1113/jphysiol.1986.sp016007; MCCORMICK DA, 1989, P NATL ACAD SCI USA, V86, P8098, DOI 10.1073/pnas.86.20.8098; MCCORMICK DA, 1988, J NEUROPHYSIOL, V59, P978, DOI 10.1152/jn.1988.59.3.978; MCCORMICK DA, 1989, TRENDS NEUROSCI, V12, P215, DOI 10.1016/0166-2236(89)90125-2; MOORE RY, 1979, ANNU REV NEUROSCI, V2, P113, DOI 10.1146/annurev.ne.02.030179.000553; MULLER W, 1992, J NEUROPHYSIOL, V68, P2264, DOI 10.1152/jn.1992.68.6.2264; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; Nestler E. J., 1984, PROTEIN PHOSPHORYLAT; NICOLL RA, 1988, SCIENCE, V241, P545, DOI 10.1126/science.2456612; NICOLL RA, 1990, PHYSIOL REV, V70, P513, DOI 10.1152/physrev.1990.70.2.513; OSTERRIEDER W, 1982, NATURE, V298, P576, DOI 10.1038/298576a0; POLLARD H, 1987, TRENDS NEUROSCI, V10, P86, DOI 10.1016/0166-2236(87)90031-2; RANE SG, 1989, NEURON, V3, P239, DOI 10.1016/0896-6273(89)90037-8; RAYMOND LA, 1993, TRENDS NEUROSCI, V16, P147, DOI 10.1016/0166-2236(93)90123-4; REHM H, 1989, BIOCHEMISTRY-US, V28, P6455, DOI 10.1021/bi00441a044; REINHART PH, 1991, J NEUROSCI, V11, P1627; RUEGG UT, 1989, TRENDS PHARMACOL SCI, V10, P218, DOI 10.1016/0165-6147(89)90263-0; SAKO T, 1988, CANCER RES, V48, P4646; SCHWARTZKROIN PA, 1980, SCIENCE, V210, P1125, DOI 10.1126/science.6777871; SHABB JB, 1992, J BIOL CHEM, V267, P5723; SIM JA, 1992, EUR J NEUROSCI, V4, P785, DOI 10.1111/j.1460-9568.1992.tb00188.x; STERIADE M, 1988, PHYSIOL REV, V68, P649, DOI 10.1152/physrev.1988.68.3.649; Steriade M., 1990, BRAINSTEM CONTROL WA; STORM JF, 1987, J PHYSIOL-LONDON, V385, P733, DOI 10.1113/jphysiol.1987.sp016517; STORM JF, 1987, NEUROSCI LETT, V75, P71, DOI 10.1016/0304-3940(87)90077-2; STRATTON KR, 1989, EUR J PHARMACOL, V173, P235, DOI 10.1016/0014-2999(89)90529-3; TRAUTWEIN W, 1990, ANNU REV PHYSIOL, V52, P257, DOI 10.1146/annurev.ph.52.030190.001353; VANHAASTERT PJM, 1987, BIOPHOSPHATES THEIR, P469; VINTERMYR OK, 1993, EXP CELL RES, V206, P157, DOI 10.1006/excr.1993.1132; WALAAS SI, 1991, PHARMACOL REV, V43, P299; WANG LY, 1991, SCIENCE, V253, P1132, DOI 10.1126/science.1653455; WATANABE T, 1983, NEUROSCI LETT, V39, P249, DOI 10.1016/0304-3940(83)90308-7; ZHANG L, 1992, J NEUROSCI, V12, P4510; ZIFA E, 1992, PHARMACOL REV, V44, P401	101	241	242	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1993	11	6					1023	1035		10.1016/0896-6273(93)90216-E	http://dx.doi.org/10.1016/0896-6273(93)90216-E			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MP548	8274274				2022-12-24	WOS:A1993MP54800004
J	BALICEGORDON, RJ; CHUA, CK; NELSON, CC; LICHTMAN, JW				BALICEGORDON, RJ; CHUA, CK; NELSON, CC; LICHTMAN, JW			GRADUAL LOSS OF SYNAPTIC CARTELS PRECEDES AXON WITHDRAWAL AT DEVELOPING NEUROMUSCULAR-JUNCTIONS	NEURON			English	Article							TRANSVERSUS ABDOMINIS MUSCLE; MAIN IMMUNOGENIC REGION; SKELETAL-MUSCLE; POLYNEURONAL INNERVATION; ACETYLCHOLINE-RECEPTOR; SPONTANEOUS ELIMINATION; MONOCLONAL-ANTIBODIES; INVIVO VISUALIZATION; GARTER SNAKE; RAT	We have studied the spatial deployment of synapses arising from different axons that converge on the same developing neuromuscular junctions. Labeling the competing synaptic ''cartels'' with different dyes in mouse muscle showed that, perinatally, each axon adds similar terminal areas, whereas later, areas occupied by the competing cartels diverged by gradual elimination of one axon's synapses and ongoing addition of synaptic area by the other. Activity-dependent labeling of synapses capable of vesicle recycling in snake muscle also revealed a gradual change in territories occupied by competing inputs, implying that an axon maintained some functional synapses even as others in its cartel were being eliminated. Thus the process of synapse elimination is gradual, with loss of one viable synapse after another, until an axon is left with no synaptic territory and withdraws.			BALICEGORDON, RJ (corresponding author), WASHINGTON UNIV,SCH MED,DEPT ANAT & NEUROBIOL,ST LOUIS,MO 63110, USA.			Balice-Gordon, Rita/0000-0002-9950-7965				Adelson E.H., 1987, Patent No. [4,661,986, 4661986]; Adelson E. H., 1984, RCA ENG, V29, P33; BALICEGORDON RJ, 1990, J NEUROSCI, V10, P894; BALICEGORDON RJ, 1993, J NEUROSCI, V13, P834; BIXBY JL, 1981, J NEUROCYTOL, V10, P81, DOI 10.1007/BF01181746; COLMAN H, 1993, DEV BIOL, V156, P1, DOI 10.1006/dbio.1993.1054; GODEMENT P, 1987, DEVELOPMENT, V101, P697; HONIG MG, 1986, J CELL BIOL, V103, P171, DOI 10.1083/jcb.103.1.171; HONIG MG, 1989, TRENDS NEUROSCI, V12, P333, DOI 10.1016/0166-2236(89)90040-4; JANSEN JKS, 1990, PROG NEUROBIOL, V34, P39, DOI 10.1016/0301-0082(90)90025-C; JOHNSON GD, 1981, J IMMUNOL METHODS, V43, P349, DOI 10.1016/0022-1759(81)90183-6; KORNELIUSSEN H, 1976, J NEUROCYTOL, V5, P591, DOI 10.1007/BF01175572; KUFFLER D, 1977, BRAIN RES, V138, P353, DOI 10.1016/0006-8993(77)90752-1; LICHTMAN J W, 1989, New Biologist, V1, P75; LICHTMAN JW, 1987, J PHYSIOL-LONDON, V393, P355, DOI 10.1113/jphysiol.1987.sp016827; LICHTMAN JW, 1985, NATURE, V314, P357, DOI 10.1038/314357a0; LICHTMAN JW, 1987, J NEUROSCI, V7, P1215; OBRIEN RAD, 1978, J PHYSIOL-LONDON, V282, P571, DOI 10.1113/jphysiol.1978.sp012482; Purves D, 1985, PRINCIPLES NEURAL DE, P271; RICH MM, 1989, J NEUROSCI, V9, P1781, DOI 10.1523/jneurosci.09-05-01781.1989; RILEY DA, 1981, J NEUROCYTOL, V10, P425, DOI 10.1007/BF01262414; RILEY DA, 1977, BRAIN RES, V134, P279, DOI 10.1016/0006-8993(77)91073-3; ROSENTHAL JL, 1977, J PHYSIOL-LONDON, V270, P299, DOI 10.1113/jphysiol.1977.sp011953; STEINBACH JH, 1981, DEV BIOL, V84, P267, DOI 10.1016/0012-1606(81)90394-8; TZARTOS S, 1987, J NEUROIMMUNOL, V15, P185, DOI 10.1016/0165-5728(87)90092-0; TZARTOS SJ, 1980, P NATL ACAD SCI-BIOL, V77, P755, DOI 10.1073/pnas.77.2.755; WILKINSON RS, 1985, J NEUROSCI, V5, P2979	27	102	105	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1993	11	5					801	815		10.1016/0896-6273(93)90110-D	http://dx.doi.org/10.1016/0896-6273(93)90110-D			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MJ041	8240805				2022-12-24	WOS:A1993MJ04100002
J	WIZENMANN, A; THIES, E; KLOSTERMANN, S; BONHOEFFER, F; BAHR, M				WIZENMANN, A; THIES, E; KLOSTERMANN, S; BONHOEFFER, F; BAHR, M			APPEARANCE OF TARGET-SPECIFIC GUIDANCE INFORMATION FOR REGENERATING AXONS AFTER CNS LESIONS	NEURON			English	Article							POSITION-SPECIFIC PROPERTIES; RETINAL GANGLION-CELLS; NERVOUS-SYSTEM; SUPERIOR COLLICULUS; TECTAL MEMBRANES; NEURITE GROWTH; INVITRO; RECOGNITION; INHIBITORS; OUTGROWTH	During development of the vertebrate visual system, an orderly projection of ganglion cells from the retina onto the superior colliculus (SC) is established. Mechanisms that might govern this process include the coordinated action of guidance and corresponding receptor molecules that are specifically distributed on the axons and their targets. In birds and mammals, information for axonal guidance and targeting appears to be confined to the time when the retinocollicular projection is being formed. Here we show that putative guidance activities for temporal and nasal retinal axons, which are not detectable in the normal adult SC, appear after optic nerve transection in adult rats. Both embryonic and adult retinal axons are able to respond to these guiding cues, although the guidance activities detectable in the deafferented adult rat SC might be different from those found during development. These findings imply that it might be possible to reestablish an ordered projection after lesions in the adult mammalian visual system.	UNIV TUBINGEN,NEUROL KLIN,D-72076 TUBINGEN,GERMANY; MAX PLANCK INST ENTWICKLUNGSBIOL,D-72076 TUBINGEN,GERMANY	Eberhard Karls University of Tubingen; Max Planck Society	WIZENMANN, A (corresponding author), UNITED MED & DENT SCH GUYS & ST THOMAS HOSP,GUYS HOSP,DEPT ANAT,LONDON,ENGLAND.		Baehr, Mathias/K-2188-2014					BAHR M, 1993, J NEUROBIOL, V24, P456, DOI 10.1002/neu.480240405; BAHR M, 1988, EXP BRAIN RES, V73, P393; BAHR M, 1991, NEUROREPORT, V2, P581; BAIER H, 1992, SCUENCE, V255, P474; BONHOEFFER F, 1984, TRENDS NEUROSCI, V7, P378, DOI 10.1016/S0166-2236(84)80060-0; BOXBERG YV, 1993, NEURON, V10, P345; BRAY GM, 1987, J EXP BIOL, V132, P5; BRUMMENDORF T, 1993, J NEUROCHEM, V61, P1; CARONI P, 1988, P R SOC LOND B, V157, P420; GODEMENT P, 1989, DEVELOPMENT, V106, P13; HANKIN M, 1991, TRENDS NEUROSCI, V14, P224, DOI 10.1016/0166-2236(91)90118-E; HANKIN MH, 1990, DEV BIOL, V138, P136, DOI 10.1016/0012-1606(90)90183-J; KAPFHAMMER JP, 1992, J NEUROSCI, V12, P2112; KEIRSTEAD SA, 1989, SCIENCE, V246, P255, DOI 10.1126/science.2799387; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; MULLER B, 1990, J EXP BIOL, V153, P29; RANSCHT B, 1991, NEURON, V7, P391, DOI 10.1016/0896-6273(91)90291-7; SCHWAB ME, 1990, EXP NEUROL, V109, P2, DOI 10.1016/S0014-4886(05)80003-2; SIMON DK, 1992, NEURON, V9, P977, DOI 10.1016/0896-6273(92)90249-D; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; STAHL B, 1990, NEURON, V5, P737; THANOS S, 1989, EUR J NEUROSCI, V1, P19, DOI 10.1111/j.1460-9568.1989.tb00770.x; TRISLER D, 1990, J EXP BIOL, V153, P11; VANSELOW J, 1991, VISUAL NEUROSCI, V6, P569, DOI 10.1017/S0952523800002558; VIELMETTER J, 1991, J COMP NEUROL, V311, P321, DOI 10.1002/cne.903110303; VIELMETTER J, 1989, NEURON, V2, P1331, DOI 10.1016/0896-6273(89)90071-8; WALTER J, 1987, DEVELOPMENT, V101, P685; WALTER J, 1990, J PHYSIOL-PARIS, V84, P104; WALTER J, 1987, DEVELOPMENT, V101, P909	29	97	97	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1993	11	5					975	983		10.1016/0896-6273(93)90126-C	http://dx.doi.org/10.1016/0896-6273(93)90126-C			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MJ041	8240818				2022-12-24	WOS:A1993MJ04100018
J	BAUDE, A; NUSSER, Z; ROBERTS, JDB; MULVIHILL, E; MCILHINNEY, RAJ; SOMOGYI, P				BAUDE, A; NUSSER, Z; ROBERTS, JDB; MULVIHILL, E; MCILHINNEY, RAJ; SOMOGYI, P			THE METABOTROPIC GLUTAMATE-RECEPTOR (MGLUR1-ALPHA) IS CONCENTRATED AT PERISYNAPTIC MEMBRANE OF NEURONAL SUBPOPULATIONS AS DETECTED BY IMMUNOGOLD REACTION	NEURON			English	Article							AMINO-ACID RECEPTORS; SOMATOSTATIN-LIKE IMMUNOREACTIVITY; GABA-A RECEPTOR; CA1 PYRAMIDAL CELLS; RAT DENTATE GYRUS; MONOCLONAL-ANTIBODIES; IMMUNOCYTOCHEMICAL LOCALIZATION; SUBCELLULAR-LOCALIZATION; SIGNAL TRANSDUCTION; GABAERGIC NEURONS	An antiserum to mGluR1alpha labeled a 160 kd protein in immunoblots of membranes derived from rat brain or cells transfected with mGluR1alpha. Immunoreactivity for mGluR1alpha was present in discrete subpopulations of neurons. The GABAergic neurons of the cerebellar cortex were strongly immunoreactive; only some Golgi cells were immunonegative. Somatostatin/GABA-immunopositive cells in the neocortex and hippocampus were enriched in mGluR1alpha. The hippocampal cells had spiny dendrites that were precisely codistributed with the local axon collaterals of pyramidal and granule cells. Electron microscopic immunometal detection of mGluR1alpha showed a preferential localization at the periphery of the extensive postsynaptic densities of type 1 synapses in both the cerebellum and the hippocampus. The receptor was also present at sites in the dendritic and somatic membrane where synapses were not located.	ZYMOGENET INC, SEATTLE, WA 98105 USA	Zymogenet Inc.	BAUDE, A (corresponding author), UNIV OXFORD, MED RES COUNCIL, ANAT NEUROPHARMACOL UNIT, MANSFIELD RD, OXFORD OX1 3TH, ENGLAND.		Nusser, Zoltan/K-8587-2014; Baude, Agnès/M-7356-2016	Baude, Agnès/0000-0002-7025-364X; Nusser, Zoltan/0000-0001-7004-4111				ABE T, 1992, J BIOL CHEM, V267, P13361; ANWYL R, 1991, TRENDS PHARMACOL SCI, V12, P324, DOI 10.1016/0165-6147(91)90588-J; ARAMORI I, 1992, NEURON, V8, P757, DOI 10.1016/0896-6273(92)90096-V; BAKST I, 1985, J COMP NEUROL, V236, P423, DOI 10.1002/cne.902360402; BARNES JM, 1992, PROG NEUROBIOL, V39, P113, DOI 10.1016/0301-0082(92)90007-2; BASHIR ZI, 1993, NATURE, V363, P347, DOI 10.1038/363347a0; BASKYS A, 1992, TRENDS NEUROSCI, V15, P92, DOI 10.1016/0166-2236(92)90018-4; BAUDE A, 1992, NEUROSCIENCE, V51, P739, DOI 10.1016/0306-4522(92)90513-2; BEHNISCH T, 1993, NEUROSCIENCE, V54, P37, DOI 10.1016/0306-4522(93)90381-O; BENKE D, 1991, FEBS LETT, V283, P145, DOI 10.1016/0014-5793(91)80573-L; BLACKSTONE CD, 1992, J NEUROCHEM, V58, P1118, DOI 10.1111/j.1471-4159.1992.tb09370.x; BRAMHAM CR, 1990, NEUROSCIENCE, V39, P405, DOI 10.1016/0306-4522(90)90277-B; BUSBY SJ, 1991, J BIOL CHEM, V266, P15286; Cajal S., 1893, ANAL SOC ESP HIST NA, V22, P53; CHIAMULERA C, 1992, EUR J PHARMACOL, V216, P335, DOI 10.1016/0014-2999(92)90382-E; CLAIBORNE BJ, 1986, J COMP NEUROL, V246, P435, DOI 10.1002/cne.902460403; COLBRAN RJ, 1992, NEUROCHEM INT, V21, P469, DOI 10.1016/0197-0186(92)90080-B; COTMAN CW, 1987, TRENDS NEUROSCI, V10, P273, DOI 10.1016/0166-2236(87)90172-X; FREUND TF, 1992, BRAIN RES BULL, V28, P27, DOI 10.1016/0361-9230(92)90227-O; Frotscher M, 1991, Hippocampus, V1, P123, DOI 10.1002/hipo.450010202; GORCS TJ, 1993, NEUROREPORT, V4, P283; GRANDES P, 1991, NEUROSCIENCE, V41, P391, DOI 10.1016/0306-4522(91)90335-L; GRAY EG, 1959, J ANAT, V93, P420; HALASY K, 1993, EUR J NEUROSCI, V5, P411, DOI 10.1111/j.1460-9568.1993.tb00508.x; HAN ZS, 1993, EUR J NEUROSCI, V5, P395, DOI 10.1111/j.1460-9568.1993.tb00507.x; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; HOUAMED KM, 1991, SCIENCE, V252, P1318, DOI 10.1126/science.1656524; ISHIZUKA N, 1990, J COMP NEUROL, V295, P580, DOI 10.1002/cne.902950407; KNOWLES WD, 1981, J NEUROSCI, V1, P1236; KOHLER C, 1987, NEUROSCI LETT, V78, P1, DOI 10.1016/0304-3940(87)90551-9; KOSAKA T, 1988, EXP BRAIN RES, V71, P388; LERANTH C, 1990, J COMP NEUROL, V295, P111, DOI 10.1002/cne.902950110; LI XG, 1993, IN PRESS J COMP NEUR; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; LIPARTITI M, 1993, LIFE SCI, V52, pPL85, DOI 10.1016/0024-3205(93)90522-5; LIU CJ, 1989, HISTOCHEMISTRY, V90, P427, DOI 10.1007/BF00494354; MARTIN LJ, 1992, NEURON, V9, P259, DOI 10.1016/0896-6273(92)90165-A; MASU M, 1991, NATURE, V349, P760, DOI 10.1038/349760a0; MCDONALD JW, 1992, EUR J PHARMACOL, V215, P353, DOI 10.1016/0014-2999(92)90058-C; MILES R, 1990, J PHYSIOL-LONDON, V428, P61, DOI 10.1113/jphysiol.1990.sp018200; MILES R, 1993, J PHYSIOL-LONDON, V463, P461, DOI 10.1113/jphysiol.1993.sp019605; MILLER RJ, 1991, TRENDS PHARMACOL SCI, V12, P365, DOI 10.1016/0165-6147(91)90604-Q; MOLNAR E, 1993, NEUROSCIENCE, V53, P307, DOI 10.1016/0306-4522(93)90198-O; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; OHISHI H, 1993, NEUROSCIENCE, V53, P1009, DOI 10.1016/0306-4522(93)90485-X; PETRALIA RS, 1992, J COMP NEUROL, V318, P329, DOI 10.1002/cne.903180309; PICKERING DS, 1993, J NEUROCHEM, V61, P85, DOI 10.1111/j.1471-4159.1993.tb03540.x; PIN JP, 1992, P NATL ACAD SCI USA, V89, P10331, DOI 10.1073/pnas.89.21.10331; RAYMOND LA, 1993, TRENDS NEUROSCI, V16, P147, DOI 10.1016/0166-2236(93)90123-4; RICHARDS JG, 1987, J NEUROSCI, V7, P1866; SACAAN AI, 1992, NEUROSCI LETT, V139, P77, DOI 10.1016/0304-3940(92)90862-2; SCHARFMAN HE, 1992, EPILEPSY RES, P93; SCHOEPP DD, 1993, TRENDS PHARMACOL SCI, V14, P13, DOI 10.1016/0165-6147(93)90107-U; SHIGEMOTO R, 1992, J COMP NEUROL, V322, P121, DOI 10.1002/cne.903220110; SILIPRANDI R, 1992, EUR J PHARMACOL, V219, P173, DOI 10.1016/0014-2999(92)90598-X; SLADECZEK F, 1985, NATURE, V317, P717, DOI 10.1038/317717a0; SLOVITER RS, 1987, J COMP NEUROL, V256, P42, DOI 10.1002/cne.902560105; SLOVITER RS, 1987, SCIENCE, V235, P73, DOI 10.1126/science.2879352; SOLTESZ I, 1990, EUR J NEUROSCI, V2, P414, DOI 10.1111/j.1460-9568.1990.tb00434.x; SOMOGYI P, 1984, J NEUROSCI, V4, P2590; SOMOGYI P, 1986, NEUROSCIENCE, V19, P1045, DOI 10.1016/0306-4522(86)90121-1; SOMOGYI P, 1982, NEUROSCIENCE, V7, P1779, DOI 10.1016/0306-4522(82)90035-5; SOMOGYI P, 1989, J NEUROSCI, V9, P2197; SUGIYAMA H, 1987, NATURE, V325, P531, DOI 10.1038/325531a0; TAMAMAKI N, 1987, BRAIN RES, V412, P156, DOI 10.1016/0006-8993(87)91452-1; TANABE Y, 1992, NEURON, V8, P169, DOI 10.1016/0896-6273(92)90118-W; THOMSON AM, 1991, EUR J NEUROSCI, V3, P587, DOI 10.1111/j.1460-9568.1991.tb00845.x; TOKUYASU KT, 1989, HISTOCHEM J, V21, P163, DOI 10.1007/BF01007491; VANDERZEE EA, 1991, BRAIN RES BULL, V26, P343, DOI 10.1016/0361-9230(91)90005-5; VINCENT SR, 1985, J COMP NEUROL, V238, P169, DOI 10.1002/cne.902380205; ZHENG F, 1992, NEURON, V9, P163, DOI 10.1016/0896-6273(92)90231-2; ZIMPRICH F, 1991, NEUROSCI LETT, V127, P125, DOI 10.1016/0304-3940(91)90910-L; ZORUMSKI CF, 1992, PROG NEUROBIOL, V39, P295, DOI 10.1016/0301-0082(92)90020-F	73	781	789	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	1993	11	4					771	787		10.1016/0896-6273(93)90086-7	http://dx.doi.org/10.1016/0896-6273(93)90086-7			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MD068	8104433				2022-12-24	WOS:A1993MD06800019
J	BIERNAT, J; GUSTKE, N; DREWES, G; MANDELKOW, EM; MANDELKOW, E				BIERNAT, J; GUSTKE, N; DREWES, G; MANDELKOW, EM; MANDELKOW, E			PHOSPHORYLATION OF SER(262) STRONGLY REDUCES BINDING OF TAU-PROTEIN TO MICROTUBULES - DISTINCTION BETWEEN PHF-LIKE IMMUNOREACTIVITY AND MICROTUBULE-BINDING	NEURON			English	Article							PAIRED HELICAL FILAMENTS; ALZHEIMER-LIKE STATE; NEUROFIBRILLARY TANGLES; ABNORMAL PHOSPHORYLATION; NEUROFILAMENT ANTIBODIES; DEPENDENT KINASE; A68 PROTEINS; DISEASE; ISOFORMS; EPITOPES	Tau protein, a component of Alzheimer paired helical filaments, can be phosphorylated by several kinases. Of particular interest is the phosphorylation at Ser/Thr-Pro motifs because the resulting state of tau is similar to that found in Alzheimer's disease, as judged by its immunoreactivity. This state can be mimicked by a brain extract kinase activity and by MAP kinase. We have now studied the effect of these modes of phosphorylation on the interaction between tau and microtubules. Although MAP kinase efficiently phosphorylates many Ser/Thr-Pro motifs of tau, its effect on microtubule binding is only moderate. By contrast, phosphorylation of a single residue, Ser262, has a major effect on binding. Ser262 is not phosphorylated by MAP kinase or other proline-directed kinases, but is phosphorylated by a 35/41 kd kinase in brain, whose purification is described.			BIERNAT, J (corresponding author), DESY,MAX PLANCK UNIT STRUCT MOLEC BIOL,NOTKESTR 85,D-22603 HAMBURG,GERMANY.			Drewes, Gerard/0000-0003-0575-6766				AIZAWA H, 1989, J BIOL CHEM, V264, P5885; BAUDIER J, 1987, J BIOL CHEM, V262, P17577; BIERNAT J, 1992, EMBO J, V11, P1593, DOI 10.1002/j.1460-2075.1992.tb05204.x; BRAMBLETT GT, 1992, LAB INVEST, V66, P212; BRION JP, 1991, BIOCHEM J, V279, P831, DOI 10.1042/bj2790831; BRUGG B, 1991, J CELL BIOL, V114, P735, DOI 10.1083/jcb.114.4.735; BURNS RG, 1984, EUR J BIOCHEM, V141, P609, DOI 10.1111/j.1432-1033.1984.tb08236.x; BUTNER KA, 1991, J CELL BIOL, V115, P717, DOI 10.1083/jcb.115.3.717; CLEVELAND DW, 1977, J MOL BIOL, V116, P227, DOI 10.1016/0022-2836(77)90214-5; CORREAS I, 1992, J BIOL CHEM, V267, P15721; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; DREWES G, 1992, EMBO J, V11, P2131, DOI 10.1002/j.1460-2075.1992.tb05272.x; ENNULAT DJ, 1989, J BIOL CHEM, V264, P5327; GEAHLEN RL, 1986, ANAL BIOCHEM, V153, P151, DOI 10.1016/0003-2697(86)90074-6; GOEDERT M, 1988, P NATL ACAD SCI USA, V85, P4051, DOI 10.1073/pnas.85.11.4051; GOEDERT M, 1992, NEURON, V8, P159, DOI 10.1016/0896-6273(92)90117-V; Goedert M, 1991, Curr Opin Neurobiol, V1, P441, DOI 10.1016/0959-4388(91)90067-H; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; GUSTKE N, 1992, FEBS LETT, V307, P199, DOI 10.1016/0014-5793(92)80767-B; HACCARD O, 1990, EUR J BIOCHEM, V192, P633, DOI 10.1111/j.1432-1033.1990.tb19270.x; HAGESTEDT T, 1989, J CELL BIOL, V109, P1643, DOI 10.1083/jcb.109.4.1643; HANGER DP, 1992, NEUROSCI LETT, V147, P58, DOI 10.1016/0304-3940(92)90774-2; HASEGAWA M, 1992, J BIOL CHEM, V267, P17047; HELLMICH MR, 1992, P NATL ACAD SCI USA, V89, P10867, DOI 10.1073/pnas.89.22.10867; HIMMLER A, 1989, MOL CELL BIOL, V9, P1381, DOI 10.1128/MCB.9.4.1381; ISHIGURO K, 1991, NEUROSCI LETT, V128, P195, DOI 10.1016/0304-3940(91)90259-V; JAKES R, 1991, EMBO J, V10, P2725, DOI 10.1002/j.1460-2075.1991.tb07820.x; JAMESON L, 1980, BIOCHEMISTRY-US, V19, P2472, DOI 10.1021/bi00552a027; KOSIK KS, 1992, SCIENCE, V256, P780, DOI 10.1126/science.1589757; KOSIK KS, 1988, NEURON, V1, P817, DOI 10.1016/0896-6273(88)90129-8; KSIEZAKREDING H, 1987, P NATL ACAD SCI USA, V84, P3410, DOI 10.1073/pnas.84.10.3410; KSIEZAKREDING H, 1992, BRAIN RES, V597, P209, DOI 10.1016/0006-8993(92)91476-U; LEDESMA MD, 1992, FEBS LETT, V308, P218, DOI 10.1016/0014-5793(92)81278-T; Lee G, 1993, CURR OPIN CELL BIOL, V5, P88, DOI 10.1016/S0955-0674(05)80013-4; Lee V M, 1992, Curr Opin Neurobiol, V2, P653, DOI 10.1016/0959-4388(92)90034-I; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; LICHTENBERGKRAAG B, 1992, P NATL ACAD SCI USA, V89, P5384, DOI 10.1073/pnas.89.12.5384; LINDWALL G, 1984, J BIOL CHEM, V259, P5301; MANDELKOW EM, 1992, FEBS LETT, V314, P315, DOI 10.1016/0014-5793(92)81496-9; MEYERSON M, 1992, EMBO J, V11, P2909, DOI 10.1002/j.1460-2075.1992.tb05360.x; MURTHY ASN, 1983, EUR J BIOCHEM, V137, P37, DOI 10.1111/j.1432-1033.1983.tb07792.x; RODER HM, 1991, J NEUROSCI, V11, P3325; STEINER B, 1990, EMBO J, V9, P3539, DOI 10.1002/j.1460-2075.1990.tb07563.x; STUDIER WF, 1990, METHOD ENZYMOL, V185, P60, DOI DOI 10.1016/0076-6879(90)85008-C; VINCENT IJ, 1992, P NATL ACAD SCI USA, V89, P2878, DOI 10.1073/pnas.89.7.2878; VULLIET R, 1992, J BIOL CHEM, V267, P22570; WIBLE BA, 1989, P NATL ACAD SCI USA, V86, P720, DOI 10.1073/pnas.86.2.720; WILLE H, 1992, J CELL BIOL, V118, P573, DOI 10.1083/jcb.118.3.573; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; WOLOZIN BL, 1986, SCIENCE, V232, P648, DOI 10.1126/science.3083509; WOOD JG, 1986, P NATL ACAD SCI USA, V83, P4040, DOI 10.1073/pnas.83.11.4040	52	633	664	0	24	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1993	11	1					153	163		10.1016/0896-6273(93)90279-Z	http://dx.doi.org/10.1016/0896-6273(93)90279-Z			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LP430	8393323				2022-12-24	WOS:A1993LP43000014
J	HOEHN, K; WATSON, TWJ; MACVICAR, BA				HOEHN, K; WATSON, TWJ; MACVICAR, BA			A NOVEL TETRODOTOXIN-INSENSITIVE, SLOW SODIUM CURRENT IN STRIATAL AND HIPPOCAMPAL-NEURONS	NEURON			English	Article							ACTIVE-CHEMICAL SYNAPSES; RAT SKELETAL-MUSCLE; ELECTRO-PHYSIOLOGICAL PROPERTIES; NEOSTRIATAL NEURONS; NEOCORTICAL NEURONS; PYRAMIDAL CELLS; RESISTANT SODIUM; GUINEA-PIG; MEMBRANE EXCITABILITY; SYNAPTIC TRANSMISSION	Slow inward currents modulate neuronal firing patterns and may generate depolarizing afterpotentials (DAPs). We report a novel, slow Na+ current (I(NaS) in striatal and hippocampal neurons that can generate DAPs. I(NaS) activated at depolarizations greater than -40 mV, was tetrodotoxin insensitive, and activated and deactivated slowly over hundreds of milliseconds. I(NaS) was dependent upon extracellular Na+, but was not affected by 0 mM extracellular Ca2+ or by Ca2+ channel blockers (Mn2+, Cd2+, or Co2+). A tetrodotoxin-insensitive, Na+-dependent plateau potential that was likely generated by I(NaS) was shown to underlie DAPs during intracellular recordings from hippocampal CA1 pyramidal neurons. Membrane depolarizations and DAPs generated by I(NaS) may contribute to alterations in neuronal firing and epileptiform bursting.			HOEHN, K (corresponding author), UNIV CALGARY,NEUROSCI RES GRP,CALGARY T2N 4N1,AB,CANADA.		MacVicar, Brian/AAI-7729-2020; MacVicar, Brian/P-1553-2015	MacVicar, Brian/0000-0003-4596-4623; MacVicar, Brian/0000-0003-4596-4623				ADACHI S, 1992, BRAIN RES, V573, P349, DOI 10.1016/0006-8993(92)90787-A; AGOPYAN N, 1988, EXP BRAIN RES, V73, P533, DOI 10.1007/BF00406611; ALMERS W, 1984, J PHYSIOL-LONDON, V353, P565, DOI 10.1113/jphysiol.1984.sp015351; ALONSO A, 1989, NATURE, V342, P175, DOI 10.1038/342175a0; ARMSTRONG CM, 1973, J GEN PHYSIOL, V62, P375, DOI 10.1085/jgp.62.4.375; BERNARDO LS, 1982, J NEUROSCI, V2, P1614; BOSSU JL, 1984, NEUROSCI LETT, V51, P241, DOI 10.1016/0304-3940(84)90558-5; BROWN AM, 1981, J PHYSIOL-LONDON, V318, P455; CALABRESI P, 1990, J NEUROPHYSIOL, V63, P651, DOI 10.1152/jn.1990.63.4.651; CALABRESI P, 1987, NEUROSCIENCE, V20, P293, DOI 10.1016/0306-4522(87)90021-2; CALABRESI P, 1987, NEUROSCIENCE, V20, P757, DOI 10.1016/0306-4522(87)90239-9; CALABRESI P, 1990, J NEUROPHYSIOL, V63, P663, DOI 10.1152/jn.1990.63.4.663; CHAGNACAMITAL Y, 1990, J COMP NEUROL, V296, P598, DOI 10.1002/cne.902960407; CONNOR JA, 1984, J PHYSIOL-LONDON, V354, P139, DOI 10.1113/jphysiol.1984.sp015368; CONNORS BW, 1982, J NEUROPHYSIOL, V48, P1302, DOI 10.1152/jn.1982.48.6.1302; COULTER DA, 1989, J PHYSIOL-LONDON, V414, P587, DOI 10.1113/jphysiol.1989.sp017705; ECKERT R, 1976, J PHYSIOL-LONDON, V254, P129, DOI 10.1113/jphysiol.1976.sp011225; FRELIN C, 1984, PFLUG ARCH EUR J PHY, V402, P121, DOI 10.1007/BF00583323; FRENCH CR, 1985, NEUROSCI LETT, V56, P289, DOI 10.1016/0304-3940(85)90257-5; FRENCH CR, 1990, J GEN PHYSIOL, V95, P1139, DOI 10.1085/jgp.95.6.1139; FRIEDMAN A, 1987, NEUROSCI LETT, V81, P117, DOI 10.1016/0304-3940(87)90350-8; FRIEDMAN A, 1992, NEUROSCI LETT, V135, P13, DOI 10.1016/0304-3940(92)90125-Q; GALLEGO R, 1983, J PHYSIOL-LONDON, V342, P591, DOI 10.1113/jphysiol.1983.sp014870; GRANIT R, 1963, J PHYSIOL-LONDON, V168, P890, DOI 10.1113/jphysiol.1963.sp007229; GREEN DJ, 1983, NATURE, V306, P784, DOI 10.1038/306784a0; HEINEMANN U, 1985, BRAIN RES, V325, P349, DOI 10.1016/0006-8993(85)90338-5; HESS P, 1984, NATURE, V309, P453, DOI 10.1038/309453a0; HILLE B, 1984, IONIC CHANNELS EXCIT, P46; HOEHN K, 1993, IN PRESS J NEUROSCI; HUGUENARD JR, 1988, J NEUROPHYSIOL, V59, P778, DOI 10.1152/jn.1988.59.3.778; IKEDA SR, 1987, J PHYSIOL-LONDON, V389, P255, DOI 10.1113/jphysiol.1987.sp016656; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P227, DOI 10.1113/jphysiol.1984.sp015154; JEFFERYS JGR, 1982, NATURE, V300, P448, DOI 10.1038/300448a0; JIANG ZG, 1991, J PHYSIOL-LONDON, V443, P533, DOI 10.1113/jphysiol.1991.sp018850; KALLEN RG, 1990, NEURON, V4, P233, DOI 10.1016/0896-6273(90)90098-Z; KANDEL ER, 1961, J NEUROPHYSIOL, V24, P243, DOI 10.1152/jn.1961.24.3.243; KANO M, 1973, J CELL PHYSIOL, V81, P85, DOI 10.1002/jcp.1040810110; KAY AR, 1987, J PHYSIOL-LONDON, V392, P603, DOI 10.1113/jphysiol.1987.sp016799; KAY AR, 1986, J NEUROSCI METH, V16, P227, DOI 10.1016/0165-0270(86)90040-3; KONNERTH A, 1984, NATURE, V307, P69, DOI 10.1038/307069a0; KONNERTH A, 1986, EXPT BRAIN RES, V14, P368; KOSTYUK PG, 1981, NEUROSCIENCE, V6, P2423, DOI 10.1016/0306-4522(81)90088-9; LANTHORN T, 1984, EXP BRAIN RES, V53, P431; LEE KS, 1977, NATURE, V265, P751, DOI 10.1038/265751a0; LEWIS DV, 1984, J NEUROPHYSIOL, V51, P387, DOI 10.1152/jn.1984.51.2.387; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P171, DOI 10.1113/jphysiol.1980.sp013357; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; MACVICAR BA, 1985, BRAIN RES, V333, P378, DOI 10.1016/0006-8993(85)91597-5; OGATA N, 1990, PFLUG ARCH EUR J PHY, V416, P594, DOI 10.1007/BF00382695; PARTRIDGE LD, 1979, BRAIN RES, V164, P69; RAGGENBASS M, 1991, NEUROSCIENCE, V11, P1609; ROGART RB, 1989, P NATL ACAD SCI USA, V86, P8170, DOI 10.1073/pnas.86.20.8170; ROY ML, 1992, NEUROSCIENCE, V12, P2104; SPITZER NC, 1984, J PHYSIOL-LONDON, V357, P51, DOI 10.1113/jphysiol.1984.sp015488; STAFSTROM CE, 1982, BRAIN RES, V236, P221, DOI 10.1016/0006-8993(82)90050-6; STAFSTROM CE, 1985, J NEUROPHYSIOL, V53, P153, DOI 10.1152/jn.1985.53.1.153; TAYLOR CP, 1982, SCIENCE, V218, P810, DOI 10.1126/science.7134978; TAYLOR CP, 1984, J NEUROPHYSIOL, V52, P143, DOI 10.1152/jn.1984.52.1.143; THOMPSON SH, 1976, J NEUROPHYSIOL, V39, P153, DOI 10.1152/jn.1976.39.1.153; TRAUB RD, 1982, NEUROSCIENCE, V7, P1233, DOI 10.1016/0306-4522(82)91130-7; WANG YY, 1990, J NEUROSCI, V10, P3335; WAXMAN SG, 1991, TRENDS NEUROSCI, V14, P461, DOI 10.1016/0166-2236(91)90046-W; WEISS RE, 1986, SCIENCE, V233, P361, DOI 10.1126/science.2425432; WILSON WA, 1974, SCIENCE, V186, P932, DOI 10.1126/science.186.4167.932; WONG RKS, 1981, J NEUROPHYSIOL, V45, P86, DOI 10.1152/jn.1981.45.1.86; YOSHIDA S, 1978, J NEUROPHYSIOL, V41, P1096, DOI 10.1152/jn.1978.41.5.1096	66	84	85	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1993	10	3					543	552		10.1016/0896-6273(93)90341-N	http://dx.doi.org/10.1016/0896-6273(93)90341-N			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KU901	8461141				2022-12-24	WOS:A1993KU90100018
J	WIERASZKO, A; LI, G; KORNECKI, E; HOGAN, MV; EHRLICH, YH				WIERASZKO, A; LI, G; KORNECKI, E; HOGAN, MV; EHRLICH, YH			LONG-TERM POTENTIATION IN THE HIPPOCAMPUS INDUCED BY PLATELET-ACTIVATING-FACTOR	NEURON			English	Article							CENTRAL NEURONS; NMDA RECEPTORS; BINDING-SITES; INDUCTION; CHANNELS; BRAIN; BLOCK	Platelet-activating factor (PAF) is an ether phospholipid that serves as an autacoid in a wide range of biological processes. We found that when PAF was added to hippocampal slices, it induced a stable and concentration-dependent increase in excitatory postsynaptic potential and population spike recordings (long-term potentiation [LTP]). The PAF effect was blocked by the PAF receptor antagonists BN 52021 and WEB 2086 and the N-methyl-D-aspartate receptor antagonists MK 801 and 2-amino-5-phosphonovalerate. However, these PAF receptor antagonists did not block LTP induced by high frequency stimulation. The facilitation induced by PAF could not be reversed by PAF receptor antagonists. Induction of either PAF- or tetanus-triggered facilitation occluded the subsequent expression of the other, suggesting a common pathway. LTP is a type of synaptic plasticity associated with the formation of memory, and PAF may play an important modulatory role in this process.	NEW YORK STATE INST BASIC RES DEV DISABIL,STATEN ISL,NY 10314; SUNY,HLTH SCI CTR,DEPT ANAT & CELL BIOL,BROOKLYN,NY 11203	Institute for Basic Research in Developmental Disabilities; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; SUNY Maritime College	WIERASZKO, A (corresponding author), CUNY COLL STATEN ISL,CSI IBR CTR DEV NEUROSCI & DEV DISABIL,STATEN ISL,NY 10301, USA.				NINDS NIH HHS [R01 NS27866] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027866] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARNES PY, 1989, PLATELET ACTIVATING; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BOUMANN WJ, 1991, LIPIDS, V26, P945; BRAQUET P, 1987, PHARMACOL REV, V39, P97; BUSSOLINO F, 1986, J BIOL CHEM, V261, P6502; CLAY KL, 1990, BIOCHIM BIOPHYS ACTA, V1046, P309, DOI 10.1016/0005-2760(90)90246-T; COLLINGRIDGE GL, 1987, TRENDS NEUROSCI, V10, P288, DOI 10.1016/0166-2236(87)90175-5; DELCERRO S, 1990, BEHAV NEURAL BIOL, V54, P213, DOI 10.1016/0163-1047(90)90595-W; DOMINGO MT, 1988, BIOCHEM BIOPH RES CO, V151, P730, DOI 10.1016/S0006-291X(88)80341-3; GROVER LM, 1990, NATURE, V347, P477, DOI 10.1038/347477a0; KORNECKI E, 1991, LIPIDS, V26, P1243, DOI 10.1007/BF02536540; KORNECKI E, 1988, SCIENCE, V240, P1792, DOI 10.1126/science.3381103; KORNECKI E, 1984, SCIENCE, V226, P1454, DOI 10.1126/science.6150550; KUMAR R, 1988, BIOCHIM BIOPHYS ACTA, V963, P375, DOI 10.1016/0005-2760(88)90304-9; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; MARCHESELLI VL, 1990, J BIOL CHEM, V265, P9140; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; MULLER D, 1988, SCIENCE, V242, P1694, DOI 10.1126/science.2904701; NICOLL RA, 1988, NEURON, V1, P97, DOI 10.1016/0896-6273(88)90193-6; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; TEYLER TJ, 1984, BRAIN RES REV, V7, P15, DOI 10.1016/0165-0173(84)90027-4; WIERASZKO A, 1989, BRAIN RES, V491, P356, DOI 10.1016/0006-8993(89)90070-X	22	141	141	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1993	10	3					553	557		10.1016/0896-6273(93)90342-O	http://dx.doi.org/10.1016/0896-6273(93)90342-O			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KU901	8461142				2022-12-24	WOS:A1993KU90100019
J	HATA, Y; DAVLETOV, B; PETRENKO, AG; JAHN, R; SUDHOF, TC				HATA, Y; DAVLETOV, B; PETRENKO, AG; JAHN, R; SUDHOF, TC			INTERACTION OF SYNAPTOTAGMIN WITH THE CYTOPLASMIC DOMAINS OF NEUREXINS	NEURON			English	Article							ALPHA-LATROTOXIN RECEPTOR; SYNAPTIC VESICLE PROTEIN; MEMBRANE; P65; CONSERVATION; BINDING; GENE	Synaptotagmin, a major intrinsic membrane protein of synaptic vesicles that binds Ca2+, was purified from bovine brain and immobilized onto Sepharose 4B. Affinity chromatography of brain membrane proteins on immobilized synaptotagmin revealed binding of alpha- and beta-neurexins to synaptotagmin in a Ca2+-independent manner. Using a series of recombinant proteins in which glutathione S-transferase was fused to the cytoplasmic domains of three different neurexins or of control proteins, it was found that synaptotagmin specifically interacts with the cytoplasmic domains of neurexins but not of control proteins. This interaction is dependent on a highly conserved, 40 amino acid sequence that makes up most of the cytoplasmic tails of the neurexins. Our data suggest a direct interaction between the cytoplasmic domains of a plasma membrane protein (the neurexins) and a protein specific for a subcellular organelle (synaptotagmin). Such an interaction could have an important role in the docking and targeting of synaptic vesicles in the nerve terminal.	UNIV TEXAS,SW MED CTR,DEPT MOLEC GENET,DALLAS,TX 75235; YALE UNIV,SCH MED,HOWARD HUGHES MED INST,NEW HAVEN,CT 06536	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; Yale University	HATA, Y (corresponding author), UNIV TEXAS,SW MED CTR,HOWARD HUGHES MED INST,DALLAS,TX 75235, USA.		Davletov, Bazbek/ABA-8569-2021	Jahn, Reinhard/0000-0003-1542-3498; Davletov, Bazbek/0000-0003-4658-3275; Petrenko, Alexander/0000-0002-6689-6546				BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; BUCKLEY K, 1985, J CELL BIOL, V100, P1284, DOI 10.1083/jcb.100.4.1284; GEPPERT M, 1991, J BIOL CHEM, V266, P13548; HERZ J, 1988, EMBO J, V7, P4119, DOI 10.1002/j.1460-2075.1988.tb03306.x; INOUE A, 1992, J BIOL CHEM, V267, P10613; JOHNSTON PA, 1989, J BIOL CHEM, V264, P1268; JOHNSTON PA, 1991, NEURON, V7, P101, DOI 10.1016/0896-6273(91)90078-E; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; PERIN MS, 1991, J BIOL CHEM, V266, P3877; PERIN MS, 1991, J BIOL CHEM, V266, P615; PERIN MS, 1991, J BIOL CHEM, V266, P623; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; PETRENKO AG, 1990, EMBO J, V9, P2023, DOI 10.1002/j.1460-2075.1990.tb08331.x; PETRENKO AG, 1991, NATURE, V353, P65, DOI 10.1038/353065a0; PETRENKO AG, 1993, IN PRESS J BIOL CHEM; ROSENTHAL L, 1989, PHARMACOL THERAPEUT, V42, P115, DOI 10.1016/0163-7258(89)90024-7; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SUDHOF TC, 1985, SCIENCE, V228, P815, DOI 10.1126/science.2988123; SUDHOF TC, 1987, SCIENCE, V238, P1142, DOI 10.1126/science.3120313; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; VALTORTA F, 1984, J CELL BIOL, V99, P124, DOI 10.1083/jcb.99.1.124; WENDLAND B, 1991, NEURON, V6, P993, DOI 10.1016/0896-6273(91)90239-V	24	151	153	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1993	10	2					307	315		10.1016/0896-6273(93)90320-Q	http://dx.doi.org/10.1016/0896-6273(93)90320-Q			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KP685	8439414				2022-12-24	WOS:A1993KP68500017
J	Yoshida, M; Colman, DR				Yoshida, M; Colman, DR			Parallel evolution and coexpression of the proteolipid proteins and protein zero in vertebrate myelin	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; PERIPHERAL MYELIN; BRAIN MYELIN; CNS MYELIN; JIMPY MICE; ADHESION MOLECULE; MESSENGER-RNAS; BASIC-PROTEIN; MUTANT MOUSE; SPLICE SITE	Vertebrate myelin contains two proteins that mediate compaction: protein zero (P-0), an immunoglobulin gene superfamily member, or proteolipid proteins, 4-hydrophobic domain-motif proteins biogenetically unrelated to P-0. The prevailing view has been that expression of P-0 and proteolipid proteins is mutually exclusive; P-0, which mediates myelin compaction in fish, is thought to be completely replaced by the newer proteolipid proteins in the terrestrial vertebrate CNS. However, we now find that proteolipid proteins are actually major myelin constituents in bony fish and amphibia, and so are coexpressed with P-0. Clearly, myelin proteolipids are not new additions to the myelin protein repertoire, but instead were ancestral sheath components, expressed similar to 440 million years ago in the first myelinated fish that existed at least similar to 100 million years before the origin of amphibians. In conclusion, P-0 and the proteolipid proteins are evolving in parallel in myelinating cells of most vertebrate species.			Yoshida, M (corresponding author), CUNY MT SINAI SCH MED,BROOKDALE CTR MOLEC BIOL,NEW YORK,NY 10029, USA.				NINDS NIH HHS [NS20147] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020147] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AHLBERG PE, 1994, NATURE, V368, P507, DOI 10.1038/368507a0; [Anonymous], MYELIN; BAUMRIND NL, 1992, DEV DYNAM, V194, P311, DOI 10.1002/aja.1001940407; BOISON D, 1995, J NEUROSCI, V15, P5502; BOISON D, 1994, P NATL ACAD SCI USA, V91, P11709, DOI 10.1073/pnas.91.24.11709; BRAUN PE, 1984, MYELIN, P97; CAMPAGNONI CW, 1994, NEUROCHEM RES, V19, P1061, DOI 10.1007/BF00968717; CAPPETTA H, 1987, HDB PALEOICHTHYOLO B, V3, P41; COLMAN DR, 1982, J CELL BIOL, V95, P598, DOI 10.1083/jcb.95.2.598; DAUTIGNY A, 1985, FEBS LETT, V188, P33, DOI 10.1016/0014-5793(85)80869-3; DAUTIGNY A, 1986, NATURE, V321, P867, DOI 10.1038/321867a0; DECOZAR M, 1987, BIOCHEM INT, V14, P833; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DIAZ RS, 1990, J NEUROCHEM, V55, P1304, DOI 10.1111/j.1471-4159.1990.tb03139.x; DOYLE JP, 1995, J CELL BIOL, V131, P465, DOI 10.1083/jcb.131.2.465; DUNCAN ID, 1990, ANN NY ACAD SCI, V605, P110, DOI 10.1111/j.1749-6632.1990.tb42386.x; DURSO D, 1990, NEURON, V4, P449, DOI 10.1016/0896-6273(90)90057-M; FILBIN MT, 1990, NATURE, V344, P871, DOI 10.1038/344871a0; FRANZ T, 1981, BRAIN RES, V226, P245, DOI 10.1016/0006-8993(81)91097-0; GARDINIER MV, 1986, MOL CELL BIOL, V6, P3755, DOI 10.1128/MCB.6.11.3755; GIESE KP, 1992, CELL, V71, P565, DOI 10.1016/0092-8674(92)90591-Y; HELYNCK G, 1983, EUR J BIOCHEM, V133, P689, DOI 10.1111/j.1432-1033.1983.tb07518.x; Hudson Lynn D., 1992, P677; IKENAKA K, 1992, J NEUROCHEM, V58, P2248, DOI 10.1111/j.1471-4159.1992.tb10970.x; KIRSCHNER DA, 1980, NATURE, V283, P207, DOI 10.1038/283207a0; KIRSCHNER DA, 1989, J NEUROCHEM, V53, P1599, DOI 10.1111/j.1471-4159.1989.tb08558.x; Kirschner Daniel A., 1992, P3; KITAGAWA K, 1993, NEURON, V11, P433, DOI 10.1016/0896-6273(93)90148-K; KRONQUIST KE, 1987, J NEUROSCI RES, V18, P395, DOI 10.1002/jnr.490180303; LAGENAUR C, 1992, J NEUROBIOL, V23, P71, DOI 10.1002/neu.480230108; LAI C, 1987, P NATL ACAD SCI USA, V84, P4337, DOI 10.1073/pnas.84.12.4337; LEMKE G, 1988, NEURON, V1, P73, DOI 10.1016/0896-6273(88)90211-5; LEMKE G, 1985, CELL, V40, P501, DOI 10.1016/0092-8674(85)90198-9; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; LIN LFH, 1982, P NATL ACAD SCI-BIOL, V79, P941, DOI 10.1073/pnas.79.3.941; MACKLIN WB, 1987, J NEUROSCI RES, V18, P383, DOI 10.1002/jnr.490180302; MACKLIN WB, 1987, FEBS LETT, V223, P417, DOI 10.1016/0014-5793(87)80331-9; MATTHIEU JM, 1986, BRAIN RES, V379, P137, DOI 10.1016/0006-8993(86)90265-9; MEYER A, 1995, TRENDS ECOL EVOL, V10, P111, DOI 10.1016/S0169-5347(00)89004-7; MILNER RJ, 1985, CELL, V42, P931, DOI 10.1016/0092-8674(85)90289-2; NAVE KA, 1987, P NATL ACAD SCI USA, V84, P5665, DOI 10.1073/pnas.84.16.5665; NAVE KA, 1986, P NATL ACAD SCI USA, V83, P9264, DOI 10.1073/pnas.83.23.9264; NAVE KA, 1994, J NEUROSCI RES, V38, P607, DOI 10.1002/jnr.490380602; PETERSON AC, 1984, J COMP NEUROL, V227, P348, DOI 10.1002/cne.902270305; POPOT JL, 1991, J MEMBRANE BIOL, V120, P233, DOI 10.1007/BF01868534; PUCKETT C, 1987, J NEUROSCI RES, V18, P511, DOI 10.1002/jnr.490180402; ROSENBLUTH J, 1980, J COMP NEUROL, V193, P729, DOI 10.1002/cne.901930310; ROTH G, 1993, BRAIN BEHAV EVOLUT, V42, P137, DOI 10.1159/000114147; SAAVEDRA RA, 1989, J MOL EVOL, V29, P149, DOI 10.1007/BF02100113; SCHAICH M, 1986, BIOL CHEM H-S, V367, P825, DOI 10.1515/bchm3.1986.367.2.825; SCHLIESS F, 1991, BIOL CHEM H-S, V372, P865, DOI 10.1515/bchm3.1991.372.2.865; SCHNEIDER A, 1992, NATURE, V358, P758, DOI 10.1038/358758a0; SCHNEIDERSCHAULIES J, 1990, J NEUROSCI RES, V27, P286, DOI 10.1002/jnr.490270307; SHIRAI S, 1992, COPEIA, V2, P505; SIMONS R, 1987, BIOCHEM BIOPH RES CO, V146, P666, DOI 10.1016/0006-291X(87)90580-8; SINOWAY MP, 1994, J NEUROSCI RES, V37, P551, DOI 10.1002/jnr.490370502; SOREQ H, 1992, METHOD ENZYMOL, V207, P225; STRATMANN A, 1995, J NEUROCHEM, V64, P2427; TAKEI K, 1993, COMP BIOCHEM PHYS B, V106, P873, DOI 10.1016/0305-0491(93)90044-6; TIMSIT S, 1992, J NEUROCHEM, V58, P1936, DOI 10.1111/j.1471-4159.1992.tb10072.x; TIMSIT SG, 1992, J NEUROCHEM, V58, P1172, DOI 10.1111/j.1471-4159.1992.tb09378.x; TINGBEALL HP, 1979, J MEMBRANE BIOL, V51, P33, DOI 10.1007/BF01869342; WAEHNELDT TV, 1987, COMP BIOCHEM PHYS B, V88, P1209, DOI 10.1016/0305-0491(87)90025-3; WAEHNELDT TV, 1985, NEUROSCI LETT, V57, P97, DOI 10.1016/0304-3940(85)90046-1; WAEHNELDT TV, 1990, ANN NY ACAD SCI, V605, P15, DOI 10.1111/j.1749-6632.1990.tb42377.x; WAEHNELDT TV, 1986, NEUROCHEM INT, V9, P463, DOI 10.1016/0197-0186(86)90136-1; WAEHNELDT TV, 1986, J NEUROCHEM, V46, P1387, DOI 10.1111/j.1471-4159.1986.tb01752.x; WAEHNELDT TV, 1989, J NEUROCHEM, V52, P1941, DOI 10.1111/j.1471-4159.1989.tb07281.x; WEIMBS T, 1992, BIOCHEMISTRY-US, V31, P12289, DOI 10.1021/bi00164a002; YAN YM, 1993, NEURON, V11, P423, DOI 10.1016/0896-6273(93)90147-J	70	86	86	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1996	16	6					1115	1126		10.1016/S0896-6273(00)80138-5	http://dx.doi.org/10.1016/S0896-6273(00)80138-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UU118	8663988	Bronze			2022-12-24	WOS:A1996UU11800009
J	BIRNBAUMER, L; CAMPBELL, KP; CATTERALL, WA; HARPOLD, MM; HOFMANN, F; HORNE, WA; MORI, Y; SCHWARTZ, A; SNUTCH, TP; TANABE, T; TSIEN, RW				BIRNBAUMER, L; CAMPBELL, KP; CATTERALL, WA; HARPOLD, MM; HOFMANN, F; HORNE, WA; MORI, Y; SCHWARTZ, A; SNUTCH, TP; TANABE, T; TSIEN, RW			THE NAMING OF VOLTAGE-GATED CALCIUM CHANNELS	NEURON			English	Note									UNIV IOWA,SCH MED,HOWARD HUGHES MED INST,IOWA CITY,IA 52242; UNIV IOWA,SCH MED,DEPT PHYSIOL & BIOPHYS,IOWA CITY,IA 52242; UNIV WASHINGTON,SCH MED,DEPT PHARMACOL,SEATTLE,WA 98195; SALK INST BIOL STUDIES,BIOTECHNOL ASSOCIATES INC,LA JOLLA,CA 92037; TECH UNIV MUNICH,DEPT PHARMACOL & TOXICOL,D-80802 MUNICH 40,GERMANY; STANFORD UNIV,SCH MED,DEPT CELLULAR & MOLEC PHYSIOL,STANFORD,CA 94305; UNIV CINCINNATI,SCH MED,INST PHARMACOL & CELL BIOPHYS,CINCINNATI,OH 45267; UNIV BRITISH COLUMBIA,DEPT ZOOL,BIOTECHNOL LAB,VANCOUVER V6T 1Z3,BC,CANADA; UNIV BRITISH COLUMBIA,DEPT NEUROSCI,VANCOUVER V6T 1Z3,BC,CANADA; YALE UNIV,SCH MED,HOWARD HUGHES MED INST,NEW HAVEN,CT 06536; YALE UNIV,SCH MED,DEPT CELLULAR & MOLEC PHYSIOL,NEW HAVEN,CT 06536	Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Washington; University of Washington Seattle; Salk Institute; Technical University of Munich; Stanford University; University System of Ohio; University of Cincinnati; University of British Columbia; University of British Columbia; Howard Hughes Medical Institute; Yale University; Yale University	BIRNBAUMER, L (corresponding author), UNIV CALIF LOS ANGELES,SCH MED,DEPT ANESTHESIOL,LOS ANGELES,CA 90024, USA.		Tuluc, Petronel/C-2527-2011; Snutch, Terrance P/L-3464-2019	Snutch, Terrance P/0000-0001-5182-1296; Campbell, Kevin/0000-0003-2066-5889					0	305	311	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1994	13	3					505	506		10.1016/0896-6273(94)90021-3	http://dx.doi.org/10.1016/0896-6273(94)90021-3			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PJ284	7917287				2022-12-24	WOS:A1994PJ28400001
J	IP, NY; BOULTON, TG; LI, YP; VERDI, JM; BIRREN, SJ; ANDERSON, DJ; YANCOPOULOS, GD				IP, NY; BOULTON, TG; LI, YP; VERDI, JM; BIRREN, SJ; ANDERSON, DJ; YANCOPOULOS, GD			CNTF, FGF, AND NCF COLLABORATE TO DRIVE THE TERMINAL DIFFERENTIATION OF MAH CELLS INTO POSTMITOTIC NEURONS	NEURON			English	Article							CILIARY NEUROTROPHIC FACTOR; LEUKEMIA INHIBITORY FACTOR; NERVE GROWTH-FACTOR; CULTURED SYMPATHETIC NEURONS; NEURAL CREST DERIVATIVES; CHOLINERGIC DIFFERENTIATION; REGIONAL DISTRIBUTION; SIGNALING PATHWAYS; RECEPTOR COMPONENT; CHROMAFFIN CELLS	The differentiation of neuronal cell progenitors depends on complex interactions between intrinsic cellular programs and environmental cues. Such interactions have recently been explored using an immortalized sympathoadrenal progenitor cell line, MAH. These studies have revealed that depolarizing conditions, in combination with exposure to FGF, can induce responsiveness to NGF. Here we report that CNTF, which utilizes an intracellular signaling pathway distinct from that of both FGF and NGF, can collaborate with FGF to promote efficiently the differentiation of MAH progenitor cells to a stage remarkably reminiscent of NGF-dependent, postmitotic sympathetic neurons. We also find that similar collaborative interactions can occur during transdifferentiation of normal cultured chromaffin cells into sympathetic neurons.	CALTECH,HOWARD HUGHES MED INST,PASADENA,CA 91125; CALTECH,DIV BIOL,PASADENA,CA 91125	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology	IP, NY (corresponding author), REGENERON PHARMACEUT INC,777 OLD SAW MILL RIVER RD,TARRYTOWN,NY 10591, USA.			Ip, Nancy Yuk-Yu/0000-0002-2763-8907				ALLSOPP TE, 1993, CELL, V73, P295, DOI 10.1016/0092-8674(93)90230-N; Anderson D J, 1993, Curr Opin Neurobiol, V3, P8, DOI 10.1016/0959-4388(93)90028-W; ANDERSON DJ, 1986, CELL, V47, P1079, DOI 10.1016/0092-8674(86)90823-8; ANDERSON DJ, 1989, NEURON, V3, P1, DOI 10.1016/0896-6273(89)90110-4; BAUMANN H, 1993, J BIOL CHEM, V268, P8414; BAZAN JF, 1991, NEURON, V7, P197, DOI 10.1016/0896-6273(91)90258-2; BIRREN SJ, 1992, SCIENCE, V257, P395, DOI 10.1126/science.1321502; BIRREN SJ, 1990, NEURON, V4, P189, DOI 10.1016/0896-6273(90)90094-V; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLAUDE P, 1988, NEURON, V1, P783, DOI 10.1016/0896-6273(88)90126-2; DAVIS S, 1993, SCIENCE, V260, P1805, DOI 10.1126/science.8390097; DAVIS S, 1993, SCIENCE, V259, P1736, DOI 10.1126/science.7681218; DAVIS S, 1991, SCIENCE, V253, P59, DOI 10.1126/science.1648265; DOUPE AJ, 1985, J NEUROSCI, V5, P2143; DOUPE AJ, 1985, J NEUROSCI, V5, P2119; ERNSBERGER U, 1989, NEURON, V2, P1275, DOI 10.1016/0896-6273(89)90312-7; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Glass David J., 1993, Trends in Cell Biology, V3, P262, DOI 10.1016/0962-8924(93)90054-5; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; HALL AK, 1992, TRENDS NEUROSCI, V15, P35, DOI 10.1016/0166-2236(92)90022-Z; HYMAN C, 1991, NATURE, V350, P230, DOI 10.1038/350230a0; Ip Nancy Y., 1992, Progress in Growth Factor Research, V4, P139, DOI 10.1016/0955-2235(92)90028-G; IP NY, 1992, CELL, V69, P1121, DOI 10.1016/0092-8674(92)90634-O; IP NY, 1993, NEURON, V10, P89, DOI 10.1016/0896-6273(93)90245-M; IP NY, 1993, NEURON, V10, P137, DOI 10.1016/0896-6273(93)90306-C; IP NY, 1993, SEMIN NEUROSCI, V5, P249; JOHNSON EM, 1992, EXP NEUROL, V115, P163, DOI 10.1016/0014-4886(92)90242-I; Le Douarin N.M., 1982, NEURAL CREST; LEUNG DW, 1992, NEURON, V8, P1045, DOI 10.1016/0896-6273(92)90126-X; LILLIEN LE, 1990, NEURON, V5, P111, DOI 10.1016/0896-6273(90)90301-U; LOPRESTI P, 1992, CELL GROWTH DIFFER, V3, P627; LUDLAM WH, 1993, DEV BIOL, V155, P497, DOI 10.1006/dbio.1993.1047; LUSCHER B, 1990, GENE DEV, V4, P2025, DOI 10.1101/gad.4.12a.2025; MARTINOU JC, 1992, NEURON, V8, P737, DOI 10.1016/0896-6273(92)90094-T; MASU Y, 1993, NATURE, V365, P27, DOI 10.1038/365027a0; MICHELSOHN AM, 1992, NEURON, V8, P589, DOI 10.1016/0896-6273(92)90285-L; MIYAJIMA A, 1992, ANNU REV IMMUNOL, V10, P295, DOI 10.1146/annurev.immunol.10.1.295; MURPHY M, 1993, DEVELOPMENT, V117, P1173; NAWA H, 1991, J NEUROCHEM, V56, P2147, DOI 10.1111/j.1471-4159.1991.tb03479.x; Patterson P H, 1992, Curr Opin Neurobiol, V2, P94, DOI 10.1016/0959-4388(92)90169-L; PATTERSON PH, 1993, CELL, V72, P123, DOI 10.1016/S0092-8674(05)80032-7; PATTERSON PH, 1990, CELL, V62, P1035, DOI 10.1016/0092-8674(90)90379-S; QIU MS, 1992, NEURON, V9, P705, DOI 10.1016/0896-6273(92)90033-A; RAO MS, 1992, DEVELOPMENT, V116, P731; RAO MS, 1992, DEV BIOL, V150, P281, DOI 10.1016/0012-1606(92)90242-9; SAADAT S, 1989, J CELL BIOL, V108, P1807, DOI 10.1083/jcb.108.5.1807; SCHLESSINGER J, 1992, NEURON, V9, P383, DOI 10.1016/0896-6273(92)90177-F; SQUINTO SP, 1990, NEURON, V5, P757, DOI 10.1016/0896-6273(90)90334-C; STAHL N, 1993, J BIOL CHEM, V268, P7628; STEMPLE DL, 1988, NEURON, V1, P517, DOI 10.1016/0896-6273(88)90182-1; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; STOCKLI KA, 1989, NATURE, V342, P920, DOI 10.1038/342920a0; STOCKLI KA, 1991, J CELL BIOL, V115, P447, DOI 10.1083/jcb.115.2.447; YAMAMORI T, 1989, SCIENCE, V246, P1412, DOI 10.1126/science.2512641	57	81	85	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1994	13	2					443	455		10.1016/0896-6273(94)90359-X	http://dx.doi.org/10.1016/0896-6273(94)90359-X			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PD430	8060620				2022-12-24	WOS:A1994PD43000015
J	JONAKAIT, GM; WEI, RT; SHENG, ZL; HART, RP; NI, L				JONAKAIT, GM; WEI, RT; SHENG, ZL; HART, RP; NI, L			INTERFERON-GAMMA PROMOTES CHOLINERGIC DIFFERENTIATION OF EMBRYONIC SEPTAL NUCLEI AND ADJACENT BASAL FOREBRAIN	NEURON			English	Article							NERVE GROWTH-FACTOR; IA-ANTIGEN EXPRESSION; NECROSIS-FACTOR-ALPHA; RAT SPINAL-CORD; NEUROTROPHIC FACTOR; CYTOKINE REGULATION; AMEBOID MICROGLIA; NEURONS INVITRO; SUBSTANCE-P; SYMPATHETIC-GANGLIA	In cultured rat embryonic septal nuclei with adjacent basal forebrain, murine interferon-gamma (IFN gamma) produces a striking increase in choline acetyltransferase (ChAT) activity and mRNA. The effect of IFN gamma on cholinergic differentiation is more potent in E14 cultures than in older cultures. IFN gamma does not cause a change in the affinity of ChAT for choline, nor does it affect cell proliferation. Whereas IFN gamma doubles neuronal cell number, the cholinergic cell number increases more than 7-fold. Ameboid microglia respond to IFN gamma with the translocation of p91 to the nucleus. The action of IFN gamma is not mediated by NGF or bFGF. The enhancement of cholinergic expression that occurs with increased cell density may be partly attributable to an endogenous IFN gamma-like molecule, since antibodies to IFN gamma offset the effects of increased cell density.			JONAKAIT, GM (corresponding author), RUTGERS STATE UNIV,DEPT BIOL SCI,NEWARK,NJ 07102, USA.		Hart, Ronald P/G-6530-2019; Hart, Ronald P/D-5219-2009	Hart, Ronald P/0000-0003-4836-8712; Hart, Ronald P/0000-0003-4836-8712				ALDERSON RF, 1990, NEURON, V5, P297, DOI 10.1016/0896-6273(90)90166-D; ALTAR CA, 1991, J NEUROSCI, V11, P828; ARAUJO DM, 1992, J NEUROSCI, V12, P1668; BARISH ME, 1991, DEV BIOL, V144, P412, DOI 10.1016/0012-1606(91)90433-4; Benveniste E N, 1989, Int Immunol, V1, P219, DOI 10.1093/intimm/1.3.219; BENVENISTE EN, 1986, NATURE, V321, P610, DOI 10.1038/321610a0; BINDER LI, 1986, ANN NY ACAD SCI, V466, P145, DOI 10.1111/j.1749-6632.1986.tb38392.x; Bisso G. M., 1992, Brain Dysfunction, V5, P121; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; BRENNEMAN DE, 1992, J NEUROCHEM, V58, P454, DOI 10.1111/j.1471-4159.1992.tb09743.x; CAVICCHIOLI L, 1991, MOL BRAIN RES, V9, P319, DOI 10.1016/0169-328X(91)90079-D; CHANG JY, 1990, J NEUROCHEM, V55, P436, DOI 10.1111/j.1471-4159.1990.tb04155.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CRAWFORD GD, 1982, P NATL ACAD SCI-BIOL, V79, P7031, DOI 10.1073/pnas.79.22.7031; DEGROOT CJA, 1991, INT J NEUROSCI, V59, P53, DOI 10.3109/00207459108985449; DREYFUS CF, 1989, TRENDS PHARMACOL SCI, V10, P145, DOI 10.1016/0165-6147(89)90166-1; ENEROTH A, 1992, J NEUROSCI RES, V31, P487, DOI 10.1002/jnr.490310311; ERKMAN L, 1989, DEV BIOL, V132, P375, DOI 10.1016/0012-1606(89)90234-0; FABRY Z, 1992, J NEUROIMMUNOL, V36, P1, DOI 10.1016/0165-5728(92)90026-H; FAGAN AM, 1990, EXP NEUROL, V110, P105, DOI 10.1016/0014-4886(90)90055-W; FIERZ W, 1985, J IMMUNOL, V134, P3785; FONNUM F, 1975, J NEUROCHEM, V24, P407, DOI 10.1111/j.1471-4159.1975.tb11895.x; FONTANA A, 1980, J NEUROL SCI, V46, P55, DOI 10.1016/0022-510X(80)90043-X; FREI K, 1987, EUR J IMMUNOL, V17, P1271, DOI 10.1002/eji.1830170909; FREI K, 1985, J IMMUNOL, V135, P4044; FREIDIN M, 1991, P NATL ACAD SCI USA, V88, P3200, DOI 10.1073/pnas.88.8.3200; FROHMAN EM, 1989, J NEUROIMMUNOL, V23, P117, DOI 10.1016/0165-5728(89)90030-1; GIULIAN D, 1986, J EXP MED, V164, P594, DOI 10.1084/jem.164.2.594; GIULIAN D, 1986, J NEUROSCI, V6, P2163; GIULIAN D, 1985, SCIENCE, V228, P497, DOI 10.1126/science.3872478; GIULIAN D, 1988, J NEUROSCI, V8, P4707; GNAHN H, 1983, DEV BRAIN RES, V9, P45, DOI 10.1016/0165-3806(83)90107-4; GRAY CW, 1992, BRAIN RES, V574, P257, DOI 10.1016/0006-8993(92)90825-T; GROTHE C, 1989, NEUROSCIENCE, V31, P649, DOI 10.1016/0306-4522(89)90430-2; HAMA T, 1989, NEUROSCI LETT, V104, P340, DOI 10.1016/0304-3940(89)90600-9; HART RP, 1991, J NEUROSCI RES, V29, P282, DOI 10.1002/jnr.490290303; HARTIKKA J, 1988, J NEUROSCI, V8, P2967; HARTIKKA J, 1988, J NEUROSCI RES, V21, P352, DOI 10.1002/jnr.490210227; HEFTI F, 1985, NEUROSCIENCE, V14, P55, DOI 10.1016/0306-4522(85)90163-0; HETIER E, 1988, J NEUROSCI RES, V21, P391, DOI 10.1002/jnr.490210230; HIRSCH MR, 1983, NEUROSCI LETT, V41, P199, DOI 10.1016/0304-3940(83)90247-1; IMPROTA T, 1988, EXP CELL RES, V179, P1, DOI 10.1016/0014-4827(88)90342-4; JONAKAIT GM, 1985, DEV BIOL, V108, P6, DOI 10.1016/0012-1606(85)90003-X; JONAKAIT GM, 1990, J NEUROSCI RES, V26, P24, DOI 10.1002/jnr.490260104; JONAKAIT GM, 1990, NEUROPEPTIDES IMMUNO, P222; KAMEGAI M, 1990, BRAIN RES, V532, P323, DOI 10.1016/0006-8993(90)91775-C; KAMEGAI M, 1990, NEURON, V2, P429; KARNOVSKY MJ, 1964, J HISTOCHEM CYTOCHEM, V12, P219, DOI 10.1177/12.3.219; KENGAKU M, 1993, MOL BRAIN RES, V18, P71, DOI 10.1016/0169-328X(93)90174-N; KIEFER R, 1990, NEUROSCIENCE, V37, P725, DOI 10.1016/0306-4522(90)90103-B; KNUSEL B, 1990, J NEUROSCI, V10, P558; KNUSEL B, 1991, P NATL ACAD SCI USA, V88, P9621; LARSSON J, 1989, NEUROSCI LETT, V100, P326, DOI 10.1016/0304-3940(89)90707-6; LEVEY AI, 1983, NEUROSCIENCE, V9, P9, DOI 10.1016/0306-4522(83)90042-8; LJUNGDAHL A, 1989, J NEUROSCI RES, V24, P451, DOI 10.1002/jnr.490240316; MARTINEZ HJ, 1987, BRAIN RES, V412, P295, DOI 10.1016/0006-8993(87)91136-X; MARTINEZ HJ, 1985, P NATL ACAD SCI USA, V82, P7777, DOI 10.1073/pnas.82.22.7777; MARTINEZ HJ, 1992, J NEUROBIOL, V23, P252; MAUTNER HG, 1981, P NATL ACAD SCI-BIOL, V78, P7449, DOI 10.1073/pnas.78.12.7449; MOBLEY WC, 1985, SCIENCE, V229, P284, DOI 10.1126/science.2861660; NUDEL U, 1983, NUCLEIC ACIDS RES, V11, P1759, DOI 10.1093/nar/11.6.1759; ODA Y, 1992, MOL BRAIN RES, V16, P287, DOI 10.1016/0169-328X(92)90237-6; PESTKA S, 1987, ANNU REV BIOCHEM, V56, P727, DOI 10.1146/annurev.biochem.56.1.727; PLIOPLYS AV, 1988, J NEUROL SCI, V85, P209, DOI 10.1016/0022-510X(88)90157-8; RUBIN BY, 1980, P NATL ACAD SCI-BIOL, V77, P5928, DOI 10.1073/pnas.77.10.5928; RUIT KG, 1992, NEURON, V8, P573, DOI 10.1016/0896-6273(92)90284-K; SANETO RP, 1986, P NATL ACAD SCI USA, V83, P9221, DOI 10.1073/pnas.83.23.9221; SATOH J, 1991, J NEUROSCI RES, V29, P1, DOI 10.1002/jnr.490290102; SATOH JI, 1991, J NEUROPATH EXP NEUR, V50, P215, DOI 10.1097/00005072-199105000-00004; SCARBOROUGH DE, 1989, ENDOCRINOLOGY, V124, P549, DOI 10.1210/endo-124-1-549; SCHMIDT B, 1990, BRAIN RES, V515, P347, DOI 10.1016/0006-8993(90)90621-H; SCHNEIDERSCHAULIES J, 1991, NEURON, V7, P995, DOI 10.1016/0896-6273(91)90344-Y; SHIMOJO M, 1991, NEUROSCI LETT, V123, P229, DOI 10.1016/0304-3940(91)90937-O; STEINIGER B, 1988, J NEUROIMMUNOL, V19, P111, DOI 10.1016/0165-5728(88)90040-9; STORCH E, 1985, ANTIVIR RES, V5, P117, DOI 10.1016/0166-3542(85)90038-5; TEDESCHI B, 1986, J CELL BIOL, V102, P2244, DOI 10.1083/jcb.102.6.2244; TIRONE F, 1989, P NATL ACAD SCI USA, V86, P2088, DOI 10.1073/pnas.86.6.2088; UNSICKER K, 1987, P NATL ACAD SCI USA, V84, P5459, DOI 10.1073/pnas.84.15.5459; WONG GHW, 1984, NATURE, V310, P688, DOI 10.1038/310688a0; YAMAMORI T, 1989, SCIENCE, V246, P1412, DOI 10.1126/science.2512641; YONG VW, 1991, P NATL ACAD SCI USA, V88, P7016, DOI 10.1073/pnas.88.16.7016; YOSHIDA K, 1992, J NEUROCHEM, V59, P919, DOI 10.1111/j.1471-4159.1992.tb08331.x; YOSHIDA K, 1991, BRAIN RES, V538, P118, DOI 10.1016/0006-8993(91)90385-9	84	60	61	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1994	12	5					1149	1159						11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NM831	8185950				2022-12-24	WOS:A1994NM83100018
J	SMITH, MA; ODOWD, DK				SMITH, MA; ODOWD, DK			CELL-SPECIFIC REGULATION OF AGRIN RNA SPLICING IN THE CHICK CILIARY GANGLION	NEURON			English	Article							ACETYLCHOLINE-RECEPTOR CLUSTERS; CULTURED MYOTUBES; BASAL LAMINA; NEURONS; EXPRESSION; MUSCLE; GENE; LOCALIZATION; MOLECULES; SYNAPSE	Alternative splicing results in production of four agrin proteins (agrin(0), agrins(8), agrin(11), and agrin(19)) with different AChR aggregating activities. However, the cellular origin of mRNAs encoding each agrin isoform remains unknown. Using single-cell PCR, we demonstrate that in the chick ciliary ganglion, nonneuronal cells express only mRNA encoding agrin(0), whereas neurons express one or any combination of agrin mRNAs. Moreover, significant differences were observed between the agrin mRNA profiles of ciliary and choroid neurons in the ganglion. The abundance of each agrin mRNA, the fraction of neurons expressing each transcript, and the combinations of transcripts expressed by neurons also change during development. Our results demonstrate that transcripts encoding agrin proteins with high AChR aggregating activity are expressed exclusively by neurons in the ciliary ganglion and that alternative splicing of agrin mRNA is regulated during development and in a cell-specific manner.	UNIV CALIF IRVINE,DEPT DEV & CELL BIOL,IRVINE,CA 92717	University of California System; University of California Irvine	SMITH, MA (corresponding author), UNIV CALIF IRVINE,DEPT ANAT & NEUROBIOL,IRVINE,CA 92717, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS027501, R01NS027501, R01NS027563, P01NS030109] Funding Source: NIH RePORTER; NINDS NIH HHS [NS27563, NS27501, NS30109] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		DOURADO MM, 1992, J PHYSIOL-LONDON, V449, P411, DOI 10.1113/jphysiol.1992.sp019093; DRYER SE, 1985, J NEUROSCI, V5, P2654; DRYER SE, 1994, IN PRESS PROG NEUROB; EPSTEIN ML, 1988, NEUROSCIENCE, V25, P1053, DOI 10.1016/0306-4522(88)90058-9; FALLON JR, 1989, J CELL BIOL, V108, P1527, DOI 10.1083/jcb.108.4.1527; FERNS M, 1992, NEURON, V8, P1079, DOI 10.1016/0896-6273(92)90129-2; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HOCH W, 1993, NEURON, V11, P479, DOI 10.1016/0896-6273(93)90152-H; JACOB MH, 1991, J NEUROSCI, V11, P1701; JACOB MH, 1983, J NEUROSCI, V3, P260; JEFFREY WR, 1985, CELL, V47, P11; LAMBOLEZ B, 1992, NEURON, V9, P247, DOI 10.1016/0896-6273(92)90164-9; LANDMESSER L, 1974, J PHYSIOL-LONDON, V241, P715, DOI 10.1113/jphysiol.1974.sp010680; LIETH E, 1992, DEV BIOL, V149, P41, DOI 10.1016/0012-1606(92)90262-F; LIETH E, 1993, J NEUROSCI, V13, P2509, DOI 10.1523/JNEUROSCI.13-06-02509.1993; MAGILLSOLC C, 1988, J CELL BIOL, V107, P1825, DOI 10.1083/jcb.107.5.1825; MARGIOTTA JF, 1989, DEV BIOL, V135, P326, DOI 10.1016/0012-1606(89)90183-8; MARWITT R, 1971, BRAIN RES, V25, P317, DOI 10.1016/0006-8993(71)90441-0; MERINEY SD, 1987, J NEUROSCI, V7, P3827; NASTUK MA, 1993, TRENDS NEUROSCI, V16, P72, DOI 10.1016/0166-2236(93)90020-M; NITKIN RM, 1987, J CELL BIOL, V105, P2471, DOI 10.1083/jcb.105.6.2471; OCONNOR LT, 1994, J NEUROSCI, V14, P1141, DOI 10.1523/JNEUROSCI.14-03-01141.1994; PILAR G, 1980, J NEUROPHYSIOL, V43, P233, DOI 10.1152/jn.1980.43.1.233; PILAR G, 1981, J PHYSIOL-LONDON, V321, P175, DOI 10.1113/jphysiol.1981.sp013978; ROLE LW, 1987, J CELL BIOL, V104, P371, DOI 10.1083/jcb.104.2.371; RUEGG MA, 1992, NEURON, V8, P691, DOI 10.1016/0896-6273(92)90090-Z; RUPP F, 1992, J NEUROSCI, V12, P3535; RUPP F, 1991, NEURON, V6, P811, DOI 10.1016/0896-6273(91)90177-2; Sambrook J, 1989, MOL CLONING LABORATO; STEWARD O, 1992, TRENDS NEUROSCI, V15, P180, DOI 10.1016/0166-2236(92)90170-D; THOMAS WS, 1993, DEV BIOL, V158, P523, DOI 10.1006/dbio.1993.1210; TSIM KWK, 1992, NEURON, V8, P677, DOI 10.1016/0896-6273(92)90089-V	32	72	72	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1994	12	4					795	804		10.1016/0896-6273(94)90332-8	http://dx.doi.org/10.1016/0896-6273(94)90332-8			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NH253	8161451	Green Published			2022-12-24	WOS:A1994NH25300008
J	DIAMOND, JS; COPENHAGEN, DR				DIAMOND, JS; COPENHAGEN, DR			THE CONTRIBUTION OF NMDA AND NON-NMDA RECEPTORS TO THE LIGHT-EVOKED INPUT-OUTPUT CHARACTERISTICS OF RETINAL GANGLION-CELLS	NEURON			English	Article							D-ASPARTATE RECEPTORS; EXCITATORY AMINO-ACIDS; TIGER SALAMANDER RETINA; CAT VISUAL-CORTEX; MEDIATED SYNAPTIC CURRENTS; LATERAL GENICULATE-NUCLEUS; RAT HIPPOCAMPAL SLICES; MOUSE CENTRAL NEURONS; MUDPUPPY RETINA; GLUTAMATE RECEPTORS	To examine how light-evoked excitatory synaptic inputs to retinal ganglion cells are transformed into output patterns of activity, action potentials were recorded with cell-attached patch-clamp techniques, and then EPSCs and EPSPs were recorded from the same cell in the whole-cell configuration. AP7, an NMDA antagonist, reduced the light-evoked peak spike frequency 36% +/- 21% (mean +/- SD) and reduced the EPSC amplitude, indicating a major role for NMDA receptors in the light response. CNQX, a non-NMDA receptor antagonist, reduced the light-evoked peak spike frequency 28% +/- 22%. CNQX also caused a voltage- and magnesium-dependent delay in spike onset. AP7 and CNQX, however, did not differ significantly in their effect on the EPSC time course, indicating that postsynaptic cellular properties are responsible for the delay observed in the presence of CNQX. These results show that the NMDA receptor contribution to the excitatory response is increased as the cell is depolarized from rest by non-NMDA input.	UNIV CALIF SAN FRANCISCO,DEPT OPHTHALMOL,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco	DIAMOND, JS (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,BIOENGN GRAD GRP,SAN FRANCISCO,CA 94143, USA.		Diamond, Jeffrey/C-1835-2015	Diamond, Jeffrey/0000-0002-1770-2629	NATIONAL EYE INSTITUTE [R37EY001869, T32EY007120, R01EY001869] Funding Source: NIH RePORTER; NEI NIH HHS [EY07120, EY01869] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ARMSTRONGJAMES M, 1993, J NEUROSCI, V13, P2149; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P107; BEKKERS JM, 1990, COLD SH Q B, V55, P131; BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; BELGUM JH, 1984, J PHYSIOL-LONDON, V354, P273, DOI 10.1113/jphysiol.1984.sp015375; BOOS R, 1990, J NEUROPHYSIOL, V64, P1368, DOI 10.1152/jn.1990.64.5.1368; COLEMAN PA, 1989, J NEUROPHYSIOL, V62, P495, DOI 10.1152/jn.1989.62.2.495; COLEMAN PA, 1988, J NEUROSCI, V8, P4728; COLEMAN PA, 1986, BRAIN RES, V381, P172, DOI 10.1016/0006-8993(86)90708-0; CULLCANDY SG, 1987, NATURE, V325, P525, DOI 10.1038/325525a0; DALE N, 1985, J PHYSIOL-LONDON, V363, P35, DOI 10.1113/jphysiol.1985.sp015694; DALE N, 1986, J NEUROSCI, V6, P2653; DAVIES J, 1980, BRIT J PHARMACOL, V70, pP52; DICKENSON AH, 1990, BRAIN RES, V506, P31, DOI 10.1016/0006-8993(90)91195-M; DIXON DB, 1992, J PHYSIOL-LONDON, V449, P589, DOI 10.1113/jphysiol.1992.sp019103; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P659, DOI 10.1113/jphysiol.1991.sp018730; EKEBERG O, 1991, BIOL CYBERN, V65, P81, DOI 10.1007/BF00202382; FAIN GL, 1973, SCIENCE, V180, P1178, DOI 10.1126/science.180.4091.1178; FOHLMEISTER JF, 1990, BRAIN RES, V510, P343, DOI 10.1016/0006-8993(90)91388-W; FORSYTHE ID, 1988, J PHYSIOL-LONDON, V396, P515, DOI 10.1113/jphysiol.1988.sp016975; FOX K, 1990, J NEUROPHYSIOL, V64, P1413, DOI 10.1152/jn.1990.64.5.1413; FRUMKES TE, 1981, J NEUROPHYSIOL, V45, P783, DOI 10.1152/jn.1981.45.4.783; GRILLNER S, 1990, COLD SH Q B, V55, P779; HESTRIN S, 1990, J PHYSIOL-LONDON, V422, P203, DOI 10.1113/jphysiol.1990.sp017980; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P449, DOI 10.1113/jphysiol.1952.sp004717; HONORE T, 1988, SCIENCE, V241, P701, DOI 10.1126/science.2899909; JAHR CE, 1990, J NEUROSCI, V10, P3178; JAHR CE, 1987, NATURE, V325, P522, DOI 10.1038/325522a0; JONES KA, 1988, J NEUROSCI, V8, P3522; KWON YH, 1992, J NEUROPHYSIOL, V68, P182, DOI 10.1152/jn.1992.68.1.182; KWON YH, 1991, J NEUROPHYSIOL, V66, P414, DOI 10.1152/jn.1991.66.2.414; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; LUKASIEWICZ P, 1988, J NEUROSCI, V8, P4470; LUKASIEWICZ PD, 1985, J PHYSIOL-LONDON, V367, P99, DOI 10.1113/jphysiol.1985.sp015816; MARTIN AR, 1955, J PHYSIOL-LONDON, V130, P114, DOI 10.1113/jphysiol.1955.sp005397; MASSEY SC, 1987, PROG NEUROBIOL, V28, P55, DOI 10.1016/0301-0082(87)90005-0; MASSEY SC, 1990, J NEUROPHYSIOL, V63, P16, DOI 10.1152/jn.1990.63.1.16; MASSEY SC, 1988, J PHYSIOL-LONDON, V405, P635, DOI 10.1113/jphysiol.1988.sp017353; MAYER ML, 1987, PROG NEUROBIOL, V28, P197, DOI 10.1016/0301-0082(87)90011-6; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MCBAIN C, 1992, J NEUROPHYSIOL, V68, P16, DOI 10.1152/jn.1992.68.1.16; MCLARNON JG, 1991, J PHARMACOL METHOD, V26, P105, DOI 10.1016/0160-5402(91)90059-E; MILLER KD, 1989, P NATL ACAD SCI USA, V86, P5183, DOI 10.1073/pnas.86.13.5183; MITTMAN S, 1990, J PHYSIOL-LONDON, V428, P175, DOI 10.1113/jphysiol.1990.sp018206; MITTMAN S, 1990, THESIS U CALIFORNIA; NISHIGORI A, 1990, VISUAL NEUROSCI, V5, P591, DOI 10.1017/S0952523800000754; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; RANDALL AD, 1990, NEUROSCI LETT, V114, P191, DOI 10.1016/0304-3940(90)90070-P; SALT TE, 1989, EXP BRAIN RES, V77, P646; SLAUGHTER MM, 1981, SCIENCE, V211, P182, DOI 10.1126/science.6255566; SLAUGHTER MM, 1983, J NEUROSCI, V3, P1701; SUGA N, 1990, COLD SPRING HARB SYM, V55, P585; TACHIBANA M, 1991, J NEUROSCI, V11, P2199; WATKINS JC, 1989, NMDA RECEPTOR; WERBLIN FS, 1978, J PHYSIOL-LONDON, V280, P449, DOI 10.1113/jphysiol.1978.sp012394; YAZEJIAN B, 1992, J NEUROPHYSIOL, V67, P106	57	88	88	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1993	11	4					725	738		10.1016/0896-6273(93)90082-3	http://dx.doi.org/10.1016/0896-6273(93)90082-3			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MD068	8104431				2022-12-24	WOS:A1993MD06800015
J	LUSKIN, MB				LUSKIN, MB			RESTRICTED PROLIFERATION AND MIGRATION OF POSTNATALLY GENERATED NEURONS DERIVED FROM THE FOREBRAIN SUBVENTRICULAR ZONE	NEURON			English	Article							RAT OLFACTORY-BULB; FETAL MONKEY NEOCORTEX; RECOMBINANT RETROVIRUS; CEREBRAL-CORTEX; CELL-MIGRATION; GRANULE CELLS; SUBEPENDYMAL LAYER; NERVOUS-SYSTEM; MOUSE; LINEAGE	The subventricular zone of the postnatal forebrain produces mainly glia, although it supports limited neurogenesis. To determine whether the subventricular zone is positionally specified, the phenotype and destination of the progeny of subventricular zone cells along the anterior-posterior axis of the lateral ventricles were analyzed. A retroviral lineage tracer containing the E. coli reporter gene lacZ was injected into different parts of the subventricular zone of neonatal rat pups, and at various times thereafter, the expression of beta-galactosidase was detected histochemically or immunohistochemically in the descendants of infected cells. A discrete region of the anterior part of the subventricular zone (SVZa) generated an immense number of neurons that differentiated into granule cells and periglomerular cells of the olfactory bulb-the two major types of interneurons. Thus, the SVZa appears to constitute a specialized source of neuronal progenitor cells. To reach the olfactory bulb, neurons arising in the SVZa migrate several millimeters along a highly restricted route. Guidance cues must be involved to prohibit widespread dispersion of these migrating neurons.			LUSKIN, MB (corresponding author), EMORY UNIV,SCH MED,DEPT ANAT & CELL BIOL,ATLANTA,GA 30322, USA.				NINDS NIH HHS [NS28380] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028380] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKESON RA, 1988, MOL NEUROBIOLOGY OLF, P297; ALTMAN J, 1966, J COMP NEUROL, V126, P337, DOI 10.1002/cne.901260302; ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; BAYER SA, 1983, EXP BRAIN RES, V50, P329; BRINON JG, 1992, CELL TISSUE RES, V269, P289, DOI 10.1007/BF00319620; CHUNG WW, 1991, J COMP NEUROL, V314, P290, DOI 10.1002/cne.903140207; COROTTO FS, 1993, NEUROSCI LETT, V149, P111, DOI 10.1016/0304-3940(93)90748-A; Getchell TV., 1991, SMELL TASTE HLTH DIS, P19; GRAY GE, 1991, NEURON, V6, P211, DOI 10.1016/0896-6273(91)90357-6; Hatten M E, 1993, Curr Opin Neurobiol, V3, P38, DOI 10.1016/0959-4388(93)90033-U; HINDS JW, 1968, J COMP NEUROL, V134, P305, DOI 10.1002/cne.901340305; HINDS JW, 1968, J COMP NEUROL, V134, P287, DOI 10.1002/cne.901340304; HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O; IP NY, 1993, NEURON, V10, P89, DOI 10.1016/0896-6273(93)90245-M; KISHI K, 1990, ARCH HISTOL CYTOL, V53, P219, DOI 10.1679/aohc.53.219; KISHI K, 1987, J COMP NEUROL, V258, P112, DOI 10.1002/cne.902580109; Lallier T., 1990, Seminars in Developmental Biology, V1, P35; LEVINE SM, 1988, J NEUROSCI, V8, P3992; LING EA, 1973, J COMP NEUROL, V149, P43, DOI 10.1002/cne.901490104; LUSKIN MB, 1985, J COMP NEUROL, V242, P611, DOI 10.1002/cne.902420409; LUSKIN MB, 1993, J NEUROSCI, V13, P1730; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; LUSKIN MB, 1992, VISUAL SYSTEM GENESI, P111; LUSKIN MB, 1993, J NIH RES, V5, P60; MARES V, 1978, J COMP NEUROL, V177, P519, DOI 10.1002/cne.901770310; MCCONNELL SK, 1988, BRAIN RES REV, V13, P1, DOI 10.1016/0165-0173(88)90002-1; MORSHEAD CM, 1992, J NEUROSCI, V12, P249; PATTERSON JA, 1973, J COMP NEUROL, V149, P83; PINCHING AJ, 1971, J CELL SCI, V9, P305; PRICE J, 1987, P NATL ACAD SCI USA, V84, P156, DOI 10.1073/pnas.84.1.156; PRICE JL, 1970, J CELL SCI, V7, P91; PRIVAT A, 1975, INT REV CYTOL, V40, P281, DOI 10.1016/S0074-7696(08)60955-9; RAEDLER E, 1978, ANAT EMBRYOL, V154, P267, DOI 10.1007/BF00345657; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425; RAKIC P, 1971, J COMP NEUROL, V141, P283, DOI 10.1002/cne.901410303; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; RAKIC P, 1990, EXPERIENTIA, V46, P882, DOI 10.1007/BF01939380; RAKIC P, 1971, BRAIN RES, V33, P471, DOI 10.1016/0006-8993(71)90119-3; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; SANES JR, 1989, TRENDS NEUROSCI, V12, P21, DOI 10.1016/0166-2236(89)90152-5; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; SCHNEIDER SP, 1978, BRAIN RES BULL, V3, P73, DOI 10.1016/0361-9230(78)90063-1; SKOFF RP, 1980, PATHOL RES PRACT, V168, P279, DOI 10.1016/S0344-0338(80)80270-6; VALVERDE F, 1992, NEUROSCIENCE, V49, P255, DOI 10.1016/0306-4522(92)90094-I; WALSH C, 1988, SCIENCE, V241, P1342, DOI 10.1126/science.3137660; WALSH C, 1992, SCIENCE, V255, P434, DOI 10.1126/science.1734520; YOUNG RW, 1985, DEV BRAIN RES, V21, P229, DOI 10.1016/0165-3806(85)90211-1; 1970, ANAT REC, V166, P257	49	1506	1559	0	29	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1993	11	1					173	189		10.1016/0896-6273(93)90281-U	http://dx.doi.org/10.1016/0896-6273(93)90281-U			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LP430	8338665				2022-12-24	WOS:A1993LP43000016
J	Ryan, TA; Ziv, NE; Smith, SJ				Ryan, TA; Ziv, NE; Smith, SJ			Potentiation of evoked vesicle turnover at individually resolved synaptic boutons	NEURON			English	Article							LONG-TERM POTENTIATION; FROG NEUROMUSCULAR-JUNCTION; TRANSMITTER RELEASE; GLUTAMATE RELEASE; PERFORANT PATH; HIPPOCAMPUS; PROBABILITY; TRANSMISSION; MECHANISM; AREA	We have studied synaptic plasticity in hippocampal cell cultures using a new imaging approach that allows unambiguous discrimination of presynaptic function at the level of single synaptic boutons. Employing a protocol designed to test for use-dependent plasticity resembling N-methyl-D-aspartate receptor-dependent long-term potentiation (NMDA-type LTP), we find that brief tetanic stimuli induce a potentiation of evoked synaptic vesicle turnover that lasts for at least 1 hr. Induction of this clearly presynaptic potentiation is blocked by putative postsynaptic glutamate receptor antagonists, suggesting that a retrograde induction signal might be involved. Potentiation appears to occur approximately equally at boutons of low and high initial release probabilities, and evidently does not involve an increase in the size of the total recycling synaptic vesicle pool.			Ryan, TA (corresponding author), STANFORD UNIV, BECKMAN CTR, SCH MED, DEPT CELLULAR & MOLEC PHYSIOL, STANFORD, CA 94305 USA.		Ziv, Noam/ABA-6551-2020; Ryan, Timothy/AAO-8286-2020	Ziv, Noam/0000-0001-9197-326X; Ryan, Timothy/0000-0003-2533-9548; Smith, Stephen/0000-0002-2290-8701	NIMH NIH HHS [MH48108] Funding Source: Medline; NINDS NIH HHS [NS28587] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH048108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028587] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARANCIO O, 1995, NATURE, V376, P74, DOI 10.1038/376074a0; BASHIR ZI, 1991, NATURE, V349, P156, DOI 10.1038/349156a0; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; BETZ WJ, 1993, J PHYSIOL-LONDON, V460, P287, DOI 10.1113/jphysiol.1993.sp019472; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; COLLINGRIDGE GL, 1995, TRENDS NEUROSCI, V18, P54, DOI 10.1016/0166-2236(95)93868-X; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; DOLPHIN AC, 1982, NATURE, V297, P496, DOI 10.1038/297496a0; EDWARDS F, 1991, NATURE, V350, P271, DOI 10.1038/350271a0; GROVER LM, 1990, NATURE, V347, P477, DOI 10.1038/347477a0; Henkel AW, 1996, P NATL ACAD SCI USA, V93, P1918, DOI 10.1073/pnas.93.5.1918; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; KULLMANN DM, 1995, NEURON, V15, P997, DOI 10.1016/0896-6273(95)90089-6; KULLMANN DM, 1992, NATURE, V357, P240, DOI 10.1038/357240a0; LARKMAN A, 1992, NATURE, V360, P70, DOI 10.1038/360070a0; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; MALGAROLI A, 1995, SCIENCE, V268, P1624, DOI 10.1126/science.7777862; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; MALINOW R, 1994, SCIENCE, V266, P1195, DOI 10.1126/science.7973700; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; MANABE T, 1994, SCIENCE, V265, P1888, DOI 10.1126/science.7916483; MILLER TM, 1984, J CELL BIOL, V98, P685, DOI 10.1083/jcb.98.2.685; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; REUTER H, 1995, NEURON, V14, P773, DOI 10.1016/0896-6273(95)90221-X; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; SCHULZ PE, 1994, J NEUROSCI, V14, P5325; Snedecor GW, 1980, STATISTICAL METHODS, P98; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; VALTORTA F, 1988, J CELL BIOL, V107, P2717, DOI 10.1083/jcb.107.6.2717	35	92	92	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	1996	17	1					125	134		10.1016/S0896-6273(00)80286-X	http://dx.doi.org/10.1016/S0896-6273(00)80286-X			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UY981	8755484	Bronze			2022-12-24	WOS:A1996UY98100013
J	Chiamvimonvat, N; PerezGarcia, MT; Ranjan, R; Marban, E; Tomaselli, GF				Chiamvimonvat, N; PerezGarcia, MT; Ranjan, R; Marban, E; Tomaselli, GF			Depth asymmetries of the pore-lining segments of the Na+ channel revealed by cysteine mutagenesis	NEURON			English	Article							SODIUM-CHANNELS; ACETYLCHOLINE-RECEPTOR; MUTATIONS; SITE; PERMEABILITY; EXPRESSION; PERMEATION; CELLS; NERVE	We used serial cysteine mutagenesis to study the structure of the outer vestibule and selectivity region of the voltage-gated Na+ channel. The voltage dependence of Cd2+ block enabled us to determine the locations within the electrical field of cysteine-substituted mutants in the P segments of all four domains. The fractional electrical distances of the substituted cysteines were compared with the differential sensitivity to modification by sulfhydryl-specific modifying reagents. These experiments indicate that the P segment of domain II is external, while the domain IV P segment is displaced internally, compared with the first and third domain P segments. Sulfhydryls with a steep voltage dependence for Cd2+ block produced changes in monovalent cation selectivity; these included substitutions at the presumed selectivity filter, as well as residues in the domain IV P segment not previously recognized as determinants of selectivity. A new structural model is presented in which each of the P segments contribute unique loops that penetrate the membrane to varying depths to form the channel pore.	JOHNS HOPKINS UNIV, SCH MED, DEPT BIOMED ENGN, BALTIMORE, MD 21205 USA	Johns Hopkins University	Chiamvimonvat, N (corresponding author), JOHNS HOPKINS UNIV, SCH MED, DEPT MED, SECT MOL & CELLULAR CARDIOL, BALTIMORE, MD 21205 USA.		Marban, Eduardo/GWC-8514-2022; Perez-Garcia, M. Teresa/F-5173-2015	Perez-Garcia, M. Teresa/0000-0001-8540-8117	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL050411, P50HL052307] Funding Source: NIH RePORTER; NHLBI NIH HHS [P50 HL52307, R01 HL50411] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; BACKX PH, 1992, SCIENCE, V257, P248, DOI 10.1126/science.1321496; Chiamvimonvat N, 1996, J PHYSIOL-LONDON, V491, P51, DOI 10.1113/jphysiol.1996.sp021195; COLQUHOUN D, 1983, FITTING STAT ANAL SI, P191; Dudley SC, 1995, BIOPHYS J, V69, P1657, DOI 10.1016/S0006-3495(95)80045-7; GUY HR, 1995, SOC GEN PHY, V50, P1; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; HILLE B, 1971, J GEN PHYSIOL, V58, P599, DOI 10.1085/jgp.58.6.599; Hille B, 1992, IONIC CHANNELS EXCIT, P341; HOLLOWAY SF, 1989, PFLUG ARCH EUR J PHY, V414, P613, DOI 10.1007/BF00582125; ISOM LL, 1992, SCIENCE, V256, P839, DOI 10.1126/science.1375395; KREIG PA, 1984, NUCLEIC ACIDS RES, V12, P7057; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; KURZ LL, 1995, BIOPHYS J, V68, P900, DOI 10.1016/S0006-3495(95)80266-3; LIPKIND GM, 1994, BIOPHYS J, V66, P1, DOI 10.1016/S0006-3495(94)80746-5; LU Q, 1995, SCIENCE, V268, P304, DOI 10.1126/science.7716526; MACKINNON R, 1995, NEURON, V14, P889, DOI 10.1016/0896-6273(95)90327-5; NODA M, 1986, NATURE, V322, P826, DOI 10.1038/322826a0; PASCUAL JM, 1995, NEURON, V14, P1055, DOI 10.1016/0896-6273(95)90344-5; PerezGarcia MT, 1996, P NATL ACAD SCI USA, V93, P300, DOI 10.1073/pnas.93.1.300; PUSCH M, 1991, EUR BIOPHYS J, V20, P127, DOI 10.1007/BF01561134; Sather William A., 1994, Current Opinion in Neurobiology, V4, P313, DOI 10.1016/0959-4388(94)90091-4; SATIN J, 1992, SCIENCE, V256, P1202, DOI 10.1126/science.256.5060.1202; SCHETZ JA, 1993, BIOL BULL, V185, P462, DOI 10.2307/1542486; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; TERLAU H, 1991, FEBS LETT, V293, P93, DOI 10.1016/0014-5793(91)81159-6; TOMASELLI GF, 1991, BIOPHYS J, V60, P721, DOI 10.1016/S0006-3495(91)82102-6; TOMASELLI GF, 1993, CIRC RES, V72, P491, DOI 10.1161/01.RES.72.3.491; TOMASELLI GF, 1995, BIOPHYS J, V68, P1814, DOI 10.1016/S0006-3495(95)80358-9; TRIMMER JS, 1989, NEURON, V3, P38; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687; YANG J, 1993, NATURE, V366, P158, DOI 10.1038/366158a0	36	93	97	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY	1996	16	5					1037	1047		10.1016/S0896-6273(00)80127-0	http://dx.doi.org/10.1016/S0896-6273(00)80127-0			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UN480	8630242	hybrid			2022-12-24	WOS:A1996UN48000019
J	Yang, NB; George, AL; Horn, R				Yang, NB; George, AL; Horn, R			Molecular basis of charge movement in voltage-gated sodium channels	NEURON			English	Article							SHAKER K+-CHANNELS; GATING CHARGE; POTASSIUM CHANNELS; S4 REGION; S4-SEQUENCE; MUTATIONS; RESIDUES; IMPORT	Voltage-dependent movement of a sodium channel S4 segment was examined by cysteine scanning mutagenesis and testing accessibility of the residues to hydrophilic cysteine-modifying reagents. These experiments indicate that 2 charged S4 residues move completely from an internally accessible to an externally accessible location in response to depolarization by passage through a short ''channel'' in the protein. The energetic problems of S4 movement have thus been solved in the same way that many ion channels achieve highly selective and rapid ion permeation through an open pore, by restricting the contact region between the permion and its channel.	VANDERBILT UNIV,SCH MED,DEPT PHARMACOL,DEPT MED,NASHVILLE,TN 37232	Vanderbilt University	Yang, NB (corresponding author), JEFFERSON MED COLL,DEPT PHYSIOL,PHILADELPHIA,PA 19107, USA.				NIAMS NIH HHS [AR41691] Funding Source: Medline; NINDS NIH HHS [NS32387] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS032387, R01NS032387] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; ARMSTRONG CM, 1992, PHYSIOL REV, V72, pS5, DOI 10.1152/physrev.1992.72.suppl_4.S5; AULD VJ, 1990, P NATL ACAD SCI USA, V87, P323, DOI 10.1073/pnas.87.1.323; CATTERALL WA, 1986, ANNU REV BIOCHEM, V55, P953, DOI 10.1146/annurev.biochem.55.1.953; Chahine M, 1995, RECEPTOR CHANNEL, V3, P161; CHAHINE M, 1994, PFLUG ARCH EUR J PHY, V427, P136, DOI 10.1007/BF00585952; CHAHINE M, 1994, NEURON, V12, P281, DOI 10.1016/0896-6273(94)90271-2; DURELL SR, 1992, BIOPHYS J, V62, P238, DOI 10.1016/S0006-3495(92)81809-X; FELIG A, 1994, PFLUGERS ARCH, V427, P406; FRENCH RJ, 1996, IN PRESS NEURON; GEORGE AL, 1992, ANN NEUROL, V31, P131, DOI 10.1002/ana.410310203; GUY HR, 1990, TRENDS NEUROSCI, V13, P201; Higuchi R., 1989, PCR TECHNOLOGY, P61; HIRSCHBERG B, 1995, IN PRESS J GEN PHYSL; JAVITCH JA, 1995, NEURON, V14, P825, DOI 10.1016/0896-6273(95)90226-0; LANCELIN JM, 1991, BIOCHEMISTRY-US, V30, P6908, DOI 10.1021/bi00242a014; LIMAN ER, 1991, NATURE, V353, P752, DOI 10.1038/353752a0; LOGOTHETIS DE, 1993, NEURON, V10, P1121, DOI 10.1016/0896-6273(93)90060-5; LOGOTHETIS DE, 1992, NEURON, V8, P531, DOI 10.1016/0896-6273(92)90281-H; LOPEZ GA, 1991, NEURON, V7, P327, DOI 10.1016/0896-6273(91)90271-Z; MADUKE M, 1993, SCIENCE, V260, P364, DOI 10.1126/science.8385804; MARTIN J, 1991, J BIOL CHEM, V266, P18051; MCCORMACK K, 1991, P NATL ACAD SCI USA, V88, P2931, DOI 10.1073/pnas.88.7.2931; MCLAUGHLIN S, 1989, ANNU REV BIOPHYS BIO, V18, P113, DOI 10.1146/annurev.biophys.18.1.113; MERRILL AR, 1990, BIOCHEMISTRY-US, V29, P8529, DOI 10.1021/bi00489a004; MILLER C, 1982, TRANSPORT BIOL MEMBR, P99; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; PEROZO E, 1994, BIOPHYS J, V66, P345, DOI 10.1016/S0006-3495(94)80783-0; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; SIGWORTH FJ, 1993, Q REV BIOPHYS, V27, P1; SLATIN SL, 1994, NATURE, V371, P158, DOI 10.1038/371158a0; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; TOSTESON MT, 1990, BIOPHYS J, V58, P1367, DOI 10.1016/S0006-3495(90)82483-8; UNWIN N, 1995, NATURE, V373, P37, DOI 10.1038/373037a0; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P279, DOI 10.1085/jgp.103.2.279; ZIZI M, 1995, J MEMBRANE BIOL, V144, P121	40	496	511	0	23	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1996	16	1					113	122		10.1016/S0896-6273(00)80028-8	http://dx.doi.org/10.1016/S0896-6273(00)80028-8			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TT307	8562074	Bronze			2022-12-24	WOS:A1996TT30700014
J	HAM, J; BABIJ, C; WHITFIELD, J; PFARR, CM; LALLEMAND, D; YANIV, M; RUBIN, LL				HAM, J; BABIJ, C; WHITFIELD, J; PFARR, CM; LALLEMAND, D; YANIV, M; RUBIN, LL			A C-JUN DOMINANT-NEGATIVE MUTANT PROTECTS SYMPATHETIC NEURONS AGAINST PROGRAMMED CELL-DEATH	NEURON			English	Article							NERVE GROWTH-FACTOR; GENE-EXPRESSION; PROTO-ONCOGENE; RNA-SYNTHESIS; DNA-BINDING; FOS; APOPTOSIS; PHOSPHORYLATION; SURVIVAL; INDUCTION	Sympathetic neurons depend on nerve growth factor (NGF) for survival and die by apoptosis in its absence. We have investigated the pattern of expression of the Jun and Fos family of transcription factors in dying sympathetic neurons using antibodies specific for each family member. When sympathetic neurons are deprived of NGF, the level of c-Jun protein significantly increases, whereas the levels of the other members of the Jun and Fos family remain relatively constant. c-Jun also becomes more phosphorylated, probably on its amino terminal transactivation domain. When microinjected into sympathetiic neurons, an expression vector for a c-Jun dominant negative mutant protects them against NGF withdrawal-induced death, indicating that AP-1 activity is essential for neuronal cell death. Furthermore, overexpression of the full-length c-Jun protein is, in itself, sufficient to induce apoptosis in sympathetic neurons.	INST PASTEUR, CTR NATL RECH SCI, DEPT BIOTECHNOL, UNITE VIRUS ONCOGENES, F-75724 PARIS 15, FRANCE	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	HAM, J (corresponding author), UNIV LONDON UNIV COLL, EISAI LONDON RES LABS, LONDON WC1E 6BT, ENGLAND.		Ham, Jonathan/C-5164-2008; Pfarr, Curt/HHD-1410-2022; lallemand, dominique/O-7445-2017; Whitfield, Jonathan/N-6690-2014	lallemand, dominique/0000-0002-0212-7342; Rubin, Lee/0000-0002-8658-841X; Whitfield, Jonathan/0000-0002-4925-7283				ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682; ALBERTS AS, 1993, DNA CELL BIOL, V12, P935, DOI 10.1089/dna.1993.12.935; ALBERTS AS, 1993, MOL CELL BIOL, V13, P2104, DOI 10.1128/MCB.13.4.2104; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BARTEL DP, 1989, GENE DEV, V3, P304, DOI 10.1101/gad.3.3.304; BOHMANN D, 1994, CELL, V78, P973, DOI 10.1016/0092-8674(94)90273-9; BOSHART M, 1985, CELL, V41, P521, DOI 10.1016/S0092-8674(85)80025-8; BOUDREAU N, 1995, SCIENCE, V267, P891, DOI 10.1126/science.7531366; BROWN PH, 1994, ONCOGENE, V9, P791; CASTELLAZZI M, 1991, P NATL ACAD SCI USA, V88, P8890, DOI 10.1073/pnas.88.20.8890; CHEN RH, 1993, P NATL ACAD SCI USA, V90, P10952, DOI 10.1073/pnas.90.23.10952; CHIU R, 1989, CELL, V59, P979, DOI 10.1016/0092-8674(89)90754-X; CURRAN T, 1992, TRANSCRIPTIONAL REGU, P797; D'MELLO SR, 1993, P NATL ACAD SCI USA, V90, P10989, DOI 10.1073/pnas.90.23.10989; DAVIS RJ, 1994, TRENDS BIOCHEM SCI, V19, P470, DOI 10.1016/0968-0004(94)90132-5; DECKWERTH TL, 1993, J CELL BIOL, V123, P1207, DOI 10.1083/jcb.123.5.1207; DEFELIPE C, 1994, J NEUROSCI, V14, P2911; DENG TL, 1993, GENE DEV, V7, P479, DOI 10.1101/gad.7.3.479; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DOHERTY P, 1988, J CELL BIOL, V107, P333, DOI 10.1083/jcb.107.1.333; EDWARDS SN, 1994, J CELL BIOL, V124, P537, DOI 10.1083/jcb.124.4.537; EDWARDS SN, 1991, J NEUROCHEM, V57, P2140, DOI 10.1111/j.1471-4159.1991.tb06434.x; ELLIS RE, 1991, ANNU REV CELL BIOL, V7, P663, DOI 10.1146/annurev.cb.07.110191.003311; ESTUS S, 1994, J CELL BIOL, V127, P1717, DOI 10.1083/jcb.127.6.1717; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; FORSSPETTER S, 1990, NEURON, V5, P187, DOI 10.1016/0896-6273(90)90308-3; FREEMAN RS, 1994, NEURON, V12, P343, DOI 10.1016/0896-6273(94)90276-3; GAGLIARDINI V, 1994, SCIENCE, V263, P826, DOI 10.1126/science.8303301; GARCIA I, 1992, SCIENCE, V258, P302, DOI 10.1126/science.1411528; GIZANGGINSBERG E, 1994, MOL ENDOCRINOL, V8, P249, DOI 10.1210/me.8.2.249; GOLD BG, 1993, NEUROSCI LETT, V154, P129, DOI 10.1016/0304-3940(93)90188-Q; HARLOW E, 1988, ANTIBODIES LABORATOR; HERBER B, 1994, ONCOGENE, V9, P1295; HERR I, 1994, CARCINOGENESIS, V15, P1105, DOI 10.1093/carcin/15.6.1105; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; HILBERG F, 1993, NATURE, V365, P179, DOI 10.1038/365179a0; HIRAI S, 1991, FEBS LETT, V287, P57, DOI 10.1016/0014-5793(91)80015-U; HIRAI SI, 1989, EMBO J, V8, P1433, DOI 10.1002/j.1460-2075.1989.tb03525.x; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; JACOBSON MD, 1994, EMBO J, V13, P1899, DOI 10.1002/j.1460-2075.1994.tb06459.x; JOHNSON EM, 1993, ANNU REV NEUROSCI, V16, P31, DOI 10.1146/annurev.ne.16.030193.000335; JOHNSON MI, 1983, METHOD ENZYMOL, V103, P334; JOHNSON RS, 1993, GENE DEV, V7, P1309, DOI 10.1101/gad.7.7b.1309; KARIN M, 1994, CURR OPIN CELL BIOL, V6, P415, DOI 10.1016/0955-0674(94)90035-3; KORSCHING S, 1993, J NEUROSCI, V13, P2739; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; LIU ZG, 1994, NATURE, V367, P281, DOI 10.1038/367281a0; LLOYD A, 1991, NATURE, V352, P632, DOI 10.1038/352635a0; MARTIN DP, 1988, J CELL BIOL, V106, P829, DOI 10.1083/jcb.106.3.829; Martin Seamus J., 1993, Trends in Cell Biology, V3, P141, DOI 10.1016/0962-8924(93)90128-N; MILLIGAN CE, 1994, J NEUROBIOL, V25, P1005, DOI 10.1002/neu.480250809; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; NUNEZ G, 1990, J IMMUNOL, V144, P3602; OPPENHEIM RW, 1990, DEV BIOL, V138, P104, DOI 10.1016/0012-1606(90)90180-Q; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; PFARR CM, 1994, CELL, V76, P747, DOI 10.1016/0092-8674(94)90513-4; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; QIN XQ, 1994, P NATL ACAD SCI USA, V91, P10918, DOI 10.1073/pnas.91.23.10918; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; RAFF MC, 1993, SCIENCE, V262, P695, DOI 10.1126/science.8235590; Rubin Lee L., 1994, Current Opinion in Neurobiology, V4, P696, DOI 10.1016/0959-4388(94)90012-4; RUBIN LL, 1993, CURR BIOL, V3, P391, DOI 10.1016/0960-9822(93)90211-6; SCHLINGENSIEPEN KH, 1993, DEV GENET, V14, P305, DOI 10.1002/dvg.1020140408; SCHUTTE J, 1989, CELL, V59, P987, DOI 10.1016/0092-8674(89)90755-1; SCOTT SA, 1990, J NEUROBIOL, V21, P630, DOI 10.1002/neu.480210410; SMEAL T, 1991, NATURE, V354, P494, DOI 10.1038/354494a0; SMEAL T, 1992, MOL CELL BIOL, V12, P3507, DOI 10.1128/MCB.12.8.3507; SMEYNE RJ, 1993, NATURE, V363, P166, DOI 10.1038/363166a0; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; SUDA K, 1978, P NATL ACAD SCI USA, V75, P4042, DOI 10.1073/pnas.75.8.4042; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; WISDOM R, 1993, MOL CELL BIOL, V13, P7429, DOI 10.1128/MCB.13.12.7429; WORONICZ JD, 1994, NATURE, V367, P277, DOI 10.1038/367277a0; WRIGHT LL, 1983, J NEUROCYTOL, V12, P727, DOI 10.1007/BF01258147; WU XW, 1994, P NATL ACAD SCI USA, V91, P3602, DOI 10.1073/pnas.91.9.3602	78	768	779	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	1995	14	5					927	939		10.1016/0896-6273(95)90331-3	http://dx.doi.org/10.1016/0896-6273(95)90331-3			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QY935	7748560	Bronze			2022-12-24	WOS:A1995QY93500005
J	PORTER, BE; WEIS, J; SANES, JR				PORTER, BE; WEIS, J; SANES, JR			A MOTONEURON-SELECTIVE STOP SIGNAL IN THE SYNAPTIC PROTEIN S-LAMININ	NEURON			English	Article							NEURONAL GROWTH CONES; NEURITE OUTGROWTH; NEUROMUSCULAR-JUNCTION; SULFATE PROTEOGLYCAN; MULTIDOMAIN PROTEIN; TECTAL MEMBRANES; TARGET CONTACT; AXONAL GROWTH; MOTOR NEURONS; CELL-ADHESION	Motor axons preferentially reinnervate original synaptic sites on denervated muscle fibers. We have shown that components of synaptic basal lamina direct this selectivity, and we identified a protein, s-laminin, that is concentrated in synaptic basal lamina. Here, we report that a recombinant s-laminin fragment inhibits neurite outgrowth promoted by laminin. A tripeptide sequence in this fragment, Leu-Arg-Glu (LRE), contributes to this inhibition and is itself sufficient to inhibit outgrowth. LRE-mediated inhibition is selective for motoneuron-like cells and is observed in mixtures with several, but not all, outgrowth-promoting substrates. Growth cones extending on laminin stop for up to several hours upon contacting deposits of the s-laminin fragment. Thus, LRE may serve as a cell type-selective and context-dependent target-derived signal that plays a role in synapse formation.			PORTER, BE (corresponding author), WASHINGTON UNIV,SCH MED,DEPT ANAT & NEUROBIOL,ST LOUIS,MO 63110, USA.		Weis, Joachim/G-1984-2014	Weis, Joachim/0000-0003-3280-6773; Porter, Brenda/0000-0001-6346-7327				BAIRD DH, 1992, J NEUROSCI, V12, P619; BAIRD DH, 1992, J NEUROBIOL, V23, P579, DOI 10.1002/neu.480230511; BANDTLOW C, 1990, J NEUROSCI, V10, P3837, DOI 10.1523/JNEUROSCI.10-12-03837.1990; BANDTLOW CE, 1993, SCIENCE, V259, P80, DOI 10.1126/science.8418499; BASTMEYER M, 1993, J NEUROBIOL, V24, P37, DOI 10.1002/neu.480240104; Bixby J L, 1992, Curr Opin Neurobiol, V2, P66, DOI 10.1016/0959-4388(92)90164-G; BIXBY JL, 1985, J NEUROSCI, V5, P3070; BIXBY JL, 1991, ANNU REV CELL BIOL, V7, P117, DOI 10.1146/annurev.cellbio.7.1.117; BUCHANAN J, 1989, J NEUROSCI, V9, P1540; BURGESON RE, 1994, MATRIX BIOL, V14, P209, DOI 10.1016/0945-053X(94)90184-8; BURKE DT, 1986, DNA-J MOLEC CELL BIO, V5, P325, DOI 10.1089/dna.1986.5.325; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; COLE GJ, 1991, NEURON, V7, P1007, DOI 10.1016/0896-6273(91)90345-Z; CONNOR EA, 1994, J NEUROBIOL, V25, P722, DOI 10.1002/neu.480250611; COOPER MW, 1992, J NEUROBIOL, V23, P814, DOI 10.1002/neu.480230704; COX EC, 1990, NEURON, V4, P31, DOI 10.1016/0896-6273(90)90441-H; DAI ZS, 1993, NEURON, V10, P827, DOI 10.1016/0896-6273(93)90199-2; DAILEY ME, 1993, JPN J PHYSL, V43, P183; Dan Yang, 1994, Current Opinion in Neurobiology, V4, P95, DOI 10.1016/0959-4388(94)90037-X; DOHRMANN U, 1986, DEV BIOL, V118, P209, DOI 10.1016/0012-1606(86)90089-8; FAISSNER A, 1990, NEURON, V5, P627, DOI 10.1016/0896-6273(90)90217-4; FUNTE LR, 1993, NEURON, V10, P1069, DOI 10.1016/0896-6273(93)90055-V; GLICKSMAN MA, 1983, J NEUROCYTOL, V12, P661, DOI 10.1007/BF01181529; GREENE LA, 1987, METHOD ENZYMOL, V147, P207; GREENE LA, 1982, DEV BIOL, V91, P305, DOI 10.1016/0012-1606(82)90037-9; GUNDERSEN RW, 1987, DEV BIOL, V121, P423, DOI 10.1016/0012-1606(87)90179-5; HALL ZW, 1993, NEURON S, V10, P99; HAMMARBACK JA, 1985, J NEUROSCI RES, V13, P213, DOI 10.1002/jnr.490130115; HUNTER DD, 1989, CELL, V59, P905, DOI 10.1016/0092-8674(89)90613-2; HUNTER DD, 1989, NATURE, V338, P229, DOI 10.1038/338229a0; HUNTER DD, 1991, J NEUROSCI, V11, P3960; IGARASHI M, 1993, SCIENCE, V259, P77, DOI 10.1126/science.8418498; JONES FS, 1988, P NATL ACAD SCI USA, V85, P2186, DOI 10.1073/pnas.85.7.2186; KAPFHAMMER JP, 1987, J NEUROSCI, V7, P1595; LAGENAUR C, 1987, P NATL ACAD SCI USA, V84, P7753, DOI 10.1073/pnas.84.21.7753; LEMMON V, 1992, J NEUROSCI, V12, P818; LETOURNEAU PC, 1975, DEV BIOL, V44, P92, DOI 10.1016/0012-1606(75)90379-6; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; LUPA MT, 1990, DEV BIOL, V142, P31, DOI 10.1016/0012-1606(90)90148-C; MINER JH, 1994, J CELL BIOL, V127, P879, DOI 10.1083/jcb.127.3.879; MUIR D, 1989, J CELL BIOL, V109, P2353, DOI 10.1083/jcb.109.5.2353; NIES DE, 1991, J BIOL CHEM, V266, P2818; NISHI T, 1991, EUR J BIOCHEM, V202, P643, DOI 10.1111/j.1432-1033.1991.tb16418.x; OAKLEY RA, 1993, J NEUROSCI, V13, P3773; OCHI M, 1992, EXP NEUROL, V118, P291, DOI 10.1016/0014-4886(92)90186-T; PESHEVA P, 1989, J CELL BIOL, V109, P1765, DOI 10.1083/jcb.109.4.1765; RIGGS P, 1990, CURR PROT MOL BIOL, V10; ROLE LW, 1985, J NEUROSCI, V5, P2197; RUPP F, 1992, J NEUROSCI, V12, P3535; RUPP F, 1991, NEURON, V6, P811, DOI 10.1016/0896-6273(91)90177-2; SANES JR, 1990, J CELL BIOL, V111, P1685, DOI 10.1083/jcb.111.4.1685; SANES JR, 1978, J CELL BIOL, V78, P176, DOI 10.1083/jcb.78.1.176; SASAKI M, 1988, J BIOL CHEM, V263, P16536; SCHNAAR RL, 1981, J NEUROSCI, V1, P204; SCHUMACHER M, 1986, NATURE, V319, P407, DOI 10.1038/319407a0; SCHWAB ME, 1993, ANNU REV NEUROSCI, V16, P565, DOI 10.1146/annurev.ne.16.030193.003025; SMITH MA, 1992, MOL CELL NEUROSCI, V3, P406, DOI 10.1016/1044-7431(92)90052-4; SNOW DM, 1991, DEVELOPMENT, V113, P1473; SOREQ H, 1990, P NATL ACAD SCI USA, V87, P9688, DOI 10.1073/pnas.87.24.9688; TAYLOR J, 1993, J NEUROSCI RES, V35, P347, DOI 10.1002/jnr.490350402; TSIM KWK, 1992, NEURON, V8, P677, DOI 10.1016/0896-6273(92)90089-V; TUTTLE JB, 1985, FED PROC, V44, P2760; WALTER J, 1987, DEVELOPMENT, V101, P685; WELLER A, 1991, J CELL BIOL, V112, P355, DOI 10.1083/jcb.112.2.355	64	116	118	0	0	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1995	14	3					549	559		10.1016/0896-6273(95)90311-9	http://dx.doi.org/10.1016/0896-6273(95)90311-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QP230	7695901	Bronze			2022-12-24	WOS:A1995QP23000008
J	SHARMA, K; KORADE, Z; FRANK, E				SHARMA, K; KORADE, Z; FRANK, E			LATE-MIGRATING NEUROEPITHELIAL CELLS FROM THE SPINAL-CORD DIFFERENTIATE INTO SENSORY GANGLION-CELLS AND MELANOCYTES	NEURON			English	Article							NEURAL CREST CELLS; DORSAL-ROOT-GANGLIA; LINEAGE; TUBE	During embryonic development, neural crest cells give rise to many structures in peripheral tissues. Other neural tube cells are thought to contribute only to structures within the CNS. In contrast to this idea, we report a second wave of migration of cells away from the spinal cord occurring after the emigration of crest cells is complete. Neuroepithelial cells from spinal cords in E5 chicken embryos migrate into the periphery and differentiate into neurons and satellite cells within sensory ganglia and into melanocytes in skin and feathers. These results show that some cell types previously considered to be the descendants exclusively of neural crest cells are also derived from neuroepithelial cells in the spinal cord.			SHARMA, K (corresponding author), UNIV PITTSBURGH,SCH MED,DEPT NEUROBIOL,PITTSBURGH,PA 15261, USA.		Korade, Zeljka/AIE-2127-2022	Korade, Zeljka/0000-0002-8690-4507	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024373] Funding Source: NIH RePORTER; NINDS NIH HHS [R01-NS24373] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALTMAN J, 1984, DEV RAT SPINAL; ANDERSON DJ, 1989, NEURON, V3, P1, DOI 10.1016/0896-6273(89)90110-4; BRIZZEE KR, 1949, J COMP NEUROL, V91, P129, DOI 10.1002/cne.900910107; BRONNERFRASER M, 1986, DEV BIOL, V115, P44, DOI 10.1016/0012-1606(86)90226-5; BRONNERFRASER M, 1988, NATURE, V335, P161, DOI 10.1038/335161a0; BRONNERFRASER M, 1989, NEURON, V3, P755, DOI 10.1016/0896-6273(89)90244-4; CARR VM, 1978, J COMP NEUROL, V182, P727; Detwiler SR, 1939, J EXP ZOOL, V81, P415, DOI 10.1002/jez.1400810306; ERICKSON CA, 1993, DEV BIOL, V159, P60, DOI 10.1006/dbio.1993.1221; FRANK E, 1991, DEVELOPMENT, V111, P895; FRITZSCH B, 1990, TRENDS NEUROSCI, V13, P14, DOI 10.1016/0166-2236(90)90056-G; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HAMBURGER V, 1949, J EXP ZOOL, V111, P457, DOI 10.1002/jez.1401110308; HILBER H, 1943, ARCH ENTWICKLUNGSMEC, V142, P100; Horstadius S., 1950, NEURAL CREST; KALCHEIM C, 1986, DEV BIOL, V116, P451, DOI 10.1016/0012-1606(86)90146-6; Le Douarin N, 1973, Dev Biol, V30, P217, DOI 10.1016/0012-1606(73)90061-4; LEDOUARIN NM, 1993, TRENDS NEUROSCI, V16, P64, DOI 10.1016/0166-2236(93)90019-I; LEDOUARIN NM, 1986, SCIENCE, V231, P1515, DOI 10.1126/science.3952494; LUNN ER, 1987, DEVELOPMENT, V101, P247; NEWGREEN DF, 1986, INT REV CYTOL, V103, P89, DOI 10.1016/S0074-7696(08)60834-7; OAKLEY RA, 1994, DEVELOPMENT, V120, P103; PANNESE E, 1974, HISTOGENESIS SPINAL; Raven CP, 1937, J COMP NEUROL, V67, P221, DOI 10.1002/cne.900670205; SCHERSON T, 1993, DEVELOPMENT, V118, P1049; SELLECK MAJ, 1993, DEV BIOL, V159, P1, DOI 10.1006/dbio.1993.1217; SERBEDZIJA GN, 1989, DEVELOPMENT, V106, P809; SHARMA K, 1994, DEVELOPMENT, V120, P1315; TANAKA H, 1990, DEVELOPMENT, V110, P565; WESTON JA, 1966, DEV BIOL, V14, P246, DOI 10.1016/0012-1606(66)90015-7; WESTON JA, 1963, DEV BIOL, V6, P279, DOI 10.1016/0012-1606(63)90016-2; YATES RD, 1961, J EXP ZOOL, V147, P167, DOI 10.1002/jez.1401470206	32	59	59	0	0	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1995	14	1					143	152		10.1016/0896-6273(95)90248-1	http://dx.doi.org/10.1016/0896-6273(95)90248-1			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QC548	7826632	Bronze			2022-12-24	WOS:A1995QC54800014
J	SON, YJ; THOMPSON, WJ				SON, YJ; THOMPSON, WJ			SCHWANN-CELL PROCESSES GUIDE REGENERATION OF PERIPHERAL AXONS	NEURON			English	Article							CENTRAL NERVOUS-SYSTEM; RAT SOLEUS MUSCLE; POLYNEURONAL INNERVATION; SKELETAL-MUSCLE; CHICK FORELIMB; NEWBORN RATS; BASAL LAMINA; GROWTH; ELIMINATION; REINNERVATION	Terminal Schwann cells overlying the neuromuscular junction sprout elaborate processes upon muscle denervation. We show here that motor axons use these processes as guides/substrates during regeneration; in so doing, they escape the confines of endplates and grow between endplates to generate polyneuronal innervation. We also show that Schwann cells in the nerve provide similar guidance. Axons extend from the cut end of a nerve in association with Schwann cell processes and appear to navigate along them. The processes extend from axotomized nerves at the same rate and in the same manner as they do from axon-containing nerves. The rate of process extension limits the rate at which axons regenerate. Thus, Schwann cell processes lead and guide peripheral regeneration.	UNIV TEXAS,DEPT ZOOL,AUSTIN,TX 78712	University of Texas System; University of Texas Austin	SON, YJ (corresponding author), UNIV TEXAS,CTR DEV BIOL,AUSTIN,TX 78712, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020480, R37NS020480] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 20480] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abercrombie M, 1942, J EXP BIOL, V19, P266; ANDERSON PN, 1983, NEUROPATH APPL NEURO, V9, P455, DOI 10.1111/j.1365-2990.1983.tb00129.x; ARD MD, 1987, J NEUROCYTOL, V16, P539, DOI 10.1007/BF01668507; ASTROW SH, 1994, J NEUROBIOL, V25, P937, DOI 10.1002/neu.480250804; ASTROW SH, 1992, J NEUROSCI, V12, P1602; BASTIANI MJ, 1986, J NEUROSCI, V6, P3542; BIXBY JL, 1988, J CELL BIOL, V107, P353, DOI 10.1083/jcb.107.1.353; BRAY GM, 1987, J EXP BIOL, V132, P5; BROWN MC, 1981, J PHYSIOL-LONDON, V318, P365; BROWN MC, 1976, J PHYSIOL-LONDON, V261, P387, DOI 10.1113/jphysiol.1976.sp011565; CARPENTER EM, 1992, DEV BIOL, V150, P144, DOI 10.1016/0012-1606(92)90014-8; DAHM LM, 1988, DEV BIOL, V130, P621, DOI 10.1016/0012-1606(88)90357-0; FALLON JR, 1985, J NEUROSCI, V5, P3169; GORIO A, 1983, NEUROSCIENCE, V8, P403, DOI 10.1016/0306-4522(83)90188-4; Gutmann E, 1944, J ANAT, V78, P15; HALL SM, 1986, NEUROPATH APPL NEURO, V12, P401, DOI 10.1111/j.1365-2990.1986.tb00151.x; HEUMANN R, 1987, J CELL BIOL, V104, P1623, DOI 10.1083/jcb.104.6.1623; HOPKINS JM, 1991, GLIA, V4, P46, DOI 10.1002/glia.440040106; IDE C, 1983, BRAIN RES, V288, P61, DOI 10.1016/0006-8993(83)90081-1; JACOBSON S, 1965, EXP NEUROL, V11, P48, DOI 10.1016/0014-4886(65)90022-1; KEYNES RJ, 1987, TRENDS NEUROSCI, V10, P137, DOI 10.1016/0166-2236(87)90037-3; KORNELIUSSEN H, 1976, J NEUROCYTOL, V5, P591, DOI 10.1007/BF01175572; KORNELIUSSEN H, 1976, CELL TISSUE RES, V167, P439, DOI 10.1007/BF00215176; KUFFLER DP, 1986, J COMP NEUROL, V249, P57, DOI 10.1002/cne.902490106; KUGELBERG E, 1970, J NEUROL NEUROSUR PS, V33, P319, DOI 10.1136/jnnp.33.3.319; LANDMESSER LT, 1980, ANNU REV NEUROSCI, V3, P279, DOI 10.1146/annurev.ne.03.030180.001431; LETINSKY MS, 1976, J NEUROCYTOL, V5, P691, DOI 10.1007/BF01181582; LOMO T, 1988, NEUROSCIENCE, V24, P673, DOI 10.1016/0306-4522(88)90360-0; NOAKES PG, 1987, J COMP NEUROL, V259, P330, DOI 10.1002/cne.902590303; PAYER AF, 1979, J COMP NEUROL, V183, P365, DOI 10.1002/cne.901830209; POLITIS MJ, 1982, BRAIN RES, V253, P1, DOI 10.1016/0006-8993(82)90667-9; Ramon y Cajal S., 1928, DEGENERATION REGENER, VI; Reynolds M L, 1993, Curr Opin Neurobiol, V3, P683, DOI 10.1016/0959-4388(93)90139-P; REYNOLDS ML, 1992, J NEUROCYTOL, V21, P50, DOI 10.1007/BF01206897; RICH MM, 1989, J NEUROSCI, V9, P1781, DOI 10.1523/jneurosci.09-05-01781.1989; RILEY DA, 1981, J NEUROCYTOL, V10, P425, DOI 10.1007/BF01262414; SJOBERG J, 1990, BRAIN RES, V529, P79, DOI 10.1016/0006-8993(90)90812-P; SMITH GV, 1988, EXP BRAIN RES, V69, P299; TELLO JF, 1907, TRAB LAB INVEST BIOL, V5, P117	39	354	367	0	16	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1995	14	1					125	132		10.1016/0896-6273(95)90246-5	http://dx.doi.org/10.1016/0896-6273(95)90246-5			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QC548	7826630	Bronze			2022-12-24	WOS:A1995QC54800012
J	DEHAMER, MK; GUEVARA, JL; HANNON, K; OLWIN, BB; CALOF, AL				DEHAMER, MK; GUEVARA, JL; HANNON, K; OLWIN, BB; CALOF, AL			GENESIS OF OLFACTORY RECEPTOR NEURONS IN-VITRO - REGULATION OF PROGENITOR-CELL DIVISIONS BY FIBROBLAST GROWTH-FACTORS	NEURON			English	Article							NEURAL CREST CELLS; STEM-CELLS; HIPPOCAMPAL-NEURONS; NERVOUS-SYSTEM; MESSENGER-RNA; FGF-RECEPTOR; TGF-ALPHA; DIFFERENTIATION; PROLIFERATION; INVITRO	Olfactory receptor neurons are produced continuously in mammalian olfactory epithelium in vivo, but in explant cultures neurogenesis ceases abruptly. We show that in vitro neurogenesis is prolonged by fibroblast growth factors (FGFs), which act in two ways. FCFs increase the likelihood that immediate neuronal precursors (INPs) divide twice, rather than once, before generating neurons; this action requires exposure of INPs to FCFs by early G1. FCFs also cause a distinct subpopulation of explants to generate large numbers of neurons continually for at least several days. The data suggest that FCFs delay differentiation of a committed neuronal transit amplifying cell (the INP) and support proliferation or survival of a rare cell, possibly a stem cell, that acts as a progenitor to INPs.	PURDUE UNIV, DEPT BIOCHEM, W LAFAYETTE, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	DEHAMER, MK (corresponding author), UNIV IOWA, DEPT BIOL SCI, IOWA CITY, IA 52242 USA.		Calof, Anne/A-8644-2013; Olwin, Bradley B/A-1333-2014	Calof, Anne/0000-0003-3676-2499; 	NINDS NIH HHS [NS32174] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032174] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANCHAN RM, 1991, NEURON, V6, P923, DOI 10.1016/0896-6273(91)90233-P; ANDERSON DJ, 1993, ANNU REV NEUROSCI, V16, P129, DOI 10.1146/annurev.ne.16.030193.001021; Baird Andrew, 1994, Current Opinion in Neurobiology, V4, P78, DOI 10.1016/0959-4388(94)90035-3; BASERGA R, 1985, BIOL CELL REPRODUCTI; BIRREN SJ, 1993, DEVELOPMENT, V119, P597; CALOF AL, 1991, J CELL BIOL, V115, P779, DOI 10.1083/jcb.115.3.779; CALOF AL, 1989, NEURON, V3, P115, DOI 10.1016/0896-6273(89)90120-7; CALOF AL, 1991, CIBA F SYMP, V160, P249; CALOF AL, 1994, PRIMARY NEURONAL CEL; CALOF AL, 1994, OLFACTION TASTE, V11, P36; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLEGG CH, 1987, J CELL BIOL, V105, P949, DOI 10.1083/jcb.105.2.949; DELL KR, 1992, J BIOL CHEM, V267, P21225; DEXTER TM, 1987, ANNU REV CELL BIOL, V3, P423; DICICCOBLOOM E, 1990, J CELL BIOL, V110, P2073, DOI 10.1083/jcb.110.6.2073; DICICCOBLOOM E, 1993, NEURON, V11, P1101, DOI 10.1016/0896-6273(93)90223-E; DIFIGLIA M, 1989, J NEUROSCI, V9, P4158; DIONNE CA, 1990, EMBO J, V9, P2685, DOI 10.1002/j.1460-2075.1990.tb07454.x; ERNSBERGER U, 1989, NEURON, V2, P1275, DOI 10.1016/0896-6273(89)90312-7; FU YM, 1991, J CELL BIOL, V114, P1261, DOI 10.1083/jcb.114.6.1261; GAO WQ, 1991, NEURON, V6, P705, DOI 10.1016/0896-6273(91)90168-Y; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GENNARINI G, 1984, EUR J BIOCHEM, V142, P57, DOI 10.1111/j.1432-1033.1984.tb08250.x; GENSBURGER C, 1987, FEBS LETT, V217, P1, DOI 10.1016/0014-5793(87)81230-9; GIVOL D, 1992, FASEB J, V6, P3362, DOI 10.1096/fasebj.6.15.1464370; Glantz SA., 2012, PRIMER BIOSTATISTICS, V7; GONZALEZ AM, 1990, J CELL BIOL, V110, P753, DOI 10.1083/jcb.110.3.753; Graziadei P. P., 1978, DEV SENSORY SYSTEMS, V9, P55; GRAZIADEI PPC, 1979, J NEUROCYTOL, V8, P1, DOI 10.1007/BF01206454; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; HALL PA, 1989, DEVELOPMENT, V106, P619; HEUER JG, 1990, NEURON, V5, P283, DOI 10.1016/0896-6273(90)90165-C; KALCHEIM C, 1992, P NATL ACAD SCI USA, V89, P1661, DOI 10.1073/pnas.89.5.1661; KILPATRICK TJ, 1993, NEURON, V10, P255, DOI 10.1016/0896-6273(93)90316-J; KLEIN R, 1989, EMBO J, V8, P3701, DOI 10.1002/j.1460-2075.1989.tb08545.x; LEE PL, 1989, SCIENCE, V245, P57, DOI 10.1126/science.2544996; LEVEY MS, 1991, J NEUROSCI, V11, P3556; LILLIEN L, 1992, DEVELOPMENT, V115, P253; MACKAYSIM A, 1991, J NEUROSCI, V11, P979; MAHANTHAPPA NK, 1993, NEURON, V10, P293, DOI 10.1016/0896-6273(93)90319-M; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; MANSUKHANI A, 1990, P NATL ACAD SCI USA, V87, P4378, DOI 10.1073/pnas.87.11.4378; MASON IJ, 1994, MECH DEVELOP, V45, P15, DOI 10.1016/0925-4773(94)90050-7; MILLAN FA, 1991, DEVELOPMENT, V111, P131; MURPHY M, 1990, J NEUROSCI RES, V25, P463, DOI 10.1002/jnr.490250404; MURRAY A, 1993, CELL CYCLE; NOWAKOWSKI RS, 1989, J NEUROCYTOL, V18, P311, DOI 10.1007/BF01190834; OLWIN BB, 1986, BIOCHEMISTRY-US, V25, P3487, DOI 10.1021/bi00360a001; ORNITZ DM, 1992, J BIOL CHEM, V267, P16305; PIXLEY SK, 1992, NEURON, V8, P1191, DOI 10.1016/0896-6273(92)90139-5; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; RATNER N, 1988, P NATL ACAD SCI USA, V85, P6992, DOI 10.1073/pnas.85.18.6992; RAY J, 1993, P NATL ACAD SCI USA, V90, P3602, DOI 10.1073/pnas.90.8.3602; REID HH, 1990, P NATL ACAD SCI USA, V87, P1596, DOI 10.1073/pnas.87.4.1596; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; RUBIN JS, 1989, P NATL ACAD SCI USA, V86, P802, DOI 10.1073/pnas.86.3.802; SCHECTERSON LC, 1992, NEURON, V9, P449, DOI 10.1016/0896-6273(92)90183-E; SHAH NM, 1994, CELL, V77, P349, DOI 10.1016/0092-8674(94)90150-3; SIEBERBLUM M, 1991, NEURON, V6, P949, DOI 10.1016/0896-6273(91)90235-R; SOPRANO KJ, 1992, MOL CELLULAR APPROAC, P73; STARK KL, 1991, DEVELOPMENT, V113, P641; TAKAHASHI T, 1994, P NATL ACAD SCI USA, V91, P375, DOI 10.1073/pnas.91.1.375; TEMPLE S, 1994, DEVELOPMENT, V120, P999; VESCOVI AL, 1993, NEURON, V11, P951, DOI 10.1016/0896-6273(93)90124-A; WATANABE T, 1990, NEURON, V4, P461, DOI 10.1016/0896-6273(90)90058-N; WOODWARD WR, 1992, J NEUROSCI, V12, P142; YEH HJ, 1991, CELL, V64, P209, DOI 10.1016/0092-8674(91)90222-K	68	163	165	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1994	13	5					1083	1097		10.1016/0896-6273(94)90047-7	http://dx.doi.org/10.1016/0896-6273(94)90047-7			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PU763	7946347	Green Submitted			2022-12-24	WOS:A1994PU76300005
J	LI, C; TAKEI, K; GEPPERT, M; DANIELL, L; STENIUS, K; CHAPMAN, ER; JAHN, R; DECAMILLI, P; SUDHOF, TC				LI, C; TAKEI, K; GEPPERT, M; DANIELL, L; STENIUS, K; CHAPMAN, ER; JAHN, R; DECAMILLI, P; SUDHOF, TC			SYNAPTIC TARGETING OF RABPHILIN-3A, A SYNAPTIC VESICLE CA2+/PHOSPHOLIPID-BINDING PROTEIN, DEPENDS ON RAB3A/3C	NEURON			English	Article							GTP-BINDING PROTEIN; TERMINAL-SPECIFIC PHOSPHOPROTEIN; GLUTATHIONE-S-TRANSFERASE; PHOSPHOLIPID-BINDING; ESCHERICHIA-COLI; BOVINE BRAIN; SYNAPTOTAGMIN; PURIFICATION; ASSOCIATION; NEURONS	rab3A, a low molecular weight CTP-binding protein of synaptic vesicles with a putative function in synaptic vesicle docking, interacts in a GTP-dependent manner with rabphilin-3A, a peripheral membrane protein that binds Ca2+ and phospholipids. We now show that rabphilin-3A is an evolutionarily conserved synaptic vesicle protein that is attached to synaptic vesicle membranes via its N terminus and exhibits a heterogeneous distribution among synapses. In rab3A-deficient mice, rabphilin-3A is decreased in synapses belonging to neurons that primarily express rab3A and accumulates in the perikarya of these neurons. In contrast, neurons expressing significant levels of rab3C still contain normal levels of rabphilin-3A in a synaptic pattern, and rabphilin-3A binds rab3C in vitro. These results suggest that analogous to the membrane recruitment of raf by ras, rab3A and rab3C may function in recruiting rabphilin-3A to the synaptic vesicle membrane in a GTP-dependent manner.	UNIV TEXAS,SW MED CTR,HOWARD HUGHES MED INST,DALLAS,TX 75235; YALE UNIV,SCH MED,DEPT CELL BIOL,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,DEPT PHARMACOL,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,HOWARD HUGHES MED INST,NEW HAVEN,CT 06510	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Yale University; Yale University; Howard Hughes Medical Institute; Yale University	LI, C (corresponding author), UNIV TEXAS,SW MED CTR,DEPT MOLEC GENET,DALLAS,TX 75235, USA.			Chapman, Edwin/0000-0001-9787-8140; Jahn, Reinhard/0000-0003-1542-3498; Takei, Kohji/0000-0002-6555-9425	NATIONAL CANCER INSTITUTE [P01CA046128] Funding Source: NIH RePORTER; NCI NIH HHS [CA46128] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BORDIER C, 1981, J BIOL CHEM, V256, P1604; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; BURTON J, 1993, NATURE, V361, P464, DOI 10.1038/361464a0; DAVLETOV B, 1993, J BIOL CHEM, V268, P6816; DECAMILLI P, 1983, J CELL BIOL, V96, P1337, DOI 10.1083/jcb.96.5.1337; DECAMILLI P, 1983, J CELL BIOL, V96, P1355, DOI 10.1083/jcb.96.5.1355; FARNSWORTH CC, 1991, P NATL ACAD SCI USA, V88, P6196, DOI 10.1073/pnas.88.14.6196; FYKSE EM, 1993, J NEUROSCI, V13, P4997; GEPPERT M, 1991, J BIOL CHEM, V266, P13548; GEPPERT M, 1994, NATURE, V369, P493, DOI 10.1038/369493a0; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; HALL A, 1994, SCIENCE, V264, P1413, DOI 10.1126/science.8197454; HOLZ RW, 1994, J BIOL CHEM, V269, P10229; JAHN R, 1985, P NATL ACAD SCI USA, V82, P4137, DOI 10.1073/pnas.82.12.4137; JOHANNES L, 1994, EMBO J, V13, P2029, DOI 10.1002/j.1460-2075.1994.tb06476.x; JOHNSTON PA, 1989, J BIOL CHEM, V264, P1268; JOHNSTON PA, 1991, NEURON, V7, P101, DOI 10.1016/0896-6273(91)90078-E; KISHIDA S, 1993, J BIOL CHEM, V268, P22259; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MATSUI Y, 1988, J BIOL CHEM, V263, P11071; MATTEOLI M, 1992, J CELL BIOL, V117, P849, DOI 10.1083/jcb.117.4.849; MATTEOLI M, 1991, J CELL BIOL, V115, P625, DOI 10.1083/jcb.115.3.625; NAVONE F, 1986, J CELL BIOL, V103, P2511, DOI 10.1083/jcb.103.6.2511; PERIN MS, 1991, J BIOL CHEM, V266, P623; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; QUEST AFG, 1994, J BIOL CHEM, V269, P2953; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SASAKI T, 1990, J BIOL CHEM, V265, P2333; SHIRATAKI H, 1993, MOL CELL BIOL, V13, P2061, DOI 10.1128/MCB.13.4.2061; SHIRATAKI H, 1992, J BIOL CHEM, V267, P10946; SLOT JW, 1985, EUR J CELL BIOL, V38, P87; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SUDHOF TC, 1985, SCIENCE, V228, P815, DOI 10.1126/science.2988123; TAKEI K, 1992, J NEUROSCI, V12, P489; TOUCHOT N, 1987, P NATL ACAD SCI USA, V84, P8210, DOI 10.1073/pnas.84.23.8210; ULLRICH O, 1993, J BIOL CHEM, V268, P18143; VONMOLLARD GF, 1994, J BIOL CHEM, V269, P10971; VONMOLLARD GF, 1990, P NATL ACAD SCI USA, V87, P1988, DOI 10.1073/pnas.87.5.1988; VONMOLLARD GF, 1991, NATURE, V349, P79, DOI 10.1038/349079a0; YAMAGUCHI T, 1993, J BIOL CHEM, V268, P27164	40	176	183	1	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1994	13	4					885	898		10.1016/0896-6273(94)90254-2	http://dx.doi.org/10.1016/0896-6273(94)90254-2			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PP533	7946335				2022-12-24	WOS:A1994PP53300011
J	THOMAS, KL; LAROCHE, S; ERRINGTON, ML; BLISS, TVP; HUNT, SP				THOMAS, KL; LAROCHE, S; ERRINGTON, ML; BLISS, TVP; HUNT, SP			SPATIAL AND TEMPORAL CHANGES IN SIGNAL-TRANSDUCTION PATHWAYS DURING LTP	NEURON			English	Article							LONG-TERM POTENTIATION; PROTEIN-KINASE-C; MICROTUBULE-ASSOCIATED PROTEINS; IMMEDIATE EARLY GENES; NERVE GROWTH-FACTOR; HIPPOCAMPAL CA1 REGION; MAP KINASE; DENTATE GYRUS; RAT-BRAIN; DIFFERENTIAL EXPRESSION	Following LTP induction in freely moving rats, in situ hybridization revealed discrete changes in the expression of one isoform in each of four families of serine/threonine kinases constitutively expressed in the dentate gyrus of the hippocampus. Expression of the alpha isoform of CaMKII showed a transient increase over the soma and a more persistent increase over the dendritic field of dentate granule cells. Of the PKC isoforms, only gamma PKC was up-regulated substantially 2 hr after LTP induction, declining to control levels 48 hr later. An increase in the expression of mRNA for ERK2 and raf-1 was seen at 24 hr only. These results show that, during the maintenance phase of LTP in the hippocampus, there are selective increases in the expression of serine/threonine kinases and that these increases have specific and characteristic temporal and spatial profiles.	UNIV PARIS 11, NEUROBIOL APPRENTISSAGE & MEMOIRE LAB, CNRS, URA 1491, F-91405 ORSAY, FRANCE; NATL INST MED RES, DIV NEUROPHYSIOL & NEUROPHARMACOL, LONDON NW7 1AA, ENGLAND	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; MRC National Institute for Medical Research	THOMAS, KL (corresponding author), MRC, DIV MICROBIOL, MOLEC BIOL LAB, HILLS RD, CAMBRIDGE CB2 2QH, CAMBS, ENGLAND.		Thomas, Kerrie L/A-6509-2010; HUNT, STEPHEN P/C-1646-2008	Thomas, Kerrie L/0000-0003-3355-9583; 				ABELIOVICH A, 1993, CELL, V75, P1253, DOI 10.1016/0092-8674(93)90613-U; Abraham W.C., 1991, KINDLING SYNAPTIC PL, P92; ABRAHAM WC, 1991, MOL NEUROBIOL, V5, P297, DOI 10.1007/BF02935553; ABRAHAM WC, 1993, NEUROSCIENCE, V56, P717, DOI 10.1016/0306-4522(93)90369-Q; AHN NG, 1992, J NEUROCHEM, V59, P147, DOI 10.1111/j.1471-4159.1992.tb08885.x; ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; ASZTELY F, 1992, EUR J NEUROSCI, V4, P681, DOI 10.1111/j.1460-9568.1992.tb00177.x; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; BASHIR ZI, 1991, NATURE, V349, P156, DOI 10.1038/349156a0; BASHIR ZI, 1993, NATURE, V363, P347, DOI 10.1038/363347a0; BENNETT MK, 1987, P NATL ACAD SCI USA, V84, P1794, DOI 10.1073/pnas.84.7.1794; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; BRANDT SJ, 1987, CELL, V49, P57, DOI 10.1016/0092-8674(87)90755-0; BURGIN KE, 1990, J NEUROSCI, V10, P1788; COLE AJ, 1989, NATURE, V340, P474, DOI 10.1038/340474a0; CURRAN T, 1987, ONCOGENE, V2, P79; DAVIS L, 1987, NATURE, V330, P477, DOI 10.1038/330477a0; DAVIS L, 1990, J NEUROSCI, V10, P3056; DEMMER J, 1993, MOL BRAIN RES, V17, P279, DOI 10.1016/0169-328X(93)90012-E; DENT P, 1992, SCIENCE, V257, P1404, DOI 10.1126/science.1326789; DRAGUNOW M, 1989, NEUROSCI LETT, V101, P441; DREWES G, 1992, EMBO J, V11, P2131, DOI 10.1002/j.1460-2075.1992.tb05272.x; FAZELI MS, 1993, J NEUROSCI, V13, P1346; FREY U, 1989, NEUROSCI LETT, V97, P135, DOI 10.1016/0304-3940(89)90152-3; GEINISMAN Y, 1991, BRAIN RES, V566, P77, DOI 10.1016/0006-8993(91)91683-R; GOEDERT M, 1991, TRENDS NEUROSCI, V14, P193, DOI 10.1016/0166-2236(91)90105-4; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; GOMEZ N, 1991, NATURE, V353, P170, DOI 10.1038/353170a0; HOWE LR, 1992, CELL, V71, P335, DOI 10.1016/0092-8674(92)90361-F; HUANG YY, 1992, NEUROSCIENCE, V49, P819, DOI 10.1016/0306-4522(92)90359-A; HUBER G, 1984, J NEUROSCI, V4, P151; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; IKAWA S, 1988, MOL CELL BIOL, V8, P2651, DOI 10.1128/MCB.8.6.2651; INOUE M, 1977, J BIOL CHEM, V252, P7610; ISHIKAWA F, 1987, ONCOGENE RES, V1, P243; ISHIKAWA F, 1987, MOL CELL BIOL, V7, P1226, DOI 10.1128/MCB.7.3.1226; KLANN E, 1993, P NATL ACAD SCI USA, V90, P8337, DOI 10.1073/pnas.90.18.8337; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; KRUG M, 1984, BRAIN RES BULL, V13, P39, DOI 10.1016/0361-9230(84)90005-4; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; LAROCHE S, 1989, NEUROSCIENCE, V28, P375, DOI 10.1016/0306-4522(89)90184-X; LIN CR, 1987, P NATL ACAD SCI USA, V84, P5962, DOI 10.1073/pnas.84.16.5962; LISMAN JE, 1988, P NATL ACAD SCI USA, V85, P5320, DOI 10.1073/pnas.85.14.5320; LOVINGER DM, 1987, BRAIN RES, V436, P177, DOI 10.1016/0006-8993(87)91573-3; LYNCH MA, 1994, NEUROSCIENCE, V60, P1, DOI 10.1016/0306-4522(94)90197-X; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; MALINOW R, 1988, NATURE, V335, P820, DOI 10.1038/335820a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MATSUDA S, 1992, EMBO J, V11, P973, DOI 10.1002/j.1460-2075.1992.tb05136.x; MATUS A, 1988, ANNU REV NEUROSCI, V11, P29, DOI 10.1146/annurev.neuro.11.1.29; MCGLADEMCCULLOH E, 1993, NATURE, V362, P640, DOI 10.1038/362640a0; MIHALY A, 1990, NEUROSCI LETT, V116, P45, DOI 10.1016/0304-3940(90)90384-L; MILBRANDT J, 1987, SCIENCE, V238, P797, DOI 10.1126/science.3672127; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; NAKIELNY S, 1992, EMBO J, V11, P2123, DOI 10.1002/j.1460-2075.1992.tb05271.x; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; OLMSTED JB, 1986, ANNU REV CELL BIOL, V2, P421, DOI 10.1146/annurev.cb.02.110186.002225; ONO Y, 1986, FEBS LETT, V206, P347, DOI 10.1016/0014-5793(86)81010-9; ONO Y, 1988, J BIOL CHEM, V263, P6927; OTANI S, 1989, NEUROSCI LETT, V106, P175, DOI 10.1016/0304-3940(89)90222-X; PONTREMOLI S, 1986, J BIOL CHEM, V261, P8309; RAPP UR, 1988, COLD SPRING HARB SYM, V53, P173, DOI 10.1101/SQB.1988.053.01.023; RAPP UR, 1988, HDB ONCOGENES, P213; RAY LB, 1987, P NATL ACAD SCI USA, V84, P3753; REYMANN KG, 1988, BRAIN RES, V440, P305, DOI 10.1016/0006-8993(88)91000-1; ROSSOMANDO AJ, 1989, P NATL ACAD SCI USA, V86, P6940, DOI 10.1073/pnas.86.18.6940; RYDER K, 1988, P NATL ACAD SCI USA, V85, P1487, DOI 10.1073/pnas.85.5.1487; RYDER K, 1989, P NATL ACAD SCI USA, V86, P1500, DOI 10.1073/pnas.86.5.1500; SACKTOR TC, 1993, P NATL ACAD SCI USA, V90, P8342, DOI 10.1073/pnas.90.18.8342; SAKI M, 1989, CANCER RES, V49, P5633; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; SMIRNOVA T, 1993, SCIENCE, V262, P433, DOI 10.1126/science.8105538; STORM SM, 1990, ONCOGENE, V5, P345; THOMAS KL, 1993, NEUROSCIENCE, V56, P741, DOI 10.1016/0306-4522(93)90371-L; TINGLEY WG, 1993, NATURE, V364, P70, DOI 10.1038/364070a0; WANG JH, 1992, P NATL ACAD SCI USA, V89, P2576, DOI 10.1073/pnas.89.7.2576; WISDEN W, 1990, NEURON, V4, P603, DOI 10.1016/0896-6273(90)90118-Y; WISDEN W, 1991, MOL NEUROBIOLOGY PRA, P205; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O	82	161	162	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	SEP	1994	13	3					737	745		10.1016/0896-6273(94)90040-X	http://dx.doi.org/10.1016/0896-6273(94)90040-X			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PJ284	7917303				2022-12-24	WOS:A1994PJ28400020
J	RYDER, EF; CEPKO, CL				RYDER, EF; CEPKO, CL			MIGRATION PATTERNS OF CLONALLY RELATED GRANULE CELLS AND THEIR PROGENITORS IN THE DEVELOPING CHICK CEREBELLUM	NEURON			English	Article							MULTIPLE ADHESION MOLECULES; DEVELOPING CEREBRAL-CORTEX; ROUS-SARCOMA VIRUS; POSTNATAL-DEVELOPMENT; MOUSE CEREBELLUM; NEURONAL MIGRATION; QUAIL CHIMERAS; SYSTEM; LAYERS; RAT	During cerebellar development, granule neurons and their progenitors undergo complex migrations. To define these migratory paths better, we used replication-incompetent retroviruses to label dividing cells early in cerebellar development. Clonally related granule cells were widely dispersed in both rostrocaudal and mediolateral planes; clones often spanned the midline. The data suggest that granule cell progenitors originate from the ventricular zone along the entire mediolateral extent of the caudal edge of the cerebellum. After reaching the cerebellar surface, progenitors move primarily rostrally and proliferate in the superficial external granule layer. Postmitotic granule cells then migrate long distances medially and laterally in the transverse plane in the deep external granule layer, where previously they had been thought simply to extend transverse processes.			RYDER, EF (corresponding author), HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115, USA.			Ryder, Elizabeth/0000-0002-3520-7648	NINDS NIH HHS [R01NS23021] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023021] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALTMAN J, 1972, J COMP NEUROL, V145, P353, DOI 10.1002/cne.901450305; ALTMAN J, 1978, J COMP NEUROL, V179, P23, DOI 10.1002/cne.901790104; ALTMAN J, 1972, J COMP NEUROL, V145, P399, DOI 10.1002/cne.901450402; Altman J., 1982, CEREBELLUM NEW VISTA, V47, P8; AUSTIN CP, 1990, DEVELOPMENT, V110, P713; BODENSTEIN L, 1986, CELL DIFFER DEV, V19, P19, DOI 10.1016/0045-6039(86)90022-9; BOERKOEL CF, 1993, VIROLOGY, V195, P669, DOI 10.1006/viro.1993.1418; BONNEVIE K, 1946, SKR NORSKE VIDENSK A, V4, P1; Cajal S. R., 1911, HISTOLOGIE SYSTEME N; CEPKO CL, 1993, METHOD ENZYMOL, V225, P933; CEPKO CL, 1992, CURRENT PROTOCOLS MO; CHUONG CM, 1987, J CELL BIOL, V104, P331, DOI 10.1083/jcb.104.2.331; CHUONG CM, 1990, EXPERIENTIA, V46, P892, DOI 10.1007/BF01939381; COSSET FL, 1990, J VIROL, V64, P1070, DOI 10.1128/JVI.64.3.1070-1078.1990; FEIRABEND HKP, 1985, ACTA MORPHOL NEER SC, V23, P115; FIELDSBERRY SC, 1992, P NATL ACAD SCI USA, V89, P693, DOI 10.1073/pnas.89.2.693; FIELDSBERRY SC, 1990, THESIS HARVARD U CAM; GAO WQ, 1993, SCIENCE, V260, P367, DOI 10.1126/science.8469990; GRAY GE, 1991, NEURON, V6, P211, DOI 10.1016/0896-6273(91)90357-6; GRAY GE, 1990, EXPERIENTIA, V46, P929, DOI 10.1007/BF01939386; HALLIDAY AL, 1992, NEURON, V9, P15, DOI 10.1016/0896-6273(92)90216-Z; HALLONET MER, 1990, DEVELOPMENT, V108, P19; HALLONET MER, 1993, EUR J NEUROSCI, V5, P1145, DOI 10.1111/j.1460-9568.1993.tb00969.x; HANAWAY J, 1967, J COMP NEUROL, V131, P1, DOI 10.1002/cne.901310102; HARKMARK W, 1954, ASPECTS CEREBELLAR A, P264; HATTEN ME, 1981, J CELL BIOL, V90, P622, DOI 10.1083/jcb.90.3.622; HAWKES R, 1992, CEREBELLUM REVISITED, P22; HEMOND SG, 1993, J NEUROSCI, V73, P1387; HYNES RO, 1986, J NEUROSCI, V6, P867; LANDAU NR, 1992, J VIROL, V66, P5110, DOI 10.1128/JVI.66.8.5110-5113.1992; Larsell O, 1967, COMP ANATOMY HISTOLO; LINDNER J, 1983, NATURE, V305, P427, DOI 10.1038/305427a0; MARES V, 1970, BRAIN RES, V23, P343, DOI 10.1016/0006-8993(70)90061-2; MARTINEZ S, 1989, EUR J NEUROSCI, V1, P549, DOI 10.1111/j.1460-9568.1989.tb00362.x; MIALE IL, 1961, EXP NEUROL, V4, P277, DOI 10.1016/0014-4886(61)90055-3; Misson JP, 1991, CEREB CORTEX, V1, P221, DOI 10.1093/cercor/1.3.221; MOONEN G, 1982, NATURE, V298, P753, DOI 10.1038/298753a0; MUGNAINI E, 1967, Z ZELLFORSCH MIK ANA, V77, P115, DOI 10.1007/BF00336702; MUGNAINI E, 1983, J COMP NEUROL, V220, P7, DOI 10.1002/cne.902200103; Mugnaini E., 1969, NEUROBIOLOGY CEREBEL, P749; ONO K, 1990, ANAT EMBRYOL, V182, P11; ONO K, 1989, EXP BRAIN RES, V78, P290; OROURKE NA, 1992, SCIENCE, V258, P299, DOI 10.1126/science.1411527; OTERO RA, 1993, J COMP NEUROL, V333, P597, DOI 10.1002/cne.903330411; PARKER BA, 1979, J VIROL, V31, P360, DOI 10.1128/JVI.31.2.360-369.1979; PERSOHN E, 1987, J CELL BIOL, V105, P569, DOI 10.1083/jcb.105.1.569; QUESADA A, 1983, J MORPHOL, V178, P323, DOI 10.1002/jmor.1051780309; RAKIC P, 1971, J COMP NEUROL, V141, P283, DOI 10.1002/cne.901410303; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; RAKIC P, 1990, EXPERIENTIA, V46, P882, DOI 10.1007/BF01939380; Rakic P, 1985, CELL CONTACT ADHESIO, P67; REDDY ST, 1991, P NATL ACAD SCI USA, V88, P10505, DOI 10.1073/pnas.88.23.10505; Schaper A., 1897, ARCH ENTWICKELUNGSME, V5, P81, DOI [10.1007/BF02153233, DOI 10.1007/BF02153233]; STOKER AW, 1988, J VIROL, V62, P1008, DOI 10.1128/JVI.62.3.1008-1015.1988; STOKER AW, 1987, J GEN VIROL, V68, P2481, DOI 10.1099/0022-1317-68-9-2481; VOOGD J, 1992, EUR J MORPHOL, V30, P81; WALSH C, 1993, NATURE, V362, P632, DOI 10.1038/362632a0	57	129	129	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1994	12	5					1011	1029		10.1016/0896-6273(94)90310-7	http://dx.doi.org/10.1016/0896-6273(94)90310-7			19	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NM831	8185941				2022-12-24	WOS:A1994NM83100006
J	KUO, CC; BEAN, BP				KUO, CC; BEAN, BP			NA+ CHANNELS MUST DEACTIVATE TO RECOVER FROM INACTIVATION	NEURON			English	Article							SINGLE SODIUM-CHANNELS; NEURO-BLASTOMA CELLS; SQUID GIANT-AXON; SHAKER POTASSIUM CHANNELS; GATING CURRENTS; MEMBRANE PATCHES; ACTIVATION; PHENYTOIN; BLOCK; KINETICS	We studied the kinetics of recovery from inactivation of voltage-dependent Na+ channels in rat hippocampal CA1 neurons. Recovery proceeded exponentially after an initial delay and was accompanied by a tiny ionic current. Both the delay and the time constant of recovery became shorter with increasing hyperpolarization. Negative to -170 mV, the rate of recovery saturated at similar to 4 ms(-1) (22 degrees C). Recovery from block by the anticonvulsant drug diphenylhydantoin was far slower, but the pattern of voltage dependence was very similar. Our results suggest that, analogous to the coupling between Na+ channel activation and the development of inactivation, recovery from inactivation is coupled to channel deactivation. Such coupling ensures very little ''leak'' Na+ current during recovery and a highly voltage-sensitive repriming of Na+ channels for the next impulse.			KUO, CC (corresponding author), HARVARD UNIV,SCH MED,DEPT NEUROBIOL,BOSTON,MA 02115, USA.			Kuo, Chung-Chin/0000-0001-8208-6829	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035034] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 35034] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALDRICH RW, 1987, J NEUROSCI, V7, P418; ALDRICH RW, 1983, NATURE, V306, P436, DOI 10.1038/306436a0; ARMSTRONG CM, 1981, PHYSIOL REV, V61, P644, DOI 10.1152/physrev.1981.61.3.644; ARMSTRONG CM, 1977, J GEN PHYSIOL, V70, P567, DOI 10.1085/jgp.70.5.567; ARMSTRONG CM, 1979, J GEN PHYSIOL, V74, P691, DOI 10.1085/jgp.74.6.691; BEAN BP, 1981, BIOPHYS J, V35, P595, DOI 10.1016/S0006-3495(81)84815-1; BEAN BP, 1983, J GEN PHYSIOL, V81, P613, DOI 10.1085/jgp.81.5.613; BEZANILLA F, 1991, SCIENCE, V254, P679, DOI 10.1126/science.1948047; BEZANILLA F, 1977, J GEN PHYSIOL, V70, P549, DOI 10.1085/jgp.70.5.549; CACHELIN AB, 1983, J PHYSIOL-LONDON, V340, P389, DOI 10.1113/jphysiol.1983.sp014768; COURTNEY KR, 1983, EUR J PHARMACOL, V88, P1, DOI 10.1016/0014-2999(83)90386-2; DEMO SD, 1991, NEURON, V7, P743, DOI 10.1016/0896-6273(91)90277-7; FERNANDEZ JM, 1984, J PHYSIOL-LONDON, V356, P565, DOI 10.1113/jphysiol.1984.sp015483; FORTI U, 1993, NEURON, V10, P437; GOLDMAN L, 1972, J GEN PHYSIOL, V59, P659, DOI 10.1085/jgp.59.6.659; GOLDMAN L, 1982, J GEN PHYSIOL, V80, P83, DOI 10.1085/jgp.80.1.83; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HILLE B, 1977, J GEN PHYSIOL, V69, P497, DOI 10.1085/jgp.69.4.497; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HORN R, 1981, NATURE, V291, P426, DOI 10.1038/291426a0; HORN R, 1984, J GEN PHYSIOL, V84, P505, DOI 10.1085/jgp.84.4.505; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; KOREN G, 1990, NEURON, V4, P39, DOI 10.1016/0896-6273(90)90442-I; MATSUKI N, 1984, J PHARMACOL EXP THER, V228, P523; MORELLO RS, 1984, J PHARMACOL EXP THER, V230, P156; PATLAK J, 1991, PHYSIOL REV, V71, P1047, DOI 10.1152/physrev.1991.71.4.1047; PATTON DE, 1993, NEURON, V11, P967; QUANDT FN, 1988, MOL PHARMACOL, V34, P557; RUPPERSBERG JP, 1991, NATURE, V353, P657, DOI 10.1038/353657a0; SLESINGER PA, 1991, NEURON, V7, P755, DOI 10.1016/0896-6273(91)90278-8; STIMERS JR, 1985, J GEN PHYSIOL, V85, P65, DOI 10.1085/jgp.85.1.65; VANDENBERG CA, 1984, J GEN PHYSIOL, V84, P535, DOI 10.1085/jgp.84.4.535; VANDENBERG CA, 1991, BIOPHYS J, V60, P1511, DOI 10.1016/S0006-3495(91)82186-5; VANDENBERG CA, 1991, BIOPHYS J, V60, P1499, DOI 10.1016/S0006-3495(91)82185-3; VASSILEV PM, 1988, SCIENCE, V241, P1658, DOI 10.1126/science.2458625; WILLOW M, 1985, MOL PHARMACOL, V27, P549; ZAGOTTA WN, 1990, J GEN PHYSIOL, V95, P29, DOI 10.1085/jgp.95.1.29; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520	38	247	247	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1994	12	4					819	829		10.1016/0896-6273(94)90335-2	http://dx.doi.org/10.1016/0896-6273(94)90335-2			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NH253	8161454				2022-12-24	WOS:A1994NH25300011
J	BESSHO, Y; NAWA, H; NAKANISHI, S				BESSHO, Y; NAWA, H; NAKANISHI, S			SELECTIVE UP-REGULATION OF AN NMDA RECEPTOR SUBUNIT MESSENGER-RNA IN CULTURED CEREBELLAR GRANULE CELLS BY K+-INDUCED DEPOLARIZATION AND NMDA TREATMENT	NEURON			English	Article							GLUTAMATE RECEPTORS; MOLECULAR DIVERSITY; EXPRESSION; DISTINCTION; SURVIVAL; SUBTYPES; NEURONS; BRAIN	High KCl or NMDA treatment promotes the survival of cultured neonatal cerebellar granule cells, and these cells become sensitive to NMDA toxicity after prolonged K+ depolarization. Following both treatments, the NMDA receptor increases, as assessed by fura-2 fluorescence analysis of NMDA receptor-mediated intracellular Ca2+ increase. Northern analysis indicates that both treatments specifically up-regulate NMDAR2A subunit mRNA through an increase in resting intracellular Ca2+ concentration. Antisense oligonucleotide analysis further indicates that NMDAR2A mRNA up-regulation is responsible for NMDA receptor induction. Our results demonstrate that regulation of a specific NMDA receptor subunit mRNA governs NMDA receptor induction, which is thought to play an important role in granule cell survival and death.	COLD SPRING HARBOR LAB,BECKMAN NEUROSCI CTR,COLD SPRING HARBOR,NY 11724	Cold Spring Harbor Laboratory	BESSHO, Y (corresponding author), KYOTO UNIV,FAC MED,DEPT IMMUNOL,KYOTO 606,JAPAN.							BALAZS R, 1988, NEUROSCIENCE, V27, P437, DOI 10.1016/0306-4522(88)90279-5; BALAZS R, 1992, NEUROSCI LETT, V137, P109, DOI 10.1016/0304-3940(92)90310-4; BESSHO Y, 1993, J NEUROCHEM, V60, P253, DOI 10.1111/j.1471-4159.1993.tb05845.x; BETZ H, 1990, NEURON, V5, P383, DOI 10.1016/0896-6273(90)90077-S; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.ne.13.030190.001131; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COX JA, 1990, NEURON, V4, P941, DOI 10.1016/0896-6273(90)90147-8; FAVARON M, 1988, P NATL ACAD SCI USA, V85, P7351, DOI 10.1073/pnas.85.19.7351; FRANKLIN JL, 1992, TRENDS NEUROSCI, V15, P501, DOI 10.1016/0166-2236(92)90103-F; GALLO V, 1987, J NEUROSCI, V7, P2203; GALLO V, 1982, P NATL ACAD SCI-BIOL, V79, P7919, DOI 10.1073/pnas.79.24.7919; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Harlow E, 1988, ANTIBODIES LABORATOR, P471; ISHII T, 1993, J BIOL CHEM, V268, P2836; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; MONAGHAN DT, 1989, ANNU REV PHARMACOL, V29, P365, DOI 10.1146/annurev.pa.29.040189.002053; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; NARAHASHI T, 1974, PHYSIOL REV, V54, P813, DOI 10.1152/physrev.1974.54.4.813; TAKAHASHI T, 1992, NEURON, V9, P1155, DOI 10.1016/0896-6273(92)90073-M; TINGLEY WG, 1993, NATURE, V364, P70, DOI 10.1038/364070a0; VANDERVALK JBF, 1991, EUR J PHARMACOL, V201, P247; WATKINS JC, 1990, TRENDS PHARMACOL SCI, V11, P25, DOI 10.1016/0165-6147(90)90038-A	28	164	165	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1994	12	1					87	95		10.1016/0896-6273(94)90154-6	http://dx.doi.org/10.1016/0896-6273(94)90154-6			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MU493	8292362				2022-12-24	WOS:A1994MU49300008
J	SLESINGER, PA; JAN, YN; JAN, LY				SLESINGER, PA; JAN, YN; JAN, LY			THE S4-S5 LOOP CONTRIBUTES TO THE ION-SELECTIVE PORE OF POTASSIUM CHANNELS	NEURON			English	Article							ACTIVATED K+ CHANNELS; TEA BLOCKADE; S4 REGION; TETRAETHYLAMMONIUM; MUTATIONS; CELLS; CHARYBDOTOXIN; INACTIVATION; MECHANISMS; CONDUCTION	Mutagenesis experiments on voltage-gated K+ channels have suggested that the ion-selective pore is comprised mostly of H5 segments. To see whether regions outside of the H5 segment might also contribute to the pore structure, we have studied the effect of single amino acid substitutions in the segment that connects the S4 and S5 putative transmembrane segments (S4-S5 loop) on various permeation properties of Shaker K+ channels. Mutations in the S4-S5 loop alter the Rb+ selectivity, the single-channel K+ and Rb+ conductances, and the sensitivity to open channel block produced by intracellular tetraethylammonium ion, Ba2+, and Mg2+. The block of Shaker K+ channels by intracellular Mg2+ is surprising, but is reminiscent of the internal Mg2+ blockade of inward rectifier K+ channels. The results suggest that the S4-S5 loop constitutes part of the ion-selective pore. Thus, the S4-S5 loop and the H5 segment are likely to contribute to the long pore characteristic of voltage-gated K+ channels.	UNIV CALIF SAN FRANCISCO,SCH MED,DEPT BIOCHEM,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,SCH MED,HOWARD HUGHES MED INST,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	SLESINGER, PA (corresponding author), UNIV CALIF SAN FRANCISCO,SCH MED,DEPT PHYSIOL,SAN FRANCISCO,CA 94143, USA.			Jan, Lily/0000-0003-3938-8498; Jan, Yuh Nung/0000-0003-1367-6299				ARMSTRONG CM, 1982, J GEN PHYSIOL, V80, P663, DOI 10.1085/jgp.80.5.663; ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; CHOI KL, 1991, P NATL ACAD SCI USA, V88, P5092, DOI 10.1073/pnas.88.12.5092; DURELL SR, 1992, BIOPHYS J, V62, P238, DOI 10.1016/S0006-3495(92)81809-X; EISENMAN G, 1962, BIOPHYS J S, V2, P258; GUY HR, 1990, TRENDS NEUROSCI, V13, P201; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARTMANN HA, 1991, SCIENCE, V251, P942, DOI 10.1126/science.2000495; HEGINBOTHAM L, 1992, SCIENCE, V258, P1152, DOI 10.1126/science.1279807; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; HILLE B, 1978, J GEN PHYSIOL, V72, P409, DOI 10.1085/jgp.72.4.409; Hille B., 1992, IONIC CHANNELS EXCIT; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; HODGKIN AL, 1955, J PHYSIOL-LONDON, V128, P61, DOI 10.1113/jphysiol.1955.sp005291; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; KAVANAUGH MP, 1991, J BIOL CHEM, V266, P7583; KIRSCH GE, 1992, NEURON, V8, P499, DOI 10.1016/0896-6273(92)90278-L; KIRSCH GE, 1992, BIOPHYS J, V62, P136, DOI 10.1016/S0006-3495(92)81800-3; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; LATORRE R, 1983, J MEMBRANE BIOL, V71, P11, DOI 10.1007/BF01870671; LIMAN ER, 1991, NATURE, V353, P752, DOI 10.1038/353752a0; LOGOTHETIS DE, 1992, NEURON, V8, P531, DOI 10.1016/0896-6273(92)90281-H; MACKINNON R, 1989, SCIENCE, V245, P1382, DOI 10.1126/science.2476850; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MACKINNON R, 1990, NEURON, V5, P767, DOI 10.1016/0896-6273(90)90335-D; MacKinnon R, 1991, Curr Opin Neurobiol, V1, P14, DOI 10.1016/0959-4388(91)90005-R; MATSUDA H, 1988, J PHYSIOL-LONDON, V397, P237, DOI 10.1113/jphysiol.1988.sp016998; MILLER C, 1991, SCIENCE, V252, P1092, DOI 10.1126/science.252.5009.1092; Miller Christopher, 1992, Current Biology, V2, P573, DOI 10.1016/0960-9822(92)90146-2; NEWLAND CF, 1992, NEURON, V8, P975, DOI 10.1016/0896-6273(92)90212-V; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; RICHARDS JH, 1991, DIRECTED MUTAGENESIS; VANDENBERG CA, 1987, P NATL ACAD SCI USA, V84, P2560, DOI 10.1073/pnas.84.8.2560; WIESS MS, 1991, SCIENCE, V254, P1627; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; YELLEN G, 1984, J GEN PHYSIOL, V84, P157, DOI 10.1085/jgp.84.2.157; YOOL AJ, 1991, NATURE, V349, P700, DOI 10.1038/349700a0; Zar JH., 1999, BIOSTAT ANAL	40	117	117	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1993	11	4					739	749		10.1016/0896-6273(93)90083-4	http://dx.doi.org/10.1016/0896-6273(93)90083-4			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MD068	8398157				2022-12-24	WOS:A1993MD06800016
J	SIMON, H; LUMSDEN, A				SIMON, H; LUMSDEN, A			RHOMBOMERE-SPECIFIC ORIGIN OF THE CONTRALATERAL VESTIBULO-ACOUSTIC EFFERENT NEURONS AND THEIR MIGRATION ACROSS THE EMBRYONIC MIDLINE	NEURON			English	Article							CHICK-EMBRYO; HORSERADISH-PEROXIDASE; INNER-EAR; CENTRAL ORGANIZATION; NEURAL CREST; HINDBRAIN; SEGMENTATION; NEUROBLASTS; EXPRESSION; MORPHOLOGY	The bilateral efferent supply to the inner ear receptor fields is located in the hindbrain. In ovo injections of DiI into the common facial/vestibulo-acoustic nerve root at 3 days of chick development (stage 16) followed by analysis at 7 days has revealed the origin of the contralateral efferent neurons of the inner ear and their relation to the transient hindbrain rhombomeres. These neurons have a rhombomere 4-specific origin and form their commissure not by axonal outgrowth but, unusually, by transmedian cell migration into the contralateral rhombomere 4 and rhombomere 5. Neurons first project their axons from the ipsilateral basal plate through the VII/VIIIth nerve exit point and then migrate in the opposite direction, crossing the floor plate at stage 19-21. This rhombomere-specific cell behavior provides evidence at the cellular level that segmentation is intimately involved in establishing the pattern of this region of the CNS.			SIMON, H (corresponding author), UNITED MED & DENT SCH GUYS & ST THOMAS HOSP,GUYS HOSP,DIV ANAT & CELL BIOL,MRC,LONDON SE1 9RT,ENGLAND.		Lumsden, Andrew/C-5146-2009					ADDENS J. L., 1933, ZEITSCHR GES ANAT ABT I ZEITSCHR ANAT U ENTWICKLUNGSGESCH, V101, P307, DOI 10.1007/BF02118182; ADDENS JL, 1934, PSYCHIATR NEUROL BLA, V3, P1; ALTSCHULER RA, 1985, BRAIN RES, V338, P1, DOI 10.1016/0006-8993(85)90242-2; ARIENSKAPPERS CU, 1921, BRAIN, V44, P125; BONE Q, 1960, J COMP NEUROL, V115, P27, DOI 10.1002/cne.901150105; BONE Q, 1964, INT REV NEUROBIOL, V6, P99, DOI 10.1016/S0074-7742(08)60768-0; BOOK KJ, 1990, J COMP NEUROL, V297, P55, DOI 10.1002/cne.902970105; BURNS FR, 1991, NEURON, V7, P209, DOI 10.1016/0896-6273(91)90259-3; CASAGRANDE VA, 1990, NEURAL BASES VISUAL, P41; DESMEDT JE, 1961, NATURE, V192, P1263, DOI 10.1038/1921263a0; FRASER S, 1990, NATURE, V344, P431, DOI 10.1038/344431a0; FRITZSCH B, 1984, NEUROSCI LETT, V46, P131, DOI 10.1016/0304-3940(84)90430-0; FRITZSCH B, 1981, NEUROSCI LETT, V26, P191, DOI 10.1016/0304-3940(81)90131-2; FRITZSCH B, 1989, NEUROSCI LETT, V96, P241, DOI 10.1016/0304-3940(89)90385-6; FUCHS PA, 1992, J NEUROSCI, V12, P800; GARCIABELLIDO A, 1979, SCI AM, V241, P102, DOI 10.1038/scientificamerican0779-102; GRAHAM A, 1989, CELL, V57, P367, DOI 10.1016/0092-8674(89)90912-4; GUTHRIE S, 1991, DEVELOPMENT, V112, P221; GUTHRIE S, 1992, DEVELOPMENT, V114, P663; GUTHRIE S, IN PRESS DEVELOPMENT; HALLONET MER, 1990, DEVELOPMENT, V108, P19; HAMBURGER V, 1951, J MORPHOL, V88, P29; HARKMARK W, 1954, J COMP NEUROL, V100, P115, DOI 10.1002/cne.901000107; HEATON MB, 1980, J COMP NEUROL, V189, P61, DOI 10.1002/cne.901890105; HONIG MG, 1986, J CELL BIOL, V106, P181; HUNT P, 1991, DEVELOPMENT, V112, P43; KEYNES RJ, 1988, DEVELOPMENT, V103, P413; LEVIMONTALCINI R, 1950, J MORPHOL, V86, P253, DOI 10.1002/jmor.1050860203; LUMSDEN A, 1990, TRENDS NEUROSCI, V13, P329, DOI 10.1016/0166-2236(90)90144-Y; LUMSDEN A, 1989, NATURE, V337, P424, DOI 10.1038/337424a0; LUMSDEN A, 1991, DEVELOPMENT, V113, P1281; MEREDITH GE, 1986, NEUROSCIENCE, V17, P225, DOI 10.1016/0306-4522(86)90238-1; MEREDITH GE, 1988, ACTA BIOL HUNG, V39, P229; MURPHY P, 1991, DEVELOPMENT, V111, P61; Neal HV, 1918, J MORPHOL, V31, P293, DOI 10.1002/jmor.1050310203; PELLEGRINI M, 1985, BRAIN RES, V344, P1, DOI 10.1016/0006-8993(85)91183-7; PUELLES L, 1978, ANAT EMBRYOL, V152, P205, DOI 10.1007/BF00315925; PUELLES L, 1977, ANAT EMBRYOL, V150, P187, DOI 10.1007/BF00316650; RASMUSSEN GL, 1946, J COMP NEUROL, V84, P141, DOI 10.1002/cne.900840204; ROSSI G, 1965, LARYNGOSCOPE, V75, P212; SIMON DK, 1992, J NEUROSCI, V12, P1212; STRUTZ J, 1982, BRAIN RES, V244, P165, DOI 10.1016/0006-8993(82)90914-3; STRUTZ J, 1982, ACTA OTO-LARYNGOL, V94, P45, DOI 10.3109/00016488209128888; TAN K, 1991, ANAT EMBRYOL, V183, P321; Vaage S., 1969, ERG ANAT ENTWICKLU, V41, P1; WARR WB, 1975, J COMP NEUROL, V161, P159, DOI 10.1002/cne.901610203; WILKINSON DG, 1990, TRENDS NEUROSCI, V13, P335, DOI 10.1016/0166-2236(90)90145-Z; WILKINSON DG, 1989, NATURE, V287, P795	48	97	97	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1993	11	2					209	220		10.1016/0896-6273(93)90179-U	http://dx.doi.org/10.1016/0896-6273(93)90179-U			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LU065	8394719				2022-12-24	WOS:A1993LU06500003
J	MAIMONE, MM; MERLIE, JP				MAIMONE, MM; MERLIE, JP			INTERACTION OF THE 43 KD POSTSYNAPTIC PROTEIN WITH ALL SUBUNITS OF THE MUSCLE NICOTINIC ACETYLCHOLINE-RECEPTOR	NEURON			English	Article							REGULATABLE GLUCOSE TRANSPORTER; MONOCLONAL-ANTIBODIES; ENDOPLASMIC-RETICULUM; TORPEDO-MARMORATA; 43-KDA PROTEIN; ALPHA-SUBUNIT; NEUROMUSCULAR-JUNCTIONS; FUNCTIONAL EXPRESSION; MUTATIONAL ANALYSIS; ALKALINE TREATMENT	The 43 kd postsynaptic protein (43K) plays a key role in the aggregation of muscle nicotinic acetylcholine receptors (AChRs) in the postsynaptic membrane of the neuromuscular junction. By transiently coexpressing 43K and a single AChR subunit (alpha, beta, gamma, or delta) in the quail fibroblast cell line, QT-6, we show that 43K interacts with each subunit to form cell surface clusters in which 43K and receptor subunit are precisely colocalized. Although the level of cell surface expression of single subunits is much lower than that of fully assembled receptor, the clustering of both single subunits and fully assembled AChR occurs efficiently. In addition, 43K-induced clustering is specific for AChR subunits. From these results, we conclude that each pentameric AChR has five potential sites for interacting with 43K during cluster formation.			MAIMONE, MM (corresponding author), WASHINGTON UNIV,SCH MED,DEPT MOLEC BIOL & PHARMACOL,ST LOUIS,MO 63110, USA.							ASHWELL JD, 1990, ANNU REV IMMUNOL, V8, P139, DOI 10.1146/annurev.immunol.8.1.139; BARRANTES FJ, 1980, FEBS LETT, V112, P73, DOI 10.1016/0014-5793(80)80131-1; BLOCH RJ, 1987, J CELL BIOL, V104, P645, DOI 10.1083/jcb.104.3.645; BLOUNT P, 1990, J CELL BIOL, V111, P2613, DOI 10.1083/jcb.111.6.2613; BLOUNT P, 1990, J CELL BIOL, V111, P2601, DOI 10.1083/jcb.111.6.2601; BLOUNT P, 1988, J BIOL CHEM, V263, P1072; BLOUNT P, 1989, NEURON, V3, P349, DOI 10.1016/0896-6273(89)90259-6; BLOUNT P, 1991, CURR TOP MEMBR, V39, P277; BOULTER J, 1986, NATURE, V319, P368, DOI 10.1038/319368a0; BRENNAN C, 1992, DEV BIOL, V149, P100, DOI 10.1016/0012-1606(92)90267-K; BURDEN SJ, 1983, CELL, V35, P687, DOI 10.1016/0092-8674(83)90101-0; BURDEN SJ, 1985, P NATL ACAD SCI USA, V82, P8270, DOI 10.1073/pnas.82.23.8270; CARTAUD J, 1981, J CELL BIOL, V90, P418, DOI 10.1083/jcb.90.2.418; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CLAUDIO T, 1989, FRONTIERS MOL BIOL M, P63; FINERMOORE J, 1984, P NATL ACAD SCI-BIOL, V81, P155, DOI 10.1073/pnas.81.1.155; FLUCHER BE, 1989, NEURON, V3, P163, DOI 10.1016/0896-6273(89)90029-9; FROEHNER SC, 1991, J CELL BIOL, V114, P1, DOI 10.1083/jcb.114.1.1; FROEHNER SC, 1993, ANNU REV NEUROSCI, V16, P347, DOI 10.1146/annurev.ne.16.030193.002023; FROEHNER SC, 1990, NEURON, V5, P403, DOI 10.1016/0896-6273(90)90079-U; FROEHNER SC, 1983, J BIOL CHEM, V258, P7112; GOLDMAN D, 1987, CELL, V48, P965, DOI 10.1016/0092-8674(87)90705-7; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; GU Y, 1991, NEURON, V6, P879, DOI 10.1016/0896-6273(91)90228-R; GU Y, 1991, J CELL BIOL, V114, P799, DOI 10.1083/jcb.114.4.799; GU Y, 1988, NEURON, V1, P117, DOI 10.1016/0896-6273(88)90195-X; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; JAMES DE, 1989, NATURE, V338, P83, DOI 10.1038/338083a0; JOHNSON GD, 1981, J IMMUNOL METHODS, V43, P349, DOI 10.1016/0022-1759(81)90183-6; KLAUSNER R D, 1989, New Biologist, V1, P3; KLAUSNER RD, 1990, CELL, V62, P611, DOI 10.1016/0092-8674(90)90104-M; KORDELI E, 1989, J CELL BIOL, V108, P127, DOI 10.1083/jcb.108.1.127; KUROSAKI T, 1987, FEBS LETT, V214, P253, DOI 10.1016/0014-5793(87)80065-0; LAROCHELLE WJ, 1987, J BIOL CHEM, V262, P8190; LAROCHELLE WJ, 1989, DEV BIOL, V132, P130, DOI 10.1016/0012-1606(89)90211-X; LAROCHELLE WJ, 1986, J BIOL CHEM, V261, P5270; LAROCHELLE WJ, 1990, J NEUROSCI, V10, P3460; LO MMS, 1980, FEBS LETT, V111, P407, DOI 10.1016/0014-5793(80)80838-6; MCMAHAN UJ, 1989, DEV NEUROSCI-BASEL, V11, P227, DOI 10.1159/000111903; MERLIE JP, 1981, J BIOL CHEM, V256, P3605; MERLIE JP, 1983, CELL, V34, P747, DOI 10.1016/0092-8674(83)90531-7; MOSCOVICI C, 1977, CELL, V11, P95, DOI 10.1016/0092-8674(77)90320-8; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; NASTUK MA, 1993, TRENDS NEUROSCI, V16, P72, DOI 10.1016/0166-2236(93)90020-M; NEUBIG RR, 1979, P NATL ACAD SCI USA, V76, P690, DOI 10.1073/pnas.76.2.690; NOAKES PG, 1993, DEV BIOL, V155, P275, DOI 10.1006/dbio.1993.1025; PELHAM HRB, 1989, ANNU REV CELL BIOL, V5, P1, DOI 10.1146/annurev.cb.05.110189.000245; PENG HB, 1985, J CELL BIOL, V100, P1698, DOI 10.1083/jcb.100.5.1698; PHILLIPS WD, 1991, J CELL BIOL, V115, P1713, DOI 10.1083/jcb.115.6.1713; PHILLIPS WD, 1991, SCIENCE, V251, P568, DOI 10.1126/science.1703661; PHILLIPS WD, 1992, BIOESSAYS, V14, P671, DOI 10.1002/bies.950141005; PIPER RC, 1992, J CELL BIOL, V117, P729, DOI 10.1083/jcb.117.4.729; PIPER RC, 1991, AM J PHYSIOL, V260, pC570, DOI 10.1152/ajpcell.1991.260.3.C570; RATNAM M, 1986, BIOCHEMISTRY-US, V25, P2621, DOI 10.1021/bi00357a051; ROSE JK, 1988, ANNU REV CELL BIOL, V4, P257, DOI 10.1146/annurev.cellbio.4.1.257; ROSS AF, 1991, J CELL BIOL, V113, P623, DOI 10.1083/jcb.113.3.623; ROUSSELET A, 1982, EMBO J, V1, P439, DOI 10.1002/j.1460-2075.1982.tb01188.x; SAEDI MS, 1991, J CELL BIOL, V112, P1007, DOI 10.1083/jcb.112.5.1007; SARGENT PB, 1984, J CELL BIOL, V98, P609, DOI 10.1083/jcb.98.2.609; SCHOFIELD PR, 1987, NATURE, V328, P221, DOI 10.1038/328221a0; SEALOCK R, 1984, J CELL BIOL, V98, P2239, DOI 10.1083/jcb.98.6.2239; SMITH MM, 1987, J BIOL CHEM, V262, P4367; SUMIKAWA K, 1989, MOL BRAIN RES, V5, P183, DOI 10.1016/0169-328X(89)90034-X; TZARTOS S, 1986, J NEUROIMMUNOL, V10, P235, DOI 10.1016/0165-5728(86)90105-0; TZARTOS SJ, 1981, J BIOL CHEM, V256, P8635; VERRALL S, 1992, CELL, V68, P23, DOI 10.1016/0092-8674(92)90203-O; YU XM, 1991, NATURE, V352, P64, DOI 10.1038/352064a0	69	90	91	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1993	11	1					53	66		10.1016/0896-6273(93)90270-2	http://dx.doi.org/10.1016/0896-6273(93)90270-2			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LP430	8338668				2022-12-24	WOS:A1993LP43000005
J	OHARA, PJ; SHEPPARD, PO; THOGERSEN, H; VENEZIA, D; HALDEMAN, BA; MCGRANE, V; HOUAMED, KM; THOMSEN, C; GILBERT, TL; MULVIHILL, ER				OHARA, PJ; SHEPPARD, PO; THOGERSEN, H; VENEZIA, D; HALDEMAN, BA; MCGRANE, V; HOUAMED, KM; THOMSEN, C; GILBERT, TL; MULVIHILL, ER			THE LIGAND-BINDING DOMAIN IN METABOTROPIC GLUTAMATE RECEPTORS IS RELATED TO BACTERIAL PERIPLASMIC BINDING-PROTEINS	NEURON			English	Article							COMPLETE NUCLEOTIDE-SEQUENCES; AMINO-ACID-TRANSPORT; SALMONELLA-TYPHIMURIUM; MOLECULAR-CLONING; NMDA RECEPTOR; FUNCTIONAL EXPRESSION; L-ARABINOSE; GUANYLATE-CYCLASE; ACTIVE-TRANSPORT; LEUCINE-BINDING	Receptors for the major excitatory neurotransmitter glutamate include metabotropic (G protein-coupled) and ionotropic (glutamate-gated ion channel) types. These receptors have large, presumably extracellular, amino-terminal domains. Sensitive sequence analysis techniques indicate that the metabotropic receptor extracellular domain is similar to bacterial periplasmic amino acid binding proteins. A structural model built using the observed similarity predicts a ligand-binding site, and mutants with conservative amino acid substitutions at this site are shown to have reduced ligand affinity. The metabotropic receptor extracellular domain is a member of a family of structural domains linked to a variety of receptor types, including ionotropic glutamate receptors.	NOVO NORDISK,DK-2760 MALOV,DENMARK		OHARA, PJ (corresponding author), ZYMOGENET INC,4225 ROOSEVELT WAY NE,SEATTLE,WA 98105, USA.							AARONSON SA, 1991, SCIENCE, V254, P1146, DOI 10.1126/science.1659742; ABE T, 1992, J BIOL CHEM, V267, P13361; ADAMS MD, 1989, J BIOL CHEM, V264, P15739; AMES GF, 1990, FEMS MICROBIOL LETT, V75, P429, DOI 10.1016/S0168-6445(05)80008-7; AMES GFL, 1986, ANNU REV BIOCHEM, V55, P397, DOI 10.1146/annurev.biochem.55.1.397; ANDERSON BF, 1990, NATURE, V344, P784, DOI 10.1038/344784a0; BAIROCH A, 1992, NUCLEIC ACIDS RES, V20, P2019, DOI 10.1093/nar/20.suppl.2019; BAKER EN, 1992, J INORG BIOCHEM, V47, P147, DOI 10.1016/0162-0134(92)84061-Q; BARNES JM, 1992, PROG NEUROBIOL, V39, P113, DOI 10.1016/0301-0082(92)90007-2; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; BERRIDGE MJ, 1982, BIOCHEM J, V206, P587, DOI 10.1042/bj2060587; BETTLER B, 1990, NEURON, V5, P583, DOI 10.1016/0896-6273(90)90213-Y; BETTLER B, 1992, NEURON, V8, P257, DOI 10.1016/0896-6273(92)90292-L; BILOFSKY HS, 1986, NUCLEIC ACIDS RES, V14, P1, DOI 10.1093/nar/14.1.1; BLUNDELL TL, 1987, NATURE, V326, P347, DOI 10.1038/326347a0; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; CONNOLLY ML, 1992, BIOPOLYMERS, V32, P1215, DOI 10.1002/bip.360320911; EGEBJERG J, 1991, NATURE, V351, P745, DOI 10.1038/351745a0; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; GASIC GP, 1992, ANNU REV PHYSIOL, V54, P507, DOI 10.1146/annurev.physiol.54.1.507; GEORGE DG, 1986, NUCLEIC ACIDS RES, V14, P11, DOI 10.1093/nar/14.1.11; GREGOR P, 1989, NATURE, V342, P689, DOI 10.1038/342689a0; GRIBSKOV M, 1987, P NATL ACAD SCI USA, V84, P4355, DOI 10.1073/pnas.84.13.4355; HAMM GH, 1986, NUCLEIC ACIDS RES, V14, P5, DOI 10.1093/nar/14.1.5; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; HIGGINS CF, 1981, P NATL ACAD SCI-BIOL, V78, P6038, DOI 10.1073/pnas.78.10.6038; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; HOSHINO T, 1989, J BACTERIOL, V171, P6300, DOI 10.1128/jb.171.11.6300-6306.1989; HOUAMED KM, 1991, SCIENCE, V252, P1318, DOI 10.1126/science.1656524; JOHANNESSEN M, 1990, THROMB HAEMOSTASIS, V63, P54; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; JONES TA, 1986, EMBO J, V5, P819, DOI 10.1002/j.1460-2075.1986.tb04287.x; KANG CH, 1991, J BIOL CHEM, V266, P23893; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; KNIGHTON DR, 1992, SCIENCE, V258, P130, DOI 10.1126/science.1439761; KUMAR KN, 1991, NATURE, V354, P70, DOI 10.1038/354070a0; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; LANDICK R, 1985, J BIOL CHEM, V260, P8257; LEVITT M, 1976, NATURE, V261, P552, DOI 10.1038/261552a0; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; MASU M, 1991, NATURE, V349, P760, DOI 10.1038/349760a0; MEGURO H, 1992, NATURE, V357, P70, DOI 10.1038/357070a0; MOLNAR E, 1993, NEUROSCIENCE, V53, P307, DOI 10.1016/0306-4522(93)90198-O; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; MOWBRAY SL, 1983, J BIOL CHEM, V258, P7991; NAKANISHI N, 1990, NEURON, V5, P569, DOI 10.1016/0896-6273(90)90212-X; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; NOHNO T, 1986, MOL GEN GENET, V205, P260, DOI 10.1007/BF00430437; OH BH, 1993, IN PRESS J BIOL CHEM; OHNISHI K, 1990, J BIOCHEM-TOKYO, V107, P202, DOI 10.1093/oxfordjournals.jbchem.a123026; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PFLUGRATH JW, 1988, J MOL BIOL, V200, P163, DOI 10.1016/0022-2836(88)90341-5; QUIOCHO FA, 1990, PHILOS T R SOC B, V326, P341, DOI 10.1098/rstb.1990.0016; QUIOCHO FA, 1984, NATURE, V310, P381, DOI 10.1038/310381a0; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; RECASENS M, 1992, MOL NEUROPHARMACOL, V2, P15; SACK JS, 1989, J MOL BIOL, V206, P171, DOI 10.1016/0022-2836(89)90531-7; SACK JS, 1989, J MOL BIOL, V206, P193, DOI 10.1016/0022-2836(89)90532-9; SAKIMURA K, 1992, NEURON, V8, P267, DOI 10.1016/0896-6273(92)90293-M; SAKIMURA K, 1990, FEBS LETT, V272, P73, DOI 10.1016/0014-5793(90)80452-O; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHOLLE A, 1987, MOL GEN GENET, V208, P247, DOI 10.1007/BF00330450; SCHULZ S, 1991, TRENDS PHARMACOL SCI, V12, P116, DOI 10.1016/0165-6147(91)90519-X; SCRIPTURE JB, 1987, J MOL BIOL, V197, P37, DOI 10.1016/0022-2836(87)90607-3; SHYJAN AW, 1992, NEURON, V9, P727, DOI 10.1016/0896-6273(92)90035-C; SINGH S, 1988, NATURE, V334, P708, DOI 10.1038/334708a0; SLADECZEK F, 1985, NATURE, V317, P717, DOI 10.1038/317717a0; SOMMER B, 1992, TRENDS PHARMACOL SCI, V13, P291, DOI 10.1016/0165-6147(92)90088-N; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; STODDARD BL, 1992, NATURE, V358, P774, DOI 10.1038/358774a0; SUN W, 1992, P NATL ACAD SCI USA, V89, P1443, DOI 10.1073/pnas.89.4.1443; TANABE Y, 1992, NEURON, V8, P169, DOI 10.1016/0896-6273(92)90118-W; THORPE DS, 1989, J BIOL CHEM, V264, P6545; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; UCHINO S, 1992, FEBS LETT, V308, P253, DOI 10.1016/0014-5793(92)81286-U; UNWIN N, 1993, J MOL BIOL, V229, P1101, DOI 10.1006/jmbi.1993.1107; VYAS NK, 1991, J BIOL CHEM, V266, P5226; VYAS NK, 1987, NATURE, V327, P635, DOI 10.1038/327635a0; WADA K, 1989, NATURE, V342, P684, DOI 10.1038/342684a0; WERNER P, 1991, NATURE, V351, P742, DOI 10.1038/351742a0; YAMAZAKI M, 1992, BIOCHEM BIOPH RES CO, V183, P886, DOI 10.1016/0006-291X(92)90566-4	84	602	619	2	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1993	11	1					41	52		10.1016/0896-6273(93)90269-W	http://dx.doi.org/10.1016/0896-6273(93)90269-W			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LP430	8338667				2022-12-24	WOS:A1993LP43000004
J	MORISHIMAKAWASHIMA, M; HASEGAWA, M; TAKIO, K; SUZUKI, M; TITANI, K; IHARA, Y				MORISHIMAKAWASHIMA, M; HASEGAWA, M; TAKIO, K; SUZUKI, M; TITANI, K; IHARA, Y			UBIQUITIN IS CONJUGATED WITH AMINO-TERMINALLY PROCESSED TAU IN PAIRED HELICAL FILAMENTS	NEURON			English	Article							ALZHEIMERS-DISEASE; NEUROFIBRILLARY TANGLES; PROTEIN-TAU; MALLORY BODIES; MULTICATALYTIC PROTEINASE; MULTIUBIQUITIN CHAIN; LEWY BODIES; HUMAN-BRAIN; LOCALIZATION; DEGRADATION	We have investigated ubiquitinated paired helical filaments, which produce a proteinaceous smear in SDS-polyacrylamide gel electrophoresis and immunoblotting. The smear consisted largely of the carboxy-terminal portion of tau and ubiquitin. The ubiquitin-targeted protein was identified as tau in paired helical filaments, and the conjugation sites were localized to the microtubule-binding region. Most ubiquitin in paired helical filaments occurred as a monoubiquitinated form, and only a small proportion of ubiquitin formed multiubiquitin chains. There was a ubiquitin-negative smear, in which tau was much less processed in the amino-terminal portion. This strongly suggests that the amino-terminal processing of tau in paired helical filaments precedes its ubiquitination.	INST PHYS & CHEM RES,DIV BIOMOLEC CHARACTERIZAT,WAKO,SAITAMA 351,JAPAN; FUJITA HLTH UNIV,SCH MED,INST COMPREHENS MED SCI,DIV BIOMED POLYMER SCI,TOYOAKE,AICHI 47011,JAPAN	RIKEN; Fujita Health University	MORISHIMAKAWASHIMA, M (corresponding author), UNIV TOKYO,FAC MED,INST BRAIN RES,DEPT NEUROPATHOL,7-3-1 HONGO,BUNKYO KU,TOKYO 113,JAPAN.							BRAAK H, 1986, NEUROSCI LETT, V65, P351, DOI 10.1016/0304-3940(86)90288-0; Brion J. P., 1985, ARCH BIOL BRUX, V95, P229; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; DECARLI C, 1992, NEURODEGENERATION, V1, P113; Denk H, 1979, Int Rev Exp Pathol, V20, P77; FINLEY D, 1991, ANNU REV CELL BIOL, V7, P25, DOI 10.1146/annurev.cb.07.110191.000325; GOEDERT M, 1991, NEUROSCI LETT, V126, P149, DOI 10.1016/0304-3940(91)90541-Z; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; GOEDERT M, 1988, P NATL ACAD SCI USA, V85, P4051, DOI 10.1073/pnas.85.11.4051; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; GREGORI L, 1990, J BIOL CHEM, V265, P8354; HASEGAWA M, 1990, NEURON, V4, P909, DOI 10.1016/0896-6273(90)90144-5; HASEGAWA M, 1992, J BIOL CHEM, V267, P17047; HASEGAWA M, 1993, IN PRESS J NEUROCHEM; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; IHARA Y, 1983, NATURE, V304, P727, DOI 10.1038/304727a0; IHARA Y, 1990, GERONTOLOGY, V36, P15; IHARA Y, 1988, BRAIN RES, V459, P138, DOI 10.1016/0006-8993(88)90293-4; IWATSUBO T, 1992, AM J PATHOL, V140, P277; KIRSCHNER DA, 1986, P NATL ACAD SCI USA, V83, P503, DOI 10.1073/pnas.83.2.503; KONDO J, 1988, NEURON, V1, P827, DOI 10.1016/0896-6273(88)90130-4; KOSIK KS, 1988, NEURON, V1, P817, DOI 10.1016/0896-6273(88)90129-8; KOWALL NW, 1987, ANN NEUROL, V22, P639, DOI 10.1002/ana.410220514; KUZUHARA S, 1988, ACTA NEUROPATHOL, V75, P345, DOI 10.1007/BF00687787; KWAK S, 1991, NEUROSCI LETT, V128, P21, DOI 10.1016/0304-3940(91)90751-E; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; LOWE J, 1990, J PATHOL, V161, P153, DOI 10.1002/path.1711610210; MASAKI T, 1981, BIOCHIM BIOPHYS ACTA, V660, P51, DOI 10.1016/0005-2744(81)90107-8; MAYER A, 1989, SCIENCE, V244, P1480, DOI 10.1126/science.2544030; MAYER RJ, 1991, BIOCHIM BIOPHYS ACTA, V1089, P141, DOI 10.1016/0167-4781(91)90002-4; MORI H, 1987, SCIENCE, V235, P1641, DOI 10.1126/science.3029875; MORI H, 1989, NEUROSCIENCE YEAR S, V1, P165; MORISHIMAKAWASHIMA M, 1991, BRAIN RES, V554, P316, DOI 10.1016/0006-8993(91)90208-D; NUKINA N, 1985, J BIOCHEM-TOKYO, V98, P1715, DOI 10.1093/oxfordjournals.jbchem.a135443; OHTA M, 1988, LAB INVEST, V59, P848; RECHSTEINER M, 1991, CELL, V66, P615, DOI 10.1016/0092-8674(91)90104-7; RIVETT AJ, 1989, ARCH BIOCHEM BIOPHYS, V268, P1, DOI 10.1016/0003-9861(89)90558-4; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; SELKOE DJ, 1982, SCIENCE, V215, P1243, DOI 10.1126/science.6120571; SELKOE DJ, 1985, BANBURY REPORT, V15, P125; VARSHAVSKY A, 1992, CELL, V69, P725, DOI 10.1016/0092-8674(92)90285-K; WATANABE N, 1992, J NEUROCHEM, V58, P960, DOI 10.1111/j.1471-4159.1992.tb09349.x; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; YAMAGUCHI H, 1990, BRAIN RES, V537, P318, DOI 10.1016/0006-8993(90)90377-N; ZATLOUKAL K, 1990, HEPATOLOGY, V11, P652, DOI 10.1002/hep.1840110419; ZATLOUKAL K, 1992, LAB INVEST, V66, P774	47	263	271	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1993	10	6					1151	1160		10.1016/0896-6273(93)90063-W	http://dx.doi.org/10.1016/0896-6273(93)90063-W			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LK373	8391280				2022-12-24	WOS:A1993LK37300015
J	DAI, ZS; PENG, HB				DAI, ZS; PENG, HB			ELEVATION IN PRESYNAPTIC CA2+ LEVEL ACCOMPANYING INITIAL NERVE MUSCLE CONTACT IN TISSUE-CULTURE	NEURON			English	Article							FIBROBLAST GROWTH-FACTOR; XENOPUS CELL-CULTURE; RETINAL GLIAL-CELLS; NEUROMUSCULAR-JUNCTION; TRANSMITTER RELEASE; MESODERM INDUCTION; SKELETAL-MUSCLE; FACTOR RECEPTOR; SPINAL NEURONS; BASAL LAMINA	Nerve-muscle cocultures were used to study the relationship between neuronal Ca2+ level and the earliest nerve-muscle interaction. Xenopus spinal cord neurons were loaded with Ca2+ indicators and monitored by digital video microscopy as a myoball was manipulated into contact with it. Transmitter release was measured from the myoball by whole-cell recording. We observed a 1.5- to 6-fold increase in Ca2+ level in the neurite upon contact with a myoball. Fifty percent of the pairs showing Ca2+ elevation were also positive for neurotransmission. This Ca2+ rise was suppressed by lifting away the myoball, by Ca2+-free solution, or by suramin, a polyanionic compound that interferes with cell surface receptors. This suppression was accompanied by a reduction in transmitter release. The specificity of the nerve-muscle contact-induced Ca2+ rise was shown by its absence upon neuron-neuron contact. Naturally formed nerve-muscle contacts also showed an elevation in presynaptic Ca2+ level. Thus, this elevation appears to be a physiological step in the early stage of synaptogenesis and is likely mediated by muscle-derived molecules.			DAI, ZS (corresponding author), UNIV N CAROLINA,DEPT CELL BIOL & ANAT & CURRICULUM NEUROBIOL,CHAPEL HILL,NC 27599, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023583] Funding Source: NIH RePORTER; NINDS NIH HHS [NS23583] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; ANDERSON MJ, 1984, J CELL BIOL, V99, P1769, DOI 10.1083/jcb.99.5.1769; ANDERSON MJ, 1986, J CELL BIOL, V102, P863, DOI 10.1083/jcb.102.3.863; AUGUSTINE GJ, 1987, ANNU REV NEUROSCI, V10, P633, DOI 10.1146/annurev.ne.10.030187.003221; BAKER LP, 1992, J CELL SCI, V102, P543; BARISH ME, 1991, J PHYSIOL-LONDON, V444, P523, DOI 10.1113/jphysiol.1991.sp018892; BETSHOLTZ C, 1986, P NATL ACAD SCI USA, V83, P6440, DOI 10.1073/pnas.83.17.6440; BIXBY JL, 1991, ANNU REV CELL BIOL, V7, P117, DOI 10.1146/annurev.cellbio.7.1.117; BUCHANAN J, 1989, J NEUROSCI, V9, P1540; COFFEY RJ, 1987, J CELL PHYSIOL, V132, P143, DOI 10.1002/jcp.1041320120; COHEN MW, 1980, J CELL BIOL, V86, P388, DOI 10.1083/jcb.86.2.388; COVAULT J, 1986, J CELL BIOL, V102, P716, DOI 10.1083/jcb.102.3.716; DIMARIO J, 1989, SCIENCE, V244, P688, DOI 10.1126/science.2717945; ERIKSSON AE, 1991, P NATL ACAD SCI USA, V88, P3441, DOI 10.1073/pnas.88.8.3441; EVERS J, 1989, J NEUROSCI, V9, P1523; FENG TP, 1990, J EXP BIOL, V153, P129; GERHART J, 1989, DEVELOPMENT, V107, P37; GONZALEZ AM, 1990, J CELL BIOL, V110, P753, DOI 10.1083/jcb.110.3.753; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HENDERSON LP, 1984, J NEUROSCI, V4, P3140; HIRANO Y, 1989, J NEUROSCI, V9, P1555; HOLLIDAY J, 1991, NEURON, V7, P787, DOI 10.1016/0896-6273(91)90281-4; HOLLIDAY J, 1990, DEV BIOL, V141, P13, DOI 10.1016/0012-1606(90)90098-4; HUANG SS, 1988, J BIOL CHEM, V263, P12608; KATER SB, 1988, TRENDS NEUROSCI, V11, P315, DOI 10.1016/0166-2236(88)90094-X; Katz B., 1969, RELEASE NEURAL TRANS; KAY BK, 1988, DEVELOPMENT, V103, P463; KIDOKORO Y, 1982, P NATL ACAD SCI-BIOL, V79, P6727, DOI 10.1073/pnas.79.21.6727; KLAGSBRUN M, 1991, CELL, V67, P229, DOI 10.1016/0092-8674(91)90173-V; KULLBERG RW, 1977, DEV BIOL, V60, P101, DOI 10.1016/0012-1606(77)90113-0; LANDMESSER L, 1988, DEV BIOL, V130, P645, DOI 10.1016/0012-1606(88)90358-2; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; MINTA A, 1989, J BIOL CHEM, V264, P8171; MITRANI E, 1990, DEVELOPMENT, V109, P387; NAKAJIMA Y, 1980, DEV BIOL, V77, P52, DOI 10.1016/0012-1606(80)90456-X; PENG HB, 1991, NEURON, V6, P237; PENG HB, 1987, SYNAPSE, V1, P10, DOI 10.1002/syn.890010104; PENG HB, 1991, METHOD CELL BIOL, V36, P511; PEPPELENBOSCH MP, 1991, J BIOL CHEM, V266, P19938; PEPPELENBOSCH MP, 1992, CELL, V69, P295, DOI 10.1016/0092-8674(92)90410-E; PURO DG, 1991, BRAIN RES, V548, P329, DOI 10.1016/0006-8993(91)91143-O; PURO DG, 1991, J NEUROSCI, V11, P1873; RAULO E, 1992, J BIOL CHEM, V267, P11408; RUOSLAHTI E, 1991, CELL, V64, P867, DOI 10.1016/0092-8674(91)90308-L; RUTISHAUSER U, 1984, NATURE, V310, P549, DOI 10.1038/310549a0; SANES JR, 1985, TRENDS NEUROSCI, V8, P523, DOI 10.1016/0166-2236(85)90188-2; SCHUBERT D, 1987, J CELL BIOL, V104, P635, DOI 10.1083/jcb.104.3.635; SMITH JC, 1989, DEVELOPMENT, V105, P665; TAKAHASHI T, 1987, J NEUROSCI, V7, P473; WANG LS, 1992, NEURON, V8, P701, DOI 10.1016/0896-6273(92)90091-Q; WILLIAMS DA, 1985, NATURE, V318, P558, DOI 10.1038/318558a0; XIE ZP, 1986, P NATL ACAD SCI USA, V83, P7069, DOI 10.1073/pnas.83.18.7069	54	52	53	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1993	10	5					827	837		10.1016/0896-6273(93)90199-2	http://dx.doi.org/10.1016/0896-6273(93)90199-2			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LD322	8098609				2022-12-24	WOS:A1993LD32200006
J	vonGersdorff, H; Vardi, E; Matthews, G; Sterling, P				vonGersdorff, H; Vardi, E; Matthews, G; Sterling, P			Evidence that vesicles on the synaptic ribbon of retinal bipolar neurons can be rapidly released	NEURON			English	Article							FREEZE-SUBSTITUTION; CALCIUM CHANNELS; CELLS; SYNAPSES; CONES; TRANSMISSION; JUNCTIONS; TERMINALS	We relate the ultrastructure of the giant bipolar synapse in goldfish retina to the jump in capacitance that accompanies depolarization-evoked exocytosis. Mean vesicle diameter is 29 +/- 4 nm, giving 26.4 aF/vesicle, so the maximum evoked capacitance (150 fF within 200 ms) represents fusion of about 5700 vesicles. Two terminals contained, respectively, 45 and 65 ribbon-type synaptic outputs, and a fully loaded ribbon tethers about 110 vesicles. Thus, the tethered pool, about 6000 vesicles, corresponds to the rapidly released pool. Further, the difference between small and large terminals in number of tethered vesicles matches their difference in capacitance jump. This suggests, within a ''fire and reload'' model of exocytosis, that the ribbon translocates synaptic vesicles very rapidly to membrane docking sites, supporting a maximum release rate of 500 vesicles/active zone/s, until the population of tethered vesicles is exhausted.	SUNY STONY BROOK, DEPT NEUROBIOL & BEHAV, STONY BROOK, NY 11794 USA; UNIV PENN, DEPT NEUROSCI, PHILADELPHIA, PA 19104 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Pennsylvania					NEI NIH HHS [EY03821, EY00828, EY06506] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY003821, R01EY000828] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ASHMORE JF, 1983, J PHYSIOL-LONDON, V340, P569, DOI 10.1113/jphysiol.1983.sp014781; BORGES S, 1995, P NATL ACAD SCI USA, V92, P6896, DOI 10.1073/pnas.92.15.6896; BRECKENRIDGE LJ, 1987, P NATL ACAD SCI USA, V84, P1945, DOI 10.1073/pnas.84.7.1945; BREWER PA, 1986, NEUROSCIENCE, V17, P881, DOI 10.1016/0306-4522(86)90052-7; BUNT AH, 1971, BRAIN RES, V25, P571, DOI 10.1016/0006-8993(71)90461-6; BURNS ME, 1995, CELL, V83, P187, DOI 10.1016/0092-8674(95)90160-4; COHEN E, 1992, EUR J NEUROSCI, V4, P506, DOI 10.1111/j.1460-9568.1992.tb00901.x; DECAMILLI P, 1995, NATURE, V375, P450, DOI 10.1038/375450a0; DETOLEDO GA, 1990, J CELL BIOL, V110, P1033, DOI 10.1083/jcb.110.4.1033; Eccles, 2013, PHYSL SYNAPSES; FETTIPLACE R, 1971, J MEMBRANE BIOL, V5, P277, DOI 10.1007/BF01870555; FIELDS RD, 1985, SCIENCE, V228, P197, DOI 10.1126/science.3975637; FREED MA, 1994, VISUAL NEUROSCI, V11, P261, DOI 10.1017/S0952523800001620; GETZ WJ, 1995, CURR BIOL, V5, P1098; GRAY EG, 1971, BRAIN RES, V35, P1, DOI 10.1016/0006-8993(71)90591-9; HARRIS KM, 1995, NEUROPHARMACOLOGY, V34, P1387, DOI 10.1016/0028-3908(95)00142-S; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HEIDELBERGER R, 1992, J PHYSIOL-LONDON, V447, P235, DOI 10.1113/jphysiol.1992.sp019000; ISHIDA AT, 1980, J COMP NEUROL, V191, P315, DOI 10.1002/cne.901910302; Jackson MB, 1995, INT REV NEUROBIOL, V38, P201, DOI 10.1016/S0074-7742(08)60527-9; KANEKO A, 1985, J PHYSIOL-LONDON, V358, P131, DOI 10.1113/jphysiol.1985.sp015544; KIER CK, 1995, J NEUROSCI, V15, P7673; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; Matthews G, 1996, ANNU REV NEUROSCI, V19, P219; PARSONS TD, 1994, NEURON, V13, P875, DOI 10.1016/0896-6273(94)90253-4; PUMPLIN DW, 1981, P NATL ACAD SCI-BIOL, V78, P7210, DOI 10.1073/pnas.78.11.7210; RAO R, 1994, BIOPHYS J, V67, P57, DOI 10.1016/S0006-3495(94)80454-0; RAVIOLA E, 1975, J CELL BIOL, V65, P192, DOI 10.1083/jcb.65.1.192; RIEKE F, 1994, NEURON, V13, P863, DOI 10.1016/0896-6273(94)90252-6; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; ROBITAILLE R, 1990, NEURON, V5, P773, DOI 10.1016/0896-6273(90)90336-E; SAITO T, 1982, J COMP NEUROL, V205, P161, DOI 10.1002/cne.902050207; SEJNOWSKI TJ, 1982, J NEUROCYTOL, V11, P897, DOI 10.1007/BF01148307; SHERRY DM, 1993, J COMP NEUROL, V329, P188, DOI 10.1002/cne.903290204; SIGWORTH FJ, 1995, J NEUROSCI METH, V56, P203, DOI 10.1016/0165-0270(94)00129-5; SMITH RG, 1987, J NEUROSCI METH, V21, P55, DOI 10.1016/0165-0270(87)90102-6; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; TATSUOKA H, 1989, J COMP NEUROL, V290, P343, DOI 10.1002/cne.902900304; TSUKAMOTO Y, 1992, VISION RES, V32, P1809, DOI 10.1016/0042-6989(92)90042-H; USUKURA J, 1987, CELL TISSUE RES, V247, P483, DOI 10.1007/BF00215740; vanSteveninck RRD, 1996, NATURE, V379, P642, DOI 10.1038/379642a0; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; vonGersdorff H, 1996, J NEUROSCI, V16, P115; YAZULLA S, 1992, J COMP NEUROL, V320, P521, DOI 10.1002/cne.903200409	45	242	243	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	1996	16	6					1221	1227		10.1016/S0896-6273(00)80148-8	http://dx.doi.org/10.1016/S0896-6273(00)80148-8			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UU118	8663998	hybrid			2022-12-24	WOS:A1996UU11800019
J	Liu, Y; Jurman, ME; Yellen, G				Liu, Y; Jurman, ME; Yellen, G			Dynamic rearrangement of the outer mouth of a K+ channel during gating	NEURON			English	Article							POTASSIUM CHANNEL; CYSTEINE-SUBSTITUTION; SENSORY RECEPTOR; BINDING-SITE; TEA BLOCKADE; INACTIVATION; BLOCKING; MUTANTS; REGION; MECHANISMS	With prolonged stimulation, voltage-activated Ki channels close by a gating process called inactivation. This inactivation gating can occur by two distinct molecular mechanisms: N-type, in which a tethered particle blocks the intracellular mouth of the pore, and C-type, which involves a closure of the external mouth. The functional motion involved in C-type inactivation was studied by introducing cysteine residues at the outer mouth of Shaker K+ channels through mutagenesis, and by measuring state-dependent changes in accessibility to chemical modification. Modification of three adjacent residues in the outer mouth was 130-10,000-fold faster in the C-type inactivated state than in the closed state. At one position, state-dependent bridging or disulfide crosslinking between subunits was also possible. These results give a consistent picture in which C-type inactivation promotes a local rearrangement and constriction of the channel at the outer mouth.			Liu, Y (corresponding author), HARVARD UNIV, MASSACHUSETTS GEN HOSP, SCH MED, DEPT NEUROBIOL, BOSTON, MA 02114 USA.			Yellen, Gary/0000-0003-4228-7866	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029693] Funding Source: NIH RePORTER; NINDS NIH HHS [NS09774, NS29693, R01 NS029693] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; ALTENBACH C, 1990, SCIENCE, V248, P1088, DOI 10.1126/science.2160734; BAUKROWITZ T, 1995, NEURON, V15, P951, DOI 10.1016/0896-6273(95)90185-X; Baukrowitz T, 1996, SCIENCE, V271, P653, DOI 10.1126/science.271.5249.653; CAREAGA CL, 1992, J MOL BIOL, V226, P1219, DOI 10.1016/0022-2836(92)91063-U; CHOI KL, 1991, P NATL ACAD SCI USA, V88, P5092, DOI 10.1073/pnas.88.12.5092; FALKE JJ, 1987, SCIENCE, V237, P1596, DOI 10.1126/science.2820061; FALKE JJ, 1988, J BIOL CHEM, V263, P14850; GRISSMER S, 1989, BIOPHYS J, V55, P203, DOI 10.1016/S0006-3495(89)82793-6; Gross A, 1996, NEURON, V16, P399, DOI 10.1016/S0896-6273(00)80057-4; GROSS A, 1994, NEURON, V13, P961, DOI 10.1016/0896-6273(94)90261-5; HARTMANN HA, 1991, SCIENCE, V251, P942, DOI 10.1126/science.2000495; HEGINBOTHAM L, 1992, NEURON, V8, P483, DOI 10.1016/0896-6273(92)90276-J; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; JURMAN ME, 1994, BIOTECHNIQUES, V17, P876; KUNKEL TA, 1991, METHOD ENZYMOL, V204, P125; KURZ LL, 1995, BIOPHYS J, V68, P900, DOI 10.1016/S0006-3495(95)80266-3; LIU Y, 1991, BIOPHYS J, V60, P424, DOI 10.1016/S0006-3495(91)82068-9; LOPEZBARNEO J, 1993, RECEPTOR CHANNEL, V1, P61; LORING RH, 1992, MOL BRAIN RES, V15, P113, DOI 10.1016/0169-328X(92)90158-8; LU Q, 1995, SCIENCE, V268, P304, DOI 10.1126/science.7716526; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MACKINNON R, 1990, NEURON, V5, P767, DOI 10.1016/0896-6273(90)90335-D; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; PARDO LA, 1992, P NATL ACAD SCI USA, V89, P2466, DOI 10.1073/pnas.89.6.2466; PASCUAL JM, 1995, NEURON, V14, P1055, DOI 10.1016/0896-6273(95)90344-5; ROBERTS DD, 1986, BIOCHEMISTRY-US, V25, P5595, DOI 10.1021/bi00367a038; Schlief T, 1996, PFLUG ARCH EUR J PHY, V431, P483, DOI 10.1007/BF02191894; SMITH DJ, 1975, BIOCHEMISTRY-US, V14, P766, DOI 10.1021/bi00675a019; Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; TOTH MS, 1993, PROTEIN SCI, V2, P1024; XU M, 1993, J BIOL CHEM, V268, P21505; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; YELLEN G, 1994, BIOPHYS J, V66, P1068, DOI 10.1016/S0006-3495(94)80888-4; YOOL AJ, 1991, NATURE, V349, P700, DOI 10.1038/349700a0; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520	40	395	404	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1996	16	4					859	867		10.1016/S0896-6273(00)80106-3	http://dx.doi.org/10.1016/S0896-6273(00)80106-3			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UG611	8608004	Bronze			2022-12-24	WOS:A1996UG61100019
J	PETTIT, OL; KOOTHAN, T; LIAO, DZ; MALINOW, R				PETTIT, OL; KOOTHAN, T; LIAO, DZ; MALINOW, R			VACCINIA VIRUS TRANSFECTION OF HIPPOCAMPAL SLICE NEURONS	NEURON			English	Article							MACHINERY; VECTOR; BRAIN	Here we describe a technique that uses a recombinant vaccinia virus to transfect neurons in rat hippocampal slices. This technique allows the use of molecular biological manipulations on neuronal tissue while maintaining intact synaptic function. This method should be useful in testing specific hypotheses regarding the role of synaptic proteins.	COLD SPRING HARBOR LAB, COLD SPRING HARBOR, NY 11724 USA	Cold Spring Harbor Laboratory	PETTIT, OL (corresponding author), UNIV IOWA, PROGRAM NEUROSCI, IOWA CITY, IA 52242 USA.							GELLER AI, 1991, J NEUROSCI METH, V36, P91, DOI 10.1016/0165-0270(91)90142-M; GELLER AI, 1988, SCIENCE, V241, P1667, DOI 10.1126/science.2843986; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; JESSELL TM, 1993, CELL 72 NEURON S, V10, P1; LASALLE GL, 1993, SCIENCE, V259, P988, DOI 10.1126/science.8382374; LUTZ PL, 1992, ANNU REV PHYSIOL, V54, P601, DOI 10.1146/annurev.physiol.54.1.601; MACKETT M, 1985, DNA CLONING PRACTICA, P191; PETTIT DL, 1994, SCIENCE, V266, P1881, DOI 10.1126/science.7997883; STEWARD O, 1988, J NEUROSCI, V8, P176; SUDHOF TC, 1993, CELL, V75, P1	10	35	35	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1995	14	4					685	688		10.1016/0896-6273(95)90212-0	http://dx.doi.org/10.1016/0896-6273(95)90212-0			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QU826	7718231	Bronze			2022-12-24	WOS:A1995QU82600002
J	GROSS, A; ABRAMSON, T; MACKINNON, R				GROSS, A; ABRAMSON, T; MACKINNON, R			TRANSFER OF THE SCORPION TOXIN RECEPTOR TO AN INSENSITIVE POTASSIUM CHANNEL	NEURON			English	Article							CA-2+-ACTIVATED K+ CHANNEL; CHARYBDOTOXIN BLOCK; BINDING-SITE; PEPTIDE INHIBITOR; HIGH-CONDUCTANCE; TEA BLOCKADE; RAT-BRAIN; VOLTAGE; TETRAETHYLAMMONIUM; EXPRESSION	Voltage dependent potassium channels belong to a family of structurally related cation channels that underlie the electrical activity of excitable cells. Many potassium channels are blocked with high affinity by scorpion toxins, whereas others are completely insensitive. We transferred toxin sensitivity from the highly sensitive Kv1.3 (KV3) to the insensitive Kv2.1 (DRK1) potassium channel by transferring the stretch of amino acids between transmembrane domains 5/6. We provide evidence that this S5-S6 linker, which has been shown to comprise the pore-forming region, is probably the only part of the ion channel that directly interacts with bound toxin. Using site-directed mutagenesis, we identified specific residues in the S5-S6 linker that are responsible for the acquisition of toxin sensitivity by Kv2.1.			GROSS, A (corresponding author), HARVARD UNIV,SCH MED,DEPT NEUROBIOL,BOSTON,MA 02115, USA.				NIGMS NIH HHS [GM43949] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043949] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON CS, 1988, J GEN PHYSIOL, V91, P317, DOI 10.1085/jgp.91.3.317; ARMSTRONG CM, 1974, J GEN PHYSIOL, V63, P533, DOI 10.1085/jgp.63.5.533; BONTEMS F, 1992, BIOCHEMISTRY-US, V31, P7756, DOI 10.1021/bi00149a003; DURELL SR, 1992, BIOPHYS J, V62, P238, DOI 10.1016/S0006-3495(92)81809-X; ESCOBAR L, 1993, BIOCHEMISTRY-US, V32, P6982, DOI 10.1021/bi00078a024; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; GARCIA ML, 1994, BIOCHEMISTRY-US, V33, P6834, DOI 10.1021/bi00188a012; GIANGIACOMO KM, 1992, BIOCHEMISTRY-US, V31, P6719, DOI 10.1021/bi00144a011; GOLDSTEIN SAN, 1992, BIOPHYS J, V62, P5, DOI 10.1016/S0006-3495(92)81760-5; GOLDSTEIN SAN, 1994, NEURON, V12, P1377, DOI 10.1016/0896-6273(94)90452-9; HARTMANN HA, 1991, SCIENCE, V251, P942, DOI 10.1126/science.2000495; HEGINBOTHAM L, 1992, NEURON, V8, P483, DOI 10.1016/0896-6273(92)90276-J; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; JOHNSON BA, 1992, BIOCHEMISTRY-US, V31, P8151, DOI 10.1021/bi00150a006; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; KAVANAUGH MP, 1992, NEURON, V8, P493, DOI 10.1016/0896-6273(92)90277-K; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; MACKINNON R, 1988, J GEN PHYSIOL, V91, P335, DOI 10.1085/jgp.91.3.335; MACKINNON R, 1989, BIOCHEMISTRY-US, V28, P8092, DOI 10.1021/bi00446a020; MACKINNON R, 1989, SCIENCE, V245, P1382, DOI 10.1126/science.2476850; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MACKINNON R, 1990, NEURON, V5, P767, DOI 10.1016/0896-6273(90)90335-D; MACKINNON R, 1989, BIOCHEMISTRY-US, V28, P8087, DOI 10.1021/bi00446a019; MACKINNON R, 1988, NEURON, V1, P997, DOI 10.1016/0896-6273(88)90156-0; MILLER C, 1988, NEURON, V1, P1003, DOI 10.1016/0896-6273(88)90157-2; PARK CS, 1992, BIOCHEMISTRY-US, V31, P7749, DOI 10.1021/bi00149a002; PARK CS, 1991, P NATL ACAD SCI USA, V88, P2046, DOI 10.1073/pnas.88.6.2046; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; STAMPE P, 1994, BIOCHEMISTRY-US, V33, P443, DOI 10.1021/bi00168a008; SWANSON R, 1990, NEURON, V4, P929, DOI 10.1016/0896-6273(90)90146-7; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; YOOL AJ, 1991, NATURE, V349, P700, DOI 10.1038/349700a0	33	69	73	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1994	13	4					961	966		10.1016/0896-6273(94)90261-5	http://dx.doi.org/10.1016/0896-6273(94)90261-5			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PP533	7946339				2022-12-24	WOS:A1994PP53300018
J	WILLIAMS, EJ; FURNESS, J; WALSH, FS; DOHERTY, P				WILLIAMS, EJ; FURNESS, J; WALSH, FS; DOHERTY, P			ACTIVATION OF THE FGF RECEPTOR UNDERLIES NEURITE OUTGROWTH STIMULATED BY L1, N-CAM, AND N-CADHERIN	NEURON			English	Article							FIBROBLAST GROWTH-FACTOR; CELL-ADHESION MOLECULES; 2ND MESSENGER SYSTEMS; NEURONAL RESPONSIVENESS; VENTRICULAR MYOCYTES; IMMUNOGLOBULIN-LIKE; TYROSINE KINASES; XENOPUS EMBRYOS; NEURAL ADHESION; NERVOUS-SYSTEM	Cell contact-dependent neurite outgrowth stimulated by CAMs requires activation of a second messenger pathway that requires the function of a tyrosine kinase upstream from calcium influx into neurons. In the present study, we present evidence that implicates activation of the fibroblast growth factor receptor (FGFR) in the pathway underlying neurite outgrowth stimulated by L1, N-CAM, and N-cadherin. We have identified a CAM homology domain in the FGF family of receptors and show that antibodies which bind to this domain specifically inhibit neurite outgrowth stimulated by the above CAMs. We also show that synthetic peptides derived from this domain can differentially and specifically inhibit neurite outgrowth stimulated by L1, N-CAM, and N-cadherin. In addition, a soluble L1-Fc chimera is shown to stimulate an increase in phosphotyrosine on the same set of neuronal proteins that are phosphorylated following activation of the FGFR with basic FGF.			WILLIAMS, EJ (corresponding author), UNITED MED & DENT SCH,GUYS HOSP,DEPT EXPTL PATHOL,LONDON BRIDGE,LONDON SE1 9RT,ENGLAND.		Doherty, Patrick/A-8752-2008		Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; ASAI T, 1993, MOL BRAIN RES, V17, P174, DOI 10.1016/0169-328X(93)90088-7; BIXBY JL, 1992, J NEUROBIOL, V23, P468, DOI 10.1002/neu.480230503; BIXBY JL, 1991, ANNU REV CELL BIOL, V7, P117, DOI 10.1146/annurev.cellbio.7.1.117; BLASCHUK OW, 1990, DEV BIOL, V139, P227, DOI 10.1016/0012-1606(90)90290-Y; BYERS S, 1992, DEV BIOL, V152, P411, DOI 10.1016/0012-1606(92)90149-B; CHAO MV, 1992, NEURON, V9, P583, DOI 10.1016/0896-6273(92)90023-7; DODD J, 1988, SCIENCE, V242, P692, DOI 10.1126/science.3055291; Doherty P, 1992, Curr Opin Neurobiol, V2, P595, DOI 10.1016/0959-4388(92)90024-F; DOHERTY P, 1990, NATURE, V343, P464, DOI 10.1038/343464a0; DOHERTY P, 1991, CELL, V67, P21, DOI 10.1016/0092-8674(91)90569-K; DOHERTY P, 1991, NEURON, V6, P247, DOI 10.1016/0896-6273(91)90360-C; Doherty P, 1989, CURR OPIN CELL BIOL, V1, P1102, DOI 10.1016/S0955-0674(89)80057-2; DOHERTY P, 1992, DEVELOPMENT, V115, P885; Doherty Patrick, 1994, Current Opinion in Neurobiology, V4, P49, DOI 10.1016/0959-4388(94)90031-0; DONALIES M, 1991, P NATL ACAD SCI USA, V88, P8024, DOI 10.1073/pnas.88.18.8024; FELSENFELD DP, 1994, NEURON, V12, P675, DOI 10.1016/0896-6273(94)90222-4; FRIESEL R, 1992, DEVELOPMENT, V116, P1051; GENNARINI G, 1991, NEURON, V6, P595, DOI 10.1016/0896-6273(91)90062-5; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; GRUMET M, 1991, J CELL BIOL, V113, P1399, DOI 10.1083/jcb.113.6.1399; HLAVIN ML, 1991, GENOMICS, V11, P416, DOI 10.1016/0888-7543(91)90150-D; HOLLENBAUGH D, 1992, CURR OPIN IMMUNOL, V4, P216, DOI 10.1016/0952-7915(92)90017-9; HUANG J, 1990, CIRCULATION, V82, P525; HUANG JMC, 1992, P NATL ACAD SCI USA, V89, P6452, DOI 10.1073/pnas.89.14.6452; JAYE M, 1992, BIOCHIM BIOPHYS ACTA, V1135, P185, DOI 10.1016/0167-4889(92)90136-Y; JOHNSON PW, 1989, NEURON, V3, P377, DOI 10.1016/0896-6273(89)90262-6; KAN MK, 1993, SCIENCE, V259, P1918, DOI 10.1126/science.8456318; KATER SB, 1991, J NEUROSCI, V11, P891; LEBEAU JM, 1991, J NEUROSCI RES, V28, P299, DOI 10.1002/jnr.490280217; LEE PL, 1989, SCIENCE, V245, P57, DOI 10.1126/science.2544996; LIU L, 1993, J NEUROSCI RES, V35, P327, DOI 10.1002/jnr.490350313; MANESS PF, 1988, P NATL ACAD SCI USA, V85, P5001, DOI 10.1073/pnas.85.14.5001; MATSUNAGA M, 1988, NATURE, V334, P62, DOI 10.1038/334062a0; MUSCI TJ, 1990, P NATL ACAD SCI USA, V87, P8365, DOI 10.1073/pnas.87.21.8365; REDIES C, 1993, GLIA, V8, P161, DOI 10.1002/glia.440080304; REICHARDT LF, 1991, ANNU REV NEUROSCI, V14, P531, DOI 10.1146/annurev.neuro.14.1.531; SAFFELL JL, 1994, J CELL BIOL, V125, P427, DOI 10.1083/jcb.125.2.427; SAFFELL JL, 1992, J CELL BIOL, V118, P663, DOI 10.1083/jcb.118.3.663; SCHLESSINGER J, 1992, NEURON, V9, P383, DOI 10.1016/0896-6273(92)90177-F; SCHUCH U, 1989, NEURON, V3, P13, DOI 10.1016/0896-6273(89)90111-6; SHISHIDO E, 1993, DEVELOPMENT, V117, P751; SIMMONS DL, 1993, CELLULAR INTERACTION, P93; SMALL SJ, 1988, NEURON, V1, P1007, DOI 10.1016/0896-6273(88)90158-4; VONBOHLEN F, 1992, EUR J NEUROSCI, V4, P896; WILLIAMS EJ, 1994, DEVELOPMENT, V120, P1685; WILLIAMS EJ, 1994, J NEUROCHEM, V62, P1231; WILLIAMS EJ, 1994, J CELL BIOL, V124, P1029, DOI 10.1083/jcb.124.6.1029; WILLIAMS EJ, 1992, J CELL BIOL, V119, P883, DOI 10.1083/jcb.119.4.883; YAYON A, 1993, P NATL ACAD SCI USA, V90, P10643, DOI 10.1073/pnas.90.22.10643; YAZAKI T, 1991, BIOMED RES-TOKYO, V12, P223, DOI 10.2220/biomedres.12.223; ZUELLIG RA, 1992, EUR J BIOCHEM, V204, P453, DOI 10.1111/j.1432-1033.1992.tb16655.x	52	543	563	0	19	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1994	13	3					583	594		10.1016/0896-6273(94)90027-2	http://dx.doi.org/10.1016/0896-6273(94)90027-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PJ284	7917292				2022-12-24	WOS:A1994PJ28400007
J	ZHU, Y; IKEDA, SR				ZHU, Y; IKEDA, SR			VIP INHIBITS N-TYPE CA2+ CHANNELS OF SYMPATHETIC NEURONS VIA A PERTUSSIS TOXIN-INSENSITIVE BUT CHOLERA TOXIN-SENSITIVE PATHWAY	NEURON			English	Article							VASOACTIVE INTESTINAL POLYPEPTIDE; SUPERIOR CERVICAL-GANGLION; AMIDE-LIKE IMMUNOREACTIVITIES; G-PROTEIN PATHWAYS; ADENYLATE-CYCLASE; CALCIUM CHANNELS; SUBSTANCE-P; ADRENERGIC INHIBITION; MEDIATED INHIBITION; TISSUE DISTRIBUTION	The best characterized Ca2+ channel modulation in mam malian sympathetic neurons is an inhibition of N-type channels via a pertussis toxin (PTX)-sensitive heterotrimeric G protein. Here, we show that vasoactive intestinal polypeptide (VIP), an abundant neuropeptide in the PNS and CNS, inhibited N-type Ca2+ channels in rat sympathetic neurons in a voltage-dependent, membrane-delimited manner. The effect of VIP was insensitive to PTX but was attenuated by cholera toxin or anti-G(s alpha) antibodies. VIP-mediated inhibition was independent of cAMP-dependent protein kinase A (PKA). The results provide evidence for a new signal transduction pathway in which N-type Ca2+ channel modulation requires activation of G(s alpha) but is independent of PKA-mediated phosphorylation.			ZHU, Y (corresponding author), MED COLL GEORGIA,DEPT PHARMACOL & TOXICOL,AUGUSTA,GA 30912, USA.			Ikeda, Stephen/0000-0002-4088-9508				AUDIGIER S, 1986, BRAIN RES, V376, P363, DOI 10.1016/0006-8993(86)90200-3; BALDWIN C, 1991, NEUROSCIENCE, V40, P175, DOI 10.1016/0306-4522(91)90183-O; BEECH DJ, 1991, P NATL ACAD SCI USA, V88, P652, DOI 10.1073/pnas.88.2.652; BERNHEIM L, 1991, NEURON, V6, P859, DOI 10.1016/0896-6273(91)90226-P; CASSEL D, 1977, P NATL ACAD SCI USA, V74, P3307, DOI 10.1073/pnas.74.8.3307; CHANG FH, 1989, J BIOL CHEM, V264, P5352; ECKSTEIN F, 1979, J BIOL CHEM, V254, P9829; ELFVIN LG, 1993, ANNU REV NEUROSCI, V16, P471, DOI 10.1146/annurev.ne.16.030193.002351; ELMSLIE KS, 1990, NEURON, V5, P75, DOI 10.1016/0896-6273(90)90035-E; FOUCART S, 1993, J PHARMACOL EXP THER, V265, P903; GILL DM, 1978, P NATL ACAD SCI USA, V75, P3050, DOI 10.1073/pnas.75.7.3050; GUTOWSKI S, 1991, J BIOL CHEM, V266, P20519; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARTZELL HC, 1991, NATURE, V351, P573, DOI 10.1038/351573a0; HASHIMOTO H, 1993, NEURON, V11, P333, DOI 10.1016/0896-6273(93)90188-W; HEDLUND B, 1988, PFLUG ARCH EUR J PHY, V411, P173, DOI 10.1007/BF00582311; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; HOKFELT T, 1977, NEUROSCIENCE, V2, P885, DOI 10.1016/0306-4522(77)90112-9; HOLZ GG, 1986, NATURE, V319, P670, DOI 10.1038/319670a0; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; IKEDA SR, 1992, PFLUG ARCH EUR J PHY, V422, P201, DOI 10.1007/BF00370422; IKEDA SR, 1991, J PHYSIOL-LONDON, V439, P181, DOI 10.1113/jphysiol.1991.sp018663; IKEDA SR, 1989, J PHYSIOL-LONDON, V409, P221, DOI 10.1113/jphysiol.1989.sp017494; IKEDA SR, 1992, J PHYSIOL-LONDON, V458, P339, DOI 10.1113/jphysiol.1992.sp019421; IP NY, 1985, J NEUROSCI, V5, P1947; ISHIHARA T, 1992, NEURON, V8, P811, DOI 10.1016/0896-6273(92)90101-I; ISHIHARA T, 1991, EMBO J, V10, P1635, DOI 10.1002/j.1460-2075.1991.tb07686.x; JOUNEAUX C, 1993, J BIOL CHEM, V268, P2368; KASAI H, 1991, P NATL ACAD SCI USA, V88, P8855, DOI 10.1073/pnas.88.19.8855; KATADA T, 1984, J BIOL CHEM, V259, P3568; KAWATANI M, 1985, SCIENCE, V229, P879, DOI 10.1126/science.3895438; LECHLEITER JD, 1988, NEURON, V1, P227, DOI 10.1016/0896-6273(88)90143-2; LIPSCOMBE D, 1989, NATURE, V340, P639, DOI 10.1038/340639a0; LOTERSZTAJN S, 1987, J BIOL CHEM, V262, P3114; LUNDBERG JM, 1980, P NATL ACAD SCI-BIOL, V77, P1651, DOI 10.1073/pnas.77.3.1651; LUTZ EM, 1993, FEBS LETT, V334, P3, DOI 10.1016/0014-5793(93)81668-P; MANTYH PW, 1992, NEUROSCIENCE, V46, P739, DOI 10.1016/0306-4522(92)90160-4; MCKENZIE FR, 1991, BIOCHEM J, V275, P175, DOI 10.1042/bj2750175; MINTZ IM, 1992, NEURON, V9, P85, DOI 10.1016/0896-6273(92)90223-Z; MIYATA A, 1989, BIOCHEM BIOPH RES CO, V164, P567, DOI 10.1016/0006-291X(89)91757-9; PLUMMER MR, 1991, J NEUROSCI, V11, P2339; REALE V, 1987, NEUROSCI LETT, V83, P89, DOI 10.1016/0304-3940(87)90221-7; ROSTENE WH, 1984, PROG NEUROBIOL, V22, P103, DOI 10.1016/0301-0082(84)90022-4; SASEK CA, 1989, J COMP NEUROL, V280, P522, DOI 10.1002/cne.902800403; SCHOFIELD GG, 1991, EUR J PHARM-MOLEC PH, V207, P195, DOI 10.1016/0922-4106(91)90031-C; SCHOFIELD GG, 1990, EUR J PHARMACOL, V180, P37, DOI 10.1016/0014-2999(90)90590-3; SCHUBERT B, 1989, SCIENCE, V245, P516, DOI 10.1126/science.2547248; SCORNIK FS, 1993, AM J PHYSIOL, V265, pH1460, DOI 10.1152/ajpheart.1993.265.4.H1460; SHAPIRO MS, 1993, NEURON, V10, P11, DOI 10.1016/0896-6273(93)90237-L; SHEN KZ, 1993, J PHYSIOL-LONDON, V462, P483, DOI 10.1113/jphysiol.1993.sp019565; SIMASKO SM, 1993, MOL PHARMACOL, V44, P622; SIMONDS WF, 1989, P NATL ACAD SCI USA, V86, P7809, DOI 10.1073/pnas.86.20.7809; SPENGLER D, 1993, NATURE, V365, P170, DOI 10.1038/365170a0; SPIEGEL AM, 1989, G PROTEIN SIGNAL TRA, P185; VOLLE RL, 1982, J NEUROCHEM, V39, P1195, DOI 10.1111/j.1471-4159.1982.tb11516.x; WANG YY, 1989, BRAIN RES, V500, P107, DOI 10.1016/0006-8993(89)90304-1; WANKE E, 1987, P NATL ACAD SCI USA, V84, P4313, DOI 10.1073/pnas.84.12.4313; WILKBLASZCZAK MA, 1994, NEURON, V12, P109, DOI 10.1016/0896-6273(94)90156-2; YATANI A, 1987, SCIENCE, V238, P1288, DOI 10.1126/science.2446390; ZHU Y, 1993, J NEUROPHYSIOL, V70, P610, DOI 10.1152/jn.1993.70.2.610	61	94	95	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1994	13	3					657	669		10.1016/0896-6273(94)90033-7	http://dx.doi.org/10.1016/0896-6273(94)90033-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PJ284	7917296				2022-12-24	WOS:A1994PJ28400013
J	CHOI, KW; BENZER, S				CHOI, KW; BENZER, S			MIGRATION OF GLIA ALONG PHOTORECEPTOR AXONS IN THE DEVELOPING DROSOPHILA EYE	NEURON			English	Article							GANGLION-CELL AXONS; 1ST OPTIC GANGLION; NEURONAL MIGRATION; RETINA; MELANOGASTER; ASTROCYTES; GUIDANCE; PATTERN; SYSTEM; ASTROTACTIN	We have identified a set of retinal basal glia, designated RBC cells, in the axon layer of the developing Drosophila eye disc. In vivo pulse labeling with bromodeoxyuridine shows that these cells originate in the optic stalk and migrate into the disc. In mutants lacking photoreceptor axons, RBG cells accumulate in the optic stalk, but do not invade the disc. The association of RBC cells with photoreceptor axons, their origin in the optic stalk, and their migration into the retina are in common with the behavior of astrocytes in the developing mammalian retina,			CHOI, KW (corresponding author), CALTECH, DIV BIOL, PASADENA, CA 91125 USA.		Choi, Kwang-Wook/C-1707-2011	Choi, Kwang-Wook/0000-0002-8997-3065	NATIONAL EYE INSTITUTE [R01EY009278] Funding Source: NIH RePORTER; NEI NIH HHS [EY09278] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ASHBURNER M, 1989, DROSOPHILA LABORATOR; BANERJEE U, 1990, NEURON, V4, P177, DOI 10.1016/0896-6273(90)90093-U; BELLEN HJ, 1989, GENE DEV, V3, P1288, DOI 10.1101/gad.3.9.1288; BIER E, 1989, GENE DEV, V3, P1273, DOI 10.1101/gad.3.9.1273; BOLWIG N, 1946, VIDENSK MEDD FRA DAN, V109, P80; BONINI NM, 1993, CELL, V72, P379, DOI 10.1016/0092-8674(93)90115-7; BRAITENBERG V, 1967, EXP BRAIN RES, V3, P271; BRONNERFRASER M, 1993, BIOESSAYS, V15, P221, DOI 10.1002/bies.950150402; Bryant PJ., 1978, GENET BIOL DROSOPHIL, P229; BUSSOW H, 1980, CELL TISSUE RES, V206, P367; CAGAN RL, 1989, DEV BIOL, V136, P346, DOI 10.1016/0012-1606(89)90261-3; CARLSON SD, 1990, ANNU REV ENTOMOL, V35, P597, DOI 10.1146/annurev.en.35.010190.003121; CAVINESS VS, 1978, ANNU REV NEUROSCI, V1, P297, DOI 10.1146/annurev.ne.01.030178.001501; CHANLING T, 1991, J COMP NEUROL, V303, P375, DOI 10.1002/cne.903030304; EDMONDSON JC, 1987, J NEUROSCI, V7, P1928; EDMONDSON JC, 1988, J CELL BIOL, V106, P505, DOI 10.1083/jcb.106.2.505; FISCHBACH KF, 1984, DEV BIOL, V104, P219, DOI 10.1016/0012-1606(84)90050-2; FISCHBACH KF, 1983, DEV BIOL, V95, P1, DOI 10.1016/0012-1606(83)90002-7; FISHELL G, 1991, DEVELOPMENT, V113, P755; GIANGRANDE A, 1994, IN PRESS DEVELOPMENT; HART AC, 1990, GENE DEV, V4, P1835, DOI 10.1101/gad.4.11.1835; HATTEN ME, 1990, TRENDS NEUROSCI, V13, P179, DOI 10.1016/0166-2236(90)90044-B; HATTEN ME, 1984, J CELL BIOL, V98, P193, DOI 10.1083/jcb.98.1.193; HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O; KLAMBT C, 1991, CELL, V64, P801, DOI 10.1016/0092-8674(91)90509-W; KLAMBT C, 1991, GLIA, V4, P205, DOI 10.1002/glia.440040212; LEDOUARIN N, 1991, GLIA, V4, P175; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; MEINERTZHAGEN IA, 1973, DEV NEUROBIOLOGY ART, P51; OKANE CJ, 1987, P NATL ACAD SCI USA, V84, P9123, DOI 10.1073/pnas.84.24.9123; READY DF, 1989, TRENDS NEUROSCI, V12, P102, DOI 10.1016/0166-2236(89)90166-5; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; ROBINOW S, 1991, J NEUROBIOL, V22, P443, DOI 10.1002/neu.480220503; RUBIN GM, 1991, TRENDS GENET, V7, P372, DOI 10.1016/0168-9525(91)90258-R; SAINTMARIE RL, 1983, J NEUROCYTOL, V12, P213, DOI 10.1007/BF01148463; Schnitzer J., 1988, Progress in Retinal Research, V7, P209, DOI 10.1016/0278-4327(88)90009-0; SCHWANZELFUKUDA M, 1989, NATURE, V338, P161, DOI 10.1038/338161a0; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; SELLECK SB, 1991, NEURON, V6, P83, DOI 10.1016/0896-6273(91)90124-I; SILVER J, 1980, J COMP NEUROL, V189, P101, DOI 10.1002/cne.901890106; SILVER J, 1984, DEV BIOL, V106, P485, DOI 10.1016/0012-1606(84)90248-3; STONE J, 1987, J COMP NEUROL, V255, P35, DOI 10.1002/cne.902550104; TESCH KH, 1975, ROUX ARCH DEV BIOL, V178, P225, DOI 10.1007/BF00848430; TRUJILLOCENOZ O, 1973, J ULTRA MOL STRUCT R, V42, P554, DOI 10.1016/S0022-5320(73)80027-9; WATANABE T, 1988, NATURE, V332, P834, DOI 10.1038/332834a0; WINBERG ML, 1992, DEVELOPMENT, V115, P903; WOLFF T, 1991, DEVELOPMENT, V113, P841; ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2	49	82	82	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1994	12	2					423	431		10.1016/0896-6273(94)90282-8	http://dx.doi.org/10.1016/0896-6273(94)90282-8			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MY500	8110466				2022-12-24	WOS:A1994MY50000016
J	TAKEI, K; MIGNERY, GA; MUGNAINI, E; SUDHOF, TC; DECAMILLI, P				TAKEI, K; MIGNERY, GA; MUGNAINI, E; SUDHOF, TC; DECAMILLI, P			INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR CAUSES FORMATION OF ER CISTERNAL STACKS IN TRANSFECTED FIBROBLASTS AND IN CEREBELLAR PURKINJE-CELLS	NEURON			English	Article							CRYSTALLOID ENDOPLASMIC-RETICULUM; CALCIUM RELEASE CHANNEL; CENTRAL-NERVOUS-SYSTEM; RYANODINE RECEPTOR; SKELETAL-MUSCLE; INSP3 RECEPTOR; SARCOPLASMIC-RETICULUM; NITRIC-OXIDE; TRISPHOSPHATE RECEPTOR; MOLECULAR-CLONING	The inositol 1,4,5-trisphosphate receptor (IP(3)R) is expressed at very high levels in cerebellar Purkinje cells. Within these neurons, it has a widespread distribution throughout the endoplasmic reticulum (ER) and is present at particularly high concentrations at sites of membrane appositions within peculiar stacks of ER cisternae. Here we report that stacks of ER cisternae, reminiscent of those observed in Purkinje cells, can be induced by overexpression of full-length IP(3)R, but not of mutant forms of the protein in COS cells. Within these stacks the IP(3)R forms a crystalline array at apposed cisternal faces. Additionally, we show that Purkinje cell stacks are not permanent structures. Our findings suggest that massive stack formation in Purkinje cells represents an adaptive response of the ER to hypoxic conditions and is due to the presence of the high concentration of IP(3)R in its membranes.	UNIV TEXAS,SW MED SCH,DEPT MOLEC GENET,DALLAS,TX 75235; UNIV TEXAS,SCH MED,HOWARD HUGHES MED INST,DALLAS,TX 75235; UNIV CONNECTICUT,NEUROMORHOL LAB,STORRS,CT 06268	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Connecticut	TAKEI, K (corresponding author), YALE UNIV,SCH MED,DEPT CELL BIOL,NEW HAVEN,CT 06510, USA.			Takei, Kohji/0000-0002-6555-9425	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK043078] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH047510, R01MH045191] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 43078] Funding Source: Medline; NIMH NIH HHS [MH47510, MH 45191] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANDERSON RGW, 1983, J CELL SCI, V63, P1; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BESTETTI G, 1980, ACTA NEUROPATHOL, V49, P75, DOI 10.1007/BF00692224; BLONDEL O, 1993, J BIOL CHEM, V268, P11356; BOLE DG, 1986, J CELL BIOL, V102, P1558, DOI 10.1083/jcb.102.5.1558; BREDT DS, 1992, NEURON, V8, P3, DOI 10.1016/0896-6273(92)90104-L; CAMERON PL, 1991, J CELL BIOL, V115, P151, DOI 10.1083/jcb.115.1.151; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; CHADWICK CC, 1990, P NATL ACAD SCI USA, V87, P2132, DOI 10.1073/pnas.87.6.2132; DECAMILLI P, 1990, NATURE, V344, P495, DOI 10.1038/344495a0; DUMESNILBOUSEZ N, 1992, J NEUROCYTOL, V21, P506, DOI 10.1007/BF01186954; ELLISMAN MH, 1990, NEURON, V5, P135, DOI 10.1016/0896-6273(90)90304-X; FERGUSON DG, 1984, J CELL BIOL, V99, P1735, DOI 10.1083/jcb.99.5.1735; FERNANDEZMORAN H, 1957, METABOLISM NERVOUS S; FLEISCHER S, 1989, ANNU REV BIOPHYS BIO, V18, P333, DOI 10.1146/annurev.bb.18.060189.002001; FRANZINIARMSTRONG C, 1983, J MUSCLE RES CELL M, V4, P233, DOI 10.1007/BF00712033; Friedrich Jr VL, 1981, NEUROANATOMICAL TRAC, P345; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; GARTHWAITE J, 1991, TRENDS NEUROSCI, V14, P60, DOI 10.1016/0166-2236(91)90022-M; GORMAN C, 1985, DNA CLONING PRACTICA, V2, P143; HANSSON HA, 1981, BRAIN RES, V216, P187, DOI 10.1016/0006-8993(81)91287-7; HERNDON RM, 1963, J CELL BIOL, V18, P167, DOI 10.1083/jcb.18.1.167; HERNDON RM, 1964, J CELL BIOL, V20, P338, DOI 10.1083/jcb.20.2.338; KAPRIELIAN Z, 1989, MOL BRAIN RES, V6, P55, DOI 10.1016/0169-328X(89)90028-4; KARLSSON U, 1966, J ULTRA MOL STRUCT R, V14, P47, DOI 10.1016/S0022-5320(66)80034-5; KOVACS K, 1977, ANAT ANZEIGER, V141, P59; KUWAJIMA G, 1992, NEURON, V9, P1133, DOI 10.1016/0896-6273(92)90071-K; LAI FA, 1988, NATURE, V331, P315, DOI 10.1038/331315a0; MAEDA N, 1990, EMBO J, V9, P61, DOI 10.1002/j.1460-2075.1990.tb08080.x; MCPHERSON PS, 1993, J BIOL CHEM, V268, P13765; MCPHERSON PS, 1991, NEURON, V7, P17, DOI 10.1016/0896-6273(91)90070-G; MCPHERSON PS, 1990, J BIOL CHEM, V265, P18454; MELDOLESI J, 1992, Current Biology, V2, P393, DOI 10.1016/0960-9822(92)90092-O; MIGNERY GA, 1990, EMBO J, V9, P3893, DOI 10.1002/j.1460-2075.1990.tb07609.x; MIGNERY GA, 1990, J BIOL CHEM, V265, P12679; MIGNERY GA, 1989, NATURE, V342, P192, DOI 10.1038/342192a0; MONCADA S, 1989, BIOCHEM PHARMACOL, V38, P1709, DOI 10.1016/0006-2952(89)90403-6; Mugnaini E, 1972, COMP ANATOMY HISTOLO, P201; NAFTOLIN F, 1985, BRAIN RES, V329, P289, DOI 10.1016/0006-8993(85)90536-0; NEALE EA, 1982, NEUROSCIENCE, V7, P1879, DOI 10.1016/0306-4522(82)90004-5; ORCI L, 1984, CELL, V36, P835, DOI 10.1016/0092-8674(84)90033-3; OTSU H, 1990, CELL STRUCT FUNCT, V15, P163, DOI 10.1247/csf.15.163; Palay SL, 1974, CEREBELLAR CORTEX CY, P11; PERIN MS, 1991, J BIOL CHEM, V266, P3877; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; Peters A., 1991, FINE STRUCTURE NERVO, V3rd, P101; PLESSERS L, 1991, J NEUROSCI, V11, P650; PRICE MT, 1976, CELL TISSUE RES, V171, P277; ROITELMAN J, 1992, J CELL BIOL, V117, P959, DOI 10.1083/jcb.117.5.959; ROSS CA, 1989, NATURE, V339, P468, DOI 10.1038/339468a0; ROSS CA, 1992, P NATL ACAD SCI USA, V89, P4265, DOI 10.1073/pnas.89.10.4265; ROSSI F, 1987, NEUROSCIENCE, V22, P99, DOI 10.1016/0306-4522(87)90201-6; RUSAKOV DA, 1993, J NEUROCYTOL, V22, P273, DOI 10.1007/BF01187126; SAITO A, 1984, J CELL BIOL, V99, P875, DOI 10.1083/jcb.99.3.875; SATOH T, 1990, J CELL BIOL, V111, P615, DOI 10.1083/jcb.111.2.615; SHARP AH, 1993, J NEUROSCI, V13, P3051; SLOT JW, 1985, EUR J CELL BIOL, V38, P87; SOTELO C, 1971, LAB INVEST, V25, P653; SUDHOF TC, 1991, EMBO J, V10, P3199, DOI 10.1002/j.1460-2075.1991.tb04882.x; TAKEI K, 1992, J NEUROSCI, V12, P489; TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0; TOKUYASU KT, 1989, HISTOCHEM J, V21, P163, DOI 10.1007/BF01007491; TSIEN RW, 1990, ANNU REV CELL BIOL, V6, P715, DOI 10.1146/annurev.cb.06.110190.003435; VANNIMWEGEN D, 1966, J ULTRA MOL STRUCT R, V14, P36, DOI 10.1016/S0022-5320(66)80033-3; VILLA A, 1991, J CELL BIOL, V113, P779, DOI 10.1083/jcb.113.4.779; VOLPE P, 1990, NEURON, V5, P713, DOI 10.1016/0896-6273(90)90225-5; WAGENKNECHT T, 1989, NATURE, V338, P167, DOI 10.1038/338167a0; WALTON PD, 1991, J CELL BIOL, V113, P1145, DOI 10.1083/jcb.113.5.1145; WORLEY PF, 1987, J BIOL CHEM, V262, P12132; YU MC, 1972, ACTA NEUROPATHOL, V22, P222, DOI 10.1007/BF00684525; ZORZATO F, 1990, J BIOL CHEM, V265, P2244	71	130	132	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1994	12	2					327	342		10.1016/0896-6273(94)90275-5	http://dx.doi.org/10.1016/0896-6273(94)90275-5			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MY500	8110462	hybrid			2022-12-24	WOS:A1994MY50000009
J	VINCENT, P; MARTY, A				VINCENT, P; MARTY, A			NEIGHBORING CEREBELLAR PURKINJE-CELLS COMMUNICATE VIA RETROGRADE INHIBITION OF COMMON PRESYNAPTIC INTERNEURONS	NEURON			English	Article							SYNAPTIC CURRENTS; NERVOUS-SYSTEM; HIPPOCAMPUS; NEURONS; CALCIUM; INVITRO; CORTEX	Paired tight-seal whole-cell recordings were obtained from neighboring Purkinje cells in cerebellar slices. Under voltage clamp, spontaneous inhibitory postsynaptic currents resulted from the activity of GABAergic interneurons, stellate and basket cells. Up to 80% of inhibitory postsynaptic currents in paired recordings were in register. This correlation was not affected by antagonists of glutamate receptors, faded with distance, and was abolished by tetrodotoxin. Earlier work showed that voltage-gated Ca2+ entry into a Purkinje cell elicits a transient presynaptic inhibition of inhibitory postsynaptic currents. It is now shown that this inhibition is not restricted to the stimulated cell, but that it is transmitted to its neighbors. The results indicate that Purkinje cells exchange information by an unconventional mechanism involving retrograde control of inhibitory synapses.			VINCENT, P (corresponding author), ECOLE NORMALE SUPER,ZENTRUM NEUROBIOL,46 RUE ULM,F-75231 PARIS 05,FRANCE.		Vincent, Pierre/A-1055-2012	Vincent, Pierre/0000-0002-8479-1908				ANDERSEN P, 1964, J NEUROPHYSIOL, V27, P1138, DOI 10.1152/jn.1964.27.6.1138; ECCLES JC, 1966, EXP BRAIN RES, V1, P161; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; GARTHWAITE J, 1991, TRENDS NEUROSCI, V14, P60, DOI 10.1016/0166-2236(91)90022-M; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Ito M, 1984, CEREBELLUM NEURAL CO; KANO M, 1992, NATURE, V356, P601, DOI 10.1038/356601a0; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; LLANO I, 1993, J PHYSIOL-LONDON, V468, P201, DOI 10.1113/jphysiol.1993.sp019767; LLANO I, 1993, J PHYSIOL-LONDON, V468, P177, DOI 10.1113/jphysiol.1993.sp019766; LLANO I, 1991, NEURON, V6, P565, DOI 10.1016/0896-6273(91)90059-9; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; MIDTGAARD J, 1992, J PHYSIOL-LONDON, V457, P355, DOI 10.1113/jphysiol.1992.sp019382; MILES R, 1990, J PHYSIOL-LONDON, V431, P659, DOI 10.1113/jphysiol.1990.sp018353; Palay S. L., 1974, CEREBELLAR CORTEX CY; PITLER TA, 1992, J NEUROSCI, V12, P4122; REGEHR WG, 1992, P NATL ACAD SCI USA, V89, P5492, DOI 10.1073/pnas.89.12.5492; SCANZIANI M, 1992, NEURON, V9, P919, DOI 10.1016/0896-6273(92)90244-8; SOTELO C, 1972, J CELL BIOL, V53, P271, DOI 10.1083/jcb.53.2.271; STOCKLE H, 1980, NEUROSCIENCE, V5, P893, DOI 10.1016/0306-4522(80)90158-X; TENBRUGGENCATE G, 1976, PFLUG ARCH EUR J PHY, V367, P107, DOI 10.1007/BF00583664; VINCENT P, 1992, J PHYSIOL-LONDON, V456, P453, DOI 10.1113/jphysiol.1992.sp019346; WILLIAMS JH, 1989, NATURE, V341, P739, DOI 10.1038/341739a0	23	112	115	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1993	11	5					885	893		10.1016/0896-6273(93)90118-B	http://dx.doi.org/10.1016/0896-6273(93)90118-B			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MJ041	8240811				2022-12-24	WOS:A1993MJ04100010
J	FRASER, DD; HOEHN, K; WEISS, S; MACVICAR, BA				FRASER, DD; HOEHN, K; WEISS, S; MACVICAR, BA			ARACHIDONIC-ACID INHIBITS SODIUM CURRENTS AND SYNAPTIC TRANSMISSION IN CULTURED STRIATAL NEURONS	NEURON			English	Article							PROTEIN-KINASE-C; LONG-TERM POTENTIATION; CHAIN FATTY-ACIDS; GLUTAMATE RELEASE; LIPOXYGENASE METABOLITES; PRESYNAPTIC INHIBITION; FUNCTIONAL MODULATION; SIGNAL TRANSDUCTION; POTASSIUM CHANNELS; SMOOTH-MUSCLE	In the striatum, dopamine generates arachidonic acid (AA) and induces synaptic depression. Here, we report that Na+ channels are a target for AA in both cultured and acutely isolated striatal neurons. AA depressed veratrine-induced Na+ influx and neurotransmitter release. Whole-cell voltage clamp revealed that peak Na+ currents are depressed, and steady-state inactivation shifts -15 mV in the presence of AA. Furthermore, inactivation was accelerated, and recovery from inactivation was delayed. These actions of AA were not produced by AA metabolites or protein kinase C activation. In addition, AA reduced both the amplitude and frequency of action potentials and depressed spontaneous inhibitory post-synaptic currents without affecting miniature inhibitory postsynaptic currents. These data suggest that AA modulates presynaptic, Na+-dependent action potentials, thereby contributing to striatal synaptic depression.			FRASER, DD (corresponding author), UNIV CALGARY,NEUROSCI RES GRP,CALGARY T2N 4N1,AB,CANADA.		MacVicar, Brian/P-1553-2015; MacVicar, Brian/AAI-7729-2020	MacVicar, Brian/0000-0003-4596-4623; MacVicar, Brian/0000-0003-4596-4623				AXELROD J, 1990, BIOCHEM SOC T, V18, P503, DOI 10.1042/bst0180503; BARNES S, 1988, J GEN PHYSIOL, V91, P421, DOI 10.1085/jgp.91.3.421; Bashir Z I, 1992, Curr Opin Neurobiol, V2, P328, DOI 10.1016/0959-4388(92)90124-4; BASHIR ZI, 1992, EUR J NEUROSCI, V4, P485, DOI 10.1111/j.1460-9568.1992.tb00898.x; BEAN BP, 1983, J GEN PHYSIOL, V81, P613, DOI 10.1085/jgp.81.5.613; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; BUTTERWORTH JF, 1990, ANESTHESIOLOGY, V72, P711, DOI 10.1097/00000542-199004000-00022; CALABRESI P, 1992, NEUROSCI LETT, V142, P95, DOI 10.1016/0304-3940(92)90628-K; CALABRESI P, 1992, J NEUROSCI, V12, P4224; CAPDEVILA J, 1981, P NATL ACAD SCI-BIOL, V78, P5362, DOI 10.1073/pnas.78.9.5362; CAPDEVILA J, 1988, ARCH BIOCHEM BIOPHYS, V261, P257, DOI 10.1016/0003-9861(88)90340-2; CASS A, 1970, J GEN PHYSIOL, V56, P100, DOI 10.1085/jgp.56.1.100; CATTERALL WA, 1992, PHYSIOL REV, V72, pS15, DOI 10.1152/physrev.1992.72.suppl_4.S15; CHAN PH, 1988, J NEUROCHEM, V50, P1185, DOI 10.1111/j.1471-4159.1988.tb10591.x; CHARLTON MP, 1979, J GEN PHYSIOL, V72, P487; COSTA MRC, 1982, J BIOL CHEM, V257, P7918; DASCAL N, 1991, NEURON, V6, P165, DOI 10.1016/0896-6273(91)90131-I; DRAPEAU C, 1990, NEUROSCI LETT, V115, P286, DOI 10.1016/0304-3940(90)90470-T; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; DUMUIS A, 1988, NATURE, V336, P68, DOI 10.1038/336068a0; DUMUIS A, 1990, NATURE, V347, P182, DOI 10.1038/347182a0; FREEMAN EJ, 1990, NEUROCHEM RES, V15, P743, DOI 10.1007/BF00973656; HERRERO I, 1991, J NEUROCHEM, V57, P718, DOI 10.1111/j.1471-4159.1991.tb03805.x; HILLE B, 1977, J GEN PHYSIOL, V69, P497, DOI 10.1085/jgp.69.4.497; HOEHN K, 1993, J NEUROSCI, V13, P1244; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; IZUMI Y, 1992, SCIENCE, V257, P1273, DOI 10.1126/science.1519065; KAY AR, 1986, J NEUROSCI METH, V16, P227, DOI 10.1016/0165-0270(86)90040-3; KEYSER DO, 1990, NEURON, V5, P545, DOI 10.1016/0896-6273(90)90092-T; KHODOROV BI, 1991, ANN NY ACAD SCI, V625, P224, DOI 10.1111/j.1749-6632.1991.tb33843.x; KIM D, 1989, SCIENCE, V244, P1174, DOI 10.1126/science.2727703; LI M, 1992, NEURON, V8, P1151, DOI 10.1016/0896-6273(92)90135-Z; LINDEN DJ, 1989, J PHYSIOL-LONDON, V419, P95, DOI 10.1113/jphysiol.1989.sp017863; LIU YB, 1993, J NEUROPHYSIOL, V69, P1000, DOI 10.1152/jn.1993.69.3.1000; LOVINGER DM, 1993, J NEUROPHYSIOL, V69, P1236, DOI 10.1152/jn.1993.69.4.1236; LYNCH MA, 1990, J NEUROCHEM, V55, P215, DOI 10.1111/j.1471-4159.1990.tb08841.x; MANABE T, 1992, NATURE, V355, P50, DOI 10.1038/355050a0; Marty A., 1983, SINGLE CHANNEL RECOR, P107; MILLER B, 1992, NATURE, V355, P722, DOI 10.1038/355722a0; MINTA A, 1989, J BIOL CHEM, V264, P19449; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; NUMANN R, 1991, SCIENCE, V254, P115, DOI 10.1126/science.1656525; ORDWAY RW, 1989, SCIENCE, V244, P1176, DOI 10.1126/science.2471269; ORDWAY RW, 1991, TRENDS NEUROSCI, V14, P96, DOI 10.1016/0166-2236(91)90069-7; PETROU S, 1993, TRENDS BIOCHEM SCI, V18, P41, DOI 10.1016/0968-0004(93)90050-W; PIN JP, 1986, J NEUROCHEM, V47, P594; PIOMELLI D, 1990, TRENDS PHARMACOL SCI, V11, P367, DOI 10.1016/0165-6147(90)90182-8; PIOMELLI D, 1991, NATURE, V353, P164, DOI 10.1038/353164a0; PIOMELLI D, 1987, NATURE, V328, P38, DOI 10.1038/328038a0; RUEGG UT, 1989, TRENDS PHARMACOL SCI, V10, P218, DOI 10.1016/0165-6147(89)90263-0; SCANZIANI M, 1992, NEURON, V9, P919, DOI 10.1016/0896-6273(92)90244-8; SCHUBERT B, 1989, SCIENCE, V245, P516, DOI 10.1126/science.2547248; SCHUBERT B, 1990, AM J PHYSIOL, V258, pH977, DOI 10.1152/ajpheart.1990.258.4.H977; SCHUMAN EM, 1991, SCIENCE, V254, P1503, DOI 10.1126/science.1720572; SCHWARTZ RD, 1992, BRAIN RES, V585, P405, DOI 10.1016/0006-8993(92)91246-B; SCHWEITZER P, 1990, NATURE, V346, P464, DOI 10.1038/346464a0; SEKIGUCHI K, 1988, J BIOCHEM-TOKYO, V103, P759, DOI 10.1093/oxfordjournals.jbchem.a122343; SHIMADA T, 1992, J GEN PHYSIOL, V100, P27, DOI 10.1085/jgp.100.1.27; SHIMIZU T, 1990, J NEUROCHEM, V55, P1, DOI 10.1111/j.1471-4159.1990.tb08813.x; Stuhmer W, 1992, Curr Opin Neurobiol, V2, P243, DOI 10.1016/0959-4388(92)90110-7; TAKENAKA T, 1988, J MEMBRANE BIOL, V106, P141, DOI 10.1007/BF01871396; WALSH JP, 1993, BRAIN RES, V6308, P123; WEISS S, 1990, J PHARMACOL EXP THER, V252, P380; WEST JW, 1991, SCIENCE, V254, P866, DOI 10.1126/science.1658937; WILLIAMS JH, 1989, NATURE, V341, P739, DOI 10.1038/341739a0; ZONA C, 1993, NEUROREPORT, V4, P359, DOI 10.1097/00001756-199304000-00004	66	93	96	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1993	11	4					633	644		10.1016/0896-6273(93)90075-3	http://dx.doi.org/10.1016/0896-6273(93)90075-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MD068	8398152				2022-12-24	WOS:A1993MD06800008
J	OKANO, K; MONCK, JR; FERNANDEZ, JM				OKANO, K; MONCK, JR; FERNANDEZ, JM			GTP-GAMMA-S STIMULATES EXOCYTOSIS IN PATCH-CLAMPED RAT MELANOTROPHS	NEURON			English	Article							ADRENAL CHROMAFFIN CELLS; PROTEIN-KINASE-C; MAST-CELLS; CAPACITANCE MEASUREMENTS; BINDING PROTEINS; CATECHOLAMINE RELEASE; GUANINE-NUCLEOTIDES; PITUITARY-CELLS; SECRETION; CALCIUM	We investigated the molecular mechanisms regulating exocytosis in patch-clamped melanotrophs by measuring the membrane capacitance. Ca2+-dependent exocytosis could be induced by membrane depolarization or by including solutions containing 2 muM free Ca2+ in the patch pipette. Ca2+-dependent exocytosis was inhibited by GDPbetaS, suggesting involvement of a GTP-binding protein. The hydrolysis-resistant GTP analogs, GTPgammaS and GppNHp, were able to stimulate exocytosis at low free Ca2+ concentrations. The stimulatory response to GTPgammaS was abolished by both GDPbetaS and GTP. The latter suggests that a sustained activation of a GTP-binding protein is necessary for exocytosis. This behavior is similar to the stimulation of exocytosis by guanine nucleotides in mast cells and other nonexcitable cells and suggests a common regulatory mechanism.			OKANO, K (corresponding author), MAYO CLIN & MAYO FDN,DEPT PHYSIOL & BIOPHYS,ROCHESTER,MN 55905, USA.							BALCH WE, 1990, TRENDS BIOCHEM SCI, V15, P473, DOI 10.1016/0968-0004(90)90301-Q; BALDINI G, 1992, P NATL ACAD SCI USA, V89, P5049, DOI 10.1073/pnas.89.11.5049; BIGAY J, 1987, EMBO J, V6, P2907, DOI 10.1002/j.1460-2075.1987.tb02594.x; BITTNER MA, 1986, J BIOL CHEM, V261, P182; BOURNE HR, 1993, CELL, V72, P65, DOI 10.1016/S0092-8674(05)80029-7; CARROLL AG, 1990, J NEUROCHEM, V55, P930, DOI 10.1111/j.1471-4159.1990.tb04580.x; CHANCE B, 1975, ANAL BIOCHEM, V66, P498, DOI 10.1016/0003-2697(75)90617-X; DEKKER LV, 1991, J NEUROCHEM, V56, P1146, DOI 10.1111/j.1471-4159.1991.tb11404.x; DEMATTEIS MA, 1991, J BIOL CHEM, V266, P10452; DOROSHENKO P, 1991, J PHYSIOL-LONDON, V436, P711, DOI 10.1113/jphysiol.1991.sp018575; DOUGLAS WW, 1968, BRIT J PHARMACOL, V34, P451, DOI 10.1111/j.1476-5381.1968.tb08474.x; FERNANDEZ JM, 1984, NATURE, V312, P453, DOI 10.1038/312453a0; FIDLER N, 1989, BIOPHYS J, V56, P1153, DOI 10.1016/S0006-3495(89)82762-6; GOMPERTS BD, 1990, ANNU REV PHYSIOL, V52, P591; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HESS SD, 1993, SCIENCE, V259, P1169, DOI 10.1126/science.8438167; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; HIGASHIJIMA T, 1991, J BIOL CHEM, V266, P3396; HOLZ RW, 1989, J BIOL CHEM, V264, P5412; IYENGAR R, 1980, J BIOL CHEM, V255, P312; JOSHI C, 1988, BIOPHYS J, V53, P885, DOI 10.1016/S0006-3495(88)83169-2; KAHN RA, 1991, J BIOL CHEM, V266, P15595; KEJA JA, 1992, J PHYSIOL-LONDON, V450, P409, DOI 10.1113/jphysiol.1992.sp019134; KNIGHT DE, 1982, J MEMBRANE BIOL, V68, P107, DOI 10.1007/BF01872259; LILLIE THW, 1992, BIOCHEM J, V288, P181, DOI 10.1042/bj2880181; LINDAU M, 1991, BIOCHIM BIOPHYS ACTA, V1071, P429, DOI 10.1016/0304-4157(91)90006-I; LUINI A, 1988, CELL MOL NEUROBIOL, V8, P129, DOI 10.1007/BF00712918; MACRAE MB, 1990, BIOCHEM J, V271, P635, DOI 10.1042/bj2710635; MATSUI Y, 1988, J BIOL CHEM, V263, P11071; MONCK JR, 1992, J CELL BIOL, V119, P1395, DOI 10.1083/jcb.119.6.1395; NEHER E, 1988, J PHYSIOL-LONDON, V395, P193, DOI 10.1113/jphysiol.1988.sp016914; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; NUSSE O, 1990, J EXP MED, V171, P775, DOI 10.1084/jem.171.3.775; NUSSE O, 1988, J CELL BIOL, V107, P2117, DOI 10.1083/jcb.107.6.2117; OBERHAUSER AF, 1992, NATURE, V360, P270, DOI 10.1038/360270a0; PADFIELD PJ, 1992, P NATL ACAD SCI USA, V89, P1656, DOI 10.1073/pnas.89.5.1656; Pfeffer S R, 1992, Trends Cell Biol, V2, P41, DOI 10.1016/0962-8924(92)90161-F; PUSCH M, 1988, PFLUG ARCH EUR J PHY, V411, P204, DOI 10.1007/BF00582316; REXACH MF, 1991, J CELL BIOL, V114, P219, DOI 10.1083/jcb.114.2.219; RONNING SA, 1986, J BIOL CHEM, V261, P7834; SENYSHYN J, 1992, FEBS LETT, V309, P41, DOI 10.1016/0014-5793(92)80735-Y; SIKDAR SK, 1990, FEBS LETT, V273, P150, DOI 10.1016/0014-5793(90)81072-V; TAMAOKI T, 1991, METHOD ENZYMOL, V201, P340; THOMAS P, 1990, NEURON, V5, P723, DOI 10.1016/0896-6273(90)90226-6; VALLAR L, 1987, J BIOL CHEM, V262, P5049; VANDERMERWE PA, 1989, BIOCHEM J, V264, P901, DOI 10.1042/bj2640901; VONMOLLARD GF, 1991, NATURE, V349, P79, DOI 10.1038/349079a0; ZAHRAOUI A, 1989, J BIOL CHEM, V264, P12394	48	42	42	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1993	11	1					165	172		10.1016/0896-6273(93)90280-5	http://dx.doi.org/10.1016/0896-6273(93)90280-5			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LP430	8338664				2022-12-24	WOS:A1993LP43000015
J	HAMMANG, JP; BEHRINGER, RR; BAETGE, EE; PALMITER, RD; BRINSTER, RL; MESSING, A				HAMMANG, JP; BEHRINGER, RR; BAETGE, EE; PALMITER, RD; BRINSTER, RL; MESSING, A			ONCOGENE EXPRESSION IN RETINAL HORIZONTAL CELLS OF TRANSGENIC MICE RESULTS IN A CASCADE OF NEURODEGENERATION	NEURON			English	Article							T-ANTIGEN EXPRESSION; RAT RETINA; MOUSE RETINA; IMMUNOHISTOCHEMICAL EVIDENCE; MONOCLONAL-ANTIBODIES; CONTAINING NEURONS; GANGLION-CELLS; AMACRINE CELLS; DIFFERENTIATION; NEOPLASIA	The phenylethanolamine N-methyltransferase promoter directs the expression of the SV40 T antigen to subsets of amacrine and horizontal neurons of the retina in a line of transgenic mice. T antigen expression begins in these cells during the first postnatal week. The horizontal cells appear to develop normally for another week but then begin to die. Subsequently, most of the horizontal cells disappear from the central and mid retina, resulting in loss of the outer plexiform layer and absence of ribbon synapses between the photoreceptors and bipolar cells. Neuronal transformation occurs only in the peripheral retina. These experiments indicate that horizontal neurons are heterogeneous with respect to susceptibility to transformation and that T antigen expression in a subset of horizontal neurons can be a direct cause of neuronal cell death. Furthermore, critical interdependencies exist between horizontal neurons after retinal neurogenesis is complete.	BRISTOL MYERS SQUIBB,PHARMACEUT RES INST,CNS CELL & MOLEC NEUROBIOL,WALLINGFORD,CT 06492; UNIV PENN,SCH VET MED,REPROD PHYSIOL LAB,PHILADELPHIA,PA 19104; UNIV WASHINGTON,DEPT BIOCHEM,HOWARD HUGHES MED INST,SEATTLE,WA 98195; UNIV WISCONSIN,SCH VET MED,DEPT PATHOBIOL SCI,MADISON,WI 53706	Bristol-Myers Squibb; University of Pennsylvania; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Wisconsin System; University of Wisconsin Madison				Brinster, Ralph/0000-0003-1408-7656	NCI NIH HHS [CA-38635] Funding Source: Medline; NICHD NIH HHS [HD-09172] Funding Source: Medline; NINDS NIH HHS [NS-22475] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD009172, R37HD009172] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA038635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022475] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS JM, 1991, SCIENCE, V254, P1161, DOI 10.1126/science.1957168; ALUBAIDI MR, 1992, P NATL ACAD SCI USA, V89, P1194, DOI 10.1073/pnas.89.4.1194; BAETGE EE, 1988, P NATL ACAD SCI USA, V85, P3648, DOI 10.1073/pnas.85.10.3648; BAETSCHER M, 1991, ONCOGENE, V6, P1133; BEAZLEY LD, 1987, DEV BRAIN RES, V33, P169, DOI 10.1016/0165-3806(87)90151-9; BLANKS JC, 1977, J COMP NEUROL, V174, P317, DOI 10.1002/cne.901740208; BLANKS JC, 1974, J COMP NEUROL, V156, P81, DOI 10.1002/cne.901560107; BOHN MC, 1987, DEV BRAIN RES, V37, P257, DOI 10.1016/0165-3806(87)90247-1; BOYCOTT BB, 1978, PROC R SOC SER B-BIO, V203, P229, DOI 10.1098/rspb.1978.0103; COHEN J, 1987, NEUROSCI LETT, V83, P138, DOI 10.1016/0304-3940(87)90230-8; DRAGER UC, 1983, NATURE, V303, P169, DOI 10.1038/303169a0; EFRAT S, 1988, NEURON, V1, P605, DOI 10.1016/0896-6273(88)90110-9; FAKTOROVICH EG, 1990, NATURE, V347, P83, DOI 10.1038/347083a0; FEDDERSEN RM, 1992, NEURON, V9, P955, DOI 10.1016/0896-6273(92)90247-B; FOSTER GA, 1985, DEV BRAIN RES, V22, P187, DOI 10.1016/0165-3806(85)90170-1; FOSTER GA, 1985, BRAIN RES, V330, P183, DOI 10.1016/0006-8993(85)90025-3; GUILLEMOT F, 1992, DEVELOPMENT, V114, P743; GURNEY EG, 1980, J VIROL, V34, P752, DOI 10.1128/JVI.34.3.752-763.1980; HADJICONSTANTINOU M, 1984, NEUROSCIENCE, V13, P547, DOI 10.1016/0306-4522(84)90247-1; HAMMANG JP, 1990, NEURON, V4, P775, DOI 10.1016/0896-6273(90)90204-S; HAMMANG JP, 1992, J COMP NEUROL, V316, P383, DOI 10.1002/cne.903160309; HANAHAN D, 1989, SCIENCE, V246, P1265, DOI 10.1126/science.2686032; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; HARLOW E, 1981, J VIROL, V39, P861, DOI 10.1128/JVI.39.3.861-869.1981; JOHNSON JE, 1986, J NEUROSCI, V6, P3031; KEYSER KT, 1987, J NEUROSCI, V7, P3996; LEWIS GP, 1992, J NEUROSCI, V12, P3968; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; MESSING A, 1988, ONCOGENE RES, V3, P87; OLNEY JW, 1968, INVEST OPHTH VISUAL, V7, P250; ORNITZ DM, 1987, SCIENCE, V238, P188, DOI 10.1126/science.2821617; PARK DH, 1986, J NEUROSCI, V6, P1108; PLEASURE SJ, 1990, J NEUROSCI, V10, P2428; POLLEY EH, 1987, DEV VERTEBRATE RETIN, P3; RADOVICK S, 1991, P NATL ACAD SCI USA, V88, P3402, DOI 10.1073/pnas.88.8.3402; RODERICK TH, 1989, GENETIC VARIANTS STR, P663; SHAW G, 1983, EUR J CELL BIOL, V30, P219; Sidman RL, 1961, STRUCTURE EYE, P487; TURNER DL, 1990, NEURON, V4, P833, DOI 10.1016/0896-6273(90)90136-4; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; VERSAUXBOTTERI C, 1986, J COMP NEUROL, V243, P422, DOI 10.1002/cne.902430311; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; YOUNG RW, 1984, J COMP NEUROL, V229, P362, DOI 10.1002/cne.902290307; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215	44	42	43	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1993	10	6					1197	1209		10.1016/0896-6273(93)90067-2	http://dx.doi.org/10.1016/0896-6273(93)90067-2			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LK373	8391281				2022-12-24	WOS:A1993LK37300019
J	VERNALLIS, AB; CONROY, WG; BERG, DK				VERNALLIS, AB; CONROY, WG; BERG, DK			NEURONS ASSEMBLE ACETYLCHOLINE-RECEPTORS WITH AS MANY AS 3 KINDS OF SUBUNITS WHILE MAINTAINING SUBUNIT SEGREGATION AMONG RECEPTOR SUBTYPES	NEURON			English	Article							CILIARY GANGLION NEURONS; MONOCLONAL-ANTIBODIES; GENE FAMILY; FUNCTIONAL EXPRESSION; NICOTINIC RECEPTORS; ALPHA-NEUROTOXIN; XENOPUS OOCYTES; BINDING-SITES; CELL-CULTURE; BRAIN	A family of genes encoding neuronal acetylcholine receptor (AChR) subunits has been identified and cloned from vertebrates. Expression studies have implied that as few as one or two kinds of subunits may be sufficient to construct neuronal AChRs and that multiple pair-wise combinations of the gene products are capable of generating functional receptors. We show here that a class of AChRs with a predominantly synaptic location on neurons contains receptors having at least three types of subunits and that the subunits are encoded by the alpha3, beta4, and alpha5 AChR genes. In addition, we show that a class of extrasynaptic AChRs on the same neurons contains the alpha7 subunits but lacks the alpha3, beta4, and alpha5 subunits. The results demonstrate that native AChRs on neurons are more complex in composition than previously appreciated and suggest that constraints on subunit interactions limit the kinds of receptor species produced.			VERNALLIS, AB (corresponding author), UNIV CALIF SAN DIEGO,DEPT BIOL,LA JOLLA,CA 92093, USA.				NINDS NIH HHS [P01 NS25916, R01 NS12601] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS012601, P01NS025916] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANAND R, 1991, J BIOL CHEM, V266, P11192; BALLIVET M, 1988, NEURON, V1, P847, DOI 10.1016/0896-6273(88)90132-8; BLOUNT P, 1990, J CELL BIOL, V111, P2601, DOI 10.1083/jcb.111.6.2601; BOULTER J, 1987, P NATL ACAD SCI USA, V84, P7763, DOI 10.1073/pnas.84.21.7763; BOULTER J, 1990, J BIOL CHEM, V265, P4472; CONROY WG, 1992, NEURON, V9, P679, DOI 10.1016/0896-6273(92)90031-8; COOPER E, 1991, NATURE, V350, P235, DOI 10.1038/350235a0; COUTURIER S, 1990, J BIOL CHEM, V265, P17560; COUTURIER S, 1990, NEURON, V5, P847, DOI 10.1016/0896-6273(90)90344-F; DENERIS ES, 1988, NEURON, V1, P45, DOI 10.1016/0896-6273(88)90208-5; DENERIS ES, 1989, J BIOL CHEM, V264, P6268; DUVOISIN RM, 1989, NEURON, V3, P487, DOI 10.1016/0896-6273(89)90207-9; GU Y, 1991, J CELL BIOL, V114, P799, DOI 10.1083/jcb.114.4.799; HALVORSEN SW, 1987, J NEUROSCI, V7, P2547; HALVORSEN SW, 1990, J NEUROSCI, V10, P1711; HALVORSEN SW, 1986, J NEUROSCI, V6, P3405; HANKE W, 1986, NATURE, V321, P171, DOI 10.1038/321171a0; JACOB MH, 1984, P NATL ACAD SCI-BIOL, V81, P3223, DOI 10.1073/pnas.81.10.3223; JACOB MH, 1983, J NEUROSCI, V3, P260; LINDSTROM J, 1981, METHOD ENZYMOL, V74, P452; LISTERUD M, 1991, SCIENCE, V254, P1518, DOI 10.1126/science.1720573; LORING RH, 1987, J NEUROSCI, V7, P2153; LORING RH, 1984, NEUROSCIENCE, V11, P989, DOI 10.1016/0306-4522(84)90209-4; MARGIOTTA JF, 1987, P NATL ACAD SCI USA, V84, P8155, DOI 10.1073/pnas.84.22.8155; MARGIOTTA JF, 1987, J NEUROSCI, V7, P3612; MCLANE KE, 1992, J NEUROIMMUNOL, V38, P115, DOI 10.1016/0165-5728(92)90096-4; NEF P, 1988, EMBO J, V7, P595, DOI 10.1002/j.1460-2075.1988.tb02852.x; NISHI R, 1981, J NEUROSCI, V1, P505; RAVDIN PM, 1979, P NATL ACAD SCI USA, V76, P2072, DOI 10.1073/pnas.76.4.2072; SCHOEPFER R, 1989, FEBS LETT, V257, P393, DOI 10.1016/0014-5793(89)81580-7; SCHOEPFER R, 1990, NEURON, V5, P35, DOI 10.1016/0896-6273(90)90031-A; SCHOEPFER R, 1988, NEURON, V1, P241, DOI 10.1016/0896-6273(88)90145-6; SMITH MA, 1985, J NEUROSCI, V5, P2726; STOLLBERG J, 1987, J NEUROSCI, V7, P1809; TZARTOS S, 1981, J BIOL CHEM, V250, P8635; VIJAYARAGHAVAN S, 1992, NEURON, V8, P353, DOI 10.1016/0896-6273(92)90301-S; VIJAYARAGHAVAN S, 1990, J NEUROSCI, V10, P3255; WADA K, 1988, SCIENCE, V240, P330, DOI 10.1126/science.2832952; WHITING P, 1986, J NEUROSCI, V6, P3061; WHITING P, 1991, MOL PHARMACOL, V40, P463; WHITING P, 1987, P NATL ACAD SCI USA, V84, P595, DOI 10.1073/pnas.84.2.595; WHITING PJ, 1991, MOL BRAIN RES, V10, P61, DOI 10.1016/0169-328X(91)90057-5; WHITING PJ, 1986, BIOCHEMISTRY-US, V25, P2082, DOI 10.1021/bi00356a037; WHITING PJ, 1988, J NEUROSCI, V8, P3395; WHITING PJ, 1987, J NEUROSCI, V7, P4005	45	269	271	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1993	10	3					451	464		10.1016/0896-6273(93)90333-M	http://dx.doi.org/10.1016/0896-6273(93)90333-M			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KU901	8461135				2022-12-24	WOS:A1993KU90100010
J	Ohno, K; Wang, HL; Milone, M; Bren, N; Brengman, JM; Nakano, S; Quiram, P; Pruitt, JN; Sine, SM; Engel, AG				Ohno, K; Wang, HL; Milone, M; Bren, N; Brengman, JM; Nakano, S; Quiram, P; Pruitt, JN; Sine, SM; Engel, AG			Congenital myasthenic syndrome caused by decreased agonist binding affinity due to a mutation in the acetylcholine receptor epsilon subunit	NEURON			English	Article							CELL-LINE TE671; GAMMA-SUBUNIT; CHOLINERGIC RECEPTOR; LIGAND-BINDING; MUSCLE-CELLS; KINETICS; FIBROBLASTS; TRANSITIONS; CLONING; MOUSE	We describe the genetic and kinetic defects for a low-affinity fast channel disease of the acetylcholine receptor (AChR) that causes a myasthenic syndrome. In two unrelated patients with very small miniature end plate (EP) potentials, but with normal EP AChR density and normal EP ultrastructure, patch-clamp studies demonstrated infrequent AChR channel events, diminished channel reopenings during ACh occupancy, and resistance to desensitization by ACh. Each patient had two heteroallelic AChR epsilon subunit gene mutations: a common epsilon P121L mutation, a signal peptide mutation (epsilon G-8R) (patient 1), and a glycosylation consensus site mutation (epsilon S143L) (patient 2). AChR expression in HEK fibroblasts was normal with epsilon P121L but was markedly reduced with the other mutations. Therefore, epsilon P121L defines the clinical phenotype. Studies of the engineered epsilon P121L AChR revealed a markedly decreased rate of channel opening, little change in affinity of the resting state for ACh, but reduced affinity of the open channel and desensitized states.	MAYO CLIN & MAYO FDN,DEPT NEUROL,MUSCLE RES LAB,ROCHESTER,MN 55905; MAYO CLIN & MAYO FDN,DEPT PHYSIOL & BIOPHYS,RECEPTOR BIOL LAB,ROCHESTER,MN 55905	Mayo Clinic; Mayo Clinic			Ohno, Kinji/H-4020-2012	Ohno, Kinji/0000-0002-1529-2750	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031744, R37NS031744, R01NS006277] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BEESON D, 1993, EUR J BIOCHEM, V215, P229, DOI 10.1111/j.1432-1033.1993.tb18027.x; BEESON D, 1989, NUCLEIC ACIDS RES, V17, P4391, DOI 10.1093/nar/17.11.4391; BLOUNT P, 1991, J BIOL CHEM, V266, P14692; BLOUNT P, 1989, NEURON, V3, P349, DOI 10.1016/0896-6273(89)90259-6; BOUZAT C, 1994, NEURON, V13, P1395, DOI 10.1016/0896-6273(94)90424-3; CHEN J, 1995, BIOPHYS J, V69, P849, DOI 10.1016/S0006-3495(95)79959-3; CHIARA D C, 1992, Biophysical Journal, V61, pA106; COLQUHOUN D, 1985, J PHYSIOL-LONDON, V369, P501, DOI 10.1113/jphysiol.1985.sp015912; ELMQVIST D, 1965, J PHYSIOL-LONDON, V178, P505, DOI 10.1113/jphysiol.1965.sp007639; Engel A.G., 1994, MYOLOGY, P1018; ENGEL AG, 1993, MUSCLE NERVE, V16, P1284, DOI 10.1002/mus.880161204; ENGEL AG, 1977, NEUROLOGY, V27, P307, DOI 10.1212/WNL.27.4.307; FU DX, 1994, J BIOL CHEM, V269, P26152; GEHLE VM, 1991, MOL BRAIN RES, V11, P17, DOI 10.1016/0169-328X(91)90016-Q; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HONGYO T, 1993, NUCLEIC ACIDS RES, V21, P3637, DOI 10.1093/nar/21.16.3637; JACKSON MB, 1989, P NATL ACAD SCI USA, V86, P2199, DOI 10.1073/pnas.86.7.2199; KATZ B, 1973, J PHYSIOL-LONDON, V231, P549, DOI 10.1113/jphysiol.1973.sp010248; KATZ B, 1957, J PHYSIOL-LONDON, V137, P267, DOI 10.1113/jphysiol.1957.sp005811; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LANG B, 1983, J PHYSIOL-LONDON, V344, P335, DOI 10.1113/jphysiol.1983.sp014943; LEE BS, 1991, J BIOL CHEM, V266, P11448; LUTHER MA, 1989, J NEUROSCI, V9, P1082; MARTIN AR, 1966, PHYSIOL REV, V46, P51, DOI 10.1152/physrev.1966.46.1.51; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; OHNO K, 1995, P NATL ACAD SCI USA, V92, P758, DOI 10.1073/pnas.92.3.758; Qin F, 1996, BIOPHYS J, V70, P264, DOI 10.1016/S0006-3495(96)79568-1; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHOEPFER R, 1988, FEBS LETT, V226, P235, DOI 10.1016/0014-5793(88)81430-3; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; SINE S, 1979, J BIOL CHEM, V254, P3315; SINE SM, 1982, J BIOL CHEM, V257, P8106; SINE SM, 1995, NEURON, V15, P229, DOI 10.1016/0896-6273(95)90080-2; SINE SM, 1991, J BIOL CHEM, V266, P19369; SINE SM, 1993, P NATL ACAD SCI USA, V90, P9436, DOI 10.1073/pnas.90.20.9436; SINE SM, 1990, J GEN PHYSIOL, V96, P395, DOI 10.1085/jgp.96.2.395; SINE SM, 1995, NEURON, V15, P205, DOI 10.1016/0896-6273(95)90077-2; THOMSEN RH, 1983, J PHARMACOL EXP THER, V227, P260; UCHITEL O, 1993, MUSCLE NERVE, V16, P1293, DOI 10.1002/mus.880161205; UPENDER M, 1995, BIOTECHNIQUES, V18, P29; WEILAND G, 1977, J BIOL CHEM, V252, P7648; ZHANG YN, 1995, J PHYSIOL-LONDON, V486, P189, DOI 10.1113/jphysiol.1995.sp020802; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	47	177	182	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1996	17	1					157	170		10.1016/S0896-6273(00)80289-5	http://dx.doi.org/10.1016/S0896-6273(00)80289-5			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UY981	8755487	Bronze			2022-12-24	WOS:A1996UY98100016
J	Patterson, SL; Abel, T; Deuel, TAS; MArtin, KC; Rose, JC; Kandel, ER				Patterson, SL; Abel, T; Deuel, TAS; MArtin, KC; Rose, JC; Kandel, ER			Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice	NEURON			English	Article							LONG-TERM POTENTIATION; NERVE GROWTH-FACTOR; NEUROTROPHIC FACTOR; MESSENGER-RNA; CYCLIC-AMP; BRAIN; EXPRESSION; RECEPTOR; NEURONS; NT-3	Brain-derived neurotrophic factor (BDNF) is expressed at high levels in hippocampal neurons, and its expression is modulated by neural activity. Knockout mice can be used to study the roles of molecules like BDNF in synaptic plasticity with more molecular specificity than is possible using pharmacological approaches. Because in conventional knockouts the disrupted gene product is absent in all tissues throughout the life of the animal, developmental effects may complicate the interpretation of deficits in the adult. Rescue experiments can help to distinguish between developmental and acute requirements for the missing gene product. We here demonstrate that treatment of hippocampal slices from BDNF knockout mice with recombinant BDNF completely reverses deficits in longterm potentiation and significantly improves deficits in basal synaptic transmission at the Schaffer collateral-CA1 synapse. Thus, BDNF has an acute role in hippocampal synaptic function.	COLUMBIA UNIV COLL PHYS & SURG, CTR NEUROBIOL & BEHAV, NEW YORK, NY 10032 USA	Columbia University	Patterson, SL (corresponding author), COLUMBIA UNIV COLL PHYS & SURG, HOWARD HUGHES MED INST, NEW YORK, NY 10032 USA.		Abel, Ted/AAX-2825-2021	Abel, Ted/0000-0003-2423-4592	NIA NIH HHS [AG 08702] Funding Source: Medline; NIDDK NIH HHS [T32DK07328] Funding Source: Medline; NIMH NIH HHS [1P50 MH 50733] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH050733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG008702] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ABELIOVICH A, 1993, CELL, V75, P1263, DOI 10.1016/0092-8674(93)90614-V; ANDERSON KD, 1995, J COMP NEUROL, V357, P296, DOI 10.1002/cne.903570209; [Anonymous], [No title captured]; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Blitzer RD, 1995, NEURON, V15, P1403, DOI 10.1016/0896-6273(95)90018-7; BLOCHL A, 1995, EUR J NEUROSCI, V7, P1220, DOI 10.1111/j.1460-9568.1995.tb01112.x; CABELLI RJ, 1995, SCIENCE, V267, P1662, DOI 10.1126/science.7886458; CARSTEN E, 1993, NEUROREPORT, V4, P895; CHAO MV, 1992, NEURON, V9, P583, DOI 10.1016/0896-6273(92)90023-7; DAVIES AM, 1994, J NEUROBIOL, V25, P1334, DOI 10.1002/neu.480251103; DRAGUNOW M, 1993, NEUROSCI LETT, V160, P232, DOI 10.1016/0304-3940(93)90420-P; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; GALL C, 1992, EPILEPSY RES, P171; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; GUNNING PW, 1981, J CELL BIOL, V89, P240, DOI 10.1083/jcb.89.2.240; HEFTI F, 1989, NEUROBIOL AGING, V10, P515, DOI 10.1016/0197-4580(89)90118-8; HEIDEMANN SR, 1985, J CELL BIOL, V100, P916, DOI 10.1083/jcb.100.3.916; Huang Y Y, 1994, Learn Mem, V1, P74; IP NY, 1993, J NEUROSCI, V13, P3394; JONES KR, 1994, CELL, V76, P989, DOI 10.1016/0092-8674(94)90377-8; KALMAN D, 1990, NEURON, V4, P355, DOI 10.1016/0896-6273(90)90048-K; KANDEL E, 1995, SCIENCE, V268, P825, DOI 10.1126/science.7754367; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; LESSER SS, 1995, J NEUROSCI, V15, P253; LESSMANN V, 1994, NEUROREPORT, V6, P21; LEVINE ES, 1995, P NATL ACAD SCI USA, V92, P8074, DOI 10.1073/pnas.92.17.8074; LEVINE ES, 1995, J NEUROSCI, V15, P3084; LINDEFORS N, 1992, EXP BRAIN RES, V88, P78, DOI 10.1007/BF02259130; LO DC, 1995, NEURON, V15, P979, DOI 10.1016/0896-6273(95)90085-3; LOHOF AM, 1993, NATURE, V363, P350, DOI 10.1038/363350a0; MATTHIES H, 1993, NEUROREPORT, V4, P712, DOI 10.1097/00001756-199306000-00028; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; MERLIO JP, 1993, NEURON, V10, P151, DOI 10.1016/0896-6273(93)90307-D; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; MOUNT HTJ, 1993, J NEUROSCI, V13, P3173; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; PATTERSON SL, 1992, NEURON, V9, P1081, DOI 10.1016/0896-6273(92)90067-N; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; STOOP R, 1995, SCIENCE, V267, P695, DOI 10.1126/science.7839148; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; VALENZUELA DM, 1993, NEURON, V10, P963, DOI 10.1016/0896-6273(93)90211-9; VERGE VMK, 1992, J NEUROSCI, V12, P4011; YAN Q, 1994, EXP NEUROL, V127, P23, DOI 10.1006/exnr.1994.1076	51	1010	1021	1	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	1996	16	6					1137	1145		10.1016/S0896-6273(00)80140-3	http://dx.doi.org/10.1016/S0896-6273(00)80140-3			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UU118	8663990	hybrid			2022-12-24	WOS:A1996UU11800011
J	LIN, DM; AULD, VJ; GOODMAN, CS				LIN, DM; AULD, VJ; GOODMAN, CS			TARGETED NEURONAL CELL ABLATION IN THE DROSOPHILA EMBRYO - PATHFINDING BY FOLLOWER GROWTH CONES IN THE ABSENCE OF PIONEERS	NEURON			English	Article							SELECT APPROPRIATE PATHWAYS; INSECT NERVOUS-SYSTEM; GENE FUSHI-TARAZU; GRASSHOPPER EMBRYOS; DIPHTHERIA-TOXIN; SUBPLATE NEURONS; PERIPHERAL-NERVE; TRANSGENIC MICE; AXONAL PATHWAY; ZEBRAFISH	We developed a rapid method that uses diphtheria toxin, the flp recognition target sequences, and the GAL4-UAS activation system, to ablate specific neurons in the Drosophila embryo and to examine the consequences in large numbers of embryos at many time points. We used this method to show that, in the absence of the aCC axon, which pioneers the intersegmental nerve in the PNS, the three U follower axons are delayed and make frequent errors. However, the pathway ultimately forms in most segments. We also ablated the axons that pioneer the first longitudinal pathways within the CNS and observed similar results; the formation of longitudinal pathways is delayed and disorganized in 70% of segments, but these tracts ultimately form in 80% of segments. Thus, pioneers facilitate the development of PNS and CNS axon pathways; in their absence, followers are delayed and make numerous errors. However, pioneers are not absolutely required, as these embryos display a remarkable ability to correct for the loss of the pioneering neurons.			LIN, DM (corresponding author), UNIV CALIF BERKELEY,HOWARD HUGHES MED INST,DEPT MOLEC & CELL BIOL,DIV NEUROBIOL,LIFE SCI ADDIT,BERKELEY,CA 94720, USA.			Auld, Vanessa/0000-0003-3976-9186	NICHD NIH HHS [HD21294] Funding Source: Medline; NIGMS NIH HHS [5T32 GM07232] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD021294, R01HD021294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007232] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BASTIANI MJ, 1986, J NEUROSCI, V6, P3518; BASTIANI MJ, 1984, J NEUROSCI, V4, P2311; BATE CM, 1981, J EMBRYOL EXP MORPH, V61, P317; BATE CM, 1976, J EMBRYOL EXP MORPH, V35, P107; BELLEN HJ, 1992, DEVELOPMENT, V114, P787; BENTLEY D, 1982, SCIENCE, V218, P1082, DOI 10.1126/science.218.4577.1082; BRAND AH, 1993, DEVELOPMENT, V118, P401; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; CHITNIS AB, 1990, J NEUROSCI, V10, P1892; CHITNIS AB, 1991, NEURON, V7, P277, DOI 10.1016/0896-6273(91)90266-3; COLLIER RJ, 1975, BACTERIOL REV, V39, P54, DOI 10.1128/MMBR.39.1.54-85.1975; DOE CQ, 1988, SCIENCE, V239, P170, DOI 10.1126/science.2892267; DULAC S, 1986, J NEUROSCI, V6, P3532; EDWARDS JS, 1981, J NEUROSCI, V1, P250; EISEN JS, 1989, NEURON, V2, P1097, DOI 10.1016/0896-6273(89)90234-1; FISCHER JA, 1988, NATURE, V332, P853, DOI 10.1038/332853a0; GHOSH A, 1990, NATURE, V347, P179, DOI 10.1038/347179a0; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; GOODMAN CS, 1982, S SOC DEV BIOL, V40, P275; Harrison RG, 1910, J EXP ZOOL, V9, P787, DOI 10.1002/jez.1400090405; HIROMI Y, 1985, CELL, V43, P603, DOI 10.1016/0092-8674(85)90232-6; HO RK, 1982, NATURE, V297, P404, DOI 10.1038/297404a0; KALB JM, 1993, P NATL ACAD SCI USA, V90, P8093, DOI 10.1073/pnas.90.17.8093; KESHISHIAN H, 1983, DEV BIOL, V96, P116, DOI 10.1016/0012-1606(83)90316-0; KLAMBT C, 1991, CELL, V64, P801, DOI 10.1016/0092-8674(91)90509-W; KLOSE M, 1989, SCIENCE, V245, P982, DOI 10.1126/science.2772651; KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057; KUNES S, 1991, GENE DEV, V5, P970, DOI 10.1101/gad.5.6.970; KUWADA JY, 1986, SCIENCE, V233, P740, DOI 10.1126/science.3738507; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LIN DM, 1994, NEURON, V13, P1055, DOI 10.1016/0896-6273(94)90045-0; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; MCCONNELL SK, 1989, SCIENCE, V245, P978, DOI 10.1126/science.2475909; MOFFAT KG, 1992, DEVELOPMENT, V114, P681; PALMITER RD, 1987, CELL, V50, P435, DOI 10.1016/0092-8674(87)90497-1; PIKE SH, 1990, J NEUROSCI, V10, P44; RAPER JA, 1983, COLD SPRING HARB SYM, V48, P587, DOI 10.1101/SQB.1983.048.01.063; RAPER JA, 1984, J NEUROSCI, V4, P2329; RAPER JA, 1983, J NEUROSCI, V3, P31; ROBERTSON HM, 1988, GENETICS, V118, P461; Sambrook J, 1989, MOL CLONING LABORATO; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; USUKURA J, 1994, CELL TISSUE RES, V275, P79, DOI 10.1007/BF00305377; WIGGLESWORTH VB, 1953, Q J MICROSC SCI, V94, P93; WILSON SW, 1990, DEVELOPMENT, V108, P121; YAMAIZUMI M, 1978, CELL, V15, P245, DOI 10.1016/0092-8674(78)90099-5	47	62	62	0	4	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1995	14	4					707	715		10.1016/0896-6273(95)90215-5	http://dx.doi.org/10.1016/0896-6273(95)90215-5			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QU826	7718234	Bronze			2022-12-24	WOS:A1995QU82600005
J	HOLLMANN, M; MARON, C; HEINEMANN, S				HOLLMANN, M; MARON, C; HEINEMANN, S			N-GLYCOSYLATION SITE TAGGING SUGGESTS A 3-TRANSMEMBRANE DOMAIN TOPOLOGY FOR THE GLUTAMATE-RECEPTOR GLUR1	NEURON			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; DEPENDENT PROTEIN-KINASE; NMDA RECEPTOR; RAT-BRAIN; FUNCTIONAL EXPRESSION; STRUCTURAL DETERMINANTS; ENDOPLASMIC-RETICULUM; CALCIUM PERMEABILITY; MOLECULAR-BIOLOGY; OPERATED CHANNELS	We investigated the transmembrane topology of the glutamate receptor GluR1 by introducing N-glycosylation sites as reporter sites for an extracellular location of the respective site. Our data show that the N-terminus is extracellular, whereas the C-terminus is intracellular. Most importantly, we found only three transmembrane domains (designated TMD A, TMD B, and TMD C), which correspond to the previously proposed TMDs I, III, and IV, respectively. Contrary to earlier models, the putative channel-lining hydrophobic domain TMD II does not span the membrane, but either lies in close proximity to the intracellular face of the plasma membrane or loops into the membrane without traversing it. Furthermore, the region between TMDs III and IV, in previous models believed to be intracellular, is an entirely extracellular domain.	SALK INST BIOL STUDIES, MOLEC NEUROBIOL LAB, LA JOLLA, CA 92037 USA	Salk Institute				Hollmann, Michael/0000-0001-8000-7787	NINDS NIH HHS [NS28709, NS11549] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS011549, R01NS028709] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABEIJON C, 1992, TRENDS BIOCHEM SCI, V17, P32, DOI 10.1016/0968-0004(92)90424-8; ASCHER P, 1988, J PHYSIOL-LONDON, V399, P247; AUBERT JP, 1981, ARCH BIOCHEM BIOPHYS, V208, P20, DOI 10.1016/0003-9861(81)90118-1; BAMBERG K, 1994, J BIOL CHEM, V269, P16909; BARNARD EA, 1987, TRENDS NEUROSCI, V10, P502, DOI 10.1016/0166-2236(87)90130-5; BAUDE A, 1994, J NEUROSCI, V14, P2830; BLACKSTONE CD, 1992, J NEUROCHEM, V58, P1118, DOI 10.1111/j.1471-4159.1992.tb09370.x; BLASCHKE M, 1993, P NATL ACAD SCI USA, V90, P6528, DOI 10.1073/pnas.90.14.6528; BLOBEL G, 1980, P NATL ACAD SCI-BIOL, V77, P1496, DOI 10.1073/pnas.77.3.1496; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; BURNASHEV N, 1992, SCIENCE, V257, P1415, DOI 10.1126/science.1382314; CHAVEZ RA, 1991, J BIOL CHEM, V266, P15532; CLAUDIO T, 1983, P NATL ACAD SCI-BIOL, V80, P1111, DOI 10.1073/pnas.80.4.1111; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DEVILLERSTHIERY A, 1993, J MEMBRANE BIOL, V136, P97, DOI 10.1007/BF02505755; DINGLEDINE R, 1992, J NEUROSCI, V12, P4080; DUKSIN D, 1982, J BIOL CHEM, V257, P3105; GREGOR P, 1989, NATURE, V342, P689, DOI 10.1038/342689a0; GUY HR, 1987, TRENDS NEUROSCI, V10, P318, DOI 10.1016/0166-2236(87)90087-7; HART GW, 1979, J BIOL CHEM, V254, P9747; HIRSCHBERG CB, 1987, ANNU REV BIOCHEM, V56, P63, DOI 10.1146/annurev.bi.56.070187.000431; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HULLEBROECK MF, 1992, BRAIN RES, V590, P187, DOI 10.1016/0006-8993(92)91094-U; HUME RI, 1991, SCIENCE, V253, P1028, DOI 10.1126/science.1653450; IMOTO K, 1993, FEBS LETT, V325, P100, DOI 10.1016/0014-5793(93)81422-V; Karlin A, 1993, Curr Opin Neurobiol, V3, P299, DOI 10.1016/0959-4388(93)90121-E; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; KOHLER M, 1993, NEURON, V10, P491, DOI 10.1016/0896-6273(93)90336-P; KRONQUIST KE, 1978, J SUPRAMOL STR CELL, V8, P51, DOI 10.1002/jss.400080105; KURYATOV A, 1994, NEURON, V12, P1291, DOI 10.1016/0896-6273(94)90445-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDOLTMARTICORENA C, 1994, BIOCHEM J, V302, P253, DOI 10.1042/bj3020253; MCGLADEMCCULLOH E, 1993, NATURE, V362, P640, DOI 10.1038/362640a0; MOLNAR E, 1994, J NEUROCHEM, V63, P683; MOLNAR E, 1993, NEUROSCIENCE, V53, P307, DOI 10.1016/0306-4522(93)90198-O; MORI H, 1992, NATURE, V358, P673, DOI 10.1038/358673a0; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; MOSS SJ, 1993, NEUROCHEM RES, V18, P105, DOI 10.1007/BF00966929; MUSSHOFF U, 1992, NEUROSCI LETT, V147, P163; NAKANISHI N, 1990, NEURON, V5, P569, DOI 10.1016/0896-6273(90)90212-X; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; PETRALIA RS, 1992, J COMP NEUROL, V318, P329, DOI 10.1002/cne.903180309; RAPOPORT TA, 1985, FEBS LETT, V187, P1, DOI 10.1016/0014-5793(85)81202-3; RAYMOND LA, 1993, NATURE, V361, P637, DOI 10.1038/361637a0; ROCHE KW, 1994, J BIOL CHEM, V269, P11679; ROGERS SW, 1991, J NEUROSCI, V11, P2713; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEEBURG PH, 1993, TRENDS PHARMACOL SCI, V14, P297, DOI 10.1016/0165-6147(93)90047-N; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; STRECKER A, 1994, EUR J BIOCHEM, V220, P1005, DOI 10.1111/j.1432-1033.1994.tb18705.x; SULLIVAN JM, 1994, NEURON, V13, P929, DOI 10.1016/0896-6273(94)90258-5; SUMIKAWA K, 1988, MOL BRAIN RES, V4, P191, DOI 10.1016/0169-328X(88)90025-3; TAVERNA FA, 1994, J BIOL CHEM, V269, P14159; TINGLEY WG, 1993, NATURE, V364, P70, DOI 10.1038/364070a0; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; UCHINO S, 1992, FEBS LETT, V308, P253, DOI 10.1016/0014-5793(92)81286-U; UNWIN N, 1993, J MOL BIOL, V229, P1101, DOI 10.1006/jmbi.1993.1107; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; WADA K, 1989, NATURE, V342, P684, DOI 10.1038/342684a0; WANG LY, 1993, SCIENCE, V259, P1173, DOI 10.1126/science.8382377; WENTHOLD RJ, 1992, J BIOL CHEM, V267, P501; WO ZG, 1994, P NATL ACAD SCI USA, V91, P7154, DOI 10.1073/pnas.91.15.7154; WRIGHT MS, 1993, J RECEPTOR RES, V13, P653, DOI 10.3109/10799899309073685; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; YOOL AJ, 1991, NATURE, V349, P700, DOI 10.1038/349700a0	70	376	384	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1994	13	6					1331	1343		10.1016/0896-6273(94)90419-7	http://dx.doi.org/10.1016/0896-6273(94)90419-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PZ689	7993626				2022-12-24	WOS:A1994PZ68900008
J	MOCHIDA, S; KOBAYASHI, H; MATSUDA, Y; YUDA, Y; MURAMOTO, K; NONOMURA, Y				MOCHIDA, S; KOBAYASHI, H; MATSUDA, Y; YUDA, Y; MURAMOTO, K; NONOMURA, Y			MYOSIN-II IS INVOLVED IN TRANSMITTER RELEASE AT SYNAPSES FORMED BETWEEN RAT SYMPATHETIC NEURONS IN CULTURE	NEURON			English	Article							LIGHT CHAIN KINASE; SUPERIOR CERVICAL-GANGLION; ACTOMYOSIN-LIKE PROTEIN; CONTRACTILE PROTEINS; DIMETHYL-SULFOXIDE; SYNAPTIC VESICLES; CHROMAFFIN CELLS; NONMUSCLE MYOSIN; NERVOUS-SYSTEM; GROWTH CONES	The presynaptic function of myosin II was studied at cholinergic synapses formed between rat superior cervical ganglion neurons in culture. Immunofluorescent staining showed that myosin II was colocalized with synaptophysin at the presynaptic nerve terminals. Antimyosin II antibody introduced into presynaptic neurons inhibited synaptic transmission. Transmission was also inhibited in a dose-dependent manner by two inhibitors of myosin light chain kinase: a peptide, SM-1, and an organic inhibitor, wortmannin. The inhibition produced by these agents was dependent on presynaptic activity. Extracellularly applied wortmannin also blocked synaptic transmission, but its effects were slower in onset. Wortmannin also decreased postsynaptic potentials and post-tetanic potentiation in intact superior cervical ganglia. These results suggest a model in which myosin light chain kinase phosphorylates myosin, and the resultant change in actin-myosin interactions is involved in neurotransmitter release.	KYOWA HAKKO KOGYO CO LTD,TOKYO RES LABS,TOKYO 194,JAPAN; MEIJI SEIKA CO,PHARMACEUT RES CTR,YOKOHAMA,KANAGAWA 222,JAPAN; UNIV TOKYO,FAC MED,DEPT PHARMACOL,TOKYO 113,JAPAN	Kyowa Kirin Ltd; Meiji Holdings Co., Ltd.; University of Tokyo	MOCHIDA, S (corresponding author), TOKYO MED COLL,DEPT PHYSIOL,TOKYO 160,JAPAN.							ADELSTEIN RS, 1980, CALCIUM CELL FUNCTIO, V1, P167; BAHLER M, 1987, NATURE, V326, P704, DOI 10.1038/326704a0; BEACH RL, 1981, BRAIN RES, V225, P75, DOI 10.1016/0006-8993(81)90319-X; BERL S, 1973, SCIENCE, V179, P441, DOI 10.1126/science.179.4072.441; BERL S, 1970, BIOCHEMISTRY-US, V9, P2058, DOI 10.1021/bi00812a005; BLITZ AL, 1974, P NATL ACAD SCI USA, V71, P4472, DOI 10.1073/pnas.71.11.4472; BRAY D, 1977, BIOCHIMIE, V59, P1, DOI 10.1016/S0300-9084(77)80079-5; BRAY D, 1973, NATURE, V244, P93, DOI 10.1038/244093a0; BURRIDGE K, 1975, J MOL BIOL, V99, P1, DOI 10.1016/S0022-2836(75)80154-9; DRENCKHAHN D, 1983, EUR J CELL BIOL, V31, P235; ECCLES RM, 1961, J PHYSIOL-LONDON, V157, P484, DOI 10.1113/jphysiol.1961.sp006738; ELFVIN LG, 1963, J ULTRA MOL STRUCT R, V8, P441, DOI 10.1016/S0022-5320(63)80049-0; FIFKOVA E, 1985, BRAIN RES REV, V9, P187, DOI 10.1016/0165-0173(85)90012-8; GERMAIN M, 1965, BIOCHEM PHARMACOL, V14, P1815, DOI 10.1016/0006-2952(65)90271-6; GERON N, 1985, BIOCHIM BIOPHYS ACTA, V819, P258, DOI 10.1016/0005-2736(85)90181-6; GUTIERREZ LM, 1989, BIOCHEM J, V264, P589, DOI 10.1042/bj2640589; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HASHIMOTO Y, 1992, J BIOL CHEM, V267, P17078; HASLAM RJ, 1977, BIOCHEM BIOPH RES CO, V77, P714, DOI 10.1016/S0006-291X(77)80037-5; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; HIROKAWA N, 1989, J CELL BIOL, V108, P111, DOI 10.1083/jcb.108.1.111; JAHN R, 1985, P NATL ACAD SCI USA, V82, P4137, DOI 10.1073/pnas.82.12.4137; JOHNSON M, 1976, NATURE, V262, P308, DOI 10.1038/262308a0; KASA P, 1991, CELL TISSUE RES, V265, P151, DOI 10.1007/BF00318149; KAWAMOTO S, 1991, J CELL BIOL, V112, P915, DOI 10.1083/jcb.112.5.915; KEMP BE, 1987, J BIOL CHEM, V262, P2542; KITANI S, 1992, BIOCHEM BIOPH RES CO, V183, P48, DOI 10.1016/0006-291X(92)91607-R; KO CP, 1976, BRAIN RES, V117, P461, DOI 10.1016/0006-8993(76)90753-8; KUCZMARSKI ER, 1979, J CELL BIOL, V80, P356, DOI 10.1083/jcb.80.2.356; LASEK RJ, 1976, CELL MOTILITY, P1021; LETOURNEAU PC, 1981, DEV BIOL, V85, P113, DOI 10.1016/0012-1606(81)90240-2; LIBET B, 1964, J PHYSIOL-LONDON, V174, P1; LIBET B, 1988, BRAIN RES, V473, P271, DOI 10.1016/0006-8993(88)90856-6; MALINOW R, 1988, NATURE, V335, P820, DOI 10.1038/335820a0; MATTHEWS MR, 1974, PERIPHERAL NERVOUS S, P111; MCLARNON JG, 1986, MOL PHARMACOL, V30, P631; MILLER M, 1992, NEURON, V8, P25, DOI 10.1016/0896-6273(92)90106-N; MOCHIDA S, 1986, NEUROSCI LETT, V72, P199, DOI 10.1016/0304-3940(86)90080-7; MOCHIDA S, 1986, NEUROSCI LETT, V72, P205, DOI 10.1016/0304-3940(86)90081-9; MORALES M, 1989, J COMP NEUROL, V279, P666, DOI 10.1002/cne.902790412; MURAKAMI N, 1992, CELL MOTIL CYTOSKEL, V22, P281, DOI 10.1002/cm.970220408; NAKAMURA S, 1984, J BIOCH, V96, P578; NAKANISHI S, 1992, J BIOL CHEM, V267, P2157; NISHIKAWA M, 1980, NATURE, V287, P863, DOI 10.1038/287863a0; OHARAIMAIZUMI M, 1992, BIOCHEM BIOPH RES CO, V185, P1016, DOI 10.1016/0006-291X(92)91728-9; OLAGUE PH, 1978, DEV BIOL, V67, P424, DOI 10.1016/0012-1606(78)90210-5; PORTER RR, 1959, BIOCHEM J, V73, P119, DOI 10.1042/bj0730119; PUSZKIN S, 1972, J NEUROCHEM, V19, P1319, DOI 10.1111/j.1471-4159.1972.tb01457.x; PUSZKIN S, 1968, SCIENCE, V161, P170, DOI 10.1126/science.161.3837.170; REES R, 1974, J COMP NEUROL, V157, P1, DOI 10.1002/cne.901570102; SAKURAI T, 1990, NEUROSCIENCE, V38, P743, DOI 10.1016/0306-4522(90)90067-E; SCHIEBLER W, 1986, J BIOL CHEM, V261, P8383; SMITH SJ, 1988, SCIENCE, V242, P708, DOI 10.1126/science.3055292; TAKAHASHI M, 1992, J BIOL CHEM, V267, P17864; TOKIMASA T, 1993, NEUROSCI RES       S, V18, P23; TRIFARO JM, 1978, NEUROSCIENCE, V3, P1, DOI 10.1016/0306-4522(78)90150-1; WAKSHULL E, 1979, J NEUROPHYSIOL, V42, P1426, DOI 10.1152/jn.1979.42.5.1426; Walsh M. P., 1985, CALCIUM CELL PHYSL, P170; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9; YANO H, 1993, J BIOL CHEM, V268, P25846	60	140	140	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1994	13	5					1131	1142		10.1016/0896-6273(94)90051-5	http://dx.doi.org/10.1016/0896-6273(94)90051-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PU763	7946350				2022-12-24	WOS:A1994PU76300009
J	POULSEN, KT; ARMANINI, MP; KLEIN, RD; HYNES, MA; PHILLIPS, HS; ROSENTHAL, A				POULSEN, KT; ARMANINI, MP; KLEIN, RD; HYNES, MA; PHILLIPS, HS; ROSENTHAL, A			TGF-BETA-2 AND TCF-BETA-3 ARE POTENT SURVIVAL FACTORS FOR MIDBRAIN DOPAMINERGIC-NEURONS	NEURON			English	Article							GROWTH-FACTOR-BETA; CELL SUPPRESSOR FACTOR; NEUROTROPHIC FACTOR; TYROSINE-HYDROXYLASE; COMPLEMENTARY-DNA; SENSORY NEURONS; NERVOUS-SYSTEM; GENE FAMILY; RAT-BRAIN; EXPRESSION	The vertebrate ventral midbrain contains 3-4 x 10(4) dopaminergic neurons that influence motor activity, emotional behavior, and cognition. Recently, glial cell line-derived neurotrophic factor (GDNF) was shown to be a potent survival factor for these dopaminergic neurons in culture. However, many midbrain dopaminergic neurons project to targets that do not express GDNF. We report here that transforming growth factors (TGFs) TGF beta 2 and TGF beta 3, which are distantly related to GDNF, also prevent the death of cultured rat embryonic midbrain dopaminergic neurons at picomolar concentrations. Furthermore, we find that TGF beta 2, TGF beta 3, and GDNF are expressed sequentially as local and target-derived trophic factors and that subpopulations of dopaminergic neurons projecting to distinct targets have access to only one of these factors. These findings are consistent with the idea that GDNF, TGF beta 2, and TGF beta 3 are physiological survival factors for developing midbrain dopaminergic neurons and may have applications as therapeutics for Parkinson's disease, a neurodegenerative disorder of dopaminergic neurons.			POULSEN, KT (corresponding author), GENENTECH INC,DEPT NEUROSCI,460 POINT SAN BRUNO BLVD,S SAN FRANCISCO,CA 94080, USA.			Hynes, Mary/0000-0001-6623-6727				BERGMAN J, 1989, J PHARMACOL EXP THER, V251, P150; BERKEMEIER LR, 1991, NEURON, V7, P857, DOI 10.1016/0896-6273(91)90287-A; Bjorklund A., 1984, HDB CHEM NEUROANAT 1, V2, P55; BUCHMAN VL, 1993, DEVELOPMENT, V118, P989; CASPER D, 1991, J NEUROSCI RES, V30, P372, DOI 10.1002/jnr.490300213; COYLE JT, 1976, J NEUROCHEM, V27, P673, DOI 10.1111/j.1471-4159.1976.tb10393.x; DEMARTIN R, 1987, EMBO J, V6, P3673, DOI 10.1002/j.1460-2075.1987.tb02700.x; DERYNCK R, 1988, EMBO J, V7, P3737, DOI 10.1002/j.1460-2075.1988.tb03257.x; DERYNCK R, 1985, NATURE, V316, P701, DOI 10.1038/316701a0; ENGELE J, 1991, J NEUROSCI, V11, P3070; FLANDERS KC, 1991, DEVELOPMENT, V113, P183; GREENBERG D, 1974, SCIENCE, V184, P1243; HYMAN C, 1991, NATURE, V350, P230, DOI 10.1038/350230a0; HYNES MA, 1994, J NEUROSCI RES, V37, P144, DOI 10.1002/jnr.490370118; JAKOWLEW SB, 1988, MOL ENDOCRINOL, V2, P747, DOI 10.1210/mend-2-8-747; KLEIN R, 1993, CELL, V75, P113, DOI 10.1016/0092-8674(93)90683-H; KNUSEL B, 1990, J NEUROSCI, V10, P558; KNUSEL B, 1991, P NATL ACAD SCI USA, V88, P961, DOI 10.1073/pnas.88.3.961; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; LINDVALL O, 1983, CHEM NEUROANATOMY, P229; MOORE RY, 1978, ANNU REV NEUROSCI, V1, P129, DOI 10.1146/annurev.ne.01.030178.001021; PELTON RW, 1991, J CELL BIOL, V115, P1091, DOI 10.1083/jcb.115.4.1091; PELTON RW, 1990, DEVELOPMENT, V110, P609; PHILLIPS HS, 1990, SCIENCE, V250, P290, DOI 10.1126/science.1688328; RITZ MC, 1987, SCIENCE, V237, P1219, DOI 10.1126/science.2820058; ROBERTS AB, 1993, GROWTH FACTORS, V8, P1; ROGERS JH, 1992, BRAIN RES, V587, P203, DOI 10.1016/0006-8993(92)90998-O; SCHAAR DG, 1993, EXP NEUROL, V124, P368, DOI 10.1006/exnr.1993.1207; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Scott J D, 1992, Curr Opin Neurobiol, V2, P289, DOI 10.1016/0959-4388(92)90117-4; SEEMAN P, 1975, SCIENCE, V188, P1217, DOI 10.1126/science.1145194; SEEMAN P, 1976, NATURE, V261, P717, DOI 10.1038/261717a0; SEEMAN P, 1993, NATURE, V365, P441, DOI 10.1038/365441a0; SEYEDIN SM, 1986, J BIOL CHEM, V261, P5693; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; SPECHT LA, 1981, J COMP NEUROL, V199, P255, DOI 10.1002/cne.901990208; STROMBERG I, 1993, EXP NEUROL, V124, P401, DOI 10.1006/exnr.1993.1214; TENDIJKE P, 1988, P NATL ACAD SCI USA, V85, P4715; WRANN M, 1987, EMBO J, V6, P1633, DOI 10.1002/j.1460-2075.1987.tb02411.x; WRIGHT EM, 1992, NEURON, V9, P139, DOI 10.1016/0896-6273(92)90229-7	40	234	247	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1994	13	5					1245	1252		10.1016/0896-6273(94)90062-0	http://dx.doi.org/10.1016/0896-6273(94)90062-0			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PU763	7946360				2022-12-24	WOS:A1994PU76300020
J	VESCOVI, AL; REYNOLDS, BA; FRASER, DD; WEISS, S				VESCOVI, AL; REYNOLDS, BA; FRASER, DD; WEISS, S			BFGF REGULATES THE PROLIFERATIVE FATE OF UNIPOTENT (NEURONAL) AND BIPOTENT (NEURONAL ASTROGLIAL) EGF-GENERATED CNS PROGENITOR CELLS	NEURON			English	Article							FIBROBLAST GROWTH-FACTOR; CENTRAL-NERVOUS-SYSTEM; RAT OPTIC-NERVE; CORD ASTROCYTES INVITRO; PRECURSOR CELLS; FACTOR PROMOTES; FACTOR RECEPTOR; ION CHANNELS; SPINAL-CORD; OLIGODENDROCYTE DEVELOPMENT	In cultures of embryonic and adult mouse striatum, we previously demonstrated that EGF induces the proliferation of putative stem cells, which give rise to spheres of undifferentiated cells that can generate neurons and astrocytes. We report here that the spheres of undifferentiated cells contain mRNA and protein for the FGF receptor (FGFR1). Indirect immunocytochemistry demonstrated that many of the cells within the EGF-generated spheres were immunoreactive for FGFR1. Exogenous application of bFGF to the EGF-generated cells induced the proliferation of two progenitor cell types. The first, a bipotent progenitor cell, gave rise to cells with the antigenic and morphological properties of neurons and astrocytes; the other gave rise to cells with neuronal characteristics only. bFGF-generated cells with neuronal morphology exhibited electrophysiological properties indicative of immature central neurons. These results support the hypothesis that sequential actions of growth factors play a role in regulating the generation of neurons and astrocytes in the developing CNS.	UNIV CALGARY, FAC MED, DEPT ANAT, NEUROSCI RES GRP, CALGARY T2N 4N1, AB, CANADA; UNIV CALGARY, FAC MED, DEPT PHARMACOL & THERAPEUT, CALGARY T2N 4N1, AB, CANADA; UNIV CALGARY, FAC MED, GRAD DEPT NEUROSCI, CALGARY T2N 4N1, AB, CANADA	University of Calgary; University of Calgary; University of Calgary			Vescovi, Angelo Luigi/A-4919-2015	Vescovi, Angelo Luigi/0000-0002-1742-4112				ANCHAN RM, 1991, NEURON, V6, P923, DOI 10.1016/0896-6273(91)90233-P; ANDERSON DJ, 1989, NEURON, V3, P1, DOI 10.1016/0896-6273(89)90110-4; BARRES BA, 1988, GLIA, V1, P10, DOI 10.1002/glia.440010104; BESNARD F, 1989, INT J DEV NEUROSCI, V7, P401, DOI 10.1016/0736-5748(89)90061-0; BEWSEY KE, 1991, BIOTECHNIQUES, V10, P724; BIRREN SJ, 1990, NEURON, V4, P189, DOI 10.1016/0896-6273(90)90094-V; BOGLER O, 1990, P NATL ACAD SCI USA, V87, P6368, DOI 10.1073/pnas.87.16.6368; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; CHENG B, 1991, NEURON, V7, P1031, DOI 10.1016/0896-6273(91)90347-3; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COULIER F, 1991, ONCOGENE, V6, P1437; DELAUNOY JP, 1988, INT J DEV NEUROSCI, V6, P129, DOI 10.1016/0736-5748(88)90037-8; DELOULME JC, 1991, J NEUROSCI RES, V29, P499, DOI 10.1002/jnr.490290410; DELOULME JC, 1991, NEUROSCIENCE, V42, P561, DOI 10.1016/0306-4522(91)90398-8; DIONNE CA, 1990, EMBO J, V9, P2685, DOI 10.1002/j.1460-2075.1990.tb07454.x; ECCLESTON PA, 1985, DEV BRAIN RES, V21, P315, DOI 10.1016/0165-3806(85)90221-4; EISEMANN A, 1991, ONCOGENE, V6, P1195; FERRARI G, 1989, DEV BIOL, V133, P140, DOI 10.1016/0012-1606(89)90305-9; FREDERIKSEN K, 1988, J NEUROSCI, V8, P1144; FREDERIKSEN K, 1988, NEURON, V1, P439, DOI 10.1016/0896-6273(88)90175-4; FREESE A, 1992, BRAIN RES, V575, P351, DOI 10.1016/0006-8993(92)90104-H; GALILEO DS, 1990, P NATL ACAD SCI USA, V87, P458, DOI 10.1073/pnas.87.1.458; GARCIARILL E, 1991, DEV BRAIN RES, V60, P267, DOI 10.1016/0165-3806(91)90056-O; GENSBURGER C, 1987, FEBS LETT, V217, P1, DOI 10.1016/0014-5793(87)81230-9; GOSPODAROWICZ D, 1975, J BIOL CHEM, V250, P2515; GROTHE C, 1989, NEUROSCIENCE, V31, P649, DOI 10.1016/0306-4522(89)90430-2; HALLIDAY AL, 1992, NEURON, V9, P15, DOI 10.1016/0896-6273(92)90216-Z; HOCKBERGER PE, 1987, J NEUROSCI, V7, P1370; JOHANSSON S, 1992, J PHYSL, V445, P120; KEEGAN K, 1991, P NATL ACAD SCI USA, V88, P1095, DOI 10.1073/pnas.88.4.1095; KILPATRICK TJ, 1993, NEURON, V10, P255, DOI 10.1016/0896-6273(93)90316-J; KLAGSBRUN M, 1991, CELL, V67, P229, DOI 10.1016/0092-8674(91)90173-V; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LILLIEN L, 1992, DEVELOPMENT, V115, P253; LUSKIN MB, 1993, J NEUROSCI, V13, P1730; MARICS I, 1989, ONCOGENE, V4, P335; MATTSON MP, 1989, J NEUROSCI, V9, P3728; MCKAY RDG, 1989, CELL, V58, P815, DOI 10.1016/0092-8674(89)90934-3; MCKINNON RD, 1990, NEURON, V5, P603, DOI 10.1016/0896-6273(90)90215-2; MCMANAMAN J, 1989, J NEUROCHEM, V53, P1763, DOI 10.1111/j.1471-4159.1989.tb09241.x; MIKI T, 1992, P NATL ACAD SCI USA, V89, P246, DOI 10.1073/pnas.89.1.246; MILLER RH, 1985, DEV BIOL, V111, P35, DOI 10.1016/0012-1606(85)90432-4; MORRISON RS, 1981, P NATL ACAD SCI-BIOL, V78, P7205, DOI 10.1073/pnas.78.11.7205; MORRISON RS, 1986, P NATL ACAD SCI USA, V83, P7537, DOI 10.1073/pnas.83.19.7537; MURPHY M, 1990, J NEUROSCI RES, V25, P463, DOI 10.1002/jnr.490250404; ORRURTREGER A, 1991, DEVELOPMENT, V113, P1419; PARTANEN J, 1991, EMBO J, V10, P1347, DOI 10.1002/j.1460-2075.1991.tb07654.x; PERRAUD F, 1988, GLIA, V1, P124, DOI 10.1002/glia.440010204; PETTMANN B, 1985, FUNKT BIOL MED, V4, P243; RAFF MC, 1988, NATURE, V333, P562, DOI 10.1038/333562a0; RAFF MC, 1984, DEV BIOL, V106, P53, DOI 10.1016/0012-1606(84)90060-5; RAFF MC, 1983, J NEUROSCI, V3, P1289; RAFF MC, 1989, SCIENCE, V243, P1450, DOI 10.1126/science.2648568; REID HH, 1990, P NATL ACAD SCI USA, V87, P1596, DOI 10.1073/pnas.87.4.1596; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; RITCHIE JM, 1992, TRENDS NEUROSCI, V15, P345; RUBIN JS, 1989, P NATL ACAD SCI USA, V86, P802, DOI 10.1073/pnas.86.3.802; Sambrook J, 1989, MOL CLONING LABORATO; SENSENBRENNER M, 1985, HORMONES CELL REGULA, V9, P345; SKOFF RP, 1990, DEV BIOL, V139, P149, DOI 10.1016/0012-1606(90)90285-Q; SONTHEIMER H, 1992, J NEUROPHYSIOL, V68, P1001, DOI 10.1152/jn.1992.68.4.1001; SONTHEIMER H, 1992, J NEUROPHYSIOL, V68, P985, DOI 10.1152/jn.1992.68.4.985; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; TEMPLE S, 1989, NATURE, V340, P471, DOI 10.1038/340471a0; TURNER DL, 1990, NEURON, V4, P833, DOI 10.1016/0896-6273(90)90136-4; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; UNSICKER K, 1987, P NATL ACAD SCI USA, V84, P5459, DOI 10.1073/pnas.84.15.5459; WALICKE P, 1986, P NATL ACAD SCI USA, V83, P3012, DOI 10.1073/pnas.83.9.3012; WALICKE PA, 1988, J NEUROSCI, V8, P2618; WANAKA A, 1990, NEURON, V5, P267, DOI 10.1016/0896-6273(90)90164-B; WERNER S, 1993, EMBO J, V12, P2635, DOI 10.1002/j.1460-2075.1993.tb05924.x; WESTERMANN R, 1990, J CELL SCI, P97; WETTS R, 1988, SCIENCE, V239, P1142, DOI 10.1126/science.2449732; WILLIAMS BP, 1991, NEURON, V7, P685, DOI 10.1016/0896-6273(91)90381-9; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W	78	577	616	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1993	11	5					951	966		10.1016/0896-6273(93)90124-A	http://dx.doi.org/10.1016/0896-6273(93)90124-A			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MJ041	8240816				2022-12-24	WOS:A1993MJ04100016
J	HOCH, W; FERNS, M; CAMPANELLI, JT; HALL, ZW; SCHELLER, RH				HOCH, W; FERNS, M; CAMPANELLI, JT; HALL, ZW; SCHELLER, RH			DEVELOPMENTAL REGULATION OF HIGHLY-ACTIVE ALTERNATIVELY SPLICED FORMS OF AGRIN	NEURON			English	Article							ACETYLCHOLINE-RECEPTOR CLUSTERS; MOTOR NEURONS; BASAL LAMINA; CULTURED MYOTUBES; MOLECULES; MUSCLE; PHOSPHORYLATION; REDISTRIBUTION; COMPONENTS; EXPRESSION	Agrin is an extracellular matrix protein involved in clustering acetylcholine receptors during development of the neuromuscular junction. We have previously shown that alternative splicing at three sites generates multiple forms of rat agrin and that a novel 8 amino acid insert is the most important in determining biological activity. In the present study we have examined the expression of agrin during development with particular emphasis on determining the tissue distribution of the splicing variants at each site. Our principal observation is that the variants containing the sequence most responsible for biological activity are expressed exclusively in neural tissue and that their expression is highly regulated during development. We also show that muscle expresses less active forms and that agrin immunoreactivity during synaptogenesis is initially not limited to synaptic sites, but becomes progressively restricted to the synapse as development proceeds.	UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco	HOCH, W (corresponding author), STANFORD UNIV,BECKMAN CTR MOLEC & GENET MED,HOWARD HUGHES MED INST,STANFORD,CA 94305, USA.			Ferns, Michael/0000-0002-1545-3024	NIGMS NIH HHS [GM07276] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMANO T, 1972, P NATL ACAD SCI USA, V69, P258, DOI 10.1073/pnas.69.1.258; ANDERSON MJ, 1977, J PHYSIOL-LONDON, V268, P757, DOI 10.1113/jphysiol.1977.sp011880; BENDA P, 1968, SCIENCE, V161, P370, DOI 10.1126/science.161.3839.370; CAMPANELLI JT, 1991, CELL, V67, P909, DOI 10.1016/0092-8674(91)90364-5; CAMPANELLI JT, 1993, IN PRESS COLD SPRING; CLARK JM, 1988, NUCLEIC ACIDS RES, V16, P9677, DOI 10.1093/nar/16.20.9677; COHEN MW, 1992, J NEUROSCI, V12, P2982, DOI 10.1523/JNEUROSCI.12-08-02982.1992; FALLON JR, 1989, J CELL BIOL, V108, P1527, DOI 10.1083/jcb.108.4.1527; FERNS M, 1992, NEURON, V8, P1079, DOI 10.1016/0896-6273(92)90129-2; FERNS MJ, 1993, NEURON, V11, P491; GODFREY EW, 1988, DEV BIOL, V130, P471, DOI 10.1016/0012-1606(88)90343-0; GORDON H, 1989, DEV BIOL, V135, P1, DOI 10.1016/0012-1606(89)90152-8; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; LIETH E, 1992, DEV BIOL, V149, P41, DOI 10.1016/0012-1606(92)90262-F; MAGILLSOLC C, 1990, J EXP BIOL, V153, P1; MAGILLSOLC C, 1988, J CELL BIOL, V107, P1825, DOI 10.1083/jcb.107.5.1825; MANTHORPE M, 1981, J NEUROCHEM, V37, P759; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.bi.55.070186.005351; PURVES D, 1985, PRINCIPLES NEURAL DE; QU ZC, 1990, NEURON, V4, P367, DOI 10.1016/0896-6273(90)90049-L; REIST NE, 1992, NEURON, V8, P865, DOI 10.1016/0896-6273(92)90200-W; REIST NE, 1987, J CELL BIOL, V105, P2457, DOI 10.1083/jcb.105.6.2457; ROLE LW, 1985, J NEUROSCI, V5, P2197; RUEGG MA, 1992, NEURON, V8, P691, DOI 10.1016/0896-6273(92)90090-Z; RUPP F, 1992, J NEUROSCI, V12, P3535; RUPP F, 1991, NEURON, V6, P811, DOI 10.1016/0896-6273(91)90177-2; Sambrook J, 1989, MOL CLONING LABORATO; TSIM KWK, 1992, NEURON, V8, P677, DOI 10.1016/0896-6273(92)90089-V; WALLACE BG, 1991, NEURON, V6, P869, DOI 10.1016/0896-6273(91)90227-Q; WALLACE BG, 1989, J NEUROSCI, V9, P1294; ZISKINDCONHAIM L, 1984, J NEUROSCI, V4, P2346	32	181	190	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1993	11	3					479	490		10.1016/0896-6273(93)90152-H	http://dx.doi.org/10.1016/0896-6273(93)90152-H			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LY498	8398141				2022-12-24	WOS:A1993LY49800008
J	PEROZO, E; MACKINNON, R; BEZANILLA, F; STEFANI, E				PEROZO, E; MACKINNON, R; BEZANILLA, F; STEFANI, E			GATING CURRENTS FROM A NONCONDUCTING MUTANT REVEAL OPEN-CLOSED CONFORMATIONS IN SHAKER K+ CHANNELS	NEURON			English	Article							DEPENDENT POTASSIUM CHANNEL; CHARYBDOTOXIN BLOCK; ION CHANNELS; BINDING-SITE; TEA BLOCKADE; VOLTAGE; DROSOPHILA; INACTIVATION; INHIBITOR; TETRAETHYLAMMONIUM	In voltage-dependent ion channels, a voltage sensor region is responsible for channel activation and an aqueous pore is responsible for ion conduction. These two processes have been traditionally considered to be independent. We describe here a mutation in the putative pore region (W434F) that completely abolishes ion conduction without affecting the gating charge of the channel. Gating currents in the nonconductive mutant were found to be identical in their kinetic and steady-state properties to those in conductive channels. Gating current measurements could be performed without subtracting pulses and in the presence of normal physiological solutions. Application of internal tetraethylammonium (an open channel blocker) induced Off charge immobilization for large depolarizations, suggesting that the internal tetraethylammonium-binding site becomes available upon depolarization. We concluded that for this mutant, although the conduction pathway is not functional, the channel can still undergo the closed-open conformation in response to voltage changes.	HARVARD UNIV, SCH MED, DEPT NEUROBIOL, BOSTON, MA 02115 USA; UNIV CALIF LOS ANGELES, DEPT CHEM & BIOCHEM, LOS ANGELES, CA 90024 USA; UNIV CALIF LOS ANGELES, DEPT PHYSIOL, LOS ANGELES, CA 90024 USA; BAYLOR COLL MED, DEPT MOLEC PHYSIOL & BIOPHYS, HOUSTON, TX 77030 USA; UNIV CALIF LOS ANGELES, JERRY LEWIS NEUROMUSCULAR RES INST, LOS ANGELES, CA 90024 USA	Harvard University; Harvard Medical School; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Baylor College of Medicine; University of California System; University of California Los Angeles	PEROZO, E (corresponding author), UNIV CALIF LOS ANGELES, JULES STEIN EYE INST, LOS ANGELES, CA 90024 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL037044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047400, R01GM030376, R37GM030376] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL37044] Funding Source: Medline; NIGMS NIH HHS [GM30376, GM47400] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON CS, 1988, J GEN PHYSIOL, V91, P317, DOI 10.1085/jgp.91.3.317; ARMSTRON.CM, 1969, J GEN PHYSIOL, V54, P553, DOI 10.1085/jgp.54.5.553; ARMSTRONG CM, 1965, J GEN PHYSIOL, V48, P859, DOI 10.1085/jgp.48.5.859; BAUMANN A, 1988, EMBO J, V7, P2457, DOI 10.1002/j.1460-2075.1988.tb03092.x; BEZANILLA F, 1991, SCIENCE, V254, P679, DOI 10.1126/science.1948047; BEZANILLA F, 1977, J GEN PHYSIOL, V70, P549, DOI 10.1085/jgp.70.5.549; COLE KS, 1960, BIOPHYS J, V1, P1, DOI 10.1016/S0006-3495(60)86871-3; FRENCH RJ, 1981, BIOPHYS J, V34, P271, DOI 10.1016/S0006-3495(81)84849-7; HARTMANN HA, 1991, SCIENCE, V251, P942, DOI 10.1126/science.2000495; HEGINBOTHAM L, 1992, NEURON, V8, P483, DOI 10.1016/0896-6273(92)90276-J; HEGINBOTHAM L, 1992, SCIENCE, V258, P1152, DOI 10.1126/science.1279807; HILLE B, 1967, J GEN PHYSIOL, V50, P1287, DOI 10.1085/jgp.50.5.1287; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; KAMB A, 1987, CELL, V50, P405, DOI 10.1016/0092-8674(87)90494-6; KAVANAUGH MP, 1992, NEURON, V8, P493, DOI 10.1016/0896-6273(92)90277-K; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; MACKINNON R, 1988, J GEN PHYSIOL, V91, P335, DOI 10.1085/jgp.91.3.335; MACKINNON R, 1989, SCIENCE, V245, P1382, DOI 10.1126/science.2476850; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MACKINNON R, 1990, NEURON, V5, P767, DOI 10.1016/0896-6273(90)90335-D; MILLER C, 1985, NATURE, V313, P316, DOI 10.1038/313316a0; PAPAZIAN DM, 1987, SCIENCE, V237, P749, DOI 10.1126/science.2441470; PEROZO E, 1992, BIOPHYS J, V62, P160, DOI 10.1016/S0006-3495(92)81802-7; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; TAGLIALATELA M, 1992, BIOPHYS J, V61, P78, DOI 10.1016/S0006-3495(92)81817-9; TAYLOR RE, 1983, J GEN PHYSIOL, V81, P773, DOI 10.1085/jgp.81.6.773; WARMKE J, 1991, SCIENCE, V252, P1560, DOI 10.1126/science.1840699; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; YOOL AJ, 1991, NATURE, V349, P700, DOI 10.1038/349700a0	30	273	275	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	AUG	1993	11	2					353	358		10.1016/0896-6273(93)90190-3	http://dx.doi.org/10.1016/0896-6273(93)90190-3			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LU065	8352943				2022-12-24	WOS:A1993LU06500014
J	LEREA, LS; MCNAMARA, JO				LEREA, LS; MCNAMARA, JO			IONOTROPIC GLUTAMATE RECEPTOR SUBTYPES ACTIVATE C-FOS TRANSCRIPTION BY DISTINCT CALCIUM-REQUIRING INTRACELLULAR SIGNALING PATHWAYS	NEURON			English	Article							DEPENDENT PROTEIN-KINASE; IMMEDIATE EARLY GENES; HIPPOCAMPAL PYRAMIDAL NEURONS; SENSITIVE ADENYLATE-CYCLASE; CEREBELLAR GRANULE CELLS; LONG-TERM POTENTIATION; EXCITATORY AMINO-ACIDS; ARACHIDONIC-ACID; MESSENGER-RNA; CYCLIC-AMP	N-Methyl-D-aspartate (NMDA) or non-NMDA receptor activation is sufficient to induce transcription of the immediate early gene c-fos in a calcium-requiring manner. We sought to determine whether the calcium-dependent mechanisms inducing c-fos transcription are identical following activation of these two receptor subtypes. We used in situ hybridization and fura-2 imaging to detect c-fos mRNA and intracellular calcium in individual dentate gyrus neurons maintained in vitro. Structurally distinct inhibitors of phospholipase A, and cyclooxygenase abolished NMDA- but not kainic acid-induced increases of c-fos mRNA. Conversely, the calmodulin antagonist calmidazolium markedly inhibited kainic acid- but not NMDA-mediated increases of c-fos mRNA. We propose that the dissociation in the mechanisms transducing the calcium influx signals to the nucleus following NMDA and non-NMDA receptor activation is due to spatially distinct sites of calcium entry, resulting in activation of different enzymes located at distinct sites in the cell.	VET ADM MED CTR, EPILEPSY RES LAB, DURHAM, NC 27705 USA; DUKE UNIV, DEPT PHARMACOL, DURHAM, NC 27710 USA; DUKE UNIV, DEPT NEUROBIOL, DURHAM, NC 27710 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Duke University; Duke University	LEREA, LS (corresponding author), VET ADM MED CTR, DEPT MED, DIV NEUROL, DURHAM, NC 27705 USA.				NIGMS NIH HHS [GM12049] Funding Source: Medline; NINDS NIH HHS [NS 17771] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM012049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS017771] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANIKSZTEJN L, 1991, NATURE, V349, P67, DOI 10.1038/349067a0; ASANO M, 1989, J PHARMACOL EXP THER, V251, P764; ASCHER P, 1988, J PHYSIOL-LONDON, V399, P247; BARTEL DP, 1989, GENE DEV, V3, P304, DOI 10.1101/gad.3.3.304; BAZAN NG, 1989, ANN NY ACAD SCI, V559, P1; BAZAN NG, 1970, BIOCHIM BIOPHYS ACTA, V218, P1, DOI 10.1016/0005-2760(70)90086-X; BEAR MF, 1990, J NEUROSCI, V10, P909; BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; BILLAH MM, 1985, J BIOL CHEM, V260, P6899; BITONTI AJ, 1980, J BIOL CHEM, V255, P2026; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; COLE AJ, 1989, NATURE, V340, P474, DOI 10.1038/340474a0; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; CURRAN T, 1985, SCIENCE, V229, P1265, DOI 10.1126/science.4035354; DUMUIS A, 1988, NATURE, V336, P68, DOI 10.1038/336068a0; EGAN RW, 1984, PROSTAGLANDINS LEUKO, P593; GINTY DD, 1991, J BIOL CHEM, V266, P17454; GLAUM SR, 1990, J PHARMACOL EXP THER, V253, P1293; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; GRIFFITH LC, 1988, J BIOL CHEM, V263, P9542; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HARRIS EW, 1984, BRAIN RES, V323, P132, DOI 10.1016/0006-8993(84)90275-0; HEADLEY PM, 1990, TRENDS PHARMACOL SCI, V11, P205, DOI 10.1016/0165-6147(90)90116-P; HISANAGA K, 1992, J NEUROCHEM, V58, P1836, DOI 10.1111/j.1471-4159.1992.tb10060.x; HWANG SB, 1985, J BIOL CHEM, V260, P5639; IINO M, 1990, J PHYSIOL-LONDON, V424, P151, DOI 10.1113/jphysiol.1990.sp018060; IZQUIERDO I, 1991, TRENDS PHARMACOL SCI, V12, P128, DOI 10.1016/0165-6147(91)90527-Y; JONES KA, 1991, NEURON, V7, P593, DOI 10.1016/0896-6273(91)90372-7; KACICH RL, 1988, MOL ENDOCRINOL, V2, P73, DOI 10.1210/mend-2-1-73; LABINER DM, 1993, J NEUROSCI, V13, P744; LAZAREWICZ JW, 1990, J NEUROCHEM, V55, P1875, DOI 10.1111/j.1471-4159.1990.tb05771.x; LEREA LS, 1992, J NEUROSCI, V12, P2973, DOI 10.1523/JNEUROSCI.12-08-02973.1992; LIPTON SA, 1989, TRENDS NEUROSCI, V12, P265, DOI 10.1016/0166-2236(89)90026-X; MACDERMOTT AB, 1986, NATURE, V321, P519, DOI 10.1038/321519a0; MATTSON MP, 1989, BRAIN RES, V490, P110, DOI 10.1016/0006-8993(89)90436-8; MCCARTHY KD, 1991, NEUROSCIENCE, V41, P325, DOI 10.1016/0306-4522(91)90330-Q; MCNAMARA JO, 1988, NEUROPHARMACOLOGY, V27, P563, DOI 10.1016/0028-3908(88)90176-1; METZ R, 1991, GENE DEV, V5, P1754, DOI 10.1101/gad.5.10.1754; MONTMINY MR, 1990, TRENDS NEUROSCI, V13, P184, DOI 10.1016/0166-2236(90)90045-C; MORGAN JI, 1986, NATURE, V322, P552, DOI 10.1038/322552a0; NELSON PH, 1987, CRC HDB EICOSANOIDS, V2, P59; PARTINGTON CR, 1980, P NATL ACAD SCI-BIOL, V77, P3024, DOI 10.1073/pnas.77.5.3024; REGEHR WG, 1990, NATURE, V345, P807, DOI 10.1038/345807a0; ROSENTHAL MD, 1989, BIOCHIM BIOPHYS ACTA, V1001, P1, DOI 10.1016/0005-2760(89)90299-3; ROZENGURT E, 1983, CELL, V34, P265, DOI 10.1016/0092-8674(83)90157-5; SAMUELSSON B, 1978, ANNU REV BIOCHEM, V47, P997, DOI 10.1146/annurev.bi.47.070178.005025; SANFELIU C, 1990, BRAIN RES, V526, P241, DOI 10.1016/0006-8993(90)91228-9; SCHAAD NC, 1987, NATURE, V328, P637, DOI 10.1038/328637a0; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; SIMONATO M, 1991, MOL BRAIN RES, V11, P115, DOI 10.1016/0169-328X(91)90113-C; STASHEFF SF, 1989, SCIENCE, V245, P648, DOI 10.1126/science.2569762; SZEKELY AM, 1989, MOL PHARMACOL, V35, P401; VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0; VISHWANATH BS, 1988, INFLAMMATION, V12, P549, DOI 10.1007/BF00914317; WESTENBROEK RE, 1990, NATURE, V347, P281, DOI 10.1038/347281a0; XIA ZG, 1991, NEURON, V6, P431, DOI 10.1016/0896-6273(91)90251-T; YAMASHITA T, 1986, J BIOL CHEM, V261, P6878; YEAGER RE, 1985, BIOCHEMISTRY-US, V24, P3776, DOI 10.1021/bi00335a054	61	208	210	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1993	10	1					31	41		10.1016/0896-6273(93)90239-N	http://dx.doi.org/10.1016/0896-6273(93)90239-N			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KK012	8427701				2022-12-24	WOS:A1993KK01200004
